data_1dc2_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1dc2 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.497 ' O ' ' OG1' ' A' ' 18' ' ' THR . 25.8 t0 . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 120.862 0.363 . . . . 0.0 110.62 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.447 ' HB3' HD11 ' A' ' 31' ' ' LEU . 40.9 m0 -76.66 -56.51 4.54 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.307 -0.87 . . . . 0.0 110.612 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.475 HD11 HD21 ' A' ' 63' ' ' LEU . 0.8 OUTLIER -41.62 -40.76 2.01 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.698 -0.626 . . . . 0.0 111.042 -179.821 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.2 -56.27 5.32 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.174 -0.954 . . . . 0.0 110.07 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.497 ' OG1' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -43.73 -53.93 5.49 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.587 -0.696 . . . . 0.0 110.719 -179.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.467 ' HB2' ' CG2' ' A' ' 28' ' ' VAL . . . -52.97 -55.91 19.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.411 -0.806 . . . . 0.0 110.445 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.447 ' HB2' ' CB ' ' A' ' 52' ' ' MET . . . -47.08 -62.58 1.35 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.567 -0.708 . . . . 0.0 111.077 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -46.15 -28.5 1.25 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.612 -0.68 . . . . 0.0 110.855 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -90.79 30.35 1.2 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.299 -0.876 . . . . 0.0 110.291 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.472 ' HA3' ' HE2' ' A' ' 53' ' ' MET . . . 44.94 27.5 1.48 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.406 -1.077 . . . . 0.0 110.406 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.17 98.47 8.17 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.258 -1.142 . . . . 0.0 110.323 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.469 HG21 HG22 ' A' ' 59' ' ' VAL . 69.9 t -78.73 -37.26 20.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.633 -0.667 . . . . 0.0 110.172 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -54.65 -52.38 62.49 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.544 -0.722 . . . . 0.0 110.899 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.42 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -58.04 -35.1 70.82 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.225 -0.922 . . . . 0.0 110.821 -179.233 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.476 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 6.2 t -76.41 -47.85 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.274 -0.891 . . . . 0.0 110.171 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.404 ' N ' ' CD1' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -52.73 -46.34 67.37 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.022 -1.049 . . . . 0.0 109.688 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.66 -31.0 67.76 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.418 -0.801 . . . . 0.0 109.559 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.447 HD11 ' HB3' ' A' ' 15' ' ' TRP . 10.2 mt -79.4 -53.26 7.08 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.402 -0.811 . . . . 0.0 110.815 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.523 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -47.88 -38.76 17.03 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.164 -0.96 . . . . 0.0 110.161 -179.695 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -83.09 -25.06 32.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.332 -0.855 . . . . 0.0 109.855 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.25 -3.81 32.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.42 -0.8 . . . . 0.0 110.03 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.82 24.44 5.23 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.523 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -61.04 133.74 56.37 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.071 -1.252 . . . . 0.0 109.809 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.448 ' HB3' ' HB1' ' A' ' 40' ' ' ALA . 3.1 mm? -57.09 112.89 5.17 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.399 -0.813 . . . . 0.0 109.778 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.47 -30.42 36.03 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 123.543 1.286 . . . . 0.0 109.88 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.471 ' HA ' ' OE2' ' A' ' 69' ' ' GLU . 33.0 m120 -121.01 56.67 1.01 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.425 -0.797 . . . . 0.0 110.125 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.448 ' HB1' ' HB3' ' A' ' 37' ' ' LEU . . . -100.9 110.89 62.23 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.856 -0.527 . . . . 0.0 109.604 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.92 124.6 9.76 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.494 1.26 . . . . 0.0 109.638 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.483 ' ND2' ' HB2' ' A' ' 44' ' ' TYR . 36.9 t30 -88.2 161.97 16.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.408 -0.808 . . . . 0.0 110.035 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.405 ' N ' ' OD1' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -74.76 -0.99 20.01 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.428 -0.795 . . . . 0.0 110.967 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.483 ' HB2' ' ND2' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -84.64 1.37 46.52 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.004 -1.06 . . . . 0.0 110.093 179.529 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.82 23.24 44.2 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.521 ' O ' ' CB ' ' A' ' 50' ' ' GLN . 46.1 mtt180 -121.66 37.63 4.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.316 -1.108 . . . . 0.0 110.968 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.485 ' O ' ' O ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER 43.52 -172.65 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.089 0 O-C-N 121.517 -0.739 . . . . 0.0 111.064 178.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.451 ' CD ' ' CB ' ' A' ' 47' ' ' ARG . 53.0 Cg_endo -85.5 -23.89 2.1 Favored 'Trans proline' 0 C--N 1.317 -1.089 0 O-C-N 123.476 1.251 . . . . 0.0 110.377 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.449 ' O ' ' HG2' ' A' ' 52' ' ' MET . 2.7 mt -102.63 -43.85 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.229 -0.919 . . . . 0.0 108.95 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.572 ' HG2' ' HA ' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -49.68 -21.17 0.97 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.381 -0.824 . . . . 0.0 109.822 178.808 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.451 ' HB ' ' CB ' ' A' ' 46' ' ' ARG . 9.3 p -112.99 33.23 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.089 -1.007 . . . . 0.0 110.579 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.511 ' CG ' ' HE3' ' A' ' 54' ' ' MET . 0.1 OUTLIER -96.96 35.08 1.61 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.061 -1.024 . . . . 0.0 109.483 179.111 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.472 ' HE2' ' HA3' ' A' ' 23' ' ' GLY . 6.2 tmm? 64.55 -6.26 0.31 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.667 -0.645 . . . . 0.0 111.109 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.573 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 44.53 26.79 0.2 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.253 -0.904 . . . . 0.0 110.57 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.536 ' HA2' ' CD2' ' A' ' 90' ' ' PHE . . . -128.79 8.73 6.44 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.423 ' HB3' HG22 ' A' ' 59' ' ' VAL . 0.6 OUTLIER -145.66 70.29 1.24 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.318 -1.107 . . . . 0.0 109.972 179.663 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.445 ' HB3' ' HB3' ' A' ' 92' ' ' ASP . . . -42.79 -36.56 1.5 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.507 -0.746 . . . . 0.0 110.7 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -46.31 -35.29 5.2 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.653 -0.654 . . . . 0.0 109.463 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.469 HG22 HG21 ' A' ' 25' ' ' VAL . 46.6 t -67.16 -51.55 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -43.85 -58.13 2.91 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.649 -0.657 . . . . 0.0 110.03 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.422 ' O ' HD22 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -47.93 -49.35 30.41 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.003 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.5 ' O ' ' HB2' ' A' ' 66' ' ' HIS . 0.4 OUTLIER -46.11 -62.67 1.23 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.704 -0.622 . . . . 0.0 110.115 178.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.476 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 0.9 OUTLIER -69.98 -55.18 10.27 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.385 -0.822 . . . . 0.0 110.615 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.488 ' CD2' HG13 ' A' ' 96' ' ' VAL . 0.4 OUTLIER -48.39 -63.69 1.01 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.302 -0.874 . . . . 0.0 110.701 -179.528 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.521 HD11 ' CD2' ' A' ' 66' ' ' HIS . 0.8 OUTLIER -50.68 -28.12 8.35 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.406 -0.809 . . . . 0.0 109.36 -179.702 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.521 ' CD2' HD11 ' A' ' 65' ' ' LEU . 2.4 m-70 -84.47 -31.98 24.26 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.778 -0.576 . . . . 0.0 109.748 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 63' ' ' LEU . . . 125.81 55.37 0.16 Allowed Glycine 0 N--CA 1.482 1.707 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.476 ' CB ' ' HB3' ' A' ' 63' ' ' LEU . . . -80.02 -150.97 0.07 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.971 -1.311 . . . . 0.0 109.049 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.471 ' OE2' ' HA ' ' A' ' 39' ' ' ASN . 2.0 mt-10 -124.38 68.0 48.45 Favored Pre-proline 0 C--N 1.3 -1.582 0 O-C-N 121.412 -0.805 . . . . 0.0 109.49 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.422 ' O ' ' HG2' ' A' ' 81' ' ' PRO . 49.0 Cg_endo -71.24 -3.89 13.84 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 O-C-N 123.716 1.377 . . . . 0.0 110.293 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.454 ' O ' ' NE ' ' A' ' 80' ' ' ARG . 37.0 m-20 -112.55 -67.67 0.98 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.303 -0.873 . . . . 0.0 109.587 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.8 t -43.69 155.52 0.07 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.57 -0.706 . . . . 0.0 110.128 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.445 ' HB2' ' C ' ' A' ' 79' ' ' THR . . . -152.07 -142.26 0.12 Allowed 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.569 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.01 139.59 20.88 Favored Pre-proline 0 N--CA 1.484 1.254 0 O-C-N 121.219 -0.926 . . . . 0.0 110.563 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -84.31 2.77 7.96 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.988 1.52 . . . . 0.0 110.428 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -101.79 -33.87 9.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.16 -0.963 . . . . 0.0 110.027 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -140.24 10.18 2.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.473 -0.767 . . . . 0.0 110.518 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 21.7 mt 53.86 38.49 28.77 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.303 -0.873 . . . . 0.0 110.731 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.463 ' HA ' ' OD1' ' A' ' 108' ' ' ASP . 36.5 m -72.91 88.38 1.35 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.423 -0.911 . . . . 0.0 110.313 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.494 ' HD3' ' CG1' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -72.78 168.43 24.36 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.471 -0.768 . . . . 0.0 109.675 179.752 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.572 ' HA ' ' HG2' ' A' ' 50' ' ' GLN . 47.9 Cg_endo -73.26 -2.26 11.82 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.697 1.367 . . . . 0.0 109.998 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 23.9 t -76.59 -36.11 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.585 -0.697 . . . . 0.0 109.612 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.522 ' O ' ' CB ' ' A' ' 87' ' ' ARG . 23.1 m80 -69.39 -40.46 77.35 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.573 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 0.3 OUTLIER -52.1 -52.27 52.48 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.304 -0.873 . . . . 0.0 110.676 179.374 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.483 ' CB ' ' HG ' ' A' ' 94' ' ' LEU . . . -55.46 -64.74 0.75 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.224 -0.922 . . . . 0.0 110.154 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.555 ' O ' ' CG ' ' A' ' 123' ' ' HIS . . . -58.94 -56.09 26.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.195 -0.941 . . . . 0.0 110.423 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.522 ' CB ' ' O ' ' A' ' 83' ' ' HIS . 0.1 OUTLIER -43.39 -25.85 0.16 Allowed 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.342 -0.849 . . . . 0.0 111.291 -179.821 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.507 ' CB ' ' HB3' ' A' ' 54' ' ' MET . 0.0 OUTLIER -104.34 -13.56 16.08 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.076 -1.015 . . . . 0.0 110.657 179.446 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.04 25.65 39.96 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.536 ' CD2' ' HA2' ' A' ' 55' ' ' GLY . 0.5 OUTLIER -106.12 93.69 4.76 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.283 -1.128 . . . . 0.0 110.722 -179.693 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.75 -44.22 82.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.509 -0.745 . . . . 0.0 109.908 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.445 ' HB3' ' HB3' ' A' ' 57' ' ' ALA . 36.2 t0 -40.75 -38.69 0.95 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.576 -0.703 . . . . 0.0 110.121 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.4 m -63.04 -58.87 5.83 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.496 -0.753 . . . . 0.0 109.593 179.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.483 ' HG ' ' CB ' ' A' ' 85' ' ' ALA . 1.2 mp -48.94 -46.29 43.07 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.398 -0.814 . . . . 0.0 110.023 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 71.6 t -49.84 -54.86 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.488 HG13 ' CD2' ' A' ' 64' ' ' LEU . 85.0 t -53.09 -57.15 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 121.26 0.552 . . . . 0.0 109.716 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -45.62 -56.3 5.34 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.33 0.586 . . . . 0.0 110.034 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.506 ' HA ' ' HB3' ' A' ' 102' ' ' ALA . 2.6 t-160 -63.7 -21.0 66.17 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.19 -0.944 . . . . 0.0 109.836 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.36 -15.59 61.37 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.247 -0.908 . . . . 0.0 110.727 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -134.47 62.2 1.65 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.237 -0.914 . . . . 0.0 110.249 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 47.54 80.31 0.06 OUTLIER Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.506 ' HB3' ' HA ' ' A' ' 98' ' ' HIS . . . -101.51 144.94 29.67 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.378 -1.072 . . . . 0.0 109.991 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -87.04 59.29 5.54 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.19 -0.944 . . . . 0.0 110.317 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.596 ' O ' ' HA ' ' A' ' 134' ' ' ALA . 0.6 OUTLIER -68.95 61.81 0.11 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.542 -0.723 . . . . 0.0 110.592 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -167.44 29.15 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.782 -1.199 . . . . 0.0 110.574 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.494 ' CG1' ' HD3' ' A' ' 80' ' ' ARG . 1.0 OUTLIER -100.65 -169.86 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 121.27 -0.894 . . . . 0.0 109.283 179.234 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -141.85 131.31 23.78 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 120.118 -0.633 . . . . 0.0 109.877 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.463 ' OD1' ' HA ' ' A' ' 79' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 O-C-N 121.474 -0.766 . . . . 0.0 109.715 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.453 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.938 -0.394 . . . . 0.0 109.938 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.453 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 44.0 Cg_endo -73.65 -32.2 7.87 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 O-C-N 123.686 1.361 . . . . 0.0 109.999 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 127' ' ' ALA . 6.8 p -65.9 -36.39 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.415 -0.803 . . . . 0.0 109.409 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -74.97 -42.69 57.12 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.475 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.2 tt -61.56 -31.84 71.89 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.33 -0.856 . . . . 0.0 109.162 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.28 -43.37 77.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.466 -0.772 . . . . 0.0 109.944 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -68.22 -46.53 70.31 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.456 -0.778 . . . . 0.0 111.16 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -61.06 -54.37 45.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.298 -0.876 . . . . 0.0 110.276 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.67 -81.03 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.277 -0.889 . . . . 0.0 110.174 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 173.89 38.76 0.04 OUTLIER Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.555 ' CG ' ' O ' ' A' ' 86' ' ' ALA . 51.3 m-70 -118.16 47.73 1.54 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.495 -1.003 . . . . 0.0 109.663 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -45.83 -53.46 9.63 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.713 -0.617 . . . . 0.0 110.315 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -48.0 -34.2 8.99 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.587 -0.696 . . . . 0.0 109.563 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.47 HG13 HD11 ' A' ' 94' ' ' LEU . 2.8 t -88.81 -44.9 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.631 -0.668 . . . . 0.0 109.331 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.479 ' O ' HG23 ' A' ' 115' ' ' VAL . . . -52.99 -49.09 66.87 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.397 -0.814 . . . . 0.0 110.176 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.74 -61.58 2.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.134 -0.979 . . . . 0.0 110.105 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.432 ' CD1' ' C ' ' A' ' 129' ' ' TYR . 12.2 t80 -53.53 -30.72 43.03 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.421 -0.799 . . . . 0.0 109.379 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.475 ' CB ' HG23 ' A' ' 115' ' ' VAL . 5.9 mt -64.04 -52.16 60.7 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.026 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -54.82 -29.81 55.75 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.303 -0.873 . . . . 0.0 110.272 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -80.94 -33.06 34.31 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.488 -0.758 . . . . 0.0 110.153 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -90.12 -21.64 22.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.358 -0.839 . . . . 0.0 110.524 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.596 ' HA ' ' O ' ' A' ' 104' ' ' LEU . . . . . . . . 0 N--CA 1.494 1.774 0 O-C-N 121.081 -1.012 . . . . 0.0 110.238 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 120.95 0.405 . . . . 0.0 110.356 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.505 ' CD1' ' N ' ' A' ' 15' ' ' TRP . 33.6 m0 -80.35 -6.94 58.8 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.345 -0.847 . . . . 0.0 110.721 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.442 HD12 ' O ' ' A' ' 37' ' ' LEU . 14.6 mt -86.61 -49.29 7.63 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.201 -0.937 . . . . 0.0 109.387 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.84 -31.16 71.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.562 -0.711 . . . . 0.0 109.37 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.496 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.2 OUTLIER -66.01 -61.17 2.19 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.656 -0.653 . . . . 0.0 109.961 179.68 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.498 ' CB ' HG22 ' A' ' 28' ' ' VAL . . . -54.26 -34.78 61.55 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.28 -0.887 . . . . 0.0 110.102 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.65 -55.89 15.07 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.248 -0.907 . . . . 0.0 109.23 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.42 -29.96 69.32 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.458 -0.776 . . . . 0.0 109.741 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -98.51 17.26 19.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.402 -0.811 . . . . 0.0 110.243 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.06 82.13 0.04 OUTLIER Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.427 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 1.1 ttt180 -143.19 63.91 1.36 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.29 -1.123 . . . . 0.0 109.819 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 94.1 t -48.73 -64.94 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.484 -0.76 . . . . 0.0 111.267 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -49.64 -38.32 31.71 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.355 -0.84 . . . . 0.0 110.959 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.42 -37.64 86.61 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.393 -0.817 . . . . 0.0 110.263 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.498 HG22 ' CB ' ' A' ' 19' ' ' ALA . 2.8 t -82.95 -45.11 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.4 -0.812 . . . . 0.0 109.924 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.429 ' N ' ' CD2' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -42.96 -43.9 4.38 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.518 -0.739 . . . . 0.0 110.335 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.94 -41.47 36.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.452 -0.78 . . . . 0.0 109.94 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.484 ' C ' ' HB2' ' A' ' 36' ' ' ALA . 27.0 mt -53.8 -65.56 0.55 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.281 -0.887 . . . . 0.0 109.729 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.516 ' CD1' ' HG ' ' A' ' 62' ' ' LEU . 2.8 mt -48.82 -43.92 38.87 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.648 -0.657 . . . . 0.0 110.637 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -70.84 -21.1 62.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.204 -0.935 . . . . 0.0 109.956 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.45 -6.47 59.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.337 -0.852 . . . . 0.0 110.615 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.16 27.28 3.21 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.484 ' HB2' ' C ' ' A' ' 31' ' ' LEU . . . -66.77 169.01 8.58 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.157 -1.202 . . . . 0.0 109.894 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.45 ' HB3' ' HB1' ' A' ' 40' ' ' ALA . 1.9 mm? -87.66 125.99 63.24 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.422 -0.799 . . . . 0.0 110.046 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.432 ' HB2' ' O ' ' A' ' 67' ' ' GLY . 42.7 Cg_endo -69.22 -36.96 11.2 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.354 1.186 . . . . 0.0 109.716 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.432 ' ND2' ' O ' ' A' ' 67' ' ' GLY . 14.1 m120 -121.41 70.91 0.94 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.502 -0.749 . . . . 0.0 109.45 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.45 ' HB1' ' HB3' ' A' ' 37' ' ' LEU . . . -93.42 104.76 13.31 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.469 -0.769 . . . . 0.0 110.129 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 39' ' ' ASN . 48.6 Cg_endo -70.73 106.8 1.91 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 123.672 1.354 . . . . 0.0 110.533 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.6 p30 -82.9 178.14 8.31 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.189 -0.945 . . . . 0.0 110.015 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.4 m -90.53 40.24 1.01 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.293 -0.88 . . . . 0.0 109.649 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -119.28 12.58 12.59 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.495 -0.753 . . . . 0.0 110.42 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 52.86 25.12 22.19 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.796 -1.722 . . . . 0.0 108.796 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -143.8 117.72 9.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.623 -0.927 . . . . 0.0 110.136 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.49 ' CB ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -60.07 -179.33 0.17 Allowed Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.409 -0.807 . . . . 0.0 109.672 179.578 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.506 ' O ' ' N ' ' A' ' 50' ' ' GLN . 39.2 Cg_endo -65.16 169.55 11.97 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.399 1.21 . . . . 0.0 110.313 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.512 ' O ' ' HG2' ' A' ' 52' ' ' MET . 3.1 mt 63.4 -61.35 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 O-C-N 121.621 -0.674 . . . . 0.0 109.984 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.506 ' N ' ' O ' ' A' ' 48' ' ' PRO . 1.7 tt0 -50.02 -23.88 2.31 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.033 -1.042 . . . . 0.0 110.011 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.3 p -108.46 8.42 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.214 -0.929 . . . . 0.0 110.572 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.512 ' HG2' ' O ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -78.29 159.12 28.63 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.959 -1.088 . . . . 0.0 109.534 179.369 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.83 -17.62 0.2 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.389 -0.819 . . . . 0.0 111.989 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.592 ' HE3' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 61.52 15.41 6.71 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.837 -1.164 . . . . 0.0 109.715 -178.842 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.419 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -112.91 17.97 22.18 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -161.2 102.41 1.25 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.37 -1.077 . . . . 0.0 110.25 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.411 ' CB ' ' HB3' ' A' ' 92' ' ' ASP . . . -63.03 -17.87 62.71 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.283 -0.886 . . . . 0.0 109.216 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.24 -42.27 73.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.478 -0.764 . . . . 0.0 109.885 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.4 t -61.5 -53.63 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.347 -0.846 . . . . 0.0 109.516 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.421 ' O ' ' CB ' ' A' ' 64' ' ' LEU . . . -53.7 -51.67 62.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.442 -0.786 . . . . 0.0 110.363 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.438 ' O ' ' HB3' ' A' ' 65' ' ' LEU . 5.6 tt0 -50.34 -44.72 54.57 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.129 -0.982 . . . . 0.0 110.539 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.516 ' HG ' ' CD1' ' A' ' 32' ' ' LEU . 1.4 tp -70.53 -57.28 4.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.571 -0.706 . . . . 0.0 109.68 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.515 ' N ' ' HG ' ' A' ' 62' ' ' LEU . 6.1 mt -57.77 -45.02 86.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.255 -0.903 . . . . 0.0 109.225 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.421 ' CB ' ' O ' ' A' ' 60' ' ' ALA . 1.0 OUTLIER -64.75 -52.9 54.55 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.58 -0.7 . . . . 0.0 110.407 179.595 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.438 ' HB3' ' O ' ' A' ' 61' ' ' GLU . 12.1 tp -50.95 -39.87 56.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.421 -0.8 . . . . 0.0 109.285 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.487 ' CB ' ' CD2' ' A' ' 32' ' ' LEU . 2.1 m-70 -78.45 -37.73 42.92 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.147 0.499 . . . . 0.0 110.003 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 38' ' ' PRO . . . 139.78 54.04 0.05 OUTLIER Glycine 0 N--CA 1.481 1.643 0 C-N-CA 120.062 -1.065 . . . . 0.0 110.823 179.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.504 ' CB ' ' CD1' ' A' ' 49' ' ' ILE . . . -68.43 -151.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.765 -1.432 . . . . 0.0 109.768 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.493 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 3.6 mm-40 -131.87 61.06 55.91 Favored Pre-proline 0 C--N 1.303 -1.42 0 O-C-N 121.494 -0.754 . . . . 0.0 109.973 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.504 ' HB2' ' CB ' ' A' ' 102' ' ' ALA . 47.3 Cg_endo -72.14 1.62 5.79 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 123.951 1.5 . . . . 0.0 110.677 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.495 ' N ' ' OD1' ' A' ' 71' ' ' ASN . 1.5 m-20 -115.96 -54.35 2.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.048 -1.032 . . . . 0.0 110.018 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -48.41 154.85 0.58 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.521 -0.737 . . . . 0.0 110.691 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -151.52 -157.52 0.82 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.444 -0.785 . . . . 0.0 109.923 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' A' ' 78' ' ' LEU . 0.5 OUTLIER -105.16 140.23 20.9 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.263 -0.898 . . . . 0.0 109.566 179.507 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.28 -11.01 24.69 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.589 1.31 . . . . 0.0 110.767 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.98 -43.65 24.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.13 -0.981 . . . . 0.0 110.16 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 108' ' ' ASP . 0.2 OUTLIER -139.6 25.62 2.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.459 -0.776 . . . . 0.0 110.171 -179.521 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.413 ' N ' ' O ' ' A' ' 74' ' ' ASP . 5.7 mt 40.6 36.57 0.39 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.525 -0.734 . . . . 0.0 110.631 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.82 92.13 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.448 -0.783 . . . . 0.0 110.55 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.478 ' CD ' ' CG1' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -73.92 163.31 69.28 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.274 -0.891 . . . . 0.0 109.241 179.146 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.473 ' HD2' ' CG ' ' A' ' 80' ' ' ARG . 46.3 Cg_endo -73.08 -3.34 13.48 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.699 1.368 . . . . 0.0 110.738 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 40.5 t -74.09 -26.37 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.234 -0.916 . . . . 0.0 109.747 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.495 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 9.2 m80 -74.07 -33.85 63.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.479 -0.763 . . . . 0.0 109.38 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.592 ' HB3' ' HE3' ' A' ' 54' ' ' MET . 0.3 OUTLIER -58.73 -50.74 72.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.677 -0.639 . . . . 0.0 110.141 179.583 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.46 ' CB ' HD11 ' A' ' 94' ' ' LEU . . . -53.57 -56.74 14.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.373 -0.83 . . . . 0.0 109.261 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.555 ' O ' ' CD2' ' A' ' 123' ' ' HIS . . . -59.99 -52.2 66.4 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.718 -0.614 . . . . 0.0 110.287 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.484 ' HD2' HD12 ' A' ' 117' ' ' LEU . 2.3 tpt180 -43.91 -37.8 3.06 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.527 -0.733 . . . . 0.0 111.229 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.9 16.28 26.43 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.22 -0.925 . . . . 0.0 110.373 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.424 ' HA2' ' HB3' ' A' ' 123' ' ' HIS . . . 51.58 55.01 22.05 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.419 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 0.4 OUTLIER -123.98 85.33 2.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.387 -1.066 . . . . 0.0 110.623 -179.626 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.25 -34.47 78.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 0.0 110.175 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.411 ' HB3' ' CB ' ' A' ' 57' ' ' ALA . 94.7 m-20 -48.53 -38.38 20.22 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.35 -0.844 . . . . 0.0 109.829 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.456 ' CG2' ' HB3' ' A' ' 85' ' ' ALA . 13.6 m -68.64 -54.26 17.47 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.478 ' CD2' HG12 ' A' ' 126' ' ' VAL . 1.1 tp -47.42 -48.74 26.24 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.528 -0.733 . . . . 0.0 109.572 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.452 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 47.5 t -48.4 -51.61 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 CA-C-O 121.372 0.605 . . . . 0.0 109.737 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.407 HG13 ' CD2' ' A' ' 64' ' ' LEU . 52.2 t -55.64 -52.88 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-O 121.32 0.581 . . . . 0.0 110.325 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.416 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 10.9 mp -52.67 -42.61 64.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.489 -0.757 . . . . 0.0 109.756 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -78.66 -24.44 45.18 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.252 -0.905 . . . . 0.0 109.49 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 5.8 mtt180 -74.4 -10.99 60.12 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.33 -0.856 . . . . 0.0 110.878 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -124.2 -106.31 0.35 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.281 -0.887 . . . . 0.0 110.616 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -142.93 50.21 0.71 Allowed Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.692 -1.242 . . . . 0.0 110.143 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.504 ' CB ' ' HB2' ' A' ' 70' ' ' PRO . . . -102.59 114.93 29.57 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.342 -1.093 . . . . 0.0 110.261 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 32.0 ttt180 -58.76 111.28 1.22 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.32 -0.863 . . . . 0.0 109.709 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.45 54.64 0.88 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.41 -0.806 . . . . 0.0 110.545 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -165.38 54.02 0.11 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.018 -1.051 . . . . 0.0 110.827 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.478 ' CG1' ' CD ' ' A' ' 80' ' ' ARG . 4.1 p -109.61 -173.93 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.2 -0.938 . . . . 0.0 109.977 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.95 137.31 37.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.535 -0.728 . . . . 0.0 109.642 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.468 ' HA ' ' O ' ' A' ' 77' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.278 -0.889 . . . . 0.0 109.766 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.53 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 89.4 mt . . . . . 0 N--CA 1.495 1.816 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.53 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 42.9 Cg_endo -69.68 -25.25 29.16 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.431 1.227 . . . . 0.0 109.46 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.513 ' HB ' ' HB3' ' A' ' 130' ' ' LEU . 9.9 p -70.69 -36.05 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.419 -0.801 . . . . 0.0 109.804 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -54.44 -34.74 62.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.44 -0.788 . . . . 0.0 110.153 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.484 HD12 ' HD2' ' A' ' 87' ' ' ARG . 0.3 OUTLIER -65.0 -57.94 7.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.51 -0.744 . . . . 0.0 110.408 -179.776 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.439 ' CB ' ' HB2' ' A' ' 123' ' ' HIS . . . -47.53 -31.44 4.34 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.644 -0.66 . . . . 0.0 110.874 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.03 -30.96 58.63 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.444 -0.785 . . . . 0.0 109.753 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.6 -53.75 8.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.431 -0.793 . . . . 0.0 110.772 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.462 ' CD1' ' CD1' ' A' ' 117' ' ' LEU . 3.1 mp -81.27 -94.22 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.31 -0.869 . . . . 0.0 110.662 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -171.66 31.61 0.13 Allowed Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.594 -1.289 . . . . 0.0 110.128 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.555 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 27.1 m-70 -88.08 49.9 1.88 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.057 -1.261 . . . . 0.0 108.837 179.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.4 ttm-85 -45.84 -38.13 6.93 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.673 -0.642 . . . . 0.0 110.554 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -66.07 -42.29 89.6 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.361 -0.837 . . . . 0.0 109.835 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.483 ' CG1' ' HA ' ' A' ' 86' ' ' ALA . 8.3 t -77.97 -29.6 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.134 -0.979 . . . . 0.0 110.321 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.409 ' HB3' ' HB1' ' A' ' 118' ' ' ALA . . . -60.15 -41.8 93.53 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.165 -0.96 . . . . 0.0 109.722 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.18 -62.63 1.69 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.519 -0.738 . . . . 0.0 110.549 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -54.33 -37.82 65.3 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.282 -0.886 . . . . 0.0 110.096 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.513 ' HB3' ' HB ' ' A' ' 115' ' ' VAL . 44.3 mt -69.6 -18.45 63.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.541 -0.724 . . . . 0.0 110.417 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -89.44 -28.86 19.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.139 -0.975 . . . . 0.0 109.927 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -84.01 -43.48 15.11 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.327 -0.858 . . . . 0.0 110.409 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -90.42 -34.52 15.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.167 -0.958 . . . . 0.0 110.598 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.667 0 O-C-N 121.289 -0.882 . . . . 0.0 110.194 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 120.95 0.405 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.43 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 7.3 m0 -54.81 -25.88 31.17 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.119 -0.988 . . . . 0.0 111.171 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.0 pp -65.93 -38.84 89.72 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.03 -1.044 . . . . 0.0 110.51 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.46 -42.61 20.06 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.13 -0.981 . . . . 0.0 110.321 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.43 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.0 OUTLIER -58.88 -56.28 24.32 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.357 -0.839 . . . . 0.0 110.286 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.75 -41.73 74.39 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.255 -0.903 . . . . 0.0 109.834 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.433 ' HB1' ' CB ' ' A' ' 52' ' ' MET . . . -55.73 -35.31 65.99 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.416 -0.803 . . . . 0.0 110.063 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.97 -23.87 59.54 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.442 -0.786 . . . . 0.0 110.512 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 -93.65 23.58 4.61 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.272 -0.892 . . . . 0.0 110.457 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 55.34 46.71 78.99 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -118.53 90.91 3.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.274 -1.133 . . . . 0.0 109.805 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.408 HG12 ' HB3' ' A' ' 58' ' ' ARG . 46.0 t -73.73 -38.96 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.357 -0.84 . . . . 0.0 110.307 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -60.88 -44.83 96.54 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.291 -0.881 . . . . 0.0 110.794 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.5 -38.65 81.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.252 -0.905 . . . . 0.0 110.199 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.4 ' HA ' HD12 ' A' ' 31' ' ' LEU . 54.5 t -73.89 -45.24 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.375 -0.828 . . . . 0.0 110.401 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.5 ' HA ' ' CD1' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -62.48 -47.89 81.99 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.077 -1.014 . . . . 0.0 109.441 179.81 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.94 -20.99 64.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.277 -0.889 . . . . 0.0 109.922 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.451 ' C ' ' HB1' ' A' ' 36' ' ' ALA . 0.2 OUTLIER -68.5 -58.83 3.72 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.323 -0.861 . . . . 0.0 110.04 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.463 ' HA ' ' CB ' ' A' ' 36' ' ' ALA . 5.0 mt -51.32 -41.68 60.7 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.351 -0.843 . . . . 0.0 110.192 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -70.5 -18.18 62.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.32 -0.862 . . . . 0.0 109.596 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.47 -8.65 47.09 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.32 -0.862 . . . . 0.0 110.706 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.12 29.05 1.71 Allowed Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.876 -1.154 . . . . 0.0 110.676 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.463 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . . . -71.28 161.13 31.58 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.022 -1.281 . . . . 0.0 110.177 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 75.5 mt -92.01 142.3 26.23 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.346 -0.846 . . . . 0.0 110.236 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.17 -42.99 1.24 Allowed 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.497 1.262 . . . . 0.0 110.121 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -121.03 58.7 0.95 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.462 -0.774 . . . . 0.0 110.092 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -79.7 116.39 60.59 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.311 -0.868 . . . . 0.0 109.776 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.52 120.53 7.0 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.68 1.358 . . . . 0.0 110.596 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -99.66 -150.07 0.37 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.447 -0.783 . . . . 0.0 109.996 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.424 ' O ' ' OG ' ' A' ' 43' ' ' SER . 0.1 OUTLIER -109.1 20.82 17.94 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.172 -0.955 . . . . 0.0 110.246 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -118.31 -1.8 11.24 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.053 -1.029 . . . . 0.0 110.849 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.54 25.77 50.85 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.929 -1.269 . . . . 0.0 109.929 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.413 ' HB3' ' HB3' ' A' ' 50' ' ' GLN . 36.5 mtt180 -123.42 16.23 9.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -1.123 . . . . 0.0 110.92 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.572 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER 45.98 -166.68 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.083 0 O-C-N 121.706 -0.621 . . . . 0.0 109.744 179.314 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.572 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 46.8 Cg_endo -78.87 172.77 14.5 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 122.758 0.873 . . . . 0.0 110.939 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.52 ' O ' ' HG2' ' A' ' 52' ' ' MET . 9.0 mt 61.74 -63.89 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 O-C-N 121.771 -0.58 . . . . 0.0 110.69 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.515 ' N ' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -49.87 -20.26 0.85 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.824 -1.172 . . . . 0.0 110.401 179.707 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.8 p -107.82 -5.38 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.192 -0.942 . . . . 0.0 110.76 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.52 ' HG2' ' O ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -63.06 165.65 6.79 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.893 -1.129 . . . . 0.0 109.955 -179.777 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 33.8 ttp -61.23 -8.43 3.67 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.341 -0.849 . . . . 0.0 111.079 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.507 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 57.09 18.2 3.93 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.133 -0.979 . . . . 0.0 110.016 -179.398 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.432 ' C ' ' CE2' ' A' ' 90' ' ' PHE . . . -112.43 3.12 26.47 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.41 95.71 2.71 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.433 -1.039 . . . . 0.0 109.727 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.77 -23.11 16.47 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.279 -0.888 . . . . 0.0 109.663 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.408 ' HB3' HG12 ' A' ' 25' ' ' VAL . 13.1 mtt180 -55.5 -40.24 71.48 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.338 -0.851 . . . . 0.0 109.572 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 95.5 t -53.6 -59.07 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.544 -0.722 . . . . 0.0 109.225 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -61.63 -26.97 68.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.518 -0.739 . . . . 0.0 109.882 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -50.71 -71.56 0.06 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.194 -0.941 . . . . 0.0 110.579 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.5 ' CD1' ' HA ' ' A' ' 29' ' ' ARG . 0.4 OUTLIER -65.55 -50.05 66.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.041 -1.037 . . . . 0.0 110.448 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.459 ' HB2' ' O ' ' A' ' 59' ' ' VAL . 0.9 OUTLIER -49.09 -57.63 6.29 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.252 -0.905 . . . . 0.0 109.933 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.428 ' HB2' ' O ' ' A' ' 60' ' ' ALA . 1.2 tt -63.33 -43.8 96.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.304 -0.872 . . . . 0.0 109.233 179.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.8 tp -56.09 -31.12 62.96 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.539 -0.726 . . . . 0.0 109.585 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.413 ' CD2' ' CD2' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -87.21 -45.61 10.48 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.548 -0.72 . . . . 0.0 109.981 -179.569 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 156.18 44.94 0.02 OUTLIER Glycine 0 N--CA 1.483 1.771 0 C-N-CA 119.811 -1.185 . . . . 0.0 110.754 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.404 ' HA ' ' HG2' ' A' ' 48' ' ' PRO . . . -70.66 -152.64 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.889 -1.36 . . . . 0.0 109.882 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -114.75 66.94 1.85 Allowed Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.336 -0.852 . . . . 0.0 110.211 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.423 ' HB3' HD11 ' A' ' 64' ' ' LEU . 50.9 Cg_endo -73.42 -32.55 7.9 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.757 1.398 . . . . 0.0 110.359 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.421 ' O ' ' NE ' ' A' ' 80' ' ' ARG . 6.8 t30 -100.75 -54.74 2.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.509 -0.744 . . . . 0.0 110.891 -179.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.1 m -48.02 151.48 0.95 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.253 -0.904 . . . . 0.0 111.147 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -135.5 -159.73 0.99 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.411 -0.806 . . . . 0.0 109.958 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.43 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -105.77 136.54 19.26 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.292 -0.88 . . . . 0.0 109.873 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.38 -23.54 20.4 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 123.41 1.216 . . . . 0.0 110.595 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.38 -60.81 2.85 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.117 -0.99 . . . . 0.0 109.745 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 62.9 p -136.76 34.14 2.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.43 -0.794 . . . . 0.0 109.801 179.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.43 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 8.0 mt 49.1 33.92 5.31 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.547 -0.721 . . . . 0.0 111.331 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 94.1 m -65.88 102.85 0.82 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.142 -0.974 . . . . 0.0 109.649 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.467 ' HD2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -82.31 167.37 30.87 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.271 -0.893 . . . . 0.0 110.193 -179.751 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -70.37 -14.76 34.48 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.771 1.406 . . . . 0.0 109.932 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 65.1 t -67.81 -29.26 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.598 -0.689 . . . . 0.0 109.94 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.45 ' CE1' ' HB3' ' A' ' 114' ' ' PRO . 23.4 m80 -75.59 -35.55 60.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.29 -0.881 . . . . 0.0 109.497 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.507 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 0.3 OUTLIER -58.21 -50.31 73.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.658 -0.651 . . . . 0.0 109.736 179.444 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.458 ' HB3' ' CD1' ' A' ' 94' ' ' LEU . . . -56.96 -64.63 0.81 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.265 -0.897 . . . . 0.0 110.066 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.462 ' HA ' ' CG1' ' A' ' 126' ' ' VAL . . . -58.84 -30.08 67.42 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.317 -0.864 . . . . 0.0 111.271 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -52.5 -54.43 32.59 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.048 -1.032 . . . . 0.0 110.237 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.26 -2.99 58.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.191 -0.943 . . . . 0.0 110.047 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.26 44.88 7.78 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.432 ' CE2' ' C ' ' A' ' 55' ' ' GLY . 0.5 OUTLIER -110.59 104.68 13.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.2 -1.176 . . . . 0.0 110.328 179.636 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.38 -38.42 30.38 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.456 -0.778 . . . . 0.0 110.109 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -47.36 -37.26 10.8 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.511 -0.743 . . . . 0.0 110.312 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.428 ' O ' HD13 ' A' ' 97' ' ' LEU . 23.8 m -70.99 -45.71 63.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.47 -0.769 . . . . 0.0 109.273 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.458 ' CD1' ' HB3' ' A' ' 85' ' ' ALA . 1.2 tp -49.67 -49.73 46.29 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.461 -0.774 . . . . 0.0 110.204 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.413 ' O ' ' CB ' ' A' ' 99' ' ' ARG . 58.0 t -55.08 -47.0 77.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.403 -0.81 . . . . 0.0 109.644 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 36.6 t -54.45 -51.21 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.526 -0.734 . . . . 0.0 109.834 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.428 HD13 ' O ' ' A' ' 93' ' ' THR . 9.1 mp -52.11 -67.02 0.29 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.51 -0.744 . . . . 0.0 110.805 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -57.24 -38.76 74.3 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.172 -0.955 . . . . 0.0 110.15 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.414 ' O ' ' HG2' ' A' ' 99' ' ' ARG . 0.1 OUTLIER -66.3 -14.66 62.36 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.392 -0.817 . . . . 0.0 110.474 179.754 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -132.96 54.03 1.98 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.135 -0.978 . . . . 0.0 110.494 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 58.19 105.15 0.01 OUTLIER Glycine 0 N--CA 1.488 2.126 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -164.9 94.69 0.68 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.322 -1.105 . . . . 0.0 110.231 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.413 ' HB3' ' NH2' ' A' ' 80' ' ' ARG . 20.3 ttt180 -52.69 104.96 0.1 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.314 -0.866 . . . . 0.0 109.717 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 134' ' ' ALA . 0.0 OUTLIER -98.58 67.18 1.74 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.424 -0.798 . . . . 0.0 110.484 -179.515 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -168.46 42.87 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.2 -0.937 . . . . 0.0 110.378 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.467 HG13 ' HD2' ' A' ' 80' ' ' ARG . 4.3 p -101.32 -178.0 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.271 -0.893 . . . . 0.0 110.021 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.57 142.01 51.19 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.521 -0.737 . . . . 0.0 109.291 179.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 . . . . . 0 N--CA 1.493 1.723 0 O-C-N 121.216 -0.928 . . . . 0.0 110.438 -179.589 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.458 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 50.1 mt . . . . . 0 N--CA 1.494 1.761 0 N-CA-C 110.235 -0.284 . . . . 0.0 110.235 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.458 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 41.3 Cg_endo -67.47 -27.53 39.59 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 O-C-N 123.676 1.356 . . . . 0.0 110.044 178.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 127' ' ' ALA . 7.8 p -80.74 -35.55 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.412 -0.805 . . . . 0.0 109.761 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -70.4 -29.85 66.58 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.467 -0.77 . . . . 0.0 110.009 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.3 tt -70.4 -44.48 67.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.422 -0.799 . . . . 0.0 110.303 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.27 -48.61 64.58 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.29 -0.881 . . . . 0.0 110.413 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -55.67 -29.47 59.39 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.293 -0.879 . . . . 0.0 110.068 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -78.31 -39.72 38.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.464 -0.773 . . . . 0.0 110.235 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.33 -88.03 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.346 -0.846 . . . . 0.0 110.281 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -177.86 25.99 0.06 OUTLIER Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.451 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 36.0 m-70 -108.11 50.59 0.77 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.024 -1.28 . . . . 0.0 108.994 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -46.09 -37.37 6.73 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.71 -0.619 . . . . 0.0 110.124 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -59.92 -42.25 93.53 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.406 -0.809 . . . . 0.0 109.201 179.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.462 ' CG1' ' HA ' ' A' ' 86' ' ' ALA . 2.6 t -81.35 -32.56 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.437 -0.789 . . . . 0.0 109.037 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.408 ' O ' HG22 ' A' ' 115' ' ' VAL . . . -69.2 -39.05 78.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.512 -0.743 . . . . 0.0 109.45 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.51 -61.21 2.79 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.277 -0.889 . . . . 0.0 109.676 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -54.48 -37.18 64.97 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.348 -0.845 . . . . 0.0 109.467 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.409 ' CD2' HD22 ' A' ' 104' ' ' LEU . 14.8 mt -63.77 -30.08 71.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.519 -0.738 . . . . 0.0 109.525 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -68.79 -30.62 69.24 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.536 -0.728 . . . . 0.0 110.121 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -87.01 -36.59 18.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.286 -0.884 . . . . 0.0 110.408 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -89.22 -15.85 32.67 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.291 -0.88 . . . . 0.0 110.678 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 104' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.23 -0.919 . . . . 0.0 110.432 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 10.7 t0 . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 121.002 0.43 . . . . 0.0 110.404 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.609 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 1.3 t90 -65.66 -10.25 34.54 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.139 -0.976 . . . . 0.0 110.442 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.443 ' CD1' HD22 ' A' ' 63' ' ' LEU . 1.8 tp -73.0 -54.37 8.76 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.245 -0.91 . . . . 0.0 109.72 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.426 ' N ' ' HG ' ' A' ' 16' ' ' LEU . . . -75.77 -42.82 49.25 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.368 -0.833 . . . . 0.0 110.488 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.609 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 3.1 p -49.37 -46.29 47.0 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.468 -0.77 . . . . 0.0 110.76 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.414 ' CB ' HG23 ' A' ' 28' ' ' VAL . . . -66.3 -47.18 74.42 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.283 -0.886 . . . . 0.0 110.299 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.449 ' CB ' HG13 ' A' ' 59' ' ' VAL . . . -52.54 -36.11 54.89 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.409 -0.807 . . . . 0.0 110.475 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.92 -26.01 43.68 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.343 -0.848 . . . . 0.0 110.323 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -93.25 19.22 8.38 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.203 -0.936 . . . . 0.0 110.735 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 52.98 53.0 35.95 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.06 61.4 0.96 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.405 -1.056 . . . . 0.0 109.93 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.425 ' CG2' HG22 ' A' ' 59' ' ' VAL . 37.5 t -50.22 -46.31 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.475 -0.766 . . . . 0.0 110.672 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -59.1 -36.43 75.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.316 -0.865 . . . . 0.0 110.349 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.402 ' O ' ' HB2' ' A' ' 31' ' ' LEU . 7.2 tt0 -73.73 -31.43 63.36 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.234 -0.916 . . . . 0.0 109.616 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.479 ' CG1' HD22 ' A' ' 62' ' ' LEU . 3.4 t -76.48 -50.19 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.554 -0.716 . . . . 0.0 109.57 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.505 ' HA ' HD21 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -49.09 -45.26 43.02 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.481 -0.762 . . . . 0.0 110.132 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.36 -41.83 38.86 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.454 -0.779 . . . . 0.0 109.877 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.408 ' C ' ' HB2' ' A' ' 36' ' ' ALA . 12.6 mt -57.14 -67.8 0.29 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.361 -0.837 . . . . 0.0 110.439 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.504 ' CD2' ' CG ' ' A' ' 66' ' ' HIS . 0.3 OUTLIER -48.54 -46.0 38.18 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.585 -0.697 . . . . 0.0 111.016 -179.382 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.13 -14.08 61.31 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.26 -0.9 . . . . 0.0 110.324 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -92.07 -8.52 45.64 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.223 -0.923 . . . . 0.0 111.024 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 146.72 -28.98 1.59 Allowed Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.741 -1.219 . . . . 0.0 110.265 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.408 ' HB2' ' C ' ' A' ' 31' ' ' LEU . . . -53.76 106.33 0.18 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.107 -1.231 . . . . 0.0 110.579 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.418 ' O ' ' CD2' ' A' ' 16' ' ' LEU . 0.6 OUTLIER -66.96 152.22 96.17 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.361 -0.837 . . . . 0.0 109.734 179.701 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -74.57 -28.49 9.94 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.715 1.376 . . . . 0.0 111.083 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -90.26 32.62 0.92 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.209 -0.932 . . . . 0.0 110.246 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.73 112.65 44.17 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.385 -0.822 . . . . 0.0 110.097 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.45 123.11 8.86 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.652 1.343 . . . . 0.0 110.148 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 48.4 p-10 -80.6 5.93 14.06 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.381 -0.824 . . . . 0.0 110.702 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 58.54 17.53 5.02 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.092 -1.005 . . . . 0.0 110.024 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -107.3 15.19 25.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.422 -0.799 . . . . 0.0 109.412 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.0 24.64 43.47 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.5 ' O ' ' CB ' ' A' ' 50' ' ' GLN . 35.3 mtt180 -135.79 32.0 3.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.308 -1.113 . . . . 0.0 111.1 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.561 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 0.6 OUTLIER 42.56 -166.72 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.119 0 O-C-N 121.501 -0.749 . . . . 0.0 110.937 178.589 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.561 ' CD ' ' HB3' ' A' ' 47' ' ' ARG . 48.9 Cg_endo -85.6 -24.57 1.85 Allowed 'Trans proline' 0 C--N 1.318 -1.036 0 O-C-N 122.998 0.999 . . . . 0.0 110.81 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.8 mt -107.04 -40.16 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.129 -0.982 . . . . 0.0 110.047 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.5 ' CB ' ' O ' ' A' ' 46' ' ' ARG . 0.9 OUTLIER -47.1 -27.11 1.27 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.488 -0.757 . . . . 0.0 110.555 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.452 ' HB ' ' CB ' ' A' ' 46' ' ' ARG . 9.0 p -97.06 -2.47 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.218 -0.926 . . . . 0.0 110.19 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.466 ' CE ' ' CE ' ' A' ' 54' ' ' MET . 56.8 ttp -52.15 154.33 2.36 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.515 -0.741 . . . . 0.0 109.789 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 1.4 tmm? -69.77 -2.91 13.31 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.377 -0.827 . . . . 0.0 111.07 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.466 ' CE ' ' CE ' ' A' ' 52' ' ' MET . 0.0 OUTLIER 52.62 22.77 2.33 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.989 -1.07 . . . . 0.0 110.115 -179.687 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.416 ' C ' ' CZ ' ' A' ' 90' ' ' PHE . . . -123.95 9.25 8.53 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 178.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.417 ' N ' ' CE2' ' A' ' 90' ' ' PHE . 0.6 OUTLIER -144.82 80.73 1.63 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.436 -1.038 . . . . 0.0 109.931 179.887 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.422 ' HA ' ' OG1' ' A' ' 93' ' ' THR . . . -52.23 -25.08 8.39 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.215 -0.928 . . . . 0.0 109.757 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.6 mtt180 -61.21 -36.73 80.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.472 -0.768 . . . . 0.0 109.503 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.449 HG13 ' CB ' ' A' ' 20' ' ' ALA . 37.3 t -55.4 -69.95 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.263 -0.898 . . . . 0.0 109.256 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.515 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -47.44 -34.42 7.22 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.296 -0.878 . . . . 0.0 109.498 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.436 ' O ' ' CB ' ' A' ' 65' ' ' LEU . 11.1 tt0 -54.27 -32.17 55.53 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.269 -0.894 . . . . 0.0 109.845 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.505 HD21 ' HA ' ' A' ' 29' ' ' ARG . 1.0 OUTLIER -87.06 -45.66 10.52 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.607 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.443 HD22 ' CD1' ' A' ' 16' ' ' LEU . 4.5 mp -62.65 -53.46 54.15 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.718 -0.614 . . . . 0.0 109.98 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.515 ' HB2' ' O ' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -63.42 -42.9 98.75 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.226 -0.921 . . . . 0.0 109.565 179.553 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.436 ' CB ' ' O ' ' A' ' 61' ' ' GLU . 10.0 tp -54.06 -37.49 64.23 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.363 -0.836 . . . . 0.0 108.804 178.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.504 ' CG ' ' CD2' ' A' ' 32' ' ' LEU . 7.8 m80 -85.76 -21.54 28.17 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.357 0.598 . . . . 0.0 109.69 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.24 56.83 0.73 Allowed Glycine 0 N--CA 1.479 1.533 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 179.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.41 ' CB ' ' HB3' ' A' ' 63' ' ' LEU . . . -64.82 -148.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.033 -1.275 . . . . 0.0 109.089 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.533 ' HB2' ' HB3' ' A' ' 47' ' ' ARG . 53.9 mt-10 -117.27 55.98 1.76 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.189 -0.944 . . . . 0.0 110.079 179.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.404 ' CD ' ' N ' ' A' ' 69' ' ' GLU . 44.3 Cg_endo -69.4 -11.19 30.74 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 O-C-N 123.631 1.332 . . . . 0.0 110.392 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -95.91 -56.48 2.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.257 -0.902 . . . . 0.0 110.415 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -50.12 148.62 3.29 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.315 -0.865 . . . . 0.0 110.919 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.69 -158.2 0.84 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.478 -0.764 . . . . 0.0 109.721 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.496 ' O ' ' N ' ' A' ' 78' ' ' LEU . 19.1 m-20 -106.43 126.21 30.99 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.321 -0.862 . . . . 0.0 109.53 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.12 -20.58 28.4 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.389 1.205 . . . . 0.0 110.434 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.79 -42.05 88.14 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.236 -0.915 . . . . 0.0 110.141 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.26 21.83 1.07 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.478 -0.764 . . . . 0.0 109.842 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 74' ' ' ASP . 1.4 mt 50.72 41.39 26.08 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.561 -0.712 . . . . 0.0 111.164 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 18.4 m -73.95 100.62 3.59 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.105 -0.997 . . . . 0.0 109.618 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.451 ' CG ' HG11 ' A' ' 106' ' ' VAL . 0.3 OUTLIER -76.84 164.02 61.93 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.381 -0.825 . . . . 0.0 109.98 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.55 -14.17 27.55 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.68 1.358 . . . . 0.0 110.649 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.405 HG12 ' HG ' ' A' ' 104' ' ' LEU . 42.0 t -63.63 -28.2 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.233 -0.917 . . . . 0.0 109.927 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.431 ' O ' ' CB ' ' A' ' 87' ' ' ARG . 29.1 m80 -65.52 -44.39 87.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.441 -0.787 . . . . 0.0 109.351 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.483 ' OD2' ' HG2' ' A' ' 50' ' ' GLN . 67.8 m-20 -49.95 -55.86 12.86 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.664 -0.647 . . . . 0.0 111.244 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.403 ' CB ' ' CD1' ' A' ' 94' ' ' LEU . . . -54.22 -68.0 0.22 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.173 -0.954 . . . . 0.0 109.971 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.506 ' HA ' ' CG1' ' A' ' 126' ' ' VAL . . . -54.92 -40.86 70.32 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.318 -0.864 . . . . 0.0 111.098 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 83' ' ' HIS . 6.2 tmm_? -51.47 -31.67 24.25 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.91 -1.119 . . . . 0.0 110.228 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -107.87 16.62 23.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.519 -0.738 . . . . 0.0 110.308 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.417 ' N ' ' CE1' ' A' ' 123' ' ' HIS . . . 55.43 48.52 69.42 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.448 ' CD2' ' OG1' ' A' ' 93' ' ' THR . 0.1 OUTLIER -116.57 91.31 3.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.455 -1.026 . . . . 0.0 110.694 -179.1 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.58 -39.01 58.71 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.313 -0.867 . . . . 0.0 110.679 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -47.32 -44.95 24.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.429 -0.795 . . . . 0.0 109.902 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.448 ' OG1' ' CD2' ' A' ' 90' ' ' PHE . 23.1 m -68.86 -40.0 79.54 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.403 ' CD1' ' CB ' ' A' ' 85' ' ' ALA . 5.0 tp -59.36 -47.49 85.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.638 -0.664 . . . . 0.0 109.924 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.4 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 53.2 t -53.84 -45.92 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.411 -0.806 . . . . 0.0 109.496 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.421 HG13 ' HA ' ' A' ' 61' ' ' GLU . 24.8 t -62.47 -43.15 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.555 -0.715 . . . . 0.0 109.545 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.411 ' HG ' HD11 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -53.59 -46.14 70.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.629 -0.669 . . . . 0.0 110.443 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -83.86 -28.28 28.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.354 -0.841 . . . . 0.0 110.426 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 1.7 mtp85 -66.25 -11.72 51.94 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.378 -0.826 . . . . 0.0 111.044 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -124.42 -79.48 0.61 Allowed 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.157 -0.964 . . . . 0.0 110.891 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -159.26 88.07 0.11 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.016 -1.233 . . . . 0.0 110.016 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.401 ' HB2' ' CD2' ' A' ' 97' ' ' LEU . . . -160.78 110.73 1.73 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.286 -1.126 . . . . 0.0 110.314 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 8.1 ttt180 -50.58 167.16 0.07 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.373 -0.83 . . . . 0.0 110.662 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.405 ' HG ' HG12 ' A' ' 82' ' ' VAL . 0.1 OUTLIER -149.14 43.47 0.96 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.417 -0.802 . . . . 0.0 110.067 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -161.01 48.47 0.22 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.195 -0.941 . . . . 0.0 110.778 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.458 ' O ' ' HG ' ' A' ' 113' ' ' LEU . 4.2 p -109.21 -174.47 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.188 -0.945 . . . . 0.0 109.563 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 7.7 ptt180 -141.67 147.85 38.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.428 -0.795 . . . . 0.0 109.521 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.4 t0 . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.336 -0.852 . . . . 0.0 110.058 -179.771 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 106' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 120.563 0.221 . . . . 0.0 110.669 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.458 ' HD2' ' HG ' ' A' ' 113' ' ' LEU . 44.7 Cg_endo -72.35 -35.96 5.93 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 O-C-N 123.868 1.457 . . . . 0.0 110.053 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.444 ' HB ' ' HB3' ' A' ' 130' ' ' LEU . 12.0 p -67.75 -26.79 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.273 -0.892 . . . . 0.0 109.831 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -65.28 -42.45 93.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.472 -0.767 . . . . 0.0 109.775 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.47 -49.64 72.82 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.529 -0.732 . . . . 0.0 110.267 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' A' ' 86' ' ' ALA . . . -48.68 -64.8 0.7 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.346 -0.846 . . . . 0.0 110.804 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -55.1 -23.7 22.0 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.278 -0.889 . . . . 0.0 110.151 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.82 -33.8 72.82 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.412 -0.805 . . . . 0.0 110.027 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -96.25 -8.56 32.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.326 -0.858 . . . . 0.0 110.384 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.33 32.71 6.24 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.497 ' ND1' ' O ' ' A' ' 86' ' ' ALA . 36.0 m170 -95.11 55.33 1.78 Allowed 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.072 -1.252 . . . . 0.0 109.478 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.407 ' O ' ' CB ' ' A' ' 128' ' ' ARG . 12.2 ttm180 -45.9 -30.13 1.63 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.594 -0.691 . . . . 0.0 110.286 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.96 -41.1 74.94 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.571 -0.706 . . . . 0.0 109.488 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.506 ' CG1' ' HA ' ' A' ' 86' ' ' ALA . 2.1 t -89.5 -39.64 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.427 -0.795 . . . . 0.0 110.343 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.59 -34.29 77.92 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.296 -0.877 . . . . 0.0 109.957 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.407 ' CB ' ' O ' ' A' ' 124' ' ' ARG . 34.5 ttt85 -74.01 -56.83 4.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.354 -0.841 . . . . 0.0 109.742 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -56.02 -26.36 48.49 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.302 -0.874 . . . . 0.0 109.605 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.444 ' HB3' ' HB ' ' A' ' 115' ' ' VAL . 14.2 mt -78.5 -50.76 11.04 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.454 -0.779 . . . . 0.0 109.994 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.6 tpt85 -52.56 -25.97 11.96 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.436 -0.79 . . . . 0.0 110.597 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -79.46 -53.12 7.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.204 -0.935 . . . . 0.0 109.957 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -81.35 -7.15 59.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.435 -0.791 . . . . 0.0 110.511 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.674 0 O-C-N 121.18 -0.95 . . . . 0.0 110.279 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.408 ' O ' ' OG1' ' A' ' 18' ' ' THR . 11.4 p30 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 120.83 0.348 . . . . 0.0 110.946 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.481 ' HB3' HD13 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -60.15 -11.56 6.43 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.343 -0.848 . . . . 0.0 111.299 -179.644 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.449 HD23 ' HB1' ' A' ' 36' ' ' ALA . 23.8 mt -78.36 -57.05 3.98 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.936 -1.102 . . . . 0.0 109.534 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.47 -48.38 80.95 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.508 -0.745 . . . . 0.0 109.471 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 14' ' ' ASP . 0.2 OUTLIER -54.52 -59.95 4.0 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.39 -0.819 . . . . 0.0 110.128 179.341 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.425 ' HB1' HG23 ' A' ' 28' ' ' VAL . . . -54.3 -56.78 15.08 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.49 -0.757 . . . . 0.0 110.181 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.408 ' HB2' ' CB ' ' A' ' 52' ' ' MET . . . -52.87 -47.87 67.53 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.45 -0.781 . . . . 0.0 109.847 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.07 -19.2 61.14 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.468 -0.77 . . . . 0.0 109.863 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.71 18.03 15.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.501 -0.749 . . . . 0.0 110.703 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.416 ' CA ' ' HE2' ' A' ' 53' ' ' MET . . . 54.17 47.85 65.89 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.65 98.84 4.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.304 -1.115 . . . . 0.0 109.716 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.46 HG22 ' HB3' ' A' ' 58' ' ' ARG . 3.1 t -74.31 -43.73 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.463 -0.773 . . . . 0.0 109.821 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -45.4 -54.26 7.55 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.455 -0.778 . . . . 0.0 110.781 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.452 ' OE1' ' CD1' ' A' ' 15' ' ' TRP . 0.0 OUTLIER -48.91 -49.46 39.88 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.371 -0.831 . . . . 0.0 110.041 179.801 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.446 HG13 ' CD1' ' A' ' 32' ' ' LEU . 6.2 t -74.13 -45.63 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.587 -0.696 . . . . 0.0 110.307 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.474 ' HA ' ' CD1' ' A' ' 62' ' ' LEU . 9.3 mmm180 -45.34 -41.65 9.13 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.501 -0.749 . . . . 0.0 109.93 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.46 -39.59 31.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.544 -0.723 . . . . 0.0 109.646 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.481 HD13 ' HB3' ' A' ' 15' ' ' TRP . 32.8 mt -61.06 -67.12 0.43 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.419 -0.8 . . . . 0.0 110.137 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.514 ' HB3' ' CE1' ' A' ' 66' ' ' HIS . 13.7 mt -51.85 -36.88 49.88 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.476 -0.765 . . . . 0.0 110.461 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 29' ' ' ARG . 46.9 mt-10 -72.37 -18.08 61.77 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.308 -0.87 . . . . 0.0 110.022 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.97 -7.5 48.81 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.359 -0.838 . . . . 0.0 110.435 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.61 23.73 6.14 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.492 ' HB2' ' HA ' ' A' ' 32' ' ' LEU . . . -61.22 164.45 5.31 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.296 -1.12 . . . . 0.0 110.073 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 40.8 tp -97.18 99.15 5.62 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.536 -0.727 . . . . 0.0 109.927 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.473 ' O ' ' HG3' ' A' ' 48' ' ' PRO . 44.1 Cg_endo -68.56 -23.11 37.37 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 O-C-N 123.656 1.345 . . . . 0.0 110.437 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.41 34.25 1.06 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.252 -0.905 . . . . 0.0 110.018 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.82 122.52 71.42 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.333 -0.855 . . . . 0.0 110.274 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -73.42 111.81 3.38 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.609 1.321 . . . . 0.0 110.38 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -90.13 166.65 13.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.404 -0.81 . . . . 0.0 109.916 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.457 ' C ' ' CG ' ' A' ' 44' ' ' TYR . 70.8 m -62.58 -157.04 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.433 -0.792 . . . . 0.0 109.732 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.573 ' CD1' ' N ' ' A' ' 44' ' ' TYR . 0.1 OUTLIER 58.86 13.72 2.9 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.166 -0.959 . . . . 0.0 109.791 -179.607 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.2 24.24 20.91 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.87 171.95 7.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.44 -1.036 . . . . 0.0 110.956 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.543 ' CB ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -113.92 -165.21 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.688 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.562 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.543 ' HD2' ' CB ' ' A' ' 47' ' ' ARG . 49.1 Cg_endo -76.19 166.48 27.67 Favored 'Trans proline' 0 C--N 1.315 -1.228 0 O-C-N 122.85 0.921 . . . . 0.0 109.787 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.516 ' O ' ' HG2' ' A' ' 52' ' ' MET . 4.7 mt 63.96 -59.6 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 121.668 -0.645 . . . . 0.0 110.224 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.513 ' N ' ' O ' ' A' ' 48' ' ' PRO . 7.3 mt-30 -43.7 -27.19 0.29 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.811 -1.181 . . . . 0.0 110.54 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.458 ' CG2' ' O ' ' A' ' 51' ' ' VAL . 6.8 p -118.8 26.06 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.426 -0.796 . . . . 0.0 110.53 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.516 ' HG2' ' O ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -83.73 41.04 0.77 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.77 -1.206 . . . . 0.0 109.421 178.872 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.416 ' HE2' ' CA ' ' A' ' 23' ' ' GLY . 2.9 tmm? 64.97 -6.82 0.31 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.285 -0.884 . . . . 0.0 110.552 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.492 ' H ' ' C ' ' A' ' 52' ' ' MET . 0.0 OUTLIER 43.12 29.89 0.23 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.307 -0.871 . . . . 0.0 110.516 -179.781 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.453 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -134.54 12.64 4.58 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -146.1 71.5 1.26 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.425 -1.044 . . . . 0.0 109.544 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.429 ' HB3' ' CE1' ' A' ' 90' ' ' PHE . . . -47.97 -27.75 2.37 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.649 -0.657 . . . . 0.0 109.89 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.46 ' HB3' HG22 ' A' ' 25' ' ' VAL . 3.1 tpt180 -52.07 -38.23 56.49 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.654 -0.654 . . . . 0.0 109.359 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 67.0 t -69.48 -49.05 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.359 -0.838 . . . . 0.0 109.028 178.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.423 ' O ' ' CB ' ' A' ' 64' ' ' LEU . . . -46.44 -45.82 18.36 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.52 -0.738 . . . . 0.0 109.664 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.412 ' O ' HD22 ' A' ' 65' ' ' LEU . 0.7 OUTLIER -58.05 -48.39 80.24 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.545 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.524 ' O ' ' HB2' ' A' ' 66' ' ' HIS . 0.2 OUTLIER -49.92 -66.73 0.34 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.586 -0.696 . . . . 0.0 109.688 178.348 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.461 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 85.1 mt -58.44 -54.68 44.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.57 -0.706 . . . . 0.0 110.178 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.437 ' CD2' ' HB3' ' A' ' 100' ' ' ALA . 1.9 tt -43.67 -68.3 0.21 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.501 -0.749 . . . . 0.0 111.212 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.413 HD12 ' C ' ' A' ' 65' ' ' LEU . 1.1 pp -56.31 -23.2 35.41 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.104 -0.997 . . . . 0.0 110.159 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.524 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 2.2 m80 -82.86 -48.79 10.36 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 121.293 -0.88 . . . . 0.0 110.153 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 149.34 43.41 0.03 OUTLIER Glycine 0 N--CA 1.483 1.79 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.461 ' CB ' ' HB3' ' A' ' 63' ' ' LEU . . . -72.25 -157.32 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.849 -1.383 . . . . 0.0 109.92 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.44 ' CG ' ' HD2' ' A' ' 48' ' ' PRO . 4.6 mm-40 -121.21 62.73 11.81 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.432 ' HG2' ' ND2' ' A' ' 71' ' ' ASN . 40.4 Cg_endo -69.05 -5.5 15.93 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.875 1.461 . . . . 0.0 111.083 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.432 ' ND2' ' HG2' ' A' ' 70' ' ' PRO . 12.2 m-80 -113.88 -67.12 1.02 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.022 -1.048 . . . . 0.0 110.065 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.8 t -44.88 163.28 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.465 -0.772 . . . . 0.0 110.83 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.449 ' HB2' ' HA ' ' A' ' 80' ' ' ARG . . . -138.59 -155.44 0.6 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.186 -0.946 . . . . 0.0 110.925 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' A' ' 78' ' ' LEU . 50.8 m-20 -107.77 126.23 30.35 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.533 -0.729 . . . . 0.0 109.766 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -74.96 -2.06 12.03 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 123.332 1.175 . . . . 0.0 110.668 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -93.32 -36.3 12.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 0.0 109.84 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.76 6.99 4.04 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.376 -0.827 . . . . 0.0 110.142 179.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 74' ' ' ASP . 1.0 OUTLIER 48.48 23.22 0.57 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.381 -0.824 . . . . 0.0 111.477 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 35.8 m -78.83 102.74 8.34 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.956 -1.09 . . . . 0.0 109.517 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.449 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -71.11 171.97 7.51 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.361 -0.837 . . . . 0.0 110.285 -179.676 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.66 -14.5 36.51 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.816 1.429 . . . . 0.0 109.375 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.426 HG13 ' CB ' ' A' ' 114' ' ' PRO . 48.7 t -72.08 -30.26 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.778 -0.576 . . . . 0.0 109.896 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.515 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 5.3 m80 -77.8 -34.68 52.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.391 -0.818 . . . . 0.0 109.25 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.02 -41.99 84.31 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 120.322 -0.551 . . . . 0.0 109.884 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.64 -61.51 1.94 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.232 -0.918 . . . . 0.0 109.653 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.533 ' HA ' ' CG1' ' A' ' 126' ' ' VAL . . . -56.88 -44.84 82.69 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.262 -0.899 . . . . 0.0 110.929 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -48.64 -43.44 36.47 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.329 -0.857 . . . . 0.0 110.291 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.42 ' HG3' ' HB3' ' A' ' 54' ' ' MET . 0.0 OUTLIER -93.82 4.68 53.57 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.454 -0.779 . . . . 0.0 110.655 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.464 ' HA3' ' ND1' ' A' ' 123' ' ' HIS . . . 60.72 51.79 56.45 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.453 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -120.45 74.87 1.08 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.385 -1.068 . . . . 0.0 110.187 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.17 -37.89 56.02 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.428 -0.795 . . . . 0.0 110.663 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.422 ' HB3' ' CD1' ' A' ' 90' ' ' PHE . 48.1 t0 -47.9 -39.24 18.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.3 -0.875 . . . . 0.0 109.559 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 87.6 m -69.8 -45.06 68.79 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.433 ' CD2' ' HG ' ' A' ' 130' ' ' LEU . 1.6 tp -55.37 -43.24 74.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.563 -0.711 . . . . 0.0 109.809 179.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 69.2 t -59.91 -47.85 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.222 -0.923 . . . . 0.0 109.429 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.417 ' O ' HD11 ' A' ' 64' ' ' LEU . 6.5 t -58.88 -50.52 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.304 -0.872 . . . . 0.0 109.004 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.406 ' C ' ' CB ' ' A' ' 102' ' ' ALA . 0.0 OUTLIER -44.56 -55.4 5.17 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.77 -0.582 . . . . 0.0 109.93 179.267 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -65.73 -30.92 71.65 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.512 -0.743 . . . . 0.0 109.89 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -14.81 36.43 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.399 -0.813 . . . . 0.0 110.665 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.437 ' HB3' ' CD2' ' A' ' 64' ' ' LEU . . . -151.31 70.13 0.96 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.98 -1.075 . . . . 0.0 111.075 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 58.22 105.82 0.01 OUTLIER Glycine 0 N--CA 1.488 2.1 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.406 ' CB ' ' C ' ' A' ' 97' ' ' LEU . . . -147.51 103.86 3.58 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.589 -0.948 . . . . 0.0 109.702 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.8 tpp180 -65.31 101.59 0.58 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.353 -0.842 . . . . 0.0 110.377 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.493 ' O ' ' HA ' ' A' ' 134' ' ' ALA . 1.7 mt -102.37 59.86 0.82 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.427 -0.796 . . . . 0.0 110.226 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -170.92 44.72 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.988 -1.07 . . . . 0.0 110.907 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.443 HG13 ' HB2' ' A' ' 80' ' ' ARG . 3.1 p -105.88 -171.24 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.243 -0.911 . . . . 0.0 109.539 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -131.26 115.1 15.87 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.178 -0.951 . . . . 0.0 110.064 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.704 0 O-C-N 121.475 -0.765 . . . . 0.0 109.558 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.457 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.457 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 45.4 Cg_endo -74.65 -48.54 0.19 Allowed 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.661 1.348 . . . . 0.0 110.025 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.2 p -55.56 -32.68 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.353 -0.842 . . . . 0.0 109.729 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.01 -38.54 79.31 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.481 -0.762 . . . . 0.0 109.688 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.401 ' O ' HD12 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -57.11 -69.36 0.16 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.508 -0.745 . . . . 0.0 110.143 179.674 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.463 ' CB ' ' HB2' ' A' ' 123' ' ' HIS . . . -44.46 -52.86 7.48 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.461 -0.774 . . . . 0.0 110.998 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -53.97 -45.04 71.27 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.347 -0.845 . . . . 0.0 110.156 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -64.89 -32.02 73.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.391 -0.818 . . . . 0.0 110.06 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.401 HD12 ' O ' ' A' ' 117' ' ' LEU . 1.0 OUTLIER -90.07 2.05 55.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.375 -0.828 . . . . 0.0 110.767 -179.668 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 89.96 11.42 63.39 Favored Glycine 0 N--CA 1.489 2.209 0 C-N-CA 119.931 -1.128 . . . . 0.0 111.075 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.464 ' ND1' ' HA3' ' A' ' 89' ' ' GLY . 47.9 m-70 -93.07 50.31 1.52 Allowed 'General case' 0 N--CA 1.484 1.232 0 O-C-N 120.841 -1.387 . . . . 0.0 109.085 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.0 mtt-85 -47.75 -31.47 4.85 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.626 -0.671 . . . . 0.0 109.407 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 125' ' ' ASP . 8.5 m-20 -62.3 -47.85 82.46 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.533 ' CG1' ' HA ' ' A' ' 86' ' ' ALA . 6.0 t -75.3 -40.52 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.426 -0.796 . . . . 0.0 109.758 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.21 -36.37 70.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.303 -0.873 . . . . 0.0 109.607 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.13 -61.19 2.73 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.418 -0.801 . . . . 0.0 110.1 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -53.26 -40.42 64.64 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.293 -0.879 . . . . 0.0 109.824 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.457 HD11 ' CB ' ' A' ' 86' ' ' ALA . 78.3 mt -67.59 -39.43 84.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.424 -0.797 . . . . 0.0 109.463 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -59.34 -19.43 46.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.19 -0.943 . . . . 0.0 110.201 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.1 -57.63 3.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.352 -0.843 . . . . 0.0 110.432 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.451 ' HB2' ' HB2' ' A' ' 104' ' ' LEU . . . -81.72 -15.49 54.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.346 -0.846 . . . . 0.0 110.959 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 104' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.199 -0.938 . . . . 0.0 110.103 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 120.7 0.285 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 40.2 m0 -46.44 -34.73 4.94 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.334 -0.854 . . . . 0.0 109.976 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.486 HD12 HD21 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -63.1 -37.84 88.8 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.6 -0.687 . . . . 0.0 109.997 178.62 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.66 -53.86 6.43 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.27 -0.893 . . . . 0.0 110.309 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -44.96 -54.09 6.93 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.565 -0.709 . . . . 0.0 110.836 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.485 ' CB ' HG21 ' A' ' 28' ' ' VAL . . . -61.3 -52.8 63.2 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.356 -0.84 . . . . 0.0 110.447 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.419 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . . . -46.78 -46.9 20.88 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.502 -0.749 . . . . 0.0 110.355 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.44 -40.01 67.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.55 -0.719 . . . . 0.0 110.425 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -86.53 26.58 1.06 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.484 -0.76 . . . . 0.0 110.414 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 49.05 24.22 4.39 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.2 mtt180 -93.65 65.39 3.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.365 -1.079 . . . . 0.0 109.738 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.485 ' CG2' HG23 ' A' ' 59' ' ' VAL . 60.2 t -55.67 -42.66 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.657 -0.652 . . . . 0.0 110.881 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -43.36 -56.03 3.77 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.471 -0.768 . . . . 0.0 110.604 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.429 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 1.8 tp10 -63.99 -34.89 79.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.481 -0.762 . . . . 0.0 110.141 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.485 HG21 ' CB ' ' A' ' 19' ' ' ALA . 4.7 t -70.29 -44.97 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.231 -0.918 . . . . 0.0 109.871 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.422 ' CD ' HD13 ' A' ' 62' ' ' LEU . 1.8 mmm180 -53.37 -45.87 69.38 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.201 -0.937 . . . . 0.0 109.254 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.59 -42.38 71.11 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 120.078 -0.649 . . . . 0.0 109.739 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 27' ' ' GLU . 44.6 mt -59.18 -63.05 1.44 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.289 -0.882 . . . . 0.0 110.969 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.532 HD23 ' HA ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -44.44 -44.52 8.52 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.424 -0.798 . . . . 0.0 110.594 -179.484 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -81.25 -18.5 45.75 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.74 -0.6 . . . . 0.0 110.443 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.42 -5.63 59.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.111 -0.993 . . . . 0.0 110.748 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.09 22.61 2.35 Favored Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.802 -1.189 . . . . 0.0 110.99 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.462 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . . . -66.6 162.24 21.43 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.916 -1.343 . . . . 0.0 109.892 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -87.19 133.49 38.68 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.365 -0.835 . . . . 0.0 110.124 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.68 -47.07 0.7 Allowed 'Trans proline' 0 C--N 1.315 -1.229 0 O-C-N 123.547 1.288 . . . . 0.0 109.906 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -102.83 51.56 0.8 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.585 -0.697 . . . . 0.0 109.59 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.35 112.34 43.25 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.524 -0.735 . . . . 0.0 110.228 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.17 140.78 34.78 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 O-C-N 123.679 1.357 . . . . 0.0 110.607 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.438 ' ND2' HG23 ' A' ' 51' ' ' VAL . 14.9 t30 -85.92 -164.74 1.08 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.302 -0.874 . . . . 0.0 109.956 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.3 -8.0 14.77 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.199 -0.938 . . . . 0.0 110.564 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -96.62 24.29 6.12 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.179 -0.951 . . . . 0.0 109.917 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.41 23.05 66.25 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.92 -152.44 0.47 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.205 -1.174 . . . . 0.0 110.159 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.52 ' HD2' ' NE2' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -130.22 -176.8 0.58 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.32 -0.862 . . . . 0.0 109.989 -179.466 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.509 ' HD2' ' CB ' ' A' ' 47' ' ' ARG . 43.2 Cg_endo -68.69 -25.84 33.65 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 O-C-N 123.36 1.19 . . . . 0.0 110.456 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.476 ' O ' ' HG2' ' A' ' 52' ' ' MET . 4.8 mt -108.93 -33.1 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.236 -0.915 . . . . 0.0 109.919 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.52 ' NE2' ' HD2' ' A' ' 47' ' ' ARG . 14.7 mt-30 -56.89 -17.62 10.18 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.31 -0.869 . . . . 0.0 110.188 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.438 HG23 ' ND2' ' A' ' 42' ' ' ASN . 8.5 p -113.52 35.09 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.329 -0.857 . . . . 0.0 110.922 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.543 ' CG ' ' HE2' ' A' ' 54' ' ' MET . 0.1 OUTLIER -100.33 37.57 1.65 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.017 -1.052 . . . . 0.0 110.567 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.413 ' CB ' ' O ' ' A' ' 52' ' ' MET . 20.4 ttp 65.3 -4.27 0.55 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.421 -0.799 . . . . 0.0 110.66 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.549 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 41.41 30.82 0.14 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.384 -0.823 . . . . 0.0 110.555 -179.681 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.438 ' C ' ' CE2' ' A' ' 90' ' ' PHE . . . -133.17 11.01 5.07 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.81 87.86 1.65 Allowed 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.443 -1.034 . . . . 0.0 109.687 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.54 -20.14 7.25 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.52 -0.737 . . . . 0.0 109.733 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.47 ' HB3' HG11 ' A' ' 25' ' ' VAL . 2.2 ttt180 -58.09 -29.71 65.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.464 -0.773 . . . . 0.0 109.671 179.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.485 HG23 ' CG2' ' A' ' 25' ' ' VAL . 2.8 t -76.64 -50.42 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.445 -0.785 . . . . 0.0 109.426 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 64' ' ' LEU . . . -49.1 -59.82 3.32 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.206 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.443 ' O ' ' CD2' ' A' ' 65' ' ' LEU . 3.4 tt0 -46.7 -52.19 14.42 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.488 -0.758 . . . . 0.0 109.544 178.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.575 ' O ' ' HB2' ' A' ' 66' ' ' HIS . 0.3 OUTLIER -45.74 -71.79 0.07 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.735 -0.603 . . . . 0.0 110.416 178.745 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.532 ' HA ' HD23 ' A' ' 32' ' ' LEU . 1.9 mt -65.31 -45.84 82.73 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.499 -0.751 . . . . 0.0 111.069 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.469 ' N ' HD11 ' A' ' 49' ' ' ILE . 0.5 OUTLIER -52.26 -70.24 0.09 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.184 -0.948 . . . . 0.0 110.641 -179.501 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.443 ' CD2' ' O ' ' A' ' 61' ' ' GLU . 2.1 pp -50.69 -25.81 4.75 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.402 -0.812 . . . . 0.0 109.88 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.575 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 3.3 m-70 -80.74 -48.8 12.0 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.604 -0.685 . . . . 0.0 109.929 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 159.46 32.34 0.02 OUTLIER Glycine 0 CA--C 1.54 1.604 0 C-N-CA 120.05 -1.072 . . . . 0.0 111.305 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.428 ' HB3' ' C ' ' A' ' 63' ' ' LEU . . . -70.37 178.4 2.91 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.436 -1.626 . . . . 0.0 109.602 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -107.78 78.9 0.78 Allowed Pre-proline 0 C--N 1.302 -1.459 0 O-C-N 121.32 -0.863 . . . . 0.0 110.23 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 68' ' ' ALA . 50.3 Cg_endo -74.71 -0.85 10.35 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 O-C-N 123.682 1.359 . . . . 0.0 110.171 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.548 ' O ' ' NE ' ' A' ' 80' ' ' ARG . 1.7 m-20 -113.71 -70.58 0.8 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.194 -0.941 . . . . 0.0 110.014 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.422 ' C ' ' O ' ' A' ' 71' ' ' ASN . 49.3 t -40.04 147.85 0.09 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.375 -0.828 . . . . 0.0 110.893 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.419 ' HB3' ' HG2' ' A' ' 80' ' ' ARG . . . -133.25 -150.33 0.4 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.525 -0.735 . . . . 0.0 109.875 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 78' ' ' LEU . 1.0 OUTLIER -114.98 130.33 24.3 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.887 . . . . 0.0 109.893 -179.904 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.74 -13.08 38.49 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.344 1.181 . . . . 0.0 110.254 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.71 -55.81 30.07 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.322 -0.861 . . . . 0.0 109.171 178.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 43.7 p -141.71 25.36 1.99 Allowed 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.567 0.699 . . . . 0.0 109.374 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.451 ' HB3' ' O ' ' A' ' 107' ' ' ARG . 2.9 mt 52.86 30.06 8.59 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.53 -0.731 . . . . 0.0 111.107 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.84 97.57 0.23 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.989 -1.069 . . . . 0.0 109.883 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.548 ' NE ' ' O ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -72.23 168.52 22.54 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.211 -0.931 . . . . 0.0 109.382 179.701 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.474 ' HA ' ' HG2' ' A' ' 50' ' ' GLN . 50.8 Cg_endo -73.7 -21.77 18.67 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.74 1.39 . . . . 0.0 109.867 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.456 HG21 ' HA ' ' A' ' 104' ' ' LEU . 56.3 t -59.57 -35.0 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.523 -0.736 . . . . 0.0 110.37 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.469 ' CE1' ' HB3' ' A' ' 114' ' ' PRO . 42.3 m80 -64.99 -31.59 72.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.441 -0.787 . . . . 0.0 110.009 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.549 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 0.7 OUTLIER -61.24 -52.08 66.27 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.528 -0.732 . . . . 0.0 110.652 -179.732 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.46 ' CB ' HD13 ' A' ' 94' ' ' LEU . . . -57.8 -61.3 2.62 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.807 -1.183 . . . . 0.0 109.745 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.518 ' HA ' ' CG1' ' A' ' 126' ' ' VAL . . . -57.14 -55.93 28.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.525 -0.734 . . . . 0.0 111.594 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.467 ' CB ' ' O ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -44.67 -28.72 0.64 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.216 -0.927 . . . . 0.0 111.529 -178.863 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.37 -8.13 23.65 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.019 -1.051 . . . . 0.0 110.807 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.08 36.01 36.81 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.438 ' CE2' ' C ' ' A' ' 55' ' ' GLY . 0.9 OUTLIER -108.2 90.86 3.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.389 -1.066 . . . . 0.0 110.525 179.903 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.545 ' CD2' ' HA ' ' A' ' 126' ' ' VAL . 0.1 OUTLIER -64.69 -36.6 84.79 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.446 -0.784 . . . . 0.0 110.384 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.406 ' HB3' ' CE1' ' A' ' 90' ' ' PHE . 40.0 t0 -53.6 -26.31 21.31 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.165 -0.959 . . . . 0.0 109.371 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 26.6 m -78.25 -46.72 19.59 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.623 -0.673 . . . . 0.0 109.873 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.46 HD13 ' CB ' ' A' ' 85' ' ' ALA . 1.1 tp -54.36 -36.98 64.42 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.216 -0.928 . . . . 0.0 109.695 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.438 ' O ' ' HG3' ' A' ' 99' ' ' ARG . 27.0 t -65.54 -47.55 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.474 -0.766 . . . . 0.0 109.425 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.446 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 84.3 t -56.12 -53.17 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.217 -0.927 . . . . 0.0 110.094 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.0 mp -52.8 -51.83 59.23 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.182 -0.949 . . . . 0.0 109.719 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -54.6 -38.22 66.51 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.618 -0.676 . . . . 0.0 109.421 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 96' ' ' VAL . 66.9 mtp180 -66.78 -13.65 61.71 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.707 -0.621 . . . . 0.0 110.141 179.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.443 ' HB3' HD11 ' A' ' 64' ' ' LEU . . . -117.32 38.72 3.48 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.387 -0.82 . . . . 0.0 110.534 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 45.8 47.33 13.76 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.4 ' O ' HD12 ' A' ' 104' ' ' LEU . . . -89.13 110.68 21.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.346 -1.091 . . . . 0.0 110.197 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.518 ' N ' ' OD1' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -49.68 138.73 13.82 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.586 -0.697 . . . . 0.0 110.491 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.456 ' HA ' HG21 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -128.3 22.87 6.03 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.427 -0.796 . . . . 0.0 110.055 179.623 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -125.52 47.3 2.22 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.021 -1.049 . . . . 0.0 110.911 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.51 HG13 ' CD ' ' A' ' 80' ' ' ARG . 3.4 p -108.7 -172.4 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.318 -0.864 . . . . 0.0 110.347 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.451 ' O ' ' HB3' ' A' ' 78' ' ' LEU . 2.6 mtm180 -132.42 158.92 40.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.454 -0.779 . . . . 0.0 109.941 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 52.1 p30 . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.382 -0.824 . . . . 0.0 110.242 -179.872 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.551 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 56.7 mt . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.551 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 40.9 Cg_endo -66.84 -21.01 51.29 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.707 1.372 . . . . 0.0 109.896 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.442 ' CG1' ' N ' ' A' ' 116' ' ' ASP . 4.8 p -85.35 -40.7 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.287 -0.883 . . . . 0.0 110.421 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.442 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 1.0 OUTLIER -59.98 -32.28 70.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.044 -1.035 . . . . 0.0 109.871 179.94 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.4 mt -70.54 -45.4 65.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.498 -0.751 . . . . 0.0 110.049 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.502 ' HA ' ' HB2' ' A' ' 123' ' ' HIS . . . -55.33 -51.28 67.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.367 -0.833 . . . . 0.0 110.066 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -68.71 -25.0 64.55 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.614 -0.678 . . . . 0.0 110.484 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.45 -62.9 1.47 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.439 -0.788 . . . . 0.0 110.643 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.12 -87.34 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.028 -1.045 . . . . 0.0 110.703 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -169.52 35.86 0.19 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.502 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 7.5 m-70 -113.65 43.56 1.77 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.561 -0.964 . . . . 0.0 109.272 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -43.52 -55.99 3.91 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.782 -0.574 . . . . 0.0 110.073 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 125' ' ' ASP . 13.4 p-10 -49.25 -34.33 14.9 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.436 0.636 . . . . 0.0 109.636 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.545 ' HA ' ' CD2' ' A' ' 91' ' ' LEU . 1.3 t -84.43 -31.08 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.414 ' N ' ' HB2' ' A' ' 118' ' ' ALA . . . -68.28 -35.74 78.33 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.436 -0.79 . . . . 0.0 109.364 179.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 26.7 ttt180 -72.42 -63.55 1.13 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.275 -0.891 . . . . 0.0 109.556 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -50.71 -28.86 9.9 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.372 -0.83 . . . . 0.0 109.812 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.448 HD22 ' CD2' ' A' ' 104' ' ' LEU . 6.7 mt -65.36 -62.08 1.74 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.406 -0.809 . . . . 0.0 109.465 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -51.96 -16.84 0.81 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.54 -0.725 . . . . 0.0 111.002 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -78.94 -53.2 7.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.969 -1.082 . . . . 0.0 109.693 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -87.33 -20.29 26.99 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.413 -0.804 . . . . 0.0 109.631 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.413 ' CB ' ' O ' ' A' ' 104' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.31 -0.869 . . . . 0.0 110.653 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.404 ' O ' ' OG1' ' A' ' 18' ' ' THR . 3.3 t0 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 120.969 0.414 . . . . 0.0 110.544 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.491 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 42.0 m0 -67.54 -5.19 14.13 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.398 -0.814 . . . . 0.0 110.972 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.439 ' HG ' ' N ' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -77.99 -55.55 5.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.922 -1.111 . . . . 0.0 109.867 179.901 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.439 ' N ' ' HG ' ' A' ' 16' ' ' LEU . . . -70.55 -43.3 69.8 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.274 -0.891 . . . . 0.0 110.31 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.491 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.8 OUTLIER -52.25 -55.53 20.68 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.422 -0.799 . . . . 0.0 110.709 -179.888 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.02 -41.0 70.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.323 -0.861 . . . . 0.0 109.895 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.63 -49.68 64.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.482 -0.761 . . . . 0.0 109.793 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.436 ' CB ' ' O ' ' A' ' 51' ' ' VAL . . . -69.24 -34.1 74.29 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.429 -0.794 . . . . 0.0 110.198 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.38 27.67 1.89 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.393 -0.817 . . . . 0.0 110.927 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 44.71 57.06 5.43 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -115.56 56.05 0.77 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.345 -1.091 . . . . 0.0 109.894 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.434 ' CG2' ' CG2' ' A' ' 59' ' ' VAL . 25.5 t -45.37 -55.01 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.583 -0.698 . . . . 0.0 110.844 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -54.23 -40.62 67.85 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.401 -0.812 . . . . 0.0 110.315 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' A' ' 31' ' ' LEU . 0.5 OUTLIER -63.95 -35.43 80.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.431 -0.793 . . . . 0.0 109.753 179.851 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.497 HG13 ' CD1' ' A' ' 32' ' ' LEU . 11.7 t -77.27 -47.69 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.345 -0.847 . . . . 0.0 111.077 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.515 ' HA ' ' CD1' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -49.27 -45.26 44.68 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.124 -0.985 . . . . 0.0 110.255 -179.493 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.05 -42.29 48.11 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.431 -0.793 . . . . 0.0 109.542 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.435 HD11 ' HB3' ' A' ' 15' ' ' TRP . 6.4 mt -60.55 -58.67 7.5 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.475 -0.766 . . . . 0.0 110.178 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.514 ' HA ' ' CB ' ' A' ' 36' ' ' ALA . 7.6 mt -51.15 -42.53 60.85 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.363 -0.835 . . . . 0.0 109.561 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -76.14 -9.43 58.62 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.625 -0.672 . . . . 0.0 110.571 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -93.9 -13.58 26.99 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.144 -0.972 . . . . 0.0 111.081 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 137.74 -0.79 2.79 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.581 -1.295 . . . . 0.0 110.909 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.514 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . . . -46.41 151.31 0.55 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.017 -1.284 . . . . 0.0 110.174 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.401 HD22 ' CB ' ' A' ' 40' ' ' ALA . 12.6 tp -90.48 139.25 26.62 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.163 -0.961 . . . . 0.0 110.302 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.432 ' HB2' ' O ' ' A' ' 67' ' ' GLY . 43.6 Cg_endo -72.61 -39.14 2.79 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 O-C-N 123.647 1.341 . . . . 0.0 110.753 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -115.62 60.4 0.71 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.039 -1.038 . . . . 0.0 110.167 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.401 ' CB ' HD22 ' A' ' 37' ' ' LEU . . . -93.11 105.5 15.55 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.454 -0.779 . . . . 0.0 109.722 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.64 102.65 0.75 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.565 1.297 . . . . 0.0 110.188 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -89.4 172.71 8.81 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.499 -0.75 . . . . 0.0 109.973 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' A' ' 44' ' ' TYR . 0.1 OUTLIER -63.2 -157.78 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.32 -0.863 . . . . 0.0 110.407 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.448 ' HB2' ' O ' ' A' ' 43' ' ' SER . 14.0 m-85 64.71 11.01 6.46 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.589 -0.694 . . . . 0.0 111.037 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 59.54 47.02 92.95 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -160.72 -171.3 3.06 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.482 -1.011 . . . . 0.0 110.743 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.625 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 2.1 mmt180 -124.4 -155.04 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.647 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.625 ' CD ' ' CB ' ' A' ' 47' ' ' ARG . 47.9 Cg_endo -75.72 166.64 27.93 Favored 'Trans proline' 0 N--CA 1.484 0.965 0 O-C-N 122.501 0.738 . . . . 0.0 110.727 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.478 ' HB ' ' O ' ' A' ' 48' ' ' PRO . 5.0 mt 65.97 -53.83 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.756 -0.59 . . . . 0.0 110.862 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.517 ' CG ' ' HB3' ' A' ' 81' ' ' PRO . 73.9 mt-30 -50.38 -29.17 9.45 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.772 -1.205 . . . . 0.0 110.187 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.436 ' O ' ' CB ' ' A' ' 21' ' ' ALA . 10.6 p -99.09 7.31 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.537 -0.727 . . . . 0.0 109.71 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.484 ' SD ' ' HB ' ' A' ' 59' ' ' VAL . 44.4 ttp -66.56 161.62 22.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.557 -0.714 . . . . 0.0 110.127 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 48.7 ttp -70.28 -4.34 21.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.259 -0.9 . . . . 0.0 110.213 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.467 ' CE ' ' CE ' ' A' ' 52' ' ' MET . 0.0 OUTLIER 53.96 23.79 4.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.003 -1.061 . . . . 0.0 110.069 -179.797 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.54 ' HA2' ' CE1' ' A' ' 90' ' ' PHE . . . -123.95 -5.63 7.41 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.48 90.4 2.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.334 -1.098 . . . . 0.0 110.129 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.43 ' CB ' ' HB3' ' A' ' 92' ' ' ASP . . . -53.48 -24.83 14.09 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.087 -1.008 . . . . 0.0 109.872 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.9 -48.37 64.17 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.549 -0.72 . . . . 0.0 110.442 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.484 ' HB ' ' SD ' ' A' ' 52' ' ' MET . 32.1 t -59.36 -57.74 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.189 -0.944 . . . . 0.0 109.694 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -46.46 -59.71 2.8 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.429 -0.794 . . . . 0.0 110.091 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.448 ' O ' ' HB3' ' A' ' 65' ' ' LEU . 17.1 tt0 -46.68 -43.47 17.8 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.382 -0.824 . . . . 0.0 109.208 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.515 ' CD1' ' HA ' ' A' ' 29' ' ' ARG . 0.3 OUTLIER -57.65 -64.74 0.79 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.284 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.47 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 2.6 mt -56.46 -48.94 76.01 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.441 ' HB2' ' O ' ' A' ' 60' ' ' ALA . 0.3 OUTLIER -56.39 -56.67 18.2 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.469 -0.77 . . . . 0.0 109.659 179.323 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.448 ' HB3' ' O ' ' A' ' 61' ' ' GLU . 9.5 tp -53.06 -30.35 35.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.311 -0.868 . . . . 0.0 109.185 179.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.476 ' CE1' ' HB3' ' A' ' 32' ' ' LEU . 1.5 m-70 -86.2 -21.3 27.54 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.716 -0.615 . . . . 0.0 109.652 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 38' ' ' PRO . . . 110.49 48.81 0.73 Allowed Glycine 0 N--CA 1.482 1.72 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 178.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.47 ' CB ' ' HB3' ' A' ' 63' ' ' LEU . . . -64.5 -150.85 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.885 -1.362 . . . . 0.0 109.402 179.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.459 ' HG3' ' HD2' ' A' ' 48' ' ' PRO . 1.7 mm-40 -119.61 53.37 2.41 Favored Pre-proline 0 C--N 1.301 -1.508 0 O-C-N 121.357 -0.84 . . . . 0.0 109.58 178.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.437 ' HG3' ' HG ' ' A' ' 64' ' ' LEU . 47.3 Cg_endo -70.4 -16.33 34.85 Favored 'Trans proline' 0 C--N 1.317 -1.082 0 O-C-N 123.755 1.397 . . . . 0.0 109.99 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -95.41 -57.27 2.45 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.516 -0.74 . . . . 0.0 110.002 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.51 178.15 0.16 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.442 -0.786 . . . . 0.0 110.215 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -150.7 -152.61 0.44 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.512 -0.742 . . . . 0.0 109.914 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.421 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 39.1 m-20 -116.78 130.44 24.56 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.341 -0.849 . . . . 0.0 109.263 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.474 ' O ' ' CB ' ' A' ' 76' ' ' ALA . 42.0 Cg_endo -69.74 -177.2 1.76 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.426 1.224 . . . . 0.0 110.322 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.474 ' CB ' ' O ' ' A' ' 75' ' ' PRO . . . 71.42 -58.59 0.57 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.475 -0.766 . . . . 0.0 109.802 -178.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.57 0.45 13.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.16 -0.962 . . . . 0.0 110.621 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.49 ' HB3' ' O ' ' A' ' 107' ' ' ARG . 1.2 mt 48.62 53.37 12.31 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.222 -0.924 . . . . 0.0 111.41 179.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 60.2 m -88.42 98.51 11.66 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.086 -1.009 . . . . 0.0 110.474 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.545 ' CG ' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -74.18 165.77 50.53 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.326 -0.859 . . . . 0.0 109.392 179.368 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.545 ' HD2' ' CG ' ' A' ' 80' ' ' ARG . 45.4 Cg_endo -79.14 -0.71 10.98 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 O-C-N 123.308 1.162 . . . . 0.0 110.339 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.418 ' CG2' ' O ' ' A' ' 103' ' ' ARG . 22.1 t -76.93 -31.55 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.558 -0.714 . . . . 0.0 109.391 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.476 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 5.7 m80 -70.65 -36.69 73.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.519 -0.738 . . . . 0.0 109.44 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.513 ' O ' ' HB3' ' A' ' 87' ' ' ARG . 67.8 m-20 -54.0 -50.24 67.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.68 -0.637 . . . . 0.0 109.688 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.457 ' CB ' HD13 ' A' ' 94' ' ' LEU . . . -55.81 -67.91 0.25 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.142 -0.974 . . . . 0.0 109.356 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.564 ' O ' ' CD2' ' A' ' 123' ' ' HIS . . . -52.92 -38.64 62.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.287 -0.883 . . . . 0.0 110.892 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.513 ' HB3' ' O ' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -44.9 -47.16 11.2 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.51 -0.744 . . . . 0.0 110.894 -179.307 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -97.12 8.38 44.63 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.209 -0.932 . . . . 0.0 110.156 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.421 ' HA3' ' ND1' ' A' ' 123' ' ' HIS . . . 70.87 40.85 63.44 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.154 -1.579 . . . . 0.0 109.154 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.54 ' CE1' ' HA2' ' A' ' 55' ' ' GLY . 1.9 t80 -106.88 116.41 31.88 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.315 -1.109 . . . . 0.0 110.673 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.416 HD11 ' O ' ' A' ' 125' ' ' ASP . 0.4 OUTLIER -94.77 -42.67 8.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.633 -0.667 . . . . 0.0 110.844 -179.487 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.43 ' HB3' ' CB ' ' A' ' 57' ' ' ALA . 92.1 m-20 -43.64 -44.46 6.36 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.383 -0.823 . . . . 0.0 109.734 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.4 m -66.41 -49.06 68.07 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.513 ' CD2' ' HG ' ' A' ' 130' ' ' LEU . 4.2 tp -53.38 -39.93 64.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.583 -0.698 . . . . 0.0 109.529 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 84.4 t -62.59 -53.16 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.375 -0.828 . . . . 0.0 108.964 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.406 HG11 ' HG3' ' A' ' 61' ' ' GLU . 63.7 t -50.23 -47.97 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.512 -0.742 . . . . 0.0 109.653 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.402 ' HA ' HD13 ' A' ' 64' ' ' LEU . 1.2 mp -56.9 -45.27 82.73 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.619 -0.676 . . . . 0.0 109.679 179.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -75.79 -29.36 58.71 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.368 -0.833 . . . . 0.0 109.874 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.72 -13.14 61.86 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.374 -0.829 . . . . 0.0 110.735 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.413 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -118.98 -93.24 0.52 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.315 -0.866 . . . . 0.0 110.792 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -156.71 45.21 0.51 Allowed Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.512 -1.328 . . . . 0.0 110.298 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -78.03 -171.4 2.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.09 -1.241 . . . . 0.0 109.692 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.427 ' C ' ' HG ' ' A' ' 104' ' ' LEU . 15.8 tpt180 -123.44 137.98 54.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.181 -0.949 . . . . 0.0 109.947 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.512 ' O ' ' HA ' ' A' ' 134' ' ' ALA . 14.0 mt -135.63 64.91 1.56 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.283 -0.885 . . . . 0.0 110.204 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -174.68 38.77 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.874 -1.142 . . . . 0.0 110.159 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.43 HG11 ' HD3' ' A' ' 80' ' ' ARG . 12.6 p -110.19 173.92 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.348 -0.845 . . . . 0.0 110.433 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.49 ' O ' ' HB3' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -127.91 138.66 52.74 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.145 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 28.0 p-10 . . . . . 0 N--CA 1.497 1.912 0 O-C-N 121.353 -0.842 . . . . 0.0 111.121 -179.14 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.415 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.415 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 41.8 Cg_endo -69.02 -30.12 26.27 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.452 1.238 . . . . 0.0 109.982 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.432 ' HB ' ' HB3' ' A' ' 130' ' ' LEU . 10.9 p -82.63 -37.63 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.343 -0.848 . . . . 0.0 109.769 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -54.19 -38.44 65.61 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.431 -0.793 . . . . 0.0 109.985 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.22 -54.07 16.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.505 -0.747 . . . . 0.0 110.038 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -46.02 -56.03 6.08 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.454 -0.779 . . . . 0.0 110.785 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -58.88 -28.46 66.17 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.296 -0.878 . . . . 0.0 109.927 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -75.32 -49.73 18.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.432 -0.792 . . . . 0.0 109.84 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.7 mt -73.77 -91.36 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.329 -0.857 . . . . 0.0 109.95 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -173.91 31.02 0.1 OUTLIER Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.684 -1.246 . . . . 0.0 110.106 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.564 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 50.4 m-70 -102.59 44.2 1.03 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.267 -1.137 . . . . 0.0 109.349 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.7 mtm180 -46.07 -40.26 10.53 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.737 -0.602 . . . . 0.0 109.967 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.416 ' O ' HD11 ' A' ' 91' ' ' LEU . 10.0 m-20 -55.82 -45.65 78.27 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.501 HG11 ' CD2' ' A' ' 94' ' ' LEU . 16.8 t -78.05 -40.45 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 119.666 -0.814 . . . . 0.0 109.087 178.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.57 -58.31 8.86 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.593 -0.692 . . . . 0.0 109.677 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.414 ' NH1' ' HG3' ' A' ' 128' ' ' ARG . 38.1 ttm-85 -45.2 -59.79 2.45 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.69 -0.631 . . . . 0.0 109.92 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.451 ' CD1' ' C ' ' A' ' 129' ' ' TYR . 5.7 t80 -57.53 -45.76 84.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.582 -0.699 . . . . 0.0 109.214 178.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.513 ' HG ' ' CD2' ' A' ' 94' ' ' LEU . 7.2 mt -54.86 -41.47 70.83 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.561 -0.712 . . . . 0.0 110.952 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 39.7 ttp85 -62.52 -40.2 96.0 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.253 -0.905 . . . . 0.0 110.202 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -81.04 -30.12 34.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.264 -0.898 . . . . 0.0 110.304 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -89.58 -18.02 27.39 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.214 -0.929 . . . . 0.0 110.164 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.512 ' HA ' ' O ' ' A' ' 104' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.18 -0.95 . . . . 0.0 110.586 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.9 t70 . . . . . 0 N--CA 1.498 1.933 0 CA-C-O 120.69 0.281 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.495 ' CB ' HD21 ' A' ' 31' ' ' LEU . 49.1 m0 -68.19 -12.66 61.33 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.176 -0.952 . . . . 0.0 110.68 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.515 ' CD1' HD21 ' A' ' 63' ' ' LEU . 35.6 mt -76.13 -60.78 2.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.166 -0.959 . . . . 0.0 109.477 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.431 ' HA ' ' HB3' ' A' ' 20' ' ' ALA . . . -57.55 -48.2 79.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.519 -0.738 . . . . 0.0 109.861 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.468 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.6 OUTLIER -44.44 -55.27 5.17 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.444 -0.785 . . . . 0.0 110.536 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.462 ' HB1' HG21 ' A' ' 28' ' ' VAL . . . -71.8 -32.4 67.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.145 -0.972 . . . . 0.0 109.942 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.474 ' CB ' HG13 ' A' ' 59' ' ' VAL . . . -67.73 -45.88 73.76 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.208 -0.933 . . . . 0.0 109.962 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.14 -25.67 68.46 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.48 -0.762 . . . . 0.0 109.616 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -104.83 25.93 9.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.453 -0.78 . . . . 0.0 110.306 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.408 ' HA3' ' HE2' ' A' ' 53' ' ' MET . . . 48.4 66.79 1.9 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.3 54.61 1.94 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.44 -1.035 . . . . 0.0 109.409 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.504 HG21 ' CG2' ' A' ' 59' ' ' VAL . 45.1 t -46.1 -56.93 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.535 -0.728 . . . . 0.0 110.869 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -40.78 -50.91 3.15 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.724 -0.61 . . . . 0.0 110.954 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.448 ' OE1' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -58.77 -41.28 86.24 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.194 -0.942 . . . . 0.0 109.622 179.592 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.462 HG21 ' HB1' ' A' ' 19' ' ' ALA . 13.6 t -69.81 -49.78 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.503 -0.748 . . . . 0.0 110.289 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.565 ' HA ' ' CD1' ' A' ' 62' ' ' LEU . 4.4 mmt180 -41.65 -52.3 3.85 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.514 -0.741 . . . . 0.0 110.122 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.462 ' O ' ' HB1' ' A' ' 34' ' ' ALA . . . -74.41 -53.35 9.75 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.809 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.495 HD21 ' CB ' ' A' ' 15' ' ' TRP . 4.7 mt -47.73 -62.74 1.31 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.431 -0.793 . . . . 0.0 110.998 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.589 ' HB3' HD21 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -44.1 -57.5 3.36 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.571 -0.706 . . . . 0.0 110.379 179.89 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -66.27 -10.88 46.65 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.667 -0.646 . . . . 0.0 110.526 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' A' ' 30' ' ' ALA . . . -86.8 -11.86 49.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.067 -1.02 . . . . 0.0 110.239 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 130.19 -6.45 6.02 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.907 -1.139 . . . . 0.0 110.999 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.456 ' CB ' ' CD2' ' A' ' 16' ' ' LEU . . . -42.78 155.9 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.19 -1.183 . . . . 0.0 110.636 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.501 ' HB3' ' CB ' ' A' ' 40' ' ' ALA . 3.2 tp -80.91 131.03 61.21 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.228 -0.92 . . . . 0.0 110.858 -178.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.416 ' O ' ' HA ' ' A' ' 68' ' ' ALA . 49.0 Cg_endo -74.4 -15.64 22.24 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.841 1.443 . . . . 0.0 110.8 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.415 ' ND2' ' HG2' ' A' ' 69' ' ' GLU . 0.5 OUTLIER -128.38 25.72 5.76 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.101 -0.999 . . . . 0.0 110.475 -179.636 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.501 ' CB ' ' HB3' ' A' ' 37' ' ' LEU . . . -66.46 123.92 86.85 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.254 -0.904 . . . . 0.0 109.873 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -76.75 149.19 29.54 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.673 1.354 . . . . 0.0 110.319 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -81.16 -163.27 0.58 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.544 -0.723 . . . . 0.0 109.922 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.407 ' C ' ' CD1' ' A' ' 44' ' ' TYR . 0.1 OUTLIER -99.12 6.17 46.59 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.883 -1.136 . . . . 0.0 110.571 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.407 ' CD1' ' C ' ' A' ' 43' ' ' SER . 2.4 m-85 -119.01 36.37 4.48 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.28 -0.887 . . . . 0.0 109.434 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.41 28.33 35.66 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.74 -157.46 0.61 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.55 -0.97 . . . . 0.0 110.822 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.553 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 0.3 OUTLIER -121.2 -173.14 0.25 Allowed Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.33 -0.856 . . . . 0.0 110.638 -178.604 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.553 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 42.2 Cg_endo -77.99 -26.52 6.52 Favored 'Trans proline' 0 C--N 1.32 -0.958 0 O-C-N 123.467 1.246 . . . . 0.0 111.438 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 12.0 mt -109.71 -37.65 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 120.768 -1.207 . . . . 0.0 109.389 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 81' ' ' PRO . 2.5 tt0 -53.8 -16.67 1.85 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.691 -0.63 . . . . 0.0 110.686 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.48 ' O ' HG21 ' A' ' 51' ' ' VAL . 7.4 p -114.35 6.78 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.023 -1.048 . . . . 0.0 111.225 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.462 ' CG ' ' HE1' ' A' ' 54' ' ' MET . 0.0 OUTLIER -67.92 168.54 11.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.774 -1.204 . . . . 0.0 109.495 179.825 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.436 ' SD ' ' HA3' ' A' ' 55' ' ' GLY . 3.1 tmm? -67.8 -1.92 6.28 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.21 -0.931 . . . . 0.0 111.301 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.493 ' HE3' ' CB ' ' A' ' 84' ' ' ASP . 12.9 mmt 48.56 23.04 0.56 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.259 -0.901 . . . . 0.0 110.361 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.436 ' HA3' ' SD ' ' A' ' 53' ' ' MET . . . -120.46 3.19 12.39 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.279 -1.928 . . . . 0.0 108.279 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.41 74.07 1.45 Allowed 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.75 -0.853 . . . . 0.0 108.88 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.46 ' HB2' ' HB2' ' A' ' 92' ' ' ASP . . . -43.71 -27.57 0.33 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.421 -0.8 . . . . 0.0 110.151 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.37 -49.33 44.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.541 -0.724 . . . . 0.0 109.639 178.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.504 ' CG2' HG21 ' A' ' 25' ' ' VAL . 63.5 t -48.72 -59.87 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.659 -0.65 . . . . 0.0 109.945 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.474 ' O ' ' CB ' ' A' ' 64' ' ' LEU . . . -45.45 -46.23 13.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.676 -0.64 . . . . 0.0 109.794 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.553 ' O ' ' HB3' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -51.19 -59.66 3.95 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.657 -0.652 . . . . 0.0 109.516 178.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.589 HD21 ' HB3' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -46.52 -72.27 0.06 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.609 -0.682 . . . . 0.0 110.373 179.114 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.575 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 4.0 mt -51.22 -50.08 59.83 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.393 -0.817 . . . . 0.0 110.616 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.544 HD12 ' CG1' ' A' ' 96' ' ' VAL . 0.9 OUTLIER -59.11 -59.14 5.94 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.489 -0.757 . . . . 0.0 110.744 -179.628 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.553 ' HB3' ' O ' ' A' ' 61' ' ' GLU . 0.8 OUTLIER -48.76 -34.58 12.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.318 -0.864 . . . . 0.0 108.736 179.755 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.444 ' ND1' ' CD1' ' A' ' 32' ' ' LEU . 0.3 OUTLIER -82.11 -30.59 31.12 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.282 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 63' ' ' LEU . . . 124.0 52.76 0.19 Allowed Glycine 0 N--CA 1.479 1.561 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.575 ' HB1' ' HB3' ' A' ' 63' ' ' LEU . . . -62.19 -154.24 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.08 -1.247 . . . . 0.0 109.529 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.467 ' HB2' ' HB3' ' A' ' 47' ' ' ARG . 4.8 mt-10 -121.31 55.9 5.49 Favored Pre-proline 0 C--N 1.302 -1.499 0 O-C-N 121.33 -0.857 . . . . 0.0 109.448 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 69' ' ' GLU . 40.6 Cg_endo -66.28 -10.46 27.55 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.847 1.446 . . . . 0.0 110.351 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.489 ' OD1' ' HA ' ' A' ' 102' ' ' ALA . 72.2 m-20 -99.06 -72.87 0.64 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.193 -0.942 . . . . 0.0 110.146 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -42.89 161.8 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.663 -0.648 . . . . 0.0 110.953 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.468 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -148.2 -149.27 0.29 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.383 -0.823 . . . . 0.0 110.184 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.535 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -105.06 135.21 19.33 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 120.956 -1.09 . . . . 0.0 110.269 -179.724 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.28 -22.04 22.5 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 N-CA-C 109.239 -1.1 . . . . 0.0 109.239 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.73 -67.77 0.26 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.588 -0.695 . . . . 0.0 109.677 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.468 ' OG1' ' OG1' ' A' ' 79' ' ' THR . 14.6 p -124.82 27.47 6.79 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.391 -0.818 . . . . 0.0 109.342 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.535 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 1.3 mt 43.94 38.21 2.08 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.464 -0.772 . . . . 0.0 110.659 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.472 ' HA ' ' OD2' ' A' ' 108' ' ' ASP . 22.2 m -73.04 100.87 3.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.443 -0.786 . . . . 0.0 109.637 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.509 ' HB2' ' CG1' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -71.12 162.47 72.29 Favored Pre-proline 0 C--N 1.302 -1.471 0 O-C-N 121.401 -0.812 . . . . 0.0 110.806 -179.48 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.476 ' HD2' ' CG ' ' A' ' 80' ' ' ARG . 42.3 Cg_endo -69.95 -14.93 36.11 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 O-C-N 124.444 1.76 . . . . 0.0 110.219 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.545 HG21 ' CG ' ' A' ' 104' ' ' LEU . 20.1 t -68.38 -29.44 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.522 -0.737 . . . . 0.0 110.102 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.475 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 6.2 m80 -70.77 -28.53 64.74 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.393 -0.817 . . . . 0.0 109.136 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.493 ' CB ' ' HE3' ' A' ' 54' ' ' MET . 72.2 m-20 -62.23 -57.13 12.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.35 -0.844 . . . . 0.0 110.042 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -49.46 -57.48 6.93 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.452 -0.78 . . . . 0.0 109.757 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.532 ' O ' ' CG ' ' A' ' 123' ' ' HIS . . . -57.19 -50.17 73.67 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.282 -0.886 . . . . 0.0 109.936 179.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.44 ' HD3' HD11 ' A' ' 121' ' ' LEU . 1.7 mmt85 -47.52 -21.51 0.35 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.588 -0.695 . . . . 0.0 111.483 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.441 ' HG2' ' HB2' ' A' ' 54' ' ' MET . 3.8 mp0 -110.69 -7.65 14.64 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.201 -0.937 . . . . 0.0 110.479 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.45 ' HA2' ' HB3' ' A' ' 123' ' ' HIS . . . 78.15 22.53 68.06 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.477 ' O ' HD13 ' A' ' 94' ' ' LEU . 0.4 OUTLIER -95.22 111.79 23.59 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.533 -0.981 . . . . 0.0 110.427 -179.628 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.494 ' CD2' HG22 ' A' ' 126' ' ' VAL . 0.5 OUTLIER -82.43 -45.14 15.18 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.551 -0.718 . . . . 0.0 110.252 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.46 ' HB2' ' HB2' ' A' ' 57' ' ' ALA . 20.9 m-20 -41.47 -43.56 2.66 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.548 0.69 . . . . 0.0 109.535 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.4 ' O ' ' HB ' ' A' ' 96' ' ' VAL . 11.5 m -61.24 -59.58 5.09 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.753 -0.592 . . . . 0.0 109.596 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.479 HD13 ' HA ' ' A' ' 91' ' ' LEU . 0.6 OUTLIER -46.75 -38.88 10.7 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.379 -0.826 . . . . 0.0 109.395 179.49 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.484 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 58.0 t -66.41 -43.88 90.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.544 ' CG1' HD12 ' A' ' 64' ' ' LEU . 45.8 t -58.58 -55.73 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.436 ' C ' ' CB ' ' A' ' 102' ' ' ALA . 6.5 mp -47.21 -61.47 1.88 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.423 -0.798 . . . . 0.0 110.133 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -61.16 -36.01 78.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.162 -0.961 . . . . 0.0 109.838 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.484 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 1.1 mtp-105 -58.4 -13.18 4.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.394 -0.816 . . . . 0.0 110.536 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.482 ' HB2' ' CD2' ' A' ' 64' ' ' LEU . . . -146.58 61.8 1.21 Allowed 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.228 -0.92 . . . . 0.0 110.625 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 60.08 107.9 0.01 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.356 -1.097 . . . . 0.0 110.356 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.489 ' HA ' ' OD1' ' A' ' 71' ' ' ASN . . . -165.64 89.36 0.44 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.423 -1.045 . . . . 0.0 110.39 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.5 96.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.968 -1.082 . . . . 0.0 109.776 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.545 ' CG ' HG21 ' A' ' 82' ' ' VAL . 1.8 mp -87.45 41.87 1.01 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.214 -0.929 . . . . 0.0 110.457 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.587 ' HB2' ' HA ' ' A' ' 134' ' ' ALA . 30.9 t0 -146.9 41.78 1.11 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.905 -1.122 . . . . 0.0 110.829 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.509 ' CG1' ' HB2' ' A' ' 80' ' ' ARG . 7.1 p -99.01 177.13 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.378 -0.826 . . . . 0.0 109.754 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.441 ' HG2' HD21 ' A' ' 113' ' ' LEU . 8.8 mtm180 -111.62 136.79 50.36 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.372 -0.83 . . . . 0.0 109.933 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.472 ' OD2' ' HA ' ' A' ' 79' ' ' THR . 5.5 t70 . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.409 -0.807 . . . . 0.0 109.447 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.513 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 16.2 mt . . . . . 0 N--CA 1.494 1.774 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 38.2 Cg_endo -64.97 -36.24 39.4 Favored 'Trans proline' 0 N--CA 1.49 1.295 0 O-C-N 123.674 1.355 . . . . 0.0 110.155 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.7 p -78.9 -33.23 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.439 -0.788 . . . . 0.0 109.264 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.504 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 3.1 t0 -60.85 -23.98 65.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.507 -0.745 . . . . 0.0 109.898 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.25 -65.12 0.96 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.427 -0.796 . . . . 0.0 110.102 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.484 ' CB ' ' HB2' ' A' ' 123' ' ' HIS . . . -44.48 -53.61 6.8 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.568 -0.707 . . . . 0.0 111.077 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.19 -45.61 75.82 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.291 -0.881 . . . . 0.0 110.444 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.504 ' HB2' ' O ' ' A' ' 116' ' ' ASP . 0.0 OUTLIER -71.51 -45.13 63.27 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.467 -0.77 . . . . 0.0 109.967 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.44 HD11 ' HD3' ' A' ' 87' ' ' ARG . 4.8 mt -69.15 -94.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.615 -0.678 . . . . 0.0 109.92 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -177.26 47.83 0.1 Allowed Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.532 ' CG ' ' O ' ' A' ' 86' ' ' ALA . 71.4 m-70 -124.91 52.55 1.56 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.463 -1.022 . . . . 0.0 109.528 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.434 ' HB2' ' CZ ' ' A' ' 124' ' ' ARG . 26.8 mtm105 -43.59 -49.17 7.64 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.811 -0.556 . . . . 0.0 110.633 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -46.16 -46.88 17.57 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.536 HG13 ' CD1' ' A' ' 130' ' ' LEU . 22.4 t -76.08 -49.91 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.933 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.4 ' HB3' ' HA ' ' A' ' 124' ' ' ARG . . . -43.6 -48.72 7.67 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.321 -0.862 . . . . 0.0 110.19 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 36.7 mtt-85 -64.28 -64.88 0.77 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.502 -0.749 . . . . 0.0 109.754 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -50.27 -41.7 51.0 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.371 -0.831 . . . . 0.0 110.818 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.536 ' CD1' HG13 ' A' ' 126' ' ' VAL . 12.2 mt -58.15 -56.99 14.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.103 -0.998 . . . . 0.0 109.767 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -47.32 -23.44 0.57 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.366 -0.834 . . . . 0.0 110.858 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -83.95 -73.46 0.42 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.197 -0.94 . . . . 0.0 109.921 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.14 -11.72 22.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.167 -0.958 . . . . 0.0 110.377 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.587 ' HA ' ' HB2' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.353 -0.842 . . . . 0.0 109.661 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 121.076 0.465 . . . . 0.0 109.916 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.479 ' O ' HG23 ' A' ' 18' ' ' THR . 31.1 m0 -85.93 -24.88 26.39 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.365 -0.835 . . . . 0.0 110.349 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.427 ' CD1' HD22 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -71.29 -37.24 71.86 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.268 -0.895 . . . . 0.0 109.379 179.511 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.48 ' CB ' ' ND2' ' A' ' 42' ' ' ASN . . . -81.21 -47.92 12.77 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.443 -0.786 . . . . 0.0 110.914 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 15' ' ' TRP . 14.6 t -48.78 -43.06 37.61 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.357 -0.84 . . . . 0.0 111.09 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.428 ' N ' ' CG2' ' A' ' 18' ' ' THR . . . -75.89 -36.52 59.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.192 -0.943 . . . . 0.0 109.999 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.453 ' HA ' HG13 ' A' ' 59' ' ' VAL . . . -69.1 -28.4 66.46 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.126 -0.984 . . . . 0.0 110.088 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.53 -36.02 33.72 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.369 -0.832 . . . . 0.0 110.64 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -84.42 21.95 1.36 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.226 -0.921 . . . . 0.0 110.861 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.428 ' HA3' ' SD ' ' A' ' 53' ' ' MET . . . 44.85 65.01 1.93 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.438 ' HB3' ' HB3' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -133.38 62.82 1.65 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.341 -1.094 . . . . 0.0 109.35 179.374 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 24' ' ' ARG . 77.3 t -34.78 -53.82 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.872 -0.518 . . . . 0.0 111.421 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -53.0 -45.06 67.71 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.355 -0.841 . . . . 0.0 110.683 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.438 ' HB3' ' HB3' ' A' ' 24' ' ' ARG . 2.1 tp10 -64.64 -28.42 69.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.235 -0.916 . . . . 0.0 110.149 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.431 ' O ' ' CD2' ' A' ' 62' ' ' LEU . 47.5 t -85.3 -51.24 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.181 -0.949 . . . . 0.0 110.428 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.49 ' HA ' ' CD2' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -43.44 -48.62 7.2 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.516 -0.74 . . . . 0.0 111.014 -179.916 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.46 -50.02 15.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.48 -0.762 . . . . 0.0 110.391 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 27' ' ' GLU . 10.7 mt -44.48 -61.03 1.68 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.495 -0.753 . . . . 0.0 110.497 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.573 ' CD2' ' CG ' ' A' ' 66' ' ' HIS . 0.4 OUTLIER -57.21 -44.56 83.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.537 -0.727 . . . . 0.0 109.704 179.429 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -68.43 -7.41 31.49 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.36 -0.838 . . . . 0.0 110.562 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -105.32 -18.07 14.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.165 -0.959 . . . . 0.0 111.014 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' A' ' 37' ' ' LEU . . . 161.09 -36.51 0.41 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.538 ' O ' ' HG ' ' A' ' 32' ' ' LEU . . . -45.63 96.31 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.404 -1.057 . . . . 0.0 110.093 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.474 ' HG ' ' HB3' ' A' ' 40' ' ' ALA . 0.8 OUTLIER -66.33 152.03 95.02 Favored Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 121.299 -0.876 . . . . 0.0 110.099 -179.071 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.488 ' HB2' ' HA ' ' A' ' 68' ' ' ALA . 44.3 Cg_endo -70.65 -34.35 11.75 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 124.025 1.539 . . . . 0.0 111.922 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.401 ' C ' HD12 ' A' ' 37' ' ' LEU . 10.2 m120 -88.3 42.73 1.08 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.924 -1.11 . . . . 0.0 110.355 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.474 ' HB3' ' HG ' ' A' ' 37' ' ' LEU . . . -97.7 107.13 37.98 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.289 -0.882 . . . . 0.0 110.097 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -69.94 133.47 25.32 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.644 1.339 . . . . 0.0 109.528 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.48 ' ND2' ' CB ' ' A' ' 17' ' ' ALA . 5.7 m120 -77.05 -176.98 4.23 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.431 -0.793 . . . . 0.0 110.059 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 69.2 m -102.39 23.86 11.18 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.31 -0.869 . . . . 0.0 109.44 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.434 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 7.4 m-85 -122.59 19.24 10.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.73 -0.606 . . . . 0.0 109.479 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.427 ' C ' ' HG2' ' A' ' 46' ' ' ARG . . . 60.94 26.9 66.12 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.447 ' HB3' ' HG2' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -129.1 130.5 46.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.219 -1.165 . . . . 0.0 109.889 -179.772 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.57 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 3.4 mmp_? -48.02 168.95 0.14 Allowed Pre-proline 0 N--CA 1.499 2.016 0 O-C-N 121.574 -0.704 . . . . 0.0 110.475 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 39.2 Cg_endo -67.01 -17.91 51.53 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.562 1.296 . . . . 0.0 110.329 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.538 HG13 HD23 ' A' ' 63' ' ' LEU . 4.9 mt -107.38 -34.16 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 177.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.447 ' HG2' ' HB3' ' A' ' 46' ' ' ARG . 44.6 tt0 -50.45 -24.85 3.37 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.627 -0.671 . . . . 0.0 109.362 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.9 p -99.53 7.93 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.471 -0.768 . . . . 0.0 110.246 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.482 ' HB2' ' O ' ' A' ' 49' ' ' ILE . 2.2 tmm? -61.66 158.07 16.22 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.232 -0.917 . . . . 0.0 109.318 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.487 ' O ' ' HG2' ' A' ' 53' ' ' MET . 54.7 ttp -70.64 -5.29 28.36 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.223 -0.923 . . . . 0.0 110.135 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.539 ' HB3' ' CB ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER 53.53 22.37 2.93 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.053 -1.03 . . . . 0.0 109.519 -179.116 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.564 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -121.38 -7.41 8.31 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.731 -1.747 . . . . 0.0 108.731 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.1 m -134.73 87.13 2.32 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.426 -1.044 . . . . 0.0 109.638 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.409 ' HB3' ' HB3' ' A' ' 92' ' ' ASP . . . -53.48 -25.7 17.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.325 -0.859 . . . . 0.0 109.643 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.409 ' CB ' HG23 ' A' ' 25' ' ' VAL . 5.9 mtt85 -54.8 -38.24 67.06 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.595 -0.691 . . . . 0.0 110.093 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.453 HG13 ' HA ' ' A' ' 20' ' ' ALA . 59.6 t -55.86 -66.71 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.022 -1.048 . . . . 0.0 109.364 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -45.82 -27.78 0.93 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.406 -0.809 . . . . 0.0 109.838 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -59.56 -53.69 55.13 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.428 -0.795 . . . . 0.0 110.152 179.54 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.49 ' CD2' ' HA ' ' A' ' 29' ' ' ARG . 0.5 OUTLIER -65.46 -42.54 92.21 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.239 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.547 ' HB3' ' HB3' ' A' ' 68' ' ' ALA . 0.3 OUTLIER -60.54 -53.54 56.3 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.148 179.729 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.471 ' CD2' ' HA ' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -61.75 -29.81 70.37 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.302 -0.959 . . . . 0.0 108.996 178.648 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.486 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 0.4 OUTLIER -54.92 -49.97 69.97 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.573 ' CG ' ' CD2' ' A' ' 32' ' ' LEU 0.261 80.3 m80 -87.25 -9.19 55.7 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.794 179.639 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 38' ' ' PRO . . . 82.29 71.32 1.31 Allowed Glycine 0 N--CA 1.482 1.741 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.547 ' HB3' ' HB3' ' A' ' 63' ' ' LEU . . . -65.38 -143.9 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.367 -1.078 . . . . 0.0 109.489 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.47 ' HB3' ' CD ' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -116.36 50.51 0.82 Allowed Pre-proline 0 C--N 1.3 -1.584 0 O-C-N 121.174 -0.954 . . . . 0.0 110.236 179.195 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.49 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 50.1 Cg_endo -72.86 52.39 2.15 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 O-C-N 123.24 1.126 . . . . 0.0 110.266 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.449 ' N ' ' HG3' ' A' ' 81' ' ' PRO . 26.0 m-20 -162.19 -74.64 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.309 -0.87 . . . . 0.0 110.065 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 6.2 m -52.22 118.99 3.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.091 -1.005 . . . . 0.0 109.235 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -107.0 -145.5 0.39 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.433 -0.792 . . . . 0.0 110.477 -178.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER -114.29 134.89 22.18 Favored Pre-proline 0 N--CA 1.487 1.41 0 O-C-N 121.241 -0.912 . . . . 0.0 110.042 -179.879 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -71.58 -9.32 24.87 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.555 1.292 . . . . 0.0 109.96 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.04 -51.15 8.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.274 -0.891 . . . . 0.0 110.107 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 11.5 p -123.29 8.86 9.12 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.527 -0.733 . . . . 0.0 110.504 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 74' ' ' ASP . 0.4 OUTLIER 43.65 37.65 1.64 Allowed 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.543 0.687 . . . . 0.0 110.061 -179.577 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.66 92.16 4.72 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.341 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.556 ' HB2' HG12 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -68.89 171.2 6.73 Favored Pre-proline 0 C--N 1.303 -1.446 0 C-N-CA 119.319 -0.952 . . . . 0.0 108.702 179.799 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.49 ' HG3' ' HA ' ' A' ' 70' ' ' PRO . 40.6 Cg_endo -73.34 1.51 6.67 Favored 'Trans proline' 0 C--N 1.299 -2.073 0 O-C-N 123.88 1.463 . . . . 0.0 110.662 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.413 HG23 HD11 ' A' ' 104' ' ' LEU . 4.3 t -90.18 -36.18 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.298 -0.876 . . . . 0.0 109.412 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.518 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 19.7 m80 -61.69 -28.68 69.58 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.431 0.634 . . . . 0.0 109.506 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.536 ' HB3' ' SD ' ' A' ' 54' ' ' MET . 43.4 m-20 -64.01 -58.78 5.67 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.38 -0.825 . . . . 0.0 110.162 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.547 ' HB3' ' CD1' ' A' ' 94' ' ' LEU . . . -49.86 -67.88 0.22 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.383 -0.823 . . . . 0.0 110.394 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.559 ' O ' ' CG ' ' A' ' 123' ' ' HIS . . . -51.83 -51.4 56.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.351 -0.843 . . . . 0.0 110.94 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.518 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -43.75 -26.58 0.26 Allowed 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.012 -1.055 . . . . 0.0 111.062 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.539 ' CB ' ' HB3' ' A' ' 54' ' ' MET . 5.7 tm-20 -105.78 -15.58 14.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.159 -0.963 . . . . 0.0 110.12 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.413 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 91.52 29.19 12.52 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.126 -1.189 . . . . 0.0 110.126 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.564 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 0.3 OUTLIER -101.52 93.07 5.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.177 -1.19 . . . . 0.0 110.881 179.945 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.409 ' O ' ' HB2' ' A' ' 94' ' ' LEU . 0.3 OUTLIER -66.76 -42.56 85.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.454 -0.778 . . . . 0.0 110.276 179.652 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.409 ' HB3' ' HB3' ' A' ' 57' ' ' ALA . 67.4 t0 -45.52 -51.47 11.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.345 -0.847 . . . . 0.0 110.239 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.493 ' HB ' ' HB2' ' A' ' 85' ' ' ALA . 98.1 m -47.41 -52.42 16.93 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.533 -0.729 . . . . 0.0 109.626 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.547 ' CD1' ' HB3' ' A' ' 85' ' ' ALA . 3.7 mp -51.21 -58.57 5.8 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.422 -0.799 . . . . 0.0 109.785 178.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.479 ' O ' ' CB ' ' A' ' 99' ' ' ARG . 46.8 t -44.07 -51.92 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-O 121.139 0.495 . . . . 0.0 109.834 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.419 HG11 HD12 ' A' ' 64' ' ' LEU . 5.7 t -54.89 -50.78 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.37 -0.831 . . . . 0.0 110.08 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.486 ' HB3' ' CB ' ' A' ' 102' ' ' ALA . 56.5 mt -52.35 -60.84 2.75 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.453 -0.779 . . . . 0.0 110.378 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -68.76 -26.55 65.29 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.435 -0.791 . . . . 0.0 110.446 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.479 ' CB ' ' O ' ' A' ' 95' ' ' VAL . 45.8 ttt85 -70.03 -9.36 55.04 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.187 -0.945 . . . . 0.0 110.637 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.0 -53.4 0.75 Allowed 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.005 -1.059 . . . . 0.0 110.928 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 178.43 110.81 0.28 Allowed Glycine 0 N--CA 1.486 1.982 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.486 ' CB ' ' HB3' ' A' ' 97' ' ' LEU . . . -177.03 141.17 0.33 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.253 -1.145 . . . . 0.0 110.381 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.63 156.39 20.04 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.621 -0.674 . . . . 0.0 109.549 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.468 ' O ' ' HA ' ' A' ' 134' ' ' ALA . 0.3 OUTLIER -144.22 46.11 1.42 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.247 -0.908 . . . . 0.0 110.433 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.418 ' OD2' ' O ' ' A' ' 134' ' ' ALA . 1.1 t70 -152.32 40.2 0.6 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.192 -0.942 . . . . 0.0 110.112 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.556 HG12 ' HB2' ' A' ' 80' ' ' ARG . 4.0 p -104.55 170.21 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.652 -0.655 . . . . 0.0 109.846 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.426 ' N ' ' CG2' ' A' ' 106' ' ' VAL . 11.3 mtp180 -97.84 176.89 5.64 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.541 -0.724 . . . . 0.0 109.812 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.908 . . . . 0.0 109.707 179.575 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.549 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.502 2.141 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.549 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 40.6 Cg_endo -69.3 -33.64 17.87 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 O-C-N 123.586 1.308 . . . . 0.0 109.347 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.448 HG21 ' HG3' ' A' ' 131' ' ' ARG . 12.8 p -78.4 -33.36 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-O 121.535 0.683 . . . . 0.0 109.437 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.89 -34.26 69.01 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.539 -0.725 . . . . 0.0 109.44 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.437 HD23 HD13 ' A' ' 121' ' ' LEU . 0.6 OUTLIER -61.19 -39.36 89.88 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.387 -0.821 . . . . 0.0 110.243 179.805 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.421 ' HB3' ' HB1' ' A' ' 127' ' ' ALA . . . -67.45 -51.96 45.27 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.208 -0.933 . . . . 0.0 110.736 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -46.89 -35.4 6.38 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.348 -0.845 . . . . 0.0 110.545 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.54 -58.83 2.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.35 -0.844 . . . . 0.0 109.575 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.437 HD13 HD23 ' A' ' 117' ' ' LEU . 50.2 mt -53.38 -93.29 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.465 -0.772 . . . . 0.0 110.463 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 178.31 36.9 0.06 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.559 ' CG ' ' O ' ' A' ' 86' ' ' ALA . 35.6 m-70 -108.51 41.33 1.6 Allowed 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.314 -1.109 . . . . 0.0 109.273 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -43.5 -33.57 1.14 Allowed 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.437 0.637 . . . . 0.0 110.16 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -63.72 -41.3 98.1 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.367 -0.833 . . . . 0.0 108.863 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.471 ' CG1' HD23 ' A' ' 94' ' ' LEU . 3.2 t -80.81 -43.9 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.716 -0.615 . . . . 0.0 110.94 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.421 ' HB1' ' HB3' ' A' ' 118' ' ' ALA . . . -51.31 -35.89 39.98 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.279 -0.888 . . . . 0.0 110.034 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.91 -65.98 0.61 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.418 -0.801 . . . . 0.0 109.887 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -54.07 -42.72 69.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.472 -0.768 . . . . 0.0 109.225 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.407 HD13 ' HB1' ' A' ' 86' ' ' ALA . 14.0 mt -55.96 -58.12 9.24 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.823 -0.548 . . . . 0.0 110.281 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.448 ' HG3' HG21 ' A' ' 115' ' ' VAL . 9.4 ttm180 -56.14 -15.68 4.06 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.176 -0.952 . . . . 0.0 110.854 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -82.66 -57.18 3.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.055 -1.028 . . . . 0.0 109.809 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -85.47 -12.32 52.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.562 -0.711 . . . . 0.0 110.501 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 104' ' ' LEU . . . . . . . . 0 N--CA 1.494 1.74 0 O-C-N 121.219 -0.926 . . . . 0.0 110.768 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.6 p30 . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 121.004 0.43 . . . . 0.0 110.698 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.512 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 0.0 OUTLIER -71.6 -5.21 31.77 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.151 -0.968 . . . . 0.0 110.4 179.773 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.505 HD11 HD13 ' A' ' 32' ' ' LEU . 22.7 mt -78.56 -61.48 1.99 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.096 -1.002 . . . . 0.0 109.629 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.0 -43.77 82.08 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.481 -0.762 . . . . 0.0 109.641 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.512 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.8 OUTLIER -54.18 -54.99 32.26 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.642 -0.662 . . . . 0.0 110.292 179.576 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.433 ' CB ' HG23 ' A' ' 28' ' ' VAL . . . -68.54 -40.07 80.87 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.337 -0.852 . . . . 0.0 109.778 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.408 ' C ' ' HA ' ' A' ' 52' ' ' MET . . . -57.62 -50.68 72.33 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.323 -0.861 . . . . 0.0 109.687 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.41 ' CB ' ' O ' ' A' ' 51' ' ' VAL . . . -58.79 -27.16 64.77 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.612 -0.68 . . . . 0.0 110.587 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.37 23.06 4.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.317 -0.864 . . . . 0.0 110.618 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.43 48.81 40.77 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.2 mtm180 -121.55 58.68 0.99 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.388 -1.066 . . . . 0.0 110.164 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.407 HG23 HG22 ' A' ' 59' ' ' VAL . 51.1 t -44.74 -51.43 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.591 -0.693 . . . . 0.0 110.886 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -51.09 -44.04 61.16 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.335 -0.853 . . . . 0.0 110.622 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.25 -39.03 88.84 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.387 -0.821 . . . . 0.0 109.969 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.433 HG23 ' CB ' ' A' ' 19' ' ' ALA . 23.6 t -76.81 -48.41 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.471 -0.768 . . . . 0.0 110.465 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.507 ' HA ' ' CD1' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -46.85 -34.94 5.8 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.348 -0.845 . . . . 0.0 109.7 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.412 ' O ' ' CB ' ' A' ' 34' ' ' ALA . . . -79.88 -51.96 8.48 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.353 -0.842 . . . . 0.0 108.901 178.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 18.6 mt -58.84 -65.13 0.71 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.935 0.874 . . . . 0.0 109.728 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.527 HD22 ' HA ' ' A' ' 63' ' ' LEU . 1.1 tp -47.21 -49.19 23.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.743 -0.598 . . . . 0.0 110.929 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -75.34 -14.56 60.49 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.152 -0.967 . . . . 0.0 110.47 179.617 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.412 ' CB ' ' O ' ' A' ' 30' ' ' ALA . . . -82.64 -9.54 59.34 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.07 -1.019 . . . . 0.0 110.532 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 125.95 17.5 2.51 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.787 -1.197 . . . . 0.0 110.825 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.417 ' HB1' ' HA ' ' A' ' 32' ' ' LEU . . . -64.44 176.04 1.2 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.053 -1.263 . . . . 0.0 110.092 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.456 ' N ' HD22 ' A' ' 37' ' ' LEU . 1.6 mm? -91.46 133.45 31.27 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.264 -0.897 . . . . 0.0 110.281 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -70.89 -49.29 0.41 Allowed 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 123.603 1.317 . . . . 0.0 110.37 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -95.62 18.48 12.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.31 -0.869 . . . . 0.0 110.484 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.4 ' HB3' ' CB ' ' A' ' 37' ' ' LEU . . . -42.38 109.09 0.68 Allowed Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 121.63 -0.669 . . . . 0.0 110.908 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.5 91.89 0.86 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.709 1.373 . . . . 0.0 110.412 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -65.33 -177.83 0.44 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.484 -0.76 . . . . 0.0 109.898 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.33 22.53 2.47 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.209 -0.932 . . . . 0.0 110.422 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.529 ' HB3' ' CD ' ' A' ' 46' ' ' ARG . 2.8 m-85 -103.09 3.86 36.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -0.904 . . . . 0.0 110.681 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 57.06 35.12 67.83 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.529 ' CD ' ' HB3' ' A' ' 44' ' ' TYR . 7.6 ptm180 -160.4 26.11 0.16 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.261 -1.141 . . . . 0.0 110.697 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.475 ' CB ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER 49.04 -174.63 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.038 0 O-C-N 121.552 -0.718 . . . . 0.0 110.154 179.689 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.592 ' O ' ' N ' ' A' ' 50' ' ' GLN . 46.2 Cg_endo -72.43 -167.33 0.32 Allowed 'Trans proline' 0 C--N 1.315 -1.207 0 O-C-N 123.141 1.074 . . . . 0.0 110.538 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.483 ' O ' ' CG ' ' A' ' 52' ' ' MET . 3.5 mt 60.2 -65.59 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.748 -0.595 . . . . 0.0 109.625 -178.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.592 ' N ' ' O ' ' A' ' 48' ' ' PRO . 19.6 mt-30 -45.8 -25.43 0.51 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.959 -1.088 . . . . 0.0 109.803 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.41 ' O ' ' CB ' ' A' ' 21' ' ' ALA . 8.9 p -119.02 40.58 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.485 -0.76 . . . . 0.0 109.789 178.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.483 ' CG ' ' O ' ' A' ' 49' ' ' ILE . 0.1 OUTLIER -102.52 37.62 1.87 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.028 -1.045 . . . . 0.0 110.21 179.863 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.431 ' CB ' ' O ' ' A' ' 52' ' ' MET . 3.6 tmm? 66.34 -11.73 0.22 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.374 -0.829 . . . . 0.0 111.158 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.479 ' H ' ' C ' ' A' ' 52' ' ' MET . 0.0 OUTLIER 48.03 27.55 1.24 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.205 -0.935 . . . . 0.0 110.358 -179.703 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.45 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -125.52 9.5 7.73 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -148.99 81.06 1.43 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.41 -1.053 . . . . 0.0 109.629 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.4 ' HB3' ' CD1' ' A' ' 90' ' ' PHE . . . -49.81 -27.87 5.6 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.464 -0.772 . . . . 0.0 109.775 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.5 mtt85 -52.23 -29.16 21.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.537 -0.727 . . . . 0.0 109.356 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.407 HG22 HG23 ' A' ' 25' ' ' VAL . 29.2 t -71.15 -51.63 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.364 -0.835 . . . . 0.0 108.946 178.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.476 ' O ' ' CB ' ' A' ' 64' ' ' LEU . . . -49.13 -42.31 38.97 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.65 -0.656 . . . . 0.0 109.676 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.488 ' O ' ' HB3' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -61.27 -55.59 30.19 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.486 -0.759 . . . . 0.0 109.317 179.012 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.507 ' CD1' ' HA ' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -44.25 -58.94 2.61 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.468 -0.77 . . . . 0.0 110.152 178.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.527 ' HA ' HD22 ' A' ' 32' ' ' LEU . 13.9 mt -69.43 -41.9 75.71 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.663 -0.648 . . . . 0.0 110.486 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.476 ' CB ' ' O ' ' A' ' 60' ' ' ALA . 0.5 OUTLIER -61.68 -55.49 29.89 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.039 -1.038 . . . . 0.0 109.739 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.488 ' HB3' ' O ' ' A' ' 61' ' ' GLU . 0.6 OUTLIER -53.97 -26.81 27.69 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.379 -0.825 . . . . 0.0 109.458 179.366 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.419 ' ND1' ' CD1' ' A' ' 32' ' ' LEU . 1.0 OUTLIER -88.6 -49.04 7.13 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.518 -0.739 . . . . 0.0 109.8 -179.847 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 151.39 50.64 0.02 OUTLIER Glycine 0 N--CA 1.481 1.676 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.438 ' HB2' ' C ' ' A' ' 63' ' ' LEU . . . -74.05 -157.58 0.05 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.798 -1.413 . . . . 0.0 109.805 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -122.21 63.99 18.69 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.35 -0.844 . . . . 0.0 110.055 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.428 ' CB ' ' HG ' ' A' ' 97' ' ' LEU . 47.3 Cg_endo -72.3 -8.66 23.11 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.858 1.451 . . . . 0.0 110.574 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -108.05 -78.77 0.58 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.291 -0.881 . . . . 0.0 109.549 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.73 -175.82 0.1 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.55 -0.719 . . . . 0.0 110.527 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.473 ' CB ' ' O ' ' A' ' 79' ' ' THR . . . -167.39 -83.19 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.425 -0.797 . . . . 0.0 110.298 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -146.71 123.36 5.73 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.291 -0.881 . . . . 0.0 109.674 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.37 -2.43 11.7 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.511 1.269 . . . . 0.0 110.645 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -96.52 -27.79 14.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.215 -0.928 . . . . 0.0 110.19 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.9 p -137.11 4.56 2.72 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.259 -0.901 . . . . 0.0 111.103 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.403 ' CD2' ' NH1' ' A' ' 80' ' ' ARG . 5.2 mt 47.01 27.93 0.81 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.246 -0.909 . . . . 0.0 111.244 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.473 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 66.4 m -69.66 88.62 0.52 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.963 -1.086 . . . . 0.0 109.783 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.511 ' HG3' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -67.98 165.11 35.14 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.309 -0.869 . . . . 0.0 109.946 -179.605 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.511 ' HD2' ' HG3' ' A' ' 80' ' ' ARG . 46.5 Cg_endo -76.0 -7.98 18.6 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.622 1.328 . . . . 0.0 109.767 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.511 HG22 ' HA ' ' A' ' 104' ' ' LEU . 6.0 t -71.54 -23.92 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.552 -0.717 . . . . 0.0 109.593 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.527 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 4.0 m80 -75.46 -23.39 56.86 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.458 ' HB3' ' SD ' ' A' ' 54' ' ' MET . 51.7 m-20 -75.39 -57.39 3.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.829 -0.544 . . . . 0.0 110.92 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.41 ' HB1' ' CD1' ' A' ' 94' ' ' LEU . . . -53.38 -50.77 64.41 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.194 -0.941 . . . . 0.0 109.507 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.505 ' HA ' ' CG1' ' A' ' 126' ' ' VAL . . . -65.51 -32.05 73.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.455 -0.778 . . . . 0.0 110.105 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.428 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 0.1 OUTLIER -56.18 -51.02 69.54 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.297 -0.877 . . . . 0.0 110.374 -179.851 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.42 ' HB2' ' HB3' ' A' ' 54' ' ' MET . 0.9 OUTLIER -93.28 16.58 12.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.301 -0.874 . . . . 0.0 110.422 -179.793 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.426 ' HA2' ' CG2' ' A' ' 126' ' ' VAL . . . 53.28 55.03 26.49 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.45 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 0.2 OUTLIER -115.5 94.93 4.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.418 -1.048 . . . . 0.0 110.744 -179.349 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.526 ' CD2' HG22 ' A' ' 126' ' ' VAL . 0.3 OUTLIER -66.69 -45.5 78.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.348 -0.845 . . . . 0.0 109.967 179.645 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -47.91 -40.05 20.75 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.52 -0.737 . . . . 0.0 109.723 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.414 ' OG1' ' CD1' ' A' ' 90' ' ' PHE . 7.1 m -66.17 -55.81 14.5 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.613 -0.68 . . . . 0.0 109.252 179.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.465 ' CD2' ' CB ' ' A' ' 130' ' ' LEU . 4.8 tp -52.03 -47.82 64.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.741 -0.6 . . . . 0.0 109.741 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 58.4 t -51.45 -43.76 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.498 -0.751 . . . . 0.0 109.697 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 23.0 t -57.55 -52.5 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.52 -0.738 . . . . 0.0 109.47 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.428 ' HG ' ' CB ' ' A' ' 70' ' ' PRO . 4.7 mp -50.51 -57.51 7.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.563 -0.711 . . . . 0.0 109.995 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -62.39 -30.13 70.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.415 -0.803 . . . . 0.0 109.69 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.9 mtt180 -68.01 -11.93 59.85 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.503 -0.748 . . . . 0.0 110.489 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.43 63.41 1.32 Allowed 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.162 -0.961 . . . . 0.0 110.859 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 53.51 101.53 0.01 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -151.97 101.25 2.72 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.256 -1.143 . . . . 0.0 110.122 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -55.82 93.62 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.493 -0.755 . . . . 0.0 109.92 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.511 ' HA ' HG22 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -84.67 8.38 17.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.35 -0.844 . . . . 0.0 110.548 -179.699 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.404 ' HB3' ' HA ' ' A' ' 134' ' ' ALA . 6.0 p30 -123.85 60.54 1.11 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.097 -1.002 . . . . 0.0 110.827 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.425 HG13 ' CG ' ' A' ' 80' ' ' ARG . 1.7 p -112.21 -170.48 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.134 -0.979 . . . . 0.0 109.766 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -138.54 126.11 22.01 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.298 -0.877 . . . . 0.0 109.788 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.1 t0 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 0.0 109.657 179.918 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.472 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.744 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.472 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 41.3 Cg_endo -68.51 -30.22 29.45 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.385 1.202 . . . . 0.0 109.559 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 4.8 p -82.99 -26.21 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.338 -0.852 . . . . 0.0 109.421 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -56.37 -40.65 74.9 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.502 -0.749 . . . . 0.0 110.664 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.5 pp -77.16 -27.78 53.89 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.217 -0.927 . . . . 0.0 109.94 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -69.21 -26.73 64.96 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.36 -0.838 . . . . 0.0 110.164 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -88.74 -34.35 17.18 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.365 -0.835 . . . . 0.0 109.646 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -74.37 -63.84 1.15 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.405 -0.809 . . . . 0.0 110.535 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.38 -86.77 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.246 -0.909 . . . . 0.0 110.602 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 174.31 52.91 0.05 OUTLIER Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.429 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 44.7 m-70 -120.95 44.22 2.57 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.474 -1.015 . . . . 0.0 109.266 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -43.55 -38.19 2.83 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.759 -0.588 . . . . 0.0 110.538 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.421 ' O ' HD23 ' A' ' 91' ' ' LEU . 80.9 m-20 -56.79 -43.47 80.92 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.526 HG22 ' CD2' ' A' ' 91' ' ' LEU . 2.1 t -82.03 -40.03 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.488 ' O ' ' CB ' ' A' ' 131' ' ' ARG . . . -55.86 -45.4 78.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.394 -0.816 . . . . 0.0 109.657 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -74.9 -52.26 11.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.383 -0.823 . . . . 0.0 109.526 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.513 ' CG ' HD12 ' A' ' 91' ' ' LEU . 80.6 t80 -61.5 -65.16 0.73 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.453 -0.779 . . . . 0.0 110.851 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.465 ' CB ' ' CD2' ' A' ' 94' ' ' LEU . 0.3 OUTLIER -52.34 -26.16 11.57 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.285 -0.884 . . . . 0.0 110.499 -179.147 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.488 ' CB ' ' O ' ' A' ' 127' ' ' ALA . 17.2 ttt-85 -73.12 -42.63 62.68 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.122 -0.986 . . . . 0.0 109.543 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.28 -33.21 72.01 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -89.28 -22.58 22.62 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.426 ' CB ' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.554 -0.716 . . . . 0.0 110.272 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.6 t70 . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 120.841 0.353 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.538 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 27.8 m0 -75.34 -10.87 59.84 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.015 -1.053 . . . . 0.0 110.699 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.51 HD11 HD11 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -78.11 -54.62 6.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.183 -0.948 . . . . 0.0 109.924 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.459 ' N ' ' HG ' ' A' ' 16' ' ' LEU . . . -69.28 -40.03 77.99 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.097 -1.002 . . . . 0.0 109.813 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.538 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 2.8 p -51.43 -56.77 11.42 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.579 -0.7 . . . . 0.0 110.687 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.441 ' CB ' HG23 ' A' ' 28' ' ' VAL . . . -56.49 -38.54 71.89 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.269 -0.895 . . . . 0.0 110.227 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.61 -23.99 66.95 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.292 -0.88 . . . . 0.0 110.14 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.54 -27.65 31.52 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.281 -0.887 . . . . 0.0 110.606 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 -94.31 22.75 5.69 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.293 -0.88 . . . . 0.0 110.454 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 55.57 66.57 2.74 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.75 75.62 1.48 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.382 -1.069 . . . . 0.0 109.588 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.414 HG11 ' HB3' ' A' ' 58' ' ' ARG . 11.6 t -56.19 -53.26 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.357 -0.84 . . . . 0.0 110.246 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -45.92 -42.23 12.52 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.457 -0.777 . . . . 0.0 111.067 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -64.78 -46.64 81.22 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.319 -0.863 . . . . 0.0 109.776 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.477 ' C ' HD22 ' A' ' 62' ' ' LEU . 13.7 t -73.49 -45.41 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.412 -0.805 . . . . 0.0 109.548 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.517 ' HG2' HD21 ' A' ' 62' ' ' LEU . 27.6 mmm-85 -48.53 -43.52 35.42 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.536 -0.727 . . . . 0.0 109.902 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.26 -45.32 33.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.542 -0.724 . . . . 0.0 109.896 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.1 mt -54.42 -56.96 13.37 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.281 -0.887 . . . . 0.0 109.876 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.566 HD22 ' CB ' ' A' ' 66' ' ' HIS . 3.0 mt -57.42 -44.82 84.95 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.394 -0.816 . . . . 0.0 110.077 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -63.18 -17.42 62.37 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.507 -0.746 . . . . 0.0 110.188 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.43 -14.12 31.11 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.325 -0.86 . . . . 0.0 110.167 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.63 28.13 1.64 Allowed Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.951 -1.119 . . . . 0.0 110.403 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.422 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . . . -58.7 152.3 19.11 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.208 -1.172 . . . . 0.0 110.078 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -66.71 122.08 80.5 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.409 -0.807 . . . . 0.0 109.989 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.408 ' HB2' ' HA3' ' A' ' 67' ' ' GLY . 42.4 Cg_endo -68.8 -42.68 4.31 Favored 'Trans proline' 0 C--N 1.312 -1.342 0 O-C-N 123.601 1.316 . . . . 0.0 110.361 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -108.9 56.71 0.62 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.429 -0.794 . . . . 0.0 109.592 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -94.38 117.2 67.05 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.396 -0.815 . . . . 0.0 110.193 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.53 109.56 2.49 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.626 1.329 . . . . 0.0 110.072 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -50.86 175.59 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.448 -0.782 . . . . 0.0 110.882 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.4 t -87.01 4.83 40.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.542 -0.724 . . . . 0.0 110.78 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -117.01 31.33 6.81 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.119 -0.988 . . . . 0.0 109.94 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 55.38 23.47 34.39 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.57 141.31 48.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.405 -1.056 . . . . 0.0 110.049 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.483 ' CG ' ' HB2' ' A' ' 69' ' ' GLU . 0.2 OUTLIER -57.12 176.96 0.21 Allowed Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.543 -0.723 . . . . 0.0 110.417 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 41.1 Cg_endo -67.29 -24.41 43.69 Favored 'Trans proline' 0 C--N 1.315 -1.208 0 O-C-N 123.576 1.303 . . . . 0.0 111.116 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.452 HG23 HD12 ' A' ' 49' ' ' ILE . 7.2 mt -109.01 -31.13 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.9 -1.125 . . . . 0.0 109.064 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.412 ' HA ' ' OD2' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -51.5 -25.9 7.38 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.563 -0.711 . . . . 0.0 109.992 179.365 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.9 p -97.21 3.34 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.21 -0.931 . . . . 0.0 109.881 179.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.431 ' HB3' ' SD ' ' A' ' 54' ' ' MET . 51.6 ttp -56.13 164.54 1.23 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.491 -0.756 . . . . 0.0 110.256 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 3.5 tmm? -75.49 -6.81 52.05 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.252 -0.905 . . . . 0.0 111.0 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.471 ' SD ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 52.55 23.42 2.57 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.181 -0.949 . . . . 0.0 110.192 -179.694 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -122.06 8.45 9.82 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -160.11 106.13 1.56 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.445 -1.033 . . . . 0.0 109.903 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.79 -26.42 68.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.325 -0.86 . . . . 0.0 109.977 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.414 ' HB3' HG11 ' A' ' 25' ' ' VAL . 53.8 mtt180 -50.68 -29.17 10.5 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.348 -0.845 . . . . 0.0 109.858 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.403 ' HB ' ' SD ' ' A' ' 52' ' ' MET . 49.0 t -74.75 -56.31 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.442 ' O ' ' CB ' ' A' ' 64' ' ' LEU . . . -54.09 -45.13 71.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.303 -0.873 . . . . 0.0 109.508 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -61.96 -35.05 77.31 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.273 -0.892 . . . . 0.0 109.197 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.535 ' O ' ' HB2' ' A' ' 66' ' ' HIS . 1.1 tp -71.86 -48.42 46.03 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.525 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 1.0 OUTLIER -72.7 -37.8 67.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.55 -0.719 . . . . 0.0 109.998 179.7 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.442 ' CB ' ' O ' ' A' ' 60' ' ' ALA . 0.6 OUTLIER -65.26 -63.2 1.16 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.431 -0.793 . . . . 0.0 110.411 -179.853 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.402 ' HG ' ' N ' ' A' ' 66' ' ' HIS . 0.4 OUTLIER -52.75 -25.31 10.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.877 . . . . 0.0 109.54 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.566 ' CB ' HD22 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -80.54 -52.13 7.96 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.559 -0.713 . . . . 0.0 109.431 179.412 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.408 ' HA3' ' HB2' ' A' ' 38' ' ' PRO . . . 159.57 32.56 0.02 OUTLIER Glycine 0 N--CA 1.481 1.643 0 C-N-CA 119.672 -1.251 . . . . 0.0 111.456 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.525 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -70.39 172.21 8.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.52 -1.576 . . . . 0.0 109.363 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.483 ' HB2' ' CG ' ' A' ' 47' ' ' ARG . 6.5 mm-40 -108.76 78.61 0.94 Allowed Pre-proline 0 C--N 1.301 -1.51 0 O-C-N 121.341 -0.849 . . . . 0.0 109.54 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.429 ' HB3' ' CD2' ' A' ' 97' ' ' LEU . 43.1 Cg_endo -68.42 -10.75 29.94 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.9 1.474 . . . . 0.0 110.521 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.3 -61.21 1.48 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.102 -0.999 . . . . 0.0 110.036 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 3.9 t -46.51 149.59 0.77 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.462 -0.774 . . . . 0.0 111.108 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -140.43 -148.14 0.24 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.503 -0.748 . . . . 0.0 109.79 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.477 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.4 OUTLIER -104.63 140.41 21.05 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.124 -0.985 . . . . 0.0 109.79 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -76.19 -12.64 19.21 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.345 1.182 . . . . 0.0 110.679 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.53 -43.9 25.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.248 -0.907 . . . . 0.0 110.27 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.22 9.8 4.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.264 -0.897 . . . . 0.0 110.614 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.477 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 0.8 OUTLIER 46.38 40.51 7.97 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.338 -0.851 . . . . 0.0 111.18 179.708 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.3 m -78.45 100.15 6.73 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.917 . . . . 0.0 110.17 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.487 ' CG ' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -69.4 161.78 71.21 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.361 -0.837 . . . . 0.0 109.393 179.769 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.487 ' HD2' ' CG ' ' A' ' 80' ' ' ARG . 44.0 Cg_endo -70.6 -16.68 34.06 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.451 1.238 . . . . 0.0 109.936 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 74.4 t -59.68 -27.79 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.417 -0.802 . . . . 0.0 109.662 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.512 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 4.8 m80 -75.7 -33.93 60.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.496 -0.753 . . . . 0.0 109.056 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.471 ' HB3' ' SD ' ' A' ' 54' ' ' MET . 3.3 m-20 -57.28 -49.03 77.36 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.806 -0.559 . . . . 0.0 109.852 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.448 ' HB1' HD12 ' A' ' 94' ' ' LEU . . . -58.68 -62.27 1.99 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.331 -0.856 . . . . 0.0 109.179 178.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.484 ' O ' ' CD2' ' A' ' 123' ' ' HIS . . . -55.62 -49.57 72.47 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.299 -0.876 . . . . 0.0 110.839 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.4 tpp85 -40.7 -38.99 0.99 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.38 -0.825 . . . . 0.0 111.401 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.37 -2.62 35.82 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.044 -1.035 . . . . 0.0 111.032 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.45 19.1 59.16 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.454 ' O ' ' CD1' ' A' ' 94' ' ' LEU . 1.0 OUTLIER -91.08 132.19 36.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.186 -1.185 . . . . 0.0 109.915 179.736 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.468 ' CD1' ' O ' ' A' ' 125' ' ' ASP . 0.4 OUTLIER -108.76 -43.6 4.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.393 -0.817 . . . . 0.0 110.354 179.859 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -45.82 -29.25 1.28 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.476 -0.765 . . . . 0.0 110.052 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.429 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 11.8 m -73.4 -43.94 59.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.644 -0.66 . . . . 0.0 109.448 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.454 ' CD1' ' O ' ' A' ' 90' ' ' PHE . 0.8 OUTLIER -56.0 -50.29 71.27 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.259 -0.901 . . . . 0.0 110.023 179.716 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.434 ' O ' ' CB ' ' A' ' 99' ' ' ARG . 43.5 t -53.78 -49.43 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.5 -0.75 . . . . 0.0 109.366 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 70.3 t -52.92 -47.71 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.515 -0.74 . . . . 0.0 109.632 179.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.429 ' CD2' ' HB3' ' A' ' 70' ' ' PRO . 96.6 mt -56.66 -72.63 0.07 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.513 -0.742 . . . . 0.0 109.986 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 17.3 t-160 -51.42 -33.35 30.19 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.477 -0.765 . . . . 0.0 110.465 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.434 ' CB ' ' O ' ' A' ' 95' ' ' VAL . 3.5 ttm180 -66.09 -15.49 63.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.41 -0.806 . . . . 0.0 110.517 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.413 ' HB2' ' CD2' ' A' ' 64' ' ' LEU . . . -142.52 75.5 1.49 Allowed 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.106 -0.996 . . . . 0.0 110.955 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 51.47 97.76 0.01 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -164.33 101.62 0.84 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.358 -1.083 . . . . 0.0 110.08 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 11.1 ttt180 -61.0 120.21 9.8 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.462 -0.774 . . . . 0.0 110.198 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.18 10.06 41.25 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.5 -0.75 . . . . 0.0 110.508 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -124.51 55.55 1.32 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.309 -0.869 . . . . 0.0 110.318 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.418 HG22 ' CZ ' ' A' ' 80' ' ' ARG . 2.3 p -106.37 -169.28 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.394 -0.817 . . . . 0.0 109.613 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 6.8 mtt180 -140.31 151.64 45.22 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.333 -0.854 . . . . 0.0 110.019 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.7 0 O-C-N 121.314 -0.867 . . . . 0.0 109.69 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.45 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.45 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 43.3 Cg_endo -70.33 -45.21 1.35 Allowed 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.633 1.333 . . . . 0.0 109.656 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.2 p -62.78 -28.05 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.401 -0.812 . . . . 0.0 109.243 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.3 -40.37 81.8 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.434 -0.791 . . . . 0.0 109.976 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.14 -22.59 64.86 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.397 -0.814 . . . . 0.0 110.128 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.438 ' HB3' ' HB2' ' A' ' 123' ' ' HIS . . . -80.39 -53.97 6.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.375 -0.828 . . . . 0.0 110.429 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -57.63 -27.53 62.88 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.287 -0.883 . . . . 0.0 110.431 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -72.11 -51.39 21.67 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.399 -0.813 . . . . 0.0 110.219 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.492 ' HB2' ' CD2' ' A' ' 123' ' ' HIS . 37.5 mt -85.41 1.17 49.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.312 -0.868 . . . . 0.0 110.599 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 75.72 40.95 30.2 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.492 ' CD2' ' HB2' ' A' ' 121' ' ' LEU . 25.3 m-70 -89.8 55.43 3.17 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.02 -1.282 . . . . 0.0 109.465 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 28.7 mtt-85 -44.48 -38.19 3.96 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.773 -0.579 . . . . 0.0 110.278 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.468 ' O ' ' CD1' ' A' ' 91' ' ' LEU . 0.5 OUTLIER -58.4 -48.36 80.9 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.39 -0.819 . . . . 0.0 109.071 178.919 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.474 HG13 ' HA ' ' A' ' 86' ' ' ALA . 3.5 t -81.33 -43.65 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.473 -0.767 . . . . 0.0 110.244 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -54.71 -49.51 70.57 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.292 -0.88 . . . . 0.0 110.541 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.1 mtp-105 -56.02 -55.13 36.6 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.208 -0.933 . . . . 0.0 110.18 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -65.03 -33.65 76.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.393 -0.817 . . . . 0.0 110.05 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 134' ' ' ALA . 10.9 mt -66.29 -67.96 0.41 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.345 -0.847 . . . . 0.0 110.468 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -48.18 -24.62 1.2 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.353 -0.842 . . . . 0.0 110.857 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -82.81 -53.8 5.6 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.306 -0.871 . . . . 0.0 110.017 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -87.44 5.98 36.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.399 -0.813 . . . . 0.0 111.034 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.495 1.813 0 O-C-N 121.096 -1.003 . . . . 0.0 110.514 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.472 ' O ' ' OG1' ' A' ' 18' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.126 0.488 . . . . 0.0 109.8 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.514 ' CD1' ' N ' ' A' ' 15' ' ' TRP . 37.0 m0 -69.76 -4.79 21.43 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.583 -0.698 . . . . 0.0 110.348 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.494 ' CD2' ' O ' ' A' ' 37' ' ' LEU . 0.8 OUTLIER -78.0 -55.66 5.11 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.268 -0.895 . . . . 0.0 109.641 179.594 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.405 ' N ' ' HG ' ' A' ' 16' ' ' LEU . . . -73.15 -37.3 66.64 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.261 -0.899 . . . . 0.0 110.752 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.489 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.7 OUTLIER -59.91 -50.67 72.85 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.291 -0.881 . . . . 0.0 110.94 -179.559 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.518 ' CB ' HG22 ' A' ' 28' ' ' VAL . . . -61.82 -36.19 80.43 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.276 -0.89 . . . . 0.0 110.526 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.01 -33.38 71.92 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.339 -0.851 . . . . 0.0 110.008 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 51' ' ' VAL . . . -81.34 -28.55 34.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.442 -0.787 . . . . 0.0 110.441 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.4 ttt180 -92.7 32.62 1.21 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.379 -0.826 . . . . 0.0 110.778 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 47.22 47.74 21.02 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.427 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -117.07 95.56 5.05 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.195 -1.179 . . . . 0.0 110.129 179.857 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.441 ' CG1' ' HD3' ' A' ' 29' ' ' ARG . 57.3 t -73.13 -57.59 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.567 -0.708 . . . . 0.0 110.019 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -47.63 -51.42 21.43 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.596 -0.69 . . . . 0.0 111.071 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.415 ' HB3' ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -48.58 -53.75 17.15 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.486 -0.759 . . . . 0.0 110.022 179.827 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.518 HG22 ' CB ' ' A' ' 19' ' ' ALA . 4.8 t -72.98 -50.68 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.365 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.441 ' HD3' ' CG1' ' A' ' 25' ' ' VAL . 0.1 OUTLIER -45.46 -49.62 13.31 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.317 -0.864 . . . . 0.0 109.898 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.12 -35.88 66.63 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.583 -0.698 . . . . 0.0 109.829 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.453 ' C ' ' HB2' ' A' ' 36' ' ' ALA . 14.8 mt -64.19 -58.55 6.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.363 -0.836 . . . . 0.0 110.437 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.499 ' CD2' ' CG ' ' A' ' 66' ' ' HIS . 0.5 OUTLIER -50.05 -37.83 35.18 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.184 -0.948 . . . . 0.0 110.292 -179.568 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -79.33 -16.17 56.75 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.394 -0.816 . . . . 0.0 110.164 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -93.48 -4.98 50.19 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.231 -0.918 . . . . 0.0 111.435 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 134.06 -19.7 4.1 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.434 -1.365 . . . . 0.0 110.937 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.453 ' HB2' ' C ' ' A' ' 31' ' ' LEU . . . -46.12 121.14 3.1 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.07 -1.253 . . . . 0.0 110.594 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.522 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 0.7 OUTLIER -75.48 128.67 83.69 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.396 -0.815 . . . . 0.0 110.421 -179.434 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.484 ' HB2' ' C ' ' A' ' 67' ' ' GLY . 46.3 Cg_endo -68.97 -37.77 10.61 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 O-C-N 123.493 1.259 . . . . 0.0 111.185 -179.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.53 48.95 1.16 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.148 -0.97 . . . . 0.0 110.069 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.522 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -100.87 95.88 5.02 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.189 -0.944 . . . . 0.0 110.192 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.43 128.76 18.84 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.432 1.227 . . . . 0.0 110.245 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -122.18 178.16 5.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.363 -0.836 . . . . 0.0 110.499 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.448 ' O ' ' CB ' ' A' ' 44' ' ' TYR . 1.1 p -60.8 -157.11 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.427 -0.796 . . . . 0.0 110.042 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.454 ' CD2' ' HG3' ' A' ' 46' ' ' ARG . 3.5 t80 68.17 5.87 4.92 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.423 -0.798 . . . . 0.0 110.644 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 52.04 25.65 17.77 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.454 ' HG3' ' CD2' ' A' ' 44' ' ' TYR . 0.1 OUTLIER -116.8 -167.45 1.3 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.317 -1.108 . . . . 0.0 110.87 -179.585 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.579 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -124.3 -161.45 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.805 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -179.884 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.579 ' CD ' ' CB ' ' A' ' 47' ' ' ARG . 51.2 Cg_endo -78.69 -32.19 2.18 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 O-C-N 122.698 0.841 . . . . 0.0 110.921 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.495 HG13 ' CB ' ' A' ' 68' ' ' ALA . 5.7 mt -109.02 -36.77 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 120.869 -1.145 . . . . 0.0 109.91 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.428 ' OE1' ' HA ' ' A' ' 46' ' ' ARG . 17.0 tt0 -48.62 -26.56 2.31 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.248 -0.908 . . . . 0.0 109.518 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.438 ' HB ' ' HB3' ' A' ' 46' ' ' ARG . 8.3 p -97.12 21.39 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.491 -0.756 . . . . 0.0 110.382 179.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.486 ' HB2' ' O ' ' A' ' 49' ' ' ILE . 0.4 OUTLIER -77.18 159.1 29.96 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.139 -0.975 . . . . 0.0 109.761 179.579 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 37.6 ttp -70.09 -5.4 26.6 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.261 -0.899 . . . . 0.0 110.165 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.454 ' SD ' ' N ' ' A' ' 85' ' ' ALA . 16.0 mmt 49.68 28.26 2.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.348 -0.845 . . . . 0.0 109.835 -179.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.439 ' C ' ' CE2' ' A' ' 90' ' ' PHE . . . -124.33 5.7 8.74 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 178.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -156.1 85.72 1.02 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.654 -0.909 . . . . 0.0 109.221 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.402 ' HB2' ' HB3' ' A' ' 92' ' ' ASP . . . -46.98 -26.94 1.12 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.589 -0.694 . . . . 0.0 110.102 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -46.55 -42.71 16.29 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.662 -0.649 . . . . 0.0 109.798 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.9 t -65.74 -60.63 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.63 -0.669 . . . . 0.0 109.282 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -48.43 -47.63 37.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.456 -0.778 . . . . 0.0 109.311 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.485 ' O ' HD23 ' A' ' 65' ' ' LEU . 0.5 OUTLIER -60.19 -40.76 91.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.589 -0.694 . . . . 0.0 109.263 178.685 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.511 ' O ' ' HB2' ' A' ' 66' ' ' HIS . 2.8 tp -66.27 -51.99 51.99 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.461 -0.774 . . . . 0.0 109.474 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.472 ' HB3' ' CG1' ' A' ' 49' ' ' ILE . 2.8 mt -67.86 -41.54 82.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.313 -0.867 . . . . 0.0 110.16 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.463 ' N ' HD13 ' A' ' 49' ' ' ILE . 0.5 OUTLIER -68.78 -57.98 4.84 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.192 -0.943 . . . . 0.0 110.372 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.485 ' CD1' ' C ' ' A' ' 65' ' ' LEU . 1.3 pp -49.94 -25.63 3.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.118 -0.989 . . . . 0.0 109.096 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.511 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 1.4 m-70 -82.11 -51.32 8.11 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.789 -0.569 . . . . 0.0 109.481 179.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.484 ' C ' ' HB2' ' A' ' 38' ' ' PRO . . . 152.74 38.78 0.03 OUTLIER Glycine 0 N--CA 1.485 1.914 0 C-N-CA 120.03 -1.081 . . . . 0.0 110.794 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.495 ' CB ' HG13 ' A' ' 49' ' ' ILE . . . -69.67 -170.19 0.29 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.867 -1.372 . . . . 0.0 110.06 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -109.17 79.37 1.17 Allowed Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.39 -0.818 . . . . 0.0 109.611 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.83 -12.55 31.01 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.8 1.421 . . . . 0.0 110.546 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.527 ' O ' ' NE ' ' A' ' 80' ' ' ARG . 26.3 t-20 -113.43 -58.46 2.15 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.285 -0.884 . . . . 0.0 110.669 -179.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.417 ' C ' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -41.1 137.46 1.31 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.26 -0.9 . . . . 0.0 110.918 -179.515 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -131.43 -155.22 0.68 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.623 -0.673 . . . . 0.0 110.286 -179.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -106.15 145.52 31.11 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.197 -0.939 . . . . 0.0 110.487 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -75.57 -25.4 11.04 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.712 1.375 . . . . 0.0 110.048 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.11 -59.32 5.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.314 -0.866 . . . . 0.0 110.175 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.449 HG21 ' OG1' ' A' ' 79' ' ' THR . 2.2 t -137.0 29.31 2.82 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.337 -0.852 . . . . 0.0 110.908 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 20.2 mt 51.53 52.91 13.72 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.203 -0.936 . . . . 0.0 111.372 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.449 ' OG1' HG21 ' A' ' 77' ' ' THR . 16.7 m -83.41 106.48 15.2 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.032 -1.042 . . . . 0.0 109.736 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.529 ' CG ' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -95.35 170.66 7.5 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.372 -0.83 . . . . 0.0 109.721 179.745 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.529 ' HD2' ' CG ' ' A' ' 80' ' ' ARG . 48.1 Cg_endo -71.74 -0.09 7.83 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.564 1.297 . . . . 0.0 110.425 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.412 HG13 ' CB ' ' A' ' 114' ' ' PRO . 43.3 t -79.87 -45.04 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -0.932 . . . . 0.0 110.279 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.429 ' O ' ' CB ' ' A' ' 87' ' ' ARG . 37.4 m80 -59.01 -37.73 77.58 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.389 -0.819 . . . . 0.0 109.221 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.42 ' HB3' ' CG ' ' A' ' 54' ' ' MET . 62.3 m-20 -54.43 -57.55 10.88 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.714 -0.616 . . . . 0.0 110.566 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.489 ' HB3' ' CD1' ' A' ' 94' ' ' LEU . . . -51.01 -63.83 1.0 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.102 -0.998 . . . . 0.0 109.884 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.584 ' O ' ' CD2' ' A' ' 123' ' ' HIS . . . -56.65 -50.73 71.2 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.337 -0.852 . . . . 0.0 110.687 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.429 ' CB ' ' O ' ' A' ' 83' ' ' HIS . 11.0 tpp85 -43.44 -28.82 0.39 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.294 -0.879 . . . . 0.0 110.852 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -103.59 -11.12 17.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.397 -0.814 . . . . 0.0 110.459 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.35 34.55 12.0 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.439 ' CE2' ' C ' ' A' ' 55' ' ' GLY . 0.4 OUTLIER -108.28 121.15 44.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.112 -1.228 . . . . 0.0 110.732 -179.818 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.417 HD23 ' CD2' ' A' ' 129' ' ' TYR . 0.4 OUTLIER -94.75 -41.65 9.14 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.497 -0.752 . . . . 0.0 110.222 179.737 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.458 ' O ' ' CG2' ' A' ' 96' ' ' VAL . 0.4 OUTLIER -52.05 -30.15 24.46 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.348 -0.845 . . . . 0.0 109.088 179.53 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.4 m -72.85 -38.57 67.03 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.535 ' CD2' ' HG ' ' A' ' 130' ' ' LEU . 1.6 tp -64.42 -47.72 78.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.571 -0.705 . . . . 0.0 109.416 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.429 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 41.4 t -57.2 -48.31 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.47 -0.769 . . . . 0.0 108.951 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.478 HG13 ' HA ' ' A' ' 61' ' ' GLU . 98.7 t -52.56 -53.78 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.781 -0.574 . . . . 0.0 110.072 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.419 ' C ' ' CB ' ' A' ' 102' ' ' ALA . 0.3 OUTLIER -52.56 -65.29 0.58 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.391 -0.818 . . . . 0.0 109.965 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -58.48 -28.47 65.38 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.272 -0.893 . . . . 0.0 110.339 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 17.7 ttp180 -67.16 -15.83 63.94 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.256 -0.903 . . . . 0.0 110.424 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.95 72.35 1.33 Allowed 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.347 -0.845 . . . . 0.0 110.863 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 54.64 102.79 0.01 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.419 ' CB ' ' C ' ' A' ' 97' ' ' LEU . . . -163.57 102.47 0.93 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.333 -1.098 . . . . 0.0 110.167 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -71.63 98.26 1.87 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.428 -0.795 . . . . 0.0 110.015 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.408 ' HA ' ' CG2' ' A' ' 82' ' ' VAL . 1.1 mp -89.9 10.53 23.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.451 -0.78 . . . . 0.0 109.706 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -103.13 36.88 2.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.311 -0.868 . . . . 0.0 110.719 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.498 ' CB ' ' HD3' ' A' ' 80' ' ' ARG . 0.7 OUTLIER -98.25 -171.82 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.024 -1.047 . . . . 0.0 109.77 179.555 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.483 ' N ' HG11 ' A' ' 106' ' ' VAL . 4.4 ptt-85 -140.44 135.48 32.05 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.625 -0.672 . . . . 0.0 109.666 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.445 ' HA ' ' O ' ' A' ' 77' ' ' THR . 41.9 p-10 . . . . . 0 N--CA 1.494 1.764 0 O-C-N 121.125 -0.984 . . . . 0.0 110.615 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.432 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.764 0 CA-C-O 120.534 0.207 . . . . 0.0 110.666 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.432 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 42.1 Cg_endo -68.27 -29.26 32.56 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.674 1.355 . . . . 0.0 110.743 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.488 ' HA ' HD12 ' A' ' 130' ' ' LEU . 9.8 p -78.71 -32.69 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.999 -1.063 . . . . 0.0 109.834 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -64.39 -26.89 68.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.345 -0.847 . . . . 0.0 109.367 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.47 -37.03 74.22 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.506 -0.746 . . . . 0.0 109.636 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.481 ' CB ' ' HB2' ' A' ' 123' ' ' HIS . . . -70.18 -35.89 74.28 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.447 -0.783 . . . . 0.0 109.915 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -63.33 -39.1 93.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.42 -0.8 . . . . 0.0 110.307 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.05 -69.62 0.51 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.371 -0.831 . . . . 0.0 110.396 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.413 HD23 ' NE2' ' A' ' 123' ' ' HIS . 0.2 OUTLIER -47.3 -89.14 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.499 -0.751 . . . . 0.0 111.142 -179.54 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 173.53 36.56 0.04 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.584 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 51.6 m-70 -101.19 43.99 1.03 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.364 -1.08 . . . . 0.0 109.11 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.77 -53.87 4.37 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-O 121.211 0.529 . . . . 0.0 110.698 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.45 -40.29 59.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.422 -0.799 . . . . 0.0 109.426 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.44 ' CG1' ' HA ' ' A' ' 86' ' ' ALA . 2.0 t -78.73 -35.5 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.383 -0.823 . . . . 0.0 109.611 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.06 -48.05 83.0 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.215 -0.928 . . . . 0.0 109.805 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.5 ttm180 -50.0 -63.94 0.96 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.486 -0.759 . . . . 0.0 109.854 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.417 ' CD2' HD23 ' A' ' 91' ' ' LEU . 3.5 t80 -52.93 -55.21 25.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.556 -0.715 . . . . 0.0 110.393 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.535 ' HG ' ' CD2' ' A' ' 94' ' ' LEU . 25.2 mt -48.07 -48.78 33.16 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.558 -0.713 . . . . 0.0 109.945 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.81 -28.95 17.24 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.367 -0.833 . . . . 0.0 109.929 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -89.0 -54.02 4.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.485 -0.759 . . . . 0.0 110.361 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -75.71 -7.49 54.49 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.32 -0.862 . . . . 0.0 110.902 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.71 0 O-C-N 121.094 -1.003 . . . . 0.0 110.067 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 120.755 0.312 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.53 ' CG ' HD13 ' A' ' 31' ' ' LEU . 3.2 t90 -72.49 -2.4 19.5 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.089 -1.007 . . . . 0.0 110.932 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.469 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 31.7 mt -81.58 -53.86 5.9 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.072 -1.017 . . . . 0.0 109.545 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.45 -38.33 87.13 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.605 -0.685 . . . . 0.0 110.245 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.45 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.1 OUTLIER -60.66 -48.58 81.16 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.321 -0.862 . . . . 0.0 109.838 179.572 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.415 ' CB ' HG22 ' A' ' 28' ' ' VAL . . . -67.96 -49.2 63.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.386 -0.821 . . . . 0.0 109.651 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -54.09 -45.42 71.78 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.38 -0.825 . . . . 0.0 109.681 179.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 51' ' ' VAL . . . -68.34 -26.71 65.74 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.474 -0.766 . . . . 0.0 109.986 179.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.5 mtp85 -95.91 27.42 3.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.428 -0.795 . . . . 0.0 110.148 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.09 42.89 40.68 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.24 69.29 0.69 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.401 -1.058 . . . . 0.0 110.667 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.413 ' CG2' HG21 ' A' ' 59' ' ' VAL . 85.9 t -58.71 -54.32 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.255 -0.903 . . . . 0.0 110.288 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -54.18 -41.58 68.7 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.428 -0.795 . . . . 0.0 110.854 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -56.73 -45.23 82.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.192 -0.943 . . . . 0.0 110.035 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.415 HG22 ' CB ' ' A' ' 19' ' ' ALA . 20.1 t -68.72 -36.68 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.248 -0.907 . . . . 0.0 110.176 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.532 ' HA ' ' CD1' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -49.98 -41.86 47.76 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.422 -0.799 . . . . 0.0 109.927 -179.665 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.401 ' O ' ' HB3' ' A' ' 34' ' ' ALA . . . -75.71 -31.32 59.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.443 -0.786 . . . . 0.0 110.239 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.53 HD13 ' CG ' ' A' ' 15' ' ' TRP . 21.8 mt -74.23 -67.51 0.61 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.452 -0.78 . . . . 0.0 110.52 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.46 HD13 ' HG ' ' A' ' 63' ' ' LEU . 6.4 mt -45.58 -45.27 13.53 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.625 -0.672 . . . . 0.0 110.282 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -71.98 -23.88 61.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.527 -0.733 . . . . 0.0 110.405 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 30' ' ' ALA . . . -79.76 -4.66 52.93 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.139 -0.976 . . . . 0.0 110.509 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.23 26.89 4.42 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.467 ' HB2' ' C ' ' A' ' 31' ' ' LEU . . . -71.41 165.28 24.11 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.432 -1.04 . . . . 0.0 110.414 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.444 HD21 ' N ' ' A' ' 40' ' ' ALA . 1.7 tp -98.02 110.7 56.93 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.555 -0.715 . . . . 0.0 110.074 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.471 ' O ' ' HG3' ' A' ' 48' ' ' PRO . 44.3 Cg_endo -70.37 -11.97 30.95 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.445 1.234 . . . . 0.0 110.844 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.43 ' O ' ' HD3' ' A' ' 41' ' ' PRO . 0.7 OUTLIER -103.01 16.05 27.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -0.928 . . . . 0.0 110.029 179.78 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.444 ' N ' HD21 ' A' ' 37' ' ' LEU . . . -76.67 111.29 15.07 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.418 -0.801 . . . . 0.0 110.118 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.43 ' HD3' ' O ' ' A' ' 39' ' ' ASN . 48.1 Cg_endo -72.8 146.61 42.98 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 123.603 1.318 . . . . 0.0 110.358 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -75.64 -156.94 0.06 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.418 -0.801 . . . . 0.0 109.864 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.15 2.14 24.63 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.335 -0.853 . . . . 0.0 110.035 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -102.0 20.49 16.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.269 -0.894 . . . . 0.0 109.907 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.85 40.24 98.57 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.68 -163.18 1.24 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.671 -0.899 . . . . 0.0 110.517 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.432 ' HG2' ' O ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -114.32 176.24 1.57 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.482 -0.761 . . . . 0.0 110.591 -179.243 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.471 ' HG3' ' O ' ' A' ' 38' ' ' PRO . 43.1 Cg_endo -70.97 -20.3 29.3 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.825 1.434 . . . . 0.0 110.791 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.487 ' O ' ' CG ' ' A' ' 52' ' ' MET . 6.3 mt -107.09 -40.28 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.284 -0.885 . . . . 0.0 109.39 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.443 ' HG3' ' HA ' ' A' ' 81' ' ' PRO . 1.1 tt0 -48.46 -28.73 3.49 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.282 -0.886 . . . . 0.0 110.477 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.428 ' O ' HG21 ' A' ' 51' ' ' VAL . 9.1 p -109.88 16.94 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.513 -0.742 . . . . 0.0 110.554 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.487 ' CG ' ' O ' ' A' ' 49' ' ' ILE . 0.5 OUTLIER -84.58 166.72 16.93 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.09 -1.006 . . . . 0.0 110.261 179.533 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -62.26 91.41 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.334 -0.854 . . . . 0.0 109.092 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.569 ' O ' ' CD2' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -56.07 -14.28 2.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.21 -0.931 . . . . 0.0 110.31 -179.429 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.401 ' C ' ' CE2' ' A' ' 90' ' ' PHE . . . -84.11 15.37 39.11 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 178.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -151.06 92.83 1.85 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.208 -1.172 . . . . 0.0 109.987 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.49 -21.06 50.55 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.254 -0.903 . . . . 0.0 109.509 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.84 -28.74 66.35 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.553 -0.717 . . . . 0.0 110.083 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.413 HG21 ' CG2' ' A' ' 25' ' ' VAL . 2.1 t -70.89 -55.21 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.268 -0.895 . . . . 0.0 109.231 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -51.42 -38.12 51.97 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.382 -0.824 . . . . 0.0 109.585 179.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -53.35 -61.1 2.52 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.626 -0.671 . . . . 0.0 110.35 179.818 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.532 ' CD1' ' HA ' ' A' ' 29' ' ' ARG . 0.1 OUTLIER -45.81 -63.62 0.93 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.324 -0.86 . . . . 0.0 110.345 179.74 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.46 ' HG ' HD13 ' A' ' 32' ' ' LEU . 7.0 mt -57.9 -57.19 13.88 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.456 -0.778 . . . . 0.0 110.118 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.476 ' CD2' ' HB3' ' A' ' 100' ' ' ALA . 0.6 OUTLIER -53.21 -54.02 42.22 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.266 -0.896 . . . . 0.0 110.109 179.878 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.472 ' HB3' ' O ' ' A' ' 61' ' ' GLU . 13.2 tp -50.27 -36.76 32.74 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.44 ' CB ' HD22 ' A' ' 32' ' ' LEU . 1.9 m-70 -79.55 -28.24 41.24 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.504 0.669 . . . . 0.0 109.64 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 117.75 50.86 0.35 Allowed Glycine 0 N--CA 1.476 1.344 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.43 ' CB ' ' HB3' ' A' ' 63' ' ' LEU . . . -60.6 -159.94 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.21 -1.17 . . . . 0.0 109.477 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.432 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 0.6 OUTLIER -120.61 59.67 7.41 Favored Pre-proline 0 C--N 1.299 -1.616 0 O-C-N 121.231 -0.918 . . . . 0.0 109.465 178.941 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.438 ' HB2' HD23 ' A' ' 97' ' ' LEU . 47.7 Cg_endo -70.29 57.51 1.72 Allowed 'Trans proline' 0 C--N 1.313 -1.293 0 O-C-N 123.7 1.369 . . . . 0.0 110.415 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -167.3 -62.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.46 -0.775 . . . . 0.0 109.942 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 22.3 m -50.03 138.79 15.06 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.4 -0.812 . . . . 0.0 110.624 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -136.94 -144.07 0.19 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.397 -0.814 . . . . 0.0 110.109 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.3 144.04 28.38 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.006 -1.059 . . . . 0.0 109.906 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -72.59 -53.73 0.14 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.549 1.289 . . . . 0.0 110.55 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.86 -9.14 49.79 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.241 -0.912 . . . . 0.0 109.714 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 79' ' ' THR . 0.2 OUTLIER -153.48 105.03 2.8 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.642 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.444 ' HB2' ' HA ' ' A' ' 108' ' ' ASP . 27.8 mt -67.77 53.29 0.06 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.507 -0.746 . . . . 0.0 111.08 -178.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.541 ' HA ' ' OD1' ' A' ' 108' ' ' ASP . 3.6 m -79.8 85.02 5.51 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.104 -0.997 . . . . 0.0 109.528 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.46 ' CG ' ' HD2' ' A' ' 81' ' ' PRO . 0.1 OUTLIER -71.96 169.95 14.3 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.488 -0.757 . . . . 0.0 109.568 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.46 ' HD2' ' CG ' ' A' ' 80' ' ' ARG . 46.9 Cg_endo -74.42 -2.32 12.23 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.578 1.304 . . . . 0.0 110.391 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.44 HG22 ' HA ' ' A' ' 104' ' ' LEU . 10.5 t -77.7 -31.32 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.465 -0.772 . . . . 0.0 109.766 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.423 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 27.2 m80 -69.78 -27.26 64.76 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.43 -0.794 . . . . 0.0 109.915 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.563 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 1.1 m-20 -67.64 -53.88 24.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.863 -0.523 . . . . 0.0 110.263 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.465 ' HB1' HG22 ' A' ' 93' ' ' THR . . . -50.02 -58.05 6.29 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.538 -0.727 . . . . 0.0 109.581 179.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.594 ' O ' ' ND1' ' A' ' 123' ' ' HIS . . . -63.41 -38.06 89.67 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.47 -0.769 . . . . 0.0 110.52 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.423 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 1.5 mmm-85 -40.7 -59.87 1.28 Allowed 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.116 -0.99 . . . . 0.0 111.125 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -85.18 3.73 37.82 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.232 -0.917 . . . . 0.0 110.156 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.75 48.22 12.99 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.569 ' CD2' ' O ' ' A' ' 54' ' ' MET . 0.3 OUTLIER -111.56 97.49 6.77 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.398 -1.06 . . . . 0.0 111.049 -179.536 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.476 HD11 ' HB3' ' A' ' 125' ' ' ASP . 0.3 OUTLIER -67.06 -42.48 84.69 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.592 -0.692 . . . . 0.0 110.498 179.603 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.4 ' O ' HG22 ' A' ' 96' ' ' VAL . 50.0 m-20 -45.65 -63.61 0.92 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.464 -0.772 . . . . 0.0 110.37 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.465 HG22 ' HB1' ' A' ' 85' ' ' ALA . 70.9 m -47.39 -38.49 13.35 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.702 -0.624 . . . . 0.0 109.549 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.448 HD22 ' HG ' ' A' ' 130' ' ' LEU . 4.1 tp -61.84 -48.85 78.71 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 98.2 t -60.96 -50.87 78.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.459 HG13 ' CD2' ' A' ' 64' ' ' LEU . 95.0 t -48.85 -57.31 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.727 -0.608 . . . . 0.0 110.209 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.438 HD23 ' HB2' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -43.07 -66.26 0.39 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.782 -0.574 . . . . 0.0 110.218 179.885 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -55.37 -32.6 62.72 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.261 -0.899 . . . . 0.0 109.816 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.419 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 0.1 OUTLIER -61.71 -13.87 26.79 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.412 -0.805 . . . . 0.0 110.274 179.439 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.476 ' HB3' ' CD2' ' A' ' 64' ' ' LEU . . . -140.71 56.68 1.58 Allowed 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.374 -0.829 . . . . 0.0 110.575 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 57.7 98.17 0.01 OUTLIER Glycine 0 N--CA 1.489 2.185 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -157.84 95.89 1.44 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.333 -1.098 . . . . 0.0 110.018 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -62.15 106.97 0.8 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.293 -0.88 . . . . 0.0 110.028 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.44 ' HA ' HG22 ' A' ' 82' ' ' VAL . 1.8 mp -96.62 26.75 4.26 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.321 -0.862 . . . . 0.0 109.898 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -123.36 47.52 1.99 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.346 -0.846 . . . . 0.0 110.792 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.444 ' CB ' ' HD3' ' A' ' 80' ' ' ARG . 5.1 p -105.18 -175.33 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.189 -0.944 . . . . 0.0 109.454 179.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -142.56 122.02 13.21 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.187 -0.946 . . . . 0.0 110.83 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.541 ' OD1' ' HA ' ' A' ' 79' ' ' THR . 1.6 m-20 . . . . . 0 N--CA 1.495 1.789 0 O-C-N 121.558 -0.714 . . . . 0.0 109.715 179.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.406 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.712 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.406 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 43.5 Cg_endo -70.37 -31.13 18.33 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.703 1.37 . . . . 0.0 110.768 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.424 HG23 ' N ' ' A' ' 131' ' ' ARG . 9.6 p -80.09 -38.93 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.16 -0.963 . . . . 0.0 110.489 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.409 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 81.7 m-20 -65.86 -34.39 78.02 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.266 -0.897 . . . . 0.0 110.023 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.01 -34.49 78.12 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.261 -0.9 . . . . 0.0 109.925 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.549 ' HA ' ' ND1' ' A' ' 123' ' ' HIS . . . -70.96 -55.23 8.79 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.314 -0.866 . . . . 0.0 110.7 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -46.84 -39.51 12.11 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.403 -0.811 . . . . 0.0 110.622 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -67.51 -51.34 52.23 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.482 -0.761 . . . . 0.0 109.904 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.413 ' HB3' ' NE2' ' A' ' 123' ' ' HIS . 0.2 OUTLIER -67.19 -87.39 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.354 -0.841 . . . . 0.0 110.225 179.807 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 179.36 32.29 0.06 OUTLIER Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.752 -1.213 . . . . 0.0 110.07 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.594 ' ND1' ' O ' ' A' ' 86' ' ' ALA . 0.9 OUTLIER -98.29 45.96 1.01 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.171 -1.193 . . . . 0.0 108.882 179.415 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -44.58 -37.17 3.41 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.502 0.668 . . . . 0.0 109.836 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.476 ' HB3' HD11 ' A' ' 91' ' ' LEU . 0.4 OUTLIER -66.58 -44.66 81.63 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.67 -0.644 . . . . 0.0 109.556 179.058 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.515 HG13 ' HA ' ' A' ' 86' ' ' ALA . 2.4 t -75.52 -44.36 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.229 -0.919 . . . . 0.0 110.031 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.423 ' HB3' ' HB1' ' A' ' 118' ' ' ALA . . . -57.27 -24.18 53.19 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.191 -0.943 . . . . 0.0 109.965 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.74 -63.0 1.18 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.297 -0.877 . . . . 0.0 109.818 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -59.05 -41.26 87.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.483 -0.761 . . . . 0.0 109.36 179.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.451 ' O ' ' N ' ' A' ' 134' ' ' ALA . 13.2 mt -51.3 -64.24 0.87 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.495 -0.753 . . . . 0.0 109.539 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.424 ' N ' HG23 ' A' ' 115' ' ' VAL . 1.7 ttt-85 -51.6 -21.69 2.76 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.298 -0.876 . . . . 0.0 110.317 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -88.51 -51.69 5.57 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.383 -0.823 . . . . 0.0 110.515 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -86.78 -16.46 36.22 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.247 -0.908 . . . . 0.0 111.206 -179.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.494 1.742 0 O-C-N 121.034 -1.041 . . . . 0.0 110.33 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 121.105 0.479 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.486 ' HB3' HD11 ' A' ' 31' ' ' LEU . 16.0 m0 -75.4 -20.22 59.06 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.148 -0.97 . . . . 0.0 109.981 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.469 HD11 HD11 ' A' ' 63' ' ' LEU . 1.2 pp -67.86 -35.22 78.16 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.396 -0.815 . . . . 0.0 110.043 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.14 -42.11 24.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.39 -0.819 . . . . 0.0 110.394 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.412 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.0 OUTLIER -59.85 -58.4 8.74 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.363 -0.836 . . . . 0.0 110.51 -179.655 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.19 -45.38 65.14 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.165 -0.959 . . . . 0.0 109.784 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.484 ' HB2' ' CB ' ' A' ' 52' ' ' MET . . . -50.83 -53.79 29.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.604 -0.685 . . . . 0.0 110.037 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.504 ' CA ' ' O ' ' A' ' 51' ' ' VAL . . . -56.01 -31.8 63.41 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.164 -0.96 . . . . 0.0 110.078 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.58 21.8 5.99 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.38 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.482 ' HA3' ' HE2' ' A' ' 53' ' ' MET . . . 49.43 76.02 0.18 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -140.76 63.84 1.45 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.57 -0.959 . . . . 0.0 109.405 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.501 ' CG1' ' NE ' ' A' ' 29' ' ' ARG . 13.6 t -49.21 -51.44 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.493 -0.755 . . . . 0.0 110.101 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.69 -51.14 52.37 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.74 -0.6 . . . . 0.0 110.669 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.576 ' HG2' HD13 ' A' ' 31' ' ' LEU . 5.4 tt0 -56.09 -44.96 79.52 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.329 -0.857 . . . . 0.0 109.874 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.463 HG12 ' CD1' ' A' ' 62' ' ' LEU . 38.4 t -71.28 -47.06 62.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.472 -0.767 . . . . 0.0 109.796 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.51 ' NH1' ' O ' ' A' ' 58' ' ' ARG . 0.1 OUTLIER -39.17 -52.68 1.91 Allowed 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.55 -0.719 . . . . 0.0 110.285 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.9 -49.53 14.02 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.679 -0.638 . . . . 0.0 110.733 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.576 HD13 ' HG2' ' A' ' 27' ' ' GLU . 41.2 mt -44.73 -66.76 0.35 Allowed 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.32 -0.863 . . . . 0.0 110.635 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.603 ' CD1' HD23 ' A' ' 63' ' ' LEU . 0.6 OUTLIER -50.2 -53.93 24.49 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.46 -0.775 . . . . 0.0 110.296 179.681 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 29' ' ' ARG . 0.5 OUTLIER -63.84 -6.86 6.52 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.442 -0.786 . . . . 0.0 110.962 179.325 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -100.81 -13.43 18.41 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.853 -1.154 . . . . 0.0 111.56 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 146.38 -10.62 1.52 Allowed Glycine 0 N--CA 1.49 2.27 0 C-N-CA 119.323 -1.418 . . . . 0.0 110.45 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.521 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . . . -56.18 140.56 43.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.929 -1.336 . . . . 0.0 109.87 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.429 ' O ' HD22 ' A' ' 16' ' ' LEU . 18.3 mt -79.21 143.07 59.95 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.382 -0.824 . . . . 0.0 110.213 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.462 ' HB3' ' HB3' ' A' ' 66' ' ' HIS . 43.5 Cg_endo -72.54 -37.35 4.22 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.358 1.188 . . . . 0.0 110.125 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -100.59 5.64 43.99 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.403 -0.811 . . . . 0.0 110.534 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.412 ' CB ' ' HB2' ' A' ' 37' ' ' LEU . . . -39.75 101.36 0.23 Allowed Pre-proline 0 N--CA 1.501 2.098 0 O-C-N 121.471 -0.768 . . . . 0.0 111.358 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -72.58 159.26 49.29 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.828 1.436 . . . . 0.0 109.651 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.51 ' N ' ' OD1' ' A' ' 42' ' ' ASN . 10.8 p-10 -131.5 170.87 14.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.473 -0.767 . . . . 0.0 109.913 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.5 m -87.13 12.37 11.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.387 -0.821 . . . . 0.0 110.434 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.438 ' HB3' ' ND2' ' A' ' 42' ' ' ASN . 4.2 t80 -93.16 19.77 7.64 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.241 -0.912 . . . . 0.0 109.644 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 48.38 23.2 2.89 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 -179.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -138.57 106.17 5.59 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.63 -0.924 . . . . 0.0 110.845 -179.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.511 ' CB ' ' HD2' ' A' ' 48' ' ' PRO . 1.1 mpt_? -54.86 -175.39 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.55 -0.719 . . . . 0.0 109.619 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.511 ' HD2' ' CB ' ' A' ' 47' ' ' ARG . 43.0 Cg_endo -69.09 170.55 15.53 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.145 1.076 . . . . 0.0 109.732 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.531 ' O ' ' CG ' ' A' ' 52' ' ' MET . 3.2 mt 63.27 -58.78 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.794 -0.566 . . . . 0.0 110.578 -179.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.488 ' N ' ' O ' ' A' ' 48' ' ' PRO . 0.4 OUTLIER -48.68 -25.57 1.85 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.569 -1.332 . . . . 0.0 109.797 179.342 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.504 ' O ' ' CA ' ' A' ' 21' ' ' ALA . 12.0 p -110.39 18.6 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 121.606 -0.684 . . . . 0.0 109.378 178.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.531 ' CG ' ' O ' ' A' ' 49' ' ' ILE . 0.5 OUTLIER -92.72 167.67 11.73 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.242 -0.911 . . . . 0.0 110.057 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.482 ' HE2' ' HA3' ' A' ' 23' ' ' GLY . 5.5 ttp -69.26 107.52 3.29 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.159 -1.016 . . . . 0.0 109.32 178.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.493 ' HE2' ' CE ' ' A' ' 52' ' ' MET . 0.0 OUTLIER -66.41 -3.91 7.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.087 -1.008 . . . . 0.0 109.861 179.501 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -89.97 16.91 55.85 Favored Glycine 0 N--CA 1.484 1.889 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 178.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.93 117.29 2.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -1.177 . . . . 0.0 109.704 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.52 -27.06 41.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.308 -0.87 . . . . 0.0 110.368 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.51 ' O ' ' NH1' ' A' ' 29' ' ' ARG . 5.8 mmt180 -48.84 -38.25 21.77 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.181 -0.95 . . . . 0.0 110.267 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.4 ' CG2' HG23 ' A' ' 25' ' ' VAL . 24.3 t -62.64 -63.56 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 120.987 -1.071 . . . . 0.0 109.116 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.13 -29.87 23.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.46 -0.775 . . . . 0.0 109.375 178.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -54.53 -66.4 0.41 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.029 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.518 ' O ' ' HB2' ' A' ' 66' ' ' HIS . 0.1 OUTLIER -44.09 -61.63 1.41 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.402 -0.811 . . . . 0.0 109.564 178.746 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.603 HD23 ' CD1' ' A' ' 32' ' ' LEU . 4.3 mm? -47.92 -66.87 0.33 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.309 0.576 . . . . 0.0 109.927 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.554 HD11 ' HG3' ' A' ' 70' ' ' PRO . 20.0 tp -52.85 -53.01 54.87 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.438 -0.788 . . . . 0.0 110.633 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.429 ' HB3' ' O ' ' A' ' 61' ' ' GLU . 13.5 tp -49.53 -39.04 32.94 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.844 0.831 . . . . 0.0 108.956 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.518 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -81.34 -31.15 33.56 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.458 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 63' ' ' LEU . . . 124.21 56.19 0.18 Allowed Glycine 0 N--CA 1.481 1.661 0 C-N-CA 120.367 -0.92 . . . . 0.0 111.116 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.518 ' CB ' ' HB3' ' A' ' 63' ' ' LEU . . . -73.91 -154.4 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.841 -1.388 . . . . 0.0 110.103 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -122.49 77.58 45.83 Favored Pre-proline 0 N--CA 1.489 1.478 0 C-N-CA 119.824 -0.75 . . . . 0.0 109.985 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.554 ' HG3' HD11 ' A' ' 64' ' ' LEU . 53.7 Cg_endo -76.85 -11.61 18.17 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 O-C-N 124.067 1.562 . . . . 0.0 110.0 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.418 ' OD1' ' CB ' ' A' ' 103' ' ' ARG . 7.1 t30 -108.5 -64.36 1.23 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.493 -0.754 . . . . 0.0 109.741 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -46.07 139.95 4.15 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.421 0.629 . . . . 0.0 110.761 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.529 ' HB1' ' HD2' ' A' ' 80' ' ' ARG . . . -132.82 -150.39 0.41 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.658 -0.651 . . . . 0.0 110.187 -179.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.504 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -101.33 143.47 26.67 Favored Pre-proline 0 C--N 1.305 -1.343 0 O-C-N 121.216 -0.928 . . . . 0.0 109.746 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -71.87 -29.87 14.8 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.517 1.272 . . . . 0.0 110.728 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -47.86 -80.83 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.412 -0.805 . . . . 0.0 110.702 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.1 p -115.31 30.71 7.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.423 -0.798 . . . . 0.0 109.878 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.504 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 2.8 mt 44.54 46.22 8.09 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.607 -0.683 . . . . 0.0 111.541 179.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.484 ' O ' ' NE2' ' A' ' 50' ' ' GLN . 0.2 OUTLIER -72.77 95.62 1.93 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.21 -0.931 . . . . 0.0 109.881 179.62 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.567 ' HG3' ' HD2' ' A' ' 81' ' ' PRO . 0.5 OUTLIER -71.92 154.4 92.65 Favored Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.397 -0.814 . . . . 0.0 109.952 179.805 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.567 ' HD2' ' HG3' ' A' ' 80' ' ' ARG . 48.3 Cg_endo -72.01 -13.71 28.96 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 O-C-N 123.577 1.303 . . . . 0.0 109.973 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.57 ' CG1' HD23 ' A' ' 130' ' ' LEU . 21.2 t -61.96 -27.4 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 CA-C-O 121.534 0.683 . . . . 0.0 109.661 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.512 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 4.2 m80 -72.72 -42.86 63.69 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.422 ' HB3' ' HE1' ' A' ' 54' ' ' MET . 0.6 OUTLIER -45.23 -51.78 10.32 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.548 -0.72 . . . . 0.0 110.091 179.249 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.527 ' CB ' ' CD1' ' A' ' 94' ' ' LEU . . . -56.78 -64.94 0.71 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.582 -0.699 . . . . 0.0 109.794 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.529 ' HA ' ' CG1' ' A' ' 126' ' ' VAL . . . -61.22 -54.0 49.72 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.58 -0.7 . . . . 0.0 111.594 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.488 ' N ' ' O ' ' A' ' 83' ' ' HIS . 0.4 OUTLIER -40.18 -31.48 0.13 Allowed 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.3 -0.875 . . . . 0.0 110.976 -179.741 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -100.88 -17.85 16.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.154 -0.966 . . . . 0.0 109.602 179.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.514 ' HA3' ' CE1' ' A' ' 123' ' ' HIS . . . 89.27 41.31 5.85 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.452 ' CG ' ' O ' ' A' ' 54' ' ' MET . 2.1 t80 -110.64 123.48 50.08 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.656 -0.908 . . . . 0.0 110.368 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.582 ' CD2' ' HA ' ' A' ' 126' ' ' VAL . 0.0 OUTLIER -94.38 -44.31 7.97 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.5 -0.75 . . . . 0.0 110.24 -179.748 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.437 ' HB2' ' CE2' ' A' ' 90' ' ' PHE . 0.9 OUTLIER -44.58 -31.35 1.11 Allowed 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 121.368 0.604 . . . . 0.0 109.858 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.503 HG22 ' HB3' ' A' ' 85' ' ' ALA . 8.7 m -76.1 -49.19 18.09 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.326 -0.859 . . . . 0.0 108.767 178.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.527 ' CD1' ' CB ' ' A' ' 85' ' ' ALA . 1.1 mp -50.74 -49.05 58.77 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.48 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 84.5 t -56.52 -60.96 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.695 -0.628 . . . . 0.0 109.536 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.537 ' CG1' HD23 ' A' ' 64' ' ' LEU . 49.1 t -47.36 -52.25 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -46.02 -64.15 0.81 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.797 -0.564 . . . . 0.0 111.038 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -63.08 -31.26 72.36 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.156 -0.965 . . . . 0.0 110.084 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 1.2 ttt85 -63.07 -12.97 30.4 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.263 -0.898 . . . . 0.0 110.825 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.474 ' CB ' ' HG ' ' A' ' 64' ' ' LEU . . . -139.94 58.54 1.59 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.216 -0.928 . . . . 0.0 110.647 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 55.93 106.03 0.01 OUTLIER Glycine 0 N--CA 1.488 2.15 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.307 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -164.36 124.76 2.08 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.426 -1.044 . . . . 0.0 109.787 179.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.418 ' CB ' ' OD1' ' A' ' 71' ' ' ASN . 10.9 ttp180 -82.58 135.52 35.06 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.237 -0.914 . . . . 0.0 110.287 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.568 ' O ' ' CB ' ' A' ' 134' ' ' ALA . 1.7 mp -121.36 21.2 11.14 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.263 -0.898 . . . . 0.0 110.504 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -123.63 54.0 1.32 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.325 -0.859 . . . . 0.0 111.126 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.522 ' CG2' ' HD3' ' A' ' 80' ' ' ARG . 3.9 p -112.93 -174.11 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.824 -1.172 . . . . 0.0 110.405 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.434 ' HG2' HD11 ' A' ' 113' ' ' LEU . 18.7 mtm180 -133.91 138.83 45.77 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.623 -0.673 . . . . 0.0 109.306 179.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.437 -0.789 . . . . 0.0 109.941 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.454 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 110.259 -0.274 . . . . 0.0 110.259 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.502 ' HB3' ' CE1' ' A' ' 83' ' ' HIS . 41.4 Cg_endo -74.05 -47.81 0.24 Allowed 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.975 1.513 . . . . 0.0 109.524 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.412 HG22 ' CB ' ' A' ' 131' ' ' ARG . 8.8 p -60.58 -35.46 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.528 -0.733 . . . . 0.0 110.382 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.63 -51.88 66.67 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.407 -0.808 . . . . 0.0 109.739 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.58 -37.32 73.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.764 -0.585 . . . . 0.0 111.078 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.461 ' HB2' ' HB3' ' A' ' 86' ' ' ALA . . . -57.5 -54.67 44.25 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.286 -0.884 . . . . 0.0 110.498 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -65.51 -17.8 64.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.286 -0.884 . . . . 0.0 110.444 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -76.12 -44.68 37.37 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.306 -0.871 . . . . 0.0 110.557 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.482 ' HB3' ' NE2' ' A' ' 123' ' ' HIS . 6.7 mp -88.26 13.83 10.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -0.904 . . . . 0.0 110.411 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 76.8 48.04 9.12 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.514 ' CE1' ' HA3' ' A' ' 89' ' ' GLY . 30.1 m-70 -120.55 45.13 2.29 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.019 -1.283 . . . . 0.0 109.343 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.442 ' HA ' ' HB3' ' A' ' 127' ' ' ALA . 1.2 mtt180 -43.82 -46.04 7.62 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.524 -0.735 . . . . 0.0 110.077 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.408 ' O ' HD23 ' A' ' 91' ' ' LEU . 6.0 t70 -54.56 -44.0 72.54 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.528 0.68 . . . . 0.0 109.63 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.582 ' HA ' ' CD2' ' A' ' 91' ' ' LEU . 1.8 t -76.74 -28.45 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.442 ' HB3' ' HA ' ' A' ' 124' ' ' ARG . . . -68.13 -57.25 6.37 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.761 -0.587 . . . . 0.0 109.801 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -50.4 -57.93 6.86 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.413 -0.804 . . . . 0.0 110.472 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -53.41 -35.99 61.01 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.37 -0.832 . . . . 0.0 109.146 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.57 HD23 ' CG1' ' A' ' 82' ' ' VAL . 10.1 mt -71.9 -59.53 2.7 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.593 -0.692 . . . . 0.0 109.24 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.412 ' CB ' HG22 ' A' ' 115' ' ' VAL . 2.1 ttt180 -49.0 -27.8 3.44 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.691 -0.631 . . . . 0.0 110.821 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -76.6 -52.04 10.45 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.111 -0.993 . . . . 0.0 109.944 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.463 ' CB ' HD11 ' A' ' 104' ' ' LEU . . . -84.54 -10.4 57.46 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.429 -0.794 . . . . 0.0 110.489 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.568 ' CB ' ' O ' ' A' ' 104' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.29 -0.881 . . . . 0.0 109.878 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.425 ' O ' ' OG1' ' A' ' 18' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.931 0.396 . . . . 0.0 110.035 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.489 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 1.1 t90 -74.96 -6.77 51.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.394 -0.816 . . . . 0.0 110.734 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.536 HD22 ' HB1' ' A' ' 36' ' ' ALA . 19.1 mt -78.69 -49.52 12.98 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.17 -0.956 . . . . 0.0 109.463 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.479 ' CB ' ' ND2' ' A' ' 42' ' ' ASN . . . -69.35 -44.99 70.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.567 -0.708 . . . . 0.0 109.988 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.489 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.0 OUTLIER -50.31 -59.89 3.52 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.473 -0.767 . . . . 0.0 110.435 179.799 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.52 ' CB ' HG21 ' A' ' 28' ' ' VAL . . . -63.52 -33.83 76.44 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.505 -0.747 . . . . 0.0 110.206 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -68.55 -43.88 75.69 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.093 -1.004 . . . . 0.0 109.699 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.98 -20.14 63.54 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.383 -0.823 . . . . 0.0 109.786 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -99.58 22.28 11.06 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.422 -0.799 . . . . 0.0 110.451 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.512 ' HA3' ' HE1' ' A' ' 53' ' ' MET . . . 47.68 55.15 9.87 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.461 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . 0.8 OUTLIER -126.37 89.93 3.09 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.513 -0.992 . . . . 0.0 109.483 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.461 ' CG2' HG23 ' A' ' 59' ' ' VAL . 55.7 t -64.31 -63.61 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.435 -0.79 . . . . 0.0 111.199 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -43.71 -33.48 1.25 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.551 -0.718 . . . . 0.0 111.043 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.461 ' HB2' ' HB3' ' A' ' 24' ' ' ARG . 0.7 OUTLIER -60.8 -65.92 0.61 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.292 -0.88 . . . . 0.0 109.661 179.288 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.52 HG21 ' CB ' ' A' ' 19' ' ' ALA . 5.1 t -63.66 -41.04 91.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.821 -0.55 . . . . 0.0 110.289 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.481 ' HA ' HD21 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -44.7 -39.09 4.84 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.629 -0.669 . . . . 0.0 110.438 -179.548 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.64 -43.99 24.89 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.458 -0.776 . . . . 0.0 110.008 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.469 HD13 ' HB3' ' A' ' 15' ' ' TRP . 50.3 mt -55.46 -64.59 0.8 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.087 -1.008 . . . . 0.0 109.663 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.569 HD23 ' CB ' ' A' ' 66' ' ' HIS . 2.3 mt -49.37 -39.3 31.59 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.471 -0.768 . . . . 0.0 110.384 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 29' ' ' ARG . 6.1 mt-10 -67.32 -25.58 66.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.527 -0.733 . . . . 0.0 110.177 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.17 -8.1 58.76 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.319 -0.863 . . . . 0.0 109.91 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.46 31.84 2.09 Favored Glycine 0 N--CA 1.489 2.179 0 C-N-CA 120.19 -1.005 . . . . 0.0 110.844 178.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.536 ' HB1' HD22 ' A' ' 16' ' ' LEU . . . -63.3 178.59 0.51 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.956 -1.32 . . . . 0.0 110.52 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -92.18 124.19 60.45 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.398 -0.814 . . . . 0.0 109.947 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.504 ' HB2' ' O ' ' A' ' 67' ' ' GLY . 43.2 Cg_endo -68.22 -39.77 9.7 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.629 1.331 . . . . 0.0 110.742 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.419 ' HA ' ' OE1' ' A' ' 69' ' ' GLU . 0.4 OUTLIER -112.24 61.63 0.63 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.236 -0.915 . . . . 0.0 109.758 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.57 109.27 37.44 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.302 -0.874 . . . . 0.0 110.296 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -71.81 113.69 3.73 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 O-C-N 123.634 1.334 . . . . 0.0 109.595 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.479 ' ND2' ' CB ' ' A' ' 17' ' ' ALA . 16.3 m120 -73.68 174.23 8.66 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.559 -0.713 . . . . 0.0 109.596 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.95 21.91 1.83 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.358 -0.839 . . . . 0.0 110.354 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -109.58 20.76 17.8 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.163 -0.961 . . . . 0.0 110.533 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 57.88 24.22 53.28 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 55.0 mtt180 -131.75 -163.85 1.38 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.346 -1.09 . . . . 0.0 109.701 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.544 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 1.6 mmt180 -109.11 -171.1 0.21 Allowed Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.189 -0.944 . . . . 0.0 110.231 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.544 ' CD ' ' HB3' ' A' ' 47' ' ' ARG . 42.6 Cg_endo -80.13 -18.16 10.14 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 O-C-N 123.303 1.159 . . . . 0.0 111.08 -178.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.519 ' O ' ' HG2' ' A' ' 52' ' ' MET . 6.6 mt -107.1 -43.44 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.991 -1.068 . . . . 0.0 108.867 178.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 49' ' ' ILE . 0.8 OUTLIER -43.88 -31.47 0.87 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.095 -1.003 . . . . 0.0 109.909 179.556 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.411 ' O ' HG21 ' A' ' 51' ' ' VAL . 7.9 p -111.53 34.16 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.442 -0.786 . . . . 0.0 110.138 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.527 ' CE ' ' HB3' ' A' ' 60' ' ' ALA . 0.1 OUTLIER -91.11 30.1 1.29 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.027 -1.045 . . . . 0.0 109.643 179.19 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.512 ' HE1' ' HA3' ' A' ' 23' ' ' GLY . 4.8 tmm? 75.61 -13.54 0.86 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.859 -0.526 . . . . 0.0 111.866 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.536 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 47.11 28.18 0.9 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.956 -1.09 . . . . 0.0 110.234 -179.873 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.47 ' HA3' ' HE3' ' A' ' 53' ' ' MET . . . -125.85 4.56 7.96 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.25 79.14 1.4 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.348 -1.089 . . . . 0.0 110.301 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.578 ' HB1' ' CE1' ' A' ' 90' ' ' PHE . . . -46.56 -34.04 4.6 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.397 -0.814 . . . . 0.0 109.592 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 56.3 mtt180 -44.44 -44.27 8.35 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.369 0.604 . . . . 0.0 109.668 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.461 HG23 ' CG2' ' A' ' 25' ' ' VAL . 60.8 t -62.05 -56.94 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.527 ' HB3' ' CE ' ' A' ' 52' ' ' MET . . . -47.61 -38.13 13.95 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.52 -0.737 . . . . 0.0 109.401 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -66.34 -35.29 79.98 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.638 -0.664 . . . . 0.0 109.843 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.514 ' HG ' ' CD1' ' A' ' 32' ' ' LEU . 1.5 tp -71.57 -44.13 65.08 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.42 -0.8 . . . . 0.0 109.477 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.486 ' O ' ' N ' ' A' ' 68' ' ' ALA . 2.6 mt -77.71 -35.14 52.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 0.0 109.427 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.51 ' CB ' ' O ' ' A' ' 60' ' ' ALA . 0.7 OUTLIER -64.84 -61.01 2.44 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.422 -0.799 . . . . 0.0 110.159 -179.709 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.473 ' CD1' ' C ' ' A' ' 65' ' ' LEU . 0.3 OUTLIER -52.37 -33.97 45.59 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.836 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.569 ' CB ' HD23 ' A' ' 32' ' ' LEU . 1.7 m80 -73.64 -39.84 64.19 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.299 0.571 . . . . 0.0 109.658 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.504 ' O ' ' HB2' ' A' ' 38' ' ' PRO . . . 134.54 45.82 0.1 Allowed Glycine 0 N--CA 1.481 1.643 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 63' ' ' LEU . . . -64.76 -162.22 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.94 -1.329 . . . . 0.0 110.208 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.476 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -116.86 61.64 2.61 Favored Pre-proline 0 C--N 1.301 -1.514 0 O-C-N 121.628 -0.67 . . . . 0.0 109.347 179.504 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.439 ' O ' ' HG3' ' A' ' 81' ' ' PRO . 52.1 Cg_endo -71.29 -2.15 10.75 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 O-C-N 123.792 1.417 . . . . 0.0 111.107 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.431 ' HA ' ' NH1' ' A' ' 80' ' ' ARG . 4.2 m-80 -108.77 -61.08 1.66 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.278 -0.889 . . . . 0.0 110.115 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 29.8 t -45.25 166.62 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.66 -0.65 . . . . 0.0 110.562 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.4 -148.62 0.17 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.104 -0.997 . . . . 0.0 110.303 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.499 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.6 OUTLIER -110.06 140.22 22.13 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.189 -0.944 . . . . 0.0 109.845 179.871 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -78.21 -23.58 8.8 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.641 1.337 . . . . 0.0 110.533 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.02 -81.3 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.888 . . . . 0.0 110.249 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 108' ' ' ASP . 0.2 OUTLIER -104.56 40.73 1.43 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.429 -0.794 . . . . 0.0 109.844 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.499 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 9.4 mt 31.95 40.56 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.0 m -67.45 104.63 1.59 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.983 -1.073 . . . . 0.0 110.181 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.47 ' CG ' HG13 ' A' ' 106' ' ' VAL . 0.7 OUTLIER -87.55 170.45 11.81 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.165 -0.959 . . . . 0.0 109.915 179.588 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.439 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 38.0 Cg_endo -68.71 -2.68 9.81 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.743 1.391 . . . . 0.0 109.72 178.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.553 ' CG1' ' HG3' ' A' ' 114' ' ' PRO . 10.5 t -82.06 -27.66 9.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 O-C-N 121.596 -0.69 . . . . 0.0 109.458 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.506 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 10.4 m80 -77.72 -40.08 42.43 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.298 -0.876 . . . . 0.0 108.794 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.542 ' O ' ' HB3' ' A' ' 87' ' ' ARG . 0.3 OUTLIER -54.64 -46.78 74.01 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.492 -0.755 . . . . 0.0 109.186 178.656 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.518 ' HB1' HD13 ' A' ' 94' ' ' LEU . . . -59.01 -69.01 0.21 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.244 -0.91 . . . . 0.0 109.214 178.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.528 ' O ' ' CD2' ' A' ' 123' ' ' HIS . . . -60.38 -15.84 29.84 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.221 -0.925 . . . . 0.0 111.104 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.542 ' HB3' ' O ' ' A' ' 84' ' ' ASP . 9.5 tpt180 -60.74 -45.82 92.83 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.854 -1.154 . . . . 0.0 109.455 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -101.66 -4.3 26.77 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.833 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.483 ' HA3' ' ND1' ' A' ' 123' ' ' HIS . . . 83.09 48.25 5.48 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.578 ' CE1' ' HB1' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -112.12 82.34 1.61 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.359 -1.083 . . . . 0.0 110.883 -179.245 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.442 HD11 ' HB3' ' A' ' 125' ' ' ASP . 0.1 OUTLIER -57.08 -46.41 82.55 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.447 -0.783 . . . . 0.0 110.782 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.411 ' OD2' ' HB3' ' A' ' 57' ' ' ALA . 35.7 t0 -45.84 -35.46 4.5 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.496 -0.753 . . . . 0.0 109.778 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 25.5 m -66.51 -59.33 3.74 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.518 HD13 ' HB1' ' A' ' 85' ' ' ALA . 1.2 mp -46.01 -52.65 11.45 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.684 -0.635 . . . . 0.0 109.462 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.441 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 26.4 t -44.84 -55.13 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.449 HG13 HD12 ' A' ' 64' ' ' LEU . 13.4 t -55.49 -45.58 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.456 ' C ' ' CB ' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -56.31 -70.01 0.13 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.889 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . 0.416 ' HA ' ' HB2' ' A' ' 102' ' ' ALA . 3.4 t-160 -51.39 -40.84 60.08 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.493 -0.754 . . . . 0.0 109.44 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.441 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 7.5 ttt180 -59.81 -14.18 13.74 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.533 -0.729 . . . . 0.0 110.036 179.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 101' ' ' GLY . . . -143.93 89.94 2.09 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 121.26 -0.9 . . . . 0.0 110.856 -179.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 100' ' ' ALA . . . 35.18 90.92 0.01 OUTLIER Glycine 0 N--CA 1.503 3.122 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 179.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.456 ' CB ' ' C ' ' A' ' 97' ' ' LEU . . . -143.91 89.81 2.08 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.107 -1.231 . . . . 0.0 110.739 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.9 ttt180 -64.72 133.73 52.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.151 -0.968 . . . . 0.0 110.078 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.91 20.29 10.04 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.48 0.657 . . . . 0.0 109.286 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.22 39.87 1.43 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.504 -0.747 . . . . 0.0 110.037 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.51 ' O ' ' CD2' ' A' ' 113' ' ' LEU . 2.5 p -109.65 -179.22 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.176 -0.952 . . . . 0.0 110.582 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.464 ' HG2' ' CD2' ' A' ' 113' ' ' LEU . 59.4 mtt180 -141.31 140.7 33.86 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.49 -0.756 . . . . 0.0 109.771 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.443 ' HA ' ' O ' ' A' ' 77' ' ' THR . 3.6 p-10 . . . . . 0 N--CA 1.495 1.813 0 O-C-N 120.984 -1.072 . . . . 0.0 110.357 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.51 ' CD2' ' O ' ' A' ' 106' ' ' VAL . 15.2 mt . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.553 ' HG3' ' CG1' ' A' ' 82' ' ' VAL . 37.8 Cg_endo -64.26 -11.07 26.14 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.844 1.444 . . . . 0.0 111.006 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.457 ' CG1' ' HB2' ' A' ' 113' ' ' LEU . 3.5 p -72.81 -32.47 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.149 -0.969 . . . . 0.0 109.725 179.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.64 -52.96 11.61 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.15 -0.969 . . . . 0.0 110.02 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.462 HD22 ' HA ' ' A' ' 87' ' ' ARG . 0.6 OUTLIER -57.2 -26.35 60.52 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.414 -0.804 . . . . 0.0 109.722 179.466 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.411 ' HB1' ' CB ' ' A' ' 127' ' ' ALA . . . -65.72 -58.25 6.12 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.374 -0.829 . . . . 0.0 108.895 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.07 -31.02 70.69 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.673 -0.642 . . . . 0.0 109.636 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -65.72 -49.73 67.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.611 -0.68 . . . . 0.0 110.343 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.521 ' HB3' ' NE2' ' A' ' 123' ' ' HIS . 22.7 mt -77.42 5.51 8.68 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.363 -0.836 . . . . 0.0 111.087 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 89.75 29.6 15.49 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 120.085 -1.055 . . . . 0.0 111.219 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.528 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 61.4 m-70 -109.37 54.48 0.66 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.002 -1.293 . . . . 0.0 109.836 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.463 ' HG3' ' N ' ' A' ' 125' ' ' ASP . 37.5 ptt180 -49.29 -39.92 32.69 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.487 0.661 . . . . 0.0 109.911 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.463 ' N ' ' HG3' ' A' ' 124' ' ' ARG . 4.6 m-20 -61.45 -45.18 95.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.618 -0.677 . . . . 0.0 109.611 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.472 ' CG1' HD11 ' A' ' 94' ' ' LEU . 3.2 t -75.65 -36.26 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.465 -0.772 . . . . 0.0 109.637 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.411 ' CB ' ' HB1' ' A' ' 118' ' ' ALA . . . -63.55 -58.16 7.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.626 -0.671 . . . . 0.0 109.417 179.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.3 ttt-85 -44.92 -55.83 5.11 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.611 -0.681 . . . . 0.0 110.505 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -60.52 -49.57 77.01 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.447 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.501 HD23 ' CG1' ' A' ' 82' ' ' VAL . 10.2 mt -53.54 -52.97 57.96 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.694 -0.629 . . . . 0.0 110.081 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 25.1 ttp180 -46.04 -37.3 6.52 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.57 -0.706 . . . . 0.0 110.282 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.79 -53.78 4.92 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.51 -0.743 . . . . 0.0 110.492 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -66.02 -7.96 20.27 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.307 -0.87 . . . . 0.0 110.385 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.354 -0.841 . . . . 0.0 109.967 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 121.014 0.435 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.511 ' HA ' ' CG2' ' A' ' 18' ' ' THR . 25.3 m0 -89.37 -15.58 32.99 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.176 -0.953 . . . . 0.0 111.03 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.476 HD21 ' O ' ' A' ' 37' ' ' LEU . 1.0 OUTLIER -79.17 -44.88 21.04 Favored 'General case' 0 N--CA 1.483 1.217 0 O-C-N 120.864 -1.148 . . . . 0.0 109.039 179.54 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.475 ' CB ' ' OD1' ' A' ' 42' ' ' ASN . . . -74.8 -41.18 60.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.437 -0.789 . . . . 0.0 110.109 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.511 ' CG2' ' HA ' ' A' ' 15' ' ' TRP . 4.3 t -58.43 -43.09 88.61 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.324 -0.86 . . . . 0.0 109.739 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.552 ' HB3' HG21 ' A' ' 28' ' ' VAL . . . -63.7 -44.12 94.6 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.345 -0.847 . . . . 0.0 110.054 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.85 -45.27 92.97 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.411 -0.806 . . . . 0.0 110.3 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.461 ' HB2' HG23 ' A' ' 51' ' ' VAL . . . -68.13 -27.49 66.49 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.358 -0.839 . . . . 0.0 111.032 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' A' ' 18' ' ' THR . 11.0 mtp180 -94.4 20.49 8.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.248 -0.908 . . . . 0.0 110.77 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.498 ' CA ' ' HE3' ' A' ' 53' ' ' MET . . . 57.83 37.29 83.74 Favored Glycine 0 N--CA 1.486 1.974 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 178.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.15 64.11 0.63 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.291 -1.123 . . . . 0.0 110.186 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.533 ' CG2' HG23 ' A' ' 59' ' ' VAL . 30.5 t -55.15 -44.78 76.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.42 -0.8 . . . . 0.0 109.179 179.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.86 -48.7 66.9 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.57 -0.706 . . . . 0.0 110.704 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' A' ' 31' ' ' LEU . 0.8 OUTLIER -62.57 -34.34 76.77 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.253 -0.904 . . . . 0.0 110.35 -179.776 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.552 HG21 ' HB3' ' A' ' 19' ' ' ALA . 21.3 t -76.73 -50.19 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.385 -0.822 . . . . 0.0 110.181 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.519 ' CD ' HD12 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -43.4 -44.01 5.48 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.285 -0.884 . . . . 0.0 109.19 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.463 ' O ' ' CB ' ' A' ' 34' ' ' ALA . . . -79.64 -54.79 5.54 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 120.124 -0.63 . . . . 0.0 109.486 178.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 27' ' ' GLU . 8.2 mt -50.56 -61.52 2.14 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.364 -0.835 . . . . 0.0 110.307 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.529 ' HA ' ' CB ' ' A' ' 36' ' ' ALA . 3.6 mt -45.76 -62.55 1.25 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.399 -0.813 . . . . 0.0 109.962 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -64.91 -16.12 62.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.455 -0.778 . . . . 0.0 110.832 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' A' ' 30' ' ' ALA . . . -85.76 -6.79 59.06 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.239 -0.913 . . . . 0.0 111.308 -179.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.27 26.35 1.67 Allowed Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.719 -1.229 . . . . 0.0 110.466 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.529 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . . . -74.61 170.64 15.36 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.145 -1.209 . . . . 0.0 110.308 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.476 ' O ' HD21 ' A' ' 16' ' ' LEU . 1.3 mm? -103.22 96.64 8.53 Favored Pre-proline 0 C--N 1.302 -1.482 0 O-C-N 121.604 -0.685 . . . . 0.0 110.367 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.486 ' HB3' ' HB3' ' A' ' 66' ' ' HIS . 41.6 Cg_endo -68.16 -14.85 41.76 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.741 1.39 . . . . 0.0 110.791 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.465 ' O ' ' HD3' ' A' ' 41' ' ' PRO . 0.4 OUTLIER -111.31 16.16 21.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.025 -1.047 . . . . 0.0 110.342 179.84 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.23 110.52 10.47 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.282 -0.886 . . . . 0.0 110.595 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 39' ' ' ASN . 45.9 Cg_endo -74.46 108.18 2.62 Favored 'Trans proline' 0 C--N 1.318 -1.03 0 O-C-N 123.552 1.29 . . . . 0.0 109.788 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.475 ' OD1' ' CB ' ' A' ' 17' ' ' ALA . 27.8 m-80 -57.43 167.62 0.96 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.64 -0.663 . . . . 0.0 110.813 -179.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.13 2.66 17.3 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.516 -0.74 . . . . 0.0 110.329 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.552 ' CD1' ' N ' ' A' ' 44' ' ' TYR . 1.2 m-85 -91.49 21.64 4.47 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.272 -0.892 . . . . 0.0 109.478 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.445 ' O ' ' NH2' ' A' ' 47' ' ' ARG . . . 53.75 22.1 17.39 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 -178.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 16.8 mtt180 -119.95 -176.65 3.23 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.661 -0.905 . . . . 0.0 110.188 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.582 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 5.2 mmt180 -106.25 -173.48 0.28 Allowed Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.641 -0.662 . . . . 0.0 110.393 -178.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.582 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 52.2 Cg_endo -79.32 0.65 9.84 Favored 'Trans proline' 0 C--N 1.318 -1.038 0 O-C-N 123.438 1.23 . . . . 0.0 110.594 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.489 ' O ' ' CG ' ' A' ' 52' ' ' MET . 7.8 mt -121.53 -43.63 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.362 -0.836 . . . . 0.0 108.94 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.455 ' HG2' ' HB3' ' A' ' 81' ' ' PRO . 5.7 mt-30 -50.07 -23.11 1.91 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.323 -0.861 . . . . 0.0 109.59 178.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.461 HG23 ' HB2' ' A' ' 21' ' ' ALA . 8.8 p -106.75 -7.44 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.73 -0.606 . . . . 0.0 110.867 -179.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.489 ' CG ' ' O ' ' A' ' 49' ' ' ILE . 0.3 OUTLIER -68.06 158.68 32.43 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.97 -1.081 . . . . 0.0 109.817 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.498 ' HE3' ' CA ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -55.59 96.4 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.094 -1.004 . . . . 0.0 109.267 179.216 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.508 ' O ' ' CD2' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -56.72 -14.8 3.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.176 -0.952 . . . . 0.0 110.414 -179.514 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.449 ' HA2' ' CD2' ' A' ' 90' ' ' PHE . . . -88.13 35.23 3.59 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 178.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -171.54 99.56 0.19 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.421 -1.047 . . . . 0.0 109.668 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.31 -25.0 64.91 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.213 -0.93 . . . . 0.0 110.017 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.89 -33.14 3.04 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.572 -0.705 . . . . 0.0 110.531 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.533 HG23 ' CG2' ' A' ' 25' ' ' VAL . 3.0 t -72.66 -58.78 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.454 -0.779 . . . . 0.0 109.341 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -41.17 -46.7 3.12 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.656 -0.653 . . . . 0.0 110.311 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.57 -55.3 33.59 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.204 -0.935 . . . . 0.0 109.643 179.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.52 ' CD1' HD13 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -47.79 -61.5 1.92 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.68 -0.637 . . . . 0.0 109.833 178.993 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.484 HD21 ' HB2' ' A' ' 48' ' ' PRO . 0.9 OUTLIER -59.66 -55.07 38.99 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.256 0.551 . . . . 0.0 109.604 179.411 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.471 ' CD2' ' HB2' ' A' ' 100' ' ' ALA . 0.6 OUTLIER -49.8 -55.62 13.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.62 -0.675 . . . . 0.0 109.439 179.48 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 22.1 tp -53.94 -37.56 64.01 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.843 0.83 . . . . 0.0 108.819 178.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.501 ' CB ' HD23 ' A' ' 32' ' ' LEU . 2.0 m-70 -80.55 -5.59 56.99 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.271 0.557 . . . . 0.0 110.302 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.436 ' O ' ' ND2' ' A' ' 39' ' ' ASN . . . 89.4 63.74 1.29 Allowed Glycine 0 N--CA 1.479 1.537 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 38' ' ' PRO . . . -79.3 -155.02 0.09 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.031 -1.276 . . . . 0.0 109.504 179.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.422 ' OE1' ' ND2' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -120.79 57.14 5.64 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.139 -0.976 . . . . 0.0 110.208 179.389 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.465 ' HB2' ' HG ' ' A' ' 97' ' ' LEU . 48.7 Cg_endo -73.99 -1.17 10.49 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.673 1.354 . . . . 0.0 110.648 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -108.66 -45.29 3.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 110.0 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.3 m -52.11 177.55 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.336 -0.852 . . . . 0.0 110.521 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -162.66 -143.35 0.08 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.361 -0.837 . . . . 0.0 110.136 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.449 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -122.49 132.55 24.25 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.046 -1.034 . . . . 0.0 110.18 -179.566 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -74.25 1.89 6.79 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 O-C-N 123.348 1.183 . . . . 0.0 110.777 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -103.57 -48.55 3.93 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.185 -0.947 . . . . 0.0 109.365 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.462 ' O ' ' CA ' ' A' ' 108' ' ' ASP . 0.2 OUTLIER -128.72 18.02 6.26 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.834 -0.541 . . . . 0.0 109.841 179.875 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.449 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 9.0 mt 44.75 34.5 1.19 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.506 -0.747 . . . . 0.0 110.689 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 83.6 m -59.03 89.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.565 -0.71 . . . . 0.0 110.552 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.514 ' HD3' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -71.04 161.61 77.19 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.168 -0.958 . . . . 0.0 109.52 179.431 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.514 ' HD2' ' HD3' ' A' ' 80' ' ' ARG . 48.4 Cg_endo -73.96 -13.09 23.98 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.696 1.366 . . . . 0.0 110.549 179.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 90.7 t -67.28 -25.35 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.45 -0.781 . . . . 0.0 110.125 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.541 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 5.2 m80 -71.64 -40.81 69.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.277 -0.89 . . . . 0.0 109.236 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.499 ' HB3' ' SD ' ' A' ' 54' ' ' MET . 9.9 m-20 -52.27 -46.72 65.95 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.547 -0.721 . . . . 0.0 110.483 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.466 ' CB ' ' HG ' ' A' ' 94' ' ' LEU . . . -57.29 -68.46 0.23 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.05 -1.031 . . . . 0.0 108.993 178.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.608 ' O ' ' ND1' ' A' ' 123' ' ' HIS . . . -52.35 -34.77 49.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.482 -0.761 . . . . 0.0 109.861 179.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.541 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 0.1 OUTLIER -40.37 -61.29 0.93 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.917 -0.489 . . . . 0.0 111.136 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -89.19 9.68 24.81 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.224 -0.923 . . . . 0.0 110.491 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.407 ' HA2' ' HB3' ' A' ' 123' ' ' HIS . . . 77.87 33.4 41.78 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.508 ' CD2' ' O ' ' A' ' 54' ' ' MET . 0.6 OUTLIER -96.82 131.74 43.25 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.148 -1.207 . . . . 0.0 110.065 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.516 ' HA ' HD13 ' A' ' 94' ' ' LEU . 0.5 OUTLIER -105.47 -47.6 3.89 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.272 -0.893 . . . . 0.0 110.45 179.87 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.424 ' O ' HG22 ' A' ' 96' ' ' VAL . 47.5 m-20 -47.32 -28.3 1.95 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.419 -0.801 . . . . 0.0 109.769 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.477 ' OG1' ' CD1' ' A' ' 90' ' ' PHE . 61.6 m -65.19 -56.82 10.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.588 -0.695 . . . . 0.0 109.604 178.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.516 HD13 ' HA ' ' A' ' 91' ' ' LEU . 1.5 mp -53.91 -49.16 69.22 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.217 -0.927 . . . . 0.0 109.661 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.455 ' O ' ' N ' ' A' ' 99' ' ' ARG . 74.7 t -44.3 -45.47 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.48 ' HA ' ' HB3' ' A' ' 99' ' ' ARG . 22.0 t -59.97 -54.09 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.556 -0.715 . . . . 0.0 109.436 179.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.465 ' HG ' ' HB2' ' A' ' 70' ' ' PRO . 7.3 mp -48.52 -50.05 33.55 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.543 0.687 . . . . 0.0 110.265 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -77.82 -21.65 51.2 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.583 -0.698 . . . . 0.0 109.881 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.48 ' HB3' ' HA ' ' A' ' 96' ' ' VAL . 1.4 ttm180 -72.94 -9.96 59.28 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.413 -0.804 . . . . 0.0 110.949 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.471 ' HB2' ' CD2' ' A' ' 64' ' ' LEU . . . -136.39 -66.73 0.53 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.064 -1.022 . . . . 0.0 110.923 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -167.51 105.51 0.24 Allowed Glycine 0 N--CA 1.486 1.979 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.46 ' HB3' ' HB3' ' A' ' 97' ' ' LEU . . . -177.29 119.37 0.11 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.317 -1.107 . . . . 0.0 110.31 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 -68.11 134.84 51.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -0.892 . . . . 0.0 109.437 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.43 HD22 ' CD2' ' A' ' 130' ' ' LEU . 1.4 tt -112.27 13.28 20.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.376 -0.828 . . . . 0.0 110.665 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.454 ' HB3' ' HA ' ' A' ' 134' ' ' ALA . 1.1 p30 -127.65 47.54 2.37 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.425 -0.797 . . . . 0.0 110.325 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.451 HG11 ' CG ' ' A' ' 80' ' ' ARG . 0.8 OUTLIER -99.73 -175.09 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.143 -0.973 . . . . 0.0 110.659 -179.848 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.437 ' O ' ' HB3' ' A' ' 78' ' ' LEU . 6.6 ttp180 -141.01 148.89 41.0 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.462 ' CA ' ' O ' ' A' ' 77' ' ' THR . 3.6 m-20 . . . . . 0 C--N 1.302 -1.483 0 O-C-N 121.356 -0.84 . . . . 0.0 110.45 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.49 ' HG ' ' HD2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.498 1.962 0 N-CA-C 110.548 -0.168 . . . . 0.0 110.548 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.49 ' HD2' ' HG ' ' A' ' 113' ' ' LEU . 40.7 Cg_endo -69.72 -23.28 31.15 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.79 1.416 . . . . 0.0 110.226 179.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.489 HG22 ' N ' ' A' ' 131' ' ' ARG . 4.7 p -86.72 -33.91 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.884 . . . . 0.0 109.776 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.31 -44.04 97.87 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.661 -0.649 . . . . 0.0 110.351 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.56 -31.09 67.66 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.283 -0.885 . . . . 0.0 109.73 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.502 ' HA ' ' ND1' ' A' ' 123' ' ' HIS . . . -81.61 -20.66 39.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.448 -0.782 . . . . 0.0 110.708 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -74.72 -40.92 61.03 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.4 -0.813 . . . . 0.0 110.691 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.47 -40.6 35.05 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.255 -0.903 . . . . 0.0 110.622 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.492 ' HB3' ' NE2' ' A' ' 123' ' ' HIS . 0.2 OUTLIER -72.57 -81.47 0.06 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.432 -0.793 . . . . 0.0 110.552 -179.339 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 162.14 47.26 0.02 OUTLIER Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.701 -1.237 . . . . 0.0 110.162 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.608 ' ND1' ' O ' ' A' ' 86' ' ' ALA . 3.6 m170 -108.49 52.94 0.7 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.127 -1.22 . . . . 0.0 109.643 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 28.4 mtt180 -48.22 -44.07 32.71 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.285 -0.884 . . . . 0.0 110.029 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.415 ' O ' ' CD1' ' A' ' 91' ' ' LEU . 5.5 t0 -54.27 -43.3 70.89 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.501 -0.75 . . . . 0.0 109.415 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.476 HG12 ' CB ' ' A' ' 86' ' ' ALA . 15.9 t -85.31 -45.55 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.277 -0.89 . . . . 0.0 110.12 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -47.31 -58.12 4.48 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.348 -0.845 . . . . 0.0 110.454 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 11.2 mtp180 -50.77 -65.85 0.49 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.473 -0.767 . . . . 0.0 110.052 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -50.36 -31.84 15.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.527 -0.733 . . . . 0.0 109.887 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.476 ' O ' ' CB ' ' A' ' 134' ' ' ALA . 11.3 mt -72.89 -57.11 4.3 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.594 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.489 ' N ' HG22 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -51.94 -21.78 3.32 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.355 -0.841 . . . . 0.0 110.689 -179.767 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -83.85 -61.18 1.89 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.311 -0.868 . . . . 0.0 109.729 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -75.1 -6.78 51.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.603 -0.686 . . . . 0.0 110.609 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.476 ' CB ' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.497 1.898 0 O-C-N 121.093 -1.004 . . . . 0.0 109.284 179.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.9 t0 . . . . . 0 N--CA 1.497 1.892 0 CA-C-O 121.057 0.456 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 22.6 m0 -95.01 -37.22 11.23 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.035 -1.041 . . . . 0.0 109.923 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.421 ' CD1' ' HB3' ' A' ' 48' ' ' PRO . 0.9 OUTLIER -71.49 -28.37 63.87 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.358 -0.839 . . . . 0.0 110.006 179.478 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.77 -44.91 12.89 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.326 -0.859 . . . . 0.0 110.185 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.429 ' CG2' ' N ' ' A' ' 19' ' ' ALA . 1.6 t -61.94 -39.08 90.85 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.408 -0.808 . . . . 0.0 110.345 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.429 ' N ' ' CG2' ' A' ' 18' ' ' THR . . . -68.8 -48.87 62.54 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.453 -0.779 . . . . 0.0 109.975 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.426 ' HB1' ' CB ' ' A' ' 52' ' ' MET . . . -56.9 -53.5 57.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.528 -0.733 . . . . 0.0 109.811 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.406 ' HA ' ' N ' ' A' ' 53' ' ' MET . . . -53.51 -28.47 31.22 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.48 -0.762 . . . . 0.0 110.182 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.57 14.41 15.08 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.468 -0.77 . . . . 0.0 110.474 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.42 ' HA3' ' CE ' ' A' ' 53' ' ' MET . . . 55.0 49.89 60.92 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -121.25 63.18 0.89 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.401 -1.058 . . . . 0.0 110.138 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.472 HG12 ' HB3' ' A' ' 58' ' ' ARG . 41.1 t -47.49 -51.17 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.549 -0.719 . . . . 0.0 110.163 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -47.12 -42.26 18.89 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.603 -0.686 . . . . 0.0 110.686 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.07 -37.24 72.48 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.249 -0.907 . . . . 0.0 110.086 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.455 ' CG1' HD13 ' A' ' 62' ' ' LEU . 21.6 t -73.45 -41.23 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.328 -0.857 . . . . 0.0 110.351 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.508 ' CD ' HD11 ' A' ' 62' ' ' LEU . 9.6 mmm180 -53.9 -44.81 70.82 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.126 -0.984 . . . . 0.0 109.639 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.42 ' O ' ' CB ' ' A' ' 34' ' ' ALA . . . -78.85 -41.25 30.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.659 -0.65 . . . . 0.0 109.917 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 35.0 mt -65.53 -59.15 4.28 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.547 -0.721 . . . . 0.0 110.236 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.526 ' HA ' ' CB ' ' A' ' 36' ' ' ALA . 33.1 tp -50.83 -45.86 59.8 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.369 -0.832 . . . . 0.0 110.526 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -76.19 -15.6 60.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.294 -0.879 . . . . 0.0 110.031 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 30' ' ' ALA . . . -82.79 -8.75 59.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.301 -0.874 . . . . 0.0 110.652 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.54 23.19 1.93 Allowed Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.782 -1.199 . . . . 0.0 110.711 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.526 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . . . -69.95 152.56 44.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.99 -1.3 . . . . 0.0 109.664 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.404 ' O ' ' CD2' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -79.08 116.59 61.33 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.274 -0.891 . . . . 0.0 110.09 -179.728 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.73 -33.03 22.18 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.372 1.196 . . . . 0.0 110.317 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -115.57 58.05 0.73 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.311 -0.868 . . . . 0.0 109.744 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.69 116.97 67.79 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.324 -0.86 . . . . 0.0 110.11 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -72.35 82.94 1.31 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.647 1.341 . . . . 0.0 110.08 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -60.92 -174.95 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.391 -0.818 . . . . 0.0 110.026 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.5 p -93.63 26.57 3.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.397 -0.815 . . . . 0.0 110.171 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -114.78 17.88 16.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.248 -0.908 . . . . 0.0 110.248 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 59.74 44.26 97.12 Favored Glycine 0 N--CA 1.484 1.88 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -174.55 161.35 3.25 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.307 -1.114 . . . . 0.0 110.79 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.624 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 2.2 mtt180 -87.7 -154.47 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.635 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.624 ' CD ' ' CB ' ' A' ' 47' ' ' ARG . 45.3 Cg_endo -77.36 -170.53 0.95 Allowed 'Trans proline' 0 N--CA 1.483 0.855 0 O-C-N 122.53 0.753 . . . . 0.0 111.008 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.523 ' O ' ' HG2' ' A' ' 52' ' ' MET . 4.0 mt 62.62 -62.86 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.729 -0.607 . . . . 0.0 110.057 -178.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.522 ' N ' ' O ' ' A' ' 48' ' ' PRO . 8.4 mt-30 -48.15 -23.55 0.89 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.596 -1.315 . . . . 0.0 109.757 179.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.1 p -118.54 31.37 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.337 -0.852 . . . . 0.0 109.873 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.523 ' HG2' ' O ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -93.03 36.66 1.03 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.139 -0.976 . . . . 0.0 109.963 179.627 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.42 ' CE ' ' HA3' ' A' ' 23' ' ' GLY . 7.7 ttp 63.44 -6.95 0.19 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.468 -0.77 . . . . 0.0 110.965 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.538 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 45.94 28.81 0.65 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.212 -0.93 . . . . 0.0 110.579 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.414 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -126.26 4.15 7.76 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.08 84.94 1.85 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.378 -1.072 . . . . 0.0 109.596 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.431 ' HB1' ' CE1' ' A' ' 90' ' ' PHE . . . -51.27 -22.97 3.08 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.417 -0.802 . . . . 0.0 110.514 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.472 ' HB3' HG12 ' A' ' 25' ' ' VAL . 1.8 mmt180 -54.07 -45.94 71.85 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.284 -0.885 . . . . 0.0 110.047 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.42 ' CG1' ' HB1' ' A' ' 20' ' ' ALA . 46.7 t -58.05 -45.22 88.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.418 -0.802 . . . . 0.0 109.723 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.427 ' O ' ' HB3' ' A' ' 64' ' ' LEU . . . -49.48 -53.19 24.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.515 -0.741 . . . . 0.0 109.719 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.421 ' N ' HG12 ' A' ' 96' ' ' VAL . 1.6 tt0 -52.21 -51.34 58.8 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.437 -0.789 . . . . 0.0 109.313 178.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.508 HD11 ' CD ' ' A' ' 29' ' ' ARG . 0.9 OUTLIER -49.55 -70.99 0.07 Allowed 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.638 0.732 . . . . 0.0 110.049 178.675 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.498 ' HB3' ' HB3' ' A' ' 68' ' ' ALA . 4.5 mm? -56.5 -46.81 80.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.867 -0.521 . . . . 0.0 110.931 -179.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.442 ' CD2' ' HB1' ' A' ' 100' ' ' ALA . 1.2 tt -61.56 -59.09 5.74 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.342 -0.849 . . . . 0.0 111.171 -179.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.35 -23.55 9.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.067 -1.021 . . . . 0.0 109.935 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.517 ' ND1' ' HG ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -88.9 -50.81 5.97 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.611 -0.681 . . . . 0.0 109.433 179.505 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.98 52.23 0.01 OUTLIER Glycine 0 N--CA 1.483 1.774 0 C-N-CA 119.937 -1.125 . . . . 0.0 111.061 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.498 ' HB3' ' HB3' ' A' ' 63' ' ' LEU . . . -79.29 -151.74 0.06 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.827 -1.396 . . . . 0.0 109.99 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.422 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 1.2 tt0 -123.28 54.89 7.3 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.365 -0.835 . . . . 0.0 110.088 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.452 ' HD3' ' HB2' ' A' ' 68' ' ' ALA . 43.0 Cg_endo -70.21 -13.91 34.06 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.641 1.337 . . . . 0.0 110.274 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.5 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 2.1 t-20 -108.36 -73.0 0.7 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.368 -0.832 . . . . 0.0 110.02 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 4.1 t -50.27 169.0 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.189 -0.944 . . . . 0.0 110.979 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.449 ' HB1' ' HA ' ' A' ' 80' ' ' ARG . . . -153.86 -155.45 0.59 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.334 -0.854 . . . . 0.0 110.149 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -101.71 135.34 19.78 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.406 -0.809 . . . . 0.0 109.746 179.876 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -74.3 -22.86 16.0 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.685 1.36 . . . . 0.0 110.661 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.03 -39.37 66.09 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.204 -0.935 . . . . 0.0 110.085 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -147.43 16.07 1.15 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.601 -0.687 . . . . 0.0 110.13 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.462 ' HB3' ' O ' ' A' ' 107' ' ' ARG . 0.4 OUTLIER 48.22 35.11 5.04 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.481 -0.762 . . . . 0.0 111.513 179.664 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.5 m -71.31 104.82 3.27 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.219 -0.926 . . . . 0.0 109.886 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.5 ' NH1' ' O ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -80.06 160.13 69.19 Favored Pre-proline 0 N--CA 1.498 1.928 0 O-C-N 121.351 -0.843 . . . . 0.0 110.747 -179.571 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.406 ' O ' ' HB2' ' A' ' 84' ' ' ASP . 45.7 Cg_endo -72.1 -17.46 28.12 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.822 1.433 . . . . 0.0 110.604 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.425 HG21 ' HG ' ' A' ' 104' ' ' LEU . 98.6 t -62.7 -24.06 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.209 -0.932 . . . . 0.0 110.205 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.495 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 13.4 m80 -76.68 -32.83 58.16 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.413 -0.804 . . . . 0.0 109.108 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.538 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 3.3 m-20 -57.98 -50.86 71.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.616 -0.678 . . . . 0.0 110.297 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.462 ' HB2' ' CD1' ' A' ' 94' ' ' LEU . . . -58.95 -58.33 9.11 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.343 -0.848 . . . . 0.0 109.856 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.55 ' HA ' ' CG1' ' A' ' 126' ' ' VAL . . . -59.36 -45.0 92.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.42 -0.8 . . . . 0.0 110.847 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.428 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 0.3 OUTLIER -47.71 -44.65 27.9 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.327 -0.858 . . . . 0.0 110.902 -179.589 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -95.96 13.32 27.31 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.284 -0.885 . . . . 0.0 110.495 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 59.84 60.1 9.29 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.431 ' CE1' ' HB1' ' A' ' 57' ' ' ALA . 0.3 OUTLIER -129.04 94.32 3.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.266 -1.138 . . . . 0.0 110.707 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.452 ' HG ' ' HA ' ' A' ' 126' ' ' VAL . 0.3 OUTLIER -69.31 -37.38 77.73 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.336 -0.853 . . . . 0.0 109.958 179.68 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.414 ' HB3' ' CB ' ' A' ' 57' ' ' ALA . 31.5 m-20 -50.08 -40.98 47.19 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.503 -0.748 . . . . 0.0 110.055 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 60.5 m -66.16 -42.45 88.96 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.462 ' CD1' ' HB2' ' A' ' 85' ' ' ALA . 1.2 tp -58.83 -38.27 78.28 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.596 -0.69 . . . . 0.0 109.312 178.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.3 t -61.41 -50.6 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.582 -0.699 . . . . 0.0 109.607 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.421 HG12 ' N ' ' A' ' 61' ' ' GLU . 92.9 t -54.17 -54.51 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.543 -0.723 . . . . 0.0 109.433 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.407 ' HB3' ' CB ' ' A' ' 102' ' ' ALA . 1.1 mp -47.51 -53.56 14.02 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.735 -0.603 . . . . 0.0 110.825 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -72.98 -29.61 63.18 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.307 -0.871 . . . . 0.0 110.084 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -65.86 -9.4 28.78 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.367 -0.833 . . . . 0.0 110.604 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.442 ' HB1' ' CD2' ' A' ' 64' ' ' LEU . . . -136.9 -74.6 0.42 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.117 -0.99 . . . . 0.0 111.051 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -160.14 102.21 0.21 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.407 ' CB ' ' HB3' ' A' ' 97' ' ' LEU . . . -162.43 111.18 1.39 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.405 -1.056 . . . . 0.0 109.878 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -77.86 145.47 36.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.38 -0.825 . . . . 0.0 110.38 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.425 ' HG ' HG21 ' A' ' 82' ' ' VAL . 2.4 mp -116.36 4.23 13.39 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.46 -0.775 . . . . 0.0 110.286 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -98.68 39.29 1.27 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.187 -0.946 . . . . 0.0 109.764 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.419 HG12 ' CD ' ' A' ' 80' ' ' ARG . 3.0 p -108.4 -170.18 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.369 -0.832 . . . . 0.0 109.791 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.462 ' O ' ' HB3' ' A' ' 78' ' ' LEU . 0.1 OUTLIER -157.43 155.09 29.86 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.344 -0.848 . . . . 0.0 109.556 179.677 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 . . . . . 0 N--CA 1.494 1.761 0 O-C-N 121.117 -0.99 . . . . 0.0 110.2 -179.91 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.452 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.846 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.452 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 46.4 Cg_endo -74.01 -50.39 0.17 Allowed 'Trans proline' 0 C--N 1.312 -1.349 0 O-C-N 123.604 1.318 . . . . 0.0 110.386 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.425 HG21 ' N ' ' A' ' 131' ' ' ARG . 12.2 p -58.62 -34.52 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.321 -0.862 . . . . 0.0 109.72 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -70.86 -25.5 62.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.53 -0.731 . . . . 0.0 109.698 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.2 tt -79.68 -28.18 40.74 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.428 -0.795 . . . . 0.0 110.073 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -73.56 -45.29 54.36 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.402 -0.811 . . . . 0.0 109.891 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -62.8 -37.11 85.44 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.465 -0.772 . . . . 0.0 109.806 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.21 -45.29 85.35 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.534 -0.729 . . . . 0.0 110.037 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.1 -81.8 0.1 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.383 -0.823 . . . . 0.0 110.378 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 167.8 53.25 0.03 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.498 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 53.4 m-70 -127.88 52.87 1.82 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -1.149 . . . . 0.0 109.483 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.4 mtp180 -47.43 -43.0 23.52 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.544 -0.723 . . . . 0.0 110.258 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -55.6 -42.94 75.53 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.391 -0.818 . . . . 0.0 109.295 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.55 ' CG1' ' HA ' ' A' ' 86' ' ' ALA . 3.0 t -78.94 -34.0 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.495 -0.753 . . . . 0.0 109.127 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.77 -31.99 72.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.501 -0.749 . . . . 0.0 109.517 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.9 mtp180 -60.65 -66.7 0.49 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.543 -0.723 . . . . 0.0 110.099 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -55.03 -28.87 55.51 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.346 -0.847 . . . . 0.0 109.627 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.468 ' O ' ' N ' ' A' ' 134' ' ' ALA . 68.1 mt -72.74 -43.52 62.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.574 -0.704 . . . . 0.0 109.569 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.425 ' N ' HG21 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -61.79 -19.53 62.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.203 -0.936 . . . . 0.0 110.391 -179.94 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.31 -50.71 7.12 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.277 -0.89 . . . . 0.0 110.399 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -88.26 -19.74 26.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.295 -0.878 . . . . 0.0 110.174 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.498 -0.751 . . . . 0.0 109.687 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.278 0.561 . . . . 0.0 110.006 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.51 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 2.2 t90 -70.37 -7.59 44.08 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.287 -0.883 . . . . 0.0 110.423 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.464 ' HG ' ' N ' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -80.4 -57.96 3.35 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.038 -1.039 . . . . 0.0 109.674 179.77 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.464 ' N ' ' HG ' ' A' ' 16' ' ' LEU . . . -63.26 -38.89 92.95 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.222 -0.924 . . . . 0.0 109.761 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.51 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 1.5 p -52.8 -54.22 37.22 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.527 -0.733 . . . . 0.0 110.385 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.477 ' CB ' HG23 ' A' ' 28' ' ' VAL . . . -59.77 -39.01 83.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.338 -0.851 . . . . 0.0 110.071 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.409 ' HB2' HG12 ' A' ' 59' ' ' VAL . . . -54.12 -61.91 2.0 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.116 -0.99 . . . . 0.0 109.561 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' A' ' 51' ' ' VAL . . . -54.64 -22.21 12.89 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.515 -0.74 . . . . 0.0 110.206 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -90.64 16.6 8.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.354 -0.841 . . . . 0.0 110.69 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 49.76 34.95 22.77 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 179.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.41 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . 6.2 mmt180 -109.49 67.54 0.65 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.338 -1.095 . . . . 0.0 110.052 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 93.2 t -49.17 -54.28 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.638 -0.663 . . . . 0.0 110.973 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -46.89 -43.02 18.46 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.5 -0.75 . . . . 0.0 110.818 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.546 ' O ' ' HB2' ' A' ' 31' ' ' LEU . 20.3 mt-10 -62.17 -44.86 95.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.233 -0.917 . . . . 0.0 110.166 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.477 HG23 ' CB ' ' A' ' 19' ' ' ALA . 3.5 t -72.92 -43.06 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.419 -0.801 . . . . 0.0 110.471 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.455 ' HD2' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -45.8 -47.81 15.67 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.409 -0.807 . . . . 0.0 109.853 -179.516 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.41 -49.06 11.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.418 -0.802 . . . . 0.0 110.379 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.546 ' HB2' ' O ' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -57.13 -56.99 14.67 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.165 -0.959 . . . . 0.0 110.255 179.849 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.578 ' HG ' ' CD2' ' A' ' 66' ' ' HIS . 15.2 tp -50.35 -49.65 53.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.5 -0.75 . . . . 0.0 110.665 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -74.73 -8.9 57.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.269 -0.894 . . . . 0.0 110.537 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.56 -11.69 39.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -0.912 . . . . 0.0 111.127 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 139.12 -9.38 3.29 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 119.619 -1.277 . . . . 0.0 110.763 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.477 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . . . -44.68 154.72 0.12 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.179 -1.189 . . . . 0.0 110.611 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.436 HD23 ' N ' ' A' ' 37' ' ' LEU . 2.3 mm? -93.73 111.31 52.11 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.378 -0.826 . . . . 0.0 110.658 -179.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.459 ' O ' ' HG3' ' A' ' 48' ' ' PRO . 43.2 Cg_endo -70.57 -19.02 32.78 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 123.622 1.327 . . . . 0.0 110.485 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -109.43 17.49 21.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.33 -0.856 . . . . 0.0 110.209 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.403 ' CB ' ' HB3' ' A' ' 37' ' ' LEU . . . -77.75 129.65 75.89 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.257 -0.902 . . . . 0.0 110.405 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -73.89 146.31 37.42 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 123.656 1.345 . . . . 0.0 109.983 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -88.96 -157.97 0.47 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.237 -0.914 . . . . 0.0 109.941 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.8 m -111.43 14.49 21.48 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.051 -1.03 . . . . 0.0 111.205 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -123.76 33.52 5.3 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.096 -1.002 . . . . 0.0 109.964 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.25 23.7 26.62 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.216 -1.553 . . . . 0.0 109.216 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.8 mtm-85 -108.05 -159.79 0.7 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.502 -0.999 . . . . 0.0 110.126 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.472 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 0.4 OUTLIER -127.89 179.69 1.19 Allowed Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.482 -0.761 . . . . 0.0 110.067 -179.651 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 42.1 Cg_endo -68.9 -24.52 33.65 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.611 1.322 . . . . 0.0 111.287 -179.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.549 ' O ' ' HG2' ' A' ' 52' ' ' MET . 4.3 mt -106.24 -36.83 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.044 -1.035 . . . . 0.0 108.64 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -54.73 -18.91 5.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.25 -0.906 . . . . 0.0 109.375 178.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.451 ' O ' ' CB ' ' A' ' 21' ' ' ALA . 9.3 p -116.07 39.23 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.478 -0.764 . . . . 0.0 110.601 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.549 ' HG2' ' O ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -103.55 39.21 1.64 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.946 -1.096 . . . . 0.0 109.443 179.267 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.412 ' CB ' ' O ' ' A' ' 52' ' ' MET . 0.0 OUTLIER 68.79 -5.61 0.98 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.729 -0.607 . . . . 0.0 110.918 -179.536 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.515 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.1 OUTLIER 39.94 89.32 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.364 -0.835 . . . . 0.0 110.937 179.82 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.538 ' HA2' ' CG ' ' A' ' 90' ' ' PHE . . . 159.13 -28.95 0.4 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.232 -1.947 . . . . 0.0 108.232 -179.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.67 79.91 1.72 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.733 -0.863 . . . . 0.0 110.16 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -48.8 -25.18 1.72 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.255 -0.903 . . . . 0.0 110.196 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.62 -39.24 57.68 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.463 -0.773 . . . . 0.0 109.789 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.409 HG12 ' HB2' ' A' ' 20' ' ' ALA . 23.8 t -69.22 -51.29 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.395 -0.816 . . . . 0.0 109.257 179.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.502 ' HB3' ' CE ' ' A' ' 52' ' ' MET . . . -48.91 -43.66 39.51 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.253 -0.904 . . . . 0.0 109.908 179.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -53.58 -51.72 62.08 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.501 -0.749 . . . . 0.0 109.677 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.479 ' HB3' HD23 ' A' ' 32' ' ' LEU . 1.2 mt -50.32 -66.51 0.38 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.593 -0.692 . . . . 0.0 109.912 178.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.479 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 11.0 mt -60.27 -39.27 86.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.676 -0.64 . . . . 0.0 110.798 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.448 ' CD2' HG12 ' A' ' 96' ' ' VAL . 0.5 OUTLIER -63.09 -60.15 3.83 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.174 -0.954 . . . . 0.0 110.458 -179.78 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.42 ' HG ' ' N ' ' A' ' 66' ' ' HIS . 0.7 OUTLIER -53.34 -22.67 7.7 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.427 -0.796 . . . . 0.0 110.019 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.578 ' CD2' ' HG ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -90.87 -25.15 19.99 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.611 -0.681 . . . . 0.0 109.679 179.849 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.94 56.58 0.5 Allowed Glycine 0 N--CA 1.481 1.643 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.479 ' CB ' ' HB3' ' A' ' 63' ' ' LEU . . . -70.1 -149.78 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.171 -1.193 . . . . 0.0 109.767 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.4 ' HB3' ' CG ' ' A' ' 47' ' ' ARG . 0.3 OUTLIER -120.46 59.31 6.85 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.498 -0.751 . . . . 0.0 109.628 179.251 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.401 ' HB2' ' HB2' ' A' ' 102' ' ' ALA . 43.5 Cg_endo -71.13 -1.53 9.71 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 O-C-N 123.808 1.425 . . . . 0.0 110.712 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -113.35 -66.4 1.09 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.128 -0.982 . . . . 0.0 110.014 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 3.1 t -50.57 166.59 0.08 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.453 -0.78 . . . . 0.0 110.534 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.447 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . . . -159.22 -140.18 0.07 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.395 -0.815 . . . . 0.0 110.04 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.462 ' O ' ' N ' ' A' ' 78' ' ' LEU . 11.0 t70 -105.05 127.35 28.88 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.062 -1.024 . . . . 0.0 109.765 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.83 -2.6 12.17 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.432 1.228 . . . . 0.0 111.208 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -97.15 -44.0 7.14 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.096 -1.003 . . . . 0.0 109.72 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -121.79 7.77 9.94 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.454 -0.779 . . . . 0.0 110.265 179.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.483 ' HB3' ' O ' ' A' ' 107' ' ' ARG . 1.3 mt 45.61 27.68 0.44 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.335 -0.853 . . . . 0.0 111.102 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.7 m -65.32 88.72 0.08 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.113 -0.992 . . . . 0.0 109.642 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.447 ' HA ' ' CB ' ' A' ' 73' ' ' ALA . 1.1 mtt180 -69.12 165.91 33.93 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.426 -0.796 . . . . 0.0 110.35 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.61 -12.97 34.32 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.728 1.383 . . . . 0.0 111.164 -179.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.416 HG13 HD23 ' A' ' 104' ' ' LEU . 39.9 t -66.13 -42.1 90.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.007 -1.058 . . . . 0.0 109.597 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.477 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 69.3 m80 -55.14 -45.49 75.65 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.609 0.719 . . . . 0.0 109.676 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.515 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 1.2 m-20 -49.32 -51.31 35.07 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.093 0.473 . . . . 0.0 110.957 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.654 ' HA ' ' CZ ' ' A' ' 90' ' ' PHE . . . -57.46 -60.69 3.27 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.172 -0.955 . . . . 0.0 109.639 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.433 ' HA ' ' CG1' ' A' ' 126' ' ' VAL . . . -63.14 -9.75 12.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.399 -0.813 . . . . 0.0 109.996 178.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -70.67 -54.38 12.1 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.039 -1.038 . . . . 0.0 110.665 -179.812 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.456 ' HB3' ' CD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -90.07 -19.11 24.74 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.141 -0.975 . . . . 0.0 109.862 -179.918 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.415 ' HA3' ' ND1' ' A' ' 123' ' ' HIS . . . 87.32 59.91 1.7 Allowed Glycine 0 N--CA 1.487 2.077 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.33 178.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.654 ' CZ ' ' HA ' ' A' ' 85' ' ' ALA . 1.3 p90 -135.17 89.02 2.47 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.012 -1.287 . . . . 0.0 109.912 178.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.451 ' CD1' ' HB3' ' A' ' 125' ' ' ASP . 0.2 OUTLIER -51.58 -35.12 40.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.868 -0.52 . . . . 0.0 110.883 -179.31 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 91' ' ' LEU . 1.7 m-20 -41.86 -33.7 0.56 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.319 -0.863 . . . . 0.0 109.128 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.489 ' HB ' ' CD2' ' A' ' 90' ' ' PHE . 1.1 m -79.52 -49.73 11.8 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.442 ' CD2' ' HG ' ' A' ' 130' ' ' LEU . 2.5 tp -54.2 -41.33 68.5 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.65 -0.656 . . . . 0.0 109.587 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 89.8 t -59.99 -53.04 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.327 -0.858 . . . . 0.0 109.182 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.448 HG12 ' CD2' ' A' ' 64' ' ' LEU . 40.6 t -51.86 -46.46 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.638 -0.664 . . . . 0.0 109.435 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.442 ' CD2' ' HB3' ' A' ' 102' ' ' ALA . 0.6 OUTLIER -52.32 -55.41 21.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.623 -0.673 . . . . 0.0 109.877 179.588 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -70.63 -28.12 64.59 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.363 -0.835 . . . . 0.0 110.168 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -68.49 -9.57 49.84 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.287 -0.883 . . . . 0.0 110.995 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -127.99 -87.12 0.57 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.168 -0.958 . . . . 0.0 110.617 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -163.68 54.39 0.29 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.442 ' HB3' ' CD2' ' A' ' 97' ' ' LEU . . . -102.26 133.1 47.7 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.252 -1.146 . . . . 0.0 110.305 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.38 152.58 33.69 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.263 -0.898 . . . . 0.0 109.639 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.416 HD23 HG13 ' A' ' 82' ' ' VAL . 6.6 mt -143.08 46.46 1.54 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.166 -0.958 . . . . 0.0 110.908 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -169.44 52.7 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.182 -0.949 . . . . 0.0 110.815 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.441 ' CG1' ' HG3' ' A' ' 80' ' ' ARG . 9.6 p -113.63 -178.14 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 0.0 109.97 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.483 ' O ' ' HB3' ' A' ' 78' ' ' LEU . 0.1 OUTLIER -129.32 138.04 51.35 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.386 -0.821 . . . . 0.0 109.882 179.129 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.5 t0 . . . . . 0 N--CA 1.494 1.749 0 O-C-N 121.421 -0.8 . . . . 0.0 110.404 -179.833 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.433 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 66.0 mt . . . . . 0 N--CA 1.493 1.713 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 40.9 Cg_endo -67.78 -28.51 36.6 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.779 1.41 . . . . 0.0 110.081 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.447 ' HB ' ' HB3' ' A' ' 130' ' ' LEU . 11.1 p -75.53 -35.89 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.399 -0.813 . . . . 0.0 109.939 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.94 -29.87 68.21 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.425 -0.797 . . . . 0.0 109.952 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.442 ' CD2' ' N ' ' A' ' 118' ' ' ALA . 4.3 tt -66.08 -58.53 5.26 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.459 -0.776 . . . . 0.0 109.934 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.442 ' N ' ' CD2' ' A' ' 117' ' ' LEU . . . -50.12 -48.01 53.73 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.383 -0.823 . . . . 0.0 110.969 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -50.77 -41.31 56.73 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.33 -0.856 . . . . 0.0 110.086 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -74.45 -55.1 6.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.57 -0.706 . . . . 0.0 109.94 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.6 mt -53.07 -82.02 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.253 -0.905 . . . . 0.0 110.549 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.82 39.62 0.03 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.415 ' ND1' ' HA3' ' A' ' 89' ' ' GLY . 27.2 m-70 -124.08 52.83 1.44 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.276 -1.132 . . . . 0.0 109.188 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.1 ttt-85 -46.21 -45.44 16.91 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.73 -0.606 . . . . 0.0 110.341 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.451 ' HB3' ' CD1' ' A' ' 91' ' ' LEU . 1.9 m-20 -52.53 -46.83 66.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.371 -0.831 . . . . 0.0 109.18 179.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.433 ' CG1' ' HA ' ' A' ' 86' ' ' ALA . 2.5 t -75.72 -27.51 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.5 -0.75 . . . . 0.0 109.556 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -75.19 -48.87 21.48 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.37 -0.831 . . . . 0.0 109.929 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.27 -54.93 41.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.28 -0.887 . . . . 0.0 110.157 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -59.33 -36.84 76.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.276 -0.89 . . . . 0.0 109.782 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.447 ' HB3' ' HB ' ' A' ' 115' ' ' VAL . 8.4 mt -64.03 -49.56 71.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.224 -0.923 . . . . 0.0 109.457 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.94 -29.77 30.65 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.301 -0.875 . . . . 0.0 110.288 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -86.34 -42.78 13.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.35 -0.844 . . . . 0.0 109.836 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -79.81 -5.66 55.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.435 -0.791 . . . . 0.0 110.513 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 104' ' ' LEU . . . . . . . . 0 N--CA 1.494 1.733 0 O-C-N 121.172 -0.955 . . . . 0.0 110.622 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 120.741 0.305 . . . . 0.0 110.357 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.483 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 0.1 OUTLIER -46.44 -62.78 1.21 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.366 -0.834 . . . . 0.0 110.345 -179.584 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.535 HD13 ' CD2' ' A' ' 63' ' ' LEU . 0.3 OUTLIER -45.81 -35.26 4.27 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.392 0.615 . . . . 0.0 110.115 179.16 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.66 -48.57 16.46 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.463 -0.773 . . . . 0.0 109.639 179.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.483 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.0 OUTLIER -52.97 -60.26 3.5 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.515 -0.74 . . . . 0.0 110.517 179.72 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.533 ' HB3' HG23 ' A' ' 28' ' ' VAL . . . -53.3 -43.44 67.56 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.332 -0.855 . . . . 0.0 109.905 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.451 ' C ' ' HA ' ' A' ' 52' ' ' MET . . . -55.39 -40.17 71.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.572 -0.705 . . . . 0.0 109.527 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.35 -34.43 70.49 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.434 -0.791 . . . . 0.0 110.363 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.9 mtm180 -94.65 22.61 6.1 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.245 -0.909 . . . . 0.0 110.885 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.526 ' HA3' ' HE2' ' A' ' 53' ' ' MET . . . 52.41 72.31 0.54 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.452 ' HB3' ' CB ' ' A' ' 27' ' ' GLU . 4.3 mtt85 -129.87 56.57 1.72 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.428 -1.042 . . . . 0.0 109.769 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 89.5 t -47.4 -55.14 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.558 -0.714 . . . . 0.0 110.649 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -61.67 -31.46 71.58 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.404 -0.81 . . . . 0.0 110.936 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.452 ' CB ' ' HB3' ' A' ' 24' ' ' ARG . 0.3 OUTLIER -76.43 -33.31 58.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.151 -0.968 . . . . 0.0 109.557 179.876 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.533 HG23 ' HB3' ' A' ' 19' ' ' ALA . 5.0 t -78.77 -46.67 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.453 -0.78 . . . . 0.0 109.653 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.491 ' HA ' HD21 ' A' ' 62' ' ' LEU . 15.2 mmm180 -49.22 -48.08 45.75 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.431 -0.793 . . . . 0.0 109.74 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.04 -37.93 69.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.646 -0.659 . . . . 0.0 109.673 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 27' ' ' GLU . 6.3 mt -66.58 -56.47 10.59 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.469 -0.77 . . . . 0.0 110.565 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.521 HD11 ' CG ' ' A' ' 66' ' ' HIS . 0.1 OUTLIER -44.45 -56.41 4.29 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.634 -0.666 . . . . 0.0 110.551 -179.809 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.48 -14.64 61.27 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.354 -0.841 . . . . 0.0 110.382 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 31' ' ' LEU . . . -79.15 -7.63 58.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.088 -1.007 . . . . 0.0 110.6 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 134.96 -12.19 4.47 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.771 -1.205 . . . . 0.0 110.578 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.73 149.32 1.79 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.172 -1.193 . . . . 0.0 110.509 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.475 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 0.2 OUTLIER -86.33 140.1 34.19 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.373 -0.829 . . . . 0.0 110.253 -179.713 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -74.79 -56.66 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.812 1.427 . . . . 0.0 110.51 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.422 ' ND2' ' O ' ' A' ' 67' ' ' GLY . 0.2 OUTLIER -95.4 55.92 1.78 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.264 -0.897 . . . . 0.0 109.825 179.565 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.475 ' HB3' ' HB3' ' A' ' 37' ' ' LEU . . . -101.76 108.25 55.22 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.169 -0.957 . . . . 0.0 110.774 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.8 132.26 19.82 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.617 1.325 . . . . 0.0 109.554 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -124.19 71.06 1.11 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.054 -1.029 . . . . 0.0 111.112 -179.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.8 m 44.46 -157.29 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.358 -0.839 . . . . 0.0 110.362 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 60.64 7.56 1.44 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.124 -0.985 . . . . 0.0 110.734 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 50.44 26.66 10.2 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.513 ' HG2' ' HB3' ' A' ' 50' ' ' GLN . 6.0 mtm-85 -125.78 -170.47 2.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.534 -0.98 . . . . 0.0 110.775 -179.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.563 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 3.5 mmp_? -119.78 -163.48 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.332 -0.855 . . . . 0.0 109.331 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.563 ' CD ' ' CB ' ' A' ' 47' ' ' ARG . 43.9 Cg_endo -80.04 -22.43 7.32 Favored 'Trans proline' 0 C--N 1.321 -0.895 0 O-C-N 122.987 0.993 . . . . 0.0 110.911 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.491 ' O ' ' HG2' ' A' ' 52' ' ' MET . 10.1 mt -107.05 -42.47 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.241 -0.912 . . . . 0.0 109.242 178.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.513 ' HB3' ' HG2' ' A' ' 46' ' ' ARG . 1.1 mt-30 -53.1 -22.55 6.32 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.158 -0.963 . . . . 0.0 109.994 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.2 p -101.61 1.76 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 0.0 110.532 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.491 ' HG2' ' O ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -70.42 157.82 37.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.874 -1.141 . . . . 0.0 109.426 179.936 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' MET . . . . . 0.526 ' HE2' ' HA3' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -52.09 -13.74 0.34 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.194 -0.941 . . . . 0.0 111.225 -179.318 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.588 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 62.93 10.96 4.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.325 -0.859 . . . . 0.0 109.543 -178.908 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.505 ' O ' ' CE1' ' A' ' 90' ' ' PHE . . . -113.82 -2.95 23.73 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.463 -1.855 . . . . 0.0 108.463 178.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.25 79.37 1.9 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.395 -1.062 . . . . 0.0 109.99 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.52 ' CB ' ' HB3' ' A' ' 92' ' ' ASP . . . -50.32 -26.27 4.66 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.425 -0.797 . . . . 0.0 109.62 179.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.49 -44.28 65.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.476 -0.765 . . . . 0.0 109.507 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.405 ' O ' ' HB3' ' A' ' 62' ' ' LEU . 43.2 t -59.5 -56.83 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.289 -0.882 . . . . 0.0 109.436 179.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.434 ' O ' ' CB ' ' A' ' 64' ' ' LEU . . . -53.72 -42.45 68.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.408 -0.808 . . . . 0.0 109.611 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -59.18 -31.88 69.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 110.091 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.508 ' O ' ' HB2' ' A' ' 66' ' ' HIS . 10.2 tp -74.46 -59.0 2.93 Favored 'General case' 0 C--N 1.31 -1.129 0 O-C-N 121.334 -0.854 . . . . 0.0 109.121 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.535 ' CD2' HD13 ' A' ' 16' ' ' LEU . 1.5 mt -63.24 -40.56 97.79 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.496 -0.752 . . . . 0.0 110.389 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.54 HD12 ' O ' ' A' ' 96' ' ' VAL . 0.4 OUTLIER -53.37 -70.5 0.09 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.135 -0.978 . . . . 0.0 110.344 -179.616 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 62' ' ' LEU . 3.2 pp -51.35 -24.41 4.68 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.443 -0.786 . . . . 0.0 109.827 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.521 ' CG ' HD11 ' A' ' 32' ' ' LEU . 1.8 m80 -84.98 -27.2 26.62 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.752 -0.593 . . . . 0.0 110.147 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 63' ' ' LEU . . . 128.94 43.54 0.22 Allowed Glycine 0 N--CA 1.479 1.521 0 C-N-CA 120.136 -1.031 . . . . 0.0 110.906 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.43 ' CB ' ' CD1' ' A' ' 49' ' ' ILE . . . -72.9 -153.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.73 -1.453 . . . . 0.0 109.22 179.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.49 ' HB2' ' HB3' ' A' ' 47' ' ' ARG . 0.3 OUTLIER -124.09 67.25 43.46 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.258 -0.901 . . . . 0.0 110.358 179.59 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -72.75 -25.93 16.55 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.91 1.479 . . . . 0.0 110.209 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -104.82 -36.44 7.39 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.334 -0.854 . . . . 0.0 110.006 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.3 m -60.76 164.27 4.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.425 -0.797 . . . . 0.0 110.792 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -165.04 -157.73 0.36 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.483 -0.761 . . . . 0.0 109.724 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.482 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.8 OUTLIER -105.02 138.35 19.48 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.157 -0.964 . . . . 0.0 109.981 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -74.67 -22.17 15.87 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.517 1.272 . . . . 0.0 110.644 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.98 -76.53 0.05 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.288 -0.883 . . . . 0.0 109.853 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.414 ' O ' ' HA ' ' A' ' 108' ' ' ASP . 0.3 OUTLIER -109.52 31.5 5.73 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.517 -0.739 . . . . 0.0 110.518 -179.744 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.482 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 4.6 mt 40.66 31.27 0.11 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.56 -0.712 . . . . 0.0 110.906 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.478 ' HA ' ' OD1' ' A' ' 108' ' ' ASP . 93.9 m -57.84 87.68 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.379 -0.826 . . . . 0.0 109.538 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -71.23 161.43 78.33 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.357 -0.839 . . . . 0.0 110.558 -179.086 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.41 ' HA ' ' HG2' ' A' ' 50' ' ' GLN . 45.1 Cg_endo -71.15 -24.46 23.47 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 124.007 1.53 . . . . 0.0 110.251 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.434 ' CG1' ' HG ' ' A' ' 104' ' ' LEU . 25.1 t -58.86 -27.62 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.429 -0.794 . . . . 0.0 109.856 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 47.8 m80 -65.67 -42.74 90.97 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.885 0.85 . . . . 0.0 109.35 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.588 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 0.9 OUTLIER -54.1 -57.41 11.21 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.732 -179.604 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.458 ' CB ' ' HG ' ' A' ' 94' ' ' LEU . . . -48.18 -63.62 1.02 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.449 -0.782 . . . . 0.0 109.867 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.513 ' O ' ' CD2' ' A' ' 123' ' ' HIS . . . -56.41 -50.32 71.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.337 -0.852 . . . . 0.0 110.571 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.412 ' HD3' HD12 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -48.71 -34.01 11.22 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.402 -0.811 . . . . 0.0 110.992 -179.349 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.436 ' CB ' ' HB3' ' A' ' 54' ' ' MET . 12.8 tp10 -93.51 -7.83 43.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.201 -0.937 . . . . 0.0 110.618 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.5 ' HA2' ' CG ' ' A' ' 123' ' ' HIS . . . 80.17 16.89 75.52 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.514 ' O ' ' CD1' ' A' ' 94' ' ' LEU . 0.3 OUTLIER -87.22 156.25 19.74 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.046 -1.267 . . . . 0.0 110.351 -179.875 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.48 ' CD2' ' HA ' ' A' ' 126' ' ' VAL . 0.0 OUTLIER -122.9 -53.62 1.85 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.66 -0.65 . . . . 0.0 109.644 179.639 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.52 ' HB3' ' CB ' ' A' ' 57' ' ' ALA . 0.2 OUTLIER -44.14 -41.36 5.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.623 -0.673 . . . . 0.0 109.689 179.835 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.5 m -58.41 -49.68 76.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.635 -0.666 . . . . 0.0 109.792 178.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.514 ' CD1' ' O ' ' A' ' 90' ' ' PHE . 0.6 OUTLIER -55.17 -54.12 47.36 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.165 -0.959 . . . . 0.0 109.585 179.727 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.2 t -50.24 -47.69 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.629 -0.669 . . . . 0.0 109.256 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.54 ' O ' HD12 ' A' ' 64' ' ' LEU . 58.4 t -52.81 -50.82 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.421 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -54.03 -68.92 0.14 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.502 -0.749 . . . . 0.0 110.293 179.399 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -52.65 -32.17 40.71 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.16 -0.962 . . . . 0.0 109.636 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 25.3 ttm-85 -68.38 -12.66 61.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.521 -0.737 . . . . 0.0 110.048 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.19 60.94 1.63 Allowed 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.234 -0.916 . . . . 0.0 110.738 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 53.94 102.66 0.01 OUTLIER Glycine 0 N--CA 1.494 2.522 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 97' ' ' LEU . . . -160.25 114.17 2.18 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.133 -1.216 . . . . 0.0 110.544 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.414 ' HD3' ' HA ' ' A' ' 103' ' ' ARG . 12.8 tpp180 -68.35 159.39 31.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.632 -0.667 . . . . 0.0 110.088 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.434 ' HG ' ' CG1' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -145.52 10.47 1.25 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.36 -0.837 . . . . 0.0 110.976 -179.577 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -111.57 46.46 1.11 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.048 -1.033 . . . . 0.0 110.268 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.442 HG11 ' HG3' ' A' ' 80' ' ' ARG . 2.5 p -105.7 167.25 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.488 -0.758 . . . . 0.0 109.307 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.431 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 6.6 ttt85 -136.37 51.7 2.0 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.389 -0.82 . . . . 0.0 110.29 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . 0.478 ' OD1' ' HA ' ' A' ' 79' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.497 1.905 0 O-C-N 121.631 -0.668 . . . . 0.0 110.39 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.482 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.81 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.482 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 37.9 Cg_endo -63.81 -57.14 0.38 Allowed 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.373 1.196 . . . . 0.0 110.941 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.478 ' CG1' HD21 ' A' ' 113' ' ' LEU . 2.4 p -51.72 -31.12 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 120.905 -1.122 . . . . 0.0 110.33 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -66.2 -28.31 68.66 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.295 -0.878 . . . . 0.0 110.35 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.412 HD12 ' HD3' ' A' ' 87' ' ' ARG . 2.2 mm? -67.92 -38.57 83.06 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.126 -0.984 . . . . 0.0 110.116 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.425 ' HB1' ' CB ' ' A' ' 127' ' ' ALA . . . -68.48 -50.88 49.09 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.411 -0.806 . . . . 0.0 110.111 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -61.0 -45.54 94.43 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.269 -0.895 . . . . 0.0 110.319 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -54.27 -52.78 60.34 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.314 -0.866 . . . . 0.0 109.719 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.67 -86.43 0.06 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.362 -0.836 . . . . 0.0 110.216 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 174.06 31.34 0.03 OUTLIER Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.513 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 45.8 m-70 -95.05 46.73 1.13 Allowed 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.417 -1.049 . . . . 0.0 108.685 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -47.14 -33.33 5.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.784 -0.573 . . . . 0.0 109.832 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.55 -40.99 98.59 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.48 ' HA ' ' CD2' ' A' ' 91' ' ' LEU . 3.4 t -75.82 -46.2 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.447 -0.783 . . . . 0.0 109.308 178.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.558 ' O ' ' CB ' ' A' ' 131' ' ' ARG . . . -53.2 -53.42 50.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.302 -0.874 . . . . 0.0 109.408 179.079 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -49.8 -53.2 26.74 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.167 -0.958 . . . . 0.0 110.493 179.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -71.57 -56.37 6.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.372 -0.83 . . . . 0.0 110.746 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.449 ' CD2' ' HB1' ' A' ' 86' ' ' ALA . 0.3 OUTLIER -60.25 -30.58 69.52 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.366 -0.834 . . . . 0.0 111.025 -179.033 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.558 ' CB ' ' O ' ' A' ' 127' ' ' ALA . 4.3 ttp-105 -73.07 -27.54 61.79 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.028 -1.045 . . . . 0.0 110.432 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.95 -42.0 77.26 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.212 -0.93 . . . . 0.0 109.23 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -87.94 -10.17 51.35 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.638 -0.664 . . . . 0.0 110.336 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.494 1.729 0 O-C-N 121.232 -0.918 . . . . 0.0 110.59 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.621 ' O ' ' N ' ' A' ' 17' ' ' ALA . 2.8 m-20 . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 120.981 0.419 . . . . 2.92 110.021 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.472 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 4.4 m0 -41.61 -36.87 1.02 Allowed 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.854 -0.738 . . . . 4.61 109.036 178.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.562 HD11 HD21 ' A' ' 63' ' ' LEU . 3.4 pp -74.99 -33.16 61.82 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.376 -0.972 . . . . 3.15 108.376 177.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.621 ' N ' ' O ' ' A' ' 14' ' ' ASP . . . -80.45 -54.24 5.86 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.942 -0.762 . . . . 2.34 108.942 177.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 14' ' ' ASP . 0.5 OUTLIER -54.3 -48.87 70.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.267 -0.896 . . . . 2.95 108.753 178.457 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.472 ' CB ' ' O ' ' A' ' 15' ' ' TRP . . . -63.87 -35.01 79.23 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.574 -0.899 . . . . 2.74 108.574 178.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.428 ' HB2' ' CB ' ' A' ' 52' ' ' MET . . . -66.87 -43.61 83.08 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.664 -0.865 . . . . 1.91 108.664 178.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.416 ' N ' ' HA ' ' A' ' 52' ' ' MET . . . -61.58 -26.8 68.2 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.558 -0.713 . . . . 2.21 109.348 179.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -95.91 20.32 10.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.647 -0.658 . . . . 5.64 110.087 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 55.81 34.18 60.88 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.38 -1.088 . . . . 2.84 110.38 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.434 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -99.53 74.44 1.89 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.283 -1.127 . . . . 4.77 109.984 179.646 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.0 t -57.85 -46.14 87.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.374 -0.829 . . . . 3.17 110.353 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -54.93 -51.45 66.05 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.387 -0.82 . . . . 4.64 110.4 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.16 -46.04 68.73 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.23 -0.919 . . . . 3.68 109.963 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.436 ' HA ' ' HB2' ' A' ' 31' ' ' LEU . 5.7 t -69.66 -42.19 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.398 -0.814 . . . . 3.02 109.622 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.611 ' HA ' ' CD1' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -48.5 -48.11 38.3 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.55 -0.719 . . . . 4.65 110.093 179.676 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.73 -35.23 45.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.505 -0.747 . . . . 4.36 110.057 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.436 ' HB2' ' HA ' ' A' ' 28' ' ' VAL . 25.8 mt -64.26 -65.69 0.64 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.369 -0.832 . . . . 3.46 110.03 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.552 HD22 ' CG ' ' A' ' 66' ' ' HIS . 3.8 mt -48.33 -42.51 31.44 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.43 -0.794 . . . . 3.6 110.544 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -75.23 -17.27 60.37 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.255 -0.903 . . . . 4.87 110.24 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.36 -7.45 58.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -0.924 . . . . 4.28 110.896 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.29 26.91 1.92 Allowed Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.888 -1.148 . . . . 3.96 110.466 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.447 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -79.14 126.79 31.19 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.176 -1.191 . . . . 3.38 110.341 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.44 123.83 37.95 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.375 -0.828 . . . . 4.1 110.337 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -72.56 -23.87 19.44 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.539 1.284 . . . . 3.49 108.966 178.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.403 ' ND2' ' O ' ' A' ' 67' ' ' GLY . 0.6 OUTLIER -112.7 51.77 0.81 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.63 -0.669 . . . . 3.8 109.246 178.829 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.88 116.4 66.44 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.413 -0.804 . . . . 2.92 110.46 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.32 121.12 6.27 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.696 1.366 . . . . 3.34 110.487 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -78.75 175.41 10.48 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.296 -0.877 . . . . 3.64 110.351 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.7 m -83.48 -6.53 59.48 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.317 -0.865 . . . . 4.16 110.502 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -84.46 12.05 7.56 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.153 -0.967 . . . . 3.91 110.375 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.22 16.22 62.07 Favored Glycine 0 N--CA 1.484 1.889 0 N-CA-C 109.064 -1.615 . . . . 3.11 109.064 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 61.3 mtt180 -113.52 -167.51 1.21 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.47 -1.018 . . . . 3.68 110.179 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.649 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 0.8 OUTLIER -108.96 -174.37 0.3 Allowed Pre-proline 0 N--CA 1.492 1.631 0 N-CA-C 108.848 -0.797 . . . . 4.08 108.848 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.721 ' HB2' HD21 ' A' ' 63' ' ' LEU . 43.3 Cg_endo -74.25 -19.59 19.66 Favored 'Trans proline' 0 C--N 1.314 -1.249 0 O-C-N 123.001 1.0 . . . . 2.19 111.4 -178.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.474 ' CG1' HD12 ' A' ' 63' ' ' LEU . 14.1 mt -108.73 -36.56 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 120.99 -1.069 . . . . 2.15 108.909 178.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.411 ' HG3' ' HA ' ' A' ' 81' ' ' PRO . 0.4 OUTLIER -56.55 -17.6 8.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.479 -0.763 . . . . 3.13 110.062 179.246 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.8 p -107.81 -5.16 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.31 -0.869 . . . . 2.14 111.277 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' MET . . . . . 0.512 ' HG3' ' SD ' ' A' ' 54' ' ' MET . 0.0 OUTLIER -62.33 164.86 6.6 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.73 -1.231 . . . . 2.02 109.728 -179.902 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 5.0 tmm? -57.13 -10.32 1.17 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.256 -0.902 . . . . 2.94 111.478 -178.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.605 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 57.67 16.97 3.74 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.08 -1.012 . . . . 1.71 109.95 -179.432 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.466 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -121.26 10.63 9.96 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 108.944 -1.662 . . . . 2.31 108.944 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.39 86.97 1.49 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.453 -1.028 . . . . 3.0 109.197 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.95 -24.72 6.84 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.466 -0.771 . . . . 2.41 110.6 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -53.62 -38.59 64.18 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.233 -0.917 . . . . 5.03 109.347 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.1 t -64.78 -49.01 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.043 -1.095 . . . . 2.35 108.043 178.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.423 ' O ' ' CB ' ' A' ' 64' ' ' LEU . . . -55.77 -43.04 76.38 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.888 -0.782 . . . . 2.1 108.888 178.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -58.65 -64.04 1.07 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.323 -0.86 . . . . 3.67 108.785 178.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.613 ' O ' ' HB2' ' A' ' 66' ' ' HIS . 0.0 OUTLIER -41.9 -59.36 1.73 Allowed 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.769 0.795 . . . . 3.45 109.811 177.936 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.721 HD21 ' HB2' ' A' ' 48' ' ' PRO . 10.4 mt -59.75 -56.01 27.19 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.271 0.558 . . . . 2.65 110.84 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.469 ' CD1' ' HA ' ' A' ' 97' ' ' LEU . 1.2 tt -56.53 -56.63 18.86 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.426 -0.796 . . . . 3.03 110.918 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.402 ' HG ' ' N ' ' A' ' 66' ' ' HIS . 0.1 OUTLIER -55.99 -29.89 60.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.141 -0.974 . . . . 4.1 109.935 -179.377 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' HIS . . . . . 0.613 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -82.39 -25.14 34.02 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.423 -0.798 . . . . 4.46 109.395 179.606 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.403 ' O ' ' ND2' ' A' ' 39' ' ' ASN . . . 124.08 42.18 0.37 Allowed Glycine 0 N--CA 1.479 1.518 0 N-CA-C 110.507 -1.037 . . . . 3.36 110.507 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.634 ' HB3' ' HB3' ' A' ' 63' ' ' LEU . . . -66.41 -161.79 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.855 -1.38 . . . . 2.73 109.474 179.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.547 ' HB2' ' HB3' ' A' ' 47' ' ' ARG . 1.7 mp0 -115.88 62.13 2.02 Favored Pre-proline 0 C--N 1.302 -1.487 0 O-C-N 121.362 -0.836 . . . . 3.37 110.324 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.508 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 43.1 Cg_endo -68.89 -11.71 32.55 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.608 1.32 . . . . 2.83 109.455 178.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.49 ' OD1' ' HB2' ' A' ' 103' ' ' ARG . 1.4 t-20 -106.05 -42.05 5.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.532 -0.73 . . . . 4.22 110.223 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -69.73 143.84 52.95 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.153 -0.967 . . . . 3.77 110.734 -179.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.405 ' HB1' ' HG2' ' A' ' 80' ' ' ARG . . . -132.98 -146.43 0.27 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.426 -0.796 . . . . 3.6 110.103 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 78' ' ' LEU . 1.0 OUTLIER -109.3 138.27 20.45 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.117 -0.989 . . . . 3.88 110.109 -179.939 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -77.35 -6.04 16.1 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.467 1.246 . . . . 4.88 110.551 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -99.12 -35.7 9.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.163 -0.961 . . . . 4.82 110.116 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.2 p -132.21 7.51 4.27 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.323 -0.861 . . . . 4.87 110.696 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.406 ' N ' ' O ' ' A' ' 74' ' ' ASP . 6.0 mt 45.59 31.66 0.99 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.319 -0.863 . . . . 4.58 110.63 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.9 m -69.12 76.9 0.35 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.413 -0.804 . . . . 3.55 110.472 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.512 ' HD2' ' HB ' ' A' ' 106' ' ' VAL . 3.8 mtt85 -57.61 161.27 6.32 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.091 -1.005 . . . . 4.15 109.273 179.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.508 ' HG3' ' HA ' ' A' ' 70' ' ' PRO . 39.4 Cg_endo -67.81 -6.84 17.88 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.555 1.292 . . . . 2.54 110.954 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.48 HG11 HD21 ' A' ' 104' ' ' LEU . 19.4 t -71.03 -35.51 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.216 -0.927 . . . . 2.74 109.674 179.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . 0.424 ' CE1' ' HD3' ' A' ' 114' ' ' PRO . 31.8 m80 -67.48 -44.89 77.46 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.381 -0.825 . . . . 3.25 109.195 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.605 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 0.3 OUTLIER -49.53 -51.76 34.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.886 -0.509 . . . . 2.28 110.902 -179.792 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.451 ' HB1' ' CD1' ' A' ' 94' ' ' LEU . . . -58.1 -58.36 8.78 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.102 -0.999 . . . . 1.9 109.682 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.565 ' O ' ' CD2' ' A' ' 123' ' ' HIS . . . -59.79 -40.44 88.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.417 -0.802 . . . . 2.32 110.348 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.9 -34.73 21.21 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.31 -0.869 . . . . 4.19 110.332 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.41 1.85 38.81 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.39 -0.819 . . . . 2.79 110.642 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.499 ' HA2' ' HB3' ' A' ' 123' ' ' HIS . . . 73.62 38.14 51.47 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.521 -1.431 . . . . 2.05 109.521 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.466 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 0.3 OUTLIER -110.8 105.17 13.92 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.311 -1.111 . . . . 2.82 111.101 -179.265 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.473 ' HG ' ' HA ' ' A' ' 126' ' ' VAL . 0.5 OUTLIER -78.64 -36.85 43.38 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.25 -0.906 . . . . 3.11 109.356 178.872 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -48.17 -43.38 31.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.592 -0.692 . . . . 2.72 109.747 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.413 ' CG2' ' HB2' ' A' ' 85' ' ' ALA . 54.6 m -65.82 -43.92 87.17 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.722 -0.844 . . . . 1.77 108.722 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.485 ' CD2' ' HG ' ' A' ' 130' ' ' LEU . 1.1 tp -57.48 -49.09 77.43 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.435 -0.791 . . . . 2.6 109.006 178.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.497 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 85.7 t -54.94 -54.56 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 108.87 -0.789 . . . . 3.16 108.87 178.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 89.1 t -49.37 -50.79 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.739 -0.601 . . . . 2.79 109.861 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.469 ' HA ' ' CD1' ' A' ' 64' ' ' LEU . 0.4 OUTLIER -52.45 -64.39 0.83 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.42 -0.8 . . . . 2.9 109.833 179.373 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -57.67 -22.99 49.15 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.34 -0.85 . . . . 3.94 110.683 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 4.3 ttt180 -73.47 -17.05 61.28 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.222 -0.924 . . . . 5.48 110.893 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.461 ' CB ' ' CD2' ' A' ' 64' ' ' LEU . . . -141.11 67.99 1.34 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.052 -1.03 . . . . 3.94 111.245 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 48.55 94.98 0.01 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.899 -0.88 . . . . 3.76 110.899 179.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.437 ' O ' HD12 ' A' ' 104' ' ' LEU . . . -150.25 101.54 3.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.396 -1.061 . . . . 3.32 109.021 179.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.49 ' HB2' ' OD1' ' A' ' 71' ' ' ASN . 3.0 tpt180 -54.23 120.95 7.21 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.314 -0.866 . . . . 5.2 111.002 -178.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.48 HD21 HG11 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -107.5 -7.12 16.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.721 -0.612 . . . . 3.44 109.911 179.45 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -98.32 48.19 0.99 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.101 -1.0 . . . . 4.2 112.525 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.512 ' HB ' ' HD2' ' A' ' 80' ' ' ARG . 1.4 p -113.02 -175.18 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.684 -1.26 . . . . 4.02 109.869 178.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 4.2 ptt180 -138.98 158.52 44.05 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.512 -0.742 . . . . 5.78 109.211 178.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.496 1.841 0 O-C-N 121.065 -1.022 . . . . 4.46 111.459 -178.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.478 ' HB3' HG12 ' A' ' 115' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 120.637 0.256 . . . . 4.51 110.884 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . 0.424 ' HD3' ' CE1' ' A' ' 83' ' ' HIS . 39.9 Cg_endo -68.0 -26.4 37.38 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.853 1.449 . . . . 3.26 108.643 177.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.478 HG12 ' HB3' ' A' ' 113' ' ' LEU . 7.2 p -76.29 -35.43 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 108.634 -0.876 . . . . 3.67 108.634 178.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.37 -26.41 66.45 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.701 -0.799 . . . . 4.01 109.767 179.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.54 -33.79 54.08 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.43 -0.794 . . . . 3.76 110.358 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.446 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . . . -74.08 -37.99 64.04 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.301 -0.875 . . . . 2.86 110.566 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -70.2 -32.3 70.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.331 -0.856 . . . . 3.91 110.561 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -70.91 -57.23 4.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.114 -0.991 . . . . 4.58 109.777 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.93 -81.07 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.304 -0.872 . . . . 3.51 109.993 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.26 40.59 0.03 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.929 -1.669 . . . . 3.39 108.929 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . 0.565 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 48.0 m-70 -107.94 53.12 0.7 Allowed 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.482 -1.011 . . . . 2.78 109.511 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . 0.427 ' O ' ' HB2' ' A' ' 128' ' ' ARG . 20.9 mtt180 -47.5 -52.41 17.41 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.766 -0.584 . . . . 4.54 109.957 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.68 -40.51 28.37 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.486 -0.759 . . . . 2.92 109.915 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.515 HG12 HD11 ' A' ' 130' ' ' LEU . 2.2 t -81.37 -47.24 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.36 -0.837 . . . . 2.25 109.501 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.12 -41.84 75.92 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.211 -0.931 . . . . 3.01 109.89 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.427 ' HB2' ' O ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -59.96 -56.65 19.09 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.275 -0.89 . . . . 4.9 109.353 179.327 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -60.59 -33.0 72.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.374 -0.829 . . . . 3.44 109.012 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.631 ' O ' ' N ' ' A' ' 134' ' ' ALA . 28.2 mt -65.63 -52.38 52.32 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.959 -0.696 . . . . 3.09 109.315 179.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 3.1 ttt-85 -57.88 -19.16 27.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.93 -1.106 . . . . 5.34 109.341 178.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.67 -51.33 6.53 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.59 -0.893 . . . . 3.81 108.59 178.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.412 ' HB2' HD22 ' A' ' 104' ' ' LEU . . . -92.5 -52.11 4.81 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.099 -1.001 . . . . 3.57 109.963 178.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.631 ' N ' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.494 1.747 0 O-C-N 121.677 -0.639 . . . . 3.93 112.282 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 121.203 0.525 . . . . 0.0 110.359 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.29 110.21 57.37 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.324 -0.86 . . . . 0.0 110.214 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -69.15 154.75 69.66 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.632 1.333 . . . . 0.0 110.495 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -167.65 142.05 3.65 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.54 -0.725 . . . . 0.0 110.203 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -145.26 -44.64 0.22 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.382 -0.824 . . . . 0.0 110.289 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 150.64 -86.85 0.14 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.4 p -49.85 112.5 0.67 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.378 -1.072 . . . . 0.0 109.843 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 t -92.45 160.05 15.25 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.209 -0.932 . . . . 0.0 110.617 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.21 97.74 5.66 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.72 -0.612 . . . . 0.0 109.983 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -146.81 90.17 5.53 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.313 -0.867 . . . . 0.0 109.965 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -76.89 76.45 4.11 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.905 1.476 . . . . 0.0 111.037 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 m -62.01 179.51 0.28 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.144 -0.972 . . . . 0.0 109.753 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.452 ' HB1' ' HG ' ' A' ' 37' ' ' LEU . . . -54.26 128.79 32.76 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.197 -0.94 . . . . 0.0 110.273 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.497 ' O ' ' OG1' ' A' ' 18' ' ' THR . 25.8 t0 -157.65 20.14 0.27 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.468 -0.77 . . . . 0.0 110.62 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.447 ' HB3' HD11 ' A' ' 31' ' ' LEU . 40.9 m0 -76.66 -56.51 4.54 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.307 -0.87 . . . . 0.0 110.612 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.475 HD11 HD21 ' A' ' 63' ' ' LEU . 0.8 OUTLIER -41.62 -40.76 2.01 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.698 -0.626 . . . . 0.0 111.042 -179.821 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.2 -56.27 5.32 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.174 -0.954 . . . . 0.0 110.07 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.497 ' OG1' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -43.73 -53.93 5.49 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.587 -0.696 . . . . 0.0 110.719 -179.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.467 ' HB2' ' CG2' ' A' ' 28' ' ' VAL . . . -52.97 -55.91 19.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.411 -0.806 . . . . 0.0 110.445 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.447 ' HB2' ' CB ' ' A' ' 52' ' ' MET . . . -47.08 -62.58 1.35 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.567 -0.708 . . . . 0.0 111.077 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -46.15 -28.5 1.25 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.612 -0.68 . . . . 0.0 110.855 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -90.79 30.35 1.2 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.299 -0.876 . . . . 0.0 110.291 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.472 ' HA3' ' HE2' ' A' ' 53' ' ' MET . . . 44.94 27.5 1.48 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.406 -1.077 . . . . 0.0 110.406 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.17 98.47 8.17 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.258 -1.142 . . . . 0.0 110.323 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.469 HG21 HG22 ' A' ' 59' ' ' VAL . 69.9 t -78.73 -37.26 20.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.633 -0.667 . . . . 0.0 110.172 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -54.65 -52.38 62.49 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.544 -0.722 . . . . 0.0 110.899 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.42 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -58.04 -35.1 70.82 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.225 -0.922 . . . . 0.0 110.821 -179.233 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.476 ' HB ' ' CD1' ' A' ' 62' ' ' LEU . 6.2 t -76.41 -47.85 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.274 -0.891 . . . . 0.0 110.171 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.404 ' N ' ' CD1' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -52.73 -46.34 67.37 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.022 -1.049 . . . . 0.0 109.688 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.66 -31.0 67.76 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.418 -0.801 . . . . 0.0 109.559 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.447 HD11 ' HB3' ' A' ' 15' ' ' TRP . 10.2 mt -79.4 -53.26 7.08 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.402 -0.811 . . . . 0.0 110.815 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.523 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -47.88 -38.76 17.03 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.164 -0.96 . . . . 0.0 110.161 -179.695 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -83.09 -25.06 32.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.332 -0.855 . . . . 0.0 109.855 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.25 -3.81 32.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.42 -0.8 . . . . 0.0 110.03 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.82 24.44 5.23 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.523 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -61.04 133.74 56.37 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.071 -1.252 . . . . 0.0 109.809 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.452 ' HG ' ' HB1' ' A' ' 13' ' ' ALA . 3.1 mm? -57.09 112.89 5.17 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.399 -0.813 . . . . 0.0 109.778 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.47 -30.42 36.03 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 123.543 1.286 . . . . 0.0 109.88 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.471 ' HA ' ' OE2' ' A' ' 69' ' ' GLU . 33.0 m120 -121.01 56.67 1.01 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.425 -0.797 . . . . 0.0 110.125 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.448 ' HB1' ' HB3' ' A' ' 37' ' ' LEU . . . -100.9 110.89 62.23 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.856 -0.527 . . . . 0.0 109.604 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.92 124.6 9.76 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.494 1.26 . . . . 0.0 109.638 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.483 ' ND2' ' HB2' ' A' ' 44' ' ' TYR . 36.9 t30 -88.2 161.97 16.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.408 -0.808 . . . . 0.0 110.035 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.405 ' N ' ' OD1' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -74.76 -0.99 20.01 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.428 -0.795 . . . . 0.0 110.967 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.483 ' HB2' ' ND2' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -84.64 1.37 46.52 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.004 -1.06 . . . . 0.0 110.093 179.529 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.82 23.24 44.2 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.521 ' O ' ' CB ' ' A' ' 50' ' ' GLN . 46.1 mtt180 -121.66 37.63 4.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.316 -1.108 . . . . 0.0 110.968 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.485 ' O ' ' O ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER 43.52 -172.65 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.089 0 O-C-N 121.517 -0.739 . . . . 0.0 111.064 178.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.451 ' CD ' ' CB ' ' A' ' 47' ' ' ARG . 53.0 Cg_endo -85.5 -23.89 2.1 Favored 'Trans proline' 0 C--N 1.317 -1.089 0 O-C-N 123.476 1.251 . . . . 0.0 110.377 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.449 ' O ' ' HG2' ' A' ' 52' ' ' MET . 2.7 mt -102.63 -43.85 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.229 -0.919 . . . . 0.0 108.95 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.572 ' HG2' ' HA ' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -49.68 -21.17 0.97 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.381 -0.824 . . . . 0.0 109.822 178.808 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.451 ' HB ' ' CB ' ' A' ' 46' ' ' ARG . 9.3 p -112.99 33.23 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.089 -1.007 . . . . 0.0 110.579 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.511 ' CG ' ' HE3' ' A' ' 54' ' ' MET . 0.1 OUTLIER -96.96 35.08 1.61 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.061 -1.024 . . . . 0.0 109.483 179.111 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.472 ' HE2' ' HA3' ' A' ' 23' ' ' GLY . 6.2 tmm? 64.55 -6.26 0.31 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.667 -0.645 . . . . 0.0 111.109 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.573 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 44.53 26.79 0.2 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.253 -0.904 . . . . 0.0 110.57 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.536 ' HA2' ' CD2' ' A' ' 90' ' ' PHE . . . -128.79 8.73 6.44 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.423 ' HB3' HG22 ' A' ' 59' ' ' VAL . 0.6 OUTLIER -145.66 70.29 1.24 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.318 -1.107 . . . . 0.0 109.972 179.663 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.445 ' HB3' ' HB3' ' A' ' 92' ' ' ASP . . . -42.79 -36.56 1.5 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.507 -0.746 . . . . 0.0 110.7 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -46.31 -35.29 5.2 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.653 -0.654 . . . . 0.0 109.463 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.469 HG22 HG21 ' A' ' 25' ' ' VAL . 46.6 t -67.16 -51.55 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -43.85 -58.13 2.91 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.649 -0.657 . . . . 0.0 110.03 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.422 ' O ' HD22 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -47.93 -49.35 30.41 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.003 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.5 ' O ' ' HB2' ' A' ' 66' ' ' HIS . 0.4 OUTLIER -46.11 -62.67 1.23 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.704 -0.622 . . . . 0.0 110.115 178.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.476 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 0.9 OUTLIER -69.98 -55.18 10.27 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.385 -0.822 . . . . 0.0 110.615 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.488 ' CD2' HG13 ' A' ' 96' ' ' VAL . 0.4 OUTLIER -48.39 -63.69 1.01 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.302 -0.874 . . . . 0.0 110.701 -179.528 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.521 HD11 ' CD2' ' A' ' 66' ' ' HIS . 0.8 OUTLIER -50.68 -28.12 8.35 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.406 -0.809 . . . . 0.0 109.36 -179.702 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.521 ' CD2' HD11 ' A' ' 65' ' ' LEU . 2.4 m-70 -84.47 -31.98 24.26 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.778 -0.576 . . . . 0.0 109.748 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 63' ' ' LEU . . . 125.81 55.37 0.16 Allowed Glycine 0 N--CA 1.482 1.707 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.476 ' CB ' ' HB3' ' A' ' 63' ' ' LEU . . . -80.02 -150.97 0.07 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.971 -1.311 . . . . 0.0 109.049 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.471 ' OE2' ' HA ' ' A' ' 39' ' ' ASN . 2.0 mt-10 -124.38 68.0 48.45 Favored Pre-proline 0 C--N 1.3 -1.582 0 O-C-N 121.412 -0.805 . . . . 0.0 109.49 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.422 ' O ' ' HG2' ' A' ' 81' ' ' PRO . 49.0 Cg_endo -71.24 -3.89 13.84 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 O-C-N 123.716 1.377 . . . . 0.0 110.293 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.454 ' O ' ' NE ' ' A' ' 80' ' ' ARG . 37.0 m-20 -112.55 -67.67 0.98 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.303 -0.873 . . . . 0.0 109.587 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.8 t -43.69 155.52 0.07 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.57 -0.706 . . . . 0.0 110.128 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.445 ' HB2' ' C ' ' A' ' 79' ' ' THR . . . -152.07 -142.26 0.12 Allowed 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.569 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.01 139.59 20.88 Favored Pre-proline 0 N--CA 1.484 1.254 0 O-C-N 121.219 -0.926 . . . . 0.0 110.563 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -84.31 2.77 7.96 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.988 1.52 . . . . 0.0 110.428 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -101.79 -33.87 9.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.16 -0.963 . . . . 0.0 110.027 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.569 ' CG2' ' CZ3' ' A' ' 110' ' ' TRP . 0.3 OUTLIER -140.24 10.18 2.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.473 -0.767 . . . . 0.0 110.518 -179.836 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 21.7 mt 53.86 38.49 28.77 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.303 -0.873 . . . . 0.0 110.731 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.463 ' HA ' ' OD1' ' A' ' 108' ' ' ASP . 36.5 m -72.91 88.38 1.35 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.423 -0.911 . . . . 0.0 110.313 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.494 ' HD3' ' CG1' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -72.78 168.43 24.36 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.471 -0.768 . . . . 0.0 109.675 179.752 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.572 ' HA ' ' HG2' ' A' ' 50' ' ' GLN . 47.9 Cg_endo -73.26 -2.26 11.82 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.697 1.367 . . . . 0.0 109.998 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 23.9 t -76.59 -36.11 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.585 -0.697 . . . . 0.0 109.612 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.522 ' O ' ' CB ' ' A' ' 87' ' ' ARG . 23.1 m80 -69.39 -40.46 77.35 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.573 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 0.3 OUTLIER -52.1 -52.27 52.48 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.304 -0.873 . . . . 0.0 110.676 179.374 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.483 ' CB ' ' HG ' ' A' ' 94' ' ' LEU . . . -55.46 -64.74 0.75 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.224 -0.922 . . . . 0.0 110.154 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.555 ' O ' ' CG ' ' A' ' 123' ' ' HIS . . . -58.94 -56.09 26.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.195 -0.941 . . . . 0.0 110.423 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.522 ' CB ' ' O ' ' A' ' 83' ' ' HIS . 0.1 OUTLIER -43.39 -25.85 0.16 Allowed 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.342 -0.849 . . . . 0.0 111.291 -179.821 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.507 ' CB ' ' HB3' ' A' ' 54' ' ' MET . 0.0 OUTLIER -104.34 -13.56 16.08 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.076 -1.015 . . . . 0.0 110.657 179.446 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.04 25.65 39.96 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.536 ' CD2' ' HA2' ' A' ' 55' ' ' GLY . 0.5 OUTLIER -106.12 93.69 4.76 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.283 -1.128 . . . . 0.0 110.722 -179.693 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.75 -44.22 82.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.509 -0.745 . . . . 0.0 109.908 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.445 ' HB3' ' HB3' ' A' ' 57' ' ' ALA . 36.2 t0 -40.75 -38.69 0.95 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.576 -0.703 . . . . 0.0 110.121 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 22.4 m -63.04 -58.87 5.83 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.496 -0.753 . . . . 0.0 109.593 179.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.483 ' HG ' ' CB ' ' A' ' 85' ' ' ALA . 1.2 mp -48.94 -46.29 43.07 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.398 -0.814 . . . . 0.0 110.023 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 71.6 t -49.84 -54.86 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.488 HG13 ' CD2' ' A' ' 64' ' ' LEU . 85.0 t -53.09 -57.15 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 121.26 0.552 . . . . 0.0 109.716 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -45.62 -56.3 5.34 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.33 0.586 . . . . 0.0 110.034 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.506 ' HA ' ' HB3' ' A' ' 102' ' ' ALA . 2.6 t-160 -63.7 -21.0 66.17 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.19 -0.944 . . . . 0.0 109.836 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.36 -15.59 61.37 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.247 -0.908 . . . . 0.0 110.727 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -134.47 62.2 1.65 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.237 -0.914 . . . . 0.0 110.249 -179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 47.54 80.31 0.06 OUTLIER Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.506 ' HB3' ' HA ' ' A' ' 98' ' ' HIS . . . -101.51 144.94 29.67 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.378 -1.072 . . . . 0.0 109.991 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -87.04 59.29 5.54 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.19 -0.944 . . . . 0.0 110.317 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.596 ' O ' ' HA ' ' A' ' 134' ' ' ALA . 0.6 OUTLIER -68.95 61.81 0.11 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.542 -0.723 . . . . 0.0 110.592 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -167.44 29.15 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.782 -1.199 . . . . 0.0 110.574 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.494 ' CG1' ' HD3' ' A' ' 80' ' ' ARG . 1.0 OUTLIER -100.65 -169.86 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 121.27 -0.894 . . . . 0.0 109.283 179.234 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.7 ptm180 -141.85 131.31 23.78 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 120.118 -0.633 . . . . 0.0 109.877 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 110' ' ' TRP . 0.4 OUTLIER -70.99 57.93 0.21 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.474 -0.766 . . . . 0.0 109.715 179.79 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 52.96 -83.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.556 -0.715 . . . . 0.0 110.542 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.569 ' CZ3' ' CG2' ' A' ' 77' ' ' THR . 0.1 OUTLIER -101.81 -8.05 21.99 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.007 -1.058 . . . . 0.0 109.874 179.556 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.449 ' O ' ' CB ' ' A' ' 112' ' ' ARG . . . -74.19 0.14 54.62 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.449 ' CB ' ' O ' ' A' ' 111' ' ' GLY . 0.9 OUTLIER 68.41 -68.82 0.16 Allowed 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.325 -1.103 . . . . 0.0 110.258 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.453 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER -166.41 163.78 11.23 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.353 -0.842 . . . . 0.0 109.938 -179.739 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.453 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 44.0 Cg_endo -73.65 -32.2 7.87 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 O-C-N 123.686 1.361 . . . . 0.0 109.999 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 127' ' ' ALA . 6.8 p -65.9 -36.39 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.415 -0.803 . . . . 0.0 109.409 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -74.97 -42.69 57.12 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.475 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 6.2 tt -61.56 -31.84 71.89 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.33 -0.856 . . . . 0.0 109.162 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.28 -43.37 77.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.466 -0.772 . . . . 0.0 109.944 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -68.22 -46.53 70.31 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.456 -0.778 . . . . 0.0 111.16 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -61.06 -54.37 45.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.298 -0.876 . . . . 0.0 110.276 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.67 -81.03 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.277 -0.889 . . . . 0.0 110.174 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 173.89 38.76 0.04 OUTLIER Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.555 ' CG ' ' O ' ' A' ' 86' ' ' ALA . 51.3 m-70 -118.16 47.73 1.54 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.495 -1.003 . . . . 0.0 109.663 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -45.83 -53.46 9.63 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.713 -0.617 . . . . 0.0 110.315 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -48.0 -34.2 8.99 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.587 -0.696 . . . . 0.0 109.563 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.47 HG13 HD11 ' A' ' 94' ' ' LEU . 2.8 t -88.81 -44.9 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.631 -0.668 . . . . 0.0 109.331 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.479 ' O ' HG23 ' A' ' 115' ' ' VAL . . . -52.99 -49.09 66.87 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.397 -0.814 . . . . 0.0 110.176 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.74 -61.58 2.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.134 -0.979 . . . . 0.0 110.105 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.432 ' CD1' ' C ' ' A' ' 129' ' ' TYR . 12.2 t80 -53.53 -30.72 43.03 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.421 -0.799 . . . . 0.0 109.379 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.475 ' CB ' HG23 ' A' ' 115' ' ' VAL . 5.9 mt -64.04 -52.16 60.7 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.026 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -54.82 -29.81 55.75 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.303 -0.873 . . . . 0.0 110.272 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -80.94 -33.06 34.31 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.488 -0.758 . . . . 0.0 110.153 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -90.12 -21.64 22.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.358 -0.839 . . . . 0.0 110.524 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.596 ' HA ' ' O ' ' A' ' 104' ' ' LEU . . . -101.27 -14.12 17.79 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.081 -1.012 . . . . 0.0 110.238 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 56.13 173.22 0.16 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 137' ' ' THR . . . -166.68 -168.72 29.29 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.425 ' C ' ' O ' ' A' ' 136' ' ' GLY . 8.9 t 35.56 34.52 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.769 -0.842 . . . . 0.0 111.707 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.407 ' N ' ' O ' ' A' ' 136' ' ' GLY . 0.0 OUTLIER -96.3 122.43 39.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.244 -0.91 . . . . 0.0 110.024 179.776 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 93.18 26.63 15.5 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.61 24.33 0.06 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.477 -1.014 . . . . 0.0 110.567 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -70.37 67.6 0.33 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.308 -0.87 . . . . 0.0 110.18 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -123.22 -66.9 0.98 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.129 -0.982 . . . . 0.0 110.44 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -101.08 -36.11 9.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.176 -0.953 . . . . 0.0 110.242 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.44 64.52 1.81 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.195 -0.94 . . . . 0.0 110.098 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.406 ' O ' ' CG1' ' A' ' 145' ' ' ILE . 3.1 tt -176.26 67.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.331 -0.856 . . . . 0.0 109.779 -179.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.5 t0 50.39 -175.68 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.321 -0.862 . . . . 0.0 109.956 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.04 97.49 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.253 -0.904 . . . . 0.0 109.551 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.3 -179.37 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.331 -0.856 . . . . 0.0 110.681 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.14 125.63 32.96 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.332 -0.855 . . . . 0.0 110.377 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 120.1 148.59 8.17 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -79.1 112.36 3.05 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 123.883 1.465 . . . . 0.0 110.413 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 1.5 m -75.92 149.83 37.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.3 -0.875 . . . . 0.0 110.095 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.43 142.69 27.44 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.288 -0.882 . . . . 0.0 110.175 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 1.8 pt -136.51 78.5 43.88 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.357 -0.839 . . . . 0.0 110.961 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -78.28 114.21 3.5 Favored 'Trans proline' 0 C--N 1.309 -1.553 0 O-C-N 123.534 1.281 . . . . 0.0 110.811 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.496 1.851 0 CA-C-O 117.955 -1.021 . . . . 0.0 110.011 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 ttt . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 121.225 0.536 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.473 ' N ' ' HD2' ' A' ' 3' ' ' PRO . 0.5 OUTLIER -57.48 -55.54 43.51 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.232 -0.917 . . . . 0.0 110.134 179.82 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 2' ' ' GLU . 47.8 Cg_endo -73.79 107.35 2.39 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 123.548 1.289 . . . . 0.0 110.229 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -81.92 144.14 31.16 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.273 -0.892 . . . . 0.0 109.849 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -103.57 11.9 35.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.289 -0.882 . . . . 0.0 110.801 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.1 50.25 0.15 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.5 m 57.16 -170.06 0.1 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.377 -1.073 . . . . 0.0 110.749 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.77 41.73 1.07 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.41 -0.807 . . . . 0.0 110.658 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.7 -39.63 23.99 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.3 -0.875 . . . . 0.0 109.735 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.23 63.78 69.57 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.507 -0.746 . . . . 0.0 109.539 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -78.82 175.99 10.36 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 123.851 1.448 . . . . 0.0 110.874 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.5 t -85.56 -76.59 0.32 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.396 -0.815 . . . . 0.0 110.206 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 40' ' ' ALA . . . 61.81 91.63 0.06 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.311 -0.868 . . . . 0.0 110.169 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -124.76 18.13 8.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.466 -0.771 . . . . 0.0 110.356 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.505 ' CD1' ' N ' ' A' ' 15' ' ' TRP . 33.6 m0 -80.35 -6.94 58.8 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.345 -0.847 . . . . 0.0 110.721 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.442 HD12 ' O ' ' A' ' 37' ' ' LEU . 14.6 mt -86.61 -49.29 7.63 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.201 -0.937 . . . . 0.0 109.387 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.84 -31.16 71.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.562 -0.711 . . . . 0.0 109.37 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.496 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.2 OUTLIER -66.01 -61.17 2.19 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.656 -0.653 . . . . 0.0 109.961 179.68 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.498 ' CB ' HG22 ' A' ' 28' ' ' VAL . . . -54.26 -34.78 61.55 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.28 -0.887 . . . . 0.0 110.102 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.65 -55.89 15.07 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.248 -0.907 . . . . 0.0 109.23 179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.42 -29.96 69.32 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.458 -0.776 . . . . 0.0 109.741 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -98.51 17.26 19.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.402 -0.811 . . . . 0.0 110.243 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.06 82.13 0.04 OUTLIER Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.427 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 1.1 ttt180 -143.19 63.91 1.36 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.29 -1.123 . . . . 0.0 109.819 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 94.1 t -48.73 -64.94 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.484 -0.76 . . . . 0.0 111.267 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -49.64 -38.32 31.71 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.355 -0.84 . . . . 0.0 110.959 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.42 -37.64 86.61 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.393 -0.817 . . . . 0.0 110.263 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.498 HG22 ' CB ' ' A' ' 19' ' ' ALA . 2.8 t -82.95 -45.11 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.4 -0.812 . . . . 0.0 109.924 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.429 ' N ' ' CD2' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -42.96 -43.9 4.38 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.518 -0.739 . . . . 0.0 110.335 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.94 -41.47 36.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.452 -0.78 . . . . 0.0 109.94 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.484 ' C ' ' HB2' ' A' ' 36' ' ' ALA . 27.0 mt -53.8 -65.56 0.55 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.281 -0.887 . . . . 0.0 109.729 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.516 ' CD1' ' HG ' ' A' ' 62' ' ' LEU . 2.8 mt -48.82 -43.92 38.87 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.648 -0.657 . . . . 0.0 110.637 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -70.84 -21.1 62.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.204 -0.935 . . . . 0.0 109.956 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.45 -6.47 59.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.337 -0.852 . . . . 0.0 110.615 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.16 27.28 3.21 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.484 ' HB2' ' C ' ' A' ' 31' ' ' LEU . . . -66.77 169.01 8.58 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.157 -1.202 . . . . 0.0 109.894 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.45 ' HB3' ' HB1' ' A' ' 40' ' ' ALA . 1.9 mm? -87.66 125.99 63.24 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.422 -0.799 . . . . 0.0 110.046 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.432 ' HB2' ' O ' ' A' ' 67' ' ' GLY . 42.7 Cg_endo -69.22 -36.96 11.2 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.354 1.186 . . . . 0.0 109.716 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.432 ' ND2' ' O ' ' A' ' 67' ' ' GLY . 14.1 m120 -121.41 70.91 0.94 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.502 -0.749 . . . . 0.0 109.45 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.45 ' HB1' ' HB3' ' A' ' 37' ' ' LEU . . . -93.42 104.76 13.31 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.469 -0.769 . . . . 0.0 110.129 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 39' ' ' ASN . 48.6 Cg_endo -70.73 106.8 1.91 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 123.672 1.354 . . . . 0.0 110.533 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.6 p30 -82.9 178.14 8.31 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.189 -0.945 . . . . 0.0 110.015 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.4 m -90.53 40.24 1.01 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.293 -0.88 . . . . 0.0 109.649 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -119.28 12.58 12.59 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.495 -0.753 . . . . 0.0 110.42 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 52.86 25.12 22.19 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.796 -1.722 . . . . 0.0 108.796 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -143.8 117.72 9.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.623 -0.927 . . . . 0.0 110.136 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.49 ' CB ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -60.07 -179.33 0.17 Allowed Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.409 -0.807 . . . . 0.0 109.672 179.578 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.506 ' O ' ' N ' ' A' ' 50' ' ' GLN . 39.2 Cg_endo -65.16 169.55 11.97 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.399 1.21 . . . . 0.0 110.313 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.512 ' O ' ' HG2' ' A' ' 52' ' ' MET . 3.1 mt 63.4 -61.35 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 O-C-N 121.621 -0.674 . . . . 0.0 109.984 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.506 ' N ' ' O ' ' A' ' 48' ' ' PRO . 1.7 tt0 -50.02 -23.88 2.31 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.033 -1.042 . . . . 0.0 110.011 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.3 p -108.46 8.42 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.214 -0.929 . . . . 0.0 110.572 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.512 ' HG2' ' O ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -78.29 159.12 28.63 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.959 -1.088 . . . . 0.0 109.534 179.369 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -48.83 -17.62 0.2 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.389 -0.819 . . . . 0.0 111.989 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.592 ' HE3' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 61.52 15.41 6.71 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.837 -1.164 . . . . 0.0 109.715 -178.842 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.419 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -112.91 17.97 22.18 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -161.2 102.41 1.25 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.37 -1.077 . . . . 0.0 110.25 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.411 ' CB ' ' HB3' ' A' ' 92' ' ' ASP . . . -63.03 -17.87 62.71 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.283 -0.886 . . . . 0.0 109.216 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.24 -42.27 73.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.478 -0.764 . . . . 0.0 109.885 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.4 t -61.5 -53.63 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.347 -0.846 . . . . 0.0 109.516 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.421 ' O ' ' CB ' ' A' ' 64' ' ' LEU . . . -53.7 -51.67 62.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.442 -0.786 . . . . 0.0 110.363 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.438 ' O ' ' HB3' ' A' ' 65' ' ' LEU . 5.6 tt0 -50.34 -44.72 54.57 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.129 -0.982 . . . . 0.0 110.539 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.516 ' HG ' ' CD1' ' A' ' 32' ' ' LEU . 1.4 tp -70.53 -57.28 4.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.571 -0.706 . . . . 0.0 109.68 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.515 ' N ' ' HG ' ' A' ' 62' ' ' LEU . 6.1 mt -57.77 -45.02 86.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.255 -0.903 . . . . 0.0 109.225 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.421 ' CB ' ' O ' ' A' ' 60' ' ' ALA . 1.0 OUTLIER -64.75 -52.9 54.55 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.58 -0.7 . . . . 0.0 110.407 179.595 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.438 ' HB3' ' O ' ' A' ' 61' ' ' GLU . 12.1 tp -50.95 -39.87 56.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.421 -0.8 . . . . 0.0 109.285 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.487 ' CB ' ' CD2' ' A' ' 32' ' ' LEU . 2.1 m-70 -78.45 -37.73 42.92 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.147 0.499 . . . . 0.0 110.003 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 38' ' ' PRO . . . 139.78 54.04 0.05 OUTLIER Glycine 0 N--CA 1.481 1.643 0 C-N-CA 120.062 -1.065 . . . . 0.0 110.823 179.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.504 ' CB ' ' CD1' ' A' ' 49' ' ' ILE . . . -68.43 -151.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.765 -1.432 . . . . 0.0 109.768 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.493 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 3.6 mm-40 -131.87 61.06 55.91 Favored Pre-proline 0 C--N 1.303 -1.42 0 O-C-N 121.494 -0.754 . . . . 0.0 109.973 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.504 ' HB2' ' CB ' ' A' ' 102' ' ' ALA . 47.3 Cg_endo -72.14 1.62 5.79 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 123.951 1.5 . . . . 0.0 110.677 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.495 ' N ' ' OD1' ' A' ' 71' ' ' ASN . 1.5 m-20 -115.96 -54.35 2.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.048 -1.032 . . . . 0.0 110.018 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -48.41 154.85 0.58 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.521 -0.737 . . . . 0.0 110.691 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -151.52 -157.52 0.82 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.444 -0.785 . . . . 0.0 109.923 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' A' ' 78' ' ' LEU . 0.5 OUTLIER -105.16 140.23 20.9 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.263 -0.898 . . . . 0.0 109.566 179.507 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.28 -11.01 24.69 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.589 1.31 . . . . 0.0 110.767 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.98 -43.65 24.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.13 -0.981 . . . . 0.0 110.16 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.47 ' CG2' ' CZ3' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -139.6 25.62 2.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.459 -0.776 . . . . 0.0 110.171 -179.521 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.413 ' N ' ' O ' ' A' ' 74' ' ' ASP . 5.7 mt 40.6 36.57 0.39 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.525 -0.734 . . . . 0.0 110.631 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.82 92.13 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.448 -0.783 . . . . 0.0 110.55 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.478 ' CD ' ' CG1' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -73.92 163.31 69.28 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.274 -0.891 . . . . 0.0 109.241 179.146 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.473 ' HD2' ' CG ' ' A' ' 80' ' ' ARG . 46.3 Cg_endo -73.08 -3.34 13.48 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.699 1.368 . . . . 0.0 110.738 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 40.5 t -74.09 -26.37 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.234 -0.916 . . . . 0.0 109.747 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.495 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 9.2 m80 -74.07 -33.85 63.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.479 -0.763 . . . . 0.0 109.38 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.592 ' HB3' ' HE3' ' A' ' 54' ' ' MET . 0.3 OUTLIER -58.73 -50.74 72.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.677 -0.639 . . . . 0.0 110.141 179.583 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.46 ' CB ' HD11 ' A' ' 94' ' ' LEU . . . -53.57 -56.74 14.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.373 -0.83 . . . . 0.0 109.261 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.555 ' O ' ' CD2' ' A' ' 123' ' ' HIS . . . -59.99 -52.2 66.4 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.718 -0.614 . . . . 0.0 110.287 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.484 ' HD2' HD12 ' A' ' 117' ' ' LEU . 2.3 tpt180 -43.91 -37.8 3.06 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.527 -0.733 . . . . 0.0 111.229 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.9 16.28 26.43 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.22 -0.925 . . . . 0.0 110.373 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.424 ' HA2' ' HB3' ' A' ' 123' ' ' HIS . . . 51.58 55.01 22.05 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.419 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 0.4 OUTLIER -123.98 85.33 2.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.387 -1.066 . . . . 0.0 110.623 -179.626 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.25 -34.47 78.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 0.0 110.175 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.411 ' HB3' ' CB ' ' A' ' 57' ' ' ALA . 94.7 m-20 -48.53 -38.38 20.22 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.35 -0.844 . . . . 0.0 109.829 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.456 ' CG2' ' HB3' ' A' ' 85' ' ' ALA . 13.6 m -68.64 -54.26 17.47 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.478 ' CD2' HG12 ' A' ' 126' ' ' VAL . 1.1 tp -47.42 -48.74 26.24 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.528 -0.733 . . . . 0.0 109.572 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.452 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 47.5 t -48.4 -51.61 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 CA-C-O 121.372 0.605 . . . . 0.0 109.737 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.407 HG13 ' CD2' ' A' ' 64' ' ' LEU . 52.2 t -55.64 -52.88 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-O 121.32 0.581 . . . . 0.0 110.325 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.416 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 10.9 mp -52.67 -42.61 64.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.489 -0.757 . . . . 0.0 109.756 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -78.66 -24.44 45.18 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.252 -0.905 . . . . 0.0 109.49 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.452 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 5.8 mtt180 -74.4 -10.99 60.12 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.33 -0.856 . . . . 0.0 110.878 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -124.2 -106.31 0.35 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.281 -0.887 . . . . 0.0 110.616 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -142.93 50.21 0.71 Allowed Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.692 -1.242 . . . . 0.0 110.143 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.504 ' CB ' ' HB2' ' A' ' 70' ' ' PRO . . . -102.59 114.93 29.57 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.342 -1.093 . . . . 0.0 110.261 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 32.0 ttt180 -58.76 111.28 1.22 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.32 -0.863 . . . . 0.0 109.709 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.45 54.64 0.88 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.41 -0.806 . . . . 0.0 110.545 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -165.38 54.02 0.11 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.018 -1.051 . . . . 0.0 110.827 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.478 ' CG1' ' CD ' ' A' ' 80' ' ' ARG . 4.1 p -109.61 -173.93 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.2 -0.938 . . . . 0.0 109.977 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.95 137.31 37.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.535 -0.728 . . . . 0.0 109.642 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 110' ' ' TRP . 0.3 OUTLIER -73.61 61.55 0.73 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.278 -0.889 . . . . 0.0 109.766 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 55.57 -83.37 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.51 -0.744 . . . . 0.0 110.2 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.489 ' N ' ' O ' ' A' ' 108' ' ' ASP . 0.2 OUTLIER -133.59 25.82 4.06 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.065 -1.022 . . . . 0.0 110.187 179.397 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -96.29 -83.8 1.68 Allowed Glycine 0 N--CA 1.479 1.535 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.73 149.84 0.48 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.424 -1.045 . . . . 0.0 110.77 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.53 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 89.4 mt -57.61 169.66 0.77 Allowed Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.48 -0.762 . . . . 0.0 109.275 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.53 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 42.9 Cg_endo -69.68 -25.25 29.16 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.431 1.227 . . . . 0.0 109.46 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.513 ' HB ' ' HB3' ' A' ' 130' ' ' LEU . 9.9 p -70.69 -36.05 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.419 -0.801 . . . . 0.0 109.804 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -54.44 -34.74 62.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.44 -0.788 . . . . 0.0 110.153 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.484 HD12 ' HD2' ' A' ' 87' ' ' ARG . 0.3 OUTLIER -65.0 -57.94 7.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.51 -0.744 . . . . 0.0 110.408 -179.776 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.439 ' CB ' ' HB2' ' A' ' 123' ' ' HIS . . . -47.53 -31.44 4.34 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.644 -0.66 . . . . 0.0 110.874 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.03 -30.96 58.63 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.444 -0.785 . . . . 0.0 109.753 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.6 -53.75 8.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.431 -0.793 . . . . 0.0 110.772 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.462 ' CD1' ' CD1' ' A' ' 117' ' ' LEU . 3.1 mp -81.27 -94.22 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.31 -0.869 . . . . 0.0 110.662 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -171.66 31.61 0.13 Allowed Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.594 -1.289 . . . . 0.0 110.128 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.555 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 27.1 m-70 -88.08 49.9 1.88 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.057 -1.261 . . . . 0.0 108.837 179.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.4 ttm-85 -45.84 -38.13 6.93 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.673 -0.642 . . . . 0.0 110.554 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -66.07 -42.29 89.6 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.361 -0.837 . . . . 0.0 109.835 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.483 ' CG1' ' HA ' ' A' ' 86' ' ' ALA . 8.3 t -77.97 -29.6 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.134 -0.979 . . . . 0.0 110.321 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.409 ' HB3' ' HB1' ' A' ' 118' ' ' ALA . . . -60.15 -41.8 93.53 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.165 -0.96 . . . . 0.0 109.722 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.18 -62.63 1.69 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.519 -0.738 . . . . 0.0 110.549 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -54.33 -37.82 65.3 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.282 -0.886 . . . . 0.0 110.096 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.513 ' HB3' ' HB ' ' A' ' 115' ' ' VAL . 44.3 mt -69.6 -18.45 63.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.541 -0.724 . . . . 0.0 110.417 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -89.44 -28.86 19.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.139 -0.975 . . . . 0.0 109.927 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -84.01 -43.48 15.11 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.327 -0.858 . . . . 0.0 110.409 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -90.42 -34.52 15.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.167 -0.958 . . . . 0.0 110.598 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 130' ' ' LEU . . . -103.6 45.22 0.97 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.289 -0.882 . . . . 0.0 110.194 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -168.61 -121.11 0.56 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -84.16 83.22 1.63 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 8.9 t -54.47 161.54 1.39 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.273 -1.133 . . . . 0.0 110.83 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -173.3 -157.95 0.09 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.566 -0.709 . . . . 0.0 109.73 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 89.78 19.58 47.25 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 78.1 p -173.65 -138.69 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.342 -1.093 . . . . 0.0 109.413 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -88.84 -163.79 1.04 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.914 -1.116 . . . . 0.0 109.512 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -111.12 49.69 0.86 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.15 -0.969 . . . . 0.0 109.92 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -128.24 98.71 5.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.59 -0.694 . . . . 0.0 109.824 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.11 136.34 42.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.437 -0.789 . . . . 0.0 110.049 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 6.6 tp -71.11 143.54 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.412 -0.805 . . . . 0.0 110.492 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.24 143.2 34.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.35 -0.843 . . . . 0.0 110.413 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -66.48 164.95 15.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.285 -0.884 . . . . 0.0 109.494 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 59.13 168.8 0.06 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.152 -0.967 . . . . 0.0 109.764 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -144.54 63.19 1.32 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.145 -0.972 . . . . 0.0 110.501 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 144.3 176.39 18.28 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.48 161.89 44.03 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.87 1.458 . . . . 0.0 110.418 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 7.6 t -74.18 140.45 45.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.344 -0.848 . . . . 0.0 110.39 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 54.28 106.06 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.484 -0.76 . . . . 0.0 110.847 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 4.1 mp -116.03 77.69 7.11 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.179 -0.95 . . . . 0.0 109.608 179.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -81.46 118.66 3.25 Favored 'Trans proline' 0 C--N 1.313 -1.311 0 O-C-N 123.759 1.399 . . . . 0.0 110.561 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.074 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.8 ttt . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.3 0.572 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -138.23 132.11 16.71 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.291 -0.88 . . . . 0.0 109.992 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -74.22 151.61 43.9 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.626 1.33 . . . . 0.0 110.655 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -98.42 82.65 2.91 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.454 -0.779 . . . . 0.0 110.069 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 55.35 63.01 2.23 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.248 -0.908 . . . . 0.0 110.31 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -110.94 48.54 0.93 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 48.0 t 51.56 -168.23 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.337 -1.096 . . . . 0.0 110.423 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -124.9 76.45 1.52 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.395 -0.816 . . . . 0.0 110.1 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 54.17 96.19 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.345 -0.847 . . . . 0.0 110.325 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -109.14 77.81 0.93 Allowed Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.332 -0.855 . . . . 0.0 110.557 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.57 135.07 25.51 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.653 1.344 . . . . 0.0 110.591 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.7 p -66.42 133.98 51.57 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.427 -0.796 . . . . 0.0 110.027 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.405 ' O ' HD22 ' A' ' 16' ' ' LEU . . . -127.89 -42.56 1.57 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.319 -0.863 . . . . 0.0 110.306 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -64.69 -9.4 19.62 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.342 -0.848 . . . . 0.0 110.905 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.43 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 7.3 m0 -54.81 -25.88 31.17 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.119 -0.988 . . . . 0.0 111.171 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.405 HD22 ' O ' ' A' ' 13' ' ' ALA . 4.0 pp -65.93 -38.84 89.72 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.03 -1.044 . . . . 0.0 110.51 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -81.46 -42.61 20.06 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.13 -0.981 . . . . 0.0 110.321 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.43 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.0 OUTLIER -58.88 -56.28 24.32 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.357 -0.839 . . . . 0.0 110.286 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.75 -41.73 74.39 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.255 -0.903 . . . . 0.0 109.834 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.433 ' HB1' ' CB ' ' A' ' 52' ' ' MET . . . -55.73 -35.31 65.99 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.416 -0.803 . . . . 0.0 110.063 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.97 -23.87 59.54 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.442 -0.786 . . . . 0.0 110.512 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 -93.65 23.58 4.61 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.272 -0.892 . . . . 0.0 110.457 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 55.34 46.71 78.99 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -118.53 90.91 3.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.274 -1.133 . . . . 0.0 109.805 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.408 HG12 ' HB3' ' A' ' 58' ' ' ARG . 46.0 t -73.73 -38.96 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.357 -0.84 . . . . 0.0 110.307 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -60.88 -44.83 96.54 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.291 -0.881 . . . . 0.0 110.794 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.5 -38.65 81.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.252 -0.905 . . . . 0.0 110.199 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.4 ' HA ' HD12 ' A' ' 31' ' ' LEU . 54.5 t -73.89 -45.24 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.375 -0.828 . . . . 0.0 110.401 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.5 ' HA ' ' CD1' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -62.48 -47.89 81.99 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.077 -1.014 . . . . 0.0 109.441 179.81 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.94 -20.99 64.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.277 -0.889 . . . . 0.0 109.922 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.451 ' C ' ' HB1' ' A' ' 36' ' ' ALA . 0.2 OUTLIER -68.5 -58.83 3.72 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.323 -0.861 . . . . 0.0 110.04 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.463 ' HA ' ' CB ' ' A' ' 36' ' ' ALA . 5.0 mt -51.32 -41.68 60.7 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.351 -0.843 . . . . 0.0 110.192 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -70.5 -18.18 62.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.32 -0.862 . . . . 0.0 109.596 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.47 -8.65 47.09 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.32 -0.862 . . . . 0.0 110.706 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.12 29.05 1.71 Allowed Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.876 -1.154 . . . . 0.0 110.676 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.463 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . . . -71.28 161.13 31.58 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.022 -1.281 . . . . 0.0 110.177 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 75.5 mt -92.01 142.3 26.23 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.346 -0.846 . . . . 0.0 110.236 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.17 -42.99 1.24 Allowed 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.497 1.262 . . . . 0.0 110.121 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -121.03 58.7 0.95 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.462 -0.774 . . . . 0.0 110.092 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -79.7 116.39 60.59 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.311 -0.868 . . . . 0.0 109.776 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.52 120.53 7.0 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.68 1.358 . . . . 0.0 110.596 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -99.66 -150.07 0.37 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.447 -0.783 . . . . 0.0 109.996 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.424 ' O ' ' OG ' ' A' ' 43' ' ' SER . 0.1 OUTLIER -109.1 20.82 17.94 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.172 -0.955 . . . . 0.0 110.246 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -118.31 -1.8 11.24 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.053 -1.029 . . . . 0.0 110.849 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.54 25.77 50.85 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.929 -1.269 . . . . 0.0 109.929 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.413 ' HB3' ' HB3' ' A' ' 50' ' ' GLN . 36.5 mtt180 -123.42 16.23 9.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -1.123 . . . . 0.0 110.92 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.572 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER 45.98 -166.68 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.083 0 O-C-N 121.706 -0.621 . . . . 0.0 109.744 179.314 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.572 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 46.8 Cg_endo -78.87 172.77 14.5 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 122.758 0.873 . . . . 0.0 110.939 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.52 ' O ' ' HG2' ' A' ' 52' ' ' MET . 9.0 mt 61.74 -63.89 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 O-C-N 121.771 -0.58 . . . . 0.0 110.69 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.515 ' N ' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -49.87 -20.26 0.85 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.824 -1.172 . . . . 0.0 110.401 179.707 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.8 p -107.82 -5.38 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.192 -0.942 . . . . 0.0 110.76 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.52 ' HG2' ' O ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -63.06 165.65 6.79 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.893 -1.129 . . . . 0.0 109.955 -179.777 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 33.8 ttp -61.23 -8.43 3.67 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.341 -0.849 . . . . 0.0 111.079 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.507 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 57.09 18.2 3.93 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.133 -0.979 . . . . 0.0 110.016 -179.398 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.432 ' C ' ' CE2' ' A' ' 90' ' ' PHE . . . -112.43 3.12 26.47 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.41 95.71 2.71 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.433 -1.039 . . . . 0.0 109.727 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.77 -23.11 16.47 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.279 -0.888 . . . . 0.0 109.663 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.408 ' HB3' HG12 ' A' ' 25' ' ' VAL . 13.1 mtt180 -55.5 -40.24 71.48 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.338 -0.851 . . . . 0.0 109.572 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.459 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 95.5 t -53.6 -59.07 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.544 -0.722 . . . . 0.0 109.225 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -61.63 -26.97 68.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.518 -0.739 . . . . 0.0 109.882 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -50.71 -71.56 0.06 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.194 -0.941 . . . . 0.0 110.579 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.5 ' CD1' ' HA ' ' A' ' 29' ' ' ARG . 0.4 OUTLIER -65.55 -50.05 66.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.041 -1.037 . . . . 0.0 110.448 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.459 ' HB2' ' O ' ' A' ' 59' ' ' VAL . 0.9 OUTLIER -49.09 -57.63 6.29 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.252 -0.905 . . . . 0.0 109.933 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.428 ' HB2' ' O ' ' A' ' 60' ' ' ALA . 1.2 tt -63.33 -43.8 96.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.304 -0.872 . . . . 0.0 109.233 179.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 12.8 tp -56.09 -31.12 62.96 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.539 -0.726 . . . . 0.0 109.585 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.413 ' CD2' ' CD2' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -87.21 -45.61 10.48 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.548 -0.72 . . . . 0.0 109.981 -179.569 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 156.18 44.94 0.02 OUTLIER Glycine 0 N--CA 1.483 1.771 0 C-N-CA 119.811 -1.185 . . . . 0.0 110.754 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.404 ' HA ' ' HG2' ' A' ' 48' ' ' PRO . . . -70.66 -152.64 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.889 -1.36 . . . . 0.0 109.882 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -114.75 66.94 1.85 Allowed Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.336 -0.852 . . . . 0.0 110.211 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.423 ' HB3' HD11 ' A' ' 64' ' ' LEU . 50.9 Cg_endo -73.42 -32.55 7.9 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.757 1.398 . . . . 0.0 110.359 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.421 ' O ' ' NE ' ' A' ' 80' ' ' ARG . 6.8 t30 -100.75 -54.74 2.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.509 -0.744 . . . . 0.0 110.891 -179.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.1 m -48.02 151.48 0.95 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.253 -0.904 . . . . 0.0 111.147 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -135.5 -159.73 0.99 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.411 -0.806 . . . . 0.0 109.958 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.43 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -105.77 136.54 19.26 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.292 -0.88 . . . . 0.0 109.873 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.38 -23.54 20.4 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 123.41 1.216 . . . . 0.0 110.595 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.38 -60.81 2.85 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.117 -0.99 . . . . 0.0 109.745 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.48 ' HA ' ' CB ' ' A' ' 109' ' ' ALA . 62.9 p -136.76 34.14 2.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.43 -0.794 . . . . 0.0 109.801 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.43 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 8.0 mt 49.1 33.92 5.31 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.547 -0.721 . . . . 0.0 111.331 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 94.1 m -65.88 102.85 0.82 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.142 -0.974 . . . . 0.0 109.649 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.467 ' HD2' HG13 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -82.31 167.37 30.87 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.271 -0.893 . . . . 0.0 110.193 -179.751 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -70.37 -14.76 34.48 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.771 1.406 . . . . 0.0 109.932 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 65.1 t -67.81 -29.26 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.598 -0.689 . . . . 0.0 109.94 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.45 ' CE1' ' HB3' ' A' ' 114' ' ' PRO . 23.4 m80 -75.59 -35.55 60.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.29 -0.881 . . . . 0.0 109.497 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.507 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 0.3 OUTLIER -58.21 -50.31 73.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.658 -0.651 . . . . 0.0 109.736 179.444 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.458 ' HB3' ' CD1' ' A' ' 94' ' ' LEU . . . -56.96 -64.63 0.81 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.265 -0.897 . . . . 0.0 110.066 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.462 ' HA ' ' CG1' ' A' ' 126' ' ' VAL . . . -58.84 -30.08 67.42 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.317 -0.864 . . . . 0.0 111.271 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -52.5 -54.43 32.59 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.048 -1.032 . . . . 0.0 110.237 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.26 -2.99 58.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.191 -0.943 . . . . 0.0 110.047 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.26 44.88 7.78 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.432 ' CE2' ' C ' ' A' ' 55' ' ' GLY . 0.5 OUTLIER -110.59 104.68 13.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.2 -1.176 . . . . 0.0 110.328 179.636 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.38 -38.42 30.38 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.456 -0.778 . . . . 0.0 110.109 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -47.36 -37.26 10.8 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.511 -0.743 . . . . 0.0 110.312 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.428 ' O ' HD13 ' A' ' 97' ' ' LEU . 23.8 m -70.99 -45.71 63.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.47 -0.769 . . . . 0.0 109.273 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.458 ' CD1' ' HB3' ' A' ' 85' ' ' ALA . 1.2 tp -49.67 -49.73 46.29 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.461 -0.774 . . . . 0.0 110.204 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.413 ' O ' ' CB ' ' A' ' 99' ' ' ARG . 58.0 t -55.08 -47.0 77.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.403 -0.81 . . . . 0.0 109.644 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 36.6 t -54.45 -51.21 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.526 -0.734 . . . . 0.0 109.834 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.428 HD13 ' O ' ' A' ' 93' ' ' THR . 9.1 mp -52.11 -67.02 0.29 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.51 -0.744 . . . . 0.0 110.805 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -57.24 -38.76 74.3 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.172 -0.955 . . . . 0.0 110.15 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.414 ' O ' ' HG2' ' A' ' 99' ' ' ARG . 0.1 OUTLIER -66.3 -14.66 62.36 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.392 -0.817 . . . . 0.0 110.474 179.754 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -132.96 54.03 1.98 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.135 -0.978 . . . . 0.0 110.494 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 58.19 105.15 0.01 OUTLIER Glycine 0 N--CA 1.488 2.126 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -164.9 94.69 0.68 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.322 -1.105 . . . . 0.0 110.231 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.413 ' HB3' ' NH2' ' A' ' 80' ' ' ARG . 20.3 ttt180 -52.69 104.96 0.1 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.314 -0.866 . . . . 0.0 109.717 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' A' ' 134' ' ' ALA . 0.0 OUTLIER -98.58 67.18 1.74 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.424 -0.798 . . . . 0.0 110.484 -179.515 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -168.46 42.87 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.2 -0.937 . . . . 0.0 110.378 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.467 HG13 ' HD2' ' A' ' 80' ' ' ARG . 4.3 p -101.32 -178.0 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.271 -0.893 . . . . 0.0 110.021 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.57 142.01 51.19 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.521 -0.737 . . . . 0.0 109.291 179.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.608 ' O ' ' N ' ' A' ' 110' ' ' TRP . 17.3 p-10 -73.36 54.55 0.43 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.216 -0.928 . . . . 0.0 110.438 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.48 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 59.0 -63.53 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.58 -0.7 . . . . 0.0 110.89 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.608 ' N ' ' O ' ' A' ' 108' ' ' ASP . 0.1 OUTLIER -50.87 -54.59 22.62 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.256 -0.903 . . . . 0.0 109.993 -179.691 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 155.65 -32.86 0.63 Allowed Glycine 0 N--CA 1.484 1.885 0 N-CA-C 110.151 -1.179 . . . . 0.0 110.151 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -53.27 168.24 0.16 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.39 -1.065 . . . . 0.0 110.927 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.458 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 50.1 mt -124.34 167.9 14.4 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.485 -0.759 . . . . 0.0 110.235 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.458 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 41.3 Cg_endo -67.47 -27.53 39.59 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 O-C-N 123.676 1.356 . . . . 0.0 110.044 178.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.408 HG22 ' O ' ' A' ' 127' ' ' ALA . 7.8 p -80.74 -35.55 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.412 -0.805 . . . . 0.0 109.761 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -70.4 -29.85 66.58 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.467 -0.77 . . . . 0.0 110.009 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.3 tt -70.4 -44.48 67.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.422 -0.799 . . . . 0.0 110.303 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.27 -48.61 64.58 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.29 -0.881 . . . . 0.0 110.413 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -55.67 -29.47 59.39 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.293 -0.879 . . . . 0.0 110.068 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -78.31 -39.72 38.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.464 -0.773 . . . . 0.0 110.235 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.33 -88.03 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.346 -0.846 . . . . 0.0 110.281 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -177.86 25.99 0.06 OUTLIER Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.451 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 36.0 m-70 -108.11 50.59 0.77 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.024 -1.28 . . . . 0.0 108.994 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -46.09 -37.37 6.73 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.71 -0.619 . . . . 0.0 110.124 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -59.92 -42.25 93.53 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.406 -0.809 . . . . 0.0 109.201 179.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.462 ' CG1' ' HA ' ' A' ' 86' ' ' ALA . 2.6 t -81.35 -32.56 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.437 -0.789 . . . . 0.0 109.037 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.408 ' O ' HG22 ' A' ' 115' ' ' VAL . . . -69.2 -39.05 78.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.512 -0.743 . . . . 0.0 109.45 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.51 -61.21 2.79 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.277 -0.889 . . . . 0.0 109.676 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -54.48 -37.18 64.97 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.348 -0.845 . . . . 0.0 109.467 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.409 ' CD2' HD22 ' A' ' 104' ' ' LEU . 14.8 mt -63.77 -30.08 71.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.519 -0.738 . . . . 0.0 109.525 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.413 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 1.3 tmm_? -68.79 -30.62 69.24 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.536 -0.728 . . . . 0.0 110.121 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -87.01 -36.59 18.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.286 -0.884 . . . . 0.0 110.408 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -89.22 -15.85 32.67 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.291 -0.88 . . . . 0.0 110.678 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 104' ' ' LEU . . . -125.19 -39.24 2.23 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.23 -0.919 . . . . 0.0 110.432 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.413 ' HA2' ' O ' ' A' ' 131' ' ' ARG . . . 84.28 140.52 4.65 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -124.41 62.96 0.57 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.6 p -53.47 137.63 35.59 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.36 -1.082 . . . . 0.0 110.344 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 5.1 ttt85 -113.33 92.16 3.9 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.414 -0.804 . . . . 0.0 110.342 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -130.31 117.24 2.23 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 70.1 m -54.47 -34.74 62.09 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.384 -1.068 . . . . 0.0 110.444 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -137.87 -61.01 0.63 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.379 -0.825 . . . . 0.0 109.862 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -108.83 99.95 9.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.439 -0.788 . . . . 0.0 110.079 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -56.82 -179.37 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.444 -0.785 . . . . 0.0 110.327 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -53.98 175.52 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.289 -0.882 . . . . 0.0 110.365 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 43.5 mm 51.81 81.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.314 -0.866 . . . . 0.0 110.097 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -49.83 110.63 0.41 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.402 -0.811 . . . . 0.0 110.253 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -49.94 126.11 13.49 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.414 -0.804 . . . . 0.0 110.362 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 61.04 114.39 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.42 -0.8 . . . . 0.0 109.879 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.89 111.89 3.51 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.315 -0.866 . . . . 0.0 110.169 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 79.28 152.86 7.19 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -74.27 135.91 21.25 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.855 1.45 . . . . 0.0 110.273 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.35 126.83 32.07 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.363 -0.836 . . . . 0.0 110.336 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -79.32 133.51 36.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.417 -0.802 . . . . 0.0 110.36 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.428 ' O ' HG21 ' A' ' 154' ' ' ILE . 5.4 tt -166.94 97.78 0.67 Allowed Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.397 -0.814 . . . . 0.0 109.764 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -73.16 90.69 0.86 Allowed 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 123.581 1.306 . . . . 0.0 110.767 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.2 t0 . . . . . 0 N--CA 1.498 1.932 0 CA-C-O 118.07 -0.967 . . . . 0.0 111.066 179.687 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mtt . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.308 0.575 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 50.75 75.0 0.71 Allowed Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.437 -0.79 . . . . 0.0 110.484 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -77.92 77.01 4.08 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.69 1.363 . . . . 0.0 110.022 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -50.65 121.75 6.27 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.548 -0.72 . . . . 0.0 110.412 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -100.71 8.12 43.49 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.492 -0.755 . . . . 0.0 110.872 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 65.14 100.39 0.01 OUTLIER Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 54.46 175.58 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.256 -1.143 . . . . 0.0 110.52 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.8 p -114.28 167.4 10.73 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.383 -0.823 . . . . 0.0 110.094 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.5 mmt -68.84 -80.11 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.354 -0.841 . . . . 0.0 110.156 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -169.37 148.53 3.51 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.212 -0.93 . . . . 0.0 110.166 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.09 90.65 0.85 Allowed 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.776 1.408 . . . . 0.0 110.744 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.1 p 178.83 -47.14 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.439 -0.788 . . . . 0.0 110.149 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 51.57 25.17 2.62 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.343 -0.848 . . . . 0.0 110.226 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -82.4 -10.31 59.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.469 -0.769 . . . . 0.0 110.404 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.609 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 1.3 t90 -65.66 -10.25 34.54 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.139 -0.976 . . . . 0.0 110.442 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.443 ' CD1' HD22 ' A' ' 63' ' ' LEU . 1.8 tp -73.0 -54.37 8.76 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.245 -0.91 . . . . 0.0 109.72 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.426 ' N ' ' HG ' ' A' ' 16' ' ' LEU . . . -75.77 -42.82 49.25 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.368 -0.833 . . . . 0.0 110.488 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.609 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 3.1 p -49.37 -46.29 47.0 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.468 -0.77 . . . . 0.0 110.76 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.414 ' CB ' HG23 ' A' ' 28' ' ' VAL . . . -66.3 -47.18 74.42 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.283 -0.886 . . . . 0.0 110.299 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.449 ' CB ' HG13 ' A' ' 59' ' ' VAL . . . -52.54 -36.11 54.89 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.409 -0.807 . . . . 0.0 110.475 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -78.92 -26.01 43.68 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.343 -0.848 . . . . 0.0 110.323 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -93.25 19.22 8.38 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.203 -0.936 . . . . 0.0 110.735 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 52.98 53.0 35.95 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.06 61.4 0.96 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.405 -1.056 . . . . 0.0 109.93 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.425 ' CG2' HG22 ' A' ' 59' ' ' VAL . 37.5 t -50.22 -46.31 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.475 -0.766 . . . . 0.0 110.672 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -59.1 -36.43 75.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.316 -0.865 . . . . 0.0 110.349 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.402 ' O ' ' HB2' ' A' ' 31' ' ' LEU . 7.2 tt0 -73.73 -31.43 63.36 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.234 -0.916 . . . . 0.0 109.616 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.479 ' CG1' HD22 ' A' ' 62' ' ' LEU . 3.4 t -76.48 -50.19 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.554 -0.716 . . . . 0.0 109.57 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.505 ' HA ' HD21 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -49.09 -45.26 43.02 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.481 -0.762 . . . . 0.0 110.132 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.36 -41.83 38.86 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.454 -0.779 . . . . 0.0 109.877 179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.408 ' C ' ' HB2' ' A' ' 36' ' ' ALA . 12.6 mt -57.14 -67.8 0.29 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.361 -0.837 . . . . 0.0 110.439 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.504 ' CD2' ' CG ' ' A' ' 66' ' ' HIS . 0.3 OUTLIER -48.54 -46.0 38.18 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.585 -0.697 . . . . 0.0 111.016 -179.382 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.13 -14.08 61.31 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.26 -0.9 . . . . 0.0 110.324 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -92.07 -8.52 45.64 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.223 -0.923 . . . . 0.0 111.024 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 146.72 -28.98 1.59 Allowed Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.741 -1.219 . . . . 0.0 110.265 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.408 ' HB2' ' C ' ' A' ' 31' ' ' LEU . . . -53.76 106.33 0.18 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.107 -1.231 . . . . 0.0 110.579 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.418 ' O ' ' CD2' ' A' ' 16' ' ' LEU . 0.6 OUTLIER -66.96 152.22 96.17 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.361 -0.837 . . . . 0.0 109.734 179.701 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -74.57 -28.49 9.94 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.715 1.376 . . . . 0.0 111.083 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -90.26 32.62 0.92 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.209 -0.932 . . . . 0.0 110.246 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -84.73 112.65 44.17 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.385 -0.822 . . . . 0.0 110.097 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.45 123.11 8.86 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.652 1.343 . . . . 0.0 110.148 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 48.4 p-10 -80.6 5.93 14.06 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.381 -0.824 . . . . 0.0 110.702 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 58.54 17.53 5.02 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.092 -1.005 . . . . 0.0 110.024 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -107.3 15.19 25.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.422 -0.799 . . . . 0.0 109.412 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.0 24.64 43.47 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.5 ' O ' ' CB ' ' A' ' 50' ' ' GLN . 35.3 mtt180 -135.79 32.0 3.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.308 -1.113 . . . . 0.0 111.1 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.561 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 0.6 OUTLIER 42.56 -166.72 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.119 0 O-C-N 121.501 -0.749 . . . . 0.0 110.937 178.589 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.561 ' CD ' ' HB3' ' A' ' 47' ' ' ARG . 48.9 Cg_endo -85.6 -24.57 1.85 Allowed 'Trans proline' 0 C--N 1.318 -1.036 0 O-C-N 122.998 0.999 . . . . 0.0 110.81 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.8 mt -107.04 -40.16 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.129 -0.982 . . . . 0.0 110.047 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.5 ' CB ' ' O ' ' A' ' 46' ' ' ARG . 0.9 OUTLIER -47.1 -27.11 1.27 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.488 -0.757 . . . . 0.0 110.555 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.452 ' HB ' ' CB ' ' A' ' 46' ' ' ARG . 9.0 p -97.06 -2.47 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.218 -0.926 . . . . 0.0 110.19 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.466 ' CE ' ' CE ' ' A' ' 54' ' ' MET . 56.8 ttp -52.15 154.33 2.36 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.515 -0.741 . . . . 0.0 109.789 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 1.4 tmm? -69.77 -2.91 13.31 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.377 -0.827 . . . . 0.0 111.07 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.466 ' CE ' ' CE ' ' A' ' 52' ' ' MET . 0.0 OUTLIER 52.62 22.77 2.33 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.989 -1.07 . . . . 0.0 110.115 -179.687 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.416 ' C ' ' CZ ' ' A' ' 90' ' ' PHE . . . -123.95 9.25 8.53 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 178.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.417 ' N ' ' CE2' ' A' ' 90' ' ' PHE . 0.6 OUTLIER -144.82 80.73 1.63 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.436 -1.038 . . . . 0.0 109.931 179.887 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.422 ' HA ' ' OG1' ' A' ' 93' ' ' THR . . . -52.23 -25.08 8.39 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.215 -0.928 . . . . 0.0 109.757 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.6 mtt180 -61.21 -36.73 80.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.472 -0.768 . . . . 0.0 109.503 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.449 HG13 ' CB ' ' A' ' 20' ' ' ALA . 37.3 t -55.4 -69.95 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.263 -0.898 . . . . 0.0 109.256 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.515 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -47.44 -34.42 7.22 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.296 -0.878 . . . . 0.0 109.498 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.436 ' O ' ' CB ' ' A' ' 65' ' ' LEU . 11.1 tt0 -54.27 -32.17 55.53 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.269 -0.894 . . . . 0.0 109.845 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.505 HD21 ' HA ' ' A' ' 29' ' ' ARG . 1.0 OUTLIER -87.06 -45.66 10.52 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.607 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.443 HD22 ' CD1' ' A' ' 16' ' ' LEU . 4.5 mp -62.65 -53.46 54.15 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.718 -0.614 . . . . 0.0 109.98 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.515 ' HB2' ' O ' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -63.42 -42.9 98.75 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.226 -0.921 . . . . 0.0 109.565 179.553 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.436 ' CB ' ' O ' ' A' ' 61' ' ' GLU . 10.0 tp -54.06 -37.49 64.23 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.363 -0.836 . . . . 0.0 108.804 178.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.504 ' CG ' ' CD2' ' A' ' 32' ' ' LEU . 7.8 m80 -85.76 -21.54 28.17 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.357 0.598 . . . . 0.0 109.69 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.24 56.83 0.73 Allowed Glycine 0 N--CA 1.479 1.533 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 179.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.41 ' CB ' ' HB3' ' A' ' 63' ' ' LEU . . . -64.82 -148.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.033 -1.275 . . . . 0.0 109.089 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.533 ' HB2' ' HB3' ' A' ' 47' ' ' ARG . 53.9 mt-10 -117.27 55.98 1.76 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.189 -0.944 . . . . 0.0 110.079 179.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.404 ' CD ' ' N ' ' A' ' 69' ' ' GLU . 44.3 Cg_endo -69.4 -11.19 30.74 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 O-C-N 123.631 1.332 . . . . 0.0 110.392 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -95.91 -56.48 2.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.257 -0.902 . . . . 0.0 110.415 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -50.12 148.62 3.29 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.315 -0.865 . . . . 0.0 110.919 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.69 -158.2 0.84 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.478 -0.764 . . . . 0.0 109.721 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.496 ' O ' ' N ' ' A' ' 78' ' ' LEU . 19.1 m-20 -106.43 126.21 30.99 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.321 -0.862 . . . . 0.0 109.53 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.12 -20.58 28.4 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.389 1.205 . . . . 0.0 110.434 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.79 -42.05 88.14 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.236 -0.915 . . . . 0.0 110.141 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.491 HG23 ' CZ3' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -148.26 21.83 1.07 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.478 -0.764 . . . . 0.0 109.842 -179.832 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 74' ' ' ASP . 1.4 mt 50.72 41.39 26.08 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.561 -0.712 . . . . 0.0 111.164 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 18.4 m -73.95 100.62 3.59 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.105 -0.997 . . . . 0.0 109.618 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.451 ' CG ' HG11 ' A' ' 106' ' ' VAL . 0.3 OUTLIER -76.84 164.02 61.93 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.381 -0.825 . . . . 0.0 109.98 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.55 -14.17 27.55 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.68 1.358 . . . . 0.0 110.649 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.405 HG12 ' HG ' ' A' ' 104' ' ' LEU . 42.0 t -63.63 -28.2 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.233 -0.917 . . . . 0.0 109.927 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.431 ' O ' ' CB ' ' A' ' 87' ' ' ARG . 29.1 m80 -65.52 -44.39 87.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.441 -0.787 . . . . 0.0 109.351 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.483 ' OD2' ' HG2' ' A' ' 50' ' ' GLN . 67.8 m-20 -49.95 -55.86 12.86 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.664 -0.647 . . . . 0.0 111.244 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.403 ' CB ' ' CD1' ' A' ' 94' ' ' LEU . . . -54.22 -68.0 0.22 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.173 -0.954 . . . . 0.0 109.971 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.506 ' HA ' ' CG1' ' A' ' 126' ' ' VAL . . . -54.92 -40.86 70.32 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.318 -0.864 . . . . 0.0 111.098 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 83' ' ' HIS . 6.2 tmm_? -51.47 -31.67 24.25 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.91 -1.119 . . . . 0.0 110.228 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -107.87 16.62 23.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.519 -0.738 . . . . 0.0 110.308 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.417 ' N ' ' CE1' ' A' ' 123' ' ' HIS . . . 55.43 48.52 69.42 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.448 ' CD2' ' OG1' ' A' ' 93' ' ' THR . 0.1 OUTLIER -116.57 91.31 3.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.455 -1.026 . . . . 0.0 110.694 -179.1 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.58 -39.01 58.71 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.313 -0.867 . . . . 0.0 110.679 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -47.32 -44.95 24.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.429 -0.795 . . . . 0.0 109.902 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.448 ' OG1' ' CD2' ' A' ' 90' ' ' PHE . 23.1 m -68.86 -40.0 79.54 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.403 ' CD1' ' CB ' ' A' ' 85' ' ' ALA . 5.0 tp -59.36 -47.49 85.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.638 -0.664 . . . . 0.0 109.924 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.4 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 53.2 t -53.84 -45.92 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.411 -0.806 . . . . 0.0 109.496 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.421 HG13 ' HA ' ' A' ' 61' ' ' GLU . 24.8 t -62.47 -43.15 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.555 -0.715 . . . . 0.0 109.545 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.411 ' HG ' HD11 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -53.59 -46.14 70.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.629 -0.669 . . . . 0.0 110.443 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -83.86 -28.28 28.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.354 -0.841 . . . . 0.0 110.426 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 1.7 mtp85 -66.25 -11.72 51.94 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.378 -0.826 . . . . 0.0 111.044 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -124.42 -79.48 0.61 Allowed 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.157 -0.964 . . . . 0.0 110.891 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -159.26 88.07 0.11 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.016 -1.233 . . . . 0.0 110.016 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.401 ' HB2' ' CD2' ' A' ' 97' ' ' LEU . . . -160.78 110.73 1.73 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.286 -1.126 . . . . 0.0 110.314 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 8.1 ttt180 -50.58 167.16 0.07 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.373 -0.83 . . . . 0.0 110.662 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.405 ' HG ' HG12 ' A' ' 82' ' ' VAL . 0.1 OUTLIER -149.14 43.47 0.96 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.417 -0.802 . . . . 0.0 110.067 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -161.01 48.47 0.22 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.195 -0.941 . . . . 0.0 110.778 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.458 ' O ' ' HG ' ' A' ' 113' ' ' LEU . 4.2 p -109.21 -174.47 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.188 -0.945 . . . . 0.0 109.563 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 7.7 ptt180 -141.67 147.85 38.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.428 -0.795 . . . . 0.0 109.521 178.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.475 ' O ' ' N ' ' A' ' 110' ' ' TRP . 3.4 t0 -69.88 63.2 0.2 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.336 -0.852 . . . . 0.0 110.058 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 52.38 -86.66 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.383 -0.823 . . . . 0.0 110.667 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.491 ' CZ3' HG23 ' A' ' 77' ' ' THR . 38.3 p90 -121.59 6.02 10.05 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.189 -0.945 . . . . 0.0 110.467 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -82.12 -77.91 1.03 Allowed Glycine 0 N--CA 1.481 1.671 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -175.76 -158.91 0.07 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.421 -1.047 . . . . 0.0 110.47 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 106' ' ' VAL . 0.6 OUTLIER -106.41 167.19 9.92 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.404 -0.81 . . . . 0.0 110.669 -179.446 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.458 ' HD2' ' HG ' ' A' ' 113' ' ' LEU . 44.7 Cg_endo -72.35 -35.96 5.93 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 O-C-N 123.868 1.457 . . . . 0.0 110.053 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.444 ' HB ' ' HB3' ' A' ' 130' ' ' LEU . 12.0 p -67.75 -26.79 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.273 -0.892 . . . . 0.0 109.831 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -65.28 -42.45 93.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.472 -0.767 . . . . 0.0 109.775 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.47 -49.64 72.82 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.529 -0.732 . . . . 0.0 110.267 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.463 ' HB2' ' HB3' ' A' ' 86' ' ' ALA . . . -48.68 -64.8 0.7 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.346 -0.846 . . . . 0.0 110.804 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -55.1 -23.7 22.0 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.278 -0.889 . . . . 0.0 110.151 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.82 -33.8 72.82 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.412 -0.805 . . . . 0.0 110.027 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -96.25 -8.56 32.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.326 -0.858 . . . . 0.0 110.384 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.33 32.71 6.24 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.497 ' ND1' ' O ' ' A' ' 86' ' ' ALA . 36.0 m170 -95.11 55.33 1.78 Allowed 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.072 -1.252 . . . . 0.0 109.478 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.407 ' O ' ' CB ' ' A' ' 128' ' ' ARG . 12.2 ttm180 -45.9 -30.13 1.63 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.594 -0.691 . . . . 0.0 110.286 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.96 -41.1 74.94 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.571 -0.706 . . . . 0.0 109.488 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.506 ' CG1' ' HA ' ' A' ' 86' ' ' ALA . 2.1 t -89.5 -39.64 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.427 -0.795 . . . . 0.0 110.343 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.59 -34.29 77.92 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.296 -0.877 . . . . 0.0 109.957 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.407 ' CB ' ' O ' ' A' ' 124' ' ' ARG . 34.5 ttt85 -74.01 -56.83 4.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.354 -0.841 . . . . 0.0 109.742 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -56.02 -26.36 48.49 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.302 -0.874 . . . . 0.0 109.605 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.444 ' HB3' ' HB ' ' A' ' 115' ' ' VAL . 14.2 mt -78.5 -50.76 11.04 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.454 -0.779 . . . . 0.0 109.994 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.6 tpt85 -52.56 -25.97 11.96 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.436 -0.79 . . . . 0.0 110.597 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -79.46 -53.12 7.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.204 -0.935 . . . . 0.0 109.957 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -81.35 -7.15 59.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.435 -0.791 . . . . 0.0 110.511 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.432 ' N ' ' O ' ' A' ' 130' ' ' LEU . . . -116.0 -31.59 5.68 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.18 -0.95 . . . . 0.0 110.279 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -111.56 -13.15 13.35 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -45.89 122.11 5.65 Favored Glycine 0 N--CA 1.498 2.769 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.48 ' O ' ' N ' ' A' ' 139' ' ' GLY . 2.1 t -135.63 49.49 2.16 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.399 -1.059 . . . . 0.0 110.726 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.71 -71.79 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.418 -0.801 . . . . 0.0 110.449 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 137' ' ' THR . . . -140.17 173.3 23.06 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.7 t -82.98 -46.83 12.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.325 -1.103 . . . . 0.0 110.15 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 21.4 m120 52.74 -162.19 0.1 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.247 -0.908 . . . . 0.0 110.159 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 29.1 p80 -152.6 31.49 0.51 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.356 -0.84 . . . . 0.0 110.362 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -156.0 27.34 0.37 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.279 -0.888 . . . . 0.0 110.223 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.459 ' O ' ' C ' ' A' ' 145' ' ' ILE . 28.5 ttp180 -86.54 135.88 33.28 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.306 -0.871 . . . . 0.0 110.34 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.481 HG23 ' O ' ' A' ' 145' ' ' ILE . 1.3 tt 33.21 71.59 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.773 -0.579 . . . . 0.0 111.426 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -47.72 92.58 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.489 -0.757 . . . . 0.0 110.94 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 145' ' ' ILE . . . -81.45 118.53 22.78 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.477 -0.764 . . . . 0.0 110.049 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -82.9 128.73 34.71 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.354 -0.841 . . . . 0.0 110.408 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -103.29 -17.08 15.46 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.422 -0.799 . . . . 0.0 109.886 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 75.08 150.24 2.34 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -71.25 123.4 9.56 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.74 1.389 . . . . 0.0 110.297 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.08 168.0 1.12 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.211 -0.931 . . . . 0.0 110.02 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -52.38 150.35 4.86 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.243 -0.911 . . . . 0.0 110.277 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 76.6 mt -122.84 93.96 47.88 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.423 -0.798 . . . . 0.0 110.201 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.52 136.22 28.0 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.717 1.377 . . . . 0.0 110.43 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 . . . . . 0 N--CA 1.494 1.754 0 CA-C-O 118.081 -0.961 . . . . 0.0 110.174 179.901 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.138 0.494 . . . . 0.0 110.221 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 46.64 57.14 17.14 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.542 -0.724 . . . . 0.0 110.527 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.97 -171.37 0.77 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.732 1.385 . . . . 0.0 110.301 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -113.47 131.34 56.07 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.25 -0.906 . . . . 0.0 110.466 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -152.56 -60.12 0.15 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.419 -0.8 . . . . 0.0 110.217 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.14 108.51 0.26 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.6 t -126.27 -141.16 0.28 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.378 -1.072 . . . . 0.0 109.398 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 39.9 t -61.43 -179.94 0.19 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.854 -1.154 . . . . 0.0 110.002 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -64.35 -54.83 26.81 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.164 -0.96 . . . . 0.0 109.852 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.532 ' CB ' ' CD ' ' A' ' 11' ' ' PRO . 0.3 OUTLIER -136.48 -65.56 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.447 -0.783 . . . . 0.0 110.029 179.416 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.532 ' CD ' ' CB ' ' A' ' 10' ' ' GLU . 48.7 Cg_endo -73.77 123.11 8.26 Favored 'Trans proline' 0 C--N 1.316 -1.132 0 O-C-N 123.185 1.097 . . . . 0.0 110.42 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.9 p -75.15 130.03 38.52 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.253 -0.904 . . . . 0.0 110.079 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.462 ' O ' ' CB ' ' A' ' 40' ' ' ALA . . . -62.09 99.37 0.13 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.346 -0.846 . . . . 0.0 110.327 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.408 ' O ' ' OG1' ' A' ' 18' ' ' THR . 11.4 p30 -131.94 3.63 4.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.125 -0.985 . . . . 0.0 110.946 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.481 ' HB3' HD13 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -60.15 -11.56 6.43 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.343 -0.848 . . . . 0.0 111.299 -179.644 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.449 HD23 ' HB1' ' A' ' 36' ' ' ALA . 23.8 mt -78.36 -57.05 3.98 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.936 -1.102 . . . . 0.0 109.534 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.47 -48.38 80.95 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.508 -0.745 . . . . 0.0 109.471 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.408 ' OG1' ' O ' ' A' ' 14' ' ' ASP . 0.2 OUTLIER -54.52 -59.95 4.0 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.39 -0.819 . . . . 0.0 110.128 179.341 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.425 ' HB1' HG23 ' A' ' 28' ' ' VAL . . . -54.3 -56.78 15.08 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.49 -0.757 . . . . 0.0 110.181 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.408 ' HB2' ' CB ' ' A' ' 52' ' ' MET . . . -52.87 -47.87 67.53 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.45 -0.781 . . . . 0.0 109.847 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.07 -19.2 61.14 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.468 -0.77 . . . . 0.0 109.863 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.71 18.03 15.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.501 -0.749 . . . . 0.0 110.703 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.416 ' CA ' ' HE2' ' A' ' 53' ' ' MET . . . 54.17 47.85 65.89 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.65 98.84 4.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.304 -1.115 . . . . 0.0 109.716 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.46 HG22 ' HB3' ' A' ' 58' ' ' ARG . 3.1 t -74.31 -43.73 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.463 -0.773 . . . . 0.0 109.821 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -45.4 -54.26 7.55 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.455 -0.778 . . . . 0.0 110.781 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.452 ' OE1' ' CD1' ' A' ' 15' ' ' TRP . 0.0 OUTLIER -48.91 -49.46 39.88 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.371 -0.831 . . . . 0.0 110.041 179.801 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.446 HG13 ' CD1' ' A' ' 32' ' ' LEU . 6.2 t -74.13 -45.63 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.587 -0.696 . . . . 0.0 110.307 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.474 ' HA ' ' CD1' ' A' ' 62' ' ' LEU . 9.3 mmm180 -45.34 -41.65 9.13 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.501 -0.749 . . . . 0.0 109.93 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.46 -39.59 31.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.544 -0.723 . . . . 0.0 109.646 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.481 HD13 ' HB3' ' A' ' 15' ' ' TRP . 32.8 mt -61.06 -67.12 0.43 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.419 -0.8 . . . . 0.0 110.137 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.514 ' HB3' ' CE1' ' A' ' 66' ' ' HIS . 13.7 mt -51.85 -36.88 49.88 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.476 -0.765 . . . . 0.0 110.461 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 29' ' ' ARG . 46.9 mt-10 -72.37 -18.08 61.77 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.308 -0.87 . . . . 0.0 110.022 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.97 -7.5 48.81 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.359 -0.838 . . . . 0.0 110.435 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.61 23.73 6.14 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.492 ' HB2' ' HA ' ' A' ' 32' ' ' LEU . . . -61.22 164.45 5.31 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.296 -1.12 . . . . 0.0 110.073 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 40.8 tp -97.18 99.15 5.62 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.536 -0.727 . . . . 0.0 109.927 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.473 ' O ' ' HG3' ' A' ' 48' ' ' PRO . 44.1 Cg_endo -68.56 -23.11 37.37 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 O-C-N 123.656 1.345 . . . . 0.0 110.437 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.41 34.25 1.06 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.252 -0.905 . . . . 0.0 110.018 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.462 ' CB ' ' O ' ' A' ' 13' ' ' ALA . . . -86.82 122.52 71.42 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.333 -0.855 . . . . 0.0 110.274 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -73.42 111.81 3.38 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.609 1.321 . . . . 0.0 110.38 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -90.13 166.65 13.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.404 -0.81 . . . . 0.0 109.916 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.457 ' C ' ' CG ' ' A' ' 44' ' ' TYR . 70.8 m -62.58 -157.04 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.433 -0.792 . . . . 0.0 109.732 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.573 ' CD1' ' N ' ' A' ' 44' ' ' TYR . 0.1 OUTLIER 58.86 13.72 2.9 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.166 -0.959 . . . . 0.0 109.791 -179.607 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.2 24.24 20.91 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.87 171.95 7.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.44 -1.036 . . . . 0.0 110.956 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.543 ' CB ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -113.92 -165.21 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.688 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.562 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.543 ' HD2' ' CB ' ' A' ' 47' ' ' ARG . 49.1 Cg_endo -76.19 166.48 27.67 Favored 'Trans proline' 0 C--N 1.315 -1.228 0 O-C-N 122.85 0.921 . . . . 0.0 109.787 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.516 ' O ' ' HG2' ' A' ' 52' ' ' MET . 4.7 mt 63.96 -59.6 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 121.668 -0.645 . . . . 0.0 110.224 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.513 ' N ' ' O ' ' A' ' 48' ' ' PRO . 7.3 mt-30 -43.7 -27.19 0.29 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.811 -1.181 . . . . 0.0 110.54 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.458 ' CG2' ' O ' ' A' ' 51' ' ' VAL . 6.8 p -118.8 26.06 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.426 -0.796 . . . . 0.0 110.53 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.516 ' HG2' ' O ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -83.73 41.04 0.77 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.77 -1.206 . . . . 0.0 109.421 178.872 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.416 ' HE2' ' CA ' ' A' ' 23' ' ' GLY . 2.9 tmm? 64.97 -6.82 0.31 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.285 -0.884 . . . . 0.0 110.552 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.492 ' H ' ' C ' ' A' ' 52' ' ' MET . 0.0 OUTLIER 43.12 29.89 0.23 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.307 -0.871 . . . . 0.0 110.516 -179.781 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.453 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -134.54 12.64 4.58 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -146.1 71.5 1.26 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.425 -1.044 . . . . 0.0 109.544 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.429 ' HB3' ' CE1' ' A' ' 90' ' ' PHE . . . -47.97 -27.75 2.37 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.649 -0.657 . . . . 0.0 109.89 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.46 ' HB3' HG22 ' A' ' 25' ' ' VAL . 3.1 tpt180 -52.07 -38.23 56.49 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.654 -0.654 . . . . 0.0 109.359 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 67.0 t -69.48 -49.05 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.359 -0.838 . . . . 0.0 109.028 178.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.423 ' O ' ' CB ' ' A' ' 64' ' ' LEU . . . -46.44 -45.82 18.36 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.52 -0.738 . . . . 0.0 109.664 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.412 ' O ' HD22 ' A' ' 65' ' ' LEU . 0.7 OUTLIER -58.05 -48.39 80.24 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.545 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.524 ' O ' ' HB2' ' A' ' 66' ' ' HIS . 0.2 OUTLIER -49.92 -66.73 0.34 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.586 -0.696 . . . . 0.0 109.688 178.348 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.461 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 85.1 mt -58.44 -54.68 44.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.57 -0.706 . . . . 0.0 110.178 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.437 ' CD2' ' HB3' ' A' ' 100' ' ' ALA . 1.9 tt -43.67 -68.3 0.21 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.501 -0.749 . . . . 0.0 111.212 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.413 HD12 ' C ' ' A' ' 65' ' ' LEU . 1.1 pp -56.31 -23.2 35.41 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.104 -0.997 . . . . 0.0 110.159 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.524 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 2.2 m80 -82.86 -48.79 10.36 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 121.293 -0.88 . . . . 0.0 110.153 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 149.34 43.41 0.03 OUTLIER Glycine 0 N--CA 1.483 1.79 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.461 ' CB ' ' HB3' ' A' ' 63' ' ' LEU . . . -72.25 -157.32 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.849 -1.383 . . . . 0.0 109.92 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.44 ' CG ' ' HD2' ' A' ' 48' ' ' PRO . 4.6 mm-40 -121.21 62.73 11.81 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.432 ' HG2' ' ND2' ' A' ' 71' ' ' ASN . 40.4 Cg_endo -69.05 -5.5 15.93 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.875 1.461 . . . . 0.0 111.083 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.432 ' ND2' ' HG2' ' A' ' 70' ' ' PRO . 12.2 m-80 -113.88 -67.12 1.02 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.022 -1.048 . . . . 0.0 110.065 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.8 t -44.88 163.28 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.465 -0.772 . . . . 0.0 110.83 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.449 ' HB2' ' HA ' ' A' ' 80' ' ' ARG . . . -138.59 -155.44 0.6 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.186 -0.946 . . . . 0.0 110.925 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' A' ' 78' ' ' LEU . 50.8 m-20 -107.77 126.23 30.35 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.533 -0.729 . . . . 0.0 109.766 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -74.96 -2.06 12.03 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 123.332 1.175 . . . . 0.0 110.668 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -93.32 -36.3 12.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 0.0 109.84 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.473 ' CG2' ' CH2' ' A' ' 110' ' ' TRP . 0.0 OUTLIER -132.76 6.99 4.04 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.376 -0.827 . . . . 0.0 110.142 179.374 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 74' ' ' ASP . 1.0 OUTLIER 48.48 23.22 0.57 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.381 -0.824 . . . . 0.0 111.477 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 35.8 m -78.83 102.74 8.34 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.956 -1.09 . . . . 0.0 109.517 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.449 ' HA ' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -71.11 171.97 7.51 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.361 -0.837 . . . . 0.0 110.285 -179.676 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.66 -14.5 36.51 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.816 1.429 . . . . 0.0 109.375 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.426 HG13 ' CB ' ' A' ' 114' ' ' PRO . 48.7 t -72.08 -30.26 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.778 -0.576 . . . . 0.0 109.896 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.515 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 5.3 m80 -77.8 -34.68 52.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.391 -0.818 . . . . 0.0 109.25 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.02 -41.99 84.31 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 120.322 -0.551 . . . . 0.0 109.884 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.64 -61.51 1.94 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.232 -0.918 . . . . 0.0 109.653 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.533 ' HA ' ' CG1' ' A' ' 126' ' ' VAL . . . -56.88 -44.84 82.69 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.262 -0.899 . . . . 0.0 110.929 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -48.64 -43.44 36.47 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.329 -0.857 . . . . 0.0 110.291 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.42 ' HG3' ' HB3' ' A' ' 54' ' ' MET . 0.0 OUTLIER -93.82 4.68 53.57 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.454 -0.779 . . . . 0.0 110.655 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.464 ' HA3' ' ND1' ' A' ' 123' ' ' HIS . . . 60.72 51.79 56.45 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.453 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 0.8 OUTLIER -120.45 74.87 1.08 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.385 -1.068 . . . . 0.0 110.187 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.17 -37.89 56.02 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.428 -0.795 . . . . 0.0 110.663 -179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.422 ' HB3' ' CD1' ' A' ' 90' ' ' PHE . 48.1 t0 -47.9 -39.24 18.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.3 -0.875 . . . . 0.0 109.559 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 87.6 m -69.8 -45.06 68.79 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.433 ' CD2' ' HG ' ' A' ' 130' ' ' LEU . 1.6 tp -55.37 -43.24 74.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.563 -0.711 . . . . 0.0 109.809 179.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 69.2 t -59.91 -47.85 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.222 -0.923 . . . . 0.0 109.429 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.417 ' O ' HD11 ' A' ' 64' ' ' LEU . 6.5 t -58.88 -50.52 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.304 -0.872 . . . . 0.0 109.004 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.406 ' C ' ' CB ' ' A' ' 102' ' ' ALA . 0.0 OUTLIER -44.56 -55.4 5.17 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.77 -0.582 . . . . 0.0 109.93 179.267 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -65.73 -30.92 71.65 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.512 -0.743 . . . . 0.0 109.89 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -14.81 36.43 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.399 -0.813 . . . . 0.0 110.665 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.437 ' HB3' ' CD2' ' A' ' 64' ' ' LEU . . . -151.31 70.13 0.96 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.98 -1.075 . . . . 0.0 111.075 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 58.22 105.82 0.01 OUTLIER Glycine 0 N--CA 1.488 2.1 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.406 ' CB ' ' C ' ' A' ' 97' ' ' LEU . . . -147.51 103.86 3.58 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.589 -0.948 . . . . 0.0 109.702 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 2.8 tpp180 -65.31 101.59 0.58 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.353 -0.842 . . . . 0.0 110.377 -179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.493 ' O ' ' HA ' ' A' ' 134' ' ' ALA . 1.7 mt -102.37 59.86 0.82 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.427 -0.796 . . . . 0.0 110.226 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -170.92 44.72 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.988 -1.07 . . . . 0.0 110.907 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.443 HG13 ' HB2' ' A' ' 80' ' ' ARG . 3.1 p -105.88 -171.24 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.243 -0.911 . . . . 0.0 109.539 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -131.26 115.1 15.87 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.178 -0.951 . . . . 0.0 110.064 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.52 160.51 1.23 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.475 -0.765 . . . . 0.0 109.558 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.449 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . -63.74 -14.03 48.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.201 -0.937 . . . . 0.0 110.254 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.473 ' CH2' ' CG2' ' A' ' 77' ' ' THR . 6.0 m-90 -89.89 17.73 6.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.307 -0.871 . . . . 0.0 110.311 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 60.21 57.94 16.59 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 16.2 mtt180 -145.96 -160.69 1.18 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.379 -1.071 . . . . 0.0 110.317 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.457 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER -140.57 171.19 8.07 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.308 -0.87 . . . . 0.0 109.963 -179.897 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.457 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 45.4 Cg_endo -74.65 -48.54 0.19 Allowed 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.661 1.348 . . . . 0.0 110.025 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.2 p -55.56 -32.68 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.353 -0.842 . . . . 0.0 109.729 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.01 -38.54 79.31 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.481 -0.762 . . . . 0.0 109.688 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.401 ' O ' HD12 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -57.11 -69.36 0.16 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.508 -0.745 . . . . 0.0 110.143 179.674 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.463 ' CB ' ' HB2' ' A' ' 123' ' ' HIS . . . -44.46 -52.86 7.48 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.461 -0.774 . . . . 0.0 110.998 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -53.97 -45.04 71.27 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.347 -0.845 . . . . 0.0 110.156 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -64.89 -32.02 73.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.391 -0.818 . . . . 0.0 110.06 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.401 HD12 ' O ' ' A' ' 117' ' ' LEU . 1.0 OUTLIER -90.07 2.05 55.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.375 -0.828 . . . . 0.0 110.767 -179.668 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 89.96 11.42 63.39 Favored Glycine 0 N--CA 1.489 2.209 0 C-N-CA 119.931 -1.128 . . . . 0.0 111.075 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.464 ' ND1' ' HA3' ' A' ' 89' ' ' GLY . 47.9 m-70 -93.07 50.31 1.52 Allowed 'General case' 0 N--CA 1.484 1.232 0 O-C-N 120.841 -1.387 . . . . 0.0 109.085 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.0 mtt-85 -47.75 -31.47 4.85 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.626 -0.671 . . . . 0.0 109.407 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 125' ' ' ASP . 8.5 m-20 -62.3 -47.85 82.46 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.533 ' CG1' ' HA ' ' A' ' 86' ' ' ALA . 6.0 t -75.3 -40.52 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.426 -0.796 . . . . 0.0 109.758 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.21 -36.37 70.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.303 -0.873 . . . . 0.0 109.607 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.13 -61.19 2.73 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.418 -0.801 . . . . 0.0 110.1 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -53.26 -40.42 64.64 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.293 -0.879 . . . . 0.0 109.824 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.457 HD11 ' CB ' ' A' ' 86' ' ' ALA . 78.3 mt -67.59 -39.43 84.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.424 -0.797 . . . . 0.0 109.463 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -59.34 -19.43 46.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.19 -0.943 . . . . 0.0 110.201 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.1 -57.63 3.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.352 -0.843 . . . . 0.0 110.432 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.451 ' HB2' ' HB2' ' A' ' 104' ' ' LEU . . . -81.72 -15.49 54.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.346 -0.846 . . . . 0.0 110.959 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 104' ' ' LEU . . . -108.04 -20.48 13.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.199 -0.938 . . . . 0.0 110.103 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -68.75 120.36 10.95 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.425 ' O ' ' OG1' ' A' ' 137' ' ' THR . . . -67.04 -135.33 0.04 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 136' ' ' GLY . 21.4 p 48.14 92.79 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.588 -0.948 . . . . 0.0 110.428 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.22 61.37 0.72 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.237 -0.914 . . . . 0.0 110.698 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 156.56 -24.22 0.5 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.0 t -127.73 171.55 11.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.173 -1.192 . . . . 0.0 110.617 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -142.06 62.63 1.43 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.456 -0.778 . . . . 0.0 109.899 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -115.43 136.94 52.57 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.419 -0.801 . . . . 0.0 110.159 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.04 147.12 54.05 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.39 -0.819 . . . . 0.0 110.421 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -163.5 44.21 0.11 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.349 -0.844 . . . . 0.0 110.109 179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.407 HG22 ' O ' ' A' ' 145' ' ' ILE . 2.1 tt -77.76 132.03 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.704 -0.623 . . . . 0.0 110.731 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.4 t70 42.2 60.1 2.41 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.548 -0.72 . . . . 0.0 110.932 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -82.92 126.12 32.13 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.362 -0.836 . . . . 0.0 110.449 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 52.96 -168.78 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.261 -0.9 . . . . 0.0 110.334 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 60.08 13.06 3.55 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.436 -0.79 . . . . 0.0 110.406 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 165.92 167.55 26.73 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.286 -1.525 . . . . 0.0 109.286 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -76.04 149.43 32.56 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 O-C-N 123.564 1.297 . . . . 0.0 110.52 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 28.6 m -63.1 173.07 1.54 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.297 -0.877 . . . . 0.0 110.25 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -51.57 162.42 0.38 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.331 -0.855 . . . . 0.0 110.835 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.415 ' O ' ' CG2' ' A' ' 154' ' ' ILE . 0.8 OUTLIER -153.07 81.82 5.05 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.428 -0.795 . . . . 0.0 110.04 179.748 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.91 135.7 23.82 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 O-C-N 123.737 1.388 . . . . 0.0 110.646 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.6 t0 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.853 -1.07 . . . . 0.0 110.392 -179.601 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.813 0 CA-C-O 121.01 0.433 . . . . 0.0 110.357 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 50.43 71.16 1.64 Allowed Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 121.278 -0.889 . . . . 0.0 109.762 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -72.17 -176.5 2.19 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.779 1.41 . . . . 0.0 109.792 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 49.82 55.59 9.18 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.345 -0.847 . . . . 0.0 110.029 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -113.44 -61.48 1.73 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.43 -0.794 . . . . 0.0 110.679 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.3 61.54 3.63 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.78 -72.63 0.15 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.481 -1.011 . . . . 0.0 109.954 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 m -149.36 177.74 9.41 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.466 -0.771 . . . . 0.0 110.14 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.31 -173.89 2.62 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.318 -0.864 . . . . 0.0 109.606 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.29 123.88 51.4 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.07 -1.019 . . . . 0.0 109.604 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.89 -172.82 1.2 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.582 1.307 . . . . 0.0 110.604 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.73 -21.21 15.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.417 -0.802 . . . . 0.0 110.334 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 52.06 24.8 2.85 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.391 -0.818 . . . . 0.0 109.573 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -86.03 9.19 17.86 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.511 -0.743 . . . . 0.0 110.868 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 40.2 m0 -46.44 -34.73 4.94 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.334 -0.854 . . . . 0.0 109.976 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.486 HD12 HD21 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -63.1 -37.84 88.8 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.6 -0.687 . . . . 0.0 109.997 178.62 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.66 -53.86 6.43 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.27 -0.893 . . . . 0.0 110.309 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -44.96 -54.09 6.93 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.565 -0.709 . . . . 0.0 110.836 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.485 ' CB ' HG21 ' A' ' 28' ' ' VAL . . . -61.3 -52.8 63.2 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.356 -0.84 . . . . 0.0 110.447 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.419 ' CB ' ' CG1' ' A' ' 59' ' ' VAL . . . -46.78 -46.9 20.88 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.502 -0.749 . . . . 0.0 110.355 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.44 -40.01 67.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.55 -0.719 . . . . 0.0 110.425 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.6 mpt_? -86.53 26.58 1.06 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.484 -0.76 . . . . 0.0 110.414 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 49.05 24.22 4.39 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.2 mtt180 -93.65 65.39 3.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.365 -1.079 . . . . 0.0 109.738 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.485 ' CG2' HG23 ' A' ' 59' ' ' VAL . 60.2 t -55.67 -42.66 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.657 -0.652 . . . . 0.0 110.881 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -43.36 -56.03 3.77 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.471 -0.768 . . . . 0.0 110.604 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.429 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 1.8 tp10 -63.99 -34.89 79.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.481 -0.762 . . . . 0.0 110.141 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.485 HG21 ' CB ' ' A' ' 19' ' ' ALA . 4.7 t -70.29 -44.97 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.231 -0.918 . . . . 0.0 109.871 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.422 ' CD ' HD13 ' A' ' 62' ' ' LEU . 1.8 mmm180 -53.37 -45.87 69.38 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.201 -0.937 . . . . 0.0 109.254 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -70.59 -42.38 71.11 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 120.078 -0.649 . . . . 0.0 109.739 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 27' ' ' GLU . 44.6 mt -59.18 -63.05 1.44 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.289 -0.882 . . . . 0.0 110.969 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.532 HD23 ' HA ' ' A' ' 63' ' ' LEU . 0.0 OUTLIER -44.44 -44.52 8.52 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.424 -0.798 . . . . 0.0 110.594 -179.484 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -81.25 -18.5 45.75 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.74 -0.6 . . . . 0.0 110.443 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.42 -5.63 59.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.111 -0.993 . . . . 0.0 110.748 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.09 22.61 2.35 Favored Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.802 -1.189 . . . . 0.0 110.99 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.462 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . . . -66.6 162.24 21.43 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.916 -1.343 . . . . 0.0 109.892 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -87.19 133.49 38.68 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.365 -0.835 . . . . 0.0 110.124 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.68 -47.07 0.7 Allowed 'Trans proline' 0 C--N 1.315 -1.229 0 O-C-N 123.547 1.288 . . . . 0.0 109.906 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -102.83 51.56 0.8 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.585 -0.697 . . . . 0.0 109.59 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -85.35 112.34 43.25 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.524 -0.735 . . . . 0.0 110.228 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.17 140.78 34.78 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 O-C-N 123.679 1.357 . . . . 0.0 110.607 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.438 ' ND2' HG23 ' A' ' 51' ' ' VAL . 14.9 t30 -85.92 -164.74 1.08 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.302 -0.874 . . . . 0.0 109.956 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.3 -8.0 14.77 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.199 -0.938 . . . . 0.0 110.564 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -96.62 24.29 6.12 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.179 -0.951 . . . . 0.0 109.917 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.41 23.05 66.25 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.92 -152.44 0.47 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.205 -1.174 . . . . 0.0 110.159 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.52 ' HD2' ' NE2' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -130.22 -176.8 0.58 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.32 -0.862 . . . . 0.0 109.989 -179.466 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.509 ' HD2' ' CB ' ' A' ' 47' ' ' ARG . 43.2 Cg_endo -68.69 -25.84 33.65 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 O-C-N 123.36 1.19 . . . . 0.0 110.456 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.476 ' O ' ' HG2' ' A' ' 52' ' ' MET . 4.8 mt -108.93 -33.1 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.236 -0.915 . . . . 0.0 109.919 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.52 ' NE2' ' HD2' ' A' ' 47' ' ' ARG . 14.7 mt-30 -56.89 -17.62 10.18 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.31 -0.869 . . . . 0.0 110.188 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.438 HG23 ' ND2' ' A' ' 42' ' ' ASN . 8.5 p -113.52 35.09 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.329 -0.857 . . . . 0.0 110.922 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.543 ' CG ' ' HE2' ' A' ' 54' ' ' MET . 0.1 OUTLIER -100.33 37.57 1.65 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.017 -1.052 . . . . 0.0 110.567 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.413 ' CB ' ' O ' ' A' ' 52' ' ' MET . 20.4 ttp 65.3 -4.27 0.55 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.421 -0.799 . . . . 0.0 110.66 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.549 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 41.41 30.82 0.14 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.384 -0.823 . . . . 0.0 110.555 -179.681 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.438 ' C ' ' CE2' ' A' ' 90' ' ' PHE . . . -133.17 11.01 5.07 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.81 87.86 1.65 Allowed 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.443 -1.034 . . . . 0.0 109.687 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.54 -20.14 7.25 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.52 -0.737 . . . . 0.0 109.733 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.47 ' HB3' HG11 ' A' ' 25' ' ' VAL . 2.2 ttt180 -58.09 -29.71 65.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.464 -0.773 . . . . 0.0 109.671 179.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.485 HG23 ' CG2' ' A' ' 25' ' ' VAL . 2.8 t -76.64 -50.42 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.445 -0.785 . . . . 0.0 109.426 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 64' ' ' LEU . . . -49.1 -59.82 3.32 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.206 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.443 ' O ' ' CD2' ' A' ' 65' ' ' LEU . 3.4 tt0 -46.7 -52.19 14.42 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.488 -0.758 . . . . 0.0 109.544 178.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.575 ' O ' ' HB2' ' A' ' 66' ' ' HIS . 0.3 OUTLIER -45.74 -71.79 0.07 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.735 -0.603 . . . . 0.0 110.416 178.745 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.532 ' HA ' HD23 ' A' ' 32' ' ' LEU . 1.9 mt -65.31 -45.84 82.73 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.499 -0.751 . . . . 0.0 111.069 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.469 ' N ' HD11 ' A' ' 49' ' ' ILE . 0.5 OUTLIER -52.26 -70.24 0.09 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.184 -0.948 . . . . 0.0 110.641 -179.501 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.443 ' CD2' ' O ' ' A' ' 61' ' ' GLU . 2.1 pp -50.69 -25.81 4.75 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.402 -0.812 . . . . 0.0 109.88 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.575 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 3.3 m-70 -80.74 -48.8 12.0 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.604 -0.685 . . . . 0.0 109.929 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 159.46 32.34 0.02 OUTLIER Glycine 0 CA--C 1.54 1.604 0 C-N-CA 120.05 -1.072 . . . . 0.0 111.305 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.428 ' HB3' ' C ' ' A' ' 63' ' ' LEU . . . -70.37 178.4 2.91 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.436 -1.626 . . . . 0.0 109.602 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -107.78 78.9 0.78 Allowed Pre-proline 0 C--N 1.302 -1.459 0 O-C-N 121.32 -0.863 . . . . 0.0 110.23 179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 68' ' ' ALA . 50.3 Cg_endo -74.71 -0.85 10.35 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 O-C-N 123.682 1.359 . . . . 0.0 110.171 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.548 ' O ' ' NE ' ' A' ' 80' ' ' ARG . 1.7 m-20 -113.71 -70.58 0.8 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.194 -0.941 . . . . 0.0 110.014 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.422 ' C ' ' O ' ' A' ' 71' ' ' ASN . 49.3 t -40.04 147.85 0.09 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.375 -0.828 . . . . 0.0 110.893 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.419 ' HB3' ' HG2' ' A' ' 80' ' ' ARG . . . -133.25 -150.33 0.4 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.525 -0.735 . . . . 0.0 109.875 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 78' ' ' LEU . 1.0 OUTLIER -114.98 130.33 24.3 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.887 . . . . 0.0 109.893 -179.904 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.74 -13.08 38.49 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.344 1.181 . . . . 0.0 110.254 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.71 -55.81 30.07 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.322 -0.861 . . . . 0.0 109.171 178.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.517 HG22 ' CZ2' ' A' ' 110' ' ' TRP . 43.7 p -141.71 25.36 1.99 Allowed 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.567 0.699 . . . . 0.0 109.374 179.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.451 ' HB3' ' O ' ' A' ' 107' ' ' ARG . 2.9 mt 52.86 30.06 8.59 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.53 -0.731 . . . . 0.0 111.107 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.84 97.57 0.23 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.989 -1.069 . . . . 0.0 109.883 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.548 ' NE ' ' O ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -72.23 168.52 22.54 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.211 -0.931 . . . . 0.0 109.382 179.701 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.474 ' HA ' ' HG2' ' A' ' 50' ' ' GLN . 50.8 Cg_endo -73.7 -21.77 18.67 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.74 1.39 . . . . 0.0 109.867 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.456 HG21 ' HA ' ' A' ' 104' ' ' LEU . 56.3 t -59.57 -35.0 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.523 -0.736 . . . . 0.0 110.37 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.469 ' CE1' ' HB3' ' A' ' 114' ' ' PRO . 42.3 m80 -64.99 -31.59 72.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.441 -0.787 . . . . 0.0 110.009 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.549 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 0.7 OUTLIER -61.24 -52.08 66.27 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.528 -0.732 . . . . 0.0 110.652 -179.732 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.46 ' CB ' HD13 ' A' ' 94' ' ' LEU . . . -57.8 -61.3 2.62 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.807 -1.183 . . . . 0.0 109.745 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.518 ' HA ' ' CG1' ' A' ' 126' ' ' VAL . . . -57.14 -55.93 28.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.525 -0.734 . . . . 0.0 111.594 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.467 ' CB ' ' O ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -44.67 -28.72 0.64 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.216 -0.927 . . . . 0.0 111.529 -178.863 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.37 -8.13 23.65 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.019 -1.051 . . . . 0.0 110.807 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.08 36.01 36.81 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.438 ' CE2' ' C ' ' A' ' 55' ' ' GLY . 0.9 OUTLIER -108.2 90.86 3.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.389 -1.066 . . . . 0.0 110.525 179.903 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.545 ' CD2' ' HA ' ' A' ' 126' ' ' VAL . 0.1 OUTLIER -64.69 -36.6 84.79 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.446 -0.784 . . . . 0.0 110.384 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.406 ' HB3' ' CE1' ' A' ' 90' ' ' PHE . 40.0 t0 -53.6 -26.31 21.31 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.165 -0.959 . . . . 0.0 109.371 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 26.6 m -78.25 -46.72 19.59 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.623 -0.673 . . . . 0.0 109.873 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.46 HD13 ' CB ' ' A' ' 85' ' ' ALA . 1.1 tp -54.36 -36.98 64.42 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.216 -0.928 . . . . 0.0 109.695 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.438 ' O ' ' HG3' ' A' ' 99' ' ' ARG . 27.0 t -65.54 -47.55 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.474 -0.766 . . . . 0.0 109.425 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.446 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 84.3 t -56.12 -53.17 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.217 -0.927 . . . . 0.0 110.094 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.0 mp -52.8 -51.83 59.23 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.182 -0.949 . . . . 0.0 109.719 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -54.6 -38.22 66.51 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.618 -0.676 . . . . 0.0 109.421 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' A' ' 96' ' ' VAL . 66.9 mtp180 -66.78 -13.65 61.71 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.707 -0.621 . . . . 0.0 110.141 179.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.443 ' HB3' HD11 ' A' ' 64' ' ' LEU . . . -117.32 38.72 3.48 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.387 -0.82 . . . . 0.0 110.534 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 45.8 47.33 13.76 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.4 ' O ' HD12 ' A' ' 104' ' ' LEU . . . -89.13 110.68 21.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.346 -1.091 . . . . 0.0 110.197 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.518 ' N ' ' OD1' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -49.68 138.73 13.82 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.586 -0.697 . . . . 0.0 110.491 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.456 ' HA ' HG21 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -128.3 22.87 6.03 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.427 -0.796 . . . . 0.0 110.055 179.623 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -125.52 47.3 2.22 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.021 -1.049 . . . . 0.0 110.911 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.51 HG13 ' CD ' ' A' ' 80' ' ' ARG . 3.4 p -108.7 -172.4 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.318 -0.864 . . . . 0.0 110.347 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.451 ' O ' ' HB3' ' A' ' 78' ' ' LEU . 2.6 mtm180 -132.42 158.92 40.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.454 -0.779 . . . . 0.0 109.941 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.606 ' O ' ' N ' ' A' ' 110' ' ' TRP . 52.1 p30 -93.73 50.51 1.46 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.382 -0.824 . . . . 0.0 110.242 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.457 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 59.06 -66.63 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.806 -0.559 . . . . 0.0 110.353 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.606 ' N ' ' O ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -45.79 -62.37 1.33 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.488 -0.758 . . . . 0.0 110.263 179.815 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 164.77 -45.14 0.3 Allowed Glycine 0 N--CA 1.483 1.782 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 57.1 mtt180 -50.59 156.25 0.95 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.424 -1.045 . . . . 0.0 111.144 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.551 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 56.7 mt -110.1 170.42 5.34 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.544 -0.722 . . . . 0.0 109.717 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.551 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 40.9 Cg_endo -66.84 -21.01 51.29 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.707 1.372 . . . . 0.0 109.896 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.442 ' CG1' ' N ' ' A' ' 116' ' ' ASP . 4.8 p -85.35 -40.7 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.287 -0.883 . . . . 0.0 110.421 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.442 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 1.0 OUTLIER -59.98 -32.28 70.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.044 -1.035 . . . . 0.0 109.871 179.94 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.4 mt -70.54 -45.4 65.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.498 -0.751 . . . . 0.0 110.049 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.502 ' HA ' ' HB2' ' A' ' 123' ' ' HIS . . . -55.33 -51.28 67.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.367 -0.833 . . . . 0.0 110.066 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -68.71 -25.0 64.55 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.614 -0.678 . . . . 0.0 110.484 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.45 -62.9 1.47 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.439 -0.788 . . . . 0.0 110.643 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.12 -87.34 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.028 -1.045 . . . . 0.0 110.703 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -169.52 35.86 0.19 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.502 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 7.5 m-70 -113.65 43.56 1.77 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.561 -0.964 . . . . 0.0 109.272 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -43.52 -55.99 3.91 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.782 -0.574 . . . . 0.0 110.073 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 125' ' ' ASP . 13.4 p-10 -49.25 -34.33 14.9 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.436 0.636 . . . . 0.0 109.636 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.545 ' HA ' ' CD2' ' A' ' 91' ' ' LEU . 1.3 t -84.43 -31.08 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.414 ' N ' ' HB2' ' A' ' 118' ' ' ALA . . . -68.28 -35.74 78.33 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.436 -0.79 . . . . 0.0 109.364 179.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 26.7 ttt180 -72.42 -63.55 1.13 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.275 -0.891 . . . . 0.0 109.556 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -50.71 -28.86 9.9 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.372 -0.83 . . . . 0.0 109.812 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.448 HD22 ' CD2' ' A' ' 104' ' ' LEU . 6.7 mt -65.36 -62.08 1.74 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.406 -0.809 . . . . 0.0 109.465 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -51.96 -16.84 0.81 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.54 -0.725 . . . . 0.0 111.002 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -78.94 -53.2 7.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.969 -1.082 . . . . 0.0 109.693 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -87.33 -20.29 26.99 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.413 -0.804 . . . . 0.0 109.631 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.413 ' CB ' ' O ' ' A' ' 104' ' ' LEU . . . -86.41 15.18 5.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.31 -0.869 . . . . 0.0 110.653 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 173.41 -52.44 0.16 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 89.39 -50.23 3.55 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.8 p -44.93 138.38 3.62 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.554 -0.968 . . . . 0.0 111.091 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -159.18 -64.51 0.08 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.445 -0.785 . . . . 0.0 110.33 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -159.46 -154.41 7.25 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.0 p 55.64 170.43 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.492 -1.005 . . . . 0.0 110.307 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -64.79 -65.05 0.72 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.264 -0.897 . . . . 0.0 109.718 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 51.35 23.63 1.81 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.448 -0.782 . . . . 0.0 110.725 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . 57.99 34.09 23.89 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.279 -0.888 . . . . 0.0 110.513 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.405 ' HG3' ' N ' ' A' ' 145' ' ' ILE . 0.0 OUTLIER -54.77 152.32 7.31 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.257 -0.902 . . . . 0.0 110.374 179.753 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.405 ' N ' ' HG3' ' A' ' 144' ' ' ARG . 36.8 mm -81.09 153.87 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.204 -0.935 . . . . 0.0 109.93 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 177.96 62.13 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.486 -0.759 . . . . 0.0 110.103 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.68 148.76 50.9 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.289 -0.882 . . . . 0.0 109.706 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.457 ' O ' ' N ' ' A' ' 150' ' ' GLY . . . -59.11 119.52 7.47 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.192 -0.942 . . . . 0.0 110.652 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 45.96 -92.63 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.523 -0.736 . . . . 0.0 110.561 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 148' ' ' ALA . . . 178.42 -133.65 2.19 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.6 160.96 45.32 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.663 1.349 . . . . 0.0 110.524 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 39.3 m -122.66 -43.01 2.29 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.47 -0.769 . . . . 0.0 109.991 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 8.5 t0 53.77 102.72 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.461 -0.775 . . . . 0.0 110.554 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.422 ' O ' HG23 ' A' ' 154' ' ' ILE . 5.1 tt -146.95 86.78 6.45 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.239 -0.913 . . . . 0.0 111.073 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -75.95 115.28 4.12 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 O-C-N 123.622 1.327 . . . . 0.0 109.763 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.233 -179.711 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.135 0.493 . . . . 0.0 109.894 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.449 ' CG ' ' O ' ' A' ' 2' ' ' GLU . 21.5 pt-20 -77.38 118.13 69.98 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.306 -0.871 . . . . 0.0 110.652 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -76.89 110.03 2.96 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.389 1.205 . . . . 0.0 109.894 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -101.38 122.57 43.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.305 -0.872 . . . . 0.0 110.183 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 60.36 -159.79 0.3 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.393 -0.817 . . . . 0.0 110.104 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -125.19 26.85 5.46 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 74.8 m 48.89 84.24 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.301 -1.117 . . . . 0.0 110.101 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -48.94 119.74 3.41 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.553 -0.717 . . . . 0.0 110.655 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -154.76 138.46 16.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.403 -0.811 . . . . 0.0 109.992 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 57.4 91.05 0.08 OUTLIER Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.421 -0.8 . . . . 0.0 110.228 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -76.78 136.73 17.19 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.803 1.423 . . . . 0.0 110.582 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.8 p -71.37 -143.29 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.461 -0.774 . . . . 0.0 109.841 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -44.88 122.85 3.44 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.059 -1.026 . . . . 0.0 110.844 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.404 ' O ' ' OG1' ' A' ' 18' ' ' THR . 3.3 t0 -166.03 -48.57 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.16 -0.963 . . . . 0.0 110.544 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.491 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 42.0 m0 -67.54 -5.19 14.13 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.398 -0.814 . . . . 0.0 110.972 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.439 ' HG ' ' N ' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -77.99 -55.55 5.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.922 -1.111 . . . . 0.0 109.867 179.901 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.439 ' N ' ' HG ' ' A' ' 16' ' ' LEU . . . -70.55 -43.3 69.8 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.274 -0.891 . . . . 0.0 110.31 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.491 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.8 OUTLIER -52.25 -55.53 20.68 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.422 -0.799 . . . . 0.0 110.709 -179.888 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.02 -41.0 70.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.323 -0.861 . . . . 0.0 109.895 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.63 -49.68 64.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.482 -0.761 . . . . 0.0 109.793 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.436 ' CB ' ' O ' ' A' ' 51' ' ' VAL . . . -69.24 -34.1 74.29 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.429 -0.794 . . . . 0.0 110.198 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.38 27.67 1.89 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.393 -0.817 . . . . 0.0 110.927 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 44.71 57.06 5.43 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -115.56 56.05 0.77 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.345 -1.091 . . . . 0.0 109.894 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.434 ' CG2' ' CG2' ' A' ' 59' ' ' VAL . 25.5 t -45.37 -55.01 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.583 -0.698 . . . . 0.0 110.844 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -54.23 -40.62 67.85 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.401 -0.812 . . . . 0.0 110.315 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' A' ' 31' ' ' LEU . 0.5 OUTLIER -63.95 -35.43 80.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.431 -0.793 . . . . 0.0 109.753 179.851 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.497 HG13 ' CD1' ' A' ' 32' ' ' LEU . 11.7 t -77.27 -47.69 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.345 -0.847 . . . . 0.0 111.077 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.515 ' HA ' ' CD1' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -49.27 -45.26 44.68 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.124 -0.985 . . . . 0.0 110.255 -179.493 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.05 -42.29 48.11 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.431 -0.793 . . . . 0.0 109.542 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.435 HD11 ' HB3' ' A' ' 15' ' ' TRP . 6.4 mt -60.55 -58.67 7.5 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.475 -0.766 . . . . 0.0 110.178 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.514 ' HA ' ' CB ' ' A' ' 36' ' ' ALA . 7.6 mt -51.15 -42.53 60.85 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.363 -0.835 . . . . 0.0 109.561 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -76.14 -9.43 58.62 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.625 -0.672 . . . . 0.0 110.571 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -93.9 -13.58 26.99 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.144 -0.972 . . . . 0.0 111.081 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 137.74 -0.79 2.79 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.581 -1.295 . . . . 0.0 110.909 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.514 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . . . -46.41 151.31 0.55 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.017 -1.284 . . . . 0.0 110.174 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.401 HD22 ' CB ' ' A' ' 40' ' ' ALA . 12.6 tp -90.48 139.25 26.62 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.163 -0.961 . . . . 0.0 110.302 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.432 ' HB2' ' O ' ' A' ' 67' ' ' GLY . 43.6 Cg_endo -72.61 -39.14 2.79 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 O-C-N 123.647 1.341 . . . . 0.0 110.753 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -115.62 60.4 0.71 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.039 -1.038 . . . . 0.0 110.167 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.401 ' CB ' HD22 ' A' ' 37' ' ' LEU . . . -93.11 105.5 15.55 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.454 -0.779 . . . . 0.0 109.722 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.64 102.65 0.75 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.565 1.297 . . . . 0.0 110.188 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -89.4 172.71 8.81 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.499 -0.75 . . . . 0.0 109.973 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' A' ' 44' ' ' TYR . 0.1 OUTLIER -63.2 -157.78 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.32 -0.863 . . . . 0.0 110.407 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.448 ' HB2' ' O ' ' A' ' 43' ' ' SER . 14.0 m-85 64.71 11.01 6.46 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.589 -0.694 . . . . 0.0 111.037 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 59.54 47.02 92.95 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -160.72 -171.3 3.06 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.482 -1.011 . . . . 0.0 110.743 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.625 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 2.1 mmt180 -124.4 -155.04 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.647 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.625 ' CD ' ' CB ' ' A' ' 47' ' ' ARG . 47.9 Cg_endo -75.72 166.64 27.93 Favored 'Trans proline' 0 N--CA 1.484 0.965 0 O-C-N 122.501 0.738 . . . . 0.0 110.727 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.478 ' HB ' ' O ' ' A' ' 48' ' ' PRO . 5.0 mt 65.97 -53.83 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.756 -0.59 . . . . 0.0 110.862 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.517 ' CG ' ' HB3' ' A' ' 81' ' ' PRO . 73.9 mt-30 -50.38 -29.17 9.45 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.772 -1.205 . . . . 0.0 110.187 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.436 ' O ' ' CB ' ' A' ' 21' ' ' ALA . 10.6 p -99.09 7.31 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.537 -0.727 . . . . 0.0 109.71 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.484 ' SD ' ' HB ' ' A' ' 59' ' ' VAL . 44.4 ttp -66.56 161.62 22.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.557 -0.714 . . . . 0.0 110.127 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 48.7 ttp -70.28 -4.34 21.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.259 -0.9 . . . . 0.0 110.213 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.467 ' CE ' ' CE ' ' A' ' 52' ' ' MET . 0.0 OUTLIER 53.96 23.79 4.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.003 -1.061 . . . . 0.0 110.069 -179.797 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.54 ' HA2' ' CE1' ' A' ' 90' ' ' PHE . . . -123.95 -5.63 7.41 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.48 90.4 2.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.334 -1.098 . . . . 0.0 110.129 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.43 ' CB ' ' HB3' ' A' ' 92' ' ' ASP . . . -53.48 -24.83 14.09 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.087 -1.008 . . . . 0.0 109.872 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.9 -48.37 64.17 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.549 -0.72 . . . . 0.0 110.442 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.484 ' HB ' ' SD ' ' A' ' 52' ' ' MET . 32.1 t -59.36 -57.74 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.189 -0.944 . . . . 0.0 109.694 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -46.46 -59.71 2.8 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.429 -0.794 . . . . 0.0 110.091 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.448 ' O ' ' HB3' ' A' ' 65' ' ' LEU . 17.1 tt0 -46.68 -43.47 17.8 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.382 -0.824 . . . . 0.0 109.208 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.515 ' CD1' ' HA ' ' A' ' 29' ' ' ARG . 0.3 OUTLIER -57.65 -64.74 0.79 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.284 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.47 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 2.6 mt -56.46 -48.94 76.01 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.441 ' HB2' ' O ' ' A' ' 60' ' ' ALA . 0.3 OUTLIER -56.39 -56.67 18.2 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.469 -0.77 . . . . 0.0 109.659 179.323 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.448 ' HB3' ' O ' ' A' ' 61' ' ' GLU . 9.5 tp -53.06 -30.35 35.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.311 -0.868 . . . . 0.0 109.185 179.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.476 ' CE1' ' HB3' ' A' ' 32' ' ' LEU . 1.5 m-70 -86.2 -21.3 27.54 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.716 -0.615 . . . . 0.0 109.652 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 38' ' ' PRO . . . 110.49 48.81 0.73 Allowed Glycine 0 N--CA 1.482 1.72 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 178.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.47 ' CB ' ' HB3' ' A' ' 63' ' ' LEU . . . -64.5 -150.85 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.885 -1.362 . . . . 0.0 109.402 179.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.459 ' HG3' ' HD2' ' A' ' 48' ' ' PRO . 1.7 mm-40 -119.61 53.37 2.41 Favored Pre-proline 0 C--N 1.301 -1.508 0 O-C-N 121.357 -0.84 . . . . 0.0 109.58 178.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.437 ' HG3' ' HG ' ' A' ' 64' ' ' LEU . 47.3 Cg_endo -70.4 -16.33 34.85 Favored 'Trans proline' 0 C--N 1.317 -1.082 0 O-C-N 123.755 1.397 . . . . 0.0 109.99 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -95.41 -57.27 2.45 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.516 -0.74 . . . . 0.0 110.002 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.51 178.15 0.16 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.442 -0.786 . . . . 0.0 110.215 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -150.7 -152.61 0.44 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.512 -0.742 . . . . 0.0 109.914 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.421 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 39.1 m-20 -116.78 130.44 24.56 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.341 -0.849 . . . . 0.0 109.263 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.474 ' O ' ' CB ' ' A' ' 76' ' ' ALA . 42.0 Cg_endo -69.74 -177.2 1.76 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.426 1.224 . . . . 0.0 110.322 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.474 ' CB ' ' O ' ' A' ' 75' ' ' PRO . . . 71.42 -58.59 0.57 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.475 -0.766 . . . . 0.0 109.802 -178.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.534 ' CG2' ' CZ3' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -115.57 0.45 13.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.16 -0.962 . . . . 0.0 110.621 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.49 ' HB3' ' O ' ' A' ' 107' ' ' ARG . 1.2 mt 48.62 53.37 12.31 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.222 -0.924 . . . . 0.0 111.41 179.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 60.2 m -88.42 98.51 11.66 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.086 -1.009 . . . . 0.0 110.474 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.545 ' CG ' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -74.18 165.77 50.53 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.326 -0.859 . . . . 0.0 109.392 179.368 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.545 ' HD2' ' CG ' ' A' ' 80' ' ' ARG . 45.4 Cg_endo -79.14 -0.71 10.98 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 O-C-N 123.308 1.162 . . . . 0.0 110.339 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.418 ' CG2' ' O ' ' A' ' 103' ' ' ARG . 22.1 t -76.93 -31.55 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.558 -0.714 . . . . 0.0 109.391 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.476 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 5.7 m80 -70.65 -36.69 73.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.519 -0.738 . . . . 0.0 109.44 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.513 ' O ' ' HB3' ' A' ' 87' ' ' ARG . 67.8 m-20 -54.0 -50.24 67.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.68 -0.637 . . . . 0.0 109.688 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.457 ' CB ' HD13 ' A' ' 94' ' ' LEU . . . -55.81 -67.91 0.25 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.142 -0.974 . . . . 0.0 109.356 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.564 ' O ' ' CD2' ' A' ' 123' ' ' HIS . . . -52.92 -38.64 62.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.287 -0.883 . . . . 0.0 110.892 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.513 ' HB3' ' O ' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -44.9 -47.16 11.2 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.51 -0.744 . . . . 0.0 110.894 -179.307 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -97.12 8.38 44.63 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.209 -0.932 . . . . 0.0 110.156 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.421 ' HA3' ' ND1' ' A' ' 123' ' ' HIS . . . 70.87 40.85 63.44 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.154 -1.579 . . . . 0.0 109.154 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.54 ' CE1' ' HA2' ' A' ' 55' ' ' GLY . 1.9 t80 -106.88 116.41 31.88 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.315 -1.109 . . . . 0.0 110.673 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.416 HD11 ' O ' ' A' ' 125' ' ' ASP . 0.4 OUTLIER -94.77 -42.67 8.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.633 -0.667 . . . . 0.0 110.844 -179.487 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.43 ' HB3' ' CB ' ' A' ' 57' ' ' ALA . 92.1 m-20 -43.64 -44.46 6.36 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.383 -0.823 . . . . 0.0 109.734 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.4 m -66.41 -49.06 68.07 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.513 ' CD2' ' HG ' ' A' ' 130' ' ' LEU . 4.2 tp -53.38 -39.93 64.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.583 -0.698 . . . . 0.0 109.529 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 84.4 t -62.59 -53.16 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.375 -0.828 . . . . 0.0 108.964 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.406 HG11 ' HG3' ' A' ' 61' ' ' GLU . 63.7 t -50.23 -47.97 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.512 -0.742 . . . . 0.0 109.653 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.402 ' HA ' HD13 ' A' ' 64' ' ' LEU . 1.2 mp -56.9 -45.27 82.73 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.619 -0.676 . . . . 0.0 109.679 179.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -75.79 -29.36 58.71 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.368 -0.833 . . . . 0.0 109.874 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.72 -13.14 61.86 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.374 -0.829 . . . . 0.0 110.735 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.413 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -118.98 -93.24 0.52 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.315 -0.866 . . . . 0.0 110.792 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -156.71 45.21 0.51 Allowed Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.512 -1.328 . . . . 0.0 110.298 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -78.03 -171.4 2.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.09 -1.241 . . . . 0.0 109.692 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.427 ' C ' ' HG ' ' A' ' 104' ' ' LEU . 15.8 tpt180 -123.44 137.98 54.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.181 -0.949 . . . . 0.0 109.947 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.512 ' O ' ' HA ' ' A' ' 134' ' ' ALA . 14.0 mt -135.63 64.91 1.56 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.283 -0.885 . . . . 0.0 110.204 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -174.68 38.77 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.874 -1.142 . . . . 0.0 110.159 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.43 HG11 ' HD3' ' A' ' 80' ' ' ARG . 12.6 p -110.19 173.92 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.348 -0.845 . . . . 0.0 110.433 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.49 ' O ' ' HB3' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -127.91 138.66 52.74 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.145 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 110' ' ' TRP . 28.0 p-10 -68.73 61.88 0.1 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.353 -0.842 . . . . 0.0 111.121 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.441 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 59.88 -74.36 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.557 -0.714 . . . . 0.0 110.877 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.534 ' CZ3' ' CG2' ' A' ' 77' ' ' THR . 4.7 m-90 -47.88 -85.09 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.415 -0.803 . . . . 0.0 111.072 -179.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -178.74 57.28 0.09 OUTLIER Glycine 0 N--CA 1.482 1.717 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.2 -164.8 1.48 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.218 -1.166 . . . . 0.0 110.143 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.415 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER -155.39 165.46 18.29 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.509 -0.744 . . . . 0.0 109.825 -179.812 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.415 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 41.8 Cg_endo -69.02 -30.12 26.27 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.452 1.238 . . . . 0.0 109.982 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.432 ' HB ' ' HB3' ' A' ' 130' ' ' LEU . 10.9 p -82.63 -37.63 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.343 -0.848 . . . . 0.0 109.769 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -54.19 -38.44 65.61 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.431 -0.793 . . . . 0.0 109.985 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.22 -54.07 16.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.505 -0.747 . . . . 0.0 110.038 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -46.02 -56.03 6.08 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.454 -0.779 . . . . 0.0 110.785 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -58.88 -28.46 66.17 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.296 -0.878 . . . . 0.0 109.927 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -75.32 -49.73 18.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.432 -0.792 . . . . 0.0 109.84 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.7 mt -73.77 -91.36 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.329 -0.857 . . . . 0.0 109.95 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -173.91 31.02 0.1 OUTLIER Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.684 -1.246 . . . . 0.0 110.106 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.564 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 50.4 m-70 -102.59 44.2 1.03 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.267 -1.137 . . . . 0.0 109.349 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.7 mtm180 -46.07 -40.26 10.53 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.737 -0.602 . . . . 0.0 109.967 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.416 ' O ' HD11 ' A' ' 91' ' ' LEU . 10.0 m-20 -55.82 -45.65 78.27 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.501 HG11 ' CD2' ' A' ' 94' ' ' LEU . 16.8 t -78.05 -40.45 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 119.666 -0.814 . . . . 0.0 109.087 178.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -57.57 -58.31 8.86 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.593 -0.692 . . . . 0.0 109.677 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.414 ' NH1' ' HG3' ' A' ' 128' ' ' ARG . 38.1 ttm-85 -45.2 -59.79 2.45 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.69 -0.631 . . . . 0.0 109.92 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.451 ' CD1' ' C ' ' A' ' 129' ' ' TYR . 5.7 t80 -57.53 -45.76 84.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.582 -0.699 . . . . 0.0 109.214 178.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.513 ' HG ' ' CD2' ' A' ' 94' ' ' LEU . 7.2 mt -54.86 -41.47 70.83 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.561 -0.712 . . . . 0.0 110.952 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 39.7 ttp85 -62.52 -40.2 96.0 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.253 -0.905 . . . . 0.0 110.202 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -81.04 -30.12 34.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.264 -0.898 . . . . 0.0 110.304 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -89.58 -18.02 27.39 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.214 -0.929 . . . . 0.0 110.164 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.512 ' HA ' ' O ' ' A' ' 104' ' ' LEU . . . -124.78 -45.0 1.92 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.18 -0.95 . . . . 0.0 110.586 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.85 -144.53 31.36 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 120.08 34.54 0.95 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 14.8 p -80.01 127.55 32.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.278 -1.131 . . . . 0.0 110.075 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.452 ' HB2' ' CB ' ' A' ' 143' ' ' ALA . 4.2 mpt_? -71.72 93.98 1.33 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.351 -0.843 . . . . 0.0 110.118 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -80.42 3.78 71.4 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.4 p -148.1 60.33 1.11 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.981 -1.305 . . . . 0.0 110.708 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -174.38 55.15 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.144 -0.972 . . . . 0.0 111.039 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 41.32 55.85 3.27 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.412 -0.805 . . . . 0.0 110.755 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.452 ' CB ' ' HB2' ' A' ' 138' ' ' ARG . . . -123.93 -63.58 1.2 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.309 -0.87 . . . . 0.0 110.208 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.69 153.22 19.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.462 -0.774 . . . . 0.0 109.713 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.6 tt -50.09 129.48 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.29 -0.881 . . . . 0.0 110.135 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -46.51 98.96 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.477 -0.764 . . . . 0.0 110.633 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -53.57 133.52 41.23 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.276 -0.89 . . . . 0.0 110.352 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -75.72 146.11 40.38 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.48 -0.762 . . . . 0.0 110.108 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -123.57 -73.69 0.64 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.323 -0.86 . . . . 0.0 110.166 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 127.26 175.63 14.17 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -76.35 121.74 6.22 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.593 1.312 . . . . 0.0 110.708 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 4.9 t -85.7 122.22 29.48 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.323 -0.861 . . . . 0.0 109.474 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.33 138.27 10.14 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.45 -0.781 . . . . 0.0 110.728 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 3.6 tp -128.31 95.16 34.07 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.518 -0.739 . . . . 0.0 110.363 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.34 138.82 33.71 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 123.688 1.362 . . . . 0.0 110.317 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.496 1.841 0 CA-C-O 117.932 -1.032 . . . . 0.0 110.161 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 mtm . . . . . 0 N--CA 1.497 1.914 0 CA-C-O 121.269 0.557 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -161.6 102.16 1.2 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.551 -0.718 . . . . 0.0 109.99 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -79.85 -163.68 0.24 Allowed 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.649 1.341 . . . . 0.0 110.264 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -128.24 93.95 3.78 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.557 -0.714 . . . . 0.0 110.404 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -174.19 50.08 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.239 -0.913 . . . . 0.0 109.741 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 84.51 139.81 4.52 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.0 t 174.07 125.71 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.437 -1.037 . . . . 0.0 110.231 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.3 p -53.64 169.94 0.13 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.266 -0.896 . . . . 0.0 110.537 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 2.6 mtp 174.45 48.5 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.442 -0.786 . . . . 0.0 110.022 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -101.69 99.64 12.26 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.231 -0.918 . . . . 0.0 110.161 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -70.75 110.09 2.67 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.63 1.332 . . . . 0.0 109.82 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.6 p -62.02 119.23 8.49 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.324 -0.86 . . . . 0.0 110.038 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -117.06 -118.53 0.32 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.426 -0.796 . . . . 0.0 110.262 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.9 t70 62.77 5.26 1.69 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.86 -1.15 . . . . 0.0 111.044 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.495 ' CB ' HD21 ' A' ' 31' ' ' LEU . 49.1 m0 -68.19 -12.66 61.33 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.176 -0.952 . . . . 0.0 110.68 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.515 ' CD1' HD21 ' A' ' 63' ' ' LEU . 35.6 mt -76.13 -60.78 2.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.166 -0.959 . . . . 0.0 109.477 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.431 ' HA ' ' HB3' ' A' ' 20' ' ' ALA . . . -57.55 -48.2 79.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.519 -0.738 . . . . 0.0 109.861 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.468 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.6 OUTLIER -44.44 -55.27 5.17 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.444 -0.785 . . . . 0.0 110.536 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.462 ' HB1' HG21 ' A' ' 28' ' ' VAL . . . -71.8 -32.4 67.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.145 -0.972 . . . . 0.0 109.942 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.474 ' CB ' HG13 ' A' ' 59' ' ' VAL . . . -67.73 -45.88 73.76 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.208 -0.933 . . . . 0.0 109.962 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.14 -25.67 68.46 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.48 -0.762 . . . . 0.0 109.616 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -104.83 25.93 9.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.453 -0.78 . . . . 0.0 110.306 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.408 ' HA3' ' HE2' ' A' ' 53' ' ' MET . . . 48.4 66.79 1.9 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.3 54.61 1.94 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.44 -1.035 . . . . 0.0 109.409 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.504 HG21 ' CG2' ' A' ' 59' ' ' VAL . 45.1 t -46.1 -56.93 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.535 -0.728 . . . . 0.0 110.869 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -40.78 -50.91 3.15 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.724 -0.61 . . . . 0.0 110.954 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.448 ' OE1' ' CD1' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -58.77 -41.28 86.24 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.194 -0.942 . . . . 0.0 109.622 179.592 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.462 HG21 ' HB1' ' A' ' 19' ' ' ALA . 13.6 t -69.81 -49.78 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.503 -0.748 . . . . 0.0 110.289 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.565 ' HA ' ' CD1' ' A' ' 62' ' ' LEU . 4.4 mmt180 -41.65 -52.3 3.85 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.514 -0.741 . . . . 0.0 110.122 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.462 ' O ' ' HB1' ' A' ' 34' ' ' ALA . . . -74.41 -53.35 9.75 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.809 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.495 HD21 ' CB ' ' A' ' 15' ' ' TRP . 4.7 mt -47.73 -62.74 1.31 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.431 -0.793 . . . . 0.0 110.998 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.589 ' HB3' HD21 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -44.1 -57.5 3.36 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.571 -0.706 . . . . 0.0 110.379 179.89 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -66.27 -10.88 46.65 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.667 -0.646 . . . . 0.0 110.526 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.462 ' HB1' ' O ' ' A' ' 30' ' ' ALA . . . -86.8 -11.86 49.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.067 -1.02 . . . . 0.0 110.239 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 130.19 -6.45 6.02 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.907 -1.139 . . . . 0.0 110.999 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.456 ' CB ' ' CD2' ' A' ' 16' ' ' LEU . . . -42.78 155.9 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.19 -1.183 . . . . 0.0 110.636 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.501 ' HB3' ' CB ' ' A' ' 40' ' ' ALA . 3.2 tp -80.91 131.03 61.21 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.228 -0.92 . . . . 0.0 110.858 -178.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.416 ' O ' ' HA ' ' A' ' 68' ' ' ALA . 49.0 Cg_endo -74.4 -15.64 22.24 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.841 1.443 . . . . 0.0 110.8 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.415 ' ND2' ' HG2' ' A' ' 69' ' ' GLU . 0.5 OUTLIER -128.38 25.72 5.76 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.101 -0.999 . . . . 0.0 110.475 -179.636 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.501 ' CB ' ' HB3' ' A' ' 37' ' ' LEU . . . -66.46 123.92 86.85 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.254 -0.904 . . . . 0.0 109.873 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -76.75 149.19 29.54 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.673 1.354 . . . . 0.0 110.319 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -81.16 -163.27 0.58 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.544 -0.723 . . . . 0.0 109.922 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.407 ' C ' ' CD1' ' A' ' 44' ' ' TYR . 0.1 OUTLIER -99.12 6.17 46.59 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.883 -1.136 . . . . 0.0 110.571 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.407 ' CD1' ' C ' ' A' ' 43' ' ' SER . 2.4 m-85 -119.01 36.37 4.48 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.28 -0.887 . . . . 0.0 109.434 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.41 28.33 35.66 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.74 -157.46 0.61 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.55 -0.97 . . . . 0.0 110.822 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.553 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 0.3 OUTLIER -121.2 -173.14 0.25 Allowed Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.33 -0.856 . . . . 0.0 110.638 -178.604 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.553 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 42.2 Cg_endo -77.99 -26.52 6.52 Favored 'Trans proline' 0 C--N 1.32 -0.958 0 O-C-N 123.467 1.246 . . . . 0.0 111.438 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 12.0 mt -109.71 -37.65 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 120.768 -1.207 . . . . 0.0 109.389 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 81' ' ' PRO . 2.5 tt0 -53.8 -16.67 1.85 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.691 -0.63 . . . . 0.0 110.686 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.48 ' O ' HG21 ' A' ' 51' ' ' VAL . 7.4 p -114.35 6.78 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.023 -1.048 . . . . 0.0 111.225 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.462 ' CG ' ' HE1' ' A' ' 54' ' ' MET . 0.0 OUTLIER -67.92 168.54 11.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.774 -1.204 . . . . 0.0 109.495 179.825 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.436 ' SD ' ' HA3' ' A' ' 55' ' ' GLY . 3.1 tmm? -67.8 -1.92 6.28 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.21 -0.931 . . . . 0.0 111.301 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.493 ' HE3' ' CB ' ' A' ' 84' ' ' ASP . 12.9 mmt 48.56 23.04 0.56 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.259 -0.901 . . . . 0.0 110.361 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.436 ' HA3' ' SD ' ' A' ' 53' ' ' MET . . . -120.46 3.19 12.39 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.279 -1.928 . . . . 0.0 108.279 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.41 74.07 1.45 Allowed 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.75 -0.853 . . . . 0.0 108.88 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.46 ' HB2' ' HB2' ' A' ' 92' ' ' ASP . . . -43.71 -27.57 0.33 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.421 -0.8 . . . . 0.0 110.151 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.37 -49.33 44.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.541 -0.724 . . . . 0.0 109.639 178.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.504 ' CG2' HG21 ' A' ' 25' ' ' VAL . 63.5 t -48.72 -59.87 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.659 -0.65 . . . . 0.0 109.945 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.474 ' O ' ' CB ' ' A' ' 64' ' ' LEU . . . -45.45 -46.23 13.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.676 -0.64 . . . . 0.0 109.794 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.553 ' O ' ' HB3' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -51.19 -59.66 3.95 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.657 -0.652 . . . . 0.0 109.516 178.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.589 HD21 ' HB3' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -46.52 -72.27 0.06 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.609 -0.682 . . . . 0.0 110.373 179.114 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.575 ' HB3' ' HB1' ' A' ' 68' ' ' ALA . 4.0 mt -51.22 -50.08 59.83 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.393 -0.817 . . . . 0.0 110.616 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.544 HD12 ' CG1' ' A' ' 96' ' ' VAL . 0.9 OUTLIER -59.11 -59.14 5.94 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.489 -0.757 . . . . 0.0 110.744 -179.628 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.553 ' HB3' ' O ' ' A' ' 61' ' ' GLU . 0.8 OUTLIER -48.76 -34.58 12.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.318 -0.864 . . . . 0.0 108.736 179.755 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.444 ' ND1' ' CD1' ' A' ' 32' ' ' LEU . 0.3 OUTLIER -82.11 -30.59 31.12 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.282 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 63' ' ' LEU . . . 124.0 52.76 0.19 Allowed Glycine 0 N--CA 1.479 1.561 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.575 ' HB1' ' HB3' ' A' ' 63' ' ' LEU . . . -62.19 -154.24 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.08 -1.247 . . . . 0.0 109.529 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.467 ' HB2' ' HB3' ' A' ' 47' ' ' ARG . 4.8 mt-10 -121.31 55.9 5.49 Favored Pre-proline 0 C--N 1.302 -1.499 0 O-C-N 121.33 -0.857 . . . . 0.0 109.448 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 69' ' ' GLU . 40.6 Cg_endo -66.28 -10.46 27.55 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.847 1.446 . . . . 0.0 110.351 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.489 ' OD1' ' HA ' ' A' ' 102' ' ' ALA . 72.2 m-20 -99.06 -72.87 0.64 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.193 -0.942 . . . . 0.0 110.146 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -42.89 161.8 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.663 -0.648 . . . . 0.0 110.953 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.468 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -148.2 -149.27 0.29 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.383 -0.823 . . . . 0.0 110.184 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.535 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -105.06 135.21 19.33 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 120.956 -1.09 . . . . 0.0 110.269 -179.724 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.28 -22.04 22.5 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 N-CA-C 109.239 -1.1 . . . . 0.0 109.239 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.73 -67.77 0.26 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.588 -0.695 . . . . 0.0 109.677 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.483 ' HA ' ' CB ' ' A' ' 109' ' ' ALA . 14.6 p -124.82 27.47 6.79 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.391 -0.818 . . . . 0.0 109.342 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.535 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 1.3 mt 43.94 38.21 2.08 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.464 -0.772 . . . . 0.0 110.659 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.472 ' HA ' ' OD2' ' A' ' 108' ' ' ASP . 22.2 m -73.04 100.87 3.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.443 -0.786 . . . . 0.0 109.637 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.509 ' HB2' ' CG1' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -71.12 162.47 72.29 Favored Pre-proline 0 C--N 1.302 -1.471 0 O-C-N 121.401 -0.812 . . . . 0.0 110.806 -179.48 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.476 ' HD2' ' CG ' ' A' ' 80' ' ' ARG . 42.3 Cg_endo -69.95 -14.93 36.11 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 O-C-N 124.444 1.76 . . . . 0.0 110.219 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.545 HG21 ' CG ' ' A' ' 104' ' ' LEU . 20.1 t -68.38 -29.44 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.522 -0.737 . . . . 0.0 110.102 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.475 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 6.2 m80 -70.77 -28.53 64.74 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.393 -0.817 . . . . 0.0 109.136 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.493 ' CB ' ' HE3' ' A' ' 54' ' ' MET . 72.2 m-20 -62.23 -57.13 12.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.35 -0.844 . . . . 0.0 110.042 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -49.46 -57.48 6.93 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.452 -0.78 . . . . 0.0 109.757 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.532 ' O ' ' CG ' ' A' ' 123' ' ' HIS . . . -57.19 -50.17 73.67 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.282 -0.886 . . . . 0.0 109.936 179.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.44 ' HD3' HD11 ' A' ' 121' ' ' LEU . 1.7 mmt85 -47.52 -21.51 0.35 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.588 -0.695 . . . . 0.0 111.483 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.441 ' HG2' ' HB2' ' A' ' 54' ' ' MET . 3.8 mp0 -110.69 -7.65 14.64 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.201 -0.937 . . . . 0.0 110.479 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.45 ' HA2' ' HB3' ' A' ' 123' ' ' HIS . . . 78.15 22.53 68.06 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.477 ' O ' HD13 ' A' ' 94' ' ' LEU . 0.4 OUTLIER -95.22 111.79 23.59 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.533 -0.981 . . . . 0.0 110.427 -179.628 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.494 ' CD2' HG22 ' A' ' 126' ' ' VAL . 0.5 OUTLIER -82.43 -45.14 15.18 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.551 -0.718 . . . . 0.0 110.252 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.46 ' HB2' ' HB2' ' A' ' 57' ' ' ALA . 20.9 m-20 -41.47 -43.56 2.66 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.548 0.69 . . . . 0.0 109.535 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.4 ' O ' ' HB ' ' A' ' 96' ' ' VAL . 11.5 m -61.24 -59.58 5.09 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.753 -0.592 . . . . 0.0 109.596 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.479 HD13 ' HA ' ' A' ' 91' ' ' LEU . 0.6 OUTLIER -46.75 -38.88 10.7 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.379 -0.826 . . . . 0.0 109.395 179.49 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.484 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 58.0 t -66.41 -43.88 90.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.544 ' CG1' HD12 ' A' ' 64' ' ' LEU . 45.8 t -58.58 -55.73 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.436 ' C ' ' CB ' ' A' ' 102' ' ' ALA . 6.5 mp -47.21 -61.47 1.88 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.423 -0.798 . . . . 0.0 110.133 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -61.16 -36.01 78.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.162 -0.961 . . . . 0.0 109.838 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.484 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 1.1 mtp-105 -58.4 -13.18 4.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.394 -0.816 . . . . 0.0 110.536 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.482 ' HB2' ' CD2' ' A' ' 64' ' ' LEU . . . -146.58 61.8 1.21 Allowed 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.228 -0.92 . . . . 0.0 110.625 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 60.08 107.9 0.01 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.356 -1.097 . . . . 0.0 110.356 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.489 ' HA ' ' OD1' ' A' ' 71' ' ' ASN . . . -165.64 89.36 0.44 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.423 -1.045 . . . . 0.0 110.39 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.5 96.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.968 -1.082 . . . . 0.0 109.776 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.545 ' CG ' HG21 ' A' ' 82' ' ' VAL . 1.8 mp -87.45 41.87 1.01 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.214 -0.929 . . . . 0.0 110.457 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.587 ' HB2' ' HA ' ' A' ' 134' ' ' ALA . 30.9 t0 -146.9 41.78 1.11 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.905 -1.122 . . . . 0.0 110.829 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.509 ' CG1' ' HB2' ' A' ' 80' ' ' ARG . 7.1 p -99.01 177.13 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.378 -0.826 . . . . 0.0 109.754 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.441 ' HG2' HD21 ' A' ' 113' ' ' LEU . 8.8 mtm180 -111.62 136.79 50.36 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.372 -0.83 . . . . 0.0 109.933 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' A' ' 110' ' ' TRP . 5.5 t70 -74.94 53.08 0.58 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.409 -0.807 . . . . 0.0 109.447 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.483 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 56.98 -78.9 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.657 -0.652 . . . . 0.0 110.382 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.522 ' N ' ' O ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -37.18 -60.67 0.63 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.6 -0.687 . . . . 0.0 110.906 -179.893 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 160.74 -34.58 0.41 Allowed Glycine 0 N--CA 1.482 1.7 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.08 134.66 17.23 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.737 -0.861 . . . . 0.0 110.933 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.513 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 16.2 mt -96.66 169.79 8.33 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.283 -0.886 . . . . 0.0 109.923 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 38.2 Cg_endo -64.97 -36.24 39.4 Favored 'Trans proline' 0 N--CA 1.49 1.295 0 O-C-N 123.674 1.355 . . . . 0.0 110.155 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.7 p -78.9 -33.23 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.439 -0.788 . . . . 0.0 109.264 179.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.504 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 3.1 t0 -60.85 -23.98 65.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.507 -0.745 . . . . 0.0 109.898 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.25 -65.12 0.96 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.427 -0.796 . . . . 0.0 110.102 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.484 ' CB ' ' HB2' ' A' ' 123' ' ' HIS . . . -44.48 -53.61 6.8 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.568 -0.707 . . . . 0.0 111.077 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.19 -45.61 75.82 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.291 -0.881 . . . . 0.0 110.444 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.504 ' HB2' ' O ' ' A' ' 116' ' ' ASP . 0.0 OUTLIER -71.51 -45.13 63.27 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.467 -0.77 . . . . 0.0 109.967 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.44 HD11 ' HD3' ' A' ' 87' ' ' ARG . 4.8 mt -69.15 -94.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.615 -0.678 . . . . 0.0 109.92 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -177.26 47.83 0.1 Allowed Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.532 ' CG ' ' O ' ' A' ' 86' ' ' ALA . 71.4 m-70 -124.91 52.55 1.56 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.463 -1.022 . . . . 0.0 109.528 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.434 ' HB2' ' CZ ' ' A' ' 124' ' ' ARG . 26.8 mtm105 -43.59 -49.17 7.64 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.811 -0.556 . . . . 0.0 110.633 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -46.16 -46.88 17.57 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.536 HG13 ' CD1' ' A' ' 130' ' ' LEU . 22.4 t -76.08 -49.91 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.933 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.4 ' HB3' ' HA ' ' A' ' 124' ' ' ARG . . . -43.6 -48.72 7.67 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.321 -0.862 . . . . 0.0 110.19 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 36.7 mtt-85 -64.28 -64.88 0.77 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.502 -0.749 . . . . 0.0 109.754 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -50.27 -41.7 51.0 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.371 -0.831 . . . . 0.0 110.818 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.536 ' CD1' HG13 ' A' ' 126' ' ' VAL . 12.2 mt -58.15 -56.99 14.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.103 -0.998 . . . . 0.0 109.767 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -47.32 -23.44 0.57 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.366 -0.834 . . . . 0.0 110.858 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.452 ' O ' ' N ' ' A' ' 136' ' ' GLY . . . -83.95 -73.46 0.42 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.197 -0.94 . . . . 0.0 109.921 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.14 -11.72 22.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.167 -0.958 . . . . 0.0 110.377 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.587 ' HA ' ' HB2' ' A' ' 105' ' ' ASP . . . -107.39 61.19 0.62 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.353 -0.842 . . . . 0.0 109.661 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 95.27 38.43 4.8 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 132' ' ' ALA . . . -56.2 -77.57 0.15 Allowed Glycine 0 N--CA 1.492 2.427 0 N-CA-C 108.924 -1.671 . . . . 0.0 108.924 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 15.4 t -90.84 131.87 36.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.441 -1.035 . . . . 0.0 109.942 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -141.02 118.47 11.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.137 -0.977 . . . . 0.0 110.282 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 169.19 -48.67 0.22 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 52.49 19.18 1.11 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.337 -1.096 . . . . 0.0 110.426 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -129.95 71.02 1.43 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.343 -0.848 . . . . 0.0 109.487 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 63.51 44.89 5.03 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.462 -0.774 . . . . 0.0 109.943 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -122.56 -170.35 2.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.384 -0.822 . . . . 0.0 110.012 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.424 ' O ' ' HB ' ' A' ' 145' ' ' ILE . 14.0 ttp85 49.53 74.4 0.2 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.423 -0.798 . . . . 0.0 110.219 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.431 HG21 HD12 ' A' ' 145' ' ' ILE . 7.7 mt 61.02 165.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.444 -0.785 . . . . 0.0 109.678 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -43.6 158.26 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.336 -0.853 . . . . 0.0 110.539 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -47.6 169.41 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.47 -0.769 . . . . 0.0 110.567 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.1 170.26 1.3 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.352 -0.843 . . . . 0.0 109.785 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -155.66 -42.47 0.08 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.542 -0.724 . . . . 0.0 109.249 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -115.5 137.33 13.75 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.413 ' O ' ' HB3' ' A' ' 152' ' ' SER . 45.9 Cg_endo -69.6 128.01 15.55 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 O-C-N 123.699 1.368 . . . . 0.0 110.401 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' SER . . . . . 0.413 ' HB3' ' O ' ' A' ' 151' ' ' PRO . 75.7 p -177.04 152.43 0.9 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.411 -0.805 . . . . 0.0 109.799 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 58.6 86.68 0.08 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.257 -0.902 . . . . 0.0 110.191 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 9.2 mt -132.86 85.13 47.47 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.252 -0.905 . . . . 0.0 110.517 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -79.86 122.47 4.88 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 O-C-N 123.89 1.468 . . . . 0.0 110.161 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 21.1 p30 . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 118.041 -0.981 . . . . 0.0 110.395 -179.696 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.874 0 CA-C-O 121.099 0.476 . . . . 0.0 110.165 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -129.2 130.44 23.38 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.284 -0.885 . . . . 0.0 110.661 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -72.16 161.89 43.28 Favored 'Trans proline' 0 C--N 1.315 -1.231 0 O-C-N 123.561 1.295 . . . . 0.0 110.245 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -106.99 114.9 29.26 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.414 -0.804 . . . . 0.0 110.458 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -166.45 130.5 2.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.349 -0.844 . . . . 0.0 110.268 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -128.72 99.76 0.5 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.5 m -60.62 174.77 0.54 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.245 -1.15 . . . . 0.0 110.451 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.7 p -155.75 -179.82 8.49 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.323 -0.861 . . . . 0.0 110.323 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 21.9 mtt -97.79 -87.01 0.33 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.231 -0.918 . . . . 0.0 110.936 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -138.5 101.52 8.14 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.16 -0.962 . . . . 0.0 110.723 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -75.81 85.23 1.65 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 123.856 1.451 . . . . 0.0 110.607 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.0 m -58.88 150.07 25.18 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.135 -0.978 . . . . 0.0 110.376 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.19 107.54 0.43 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.28 -0.888 . . . . 0.0 110.502 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.49 28.73 8.47 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.367 -0.833 . . . . 0.0 109.916 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.479 ' O ' HG23 ' A' ' 18' ' ' THR . 31.1 m0 -85.93 -24.88 26.39 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.365 -0.835 . . . . 0.0 110.349 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.427 ' CD1' HD22 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -71.29 -37.24 71.86 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.268 -0.895 . . . . 0.0 109.379 179.511 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.48 ' CB ' ' ND2' ' A' ' 42' ' ' ASN . . . -81.21 -47.92 12.77 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.443 -0.786 . . . . 0.0 110.914 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 15' ' ' TRP . 14.6 t -48.78 -43.06 37.61 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.357 -0.84 . . . . 0.0 111.09 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.428 ' N ' ' CG2' ' A' ' 18' ' ' THR . . . -75.89 -36.52 59.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.192 -0.943 . . . . 0.0 109.999 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.453 ' HA ' HG13 ' A' ' 59' ' ' VAL . . . -69.1 -28.4 66.46 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.126 -0.984 . . . . 0.0 110.088 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.53 -36.02 33.72 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.369 -0.832 . . . . 0.0 110.64 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -84.42 21.95 1.36 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.226 -0.921 . . . . 0.0 110.861 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.428 ' HA3' ' SD ' ' A' ' 53' ' ' MET . . . 44.85 65.01 1.93 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.438 ' HB3' ' HB3' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -133.38 62.82 1.65 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.341 -1.094 . . . . 0.0 109.35 179.374 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 24' ' ' ARG . 77.3 t -34.78 -53.82 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.872 -0.518 . . . . 0.0 111.421 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -53.0 -45.06 67.71 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.355 -0.841 . . . . 0.0 110.683 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.438 ' HB3' ' HB3' ' A' ' 24' ' ' ARG . 2.1 tp10 -64.64 -28.42 69.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.235 -0.916 . . . . 0.0 110.149 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.431 ' O ' ' CD2' ' A' ' 62' ' ' LEU . 47.5 t -85.3 -51.24 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.181 -0.949 . . . . 0.0 110.428 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.49 ' HA ' ' CD2' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -43.44 -48.62 7.2 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.516 -0.74 . . . . 0.0 111.014 -179.916 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.46 -50.02 15.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.48 -0.762 . . . . 0.0 110.391 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 27' ' ' GLU . 10.7 mt -44.48 -61.03 1.68 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.495 -0.753 . . . . 0.0 110.497 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.573 ' CD2' ' CG ' ' A' ' 66' ' ' HIS . 0.4 OUTLIER -57.21 -44.56 83.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.537 -0.727 . . . . 0.0 109.704 179.429 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -68.43 -7.41 31.49 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.36 -0.838 . . . . 0.0 110.562 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -105.32 -18.07 14.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.165 -0.959 . . . . 0.0 111.014 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' A' ' 37' ' ' LEU . . . 161.09 -36.51 0.41 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.538 ' O ' ' HG ' ' A' ' 32' ' ' LEU . . . -45.63 96.31 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.404 -1.057 . . . . 0.0 110.093 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.474 ' HG ' ' HB3' ' A' ' 40' ' ' ALA . 0.8 OUTLIER -66.33 152.03 95.02 Favored Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 121.299 -0.876 . . . . 0.0 110.099 -179.071 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.488 ' HB2' ' HA ' ' A' ' 68' ' ' ALA . 44.3 Cg_endo -70.65 -34.35 11.75 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 124.025 1.539 . . . . 0.0 111.922 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.401 ' C ' HD12 ' A' ' 37' ' ' LEU . 10.2 m120 -88.3 42.73 1.08 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.924 -1.11 . . . . 0.0 110.355 -179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.474 ' HB3' ' HG ' ' A' ' 37' ' ' LEU . . . -97.7 107.13 37.98 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.289 -0.882 . . . . 0.0 110.097 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -69.94 133.47 25.32 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.644 1.339 . . . . 0.0 109.528 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.48 ' ND2' ' CB ' ' A' ' 17' ' ' ALA . 5.7 m120 -77.05 -176.98 4.23 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.431 -0.793 . . . . 0.0 110.059 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 69.2 m -102.39 23.86 11.18 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.31 -0.869 . . . . 0.0 109.44 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.434 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 7.4 m-85 -122.59 19.24 10.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.73 -0.606 . . . . 0.0 109.479 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.427 ' C ' ' HG2' ' A' ' 46' ' ' ARG . . . 60.94 26.9 66.12 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.447 ' HB3' ' HG2' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -129.1 130.5 46.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.219 -1.165 . . . . 0.0 109.889 -179.772 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.57 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 3.4 mmp_? -48.02 168.95 0.14 Allowed Pre-proline 0 N--CA 1.499 2.016 0 O-C-N 121.574 -0.704 . . . . 0.0 110.475 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 39.2 Cg_endo -67.01 -17.91 51.53 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.562 1.296 . . . . 0.0 110.329 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.538 HG13 HD23 ' A' ' 63' ' ' LEU . 4.9 mt -107.38 -34.16 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 177.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.447 ' HG2' ' HB3' ' A' ' 46' ' ' ARG . 44.6 tt0 -50.45 -24.85 3.37 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.627 -0.671 . . . . 0.0 109.362 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.9 p -99.53 7.93 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.471 -0.768 . . . . 0.0 110.246 179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.482 ' HB2' ' O ' ' A' ' 49' ' ' ILE . 2.2 tmm? -61.66 158.07 16.22 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.232 -0.917 . . . . 0.0 109.318 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.487 ' O ' ' HG2' ' A' ' 53' ' ' MET . 54.7 ttp -70.64 -5.29 28.36 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.223 -0.923 . . . . 0.0 110.135 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.539 ' HB3' ' CB ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER 53.53 22.37 2.93 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.053 -1.03 . . . . 0.0 109.519 -179.116 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.564 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -121.38 -7.41 8.31 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.731 -1.747 . . . . 0.0 108.731 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.1 m -134.73 87.13 2.32 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.426 -1.044 . . . . 0.0 109.638 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.409 ' HB3' ' HB3' ' A' ' 92' ' ' ASP . . . -53.48 -25.7 17.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.325 -0.859 . . . . 0.0 109.643 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.409 ' CB ' HG23 ' A' ' 25' ' ' VAL . 5.9 mtt85 -54.8 -38.24 67.06 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.595 -0.691 . . . . 0.0 110.093 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.453 HG13 ' HA ' ' A' ' 20' ' ' ALA . 59.6 t -55.86 -66.71 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.022 -1.048 . . . . 0.0 109.364 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -45.82 -27.78 0.93 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.406 -0.809 . . . . 0.0 109.838 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -59.56 -53.69 55.13 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.428 -0.795 . . . . 0.0 110.152 179.54 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.49 ' CD2' ' HA ' ' A' ' 29' ' ' ARG . 0.5 OUTLIER -65.46 -42.54 92.21 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.239 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.547 ' HB3' ' HB3' ' A' ' 68' ' ' ALA . 0.3 OUTLIER -60.54 -53.54 56.3 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.148 179.729 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.471 ' CD2' ' HA ' ' A' ' 97' ' ' LEU . 0.3 OUTLIER -61.75 -29.81 70.37 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.302 -0.959 . . . . 0.0 108.996 178.648 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.486 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 0.4 OUTLIER -54.92 -49.97 69.97 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.573 ' CG ' ' CD2' ' A' ' 32' ' ' LEU 0.261 80.3 m80 -87.25 -9.19 55.7 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.794 179.639 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 38' ' ' PRO . . . 82.29 71.32 1.31 Allowed Glycine 0 N--CA 1.482 1.741 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.547 ' HB3' ' HB3' ' A' ' 63' ' ' LEU . . . -65.38 -143.9 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.367 -1.078 . . . . 0.0 109.489 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.47 ' HB3' ' CD ' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -116.36 50.51 0.82 Allowed Pre-proline 0 C--N 1.3 -1.584 0 O-C-N 121.174 -0.954 . . . . 0.0 110.236 179.195 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.49 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 50.1 Cg_endo -72.86 52.39 2.15 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 O-C-N 123.24 1.126 . . . . 0.0 110.266 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.449 ' N ' ' HG3' ' A' ' 81' ' ' PRO . 26.0 m-20 -162.19 -74.64 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.309 -0.87 . . . . 0.0 110.065 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 6.2 m -52.22 118.99 3.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.091 -1.005 . . . . 0.0 109.235 179.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -107.0 -145.5 0.39 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.433 -0.792 . . . . 0.0 110.477 -178.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER -114.29 134.89 22.18 Favored Pre-proline 0 N--CA 1.487 1.41 0 O-C-N 121.241 -0.912 . . . . 0.0 110.042 -179.879 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -71.58 -9.32 24.87 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.555 1.292 . . . . 0.0 109.96 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.04 -51.15 8.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.274 -0.891 . . . . 0.0 110.107 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.562 ' HB ' ' CH2' ' A' ' 110' ' ' TRP . 11.5 p -123.29 8.86 9.12 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.527 -0.733 . . . . 0.0 110.504 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.464 ' N ' ' O ' ' A' ' 74' ' ' ASP . 0.4 OUTLIER 43.65 37.65 1.64 Allowed 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.543 0.687 . . . . 0.0 110.061 -179.577 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.66 92.16 4.72 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.341 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.556 ' HB2' HG12 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -68.89 171.2 6.73 Favored Pre-proline 0 C--N 1.303 -1.446 0 C-N-CA 119.319 -0.952 . . . . 0.0 108.702 179.799 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.49 ' HG3' ' HA ' ' A' ' 70' ' ' PRO . 40.6 Cg_endo -73.34 1.51 6.67 Favored 'Trans proline' 0 C--N 1.299 -2.073 0 O-C-N 123.88 1.463 . . . . 0.0 110.662 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.413 HG23 HD11 ' A' ' 104' ' ' LEU . 4.3 t -90.18 -36.18 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.298 -0.876 . . . . 0.0 109.412 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.518 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 19.7 m80 -61.69 -28.68 69.58 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.431 0.634 . . . . 0.0 109.506 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.536 ' HB3' ' SD ' ' A' ' 54' ' ' MET . 43.4 m-20 -64.01 -58.78 5.67 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.38 -0.825 . . . . 0.0 110.162 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.547 ' HB3' ' CD1' ' A' ' 94' ' ' LEU . . . -49.86 -67.88 0.22 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.383 -0.823 . . . . 0.0 110.394 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.559 ' O ' ' CG ' ' A' ' 123' ' ' HIS . . . -51.83 -51.4 56.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.351 -0.843 . . . . 0.0 110.94 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.518 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -43.75 -26.58 0.26 Allowed 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.012 -1.055 . . . . 0.0 111.062 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.539 ' CB ' ' HB3' ' A' ' 54' ' ' MET . 5.7 tm-20 -105.78 -15.58 14.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.159 -0.963 . . . . 0.0 110.12 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.413 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 91.52 29.19 12.52 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.126 -1.189 . . . . 0.0 110.126 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.564 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 0.3 OUTLIER -101.52 93.07 5.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.177 -1.19 . . . . 0.0 110.881 179.945 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.409 ' O ' ' HB2' ' A' ' 94' ' ' LEU . 0.3 OUTLIER -66.76 -42.56 85.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.454 -0.778 . . . . 0.0 110.276 179.652 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.409 ' HB3' ' HB3' ' A' ' 57' ' ' ALA . 67.4 t0 -45.52 -51.47 11.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.345 -0.847 . . . . 0.0 110.239 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.493 ' HB ' ' HB2' ' A' ' 85' ' ' ALA . 98.1 m -47.41 -52.42 16.93 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.533 -0.729 . . . . 0.0 109.626 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.547 ' CD1' ' HB3' ' A' ' 85' ' ' ALA . 3.7 mp -51.21 -58.57 5.8 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.422 -0.799 . . . . 0.0 109.785 178.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.479 ' O ' ' CB ' ' A' ' 99' ' ' ARG . 46.8 t -44.07 -51.92 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-O 121.139 0.495 . . . . 0.0 109.834 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.419 HG11 HD12 ' A' ' 64' ' ' LEU . 5.7 t -54.89 -50.78 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.37 -0.831 . . . . 0.0 110.08 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.486 ' HB3' ' CB ' ' A' ' 102' ' ' ALA . 56.5 mt -52.35 -60.84 2.75 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.453 -0.779 . . . . 0.0 110.378 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -68.76 -26.55 65.29 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.435 -0.791 . . . . 0.0 110.446 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.479 ' CB ' ' O ' ' A' ' 95' ' ' VAL . 45.8 ttt85 -70.03 -9.36 55.04 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.187 -0.945 . . . . 0.0 110.637 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.0 -53.4 0.75 Allowed 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.005 -1.059 . . . . 0.0 110.928 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 178.43 110.81 0.28 Allowed Glycine 0 N--CA 1.486 1.982 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.486 ' CB ' ' HB3' ' A' ' 97' ' ' LEU . . . -177.03 141.17 0.33 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.253 -1.145 . . . . 0.0 110.381 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.63 156.39 20.04 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.621 -0.674 . . . . 0.0 109.549 179.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.468 ' O ' ' HA ' ' A' ' 134' ' ' ALA . 0.3 OUTLIER -144.22 46.11 1.42 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.247 -0.908 . . . . 0.0 110.433 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.418 ' OD2' ' O ' ' A' ' 134' ' ' ALA . 1.1 t70 -152.32 40.2 0.6 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.192 -0.942 . . . . 0.0 110.112 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.556 HG12 ' HB2' ' A' ' 80' ' ' ARG . 4.0 p -104.55 170.21 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.652 -0.655 . . . . 0.0 109.846 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.426 ' N ' ' CG2' ' A' ' 106' ' ' VAL . 11.3 mtp180 -97.84 176.89 5.64 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.541 -0.724 . . . . 0.0 109.812 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.503 ' O ' ' HB1' ' A' ' 109' ' ' ALA . 22.4 p-10 -117.63 30.92 7.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.908 . . . . 0.0 109.707 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.503 ' HB1' ' O ' ' A' ' 108' ' ' ASP . . . 64.6 -57.04 0.26 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.751 -0.593 . . . . 0.0 110.264 -179.1 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.562 ' CH2' ' HB ' ' A' ' 77' ' ' THR . 7.6 m-90 -56.6 -60.66 3.22 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.159 -0.963 . . . . 0.0 109.541 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 155.87 -26.53 0.57 Allowed Glycine 0 N--CA 1.484 1.883 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.477 ' HG3' ' HB3' ' A' ' 116' ' ' ASP . 0.4 OUTLIER -80.35 107.58 13.26 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.315 -1.109 . . . . 0.0 110.783 -179.442 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.549 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER -55.74 177.36 0.15 Allowed Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 121.429 -0.794 . . . . 0.0 110.235 179.759 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.549 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 40.6 Cg_endo -69.3 -33.64 17.87 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 O-C-N 123.586 1.308 . . . . 0.0 109.347 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.448 HG21 ' HG3' ' A' ' 131' ' ' ARG . 12.8 p -78.4 -33.36 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-O 121.535 0.683 . . . . 0.0 109.437 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.477 ' HB3' ' HG3' ' A' ' 112' ' ' ARG . 0.6 OUTLIER -71.89 -34.26 69.01 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.539 -0.725 . . . . 0.0 109.44 179.438 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.437 HD23 HD13 ' A' ' 121' ' ' LEU . 0.6 OUTLIER -61.19 -39.36 89.88 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.387 -0.821 . . . . 0.0 110.243 179.805 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.421 ' HB3' ' HB1' ' A' ' 127' ' ' ALA . . . -67.45 -51.96 45.27 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.208 -0.933 . . . . 0.0 110.736 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -46.89 -35.4 6.38 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.348 -0.845 . . . . 0.0 110.545 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.54 -58.83 2.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.35 -0.844 . . . . 0.0 109.575 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.437 HD13 HD23 ' A' ' 117' ' ' LEU . 50.2 mt -53.38 -93.29 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.465 -0.772 . . . . 0.0 110.463 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 178.31 36.9 0.06 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.559 ' CG ' ' O ' ' A' ' 86' ' ' ALA . 35.6 m-70 -108.51 41.33 1.6 Allowed 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.314 -1.109 . . . . 0.0 109.273 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -43.5 -33.57 1.14 Allowed 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.437 0.637 . . . . 0.0 110.16 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -63.72 -41.3 98.1 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.367 -0.833 . . . . 0.0 108.863 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.471 ' CG1' HD23 ' A' ' 94' ' ' LEU . 3.2 t -80.81 -43.9 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.716 -0.615 . . . . 0.0 110.94 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.421 ' HB1' ' HB3' ' A' ' 118' ' ' ALA . . . -51.31 -35.89 39.98 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.279 -0.888 . . . . 0.0 110.034 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.91 -65.98 0.61 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.418 -0.801 . . . . 0.0 109.887 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -54.07 -42.72 69.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.472 -0.768 . . . . 0.0 109.225 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.407 HD13 ' HB1' ' A' ' 86' ' ' ALA . 14.0 mt -55.96 -58.12 9.24 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.823 -0.548 . . . . 0.0 110.281 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.448 ' HG3' HG21 ' A' ' 115' ' ' VAL . 9.4 ttm180 -56.14 -15.68 4.06 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.176 -0.952 . . . . 0.0 110.854 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -82.66 -57.18 3.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.055 -1.028 . . . . 0.0 109.809 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -85.47 -12.32 52.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.562 -0.711 . . . . 0.0 110.501 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 104' ' ' LEU . . . -108.57 -48.52 3.31 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.219 -0.926 . . . . 0.0 110.768 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.03 150.65 13.02 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 108.834 -1.707 . . . . 0.0 108.834 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -108.74 -26.29 5.37 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 10.8 p -71.67 132.82 45.12 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.24 -1.153 . . . . 0.0 110.725 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.421 ' C ' ' CD ' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -101.48 -18.98 15.72 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.295 -0.878 . . . . 0.0 109.882 179.164 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -178.48 -89.55 0.08 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -131.27 126.54 35.7 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.309 -1.112 . . . . 0.0 110.215 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -130.45 21.35 5.17 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.28 -0.888 . . . . 0.0 110.483 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 48.61 24.77 0.82 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.195 -0.94 . . . . 0.0 110.228 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -117.04 -61.05 1.77 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.51 -0.744 . . . . 0.0 110.146 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.81 146.75 49.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.528 -0.733 . . . . 0.0 110.08 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.462 HD13 HG22 ' A' ' 145' ' ' ILE . 5.3 mt 55.91 88.73 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.452 -0.78 . . . . 0.0 110.376 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -43.69 107.04 0.08 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.563 -0.711 . . . . 0.0 110.071 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -75.31 123.52 25.49 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.522 -0.736 . . . . 0.0 110.606 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -76.73 164.47 25.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.606 -0.684 . . . . 0.0 110.304 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -55.77 -169.88 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.631 -0.668 . . . . 0.0 110.609 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -74.8 144.21 32.23 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.85 163.85 37.56 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 O-C-N 123.641 1.337 . . . . 0.0 110.938 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.69 10.08 24.86 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.39 -0.819 . . . . 0.0 110.644 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -67.9 146.36 53.7 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.963 -1.085 . . . . 0.0 109.901 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 16.9 mm -137.46 83.71 25.11 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.211 -0.93 . . . . 0.0 110.12 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 156' ' ' ASP . 48.5 Cg_endo -78.16 123.96 6.39 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.817 1.43 . . . . 0.0 109.795 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . 0.431 ' O ' ' O ' ' A' ' 155' ' ' PRO . 4.0 t70 . . . . . 0 N--CA 1.495 1.8 0 CA-C-O 118.088 -0.958 . . . . 0.0 110.68 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 ptp . . . . . 0 N--CA 1.497 1.921 0 CA-C-O 121.232 0.539 . . . . 0.0 110.374 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -139.81 83.28 16.66 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.381 -0.825 . . . . 0.0 110.118 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -74.82 105.97 2.17 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.662 1.349 . . . . 0.0 110.379 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -123.17 83.08 2.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.358 -0.839 . . . . 0.0 110.288 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.52 156.22 31.11 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.285 -0.885 . . . . 0.0 110.236 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.7 -155.47 52.1 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.3 t 52.86 91.26 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.311 -1.111 . . . . 0.0 110.681 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 83.9 p -91.38 59.71 3.95 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.373 -0.829 . . . . 0.0 109.686 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 5.9 tpt -91.52 38.6 0.98 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.327 -0.858 . . . . 0.0 110.547 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.44 147.27 24.93 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.421 -0.8 . . . . 0.0 109.842 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -74.13 124.56 9.15 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.6 1.316 . . . . 0.0 109.817 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -50.17 100.78 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.391 -0.818 . . . . 0.0 110.292 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.462 ' HB1' ' HB2' ' A' ' 37' ' ' LEU . . . -61.76 -13.73 26.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.463 -0.773 . . . . 0.0 110.544 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -81.29 4.46 20.43 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.072 -1.018 . . . . 0.0 110.698 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.512 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 0.0 OUTLIER -71.6 -5.21 31.77 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.151 -0.968 . . . . 0.0 110.4 179.773 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.505 HD11 HD13 ' A' ' 32' ' ' LEU . 22.7 mt -78.56 -61.48 1.99 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.096 -1.002 . . . . 0.0 109.629 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.0 -43.77 82.08 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.481 -0.762 . . . . 0.0 109.641 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.512 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.8 OUTLIER -54.18 -54.99 32.26 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.642 -0.662 . . . . 0.0 110.292 179.576 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.433 ' CB ' HG23 ' A' ' 28' ' ' VAL . . . -68.54 -40.07 80.87 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.337 -0.852 . . . . 0.0 109.778 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.408 ' C ' ' HA ' ' A' ' 52' ' ' MET . . . -57.62 -50.68 72.33 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.323 -0.861 . . . . 0.0 109.687 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.41 ' CB ' ' O ' ' A' ' 51' ' ' VAL . . . -58.79 -27.16 64.77 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.612 -0.68 . . . . 0.0 110.587 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.37 23.06 4.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.317 -0.864 . . . . 0.0 110.618 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.43 48.81 40.77 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.2 mtm180 -121.55 58.68 0.99 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.388 -1.066 . . . . 0.0 110.164 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.407 HG23 HG22 ' A' ' 59' ' ' VAL . 51.1 t -44.74 -51.43 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.591 -0.693 . . . . 0.0 110.886 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -51.09 -44.04 61.16 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.335 -0.853 . . . . 0.0 110.622 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.25 -39.03 88.84 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.387 -0.821 . . . . 0.0 109.969 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.433 HG23 ' CB ' ' A' ' 19' ' ' ALA . 23.6 t -76.81 -48.41 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.471 -0.768 . . . . 0.0 110.465 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.507 ' HA ' ' CD1' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -46.85 -34.94 5.8 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.348 -0.845 . . . . 0.0 109.7 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.412 ' O ' ' CB ' ' A' ' 34' ' ' ALA . . . -79.88 -51.96 8.48 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.353 -0.842 . . . . 0.0 108.901 178.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 18.6 mt -58.84 -65.13 0.71 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.935 0.874 . . . . 0.0 109.728 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.527 HD22 ' HA ' ' A' ' 63' ' ' LEU . 1.1 tp -47.21 -49.19 23.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.743 -0.598 . . . . 0.0 110.929 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -75.34 -14.56 60.49 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.152 -0.967 . . . . 0.0 110.47 179.617 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.412 ' CB ' ' O ' ' A' ' 30' ' ' ALA . . . -82.64 -9.54 59.34 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.07 -1.019 . . . . 0.0 110.532 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 125.95 17.5 2.51 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.787 -1.197 . . . . 0.0 110.825 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.417 ' HB1' ' HA ' ' A' ' 32' ' ' LEU . . . -64.44 176.04 1.2 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.053 -1.263 . . . . 0.0 110.092 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.462 ' HB2' ' HB1' ' A' ' 13' ' ' ALA . 1.6 mm? -91.46 133.45 31.27 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.264 -0.897 . . . . 0.0 110.281 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -70.89 -49.29 0.41 Allowed 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 123.603 1.317 . . . . 0.0 110.37 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -95.62 18.48 12.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.31 -0.869 . . . . 0.0 110.484 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.4 ' HB3' ' CB ' ' A' ' 37' ' ' LEU . . . -42.38 109.09 0.68 Allowed Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 121.63 -0.669 . . . . 0.0 110.908 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.5 91.89 0.86 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.709 1.373 . . . . 0.0 110.412 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -65.33 -177.83 0.44 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.484 -0.76 . . . . 0.0 109.898 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.33 22.53 2.47 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.209 -0.932 . . . . 0.0 110.422 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.529 ' HB3' ' CD ' ' A' ' 46' ' ' ARG . 2.8 m-85 -103.09 3.86 36.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -0.904 . . . . 0.0 110.681 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 57.06 35.12 67.83 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.529 ' CD ' ' HB3' ' A' ' 44' ' ' TYR . 7.6 ptm180 -160.4 26.11 0.16 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.261 -1.141 . . . . 0.0 110.697 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.475 ' CB ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER 49.04 -174.63 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.038 0 O-C-N 121.552 -0.718 . . . . 0.0 110.154 179.689 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.592 ' O ' ' N ' ' A' ' 50' ' ' GLN . 46.2 Cg_endo -72.43 -167.33 0.32 Allowed 'Trans proline' 0 C--N 1.315 -1.207 0 O-C-N 123.141 1.074 . . . . 0.0 110.538 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.483 ' O ' ' CG ' ' A' ' 52' ' ' MET . 3.5 mt 60.2 -65.59 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.748 -0.595 . . . . 0.0 109.625 -178.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.592 ' N ' ' O ' ' A' ' 48' ' ' PRO . 19.6 mt-30 -45.8 -25.43 0.51 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.959 -1.088 . . . . 0.0 109.803 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.41 ' O ' ' CB ' ' A' ' 21' ' ' ALA . 8.9 p -119.02 40.58 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.485 -0.76 . . . . 0.0 109.789 178.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.483 ' CG ' ' O ' ' A' ' 49' ' ' ILE . 0.1 OUTLIER -102.52 37.62 1.87 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.028 -1.045 . . . . 0.0 110.21 179.863 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.431 ' CB ' ' O ' ' A' ' 52' ' ' MET . 3.6 tmm? 66.34 -11.73 0.22 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.374 -0.829 . . . . 0.0 111.158 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.479 ' H ' ' C ' ' A' ' 52' ' ' MET . 0.0 OUTLIER 48.03 27.55 1.24 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.205 -0.935 . . . . 0.0 110.358 -179.703 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.45 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -125.52 9.5 7.73 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -148.99 81.06 1.43 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.41 -1.053 . . . . 0.0 109.629 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.4 ' HB3' ' CD1' ' A' ' 90' ' ' PHE . . . -49.81 -27.87 5.6 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.464 -0.772 . . . . 0.0 109.775 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.5 mtt85 -52.23 -29.16 21.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.537 -0.727 . . . . 0.0 109.356 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.407 HG22 HG23 ' A' ' 25' ' ' VAL . 29.2 t -71.15 -51.63 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.364 -0.835 . . . . 0.0 108.946 178.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.476 ' O ' ' CB ' ' A' ' 64' ' ' LEU . . . -49.13 -42.31 38.97 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.65 -0.656 . . . . 0.0 109.676 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.488 ' O ' ' HB3' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -61.27 -55.59 30.19 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.486 -0.759 . . . . 0.0 109.317 179.012 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.507 ' CD1' ' HA ' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -44.25 -58.94 2.61 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.468 -0.77 . . . . 0.0 110.152 178.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.527 ' HA ' HD22 ' A' ' 32' ' ' LEU . 13.9 mt -69.43 -41.9 75.71 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.663 -0.648 . . . . 0.0 110.486 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.476 ' CB ' ' O ' ' A' ' 60' ' ' ALA . 0.5 OUTLIER -61.68 -55.49 29.89 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.039 -1.038 . . . . 0.0 109.739 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.488 ' HB3' ' O ' ' A' ' 61' ' ' GLU . 0.6 OUTLIER -53.97 -26.81 27.69 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.379 -0.825 . . . . 0.0 109.458 179.366 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.419 ' ND1' ' CD1' ' A' ' 32' ' ' LEU . 1.0 OUTLIER -88.6 -49.04 7.13 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.518 -0.739 . . . . 0.0 109.8 -179.847 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 151.39 50.64 0.02 OUTLIER Glycine 0 N--CA 1.481 1.676 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.438 ' HB2' ' C ' ' A' ' 63' ' ' LEU . . . -74.05 -157.58 0.05 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.798 -1.413 . . . . 0.0 109.805 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -122.21 63.99 18.69 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.35 -0.844 . . . . 0.0 110.055 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.428 ' CB ' ' HG ' ' A' ' 97' ' ' LEU . 47.3 Cg_endo -72.3 -8.66 23.11 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.858 1.451 . . . . 0.0 110.574 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -108.05 -78.77 0.58 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.291 -0.881 . . . . 0.0 109.549 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.73 -175.82 0.1 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.55 -0.719 . . . . 0.0 110.527 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.473 ' CB ' ' O ' ' A' ' 79' ' ' THR . . . -167.39 -83.19 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.425 -0.797 . . . . 0.0 110.298 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -146.71 123.36 5.73 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.291 -0.881 . . . . 0.0 109.674 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.37 -2.43 11.7 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.511 1.269 . . . . 0.0 110.645 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -96.52 -27.79 14.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.215 -0.928 . . . . 0.0 110.19 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.468 ' HA ' ' HB2' ' A' ' 109' ' ' ALA . 71.9 p -137.11 4.56 2.72 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.259 -0.901 . . . . 0.0 111.103 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.403 ' CD2' ' NH1' ' A' ' 80' ' ' ARG . 5.2 mt 47.01 27.93 0.81 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.246 -0.909 . . . . 0.0 111.244 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.473 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 66.4 m -69.66 88.62 0.52 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.963 -1.086 . . . . 0.0 109.783 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.511 ' HG3' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -67.98 165.11 35.14 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.309 -0.869 . . . . 0.0 109.946 -179.605 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.511 ' HD2' ' HG3' ' A' ' 80' ' ' ARG . 46.5 Cg_endo -76.0 -7.98 18.6 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.622 1.328 . . . . 0.0 109.767 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.511 HG22 ' HA ' ' A' ' 104' ' ' LEU . 6.0 t -71.54 -23.92 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.552 -0.717 . . . . 0.0 109.593 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.527 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 4.0 m80 -75.46 -23.39 56.86 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.458 ' HB3' ' SD ' ' A' ' 54' ' ' MET . 51.7 m-20 -75.39 -57.39 3.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.829 -0.544 . . . . 0.0 110.92 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.41 ' HB1' ' CD1' ' A' ' 94' ' ' LEU . . . -53.38 -50.77 64.41 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.194 -0.941 . . . . 0.0 109.507 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.505 ' HA ' ' CG1' ' A' ' 126' ' ' VAL . . . -65.51 -32.05 73.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.455 -0.778 . . . . 0.0 110.105 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.428 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 0.1 OUTLIER -56.18 -51.02 69.54 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.297 -0.877 . . . . 0.0 110.374 -179.851 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.42 ' HB2' ' HB3' ' A' ' 54' ' ' MET . 0.9 OUTLIER -93.28 16.58 12.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.301 -0.874 . . . . 0.0 110.422 -179.793 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.426 ' HA2' ' CG2' ' A' ' 126' ' ' VAL . . . 53.28 55.03 26.49 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.45 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 0.2 OUTLIER -115.5 94.93 4.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.418 -1.048 . . . . 0.0 110.744 -179.349 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.526 ' CD2' HG22 ' A' ' 126' ' ' VAL . 0.3 OUTLIER -66.69 -45.5 78.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.348 -0.845 . . . . 0.0 109.967 179.645 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -47.91 -40.05 20.75 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.52 -0.737 . . . . 0.0 109.723 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.414 ' OG1' ' CD1' ' A' ' 90' ' ' PHE . 7.1 m -66.17 -55.81 14.5 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.613 -0.68 . . . . 0.0 109.252 179.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.465 ' CD2' ' CB ' ' A' ' 130' ' ' LEU . 4.8 tp -52.03 -47.82 64.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.741 -0.6 . . . . 0.0 109.741 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 58.4 t -51.45 -43.76 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.498 -0.751 . . . . 0.0 109.697 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 23.0 t -57.55 -52.5 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.52 -0.738 . . . . 0.0 109.47 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.428 ' HG ' ' CB ' ' A' ' 70' ' ' PRO . 4.7 mp -50.51 -57.51 7.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.563 -0.711 . . . . 0.0 109.995 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -62.39 -30.13 70.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.415 -0.803 . . . . 0.0 109.69 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.9 mtt180 -68.01 -11.93 59.85 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.503 -0.748 . . . . 0.0 110.489 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.43 63.41 1.32 Allowed 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.162 -0.961 . . . . 0.0 110.859 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 53.51 101.53 0.01 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -151.97 101.25 2.72 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.256 -1.143 . . . . 0.0 110.122 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -55.82 93.62 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.493 -0.755 . . . . 0.0 109.92 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.511 ' HA ' HG22 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -84.67 8.38 17.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.35 -0.844 . . . . 0.0 110.548 -179.699 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.404 ' HB3' ' HA ' ' A' ' 134' ' ' ALA . 6.0 p30 -123.85 60.54 1.11 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.097 -1.002 . . . . 0.0 110.827 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.425 HG13 ' CG ' ' A' ' 80' ' ' ARG . 1.7 p -112.21 -170.48 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.134 -0.979 . . . . 0.0 109.766 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -138.54 126.11 22.01 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.298 -0.877 . . . . 0.0 109.788 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -66.05 133.94 51.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 0.0 109.657 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.468 ' HB2' ' HA ' ' A' ' 77' ' ' THR . . . -46.44 -31.56 2.75 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.553 -0.717 . . . . 0.0 110.909 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.439 ' CZ2' ' CG2' ' A' ' 77' ' ' THR . 7.3 m95 -59.56 -65.03 0.74 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.447 -0.783 . . . . 0.0 109.955 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 163.46 -28.33 0.23 Allowed Glycine 0 N--CA 1.48 1.618 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -85.8 137.5 32.74 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.287 -1.126 . . . . 0.0 110.422 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.472 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER -84.17 176.65 3.55 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.499 -0.751 . . . . 0.0 109.465 179.399 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.472 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 41.3 Cg_endo -68.51 -30.22 29.45 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.385 1.202 . . . . 0.0 109.559 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 4.8 p -82.99 -26.21 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.338 -0.852 . . . . 0.0 109.421 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -56.37 -40.65 74.9 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.502 -0.749 . . . . 0.0 110.664 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.5 pp -77.16 -27.78 53.89 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.217 -0.927 . . . . 0.0 109.94 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -69.21 -26.73 64.96 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.36 -0.838 . . . . 0.0 110.164 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -88.74 -34.35 17.18 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.365 -0.835 . . . . 0.0 109.646 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -74.37 -63.84 1.15 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.405 -0.809 . . . . 0.0 110.535 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -54.38 -86.77 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.246 -0.909 . . . . 0.0 110.602 -179.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 174.31 52.91 0.05 OUTLIER Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.429 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 44.7 m-70 -120.95 44.22 2.57 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.474 -1.015 . . . . 0.0 109.266 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -43.55 -38.19 2.83 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.759 -0.588 . . . . 0.0 110.538 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.421 ' O ' HD23 ' A' ' 91' ' ' LEU . 80.9 m-20 -56.79 -43.47 80.92 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.526 HG22 ' CD2' ' A' ' 91' ' ' LEU . 2.1 t -82.03 -40.03 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.488 ' O ' ' CB ' ' A' ' 131' ' ' ARG . . . -55.86 -45.4 78.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.394 -0.816 . . . . 0.0 109.657 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -74.9 -52.26 11.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.383 -0.823 . . . . 0.0 109.526 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.513 ' CG ' HD12 ' A' ' 91' ' ' LEU . 80.6 t80 -61.5 -65.16 0.73 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.453 -0.779 . . . . 0.0 110.851 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.465 ' CB ' ' CD2' ' A' ' 94' ' ' LEU . 0.3 OUTLIER -52.34 -26.16 11.57 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.285 -0.884 . . . . 0.0 110.499 -179.147 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.488 ' CB ' ' O ' ' A' ' 127' ' ' ALA . 17.2 ttt-85 -73.12 -42.63 62.68 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.122 -0.986 . . . . 0.0 109.543 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.28 -33.21 72.01 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -89.28 -22.58 22.62 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.426 ' CB ' ' O ' ' A' ' 130' ' ' LEU . . . -92.18 5.23 51.16 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.554 -0.716 . . . . 0.0 110.272 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -57.83 169.78 4.28 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 163.17 -28.14 0.24 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 16.4 p -117.98 -157.27 0.67 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.291 -1.123 . . . . 0.0 110.227 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.25 -153.49 0.47 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.487 -0.758 . . . . 0.0 109.952 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -149.71 -107.84 0.43 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.408 ' O ' ' O ' ' A' ' 141' ' ' ASN . 0.7 OUTLIER -58.47 177.19 0.14 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.278 -1.131 . . . . 0.0 109.574 179.517 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.408 ' O ' ' O ' ' A' ' 140' ' ' SER . 6.6 t30 57.29 108.85 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.302 -0.874 . . . . 0.0 110.257 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -46.54 154.73 0.28 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.261 -0.899 . . . . 0.0 110.795 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -165.45 -58.81 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.44 -0.788 . . . . 0.0 110.657 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 4.6 ttt-85 -72.17 112.87 8.62 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.365 -0.835 . . . . 0.0 110.818 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.4 tt -74.59 152.1 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.399 -0.813 . . . . 0.0 109.631 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.426 ' N ' ' OD1' ' A' ' 146' ' ' ASP . 27.3 p-10 -49.18 173.06 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.305 -0.872 . . . . 0.0 110.832 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -49.1 126.87 13.44 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.229 -0.92 . . . . 0.0 109.935 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 58.71 167.88 0.05 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.202 -0.936 . . . . 0.0 109.588 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -84.78 129.61 34.8 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.128 -0.982 . . . . 0.0 110.431 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 73.11 -144.69 35.15 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.47 147.52 46.55 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.623 1.328 . . . . 0.0 110.404 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 40.8 m -57.27 -176.76 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.474 -0.766 . . . . 0.0 110.21 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -170.33 -169.58 0.85 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.277 -0.889 . . . . 0.0 110.686 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.452 HG21 HD12 ' A' ' 154' ' ' ILE . 21.0 mm -131.7 88.44 42.56 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.47 -0.769 . . . . 0.0 109.584 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.29 142.16 33.25 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.795 1.418 . . . . 0.0 110.43 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 118.014 -0.994 . . . . 0.0 110.233 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.774 0 CA-C-O 121.121 0.486 . . . . 0.0 110.122 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -170.7 79.7 0.56 Allowed Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.416 -0.802 . . . . 0.0 110.359 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -74.03 93.23 0.88 Allowed 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.72 1.379 . . . . 0.0 110.194 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -100.31 54.89 0.9 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.383 -0.823 . . . . 0.0 110.384 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.32 -64.07 1.01 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.319 -0.863 . . . . 0.0 109.769 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.78 -145.93 24.01 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.6 m -59.69 162.39 5.25 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.45 -1.03 . . . . 0.0 110.523 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.6 t 179.81 165.31 1.15 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.594 -0.691 . . . . 0.0 109.599 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 52.83 31.81 11.26 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.291 -0.881 . . . . 0.0 110.332 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.1 123.33 64.3 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.35 -0.844 . . . . 0.0 110.438 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -73.03 75.22 2.8 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.672 1.354 . . . . 0.0 110.391 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.0 m -152.05 -42.91 0.11 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.366 -0.834 . . . . 0.0 110.166 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.66 -14.27 57.55 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.369 -0.832 . . . . 0.0 110.483 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -71.56 -5.76 35.71 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.286 -0.884 . . . . 0.0 110.909 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.538 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 27.8 m0 -75.34 -10.87 59.84 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.015 -1.053 . . . . 0.0 110.699 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.51 HD11 HD11 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -78.11 -54.62 6.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.183 -0.948 . . . . 0.0 109.924 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.459 ' N ' ' HG ' ' A' ' 16' ' ' LEU . . . -69.28 -40.03 77.99 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.097 -1.002 . . . . 0.0 109.813 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.538 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 2.8 p -51.43 -56.77 11.42 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.579 -0.7 . . . . 0.0 110.687 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.441 ' CB ' HG23 ' A' ' 28' ' ' VAL . . . -56.49 -38.54 71.89 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.269 -0.895 . . . . 0.0 110.227 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.61 -23.99 66.95 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.292 -0.88 . . . . 0.0 110.14 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.54 -27.65 31.52 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.281 -0.887 . . . . 0.0 110.606 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 -94.31 22.75 5.69 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.293 -0.88 . . . . 0.0 110.454 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 55.57 66.57 2.74 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.75 75.62 1.48 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.382 -1.069 . . . . 0.0 109.588 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.414 HG11 ' HB3' ' A' ' 58' ' ' ARG . 11.6 t -56.19 -53.26 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.357 -0.84 . . . . 0.0 110.246 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -45.92 -42.23 12.52 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.457 -0.777 . . . . 0.0 111.067 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -64.78 -46.64 81.22 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.319 -0.863 . . . . 0.0 109.776 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.477 ' C ' HD22 ' A' ' 62' ' ' LEU . 13.7 t -73.49 -45.41 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.412 -0.805 . . . . 0.0 109.548 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.517 ' HG2' HD21 ' A' ' 62' ' ' LEU . 27.6 mmm-85 -48.53 -43.52 35.42 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.536 -0.727 . . . . 0.0 109.902 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.26 -45.32 33.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.542 -0.724 . . . . 0.0 109.896 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.1 mt -54.42 -56.96 13.37 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.281 -0.887 . . . . 0.0 109.876 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.566 HD22 ' CB ' ' A' ' 66' ' ' HIS . 3.0 mt -57.42 -44.82 84.95 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.394 -0.816 . . . . 0.0 110.077 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -63.18 -17.42 62.37 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.507 -0.746 . . . . 0.0 110.188 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.43 -14.12 31.11 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.325 -0.86 . . . . 0.0 110.167 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.63 28.13 1.64 Allowed Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.951 -1.119 . . . . 0.0 110.403 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.422 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . . . -58.7 152.3 19.11 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.208 -1.172 . . . . 0.0 110.078 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -66.71 122.08 80.5 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.409 -0.807 . . . . 0.0 109.989 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.408 ' HB2' ' HA3' ' A' ' 67' ' ' GLY . 42.4 Cg_endo -68.8 -42.68 4.31 Favored 'Trans proline' 0 C--N 1.312 -1.342 0 O-C-N 123.601 1.316 . . . . 0.0 110.361 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -108.9 56.71 0.62 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.429 -0.794 . . . . 0.0 109.592 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -94.38 117.2 67.05 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.396 -0.815 . . . . 0.0 110.193 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.53 109.56 2.49 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.626 1.329 . . . . 0.0 110.072 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -50.86 175.59 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.448 -0.782 . . . . 0.0 110.882 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.4 t -87.01 4.83 40.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.542 -0.724 . . . . 0.0 110.78 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -117.01 31.33 6.81 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.119 -0.988 . . . . 0.0 109.94 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 55.38 23.47 34.39 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.57 141.31 48.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.405 -1.056 . . . . 0.0 110.049 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.483 ' CG ' ' HB2' ' A' ' 69' ' ' GLU . 0.2 OUTLIER -57.12 176.96 0.21 Allowed Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.543 -0.723 . . . . 0.0 110.417 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 41.1 Cg_endo -67.29 -24.41 43.69 Favored 'Trans proline' 0 C--N 1.315 -1.208 0 O-C-N 123.576 1.303 . . . . 0.0 111.116 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.452 HG23 HD12 ' A' ' 49' ' ' ILE . 7.2 mt -109.01 -31.13 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.9 -1.125 . . . . 0.0 109.064 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.412 ' HA ' ' OD2' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -51.5 -25.9 7.38 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.563 -0.711 . . . . 0.0 109.992 179.365 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.9 p -97.21 3.34 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.21 -0.931 . . . . 0.0 109.881 179.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.431 ' HB3' ' SD ' ' A' ' 54' ' ' MET . 51.6 ttp -56.13 164.54 1.23 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.491 -0.756 . . . . 0.0 110.256 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 3.5 tmm? -75.49 -6.81 52.05 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.252 -0.905 . . . . 0.0 111.0 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.471 ' SD ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 52.55 23.42 2.57 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.181 -0.949 . . . . 0.0 110.192 -179.694 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -122.06 8.45 9.82 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -160.11 106.13 1.56 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.445 -1.033 . . . . 0.0 109.903 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.79 -26.42 68.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.325 -0.86 . . . . 0.0 109.977 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.414 ' HB3' HG11 ' A' ' 25' ' ' VAL . 53.8 mtt180 -50.68 -29.17 10.5 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.348 -0.845 . . . . 0.0 109.858 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.403 ' HB ' ' SD ' ' A' ' 52' ' ' MET . 49.0 t -74.75 -56.31 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.442 ' O ' ' CB ' ' A' ' 64' ' ' LEU . . . -54.09 -45.13 71.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.303 -0.873 . . . . 0.0 109.508 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -61.96 -35.05 77.31 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.273 -0.892 . . . . 0.0 109.197 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.535 ' O ' ' HB2' ' A' ' 66' ' ' HIS . 1.1 tp -71.86 -48.42 46.03 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.525 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 1.0 OUTLIER -72.7 -37.8 67.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.55 -0.719 . . . . 0.0 109.998 179.7 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.442 ' CB ' ' O ' ' A' ' 60' ' ' ALA . 0.6 OUTLIER -65.26 -63.2 1.16 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.431 -0.793 . . . . 0.0 110.411 -179.853 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.402 ' HG ' ' N ' ' A' ' 66' ' ' HIS . 0.4 OUTLIER -52.75 -25.31 10.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.877 . . . . 0.0 109.54 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.566 ' CB ' HD22 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -80.54 -52.13 7.96 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.559 -0.713 . . . . 0.0 109.431 179.412 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.408 ' HA3' ' HB2' ' A' ' 38' ' ' PRO . . . 159.57 32.56 0.02 OUTLIER Glycine 0 N--CA 1.481 1.643 0 C-N-CA 119.672 -1.251 . . . . 0.0 111.456 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.525 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -70.39 172.21 8.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.52 -1.576 . . . . 0.0 109.363 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.483 ' HB2' ' CG ' ' A' ' 47' ' ' ARG . 6.5 mm-40 -108.76 78.61 0.94 Allowed Pre-proline 0 C--N 1.301 -1.51 0 O-C-N 121.341 -0.849 . . . . 0.0 109.54 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.429 ' HB3' ' CD2' ' A' ' 97' ' ' LEU . 43.1 Cg_endo -68.42 -10.75 29.94 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.9 1.474 . . . . 0.0 110.521 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.3 -61.21 1.48 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.102 -0.999 . . . . 0.0 110.036 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 3.9 t -46.51 149.59 0.77 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.462 -0.774 . . . . 0.0 111.108 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -140.43 -148.14 0.24 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.503 -0.748 . . . . 0.0 109.79 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.477 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.4 OUTLIER -104.63 140.41 21.05 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.124 -0.985 . . . . 0.0 109.79 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -76.19 -12.64 19.21 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.345 1.182 . . . . 0.0 110.679 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.53 -43.9 25.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.248 -0.907 . . . . 0.0 110.27 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.606 ' CG2' ' CZ3' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -133.22 9.8 4.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.264 -0.897 . . . . 0.0 110.614 179.793 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.477 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 0.8 OUTLIER 46.38 40.51 7.97 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.338 -0.851 . . . . 0.0 111.18 179.708 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.3 m -78.45 100.15 6.73 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.917 . . . . 0.0 110.17 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.487 ' CG ' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -69.4 161.78 71.21 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.361 -0.837 . . . . 0.0 109.393 179.769 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.487 ' HD2' ' CG ' ' A' ' 80' ' ' ARG . 44.0 Cg_endo -70.6 -16.68 34.06 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.451 1.238 . . . . 0.0 109.936 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 74.4 t -59.68 -27.79 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.417 -0.802 . . . . 0.0 109.662 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.512 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 4.8 m80 -75.7 -33.93 60.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.496 -0.753 . . . . 0.0 109.056 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.471 ' HB3' ' SD ' ' A' ' 54' ' ' MET . 3.3 m-20 -57.28 -49.03 77.36 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.806 -0.559 . . . . 0.0 109.852 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.448 ' HB1' HD12 ' A' ' 94' ' ' LEU . . . -58.68 -62.27 1.99 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.331 -0.856 . . . . 0.0 109.179 178.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.484 ' O ' ' CD2' ' A' ' 123' ' ' HIS . . . -55.62 -49.57 72.47 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.299 -0.876 . . . . 0.0 110.839 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 5.4 tpp85 -40.7 -38.99 0.99 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.38 -0.825 . . . . 0.0 111.401 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.37 -2.62 35.82 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.044 -1.035 . . . . 0.0 111.032 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.45 19.1 59.16 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.454 ' O ' ' CD1' ' A' ' 94' ' ' LEU . 1.0 OUTLIER -91.08 132.19 36.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.186 -1.185 . . . . 0.0 109.915 179.736 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.468 ' CD1' ' O ' ' A' ' 125' ' ' ASP . 0.4 OUTLIER -108.76 -43.6 4.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.393 -0.817 . . . . 0.0 110.354 179.859 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -45.82 -29.25 1.28 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.476 -0.765 . . . . 0.0 110.052 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.429 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 11.8 m -73.4 -43.94 59.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.644 -0.66 . . . . 0.0 109.448 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.454 ' CD1' ' O ' ' A' ' 90' ' ' PHE . 0.8 OUTLIER -56.0 -50.29 71.27 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.259 -0.901 . . . . 0.0 110.023 179.716 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.434 ' O ' ' CB ' ' A' ' 99' ' ' ARG . 43.5 t -53.78 -49.43 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.5 -0.75 . . . . 0.0 109.366 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 70.3 t -52.92 -47.71 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.515 -0.74 . . . . 0.0 109.632 179.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.429 ' CD2' ' HB3' ' A' ' 70' ' ' PRO . 96.6 mt -56.66 -72.63 0.07 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.513 -0.742 . . . . 0.0 109.986 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 17.3 t-160 -51.42 -33.35 30.19 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.477 -0.765 . . . . 0.0 110.465 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.434 ' CB ' ' O ' ' A' ' 95' ' ' VAL . 3.5 ttm180 -66.09 -15.49 63.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.41 -0.806 . . . . 0.0 110.517 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.413 ' HB2' ' CD2' ' A' ' 64' ' ' LEU . . . -142.52 75.5 1.49 Allowed 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.106 -0.996 . . . . 0.0 110.955 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 51.47 97.76 0.01 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -164.33 101.62 0.84 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.358 -1.083 . . . . 0.0 110.08 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 11.1 ttt180 -61.0 120.21 9.8 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.462 -0.774 . . . . 0.0 110.198 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.18 10.06 41.25 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.5 -0.75 . . . . 0.0 110.508 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -124.51 55.55 1.32 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.309 -0.869 . . . . 0.0 110.318 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.418 HG22 ' CZ ' ' A' ' 80' ' ' ARG . 2.3 p -106.37 -169.28 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.394 -0.817 . . . . 0.0 109.613 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 6.8 mtt180 -140.31 151.64 45.22 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.333 -0.854 . . . . 0.0 110.019 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -77.95 59.96 2.24 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.314 -0.867 . . . . 0.0 109.69 179.662 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.459 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 61.38 -65.97 0.07 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.742 -0.599 . . . . 0.0 110.672 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.606 ' CZ3' ' CG2' ' A' ' 77' ' ' THR . 5.4 m-90 -66.18 -58.51 5.25 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.2 -0.937 . . . . 0.0 110.321 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 176.0 -24.85 0.06 OUTLIER Glycine 0 N--CA 1.483 1.828 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.13 157.78 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.321 -1.106 . . . . 0.0 111.132 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.45 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER -126.71 169.95 10.88 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.323 -0.861 . . . . 0.0 110.402 -179.655 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.45 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 43.3 Cg_endo -70.33 -45.21 1.35 Allowed 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.633 1.333 . . . . 0.0 109.656 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 10.2 p -62.78 -28.05 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.401 -0.812 . . . . 0.0 109.243 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.3 -40.37 81.8 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.434 -0.791 . . . . 0.0 109.976 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.14 -22.59 64.86 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.397 -0.814 . . . . 0.0 110.128 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.438 ' HB3' ' HB2' ' A' ' 123' ' ' HIS . . . -80.39 -53.97 6.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.375 -0.828 . . . . 0.0 110.429 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -57.63 -27.53 62.88 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.287 -0.883 . . . . 0.0 110.431 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -72.11 -51.39 21.67 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.399 -0.813 . . . . 0.0 110.219 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.492 ' HB2' ' CD2' ' A' ' 123' ' ' HIS . 37.5 mt -85.41 1.17 49.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.312 -0.868 . . . . 0.0 110.599 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 75.72 40.95 30.2 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.492 ' CD2' ' HB2' ' A' ' 121' ' ' LEU . 25.3 m-70 -89.8 55.43 3.17 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.02 -1.282 . . . . 0.0 109.465 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 28.7 mtt-85 -44.48 -38.19 3.96 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.773 -0.579 . . . . 0.0 110.278 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.468 ' O ' ' CD1' ' A' ' 91' ' ' LEU . 0.5 OUTLIER -58.4 -48.36 80.9 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.39 -0.819 . . . . 0.0 109.071 178.919 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.474 HG13 ' HA ' ' A' ' 86' ' ' ALA . 3.5 t -81.33 -43.65 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.473 -0.767 . . . . 0.0 110.244 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -54.71 -49.51 70.57 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.292 -0.88 . . . . 0.0 110.541 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.1 mtp-105 -56.02 -55.13 36.6 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.208 -0.933 . . . . 0.0 110.18 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -65.03 -33.65 76.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.393 -0.817 . . . . 0.0 110.05 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.433 ' O ' ' N ' ' A' ' 134' ' ' ALA . 10.9 mt -66.29 -67.96 0.41 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.345 -0.847 . . . . 0.0 110.468 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -48.18 -24.62 1.2 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.353 -0.842 . . . . 0.0 110.857 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -82.81 -53.8 5.6 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.306 -0.871 . . . . 0.0 110.017 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -87.44 5.98 36.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.399 -0.813 . . . . 0.0 111.034 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 130' ' ' LEU . . . -115.88 51.94 0.92 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.096 -1.003 . . . . 0.0 110.514 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 57.11 -137.79 48.72 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 113.81 13.88 9.89 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 50.7 p 42.76 73.98 0.12 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.572 -0.957 . . . . 0.0 110.957 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.14 101.79 0.44 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.339 -0.85 . . . . 0.0 109.937 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 148.37 -26.5 1.38 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.5 t -156.81 -168.52 2.69 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.316 -1.108 . . . . 0.0 110.016 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -134.35 51.05 2.14 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.261 -0.899 . . . . 0.0 110.206 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 4.4 m80 -135.98 -80.59 0.41 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.308 -0.87 . . . . 0.0 110.352 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -165.79 48.93 0.09 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.244 -0.91 . . . . 0.0 109.944 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.51 173.01 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.389 -0.819 . . . . 0.0 110.413 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.4 tp -52.91 149.18 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.482 -0.761 . . . . 0.0 110.222 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 56.6 104.29 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.336 -0.853 . . . . 0.0 110.196 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -49.37 143.16 6.74 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.393 -0.817 . . . . 0.0 110.652 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.24 157.28 1.43 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.466 -0.771 . . . . 0.0 110.353 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -87.53 136.93 32.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.334 -0.854 . . . . 0.0 110.388 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 165.73 132.98 1.44 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -74.05 108.24 2.61 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.669 1.352 . . . . 0.0 110.347 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 51.5 p -79.86 155.75 27.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.413 -0.804 . . . . 0.0 110.242 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -61.03 127.34 31.08 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.43 -0.794 . . . . 0.0 109.873 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.422 ' O ' ' CG1' ' A' ' 154' ' ' ILE . 1.2 pp -129.34 88.49 50.48 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.256 -0.903 . . . . 0.0 110.606 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.81 95.12 0.8 Allowed 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.613 1.322 . . . . 0.0 110.151 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.268 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.09 0.471 . . . . 0.0 110.228 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.52 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -48.94 -61.29 3.46 Favored Pre-proline 0 N--CA 1.499 2.009 0 O-C-N 121.453 -0.779 . . . . 0.0 110.595 -179.757 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.52 ' CD ' ' CB ' ' A' ' 2' ' ' GLU . 45.5 Cg_endo -72.75 86.51 1.05 Allowed 'Trans proline' 0 C--N 1.316 -1.161 0 O-C-N 123.561 1.295 . . . . 0.0 110.633 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 176.54 -168.87 0.06 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.419 -0.801 . . . . 0.0 109.764 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -141.36 45.01 1.75 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.333 -0.854 . . . . 0.0 110.432 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 116.11 129.32 4.41 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.8 m -53.09 -96.48 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.356 -1.085 . . . . 0.0 110.948 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 m -109.63 -170.59 1.68 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.809 -1.182 . . . . 0.0 110.403 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.0 132.65 50.97 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.498 -0.751 . . . . 0.0 110.326 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.463 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 5.1 mt-10 -69.87 -54.68 9.76 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.359 -0.838 . . . . 0.0 110.373 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 10' ' ' GLU . 48.1 Cg_endo -73.98 69.88 4.58 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 O-C-N 123.547 1.288 . . . . 0.0 110.71 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 31.9 p -159.08 110.66 2.11 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.359 -0.838 . . . . 0.0 110.546 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 49.85 24.41 1.28 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.366 -0.834 . . . . 0.0 110.888 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.472 ' O ' ' OG1' ' A' ' 18' ' ' THR . 0.4 OUTLIER -85.13 -44.5 12.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.221 -0.924 . . . . 0.0 109.8 179.774 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.514 ' CD1' ' N ' ' A' ' 15' ' ' TRP . 37.0 m0 -69.76 -4.79 21.43 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.583 -0.698 . . . . 0.0 110.348 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.494 ' CD2' ' O ' ' A' ' 37' ' ' LEU . 0.8 OUTLIER -78.0 -55.66 5.11 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.268 -0.895 . . . . 0.0 109.641 179.594 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.405 ' N ' ' HG ' ' A' ' 16' ' ' LEU . . . -73.15 -37.3 66.64 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.261 -0.899 . . . . 0.0 110.752 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.489 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.7 OUTLIER -59.91 -50.67 72.85 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.291 -0.881 . . . . 0.0 110.94 -179.559 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.518 ' CB ' HG22 ' A' ' 28' ' ' VAL . . . -61.82 -36.19 80.43 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.276 -0.89 . . . . 0.0 110.526 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.01 -33.38 71.92 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.339 -0.851 . . . . 0.0 110.008 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 51' ' ' VAL . . . -81.34 -28.55 34.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.442 -0.787 . . . . 0.0 110.441 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.4 ttt180 -92.7 32.62 1.21 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.379 -0.826 . . . . 0.0 110.778 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 47.22 47.74 21.02 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.427 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -117.07 95.56 5.05 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.195 -1.179 . . . . 0.0 110.129 179.857 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.441 ' CG1' ' HD3' ' A' ' 29' ' ' ARG . 57.3 t -73.13 -57.59 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.567 -0.708 . . . . 0.0 110.019 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -47.63 -51.42 21.43 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.596 -0.69 . . . . 0.0 111.071 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.415 ' HB3' ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -48.58 -53.75 17.15 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.486 -0.759 . . . . 0.0 110.022 179.827 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.518 HG22 ' CB ' ' A' ' 19' ' ' ALA . 4.8 t -72.98 -50.68 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.365 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.441 ' HD3' ' CG1' ' A' ' 25' ' ' VAL . 0.1 OUTLIER -45.46 -49.62 13.31 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.317 -0.864 . . . . 0.0 109.898 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.12 -35.88 66.63 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.583 -0.698 . . . . 0.0 109.829 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.453 ' C ' ' HB2' ' A' ' 36' ' ' ALA . 14.8 mt -64.19 -58.55 6.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.363 -0.836 . . . . 0.0 110.437 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.499 ' CD2' ' CG ' ' A' ' 66' ' ' HIS . 0.5 OUTLIER -50.05 -37.83 35.18 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.184 -0.948 . . . . 0.0 110.292 -179.568 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -79.33 -16.17 56.75 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.394 -0.816 . . . . 0.0 110.164 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -93.48 -4.98 50.19 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.231 -0.918 . . . . 0.0 111.435 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 134.06 -19.7 4.1 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.434 -1.365 . . . . 0.0 110.937 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.453 ' HB2' ' C ' ' A' ' 31' ' ' LEU . . . -46.12 121.14 3.1 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.07 -1.253 . . . . 0.0 110.594 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.522 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 0.7 OUTLIER -75.48 128.67 83.69 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.396 -0.815 . . . . 0.0 110.421 -179.434 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.484 ' HB2' ' C ' ' A' ' 67' ' ' GLY . 46.3 Cg_endo -68.97 -37.77 10.61 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 O-C-N 123.493 1.259 . . . . 0.0 111.185 -179.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.53 48.95 1.16 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.148 -0.97 . . . . 0.0 110.069 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.522 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -100.87 95.88 5.02 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.189 -0.944 . . . . 0.0 110.192 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.43 128.76 18.84 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.432 1.227 . . . . 0.0 110.245 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -122.18 178.16 5.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.363 -0.836 . . . . 0.0 110.499 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.448 ' O ' ' CB ' ' A' ' 44' ' ' TYR . 1.1 p -60.8 -157.11 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.427 -0.796 . . . . 0.0 110.042 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.454 ' CD2' ' HG3' ' A' ' 46' ' ' ARG . 3.5 t80 68.17 5.87 4.92 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.423 -0.798 . . . . 0.0 110.644 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 52.04 25.65 17.77 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.454 ' HG3' ' CD2' ' A' ' 44' ' ' TYR . 0.1 OUTLIER -116.8 -167.45 1.3 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.317 -1.108 . . . . 0.0 110.87 -179.585 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.579 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -124.3 -161.45 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.805 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -179.884 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.579 ' CD ' ' CB ' ' A' ' 47' ' ' ARG . 51.2 Cg_endo -78.69 -32.19 2.18 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 O-C-N 122.698 0.841 . . . . 0.0 110.921 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.495 HG13 ' CB ' ' A' ' 68' ' ' ALA . 5.7 mt -109.02 -36.77 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 120.869 -1.145 . . . . 0.0 109.91 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.428 ' OE1' ' HA ' ' A' ' 46' ' ' ARG . 17.0 tt0 -48.62 -26.56 2.31 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.248 -0.908 . . . . 0.0 109.518 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.438 ' HB ' ' HB3' ' A' ' 46' ' ' ARG . 8.3 p -97.12 21.39 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.491 -0.756 . . . . 0.0 110.382 179.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.486 ' HB2' ' O ' ' A' ' 49' ' ' ILE . 0.4 OUTLIER -77.18 159.1 29.96 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.139 -0.975 . . . . 0.0 109.761 179.579 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 37.6 ttp -70.09 -5.4 26.6 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.261 -0.899 . . . . 0.0 110.165 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.454 ' SD ' ' N ' ' A' ' 85' ' ' ALA . 16.0 mmt 49.68 28.26 2.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.348 -0.845 . . . . 0.0 109.835 -179.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.439 ' C ' ' CE2' ' A' ' 90' ' ' PHE . . . -124.33 5.7 8.74 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 178.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -156.1 85.72 1.02 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.654 -0.909 . . . . 0.0 109.221 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.402 ' HB2' ' HB3' ' A' ' 92' ' ' ASP . . . -46.98 -26.94 1.12 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.589 -0.694 . . . . 0.0 110.102 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -46.55 -42.71 16.29 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.662 -0.649 . . . . 0.0 109.798 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.9 t -65.74 -60.63 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.63 -0.669 . . . . 0.0 109.282 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -48.43 -47.63 37.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.456 -0.778 . . . . 0.0 109.311 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.485 ' O ' HD23 ' A' ' 65' ' ' LEU . 0.5 OUTLIER -60.19 -40.76 91.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.589 -0.694 . . . . 0.0 109.263 178.685 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.511 ' O ' ' HB2' ' A' ' 66' ' ' HIS . 2.8 tp -66.27 -51.99 51.99 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.461 -0.774 . . . . 0.0 109.474 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.472 ' HB3' ' CG1' ' A' ' 49' ' ' ILE . 2.8 mt -67.86 -41.54 82.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.313 -0.867 . . . . 0.0 110.16 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.463 ' N ' HD13 ' A' ' 49' ' ' ILE . 0.5 OUTLIER -68.78 -57.98 4.84 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.192 -0.943 . . . . 0.0 110.372 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.485 ' CD1' ' C ' ' A' ' 65' ' ' LEU . 1.3 pp -49.94 -25.63 3.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.118 -0.989 . . . . 0.0 109.096 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.511 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 1.4 m-70 -82.11 -51.32 8.11 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.789 -0.569 . . . . 0.0 109.481 179.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.484 ' C ' ' HB2' ' A' ' 38' ' ' PRO . . . 152.74 38.78 0.03 OUTLIER Glycine 0 N--CA 1.485 1.914 0 C-N-CA 120.03 -1.081 . . . . 0.0 110.794 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.495 ' CB ' HG13 ' A' ' 49' ' ' ILE . . . -69.67 -170.19 0.29 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.867 -1.372 . . . . 0.0 110.06 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -109.17 79.37 1.17 Allowed Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.39 -0.818 . . . . 0.0 109.611 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.83 -12.55 31.01 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.8 1.421 . . . . 0.0 110.546 -179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.527 ' O ' ' NE ' ' A' ' 80' ' ' ARG . 26.3 t-20 -113.43 -58.46 2.15 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.285 -0.884 . . . . 0.0 110.669 -179.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.417 ' C ' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -41.1 137.46 1.31 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.26 -0.9 . . . . 0.0 110.918 -179.515 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -131.43 -155.22 0.68 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.623 -0.673 . . . . 0.0 110.286 -179.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -106.15 145.52 31.11 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.197 -0.939 . . . . 0.0 110.487 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -75.57 -25.4 11.04 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.712 1.375 . . . . 0.0 110.048 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.11 -59.32 5.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.314 -0.866 . . . . 0.0 110.175 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.515 ' CA ' ' HB3' ' A' ' 109' ' ' ALA . 2.2 t -137.0 29.31 2.82 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.337 -0.852 . . . . 0.0 110.908 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 20.2 mt 51.53 52.91 13.72 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.203 -0.936 . . . . 0.0 111.372 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.449 ' OG1' HG21 ' A' ' 77' ' ' THR . 16.7 m -83.41 106.48 15.2 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.032 -1.042 . . . . 0.0 109.736 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.529 ' CG ' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -95.35 170.66 7.5 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.372 -0.83 . . . . 0.0 109.721 179.745 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.529 ' HD2' ' CG ' ' A' ' 80' ' ' ARG . 48.1 Cg_endo -71.74 -0.09 7.83 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.564 1.297 . . . . 0.0 110.425 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.412 HG13 ' CB ' ' A' ' 114' ' ' PRO . 43.3 t -79.87 -45.04 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -0.932 . . . . 0.0 110.279 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.429 ' O ' ' CB ' ' A' ' 87' ' ' ARG . 37.4 m80 -59.01 -37.73 77.58 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.389 -0.819 . . . . 0.0 109.221 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.42 ' HB3' ' CG ' ' A' ' 54' ' ' MET . 62.3 m-20 -54.43 -57.55 10.88 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.714 -0.616 . . . . 0.0 110.566 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.489 ' HB3' ' CD1' ' A' ' 94' ' ' LEU . . . -51.01 -63.83 1.0 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.102 -0.998 . . . . 0.0 109.884 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.584 ' O ' ' CD2' ' A' ' 123' ' ' HIS . . . -56.65 -50.73 71.2 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.337 -0.852 . . . . 0.0 110.687 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.429 ' CB ' ' O ' ' A' ' 83' ' ' HIS . 11.0 tpp85 -43.44 -28.82 0.39 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.294 -0.879 . . . . 0.0 110.852 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -103.59 -11.12 17.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.397 -0.814 . . . . 0.0 110.459 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.35 34.55 12.0 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.439 ' CE2' ' C ' ' A' ' 55' ' ' GLY . 0.4 OUTLIER -108.28 121.15 44.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.112 -1.228 . . . . 0.0 110.732 -179.818 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.417 HD23 ' CD2' ' A' ' 129' ' ' TYR . 0.4 OUTLIER -94.75 -41.65 9.14 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.497 -0.752 . . . . 0.0 110.222 179.737 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.458 ' O ' ' CG2' ' A' ' 96' ' ' VAL . 0.4 OUTLIER -52.05 -30.15 24.46 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.348 -0.845 . . . . 0.0 109.088 179.53 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.4 m -72.85 -38.57 67.03 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.535 ' CD2' ' HG ' ' A' ' 130' ' ' LEU . 1.6 tp -64.42 -47.72 78.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.571 -0.705 . . . . 0.0 109.416 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.429 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 41.4 t -57.2 -48.31 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.47 -0.769 . . . . 0.0 108.951 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.478 HG13 ' HA ' ' A' ' 61' ' ' GLU . 98.7 t -52.56 -53.78 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.781 -0.574 . . . . 0.0 110.072 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.419 ' C ' ' CB ' ' A' ' 102' ' ' ALA . 0.3 OUTLIER -52.56 -65.29 0.58 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.391 -0.818 . . . . 0.0 109.965 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -58.48 -28.47 65.38 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.272 -0.893 . . . . 0.0 110.339 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 17.7 ttp180 -67.16 -15.83 63.94 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.256 -0.903 . . . . 0.0 110.424 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.95 72.35 1.33 Allowed 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.347 -0.845 . . . . 0.0 110.863 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 54.64 102.79 0.01 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.419 ' CB ' ' C ' ' A' ' 97' ' ' LEU . . . -163.57 102.47 0.93 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.333 -1.098 . . . . 0.0 110.167 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -71.63 98.26 1.87 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.428 -0.795 . . . . 0.0 110.015 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.408 ' HA ' ' CG2' ' A' ' 82' ' ' VAL . 1.1 mp -89.9 10.53 23.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.451 -0.78 . . . . 0.0 109.706 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -103.13 36.88 2.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.311 -0.868 . . . . 0.0 110.719 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.498 ' CB ' ' HD3' ' A' ' 80' ' ' ARG . 0.7 OUTLIER -98.25 -171.82 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.024 -1.047 . . . . 0.0 109.77 179.555 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.483 ' N ' HG11 ' A' ' 106' ' ' VAL . 4.4 ptt-85 -140.44 135.48 32.05 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.625 -0.672 . . . . 0.0 109.666 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.509 ' O ' ' N ' ' A' ' 110' ' ' TRP . 41.9 p-10 -79.47 44.04 0.59 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.125 -0.984 . . . . 0.0 110.615 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.515 ' HB3' ' CA ' ' A' ' 77' ' ' THR . . . 38.71 -86.52 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.135 0 CA-C-O 121.006 0.431 . . . . 0.0 112.122 178.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.509 ' N ' ' O ' ' A' ' 108' ' ' ASP . 7.7 m0 -76.75 51.08 0.74 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.257 -0.902 . . . . 0.0 110.856 -179.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.492 ' O ' ' CG ' ' A' ' 112' ' ' ARG . . . -155.31 -89.34 0.07 OUTLIER Glycine 0 N--CA 1.479 1.521 0 N-CA-C 108.338 -1.905 . . . . 0.0 108.338 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.492 ' CG ' ' O ' ' A' ' 111' ' ' GLY . 0.0 OUTLIER 164.85 -57.48 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 O-C-N 122.084 -0.656 . . . . 0.0 109.773 179.079 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.432 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.0 OUTLIER -173.43 159.62 3.27 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.237 -0.914 . . . . 0.0 110.666 -179.603 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.432 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 42.1 Cg_endo -68.27 -29.26 32.56 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.674 1.355 . . . . 0.0 110.743 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.488 ' HA ' HD12 ' A' ' 130' ' ' LEU . 9.8 p -78.71 -32.69 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.999 -1.063 . . . . 0.0 109.834 179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -64.39 -26.89 68.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.345 -0.847 . . . . 0.0 109.367 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.47 -37.03 74.22 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.506 -0.746 . . . . 0.0 109.636 179.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.481 ' CB ' ' HB2' ' A' ' 123' ' ' HIS . . . -70.18 -35.89 74.28 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.447 -0.783 . . . . 0.0 109.915 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -63.33 -39.1 93.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.42 -0.8 . . . . 0.0 110.307 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.05 -69.62 0.51 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.371 -0.831 . . . . 0.0 110.396 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.413 HD23 ' NE2' ' A' ' 123' ' ' HIS . 0.2 OUTLIER -47.3 -89.14 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.499 -0.751 . . . . 0.0 111.142 -179.54 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 173.53 36.56 0.04 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.584 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 51.6 m-70 -101.19 43.99 1.03 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.364 -1.08 . . . . 0.0 109.11 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.77 -53.87 4.37 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-O 121.211 0.529 . . . . 0.0 110.698 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -51.45 -40.29 59.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.422 -0.799 . . . . 0.0 109.426 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.44 ' CG1' ' HA ' ' A' ' 86' ' ' ALA . 2.0 t -78.73 -35.5 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.383 -0.823 . . . . 0.0 109.611 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.06 -48.05 83.0 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.215 -0.928 . . . . 0.0 109.805 179.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.5 ttm180 -50.0 -63.94 0.96 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.486 -0.759 . . . . 0.0 109.854 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.417 ' CD2' HD23 ' A' ' 91' ' ' LEU . 3.5 t80 -52.93 -55.21 25.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.556 -0.715 . . . . 0.0 110.393 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.535 ' HG ' ' CD2' ' A' ' 94' ' ' LEU . 25.2 mt -48.07 -48.78 33.16 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.558 -0.713 . . . . 0.0 109.945 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.81 -28.95 17.24 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.367 -0.833 . . . . 0.0 109.929 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -89.0 -54.02 4.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.485 -0.759 . . . . 0.0 110.361 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -75.71 -7.49 54.49 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.32 -0.862 . . . . 0.0 110.902 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 130' ' ' LEU . . . -112.73 -60.31 1.89 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.094 -1.003 . . . . 0.0 110.067 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 114.35 91.32 1.83 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -90.91 129.89 10.01 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 37.6 p -68.36 134.02 49.62 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.425 -1.044 . . . . 0.0 110.253 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.6 155.46 44.97 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.338 -0.851 . . . . 0.0 110.488 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -79.78 -5.63 89.36 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.07 -88.49 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.311 -1.111 . . . . 0.0 110.293 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -107.85 78.48 1.19 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.057 -1.027 . . . . 0.0 110.022 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -78.32 78.92 4.78 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.221 -0.924 . . . . 0.0 109.95 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -98.31 8.2 45.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.311 -0.868 . . . . 0.0 110.34 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 10.0 ttt180 -83.33 126.72 32.99 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.216 -0.928 . . . . 0.0 109.957 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -85.87 155.34 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.302 -0.874 . . . . 0.0 109.536 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -51.48 172.82 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.179 -0.951 . . . . 0.0 110.268 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.92 132.94 49.83 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.145 -0.972 . . . . 0.0 110.147 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.33 145.41 38.1 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.239 -0.913 . . . . 0.0 109.755 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -45.39 111.8 0.38 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.31 -0.869 . . . . 0.0 110.101 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -160.83 118.92 0.85 Allowed Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.516 -1.326 . . . . 0.0 110.47 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -74.3 -165.72 0.28 Allowed 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.76 1.4 . . . . 0.0 110.826 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.93 112.91 0.86 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.402 -0.811 . . . . 0.0 110.661 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -69.67 155.75 40.03 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.409 -0.807 . . . . 0.0 110.21 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 11.6 pt -103.0 161.98 21.49 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.248 -0.908 . . . . 0.0 110.418 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.5 127.6 11.93 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.856 1.451 . . . . 0.0 110.139 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.1 t70 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 118.083 -0.961 . . . . 0.0 109.998 -179.749 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.138 0.494 . . . . 0.0 110.279 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.97 128.34 5.58 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.221 -0.924 . . . . 0.0 110.575 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -76.03 59.38 5.85 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.575 1.303 . . . . 0.0 110.561 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 48.59 82.12 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.414 -0.804 . . . . 0.0 110.701 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 59.68 87.96 0.08 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.52 -0.738 . . . . 0.0 110.275 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -121.37 20.8 8.3 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.7 p -89.58 28.86 1.22 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.297 -1.12 . . . . 0.0 110.383 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.3 t -102.1 108.22 19.56 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.374 -0.829 . . . . 0.0 110.055 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 16.4 mtp -88.9 -60.06 2.06 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.265 -0.897 . . . . 0.0 110.468 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -116.08 77.31 6.96 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.345 -0.847 . . . . 0.0 110.279 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -70.89 109.74 2.61 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 O-C-N 123.568 1.299 . . . . 0.0 109.78 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -47.41 161.13 0.09 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.484 -0.76 . . . . 0.0 110.986 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -173.53 -39.83 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.568 -0.708 . . . . 0.0 110.006 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -92.73 -16.64 25.21 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.376 -0.827 . . . . 0.0 111.03 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.53 ' CG ' HD13 ' A' ' 31' ' ' LEU . 3.2 t90 -72.49 -2.4 19.5 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.089 -1.007 . . . . 0.0 110.932 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.469 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 31.7 mt -81.58 -53.86 5.9 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.072 -1.017 . . . . 0.0 109.545 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.45 -38.33 87.13 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.605 -0.685 . . . . 0.0 110.245 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.45 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.1 OUTLIER -60.66 -48.58 81.16 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.321 -0.862 . . . . 0.0 109.838 179.572 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.415 ' CB ' HG22 ' A' ' 28' ' ' VAL . . . -67.96 -49.2 63.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.386 -0.821 . . . . 0.0 109.651 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.469 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -54.09 -45.42 71.78 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.38 -0.825 . . . . 0.0 109.681 179.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 51' ' ' VAL . . . -68.34 -26.71 65.74 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.474 -0.766 . . . . 0.0 109.986 179.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.5 mtp85 -95.91 27.42 3.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.428 -0.795 . . . . 0.0 110.148 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.09 42.89 40.68 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.24 69.29 0.69 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.401 -1.058 . . . . 0.0 110.667 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.413 ' CG2' HG21 ' A' ' 59' ' ' VAL . 85.9 t -58.71 -54.32 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.255 -0.903 . . . . 0.0 110.288 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -54.18 -41.58 68.7 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.428 -0.795 . . . . 0.0 110.854 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -56.73 -45.23 82.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.192 -0.943 . . . . 0.0 110.035 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.415 HG22 ' CB ' ' A' ' 19' ' ' ALA . 20.1 t -68.72 -36.68 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.248 -0.907 . . . . 0.0 110.176 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.532 ' HA ' ' CD1' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -49.98 -41.86 47.76 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.422 -0.799 . . . . 0.0 109.927 -179.665 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.401 ' O ' ' HB3' ' A' ' 34' ' ' ALA . . . -75.71 -31.32 59.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.443 -0.786 . . . . 0.0 110.239 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.53 HD13 ' CG ' ' A' ' 15' ' ' TRP . 21.8 mt -74.23 -67.51 0.61 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.452 -0.78 . . . . 0.0 110.52 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.46 HD13 ' HG ' ' A' ' 63' ' ' LEU . 6.4 mt -45.58 -45.27 13.53 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.625 -0.672 . . . . 0.0 110.282 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -71.98 -23.88 61.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.527 -0.733 . . . . 0.0 110.405 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 30' ' ' ALA . . . -79.76 -4.66 52.93 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.139 -0.976 . . . . 0.0 110.509 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.23 26.89 4.42 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.467 ' HB2' ' C ' ' A' ' 31' ' ' LEU . . . -71.41 165.28 24.11 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.432 -1.04 . . . . 0.0 110.414 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.444 HD21 ' N ' ' A' ' 40' ' ' ALA . 1.7 tp -98.02 110.7 56.93 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.555 -0.715 . . . . 0.0 110.074 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.471 ' O ' ' HG3' ' A' ' 48' ' ' PRO . 44.3 Cg_endo -70.37 -11.97 30.95 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.445 1.234 . . . . 0.0 110.844 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.43 ' O ' ' HD3' ' A' ' 41' ' ' PRO . 0.7 OUTLIER -103.01 16.05 27.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -0.928 . . . . 0.0 110.029 179.78 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.444 ' N ' HD21 ' A' ' 37' ' ' LEU . . . -76.67 111.29 15.07 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.418 -0.801 . . . . 0.0 110.118 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.43 ' HD3' ' O ' ' A' ' 39' ' ' ASN . 48.1 Cg_endo -72.8 146.61 42.98 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 123.603 1.318 . . . . 0.0 110.358 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -75.64 -156.94 0.06 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.418 -0.801 . . . . 0.0 109.864 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.15 2.14 24.63 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.335 -0.853 . . . . 0.0 110.035 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -102.0 20.49 16.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.269 -0.894 . . . . 0.0 109.907 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.85 40.24 98.57 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.68 -163.18 1.24 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.671 -0.899 . . . . 0.0 110.517 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.432 ' HG2' ' O ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -114.32 176.24 1.57 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.482 -0.761 . . . . 0.0 110.591 -179.243 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.471 ' HG3' ' O ' ' A' ' 38' ' ' PRO . 43.1 Cg_endo -70.97 -20.3 29.3 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.825 1.434 . . . . 0.0 110.791 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.487 ' O ' ' CG ' ' A' ' 52' ' ' MET . 6.3 mt -107.09 -40.28 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.284 -0.885 . . . . 0.0 109.39 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.443 ' HG3' ' HA ' ' A' ' 81' ' ' PRO . 1.1 tt0 -48.46 -28.73 3.49 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.282 -0.886 . . . . 0.0 110.477 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.428 ' O ' HG21 ' A' ' 51' ' ' VAL . 9.1 p -109.88 16.94 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.513 -0.742 . . . . 0.0 110.554 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.487 ' CG ' ' O ' ' A' ' 49' ' ' ILE . 0.5 OUTLIER -84.58 166.72 16.93 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.09 -1.006 . . . . 0.0 110.261 179.533 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -62.26 91.41 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.334 -0.854 . . . . 0.0 109.092 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.569 ' O ' ' CD2' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -56.07 -14.28 2.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.21 -0.931 . . . . 0.0 110.31 -179.429 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.401 ' C ' ' CE2' ' A' ' 90' ' ' PHE . . . -84.11 15.37 39.11 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 178.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -151.06 92.83 1.85 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.208 -1.172 . . . . 0.0 109.987 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.49 -21.06 50.55 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.254 -0.903 . . . . 0.0 109.509 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.84 -28.74 66.35 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.553 -0.717 . . . . 0.0 110.083 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.413 HG21 ' CG2' ' A' ' 25' ' ' VAL . 2.1 t -70.89 -55.21 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.268 -0.895 . . . . 0.0 109.231 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -51.42 -38.12 51.97 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.382 -0.824 . . . . 0.0 109.585 179.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -53.35 -61.1 2.52 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.626 -0.671 . . . . 0.0 110.35 179.818 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.532 ' CD1' ' HA ' ' A' ' 29' ' ' ARG . 0.1 OUTLIER -45.81 -63.62 0.93 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.324 -0.86 . . . . 0.0 110.345 179.74 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.46 ' HG ' HD13 ' A' ' 32' ' ' LEU . 7.0 mt -57.9 -57.19 13.88 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.456 -0.778 . . . . 0.0 110.118 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.476 ' CD2' ' HB3' ' A' ' 100' ' ' ALA . 0.6 OUTLIER -53.21 -54.02 42.22 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.266 -0.896 . . . . 0.0 110.109 179.878 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.472 ' HB3' ' O ' ' A' ' 61' ' ' GLU . 13.2 tp -50.27 -36.76 32.74 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.44 ' CB ' HD22 ' A' ' 32' ' ' LEU . 1.9 m-70 -79.55 -28.24 41.24 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.504 0.669 . . . . 0.0 109.64 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 117.75 50.86 0.35 Allowed Glycine 0 N--CA 1.476 1.344 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.43 ' CB ' ' HB3' ' A' ' 63' ' ' LEU . . . -60.6 -159.94 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.21 -1.17 . . . . 0.0 109.477 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.432 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 0.6 OUTLIER -120.61 59.67 7.41 Favored Pre-proline 0 C--N 1.299 -1.616 0 O-C-N 121.231 -0.918 . . . . 0.0 109.465 178.941 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.438 ' HB2' HD23 ' A' ' 97' ' ' LEU . 47.7 Cg_endo -70.29 57.51 1.72 Allowed 'Trans proline' 0 C--N 1.313 -1.293 0 O-C-N 123.7 1.369 . . . . 0.0 110.415 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -167.3 -62.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.46 -0.775 . . . . 0.0 109.942 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 22.3 m -50.03 138.79 15.06 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.4 -0.812 . . . . 0.0 110.624 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -136.94 -144.07 0.19 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.397 -0.814 . . . . 0.0 110.109 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.3 144.04 28.38 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.006 -1.059 . . . . 0.0 109.906 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -72.59 -53.73 0.14 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.549 1.289 . . . . 0.0 110.55 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.86 -9.14 49.79 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.241 -0.912 . . . . 0.0 109.714 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.465 ' CG2' ' CH2' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -153.48 105.03 2.8 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.642 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.444 ' HB2' ' HA ' ' A' ' 108' ' ' ASP . 27.8 mt -67.77 53.29 0.06 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.507 -0.746 . . . . 0.0 111.08 -178.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.541 ' HA ' ' OD1' ' A' ' 108' ' ' ASP . 3.6 m -79.8 85.02 5.51 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.104 -0.997 . . . . 0.0 109.528 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.46 ' CG ' ' HD2' ' A' ' 81' ' ' PRO . 0.1 OUTLIER -71.96 169.95 14.3 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.488 -0.757 . . . . 0.0 109.568 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.46 ' HD2' ' CG ' ' A' ' 80' ' ' ARG . 46.9 Cg_endo -74.42 -2.32 12.23 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.578 1.304 . . . . 0.0 110.391 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.44 HG22 ' HA ' ' A' ' 104' ' ' LEU . 10.5 t -77.7 -31.32 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.465 -0.772 . . . . 0.0 109.766 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.423 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 27.2 m80 -69.78 -27.26 64.76 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.43 -0.794 . . . . 0.0 109.915 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.563 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 1.1 m-20 -67.64 -53.88 24.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.863 -0.523 . . . . 0.0 110.263 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.465 ' HB1' HG22 ' A' ' 93' ' ' THR . . . -50.02 -58.05 6.29 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.538 -0.727 . . . . 0.0 109.581 179.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.594 ' O ' ' ND1' ' A' ' 123' ' ' HIS . . . -63.41 -38.06 89.67 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.47 -0.769 . . . . 0.0 110.52 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.423 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 1.5 mmm-85 -40.7 -59.87 1.28 Allowed 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.116 -0.99 . . . . 0.0 111.125 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -85.18 3.73 37.82 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.232 -0.917 . . . . 0.0 110.156 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.75 48.22 12.99 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.569 ' CD2' ' O ' ' A' ' 54' ' ' MET . 0.3 OUTLIER -111.56 97.49 6.77 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.398 -1.06 . . . . 0.0 111.049 -179.536 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.476 HD11 ' HB3' ' A' ' 125' ' ' ASP . 0.3 OUTLIER -67.06 -42.48 84.69 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.592 -0.692 . . . . 0.0 110.498 179.603 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.4 ' O ' HG22 ' A' ' 96' ' ' VAL . 50.0 m-20 -45.65 -63.61 0.92 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.464 -0.772 . . . . 0.0 110.37 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.465 HG22 ' HB1' ' A' ' 85' ' ' ALA . 70.9 m -47.39 -38.49 13.35 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.702 -0.624 . . . . 0.0 109.549 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.448 HD22 ' HG ' ' A' ' 130' ' ' LEU . 4.1 tp -61.84 -48.85 78.71 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 98.2 t -60.96 -50.87 78.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.459 HG13 ' CD2' ' A' ' 64' ' ' LEU . 95.0 t -48.85 -57.31 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.727 -0.608 . . . . 0.0 110.209 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.438 HD23 ' HB2' ' A' ' 70' ' ' PRO . 0.1 OUTLIER -43.07 -66.26 0.39 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.782 -0.574 . . . . 0.0 110.218 179.885 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -55.37 -32.6 62.72 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.261 -0.899 . . . . 0.0 109.816 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.419 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 0.1 OUTLIER -61.71 -13.87 26.79 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.412 -0.805 . . . . 0.0 110.274 179.439 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.476 ' HB3' ' CD2' ' A' ' 64' ' ' LEU . . . -140.71 56.68 1.58 Allowed 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.374 -0.829 . . . . 0.0 110.575 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 57.7 98.17 0.01 OUTLIER Glycine 0 N--CA 1.489 2.185 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -157.84 95.89 1.44 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.333 -1.098 . . . . 0.0 110.018 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -62.15 106.97 0.8 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.293 -0.88 . . . . 0.0 110.028 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.44 ' HA ' HG22 ' A' ' 82' ' ' VAL . 1.8 mp -96.62 26.75 4.26 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.321 -0.862 . . . . 0.0 109.898 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -123.36 47.52 1.99 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.346 -0.846 . . . . 0.0 110.792 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.444 ' CB ' ' HD3' ' A' ' 80' ' ' ARG . 5.1 p -105.18 -175.33 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.189 -0.944 . . . . 0.0 109.454 179.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -142.56 122.02 13.21 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.187 -0.946 . . . . 0.0 110.83 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.541 ' OD1' ' HA ' ' A' ' 79' ' ' THR . 1.6 m-20 -52.2 165.87 0.2 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.558 -0.714 . . . . 0.0 109.715 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.425 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . -70.97 -15.55 62.59 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 109.772 179.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.465 ' CH2' ' CG2' ' A' ' 77' ' ' THR . 6.8 m-90 -86.92 15.61 5.74 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.252 -0.905 . . . . 0.0 109.877 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.59 12.32 55.98 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 108' ' ' ASP . 2.6 ttm180 -94.52 129.0 41.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.417 -1.049 . . . . 0.0 109.73 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.406 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.0 OUTLIER -91.62 163.5 27.94 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.135 -0.978 . . . . 0.0 109.725 179.843 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.406 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 43.5 Cg_endo -70.37 -31.13 18.33 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.703 1.37 . . . . 0.0 110.768 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.424 HG23 ' N ' ' A' ' 131' ' ' ARG . 9.6 p -80.09 -38.93 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.16 -0.963 . . . . 0.0 110.489 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.409 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 81.7 m-20 -65.86 -34.39 78.02 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.266 -0.897 . . . . 0.0 110.023 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.01 -34.49 78.12 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.261 -0.9 . . . . 0.0 109.925 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.549 ' HA ' ' ND1' ' A' ' 123' ' ' HIS . . . -70.96 -55.23 8.79 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.314 -0.866 . . . . 0.0 110.7 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -46.84 -39.51 12.11 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.403 -0.811 . . . . 0.0 110.622 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -67.51 -51.34 52.23 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.482 -0.761 . . . . 0.0 109.904 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.413 ' HB3' ' NE2' ' A' ' 123' ' ' HIS . 0.2 OUTLIER -67.19 -87.39 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.354 -0.841 . . . . 0.0 110.225 179.807 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 179.36 32.29 0.06 OUTLIER Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.752 -1.213 . . . . 0.0 110.07 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.594 ' ND1' ' O ' ' A' ' 86' ' ' ALA . 0.9 OUTLIER -98.29 45.96 1.01 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.171 -1.193 . . . . 0.0 108.882 179.415 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -44.58 -37.17 3.41 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.502 0.668 . . . . 0.0 109.836 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.476 ' HB3' HD11 ' A' ' 91' ' ' LEU . 0.4 OUTLIER -66.58 -44.66 81.63 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.67 -0.644 . . . . 0.0 109.556 179.058 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.515 HG13 ' HA ' ' A' ' 86' ' ' ALA . 2.4 t -75.52 -44.36 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.229 -0.919 . . . . 0.0 110.031 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.423 ' HB3' ' HB1' ' A' ' 118' ' ' ALA . . . -57.27 -24.18 53.19 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.191 -0.943 . . . . 0.0 109.965 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.74 -63.0 1.18 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.297 -0.877 . . . . 0.0 109.818 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -59.05 -41.26 87.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.483 -0.761 . . . . 0.0 109.36 179.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.451 ' O ' ' N ' ' A' ' 134' ' ' ALA . 13.2 mt -51.3 -64.24 0.87 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.495 -0.753 . . . . 0.0 109.539 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.424 ' N ' HG23 ' A' ' 115' ' ' VAL . 1.7 ttt-85 -51.6 -21.69 2.76 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.298 -0.876 . . . . 0.0 110.317 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -88.51 -51.69 5.57 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.383 -0.823 . . . . 0.0 110.515 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -86.78 -16.46 36.22 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.247 -0.908 . . . . 0.0 111.206 -179.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 130' ' ' LEU . . . -84.88 49.71 1.78 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.034 -1.041 . . . . 0.0 110.33 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 79.35 137.1 1.4 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -160.06 45.16 0.42 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 10.9 t -63.83 153.43 36.7 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.316 -1.108 . . . . 0.0 110.514 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.5 tpt85 -98.9 108.8 21.57 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.349 -0.844 . . . . 0.0 109.972 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -176.4 111.32 0.34 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.9 t 59.27 163.62 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.297 -1.119 . . . . 0.0 110.07 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -73.47 -51.41 17.26 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.196 -0.94 . . . . 0.0 109.856 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.433 ' O ' ' CD2' ' A' ' 142' ' ' HIS . 68.6 t60 -148.4 78.01 1.41 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.467 -0.771 . . . . 0.0 109.652 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -154.38 -53.18 0.1 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.301 -0.874 . . . . 0.0 110.224 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.07 114.75 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.5 -0.75 . . . . 0.0 110.527 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.428 ' O ' ' N ' ' A' ' 147' ' ' ALA . 10.5 mt -69.03 132.82 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.32 -0.862 . . . . 0.0 109.524 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -55.3 90.45 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.281 -0.887 . . . . 0.0 110.173 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 145' ' ' ILE . . . -60.86 159.4 11.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.24 -0.912 . . . . 0.0 110.43 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -47.98 146.98 2.25 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.646 -0.659 . . . . 0.0 110.537 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -174.45 -50.0 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.185 -0.947 . . . . 0.0 110.236 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -73.3 168.87 53.59 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.42 119.74 6.58 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 O-C-N 123.95 1.5 . . . . 0.0 110.401 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.8 14.8 14.37 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.251 -0.906 . . . . 0.0 110.645 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.58 134.05 56.66 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.139 -0.975 . . . . 0.0 110.01 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 5.1 mt -115.11 81.97 8.39 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.327 -0.858 . . . . 0.0 110.071 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -75.52 160.46 38.43 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 123.816 1.43 . . . . 0.0 110.369 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.725 0 CA-C-O 118.073 -0.965 . . . . 0.0 110.27 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 ptt? . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 121.163 0.506 . . . . 0.0 110.419 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -151.84 71.77 8.0 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.4 -0.813 . . . . 0.0 110.19 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.496 ' O ' ' N ' ' A' ' 5' ' ' ALA . 47.3 Cg_endo -73.69 161.42 41.94 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 123.605 1.318 . . . . 0.0 110.006 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.97 78.19 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.411 -0.806 . . . . 0.0 110.144 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.496 ' N ' ' O ' ' A' ' 3' ' ' PRO . . . -128.36 87.8 2.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.599 -0.688 . . . . 0.0 110.309 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 96.16 -178.99 34.86 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 71.4 m -129.43 140.03 51.45 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.298 -1.119 . . . . 0.0 110.675 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.6 m -120.53 19.04 12.03 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.502 -0.749 . . . . 0.0 110.202 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 3.7 tpp -73.29 -38.16 65.98 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.26 -0.9 . . . . 0.0 109.791 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -179.52 95.32 0.2 Allowed Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.364 -0.835 . . . . 0.0 109.743 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.32 99.98 1.26 Allowed 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.834 1.439 . . . . 0.0 110.901 -179.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 86.0 p -140.86 -64.16 0.46 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.575 -0.703 . . . . 0.0 109.429 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.46 ' O ' HD23 ' A' ' 16' ' ' LEU . . . 45.29 25.0 0.17 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.587 -0.696 . . . . 0.0 110.723 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -108.55 11.19 26.91 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.392 -0.817 . . . . 0.0 110.411 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.486 ' HB3' HD11 ' A' ' 31' ' ' LEU . 16.0 m0 -75.4 -20.22 59.06 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.148 -0.97 . . . . 0.0 109.981 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.469 HD11 HD11 ' A' ' 63' ' ' LEU . 1.2 pp -67.86 -35.22 78.16 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.396 -0.815 . . . . 0.0 110.043 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.14 -42.11 24.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.39 -0.819 . . . . 0.0 110.394 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.412 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.0 OUTLIER -59.85 -58.4 8.74 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.363 -0.836 . . . . 0.0 110.51 -179.655 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.19 -45.38 65.14 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.165 -0.959 . . . . 0.0 109.784 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.484 ' HB2' ' CB ' ' A' ' 52' ' ' MET . . . -50.83 -53.79 29.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.604 -0.685 . . . . 0.0 110.037 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.504 ' CA ' ' O ' ' A' ' 51' ' ' VAL . . . -56.01 -31.8 63.41 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.164 -0.96 . . . . 0.0 110.078 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.58 21.8 5.99 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.38 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.482 ' HA3' ' HE2' ' A' ' 53' ' ' MET . . . 49.43 76.02 0.18 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -140.76 63.84 1.45 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.57 -0.959 . . . . 0.0 109.405 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.501 ' CG1' ' NE ' ' A' ' 29' ' ' ARG . 13.6 t -49.21 -51.44 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.493 -0.755 . . . . 0.0 110.101 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.69 -51.14 52.37 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.74 -0.6 . . . . 0.0 110.669 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.576 ' HG2' HD13 ' A' ' 31' ' ' LEU . 5.4 tt0 -56.09 -44.96 79.52 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.329 -0.857 . . . . 0.0 109.874 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.463 HG12 ' CD1' ' A' ' 62' ' ' LEU . 38.4 t -71.28 -47.06 62.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.472 -0.767 . . . . 0.0 109.796 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.51 ' NH1' ' O ' ' A' ' 58' ' ' ARG . 0.1 OUTLIER -39.17 -52.68 1.91 Allowed 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.55 -0.719 . . . . 0.0 110.285 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.9 -49.53 14.02 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.679 -0.638 . . . . 0.0 110.733 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.576 HD13 ' HG2' ' A' ' 27' ' ' GLU . 41.2 mt -44.73 -66.76 0.35 Allowed 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.32 -0.863 . . . . 0.0 110.635 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.603 ' CD1' HD23 ' A' ' 63' ' ' LEU . 0.6 OUTLIER -50.2 -53.93 24.49 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.46 -0.775 . . . . 0.0 110.296 179.681 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 29' ' ' ARG . 0.5 OUTLIER -63.84 -6.86 6.52 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.442 -0.786 . . . . 0.0 110.962 179.325 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -100.81 -13.43 18.41 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.853 -1.154 . . . . 0.0 111.56 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 146.38 -10.62 1.52 Allowed Glycine 0 N--CA 1.49 2.27 0 C-N-CA 119.323 -1.418 . . . . 0.0 110.45 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.521 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . . . -56.18 140.56 43.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.929 -1.336 . . . . 0.0 109.87 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.429 ' O ' HD22 ' A' ' 16' ' ' LEU . 18.3 mt -79.21 143.07 59.95 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.382 -0.824 . . . . 0.0 110.213 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.462 ' HB3' ' HB3' ' A' ' 66' ' ' HIS . 43.5 Cg_endo -72.54 -37.35 4.22 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.358 1.188 . . . . 0.0 110.125 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -100.59 5.64 43.99 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.403 -0.811 . . . . 0.0 110.534 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.412 ' CB ' ' HB2' ' A' ' 37' ' ' LEU . . . -39.75 101.36 0.23 Allowed Pre-proline 0 N--CA 1.501 2.098 0 O-C-N 121.471 -0.768 . . . . 0.0 111.358 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -72.58 159.26 49.29 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.828 1.436 . . . . 0.0 109.651 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.51 ' N ' ' OD1' ' A' ' 42' ' ' ASN . 10.8 p-10 -131.5 170.87 14.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.473 -0.767 . . . . 0.0 109.913 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.5 m -87.13 12.37 11.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.387 -0.821 . . . . 0.0 110.434 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.438 ' HB3' ' ND2' ' A' ' 42' ' ' ASN . 4.2 t80 -93.16 19.77 7.64 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.241 -0.912 . . . . 0.0 109.644 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 48.38 23.2 2.89 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 -179.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -138.57 106.17 5.59 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.63 -0.924 . . . . 0.0 110.845 -179.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.511 ' CB ' ' HD2' ' A' ' 48' ' ' PRO . 1.1 mpt_? -54.86 -175.39 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.55 -0.719 . . . . 0.0 109.619 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.511 ' HD2' ' CB ' ' A' ' 47' ' ' ARG . 43.0 Cg_endo -69.09 170.55 15.53 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.145 1.076 . . . . 0.0 109.732 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.531 ' O ' ' CG ' ' A' ' 52' ' ' MET . 3.2 mt 63.27 -58.78 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.794 -0.566 . . . . 0.0 110.578 -179.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.488 ' N ' ' O ' ' A' ' 48' ' ' PRO . 0.4 OUTLIER -48.68 -25.57 1.85 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.569 -1.332 . . . . 0.0 109.797 179.342 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.504 ' O ' ' CA ' ' A' ' 21' ' ' ALA . 12.0 p -110.39 18.6 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 121.606 -0.684 . . . . 0.0 109.378 178.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.531 ' CG ' ' O ' ' A' ' 49' ' ' ILE . 0.5 OUTLIER -92.72 167.67 11.73 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.242 -0.911 . . . . 0.0 110.057 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.482 ' HE2' ' HA3' ' A' ' 23' ' ' GLY . 5.5 ttp -69.26 107.52 3.29 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.159 -1.016 . . . . 0.0 109.32 178.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.493 ' HE2' ' CE ' ' A' ' 52' ' ' MET . 0.0 OUTLIER -66.41 -3.91 7.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.087 -1.008 . . . . 0.0 109.861 179.501 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -89.97 16.91 55.85 Favored Glycine 0 N--CA 1.484 1.889 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 178.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.93 117.29 2.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -1.177 . . . . 0.0 109.704 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.52 -27.06 41.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.308 -0.87 . . . . 0.0 110.368 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.51 ' O ' ' NH1' ' A' ' 29' ' ' ARG . 5.8 mmt180 -48.84 -38.25 21.77 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.181 -0.95 . . . . 0.0 110.267 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.4 ' CG2' HG23 ' A' ' 25' ' ' VAL . 24.3 t -62.64 -63.56 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 120.987 -1.071 . . . . 0.0 109.116 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -52.13 -29.87 23.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.46 -0.775 . . . . 0.0 109.375 178.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -54.53 -66.4 0.41 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.029 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.518 ' O ' ' HB2' ' A' ' 66' ' ' HIS . 0.1 OUTLIER -44.09 -61.63 1.41 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.402 -0.811 . . . . 0.0 109.564 178.746 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.603 HD23 ' CD1' ' A' ' 32' ' ' LEU . 4.3 mm? -47.92 -66.87 0.33 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.309 0.576 . . . . 0.0 109.927 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.554 HD11 ' HG3' ' A' ' 70' ' ' PRO . 20.0 tp -52.85 -53.01 54.87 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.438 -0.788 . . . . 0.0 110.633 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.429 ' HB3' ' O ' ' A' ' 61' ' ' GLU . 13.5 tp -49.53 -39.04 32.94 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.844 0.831 . . . . 0.0 108.956 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.518 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -81.34 -31.15 33.56 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.458 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 63' ' ' LEU . . . 124.21 56.19 0.18 Allowed Glycine 0 N--CA 1.481 1.661 0 C-N-CA 120.367 -0.92 . . . . 0.0 111.116 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.518 ' CB ' ' HB3' ' A' ' 63' ' ' LEU . . . -73.91 -154.4 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.841 -1.388 . . . . 0.0 110.103 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -122.49 77.58 45.83 Favored Pre-proline 0 N--CA 1.489 1.478 0 C-N-CA 119.824 -0.75 . . . . 0.0 109.985 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.554 ' HG3' HD11 ' A' ' 64' ' ' LEU . 53.7 Cg_endo -76.85 -11.61 18.17 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 O-C-N 124.067 1.562 . . . . 0.0 110.0 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.418 ' OD1' ' CB ' ' A' ' 103' ' ' ARG . 7.1 t30 -108.5 -64.36 1.23 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.493 -0.754 . . . . 0.0 109.741 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -46.07 139.95 4.15 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.421 0.629 . . . . 0.0 110.761 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.529 ' HB1' ' HD2' ' A' ' 80' ' ' ARG . . . -132.82 -150.39 0.41 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.658 -0.651 . . . . 0.0 110.187 -179.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.504 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -101.33 143.47 26.67 Favored Pre-proline 0 C--N 1.305 -1.343 0 O-C-N 121.216 -0.928 . . . . 0.0 109.746 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -71.87 -29.87 14.8 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.517 1.272 . . . . 0.0 110.728 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -47.86 -80.83 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.412 -0.805 . . . . 0.0 110.702 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.574 HG23 ' CZ2' ' A' ' 110' ' ' TRP . 4.1 p -115.31 30.71 7.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.423 -0.798 . . . . 0.0 109.878 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.504 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 2.8 mt 44.54 46.22 8.09 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.607 -0.683 . . . . 0.0 111.541 179.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.484 ' O ' ' NE2' ' A' ' 50' ' ' GLN . 0.2 OUTLIER -72.77 95.62 1.93 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.21 -0.931 . . . . 0.0 109.881 179.62 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.567 ' HG3' ' HD2' ' A' ' 81' ' ' PRO . 0.5 OUTLIER -71.92 154.4 92.65 Favored Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.397 -0.814 . . . . 0.0 109.952 179.805 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.567 ' HD2' ' HG3' ' A' ' 80' ' ' ARG . 48.3 Cg_endo -72.01 -13.71 28.96 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 O-C-N 123.577 1.303 . . . . 0.0 109.973 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.57 ' CG1' HD23 ' A' ' 130' ' ' LEU . 21.2 t -61.96 -27.4 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 CA-C-O 121.534 0.683 . . . . 0.0 109.661 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.512 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 4.2 m80 -72.72 -42.86 63.69 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.422 ' HB3' ' HE1' ' A' ' 54' ' ' MET . 0.6 OUTLIER -45.23 -51.78 10.32 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.548 -0.72 . . . . 0.0 110.091 179.249 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.527 ' CB ' ' CD1' ' A' ' 94' ' ' LEU . . . -56.78 -64.94 0.71 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.582 -0.699 . . . . 0.0 109.794 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.529 ' HA ' ' CG1' ' A' ' 126' ' ' VAL . . . -61.22 -54.0 49.72 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.58 -0.7 . . . . 0.0 111.594 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.488 ' N ' ' O ' ' A' ' 83' ' ' HIS . 0.4 OUTLIER -40.18 -31.48 0.13 Allowed 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.3 -0.875 . . . . 0.0 110.976 -179.741 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -100.88 -17.85 16.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.154 -0.966 . . . . 0.0 109.602 179.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.514 ' HA3' ' CE1' ' A' ' 123' ' ' HIS . . . 89.27 41.31 5.85 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.452 ' CG ' ' O ' ' A' ' 54' ' ' MET . 2.1 t80 -110.64 123.48 50.08 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.656 -0.908 . . . . 0.0 110.368 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.582 ' CD2' ' HA ' ' A' ' 126' ' ' VAL . 0.0 OUTLIER -94.38 -44.31 7.97 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.5 -0.75 . . . . 0.0 110.24 -179.748 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.437 ' HB2' ' CE2' ' A' ' 90' ' ' PHE . 0.9 OUTLIER -44.58 -31.35 1.11 Allowed 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 121.368 0.604 . . . . 0.0 109.858 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.503 HG22 ' HB3' ' A' ' 85' ' ' ALA . 8.7 m -76.1 -49.19 18.09 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.326 -0.859 . . . . 0.0 108.767 178.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.527 ' CD1' ' CB ' ' A' ' 85' ' ' ALA . 1.1 mp -50.74 -49.05 58.77 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.48 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 84.5 t -56.52 -60.96 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.695 -0.628 . . . . 0.0 109.536 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.537 ' CG1' HD23 ' A' ' 64' ' ' LEU . 49.1 t -47.36 -52.25 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -46.02 -64.15 0.81 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.797 -0.564 . . . . 0.0 111.038 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -63.08 -31.26 72.36 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.156 -0.965 . . . . 0.0 110.084 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.48 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 1.2 ttt85 -63.07 -12.97 30.4 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.263 -0.898 . . . . 0.0 110.825 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.474 ' CB ' ' HG ' ' A' ' 64' ' ' LEU . . . -139.94 58.54 1.59 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.216 -0.928 . . . . 0.0 110.647 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 55.93 106.03 0.01 OUTLIER Glycine 0 N--CA 1.488 2.15 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.307 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -164.36 124.76 2.08 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.426 -1.044 . . . . 0.0 109.787 179.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.418 ' CB ' ' OD1' ' A' ' 71' ' ' ASN . 10.9 ttp180 -82.58 135.52 35.06 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.237 -0.914 . . . . 0.0 110.287 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.568 ' O ' ' CB ' ' A' ' 134' ' ' ALA . 1.7 mp -121.36 21.2 11.14 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.263 -0.898 . . . . 0.0 110.504 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -123.63 54.0 1.32 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.325 -0.859 . . . . 0.0 111.126 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.522 ' CG2' ' HD3' ' A' ' 80' ' ' ARG . 3.9 p -112.93 -174.11 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.824 -1.172 . . . . 0.0 110.405 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.434 ' HG2' HD11 ' A' ' 113' ' ' LEU . 18.7 mtm180 -133.91 138.83 45.77 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.623 -0.673 . . . . 0.0 109.306 179.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.617 ' O ' ' N ' ' A' ' 110' ' ' TRP . 0.3 OUTLIER -71.63 53.1 0.22 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.437 -0.789 . . . . 0.0 109.941 179.651 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.564 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 55.53 -73.19 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.481 -0.762 . . . . 0.0 110.24 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.617 ' N ' ' O ' ' A' ' 108' ' ' ASP . 0.5 OUTLIER -46.04 -64.43 0.75 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.483 -0.761 . . . . 0.0 109.546 179.485 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 167.01 -39.23 0.24 Allowed Glycine 0 C--N 1.302 -1.32 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 179.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -44.12 122.03 2.74 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.756 -0.849 . . . . 0.0 110.392 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.454 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER -92.32 172.67 5.99 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.689 -0.632 . . . . 0.0 110.259 -179.579 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.502 ' HB3' ' CE1' ' A' ' 83' ' ' HIS . 41.4 Cg_endo -74.05 -47.81 0.24 Allowed 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.975 1.513 . . . . 0.0 109.524 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.412 HG22 ' CB ' ' A' ' 131' ' ' ARG . 8.8 p -60.58 -35.46 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.528 -0.733 . . . . 0.0 110.382 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.63 -51.88 66.67 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.407 -0.808 . . . . 0.0 109.739 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.58 -37.32 73.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.764 -0.585 . . . . 0.0 111.078 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.461 ' HB2' ' HB3' ' A' ' 86' ' ' ALA . . . -57.5 -54.67 44.25 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.286 -0.884 . . . . 0.0 110.498 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -65.51 -17.8 64.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.286 -0.884 . . . . 0.0 110.444 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -76.12 -44.68 37.37 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.306 -0.871 . . . . 0.0 110.557 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.482 ' HB3' ' NE2' ' A' ' 123' ' ' HIS . 6.7 mp -88.26 13.83 10.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -0.904 . . . . 0.0 110.411 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 76.8 48.04 9.12 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.514 ' CE1' ' HA3' ' A' ' 89' ' ' GLY . 30.1 m-70 -120.55 45.13 2.29 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.019 -1.283 . . . . 0.0 109.343 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.442 ' HA ' ' HB3' ' A' ' 127' ' ' ALA . 1.2 mtt180 -43.82 -46.04 7.62 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.524 -0.735 . . . . 0.0 110.077 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.408 ' O ' HD23 ' A' ' 91' ' ' LEU . 6.0 t70 -54.56 -44.0 72.54 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.528 0.68 . . . . 0.0 109.63 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.582 ' HA ' ' CD2' ' A' ' 91' ' ' LEU . 1.8 t -76.74 -28.45 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.442 ' HB3' ' HA ' ' A' ' 124' ' ' ARG . . . -68.13 -57.25 6.37 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.761 -0.587 . . . . 0.0 109.801 178.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -50.4 -57.93 6.86 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.413 -0.804 . . . . 0.0 110.472 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 33.5 t80 -53.41 -35.99 61.01 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.37 -0.832 . . . . 0.0 109.146 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.57 HD23 ' CG1' ' A' ' 82' ' ' VAL . 10.1 mt -71.9 -59.53 2.7 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.593 -0.692 . . . . 0.0 109.24 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.412 ' CB ' HG22 ' A' ' 115' ' ' VAL . 2.1 ttt180 -49.0 -27.8 3.44 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.691 -0.631 . . . . 0.0 110.821 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -76.6 -52.04 10.45 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.111 -0.993 . . . . 0.0 109.944 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.463 ' CB ' HD11 ' A' ' 104' ' ' LEU . . . -84.54 -10.4 57.46 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.429 -0.794 . . . . 0.0 110.489 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.568 ' CB ' ' O ' ' A' ' 104' ' ' LEU . . . -95.95 -15.46 22.34 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.29 -0.881 . . . . 0.0 109.878 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.408 ' O ' ' O ' ' A' ' 134' ' ' ALA . . . -60.92 -117.26 0.01 OUTLIER Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 162.99 -32.19 0.29 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.9 p -79.94 135.65 36.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.627 -0.926 . . . . 0.0 110.659 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.84 -24.73 23.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.146 -0.971 . . . . 0.0 109.551 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -104.28 175.17 22.67 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.5 p -92.61 -34.36 14.04 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.179 -1.189 . . . . 0.0 111.262 -179.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -101.76 115.35 30.35 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.21 -0.931 . . . . 0.0 109.824 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 177.19 178.48 0.27 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.233 -0.917 . . . . 0.0 110.71 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -161.1 55.49 0.29 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.281 -0.887 . . . . 0.0 110.283 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.46 157.14 0.23 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.514 -0.741 . . . . 0.0 111.031 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.417 ' O ' ' CB ' ' A' ' 146' ' ' ASP . 3.3 tp -53.58 129.17 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.459 -0.776 . . . . 0.0 110.233 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.417 ' CB ' ' O ' ' A' ' 145' ' ' ILE . 0.3 OUTLIER 172.15 76.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.464 -0.773 . . . . 0.0 109.783 179.439 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -78.79 117.2 19.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -0.929 . . . . 0.0 109.61 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.97 145.21 53.81 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.348 -0.845 . . . . 0.0 109.53 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -49.9 144.64 6.33 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.3 -0.875 . . . . 0.0 110.165 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 47.14 -162.69 0.22 Allowed Glycine 0 N--CA 1.497 2.731 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -76.11 149.46 32.34 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.713 1.375 . . . . 0.0 110.001 179.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.82 60.77 1.79 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.152 -0.968 . . . . 0.0 109.231 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -54.03 97.63 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.508 -0.745 . . . . 0.0 111.181 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 71.8 mt -132.16 103.75 13.96 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.448 -0.783 . . . . 0.0 109.867 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -73.53 105.47 2.0 Allowed 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.88 1.463 . . . . 0.0 110.257 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 117.863 -1.065 . . . . 0.0 110.455 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.757 0 CA-C-O 121.376 0.608 . . . . 0.0 110.095 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 56.02 69.51 1.84 Allowed Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.458 -0.776 . . . . 0.0 110.661 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -74.59 69.91 5.09 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.795 1.418 . . . . 0.0 110.18 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -175.12 116.61 0.16 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.38 -0.825 . . . . 0.0 110.218 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -122.38 -56.58 1.8 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.108 -0.995 . . . . 0.0 110.752 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -76.38 -75.69 0.86 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.4 t 52.15 48.32 22.95 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.43 -1.041 . . . . 0.0 110.366 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 65.2 p -51.16 119.1 3.69 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.388 -0.82 . . . . 0.0 110.203 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.409 ' O ' ' HB2' ' A' ' 10' ' ' GLU . 13.0 ttm -175.73 126.25 0.23 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.502 -0.749 . . . . 0.0 109.999 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 9' ' ' MET . 0.0 OUTLIER 62.42 137.63 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.69 -0.631 . . . . 0.0 110.286 179.449 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -71.93 119.27 6.08 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 O-C-N 123.632 1.332 . . . . 0.0 110.403 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 t -98.32 -16.58 19.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.653 -0.655 . . . . 0.0 110.166 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.458 ' HB2' ' HB2' ' A' ' 37' ' ' LEU . . . -154.57 54.16 0.67 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.293 -0.879 . . . . 0.0 109.921 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.425 ' O ' ' OG1' ' A' ' 18' ' ' THR . 0.2 OUTLIER -114.71 2.94 14.59 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.727 -0.608 . . . . 0.0 110.035 179.735 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.489 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 1.1 t90 -74.96 -6.77 51.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.394 -0.816 . . . . 0.0 110.734 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.536 HD22 ' HB1' ' A' ' 36' ' ' ALA . 19.1 mt -78.69 -49.52 12.98 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.17 -0.956 . . . . 0.0 109.463 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.479 ' CB ' ' ND2' ' A' ' 42' ' ' ASN . . . -69.35 -44.99 70.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.567 -0.708 . . . . 0.0 109.988 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.489 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.0 OUTLIER -50.31 -59.89 3.52 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.473 -0.767 . . . . 0.0 110.435 179.799 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.52 ' CB ' HG21 ' A' ' 28' ' ' VAL . . . -63.52 -33.83 76.44 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.505 -0.747 . . . . 0.0 110.206 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.431 ' HB3' ' O ' ' A' ' 16' ' ' LEU . . . -68.55 -43.88 75.69 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.093 -1.004 . . . . 0.0 109.699 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.98 -20.14 63.54 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.383 -0.823 . . . . 0.0 109.786 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -99.58 22.28 11.06 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.422 -0.799 . . . . 0.0 110.451 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.512 ' HA3' ' HE1' ' A' ' 53' ' ' MET . . . 47.68 55.15 9.87 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.461 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . 0.8 OUTLIER -126.37 89.93 3.09 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.513 -0.992 . . . . 0.0 109.483 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.461 ' CG2' HG23 ' A' ' 59' ' ' VAL . 55.7 t -64.31 -63.61 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.435 -0.79 . . . . 0.0 111.199 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -43.71 -33.48 1.25 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.551 -0.718 . . . . 0.0 111.043 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.461 ' HB2' ' HB3' ' A' ' 24' ' ' ARG . 0.7 OUTLIER -60.8 -65.92 0.61 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.292 -0.88 . . . . 0.0 109.661 179.288 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.52 HG21 ' CB ' ' A' ' 19' ' ' ALA . 5.1 t -63.66 -41.04 91.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.821 -0.55 . . . . 0.0 110.289 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.481 ' HA ' HD21 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -44.7 -39.09 4.84 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.629 -0.669 . . . . 0.0 110.438 -179.548 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.64 -43.99 24.89 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.458 -0.776 . . . . 0.0 110.008 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.469 HD13 ' HB3' ' A' ' 15' ' ' TRP . 50.3 mt -55.46 -64.59 0.8 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.087 -1.008 . . . . 0.0 109.663 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.569 HD23 ' CB ' ' A' ' 66' ' ' HIS . 2.3 mt -49.37 -39.3 31.59 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.471 -0.768 . . . . 0.0 110.384 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 29' ' ' ARG . 6.1 mt-10 -67.32 -25.58 66.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.527 -0.733 . . . . 0.0 110.177 179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.17 -8.1 58.76 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.319 -0.863 . . . . 0.0 109.91 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.46 31.84 2.09 Favored Glycine 0 N--CA 1.489 2.179 0 C-N-CA 120.19 -1.005 . . . . 0.0 110.844 178.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.536 ' HB1' HD22 ' A' ' 16' ' ' LEU . . . -63.3 178.59 0.51 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.956 -1.32 . . . . 0.0 110.52 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 13' ' ' ALA . 0.4 OUTLIER -92.18 124.19 60.45 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.398 -0.814 . . . . 0.0 109.947 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.504 ' HB2' ' O ' ' A' ' 67' ' ' GLY . 43.2 Cg_endo -68.22 -39.77 9.7 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.629 1.331 . . . . 0.0 110.742 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.419 ' HA ' ' OE1' ' A' ' 69' ' ' GLU . 0.4 OUTLIER -112.24 61.63 0.63 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.236 -0.915 . . . . 0.0 109.758 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.57 109.27 37.44 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.302 -0.874 . . . . 0.0 110.296 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -71.81 113.69 3.73 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 O-C-N 123.634 1.334 . . . . 0.0 109.595 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.479 ' ND2' ' CB ' ' A' ' 17' ' ' ALA . 16.3 m120 -73.68 174.23 8.66 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.559 -0.713 . . . . 0.0 109.596 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.95 21.91 1.83 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.358 -0.839 . . . . 0.0 110.354 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -109.58 20.76 17.8 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.163 -0.961 . . . . 0.0 110.533 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 57.88 24.22 53.28 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 55.0 mtt180 -131.75 -163.85 1.38 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.346 -1.09 . . . . 0.0 109.701 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.544 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 1.6 mmt180 -109.11 -171.1 0.21 Allowed Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.189 -0.944 . . . . 0.0 110.231 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.544 ' CD ' ' HB3' ' A' ' 47' ' ' ARG . 42.6 Cg_endo -80.13 -18.16 10.14 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 O-C-N 123.303 1.159 . . . . 0.0 111.08 -178.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.519 ' O ' ' HG2' ' A' ' 52' ' ' MET . 6.6 mt -107.1 -43.44 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.991 -1.068 . . . . 0.0 108.867 178.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 49' ' ' ILE . 0.8 OUTLIER -43.88 -31.47 0.87 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.095 -1.003 . . . . 0.0 109.909 179.556 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.411 ' O ' HG21 ' A' ' 51' ' ' VAL . 7.9 p -111.53 34.16 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.442 -0.786 . . . . 0.0 110.138 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.527 ' CE ' ' HB3' ' A' ' 60' ' ' ALA . 0.1 OUTLIER -91.11 30.1 1.29 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.027 -1.045 . . . . 0.0 109.643 179.19 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.512 ' HE1' ' HA3' ' A' ' 23' ' ' GLY . 4.8 tmm? 75.61 -13.54 0.86 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.859 -0.526 . . . . 0.0 111.866 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.536 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 47.11 28.18 0.9 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.956 -1.09 . . . . 0.0 110.234 -179.873 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.47 ' HA3' ' HE3' ' A' ' 53' ' ' MET . . . -125.85 4.56 7.96 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.25 79.14 1.4 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.348 -1.089 . . . . 0.0 110.301 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.578 ' HB1' ' CE1' ' A' ' 90' ' ' PHE . . . -46.56 -34.04 4.6 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.397 -0.814 . . . . 0.0 109.592 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 56.3 mtt180 -44.44 -44.27 8.35 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.369 0.604 . . . . 0.0 109.668 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.461 HG23 ' CG2' ' A' ' 25' ' ' VAL . 60.8 t -62.05 -56.94 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.527 ' HB3' ' CE ' ' A' ' 52' ' ' MET . . . -47.61 -38.13 13.95 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.52 -0.737 . . . . 0.0 109.401 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -66.34 -35.29 79.98 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.638 -0.664 . . . . 0.0 109.843 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.514 ' HG ' ' CD1' ' A' ' 32' ' ' LEU . 1.5 tp -71.57 -44.13 65.08 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.42 -0.8 . . . . 0.0 109.477 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.486 ' O ' ' N ' ' A' ' 68' ' ' ALA . 2.6 mt -77.71 -35.14 52.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 0.0 109.427 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.51 ' CB ' ' O ' ' A' ' 60' ' ' ALA . 0.7 OUTLIER -64.84 -61.01 2.44 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.422 -0.799 . . . . 0.0 110.159 -179.709 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.473 ' CD1' ' C ' ' A' ' 65' ' ' LEU . 0.3 OUTLIER -52.37 -33.97 45.59 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.836 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.569 ' CB ' HD23 ' A' ' 32' ' ' LEU . 1.7 m80 -73.64 -39.84 64.19 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.299 0.571 . . . . 0.0 109.658 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.504 ' O ' ' HB2' ' A' ' 38' ' ' PRO . . . 134.54 45.82 0.1 Allowed Glycine 0 N--CA 1.481 1.643 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.486 ' N ' ' O ' ' A' ' 63' ' ' LEU . . . -64.76 -162.22 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.94 -1.329 . . . . 0.0 110.208 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.476 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -116.86 61.64 2.61 Favored Pre-proline 0 C--N 1.301 -1.514 0 O-C-N 121.628 -0.67 . . . . 0.0 109.347 179.504 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.439 ' O ' ' HG3' ' A' ' 81' ' ' PRO . 52.1 Cg_endo -71.29 -2.15 10.75 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 O-C-N 123.792 1.417 . . . . 0.0 111.107 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.431 ' HA ' ' NH1' ' A' ' 80' ' ' ARG . 4.2 m-80 -108.77 -61.08 1.66 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.278 -0.889 . . . . 0.0 110.115 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 29.8 t -45.25 166.62 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.66 -0.65 . . . . 0.0 110.562 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -160.4 -148.62 0.17 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.104 -0.997 . . . . 0.0 110.303 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.499 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.6 OUTLIER -110.06 140.22 22.13 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.189 -0.944 . . . . 0.0 109.845 179.871 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -78.21 -23.58 8.8 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.641 1.337 . . . . 0.0 110.533 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.02 -81.3 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.888 . . . . 0.0 110.249 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.534 HG21 ' CZ2' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -104.56 40.73 1.43 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.429 -0.794 . . . . 0.0 109.844 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.499 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 9.4 mt 31.95 40.56 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.0 m -67.45 104.63 1.59 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.983 -1.073 . . . . 0.0 110.181 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.47 ' CG ' HG13 ' A' ' 106' ' ' VAL . 0.7 OUTLIER -87.55 170.45 11.81 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.165 -0.959 . . . . 0.0 109.915 179.588 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.439 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 38.0 Cg_endo -68.71 -2.68 9.81 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.743 1.391 . . . . 0.0 109.72 178.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.553 ' CG1' ' HG3' ' A' ' 114' ' ' PRO . 10.5 t -82.06 -27.66 9.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 O-C-N 121.596 -0.69 . . . . 0.0 109.458 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.506 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 10.4 m80 -77.72 -40.08 42.43 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.298 -0.876 . . . . 0.0 108.794 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.542 ' O ' ' HB3' ' A' ' 87' ' ' ARG . 0.3 OUTLIER -54.64 -46.78 74.01 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.492 -0.755 . . . . 0.0 109.186 178.656 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.518 ' HB1' HD13 ' A' ' 94' ' ' LEU . . . -59.01 -69.01 0.21 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.244 -0.91 . . . . 0.0 109.214 178.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.528 ' O ' ' CD2' ' A' ' 123' ' ' HIS . . . -60.38 -15.84 29.84 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.221 -0.925 . . . . 0.0 111.104 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.542 ' HB3' ' O ' ' A' ' 84' ' ' ASP . 9.5 tpt180 -60.74 -45.82 92.83 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.854 -1.154 . . . . 0.0 109.455 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -101.66 -4.3 26.77 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.833 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.483 ' HA3' ' ND1' ' A' ' 123' ' ' HIS . . . 83.09 48.25 5.48 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.578 ' CE1' ' HB1' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -112.12 82.34 1.61 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.359 -1.083 . . . . 0.0 110.883 -179.245 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.442 HD11 ' HB3' ' A' ' 125' ' ' ASP . 0.1 OUTLIER -57.08 -46.41 82.55 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.447 -0.783 . . . . 0.0 110.782 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.411 ' OD2' ' HB3' ' A' ' 57' ' ' ALA . 35.7 t0 -45.84 -35.46 4.5 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.496 -0.753 . . . . 0.0 109.778 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 25.5 m -66.51 -59.33 3.74 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.518 HD13 ' HB1' ' A' ' 85' ' ' ALA . 1.2 mp -46.01 -52.65 11.45 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.684 -0.635 . . . . 0.0 109.462 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.441 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 26.4 t -44.84 -55.13 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.449 HG13 HD12 ' A' ' 64' ' ' LEU . 13.4 t -55.49 -45.58 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.456 ' C ' ' CB ' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -56.31 -70.01 0.13 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.889 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . 0.416 ' HA ' ' HB2' ' A' ' 102' ' ' ALA . 3.4 t-160 -51.39 -40.84 60.08 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.493 -0.754 . . . . 0.0 109.44 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.441 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 7.5 ttt180 -59.81 -14.18 13.74 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.533 -0.729 . . . . 0.0 110.036 179.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 101' ' ' GLY . . . -143.93 89.94 2.09 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 121.26 -0.9 . . . . 0.0 110.856 -179.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 100' ' ' ALA . . . 35.18 90.92 0.01 OUTLIER Glycine 0 N--CA 1.503 3.122 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 179.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.456 ' CB ' ' C ' ' A' ' 97' ' ' LEU . . . -143.91 89.81 2.08 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.107 -1.231 . . . . 0.0 110.739 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.9 ttt180 -64.72 133.73 52.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.151 -0.968 . . . . 0.0 110.078 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.91 20.29 10.04 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.48 0.657 . . . . 0.0 109.286 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.22 39.87 1.43 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.504 -0.747 . . . . 0.0 110.037 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.51 ' O ' ' CD2' ' A' ' 113' ' ' LEU . 2.5 p -109.65 -179.22 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.176 -0.952 . . . . 0.0 110.582 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.464 ' HG2' ' CD2' ' A' ' 113' ' ' LEU . 59.4 mtt180 -141.31 140.7 33.86 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.49 -0.756 . . . . 0.0 109.771 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.45 ' O ' ' HB1' ' A' ' 109' ' ' ALA . 3.6 p-10 -71.27 56.81 0.23 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.984 -1.072 . . . . 0.0 110.357 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.45 ' HB1' ' O ' ' A' ' 108' ' ' ASP . . . 59.69 -89.57 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.207 -0.933 . . . . 0.0 110.613 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.595 ' CD1' ' O ' ' A' ' 110' ' ' TRP . 46.2 p90 -112.2 72.23 0.77 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.854 -1.153 . . . . 0.0 111.103 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.467 ' O ' ' CG ' ' A' ' 112' ' ' ARG . . . -161.62 -83.62 0.05 OUTLIER Glycine 0 N--CA 1.478 1.478 0 N-CA-C 109.631 -1.387 . . . . 0.0 109.631 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.467 ' CG ' ' O ' ' A' ' 111' ' ' GLY . 0.0 OUTLIER 171.81 -154.87 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.515 -0.991 . . . . 0.0 109.963 -179.776 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.51 ' CD2' ' O ' ' A' ' 106' ' ' VAL . 15.2 mt -92.02 164.16 24.56 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.402 -0.811 . . . . 0.0 109.606 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.553 ' HG3' ' CG1' ' A' ' 82' ' ' VAL . 37.8 Cg_endo -64.26 -11.07 26.14 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.844 1.444 . . . . 0.0 111.006 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.457 ' CG1' ' HB2' ' A' ' 113' ' ' LEU . 3.5 p -72.81 -32.47 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.149 -0.969 . . . . 0.0 109.725 179.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.64 -52.96 11.61 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.15 -0.969 . . . . 0.0 110.02 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.462 HD22 ' HA ' ' A' ' 87' ' ' ARG . 0.6 OUTLIER -57.2 -26.35 60.52 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.414 -0.804 . . . . 0.0 109.722 179.466 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.411 ' HB1' ' CB ' ' A' ' 127' ' ' ALA . . . -65.72 -58.25 6.12 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.374 -0.829 . . . . 0.0 108.895 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.07 -31.02 70.69 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.673 -0.642 . . . . 0.0 109.636 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -65.72 -49.73 67.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.611 -0.68 . . . . 0.0 110.343 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.521 ' HB3' ' NE2' ' A' ' 123' ' ' HIS . 22.7 mt -77.42 5.51 8.68 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.363 -0.836 . . . . 0.0 111.087 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 89.75 29.6 15.49 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 120.085 -1.055 . . . . 0.0 111.219 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.528 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 61.4 m-70 -109.37 54.48 0.66 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.002 -1.293 . . . . 0.0 109.836 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.463 ' HG3' ' N ' ' A' ' 125' ' ' ASP . 37.5 ptt180 -49.29 -39.92 32.69 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.487 0.661 . . . . 0.0 109.911 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.463 ' N ' ' HG3' ' A' ' 124' ' ' ARG . 4.6 m-20 -61.45 -45.18 95.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.618 -0.677 . . . . 0.0 109.611 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.472 ' CG1' HD11 ' A' ' 94' ' ' LEU . 3.2 t -75.65 -36.26 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.465 -0.772 . . . . 0.0 109.637 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.411 ' CB ' ' HB1' ' A' ' 118' ' ' ALA . . . -63.55 -58.16 7.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.626 -0.671 . . . . 0.0 109.417 179.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.3 ttt-85 -44.92 -55.83 5.11 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.611 -0.681 . . . . 0.0 110.505 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -60.52 -49.57 77.01 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.447 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.501 HD23 ' CG1' ' A' ' 82' ' ' VAL . 10.2 mt -53.54 -52.97 57.96 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.694 -0.629 . . . . 0.0 110.081 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 25.1 ttp180 -46.04 -37.3 6.52 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.57 -0.706 . . . . 0.0 110.282 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.79 -53.78 4.92 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.51 -0.743 . . . . 0.0 110.492 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -66.02 -7.96 20.27 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.307 -0.87 . . . . 0.0 110.385 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 130' ' ' LEU . . . -117.2 -18.91 9.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.354 -0.841 . . . . 0.0 109.967 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.1 169.24 43.44 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.435 ' O ' ' OG1' ' A' ' 137' ' ' THR . . . -80.93 -127.08 0.76 Allowed Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 136' ' ' GLY . 61.0 p 44.1 27.38 0.2 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.703 -0.881 . . . . 0.0 111.063 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.62 149.17 52.4 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.286 -0.884 . . . . 0.0 109.665 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 179.95 -102.65 0.17 Allowed Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.735 -1.221 . . . . 0.0 110.124 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 68.0 m -103.11 -16.08 15.86 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.404 -1.056 . . . . 0.0 110.309 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -116.66 158.67 23.41 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.341 -0.849 . . . . 0.0 109.638 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 33.6 m-70 -83.12 -13.05 56.4 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.392 -0.818 . . . . 0.0 109.721 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -141.2 84.88 1.94 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.453 -0.78 . . . . 0.0 109.928 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.501 ' NH1' ' HA ' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -79.36 87.74 5.01 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.259 -0.901 . . . . 0.0 109.588 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.417 ' O ' ' CB ' ' A' ' 146' ' ' ASP . 2.4 mt -89.06 165.55 2.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.44 -0.787 . . . . 0.0 109.455 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.417 ' CB ' ' O ' ' A' ' 145' ' ' ILE . 0.7 OUTLIER 65.05 115.0 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.398 -0.814 . . . . 0.0 109.523 -179.38 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.501 ' HA ' ' NH1' ' A' ' 144' ' ' ARG . . . -85.98 117.53 24.88 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.418 -0.801 . . . . 0.0 110.006 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -48.61 122.13 5.24 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.594 -0.691 . . . . 0.0 110.292 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 -88.93 -2.64 58.69 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.46 -0.775 . . . . 0.0 110.415 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 102.06 150.44 23.17 Favored Glycine 0 N--CA 1.488 2.16 0 C-N-CA 119.982 -1.104 . . . . 0.0 110.509 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.405 ' O ' ' O ' ' A' ' 152' ' ' SER . 44.8 Cg_endo -73.17 -173.72 1.36 Allowed 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 124.123 1.591 . . . . 0.0 110.36 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' SER . . . . . 0.405 ' O ' ' O ' ' A' ' 151' ' ' PRO . 0.4 OUTLIER 57.85 113.15 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.443 -0.786 . . . . 0.0 110.432 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.6 t0 56.87 -178.24 0.05 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.21 -0.931 . . . . 0.0 110.238 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.507 ' O ' HG23 ' A' ' 154' ' ' ILE . 0.5 OUTLIER -138.32 81.13 26.16 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 120.998 -1.063 . . . . 0.0 111.174 -179.465 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -76.21 133.82 15.22 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.789 1.415 . . . . 0.0 110.222 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.7 p30 . . . . . 0 N--CA 1.498 1.931 0 CA-C-O 117.974 -1.013 . . . . 0.0 110.561 -179.428 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.825 0 CA-C-O 121.017 0.436 . . . . 0.0 110.123 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -140.1 99.59 7.32 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.242 -0.911 . . . . 0.0 110.409 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -75.91 65.99 6.82 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.691 1.364 . . . . 0.0 110.594 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.46 116.16 27.15 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.142 -0.974 . . . . 0.0 110.589 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.08 55.98 3.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.446 -0.784 . . . . 0.0 110.067 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.73 -52.91 3.95 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.9 m 58.21 164.77 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.444 -1.033 . . . . 0.0 110.505 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.34 71.69 0.14 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.582 -0.699 . . . . 0.0 109.915 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 45.0 ttm -124.13 -68.78 0.84 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.322 -0.861 . . . . 0.0 110.687 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.499 ' CB ' ' CD ' ' A' ' 11' ' ' PRO . 1.9 mp0 -44.8 -59.84 3.69 Favored Pre-proline 0 N--CA 1.502 2.135 0 O-C-N 121.596 -0.69 . . . . 0.0 111.179 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.499 ' CD ' ' CB ' ' A' ' 10' ' ' GLU . 46.1 Cg_endo -72.43 177.61 7.17 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.429 1.226 . . . . 0.0 110.436 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 64.34 11.01 6.1 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.479 -0.763 . . . . 0.0 110.761 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.52 -14.34 60.8 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.178 -0.951 . . . . 0.0 110.213 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -79.35 -2.18 40.39 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.396 -0.815 . . . . 0.0 110.23 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.511 ' HA ' ' CG2' ' A' ' 18' ' ' THR . 25.3 m0 -89.37 -15.58 32.99 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.176 -0.953 . . . . 0.0 111.03 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.476 HD21 ' O ' ' A' ' 37' ' ' LEU . 1.0 OUTLIER -79.17 -44.88 21.04 Favored 'General case' 0 N--CA 1.483 1.217 0 O-C-N 120.864 -1.148 . . . . 0.0 109.039 179.54 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.475 ' CB ' ' OD1' ' A' ' 42' ' ' ASN . . . -74.8 -41.18 60.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.437 -0.789 . . . . 0.0 110.109 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.511 ' CG2' ' HA ' ' A' ' 15' ' ' TRP . 4.3 t -58.43 -43.09 88.61 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.324 -0.86 . . . . 0.0 109.739 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.552 ' HB3' HG21 ' A' ' 28' ' ' VAL . . . -63.7 -44.12 94.6 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.345 -0.847 . . . . 0.0 110.054 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.85 -45.27 92.97 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.411 -0.806 . . . . 0.0 110.3 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.461 ' HB2' HG23 ' A' ' 51' ' ' VAL . . . -68.13 -27.49 66.49 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.358 -0.839 . . . . 0.0 111.032 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' A' ' 18' ' ' THR . 11.0 mtp180 -94.4 20.49 8.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.248 -0.908 . . . . 0.0 110.77 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.498 ' CA ' ' HE3' ' A' ' 53' ' ' MET . . . 57.83 37.29 83.74 Favored Glycine 0 N--CA 1.486 1.974 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 178.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.15 64.11 0.63 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.291 -1.123 . . . . 0.0 110.186 179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.533 ' CG2' HG23 ' A' ' 59' ' ' VAL . 30.5 t -55.15 -44.78 76.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.42 -0.8 . . . . 0.0 109.179 179.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.86 -48.7 66.9 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.57 -0.706 . . . . 0.0 110.704 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.479 ' O ' ' HB2' ' A' ' 31' ' ' LEU . 0.8 OUTLIER -62.57 -34.34 76.77 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.253 -0.904 . . . . 0.0 110.35 -179.776 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.552 HG21 ' HB3' ' A' ' 19' ' ' ALA . 21.3 t -76.73 -50.19 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.385 -0.822 . . . . 0.0 110.181 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.519 ' CD ' HD12 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -43.4 -44.01 5.48 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.285 -0.884 . . . . 0.0 109.19 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.463 ' O ' ' CB ' ' A' ' 34' ' ' ALA . . . -79.64 -54.79 5.54 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 120.124 -0.63 . . . . 0.0 109.486 178.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 27' ' ' GLU . 8.2 mt -50.56 -61.52 2.14 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.364 -0.835 . . . . 0.0 110.307 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.529 ' HA ' ' CB ' ' A' ' 36' ' ' ALA . 3.6 mt -45.76 -62.55 1.25 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.399 -0.813 . . . . 0.0 109.962 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -64.91 -16.12 62.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.455 -0.778 . . . . 0.0 110.832 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' A' ' 30' ' ' ALA . . . -85.76 -6.79 59.06 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.239 -0.913 . . . . 0.0 111.308 -179.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.27 26.35 1.67 Allowed Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.719 -1.229 . . . . 0.0 110.466 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.529 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . . . -74.61 170.64 15.36 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.145 -1.209 . . . . 0.0 110.308 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.476 ' O ' HD21 ' A' ' 16' ' ' LEU . 1.3 mm? -103.22 96.64 8.53 Favored Pre-proline 0 C--N 1.302 -1.482 0 O-C-N 121.604 -0.685 . . . . 0.0 110.367 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.486 ' HB3' ' HB3' ' A' ' 66' ' ' HIS . 41.6 Cg_endo -68.16 -14.85 41.76 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.741 1.39 . . . . 0.0 110.791 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.465 ' O ' ' HD3' ' A' ' 41' ' ' PRO . 0.4 OUTLIER -111.31 16.16 21.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.025 -1.047 . . . . 0.0 110.342 179.84 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.23 110.52 10.47 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.282 -0.886 . . . . 0.0 110.595 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 39' ' ' ASN . 45.9 Cg_endo -74.46 108.18 2.62 Favored 'Trans proline' 0 C--N 1.318 -1.03 0 O-C-N 123.552 1.29 . . . . 0.0 109.788 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.475 ' OD1' ' CB ' ' A' ' 17' ' ' ALA . 27.8 m-80 -57.43 167.62 0.96 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.64 -0.663 . . . . 0.0 110.813 -179.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.13 2.66 17.3 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.516 -0.74 . . . . 0.0 110.329 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.552 ' CD1' ' N ' ' A' ' 44' ' ' TYR . 1.2 m-85 -91.49 21.64 4.47 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.272 -0.892 . . . . 0.0 109.478 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.445 ' O ' ' NH2' ' A' ' 47' ' ' ARG . . . 53.75 22.1 17.39 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 -178.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 16.8 mtt180 -119.95 -176.65 3.23 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.661 -0.905 . . . . 0.0 110.188 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.582 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 5.2 mmt180 -106.25 -173.48 0.28 Allowed Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.641 -0.662 . . . . 0.0 110.393 -178.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.582 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 52.2 Cg_endo -79.32 0.65 9.84 Favored 'Trans proline' 0 C--N 1.318 -1.038 0 O-C-N 123.438 1.23 . . . . 0.0 110.594 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.489 ' O ' ' CG ' ' A' ' 52' ' ' MET . 7.8 mt -121.53 -43.63 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.362 -0.836 . . . . 0.0 108.94 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.455 ' HG2' ' HB3' ' A' ' 81' ' ' PRO . 5.7 mt-30 -50.07 -23.11 1.91 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.323 -0.861 . . . . 0.0 109.59 178.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.461 HG23 ' HB2' ' A' ' 21' ' ' ALA . 8.8 p -106.75 -7.44 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.73 -0.606 . . . . 0.0 110.867 -179.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.489 ' CG ' ' O ' ' A' ' 49' ' ' ILE . 0.3 OUTLIER -68.06 158.68 32.43 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.97 -1.081 . . . . 0.0 109.817 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.498 ' HE3' ' CA ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -55.59 96.4 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.094 -1.004 . . . . 0.0 109.267 179.216 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.508 ' O ' ' CD2' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -56.72 -14.8 3.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.176 -0.952 . . . . 0.0 110.414 -179.514 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.449 ' HA2' ' CD2' ' A' ' 90' ' ' PHE . . . -88.13 35.23 3.59 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 178.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -171.54 99.56 0.19 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.421 -1.047 . . . . 0.0 109.668 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.31 -25.0 64.91 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.213 -0.93 . . . . 0.0 110.017 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.89 -33.14 3.04 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.572 -0.705 . . . . 0.0 110.531 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.533 HG23 ' CG2' ' A' ' 25' ' ' VAL . 3.0 t -72.66 -58.78 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.454 -0.779 . . . . 0.0 109.341 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -41.17 -46.7 3.12 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.656 -0.653 . . . . 0.0 110.311 179.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.57 -55.3 33.59 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.204 -0.935 . . . . 0.0 109.643 179.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.52 ' CD1' HD13 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -47.79 -61.5 1.92 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.68 -0.637 . . . . 0.0 109.833 178.993 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.484 HD21 ' HB2' ' A' ' 48' ' ' PRO . 0.9 OUTLIER -59.66 -55.07 38.99 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.256 0.551 . . . . 0.0 109.604 179.411 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.471 ' CD2' ' HB2' ' A' ' 100' ' ' ALA . 0.6 OUTLIER -49.8 -55.62 13.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.62 -0.675 . . . . 0.0 109.439 179.48 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 22.1 tp -53.94 -37.56 64.01 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.843 0.83 . . . . 0.0 108.819 178.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.501 ' CB ' HD23 ' A' ' 32' ' ' LEU . 2.0 m-70 -80.55 -5.59 56.99 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.271 0.557 . . . . 0.0 110.302 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.436 ' O ' ' ND2' ' A' ' 39' ' ' ASN . . . 89.4 63.74 1.29 Allowed Glycine 0 N--CA 1.479 1.537 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 38' ' ' PRO . . . -79.3 -155.02 0.09 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.031 -1.276 . . . . 0.0 109.504 179.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.422 ' OE1' ' ND2' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -120.79 57.14 5.64 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.139 -0.976 . . . . 0.0 110.208 179.389 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.465 ' HB2' ' HG ' ' A' ' 97' ' ' LEU . 48.7 Cg_endo -73.99 -1.17 10.49 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.673 1.354 . . . . 0.0 110.648 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -108.66 -45.29 3.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 110.0 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.3 m -52.11 177.55 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.336 -0.852 . . . . 0.0 110.521 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -162.66 -143.35 0.08 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.361 -0.837 . . . . 0.0 110.136 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.449 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -122.49 132.55 24.25 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.046 -1.034 . . . . 0.0 110.18 -179.566 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -74.25 1.89 6.79 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 O-C-N 123.348 1.183 . . . . 0.0 110.777 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -103.57 -48.55 3.93 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.185 -0.947 . . . . 0.0 109.365 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.566 ' CG2' ' CZ3' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -128.72 18.02 6.26 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.834 -0.541 . . . . 0.0 109.841 179.875 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.449 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 9.0 mt 44.75 34.5 1.19 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.506 -0.747 . . . . 0.0 110.689 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 83.6 m -59.03 89.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.565 -0.71 . . . . 0.0 110.552 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.514 ' HD3' ' HD2' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -71.04 161.61 77.19 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.168 -0.958 . . . . 0.0 109.52 179.431 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.514 ' HD2' ' HD3' ' A' ' 80' ' ' ARG . 48.4 Cg_endo -73.96 -13.09 23.98 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.696 1.366 . . . . 0.0 110.549 179.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 90.7 t -67.28 -25.35 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.45 -0.781 . . . . 0.0 110.125 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.541 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 5.2 m80 -71.64 -40.81 69.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.277 -0.89 . . . . 0.0 109.236 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.499 ' HB3' ' SD ' ' A' ' 54' ' ' MET . 9.9 m-20 -52.27 -46.72 65.95 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.547 -0.721 . . . . 0.0 110.483 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.466 ' CB ' ' HG ' ' A' ' 94' ' ' LEU . . . -57.29 -68.46 0.23 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.05 -1.031 . . . . 0.0 108.993 178.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.608 ' O ' ' ND1' ' A' ' 123' ' ' HIS . . . -52.35 -34.77 49.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.482 -0.761 . . . . 0.0 109.861 179.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.541 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 0.1 OUTLIER -40.37 -61.29 0.93 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.917 -0.489 . . . . 0.0 111.136 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -89.19 9.68 24.81 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.224 -0.923 . . . . 0.0 110.491 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.407 ' HA2' ' HB3' ' A' ' 123' ' ' HIS . . . 77.87 33.4 41.78 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.508 ' CD2' ' O ' ' A' ' 54' ' ' MET . 0.6 OUTLIER -96.82 131.74 43.25 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.148 -1.207 . . . . 0.0 110.065 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.516 ' HA ' HD13 ' A' ' 94' ' ' LEU . 0.5 OUTLIER -105.47 -47.6 3.89 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.272 -0.893 . . . . 0.0 110.45 179.87 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.424 ' O ' HG22 ' A' ' 96' ' ' VAL . 47.5 m-20 -47.32 -28.3 1.95 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.419 -0.801 . . . . 0.0 109.769 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.477 ' OG1' ' CD1' ' A' ' 90' ' ' PHE . 61.6 m -65.19 -56.82 10.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.588 -0.695 . . . . 0.0 109.604 178.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.516 HD13 ' HA ' ' A' ' 91' ' ' LEU . 1.5 mp -53.91 -49.16 69.22 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.217 -0.927 . . . . 0.0 109.661 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.455 ' O ' ' N ' ' A' ' 99' ' ' ARG . 74.7 t -44.3 -45.47 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.48 ' HA ' ' HB3' ' A' ' 99' ' ' ARG . 22.0 t -59.97 -54.09 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.556 -0.715 . . . . 0.0 109.436 179.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.465 ' HG ' ' HB2' ' A' ' 70' ' ' PRO . 7.3 mp -48.52 -50.05 33.55 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.543 0.687 . . . . 0.0 110.265 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -77.82 -21.65 51.2 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.583 -0.698 . . . . 0.0 109.881 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.48 ' HB3' ' HA ' ' A' ' 96' ' ' VAL . 1.4 ttm180 -72.94 -9.96 59.28 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.413 -0.804 . . . . 0.0 110.949 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.471 ' HB2' ' CD2' ' A' ' 64' ' ' LEU . . . -136.39 -66.73 0.53 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.064 -1.022 . . . . 0.0 110.923 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -167.51 105.51 0.24 Allowed Glycine 0 N--CA 1.486 1.979 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.46 ' HB3' ' HB3' ' A' ' 97' ' ' LEU . . . -177.29 119.37 0.11 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.317 -1.107 . . . . 0.0 110.31 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 -68.11 134.84 51.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -0.892 . . . . 0.0 109.437 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.43 HD22 ' CD2' ' A' ' 130' ' ' LEU . 1.4 tt -112.27 13.28 20.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.376 -0.828 . . . . 0.0 110.665 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.454 ' HB3' ' HA ' ' A' ' 134' ' ' ALA . 1.1 p30 -127.65 47.54 2.37 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.425 -0.797 . . . . 0.0 110.325 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.451 HG11 ' CG ' ' A' ' 80' ' ' ARG . 0.8 OUTLIER -99.73 -175.09 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.143 -0.973 . . . . 0.0 110.659 -179.848 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.437 ' O ' ' HB3' ' A' ' 78' ' ' LEU . 6.6 ttp180 -141.01 148.89 41.0 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.462 ' CA ' ' O ' ' A' ' 77' ' ' THR . 3.6 m-20 -89.55 45.08 1.25 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.356 -0.84 . . . . 0.0 110.45 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 62.11 -77.92 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.357 -0.839 . . . . 0.0 110.38 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.566 ' CZ3' ' CG2' ' A' ' 77' ' ' THR . 1.1 p-90 -136.74 16.3 3.1 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.206 -0.934 . . . . 0.0 110.498 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -86.77 -79.71 1.21 Allowed Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 178.14 133.82 0.07 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.476 -1.014 . . . . 0.0 110.13 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.49 ' HG ' ' HD2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER -51.02 166.39 0.32 Allowed Pre-proline 0 N--CA 1.498 1.962 0 O-C-N 121.387 -0.821 . . . . 0.0 110.548 179.791 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.49 ' HD2' ' HG ' ' A' ' 113' ' ' LEU . 40.7 Cg_endo -69.72 -23.28 31.15 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.79 1.416 . . . . 0.0 110.226 179.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.489 HG22 ' N ' ' A' ' 131' ' ' ARG . 4.7 p -86.72 -33.91 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.884 . . . . 0.0 109.776 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.31 -44.04 97.87 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.661 -0.649 . . . . 0.0 110.351 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.56 -31.09 67.66 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.283 -0.885 . . . . 0.0 109.73 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.502 ' HA ' ' ND1' ' A' ' 123' ' ' HIS . . . -81.61 -20.66 39.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.448 -0.782 . . . . 0.0 110.708 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -74.72 -40.92 61.03 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.4 -0.813 . . . . 0.0 110.691 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.47 -40.6 35.05 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.255 -0.903 . . . . 0.0 110.622 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.492 ' HB3' ' NE2' ' A' ' 123' ' ' HIS . 0.2 OUTLIER -72.57 -81.47 0.06 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.432 -0.793 . . . . 0.0 110.552 -179.339 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 162.14 47.26 0.02 OUTLIER Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.701 -1.237 . . . . 0.0 110.162 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.608 ' ND1' ' O ' ' A' ' 86' ' ' ALA . 3.6 m170 -108.49 52.94 0.7 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.127 -1.22 . . . . 0.0 109.643 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 28.4 mtt180 -48.22 -44.07 32.71 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.285 -0.884 . . . . 0.0 110.029 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.415 ' O ' ' CD1' ' A' ' 91' ' ' LEU . 5.5 t0 -54.27 -43.3 70.89 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.501 -0.75 . . . . 0.0 109.415 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.476 HG12 ' CB ' ' A' ' 86' ' ' ALA . 15.9 t -85.31 -45.55 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.277 -0.89 . . . . 0.0 110.12 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -47.31 -58.12 4.48 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.348 -0.845 . . . . 0.0 110.454 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 11.2 mtp180 -50.77 -65.85 0.49 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.473 -0.767 . . . . 0.0 110.052 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -50.36 -31.84 15.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.527 -0.733 . . . . 0.0 109.887 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.476 ' O ' ' CB ' ' A' ' 134' ' ' ALA . 11.3 mt -72.89 -57.11 4.3 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.594 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.489 ' N ' HG22 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -51.94 -21.78 3.32 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.355 -0.841 . . . . 0.0 110.689 -179.767 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -83.85 -61.18 1.89 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.311 -0.868 . . . . 0.0 109.729 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -75.1 -6.78 51.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.603 -0.686 . . . . 0.0 110.609 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.476 ' CB ' ' O ' ' A' ' 130' ' ' LEU . . . -99.55 -20.78 16.21 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.093 -1.004 . . . . 0.0 109.284 179.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -53.42 146.63 19.96 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -138.14 17.38 3.38 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.9 t -79.7 104.47 10.32 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.493 -1.004 . . . . 0.0 110.821 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 178.07 57.59 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.472 -0.767 . . . . 0.0 110.129 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -162.5 -119.11 0.48 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 68.4 p -98.81 40.36 1.2 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.429 -1.042 . . . . 0.0 110.647 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -112.59 -178.29 3.36 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.084 -1.01 . . . . 0.0 109.813 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -55.28 -171.28 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.263 -0.898 . . . . 0.0 110.057 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -138.72 149.08 44.68 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.948 -1.095 . . . . 0.0 110.676 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -70.38 154.31 42.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.409 -0.807 . . . . 0.0 110.362 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.411 ' O ' ' CB ' ' A' ' 146' ' ' ASP . 1.2 tt -75.59 61.69 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.281 -0.887 . . . . 0.0 110.0 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.411 ' CB ' ' O ' ' A' ' 145' ' ' ILE . 1.1 t0 65.09 172.94 0.21 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.498 -0.751 . . . . 0.0 110.457 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.424 ' O ' ' C ' ' A' ' 148' ' ' ALA . . . -53.1 158.51 1.48 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.405 -0.809 . . . . 0.0 109.801 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 147' ' ' ALA . . . -39.58 120.45 1.09 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.506 -0.746 . . . . 0.0 111.009 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -52.43 130.57 31.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.351 -0.843 . . . . 0.0 109.523 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -145.88 -151.45 5.42 Favored Glycine 0 N--CA 1.489 2.178 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.225 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -75.41 127.46 10.42 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 124.11 1.584 . . . . 0.0 110.079 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 6.5 p -162.32 118.53 1.97 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.235 -0.915 . . . . 0.0 110.568 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 55.02 96.55 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.466 -0.771 . . . . 0.0 109.978 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 2.1 mt -114.91 87.97 16.04 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.302 -0.874 . . . . 0.0 109.455 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -78.48 110.56 2.86 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.82 1.431 . . . . 0.0 110.52 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 12.9 t0 . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.032 179.892 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.0 ptt? . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.297 0.57 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.427 ' N ' ' HD2' ' A' ' 3' ' ' PRO . 0.8 OUTLIER -54.67 -55.26 40.01 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.188 -0.945 . . . . 0.0 110.237 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 2' ' ' GLU . 50.5 Cg_endo -76.41 178.85 7.01 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.528 1.278 . . . . 0.0 110.414 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 49.52 64.18 1.86 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.488 -0.758 . . . . 0.0 110.764 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.85 -25.64 63.44 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.29 -0.881 . . . . 0.0 110.328 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -149.41 155.75 26.46 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -123.15 173.9 7.59 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.411 -1.053 . . . . 0.0 110.335 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 58.6 -177.37 0.08 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.427 -0.796 . . . . 0.0 110.294 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 35.3 mtm -64.27 -157.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.321 -0.862 . . . . 0.0 109.972 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 52.24 61.58 11.81 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.244 -0.91 . . . . 0.0 110.502 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -75.2 157.16 42.09 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.746 1.393 . . . . 0.0 110.653 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.8 149.04 36.27 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.429 -0.794 . . . . 0.0 110.264 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -169.64 -153.88 0.11 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.26 -0.9 . . . . 0.0 110.316 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.9 t0 62.2 14.88 7.03 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.262 -0.899 . . . . 0.0 110.865 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 22.6 m0 -95.01 -37.22 11.23 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.035 -1.041 . . . . 0.0 109.923 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.421 ' CD1' ' HB3' ' A' ' 48' ' ' PRO . 0.9 OUTLIER -71.49 -28.37 63.87 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.358 -0.839 . . . . 0.0 110.006 179.478 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.77 -44.91 12.89 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.326 -0.859 . . . . 0.0 110.185 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.429 ' CG2' ' N ' ' A' ' 19' ' ' ALA . 1.6 t -61.94 -39.08 90.85 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.408 -0.808 . . . . 0.0 110.345 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.429 ' N ' ' CG2' ' A' ' 18' ' ' THR . . . -68.8 -48.87 62.54 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.453 -0.779 . . . . 0.0 109.975 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.426 ' HB1' ' CB ' ' A' ' 52' ' ' MET . . . -56.9 -53.5 57.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.528 -0.733 . . . . 0.0 109.811 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.406 ' HA ' ' N ' ' A' ' 53' ' ' MET . . . -53.51 -28.47 31.22 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.48 -0.762 . . . . 0.0 110.182 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.57 14.41 15.08 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.468 -0.77 . . . . 0.0 110.474 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.42 ' HA3' ' CE ' ' A' ' 53' ' ' MET . . . 55.0 49.89 60.92 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -121.25 63.18 0.89 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.401 -1.058 . . . . 0.0 110.138 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.472 HG12 ' HB3' ' A' ' 58' ' ' ARG . 41.1 t -47.49 -51.17 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.549 -0.719 . . . . 0.0 110.163 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -47.12 -42.26 18.89 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.603 -0.686 . . . . 0.0 110.686 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.07 -37.24 72.48 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.249 -0.907 . . . . 0.0 110.086 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.455 ' CG1' HD13 ' A' ' 62' ' ' LEU . 21.6 t -73.45 -41.23 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.328 -0.857 . . . . 0.0 110.351 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.508 ' CD ' HD11 ' A' ' 62' ' ' LEU . 9.6 mmm180 -53.9 -44.81 70.82 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.126 -0.984 . . . . 0.0 109.639 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.42 ' O ' ' CB ' ' A' ' 34' ' ' ALA . . . -78.85 -41.25 30.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.659 -0.65 . . . . 0.0 109.917 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 35.0 mt -65.53 -59.15 4.28 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.547 -0.721 . . . . 0.0 110.236 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.526 ' HA ' ' CB ' ' A' ' 36' ' ' ALA . 33.1 tp -50.83 -45.86 59.8 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.369 -0.832 . . . . 0.0 110.526 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -76.19 -15.6 60.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.294 -0.879 . . . . 0.0 110.031 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 30' ' ' ALA . . . -82.79 -8.75 59.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.301 -0.874 . . . . 0.0 110.652 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.54 23.19 1.93 Allowed Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.782 -1.199 . . . . 0.0 110.711 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.526 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . . . -69.95 152.56 44.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.99 -1.3 . . . . 0.0 109.664 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.404 ' O ' ' CD2' ' A' ' 16' ' ' LEU . 0.0 OUTLIER -79.08 116.59 61.33 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.274 -0.891 . . . . 0.0 110.09 -179.728 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.73 -33.03 22.18 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.372 1.196 . . . . 0.0 110.317 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -115.57 58.05 0.73 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.311 -0.868 . . . . 0.0 109.744 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -88.69 116.97 67.79 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.324 -0.86 . . . . 0.0 110.11 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -72.35 82.94 1.31 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.647 1.341 . . . . 0.0 110.08 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -60.92 -174.95 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.391 -0.818 . . . . 0.0 110.026 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.5 p -93.63 26.57 3.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.397 -0.815 . . . . 0.0 110.171 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -114.78 17.88 16.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.248 -0.908 . . . . 0.0 110.248 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 59.74 44.26 97.12 Favored Glycine 0 N--CA 1.484 1.88 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -174.55 161.35 3.25 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.307 -1.114 . . . . 0.0 110.79 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.624 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 2.2 mtt180 -87.7 -154.47 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.635 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.624 ' CD ' ' CB ' ' A' ' 47' ' ' ARG . 45.3 Cg_endo -77.36 -170.53 0.95 Allowed 'Trans proline' 0 N--CA 1.483 0.855 0 O-C-N 122.53 0.753 . . . . 0.0 111.008 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.523 ' O ' ' HG2' ' A' ' 52' ' ' MET . 4.0 mt 62.62 -62.86 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.729 -0.607 . . . . 0.0 110.057 -178.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.522 ' N ' ' O ' ' A' ' 48' ' ' PRO . 8.4 mt-30 -48.15 -23.55 0.89 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.596 -1.315 . . . . 0.0 109.757 179.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.1 p -118.54 31.37 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.337 -0.852 . . . . 0.0 109.873 178.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.523 ' HG2' ' O ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -93.03 36.66 1.03 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.139 -0.976 . . . . 0.0 109.963 179.627 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.42 ' CE ' ' HA3' ' A' ' 23' ' ' GLY . 7.7 ttp 63.44 -6.95 0.19 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.468 -0.77 . . . . 0.0 110.965 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.538 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 45.94 28.81 0.65 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.212 -0.93 . . . . 0.0 110.579 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.414 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -126.26 4.15 7.76 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.08 84.94 1.85 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.378 -1.072 . . . . 0.0 109.596 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.431 ' HB1' ' CE1' ' A' ' 90' ' ' PHE . . . -51.27 -22.97 3.08 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.417 -0.802 . . . . 0.0 110.514 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.472 ' HB3' HG12 ' A' ' 25' ' ' VAL . 1.8 mmt180 -54.07 -45.94 71.85 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.284 -0.885 . . . . 0.0 110.047 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.42 ' CG1' ' HB1' ' A' ' 20' ' ' ALA . 46.7 t -58.05 -45.22 88.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.418 -0.802 . . . . 0.0 109.723 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.427 ' O ' ' HB3' ' A' ' 64' ' ' LEU . . . -49.48 -53.19 24.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.515 -0.741 . . . . 0.0 109.719 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.421 ' N ' HG12 ' A' ' 96' ' ' VAL . 1.6 tt0 -52.21 -51.34 58.8 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.437 -0.789 . . . . 0.0 109.313 178.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.508 HD11 ' CD ' ' A' ' 29' ' ' ARG . 0.9 OUTLIER -49.55 -70.99 0.07 Allowed 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.638 0.732 . . . . 0.0 110.049 178.675 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.498 ' HB3' ' HB3' ' A' ' 68' ' ' ALA . 4.5 mm? -56.5 -46.81 80.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.867 -0.521 . . . . 0.0 110.931 -179.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.442 ' CD2' ' HB1' ' A' ' 100' ' ' ALA . 1.2 tt -61.56 -59.09 5.74 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.342 -0.849 . . . . 0.0 111.171 -179.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -53.35 -23.55 9.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.067 -1.021 . . . . 0.0 109.935 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.517 ' ND1' ' HG ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -88.9 -50.81 5.97 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.611 -0.681 . . . . 0.0 109.433 179.505 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.98 52.23 0.01 OUTLIER Glycine 0 N--CA 1.483 1.774 0 C-N-CA 119.937 -1.125 . . . . 0.0 111.061 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.498 ' HB3' ' HB3' ' A' ' 63' ' ' LEU . . . -79.29 -151.74 0.06 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.827 -1.396 . . . . 0.0 109.99 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.422 ' N ' ' CD ' ' A' ' 70' ' ' PRO . 1.2 tt0 -123.28 54.89 7.3 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.365 -0.835 . . . . 0.0 110.088 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.452 ' HD3' ' HB2' ' A' ' 68' ' ' ALA . 43.0 Cg_endo -70.21 -13.91 34.06 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.641 1.337 . . . . 0.0 110.274 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.5 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 2.1 t-20 -108.36 -73.0 0.7 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.368 -0.832 . . . . 0.0 110.02 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 4.1 t -50.27 169.0 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.189 -0.944 . . . . 0.0 110.979 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.449 ' HB1' ' HA ' ' A' ' 80' ' ' ARG . . . -153.86 -155.45 0.59 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.334 -0.854 . . . . 0.0 110.149 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -101.71 135.34 19.78 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.406 -0.809 . . . . 0.0 109.746 179.876 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -74.3 -22.86 16.0 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.685 1.36 . . . . 0.0 110.661 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.03 -39.37 66.09 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.204 -0.935 . . . . 0.0 110.085 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.484 ' CG2' ' CH2' ' A' ' 110' ' ' TRP . 0.3 OUTLIER -147.43 16.07 1.15 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.601 -0.687 . . . . 0.0 110.13 179.929 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.462 ' HB3' ' O ' ' A' ' 107' ' ' ARG . 0.4 OUTLIER 48.22 35.11 5.04 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.481 -0.762 . . . . 0.0 111.513 179.664 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.5 m -71.31 104.82 3.27 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.219 -0.926 . . . . 0.0 109.886 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.5 ' NH1' ' O ' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -80.06 160.13 69.19 Favored Pre-proline 0 N--CA 1.498 1.928 0 O-C-N 121.351 -0.843 . . . . 0.0 110.747 -179.571 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.406 ' O ' ' HB2' ' A' ' 84' ' ' ASP . 45.7 Cg_endo -72.1 -17.46 28.12 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.822 1.433 . . . . 0.0 110.604 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.425 HG21 ' HG ' ' A' ' 104' ' ' LEU . 98.6 t -62.7 -24.06 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.209 -0.932 . . . . 0.0 110.205 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.495 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 13.4 m80 -76.68 -32.83 58.16 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.413 -0.804 . . . . 0.0 109.108 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.538 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 3.3 m-20 -57.98 -50.86 71.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.616 -0.678 . . . . 0.0 110.297 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.462 ' HB2' ' CD1' ' A' ' 94' ' ' LEU . . . -58.95 -58.33 9.11 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.343 -0.848 . . . . 0.0 109.856 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.55 ' HA ' ' CG1' ' A' ' 126' ' ' VAL . . . -59.36 -45.0 92.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.42 -0.8 . . . . 0.0 110.847 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.428 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 0.3 OUTLIER -47.71 -44.65 27.9 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.327 -0.858 . . . . 0.0 110.902 -179.589 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -95.96 13.32 27.31 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.284 -0.885 . . . . 0.0 110.495 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 59.84 60.1 9.29 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.431 ' CE1' ' HB1' ' A' ' 57' ' ' ALA . 0.3 OUTLIER -129.04 94.32 3.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.266 -1.138 . . . . 0.0 110.707 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.452 ' HG ' ' HA ' ' A' ' 126' ' ' VAL . 0.3 OUTLIER -69.31 -37.38 77.73 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.336 -0.853 . . . . 0.0 109.958 179.68 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.414 ' HB3' ' CB ' ' A' ' 57' ' ' ALA . 31.5 m-20 -50.08 -40.98 47.19 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.503 -0.748 . . . . 0.0 110.055 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 60.5 m -66.16 -42.45 88.96 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.462 ' CD1' ' HB2' ' A' ' 85' ' ' ALA . 1.2 tp -58.83 -38.27 78.28 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.596 -0.69 . . . . 0.0 109.312 178.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.3 t -61.41 -50.6 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.582 -0.699 . . . . 0.0 109.607 179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.421 HG12 ' N ' ' A' ' 61' ' ' GLU . 92.9 t -54.17 -54.51 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.543 -0.723 . . . . 0.0 109.433 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.407 ' HB3' ' CB ' ' A' ' 102' ' ' ALA . 1.1 mp -47.51 -53.56 14.02 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.735 -0.603 . . . . 0.0 110.825 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -72.98 -29.61 63.18 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.307 -0.871 . . . . 0.0 110.084 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -65.86 -9.4 28.78 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.367 -0.833 . . . . 0.0 110.604 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.442 ' HB1' ' CD2' ' A' ' 64' ' ' LEU . . . -136.9 -74.6 0.42 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.117 -0.99 . . . . 0.0 111.051 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -160.14 102.21 0.21 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.407 ' CB ' ' HB3' ' A' ' 97' ' ' LEU . . . -162.43 111.18 1.39 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.405 -1.056 . . . . 0.0 109.878 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -77.86 145.47 36.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.38 -0.825 . . . . 0.0 110.38 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.425 ' HG ' HG21 ' A' ' 82' ' ' VAL . 2.4 mp -116.36 4.23 13.39 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.46 -0.775 . . . . 0.0 110.286 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -98.68 39.29 1.27 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.187 -0.946 . . . . 0.0 109.764 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.419 HG12 ' CD ' ' A' ' 80' ' ' ARG . 3.0 p -108.4 -170.18 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.369 -0.832 . . . . 0.0 109.791 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.462 ' O ' ' HB3' ' A' ' 78' ' ' LEU . 0.1 OUTLIER -157.43 155.09 29.86 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.344 -0.848 . . . . 0.0 109.556 179.677 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 110' ' ' TRP . 85.4 m-20 -74.49 58.09 0.75 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.117 -0.99 . . . . 0.0 110.2 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.428 ' HB3' ' CE3' ' A' ' 110' ' ' TRP . . . 54.8 -88.36 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.465 -0.772 . . . . 0.0 110.74 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.484 ' CH2' ' CG2' ' A' ' 77' ' ' THR . 42.9 p90 -117.5 34.98 4.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.918 -1.114 . . . . 0.0 110.279 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -113.39 -84.94 1.36 Allowed Glycine 0 N--CA 1.481 1.674 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -169.75 -160.13 0.23 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.263 -1.139 . . . . 0.0 110.502 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.452 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.3 OUTLIER -103.82 175.9 2.02 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.455 -0.778 . . . . 0.0 109.883 179.742 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.452 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 46.4 Cg_endo -74.01 -50.39 0.17 Allowed 'Trans proline' 0 C--N 1.312 -1.349 0 O-C-N 123.604 1.318 . . . . 0.0 110.386 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.425 HG21 ' N ' ' A' ' 131' ' ' ARG . 12.2 p -58.62 -34.52 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.321 -0.862 . . . . 0.0 109.72 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -70.86 -25.5 62.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.53 -0.731 . . . . 0.0 109.698 179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.2 tt -79.68 -28.18 40.74 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.428 -0.795 . . . . 0.0 110.073 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -73.56 -45.29 54.36 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.402 -0.811 . . . . 0.0 109.891 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -62.8 -37.11 85.44 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.465 -0.772 . . . . 0.0 109.806 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.21 -45.29 85.35 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.534 -0.729 . . . . 0.0 110.037 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.1 -81.8 0.1 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.383 -0.823 . . . . 0.0 110.378 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 167.8 53.25 0.03 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.498 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 53.4 m-70 -127.88 52.87 1.82 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -1.149 . . . . 0.0 109.483 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.4 mtp180 -47.43 -43.0 23.52 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.544 -0.723 . . . . 0.0 110.258 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -55.6 -42.94 75.53 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.391 -0.818 . . . . 0.0 109.295 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.55 ' CG1' ' HA ' ' A' ' 86' ' ' ALA . 3.0 t -78.94 -34.0 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.495 -0.753 . . . . 0.0 109.127 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.77 -31.99 72.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.501 -0.749 . . . . 0.0 109.517 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.9 mtp180 -60.65 -66.7 0.49 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.543 -0.723 . . . . 0.0 110.099 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -55.03 -28.87 55.51 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.346 -0.847 . . . . 0.0 109.627 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.468 ' O ' ' N ' ' A' ' 134' ' ' ALA . 68.1 mt -72.74 -43.52 62.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.574 -0.704 . . . . 0.0 109.569 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.425 ' N ' HG21 ' A' ' 115' ' ' VAL . 0.1 OUTLIER -61.79 -19.53 62.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.203 -0.936 . . . . 0.0 110.391 -179.94 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.31 -50.71 7.12 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.277 -0.89 . . . . 0.0 110.399 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -88.26 -19.74 26.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.295 -0.878 . . . . 0.0 110.174 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 130' ' ' LEU . . . -112.87 34.98 4.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.498 -0.751 . . . . 0.0 109.687 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -51.63 121.25 12.08 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -125.96 73.86 0.43 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 7.8 t -54.21 123.6 13.27 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.373 -1.075 . . . . 0.0 110.33 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.21 179.18 8.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.139 -0.976 . . . . 0.0 110.637 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 155.31 -103.79 0.24 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 89.6 p -132.75 177.98 7.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.453 -1.028 . . . . 0.0 110.216 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 60.64 -162.47 0.27 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.271 -0.893 . . . . 0.0 110.583 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -86.87 -24.0 25.05 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.367 -0.833 . . . . 0.0 110.715 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . 53.19 -146.31 0.54 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.103 -0.998 . . . . 0.0 110.359 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.34 165.9 1.88 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.161 -0.962 . . . . 0.0 110.294 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 3.3 tp -85.43 137.45 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.444 -0.785 . . . . 0.0 110.1 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -177.23 73.17 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.196 -0.94 . . . . 0.0 110.513 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.73 141.9 58.6 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.304 -0.872 . . . . 0.0 110.177 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.49 164.78 21.75 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.368 -0.832 . . . . 0.0 110.545 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.437 ' CG ' ' O ' ' A' ' 149' ' ' GLU . 6.4 pt-20 -83.44 109.79 17.64 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.313 -0.867 . . . . 0.0 110.029 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 93.43 -148.8 19.18 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.57 156.52 61.06 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.731 1.385 . . . . 0.0 110.415 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.22 -51.15 2.63 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.284 -0.885 . . . . 0.0 110.535 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -52.06 141.65 17.82 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.253 -0.904 . . . . 0.0 110.495 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 3.5 mt -126.58 78.11 72.83 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.364 -0.835 . . . . 0.0 110.375 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -77.47 166.47 25.86 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.805 1.424 . . . . 0.0 109.761 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 . . . . . 0 N--CA 1.496 1.875 0 CA-C-O 117.938 -1.03 . . . . 0.0 110.538 -179.847 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.097 0.475 . . . . 0.0 110.063 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.416 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 64.1 mt-10 47.68 54.67 15.96 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.445 -0.784 . . . . 0.0 110.178 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.416 ' CD ' ' N ' ' A' ' 2' ' ' GLU . 44.5 Cg_endo -71.5 69.59 2.69 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.822 1.433 . . . . 0.0 110.532 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.8 152.64 35.38 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.461 -0.775 . . . . 0.0 110.094 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.46 -169.79 0.58 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.299 -0.875 . . . . 0.0 110.005 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 66.09 -121.78 19.64 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 50.94 77.45 0.13 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.419 -1.047 . . . . 0.0 110.328 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.11 -140.74 0.16 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.377 -0.827 . . . . 0.0 110.107 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.09 -0.05 21.38 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.012 -1.055 . . . . 0.0 110.946 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -57.91 135.05 83.54 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.088 -1.008 . . . . 0.0 110.111 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.61 -176.36 1.42 Allowed 'Trans proline' 0 C--N 1.312 -1.375 0 O-C-N 123.611 1.321 . . . . 0.0 110.714 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 m -129.24 -30.27 2.18 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.359 -0.838 . . . . 0.0 110.845 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -52.99 -28.32 23.33 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.128 -0.983 . . . . 0.0 110.165 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.11 -12.77 52.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.434 -0.791 . . . . 0.0 110.006 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.51 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 2.2 t90 -70.37 -7.59 44.08 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.287 -0.883 . . . . 0.0 110.423 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.464 ' HG ' ' N ' ' A' ' 17' ' ' ALA . 0.9 OUTLIER -80.4 -57.96 3.35 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.038 -1.039 . . . . 0.0 109.674 179.77 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.464 ' N ' ' HG ' ' A' ' 16' ' ' LEU . . . -63.26 -38.89 92.95 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.222 -0.924 . . . . 0.0 109.761 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.51 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 1.5 p -52.8 -54.22 37.22 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.527 -0.733 . . . . 0.0 110.385 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.477 ' CB ' HG23 ' A' ' 28' ' ' VAL . . . -59.77 -39.01 83.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.338 -0.851 . . . . 0.0 110.071 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.409 ' HB2' HG12 ' A' ' 59' ' ' VAL . . . -54.12 -61.91 2.0 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.116 -0.99 . . . . 0.0 109.561 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' A' ' 51' ' ' VAL . . . -54.64 -22.21 12.89 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.515 -0.74 . . . . 0.0 110.206 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -90.64 16.6 8.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.354 -0.841 . . . . 0.0 110.69 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 49.76 34.95 22.77 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 179.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.41 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . 6.2 mmt180 -109.49 67.54 0.65 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.338 -1.095 . . . . 0.0 110.052 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 93.2 t -49.17 -54.28 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.638 -0.663 . . . . 0.0 110.973 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -46.89 -43.02 18.46 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.5 -0.75 . . . . 0.0 110.818 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.546 ' O ' ' HB2' ' A' ' 31' ' ' LEU . 20.3 mt-10 -62.17 -44.86 95.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.233 -0.917 . . . . 0.0 110.166 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.477 HG23 ' CB ' ' A' ' 19' ' ' ALA . 3.5 t -72.92 -43.06 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.419 -0.801 . . . . 0.0 110.471 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.455 ' HD2' HD13 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -45.8 -47.81 15.67 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.409 -0.807 . . . . 0.0 109.853 -179.516 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.41 -49.06 11.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.418 -0.802 . . . . 0.0 110.379 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.546 ' HB2' ' O ' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -57.13 -56.99 14.67 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.165 -0.959 . . . . 0.0 110.255 179.849 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.578 ' HG ' ' CD2' ' A' ' 66' ' ' HIS . 15.2 tp -50.35 -49.65 53.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.5 -0.75 . . . . 0.0 110.665 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -74.73 -8.9 57.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.269 -0.894 . . . . 0.0 110.537 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.56 -11.69 39.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -0.912 . . . . 0.0 111.127 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 139.12 -9.38 3.29 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 119.619 -1.277 . . . . 0.0 110.763 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.477 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . . . -44.68 154.72 0.12 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.179 -1.189 . . . . 0.0 110.611 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.436 HD23 ' N ' ' A' ' 37' ' ' LEU . 2.3 mm? -93.73 111.31 52.11 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.378 -0.826 . . . . 0.0 110.658 -179.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.459 ' O ' ' HG3' ' A' ' 48' ' ' PRO . 43.2 Cg_endo -70.57 -19.02 32.78 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 123.622 1.327 . . . . 0.0 110.485 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -109.43 17.49 21.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.33 -0.856 . . . . 0.0 110.209 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.403 ' CB ' ' HB3' ' A' ' 37' ' ' LEU . . . -77.75 129.65 75.89 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.257 -0.902 . . . . 0.0 110.405 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -73.89 146.31 37.42 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 123.656 1.345 . . . . 0.0 109.983 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -88.96 -157.97 0.47 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.237 -0.914 . . . . 0.0 109.941 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.8 m -111.43 14.49 21.48 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.051 -1.03 . . . . 0.0 111.205 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -123.76 33.52 5.3 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.096 -1.002 . . . . 0.0 109.964 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.25 23.7 26.62 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.216 -1.553 . . . . 0.0 109.216 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.8 mtm-85 -108.05 -159.79 0.7 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.502 -0.999 . . . . 0.0 110.126 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.472 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 0.4 OUTLIER -127.89 179.69 1.19 Allowed Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.482 -0.761 . . . . 0.0 110.067 -179.651 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 42.1 Cg_endo -68.9 -24.52 33.65 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.611 1.322 . . . . 0.0 111.287 -179.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.549 ' O ' ' HG2' ' A' ' 52' ' ' MET . 4.3 mt -106.24 -36.83 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.044 -1.035 . . . . 0.0 108.64 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -54.73 -18.91 5.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.25 -0.906 . . . . 0.0 109.375 178.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.451 ' O ' ' CB ' ' A' ' 21' ' ' ALA . 9.3 p -116.07 39.23 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.478 -0.764 . . . . 0.0 110.601 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.549 ' HG2' ' O ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -103.55 39.21 1.64 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.946 -1.096 . . . . 0.0 109.443 179.267 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.412 ' CB ' ' O ' ' A' ' 52' ' ' MET . 0.0 OUTLIER 68.79 -5.61 0.98 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.729 -0.607 . . . . 0.0 110.918 -179.536 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.515 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.1 OUTLIER 39.94 89.32 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.364 -0.835 . . . . 0.0 110.937 179.82 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.538 ' HA2' ' CG ' ' A' ' 90' ' ' PHE . . . 159.13 -28.95 0.4 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.232 -1.947 . . . . 0.0 108.232 -179.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.67 79.91 1.72 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.733 -0.863 . . . . 0.0 110.16 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -48.8 -25.18 1.72 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.255 -0.903 . . . . 0.0 110.196 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.62 -39.24 57.68 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.463 -0.773 . . . . 0.0 109.789 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.409 HG12 ' HB2' ' A' ' 20' ' ' ALA . 23.8 t -69.22 -51.29 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.395 -0.816 . . . . 0.0 109.257 179.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.502 ' HB3' ' CE ' ' A' ' 52' ' ' MET . . . -48.91 -43.66 39.51 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.253 -0.904 . . . . 0.0 109.908 179.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -53.58 -51.72 62.08 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.501 -0.749 . . . . 0.0 109.677 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.479 ' HB3' HD23 ' A' ' 32' ' ' LEU . 1.2 mt -50.32 -66.51 0.38 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.593 -0.692 . . . . 0.0 109.912 178.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.479 ' HB3' ' CB ' ' A' ' 68' ' ' ALA . 11.0 mt -60.27 -39.27 86.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.676 -0.64 . . . . 0.0 110.798 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.448 ' CD2' HG12 ' A' ' 96' ' ' VAL . 0.5 OUTLIER -63.09 -60.15 3.83 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.174 -0.954 . . . . 0.0 110.458 -179.78 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.42 ' HG ' ' N ' ' A' ' 66' ' ' HIS . 0.7 OUTLIER -53.34 -22.67 7.7 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.427 -0.796 . . . . 0.0 110.019 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.578 ' CD2' ' HG ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -90.87 -25.15 19.99 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.611 -0.681 . . . . 0.0 109.679 179.849 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.94 56.58 0.5 Allowed Glycine 0 N--CA 1.481 1.643 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.479 ' CB ' ' HB3' ' A' ' 63' ' ' LEU . . . -70.1 -149.78 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.171 -1.193 . . . . 0.0 109.767 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.4 ' HB3' ' CG ' ' A' ' 47' ' ' ARG . 0.3 OUTLIER -120.46 59.31 6.85 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.498 -0.751 . . . . 0.0 109.628 179.251 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.401 ' HB2' ' HB2' ' A' ' 102' ' ' ALA . 43.5 Cg_endo -71.13 -1.53 9.71 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 O-C-N 123.808 1.425 . . . . 0.0 110.712 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -113.35 -66.4 1.09 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.128 -0.982 . . . . 0.0 110.014 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 3.1 t -50.57 166.59 0.08 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.453 -0.78 . . . . 0.0 110.534 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.447 ' CB ' ' HA ' ' A' ' 80' ' ' ARG . . . -159.22 -140.18 0.07 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.395 -0.815 . . . . 0.0 110.04 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.462 ' O ' ' N ' ' A' ' 78' ' ' LEU . 11.0 t70 -105.05 127.35 28.88 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.062 -1.024 . . . . 0.0 109.765 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.83 -2.6 12.17 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.432 1.228 . . . . 0.0 111.208 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -97.15 -44.0 7.14 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.096 -1.003 . . . . 0.0 109.72 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.453 ' CG2' ' CH2' ' A' ' 110' ' ' TRP . 0.5 OUTLIER -121.79 7.77 9.94 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.454 -0.779 . . . . 0.0 110.265 179.529 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.483 ' HB3' ' O ' ' A' ' 107' ' ' ARG . 1.3 mt 45.61 27.68 0.44 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.335 -0.853 . . . . 0.0 111.102 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.7 m -65.32 88.72 0.08 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.113 -0.992 . . . . 0.0 109.642 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.447 ' HA ' ' CB ' ' A' ' 73' ' ' ALA . 1.1 mtt180 -69.12 165.91 33.93 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.426 -0.796 . . . . 0.0 110.35 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -69.61 -12.97 34.32 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.728 1.383 . . . . 0.0 111.164 -179.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.416 HG13 HD23 ' A' ' 104' ' ' LEU . 39.9 t -66.13 -42.1 90.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.007 -1.058 . . . . 0.0 109.597 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.477 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 69.3 m80 -55.14 -45.49 75.65 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.609 0.719 . . . . 0.0 109.676 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.515 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 1.2 m-20 -49.32 -51.31 35.07 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.093 0.473 . . . . 0.0 110.957 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.654 ' HA ' ' CZ ' ' A' ' 90' ' ' PHE . . . -57.46 -60.69 3.27 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.172 -0.955 . . . . 0.0 109.639 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.433 ' HA ' ' CG1' ' A' ' 126' ' ' VAL . . . -63.14 -9.75 12.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.399 -0.813 . . . . 0.0 109.996 178.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -70.67 -54.38 12.1 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.039 -1.038 . . . . 0.0 110.665 -179.812 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.456 ' HB3' ' CD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -90.07 -19.11 24.74 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.141 -0.975 . . . . 0.0 109.862 -179.918 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.415 ' HA3' ' ND1' ' A' ' 123' ' ' HIS . . . 87.32 59.91 1.7 Allowed Glycine 0 N--CA 1.487 2.077 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.33 178.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.654 ' CZ ' ' HA ' ' A' ' 85' ' ' ALA . 1.3 p90 -135.17 89.02 2.47 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.012 -1.287 . . . . 0.0 109.912 178.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.451 ' CD1' ' HB3' ' A' ' 125' ' ' ASP . 0.2 OUTLIER -51.58 -35.12 40.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.868 -0.52 . . . . 0.0 110.883 -179.31 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 91' ' ' LEU . 1.7 m-20 -41.86 -33.7 0.56 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.319 -0.863 . . . . 0.0 109.128 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.489 ' HB ' ' CD2' ' A' ' 90' ' ' PHE . 1.1 m -79.52 -49.73 11.8 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.442 ' CD2' ' HG ' ' A' ' 130' ' ' LEU . 2.5 tp -54.2 -41.33 68.5 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.65 -0.656 . . . . 0.0 109.587 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 89.8 t -59.99 -53.04 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.327 -0.858 . . . . 0.0 109.182 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.448 HG12 ' CD2' ' A' ' 64' ' ' LEU . 40.6 t -51.86 -46.46 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.638 -0.664 . . . . 0.0 109.435 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.442 ' CD2' ' HB3' ' A' ' 102' ' ' ALA . 0.6 OUTLIER -52.32 -55.41 21.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.623 -0.673 . . . . 0.0 109.877 179.588 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -70.63 -28.12 64.59 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.363 -0.835 . . . . 0.0 110.168 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 -68.49 -9.57 49.84 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.287 -0.883 . . . . 0.0 110.995 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -127.99 -87.12 0.57 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.168 -0.958 . . . . 0.0 110.617 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -163.68 54.39 0.29 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.442 ' HB3' ' CD2' ' A' ' 97' ' ' LEU . . . -102.26 133.1 47.7 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.252 -1.146 . . . . 0.0 110.305 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.38 152.58 33.69 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.263 -0.898 . . . . 0.0 109.639 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.416 HD23 HG13 ' A' ' 82' ' ' VAL . 6.6 mt -143.08 46.46 1.54 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.166 -0.958 . . . . 0.0 110.908 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -169.44 52.7 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.182 -0.949 . . . . 0.0 110.815 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.441 ' CG1' ' HG3' ' A' ' 80' ' ' ARG . 9.6 p -113.63 -178.14 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 0.0 109.97 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.483 ' O ' ' HB3' ' A' ' 78' ' ' LEU . 0.1 OUTLIER -129.32 138.04 51.35 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.386 -0.821 . . . . 0.0 109.882 179.129 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.631 ' O ' ' N ' ' A' ' 110' ' ' TRP . 15.5 t0 -72.09 58.92 0.37 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.421 -0.8 . . . . 0.0 110.404 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.415 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 56.75 -66.34 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.552 -0.718 . . . . 0.0 110.76 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.631 ' N ' ' O ' ' A' ' 108' ' ' ASP . 6.6 m-90 -45.76 -65.11 0.59 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.377 -0.827 . . . . 0.0 110.596 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 159.97 -28.7 0.36 Allowed Glycine 0 N--CA 1.483 1.82 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -62.49 135.38 57.39 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.486 -1.009 . . . . 0.0 110.703 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.433 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 66.0 mt -87.65 165.39 30.43 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.42 -0.8 . . . . 0.0 110.226 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 40.9 Cg_endo -67.78 -28.51 36.6 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.779 1.41 . . . . 0.0 110.081 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.447 ' HB ' ' HB3' ' A' ' 130' ' ' LEU . 11.1 p -75.53 -35.89 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.399 -0.813 . . . . 0.0 109.939 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.94 -29.87 68.21 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.425 -0.797 . . . . 0.0 109.952 179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.442 ' CD2' ' N ' ' A' ' 118' ' ' ALA . 4.3 tt -66.08 -58.53 5.26 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.459 -0.776 . . . . 0.0 109.934 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.442 ' N ' ' CD2' ' A' ' 117' ' ' LEU . . . -50.12 -48.01 53.73 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.383 -0.823 . . . . 0.0 110.969 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -50.77 -41.31 56.73 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.33 -0.856 . . . . 0.0 110.086 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -74.45 -55.1 6.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.57 -0.706 . . . . 0.0 109.94 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.6 mt -53.07 -82.02 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.253 -0.905 . . . . 0.0 110.549 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.82 39.62 0.03 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.415 ' ND1' ' HA3' ' A' ' 89' ' ' GLY . 27.2 m-70 -124.08 52.83 1.44 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.276 -1.132 . . . . 0.0 109.188 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.1 ttt-85 -46.21 -45.44 16.91 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.73 -0.606 . . . . 0.0 110.341 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.451 ' HB3' ' CD1' ' A' ' 91' ' ' LEU . 1.9 m-20 -52.53 -46.83 66.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.371 -0.831 . . . . 0.0 109.18 179.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.433 ' CG1' ' HA ' ' A' ' 86' ' ' ALA . 2.5 t -75.72 -27.51 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.5 -0.75 . . . . 0.0 109.556 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -75.19 -48.87 21.48 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.37 -0.831 . . . . 0.0 109.929 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.27 -54.93 41.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.28 -0.887 . . . . 0.0 110.157 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -59.33 -36.84 76.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.276 -0.89 . . . . 0.0 109.782 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.447 ' HB3' ' HB ' ' A' ' 115' ' ' VAL . 8.4 mt -64.03 -49.56 71.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.224 -0.923 . . . . 0.0 109.457 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.94 -29.77 30.65 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.301 -0.875 . . . . 0.0 110.288 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -86.34 -42.78 13.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.35 -0.844 . . . . 0.0 109.836 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -79.81 -5.66 55.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.435 -0.791 . . . . 0.0 110.513 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 104' ' ' LEU . . . -129.6 -65.72 0.83 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.172 -0.955 . . . . 0.0 110.622 -179.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -63.44 144.36 49.11 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 94.83 -76.26 0.92 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 41.0 p -70.4 133.61 47.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.41 -1.053 . . . . 0.0 110.103 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 6.0 mtt85 -98.21 -70.81 0.71 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.278 -0.889 . . . . 0.0 110.767 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -115.21 -145.82 8.75 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.5 p -129.22 39.86 3.7 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.478 -1.013 . . . . 0.0 110.619 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -66.08 133.81 51.53 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.312 -0.867 . . . . 0.0 110.391 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 54.58 32.81 17.77 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.347 -0.845 . . . . 0.0 110.412 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . 50.59 29.35 4.03 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.489 -0.757 . . . . 0.0 110.51 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.47 88.09 0.11 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.495 -0.753 . . . . 0.0 111.302 179.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 3.0 mt 40.43 79.56 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.677 -0.639 . . . . 0.0 111.7 179.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 177.05 121.82 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.109 -0.995 . . . . 0.0 110.596 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -72.05 139.01 48.26 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.302 -0.873 . . . . 0.0 109.888 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 56.24 177.85 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.234 -0.916 . . . . 0.0 110.199 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -150.99 95.97 2.27 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.231 -0.918 . . . . 0.0 110.21 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 173.73 -125.88 1.17 Allowed Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.738 -1.22 . . . . 0.0 110.348 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -80.78 -87.46 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.304 0 O-C-N 123.745 1.392 . . . . 0.0 111.64 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 64.48 16.7 10.41 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.037 -1.039 . . . . 0.0 110.665 -179.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.9 t70 57.12 -174.79 0.07 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.145 -0.972 . . . . 0.0 110.662 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.42 HD12 HG22 ' A' ' 154' ' ' ILE . 86.3 mt -125.63 74.44 69.69 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.396 -0.815 . . . . 0.0 110.162 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -78.39 146.66 22.18 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.819 1.431 . . . . 0.0 110.764 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.495 1.812 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.078 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 121.254 0.55 . . . . 0.0 109.981 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -50.04 139.81 17.29 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.375 -0.828 . . . . 0.0 110.588 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.58 -178.45 4.05 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.548 1.289 . . . . 0.0 110.031 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 47.8 70.0 0.47 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.524 -0.735 . . . . 0.0 110.197 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -110.87 56.42 0.63 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.343 -0.848 . . . . 0.0 110.444 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -143.39 -81.17 0.05 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.5 m -99.4 156.08 17.2 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.216 -1.167 . . . . 0.0 111.028 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.0 t -100.85 140.89 34.5 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.396 -0.815 . . . . 0.0 109.865 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 63.15 137.37 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.408 -0.808 . . . . 0.0 110.481 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -122.81 106.14 34.65 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.372 -0.83 . . . . 0.0 109.724 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.04 107.61 2.41 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.559 1.294 . . . . 0.0 110.794 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.23 -170.81 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.384 -0.823 . . . . 0.0 110.261 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.22 51.1 2.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.391 -0.818 . . . . 0.0 110.098 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -83.39 -2.68 56.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.408 -0.808 . . . . 0.0 110.357 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.483 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 0.1 OUTLIER -46.44 -62.78 1.21 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.366 -0.834 . . . . 0.0 110.345 -179.584 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.535 HD13 ' CD2' ' A' ' 63' ' ' LEU . 0.3 OUTLIER -45.81 -35.26 4.27 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.392 0.615 . . . . 0.0 110.115 179.16 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -77.66 -48.57 16.46 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.463 -0.773 . . . . 0.0 109.639 179.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.483 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.0 OUTLIER -52.97 -60.26 3.5 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.515 -0.74 . . . . 0.0 110.517 179.72 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.533 ' HB3' HG23 ' A' ' 28' ' ' VAL . . . -53.3 -43.44 67.56 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.332 -0.855 . . . . 0.0 109.905 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.451 ' C ' ' HA ' ' A' ' 52' ' ' MET . . . -55.39 -40.17 71.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.572 -0.705 . . . . 0.0 109.527 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.35 -34.43 70.49 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.434 -0.791 . . . . 0.0 110.363 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.9 mtm180 -94.65 22.61 6.1 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.245 -0.909 . . . . 0.0 110.885 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.526 ' HA3' ' HE2' ' A' ' 53' ' ' MET . . . 52.41 72.31 0.54 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 179.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.452 ' HB3' ' CB ' ' A' ' 27' ' ' GLU . 4.3 mtt85 -129.87 56.57 1.72 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.428 -1.042 . . . . 0.0 109.769 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 89.5 t -47.4 -55.14 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.558 -0.714 . . . . 0.0 110.649 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -61.67 -31.46 71.58 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.404 -0.81 . . . . 0.0 110.936 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.452 ' CB ' ' HB3' ' A' ' 24' ' ' ARG . 0.3 OUTLIER -76.43 -33.31 58.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.151 -0.968 . . . . 0.0 109.557 179.876 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.533 HG23 ' HB3' ' A' ' 19' ' ' ALA . 5.0 t -78.77 -46.67 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.453 -0.78 . . . . 0.0 109.653 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.491 ' HA ' HD21 ' A' ' 62' ' ' LEU . 15.2 mmm180 -49.22 -48.08 45.75 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.431 -0.793 . . . . 0.0 109.74 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.04 -37.93 69.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.646 -0.659 . . . . 0.0 109.673 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 27' ' ' GLU . 6.3 mt -66.58 -56.47 10.59 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.469 -0.77 . . . . 0.0 110.565 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.521 HD11 ' CG ' ' A' ' 66' ' ' HIS . 0.1 OUTLIER -44.45 -56.41 4.29 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.634 -0.666 . . . . 0.0 110.551 -179.809 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.48 -14.64 61.27 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.354 -0.841 . . . . 0.0 110.382 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.414 ' HB3' ' O ' ' A' ' 31' ' ' LEU . . . -79.15 -7.63 58.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.088 -1.007 . . . . 0.0 110.6 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 134.96 -12.19 4.47 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.771 -1.205 . . . . 0.0 110.578 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -48.73 149.32 1.79 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.172 -1.193 . . . . 0.0 110.509 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.475 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 0.2 OUTLIER -86.33 140.1 34.19 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.373 -0.829 . . . . 0.0 110.253 -179.713 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -74.79 -56.66 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.812 1.427 . . . . 0.0 110.51 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.422 ' ND2' ' O ' ' A' ' 67' ' ' GLY . 0.2 OUTLIER -95.4 55.92 1.78 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.264 -0.897 . . . . 0.0 109.825 179.565 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.475 ' HB3' ' HB3' ' A' ' 37' ' ' LEU . . . -101.76 108.25 55.22 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.169 -0.957 . . . . 0.0 110.774 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.8 132.26 19.82 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.617 1.325 . . . . 0.0 109.554 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -124.19 71.06 1.11 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.054 -1.029 . . . . 0.0 111.112 -179.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.8 m 44.46 -157.29 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.358 -0.839 . . . . 0.0 110.362 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 60.64 7.56 1.44 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.124 -0.985 . . . . 0.0 110.734 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 50.44 26.66 10.2 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.513 ' HG2' ' HB3' ' A' ' 50' ' ' GLN . 6.0 mtm-85 -125.78 -170.47 2.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.534 -0.98 . . . . 0.0 110.775 -179.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.563 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 3.5 mmp_? -119.78 -163.48 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.332 -0.855 . . . . 0.0 109.331 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.563 ' CD ' ' CB ' ' A' ' 47' ' ' ARG . 43.9 Cg_endo -80.04 -22.43 7.32 Favored 'Trans proline' 0 C--N 1.321 -0.895 0 O-C-N 122.987 0.993 . . . . 0.0 110.911 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.491 ' O ' ' HG2' ' A' ' 52' ' ' MET . 10.1 mt -107.05 -42.47 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.241 -0.912 . . . . 0.0 109.242 178.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.513 ' HB3' ' HG2' ' A' ' 46' ' ' ARG . 1.1 mt-30 -53.1 -22.55 6.32 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.158 -0.963 . . . . 0.0 109.994 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.2 p -101.61 1.76 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 0.0 110.532 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.491 ' HG2' ' O ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -70.42 157.82 37.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.874 -1.141 . . . . 0.0 109.426 179.936 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' MET . . . . . 0.526 ' HE2' ' HA3' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -52.09 -13.74 0.34 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.194 -0.941 . . . . 0.0 111.225 -179.318 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.588 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 62.93 10.96 4.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.325 -0.859 . . . . 0.0 109.543 -178.908 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.505 ' O ' ' CE1' ' A' ' 90' ' ' PHE . . . -113.82 -2.95 23.73 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.463 -1.855 . . . . 0.0 108.463 178.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.25 79.37 1.9 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.395 -1.062 . . . . 0.0 109.99 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.52 ' CB ' ' HB3' ' A' ' 92' ' ' ASP . . . -50.32 -26.27 4.66 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.425 -0.797 . . . . 0.0 109.62 179.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.49 -44.28 65.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.476 -0.765 . . . . 0.0 109.507 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.405 ' O ' ' HB3' ' A' ' 62' ' ' LEU . 43.2 t -59.5 -56.83 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.289 -0.882 . . . . 0.0 109.436 179.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.434 ' O ' ' CB ' ' A' ' 64' ' ' LEU . . . -53.72 -42.45 68.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.408 -0.808 . . . . 0.0 109.611 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -59.18 -31.88 69.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 110.091 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.508 ' O ' ' HB2' ' A' ' 66' ' ' HIS . 10.2 tp -74.46 -59.0 2.93 Favored 'General case' 0 C--N 1.31 -1.129 0 O-C-N 121.334 -0.854 . . . . 0.0 109.121 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.535 ' CD2' HD13 ' A' ' 16' ' ' LEU . 1.5 mt -63.24 -40.56 97.79 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.496 -0.752 . . . . 0.0 110.389 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.54 HD12 ' O ' ' A' ' 96' ' ' VAL . 0.4 OUTLIER -53.37 -70.5 0.09 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.135 -0.978 . . . . 0.0 110.344 -179.616 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 62' ' ' LEU . 3.2 pp -51.35 -24.41 4.68 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.443 -0.786 . . . . 0.0 109.827 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.521 ' CG ' HD11 ' A' ' 32' ' ' LEU . 1.8 m80 -84.98 -27.2 26.62 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.752 -0.593 . . . . 0.0 110.147 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 63' ' ' LEU . . . 128.94 43.54 0.22 Allowed Glycine 0 N--CA 1.479 1.521 0 C-N-CA 120.136 -1.031 . . . . 0.0 110.906 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.43 ' CB ' ' CD1' ' A' ' 49' ' ' ILE . . . -72.9 -153.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.73 -1.453 . . . . 0.0 109.22 179.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.49 ' HB2' ' HB3' ' A' ' 47' ' ' ARG . 0.3 OUTLIER -124.09 67.25 43.46 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.258 -0.901 . . . . 0.0 110.358 179.59 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -72.75 -25.93 16.55 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.91 1.479 . . . . 0.0 110.209 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -104.82 -36.44 7.39 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.334 -0.854 . . . . 0.0 110.006 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.3 m -60.76 164.27 4.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.425 -0.797 . . . . 0.0 110.792 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -165.04 -157.73 0.36 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.483 -0.761 . . . . 0.0 109.724 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.482 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.8 OUTLIER -105.02 138.35 19.48 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.157 -0.964 . . . . 0.0 109.981 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -74.67 -22.17 15.87 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.517 1.272 . . . . 0.0 110.644 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.98 -76.53 0.05 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.288 -0.883 . . . . 0.0 109.853 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.516 ' CG2' ' CZ3' ' A' ' 110' ' ' TRP . 0.3 OUTLIER -109.52 31.5 5.73 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.517 -0.739 . . . . 0.0 110.518 -179.744 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.536 ' HB2' ' N ' ' A' ' 109' ' ' ALA . 4.6 mt 40.66 31.27 0.11 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.56 -0.712 . . . . 0.0 110.906 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.478 ' HA ' ' OD1' ' A' ' 108' ' ' ASP . 93.9 m -57.84 87.68 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.379 -0.826 . . . . 0.0 109.538 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -71.23 161.43 78.33 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.357 -0.839 . . . . 0.0 110.558 -179.086 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.41 ' HA ' ' HG2' ' A' ' 50' ' ' GLN . 45.1 Cg_endo -71.15 -24.46 23.47 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 124.007 1.53 . . . . 0.0 110.251 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.434 ' CG1' ' HG ' ' A' ' 104' ' ' LEU . 25.1 t -58.86 -27.62 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.429 -0.794 . . . . 0.0 109.856 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 47.8 m80 -65.67 -42.74 90.97 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.885 0.85 . . . . 0.0 109.35 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.588 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 0.9 OUTLIER -54.1 -57.41 11.21 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.732 -179.604 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.458 ' CB ' ' HG ' ' A' ' 94' ' ' LEU . . . -48.18 -63.62 1.02 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.449 -0.782 . . . . 0.0 109.867 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.513 ' O ' ' CD2' ' A' ' 123' ' ' HIS . . . -56.41 -50.32 71.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.337 -0.852 . . . . 0.0 110.571 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.412 ' HD3' HD12 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -48.71 -34.01 11.22 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.402 -0.811 . . . . 0.0 110.992 -179.349 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.436 ' CB ' ' HB3' ' A' ' 54' ' ' MET . 12.8 tp10 -93.51 -7.83 43.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.201 -0.937 . . . . 0.0 110.618 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.5 ' HA2' ' CG ' ' A' ' 123' ' ' HIS . . . 80.17 16.89 75.52 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.514 ' O ' ' CD1' ' A' ' 94' ' ' LEU . 0.3 OUTLIER -87.22 156.25 19.74 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.046 -1.267 . . . . 0.0 110.351 -179.875 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.48 ' CD2' ' HA ' ' A' ' 126' ' ' VAL . 0.0 OUTLIER -122.9 -53.62 1.85 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.66 -0.65 . . . . 0.0 109.644 179.639 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.52 ' HB3' ' CB ' ' A' ' 57' ' ' ALA . 0.2 OUTLIER -44.14 -41.36 5.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.623 -0.673 . . . . 0.0 109.689 179.835 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.5 m -58.41 -49.68 76.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.635 -0.666 . . . . 0.0 109.792 178.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.514 ' CD1' ' O ' ' A' ' 90' ' ' PHE . 0.6 OUTLIER -55.17 -54.12 47.36 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.165 -0.959 . . . . 0.0 109.585 179.727 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.2 t -50.24 -47.69 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.629 -0.669 . . . . 0.0 109.256 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.54 ' O ' HD12 ' A' ' 64' ' ' LEU . 58.4 t -52.81 -50.82 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.421 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -54.03 -68.92 0.14 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.502 -0.749 . . . . 0.0 110.293 179.399 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -52.65 -32.17 40.71 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.16 -0.962 . . . . 0.0 109.636 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 25.3 ttm-85 -68.38 -12.66 61.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.521 -0.737 . . . . 0.0 110.048 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.19 60.94 1.63 Allowed 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.234 -0.916 . . . . 0.0 110.738 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 53.94 102.66 0.01 OUTLIER Glycine 0 N--CA 1.494 2.522 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 97' ' ' LEU . . . -160.25 114.17 2.18 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.133 -1.216 . . . . 0.0 110.544 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.414 ' HD3' ' HA ' ' A' ' 103' ' ' ARG . 12.8 tpp180 -68.35 159.39 31.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.632 -0.667 . . . . 0.0 110.088 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.434 ' HG ' ' CG1' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -145.52 10.47 1.25 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.36 -0.837 . . . . 0.0 110.976 -179.577 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -111.57 46.46 1.11 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.048 -1.033 . . . . 0.0 110.268 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.442 HG11 ' HG3' ' A' ' 80' ' ' ARG . 2.5 p -105.7 167.25 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.488 -0.758 . . . . 0.0 109.307 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.431 ' O ' ' HG2' ' A' ' 107' ' ' ARG . 6.6 ttt85 -136.37 51.7 2.0 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.389 -0.82 . . . . 0.0 110.29 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.504 ' O ' ' N ' ' A' ' 110' ' ' TRP . 0.2 OUTLIER 41.34 35.93 0.47 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.631 -0.668 . . . . 0.0 110.39 179.837 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.536 ' N ' ' HB2' ' A' ' 78' ' ' LEU . . . 64.2 -66.07 0.12 Allowed 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.59 -0.694 . . . . 0.0 109.82 -179.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.516 ' CZ3' ' CG2' ' A' ' 77' ' ' THR . 0.8 OUTLIER -154.85 40.75 0.44 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.398 -0.814 . . . . 0.0 109.874 179.295 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -119.96 -64.06 0.27 Allowed Glycine 0 N--CA 1.481 1.688 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.78 -156.52 0.36 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.32 -1.106 . . . . 0.0 110.397 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.482 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER -133.3 159.69 71.58 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.347 -0.845 . . . . 0.0 109.883 -179.965 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.482 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 37.9 Cg_endo -63.81 -57.14 0.38 Allowed 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.373 1.196 . . . . 0.0 110.941 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.478 ' CG1' HD21 ' A' ' 113' ' ' LEU . 2.4 p -51.72 -31.12 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 120.905 -1.122 . . . . 0.0 110.33 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -66.2 -28.31 68.66 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.295 -0.878 . . . . 0.0 110.35 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.412 HD12 ' HD3' ' A' ' 87' ' ' ARG . 2.2 mm? -67.92 -38.57 83.06 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.126 -0.984 . . . . 0.0 110.116 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.425 ' HB1' ' CB ' ' A' ' 127' ' ' ALA . . . -68.48 -50.88 49.09 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.411 -0.806 . . . . 0.0 110.111 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -61.0 -45.54 94.43 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.269 -0.895 . . . . 0.0 110.319 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -54.27 -52.78 60.34 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.314 -0.866 . . . . 0.0 109.719 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.67 -86.43 0.06 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.362 -0.836 . . . . 0.0 110.216 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 174.06 31.34 0.03 OUTLIER Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.513 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 45.8 m-70 -95.05 46.73 1.13 Allowed 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.417 -1.049 . . . . 0.0 108.685 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -47.14 -33.33 5.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.784 -0.573 . . . . 0.0 109.832 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.55 -40.99 98.59 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.48 ' HA ' ' CD2' ' A' ' 91' ' ' LEU . 3.4 t -75.82 -46.2 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.447 -0.783 . . . . 0.0 109.308 178.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.558 ' O ' ' CB ' ' A' ' 131' ' ' ARG . . . -53.2 -53.42 50.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.302 -0.874 . . . . 0.0 109.408 179.079 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -49.8 -53.2 26.74 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.167 -0.958 . . . . 0.0 110.493 179.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -71.57 -56.37 6.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.372 -0.83 . . . . 0.0 110.746 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.449 ' CD2' ' HB1' ' A' ' 86' ' ' ALA . 0.3 OUTLIER -60.25 -30.58 69.52 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.366 -0.834 . . . . 0.0 111.025 -179.033 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.558 ' CB ' ' O ' ' A' ' 127' ' ' ALA . 4.3 ttp-105 -73.07 -27.54 61.79 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.028 -1.045 . . . . 0.0 110.432 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.95 -42.0 77.26 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.212 -0.93 . . . . 0.0 109.23 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -87.94 -10.17 51.35 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.638 -0.664 . . . . 0.0 110.336 179.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' A' ' 130' ' ' LEU . . . -104.12 -10.05 18.27 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.232 -0.918 . . . . 0.0 110.59 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -49.25 155.5 1.87 Allowed Glycine 0 N--CA 1.494 2.547 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -139.08 22.22 2.94 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.77 173.56 0.99 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.294 -1.121 . . . . 0.0 110.006 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.78 61.36 1.25 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.32 -0.863 . . . . 0.0 110.475 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.4 ' O ' ' C ' ' A' ' 140' ' ' SER . . . -153.71 36.92 0.73 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 139' ' ' GLY . 0.1 OUTLIER 43.07 -150.13 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.553 -0.969 . . . . 0.0 110.11 -179.974 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -101.77 39.22 1.49 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.12 -0.988 . . . . 0.0 109.73 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -115.56 21.42 13.99 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.291 -0.88 . . . . 0.0 110.613 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -172.93 -143.07 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.398 -0.814 . . . . 0.0 109.876 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 53.51 81.35 0.09 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.952 -1.093 . . . . 0.0 110.65 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 25.8 mt 56.19 97.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.422 -0.798 . . . . 0.0 110.615 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 177.73 65.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.309 -0.869 . . . . 0.0 109.958 179.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.76 156.44 17.01 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.162 -0.961 . . . . 0.0 110.267 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.78 150.39 5.34 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.349 -0.844 . . . . 0.0 110.379 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -91.19 110.85 22.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.491 -0.756 . . . . 0.0 110.157 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -137.66 -94.88 0.36 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.189 -1.565 . . . . 0.0 109.189 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.47 -162.69 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.897 1.472 . . . . 0.0 110.31 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 1.1 p 60.82 -170.44 0.15 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.291 -0.881 . . . . 0.0 110.119 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -58.19 150.17 22.17 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.435 -0.791 . . . . 0.0 110.048 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.447 ' O ' HG21 ' A' ' 154' ' ' ILE . 13.6 tt -148.09 74.16 11.0 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.345 -0.847 . . . . 0.0 110.503 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -77.65 156.77 31.87 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.83 1.437 . . . . 0.0 110.716 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.1 t0 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.125 -0.94 . . . . 0.0 110.05 179.618 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.486 ' CG ' ' H ' ' A' ' 2' ' ' GLU . 8.2 ttt . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 120.95 0.405 . . . . 17.28 110.719 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.486 ' H ' ' CG ' ' A' ' 1' ' ' MET . 8.3 tp10 -108.55 71.25 0.4 Allowed Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 120.97 -1.081 . . . . 14.24 112.453 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -75.05 178.83 6.76 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 N-CA-C 107.622 -1.722 . . . . 12.89 107.622 176.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 50.01 27.27 2.38 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.765 -1.21 . . . . 11.63 109.359 -179.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.577 ' C ' ' H ' ' A' ' 7' ' ' SER . . . 53.39 -93.56 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 115.161 1.541 . . . . 10.87 115.161 177.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.38 -36.72 2.59 Favored Glycine 0 N--CA 1.506 3.344 0 N-CA-C 105.331 -3.108 . . . . 9.5 105.331 -174.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.577 ' H ' ' C ' ' A' ' 5' ' ' ALA . 0.1 OUTLIER -97.27 23.41 7.5 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 106.292 -1.744 . . . . 8.56 106.292 175.229 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.522 ' C ' ' H ' ' A' ' 10' ' ' GLU . 3.3 p -84.12 20.9 1.46 Allowed 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.245 0.545 . . . . 7.61 110.186 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.586 ' N ' ' SD ' ' A' ' 9' ' ' MET . 0.0 OUTLIER -67.24 7.97 0.36 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.063 -1.023 . . . . 9.58 110.193 178.521 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.685 ' C ' ' H ' ' A' ' 12' ' ' SER . 1.4 mm-40 27.22 98.75 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.667 0 C-N-CA 122.549 0.34 . . . . 6.56 111.815 -178.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.576 ' O ' ' O ' ' A' ' 12' ' ' SER . 51.9 Cg_endo -77.64 14.92 1.34 Allowed 'Trans proline' 0 C--N 1.304 -1.787 0 N-CA-C 105.432 -2.565 . . . . 5.85 105.432 175.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.685 ' H ' ' C ' ' A' ' 10' ' ' GLU . 13.6 p 18.1 120.87 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 114.175 -1.375 . . . . 4.38 113.502 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.801 ' O ' ' HG ' ' A' ' 16' ' ' LEU . . . -45.3 -23.51 0.2 Allowed 'General case' 0 C--O 1.204 -1.342 0 N-CA-C 107.407 -1.331 . . . . 3.34 107.407 176.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.621 ' O ' ' N ' ' A' ' 17' ' ' ALA . 2.8 m-20 -26.61 -43.32 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 115.699 -0.682 . . . . 2.92 110.021 177.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.507 ' N ' ' O ' ' A' ' 13' ' ' ALA . 4.4 m0 -41.61 -36.87 1.02 Allowed 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.854 -0.738 . . . . 4.61 109.036 178.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.801 ' HG ' ' O ' ' A' ' 13' ' ' ALA . 3.4 pp -74.99 -33.16 61.82 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.376 -0.972 . . . . 3.15 108.376 177.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.621 ' N ' ' O ' ' A' ' 14' ' ' ASP . . . -80.45 -54.24 5.86 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.942 -0.762 . . . . 2.34 108.942 177.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 14' ' ' ASP . 0.5 OUTLIER -54.3 -48.87 70.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.267 -0.896 . . . . 2.95 108.753 178.457 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.472 ' CB ' ' O ' ' A' ' 15' ' ' TRP . . . -63.87 -35.01 79.23 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.574 -0.899 . . . . 2.74 108.574 178.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.428 ' HB2' ' CB ' ' A' ' 52' ' ' MET . . . -66.87 -43.61 83.08 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.664 -0.865 . . . . 1.91 108.664 178.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.416 ' N ' ' HA ' ' A' ' 52' ' ' MET . . . -61.58 -26.8 68.2 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.558 -0.713 . . . . 2.21 109.348 179.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -95.91 20.32 10.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.647 -0.658 . . . . 5.64 110.087 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 55.81 34.18 60.88 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.38 -1.088 . . . . 2.84 110.38 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.434 ' HB3' ' HB3' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -99.53 74.44 1.89 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.283 -1.127 . . . . 4.77 109.984 179.646 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 62.0 t -57.85 -46.14 87.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.374 -0.829 . . . . 3.17 110.353 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -54.93 -51.45 66.05 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.387 -0.82 . . . . 4.64 110.4 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.16 -46.04 68.73 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.23 -0.919 . . . . 3.68 109.963 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.436 ' HA ' ' HB2' ' A' ' 31' ' ' LEU . 5.7 t -69.66 -42.19 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.398 -0.814 . . . . 3.02 109.622 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.611 ' HA ' ' CD1' ' A' ' 62' ' ' LEU . 0.0 OUTLIER -48.5 -48.11 38.3 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.55 -0.719 . . . . 4.65 110.093 179.676 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.73 -35.23 45.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.505 -0.747 . . . . 4.36 110.057 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.436 ' HB2' ' HA ' ' A' ' 28' ' ' VAL . 25.8 mt -64.26 -65.69 0.64 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.369 -0.832 . . . . 3.46 110.03 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.552 HD22 ' CG ' ' A' ' 66' ' ' HIS . 3.8 mt -48.33 -42.51 31.44 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.43 -0.794 . . . . 3.6 110.544 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -75.23 -17.27 60.37 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.255 -0.903 . . . . 4.87 110.24 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.36 -7.45 58.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -0.924 . . . . 4.28 110.896 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.29 26.91 1.92 Allowed Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.888 -1.148 . . . . 3.96 110.466 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.447 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -79.14 126.79 31.19 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.176 -1.191 . . . . 3.38 110.341 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.434 ' N ' ' HB2' ' A' ' 13' ' ' ALA . 0.4 OUTLIER -53.44 123.83 37.95 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.375 -0.828 . . . . 4.1 110.337 179.938 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -72.56 -23.87 19.44 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.539 1.284 . . . . 3.49 108.966 178.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.403 ' ND2' ' O ' ' A' ' 67' ' ' GLY . 0.6 OUTLIER -112.7 51.77 0.81 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.63 -0.669 . . . . 3.8 109.246 178.829 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.88 116.4 66.44 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.413 -0.804 . . . . 2.92 110.46 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.32 121.12 6.27 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.696 1.366 . . . . 3.34 110.487 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -78.75 175.41 10.48 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.296 -0.877 . . . . 3.64 110.351 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.7 m -83.48 -6.53 59.48 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.317 -0.865 . . . . 4.16 110.502 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -84.46 12.05 7.56 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.153 -0.967 . . . . 3.91 110.375 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.22 16.22 62.07 Favored Glycine 0 N--CA 1.484 1.889 0 N-CA-C 109.064 -1.615 . . . . 3.11 109.064 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 61.3 mtt180 -113.52 -167.51 1.21 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.47 -1.018 . . . . 3.68 110.179 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.649 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 0.8 OUTLIER -108.96 -174.37 0.3 Allowed Pre-proline 0 N--CA 1.492 1.631 0 N-CA-C 108.848 -0.797 . . . . 4.08 108.848 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.721 ' HB2' HD21 ' A' ' 63' ' ' LEU . 43.3 Cg_endo -74.25 -19.59 19.66 Favored 'Trans proline' 0 C--N 1.314 -1.249 0 O-C-N 123.001 1.0 . . . . 2.19 111.4 -178.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.474 ' CG1' HD12 ' A' ' 63' ' ' LEU . 14.1 mt -108.73 -36.56 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 120.99 -1.069 . . . . 2.15 108.909 178.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.411 ' HG3' ' HA ' ' A' ' 81' ' ' PRO . 0.4 OUTLIER -56.55 -17.6 8.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.479 -0.763 . . . . 3.13 110.062 179.246 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.8 p -107.81 -5.16 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.31 -0.869 . . . . 2.14 111.277 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.512 ' HG3' ' SD ' ' A' ' 54' ' ' MET . 0.0 OUTLIER -62.33 164.86 6.6 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.73 -1.231 . . . . 2.02 109.728 -179.902 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 5.0 tmm? -57.13 -10.32 1.17 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.256 -0.902 . . . . 2.94 111.478 -178.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.605 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 57.67 16.97 3.74 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.08 -1.012 . . . . 1.71 109.95 -179.432 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.466 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -121.26 10.63 9.96 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 108.944 -1.662 . . . . 2.31 108.944 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.39 86.97 1.49 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.453 -1.028 . . . . 3.0 109.197 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.95 -24.72 6.84 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.466 -0.771 . . . . 2.41 110.6 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -53.62 -38.59 64.18 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.233 -0.917 . . . . 5.03 109.347 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.1 t -64.78 -49.01 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.043 -1.095 . . . . 2.35 108.043 178.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.423 ' O ' ' CB ' ' A' ' 64' ' ' LEU . . . -55.77 -43.04 76.38 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.888 -0.782 . . . . 2.1 108.888 178.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -58.65 -64.04 1.07 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.323 -0.86 . . . . 3.67 108.785 178.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.613 ' O ' ' HB2' ' A' ' 66' ' ' HIS . 0.0 OUTLIER -41.9 -59.36 1.73 Allowed 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.769 0.795 . . . . 3.45 109.811 177.936 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.721 HD21 ' HB2' ' A' ' 48' ' ' PRO . 10.4 mt -59.75 -56.01 27.19 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.271 0.558 . . . . 2.65 110.84 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.469 ' CD1' ' HA ' ' A' ' 97' ' ' LEU . 1.2 tt -56.53 -56.63 18.86 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.426 -0.796 . . . . 3.03 110.918 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.402 ' HG ' ' N ' ' A' ' 66' ' ' HIS . 0.1 OUTLIER -55.99 -29.89 60.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.141 -0.974 . . . . 4.1 109.935 -179.377 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . 0.613 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -82.39 -25.14 34.02 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.423 -0.798 . . . . 4.46 109.395 179.606 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.403 ' O ' ' ND2' ' A' ' 39' ' ' ASN . . . 124.08 42.18 0.37 Allowed Glycine 0 N--CA 1.479 1.518 0 N-CA-C 110.507 -1.037 . . . . 3.36 110.507 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.634 ' HB3' ' HB3' ' A' ' 63' ' ' LEU . . . -66.41 -161.79 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.855 -1.38 . . . . 2.73 109.474 179.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.547 ' HB2' ' HB3' ' A' ' 47' ' ' ARG . 1.7 mp0 -115.88 62.13 2.02 Favored Pre-proline 0 C--N 1.302 -1.487 0 O-C-N 121.362 -0.836 . . . . 3.37 110.324 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.508 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 43.1 Cg_endo -68.89 -11.71 32.55 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.608 1.32 . . . . 2.83 109.455 178.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.49 ' OD1' ' HB2' ' A' ' 103' ' ' ARG . 1.4 t-20 -106.05 -42.05 5.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.532 -0.73 . . . . 4.22 110.223 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -69.73 143.84 52.95 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.153 -0.967 . . . . 3.77 110.734 -179.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.405 ' HB1' ' HG2' ' A' ' 80' ' ' ARG . . . -132.98 -146.43 0.27 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.426 -0.796 . . . . 3.6 110.103 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 78' ' ' LEU . 1.0 OUTLIER -109.3 138.27 20.45 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.117 -0.989 . . . . 3.88 110.109 -179.939 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -77.35 -6.04 16.1 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.467 1.246 . . . . 4.88 110.551 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -99.12 -35.7 9.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.163 -0.961 . . . . 4.82 110.116 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.612 ' CG2' ' CZ3' ' A' ' 110' ' ' TRP . 1.2 p -132.21 7.51 4.27 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.323 -0.861 . . . . 4.87 110.696 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.406 ' N ' ' O ' ' A' ' 74' ' ' ASP . 6.0 mt 45.59 31.66 0.99 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.319 -0.863 . . . . 4.58 110.63 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.9 m -69.12 76.9 0.35 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.413 -0.804 . . . . 3.55 110.472 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.512 ' HD2' ' HB ' ' A' ' 106' ' ' VAL . 3.8 mtt85 -57.61 161.27 6.32 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.091 -1.005 . . . . 4.15 109.273 179.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.508 ' HG3' ' HA ' ' A' ' 70' ' ' PRO . 39.4 Cg_endo -67.81 -6.84 17.88 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.555 1.292 . . . . 2.54 110.954 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.48 HG11 HD21 ' A' ' 104' ' ' LEU . 19.4 t -71.03 -35.51 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.216 -0.927 . . . . 2.74 109.674 179.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . 0.424 ' CE1' ' HD3' ' A' ' 114' ' ' PRO . 31.8 m80 -67.48 -44.89 77.46 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.381 -0.825 . . . . 3.25 109.195 179.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.605 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 0.3 OUTLIER -49.53 -51.76 34.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.886 -0.509 . . . . 2.28 110.902 -179.792 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.451 ' HB1' ' CD1' ' A' ' 94' ' ' LEU . . . -58.1 -58.36 8.78 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.102 -0.999 . . . . 1.9 109.682 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.565 ' O ' ' CD2' ' A' ' 123' ' ' HIS . . . -59.79 -40.44 88.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.417 -0.802 . . . . 2.32 110.348 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.9 -34.73 21.21 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.31 -0.869 . . . . 4.19 110.332 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.41 1.85 38.81 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.39 -0.819 . . . . 2.79 110.642 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.499 ' HA2' ' HB3' ' A' ' 123' ' ' HIS . . . 73.62 38.14 51.47 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.521 -1.431 . . . . 2.05 109.521 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.466 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 0.3 OUTLIER -110.8 105.17 13.92 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.311 -1.111 . . . . 2.82 111.101 -179.265 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.473 ' HG ' ' HA ' ' A' ' 126' ' ' VAL . 0.5 OUTLIER -78.64 -36.85 43.38 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.25 -0.906 . . . . 3.11 109.356 178.872 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -48.17 -43.38 31.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.592 -0.692 . . . . 2.72 109.747 179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.413 ' CG2' ' HB2' ' A' ' 85' ' ' ALA . 54.6 m -65.82 -43.92 87.17 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.722 -0.844 . . . . 1.77 108.722 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.485 ' CD2' ' HG ' ' A' ' 130' ' ' LEU . 1.1 tp -57.48 -49.09 77.43 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.435 -0.791 . . . . 2.6 109.006 178.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.497 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 85.7 t -54.94 -54.56 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 108.87 -0.789 . . . . 3.16 108.87 178.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 89.1 t -49.37 -50.79 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.739 -0.601 . . . . 2.79 109.861 178.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.469 ' HA ' ' CD1' ' A' ' 64' ' ' LEU . 0.4 OUTLIER -52.45 -64.39 0.83 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.42 -0.8 . . . . 2.9 109.833 179.373 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -57.67 -22.99 49.15 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.34 -0.85 . . . . 3.94 110.683 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.497 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 4.3 ttt180 -73.47 -17.05 61.28 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.222 -0.924 . . . . 5.48 110.893 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.461 ' CB ' ' CD2' ' A' ' 64' ' ' LEU . . . -141.11 67.99 1.34 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.052 -1.03 . . . . 3.94 111.245 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 48.55 94.98 0.01 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.899 -0.88 . . . . 3.76 110.899 179.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.437 ' O ' HD12 ' A' ' 104' ' ' LEU . . . -150.25 101.54 3.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.396 -1.061 . . . . 3.32 109.021 179.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.49 ' HB2' ' OD1' ' A' ' 71' ' ' ASN . 3.0 tpt180 -54.23 120.95 7.21 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.314 -0.866 . . . . 5.2 111.002 -178.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.48 HD21 HG11 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -107.5 -7.12 16.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.721 -0.612 . . . . 3.44 109.911 179.45 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -98.32 48.19 0.99 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.101 -1.0 . . . . 4.2 112.525 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.512 ' HB ' ' HD2' ' A' ' 80' ' ' ARG . 1.4 p -113.02 -175.18 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.684 -1.26 . . . . 4.02 109.869 178.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 4.2 ptt180 -138.98 158.52 44.05 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.512 -0.742 . . . . 5.78 109.211 178.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . 0.48 ' O ' ' N ' ' A' ' 110' ' ' TRP . 0.4 OUTLIER -79.31 48.15 0.86 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.065 -1.022 . . . . 4.46 111.459 -178.74 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.575 ' HB1' ' CE3' ' A' ' 110' ' ' TRP . . . 63.49 -63.2 0.13 Allowed 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.462 -0.774 . . . . 4.92 112.205 178.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' TRP . . . . . 0.612 ' CZ3' ' CG2' ' A' ' 77' ' ' THR . 2.5 m-90 -54.14 -65.88 0.49 Allowed 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 120.094 -0.643 . . . . 5.97 111.652 -176.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.1 38.65 0.02 OUTLIER Glycine 0 N--CA 1.483 1.776 0 C-N-CA 119.358 -1.401 . . . . 5.32 110.917 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -140.55 138.97 34.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.997 -1.296 . . . . 5.95 110.612 179.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.478 ' HB3' HG12 ' A' ' 115' ' ' VAL . 0.2 OUTLIER -90.33 170.53 10.02 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.465 -0.772 . . . . 4.51 110.884 -179.515 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.424 ' HD3' ' CE1' ' A' ' 83' ' ' HIS . 39.9 Cg_endo -68.0 -26.4 37.38 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.853 1.449 . . . . 3.26 108.643 177.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.478 HG12 ' HB3' ' A' ' 113' ' ' LEU . 7.2 p -76.29 -35.43 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 108.634 -0.876 . . . . 3.67 108.634 178.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.37 -26.41 66.45 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.701 -0.799 . . . . 4.01 109.767 179.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.54 -33.79 54.08 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.43 -0.794 . . . . 3.76 110.358 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.446 ' HB3' ' HB3' ' A' ' 86' ' ' ALA . . . -74.08 -37.99 64.04 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.301 -0.875 . . . . 2.86 110.566 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -70.2 -32.3 70.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.331 -0.856 . . . . 3.91 110.561 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -70.91 -57.23 4.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.114 -0.991 . . . . 4.58 109.777 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.93 -81.07 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.304 -0.872 . . . . 3.51 109.993 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.26 40.59 0.03 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.929 -1.669 . . . . 3.39 108.929 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.565 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 48.0 m-70 -107.94 53.12 0.7 Allowed 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.482 -1.011 . . . . 2.78 109.511 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . 0.427 ' O ' ' HB2' ' A' ' 128' ' ' ARG . 20.9 mtt180 -47.5 -52.41 17.41 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.766 -0.584 . . . . 4.54 109.957 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.68 -40.51 28.37 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.486 -0.759 . . . . 2.92 109.915 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.515 HG12 HD11 ' A' ' 130' ' ' LEU . 2.2 t -81.37 -47.24 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.36 -0.837 . . . . 2.25 109.501 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -56.12 -41.84 75.92 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.211 -0.931 . . . . 3.01 109.89 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.427 ' HB2' ' O ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -59.96 -56.65 19.09 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.275 -0.89 . . . . 4.9 109.353 179.327 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -60.59 -33.0 72.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.374 -0.829 . . . . 3.44 109.012 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.631 ' O ' ' N ' ' A' ' 134' ' ' ALA . 28.2 mt -65.63 -52.38 52.32 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.959 -0.696 . . . . 3.09 109.315 179.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 3.1 ttt-85 -57.88 -19.16 27.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.93 -1.106 . . . . 5.34 109.341 178.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.568 ' O ' ' NH2' ' A' ' 138' ' ' ARG . . . -85.67 -51.33 6.53 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.59 -0.893 . . . . 3.81 108.59 178.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.412 ' HB2' HD22 ' A' ' 104' ' ' LEU . . . -92.5 -52.11 4.81 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.099 -1.001 . . . . 3.57 109.963 178.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.631 ' N ' ' O ' ' A' ' 130' ' ' LEU . . . -88.34 8.03 29.55 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.677 -0.639 . . . . 3.93 112.282 -179.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 130' ' ' LEU . . . -64.62 127.08 33.62 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.094 -2.002 . . . . 4.53 108.094 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.708 ' O ' HG22 ' A' ' 137' ' ' THR . . . -83.34 43.92 3.21 Favored Glycine 0 N--CA 1.495 2.589 0 O-C-N 121.011 -1.288 . . . . 6.23 111.173 -178.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' THR . . . . . 0.708 HG22 ' O ' ' A' ' 136' ' ' GLY . 0.2 OUTLIER -164.0 -61.5 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.955 -1.321 . . . . 5.97 110.743 179.089 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.649 ' O ' ' O ' ' A' ' 139' ' ' GLY . 0.0 OUTLIER 73.86 -58.2 0.6 Allowed 'General case' 0 N--CA 1.508 2.442 0 O-C-N 120.869 -1.144 . . . . 12.96 112.105 178.669 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.777 ' O ' ' HB3' ' A' ' 140' ' ' SER . . . -47.43 -117.03 0.0 OUTLIER Glycine 1 N--CA 1.522 4.391 0 O-C-N 120.402 -1.436 . . . . 9.09 110.59 179.489 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' SER . . . . . 0.777 ' HB3' ' O ' ' A' ' 139' ' ' GLY . 54.0 p 125.96 46.48 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.376 0 N-CA-C 114.033 1.123 . . . . 10.12 114.033 177.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -113.35 -89.87 0.52 Allowed 'General case' 0 N--CA 1.507 2.395 0 N-CA-C 106.852 -1.536 . . . . 10.42 106.852 176.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' HIS . . . . . 0.615 ' O ' ' HB2' ' A' ' 143' ' ' ALA 0.277 4.7 t-160 -88.98 -7.35 56.17 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 103.652 -2.722 . . . . 10.47 103.652 173.511 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.615 ' HB2' ' O ' ' A' ' 142' ' ' HIS . . . 157.09 -151.5 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 102.185 -3.265 . . . . 6.67 102.185 -178.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ARG . . . . . 0.631 ' HD2' ' O ' ' A' ' 137' ' ' THR . 14.0 ttt85 -79.77 59.45 3.1 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 103.943 -2.614 . . . . 6.84 103.943 174.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.488 ' CG2' ' O ' ' A' ' 144' ' ' ARG . 1.4 tp 46.07 47.15 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 N-CA-C 105.758 -1.941 . . . . 8.33 105.758 -172.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 53.43 45.12 28.96 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.473 -1.24 . . . . 8.23 107.72 -177.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' A' ' 144' ' ' ARG . . . 65.93 165.49 0.19 Allowed 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 106.838 -1.541 . . . . 8.52 106.838 -177.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.26 78.79 0.15 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.465 -1.397 . . . . 10.33 108.728 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.514 ' HB3' ' CB ' ' A' ' 153' ' ' ASP . 95.7 mt-10 -138.06 -31.59 0.76 Allowed 'General case' 0 C--N 1.291 -1.962 0 O-C-N 121.479 -0.763 . . . . 12.55 110.735 -177.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 106.98 -111.79 3.6 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 107.063 -2.415 . . . . 13.42 107.063 -177.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.869 ' O ' ' OG ' ' A' ' 152' ' ' SER . 37.9 Cg_endo -67.95 -26.61 37.47 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.101 1.053 . . . . 15.9 110.397 178.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' SER . . . . . 0.869 ' OG ' ' O ' ' A' ' 151' ' ' PRO . 0.0 OUTLIER 151.9 1.93 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.185 0 O-C-N 121.808 -0.557 . . . . 16.09 111.04 179.177 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.514 ' CB ' ' HB3' ' A' ' 149' ' ' GLU . 0.7 OUTLIER 49.86 36.17 10.82 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.583 -1.265 . . . . 17.73 107.583 -176.331 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ILE . . . . . 0.423 ' CD1' ' N ' ' A' ' 154' ' ' ILE . 0.2 OUTLIER -65.19 159.98 61.23 Favored Pre-proline 0 N--CA 1.498 1.949 0 N-CA-C 109.473 -0.566 . . . . 20.05 109.473 -179.556 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -75.71 115.51 4.21 Favored 'Trans proline' 0 C--N 1.316 -1.139 0 O-C-N 123.682 1.359 . . . . 21.31 110.323 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.6 p30 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.947 -1.025 . . . . 23.42 110.019 -179.946 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.494 ' O ' ' OG1' ' A' ' 18' ' ' THR . 25.8 t0 . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 120.862 0.363 . . . . 0.0 110.62 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.477 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 40.9 m0 -76.66 -56.51 4.54 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.307 -0.87 . . . . 0.0 110.612 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.7 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 0.8 OUTLIER -41.62 -40.76 2.01 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.698 -0.626 . . . . 0.0 111.042 -179.821 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.2 -56.27 5.32 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.174 -0.954 . . . . 0.0 110.07 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.494 ' OG1' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -43.73 -53.93 5.49 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.587 -0.696 . . . . 0.0 110.719 -179.939 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.665 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -52.97 -55.91 19.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.411 -0.806 . . . . 0.0 110.445 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.457 ' CB ' HG11 ' A' ' 59' ' ' VAL . . . -47.08 -62.58 1.35 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.567 -0.708 . . . . 0.0 111.077 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.622 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -46.15 -28.5 1.25 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.612 -0.68 . . . . 0.0 110.855 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -90.79 30.35 1.2 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.299 -0.876 . . . . 0.0 110.291 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.553 ' CA ' ' HE2' ' A' ' 53' ' ' MET . . . 44.94 27.5 1.48 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.406 -1.077 . . . . 0.0 110.406 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.541 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -105.17 98.47 8.17 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.258 -1.142 . . . . 0.0 110.323 -179.771 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.817 HG22 ' CG2' ' A' ' 59' ' ' VAL . 69.9 t -78.73 -37.26 20.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.633 -0.667 . . . . 0.0 110.172 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -54.65 -52.38 62.49 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.544 -0.722 . . . . 0.0 110.899 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.456 ' O ' HD12 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -58.04 -35.1 70.82 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.225 -0.922 . . . . 0.0 110.821 -179.233 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.852 HG12 HD13 ' A' ' 62' ' ' LEU . 6.2 t -76.41 -47.85 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.274 -0.891 . . . . 0.0 110.171 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.809 ' N ' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -52.73 -46.34 67.37 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.022 -1.049 . . . . 0.0 109.688 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -70.66 -31.0 67.76 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.418 -0.801 . . . . 0.0 109.559 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' ' 27' ' ' GLU . 10.2 mt -79.4 -53.26 7.08 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.402 -0.811 . . . . 0.0 110.815 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.924 HD12 ' CD2' ' A' ' 66' ' ' HIS . 0.0 OUTLIER -47.88 -38.76 17.03 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.164 -0.96 . . . . 0.0 110.161 -179.695 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -83.09 -25.06 32.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.332 -0.855 . . . . 0.0 109.855 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.426 ' HB2' ' O ' ' A' ' 30' ' ' ALA . . . -74.25 -3.81 32.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.42 -0.8 . . . . 0.0 110.03 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.82 24.44 5.23 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.761 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -61.04 133.74 56.37 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.071 -1.252 . . . . 0.0 109.809 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.968 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 3.1 mm? -57.09 112.89 5.17 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.399 -0.813 . . . . 0.0 109.778 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.47 -30.42 36.03 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 123.543 1.286 . . . . 0.0 109.88 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.52 ' HA ' ' OE2' ' A' ' 69' ' ' GLU . 33.0 m120 -121.01 56.67 1.01 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.425 -0.797 . . . . 0.0 110.125 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.968 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -100.9 110.89 62.23 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.856 -0.527 . . . . 0.0 109.604 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.92 124.6 9.76 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.494 1.26 . . . . 0.0 109.638 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.498 ' ND2' ' HB2' ' A' ' 44' ' ' TYR . 36.9 t30 -88.2 161.97 16.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.408 -0.808 . . . . 0.0 110.035 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.405 ' N ' ' OD1' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -74.76 -0.99 20.01 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.428 -0.795 . . . . 0.0 110.967 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.498 ' HB2' ' ND2' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -84.64 1.37 46.52 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.004 -1.06 . . . . 0.0 110.093 179.529 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.82 23.24 44.2 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.521 ' O ' ' CB ' ' A' ' 50' ' ' GLN . 46.1 mtt180 -121.66 37.63 4.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.316 -1.108 . . . . 0.0 110.968 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.487 ' HG3' ' HD3' ' A' ' 48' ' ' PRO . 0.0 OUTLIER 43.52 -172.65 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.089 0 O-C-N 121.517 -0.739 . . . . 0.0 111.064 178.926 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.694 ' HB2' HD22 ' A' ' 63' ' ' LEU . 53.0 Cg_endo -85.5 -23.89 2.1 Favored 'Trans proline' 0 C--N 1.317 -1.089 0 O-C-N 123.476 1.251 . . . . 0.0 110.377 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.582 HG13 ' HB1' ' A' ' 68' ' ' ALA . 2.7 mt -102.63 -43.85 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.229 -0.919 . . . . 0.0 108.95 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.58 ' HG2' ' HA ' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -49.68 -21.17 0.97 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.381 -0.824 . . . . 0.0 109.822 178.808 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.622 HG22 ' HB2' ' A' ' 21' ' ' ALA . 9.3 p -112.99 33.23 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.089 -1.007 . . . . 0.0 110.579 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.563 ' HE1' ' HB2' ' A' ' 60' ' ' ALA . 0.1 OUTLIER -96.96 35.08 1.61 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.061 -1.024 . . . . 0.0 109.483 179.111 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.553 ' HE2' ' CA ' ' A' ' 23' ' ' GLY . 6.2 tmm? 64.55 -6.26 0.31 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.667 -0.645 . . . . 0.0 111.109 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.588 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 44.53 26.79 0.2 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.253 -0.904 . . . . 0.0 110.57 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.537 ' HA2' ' CD2' ' A' ' 90' ' ' PHE . . . -128.79 8.73 6.44 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.648 ' HB3' HG23 ' A' ' 59' ' ' VAL . 0.6 OUTLIER -145.66 70.29 1.24 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.318 -1.107 . . . . 0.0 109.972 179.663 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.505 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . . . -42.79 -36.56 1.5 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.507 -0.746 . . . . 0.0 110.7 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -46.31 -35.29 5.2 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.653 -0.654 . . . . 0.0 109.463 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.817 ' CG2' HG22 ' A' ' 25' ' ' VAL . 46.6 t -67.16 -51.55 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.563 ' HB2' ' HE1' ' A' ' 52' ' ' MET . . . -43.85 -58.13 2.91 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.649 -0.657 . . . . 0.0 110.03 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.93 -49.35 30.41 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.852 HD13 HG12 ' A' ' 28' ' ' VAL . 0.4 OUTLIER -46.11 -62.67 1.23 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.704 -0.622 . . . . 0.0 110.115 178.935 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.883 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 0.9 OUTLIER -69.98 -55.18 10.27 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.385 -0.822 . . . . 0.0 110.615 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.904 HD22 ' CG1' ' A' ' 96' ' ' VAL . 0.4 OUTLIER -48.39 -63.69 1.01 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.302 -0.874 . . . . 0.0 110.701 -179.528 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.723 HD12 ' C ' ' A' ' 65' ' ' LEU . 0.8 OUTLIER -50.68 -28.12 8.35 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.406 -0.809 . . . . 0.0 109.36 -179.702 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.924 ' CD2' HD12 ' A' ' 32' ' ' LEU . 2.4 m80 -84.47 -31.98 24.26 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.778 -0.576 . . . . 0.0 109.748 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 63' ' ' LEU . . . 125.81 55.37 0.16 Allowed Glycine 0 N--CA 1.482 1.707 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.883 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -80.02 -150.97 0.07 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.971 -1.311 . . . . 0.0 109.049 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.52 ' OE2' ' HA ' ' A' ' 39' ' ' ASN . 2.0 mt-10 -124.38 68.0 48.45 Favored Pre-proline 0 C--N 1.3 -1.582 0 O-C-N 121.412 -0.805 . . . . 0.0 109.49 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.518 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 49.0 Cg_endo -71.24 -3.89 13.84 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 O-C-N 123.716 1.377 . . . . 0.0 110.293 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.454 ' O ' ' NE ' ' A' ' 80' ' ' ARG . 37.0 m-20 -112.55 -67.67 0.98 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.303 -0.873 . . . . 0.0 109.587 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.8 t -43.69 155.52 0.07 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.57 -0.706 . . . . 0.0 110.128 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.556 ' HB2' ' HA ' ' A' ' 80' ' ' ARG . . . -152.07 -142.26 0.12 Allowed 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.569 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.413 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 0.4 OUTLIER -100.01 139.59 20.88 Favored Pre-proline 0 N--CA 1.484 1.254 0 O-C-N 121.219 -0.926 . . . . 0.0 110.563 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 74' ' ' ASP . 55.2 Cg_endo -84.31 2.77 7.96 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.988 1.52 . . . . 0.0 110.428 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -101.79 -33.87 9.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.16 -0.963 . . . . 0.0 110.027 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -140.24 10.18 2.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.473 -0.767 . . . . 0.0 110.518 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 78' ' ' LEU . 21.7 mt 53.86 38.49 28.77 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.303 -0.873 . . . . 0.0 110.731 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.475 ' HA ' ' OD1' ' A' ' 108' ' ' ASP . 36.5 m -72.91 88.38 1.35 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.423 -0.911 . . . . 0.0 110.313 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.781 ' CD ' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -72.78 168.43 24.36 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.471 -0.768 . . . . 0.0 109.675 179.752 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.58 ' HA ' ' HG2' ' A' ' 50' ' ' GLN . 47.9 Cg_endo -73.26 -2.26 11.82 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.697 1.367 . . . . 0.0 109.998 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 23.9 t -76.59 -36.11 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.585 -0.697 . . . . 0.0 109.612 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.522 ' O ' ' CB ' ' A' ' 87' ' ' ARG . 23.1 m80 -69.39 -40.46 77.35 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.588 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 0.3 OUTLIER -52.1 -52.27 52.48 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.304 -0.873 . . . . 0.0 110.676 179.374 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.674 ' HB1' ' CD1' ' A' ' 94' ' ' LEU . . . -55.46 -64.74 0.75 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.224 -0.922 . . . . 0.0 110.154 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.825 ' HB1' ' HB2' ' A' ' 118' ' ' ALA . . . -58.94 -56.09 26.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.195 -0.941 . . . . 0.0 110.423 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.522 ' CB ' ' O ' ' A' ' 83' ' ' HIS . 0.1 OUTLIER -43.39 -25.85 0.16 Allowed 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.342 -0.849 . . . . 0.0 111.291 -179.821 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.53 ' CB ' ' HB3' ' A' ' 54' ' ' MET . 0.0 OUTLIER -104.34 -13.56 16.08 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.076 -1.015 . . . . 0.0 110.657 179.446 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.04 25.65 39.96 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.537 ' CD2' ' HA2' ' A' ' 55' ' ' GLY . 0.5 OUTLIER -106.12 93.69 4.76 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.283 -1.128 . . . . 0.0 110.722 -179.693 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.434 HD21 ' CG ' ' A' ' 129' ' ' TYR . 0.2 OUTLIER -66.75 -44.22 82.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.509 -0.745 . . . . 0.0 109.908 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.511 ' O ' HG23 ' A' ' 96' ' ' VAL . 36.2 t0 -40.75 -38.69 0.95 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.576 -0.703 . . . . 0.0 110.121 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.404 ' CG2' ' HB2' ' A' ' 85' ' ' ALA . 22.4 m -63.04 -58.87 5.83 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.496 -0.753 . . . . 0.0 109.593 179.004 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.806 ' CD2' HD21 ' A' ' 130' ' ' LEU . 1.2 mp -48.94 -46.29 43.07 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.398 -0.814 . . . . 0.0 110.023 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 71.6 t -49.84 -54.86 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.904 ' CG1' HD22 ' A' ' 64' ' ' LEU . 85.0 t -53.09 -57.15 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 121.26 0.552 . . . . 0.0 109.716 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.774 ' C ' ' HB2' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -45.62 -56.3 5.34 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.33 0.586 . . . . 0.0 110.034 179.785 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -63.7 -21.0 66.17 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.19 -0.944 . . . . 0.0 109.836 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.36 -15.59 61.37 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.247 -0.908 . . . . 0.0 110.727 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.783 ' HB3' HD11 ' A' ' 64' ' ' LEU . . . -134.47 62.2 1.65 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.237 -0.914 . . . . 0.0 110.249 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 47.54 80.31 0.06 OUTLIER Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.774 ' HB2' ' C ' ' A' ' 97' ' ' LEU . . . -101.51 144.94 29.67 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.378 -1.072 . . . . 0.0 109.991 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -87.04 59.29 5.54 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.19 -0.944 . . . . 0.0 110.317 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.609 ' O ' ' HA ' ' A' ' 134' ' ' ALA . 0.6 OUTLIER -68.95 61.81 0.11 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.542 -0.723 . . . . 0.0 110.592 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -167.44 29.15 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.782 -1.199 . . . . 0.0 110.574 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.781 HG11 ' CD ' ' A' ' 80' ' ' ARG . 1.0 OUTLIER -100.65 -169.86 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 121.27 -0.894 . . . . 0.0 109.283 179.234 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.608 ' H ' HG22 ' A' ' 106' ' ' VAL . 3.7 ptm180 -141.85 131.31 23.78 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 120.118 -0.633 . . . . 0.0 109.877 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.475 ' OD1' ' HA ' ' A' ' 79' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 O-C-N 121.474 -0.766 . . . . 0.0 109.715 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.478 ' HB3' HG12 ' A' ' 115' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.938 -0.394 . . . . 0.0 109.938 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.476 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 44.0 Cg_endo -73.65 -32.2 7.87 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 O-C-N 123.686 1.361 . . . . 0.0 109.999 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.577 HG23 ' CB ' ' A' ' 130' ' ' LEU . 6.8 p -65.9 -36.39 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.415 -0.803 . . . . 0.0 109.409 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -74.97 -42.69 57.12 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.475 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.405 ' HG ' HD12 ' A' ' 121' ' ' LEU . 6.2 tt -61.56 -31.84 71.89 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.33 -0.856 . . . . 0.0 109.162 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.825 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -68.28 -43.37 77.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.466 -0.772 . . . . 0.0 109.944 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -68.22 -46.53 70.31 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.456 -0.778 . . . . 0.0 111.16 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -61.06 -54.37 45.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.298 -0.876 . . . . 0.0 110.276 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.405 HD12 ' HG ' ' A' ' 117' ' ' LEU . 0.2 OUTLIER -56.67 -81.03 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.277 -0.889 . . . . 0.0 110.174 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 173.89 38.76 0.04 OUTLIER Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.555 ' CG ' ' O ' ' A' ' 86' ' ' ALA . 51.3 m-70 -118.16 47.73 1.54 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.495 -1.003 . . . . 0.0 109.663 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -45.83 -53.46 9.63 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.713 -0.617 . . . . 0.0 110.315 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.424 ' O ' HD11 ' A' ' 91' ' ' LEU . 17.2 m-20 -48.0 -34.2 8.99 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.587 -0.696 . . . . 0.0 109.563 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.746 HG11 ' HA ' ' A' ' 86' ' ' ALA . 2.8 t -88.81 -44.9 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.631 -0.668 . . . . 0.0 109.331 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.439 ' O ' HG23 ' A' ' 115' ' ' VAL . . . -52.99 -49.09 66.87 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.397 -0.814 . . . . 0.0 110.176 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.74 -61.58 2.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.134 -0.979 . . . . 0.0 110.105 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.434 ' CG ' HD21 ' A' ' 91' ' ' LEU . 12.2 t80 -53.53 -30.72 43.03 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.421 -0.799 . . . . 0.0 109.379 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.806 HD21 ' CD2' ' A' ' 94' ' ' LEU . 5.9 mt -64.04 -52.16 60.7 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.026 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -54.82 -29.81 55.75 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.303 -0.873 . . . . 0.0 110.272 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -80.94 -33.06 34.31 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.488 -0.758 . . . . 0.0 110.153 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.435 ' HB1' HD13 ' A' ' 104' ' ' LEU . . . -90.12 -21.64 22.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.358 -0.839 . . . . 0.0 110.524 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.609 ' HA ' ' O ' ' A' ' 104' ' ' LEU . . . . . . . . 0 N--CA 1.494 1.774 0 O-C-N 121.081 -1.012 . . . . 0.0 110.238 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.402 ' O ' ' OG1' ' A' ' 18' ' ' THR . 6.9 m-20 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 120.95 0.405 . . . . 0.0 110.356 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.552 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 33.6 m0 -80.35 -6.94 58.8 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.345 -0.847 . . . . 0.0 110.721 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.672 HD11 ' HB1' ' A' ' 36' ' ' ALA . 14.6 mt -86.61 -49.29 7.63 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.201 -0.937 . . . . 0.0 109.387 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.84 -31.16 71.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.562 -0.711 . . . . 0.0 109.37 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.552 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.2 OUTLIER -66.01 -61.17 2.19 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.656 -0.653 . . . . 0.0 109.961 179.68 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.742 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -54.26 -34.78 61.55 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.28 -0.887 . . . . 0.0 110.102 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.77 ' HB1' ' CB ' ' A' ' 52' ' ' MET . . . -65.65 -55.89 15.07 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.248 -0.907 . . . . 0.0 109.23 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.42 -29.96 69.32 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.458 -0.776 . . . . 0.0 109.741 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -98.51 17.26 19.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.402 -0.811 . . . . 0.0 110.243 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.408 ' CA ' ' HE2' ' A' ' 53' ' ' MET . . . 50.06 82.13 0.04 OUTLIER Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.736 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 1.1 ttt180 -143.19 63.91 1.36 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.29 -1.123 . . . . 0.0 109.819 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.529 HG12 ' HD3' ' A' ' 29' ' ' ARG . 94.1 t -48.73 -64.94 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.484 -0.76 . . . . 0.0 111.267 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -49.64 -38.32 31.71 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.355 -0.84 . . . . 0.0 110.959 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.42 -37.64 86.61 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.393 -0.817 . . . . 0.0 110.263 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.826 HG12 HD12 ' A' ' 32' ' ' LEU . 2.8 t -82.95 -45.11 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.4 -0.812 . . . . 0.0 109.924 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.529 ' HD3' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -42.96 -43.9 4.38 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.518 -0.739 . . . . 0.0 110.335 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.94 -41.47 36.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.452 -0.78 . . . . 0.0 109.94 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.431 ' HB2' ' HA ' ' A' ' 28' ' ' VAL . 27.0 mt -53.8 -65.56 0.55 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.281 -0.887 . . . . 0.0 109.729 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.949 HD22 ' CB ' ' A' ' 66' ' ' HIS . 2.8 mt -48.82 -43.92 38.87 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.648 -0.657 . . . . 0.0 110.637 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -70.84 -21.1 62.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.204 -0.935 . . . . 0.0 109.956 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.45 -6.47 59.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.337 -0.852 . . . . 0.0 110.615 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.16 27.28 3.21 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.891 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -66.77 169.01 8.58 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.157 -1.202 . . . . 0.0 109.894 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.572 HD13 ' HD2' ' A' ' 38' ' ' PRO . 1.9 mm? -87.66 125.99 63.24 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.422 -0.799 . . . . 0.0 110.046 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.572 ' HD2' HD13 ' A' ' 37' ' ' LEU . 42.7 Cg_endo -69.22 -36.96 11.2 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.354 1.186 . . . . 0.0 109.716 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.423 ' O ' ' HD3' ' A' ' 41' ' ' PRO . 74.7 m-20 -121.41 70.91 0.94 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.502 -0.749 . . . . 0.0 109.45 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.497 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -93.42 104.76 13.31 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.469 -0.769 . . . . 0.0 110.129 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' ' 39' ' ' ASN . 48.6 Cg_endo -70.73 106.8 1.91 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 123.672 1.354 . . . . 0.0 110.533 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.6 p30 -82.9 178.14 8.31 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.189 -0.945 . . . . 0.0 110.015 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.4 m -90.53 40.24 1.01 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.293 -0.88 . . . . 0.0 109.649 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -119.28 12.58 12.59 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.495 -0.753 . . . . 0.0 110.42 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 52.86 25.12 22.19 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.796 -1.722 . . . . 0.0 108.796 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -143.8 117.72 9.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.623 -0.927 . . . . 0.0 110.136 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.499 ' CB ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -60.07 -179.33 0.17 Allowed Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.409 -0.807 . . . . 0.0 109.672 179.578 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.533 ' O ' ' N ' ' A' ' 50' ' ' GLN . 39.2 Cg_endo -65.16 169.55 11.97 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.399 1.21 . . . . 0.0 110.313 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.553 HG13 ' HB1' ' A' ' 68' ' ' ALA . 3.1 mt 63.4 -61.35 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 O-C-N 121.621 -0.674 . . . . 0.0 109.984 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.533 ' N ' ' O ' ' A' ' 48' ' ' PRO . 1.7 tt0 -50.02 -23.88 2.31 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.033 -1.042 . . . . 0.0 110.011 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.3 p -108.46 8.42 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.214 -0.929 . . . . 0.0 110.572 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.77 ' CB ' ' HB1' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -78.29 159.12 28.63 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.959 -1.088 . . . . 0.0 109.534 179.369 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.408 ' HE2' ' CA ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -48.83 -17.62 0.2 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.389 -0.819 . . . . 0.0 111.989 -178.84 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.728 ' HE2' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 61.52 15.41 6.71 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.837 -1.164 . . . . 0.0 109.715 -178.842 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.413 ' C ' ' CE2' ' A' ' 90' ' ' PHE . . . -112.91 17.97 22.18 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -161.2 102.41 1.25 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.37 -1.077 . . . . 0.0 110.25 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.438 ' CB ' ' HB3' ' A' ' 92' ' ' ASP . . . -63.03 -17.87 62.71 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.283 -0.886 . . . . 0.0 109.216 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.24 -42.27 73.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.478 -0.764 . . . . 0.0 109.885 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.588 HG12 HD12 ' A' ' 63' ' ' LEU . 7.4 t -61.5 -53.63 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.347 -0.846 . . . . 0.0 109.516 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.421 ' O ' ' CB ' ' A' ' 64' ' ' LEU . . . -53.7 -51.67 62.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.442 -0.786 . . . . 0.0 110.363 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.462 ' O ' ' HB3' ' A' ' 65' ' ' LEU . 5.6 tt0 -50.34 -44.72 54.57 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.129 -0.982 . . . . 0.0 110.539 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.645 ' CD1' HD13 ' A' ' 32' ' ' LEU . 1.4 tp -70.53 -57.28 4.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.571 -0.706 . . . . 0.0 109.68 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.635 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 6.1 mt -57.77 -45.02 86.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.255 -0.903 . . . . 0.0 109.225 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.854 HD22 HG12 ' A' ' 96' ' ' VAL . 1.0 OUTLIER -64.75 -52.9 54.55 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.58 -0.7 . . . . 0.0 110.407 179.595 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.462 ' HB3' ' O ' ' A' ' 61' ' ' GLU . 12.1 tp -50.95 -39.87 56.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.421 -0.8 . . . . 0.0 109.285 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.949 ' CB ' HD22 ' A' ' 32' ' ' LEU . 4.4 m80 -78.45 -37.73 42.92 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.147 0.499 . . . . 0.0 110.003 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 38' ' ' PRO . . . 139.78 54.04 0.05 OUTLIER Glycine 0 N--CA 1.481 1.643 0 C-N-CA 120.062 -1.065 . . . . 0.0 110.823 179.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.635 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -68.43 -151.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.765 -1.432 . . . . 0.0 109.768 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.486 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 3.6 mm-40 -131.87 61.06 55.91 Favored Pre-proline 0 C--N 1.303 -1.42 0 O-C-N 121.494 -0.754 . . . . 0.0 109.973 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.558 ' HA ' ' CG ' ' A' ' 81' ' ' PRO . 47.3 Cg_endo -72.14 1.62 5.79 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 123.951 1.5 . . . . 0.0 110.677 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.495 ' N ' ' OD1' ' A' ' 71' ' ' ASN . 1.5 m-20 -115.96 -54.35 2.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.048 -1.032 . . . . 0.0 110.018 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -48.41 154.85 0.58 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.521 -0.737 . . . . 0.0 110.691 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.43 ' HB2' ' HE ' ' A' ' 80' ' ' ARG . . . -151.52 -157.52 0.82 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.444 -0.785 . . . . 0.0 109.923 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' A' ' 78' ' ' LEU . 0.5 OUTLIER -105.16 140.23 20.9 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.263 -0.898 . . . . 0.0 109.566 179.507 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.28 -11.01 24.69 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.589 1.31 . . . . 0.0 110.767 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.98 -43.65 24.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.13 -0.981 . . . . 0.0 110.16 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.519 ' O ' ' HA ' ' A' ' 108' ' ' ASP . 0.2 OUTLIER -139.6 25.62 2.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.459 -0.776 . . . . 0.0 110.171 -179.521 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.438 HD22 HH11 ' A' ' 80' ' ' ARG . 5.7 mt 40.6 36.57 0.39 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.525 -0.734 . . . . 0.0 110.631 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.82 92.13 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.448 -0.783 . . . . 0.0 110.55 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.896 ' CD ' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -73.92 163.31 69.28 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.274 -0.891 . . . . 0.0 109.241 179.146 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.558 ' CG ' ' HA ' ' A' ' 70' ' ' PRO . 46.3 Cg_endo -73.08 -3.34 13.48 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.699 1.368 . . . . 0.0 110.738 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 40.5 t -74.09 -26.37 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.234 -0.916 . . . . 0.0 109.747 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.495 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 9.2 m80 -74.07 -33.85 63.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.479 -0.763 . . . . 0.0 109.38 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.728 ' HB3' ' HE2' ' A' ' 54' ' ' MET . 0.3 OUTLIER -58.73 -50.74 72.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.677 -0.639 . . . . 0.0 110.141 179.583 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.581 ' CB ' HD13 ' A' ' 94' ' ' LEU . . . -53.57 -56.74 14.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.373 -0.83 . . . . 0.0 109.261 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.905 ' HB2' HD11 ' A' ' 130' ' ' LEU . . . -59.99 -52.2 66.4 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.718 -0.614 . . . . 0.0 110.287 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -43.91 -37.8 3.06 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.527 -0.733 . . . . 0.0 111.229 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.9 16.28 26.43 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.22 -0.925 . . . . 0.0 110.373 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' A' ' 123' ' ' HIS . . . 51.58 55.01 22.05 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.413 ' CE2' ' C ' ' A' ' 55' ' ' GLY . 0.4 OUTLIER -123.98 85.33 2.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.387 -1.066 . . . . 0.0 110.623 -179.626 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.25 -34.47 78.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 0.0 110.175 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.549 ' O ' HG23 ' A' ' 96' ' ' VAL . 94.7 m-20 -48.53 -38.38 20.22 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.35 -0.844 . . . . 0.0 109.829 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.6 m -68.64 -54.26 17.47 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.816 HD22 HG13 ' A' ' 126' ' ' VAL . 1.1 tp -47.42 -48.74 26.24 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.528 -0.733 . . . . 0.0 109.572 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 47.5 t -48.4 -51.61 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 CA-C-O 121.372 0.605 . . . . 0.0 109.737 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.854 HG12 HD22 ' A' ' 64' ' ' LEU . 52.2 t -55.64 -52.88 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-O 121.32 0.581 . . . . 0.0 110.325 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.461 HD12 ' N ' ' A' ' 97' ' ' LEU . 10.9 mp -52.67 -42.61 64.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.489 -0.757 . . . . 0.0 109.756 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -78.66 -24.44 45.18 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.252 -0.905 . . . . 0.0 109.49 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.449 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 5.8 mtt180 -74.4 -10.99 60.12 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.33 -0.856 . . . . 0.0 110.878 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.809 ' CB ' HD21 ' A' ' 64' ' ' LEU . . . -124.2 -106.31 0.35 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.281 -0.887 . . . . 0.0 110.616 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -142.93 50.21 0.71 Allowed Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.692 -1.242 . . . . 0.0 110.143 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.519 ' CB ' ' HB2' ' A' ' 70' ' ' PRO . . . -102.59 114.93 29.57 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.342 -1.093 . . . . 0.0 110.261 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 32.0 ttt180 -58.76 111.28 1.22 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.32 -0.863 . . . . 0.0 109.709 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.45 54.64 0.88 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.41 -0.806 . . . . 0.0 110.545 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -165.38 54.02 0.11 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.018 -1.051 . . . . 0.0 110.827 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.896 HG11 ' CD ' ' A' ' 80' ' ' ARG . 4.1 p -109.61 -173.93 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.2 -0.938 . . . . 0.0 109.977 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.701 ' H ' HG22 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -137.95 137.31 37.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.535 -0.728 . . . . 0.0 109.642 179.575 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.519 ' HA ' ' O ' ' A' ' 77' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.278 -0.889 . . . . 0.0 109.766 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.541 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 89.4 mt . . . . . 0 N--CA 1.495 1.816 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.66 ' HG2' HD22 ' A' ' 130' ' ' LEU . 42.9 Cg_endo -69.68 -25.25 29.16 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.431 1.227 . . . . 0.0 109.46 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.55 ' HB ' ' HB3' ' A' ' 130' ' ' LEU . 9.9 p -70.69 -36.05 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.419 -0.801 . . . . 0.0 109.804 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.414 ' N ' HG13 ' A' ' 115' ' ' VAL . 1.9 m-20 -54.44 -34.74 62.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.44 -0.788 . . . . 0.0 110.153 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.596 HD12 HD13 ' A' ' 121' ' ' LEU . 0.3 OUTLIER -65.0 -57.94 7.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.51 -0.744 . . . . 0.0 110.408 -179.776 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.649 ' HB1' ' HB2' ' A' ' 127' ' ' ALA . . . -47.53 -31.44 4.34 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.644 -0.66 . . . . 0.0 110.874 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.03 -30.96 58.63 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.444 -0.785 . . . . 0.0 109.753 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.6 -53.75 8.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.431 -0.793 . . . . 0.0 110.772 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.596 HD13 HD12 ' A' ' 117' ' ' LEU . 3.1 mp -81.27 -94.22 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.31 -0.869 . . . . 0.0 110.662 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -171.66 31.61 0.13 Allowed Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.594 -1.289 . . . . 0.0 110.128 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.555 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 27.1 m-70 -88.08 49.9 1.88 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.057 -1.261 . . . . 0.0 108.837 179.167 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.4 ttm-85 -45.84 -38.13 6.93 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.673 -0.642 . . . . 0.0 110.554 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -66.07 -42.29 89.6 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.361 -0.837 . . . . 0.0 109.835 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.816 HG13 HD22 ' A' ' 94' ' ' LEU . 8.3 t -77.97 -29.6 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.134 -0.979 . . . . 0.0 110.321 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.649 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . . . -60.15 -41.8 93.53 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.165 -0.96 . . . . 0.0 109.722 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.18 -62.63 1.69 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.519 -0.738 . . . . 0.0 110.549 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.424 ' HB3' HD23 ' A' ' 94' ' ' LEU . 0.6 OUTLIER -54.33 -37.82 65.3 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.282 -0.886 . . . . 0.0 110.096 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.905 HD11 ' HB2' ' A' ' 86' ' ' ALA . 44.3 mt -69.6 -18.45 63.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.541 -0.724 . . . . 0.0 110.417 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -89.44 -28.86 19.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.139 -0.975 . . . . 0.0 109.927 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -84.01 -43.48 15.11 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.327 -0.858 . . . . 0.0 110.409 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -90.42 -34.52 15.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.167 -0.958 . . . . 0.0 110.598 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.874 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.667 0 O-C-N 121.289 -0.882 . . . . 0.0 110.194 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 120.95 0.405 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.484 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 7.3 m0 -54.81 -25.88 31.17 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.119 -0.988 . . . . 0.0 111.171 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.904 HD13 HD21 ' A' ' 63' ' ' LEU . 4.0 pp -65.93 -38.84 89.72 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.03 -1.044 . . . . 0.0 110.51 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.663 ' N ' HD12 ' A' ' 16' ' ' LEU . . . -81.46 -42.61 20.06 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.13 -0.981 . . . . 0.0 110.321 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.484 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.0 OUTLIER -58.88 -56.28 24.32 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.357 -0.839 . . . . 0.0 110.286 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.75 -41.73 74.39 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.255 -0.903 . . . . 0.0 109.834 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.543 ' HB1' HG11 ' A' ' 59' ' ' VAL . . . -55.73 -35.31 65.99 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.416 -0.803 . . . . 0.0 110.063 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.97 -23.87 59.54 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.442 -0.786 . . . . 0.0 110.512 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 -93.65 23.58 4.61 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.272 -0.892 . . . . 0.0 110.457 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 55.34 46.71 78.99 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -118.53 90.91 3.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.274 -1.133 . . . . 0.0 109.805 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.683 HG22 HG23 ' A' ' 59' ' ' VAL . 46.0 t -73.73 -38.96 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.357 -0.84 . . . . 0.0 110.307 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -60.88 -44.83 96.54 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.291 -0.881 . . . . 0.0 110.794 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.757 ' O ' HD12 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -68.5 -38.65 81.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.252 -0.905 . . . . 0.0 110.199 -179.696 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 54.5 t -73.89 -45.24 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.375 -0.828 . . . . 0.0 110.401 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.548 ' HA ' ' CD1' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -62.48 -47.89 81.99 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.077 -1.014 . . . . 0.0 109.441 179.81 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.94 -20.99 64.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.277 -0.889 . . . . 0.0 109.922 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.757 HD12 ' O ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -68.5 -58.83 3.72 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.323 -0.861 . . . . 0.0 110.04 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.841 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 5.0 mt -51.32 -41.68 60.7 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.351 -0.843 . . . . 0.0 110.192 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -70.5 -18.18 62.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.32 -0.862 . . . . 0.0 109.596 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.47 -8.65 47.09 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.32 -0.862 . . . . 0.0 110.706 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.12 29.05 1.71 Allowed Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.876 -1.154 . . . . 0.0 110.676 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.841 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -71.28 161.13 31.58 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.022 -1.281 . . . . 0.0 110.177 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.816 ' HB2' ' HB2' ' A' ' 40' ' ' ALA . 75.5 mt -92.01 142.3 26.23 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.346 -0.846 . . . . 0.0 110.236 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.17 -42.99 1.24 Allowed 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.497 1.262 . . . . 0.0 110.121 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -121.03 58.7 0.95 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.462 -0.774 . . . . 0.0 110.092 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.816 ' HB2' ' HB2' ' A' ' 37' ' ' LEU . . . -79.7 116.39 60.59 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.311 -0.868 . . . . 0.0 109.776 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.52 120.53 7.0 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.68 1.358 . . . . 0.0 110.596 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.425 HD22 ' HB3' ' A' ' 17' ' ' ALA . 1.6 t-20 -99.66 -150.07 0.37 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.447 -0.783 . . . . 0.0 109.996 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.424 ' O ' ' OG ' ' A' ' 43' ' ' SER . 0.1 OUTLIER -109.1 20.82 17.94 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.172 -0.955 . . . . 0.0 110.246 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -118.31 -1.8 11.24 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.053 -1.029 . . . . 0.0 110.849 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.54 25.77 50.85 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.929 -1.269 . . . . 0.0 109.929 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.429 ' HB3' ' HB3' ' A' ' 50' ' ' GLN . 36.5 mtt180 -123.42 16.23 9.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -1.123 . . . . 0.0 110.92 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.637 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER 45.98 -166.68 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.083 0 O-C-N 121.706 -0.621 . . . . 0.0 109.744 179.314 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.637 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 46.8 Cg_endo -78.87 172.77 14.5 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 122.758 0.873 . . . . 0.0 110.939 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.542 ' O ' ' HG2' ' A' ' 52' ' ' MET . 9.0 mt 61.74 -63.89 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 O-C-N 121.771 -0.58 . . . . 0.0 110.69 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.515 ' N ' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -49.87 -20.26 0.85 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.824 -1.172 . . . . 0.0 110.401 179.707 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 51' ' ' VAL . 12.8 p -107.82 -5.38 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.192 -0.942 . . . . 0.0 110.76 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.542 ' HG2' ' O ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -63.06 165.65 6.79 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.893 -1.129 . . . . 0.0 109.955 -179.777 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 33.8 ttp -61.23 -8.43 3.67 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.341 -0.849 . . . . 0.0 111.079 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.623 ' HE1' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 57.09 18.2 3.93 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.133 -0.979 . . . . 0.0 110.016 -179.398 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.432 ' C ' ' CE2' ' A' ' 90' ' ' PHE . . . -112.43 3.12 26.47 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.41 95.71 2.71 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.433 -1.039 . . . . 0.0 109.727 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.77 -23.11 16.47 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.279 -0.888 . . . . 0.0 109.663 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.442 ' HA ' ' HB2' ' A' ' 61' ' ' GLU . 13.1 mtt180 -55.5 -40.24 71.48 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.338 -0.851 . . . . 0.0 109.572 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.683 HG23 HG22 ' A' ' 25' ' ' VAL . 95.5 t -53.6 -59.07 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.544 -0.722 . . . . 0.0 109.225 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -61.63 -26.97 68.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.518 -0.739 . . . . 0.0 109.882 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.442 ' HB2' ' HA ' ' A' ' 58' ' ' ARG . 3.6 tp10 -50.71 -71.56 0.06 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.194 -0.941 . . . . 0.0 110.579 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.548 ' CD1' ' HA ' ' A' ' 29' ' ' ARG . 0.4 OUTLIER -65.55 -50.05 66.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.041 -1.037 . . . . 0.0 110.448 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.904 HD21 HD13 ' A' ' 16' ' ' LEU . 0.9 OUTLIER -49.09 -57.63 6.29 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.252 -0.905 . . . . 0.0 109.933 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.655 HD13 HG12 ' A' ' 96' ' ' VAL . 1.2 tt -63.33 -43.8 96.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.304 -0.872 . . . . 0.0 109.233 179.023 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.448 ' HB3' ' HA ' ' A' ' 62' ' ' LEU . 12.8 tp -56.09 -31.12 62.96 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.539 -0.726 . . . . 0.0 109.585 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.718 ' CB ' HD22 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -87.21 -45.61 10.48 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.548 -0.72 . . . . 0.0 109.981 -179.569 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 156.18 44.94 0.02 OUTLIER Glycine 0 N--CA 1.483 1.771 0 C-N-CA 119.811 -1.185 . . . . 0.0 110.754 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.465 ' HA ' ' HG2' ' A' ' 48' ' ' PRO . . . -70.66 -152.64 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.889 -1.36 . . . . 0.0 109.882 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -114.75 66.94 1.85 Allowed Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.336 -0.852 . . . . 0.0 110.211 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.502 ' HG3' HD21 ' A' ' 64' ' ' LEU . 50.9 Cg_endo -73.42 -32.55 7.9 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.757 1.398 . . . . 0.0 110.359 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.421 ' O ' ' NE ' ' A' ' 80' ' ' ARG . 6.8 t30 -100.75 -54.74 2.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.509 -0.744 . . . . 0.0 110.891 -179.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.1 m -48.02 151.48 0.95 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.253 -0.904 . . . . 0.0 111.147 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.602 ' HB2' ' HG2' ' A' ' 80' ' ' ARG . . . -135.5 -159.73 0.99 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.411 -0.806 . . . . 0.0 109.958 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.44 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -105.77 136.54 19.26 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.292 -0.88 . . . . 0.0 109.873 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.38 -23.54 20.4 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 123.41 1.216 . . . . 0.0 110.595 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.38 -60.81 2.85 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.117 -0.99 . . . . 0.0 109.745 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 62.9 p -136.76 34.14 2.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.43 -0.794 . . . . 0.0 109.801 179.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.505 ' HA ' HD23 ' A' ' 78' ' ' LEU . 8.0 mt 49.1 33.92 5.31 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.547 -0.721 . . . . 0.0 111.331 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 94.1 m -65.88 102.85 0.82 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.142 -0.974 . . . . 0.0 109.649 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.602 ' HG2' ' HB2' ' A' ' 73' ' ' ALA . 0.1 OUTLIER -82.31 167.37 30.87 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.271 -0.893 . . . . 0.0 110.193 -179.751 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -70.37 -14.76 34.48 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.771 1.406 . . . . 0.0 109.932 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 65.1 t -67.81 -29.26 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.598 -0.689 . . . . 0.0 109.94 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.436 ' CE1' ' HB3' ' A' ' 114' ' ' PRO . 23.4 m80 -75.59 -35.55 60.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.29 -0.881 . . . . 0.0 109.497 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.623 ' HB3' ' HE1' ' A' ' 54' ' ' MET . 0.3 OUTLIER -58.21 -50.31 73.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.658 -0.651 . . . . 0.0 109.736 179.444 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.409 ' HB3' ' CD1' ' A' ' 94' ' ' LEU . . . -56.96 -64.63 0.81 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.265 -0.897 . . . . 0.0 110.066 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.778 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -58.84 -30.08 67.42 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.317 -0.864 . . . . 0.0 111.271 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.4 ' HB3' ' O ' ' A' ' 84' ' ' ASP . 6.2 tpt180 -52.5 -54.43 32.59 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.048 -1.032 . . . . 0.0 110.237 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.26 -2.99 58.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.191 -0.943 . . . . 0.0 110.047 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.473 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 81.26 44.88 7.78 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.432 ' CE2' ' C ' ' A' ' 55' ' ' GLY . 0.5 OUTLIER -110.59 104.68 13.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.2 -1.176 . . . . 0.0 110.328 179.636 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.536 HD11 ' O ' ' A' ' 125' ' ' ASP . 0.3 OUTLIER -80.38 -38.42 30.38 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.456 -0.778 . . . . 0.0 110.109 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.648 ' O ' HG23 ' A' ' 96' ' ' VAL . 0.8 OUTLIER -47.36 -37.26 10.8 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.511 -0.743 . . . . 0.0 110.312 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.8 m -70.99 -45.71 63.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.47 -0.769 . . . . 0.0 109.273 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.602 HD21 ' HG ' ' A' ' 130' ' ' LEU . 1.2 tp -49.67 -49.73 46.29 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.461 -0.774 . . . . 0.0 110.204 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.413 ' O ' ' CB ' ' A' ' 99' ' ' ARG . 58.0 t -55.08 -47.0 77.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.403 -0.81 . . . . 0.0 109.644 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.655 HG12 HD13 ' A' ' 64' ' ' LEU . 36.6 t -54.45 -51.21 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.526 -0.734 . . . . 0.0 109.834 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.536 ' HA ' HD11 ' A' ' 64' ' ' LEU . 9.1 mp -52.11 -67.02 0.29 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.51 -0.744 . . . . 0.0 110.805 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -57.24 -38.76 74.3 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.172 -0.955 . . . . 0.0 110.15 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.42 ' O ' ' HG2' ' A' ' 99' ' ' ARG . 0.1 OUTLIER -66.3 -14.66 62.36 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.392 -0.817 . . . . 0.0 110.474 179.754 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -132.96 54.03 1.98 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.135 -0.978 . . . . 0.0 110.494 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 58.19 105.15 0.01 OUTLIER Glycine 0 N--CA 1.488 2.126 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -164.9 94.69 0.68 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.322 -1.105 . . . . 0.0 110.231 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.423 ' HB3' ' NH2' ' A' ' 80' ' ' ARG . 20.3 ttt180 -52.69 104.96 0.1 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.314 -0.866 . . . . 0.0 109.717 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.505 ' CD2' HD23 ' A' ' 130' ' ' LEU . 0.0 OUTLIER -98.58 67.18 1.74 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.424 -0.798 . . . . 0.0 110.484 -179.515 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -168.46 42.87 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.2 -0.937 . . . . 0.0 110.378 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.66 HG22 ' H ' ' A' ' 107' ' ' ARG . 4.3 p -101.32 -178.0 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.271 -0.893 . . . . 0.0 110.021 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.66 ' H ' HG22 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -128.57 142.01 51.19 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.521 -0.737 . . . . 0.0 109.291 179.157 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 . . . . . 0 N--CA 1.493 1.723 0 O-C-N 121.216 -0.928 . . . . 0.0 110.438 -179.589 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.489 HD23 ' O ' ' A' ' 106' ' ' VAL . 50.1 mt . . . . . 0 N--CA 1.494 1.761 0 N-CA-C 110.235 -0.284 . . . . 0.0 110.235 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 41.3 Cg_endo -67.47 -27.53 39.59 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 O-C-N 123.676 1.356 . . . . 0.0 110.044 178.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 127' ' ' ALA . 7.8 p -80.74 -35.55 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.412 -0.805 . . . . 0.0 109.761 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.403 ' N ' HG13 ' A' ' 115' ' ' VAL . 37.7 t70 -70.4 -29.85 66.58 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.467 -0.77 . . . . 0.0 110.009 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.3 tt -70.4 -44.48 67.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.422 -0.799 . . . . 0.0 110.303 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.654 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -68.27 -48.61 64.58 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.29 -0.881 . . . . 0.0 110.413 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.54 ' HG2' ' HB1' ' A' ' 127' ' ' ALA . 2.4 mm-40 -55.67 -29.47 59.39 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.293 -0.879 . . . . 0.0 110.068 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -78.31 -39.72 38.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.464 -0.773 . . . . 0.0 110.235 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.33 -88.03 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.346 -0.846 . . . . 0.0 110.281 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -177.86 25.99 0.06 OUTLIER Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.451 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 36.0 m-70 -108.11 50.59 0.77 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.024 -1.28 . . . . 0.0 108.994 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.481 ' HA ' ' HB3' ' A' ' 127' ' ' ALA . 5.4 ttt180 -46.09 -37.37 6.73 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.71 -0.619 . . . . 0.0 110.124 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.536 ' O ' HD11 ' A' ' 91' ' ' LEU . 7.2 p-10 -59.92 -42.25 93.53 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.406 -0.809 . . . . 0.0 109.201 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.778 HG11 ' HA ' ' A' ' 86' ' ' ALA . 2.6 t -81.35 -32.56 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.437 -0.789 . . . . 0.0 109.037 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.54 ' HB1' ' HG2' ' A' ' 119' ' ' GLU . . . -69.2 -39.05 78.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.512 -0.743 . . . . 0.0 109.45 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.51 -61.21 2.79 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.277 -0.889 . . . . 0.0 109.676 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.432 ' HD2' HD23 ' A' ' 94' ' ' LEU . 71.0 t80 -54.48 -37.18 64.97 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.348 -0.845 . . . . 0.0 109.467 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.776 HD11 ' HB2' ' A' ' 86' ' ' ALA . 14.8 mt -63.77 -30.08 71.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.519 -0.738 . . . . 0.0 109.525 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -68.79 -30.62 69.24 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.536 -0.728 . . . . 0.0 110.121 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -87.01 -36.59 18.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.286 -0.884 . . . . 0.0 110.408 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -89.22 -15.85 32.67 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.291 -0.88 . . . . 0.0 110.678 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.691 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.23 -0.919 . . . . 0.0 110.432 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.441 ' OD1' HG23 ' A' ' 18' ' ' THR . 10.7 t0 . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 121.002 0.43 . . . . 0.0 110.404 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.666 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 1.3 t90 -65.66 -10.25 34.54 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.139 -0.976 . . . . 0.0 110.442 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.693 HD23 ' HB3' ' A' ' 40' ' ' ALA . 1.8 tp -73.0 -54.37 8.76 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.245 -0.91 . . . . 0.0 109.72 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.649 ' HB2' ' HA ' ' A' ' 48' ' ' PRO . . . -75.77 -42.82 49.25 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.368 -0.833 . . . . 0.0 110.488 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.666 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 3.1 p -49.37 -46.29 47.0 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.468 -0.77 . . . . 0.0 110.76 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.62 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -66.3 -47.18 74.42 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.283 -0.886 . . . . 0.0 110.299 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.48 ' HB1' HG11 ' A' ' 59' ' ' VAL . . . -52.54 -36.11 54.89 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.409 -0.807 . . . . 0.0 110.475 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.402 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -78.92 -26.01 43.68 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.343 -0.848 . . . . 0.0 110.323 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -93.25 19.22 8.38 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.203 -0.936 . . . . 0.0 110.735 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 52.98 53.0 35.95 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.86 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -122.06 61.4 0.96 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.405 -1.056 . . . . 0.0 109.93 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.991 HG22 HG23 ' A' ' 59' ' ' VAL . 37.5 t -50.22 -46.31 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.475 -0.766 . . . . 0.0 110.672 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -59.1 -36.43 75.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.316 -0.865 . . . . 0.0 110.349 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -73.73 -31.43 63.36 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.234 -0.916 . . . . 0.0 109.616 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.86 HG23 ' O ' ' A' ' 24' ' ' ARG . 3.4 t -76.48 -50.19 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.554 -0.716 . . . . 0.0 109.57 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.936 ' HA ' HD22 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -49.09 -45.26 43.02 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.481 -0.762 . . . . 0.0 110.132 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -77.36 -41.83 38.86 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.454 -0.779 . . . . 0.0 109.877 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.459 HD11 ' CD1' ' A' ' 15' ' ' TRP . 12.6 mt -57.14 -67.8 0.29 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.361 -0.837 . . . . 0.0 110.439 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.905 ' HB3' HD11 ' A' ' 62' ' ' LEU . 0.3 OUTLIER -48.54 -46.0 38.18 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.585 -0.697 . . . . 0.0 111.016 -179.382 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.13 -14.08 61.31 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.26 -0.9 . . . . 0.0 110.324 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 30' ' ' ALA . . . -92.07 -8.52 45.64 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.223 -0.923 . . . . 0.0 111.024 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 146.72 -28.98 1.59 Allowed Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.741 -1.219 . . . . 0.0 110.265 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.745 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -53.76 106.33 0.18 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.107 -1.231 . . . . 0.0 110.579 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.69 ' HG ' ' HB2' ' A' ' 40' ' ' ALA . 0.6 OUTLIER -66.96 152.22 96.17 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.361 -0.837 . . . . 0.0 109.734 179.701 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -74.57 -28.49 9.94 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.715 1.376 . . . . 0.0 111.083 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -90.26 32.62 0.92 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.209 -0.932 . . . . 0.0 110.246 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.693 ' HB3' HD23 ' A' ' 16' ' ' LEU . . . -84.73 112.65 44.17 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.385 -0.822 . . . . 0.0 110.097 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.45 123.11 8.86 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.652 1.343 . . . . 0.0 110.148 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.546 HD22 HG11 ' A' ' 51' ' ' VAL . 48.4 p-10 -80.6 5.93 14.06 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.381 -0.824 . . . . 0.0 110.702 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 58.54 17.53 5.02 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.092 -1.005 . . . . 0.0 110.024 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -107.3 15.19 25.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.422 -0.799 . . . . 0.0 109.412 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.0 24.64 43.47 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.5 ' O ' ' CB ' ' A' ' 50' ' ' GLN . 35.3 mtt180 -135.79 32.0 3.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.308 -1.113 . . . . 0.0 111.1 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.583 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 0.6 OUTLIER 42.56 -166.72 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.119 0 O-C-N 121.501 -0.749 . . . . 0.0 110.937 178.589 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.649 ' HA ' ' HB2' ' A' ' 17' ' ' ALA . 48.9 Cg_endo -85.6 -24.57 1.85 Allowed 'Trans proline' 0 C--N 1.318 -1.036 0 O-C-N 122.998 0.999 . . . . 0.0 110.81 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.65 HG12 HD22 ' A' ' 63' ' ' LEU . 5.8 mt -107.04 -40.16 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.129 -0.982 . . . . 0.0 110.047 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.5 ' CB ' ' O ' ' A' ' 46' ' ' ARG . 0.9 OUTLIER -47.1 -27.11 1.27 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.488 -0.757 . . . . 0.0 110.555 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.546 HG11 HD22 ' A' ' 42' ' ' ASN . 9.0 p -97.06 -2.47 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.218 -0.926 . . . . 0.0 110.19 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.466 ' CE ' ' CE ' ' A' ' 54' ' ' MET . 56.8 ttp -52.15 154.33 2.36 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.515 -0.741 . . . . 0.0 109.789 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 1.4 tmm? -69.77 -2.91 13.31 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.377 -0.827 . . . . 0.0 111.07 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.468 ' SD ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 52.62 22.77 2.33 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.989 -1.07 . . . . 0.0 110.115 -179.687 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.416 ' C ' ' CZ ' ' A' ' 90' ' ' PHE . . . -123.95 9.25 8.53 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 178.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.522 ' HB3' HG23 ' A' ' 59' ' ' VAL . 0.6 OUTLIER -144.82 80.73 1.63 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.436 -1.038 . . . . 0.0 109.931 179.887 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -52.23 -25.08 8.39 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.215 -0.928 . . . . 0.0 109.757 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.6 mtt180 -61.21 -36.73 80.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.472 -0.768 . . . . 0.0 109.503 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.991 HG23 HG22 ' A' ' 25' ' ' VAL . 37.3 t -55.4 -69.95 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.263 -0.898 . . . . 0.0 109.256 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -47.44 -34.42 7.22 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.296 -0.878 . . . . 0.0 109.498 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.436 ' O ' ' CB ' ' A' ' 65' ' ' LEU . 11.1 tt0 -54.27 -32.17 55.53 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.269 -0.894 . . . . 0.0 109.845 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.936 HD22 ' HA ' ' A' ' 29' ' ' ARG . 1.0 OUTLIER -87.06 -45.66 10.52 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.607 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.699 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 4.5 mp -62.65 -53.46 54.15 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.718 -0.614 . . . . 0.0 109.98 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.602 ' CD2' ' HB3' ' A' ' 100' ' ' ALA . 0.2 OUTLIER -63.42 -42.9 98.75 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.226 -0.921 . . . . 0.0 109.565 179.553 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.436 ' CB ' ' O ' ' A' ' 61' ' ' GLU . 10.0 tp -54.06 -37.49 64.23 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.363 -0.836 . . . . 0.0 108.804 178.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.737 ' CG ' HD22 ' A' ' 32' ' ' LEU . 7.8 m80 -85.76 -21.54 28.17 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.357 0.598 . . . . 0.0 109.69 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.24 56.83 0.73 Allowed Glycine 0 N--CA 1.479 1.533 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 179.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.699 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -64.82 -148.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.033 -1.275 . . . . 0.0 109.089 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.576 ' HB2' ' HB3' ' A' ' 47' ' ' ARG . 53.9 mt-10 -117.27 55.98 1.76 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.189 -0.944 . . . . 0.0 110.079 179.252 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.566 ' HB2' ' HB2' ' A' ' 102' ' ' ALA . 44.3 Cg_endo -69.4 -11.19 30.74 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 O-C-N 123.631 1.332 . . . . 0.0 110.392 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.433 ' HA ' ' CZ ' ' A' ' 80' ' ' ARG . 2.8 m120 -95.91 -56.48 2.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.257 -0.902 . . . . 0.0 110.415 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -50.12 148.62 3.29 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.315 -0.865 . . . . 0.0 110.919 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.69 -158.2 0.84 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.478 -0.764 . . . . 0.0 109.721 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.496 ' O ' ' N ' ' A' ' 78' ' ' LEU . 19.1 m-20 -106.43 126.21 30.99 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.321 -0.862 . . . . 0.0 109.53 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.12 -20.58 28.4 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.389 1.205 . . . . 0.0 110.434 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.79 -42.05 88.14 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.236 -0.915 . . . . 0.0 110.141 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.26 21.83 1.07 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.478 -0.764 . . . . 0.0 109.842 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 74' ' ' ASP . 1.4 mt 50.72 41.39 26.08 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.561 -0.712 . . . . 0.0 111.164 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 18.4 m -73.95 100.62 3.59 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.105 -0.997 . . . . 0.0 109.618 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.9 ' HG3' HG11 ' A' ' 106' ' ' VAL . 0.3 OUTLIER -76.84 164.02 61.93 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.381 -0.825 . . . . 0.0 109.98 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.55 -14.17 27.55 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.68 1.358 . . . . 0.0 110.649 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 42.0 t -63.63 -28.2 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.233 -0.917 . . . . 0.0 109.927 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.431 ' O ' ' CB ' ' A' ' 87' ' ' ARG . 29.1 m80 -65.52 -44.39 87.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.441 -0.787 . . . . 0.0 109.351 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.497 ' OD2' ' HG2' ' A' ' 50' ' ' GLN . 67.8 m-20 -49.95 -55.86 12.86 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.664 -0.647 . . . . 0.0 111.244 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.599 ' CB ' HD13 ' A' ' 94' ' ' LEU . . . -54.22 -68.0 0.22 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.173 -0.954 . . . . 0.0 109.971 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.846 ' HB1' ' HB2' ' A' ' 118' ' ' ALA . . . -54.92 -40.86 70.32 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.318 -0.864 . . . . 0.0 111.098 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 83' ' ' HIS . 6.2 tmm_? -51.47 -31.67 24.25 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.91 -1.119 . . . . 0.0 110.228 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -107.87 16.62 23.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.519 -0.738 . . . . 0.0 110.308 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.502 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 55.43 48.52 69.42 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.417 ' CE2' ' N ' ' A' ' 56' ' ' SER . 0.1 OUTLIER -116.57 91.31 3.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.455 -1.026 . . . . 0.0 110.694 -179.1 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.563 HD23 ' HB3' ' A' ' 94' ' ' LEU . 0.4 OUTLIER -75.58 -39.01 58.71 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.313 -0.867 . . . . 0.0 110.679 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.598 ' O ' HG23 ' A' ' 96' ' ' VAL . 27.3 m-20 -47.32 -44.95 24.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.429 -0.795 . . . . 0.0 109.902 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.455 HG21 ' HE3' ' A' ' 54' ' ' MET . 23.1 m -68.86 -40.0 79.54 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.615 HD21 HD21 ' A' ' 130' ' ' LEU . 5.0 tp -59.36 -47.49 85.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.638 -0.664 . . . . 0.0 109.924 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 53.2 t -53.84 -45.92 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.411 -0.806 . . . . 0.0 109.496 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 92' ' ' ASP . 24.8 t -62.47 -43.15 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.555 -0.715 . . . . 0.0 109.545 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.739 HD23 ' CB ' ' A' ' 102' ' ' ALA . 0.2 OUTLIER -53.59 -46.14 70.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.629 -0.669 . . . . 0.0 110.443 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -83.86 -28.28 28.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.354 -0.841 . . . . 0.0 110.426 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.7 mtp85 -66.25 -11.72 51.94 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.378 -0.826 . . . . 0.0 111.044 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.602 ' HB3' ' CD2' ' A' ' 64' ' ' LEU . . . -124.42 -79.48 0.61 Allowed 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.157 -0.964 . . . . 0.0 110.891 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -159.26 88.07 0.11 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.016 -1.233 . . . . 0.0 110.016 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.739 ' CB ' HD23 ' A' ' 97' ' ' LEU . . . -160.78 110.73 1.73 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.286 -1.126 . . . . 0.0 110.314 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 8.1 ttt180 -50.58 167.16 0.07 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.373 -0.83 . . . . 0.0 110.662 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.568 ' CD2' HD23 ' A' ' 130' ' ' LEU . 0.1 OUTLIER -149.14 43.47 0.96 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.417 -0.802 . . . . 0.0 110.067 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -161.01 48.47 0.22 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.195 -0.941 . . . . 0.0 110.778 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.9 HG11 ' HG3' ' A' ' 80' ' ' ARG . 4.2 p -109.21 -174.47 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.188 -0.945 . . . . 0.0 109.563 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.67 ' H ' HG22 ' A' ' 106' ' ' VAL . 7.7 ptt180 -141.67 147.85 38.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.428 -0.795 . . . . 0.0 109.521 178.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.4 t0 . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.336 -0.852 . . . . 0.0 110.058 -179.771 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.494 ' HG ' ' HD2' ' A' ' 114' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 120.563 0.221 . . . . 0.0 110.669 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.494 ' HD2' ' HG ' ' A' ' 113' ' ' LEU . 44.7 Cg_endo -72.35 -35.96 5.93 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 O-C-N 123.868 1.457 . . . . 0.0 110.053 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.494 HG12 ' HB3' ' A' ' 113' ' ' LEU . 12.0 p -67.75 -26.79 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.273 -0.892 . . . . 0.0 109.831 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -65.28 -42.45 93.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.472 -0.767 . . . . 0.0 109.775 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.564 ' O ' HD12 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -63.47 -49.64 72.82 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.529 -0.732 . . . . 0.0 110.267 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.846 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -48.68 -64.8 0.7 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.346 -0.846 . . . . 0.0 110.804 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -55.1 -23.7 22.0 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.278 -0.889 . . . . 0.0 110.151 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.82 -33.8 72.82 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.412 -0.805 . . . . 0.0 110.027 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.564 HD12 ' O ' ' A' ' 117' ' ' LEU . 0.7 OUTLIER -96.25 -8.56 32.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.326 -0.858 . . . . 0.0 110.384 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.33 32.71 6.24 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.497 ' ND1' ' O ' ' A' ' 86' ' ' ALA . 36.0 m170 -95.11 55.33 1.78 Allowed 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.072 -1.252 . . . . 0.0 109.478 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.407 ' O ' ' CB ' ' A' ' 128' ' ' ARG . 12.2 ttm180 -45.9 -30.13 1.63 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.594 -0.691 . . . . 0.0 110.286 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.434 ' HB3' HD12 ' A' ' 91' ' ' LEU . 0.6 OUTLIER -69.96 -41.1 74.94 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.571 -0.706 . . . . 0.0 109.488 179.32 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.783 HG11 ' HA ' ' A' ' 86' ' ' ALA . 2.1 t -89.5 -39.64 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.427 -0.795 . . . . 0.0 110.343 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.59 -34.29 77.92 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.296 -0.877 . . . . 0.0 109.957 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.407 ' CB ' ' O ' ' A' ' 124' ' ' ARG . 34.5 ttt85 -74.01 -56.83 4.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.354 -0.841 . . . . 0.0 109.742 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -56.02 -26.36 48.49 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.302 -0.874 . . . . 0.0 109.605 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.777 HD11 ' HB2' ' A' ' 86' ' ' ALA . 14.2 mt -78.5 -50.76 11.04 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.454 -0.779 . . . . 0.0 109.994 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.6 tpt85 -52.56 -25.97 11.96 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.436 -0.79 . . . . 0.0 110.597 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -79.46 -53.12 7.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.204 -0.935 . . . . 0.0 109.957 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -81.35 -7.15 59.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.435 -0.791 . . . . 0.0 110.511 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.674 0 O-C-N 121.18 -0.95 . . . . 0.0 110.279 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.408 ' O ' ' OG1' ' A' ' 18' ' ' THR . 11.4 p30 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 120.83 0.348 . . . . 0.0 110.946 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.452 ' CD1' ' OE1' ' A' ' 27' ' ' GLU . 0.3 OUTLIER -60.15 -11.56 6.43 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.343 -0.848 . . . . 0.0 111.299 -179.644 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.525 HD21 ' HB1' ' A' ' 36' ' ' ALA . 23.8 mt -78.36 -57.05 3.98 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.936 -1.102 . . . . 0.0 109.534 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.496 ' HB3' ' OD1' ' A' ' 42' ' ' ASN . . . -58.47 -48.38 80.95 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.508 -0.745 . . . . 0.0 109.471 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.424 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.2 OUTLIER -54.52 -59.95 4.0 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.39 -0.819 . . . . 0.0 110.128 179.341 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.522 ' HB1' ' HB3' ' A' ' 27' ' ' GLU . . . -54.3 -56.78 15.08 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.49 -0.757 . . . . 0.0 110.181 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.628 ' CB ' HG11 ' A' ' 59' ' ' VAL . . . -52.87 -47.87 67.53 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.45 -0.781 . . . . 0.0 109.847 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.555 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -61.07 -19.2 61.14 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.468 -0.77 . . . . 0.0 109.863 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.71 18.03 15.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.501 -0.749 . . . . 0.0 110.703 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 54.17 47.85 65.89 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.65 98.84 4.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.304 -1.115 . . . . 0.0 109.716 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.661 HG12 ' CG ' ' A' ' 29' ' ' ARG . 3.1 t -74.31 -43.73 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.463 -0.773 . . . . 0.0 109.821 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -45.4 -54.26 7.55 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.455 -0.778 . . . . 0.0 110.781 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.522 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -48.91 -49.46 39.88 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.371 -0.831 . . . . 0.0 110.041 179.801 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 1.01 HG12 HD12 ' A' ' 32' ' ' LEU . 6.2 t -74.13 -45.63 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.587 -0.696 . . . . 0.0 110.307 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.936 ' HA ' HD11 ' A' ' 62' ' ' LEU . 9.3 mmm180 -45.34 -41.65 9.13 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.501 -0.749 . . . . 0.0 109.93 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.46 -39.59 31.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.544 -0.723 . . . . 0.0 109.646 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.48 ' HB2' ' HA ' ' A' ' 28' ' ' VAL . 32.8 mt -61.06 -67.12 0.43 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.419 -0.8 . . . . 0.0 110.137 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.01 HD12 HG12 ' A' ' 28' ' ' VAL . 13.7 mt -51.85 -36.88 49.88 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.476 -0.765 . . . . 0.0 110.461 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.422 ' HB2' ' O ' ' A' ' 29' ' ' ARG . 46.9 mt-10 -72.37 -18.08 61.77 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.308 -0.87 . . . . 0.0 110.022 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.97 -7.5 48.81 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.359 -0.838 . . . . 0.0 110.435 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.61 23.73 6.14 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.525 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -61.22 164.45 5.31 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.296 -1.12 . . . . 0.0 110.073 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.457 ' O ' HD12 ' A' ' 16' ' ' LEU . 40.8 tp -97.18 99.15 5.62 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.536 -0.727 . . . . 0.0 109.927 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.54 ' HB3' HD21 ' A' ' 32' ' ' LEU . 44.1 Cg_endo -68.56 -23.11 37.37 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 O-C-N 123.656 1.345 . . . . 0.0 110.437 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.41 34.25 1.06 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.252 -0.905 . . . . 0.0 110.018 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.82 122.52 71.42 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.333 -0.855 . . . . 0.0 110.274 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -73.42 111.81 3.38 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.609 1.321 . . . . 0.0 110.38 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.496 ' OD1' ' HB3' ' A' ' 17' ' ' ALA . 2.2 m-80 -90.13 166.65 13.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.404 -0.81 . . . . 0.0 109.916 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.457 ' C ' ' CG ' ' A' ' 44' ' ' TYR . 70.8 m -62.58 -157.04 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.433 -0.792 . . . . 0.0 109.732 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.573 ' CD1' ' N ' ' A' ' 44' ' ' TYR . 0.1 OUTLIER 58.86 13.72 2.9 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.166 -0.959 . . . . 0.0 109.791 -179.607 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.2 24.24 20.91 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.87 171.95 7.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.44 -1.036 . . . . 0.0 110.956 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.571 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -113.92 -165.21 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.688 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.562 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.571 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 49.1 Cg_endo -76.19 166.48 27.67 Favored 'Trans proline' 0 C--N 1.315 -1.228 0 O-C-N 122.85 0.921 . . . . 0.0 109.787 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.541 ' O ' ' HG2' ' A' ' 52' ' ' MET . 4.7 mt 63.96 -59.6 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 121.668 -0.645 . . . . 0.0 110.224 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.513 ' N ' ' O ' ' A' ' 48' ' ' PRO . 7.3 mt-30 -43.7 -27.19 0.29 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.811 -1.181 . . . . 0.0 110.54 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.708 HG22 ' O ' ' A' ' 51' ' ' VAL . 6.8 p -118.8 26.06 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.426 -0.796 . . . . 0.0 110.53 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.727 ' HE1' ' HB2' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -83.73 41.04 0.77 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.77 -1.206 . . . . 0.0 109.421 178.872 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.434 ' HB3' ' HE2' ' A' ' 53' ' ' MET . 2.9 tmm? 64.97 -6.82 0.31 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.285 -0.884 . . . . 0.0 110.552 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.451 ' H ' ' C ' ' A' ' 52' ' ' MET . 0.0 OUTLIER 43.12 29.89 0.23 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.307 -0.871 . . . . 0.0 110.516 -179.781 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.451 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -134.54 12.64 4.58 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -146.1 71.5 1.26 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.425 -1.044 . . . . 0.0 109.544 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.562 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . . . -47.97 -27.75 2.37 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.649 -0.657 . . . . 0.0 109.89 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.508 ' HG2' HG11 ' A' ' 25' ' ' VAL . 3.1 tpt180 -52.07 -38.23 56.49 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.654 -0.654 . . . . 0.0 109.359 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.628 HG11 ' CB ' ' A' ' 20' ' ' ALA . 67.0 t -69.48 -49.05 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.359 -0.838 . . . . 0.0 109.028 178.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.727 ' HB2' ' HE1' ' A' ' 52' ' ' MET . . . -46.44 -45.82 18.36 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.52 -0.738 . . . . 0.0 109.664 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.485 ' O ' HD23 ' A' ' 65' ' ' LEU . 0.7 OUTLIER -58.05 -48.39 80.24 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.545 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.936 HD11 ' HA ' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -49.92 -66.73 0.34 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.586 -0.696 . . . . 0.0 109.688 178.348 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.967 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 85.1 mt -58.44 -54.68 44.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.57 -0.706 . . . . 0.0 110.178 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.826 HD13 HG12 ' A' ' 96' ' ' VAL . 1.9 tt -43.67 -68.3 0.21 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.501 -0.749 . . . . 0.0 111.212 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.485 HD23 ' O ' ' A' ' 61' ' ' GLU . 1.1 pp -56.31 -23.2 35.41 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.104 -0.997 . . . . 0.0 110.159 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.76 ' CG ' HD22 ' A' ' 32' ' ' LEU . 2.2 m80 -82.86 -48.79 10.36 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 121.293 -0.88 . . . . 0.0 110.153 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 149.34 43.41 0.03 OUTLIER Glycine 0 N--CA 1.483 1.79 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.967 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -72.25 -157.32 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.849 -1.383 . . . . 0.0 109.92 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.449 ' CG ' ' HD2' ' A' ' 48' ' ' PRO . 4.6 mm-40 -121.21 62.73 11.81 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.43 ' HG2' ' ND2' ' A' ' 71' ' ' ASN . 40.4 Cg_endo -69.05 -5.5 15.93 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.875 1.461 . . . . 0.0 111.083 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.43 ' ND2' ' HG2' ' A' ' 70' ' ' PRO . 12.2 m-80 -113.88 -67.12 1.02 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.022 -1.048 . . . . 0.0 110.065 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.8 t -44.88 163.28 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.465 -0.772 . . . . 0.0 110.83 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.885 ' HB2' ' HG2' ' A' ' 80' ' ' ARG . . . -138.59 -155.44 0.6 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.186 -0.946 . . . . 0.0 110.925 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' A' ' 78' ' ' LEU . 50.8 m-20 -107.77 126.23 30.35 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.533 -0.729 . . . . 0.0 109.766 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -74.96 -2.06 12.03 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 123.332 1.175 . . . . 0.0 110.668 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -93.32 -36.3 12.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 0.0 109.84 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.76 6.99 4.04 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.376 -0.827 . . . . 0.0 110.142 179.374 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.688 HD13 ' O ' ' A' ' 107' ' ' ARG . 1.0 OUTLIER 48.48 23.22 0.57 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.381 -0.824 . . . . 0.0 111.477 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 35.8 m -78.83 102.74 8.34 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.956 -1.09 . . . . 0.0 109.517 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.885 ' HG2' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -71.11 171.97 7.51 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.361 -0.837 . . . . 0.0 110.285 -179.676 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.66 -14.5 36.51 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.816 1.429 . . . . 0.0 109.375 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.599 HG12 ' CB ' ' A' ' 114' ' ' PRO . 48.7 t -72.08 -30.26 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.778 -0.576 . . . . 0.0 109.896 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.562 ' HB3' HD13 ' A' ' 117' ' ' LEU . 5.3 m80 -77.8 -34.68 52.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.391 -0.818 . . . . 0.0 109.25 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.02 -41.99 84.31 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 120.322 -0.551 . . . . 0.0 109.884 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.549 ' HB3' ' CD1' ' A' ' 94' ' ' LEU . . . -66.64 -61.51 1.94 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.232 -0.918 . . . . 0.0 109.653 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 1.033 ' HB1' ' HB2' ' A' ' 118' ' ' ALA . . . -56.88 -44.84 82.69 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.262 -0.899 . . . . 0.0 110.929 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.617 ' O ' HD22 ' A' ' 121' ' ' LEU . 2.9 ttp180 -48.64 -43.44 36.47 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.329 -0.857 . . . . 0.0 110.291 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.439 ' HG3' ' HB3' ' A' ' 54' ' ' MET . 0.0 OUTLIER -93.82 4.68 53.57 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.454 -0.779 . . . . 0.0 110.655 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.604 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 60.72 51.79 56.45 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.562 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.8 OUTLIER -120.45 74.87 1.08 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.385 -1.068 . . . . 0.0 110.187 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.415 HD11 ' O ' ' A' ' 125' ' ' ASP . 0.3 OUTLIER -52.17 -37.89 56.02 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.428 -0.795 . . . . 0.0 110.663 -179.844 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.782 ' O ' HG23 ' A' ' 96' ' ' VAL . 48.1 t0 -47.9 -39.24 18.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.3 -0.875 . . . . 0.0 109.559 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 87.6 m -69.8 -45.06 68.79 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.761 HD21 ' CD2' ' A' ' 130' ' ' LEU . 1.6 tp -55.37 -43.24 74.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.563 -0.711 . . . . 0.0 109.809 179.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 69.2 t -59.91 -47.85 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.222 -0.923 . . . . 0.0 109.429 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.826 HG12 HD13 ' A' ' 64' ' ' LEU . 6.5 t -58.88 -50.52 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.304 -0.872 . . . . 0.0 109.004 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.76 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 0.0 OUTLIER -44.56 -55.4 5.17 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.77 -0.582 . . . . 0.0 109.93 179.267 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -65.73 -30.92 71.65 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.512 -0.743 . . . . 0.0 109.89 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -14.81 36.43 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.399 -0.813 . . . . 0.0 110.665 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.562 ' CB ' HD21 ' A' ' 64' ' ' LEU . . . -151.31 70.13 0.96 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.98 -1.075 . . . . 0.0 111.075 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 58.22 105.82 0.01 OUTLIER Glycine 0 N--CA 1.488 2.1 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.76 ' HB2' ' O ' ' A' ' 97' ' ' LEU . . . -147.51 103.86 3.58 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.589 -0.948 . . . . 0.0 109.702 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.415 ' O ' HG21 ' A' ' 82' ' ' VAL . 2.8 tpp180 -65.31 101.59 0.58 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.353 -0.842 . . . . 0.0 110.377 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 134' ' ' ALA . 1.7 mt -102.37 59.86 0.82 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.427 -0.796 . . . . 0.0 110.226 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -170.92 44.72 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.988 -1.07 . . . . 0.0 110.907 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.668 HG22 ' H ' ' A' ' 107' ' ' ARG . 3.1 p -105.88 -171.24 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.243 -0.911 . . . . 0.0 109.539 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.688 ' O ' HD13 ' A' ' 78' ' ' LEU . 0.5 OUTLIER -131.26 115.1 15.87 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.178 -0.951 . . . . 0.0 110.064 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.704 0 O-C-N 121.475 -0.765 . . . . 0.0 109.558 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.486 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.599 ' CB ' HG12 ' A' ' 82' ' ' VAL . 45.4 Cg_endo -74.65 -48.54 0.19 Allowed 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.661 1.348 . . . . 0.0 110.025 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 127' ' ' ALA . 7.2 p -55.56 -32.68 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.353 -0.842 . . . . 0.0 109.729 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.01 -38.54 79.31 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.481 -0.762 . . . . 0.0 109.688 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.631 ' O ' HD12 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -57.11 -69.36 0.16 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.508 -0.745 . . . . 0.0 110.143 179.674 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 1.033 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -44.46 -52.86 7.48 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.461 -0.774 . . . . 0.0 110.998 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -53.97 -45.04 71.27 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.347 -0.845 . . . . 0.0 110.156 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -64.89 -32.02 73.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.391 -0.818 . . . . 0.0 110.06 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.631 HD12 ' O ' ' A' ' 117' ' ' LEU . 1.0 OUTLIER -90.07 2.05 55.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.375 -0.828 . . . . 0.0 110.767 -179.668 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 89.96 11.42 63.39 Favored Glycine 0 N--CA 1.489 2.209 0 C-N-CA 119.931 -1.128 . . . . 0.0 111.075 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.698 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . 47.9 m-70 -93.07 50.31 1.52 Allowed 'General case' 0 N--CA 1.484 1.232 0 O-C-N 120.841 -1.387 . . . . 0.0 109.085 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.0 mtt-85 -47.75 -31.47 4.85 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.626 -0.671 . . . . 0.0 109.407 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 125' ' ' ASP . 8.5 m-20 -62.3 -47.85 82.46 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.82 HG11 ' HA ' ' A' ' 86' ' ' ALA . 6.0 t -75.3 -40.52 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.426 -0.796 . . . . 0.0 109.758 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.698 ' O ' HG23 ' A' ' 115' ' ' VAL . . . -57.21 -36.37 70.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.303 -0.873 . . . . 0.0 109.607 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.13 -61.19 2.73 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.418 -0.801 . . . . 0.0 110.1 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.417 ' HD2' HD23 ' A' ' 94' ' ' LEU . 19.2 t80 -53.26 -40.42 64.64 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.293 -0.879 . . . . 0.0 109.824 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.93 HD11 ' HB2' ' A' ' 86' ' ' ALA . 78.3 mt -67.59 -39.43 84.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.424 -0.797 . . . . 0.0 109.463 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.486 ' HG3' HG21 ' A' ' 115' ' ' VAL . 3.2 ttt180 -59.34 -19.43 46.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.19 -0.943 . . . . 0.0 110.201 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.1 -57.63 3.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.352 -0.843 . . . . 0.0 110.432 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -81.72 -15.49 54.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.346 -0.846 . . . . 0.0 110.959 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.717 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.199 -0.938 . . . . 0.0 110.103 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 120.7 0.285 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.411 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 40.2 m0 -46.44 -34.73 4.94 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.334 -0.854 . . . . 0.0 109.976 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.858 ' HB2' HD21 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -63.1 -37.84 88.8 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.6 -0.687 . . . . 0.0 109.997 178.62 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.66 -53.86 6.43 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.27 -0.893 . . . . 0.0 110.309 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.411 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.0 OUTLIER -44.96 -54.09 6.93 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.565 -0.709 . . . . 0.0 110.836 -179.591 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.777 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -61.3 -52.8 63.2 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.356 -0.84 . . . . 0.0 110.447 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.801 ' HB1' HG11 ' A' ' 59' ' ' VAL . . . -46.78 -46.9 20.88 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.502 -0.749 . . . . 0.0 110.355 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.442 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -54.44 -40.01 67.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.55 -0.719 . . . . 0.0 110.425 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.409 ' HB3' ' HD2' ' A' ' 24' ' ' ARG . 5.6 mpt_? -86.53 26.58 1.06 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.484 -0.76 . . . . 0.0 110.414 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 49.05 24.22 4.39 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.727 ' O ' HG23 ' A' ' 28' ' ' VAL . 10.2 mtt180 -93.65 65.39 3.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.365 -1.079 . . . . 0.0 109.738 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 1.059 HG22 HG22 ' A' ' 59' ' ' VAL . 60.2 t -55.67 -42.66 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.657 -0.652 . . . . 0.0 110.881 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -43.36 -56.03 3.77 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.471 -0.768 . . . . 0.0 110.604 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.432 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 1.8 tp10 -63.99 -34.89 79.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.481 -0.762 . . . . 0.0 110.141 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.826 HG12 HD13 ' A' ' 62' ' ' LEU . 4.7 t -70.29 -44.97 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.231 -0.918 . . . . 0.0 109.871 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.822 ' CA ' HD11 ' A' ' 62' ' ' LEU . 1.8 mmm180 -53.37 -45.87 69.38 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.201 -0.937 . . . . 0.0 109.254 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -70.59 -42.38 71.11 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 120.078 -0.649 . . . . 0.0 109.739 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 27' ' ' GLU . 44.6 mt -59.18 -63.05 1.44 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.289 -0.882 . . . . 0.0 110.969 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.889 HD12 ' CD2' ' A' ' 66' ' ' HIS . 0.0 OUTLIER -44.44 -44.52 8.52 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.424 -0.798 . . . . 0.0 110.594 -179.484 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -81.25 -18.5 45.75 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.74 -0.6 . . . . 0.0 110.443 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.465 ' HB2' ' O ' ' A' ' 30' ' ' ALA . . . -84.42 -5.63 59.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.111 -0.993 . . . . 0.0 110.748 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.09 22.61 2.35 Favored Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.802 -1.189 . . . . 0.0 110.99 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.882 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -66.6 162.24 21.43 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.916 -1.343 . . . . 0.0 109.892 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.734 HD13 ' HD2' ' A' ' 38' ' ' PRO . 1.8 mm? -87.19 133.49 38.68 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.365 -0.835 . . . . 0.0 110.124 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.734 ' HD2' HD13 ' A' ' 37' ' ' LEU . 44.3 Cg_endo -70.68 -47.07 0.7 Allowed 'Trans proline' 0 C--N 1.315 -1.229 0 O-C-N 123.547 1.288 . . . . 0.0 109.906 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -102.83 51.56 0.8 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.585 -0.697 . . . . 0.0 109.59 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.627 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -85.35 112.34 43.25 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.524 -0.735 . . . . 0.0 110.228 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.17 140.78 34.78 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 O-C-N 123.679 1.357 . . . . 0.0 110.607 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.508 ' ND2' HG21 ' A' ' 51' ' ' VAL . 14.9 t30 -85.92 -164.74 1.08 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.302 -0.874 . . . . 0.0 109.956 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.3 -8.0 14.77 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.199 -0.938 . . . . 0.0 110.564 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -96.62 24.29 6.12 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.179 -0.951 . . . . 0.0 109.917 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.41 23.05 66.25 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.92 -152.44 0.47 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.205 -1.174 . . . . 0.0 110.159 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.525 ' CB ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -130.22 -176.8 0.58 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.32 -0.862 . . . . 0.0 109.989 -179.466 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.645 ' HB2' HD22 ' A' ' 63' ' ' LEU . 43.2 Cg_endo -68.69 -25.84 33.65 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 O-C-N 123.36 1.19 . . . . 0.0 110.456 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.503 ' O ' ' HG2' ' A' ' 52' ' ' MET . 4.8 mt -108.93 -33.1 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.236 -0.915 . . . . 0.0 109.919 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.497 ' HG3' ' HB3' ' A' ' 81' ' ' PRO . 13.0 mt-30 -56.89 -17.62 10.18 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.31 -0.869 . . . . 0.0 110.188 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.508 HG21 ' ND2' ' A' ' 42' ' ' ASN . 8.5 p -113.52 35.09 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.329 -0.857 . . . . 0.0 110.922 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.675 ' HE1' ' HB2' ' A' ' 60' ' ' ALA . 0.1 OUTLIER -100.33 37.57 1.65 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.017 -1.052 . . . . 0.0 110.567 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.413 ' CB ' ' O ' ' A' ' 52' ' ' MET . 20.4 ttp 65.3 -4.27 0.55 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.421 -0.799 . . . . 0.0 110.66 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.565 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 41.41 30.82 0.14 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.384 -0.823 . . . . 0.0 110.555 -179.681 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.438 ' C ' ' CE2' ' A' ' 90' ' ' PHE . . . -133.17 11.01 5.07 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.571 ' HB3' HG23 ' A' ' 59' ' ' VAL . 0.5 OUTLIER -147.81 87.86 1.65 Allowed 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.443 -1.034 . . . . 0.0 109.687 179.801 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.54 -20.14 7.25 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.52 -0.737 . . . . 0.0 109.733 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -58.09 -29.71 65.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.464 -0.773 . . . . 0.0 109.671 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 1.059 HG22 HG22 ' A' ' 25' ' ' VAL . 2.8 t -76.64 -50.42 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.445 -0.785 . . . . 0.0 109.426 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.675 ' HB2' ' HE1' ' A' ' 52' ' ' MET . . . -49.1 -59.82 3.32 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.206 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.593 ' O ' HD23 ' A' ' 65' ' ' LEU . 3.4 tt0 -46.7 -52.19 14.42 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.488 -0.758 . . . . 0.0 109.544 178.411 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.826 HD13 HG12 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -45.74 -71.79 0.07 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.735 -0.603 . . . . 0.0 110.416 178.745 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.858 HD21 ' HB2' ' A' ' 16' ' ' LEU . 1.9 mt -65.31 -45.84 82.73 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.499 -0.751 . . . . 0.0 111.069 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.88 HD22 ' CG1' ' A' ' 96' ' ' VAL . 0.5 OUTLIER -52.26 -70.24 0.09 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.184 -0.948 . . . . 0.0 110.641 -179.501 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.593 HD23 ' O ' ' A' ' 61' ' ' GLU . 2.1 pp -50.69 -25.81 4.75 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.402 -0.812 . . . . 0.0 109.88 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.889 ' CD2' HD12 ' A' ' 32' ' ' LEU . 1.4 m80 -80.74 -48.8 12.0 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.604 -0.685 . . . . 0.0 109.929 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 159.46 32.34 0.02 OUTLIER Glycine 0 CA--C 1.54 1.604 0 C-N-CA 120.05 -1.072 . . . . 0.0 111.305 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.586 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -70.37 178.4 2.91 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.436 -1.626 . . . . 0.0 109.602 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.445 ' HB2' ' HG2' ' A' ' 47' ' ' ARG . 0.6 OUTLIER -107.78 78.9 0.78 Allowed Pre-proline 0 C--N 1.302 -1.459 0 O-C-N 121.32 -0.863 . . . . 0.0 110.23 179.516 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 68' ' ' ALA . 50.3 Cg_endo -74.71 -0.85 10.35 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 O-C-N 123.682 1.359 . . . . 0.0 110.171 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.548 ' O ' ' NE ' ' A' ' 80' ' ' ARG . 1.7 m-20 -113.71 -70.58 0.8 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.194 -0.941 . . . . 0.0 110.014 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.422 ' C ' ' O ' ' A' ' 71' ' ' ASN . 49.3 t -40.04 147.85 0.09 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.375 -0.828 . . . . 0.0 110.893 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.572 ' HB2' ' HG2' ' A' ' 80' ' ' ARG . . . -133.25 -150.33 0.4 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.525 -0.735 . . . . 0.0 109.875 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 78' ' ' LEU . 1.0 OUTLIER -114.98 130.33 24.3 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.887 . . . . 0.0 109.893 -179.904 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.74 -13.08 38.49 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.344 1.181 . . . . 0.0 110.254 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.71 -55.81 30.07 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.322 -0.861 . . . . 0.0 109.171 178.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 43.7 p -141.71 25.36 1.99 Allowed 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.567 0.699 . . . . 0.0 109.374 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.501 ' HA ' HD23 ' A' ' 78' ' ' LEU . 2.9 mt 52.86 30.06 8.59 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.53 -0.731 . . . . 0.0 111.107 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.84 97.57 0.23 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.989 -1.069 . . . . 0.0 109.883 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.888 ' CG ' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -72.23 168.52 22.54 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.211 -0.931 . . . . 0.0 109.382 179.701 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.497 ' HB3' ' HG3' ' A' ' 50' ' ' GLN . 50.8 Cg_endo -73.7 -21.77 18.67 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.74 1.39 . . . . 0.0 109.867 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.431 ' CG1' ' HG ' ' A' ' 104' ' ' LEU . 56.3 t -59.57 -35.0 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.523 -0.736 . . . . 0.0 110.37 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.467 ' O ' ' CB ' ' A' ' 87' ' ' ARG . 42.3 m80 -64.99 -31.59 72.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.441 -0.787 . . . . 0.0 110.009 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.565 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 0.7 OUTLIER -61.24 -52.08 66.27 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.528 -0.732 . . . . 0.0 110.652 -179.732 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.548 ' HB3' ' CD1' ' A' ' 94' ' ' LEU . . . -57.8 -61.3 2.62 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.807 -1.183 . . . . 0.0 109.745 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.88 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -57.14 -55.93 28.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.525 -0.734 . . . . 0.0 111.594 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.467 ' CB ' ' O ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -44.67 -28.72 0.64 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.216 -0.927 . . . . 0.0 111.529 -178.863 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.37 -8.13 23.65 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.019 -1.051 . . . . 0.0 110.807 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.558 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 77.08 36.01 36.81 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.548 ' HD1' ' HG1' ' A' ' 93' ' ' THR . 0.9 OUTLIER -108.2 90.86 3.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.389 -1.066 . . . . 0.0 110.525 179.903 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.515 ' CD2' ' HA ' ' A' ' 126' ' ' VAL . 0.1 OUTLIER -64.69 -36.6 84.79 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.446 -0.784 . . . . 0.0 110.384 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.502 ' O ' HG23 ' A' ' 96' ' ' VAL . 40.0 t0 -53.6 -26.31 21.31 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.165 -0.959 . . . . 0.0 109.371 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.548 ' HG1' ' HD1' ' A' ' 90' ' ' PHE . 26.6 m -78.25 -46.72 19.59 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.623 -0.673 . . . . 0.0 109.873 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.829 HD21 ' HG ' ' A' ' 130' ' ' LEU . 1.1 tp -54.36 -36.98 64.42 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.216 -0.928 . . . . 0.0 109.695 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 91' ' ' LEU . 27.0 t -65.54 -47.55 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.474 -0.766 . . . . 0.0 109.425 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.88 ' CG1' HD22 ' A' ' 64' ' ' LEU . 84.3 t -56.12 -53.17 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.217 -0.927 . . . . 0.0 110.094 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.0 mp -52.8 -51.83 59.23 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.182 -0.949 . . . . 0.0 109.719 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -54.6 -38.22 66.51 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.618 -0.676 . . . . 0.0 109.421 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 96' ' ' VAL . 66.9 mtp180 -66.78 -13.65 61.71 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.707 -0.621 . . . . 0.0 110.141 179.131 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.742 ' HB3' HD11 ' A' ' 64' ' ' LEU . . . -117.32 38.72 3.48 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.387 -0.82 . . . . 0.0 110.534 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 45.8 47.33 13.76 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.455 ' O ' HD12 ' A' ' 104' ' ' LEU . . . -89.13 110.68 21.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.346 -1.091 . . . . 0.0 110.197 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.518 ' N ' ' OD1' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -49.68 138.73 13.82 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.586 -0.697 . . . . 0.0 110.491 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.854 HD23 HD23 ' A' ' 130' ' ' LEU . 0.2 OUTLIER -128.3 22.87 6.03 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.427 -0.796 . . . . 0.0 110.055 179.623 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -125.52 47.3 2.22 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.021 -1.049 . . . . 0.0 110.911 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.888 HG11 ' CG ' ' A' ' 80' ' ' ARG . 3.4 p -108.7 -172.4 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.318 -0.864 . . . . 0.0 110.347 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.725 ' H ' HG22 ' A' ' 106' ' ' VAL . 2.6 mtm180 -132.42 158.92 40.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.454 -0.779 . . . . 0.0 109.941 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 52.1 p30 . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.382 -0.824 . . . . 0.0 110.242 -179.872 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.598 HD21 ' HG3' ' A' ' 107' ' ' ARG . 56.7 mt . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.538 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 40.9 Cg_endo -66.84 -21.01 51.29 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.707 1.372 . . . . 0.0 109.896 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.564 ' HA ' HD13 ' A' ' 130' ' ' LEU . 4.8 p -85.35 -40.7 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.287 -0.883 . . . . 0.0 110.421 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.442 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 1.0 OUTLIER -59.98 -32.28 70.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.044 -1.035 . . . . 0.0 109.871 179.94 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.4 mt -70.54 -45.4 65.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.498 -0.751 . . . . 0.0 110.049 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.533 ' CB ' ' HB2' ' A' ' 127' ' ' ALA . . . -55.33 -51.28 67.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.367 -0.833 . . . . 0.0 110.066 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.564 ' N ' ' HB2' ' A' ' 127' ' ' ALA . 10.7 pt-20 -68.71 -25.0 64.55 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.614 -0.678 . . . . 0.0 110.484 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.45 -62.9 1.47 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.439 -0.788 . . . . 0.0 110.643 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.12 -87.34 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.028 -1.045 . . . . 0.0 110.703 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -169.52 35.86 0.19 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.511 ' HB2' ' HA ' ' A' ' 118' ' ' ALA . 7.5 m-70 -113.65 43.56 1.77 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.561 -0.964 . . . . 0.0 109.272 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -43.52 -55.99 3.91 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.782 -0.574 . . . . 0.0 110.073 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 125' ' ' ASP . 13.4 p-10 -49.25 -34.33 14.9 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.436 0.636 . . . . 0.0 109.636 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.88 HG11 ' HA ' ' A' ' 86' ' ' ALA . 1.3 t -84.43 -31.08 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.564 ' HB2' ' N ' ' A' ' 119' ' ' GLU . . . -68.28 -35.74 78.33 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.436 -0.79 . . . . 0.0 109.364 179.14 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 26.7 ttt180 -72.42 -63.55 1.13 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.275 -0.891 . . . . 0.0 109.556 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.692 ' HD2' HD23 ' A' ' 94' ' ' LEU . 66.6 t80 -50.71 -28.86 9.9 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.372 -0.83 . . . . 0.0 109.812 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.854 HD23 HD23 ' A' ' 104' ' ' LEU . 6.7 mt -65.36 -62.08 1.74 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.406 -0.809 . . . . 0.0 109.465 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -51.96 -16.84 0.81 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.54 -0.725 . . . . 0.0 111.002 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -78.94 -53.2 7.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.969 -1.082 . . . . 0.0 109.693 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -87.33 -20.29 26.99 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.413 -0.804 . . . . 0.0 109.631 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.413 ' CB ' ' O ' ' A' ' 104' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.31 -0.869 . . . . 0.0 110.653 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.3 t0 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 120.969 0.414 . . . . 0.0 110.544 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.551 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 42.0 m0 -67.54 -5.19 14.13 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.398 -0.814 . . . . 0.0 110.972 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.732 HD11 HD21 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -77.99 -55.55 5.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.922 -1.111 . . . . 0.0 109.867 179.901 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.5 ' O ' ' HB3' ' A' ' 20' ' ' ALA . . . -70.55 -43.3 69.8 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.274 -0.891 . . . . 0.0 110.31 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.551 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.8 OUTLIER -52.25 -55.53 20.68 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.422 -0.799 . . . . 0.0 110.709 -179.888 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.808 ' HB1' ' HB3' ' A' ' 24' ' ' ARG . . . -55.02 -41.0 70.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.323 -0.861 . . . . 0.0 109.895 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.572 ' HA ' HG11 ' A' ' 59' ' ' VAL . . . -52.63 -49.68 64.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.482 -0.761 . . . . 0.0 109.793 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.593 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -69.24 -34.1 74.29 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.429 -0.794 . . . . 0.0 110.198 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.38 27.67 1.89 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.393 -0.817 . . . . 0.0 110.927 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 44.71 57.06 5.43 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.808 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -115.56 56.05 0.77 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.345 -1.091 . . . . 0.0 109.894 179.891 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.669 HG22 HG23 ' A' ' 59' ' ' VAL . 25.5 t -45.37 -55.01 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.583 -0.698 . . . . 0.0 110.844 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -54.23 -40.62 67.85 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.401 -0.812 . . . . 0.0 110.315 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.747 ' O ' HD12 ' A' ' 31' ' ' LEU . 0.5 OUTLIER -63.95 -35.43 80.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.431 -0.793 . . . . 0.0 109.753 179.851 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.877 HG12 HD12 ' A' ' 32' ' ' LEU . 11.7 t -77.27 -47.69 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.345 -0.847 . . . . 0.0 111.077 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.979 ' CA ' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -49.27 -45.26 44.68 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.124 -0.985 . . . . 0.0 110.255 -179.493 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.05 -42.29 48.11 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.431 -0.793 . . . . 0.0 109.542 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.747 HD12 ' O ' ' A' ' 27' ' ' GLU . 6.4 mt -60.55 -58.67 7.5 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.475 -0.766 . . . . 0.0 110.178 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.932 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 7.6 mt -51.15 -42.53 60.85 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.363 -0.835 . . . . 0.0 109.561 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -76.14 -9.43 58.62 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.625 -0.672 . . . . 0.0 110.571 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -93.9 -13.58 26.99 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.144 -0.972 . . . . 0.0 111.081 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 137.74 -0.79 2.79 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.581 -1.295 . . . . 0.0 110.909 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.932 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -46.41 151.31 0.55 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.017 -1.284 . . . . 0.0 110.174 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.77 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 12.6 tp -90.48 139.25 26.62 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.163 -0.961 . . . . 0.0 110.302 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.445 ' HB2' ' O ' ' A' ' 67' ' ' GLY . 43.6 Cg_endo -72.61 -39.14 2.79 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 O-C-N 123.647 1.341 . . . . 0.0 110.753 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -115.62 60.4 0.71 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.039 -1.038 . . . . 0.0 110.167 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.77 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -93.11 105.5 15.55 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.454 -0.779 . . . . 0.0 109.722 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.64 102.65 0.75 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.565 1.297 . . . . 0.0 110.188 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -89.4 172.71 8.81 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.499 -0.75 . . . . 0.0 109.973 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.441 ' O ' ' HB2' ' A' ' 44' ' ' TYR . 0.1 OUTLIER -63.2 -157.78 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.32 -0.863 . . . . 0.0 110.407 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.441 ' HB2' ' O ' ' A' ' 43' ' ' SER . 14.0 m-85 64.71 11.01 6.46 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.589 -0.694 . . . . 0.0 111.037 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 59.54 47.02 92.95 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -160.72 -171.3 3.06 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.482 -1.011 . . . . 0.0 110.743 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.638 ' CB ' ' HD2' ' A' ' 48' ' ' PRO . 2.1 mmt180 -124.4 -155.04 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.647 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.638 ' HD2' ' CB ' ' A' ' 47' ' ' ARG . 47.9 Cg_endo -75.72 166.64 27.93 Favored 'Trans proline' 0 N--CA 1.484 0.965 0 O-C-N 122.501 0.738 . . . . 0.0 110.727 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.502 ' HA ' ' HB2' ' A' ' 52' ' ' MET . 5.0 mt 65.97 -53.83 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.756 -0.59 . . . . 0.0 110.862 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.52 ' CG ' ' HB3' ' A' ' 81' ' ' PRO . 73.9 mt-30 -50.38 -29.17 9.45 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.772 -1.205 . . . . 0.0 110.187 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.593 HG22 ' HB2' ' A' ' 21' ' ' ALA . 10.6 p -99.09 7.31 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.537 -0.727 . . . . 0.0 109.71 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.522 ' CE ' ' HE3' ' A' ' 54' ' ' MET . 44.4 ttp -66.56 161.62 22.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.557 -0.714 . . . . 0.0 110.127 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 48.7 ttp -70.28 -4.34 21.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.259 -0.9 . . . . 0.0 110.213 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.522 ' HE3' ' CE ' ' A' ' 52' ' ' MET . 0.0 OUTLIER 53.96 23.79 4.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.003 -1.061 . . . . 0.0 110.069 -179.797 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.539 ' HA2' ' CE1' ' A' ' 90' ' ' PHE . . . -123.95 -5.63 7.41 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.48 90.4 2.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.334 -1.098 . . . . 0.0 110.129 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.659 ' HB2' ' HE2' ' A' ' 90' ' ' PHE . . . -53.48 -24.83 14.09 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.087 -1.008 . . . . 0.0 109.872 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.9 -48.37 64.17 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.549 -0.72 . . . . 0.0 110.442 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.669 HG23 HG22 ' A' ' 25' ' ' VAL . 32.1 t -59.36 -57.74 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.189 -0.944 . . . . 0.0 109.694 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -46.46 -59.71 2.8 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.429 -0.794 . . . . 0.0 110.091 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.553 ' HA ' HG11 ' A' ' 96' ' ' VAL . 17.1 tt0 -46.68 -43.47 17.8 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.382 -0.824 . . . . 0.0 109.208 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.979 HD11 ' CA ' ' A' ' 29' ' ' ARG . 0.3 OUTLIER -57.65 -64.74 0.79 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.284 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.841 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 2.6 mt -56.46 -48.94 76.01 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.637 HD13 HG12 ' A' ' 96' ' ' VAL . 0.3 OUTLIER -56.39 -56.67 18.2 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.469 -0.77 . . . . 0.0 109.659 179.323 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.469 ' HB3' ' O ' ' A' ' 61' ' ' GLU . 9.5 tp -53.06 -30.35 35.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.311 -0.868 . . . . 0.0 109.185 179.068 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.824 ' CG ' HD22 ' A' ' 32' ' ' LEU . 1.5 m-70 -86.2 -21.3 27.54 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.716 -0.615 . . . . 0.0 109.652 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.445 ' O ' ' HB2' ' A' ' 38' ' ' PRO . . . 110.49 48.81 0.73 Allowed Glycine 0 N--CA 1.482 1.72 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 178.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.841 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -64.5 -150.85 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.885 -1.362 . . . . 0.0 109.402 179.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.49 ' HG3' ' HD2' ' A' ' 48' ' ' PRO . 1.7 mm-40 -119.61 53.37 2.41 Favored Pre-proline 0 C--N 1.301 -1.508 0 O-C-N 121.357 -0.84 . . . . 0.0 109.58 178.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.456 ' HG3' ' HG ' ' A' ' 64' ' ' LEU . 47.3 Cg_endo -70.4 -16.33 34.85 Favored 'Trans proline' 0 C--N 1.317 -1.082 0 O-C-N 123.755 1.397 . . . . 0.0 109.99 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -95.41 -57.27 2.45 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.516 -0.74 . . . . 0.0 110.002 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.51 178.15 0.16 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.442 -0.786 . . . . 0.0 110.215 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -150.7 -152.61 0.44 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.512 -0.742 . . . . 0.0 109.914 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.439 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 39.1 m-20 -116.78 130.44 24.56 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.341 -0.849 . . . . 0.0 109.263 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.674 ' O ' ' HB3' ' A' ' 76' ' ' ALA . 42.0 Cg_endo -69.74 -177.2 1.76 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.426 1.224 . . . . 0.0 110.322 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.674 ' HB3' ' O ' ' A' ' 75' ' ' PRO . . . 71.42 -58.59 0.57 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.475 -0.766 . . . . 0.0 109.802 -178.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.57 0.45 13.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.16 -0.962 . . . . 0.0 110.621 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.508 ' HB3' ' O ' ' A' ' 107' ' ' ARG . 1.2 mt 48.62 53.37 12.31 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.222 -0.924 . . . . 0.0 111.41 179.429 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 60.2 m -88.42 98.51 11.66 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.086 -1.009 . . . . 0.0 110.474 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.693 ' CD ' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -74.18 165.77 50.53 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.326 -0.859 . . . . 0.0 109.392 179.368 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.581 ' HD2' ' CG ' ' A' ' 80' ' ' ARG . 45.4 Cg_endo -79.14 -0.71 10.98 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 O-C-N 123.308 1.162 . . . . 0.0 110.339 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.699 HG21 ' O ' ' A' ' 103' ' ' ARG . 22.1 t -76.93 -31.55 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.558 -0.714 . . . . 0.0 109.391 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.476 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 5.7 m80 -70.65 -36.69 73.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.519 -0.738 . . . . 0.0 109.44 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.519 ' O ' ' HB3' ' A' ' 87' ' ' ARG . 67.8 m-20 -54.0 -50.24 67.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.68 -0.637 . . . . 0.0 109.688 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.755 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -55.81 -67.91 0.25 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.142 -0.974 . . . . 0.0 109.356 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.763 ' HB2' HD11 ' A' ' 130' ' ' LEU . . . -52.92 -38.64 62.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.287 -0.883 . . . . 0.0 110.892 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.519 ' HB3' ' O ' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -44.9 -47.16 11.2 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.51 -0.744 . . . . 0.0 110.894 -179.307 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -97.12 8.38 44.63 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.209 -0.932 . . . . 0.0 110.156 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.446 ' HA3' ' ND1' ' A' ' 123' ' ' HIS . . . 70.87 40.85 63.44 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.154 -1.579 . . . . 0.0 109.154 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.659 ' HE2' ' HB2' ' A' ' 57' ' ' ALA . 1.9 t80 -106.88 116.41 31.88 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.315 -1.109 . . . . 0.0 110.673 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.457 HD21 ' CG ' ' A' ' 129' ' ' TYR . 0.4 OUTLIER -94.77 -42.67 8.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.633 -0.667 . . . . 0.0 110.844 -179.487 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.604 ' O ' HG23 ' A' ' 96' ' ' VAL . 92.1 m-20 -43.64 -44.46 6.36 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.383 -0.823 . . . . 0.0 109.734 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.4 m -66.41 -49.06 68.07 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.798 HD22 HG13 ' A' ' 126' ' ' VAL . 4.2 tp -53.38 -39.93 64.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.583 -0.698 . . . . 0.0 109.529 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.418 ' O ' ' N ' ' A' ' 99' ' ' ARG . 84.4 t -62.59 -53.16 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.375 -0.828 . . . . 0.0 108.964 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.637 HG12 HD13 ' A' ' 64' ' ' LEU . 63.7 t -50.23 -47.97 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.512 -0.742 . . . . 0.0 109.653 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.53 ' HA ' HD11 ' A' ' 64' ' ' LEU . 1.2 mp -56.9 -45.27 82.73 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.619 -0.676 . . . . 0.0 109.679 179.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -75.79 -29.36 58.71 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.368 -0.833 . . . . 0.0 109.874 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 95' ' ' VAL . 0.4 OUTLIER -67.72 -13.14 61.86 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.374 -0.829 . . . . 0.0 110.735 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.586 ' HB3' HD21 ' A' ' 64' ' ' LEU . . . -118.98 -93.24 0.52 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.315 -0.866 . . . . 0.0 110.792 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -156.71 45.21 0.51 Allowed Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.512 -1.328 . . . . 0.0 110.298 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -78.03 -171.4 2.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.09 -1.241 . . . . 0.0 109.692 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.699 ' O ' HG21 ' A' ' 82' ' ' VAL . 15.8 tpt180 -123.44 137.98 54.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.181 -0.949 . . . . 0.0 109.947 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.521 ' O ' ' HA ' ' A' ' 134' ' ' ALA . 14.0 mt -135.63 64.91 1.56 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.283 -0.885 . . . . 0.0 110.204 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -174.68 38.77 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.874 -1.142 . . . . 0.0 110.159 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.693 HG11 ' CD ' ' A' ' 80' ' ' ARG . 12.6 p -110.19 173.92 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.348 -0.845 . . . . 0.0 110.433 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.584 ' N ' HG22 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -127.91 138.66 52.74 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.145 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 28.0 p-10 . . . . . 0 N--CA 1.497 1.912 0 O-C-N 121.353 -0.842 . . . . 0.0 111.121 -179.14 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.435 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.435 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 41.8 Cg_endo -69.02 -30.12 26.27 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.452 1.238 . . . . 0.0 109.982 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.447 ' HB ' ' HB3' ' A' ' 130' ' ' LEU . 10.9 p -82.63 -37.63 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.343 -0.848 . . . . 0.0 109.769 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.443 ' N ' HG13 ' A' ' 115' ' ' VAL . 24.5 t0 -54.19 -38.44 65.61 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.431 -0.793 . . . . 0.0 109.985 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.22 -54.07 16.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.505 -0.747 . . . . 0.0 110.038 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.537 ' CB ' ' HB2' ' A' ' 127' ' ' ALA . . . -46.02 -56.03 6.08 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.454 -0.779 . . . . 0.0 110.785 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -58.88 -28.46 66.17 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.296 -0.878 . . . . 0.0 109.927 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -75.32 -49.73 18.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.432 -0.792 . . . . 0.0 109.84 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.7 mt -73.77 -91.36 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.329 -0.857 . . . . 0.0 109.95 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -173.91 31.02 0.1 OUTLIER Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.684 -1.246 . . . . 0.0 110.106 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.564 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 50.4 m-70 -102.59 44.2 1.03 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.267 -1.137 . . . . 0.0 109.349 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.577 ' HA ' ' HB3' ' A' ' 127' ' ' ALA . 1.7 mtm180 -46.07 -40.26 10.53 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.737 -0.602 . . . . 0.0 109.967 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -55.82 -45.65 78.27 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.798 HG13 HD22 ' A' ' 94' ' ' LEU . 16.8 t -78.05 -40.45 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 119.666 -0.814 . . . . 0.0 109.087 178.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.577 ' HB3' ' HA ' ' A' ' 124' ' ' ARG . . . -57.57 -58.31 8.86 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.593 -0.692 . . . . 0.0 109.677 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.409 ' NH1' ' HG3' ' A' ' 128' ' ' ARG . 38.1 ttm-85 -45.2 -59.79 2.45 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.69 -0.631 . . . . 0.0 109.92 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.457 ' CG ' HD21 ' A' ' 91' ' ' LEU . 5.7 t80 -57.53 -45.76 84.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.582 -0.699 . . . . 0.0 109.214 178.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.763 HD11 ' HB2' ' A' ' 86' ' ' ALA . 7.2 mt -54.86 -41.47 70.83 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.561 -0.712 . . . . 0.0 110.952 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 39.7 ttp85 -62.52 -40.2 96.0 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.253 -0.905 . . . . 0.0 110.202 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -81.04 -30.12 34.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.264 -0.898 . . . . 0.0 110.304 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -89.58 -18.02 27.39 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.214 -0.929 . . . . 0.0 110.164 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.582 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.18 -0.95 . . . . 0.0 110.586 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.9 t70 . . . . . 0 N--CA 1.498 1.933 0 CA-C-O 120.69 0.281 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.524 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 49.1 m0 -68.19 -12.66 61.33 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.176 -0.952 . . . . 0.0 110.68 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.041 ' HB3' HD21 ' A' ' 63' ' ' LEU . 35.6 mt -76.13 -60.78 2.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.166 -0.959 . . . . 0.0 109.477 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.571 ' HB2' ' HA ' ' A' ' 48' ' ' PRO . . . -57.55 -48.2 79.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.519 -0.738 . . . . 0.0 109.861 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.524 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.6 OUTLIER -44.44 -55.27 5.17 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.444 -0.785 . . . . 0.0 110.536 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.808 ' HB1' ' HB3' ' A' ' 24' ' ' ARG . . . -71.8 -32.4 67.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.145 -0.972 . . . . 0.0 109.942 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.455 ' HB1' HG11 ' A' ' 59' ' ' VAL . . . -67.73 -45.88 73.76 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.208 -0.933 . . . . 0.0 109.962 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.14 -25.67 68.46 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.48 -0.762 . . . . 0.0 109.616 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -104.83 25.93 9.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.453 -0.78 . . . . 0.0 110.306 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.571 ' HA3' ' HE2' ' A' ' 53' ' ' MET . . . 48.4 66.79 1.9 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.808 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -133.3 54.61 1.94 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.44 -1.035 . . . . 0.0 109.409 -179.898 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 1.03 HG22 HG23 ' A' ' 59' ' ' VAL . 45.1 t -46.1 -56.93 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.535 -0.728 . . . . 0.0 110.869 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -40.78 -50.91 3.15 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.724 -0.61 . . . . 0.0 110.954 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.709 ' O ' HD12 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -58.77 -41.28 86.24 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.194 -0.942 . . . . 0.0 109.622 179.592 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.749 HG12 HD13 ' A' ' 62' ' ' LEU . 13.6 t -69.81 -49.78 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.503 -0.748 . . . . 0.0 110.289 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.786 ' HA ' HD11 ' A' ' 62' ' ' LEU . 4.4 mmt180 -41.65 -52.3 3.85 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.514 -0.741 . . . . 0.0 110.122 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.41 -53.35 9.75 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.809 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.709 HD12 ' O ' ' A' ' 27' ' ' GLU . 4.7 mt -47.73 -62.74 1.31 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.431 -0.793 . . . . 0.0 110.998 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.779 ' HG ' HD22 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -44.1 -57.5 3.36 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.571 -0.706 . . . . 0.0 110.379 179.89 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -66.27 -10.88 46.65 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.667 -0.646 . . . . 0.0 110.526 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.51 ' HB3' ' O ' ' A' ' 31' ' ' LEU . . . -86.8 -11.86 49.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.067 -1.02 . . . . 0.0 110.239 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 130.19 -6.45 6.02 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.907 -1.139 . . . . 0.0 110.999 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.898 ' CB ' HD21 ' A' ' 16' ' ' LEU . . . -42.78 155.9 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.19 -1.183 . . . . 0.0 110.636 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.985 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 3.2 tp -80.91 131.03 61.21 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.228 -0.92 . . . . 0.0 110.858 -178.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.445 ' O ' ' HA ' ' A' ' 68' ' ' ALA . 49.0 Cg_endo -74.4 -15.64 22.24 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.841 1.443 . . . . 0.0 110.8 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -128.38 25.72 5.76 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.101 -0.999 . . . . 0.0 110.475 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.985 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -66.46 123.92 86.85 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.254 -0.904 . . . . 0.0 109.873 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -76.75 149.19 29.54 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.673 1.354 . . . . 0.0 110.319 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -81.16 -163.27 0.58 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.544 -0.723 . . . . 0.0 109.922 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.407 ' C ' ' CD1' ' A' ' 44' ' ' TYR . 0.1 OUTLIER -99.12 6.17 46.59 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.883 -1.136 . . . . 0.0 110.571 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.407 ' CD1' ' C ' ' A' ' 43' ' ' SER . 2.4 m-85 -119.01 36.37 4.48 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.28 -0.887 . . . . 0.0 109.434 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.41 28.33 35.66 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.74 -157.46 0.61 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.55 -0.97 . . . . 0.0 110.822 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.609 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 0.3 OUTLIER -121.2 -173.14 0.25 Allowed Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.33 -0.856 . . . . 0.0 110.638 -178.604 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.794 ' HB2' HD22 ' A' ' 63' ' ' LEU . 42.2 Cg_endo -77.99 -26.52 6.52 Favored 'Trans proline' 0 C--N 1.32 -0.958 0 O-C-N 123.467 1.246 . . . . 0.0 111.438 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.425 ' CD1' ' HA ' ' A' ' 60' ' ' ALA . 12.0 mt -109.71 -37.65 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 120.768 -1.207 . . . . 0.0 109.389 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.479 ' HB2' ' HB3' ' A' ' 81' ' ' PRO . 2.5 tt0 -53.8 -16.67 1.85 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.691 -0.63 . . . . 0.0 110.686 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 51' ' ' VAL . 7.4 p -114.35 6.78 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.023 -1.048 . . . . 0.0 111.225 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.475 ' CE ' ' HE1' ' A' ' 54' ' ' MET . 0.0 OUTLIER -67.92 168.54 11.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.774 -1.204 . . . . 0.0 109.495 179.825 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.571 ' HE2' ' HA3' ' A' ' 23' ' ' GLY . 3.1 tmm? -67.8 -1.92 6.28 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.21 -0.931 . . . . 0.0 111.301 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.475 ' HE1' ' CE ' ' A' ' 52' ' ' MET . 12.9 mmt 48.56 23.04 0.56 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.259 -0.901 . . . . 0.0 110.361 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.433 ' HA3' ' SD ' ' A' ' 53' ' ' MET . . . -120.46 3.19 12.39 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.279 -1.928 . . . . 0.0 108.279 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.41 74.07 1.45 Allowed 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.75 -0.853 . . . . 0.0 108.88 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.757 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . . . -43.71 -27.57 0.33 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.421 -0.8 . . . . 0.0 110.151 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.474 ' HB3' HG11 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -49.37 -49.33 44.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.541 -0.724 . . . . 0.0 109.639 178.744 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 1.03 HG23 HG22 ' A' ' 25' ' ' VAL . 63.5 t -48.72 -59.87 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.659 -0.65 . . . . 0.0 109.945 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.486 ' O ' ' HB3' ' A' ' 64' ' ' LEU . . . -45.45 -46.23 13.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.676 -0.64 . . . . 0.0 109.794 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.57 ' O ' ' HB3' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -51.19 -59.66 3.95 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.657 -0.652 . . . . 0.0 109.516 178.982 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.786 HD11 ' HA ' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -46.52 -72.27 0.06 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.609 -0.682 . . . . 0.0 110.373 179.114 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.041 HD21 ' HB3' ' A' ' 16' ' ' LEU . 4.0 mt -51.22 -50.08 59.83 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.393 -0.817 . . . . 0.0 110.616 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.945 HD13 HG12 ' A' ' 96' ' ' VAL . 0.9 OUTLIER -59.11 -59.14 5.94 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.489 -0.757 . . . . 0.0 110.744 -179.628 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.679 ' O ' HD12 ' A' ' 65' ' ' LEU . 0.8 OUTLIER -48.76 -34.58 12.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.318 -0.864 . . . . 0.0 108.736 179.755 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.444 ' ND1' ' CD1' ' A' ' 32' ' ' LEU . 0.3 OUTLIER -82.11 -30.59 31.12 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.282 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 63' ' ' LEU . . . 124.0 52.76 0.19 Allowed Glycine 0 N--CA 1.479 1.561 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.655 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -62.19 -154.24 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.08 -1.247 . . . . 0.0 109.529 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.504 ' HB2' ' HB3' ' A' ' 47' ' ' ARG . 4.8 mt-10 -121.31 55.9 5.49 Favored Pre-proline 0 C--N 1.302 -1.499 0 O-C-N 121.33 -0.857 . . . . 0.0 109.448 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 69' ' ' GLU . 40.6 Cg_endo -66.28 -10.46 27.55 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.847 1.446 . . . . 0.0 110.351 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.532 ' HA ' ' NH2' ' A' ' 80' ' ' ARG . 72.2 m-20 -99.06 -72.87 0.64 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.193 -0.942 . . . . 0.0 110.146 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -42.89 161.8 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.663 -0.648 . . . . 0.0 110.953 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.468 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -148.2 -149.27 0.29 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.383 -0.823 . . . . 0.0 110.184 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.522 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -105.06 135.21 19.33 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 120.956 -1.09 . . . . 0.0 110.269 -179.724 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.28 -22.04 22.5 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 N-CA-C 109.239 -1.1 . . . . 0.0 109.239 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.73 -67.77 0.26 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.588 -0.695 . . . . 0.0 109.677 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.44 ' OG1' ' OG1' ' A' ' 79' ' ' THR . 14.6 p -124.82 27.47 6.79 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.391 -0.818 . . . . 0.0 109.342 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.522 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 1.3 mt 43.94 38.21 2.08 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.464 -0.772 . . . . 0.0 110.659 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.463 ' HA ' ' OD2' ' A' ' 108' ' ' ASP . 22.2 m -73.04 100.87 3.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.443 -0.786 . . . . 0.0 109.637 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.888 ' HG3' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -71.12 162.47 72.29 Favored Pre-proline 0 C--N 1.302 -1.471 0 O-C-N 121.401 -0.812 . . . . 0.0 110.806 -179.48 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.505 ' HA ' ' OD2' ' A' ' 84' ' ' ASP . 42.3 Cg_endo -69.95 -14.93 36.11 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 O-C-N 124.444 1.76 . . . . 0.0 110.219 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.897 HG21 ' HA ' ' A' ' 104' ' ' LEU . 20.1 t -68.38 -29.44 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.522 -0.737 . . . . 0.0 110.102 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.475 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 6.2 m80 -70.77 -28.53 64.74 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.393 -0.817 . . . . 0.0 109.136 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.505 ' OD2' ' HA ' ' A' ' 81' ' ' PRO . 72.2 m-20 -62.23 -57.13 12.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.35 -0.844 . . . . 0.0 110.042 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.615 ' HB2' ' CG2' ' A' ' 93' ' ' THR . . . -49.46 -57.48 6.93 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.452 -0.78 . . . . 0.0 109.757 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.876 ' CB ' HG11 ' A' ' 126' ' ' VAL . . . -57.19 -50.17 73.67 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.282 -0.886 . . . . 0.0 109.936 179.028 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.427 ' HD3' ' CD1' ' A' ' 121' ' ' LEU . 1.7 mmt85 -47.52 -21.51 0.35 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.588 -0.695 . . . . 0.0 111.483 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.458 ' HG2' ' HB2' ' A' ' 54' ' ' MET . 3.8 mp0 -110.69 -7.65 14.64 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.201 -0.937 . . . . 0.0 110.479 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.464 ' HA2' ' HB3' ' A' ' 123' ' ' HIS . . . 78.15 22.53 68.06 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.757 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -95.22 111.79 23.59 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.533 -0.981 . . . . 0.0 110.427 -179.628 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.715 HD22 HG22 ' A' ' 126' ' ' VAL . 0.5 OUTLIER -82.43 -45.14 15.18 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.551 -0.718 . . . . 0.0 110.252 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.493 ' O ' HG23 ' A' ' 96' ' ' VAL . 20.9 m-20 -41.47 -43.56 2.66 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.548 0.69 . . . . 0.0 109.535 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.615 ' CG2' ' HB2' ' A' ' 85' ' ' ALA . 11.5 m -61.24 -59.58 5.09 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.753 -0.592 . . . . 0.0 109.596 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.743 HD12 ' O ' ' A' ' 90' ' ' PHE . 0.6 OUTLIER -46.75 -38.88 10.7 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.379 -0.826 . . . . 0.0 109.395 179.49 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.474 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 58.0 t -66.41 -43.88 90.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.945 HG12 HD13 ' A' ' 64' ' ' LEU . 45.8 t -58.58 -55.73 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.453 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 6.5 mp -47.21 -61.47 1.88 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.423 -0.798 . . . . 0.0 110.133 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -61.16 -36.01 78.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.162 -0.961 . . . . 0.0 109.838 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 1.1 mtp-105 -58.4 -13.18 4.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.394 -0.816 . . . . 0.0 110.536 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.802 ' HB3' HD11 ' A' ' 64' ' ' LEU . . . -146.58 61.8 1.21 Allowed 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.228 -0.92 . . . . 0.0 110.625 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 60.08 107.9 0.01 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.356 -1.097 . . . . 0.0 110.356 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.519 ' HA ' ' OD1' ' A' ' 71' ' ' ASN . . . -165.64 89.36 0.44 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.423 -1.045 . . . . 0.0 110.39 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.5 96.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.968 -1.082 . . . . 0.0 109.776 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.897 ' HA ' HG21 ' A' ' 82' ' ' VAL . 1.8 mp -87.45 41.87 1.01 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.214 -0.929 . . . . 0.0 110.457 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.63 ' HB2' ' HA ' ' A' ' 134' ' ' ALA . 30.9 t0 -146.9 41.78 1.11 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.905 -1.122 . . . . 0.0 110.829 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.888 HG11 ' HG3' ' A' ' 80' ' ' ARG . 7.1 p -99.01 177.13 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.378 -0.826 . . . . 0.0 109.754 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.557 ' H ' HG22 ' A' ' 106' ' ' VAL . 8.8 mtm180 -111.62 136.79 50.36 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.372 -0.83 . . . . 0.0 109.933 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.463 ' OD2' ' HA ' ' A' ' 79' ' ' THR . 5.5 t70 . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.409 -0.807 . . . . 0.0 109.447 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.618 ' O ' HD12 ' A' ' 117' ' ' LEU . 16.2 mt . . . . . 0 N--CA 1.494 1.774 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 38.2 Cg_endo -64.97 -36.24 39.4 Favored 'Trans proline' 0 N--CA 1.49 1.295 0 O-C-N 123.674 1.355 . . . . 0.0 110.155 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 127' ' ' ALA . 10.7 p -78.9 -33.23 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.439 -0.788 . . . . 0.0 109.264 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.512 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 3.1 t0 -60.85 -23.98 65.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.507 -0.745 . . . . 0.0 109.898 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.618 HD12 ' O ' ' A' ' 113' ' ' LEU . 0.3 OUTLIER -76.25 -65.12 0.96 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.427 -0.796 . . . . 0.0 110.102 179.848 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.537 ' HB1' ' HB2' ' A' ' 123' ' ' HIS . . . -44.48 -53.61 6.8 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.568 -0.707 . . . . 0.0 111.077 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.19 -45.61 75.82 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.291 -0.881 . . . . 0.0 110.444 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.512 ' HB2' ' O ' ' A' ' 116' ' ' ASP . 0.0 OUTLIER -71.51 -45.13 63.27 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.467 -0.77 . . . . 0.0 109.967 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.427 ' CD1' ' HD3' ' A' ' 87' ' ' ARG . 4.8 mt -69.15 -94.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.615 -0.678 . . . . 0.0 109.92 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -177.26 47.83 0.1 Allowed Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.537 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . 71.4 m-70 -124.91 52.55 1.56 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.463 -1.022 . . . . 0.0 109.528 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 124' ' ' ARG . 26.8 mtm105 -43.59 -49.17 7.64 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.811 -0.556 . . . . 0.0 110.633 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.4 ' C ' HD21 ' A' ' 91' ' ' LEU . 36.8 t0 -46.16 -46.88 17.57 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.876 HG11 ' CB ' ' A' ' 86' ' ' ALA . 22.4 t -76.08 -49.91 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.933 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.447 ' O ' HG23 ' A' ' 115' ' ' VAL . . . -43.6 -48.72 7.67 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.321 -0.862 . . . . 0.0 110.19 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 36.7 mtt-85 -64.28 -64.88 0.77 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.502 -0.749 . . . . 0.0 109.754 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -50.27 -41.7 51.0 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.371 -0.831 . . . . 0.0 110.818 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.71 ' O ' ' HB3' ' A' ' 134' ' ' ALA . 12.2 mt -58.15 -56.99 14.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.103 -0.998 . . . . 0.0 109.767 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -47.32 -23.44 0.57 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.366 -0.834 . . . . 0.0 110.858 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -83.95 -73.46 0.42 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.197 -0.94 . . . . 0.0 109.921 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.14 -11.72 22.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.167 -0.958 . . . . 0.0 110.377 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.71 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.353 -0.842 . . . . 0.0 109.661 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 121.076 0.465 . . . . 0.0 109.916 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.54 ' O ' HD13 ' A' ' 31' ' ' LEU . 31.1 m0 -85.93 -24.88 26.39 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.365 -0.835 . . . . 0.0 110.349 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.134 HD11 HD21 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -71.29 -37.24 71.86 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.268 -0.895 . . . . 0.0 109.379 179.511 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.677 ' HB2' ' ND2' ' A' ' 42' ' ' ASN . . . -81.21 -47.92 12.77 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.443 -0.786 . . . . 0.0 110.914 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.518 HG23 ' N ' ' A' ' 19' ' ' ALA . 14.6 t -48.78 -43.06 37.61 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.357 -0.84 . . . . 0.0 111.09 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.6 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -75.89 -36.52 59.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.192 -0.943 . . . . 0.0 109.999 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.4 ' CB ' HG11 ' A' ' 59' ' ' VAL . . . -69.1 -28.4 66.46 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.126 -0.984 . . . . 0.0 110.088 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.435 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -80.53 -36.02 33.72 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.369 -0.832 . . . . 0.0 110.64 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -84.42 21.95 1.36 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.226 -0.921 . . . . 0.0 110.861 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.53 ' HA3' ' HE1' ' A' ' 53' ' ' MET . . . 44.85 65.01 1.93 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.496 ' HB3' ' HB3' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -133.38 62.82 1.65 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.341 -1.094 . . . . 0.0 109.35 179.374 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 24' ' ' ARG . 77.3 t -34.78 -53.82 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.872 -0.518 . . . . 0.0 111.421 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -53.0 -45.06 67.71 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.355 -0.841 . . . . 0.0 110.683 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.496 ' HB3' ' HB3' ' A' ' 24' ' ' ARG . 2.1 tp10 -64.64 -28.42 69.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.235 -0.916 . . . . 0.0 110.149 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 1.069 HG12 HD23 ' A' ' 62' ' ' LEU . 47.5 t -85.3 -51.24 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.181 -0.949 . . . . 0.0 110.428 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 1.013 ' HA ' HD22 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -43.44 -48.62 7.2 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.516 -0.74 . . . . 0.0 111.014 -179.916 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.46 -50.02 15.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.48 -0.762 . . . . 0.0 110.391 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.54 HD13 ' O ' ' A' ' 15' ' ' TRP . 10.7 mt -44.48 -61.03 1.68 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.495 -0.753 . . . . 0.0 110.497 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.859 ' HB3' HD11 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -57.21 -44.56 83.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.537 -0.727 . . . . 0.0 109.704 179.429 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -68.43 -7.41 31.49 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.36 -0.838 . . . . 0.0 110.562 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -105.32 -18.07 14.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.165 -0.959 . . . . 0.0 111.014 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' A' ' 37' ' ' LEU . . . 161.09 -36.51 0.41 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.724 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -45.63 96.31 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.404 -1.057 . . . . 0.0 110.093 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.636 ' HG ' ' HB2' ' A' ' 40' ' ' ALA . 0.8 OUTLIER -66.33 152.03 95.02 Favored Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 121.299 -0.876 . . . . 0.0 110.099 -179.071 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.465 ' HB2' ' HA ' ' A' ' 68' ' ' ALA . 44.3 Cg_endo -70.65 -34.35 11.75 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 124.025 1.539 . . . . 0.0 111.922 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -88.3 42.73 1.08 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.924 -1.11 . . . . 0.0 110.355 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.636 ' HB2' ' HG ' ' A' ' 37' ' ' LEU . . . -97.7 107.13 37.98 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.289 -0.882 . . . . 0.0 110.097 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -69.94 133.47 25.32 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.644 1.339 . . . . 0.0 109.528 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.677 ' ND2' ' HB2' ' A' ' 17' ' ' ALA . 5.7 m120 -77.05 -176.98 4.23 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.431 -0.793 . . . . 0.0 110.059 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 69.2 m -102.39 23.86 11.18 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.31 -0.869 . . . . 0.0 109.44 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.46 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 7.4 m-85 -122.59 19.24 10.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.73 -0.606 . . . . 0.0 109.479 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.431 ' C ' ' HG2' ' A' ' 46' ' ' ARG . . . 60.94 26.9 66.12 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.46 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 0.0 OUTLIER -129.1 130.5 46.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.219 -1.165 . . . . 0.0 109.889 -179.772 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.581 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 3.4 mmp_? -48.02 168.95 0.14 Allowed Pre-proline 0 N--CA 1.499 2.016 0 O-C-N 121.574 -0.704 . . . . 0.0 110.475 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.581 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 39.2 Cg_endo -67.01 -17.91 51.53 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.562 1.296 . . . . 0.0 110.329 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.765 ' CG1' HD22 ' A' ' 63' ' ' LEU . 4.9 mt -107.38 -34.16 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 177.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.436 ' HG2' ' HB3' ' A' ' 46' ' ' ARG . 44.6 tt0 -50.45 -24.85 3.37 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.627 -0.671 . . . . 0.0 109.362 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.505 HG11 ' HB1' ' A' ' 17' ' ' ALA . 11.9 p -99.53 7.93 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.471 -0.768 . . . . 0.0 110.246 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.503 ' HB2' ' O ' ' A' ' 49' ' ' ILE . 2.2 tmm? -61.66 158.07 16.22 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.232 -0.917 . . . . 0.0 109.318 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.53 ' HE1' ' HA3' ' A' ' 23' ' ' GLY . 54.7 ttp -70.64 -5.29 28.36 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.223 -0.923 . . . . 0.0 110.135 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.566 ' HB3' ' CB ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER 53.53 22.37 2.93 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.053 -1.03 . . . . 0.0 109.519 -179.116 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.563 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -121.38 -7.41 8.31 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.731 -1.747 . . . . 0.0 108.731 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.1 m -134.73 87.13 2.32 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.426 -1.044 . . . . 0.0 109.638 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.556 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . . . -53.48 -25.7 17.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.325 -0.859 . . . . 0.0 109.643 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.408 ' O ' ' CB ' ' A' ' 61' ' ' GLU . 5.9 mtt85 -54.8 -38.24 67.06 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.595 -0.691 . . . . 0.0 110.093 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.4 HG11 ' CB ' ' A' ' 20' ' ' ALA . 59.6 t -55.86 -66.71 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.022 -1.048 . . . . 0.0 109.364 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -45.82 -27.78 0.93 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.406 -0.809 . . . . 0.0 109.838 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -59.56 -53.69 55.13 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.428 -0.795 . . . . 0.0 110.152 179.54 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 1.069 HD23 HG12 ' A' ' 28' ' ' VAL . 0.5 OUTLIER -65.46 -42.54 92.21 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.239 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.134 HD21 HD11 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -60.54 -53.54 56.3 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.148 179.729 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.847 HD13 HG12 ' A' ' 96' ' ' VAL . 0.3 OUTLIER -61.75 -29.81 70.37 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.302 -0.959 . . . . 0.0 108.996 178.648 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.507 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 0.4 OUTLIER -54.92 -49.97 69.97 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.963 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.676 ' CG ' HD22 ' A' ' 32' ' ' LEU 0.261 80.3 m80 -87.25 -9.19 55.7 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.794 179.639 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 38' ' ' PRO . . . 82.29 71.32 1.31 Allowed Glycine 0 N--CA 1.482 1.741 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.549 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -65.38 -143.9 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.367 -1.078 . . . . 0.0 109.489 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.505 ' HB3' ' HD3' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -116.36 50.51 0.82 Allowed Pre-proline 0 C--N 1.3 -1.584 0 O-C-N 121.174 -0.954 . . . . 0.0 110.236 179.195 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.602 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 50.1 Cg_endo -72.86 52.39 2.15 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 O-C-N 123.24 1.126 . . . . 0.0 110.266 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.481 ' N ' ' HG3' ' A' ' 81' ' ' PRO . 26.0 m-20 -162.19 -74.64 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.309 -0.87 . . . . 0.0 110.065 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.412 ' HB3' ' NH1' ' A' ' 47' ' ' ARG . 6.2 m -52.22 118.99 3.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.091 -1.005 . . . . 0.0 109.235 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.614 ' HB2' ' HA ' ' A' ' 80' ' ' ARG . . . -107.0 -145.5 0.39 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.433 -0.792 . . . . 0.0 110.477 -178.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER -114.29 134.89 22.18 Favored Pre-proline 0 N--CA 1.487 1.41 0 O-C-N 121.241 -0.912 . . . . 0.0 110.042 -179.879 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -71.58 -9.32 24.87 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.555 1.292 . . . . 0.0 109.96 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.04 -51.15 8.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.274 -0.891 . . . . 0.0 110.107 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 11.5 p -123.29 8.86 9.12 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.527 -0.733 . . . . 0.0 110.504 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.488 ' HA ' HD23 ' A' ' 78' ' ' LEU . 0.4 OUTLIER 43.65 37.65 1.64 Allowed 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.543 0.687 . . . . 0.0 110.061 -179.577 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.66 92.16 4.72 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.341 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.826 ' CG ' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -68.89 171.2 6.73 Favored Pre-proline 0 C--N 1.303 -1.446 0 C-N-CA 119.319 -0.952 . . . . 0.0 108.702 179.799 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.602 ' HG3' ' HA ' ' A' ' 70' ' ' PRO . 40.6 Cg_endo -73.34 1.51 6.67 Favored 'Trans proline' 0 C--N 1.299 -2.073 0 O-C-N 123.88 1.463 . . . . 0.0 110.662 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.589 HG11 ' HG ' ' A' ' 104' ' ' LEU . 4.3 t -90.18 -36.18 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.298 -0.876 . . . . 0.0 109.412 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.545 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 19.7 m80 -61.69 -28.68 69.58 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.431 0.634 . . . . 0.0 109.506 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.564 ' HB3' ' SD ' ' A' ' 54' ' ' MET . 43.4 m-20 -64.01 -58.78 5.67 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.38 -0.825 . . . . 0.0 110.162 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.45 ' CB ' ' CD1' ' A' ' 94' ' ' LEU . . . -49.86 -67.88 0.22 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.383 -0.823 . . . . 0.0 110.394 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.803 ' HB2' HD11 ' A' ' 130' ' ' LEU . . . -51.83 -51.4 56.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.351 -0.843 . . . . 0.0 110.94 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.545 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -43.75 -26.58 0.26 Allowed 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.012 -1.055 . . . . 0.0 111.062 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.566 ' CB ' ' HB3' ' A' ' 54' ' ' MET . 5.7 tm-20 -105.78 -15.58 14.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.159 -0.963 . . . . 0.0 110.12 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.561 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 91.52 29.19 12.52 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.126 -1.189 . . . . 0.0 110.126 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.563 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 0.3 OUTLIER -101.52 93.07 5.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.177 -1.19 . . . . 0.0 110.881 179.945 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.586 HD11 ' O ' ' A' ' 125' ' ' ASP . 0.3 OUTLIER -66.76 -42.56 85.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.454 -0.778 . . . . 0.0 110.276 179.652 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.692 ' O ' HG23 ' A' ' 96' ' ' VAL . 67.4 t0 -45.52 -51.47 11.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.345 -0.847 . . . . 0.0 110.239 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 98.1 m -47.41 -52.42 16.93 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.533 -0.729 . . . . 0.0 109.626 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.678 ' HA ' HD12 ' A' ' 97' ' ' LEU . 3.7 mp -51.21 -58.57 5.8 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.422 -0.799 . . . . 0.0 109.785 178.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.479 ' O ' ' CB ' ' A' ' 99' ' ' ARG . 46.8 t -44.07 -51.92 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-O 121.139 0.495 . . . . 0.0 109.834 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.847 HG12 HD13 ' A' ' 64' ' ' LEU . 5.7 t -54.89 -50.78 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.37 -0.831 . . . . 0.0 110.08 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.678 ' HA ' HD21 ' A' ' 64' ' ' LEU . 56.5 mt -52.35 -60.84 2.75 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.453 -0.779 . . . . 0.0 110.378 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -68.76 -26.55 65.29 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.435 -0.791 . . . . 0.0 110.446 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.479 ' CB ' ' O ' ' A' ' 95' ' ' VAL . 45.8 ttt85 -70.03 -9.36 55.04 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.187 -0.945 . . . . 0.0 110.637 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.449 ' HB3' HD22 ' A' ' 64' ' ' LEU . . . -136.0 -53.4 0.75 Allowed 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.005 -1.059 . . . . 0.0 110.928 -179.241 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 102' ' ' ALA . . . 178.43 110.81 0.28 Allowed Glycine 0 N--CA 1.486 1.982 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.489 ' CB ' ' HB3' ' A' ' 97' ' ' LEU . . . -177.03 141.17 0.33 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.253 -1.145 . . . . 0.0 110.381 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.729 ' O ' HD12 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -86.63 156.39 20.04 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.621 -0.674 . . . . 0.0 109.549 179.306 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.729 HD12 ' O ' ' A' ' 103' ' ' ARG . 0.3 OUTLIER -144.22 46.11 1.42 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.247 -0.908 . . . . 0.0 110.433 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.418 ' OD2' ' O ' ' A' ' 134' ' ' ALA . 1.1 t70 -152.32 40.2 0.6 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.192 -0.942 . . . . 0.0 110.112 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.826 HG11 ' CG ' ' A' ' 80' ' ' ARG . 4.0 p -104.55 170.21 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.652 -0.655 . . . . 0.0 109.846 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.533 ' N ' HG22 ' A' ' 106' ' ' VAL . 11.3 mtp180 -97.84 176.89 5.64 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.541 -0.724 . . . . 0.0 109.812 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.908 . . . . 0.0 109.707 179.575 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.579 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.502 2.141 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.579 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 40.6 Cg_endo -69.3 -33.64 17.87 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 O-C-N 123.586 1.308 . . . . 0.0 109.347 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.472 HG12 ' HB3' ' A' ' 113' ' ' LEU . 12.8 p -78.4 -33.36 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-O 121.535 0.683 . . . . 0.0 109.437 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.89 -34.26 69.01 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.539 -0.725 . . . . 0.0 109.44 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.651 HD22 HD11 ' A' ' 121' ' ' LEU . 0.6 OUTLIER -61.19 -39.36 89.88 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.387 -0.821 . . . . 0.0 110.243 179.805 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.578 ' HB1' ' HB2' ' A' ' 123' ' ' HIS . . . -67.45 -51.96 45.27 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.208 -0.933 . . . . 0.0 110.736 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -46.89 -35.4 6.38 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.348 -0.845 . . . . 0.0 110.545 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.54 -58.83 2.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.35 -0.844 . . . . 0.0 109.575 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.651 HD11 HD22 ' A' ' 117' ' ' LEU . 50.2 mt -53.38 -93.29 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.465 -0.772 . . . . 0.0 110.463 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 178.31 36.9 0.06 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.578 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . 35.6 m-70 -108.51 41.33 1.6 Allowed 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.314 -1.109 . . . . 0.0 109.273 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -43.5 -33.57 1.14 Allowed 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.437 0.637 . . . . 0.0 110.16 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.586 ' O ' HD11 ' A' ' 91' ' ' LEU . 2.5 t0 -63.72 -41.3 98.1 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.367 -0.833 . . . . 0.0 108.863 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.707 HG11 ' HA ' ' A' ' 86' ' ' ALA . 3.2 t -80.81 -43.9 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.716 -0.615 . . . . 0.0 110.94 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.464 ' HB2' ' HB3' ' A' ' 118' ' ' ALA . . . -51.31 -35.89 39.98 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.279 -0.888 . . . . 0.0 110.034 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.91 -65.98 0.61 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.418 -0.801 . . . . 0.0 109.887 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.476 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 11.6 t80 -54.07 -42.72 69.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.472 -0.768 . . . . 0.0 109.225 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.803 HD11 ' HB2' ' A' ' 86' ' ' ALA . 14.0 mt -55.96 -58.12 9.24 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.823 -0.548 . . . . 0.0 110.281 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.409 ' HG3' HG21 ' A' ' 115' ' ' VAL . 9.4 ttm180 -56.14 -15.68 4.06 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.176 -0.952 . . . . 0.0 110.854 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 129' ' ' TYR . . . -82.66 -57.18 3.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.055 -1.028 . . . . 0.0 109.809 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -85.47 -12.32 52.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.562 -0.711 . . . . 0.0 110.501 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.613 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.494 1.74 0 O-C-N 121.219 -0.926 . . . . 0.0 110.768 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.6 p30 . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 121.004 0.43 . . . . 0.0 110.698 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.676 ' HB3' HD13 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -71.6 -5.21 31.77 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.151 -0.968 . . . . 0.0 110.4 179.773 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.851 HD21 ' CB ' ' A' ' 36' ' ' ALA . 22.7 mt -78.56 -61.48 1.99 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.096 -1.002 . . . . 0.0 109.629 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.521 ' HB1' HG11 ' A' ' 51' ' ' VAL . . . -57.0 -43.77 82.08 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.481 -0.762 . . . . 0.0 109.641 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.571 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.8 OUTLIER -54.18 -54.99 32.26 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.642 -0.662 . . . . 0.0 110.292 179.576 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.621 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -68.54 -40.07 80.87 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.337 -0.852 . . . . 0.0 109.778 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.534 ' HB1' HG11 ' A' ' 59' ' ' VAL . . . -57.62 -50.68 72.33 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.323 -0.861 . . . . 0.0 109.687 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.644 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -58.79 -27.16 64.77 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.612 -0.68 . . . . 0.0 110.587 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.37 23.06 4.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.317 -0.864 . . . . 0.0 110.618 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.43 48.81 40.77 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.2 mtm180 -121.55 58.68 0.99 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.388 -1.066 . . . . 0.0 110.164 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.772 HG22 HG22 ' A' ' 59' ' ' VAL . 51.1 t -44.74 -51.43 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.591 -0.693 . . . . 0.0 110.886 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -51.09 -44.04 61.16 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.335 -0.853 . . . . 0.0 110.622 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.468 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 1.0 OUTLIER -61.25 -39.03 88.84 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.387 -0.821 . . . . 0.0 109.969 179.731 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.837 HG12 HD13 ' A' ' 62' ' ' LEU . 23.6 t -76.81 -48.41 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.471 -0.768 . . . . 0.0 110.465 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.931 ' HA ' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -46.85 -34.94 5.8 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.348 -0.845 . . . . 0.0 109.7 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.56 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -79.88 -51.96 8.48 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.353 -0.842 . . . . 0.0 108.901 178.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.676 HD13 ' HB3' ' A' ' 15' ' ' TRP . 18.6 mt -58.84 -65.13 0.71 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.935 0.874 . . . . 0.0 109.728 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.811 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 1.1 tp -47.21 -49.19 23.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.743 -0.598 . . . . 0.0 110.929 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.521 ' HB2' ' O ' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -75.34 -14.56 60.49 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.152 -0.967 . . . . 0.0 110.47 179.617 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.56 ' HB2' ' O ' ' A' ' 30' ' ' ALA . . . -82.64 -9.54 59.34 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.07 -1.019 . . . . 0.0 110.532 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 125.95 17.5 2.51 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.787 -1.197 . . . . 0.0 110.825 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.851 ' CB ' HD21 ' A' ' 16' ' ' LEU . . . -64.44 176.04 1.2 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.053 -1.263 . . . . 0.0 110.092 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.643 HD13 ' HD2' ' A' ' 38' ' ' PRO . 1.6 mm? -91.46 133.45 31.27 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.264 -0.897 . . . . 0.0 110.281 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.643 ' HD2' HD13 ' A' ' 37' ' ' LEU . 44.8 Cg_endo -70.89 -49.29 0.41 Allowed 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 123.603 1.317 . . . . 0.0 110.37 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -95.62 18.48 12.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.31 -0.869 . . . . 0.0 110.484 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.573 ' HB2' ' CB ' ' A' ' 37' ' ' LEU . . . -42.38 109.09 0.68 Allowed Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 121.63 -0.669 . . . . 0.0 110.908 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.5 91.89 0.86 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.709 1.373 . . . . 0.0 110.412 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -65.33 -177.83 0.44 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.484 -0.76 . . . . 0.0 109.898 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.33 22.53 2.47 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.209 -0.932 . . . . 0.0 110.422 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.538 ' HB3' ' CD ' ' A' ' 46' ' ' ARG . 2.8 m-85 -103.09 3.86 36.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -0.904 . . . . 0.0 110.681 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 57.06 35.12 67.83 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.538 ' CD ' ' HB3' ' A' ' 44' ' ' TYR . 7.6 ptm180 -160.4 26.11 0.16 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.261 -1.141 . . . . 0.0 110.697 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.5 ' CB ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER 49.04 -174.63 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.038 0 O-C-N 121.552 -0.718 . . . . 0.0 110.154 179.689 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.734 ' HB2' HD13 ' A' ' 63' ' ' LEU . 46.2 Cg_endo -72.43 -167.33 0.32 Allowed 'Trans proline' 0 C--N 1.315 -1.207 0 O-C-N 123.141 1.074 . . . . 0.0 110.538 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.506 ' O ' ' HG2' ' A' ' 52' ' ' MET . 3.5 mt 60.2 -65.59 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.748 -0.595 . . . . 0.0 109.625 -178.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.592 ' N ' ' O ' ' A' ' 48' ' ' PRO . 5.6 mt-30 -45.8 -25.43 0.51 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.959 -1.088 . . . . 0.0 109.803 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.644 HG22 ' HB2' ' A' ' 21' ' ' ALA . 8.9 p -119.02 40.58 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.485 -0.76 . . . . 0.0 109.789 178.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.562 ' HE1' ' HB2' ' A' ' 60' ' ' ALA . 0.1 OUTLIER -102.52 37.62 1.87 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.028 -1.045 . . . . 0.0 110.21 179.863 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.431 ' CB ' ' O ' ' A' ' 52' ' ' MET . 3.6 tmm? 66.34 -11.73 0.22 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.374 -0.829 . . . . 0.0 111.158 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.498 ' HE1' ' CG ' ' A' ' 52' ' ' MET . 0.0 OUTLIER 48.03 27.55 1.24 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.205 -0.935 . . . . 0.0 110.358 -179.703 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.445 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -125.52 9.5 7.73 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.56 ' HB3' HG23 ' A' ' 59' ' ' VAL . 1.0 OUTLIER -148.99 81.06 1.43 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.41 -1.053 . . . . 0.0 109.629 -179.955 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -49.81 -27.87 5.6 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.464 -0.772 . . . . 0.0 109.775 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.5 mtt85 -52.23 -29.16 21.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.537 -0.727 . . . . 0.0 109.356 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.772 HG22 HG22 ' A' ' 25' ' ' VAL . 29.2 t -71.15 -51.63 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.364 -0.835 . . . . 0.0 108.946 178.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.562 ' HB2' ' HE1' ' A' ' 52' ' ' MET . . . -49.13 -42.31 38.97 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.65 -0.656 . . . . 0.0 109.676 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.5 ' O ' ' HB3' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -61.27 -55.59 30.19 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.486 -0.759 . . . . 0.0 109.317 179.012 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.931 HD11 ' HA ' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -44.25 -58.94 2.61 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.468 -0.77 . . . . 0.0 110.152 178.999 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.81 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 13.9 mt -69.43 -41.9 75.71 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.663 -0.648 . . . . 0.0 110.486 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.891 HD22 HG12 ' A' ' 96' ' ' VAL . 0.5 OUTLIER -61.68 -55.49 29.89 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.039 -1.038 . . . . 0.0 109.739 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.545 ' O ' HD12 ' A' ' 65' ' ' LEU . 0.6 OUTLIER -53.97 -26.81 27.69 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.379 -0.825 . . . . 0.0 109.458 179.366 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.419 ' ND1' ' CD1' ' A' ' 32' ' ' LEU . 1.0 OUTLIER -88.6 -49.04 7.13 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.518 -0.739 . . . . 0.0 109.8 -179.847 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 151.39 50.64 0.02 OUTLIER Glycine 0 N--CA 1.481 1.676 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.81 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -74.05 -157.58 0.05 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.798 -1.413 . . . . 0.0 109.805 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -122.21 63.99 18.69 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.35 -0.844 . . . . 0.0 110.055 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.608 ' HG3' HD12 ' A' ' 64' ' ' LEU . 47.3 Cg_endo -72.3 -8.66 23.11 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.858 1.451 . . . . 0.0 110.574 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -108.05 -78.77 0.58 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.291 -0.881 . . . . 0.0 109.549 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.73 -175.82 0.1 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.55 -0.719 . . . . 0.0 110.527 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.751 ' HB1' ' O ' ' A' ' 79' ' ' THR . . . -167.39 -83.19 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.425 -0.797 . . . . 0.0 110.298 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -146.71 123.36 5.73 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.291 -0.881 . . . . 0.0 109.674 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.37 -2.43 11.7 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.511 1.269 . . . . 0.0 110.645 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -96.52 -27.79 14.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.215 -0.928 . . . . 0.0 110.19 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.9 p -137.11 4.56 2.72 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.259 -0.901 . . . . 0.0 111.103 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.52 ' HA ' HD23 ' A' ' 78' ' ' LEU . 5.2 mt 47.01 27.93 0.81 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.246 -0.909 . . . . 0.0 111.244 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.751 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 66.4 m -69.66 88.62 0.52 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.963 -1.086 . . . . 0.0 109.783 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.773 ' HD3' HG21 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -67.98 165.11 35.14 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.309 -0.869 . . . . 0.0 109.946 -179.605 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.56 ' HD2' ' HG3' ' A' ' 80' ' ' ARG . 46.5 Cg_endo -76.0 -7.98 18.6 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.622 1.328 . . . . 0.0 109.767 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.407 ' H ' HG23 ' A' ' 82' ' ' VAL . 6.0 t -71.54 -23.92 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.552 -0.717 . . . . 0.0 109.593 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.527 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 4.0 m80 -75.46 -23.39 56.86 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.475 ' HB3' ' SD ' ' A' ' 54' ' ' MET . 51.7 m-20 -75.39 -57.39 3.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.829 -0.544 . . . . 0.0 110.92 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.755 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -53.38 -50.77 64.41 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.194 -0.941 . . . . 0.0 109.507 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.844 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -65.51 -32.05 73.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.455 -0.778 . . . . 0.0 110.105 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.56 ' HA ' HD13 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -56.18 -51.02 69.54 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.297 -0.877 . . . . 0.0 110.374 -179.851 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.465 ' HB2' ' HB3' ' A' ' 54' ' ' MET . 0.9 OUTLIER -93.28 16.58 12.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.301 -0.874 . . . . 0.0 110.422 -179.793 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.686 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 53.28 55.03 26.49 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.445 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 0.2 OUTLIER -115.5 94.93 4.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.418 -1.048 . . . . 0.0 110.744 -179.349 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.828 HD11 ' CG ' ' A' ' 129' ' ' TYR . 0.3 OUTLIER -66.69 -45.5 78.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.348 -0.845 . . . . 0.0 109.967 179.645 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.882 ' O ' HG23 ' A' ' 96' ' ' VAL . 69.6 m-20 -47.91 -40.05 20.75 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.52 -0.737 . . . . 0.0 109.723 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.432 HG23 ' HE1' ' A' ' 52' ' ' MET . 7.1 m -66.17 -55.81 14.5 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.613 -0.68 . . . . 0.0 109.252 179.001 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.815 HD21 ' HB2' ' A' ' 130' ' ' LEU . 4.8 tp -52.03 -47.82 64.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.741 -0.6 . . . . 0.0 109.741 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 91' ' ' LEU . 58.4 t -51.45 -43.76 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.498 -0.751 . . . . 0.0 109.697 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.891 HG12 HD22 ' A' ' 64' ' ' LEU . 23.0 t -57.55 -52.5 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.52 -0.738 . . . . 0.0 109.47 179.215 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.505 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 4.7 mp -50.51 -57.51 7.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.563 -0.711 . . . . 0.0 109.995 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -62.39 -30.13 70.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.415 -0.803 . . . . 0.0 109.69 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.9 mtt180 -68.01 -11.93 59.85 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.503 -0.748 . . . . 0.0 110.489 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.585 ' CB ' HD21 ' A' ' 64' ' ' LEU . . . -144.43 63.41 1.32 Allowed 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.162 -0.961 . . . . 0.0 110.859 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 53.51 101.53 0.01 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 97' ' ' LEU . . . -151.97 101.25 2.72 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.256 -1.143 . . . . 0.0 110.122 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -55.82 93.62 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.493 -0.755 . . . . 0.0 109.92 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.563 HD22 ' HB3' ' A' ' 133' ' ' ALA . 0.0 OUTLIER -84.67 8.38 17.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.35 -0.844 . . . . 0.0 110.548 -179.699 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.46 ' HB3' ' HA ' ' A' ' 134' ' ' ALA . 6.0 p30 -123.85 60.54 1.11 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.097 -1.002 . . . . 0.0 110.827 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.773 HG21 ' HD3' ' A' ' 80' ' ' ARG . 1.7 p -112.21 -170.48 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.134 -0.979 . . . . 0.0 109.766 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.647 ' H ' HG22 ' A' ' 106' ' ' VAL . 0.2 OUTLIER -138.54 126.11 22.01 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.298 -0.877 . . . . 0.0 109.788 179.417 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.1 t0 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 0.0 109.657 179.918 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.501 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.744 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.501 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 41.3 Cg_endo -68.51 -30.22 29.45 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.385 1.202 . . . . 0.0 109.559 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.847 ' HB ' HD11 ' A' ' 130' ' ' LEU . 4.8 p -82.99 -26.21 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.338 -0.852 . . . . 0.0 109.421 179.029 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -56.37 -40.65 74.9 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.502 -0.749 . . . . 0.0 110.664 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.56 HD13 ' HA ' ' A' ' 87' ' ' ARG . 3.5 pp -77.16 -27.78 53.89 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.217 -0.927 . . . . 0.0 109.94 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.588 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -69.21 -26.73 64.96 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.36 -0.838 . . . . 0.0 110.164 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -88.74 -34.35 17.18 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.365 -0.835 . . . . 0.0 109.646 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -74.37 -63.84 1.15 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.405 -0.809 . . . . 0.0 110.535 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.407 ' HB3' ' NE2' ' A' ' 123' ' ' HIS . 0.2 OUTLIER -54.38 -86.77 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.246 -0.909 . . . . 0.0 110.602 -179.486 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 174.31 52.91 0.05 OUTLIER Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.429 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 44.7 m-70 -120.95 44.22 2.57 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.474 -1.015 . . . . 0.0 109.266 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.677 ' HA ' ' HB3' ' A' ' 127' ' ' ALA . 9.5 ptm180 -43.55 -38.19 2.83 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.759 -0.588 . . . . 0.0 110.538 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.506 ' O ' HD21 ' A' ' 91' ' ' LEU . 80.9 m-20 -56.79 -43.47 80.92 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.844 HG11 ' HA ' ' A' ' 86' ' ' ALA . 2.1 t -82.03 -40.03 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.677 ' HB3' ' HA ' ' A' ' 124' ' ' ARG . . . -55.86 -45.4 78.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.394 -0.816 . . . . 0.0 109.657 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -74.9 -52.26 11.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.383 -0.823 . . . . 0.0 109.526 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.828 ' CG ' HD11 ' A' ' 91' ' ' LEU . 80.6 t80 -61.5 -65.16 0.73 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.453 -0.779 . . . . 0.0 110.851 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.847 HD11 ' HB ' ' A' ' 115' ' ' VAL . 0.3 OUTLIER -52.34 -26.16 11.57 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.285 -0.884 . . . . 0.0 110.499 -179.147 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.498 ' HB2' HG21 ' A' ' 115' ' ' VAL . 17.2 ttt-85 -73.12 -42.63 62.68 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.122 -0.986 . . . . 0.0 109.543 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.28 -33.21 72.01 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.563 ' HB3' HD22 ' A' ' 104' ' ' LEU . . . -89.28 -22.58 22.62 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.46 ' HA ' ' HB3' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.554 -0.716 . . . . 0.0 110.272 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.6 t70 . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 120.841 0.353 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.599 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 27.8 m0 -75.34 -10.87 59.84 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.015 -1.053 . . . . 0.0 110.699 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.788 HD21 HD21 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -78.11 -54.62 6.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.183 -0.948 . . . . 0.0 109.924 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.469 ' N ' ' HG ' ' A' ' 16' ' ' LEU . . . -69.28 -40.03 77.99 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.097 -1.002 . . . . 0.0 109.813 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.599 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 2.8 p -51.43 -56.77 11.42 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.579 -0.7 . . . . 0.0 110.687 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.741 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -56.49 -38.54 71.89 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.269 -0.895 . . . . 0.0 110.227 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.61 -23.99 66.95 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.292 -0.88 . . . . 0.0 110.14 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.506 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -82.54 -27.65 31.52 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.281 -0.887 . . . . 0.0 110.606 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 -94.31 22.75 5.69 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.293 -0.88 . . . . 0.0 110.454 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 55.57 66.57 2.74 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.75 75.62 1.48 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.382 -1.069 . . . . 0.0 109.588 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.875 HG22 ' CG2' ' A' ' 59' ' ' VAL . 11.6 t -56.19 -53.26 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.357 -0.84 . . . . 0.0 110.246 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -45.92 -42.23 12.52 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.457 -0.777 . . . . 0.0 111.067 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.654 ' O ' HD12 ' A' ' 31' ' ' LEU . 1.3 mp0 -64.78 -46.64 81.22 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.319 -0.863 . . . . 0.0 109.776 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.944 HG12 HD12 ' A' ' 32' ' ' LEU . 13.7 t -73.49 -45.41 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.412 -0.805 . . . . 0.0 109.548 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.873 ' CG ' HG12 ' A' ' 25' ' ' VAL . 27.6 mmm-85 -48.53 -43.52 35.42 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.536 -0.727 . . . . 0.0 109.902 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.26 -45.32 33.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.542 -0.724 . . . . 0.0 109.896 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.654 HD12 ' O ' ' A' ' 27' ' ' GLU . 4.1 mt -54.42 -56.96 13.37 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.281 -0.887 . . . . 0.0 109.876 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.944 HD12 HG12 ' A' ' 28' ' ' VAL . 3.0 mt -57.42 -44.82 84.95 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.394 -0.816 . . . . 0.0 110.077 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -63.18 -17.42 62.37 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.507 -0.746 . . . . 0.0 110.188 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.43 -14.12 31.11 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.325 -0.86 . . . . 0.0 110.167 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.63 28.13 1.64 Allowed Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.951 -1.119 . . . . 0.0 110.403 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.655 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -58.7 152.3 19.11 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.208 -1.172 . . . . 0.0 110.078 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.897 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 2.1 mm? -66.71 122.08 80.5 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.409 -0.807 . . . . 0.0 109.989 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.481 ' HD2' HD13 ' A' ' 37' ' ' LEU . 42.4 Cg_endo -68.8 -42.68 4.31 Favored 'Trans proline' 0 C--N 1.312 -1.342 0 O-C-N 123.601 1.316 . . . . 0.0 110.361 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -108.9 56.71 0.62 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.429 -0.794 . . . . 0.0 109.592 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.897 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -94.38 117.2 67.05 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.396 -0.815 . . . . 0.0 110.193 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.53 109.56 2.49 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.626 1.329 . . . . 0.0 110.072 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.586 ' ND2' HG11 ' A' ' 51' ' ' VAL . 18.3 t-20 -50.86 175.59 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.448 -0.782 . . . . 0.0 110.882 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.4 t -87.01 4.83 40.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.542 -0.724 . . . . 0.0 110.78 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -117.01 31.33 6.81 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.119 -0.988 . . . . 0.0 109.94 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 55.38 23.47 34.39 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.57 141.31 48.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.405 -1.056 . . . . 0.0 110.049 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.509 ' CG ' ' HB2' ' A' ' 69' ' ' GLU . 0.2 OUTLIER -57.12 176.96 0.21 Allowed Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.543 -0.723 . . . . 0.0 110.417 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.446 ' HD2' ' CB ' ' A' ' 47' ' ' ARG . 41.1 Cg_endo -67.29 -24.41 43.69 Favored 'Trans proline' 0 C--N 1.315 -1.208 0 O-C-N 123.576 1.303 . . . . 0.0 111.116 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.491 HG13 HD13 ' A' ' 63' ' ' LEU . 7.2 mt -109.01 -31.13 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.9 -1.125 . . . . 0.0 109.064 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.471 ' HA ' ' OD2' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -51.5 -25.9 7.38 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.563 -0.711 . . . . 0.0 109.992 179.365 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.586 HG11 ' ND2' ' A' ' 42' ' ' ASN . 10.9 p -97.21 3.34 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.21 -0.931 . . . . 0.0 109.881 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.564 ' CE ' ' HB2' ' A' ' 60' ' ' ALA . 51.6 ttp -56.13 164.54 1.23 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.491 -0.756 . . . . 0.0 110.256 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 3.5 tmm? -75.49 -6.81 52.05 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.252 -0.905 . . . . 0.0 111.0 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.495 ' SD ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 52.55 23.42 2.57 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.181 -0.949 . . . . 0.0 110.192 -179.694 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -122.06 8.45 9.82 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -160.11 106.13 1.56 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.445 -1.033 . . . . 0.0 109.903 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.638 ' HB2' ' HB3' ' A' ' 92' ' ' ASP . . . -63.79 -26.42 68.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.325 -0.86 . . . . 0.0 109.977 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.422 ' HB3' HG11 ' A' ' 25' ' ' VAL . 53.8 mtt180 -50.68 -29.17 10.5 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.348 -0.845 . . . . 0.0 109.858 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.875 ' CG2' HG22 ' A' ' 25' ' ' VAL . 49.0 t -74.75 -56.31 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.564 ' HB2' ' CE ' ' A' ' 52' ' ' MET . . . -54.09 -45.13 71.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.303 -0.873 . . . . 0.0 109.508 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.455 ' O ' HD23 ' A' ' 65' ' ' LEU . 12.4 tt0 -61.96 -35.05 77.31 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.273 -0.892 . . . . 0.0 109.197 179.292 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.682 ' CD1' HD13 ' A' ' 32' ' ' LEU . 1.1 tp -71.86 -48.42 46.03 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.294 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.788 HD21 HD21 ' A' ' 16' ' ' LEU . 1.0 OUTLIER -72.7 -37.8 67.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.55 -0.719 . . . . 0.0 109.998 179.7 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.783 HD21 ' CB ' ' A' ' 100' ' ' ALA . 0.6 OUTLIER -65.26 -63.2 1.16 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.431 -0.793 . . . . 0.0 110.411 -179.853 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.566 ' O ' HD12 ' A' ' 65' ' ' LEU . 0.4 OUTLIER -52.75 -25.31 10.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.877 . . . . 0.0 109.54 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.899 ' CG ' HD22 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -80.54 -52.13 7.96 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.559 -0.713 . . . . 0.0 109.431 179.412 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.444 ' HA3' ' HB2' ' A' ' 38' ' ' PRO . . . 159.57 32.56 0.02 OUTLIER Glycine 0 N--CA 1.481 1.643 0 C-N-CA 119.672 -1.251 . . . . 0.0 111.456 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.526 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -70.39 172.21 8.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.52 -1.576 . . . . 0.0 109.363 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.509 ' HB2' ' CG ' ' A' ' 47' ' ' ARG . 6.5 mm-40 -108.76 78.61 0.94 Allowed Pre-proline 0 C--N 1.301 -1.51 0 O-C-N 121.341 -0.849 . . . . 0.0 109.54 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.494 ' HG3' HD12 ' A' ' 64' ' ' LEU . 43.1 Cg_endo -68.42 -10.75 29.94 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.9 1.474 . . . . 0.0 110.521 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -104.3 -61.21 1.48 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.102 -0.999 . . . . 0.0 110.036 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 3.9 t -46.51 149.59 0.77 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.462 -0.774 . . . . 0.0 111.108 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -140.43 -148.14 0.24 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.503 -0.748 . . . . 0.0 109.79 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.455 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.4 OUTLIER -104.63 140.41 21.05 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.124 -0.985 . . . . 0.0 109.79 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -76.19 -12.64 19.21 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.345 1.182 . . . . 0.0 110.679 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.53 -43.9 25.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.248 -0.907 . . . . 0.0 110.27 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.22 9.8 4.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.264 -0.897 . . . . 0.0 110.614 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.507 ' HA ' HD23 ' A' ' 78' ' ' LEU . 0.8 OUTLIER 46.38 40.51 7.97 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.338 -0.851 . . . . 0.0 111.18 179.708 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.3 m -78.45 100.15 6.73 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.917 . . . . 0.0 110.17 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.747 ' HB2' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -69.4 161.78 71.21 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.361 -0.837 . . . . 0.0 109.393 179.769 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.506 ' HD2' ' CG ' ' A' ' 80' ' ' ARG . 44.0 Cg_endo -70.6 -16.68 34.06 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.451 1.238 . . . . 0.0 109.936 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 74.4 t -59.68 -27.79 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.417 -0.802 . . . . 0.0 109.662 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.512 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 4.8 m80 -75.7 -33.93 60.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.496 -0.753 . . . . 0.0 109.056 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.495 ' HB3' ' SD ' ' A' ' 54' ' ' MET . 3.3 m-20 -57.28 -49.03 77.36 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.806 -0.559 . . . . 0.0 109.852 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.701 ' HB1' HD12 ' A' ' 94' ' ' LEU . . . -58.68 -62.27 1.99 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.331 -0.856 . . . . 0.0 109.179 178.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.785 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -55.62 -49.57 72.47 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.299 -0.876 . . . . 0.0 110.839 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.618 ' HD3' HD12 ' A' ' 117' ' ' LEU . 5.4 tpp85 -40.7 -38.99 0.99 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.38 -0.825 . . . . 0.0 111.401 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.37 -2.62 35.82 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.044 -1.035 . . . . 0.0 111.032 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.45 19.1 59.16 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.553 ' HE2' ' HB2' ' A' ' 57' ' ' ALA . 1.0 OUTLIER -91.08 132.19 36.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.186 -1.185 . . . . 0.0 109.915 179.736 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.666 HD11 ' O ' ' A' ' 125' ' ' ASP . 0.4 OUTLIER -108.76 -43.6 4.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.393 -0.817 . . . . 0.0 110.354 179.859 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.638 ' HB3' ' HB2' ' A' ' 57' ' ' ALA . 34.6 t0 -45.82 -29.25 1.28 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.476 -0.765 . . . . 0.0 110.052 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.437 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 11.8 m -73.4 -43.94 59.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.644 -0.66 . . . . 0.0 109.448 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.719 HD13 HG13 ' A' ' 126' ' ' VAL . 0.8 OUTLIER -56.0 -50.29 71.27 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.259 -0.901 . . . . 0.0 110.023 179.716 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.434 ' O ' ' CB ' ' A' ' 99' ' ' ARG . 43.5 t -53.78 -49.43 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.5 -0.75 . . . . 0.0 109.366 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.742 ' CG1' HD22 ' A' ' 64' ' ' LEU . 70.3 t -52.92 -47.71 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.515 -0.74 . . . . 0.0 109.632 179.049 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.466 ' CD2' ' HB3' ' A' ' 70' ' ' PRO . 96.6 mt -56.66 -72.63 0.07 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.513 -0.742 . . . . 0.0 109.986 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 17.3 t-160 -51.42 -33.35 30.19 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.477 -0.765 . . . . 0.0 110.465 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.434 ' CB ' ' O ' ' A' ' 95' ' ' VAL . 3.5 ttm180 -66.09 -15.49 63.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.41 -0.806 . . . . 0.0 110.517 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.783 ' CB ' HD21 ' A' ' 64' ' ' LEU . . . -142.52 75.5 1.49 Allowed 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.106 -0.996 . . . . 0.0 110.955 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 51.47 97.76 0.01 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -164.33 101.62 0.84 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.358 -1.083 . . . . 0.0 110.08 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 11.1 ttt180 -61.0 120.21 9.8 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.462 -0.774 . . . . 0.0 110.198 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.18 10.06 41.25 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.5 -0.75 . . . . 0.0 110.508 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -124.51 55.55 1.32 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.309 -0.869 . . . . 0.0 110.318 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.747 HG11 ' HB2' ' A' ' 80' ' ' ARG . 2.3 p -106.37 -169.28 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.394 -0.817 . . . . 0.0 109.613 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.648 ' H ' HG22 ' A' ' 106' ' ' VAL . 6.8 mtt180 -140.31 151.64 45.22 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.333 -0.854 . . . . 0.0 110.019 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.7 0 O-C-N 121.314 -0.867 . . . . 0.0 109.69 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.477 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.477 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 43.3 Cg_endo -70.33 -45.21 1.35 Allowed 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.633 1.333 . . . . 0.0 109.656 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.458 ' HA ' HD13 ' A' ' 130' ' ' LEU . 10.2 p -62.78 -28.05 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.401 -0.812 . . . . 0.0 109.243 179.195 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.3 -40.37 81.8 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.434 -0.791 . . . . 0.0 109.976 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.618 HD12 ' HD3' ' A' ' 87' ' ' ARG . 1.0 OUTLIER -68.14 -22.59 64.86 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.397 -0.814 . . . . 0.0 110.128 179.732 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.448 ' HB1' ' HB2' ' A' ' 127' ' ' ALA . . . -80.39 -53.97 6.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.375 -0.828 . . . . 0.0 110.429 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -57.63 -27.53 62.88 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.287 -0.883 . . . . 0.0 110.431 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -72.11 -51.39 21.67 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.399 -0.813 . . . . 0.0 110.219 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.515 ' HB2' ' CD2' ' A' ' 123' ' ' HIS . 37.5 mt -85.41 1.17 49.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.312 -0.868 . . . . 0.0 110.599 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 75.72 40.95 30.2 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.515 ' CD2' ' HB2' ' A' ' 121' ' ' LEU . 25.3 m-70 -89.8 55.43 3.17 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.02 -1.282 . . . . 0.0 109.465 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 28.7 mtt-85 -44.48 -38.19 3.96 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.773 -0.579 . . . . 0.0 110.278 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.666 ' O ' HD11 ' A' ' 91' ' ' LEU . 0.5 OUTLIER -58.4 -48.36 80.9 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.39 -0.819 . . . . 0.0 109.071 178.919 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.785 HG11 ' HA ' ' A' ' 86' ' ' ALA . 3.5 t -81.33 -43.65 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.473 -0.767 . . . . 0.0 110.244 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.448 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . . . -54.71 -49.51 70.57 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.292 -0.88 . . . . 0.0 110.541 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.1 mtp-105 -56.02 -55.13 36.6 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.208 -0.933 . . . . 0.0 110.18 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -65.03 -33.65 76.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.393 -0.817 . . . . 0.0 110.05 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.72 HD11 ' HB2' ' A' ' 86' ' ' ALA . 10.9 mt -66.29 -67.96 0.41 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.345 -0.847 . . . . 0.0 110.468 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -48.18 -24.62 1.2 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.353 -0.842 . . . . 0.0 110.857 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -82.81 -53.8 5.6 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.306 -0.871 . . . . 0.0 110.017 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -87.44 5.98 36.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.399 -0.813 . . . . 0.0 111.034 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.495 1.813 0 O-C-N 121.096 -1.003 . . . . 0.0 110.514 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.126 0.488 . . . . 0.0 109.8 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.533 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 37.0 m0 -69.76 -4.79 21.43 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.583 -0.698 . . . . 0.0 110.348 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.981 HD11 HD21 ' A' ' 63' ' ' LEU . 0.8 OUTLIER -78.0 -55.66 5.11 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.268 -0.895 . . . . 0.0 109.641 179.594 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.412 ' N ' ' HG ' ' A' ' 16' ' ' LEU . . . -73.15 -37.3 66.64 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.261 -0.899 . . . . 0.0 110.752 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.533 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.7 OUTLIER -59.91 -50.67 72.85 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.291 -0.881 . . . . 0.0 110.94 -179.559 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.725 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -61.82 -36.19 80.43 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.276 -0.89 . . . . 0.0 110.526 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.654 ' HA ' HG11 ' A' ' 59' ' ' VAL . . . -60.01 -33.38 71.92 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.339 -0.851 . . . . 0.0 110.008 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.603 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -81.34 -28.55 34.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.442 -0.787 . . . . 0.0 110.441 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.4 ttt180 -92.7 32.62 1.21 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.379 -0.826 . . . . 0.0 110.778 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 47.22 47.74 21.02 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.558 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -117.07 95.56 5.05 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.195 -1.179 . . . . 0.0 110.129 179.857 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.6 HG12 ' HD3' ' A' ' 29' ' ' ARG . 57.3 t -73.13 -57.59 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.567 -0.708 . . . . 0.0 110.019 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -47.63 -51.42 21.43 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.596 -0.69 . . . . 0.0 111.071 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.436 ' HB3' ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -48.58 -53.75 17.15 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.486 -0.759 . . . . 0.0 110.022 179.827 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.92 HG12 HD12 ' A' ' 32' ' ' LEU . 4.8 t -72.98 -50.68 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.365 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.6 ' HD3' HG12 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -45.46 -49.62 13.31 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.317 -0.864 . . . . 0.0 109.898 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.12 -35.88 66.63 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.583 -0.698 . . . . 0.0 109.829 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.499 ' HB2' ' HA ' ' A' ' 28' ' ' VAL . 14.8 mt -64.19 -58.55 6.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.363 -0.836 . . . . 0.0 110.437 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.971 HD22 ' CG ' ' A' ' 66' ' ' HIS . 0.5 OUTLIER -50.05 -37.83 35.18 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.184 -0.948 . . . . 0.0 110.292 -179.568 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -79.33 -16.17 56.75 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.394 -0.816 . . . . 0.0 110.164 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -93.48 -4.98 50.19 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.231 -0.918 . . . . 0.0 111.435 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 134.06 -19.7 4.1 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.434 -1.365 . . . . 0.0 110.937 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.65 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -46.12 121.14 3.1 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.07 -1.253 . . . . 0.0 110.594 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.542 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 0.7 OUTLIER -75.48 128.67 83.69 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.396 -0.815 . . . . 0.0 110.421 -179.434 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.506 ' HB2' ' C ' ' A' ' 67' ' ' GLY . 46.3 Cg_endo -68.97 -37.77 10.61 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 O-C-N 123.493 1.259 . . . . 0.0 111.185 -179.261 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.53 48.95 1.16 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.148 -0.97 . . . . 0.0 110.069 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.542 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -100.87 95.88 5.02 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.189 -0.944 . . . . 0.0 110.192 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.43 128.76 18.84 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.432 1.227 . . . . 0.0 110.245 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -122.18 178.16 5.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.363 -0.836 . . . . 0.0 110.499 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.448 ' O ' ' CB ' ' A' ' 44' ' ' TYR . 1.1 p -60.8 -157.11 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.427 -0.796 . . . . 0.0 110.042 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.448 ' CB ' ' O ' ' A' ' 43' ' ' SER . 3.5 t80 68.17 5.87 4.92 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.423 -0.798 . . . . 0.0 110.644 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 52.04 25.65 17.77 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.471 ' HB3' ' HB ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -116.8 -167.45 1.3 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.317 -1.108 . . . . 0.0 110.87 -179.585 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.579 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -124.3 -161.45 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.805 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -179.884 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.664 ' HB2' HD22 ' A' ' 63' ' ' LEU . 51.2 Cg_endo -78.69 -32.19 2.18 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 O-C-N 122.698 0.841 . . . . 0.0 110.921 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.524 HG13 ' HB1' ' A' ' 68' ' ' ALA . 5.7 mt -109.02 -36.77 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 120.869 -1.145 . . . . 0.0 109.91 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.469 ' OE1' ' HA ' ' A' ' 46' ' ' ARG . 17.0 tt0 -48.62 -26.56 2.31 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.248 -0.908 . . . . 0.0 109.518 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.603 HG22 ' HB2' ' A' ' 21' ' ' ALA . 8.3 p -97.12 21.39 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.491 -0.756 . . . . 0.0 110.382 179.273 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.704 ' CE ' ' HB2' ' A' ' 60' ' ' ALA . 0.4 OUTLIER -77.18 159.1 29.96 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.139 -0.975 . . . . 0.0 109.761 179.579 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 37.6 ttp -70.09 -5.4 26.6 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.261 -0.899 . . . . 0.0 110.165 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.618 ' HE2' ' HB3' ' A' ' 52' ' ' MET . 16.0 mmt 49.68 28.26 2.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.348 -0.845 . . . . 0.0 109.835 -179.151 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.439 ' C ' ' CE2' ' A' ' 90' ' ' PHE . . . -124.33 5.7 8.74 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 178.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -156.1 85.72 1.02 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.654 -0.909 . . . . 0.0 109.221 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.423 ' HB2' ' HB3' ' A' ' 92' ' ' ASP . . . -46.98 -26.94 1.12 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.589 -0.694 . . . . 0.0 110.102 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -46.55 -42.71 16.29 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.662 -0.649 . . . . 0.0 109.798 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.654 HG11 ' HA ' ' A' ' 20' ' ' ALA . 10.9 t -65.74 -60.63 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.63 -0.669 . . . . 0.0 109.282 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.704 ' HB2' ' CE ' ' A' ' 52' ' ' MET . . . -48.43 -47.63 37.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.456 -0.778 . . . . 0.0 109.311 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.482 ' O ' HD23 ' A' ' 65' ' ' LEU . 0.5 OUTLIER -60.19 -40.76 91.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.589 -0.694 . . . . 0.0 109.263 178.685 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.688 HD21 HG12 ' A' ' 28' ' ' VAL . 2.8 tp -66.27 -51.99 51.99 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.461 -0.774 . . . . 0.0 109.474 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.981 HD21 HD11 ' A' ' 16' ' ' LEU . 2.8 mt -67.86 -41.54 82.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.313 -0.867 . . . . 0.0 110.16 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.508 ' CD1' HG12 ' A' ' 96' ' ' VAL . 0.5 OUTLIER -68.78 -57.98 4.84 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.192 -0.943 . . . . 0.0 110.372 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.743 HD12 ' C ' ' A' ' 65' ' ' LEU . 1.3 pp -49.94 -25.63 3.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.118 -0.989 . . . . 0.0 109.096 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.971 ' CG ' HD22 ' A' ' 32' ' ' LEU . 0.5 OUTLIER -82.11 -51.32 8.11 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.789 -0.569 . . . . 0.0 109.481 179.227 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.506 ' C ' ' HB2' ' A' ' 38' ' ' PRO . . . 152.74 38.78 0.03 OUTLIER Glycine 0 N--CA 1.485 1.914 0 C-N-CA 120.03 -1.081 . . . . 0.0 110.794 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.524 ' HB1' HG13 ' A' ' 49' ' ' ILE . . . -69.67 -170.19 0.29 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.867 -1.372 . . . . 0.0 110.06 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -109.17 79.37 1.17 Allowed Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.39 -0.818 . . . . 0.0 109.611 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.448 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 49.5 Cg_endo -70.83 -12.55 31.01 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.8 1.421 . . . . 0.0 110.546 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.527 ' O ' ' NE ' ' A' ' 80' ' ' ARG . 26.3 t-20 -113.43 -58.46 2.15 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.285 -0.884 . . . . 0.0 110.669 -179.266 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.417 ' C ' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -41.1 137.46 1.31 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.26 -0.9 . . . . 0.0 110.918 -179.515 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.459 ' HB2' ' CD ' ' A' ' 80' ' ' ARG . . . -131.43 -155.22 0.68 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.623 -0.673 . . . . 0.0 110.286 -179.172 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -106.15 145.52 31.11 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.197 -0.939 . . . . 0.0 110.487 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -75.57 -25.4 11.04 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.712 1.375 . . . . 0.0 110.048 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.11 -59.32 5.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.314 -0.866 . . . . 0.0 110.175 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 77' ' ' THR . 2.2 t -137.0 29.31 2.82 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.337 -0.852 . . . . 0.0 110.908 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.459 ' HA ' HD23 ' A' ' 78' ' ' LEU . 20.2 mt 51.53 52.91 13.72 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.203 -0.936 . . . . 0.0 111.372 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 16.7 m -83.41 106.48 15.2 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.032 -1.042 . . . . 0.0 109.736 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.654 ' HB2' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -95.35 170.66 7.5 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.372 -0.83 . . . . 0.0 109.721 179.745 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.553 ' HD2' ' CG ' ' A' ' 80' ' ' ARG . 48.1 Cg_endo -71.74 -0.09 7.83 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.564 1.297 . . . . 0.0 110.425 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.874 HG21 ' HA ' ' A' ' 104' ' ' LEU . 43.3 t -79.87 -45.04 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -0.932 . . . . 0.0 110.279 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.429 ' O ' ' CB ' ' A' ' 87' ' ' ARG . 37.4 m80 -59.01 -37.73 77.58 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.389 -0.819 . . . . 0.0 109.221 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.459 ' CB ' ' HE3' ' A' ' 54' ' ' MET . 62.3 m-20 -54.43 -57.55 10.88 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.714 -0.616 . . . . 0.0 110.566 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.476 ' CB ' HD13 ' A' ' 94' ' ' LEU . . . -51.01 -63.83 1.0 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.102 -0.998 . . . . 0.0 109.884 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.941 ' HB2' HD11 ' A' ' 130' ' ' LEU . . . -56.65 -50.73 71.2 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.337 -0.852 . . . . 0.0 110.687 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.429 ' CB ' ' O ' ' A' ' 83' ' ' HIS . 11.0 tpp85 -43.44 -28.82 0.39 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.294 -0.879 . . . . 0.0 110.852 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -103.59 -11.12 17.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.397 -0.814 . . . . 0.0 110.459 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.598 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 86.35 34.55 12.0 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.439 ' CE2' ' C ' ' A' ' 55' ' ' GLY . 0.4 OUTLIER -108.28 121.15 44.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.112 -1.228 . . . . 0.0 110.732 -179.818 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.565 HD11 ' O ' ' A' ' 125' ' ' ASP . 0.4 OUTLIER -94.75 -41.65 9.14 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.497 -0.752 . . . . 0.0 110.222 179.737 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.878 ' O ' HG23 ' A' ' 96' ' ' VAL . 0.4 OUTLIER -52.05 -30.15 24.46 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.348 -0.845 . . . . 0.0 109.088 179.53 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.521 ' O ' HD12 ' A' ' 97' ' ' LEU . 72.4 m -72.85 -38.57 67.03 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.912 HD21 ' CD2' ' A' ' 130' ' ' LEU . 1.6 tp -64.42 -47.72 78.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.571 -0.705 . . . . 0.0 109.416 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.45 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 41.4 t -57.2 -48.31 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.47 -0.769 . . . . 0.0 108.951 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.878 HG23 ' O ' ' A' ' 92' ' ' ASP . 98.7 t -52.56 -53.78 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.781 -0.574 . . . . 0.0 110.072 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.521 HD12 ' O ' ' A' ' 93' ' ' THR . 0.3 OUTLIER -52.56 -65.29 0.58 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.391 -0.818 . . . . 0.0 109.965 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -58.48 -28.47 65.38 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.272 -0.893 . . . . 0.0 110.339 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.45 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 17.7 ttp180 -67.16 -15.83 63.94 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.256 -0.903 . . . . 0.0 110.424 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.95 72.35 1.33 Allowed 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.347 -0.845 . . . . 0.0 110.863 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 54.64 102.79 0.01 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.419 ' CB ' ' C ' ' A' ' 97' ' ' LEU . . . -163.57 102.47 0.93 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.333 -1.098 . . . . 0.0 110.167 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -71.63 98.26 1.87 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.428 -0.795 . . . . 0.0 110.015 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.874 ' HA ' HG21 ' A' ' 82' ' ' VAL . 1.1 mp -89.9 10.53 23.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.451 -0.78 . . . . 0.0 109.706 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -103.13 36.88 2.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.311 -0.868 . . . . 0.0 110.719 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.654 HG11 ' HB2' ' A' ' 80' ' ' ARG . 0.7 OUTLIER -98.25 -171.82 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.024 -1.047 . . . . 0.0 109.77 179.555 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.567 ' H ' HG22 ' A' ' 106' ' ' VAL . 4.4 ptt-85 -140.44 135.48 32.05 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.625 -0.672 . . . . 0.0 109.666 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.508 ' HA ' ' O ' ' A' ' 77' ' ' THR . 41.9 p-10 . . . . . 0 N--CA 1.494 1.764 0 O-C-N 121.125 -0.984 . . . . 0.0 110.615 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.462 HD23 ' HD2' ' A' ' 114' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.764 0 CA-C-O 120.534 0.207 . . . . 0.0 110.666 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.462 ' HD2' HD23 ' A' ' 113' ' ' LEU . 42.1 Cg_endo -68.27 -29.26 32.56 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.674 1.355 . . . . 0.0 110.743 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.8 p -78.71 -32.69 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.999 -1.063 . . . . 0.0 109.834 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -64.39 -26.89 68.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.345 -0.847 . . . . 0.0 109.367 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.498 HD23 ' CD1' ' A' ' 121' ' ' LEU . 0.2 OUTLIER -70.47 -37.03 74.22 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.506 -0.746 . . . . 0.0 109.636 179.258 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.5 ' CB ' ' HB2' ' A' ' 123' ' ' HIS . . . -70.18 -35.89 74.28 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.447 -0.783 . . . . 0.0 109.915 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -63.33 -39.1 93.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.42 -0.8 . . . . 0.0 110.307 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.05 -69.62 0.51 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.371 -0.831 . . . . 0.0 110.396 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.498 ' CD1' HD23 ' A' ' 117' ' ' LEU . 0.2 OUTLIER -47.3 -89.14 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.499 -0.751 . . . . 0.0 111.142 -179.54 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 173.53 36.56 0.04 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.584 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 51.6 m-70 -101.19 43.99 1.03 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.364 -1.08 . . . . 0.0 109.11 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.77 -53.87 4.37 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-O 121.211 0.529 . . . . 0.0 110.698 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.565 ' O ' HD11 ' A' ' 91' ' ' LEU . 0.5 OUTLIER -51.45 -40.29 59.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.422 -0.799 . . . . 0.0 109.426 179.292 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.803 HG11 ' HA ' ' A' ' 86' ' ' ALA . 2.0 t -78.73 -35.5 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.383 -0.823 . . . . 0.0 109.611 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.473 ' HB2' ' CB ' ' A' ' 118' ' ' ALA . . . -59.06 -48.05 83.0 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.215 -0.928 . . . . 0.0 109.805 179.276 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.5 ttm180 -50.0 -63.94 0.96 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.486 -0.759 . . . . 0.0 109.854 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.427 ' CD2' HD21 ' A' ' 91' ' ' LEU . 3.5 t80 -52.93 -55.21 25.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.556 -0.715 . . . . 0.0 110.393 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.941 HD11 ' HB2' ' A' ' 86' ' ' ALA . 25.2 mt -48.07 -48.78 33.16 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.558 -0.713 . . . . 0.0 109.945 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.81 -28.95 17.24 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.367 -0.833 . . . . 0.0 109.929 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -89.0 -54.02 4.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.485 -0.759 . . . . 0.0 110.361 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.725 ' HB1' HD13 ' A' ' 104' ' ' LEU . . . -75.71 -7.49 54.49 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.32 -0.862 . . . . 0.0 110.902 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.638 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.71 0 O-C-N 121.094 -1.003 . . . . 0.0 110.067 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 120.755 0.312 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.592 ' CE3' HD21 ' A' ' 31' ' ' LEU . 3.2 t90 -72.49 -2.4 19.5 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.089 -1.007 . . . . 0.0 110.932 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.602 HD11 ' HB1' ' A' ' 36' ' ' ALA . 31.7 mt -81.58 -53.86 5.9 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.072 -1.017 . . . . 0.0 109.545 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.45 -38.33 87.13 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.605 -0.685 . . . . 0.0 110.245 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.503 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.1 OUTLIER -60.66 -48.58 81.16 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.321 -0.862 . . . . 0.0 109.838 179.572 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.654 ' HB1' ' HB3' ' A' ' 24' ' ' ARG . . . -67.96 -49.2 63.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.386 -0.821 . . . . 0.0 109.651 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.542 ' HB1' ' CB ' ' A' ' 52' ' ' MET . . . -54.09 -45.42 71.78 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.38 -0.825 . . . . 0.0 109.681 179.48 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.34 -26.71 65.74 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.474 -0.766 . . . . 0.0 109.986 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.5 mtp85 -95.91 27.42 3.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.428 -0.795 . . . . 0.0 110.148 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.09 42.89 40.68 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.654 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -113.24 69.29 0.69 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.401 -1.058 . . . . 0.0 110.667 -179.576 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 1.03 HG22 HG22 ' A' ' 59' ' ' VAL . 85.9 t -58.71 -54.32 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.255 -0.903 . . . . 0.0 110.288 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -54.18 -41.58 68.7 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.428 -0.795 . . . . 0.0 110.854 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.407 ' OE1' ' HG2' ' A' ' 24' ' ' ARG . 1.6 tp10 -56.73 -45.23 82.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.192 -0.943 . . . . 0.0 110.035 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.959 HG12 HD12 ' A' ' 32' ' ' LEU . 20.1 t -68.72 -36.68 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.248 -0.907 . . . . 0.0 110.176 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.949 ' HA ' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -49.98 -41.86 47.76 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.422 -0.799 . . . . 0.0 109.927 -179.665 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.587 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -75.71 -31.32 59.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.443 -0.786 . . . . 0.0 110.239 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.818 HD12 ' HA ' ' A' ' 28' ' ' VAL . 21.8 mt -74.23 -67.51 0.61 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.452 -0.78 . . . . 0.0 110.52 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.959 HD12 HG12 ' A' ' 28' ' ' VAL . 6.4 mt -45.58 -45.27 13.53 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.625 -0.672 . . . . 0.0 110.282 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -71.98 -23.88 61.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.527 -0.733 . . . . 0.0 110.405 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 30' ' ' ALA . . . -79.76 -4.66 52.93 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.139 -0.976 . . . . 0.0 110.509 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.23 26.89 4.42 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.776 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -71.41 165.28 24.11 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.432 -1.04 . . . . 0.0 110.414 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.501 ' O ' HD12 ' A' ' 16' ' ' LEU . 1.7 tp -98.02 110.7 56.93 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.555 -0.715 . . . . 0.0 110.074 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.496 ' O ' ' HG3' ' A' ' 48' ' ' PRO . 44.3 Cg_endo -70.37 -11.97 30.95 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.445 1.234 . . . . 0.0 110.844 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.436 ' O ' ' HD3' ' A' ' 41' ' ' PRO . 4.3 m-20 -103.01 16.05 27.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -0.928 . . . . 0.0 110.029 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.406 ' N ' HD23 ' A' ' 37' ' ' LEU . . . -76.67 111.29 15.07 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.418 -0.801 . . . . 0.0 110.118 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 39' ' ' ASN . 48.1 Cg_endo -72.8 146.61 42.98 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 123.603 1.318 . . . . 0.0 110.358 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -75.64 -156.94 0.06 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.418 -0.801 . . . . 0.0 109.864 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.15 2.14 24.63 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.335 -0.853 . . . . 0.0 110.035 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -102.0 20.49 16.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.269 -0.894 . . . . 0.0 109.907 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.85 40.24 98.57 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.68 -163.18 1.24 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.671 -0.899 . . . . 0.0 110.517 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.483 ' O ' HG12 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -114.32 176.24 1.57 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.482 -0.761 . . . . 0.0 110.591 -179.243 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.496 ' HG3' ' O ' ' A' ' 38' ' ' PRO . 43.1 Cg_endo -70.97 -20.3 29.3 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.825 1.434 . . . . 0.0 110.791 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.487 ' O ' ' CG ' ' A' ' 52' ' ' MET . 6.3 mt -107.09 -40.28 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.284 -0.885 . . . . 0.0 109.39 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.47 ' HB2' ' HB2' ' A' ' 47' ' ' ARG . 1.1 tt0 -48.46 -28.73 3.49 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.282 -0.886 . . . . 0.0 110.477 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 47' ' ' ARG . 9.1 p -109.88 16.94 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.513 -0.742 . . . . 0.0 110.554 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.556 ' CE ' ' HB2' ' A' ' 60' ' ' ALA . 0.5 OUTLIER -84.58 166.72 16.93 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.09 -1.006 . . . . 0.0 110.261 179.533 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -62.26 91.41 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.334 -0.854 . . . . 0.0 109.092 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.591 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -56.07 -14.28 2.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.21 -0.931 . . . . 0.0 110.31 -179.429 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.401 ' C ' ' CE2' ' A' ' 90' ' ' PHE . . . -84.11 15.37 39.11 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 178.412 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.624 ' O ' HG23 ' A' ' 59' ' ' VAL . 0.4 OUTLIER -151.06 92.83 1.85 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.208 -1.172 . . . . 0.0 109.987 179.703 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.643 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . . . -58.49 -21.06 50.55 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.254 -0.903 . . . . 0.0 109.509 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.84 -28.74 66.35 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.553 -0.717 . . . . 0.0 110.083 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 1.03 HG22 HG22 ' A' ' 25' ' ' VAL . 2.1 t -70.89 -55.21 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.268 -0.895 . . . . 0.0 109.231 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.556 ' HB2' ' CE ' ' A' ' 52' ' ' MET . . . -51.42 -38.12 51.97 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.382 -0.824 . . . . 0.0 109.585 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.493 ' O ' ' HB3' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -53.35 -61.1 2.52 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.626 -0.671 . . . . 0.0 110.35 179.818 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.949 HD11 ' HA ' ' A' ' 29' ' ' ARG . 0.1 OUTLIER -45.81 -63.62 0.93 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.324 -0.86 . . . . 0.0 110.345 179.74 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.839 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 7.0 mt -57.9 -57.19 13.88 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.456 -0.778 . . . . 0.0 110.118 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.815 HD22 ' CG1' ' A' ' 96' ' ' VAL . 0.6 OUTLIER -53.21 -54.02 42.22 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.266 -0.896 . . . . 0.0 110.109 179.878 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.493 ' HB3' ' O ' ' A' ' 61' ' ' GLU . 13.2 tp -50.27 -36.76 32.74 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.87 ' CG ' HD22 ' A' ' 32' ' ' LEU . 2.1 m80 -79.55 -28.24 41.24 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.504 0.669 . . . . 0.0 109.64 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 117.75 50.86 0.35 Allowed Glycine 0 N--CA 1.476 1.344 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.839 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -60.6 -159.94 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.21 -1.17 . . . . 0.0 109.477 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.45 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 0.6 OUTLIER -120.61 59.67 7.41 Favored Pre-proline 0 C--N 1.299 -1.616 0 O-C-N 121.231 -0.918 . . . . 0.0 109.465 178.941 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.431 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 47.7 Cg_endo -70.29 57.51 1.72 Allowed 'Trans proline' 0 C--N 1.313 -1.293 0 O-C-N 123.7 1.369 . . . . 0.0 110.415 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -167.3 -62.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.46 -0.775 . . . . 0.0 109.942 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 22.3 m -50.03 138.79 15.06 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.4 -0.812 . . . . 0.0 110.624 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.425 ' HB2' ' HA ' ' A' ' 80' ' ' ARG . . . -136.94 -144.07 0.19 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.397 -0.814 . . . . 0.0 110.109 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.3 144.04 28.38 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.006 -1.059 . . . . 0.0 109.906 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -72.59 -53.73 0.14 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.549 1.289 . . . . 0.0 110.55 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.86 -9.14 49.79 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.241 -0.912 . . . . 0.0 109.714 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 79' ' ' THR . 0.2 OUTLIER -153.48 105.03 2.8 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.642 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.608 HD22 ' NH1' ' A' ' 80' ' ' ARG . 27.8 mt -67.77 53.29 0.06 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.507 -0.746 . . . . 0.0 111.08 -178.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.514 ' HA ' ' OD1' ' A' ' 108' ' ' ASP . 3.6 m -79.8 85.02 5.51 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.104 -0.997 . . . . 0.0 109.528 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.78 ' CD ' HG11 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -71.96 169.95 14.3 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.488 -0.757 . . . . 0.0 109.568 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.486 ' HD2' ' CG ' ' A' ' 80' ' ' ARG . 46.9 Cg_endo -74.42 -2.32 12.23 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.578 1.304 . . . . 0.0 110.391 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.902 HG13 HD23 ' A' ' 104' ' ' LEU . 10.5 t -77.7 -31.32 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.465 -0.772 . . . . 0.0 109.766 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.411 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 27.2 m80 -69.78 -27.26 64.76 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.43 -0.794 . . . . 0.0 109.915 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.591 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 1.1 m-20 -67.64 -53.88 24.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.863 -0.523 . . . . 0.0 110.263 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.51 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -50.02 -58.05 6.29 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.538 -0.727 . . . . 0.0 109.581 179.352 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.809 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -63.41 -38.06 89.67 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.47 -0.769 . . . . 0.0 110.52 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 1.5 mmm-85 -40.7 -59.87 1.28 Allowed 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.116 -0.99 . . . . 0.0 111.125 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -85.18 3.73 37.82 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.232 -0.917 . . . . 0.0 110.156 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.645 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 74.75 48.22 12.99 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.643 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.3 OUTLIER -111.56 97.49 6.77 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.398 -1.06 . . . . 0.0 111.049 -179.536 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.49 HD12 ' HB3' ' A' ' 125' ' ' ASP . 0.3 OUTLIER -67.06 -42.48 84.69 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.592 -0.692 . . . . 0.0 110.498 179.603 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.431 ' O ' HG23 ' A' ' 96' ' ' VAL . 50.0 m-20 -45.65 -63.61 0.92 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.464 -0.772 . . . . 0.0 110.37 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.472 ' O ' HD12 ' A' ' 97' ' ' LEU . 70.9 m -47.39 -38.49 13.35 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.702 -0.624 . . . . 0.0 109.549 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.718 HD21 ' HG ' ' A' ' 130' ' ' LEU . 4.1 tp -61.84 -48.85 78.71 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.405 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.426 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 98.2 t -60.96 -50.87 78.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.491 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.815 ' CG1' HD22 ' A' ' 64' ' ' LEU . 95.0 t -48.85 -57.31 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.727 -0.608 . . . . 0.0 110.209 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.632 HD23 ' HB1' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -43.07 -66.26 0.39 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.782 -0.574 . . . . 0.0 110.218 179.885 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -55.37 -32.6 62.72 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.261 -0.899 . . . . 0.0 109.816 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 0.1 OUTLIER -61.71 -13.87 26.79 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.412 -0.805 . . . . 0.0 110.274 179.439 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.674 ' HB3' HD11 ' A' ' 64' ' ' LEU . . . -140.71 56.68 1.58 Allowed 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.374 -0.829 . . . . 0.0 110.575 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 57.7 98.17 0.01 OUTLIER Glycine 0 N--CA 1.489 2.185 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.632 ' HB1' HD23 ' A' ' 97' ' ' LEU . . . -157.84 95.89 1.44 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.333 -1.098 . . . . 0.0 110.018 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -62.15 106.97 0.8 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.293 -0.88 . . . . 0.0 110.028 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.902 HD23 HG13 ' A' ' 82' ' ' VAL . 1.8 mp -96.62 26.75 4.26 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.321 -0.862 . . . . 0.0 109.898 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -123.36 47.52 1.99 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.346 -0.846 . . . . 0.0 110.792 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.78 HG11 ' CD ' ' A' ' 80' ' ' ARG . 5.1 p -105.18 -175.33 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.189 -0.944 . . . . 0.0 109.454 179.172 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.694 ' H ' HG22 ' A' ' 106' ' ' VAL . 1.0 OUTLIER -142.56 122.02 13.21 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.187 -0.946 . . . . 0.0 110.83 -179.589 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.514 ' OD1' ' HA ' ' A' ' 79' ' ' THR . 1.6 m-20 . . . . . 0 N--CA 1.495 1.789 0 O-C-N 121.558 -0.714 . . . . 0.0 109.715 179.079 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.425 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.712 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.425 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 43.5 Cg_endo -70.37 -31.13 18.33 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.703 1.37 . . . . 0.0 110.768 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.447 HG13 ' N ' ' A' ' 116' ' ' ASP . 9.6 p -80.09 -38.93 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.16 -0.963 . . . . 0.0 110.489 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.447 ' N ' HG13 ' A' ' 115' ' ' VAL . 81.7 m-20 -65.86 -34.39 78.02 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.266 -0.897 . . . . 0.0 110.023 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.01 -34.49 78.12 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.261 -0.9 . . . . 0.0 109.925 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.869 ' HB1' ' HB2' ' A' ' 123' ' ' HIS . . . -70.96 -55.23 8.79 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.314 -0.866 . . . . 0.0 110.7 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.51 ' HG3' ' HB1' ' A' ' 127' ' ' ALA . 12.8 mt-10 -46.84 -39.51 12.11 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.403 -0.811 . . . . 0.0 110.622 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -67.51 -51.34 52.23 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.482 -0.761 . . . . 0.0 109.904 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.436 ' HB3' ' NE2' ' A' ' 123' ' ' HIS . 0.2 OUTLIER -67.19 -87.39 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.354 -0.841 . . . . 0.0 110.225 179.807 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 179.36 32.29 0.06 OUTLIER Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.752 -1.213 . . . . 0.0 110.07 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.869 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . 0.9 OUTLIER -98.29 45.96 1.01 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.171 -1.193 . . . . 0.0 108.882 179.415 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -44.58 -37.17 3.41 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.502 0.668 . . . . 0.0 109.836 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.49 ' HB3' HD12 ' A' ' 91' ' ' LEU . 0.4 OUTLIER -66.58 -44.66 81.63 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.67 -0.644 . . . . 0.0 109.556 179.058 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.809 HG11 ' HA ' ' A' ' 86' ' ' ALA . 2.4 t -75.52 -44.36 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.229 -0.919 . . . . 0.0 110.031 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.51 ' HB1' ' HG3' ' A' ' 119' ' ' GLU . . . -57.27 -24.18 53.19 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.191 -0.943 . . . . 0.0 109.965 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.74 -63.0 1.18 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.297 -0.877 . . . . 0.0 109.818 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -59.05 -41.26 87.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.483 -0.761 . . . . 0.0 109.36 179.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.718 ' HG ' HD21 ' A' ' 94' ' ' LEU . 13.2 mt -51.3 -64.24 0.87 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.495 -0.753 . . . . 0.0 109.539 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.7 ttt-85 -51.6 -21.69 2.76 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.298 -0.876 . . . . 0.0 110.317 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -88.51 -51.69 5.57 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.383 -0.823 . . . . 0.0 110.515 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -86.78 -16.46 36.22 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.247 -0.908 . . . . 0.0 111.206 -179.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.494 1.742 0 O-C-N 121.034 -1.041 . . . . 0.0 110.33 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 121.105 0.479 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.45 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 16.0 m0 -75.4 -20.22 59.06 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.148 -0.97 . . . . 0.0 109.981 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.719 HD13 HD11 ' A' ' 63' ' ' LEU . 1.2 pp -67.86 -35.22 78.16 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.396 -0.815 . . . . 0.0 110.043 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.14 -42.11 24.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.39 -0.819 . . . . 0.0 110.394 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.45 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.0 OUTLIER -59.85 -58.4 8.74 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.363 -0.836 . . . . 0.0 110.51 -179.655 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.19 -45.38 65.14 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.165 -0.959 . . . . 0.0 109.784 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.553 ' HB1' ' CB ' ' A' ' 52' ' ' MET . . . -50.83 -53.79 29.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.604 -0.685 . . . . 0.0 110.037 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.799 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -56.01 -31.8 63.41 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.164 -0.96 . . . . 0.0 110.078 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.58 21.8 5.99 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.38 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 49.43 76.02 0.18 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -140.76 63.84 1.45 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.57 -0.959 . . . . 0.0 109.405 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.501 ' CG1' ' NE ' ' A' ' 29' ' ' ARG . 13.6 t -49.21 -51.44 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.493 -0.755 . . . . 0.0 110.101 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.69 -51.14 52.37 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.74 -0.6 . . . . 0.0 110.669 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.506 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 5.4 tt0 -56.09 -44.96 79.52 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.329 -0.857 . . . . 0.0 109.874 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.81 HG12 ' CD1' ' A' ' 62' ' ' LEU . 38.4 t -71.28 -47.06 62.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.472 -0.767 . . . . 0.0 109.796 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.511 ' HA ' ' CD1' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -39.17 -52.68 1.91 Allowed 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.55 -0.719 . . . . 0.0 110.285 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.9 -49.53 14.02 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.679 -0.638 . . . . 0.0 110.733 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 27' ' ' GLU . 41.2 mt -44.73 -66.76 0.35 Allowed 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.32 -0.863 . . . . 0.0 110.635 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.98 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 0.6 OUTLIER -50.2 -53.93 24.49 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.46 -0.775 . . . . 0.0 110.296 179.681 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 29' ' ' ARG . 0.5 OUTLIER -63.84 -6.86 6.52 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.442 -0.786 . . . . 0.0 110.962 179.325 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -100.81 -13.43 18.41 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.853 -1.154 . . . . 0.0 111.56 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 146.38 -10.62 1.52 Allowed Glycine 0 N--CA 1.49 2.27 0 C-N-CA 119.323 -1.418 . . . . 0.0 110.45 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.98 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -56.18 140.56 43.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.929 -1.336 . . . . 0.0 109.87 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.951 ' HB2' ' HB2' ' A' ' 40' ' ' ALA . 18.3 mt -79.21 143.07 59.95 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.382 -0.824 . . . . 0.0 110.213 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.491 ' HB3' ' HB3' ' A' ' 66' ' ' HIS . 43.5 Cg_endo -72.54 -37.35 4.22 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.358 1.188 . . . . 0.0 110.125 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -100.59 5.64 43.99 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.403 -0.811 . . . . 0.0 110.534 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.951 ' HB2' ' HB2' ' A' ' 37' ' ' LEU . . . -39.75 101.36 0.23 Allowed Pre-proline 0 N--CA 1.501 2.098 0 O-C-N 121.471 -0.768 . . . . 0.0 111.358 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 40' ' ' ALA . 54.1 Cg_endo -72.58 159.26 49.29 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.828 1.436 . . . . 0.0 109.651 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.51 ' N ' ' OD1' ' A' ' 42' ' ' ASN . 10.8 p-10 -131.5 170.87 14.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.473 -0.767 . . . . 0.0 109.913 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.5 m -87.13 12.37 11.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.387 -0.821 . . . . 0.0 110.434 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.465 ' HB3' ' ND2' ' A' ' 42' ' ' ASN . 4.2 t80 -93.16 19.77 7.64 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.241 -0.912 . . . . 0.0 109.644 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 48.38 23.2 2.89 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 -179.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -138.57 106.17 5.59 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.63 -0.924 . . . . 0.0 110.845 -179.242 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.532 ' CB ' ' HD2' ' A' ' 48' ' ' PRO . 1.1 mpt_? -54.86 -175.39 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.55 -0.719 . . . . 0.0 109.619 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.532 ' HD2' ' CB ' ' A' ' 47' ' ' ARG . 43.0 Cg_endo -69.09 170.55 15.53 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.145 1.076 . . . . 0.0 109.732 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.531 ' O ' ' CG ' ' A' ' 52' ' ' MET . 3.2 mt 63.27 -58.78 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.794 -0.566 . . . . 0.0 110.578 -179.09 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.488 ' N ' ' O ' ' A' ' 48' ' ' PRO . 0.4 OUTLIER -48.68 -25.57 1.85 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.569 -1.332 . . . . 0.0 109.797 179.342 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.799 HG22 ' HB2' ' A' ' 21' ' ' ALA . 12.0 p -110.39 18.6 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 121.606 -0.684 . . . . 0.0 109.378 178.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.553 ' CB ' ' HB1' ' A' ' 20' ' ' ALA . 0.5 OUTLIER -92.72 167.67 11.73 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.242 -0.911 . . . . 0.0 110.057 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 5.5 ttp -69.26 107.52 3.29 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.159 -1.016 . . . . 0.0 109.32 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.527 ' HE2' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -66.41 -3.91 7.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.087 -1.008 . . . . 0.0 109.861 179.501 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -89.97 16.91 55.85 Favored Glycine 0 N--CA 1.484 1.889 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 178.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.93 117.29 2.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -1.177 . . . . 0.0 109.704 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.513 ' HB2' ' HE2' ' A' ' 90' ' ' PHE . . . -79.52 -27.06 41.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.308 -0.87 . . . . 0.0 110.368 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.51 ' O ' ' NH1' ' A' ' 29' ' ' ARG . 5.8 mmt180 -48.84 -38.25 21.77 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.181 -0.95 . . . . 0.0 110.267 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.438 HG22 ' CG2' ' A' ' 25' ' ' VAL . 24.3 t -62.64 -63.56 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 120.987 -1.071 . . . . 0.0 109.116 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.528 ' HB2' ' CE ' ' A' ' 52' ' ' MET . . . -52.13 -29.87 23.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.46 -0.775 . . . . 0.0 109.375 178.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -54.53 -66.4 0.41 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.029 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.81 ' CD1' HG12 ' A' ' 28' ' ' VAL . 0.1 OUTLIER -44.09 -61.63 1.41 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.402 -0.811 . . . . 0.0 109.564 178.746 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.816 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 4.3 mm? -47.92 -66.87 0.33 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.309 0.576 . . . . 0.0 109.927 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 1.032 HD23 HG12 ' A' ' 96' ' ' VAL . 20.0 tp -52.85 -53.01 54.87 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.438 -0.788 . . . . 0.0 110.633 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.451 ' HB3' ' O ' ' A' ' 61' ' ' GLU . 13.5 tp -49.53 -39.04 32.94 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.844 0.831 . . . . 0.0 108.956 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.927 ' CG ' HD22 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -81.34 -31.15 33.56 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.458 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 63' ' ' LEU . . . 124.21 56.19 0.18 Allowed Glycine 0 N--CA 1.481 1.661 0 C-N-CA 120.367 -0.92 . . . . 0.0 111.116 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.816 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -73.91 -154.4 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.841 -1.388 . . . . 0.0 110.103 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -122.49 77.58 45.83 Favored Pre-proline 0 N--CA 1.489 1.478 0 C-N-CA 119.824 -0.75 . . . . 0.0 109.985 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.508 ' HG3' ' CD1' ' A' ' 64' ' ' LEU . 53.7 Cg_endo -76.85 -11.61 18.17 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 O-C-N 124.067 1.562 . . . . 0.0 110.0 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.418 ' OD1' ' CB ' ' A' ' 103' ' ' ARG . 7.1 t30 -108.5 -64.36 1.23 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.493 -0.754 . . . . 0.0 109.741 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -46.07 139.95 4.15 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.421 0.629 . . . . 0.0 110.761 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.535 ' HB2' ' HA ' ' A' ' 80' ' ' ARG . . . -132.82 -150.39 0.41 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.658 -0.651 . . . . 0.0 110.187 -179.46 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.515 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -101.33 143.47 26.67 Favored Pre-proline 0 C--N 1.305 -1.343 0 O-C-N 121.216 -0.928 . . . . 0.0 109.746 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -71.87 -29.87 14.8 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.517 1.272 . . . . 0.0 110.728 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -47.86 -80.83 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.412 -0.805 . . . . 0.0 110.702 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.1 p -115.31 30.71 7.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.423 -0.798 . . . . 0.0 109.878 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.515 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 2.8 mt 44.54 46.22 8.09 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.607 -0.683 . . . . 0.0 111.541 179.303 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.484 ' O ' ' NE2' ' A' ' 50' ' ' GLN . 0.2 OUTLIER -72.77 95.62 1.93 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.21 -0.931 . . . . 0.0 109.881 179.62 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.754 ' HD3' HG21 ' A' ' 106' ' ' VAL . 0.5 OUTLIER -71.92 154.4 92.65 Favored Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.397 -0.814 . . . . 0.0 109.952 179.805 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.597 ' HD2' ' HG3' ' A' ' 80' ' ' ARG . 48.3 Cg_endo -72.01 -13.71 28.96 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 O-C-N 123.577 1.303 . . . . 0.0 109.973 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.418 ' CG1' HD21 ' A' ' 130' ' ' LEU . 21.2 t -61.96 -27.4 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 CA-C-O 121.534 0.683 . . . . 0.0 109.661 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.512 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 4.2 m80 -72.72 -42.86 63.69 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.527 ' HB3' ' HE2' ' A' ' 54' ' ' MET . 0.6 OUTLIER -45.23 -51.78 10.32 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.548 -0.72 . . . . 0.0 110.091 179.249 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.528 ' HB1' HD13 ' A' ' 94' ' ' LEU . . . -56.78 -64.94 0.71 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.582 -0.699 . . . . 0.0 109.794 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.824 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -61.22 -54.0 49.72 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.58 -0.7 . . . . 0.0 111.594 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.724 ' O ' HD22 ' A' ' 121' ' ' LEU . 0.4 OUTLIER -40.18 -31.48 0.13 Allowed 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.3 -0.875 . . . . 0.0 110.976 -179.741 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -100.88 -17.85 16.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.154 -0.966 . . . . 0.0 109.602 179.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.537 ' HA3' ' CE1' ' A' ' 123' ' ' HIS . . . 89.27 41.31 5.85 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.513 ' HE2' ' HB2' ' A' ' 57' ' ' ALA . 2.1 t80 -110.64 123.48 50.08 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.656 -0.908 . . . . 0.0 110.368 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.545 ' CD2' ' HA ' ' A' ' 126' ' ' VAL . 0.0 OUTLIER -94.38 -44.31 7.97 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.5 -0.75 . . . . 0.0 110.24 -179.748 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.812 ' O ' HG23 ' A' ' 96' ' ' VAL . 0.9 OUTLIER -44.58 -31.35 1.11 Allowed 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 121.368 0.604 . . . . 0.0 109.858 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.456 HG22 HD13 ' A' ' 97' ' ' LEU . 8.7 m -76.1 -49.19 18.09 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.326 -0.859 . . . . 0.0 108.767 178.454 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 1.005 HD21 ' HG ' ' A' ' 130' ' ' LEU . 1.1 mp -50.74 -49.05 58.77 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.01 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.503 HG23 HD12 ' A' ' 91' ' ' LEU . 84.5 t -56.52 -60.96 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.695 -0.628 . . . . 0.0 109.536 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 1.032 HG12 HD23 ' A' ' 64' ' ' LEU . 49.1 t -47.36 -52.25 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.456 HD13 HG22 ' A' ' 93' ' ' THR . 0.1 OUTLIER -46.02 -64.15 0.81 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.797 -0.564 . . . . 0.0 111.038 179.228 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -63.08 -31.26 72.36 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.156 -0.965 . . . . 0.0 110.084 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.488 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 1.2 ttt85 -63.07 -12.97 30.4 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.263 -0.898 . . . . 0.0 110.825 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.665 ' HB3' HD21 ' A' ' 64' ' ' LEU . . . -139.94 58.54 1.59 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.216 -0.928 . . . . 0.0 110.647 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 55.93 106.03 0.01 OUTLIER Glycine 0 N--CA 1.488 2.15 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.307 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -164.36 124.76 2.08 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.426 -1.044 . . . . 0.0 109.787 179.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.418 ' CB ' ' OD1' ' A' ' 71' ' ' ASN . 10.9 ttp180 -82.58 135.52 35.06 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.237 -0.914 . . . . 0.0 110.287 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.77 HD13 ' HB1' ' A' ' 133' ' ' ALA . 1.7 mp -121.36 21.2 11.14 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.263 -0.898 . . . . 0.0 110.504 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -123.63 54.0 1.32 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.325 -0.859 . . . . 0.0 111.126 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.754 HG21 ' HD3' ' A' ' 80' ' ' ARG . 3.9 p -112.93 -174.11 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.824 -1.172 . . . . 0.0 110.405 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.712 ' H ' HG22 ' A' ' 106' ' ' VAL . 18.7 mtm180 -133.91 138.83 45.77 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.623 -0.673 . . . . 0.0 109.306 179.045 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.437 -0.789 . . . . 0.0 109.941 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.484 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 110.259 -0.274 . . . . 0.0 110.259 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.49 ' HB3' ' CE1' ' A' ' 83' ' ' HIS . 41.4 Cg_endo -74.05 -47.81 0.24 Allowed 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.975 1.513 . . . . 0.0 109.524 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.419 HG13 ' N ' ' A' ' 116' ' ' ASP . 8.8 p -60.58 -35.46 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.528 -0.733 . . . . 0.0 110.382 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.419 ' N ' HG13 ' A' ' 115' ' ' VAL . 0.7 OUTLIER -61.63 -51.88 66.67 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.407 -0.808 . . . . 0.0 109.739 179.873 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.57 HD23 HD13 ' A' ' 121' ' ' LEU . 0.3 OUTLIER -57.58 -37.32 73.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.764 -0.585 . . . . 0.0 111.078 -179.382 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.764 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -57.5 -54.67 44.25 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.286 -0.884 . . . . 0.0 110.498 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -65.51 -17.8 64.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.286 -0.884 . . . . 0.0 110.444 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -76.12 -44.68 37.37 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.306 -0.871 . . . . 0.0 110.557 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.724 HD22 ' O ' ' A' ' 87' ' ' ARG . 6.7 mp -88.26 13.83 10.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -0.904 . . . . 0.0 110.411 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 76.8 48.04 9.12 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.537 ' CE1' ' HA3' ' A' ' 89' ' ' GLY . 30.1 m-70 -120.55 45.13 2.29 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.019 -1.283 . . . . 0.0 109.343 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -43.82 -46.04 7.62 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.524 -0.735 . . . . 0.0 110.077 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.497 ' O ' HD21 ' A' ' 91' ' ' LEU . 6.0 t70 -54.56 -44.0 72.54 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.528 0.68 . . . . 0.0 109.63 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.824 HG11 ' HA ' ' A' ' 86' ' ' ALA . 1.8 t -76.74 -28.45 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.13 -57.25 6.37 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.761 -0.587 . . . . 0.0 109.801 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -50.4 -57.93 6.86 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.413 -0.804 . . . . 0.0 110.472 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.479 ' HB3' HD23 ' A' ' 94' ' ' LEU . 33.5 t80 -53.41 -35.99 61.01 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.37 -0.832 . . . . 0.0 109.146 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 1.005 ' HG ' HD21 ' A' ' 94' ' ' LEU . 10.1 mt -71.9 -59.53 2.7 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.593 -0.692 . . . . 0.0 109.24 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -49.0 -27.8 3.44 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.691 -0.631 . . . . 0.0 110.821 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -76.6 -52.04 10.45 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.111 -0.993 . . . . 0.0 109.944 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.77 ' HB1' HD13 ' A' ' 104' ' ' LEU . . . -84.54 -10.4 57.46 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.429 -0.794 . . . . 0.0 110.489 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.568 ' CB ' ' O ' ' A' ' 104' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.29 -0.881 . . . . 0.0 109.878 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.404 ' O ' ' OG1' ' A' ' 18' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.931 0.396 . . . . 0.0 110.035 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.539 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 1.1 t90 -74.96 -6.77 51.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.394 -0.816 . . . . 0.0 110.734 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.752 HD11 ' HB1' ' A' ' 36' ' ' ALA . 19.1 mt -78.69 -49.52 12.98 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.17 -0.956 . . . . 0.0 109.463 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.498 ' HB2' ' ND2' ' A' ' 42' ' ' ASN . . . -69.35 -44.99 70.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.567 -0.708 . . . . 0.0 109.988 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.539 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.0 OUTLIER -50.31 -59.89 3.52 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.473 -0.767 . . . . 0.0 110.435 179.799 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.729 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -63.52 -33.83 76.44 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.505 -0.747 . . . . 0.0 110.206 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.527 ' HB1' ' CB ' ' A' ' 52' ' ' MET . . . -68.55 -43.88 75.69 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.093 -1.004 . . . . 0.0 109.699 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.98 -20.14 63.54 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.383 -0.823 . . . . 0.0 109.786 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -99.58 22.28 11.06 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.422 -0.799 . . . . 0.0 110.451 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.493 ' HA3' ' HE2' ' A' ' 53' ' ' MET . . . 47.68 55.15 9.87 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.473 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . 0.8 OUTLIER -126.37 89.93 3.09 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.513 -0.992 . . . . 0.0 109.483 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.543 HG22 ' CG2' ' A' ' 59' ' ' VAL . 55.7 t -64.31 -63.61 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.435 -0.79 . . . . 0.0 111.199 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -43.71 -33.48 1.25 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.551 -0.718 . . . . 0.0 111.043 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.673 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -60.8 -65.92 0.61 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.292 -0.88 . . . . 0.0 109.661 179.288 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.859 HG12 HD12 ' A' ' 32' ' ' LEU . 5.1 t -63.66 -41.04 91.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.821 -0.55 . . . . 0.0 110.289 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.455 ' CA ' HD22 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -44.7 -39.09 4.84 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.629 -0.669 . . . . 0.0 110.438 -179.548 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.64 -43.99 24.89 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.458 -0.776 . . . . 0.0 110.008 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.61 HD12 ' HA ' ' A' ' 28' ' ' VAL . 50.3 mt -55.46 -64.59 0.8 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.087 -1.008 . . . . 0.0 109.663 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.923 HD22 ' CG ' ' A' ' 66' ' ' HIS . 2.3 mt -49.37 -39.3 31.59 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.471 -0.768 . . . . 0.0 110.384 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -67.32 -25.58 66.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.527 -0.733 . . . . 0.0 110.177 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.17 -8.1 58.76 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.319 -0.863 . . . . 0.0 109.91 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.46 31.84 2.09 Favored Glycine 0 N--CA 1.489 2.179 0 C-N-CA 120.19 -1.005 . . . . 0.0 110.844 178.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.752 ' HB1' HD11 ' A' ' 16' ' ' LEU . . . -63.3 178.59 0.51 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.956 -1.32 . . . . 0.0 110.52 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.719 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 0.4 OUTLIER -92.18 124.19 60.45 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.398 -0.814 . . . . 0.0 109.947 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.513 ' HB2' ' O ' ' A' ' 67' ' ' GLY . 43.2 Cg_endo -68.22 -39.77 9.7 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.629 1.331 . . . . 0.0 110.742 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.469 ' HA ' ' OE1' ' A' ' 69' ' ' GLU . 3.2 m-20 -112.24 61.63 0.63 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.236 -0.915 . . . . 0.0 109.758 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.719 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -92.57 109.27 37.44 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.302 -0.874 . . . . 0.0 110.296 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -71.81 113.69 3.73 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 O-C-N 123.634 1.334 . . . . 0.0 109.595 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.498 ' ND2' ' HB2' ' A' ' 17' ' ' ALA . 16.3 m120 -73.68 174.23 8.66 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.559 -0.713 . . . . 0.0 109.596 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.95 21.91 1.83 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.358 -0.839 . . . . 0.0 110.354 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -109.58 20.76 17.8 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.163 -0.961 . . . . 0.0 110.533 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 57.88 24.22 53.28 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 55.0 mtt180 -131.75 -163.85 1.38 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.346 -1.09 . . . . 0.0 109.701 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.609 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 1.6 mmt180 -109.11 -171.1 0.21 Allowed Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.189 -0.944 . . . . 0.0 110.231 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.609 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 42.6 Cg_endo -80.13 -18.16 10.14 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 O-C-N 123.303 1.159 . . . . 0.0 111.08 -178.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.546 ' O ' ' HG2' ' A' ' 52' ' ' MET . 6.6 mt -107.1 -43.44 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.991 -1.068 . . . . 0.0 108.867 178.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 49' ' ' ILE . 0.8 OUTLIER -43.88 -31.47 0.87 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.095 -1.003 . . . . 0.0 109.909 179.556 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 51' ' ' VAL . 7.9 p -111.53 34.16 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.442 -0.786 . . . . 0.0 110.138 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.591 ' CE ' ' HB2' ' A' ' 60' ' ' ALA . 0.1 OUTLIER -91.11 30.1 1.29 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.027 -1.045 . . . . 0.0 109.643 179.19 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.506 ' CB ' ' O ' ' A' ' 52' ' ' MET . 4.8 tmm? 75.61 -13.54 0.86 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.859 -0.526 . . . . 0.0 111.866 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.552 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 47.11 28.18 0.9 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.956 -1.09 . . . . 0.0 110.234 -179.873 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.456 ' C ' ' CE2' ' A' ' 90' ' ' PHE . . . -125.85 4.56 7.96 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.452 ' HB3' HG23 ' A' ' 59' ' ' VAL . 0.5 OUTLIER -149.25 79.14 1.4 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.348 -1.089 . . . . 0.0 110.301 179.294 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -46.56 -34.04 4.6 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.397 -0.814 . . . . 0.0 109.592 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 56.3 mtt180 -44.44 -44.27 8.35 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.369 0.604 . . . . 0.0 109.668 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.543 ' CG2' HG22 ' A' ' 25' ' ' VAL . 60.8 t -62.05 -56.94 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.036 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.591 ' HB2' ' CE ' ' A' ' 52' ' ' MET . . . -47.61 -38.13 13.95 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.52 -0.737 . . . . 0.0 109.401 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -66.34 -35.29 79.98 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.638 -0.664 . . . . 0.0 109.843 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.61 ' CD1' HD13 ' A' ' 32' ' ' LEU . 1.5 tp -71.57 -44.13 65.08 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.42 -0.8 . . . . 0.0 109.477 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.625 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 2.6 mt -77.71 -35.14 52.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 0.0 109.427 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.836 HD11 ' HB3' ' A' ' 100' ' ' ALA . 0.7 OUTLIER -64.84 -61.01 2.44 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.422 -0.799 . . . . 0.0 110.159 -179.709 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.7 HD12 ' C ' ' A' ' 65' ' ' LEU . 0.3 OUTLIER -52.37 -33.97 45.59 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.836 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.923 ' CG ' HD22 ' A' ' 32' ' ' LEU . 1.7 m80 -73.64 -39.84 64.19 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.299 0.571 . . . . 0.0 109.658 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.513 ' O ' ' HB2' ' A' ' 38' ' ' PRO . . . 134.54 45.82 0.1 Allowed Glycine 0 N--CA 1.481 1.643 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.625 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -64.76 -162.22 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.94 -1.329 . . . . 0.0 110.208 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.531 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -116.86 61.64 2.61 Favored Pre-proline 0 C--N 1.301 -1.514 0 O-C-N 121.628 -0.67 . . . . 0.0 109.347 179.504 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.483 ' O ' ' HG3' ' A' ' 81' ' ' PRO . 52.1 Cg_endo -71.29 -2.15 10.75 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 O-C-N 123.792 1.417 . . . . 0.0 111.107 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.479 ' HA ' ' NH1' ' A' ' 80' ' ' ARG . 4.2 m-80 -108.77 -61.08 1.66 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.278 -0.889 . . . . 0.0 110.115 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 29.8 t -45.25 166.62 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.66 -0.65 . . . . 0.0 110.562 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.422 ' HB2' ' HG2' ' A' ' 80' ' ' ARG . . . -160.4 -148.62 0.17 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.104 -0.997 . . . . 0.0 110.303 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.54 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.6 OUTLIER -110.06 140.22 22.13 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.189 -0.944 . . . . 0.0 109.845 179.871 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -78.21 -23.58 8.8 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.641 1.337 . . . . 0.0 110.533 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.02 -81.3 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.888 . . . . 0.0 110.249 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' A' ' 108' ' ' ASP . 0.2 OUTLIER -104.56 40.73 1.43 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.429 -0.794 . . . . 0.0 109.844 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.54 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 9.4 mt 31.95 40.56 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.0 m -67.45 104.63 1.59 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.983 -1.073 . . . . 0.0 110.181 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.841 ' HG3' HG11 ' A' ' 106' ' ' VAL . 0.7 OUTLIER -87.55 170.45 11.81 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.165 -0.959 . . . . 0.0 109.915 179.588 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.483 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 38.0 Cg_endo -68.71 -2.68 9.81 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.743 1.391 . . . . 0.0 109.72 178.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.738 HG13 HD23 ' A' ' 104' ' ' LEU . 10.5 t -82.06 -27.66 9.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 O-C-N 121.596 -0.69 . . . . 0.0 109.458 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.506 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 10.4 m80 -77.72 -40.08 42.43 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.298 -0.876 . . . . 0.0 108.794 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.558 ' O ' ' HB3' ' A' ' 87' ' ' ARG . 0.3 OUTLIER -54.64 -46.78 74.01 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.492 -0.755 . . . . 0.0 109.186 178.656 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.805 ' HB1' ' CD1' ' A' ' 94' ' ' LEU . . . -59.01 -69.01 0.21 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.244 -0.91 . . . . 0.0 109.214 178.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.807 ' HB1' ' HB2' ' A' ' 118' ' ' ALA . . . -60.38 -15.84 29.84 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.221 -0.925 . . . . 0.0 111.104 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.619 ' HA ' HD21 ' A' ' 117' ' ' LEU . 9.5 tpt180 -60.74 -45.82 92.83 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.854 -1.154 . . . . 0.0 109.455 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -101.66 -4.3 26.77 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.833 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.882 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 83.09 48.25 5.48 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.456 ' CE2' ' C ' ' A' ' 55' ' ' GLY . 0.4 OUTLIER -112.12 82.34 1.61 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.359 -1.083 . . . . 0.0 110.883 -179.245 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.622 HD11 ' O ' ' A' ' 125' ' ' ASP . 0.1 OUTLIER -57.08 -46.41 82.55 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.447 -0.783 . . . . 0.0 110.782 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.837 ' O ' HG23 ' A' ' 96' ' ' VAL . 35.7 t0 -45.84 -35.46 4.5 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.496 -0.753 . . . . 0.0 109.778 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 25.5 m -66.51 -59.33 3.74 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.841 HD13 HG13 ' A' ' 126' ' ' VAL . 1.2 mp -46.01 -52.65 11.45 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.684 -0.635 . . . . 0.0 109.462 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.461 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 26.4 t -44.84 -55.13 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.837 HG23 ' O ' ' A' ' 92' ' ' ASP . 13.4 t -55.49 -45.58 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.505 ' C ' ' HB2' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -56.31 -70.01 0.13 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.889 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 98' ' ' HIS . . . . . 0.469 ' HA ' ' HB3' ' A' ' 102' ' ' ALA . 3.4 t-160 -51.39 -40.84 60.08 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.493 -0.754 . . . . 0.0 109.44 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 7.5 ttt180 -59.81 -14.18 13.74 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.533 -0.729 . . . . 0.0 110.036 179.01 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.836 ' HB3' HD11 ' A' ' 64' ' ' LEU . . . -143.93 89.94 2.09 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 121.26 -0.9 . . . . 0.0 110.856 -179.26 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 100' ' ' ALA . . . 35.18 90.92 0.01 OUTLIER Glycine 0 N--CA 1.503 3.122 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 179.276 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.505 ' HB2' ' C ' ' A' ' 97' ' ' LEU . . . -143.91 89.81 2.08 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.107 -1.231 . . . . 0.0 110.739 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.9 ttt180 -64.72 133.73 52.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.151 -0.968 . . . . 0.0 110.078 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.738 HD23 HG13 ' A' ' 82' ' ' VAL . 0.8 OUTLIER -122.91 20.29 10.04 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.48 0.657 . . . . 0.0 109.286 179.631 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.22 39.87 1.43 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.504 -0.747 . . . . 0.0 110.037 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.841 HG11 ' HG3' ' A' ' 80' ' ' ARG . 2.5 p -109.65 -179.22 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.176 -0.952 . . . . 0.0 110.582 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.578 ' H ' HG22 ' A' ' 106' ' ' VAL . 59.4 mtt180 -141.31 140.7 33.86 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.49 -0.756 . . . . 0.0 109.771 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.49 ' HA ' ' O ' ' A' ' 77' ' ' THR . 3.6 p-10 . . . . . 0 N--CA 1.495 1.813 0 O-C-N 120.984 -1.072 . . . . 0.0 110.357 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.819 ' HB2' HG12 ' A' ' 115' ' ' VAL . 15.2 mt . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.592 ' HG3' ' CG1' ' A' ' 82' ' ' VAL . 37.8 Cg_endo -64.26 -11.07 26.14 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.844 1.444 . . . . 0.0 111.006 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.819 HG12 ' HB2' ' A' ' 113' ' ' LEU . 3.5 p -72.81 -32.47 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.149 -0.969 . . . . 0.0 109.725 179.215 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.64 -52.96 11.61 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.15 -0.969 . . . . 0.0 110.02 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.619 HD21 ' HA ' ' A' ' 87' ' ' ARG . 0.6 OUTLIER -57.2 -26.35 60.52 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.414 -0.804 . . . . 0.0 109.722 179.466 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.807 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -65.72 -58.25 6.12 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.374 -0.829 . . . . 0.0 108.895 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.07 -31.02 70.69 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.673 -0.642 . . . . 0.0 109.636 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.403 ' HB2' ' HA ' ' A' ' 117' ' ' LEU . 2.0 mt-10 -65.72 -49.73 67.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.611 -0.68 . . . . 0.0 110.343 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.551 ' HB3' ' NE2' ' A' ' 123' ' ' HIS . 22.7 mt -77.42 5.51 8.68 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.363 -0.836 . . . . 0.0 111.087 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 89.75 29.6 15.49 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 120.085 -1.055 . . . . 0.0 111.219 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.551 ' NE2' ' HB3' ' A' ' 121' ' ' LEU . 61.4 m-70 -109.37 54.48 0.66 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.002 -1.293 . . . . 0.0 109.836 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.486 ' HG3' ' N ' ' A' ' 125' ' ' ASP . 37.5 ptt180 -49.29 -39.92 32.69 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.487 0.661 . . . . 0.0 109.911 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.622 ' O ' HD11 ' A' ' 91' ' ' LEU . 4.6 m-20 -61.45 -45.18 95.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.618 -0.677 . . . . 0.0 109.611 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.882 HG21 ' HA2' ' A' ' 89' ' ' GLY . 3.2 t -75.65 -36.26 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.465 -0.772 . . . . 0.0 109.637 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.55 -58.16 7.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.626 -0.671 . . . . 0.0 109.417 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.3 ttt-85 -44.92 -55.83 5.11 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.611 -0.681 . . . . 0.0 110.505 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -60.52 -49.57 77.01 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.447 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.693 HD11 ' HB2' ' A' ' 86' ' ' ALA . 10.2 mt -53.54 -52.97 57.96 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.694 -0.629 . . . . 0.0 110.081 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.448 ' CA ' HG21 ' A' ' 115' ' ' VAL . 25.1 ttp180 -46.04 -37.3 6.52 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.57 -0.706 . . . . 0.0 110.282 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.79 -53.78 4.92 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.51 -0.743 . . . . 0.0 110.492 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -66.02 -7.96 20.27 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.307 -0.87 . . . . 0.0 110.385 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.354 -0.841 . . . . 0.0 109.967 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 121.014 0.435 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.568 ' HA ' ' CG2' ' A' ' 18' ' ' THR . 25.3 m0 -89.37 -15.58 32.99 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.176 -0.953 . . . . 0.0 111.03 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.743 HD23 ' O ' ' A' ' 37' ' ' LEU . 1.0 OUTLIER -79.17 -44.88 21.04 Favored 'General case' 0 N--CA 1.483 1.217 0 O-C-N 120.864 -1.148 . . . . 0.0 109.039 179.54 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.475 ' CB ' ' OD1' ' A' ' 42' ' ' ASN . . . -74.8 -41.18 60.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.437 -0.789 . . . . 0.0 110.109 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.568 ' CG2' ' HA ' ' A' ' 15' ' ' TRP . 4.3 t -58.43 -43.09 88.61 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.324 -0.86 . . . . 0.0 109.739 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.646 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -63.7 -44.12 94.6 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.345 -0.847 . . . . 0.0 110.054 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.584 ' HB1' ' CB ' ' A' ' 52' ' ' MET . . . -59.85 -45.27 92.97 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.411 -0.806 . . . . 0.0 110.3 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.571 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -68.13 -27.49 66.49 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.358 -0.839 . . . . 0.0 111.032 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' A' ' 18' ' ' THR . 11.0 mtp180 -94.4 20.49 8.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.248 -0.908 . . . . 0.0 110.77 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.83 37.29 83.74 Favored Glycine 0 N--CA 1.486 1.974 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.542 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -107.15 64.11 0.63 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.291 -1.123 . . . . 0.0 110.186 179.58 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.957 HG22 HG22 ' A' ' 59' ' ' VAL . 30.5 t -55.15 -44.78 76.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.42 -0.8 . . . . 0.0 109.179 179.296 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.86 -48.7 66.9 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.57 -0.706 . . . . 0.0 110.704 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.473 ' O ' ' HB2' ' A' ' 31' ' ' LEU . 0.8 OUTLIER -62.57 -34.34 76.77 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.253 -0.904 . . . . 0.0 110.35 -179.776 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 1.014 HG12 HD12 ' A' ' 32' ' ' LEU . 21.3 t -76.73 -50.19 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.385 -0.822 . . . . 0.0 110.181 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.959 ' CA ' HD11 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -43.4 -44.01 5.48 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.285 -0.884 . . . . 0.0 109.19 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.501 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -79.64 -54.79 5.54 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 120.124 -0.63 . . . . 0.0 109.486 178.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 27' ' ' GLU . 8.2 mt -50.56 -61.52 2.14 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.364 -0.835 . . . . 0.0 110.307 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.014 HD12 HG12 ' A' ' 28' ' ' VAL . 3.6 mt -45.76 -62.55 1.25 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.399 -0.813 . . . . 0.0 109.962 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -64.91 -16.12 62.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.455 -0.778 . . . . 0.0 110.832 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.501 ' HB2' ' O ' ' A' ' 30' ' ' ALA . . . -85.76 -6.79 59.06 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.239 -0.913 . . . . 0.0 111.308 -179.201 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.27 26.35 1.67 Allowed Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.719 -1.229 . . . . 0.0 110.466 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.935 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -74.61 170.64 15.36 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.145 -1.209 . . . . 0.0 110.308 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.898 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 1.3 mm? -103.22 96.64 8.53 Favored Pre-proline 0 C--N 1.302 -1.482 0 O-C-N 121.604 -0.685 . . . . 0.0 110.367 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.54 ' HB3' ' HB3' ' A' ' 66' ' ' HIS . 41.6 Cg_endo -68.16 -14.85 41.76 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.741 1.39 . . . . 0.0 110.791 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.472 ' O ' ' HD3' ' A' ' 41' ' ' PRO . 2.1 m-20 -111.31 16.16 21.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.025 -1.047 . . . . 0.0 110.342 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.898 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -75.23 110.52 10.47 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.282 -0.886 . . . . 0.0 110.595 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 39' ' ' ASN . 45.9 Cg_endo -74.46 108.18 2.62 Favored 'Trans proline' 0 C--N 1.318 -1.03 0 O-C-N 123.552 1.29 . . . . 0.0 109.788 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.475 ' OD1' ' CB ' ' A' ' 17' ' ' ALA . 27.8 m-80 -57.43 167.62 0.96 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.64 -0.663 . . . . 0.0 110.813 -179.116 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.13 2.66 17.3 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.516 -0.74 . . . . 0.0 110.329 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.552 ' CD1' ' N ' ' A' ' 44' ' ' TYR . 1.2 m-85 -91.49 21.64 4.47 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.272 -0.892 . . . . 0.0 109.478 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.445 ' O ' ' NH2' ' A' ' 47' ' ' ARG . . . 53.75 22.1 17.39 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 -178.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 16.8 mtt180 -119.95 -176.65 3.23 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.661 -0.905 . . . . 0.0 110.188 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.638 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 5.2 mmt180 -106.25 -173.48 0.28 Allowed Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.641 -0.662 . . . . 0.0 110.393 -178.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.638 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 52.2 Cg_endo -79.32 0.65 9.84 Favored 'Trans proline' 0 C--N 1.318 -1.038 0 O-C-N 123.438 1.23 . . . . 0.0 110.594 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.518 HG12 HD13 ' A' ' 63' ' ' LEU . 7.8 mt -121.53 -43.63 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.362 -0.836 . . . . 0.0 108.94 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.486 ' HG2' ' HB3' ' A' ' 81' ' ' PRO . 5.7 mt-30 -50.07 -23.11 1.91 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.323 -0.861 . . . . 0.0 109.59 178.327 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.571 HG22 ' HB2' ' A' ' 21' ' ' ALA . 8.8 p -106.75 -7.44 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.73 -0.606 . . . . 0.0 110.867 -179.379 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.617 ' HE1' ' HB2' ' A' ' 60' ' ' ALA . 0.3 OUTLIER -68.06 158.68 32.43 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.97 -1.081 . . . . 0.0 109.817 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.59 96.4 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.094 -1.004 . . . . 0.0 109.267 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.543 ' HE1' ' CE ' ' A' ' 52' ' ' MET . 0.0 OUTLIER -56.72 -14.8 3.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.176 -0.952 . . . . 0.0 110.414 -179.514 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.443 ' HA2' ' CD2' ' A' ' 90' ' ' PHE . . . -88.13 35.23 3.59 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 178.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -171.54 99.56 0.19 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.421 -1.047 . . . . 0.0 109.668 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.501 ' HB2' ' HE1' ' A' ' 90' ' ' PHE . . . -68.31 -25.0 64.91 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.213 -0.93 . . . . 0.0 110.017 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.89 -33.14 3.04 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.572 -0.705 . . . . 0.0 110.531 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.994 HG12 HD11 ' A' ' 63' ' ' LEU . 3.0 t -72.66 -58.78 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.454 -0.779 . . . . 0.0 109.341 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.617 ' HB2' ' HE1' ' A' ' 52' ' ' MET . . . -41.17 -46.7 3.12 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.656 -0.653 . . . . 0.0 110.311 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.625 ' OE2' HG13 ' A' ' 96' ' ' VAL . 0.8 OUTLIER -55.57 -55.3 33.59 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.204 -0.935 . . . . 0.0 109.643 179.235 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.997 HD13 HG12 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -47.79 -61.5 1.92 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.68 -0.637 . . . . 0.0 109.833 178.993 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.994 HD11 HG12 ' A' ' 59' ' ' VAL . 0.9 OUTLIER -59.66 -55.07 38.99 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.256 0.551 . . . . 0.0 109.604 179.411 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.828 HD13 HG12 ' A' ' 96' ' ' VAL . 0.6 OUTLIER -49.8 -55.62 13.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.62 -0.675 . . . . 0.0 109.439 179.48 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 22.1 tp -53.94 -37.56 64.01 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.843 0.83 . . . . 0.0 108.819 178.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.971 ' CG ' HD22 ' A' ' 32' ' ' LEU . 1.9 m80 -80.55 -5.59 56.99 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.271 0.557 . . . . 0.0 110.302 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.4 63.74 1.29 Allowed Glycine 0 N--CA 1.479 1.537 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.557 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -79.3 -155.02 0.09 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.031 -1.276 . . . . 0.0 109.504 179.255 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.79 57.14 5.64 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.139 -0.976 . . . . 0.0 110.208 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.509 ' HB2' ' HG ' ' A' ' 97' ' ' LEU . 48.7 Cg_endo -73.99 -1.17 10.49 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.673 1.354 . . . . 0.0 110.648 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -108.66 -45.29 3.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 110.0 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.3 m -52.11 177.55 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.336 -0.852 . . . . 0.0 110.521 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -162.66 -143.35 0.08 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.361 -0.837 . . . . 0.0 110.136 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.442 ' O ' ' N ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -122.49 132.55 24.25 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.046 -1.034 . . . . 0.0 110.18 -179.566 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -74.25 1.89 6.79 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 O-C-N 123.348 1.183 . . . . 0.0 110.777 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -103.57 -48.55 3.93 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.185 -0.947 . . . . 0.0 109.365 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 108' ' ' ASP . 0.2 OUTLIER -128.72 18.02 6.26 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.834 -0.541 . . . . 0.0 109.841 179.875 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.51 ' HA ' HD23 ' A' ' 78' ' ' LEU . 9.0 mt 44.75 34.5 1.19 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.506 -0.747 . . . . 0.0 110.689 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 83.6 m -59.03 89.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.565 -0.71 . . . . 0.0 110.552 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.88 ' HG3' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -71.04 161.61 77.19 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.168 -0.958 . . . . 0.0 109.52 179.431 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.531 ' HD2' ' HD3' ' A' ' 80' ' ' ARG . 48.4 Cg_endo -73.96 -13.09 23.98 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.696 1.366 . . . . 0.0 110.549 179.422 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.425 HG13 HD23 ' A' ' 94' ' ' LEU . 90.7 t -67.28 -25.35 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.45 -0.781 . . . . 0.0 110.125 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.531 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 5.2 m80 -71.64 -40.81 69.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.277 -0.89 . . . . 0.0 109.236 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.52 ' HB3' ' SD ' ' A' ' 54' ' ' MET . 9.9 m-20 -52.27 -46.72 65.95 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.547 -0.721 . . . . 0.0 110.483 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.47 ' CB ' ' HG ' ' A' ' 94' ' ' LEU . . . -57.29 -68.46 0.23 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.05 -1.031 . . . . 0.0 108.993 178.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.799 ' CA ' HG11 ' A' ' 126' ' ' VAL . . . -52.35 -34.77 49.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.482 -0.761 . . . . 0.0 109.861 179.127 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.531 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 0.1 OUTLIER -40.37 -61.29 0.93 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.917 -0.489 . . . . 0.0 111.136 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -89.19 9.68 24.81 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.224 -0.923 . . . . 0.0 110.491 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.423 ' HA2' ' HB3' ' A' ' 123' ' ' HIS . . . 77.87 33.4 41.78 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.52 ' HD1' ' HG1' ' A' ' 93' ' ' THR . 0.6 OUTLIER -96.82 131.74 43.25 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.148 -1.207 . . . . 0.0 110.065 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.591 HD11 ' O ' ' A' ' 125' ' ' ASP . 0.5 OUTLIER -105.47 -47.6 3.89 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.272 -0.893 . . . . 0.0 110.45 179.87 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.776 ' O ' HG23 ' A' ' 96' ' ' VAL . 47.5 m-20 -47.32 -28.3 1.95 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.419 -0.801 . . . . 0.0 109.769 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.52 ' HG1' ' HD1' ' A' ' 90' ' ' PHE . 61.6 m -65.19 -56.82 10.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.588 -0.695 . . . . 0.0 109.604 178.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.697 ' CD2' HD21 ' A' ' 130' ' ' LEU . 1.5 mp -53.91 -49.16 69.22 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.217 -0.927 . . . . 0.0 109.661 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.455 ' O ' ' N ' ' A' ' 99' ' ' ARG . 74.7 t -44.3 -45.47 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.828 HG12 HD13 ' A' ' 64' ' ' LEU . 22.0 t -59.97 -54.09 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.556 -0.715 . . . . 0.0 109.436 179.033 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.509 ' HG ' ' HB2' ' A' ' 70' ' ' PRO . 7.3 mp -48.52 -50.05 33.55 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.543 0.687 . . . . 0.0 110.265 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -77.82 -21.65 51.2 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.583 -0.698 . . . . 0.0 109.881 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.539 ' HB3' ' HA ' ' A' ' 96' ' ' VAL . 1.4 ttm180 -72.94 -9.96 59.28 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.413 -0.804 . . . . 0.0 110.949 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.812 ' CB ' HD21 ' A' ' 64' ' ' LEU . . . -136.39 -66.73 0.53 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.064 -1.022 . . . . 0.0 110.923 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -167.51 105.51 0.24 Allowed Glycine 0 N--CA 1.486 1.979 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.458 ' HB3' ' C ' ' A' ' 97' ' ' LEU . . . -177.29 119.37 0.11 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.317 -1.107 . . . . 0.0 110.31 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 -68.11 134.84 51.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -0.892 . . . . 0.0 109.437 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 1.036 HD21 HD23 ' A' ' 130' ' ' LEU . 1.4 tt -112.27 13.28 20.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.376 -0.828 . . . . 0.0 110.665 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.499 ' HB3' ' HA ' ' A' ' 134' ' ' ALA . 1.1 p30 -127.65 47.54 2.37 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.425 -0.797 . . . . 0.0 110.325 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.88 HG11 ' HG3' ' A' ' 80' ' ' ARG . 0.8 OUTLIER -99.73 -175.09 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.143 -0.973 . . . . 0.0 110.659 -179.848 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.584 ' H ' HG22 ' A' ' 106' ' ' VAL . 6.6 ttp180 -141.01 148.89 41.0 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.487 ' HA ' ' O ' ' A' ' 77' ' ' THR . 3.6 m-20 . . . . . 0 C--N 1.302 -1.483 0 O-C-N 121.356 -0.84 . . . . 0.0 110.45 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.525 ' HG ' ' HD2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.498 1.962 0 N-CA-C 110.548 -0.168 . . . . 0.0 110.548 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.525 ' HD2' ' HG ' ' A' ' 113' ' ' LEU . 40.7 Cg_endo -69.72 -23.28 31.15 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.79 1.416 . . . . 0.0 110.226 179.008 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.614 HG21 ' CG ' ' A' ' 131' ' ' ARG . 4.7 p -86.72 -33.91 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.884 . . . . 0.0 109.776 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.31 -44.04 97.87 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.661 -0.649 . . . . 0.0 110.351 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.56 -31.09 67.66 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.283 -0.885 . . . . 0.0 109.73 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.782 ' HB1' ' HB2' ' A' ' 123' ' ' HIS . . . -81.61 -20.66 39.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.448 -0.782 . . . . 0.0 110.708 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -74.72 -40.92 61.03 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.4 -0.813 . . . . 0.0 110.691 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.47 -40.6 35.05 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.255 -0.903 . . . . 0.0 110.622 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.511 ' HB3' ' NE2' ' A' ' 123' ' ' HIS . 0.2 OUTLIER -72.57 -81.47 0.06 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.432 -0.793 . . . . 0.0 110.552 -179.339 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 162.14 47.26 0.02 OUTLIER Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.701 -1.237 . . . . 0.0 110.162 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.782 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . 3.6 m170 -108.49 52.94 0.7 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.127 -1.22 . . . . 0.0 109.643 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 28.4 mtt180 -48.22 -44.07 32.71 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.285 -0.884 . . . . 0.0 110.029 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.591 ' O ' HD11 ' A' ' 91' ' ' LEU . 5.5 t0 -54.27 -43.3 70.89 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.501 -0.75 . . . . 0.0 109.415 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.799 HG11 ' CA ' ' A' ' 86' ' ' ALA . 15.9 t -85.31 -45.55 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.277 -0.89 . . . . 0.0 110.12 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -47.31 -58.12 4.48 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.348 -0.845 . . . . 0.0 110.454 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 11.2 mtp180 -50.77 -65.85 0.49 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.473 -0.767 . . . . 0.0 110.052 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -50.36 -31.84 15.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.527 -0.733 . . . . 0.0 109.887 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 1.036 HD23 HD21 ' A' ' 104' ' ' LEU . 11.3 mt -72.89 -57.11 4.3 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.594 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.614 ' CG ' HG21 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -51.94 -21.78 3.32 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.355 -0.841 . . . . 0.0 110.689 -179.767 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -83.85 -61.18 1.89 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.311 -0.868 . . . . 0.0 109.729 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 1.016 ' HB3' HD22 ' A' ' 104' ' ' LEU . . . -75.1 -6.78 51.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.603 -0.686 . . . . 0.0 110.609 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.499 ' HA ' ' HB3' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.497 1.898 0 O-C-N 121.093 -1.004 . . . . 0.0 109.284 179.004 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.9 t0 . . . . . 0 N--CA 1.497 1.892 0 CA-C-O 121.057 0.456 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.455 ' HE3' HD22 ' A' ' 31' ' ' LEU . 22.6 m0 -95.01 -37.22 11.23 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.035 -1.041 . . . . 0.0 109.923 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.652 ' CD2' ' HB1' ' A' ' 36' ' ' ALA . 0.9 OUTLIER -71.49 -28.37 63.87 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.358 -0.839 . . . . 0.0 110.006 179.478 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.77 -44.91 12.89 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.326 -0.859 . . . . 0.0 110.185 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.429 ' CG2' ' N ' ' A' ' 19' ' ' ALA . 1.6 t -61.94 -39.08 90.85 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.408 -0.808 . . . . 0.0 110.345 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.607 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -68.8 -48.87 62.54 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.453 -0.779 . . . . 0.0 109.975 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.703 ' CB ' HG11 ' A' ' 59' ' ' VAL . . . -56.9 -53.5 57.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.528 -0.733 . . . . 0.0 109.811 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.567 ' HB2' ' O ' ' A' ' 51' ' ' VAL . . . -53.51 -28.47 31.22 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.48 -0.762 . . . . 0.0 110.182 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.57 14.41 15.08 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.468 -0.77 . . . . 0.0 110.474 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.444 ' HA3' ' CE ' ' A' ' 53' ' ' MET . . . 55.0 49.89 60.92 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -121.25 63.18 0.89 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.401 -1.058 . . . . 0.0 110.138 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.589 HG22 HG23 ' A' ' 59' ' ' VAL . 41.1 t -47.49 -51.17 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.549 -0.719 . . . . 0.0 110.163 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -47.12 -42.26 18.89 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.603 -0.686 . . . . 0.0 110.686 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.07 -37.24 72.48 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.249 -0.907 . . . . 0.0 110.086 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.984 HG12 HD13 ' A' ' 62' ' ' LEU . 21.6 t -73.45 -41.23 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.328 -0.857 . . . . 0.0 110.351 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.903 ' CA ' HD11 ' A' ' 62' ' ' LEU . 9.6 mmm180 -53.9 -44.81 70.82 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.126 -0.984 . . . . 0.0 109.639 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.63 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -78.85 -41.25 30.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.659 -0.65 . . . . 0.0 109.917 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.455 HD22 ' HE3' ' A' ' 15' ' ' TRP . 35.0 mt -65.53 -59.15 4.28 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.547 -0.721 . . . . 0.0 110.236 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.967 HD23 HD22 ' A' ' 62' ' ' LEU . 33.1 tp -50.83 -45.86 59.8 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.369 -0.832 . . . . 0.0 110.526 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -76.19 -15.6 60.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.294 -0.879 . . . . 0.0 110.031 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.63 ' HB2' ' O ' ' A' ' 30' ' ' ALA . . . -82.79 -8.75 59.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.301 -0.874 . . . . 0.0 110.652 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.54 23.19 1.93 Allowed Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.782 -1.199 . . . . 0.0 110.711 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.939 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -69.95 152.56 44.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.99 -1.3 . . . . 0.0 109.664 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.851 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -79.08 116.59 61.33 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.274 -0.891 . . . . 0.0 110.09 -179.728 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.73 -33.03 22.18 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.372 1.196 . . . . 0.0 110.317 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -115.57 58.05 0.73 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.311 -0.868 . . . . 0.0 109.744 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.851 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -88.69 116.97 67.79 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.324 -0.86 . . . . 0.0 110.11 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -72.35 82.94 1.31 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.647 1.341 . . . . 0.0 110.08 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -60.92 -174.95 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.391 -0.818 . . . . 0.0 110.026 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.5 p -93.63 26.57 3.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.397 -0.815 . . . . 0.0 110.171 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -114.78 17.88 16.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.248 -0.908 . . . . 0.0 110.248 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 59.74 44.26 97.12 Favored Glycine 0 N--CA 1.484 1.88 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -174.55 161.35 3.25 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.307 -1.114 . . . . 0.0 110.79 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.633 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 2.2 mtt180 -87.7 -154.47 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.635 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.633 ' CD ' ' HB3' ' A' ' 47' ' ' ARG . 45.3 Cg_endo -77.36 -170.53 0.95 Allowed 'Trans proline' 0 N--CA 1.483 0.855 0 O-C-N 122.53 0.753 . . . . 0.0 111.008 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.555 ' O ' ' HG2' ' A' ' 52' ' ' MET . 4.0 mt 62.62 -62.86 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.729 -0.607 . . . . 0.0 110.057 -178.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.522 ' N ' ' O ' ' A' ' 48' ' ' PRO . 8.4 mt-30 -48.15 -23.55 0.89 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.596 -1.315 . . . . 0.0 109.757 179.014 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.567 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 9.1 p -118.54 31.37 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.337 -0.852 . . . . 0.0 109.873 178.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.7 ' HE1' ' HB2' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -93.03 36.66 1.03 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.139 -0.976 . . . . 0.0 109.963 179.627 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.444 ' CE ' ' HA3' ' A' ' 23' ' ' GLY . 7.7 ttp 63.44 -6.95 0.19 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.468 -0.77 . . . . 0.0 110.965 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.561 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 45.94 28.81 0.65 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.212 -0.93 . . . . 0.0 110.579 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.407 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -126.26 4.15 7.76 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.08 84.94 1.85 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.378 -1.072 . . . . 0.0 109.596 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.442 ' CB ' ' HB3' ' A' ' 92' ' ' ASP . . . -51.27 -22.97 3.08 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.417 -0.802 . . . . 0.0 110.514 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.548 ' HB2' HG21 ' A' ' 25' ' ' VAL . 1.8 mmt180 -54.07 -45.94 71.85 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.284 -0.885 . . . . 0.0 110.047 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.703 HG11 ' CB ' ' A' ' 20' ' ' ALA . 46.7 t -58.05 -45.22 88.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.418 -0.802 . . . . 0.0 109.723 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.7 ' HB2' ' HE1' ' A' ' 52' ' ' MET . . . -49.48 -53.19 24.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.515 -0.741 . . . . 0.0 109.719 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.473 ' O ' HD23 ' A' ' 65' ' ' LEU . 1.6 tt0 -52.21 -51.34 58.8 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.437 -0.789 . . . . 0.0 109.313 178.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.984 HD13 HG12 ' A' ' 28' ' ' VAL . 0.9 OUTLIER -49.55 -70.99 0.07 Allowed 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.638 0.732 . . . . 0.0 110.049 178.675 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.837 HD22 HD22 ' A' ' 32' ' ' LEU . 4.5 mm? -56.5 -46.81 80.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.867 -0.521 . . . . 0.0 110.931 -179.144 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.915 HD13 HG12 ' A' ' 96' ' ' VAL . 1.2 tt -61.56 -59.09 5.74 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.342 -0.849 . . . . 0.0 111.171 -179.157 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.473 HD23 ' O ' ' A' ' 61' ' ' GLU . 0.6 OUTLIER -53.35 -23.55 9.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.067 -1.021 . . . . 0.0 109.935 -179.328 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.519 ' ND1' ' HG ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -88.9 -50.81 5.97 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.611 -0.681 . . . . 0.0 109.433 179.505 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.98 52.23 0.01 OUTLIER Glycine 0 N--CA 1.483 1.774 0 C-N-CA 119.937 -1.125 . . . . 0.0 111.061 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.799 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -79.29 -151.74 0.06 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.827 -1.396 . . . . 0.0 109.99 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.428 ' HB2' ' CB ' ' A' ' 47' ' ' ARG . 1.2 tt0 -123.28 54.89 7.3 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.365 -0.835 . . . . 0.0 110.088 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.5 ' HG3' HD12 ' A' ' 64' ' ' LEU . 43.0 Cg_endo -70.21 -13.91 34.06 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.641 1.337 . . . . 0.0 110.274 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.5 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 2.1 t-20 -108.36 -73.0 0.7 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.368 -0.832 . . . . 0.0 110.02 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 4.1 t -50.27 169.0 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.189 -0.944 . . . . 0.0 110.979 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.465 ' HB1' ' O ' ' A' ' 79' ' ' THR . . . -153.86 -155.45 0.59 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.334 -0.854 . . . . 0.0 110.149 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -101.71 135.34 19.78 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.406 -0.809 . . . . 0.0 109.746 179.876 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -74.3 -22.86 16.0 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.685 1.36 . . . . 0.0 110.661 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.03 -39.37 66.09 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.204 -0.935 . . . . 0.0 110.085 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -147.43 16.07 1.15 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.601 -0.687 . . . . 0.0 110.13 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.476 ' HB3' ' O ' ' A' ' 107' ' ' ARG . 0.4 OUTLIER 48.22 35.11 5.04 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.481 -0.762 . . . . 0.0 111.513 179.664 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.465 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 2.5 m -71.31 104.82 3.27 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.219 -0.926 . . . . 0.0 109.886 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.833 ' CG ' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -80.06 160.13 69.19 Favored Pre-proline 0 N--CA 1.498 1.928 0 O-C-N 121.351 -0.843 . . . . 0.0 110.747 -179.571 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.417 ' O ' ' HB2' ' A' ' 84' ' ' ASP . 45.7 Cg_endo -72.1 -17.46 28.12 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.822 1.433 . . . . 0.0 110.604 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 98.6 t -62.7 -24.06 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.209 -0.932 . . . . 0.0 110.205 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.495 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 13.4 m80 -76.68 -32.83 58.16 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.413 -0.804 . . . . 0.0 109.108 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.561 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 3.3 m-20 -57.98 -50.86 71.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.616 -0.678 . . . . 0.0 110.297 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.491 ' HB3' ' CD1' ' A' ' 94' ' ' LEU . . . -58.95 -58.33 9.11 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.343 -0.848 . . . . 0.0 109.856 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.884 ' HB2' HD11 ' A' ' 130' ' ' LEU . . . -59.36 -45.0 92.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.42 -0.8 . . . . 0.0 110.847 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 0.3 OUTLIER -47.71 -44.65 27.9 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.327 -0.858 . . . . 0.0 110.902 -179.589 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -95.96 13.32 27.31 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.284 -0.885 . . . . 0.0 110.495 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.575 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 59.84 60.1 9.29 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.407 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 0.3 OUTLIER -129.04 94.32 3.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.266 -1.138 . . . . 0.0 110.707 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.651 HD11 ' O ' ' A' ' 125' ' ' ASP . 0.3 OUTLIER -69.31 -37.38 77.73 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.336 -0.853 . . . . 0.0 109.958 179.68 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.442 ' HB3' ' CB ' ' A' ' 57' ' ' ALA . 31.5 m-20 -50.08 -40.98 47.19 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.503 -0.748 . . . . 0.0 110.055 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 60.5 m -66.16 -42.45 88.96 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.725 HD21 ' HG ' ' A' ' 130' ' ' LEU . 1.2 tp -58.83 -38.27 78.28 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.596 -0.69 . . . . 0.0 109.312 178.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 91' ' ' LEU . 47.3 t -61.41 -50.6 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.582 -0.699 . . . . 0.0 109.607 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.915 HG12 HD13 ' A' ' 64' ' ' LEU . 92.9 t -54.17 -54.51 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.543 -0.723 . . . . 0.0 109.433 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.681 HD23 ' HB1' ' A' ' 102' ' ' ALA . 1.1 mp -47.51 -53.56 14.02 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.735 -0.603 . . . . 0.0 110.825 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -72.98 -29.61 63.18 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.307 -0.871 . . . . 0.0 110.084 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -65.86 -9.4 28.78 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.367 -0.833 . . . . 0.0 110.604 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.88 ' HB2' HD21 ' A' ' 64' ' ' LEU . . . -136.9 -74.6 0.42 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.117 -0.99 . . . . 0.0 111.051 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -160.14 102.21 0.21 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.681 ' HB1' HD23 ' A' ' 97' ' ' LEU . . . -162.43 111.18 1.39 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.405 -1.056 . . . . 0.0 109.878 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -77.86 145.47 36.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.38 -0.825 . . . . 0.0 110.38 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.745 HD22 ' HB3' ' A' ' 133' ' ' ALA . 2.4 mp -116.36 4.23 13.39 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.46 -0.775 . . . . 0.0 110.286 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -98.68 39.29 1.27 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.187 -0.946 . . . . 0.0 109.764 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.833 HG11 ' CG ' ' A' ' 80' ' ' ARG . 3.0 p -108.4 -170.18 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.369 -0.832 . . . . 0.0 109.791 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.695 ' H ' HG22 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -157.43 155.09 29.86 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.344 -0.848 . . . . 0.0 109.556 179.677 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 . . . . . 0 N--CA 1.494 1.761 0 O-C-N 121.117 -0.99 . . . . 0.0 110.2 -179.91 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.481 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.846 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.481 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 46.4 Cg_endo -74.01 -50.39 0.17 Allowed 'Trans proline' 0 C--N 1.312 -1.349 0 O-C-N 123.604 1.318 . . . . 0.0 110.386 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.4 HG13 ' N ' ' A' ' 116' ' ' ASP . 12.2 p -58.62 -34.52 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.321 -0.862 . . . . 0.0 109.72 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.4 ' N ' HG13 ' A' ' 115' ' ' VAL . 6.5 m-20 -70.86 -25.5 62.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.53 -0.731 . . . . 0.0 109.698 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.2 tt -79.68 -28.18 40.74 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.428 -0.795 . . . . 0.0 110.073 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -73.56 -45.29 54.36 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.402 -0.811 . . . . 0.0 109.891 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -62.8 -37.11 85.44 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.465 -0.772 . . . . 0.0 109.806 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.21 -45.29 85.35 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.534 -0.729 . . . . 0.0 110.037 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.1 -81.8 0.1 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.383 -0.823 . . . . 0.0 110.378 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 167.8 53.25 0.03 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.498 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 53.4 m-70 -127.88 52.87 1.82 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -1.149 . . . . 0.0 109.483 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.4 mtp180 -47.43 -43.0 23.52 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.544 -0.723 . . . . 0.0 110.258 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.651 ' O ' HD11 ' A' ' 91' ' ' LEU . 76.7 m-20 -55.6 -42.94 75.53 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.391 -0.818 . . . . 0.0 109.295 179.194 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.865 HG11 ' HA ' ' A' ' 86' ' ' ALA . 3.0 t -78.94 -34.0 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.495 -0.753 . . . . 0.0 109.127 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.77 -31.99 72.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.501 -0.749 . . . . 0.0 109.517 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.9 mtp180 -60.65 -66.7 0.49 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.543 -0.723 . . . . 0.0 110.099 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.464 ' HB3' HD23 ' A' ' 94' ' ' LEU . 10.1 t80 -55.03 -28.87 55.51 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.346 -0.847 . . . . 0.0 109.627 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.884 HD11 ' HB2' ' A' ' 86' ' ' ALA . 68.1 mt -72.74 -43.52 62.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.574 -0.704 . . . . 0.0 109.569 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.79 -19.53 62.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.203 -0.936 . . . . 0.0 110.391 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.31 -50.71 7.12 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.277 -0.89 . . . . 0.0 110.399 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.745 ' HB3' HD22 ' A' ' 104' ' ' LEU . . . -88.26 -19.74 26.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.295 -0.878 . . . . 0.0 110.174 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.698 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.498 -0.751 . . . . 0.0 109.687 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.278 0.561 . . . . 0.0 110.006 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.571 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 2.2 t90 -70.37 -7.59 44.08 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.287 -0.883 . . . . 0.0 110.423 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.951 HD21 HD21 ' A' ' 63' ' ' LEU . 0.9 OUTLIER -80.4 -57.96 3.35 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.038 -1.039 . . . . 0.0 109.674 179.77 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.468 ' N ' ' HG ' ' A' ' 16' ' ' LEU . . . -63.26 -38.89 92.95 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.222 -0.924 . . . . 0.0 109.761 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.571 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 1.5 p -52.8 -54.22 37.22 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.527 -0.733 . . . . 0.0 110.385 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.713 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -59.77 -39.01 83.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.338 -0.851 . . . . 0.0 110.071 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.469 ' HB1' HG11 ' A' ' 59' ' ' VAL . . . -54.12 -61.91 2.0 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.116 -0.99 . . . . 0.0 109.561 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.937 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -54.64 -22.21 12.89 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.515 -0.74 . . . . 0.0 110.206 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -90.64 16.6 8.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.354 -0.841 . . . . 0.0 110.69 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 49.76 34.95 22.77 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 179.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.434 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . 6.2 mmt180 -109.49 67.54 0.65 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.338 -1.095 . . . . 0.0 110.052 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.476 HG22 HG22 ' A' ' 59' ' ' VAL . 93.2 t -49.17 -54.28 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.638 -0.663 . . . . 0.0 110.973 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -46.89 -43.02 18.46 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.5 -0.75 . . . . 0.0 110.818 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.55 ' O ' ' HB2' ' A' ' 31' ' ' LEU . 20.3 mt-10 -62.17 -44.86 95.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.233 -0.917 . . . . 0.0 110.166 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.757 HG12 HD13 ' A' ' 62' ' ' LEU . 3.5 t -72.92 -43.06 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.419 -0.801 . . . . 0.0 110.471 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.83 ' CA ' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -45.8 -47.81 15.67 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.409 -0.807 . . . . 0.0 109.853 -179.516 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.41 -49.06 11.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.418 -0.802 . . . . 0.0 110.379 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.55 ' HB2' ' O ' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -57.13 -56.99 14.67 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.165 -0.959 . . . . 0.0 110.255 179.849 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 1.016 HD23 HD22 ' A' ' 62' ' ' LEU . 15.2 tp -50.35 -49.65 53.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.5 -0.75 . . . . 0.0 110.665 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -74.73 -8.9 57.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.269 -0.894 . . . . 0.0 110.537 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.56 -11.69 39.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -0.912 . . . . 0.0 111.127 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 139.12 -9.38 3.29 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 119.619 -1.277 . . . . 0.0 110.763 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.961 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -44.68 154.72 0.12 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.179 -1.189 . . . . 0.0 110.611 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.884 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 2.3 mm? -93.73 111.31 52.11 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.378 -0.826 . . . . 0.0 110.658 -179.14 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.484 ' O ' ' HG3' ' A' ' 48' ' ' PRO . 43.2 Cg_endo -70.57 -19.02 32.78 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 123.622 1.327 . . . . 0.0 110.485 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -109.43 17.49 21.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.33 -0.856 . . . . 0.0 110.209 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.884 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -77.75 129.65 75.89 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.257 -0.902 . . . . 0.0 110.405 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -73.89 146.31 37.42 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 123.656 1.345 . . . . 0.0 109.983 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -88.96 -157.97 0.47 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.237 -0.914 . . . . 0.0 109.941 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.8 m -111.43 14.49 21.48 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.051 -1.03 . . . . 0.0 111.205 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -123.76 33.52 5.3 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.096 -1.002 . . . . 0.0 109.964 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.25 23.7 26.62 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.216 -1.553 . . . . 0.0 109.216 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.8 mtm-85 -108.05 -159.79 0.7 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.502 -0.999 . . . . 0.0 110.126 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.626 ' O ' HG12 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -127.89 179.69 1.19 Allowed Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.482 -0.761 . . . . 0.0 110.067 -179.651 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.692 ' HB2' HD22 ' A' ' 63' ' ' LEU . 42.1 Cg_endo -68.9 -24.52 33.65 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.611 1.322 . . . . 0.0 111.287 -179.424 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.579 ' O ' ' HG2' ' A' ' 52' ' ' MET . 4.3 mt -106.24 -36.83 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.044 -1.035 . . . . 0.0 108.64 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.403 ' HB2' ' HB2' ' A' ' 47' ' ' ARG . 24.6 mt-30 -54.73 -18.91 5.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.25 -0.906 . . . . 0.0 109.375 178.43 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.937 HG22 ' HB2' ' A' ' 21' ' ' ALA . 9.3 p -116.07 39.23 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.478 -0.764 . . . . 0.0 110.601 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.579 ' HG2' ' O ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -103.55 39.21 1.64 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.946 -1.096 . . . . 0.0 109.443 179.267 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' MET . . . . . 0.412 ' CB ' ' O ' ' A' ' 52' ' ' MET . 0.0 OUTLIER 68.79 -5.61 0.98 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.729 -0.607 . . . . 0.0 110.918 -179.536 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.534 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.1 OUTLIER 39.94 89.32 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.364 -0.835 . . . . 0.0 110.937 179.82 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.533 ' HA2' ' CG ' ' A' ' 90' ' ' PHE . . . 159.13 -28.95 0.4 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.232 -1.947 . . . . 0.0 108.232 -179.287 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.67 79.91 1.72 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.733 -0.863 . . . . 0.0 110.16 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -48.8 -25.18 1.72 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.255 -0.903 . . . . 0.0 110.196 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.62 -39.24 57.68 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.463 -0.773 . . . . 0.0 109.789 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.476 HG22 HG22 ' A' ' 25' ' ' VAL . 23.8 t -69.22 -51.29 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.395 -0.816 . . . . 0.0 109.257 179.448 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.557 ' HB2' ' HE1' ' A' ' 52' ' ' MET . . . -48.91 -43.66 39.51 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.253 -0.904 . . . . 0.0 109.908 179.008 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.436 ' O ' HD23 ' A' ' 65' ' ' LEU . 5.4 tt0 -53.58 -51.72 62.08 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.501 -0.749 . . . . 0.0 109.677 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 1.016 HD22 HD23 ' A' ' 32' ' ' LEU . 1.2 mt -50.32 -66.51 0.38 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.593 -0.692 . . . . 0.0 109.912 178.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.951 HD21 HD21 ' A' ' 16' ' ' LEU . 11.0 mt -60.27 -39.27 86.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.676 -0.64 . . . . 0.0 110.798 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.891 HD22 HG13 ' A' ' 96' ' ' VAL . 0.5 OUTLIER -63.09 -60.15 3.83 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.174 -0.954 . . . . 0.0 110.458 -179.78 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.436 HD23 ' O ' ' A' ' 61' ' ' GLU . 0.7 OUTLIER -53.34 -22.67 7.7 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.427 -0.796 . . . . 0.0 110.019 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.582 ' CD2' ' HG ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -90.87 -25.15 19.99 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.611 -0.681 . . . . 0.0 109.679 179.849 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.94 56.58 0.5 Allowed Glycine 0 N--CA 1.481 1.643 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.854 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -70.1 -149.78 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.171 -1.193 . . . . 0.0 109.767 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.428 ' HG2' ' HB3' ' A' ' 72' ' ' CYS . 0.3 OUTLIER -120.46 59.31 6.85 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.498 -0.751 . . . . 0.0 109.628 179.251 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.415 ' HD3' ' C ' ' A' ' 68' ' ' ALA . 43.5 Cg_endo -71.13 -1.53 9.71 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 O-C-N 123.808 1.425 . . . . 0.0 110.712 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -113.35 -66.4 1.09 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.128 -0.982 . . . . 0.0 110.014 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.428 ' HB3' ' HG2' ' A' ' 69' ' ' GLU . 3.1 t -50.57 166.59 0.08 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.453 -0.78 . . . . 0.0 110.534 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.575 ' HB2' ' HA ' ' A' ' 80' ' ' ARG . . . -159.22 -140.18 0.07 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.395 -0.815 . . . . 0.0 110.04 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 78' ' ' LEU . 11.0 t70 -105.05 127.35 28.88 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.062 -1.024 . . . . 0.0 109.765 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.83 -2.6 12.17 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.432 1.228 . . . . 0.0 111.208 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.41 ' HB3' ' OD2' ' A' ' 74' ' ' ASP . . . -97.15 -44.0 7.14 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.096 -1.003 . . . . 0.0 109.72 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -121.79 7.77 9.94 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.454 -0.779 . . . . 0.0 110.265 179.529 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.501 ' HB3' ' O ' ' A' ' 107' ' ' ARG . 1.3 mt 45.61 27.68 0.44 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.335 -0.853 . . . . 0.0 111.102 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.7 m -65.32 88.72 0.08 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.113 -0.992 . . . . 0.0 109.642 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.892 ' CG ' HG11 ' A' ' 106' ' ' VAL . 1.1 mtt180 -69.12 165.91 33.93 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.426 -0.796 . . . . 0.0 110.35 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.407 ' HG3' ' C ' ' A' ' 70' ' ' PRO . 42.8 Cg_endo -69.61 -12.97 34.32 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.728 1.383 . . . . 0.0 111.164 -179.08 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.9 t -66.13 -42.1 90.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.007 -1.058 . . . . 0.0 109.597 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.473 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 69.3 m80 -55.14 -45.49 75.65 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.609 0.719 . . . . 0.0 109.676 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.534 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 1.2 m-20 -49.32 -51.31 35.07 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.093 0.473 . . . . 0.0 110.957 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.666 ' HA ' ' CZ ' ' A' ' 90' ' ' PHE . . . -57.46 -60.69 3.27 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.172 -0.955 . . . . 0.0 109.639 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.824 ' HB1' ' HB2' ' A' ' 118' ' ' ALA . . . -63.14 -9.75 12.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.399 -0.813 . . . . 0.0 109.996 178.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.473 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -70.67 -54.38 12.1 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.039 -1.038 . . . . 0.0 110.665 -179.812 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.479 ' HB3' ' CD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -90.07 -19.11 24.74 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.141 -0.975 . . . . 0.0 109.862 -179.918 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.822 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 87.32 59.91 1.7 Allowed Glycine 0 N--CA 1.487 2.077 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.33 178.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.666 ' CZ ' ' HA ' ' A' ' 85' ' ' ALA . 1.3 p90 -135.17 89.02 2.47 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.012 -1.287 . . . . 0.0 109.912 178.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.714 HD11 ' O ' ' A' ' 125' ' ' ASP . 0.2 OUTLIER -51.58 -35.12 40.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.868 -0.52 . . . . 0.0 110.883 -179.31 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 91' ' ' LEU . 1.7 m-20 -41.86 -33.7 0.56 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.319 -0.863 . . . . 0.0 109.128 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.577 ' O ' HD12 ' A' ' 97' ' ' LEU . 1.1 m -79.52 -49.73 11.8 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.18 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.832 HD21 ' HG ' ' A' ' 130' ' ' LEU . 2.5 tp -54.2 -41.33 68.5 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.65 -0.656 . . . . 0.0 109.587 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 89.8 t -59.99 -53.04 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.327 -0.858 . . . . 0.0 109.182 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.891 HG13 HD22 ' A' ' 64' ' ' LEU . 40.6 t -51.86 -46.46 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.638 -0.664 . . . . 0.0 109.435 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.873 HD23 ' HB1' ' A' ' 102' ' ' ALA . 0.6 OUTLIER -52.32 -55.41 21.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.623 -0.673 . . . . 0.0 109.877 179.588 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -70.63 -28.12 64.59 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.363 -0.835 . . . . 0.0 110.168 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.434 ' HB2' ' HA ' ' A' ' 96' ' ' VAL . 3.1 mtt180 -68.49 -9.57 49.84 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.287 -0.883 . . . . 0.0 110.995 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.832 ' HB2' HD21 ' A' ' 64' ' ' LEU . . . -127.99 -87.12 0.57 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.168 -0.958 . . . . 0.0 110.617 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -163.68 54.39 0.29 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.873 ' HB1' HD23 ' A' ' 97' ' ' LEU . . . -102.26 133.1 47.7 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.252 -1.146 . . . . 0.0 110.305 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.38 152.58 33.69 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.263 -0.898 . . . . 0.0 109.639 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.464 HD13 ' HB1' ' A' ' 133' ' ' ALA . 6.6 mt -143.08 46.46 1.54 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.166 -0.958 . . . . 0.0 110.908 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -169.44 52.7 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.182 -0.949 . . . . 0.0 110.815 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.892 HG11 ' CG ' ' A' ' 80' ' ' ARG . 9.6 p -113.63 -178.14 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 0.0 109.97 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.664 ' H ' HG22 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -129.32 138.04 51.35 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.386 -0.821 . . . . 0.0 109.882 179.129 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.5 t0 . . . . . 0 N--CA 1.494 1.749 0 O-C-N 121.421 -0.8 . . . . 0.0 110.404 -179.833 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.428 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 66.0 mt . . . . . 0 N--CA 1.493 1.713 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 40.9 Cg_endo -67.78 -28.51 36.6 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.779 1.41 . . . . 0.0 110.081 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.509 HG21 ' CA ' ' A' ' 131' ' ' ARG . 11.1 p -75.53 -35.89 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.399 -0.813 . . . . 0.0 109.939 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.422 ' N ' HG13 ' A' ' 115' ' ' VAL . 1.0 OUTLIER -68.94 -29.87 68.21 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.425 -0.797 . . . . 0.0 109.952 179.744 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.826 HD23 ' N ' ' A' ' 118' ' ' ALA . 4.3 tt -66.08 -58.53 5.26 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.459 -0.776 . . . . 0.0 109.934 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.826 ' N ' HD23 ' A' ' 117' ' ' LEU . . . -50.12 -48.01 53.73 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.383 -0.823 . . . . 0.0 110.969 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -50.77 -41.31 56.73 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.33 -0.856 . . . . 0.0 110.086 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -74.45 -55.1 6.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.57 -0.706 . . . . 0.0 109.94 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.487 HD12 HD21 ' A' ' 117' ' ' LEU . 1.6 mt -53.07 -82.02 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.253 -0.905 . . . . 0.0 110.549 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.82 39.62 0.03 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.543 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . 27.2 m-70 -124.08 52.83 1.44 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.276 -1.132 . . . . 0.0 109.188 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.476 ' HA ' ' HB3' ' A' ' 127' ' ' ALA . 1.1 ttt-85 -46.21 -45.44 16.91 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.73 -0.606 . . . . 0.0 110.341 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.714 ' O ' HD11 ' A' ' 91' ' ' LEU . 1.9 m-20 -52.53 -46.83 66.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.371 -0.831 . . . . 0.0 109.18 179.131 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.822 HG21 ' HA2' ' A' ' 89' ' ' GLY . 2.5 t -75.72 -27.51 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.5 -0.75 . . . . 0.0 109.556 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.476 ' HB3' ' HA ' ' A' ' 124' ' ' ARG . . . -75.19 -48.87 21.48 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.37 -0.831 . . . . 0.0 109.929 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.27 -54.93 41.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.28 -0.887 . . . . 0.0 110.157 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.631 ' HD2' HD23 ' A' ' 94' ' ' LEU . 36.8 t80 -59.33 -36.84 76.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.276 -0.89 . . . . 0.0 109.782 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.832 ' HG ' HD21 ' A' ' 94' ' ' LEU . 8.4 mt -64.03 -49.56 71.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.224 -0.923 . . . . 0.0 109.457 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.509 ' CA ' HG21 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -52.94 -29.77 30.65 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.301 -0.875 . . . . 0.0 110.288 179.856 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -86.34 -42.78 13.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.35 -0.844 . . . . 0.0 109.836 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.464 ' HB1' HD13 ' A' ' 104' ' ' LEU . . . -79.81 -5.66 55.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.435 -0.791 . . . . 0.0 110.513 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.733 0 O-C-N 121.172 -0.955 . . . . 0.0 110.622 -179.568 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.415 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 5.7 m-20 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 120.741 0.305 . . . . 0.0 110.357 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.527 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 0.1 OUTLIER -46.44 -62.78 1.21 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.366 -0.834 . . . . 0.0 110.345 -179.584 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.001 ' HB2' HD21 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -45.81 -35.26 4.27 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.392 0.615 . . . . 0.0 110.115 179.16 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 14' ' ' ASP . . . -77.66 -48.57 16.46 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.463 -0.773 . . . . 0.0 109.639 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.527 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.0 OUTLIER -52.97 -60.26 3.5 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.515 -0.74 . . . . 0.0 110.517 179.72 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.815 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -53.3 -43.44 67.56 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.332 -0.855 . . . . 0.0 109.905 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.484 ' C ' ' HA ' ' A' ' 52' ' ' MET . . . -55.39 -40.17 71.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.572 -0.705 . . . . 0.0 109.527 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.35 -34.43 70.49 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.434 -0.791 . . . . 0.0 110.363 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.9 mtm180 -94.65 22.61 6.1 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.245 -0.909 . . . . 0.0 110.885 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 52.41 72.31 0.54 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.926 ' O ' HG23 ' A' ' 28' ' ' VAL . 4.3 mtt85 -129.87 56.57 1.72 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.428 -1.042 . . . . 0.0 109.769 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.85 HG22 HG23 ' A' ' 59' ' ' VAL . 89.5 t -47.4 -55.14 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.558 -0.714 . . . . 0.0 110.649 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -61.67 -31.46 71.58 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.404 -0.81 . . . . 0.0 110.936 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.456 ' CB ' ' HB3' ' A' ' 24' ' ' ARG . 0.3 OUTLIER -76.43 -33.31 58.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.151 -0.968 . . . . 0.0 109.557 179.876 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.926 HG23 ' O ' ' A' ' 24' ' ' ARG . 5.0 t -78.77 -46.67 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.453 -0.78 . . . . 0.0 109.653 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.533 ' HA ' HD22 ' A' ' 62' ' ' LEU . 15.2 mmm180 -49.22 -48.08 45.75 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.431 -0.793 . . . . 0.0 109.74 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.622 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -72.04 -37.93 69.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.646 -0.659 . . . . 0.0 109.673 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.419 ' HB2' ' O ' ' A' ' 27' ' ' GLU . 6.3 mt -66.58 -56.47 10.59 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.469 -0.77 . . . . 0.0 110.565 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.947 ' HB2' HD21 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -44.45 -56.41 4.29 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.634 -0.666 . . . . 0.0 110.551 -179.809 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.48 -14.64 61.27 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.354 -0.841 . . . . 0.0 110.382 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.622 ' HB2' ' O ' ' A' ' 30' ' ' ALA . . . -79.15 -7.63 58.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.088 -1.007 . . . . 0.0 110.6 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 134.96 -12.19 4.47 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.771 -1.205 . . . . 0.0 110.578 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.941 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -48.73 149.32 1.79 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.172 -1.193 . . . . 0.0 110.509 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.935 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 0.2 OUTLIER -86.33 140.1 34.19 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.373 -0.829 . . . . 0.0 110.253 -179.713 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -74.79 -56.66 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.812 1.427 . . . . 0.0 110.51 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.422 ' ND2' ' O ' ' A' ' 67' ' ' GLY . 0.2 OUTLIER -95.4 55.92 1.78 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.264 -0.897 . . . . 0.0 109.825 179.565 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.935 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -101.76 108.25 55.22 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.169 -0.957 . . . . 0.0 110.774 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.8 132.26 19.82 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.617 1.325 . . . . 0.0 109.554 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.41 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 19.1 p-10 -124.19 71.06 1.11 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.054 -1.029 . . . . 0.0 111.112 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.8 m 44.46 -157.29 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.358 -0.839 . . . . 0.0 110.362 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 60.64 7.56 1.44 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.124 -0.985 . . . . 0.0 110.734 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 50.44 26.66 10.2 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.537 ' HG2' ' HB3' ' A' ' 50' ' ' GLN . 6.0 mtm-85 -125.78 -170.47 2.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.534 -0.98 . . . . 0.0 110.775 -179.28 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.563 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 3.5 mmp_? -119.78 -163.48 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.332 -0.855 . . . . 0.0 109.331 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.945 ' HB2' HD22 ' A' ' 63' ' ' LEU . 43.9 Cg_endo -80.04 -22.43 7.32 Favored 'Trans proline' 0 C--N 1.321 -0.895 0 O-C-N 122.987 0.993 . . . . 0.0 110.911 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.508 ' O ' ' HG2' ' A' ' 52' ' ' MET . 10.1 mt -107.05 -42.47 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.241 -0.912 . . . . 0.0 109.242 178.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.537 ' HB3' ' HG2' ' A' ' 46' ' ' ARG . 1.1 mt-30 -53.1 -22.55 6.32 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.158 -0.963 . . . . 0.0 109.994 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 47' ' ' ARG . 9.2 p -101.61 1.76 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 0.0 110.532 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.508 ' HG2' ' O ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -70.42 157.82 37.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.874 -1.141 . . . . 0.0 109.426 179.936 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -52.09 -13.74 0.34 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.194 -0.941 . . . . 0.0 111.225 -179.318 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.658 ' HE2' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 62.93 10.96 4.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.325 -0.859 . . . . 0.0 109.543 -178.908 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.505 ' O ' ' CE1' ' A' ' 90' ' ' PHE . . . -113.82 -2.95 23.73 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.463 -1.855 . . . . 0.0 108.463 178.638 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.505 ' HB3' HG23 ' A' ' 59' ' ' VAL . 0.9 OUTLIER -130.25 79.37 1.9 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.395 -1.062 . . . . 0.0 109.99 179.866 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.54 ' CB ' ' HB3' ' A' ' 92' ' ' ASP . . . -50.32 -26.27 4.66 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.425 -0.797 . . . . 0.0 109.62 179.415 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.49 -44.28 65.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.476 -0.765 . . . . 0.0 109.507 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.85 HG23 HG22 ' A' ' 25' ' ' VAL . 43.2 t -59.5 -56.83 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.289 -0.882 . . . . 0.0 109.436 179.235 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.491 ' HB2' ' CE ' ' A' ' 52' ' ' MET . . . -53.72 -42.45 68.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.408 -0.808 . . . . 0.0 109.611 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.725 ' O ' HD23 ' A' ' 65' ' ' LEU . 4.0 tt0 -59.18 -31.88 69.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 110.091 179.627 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.947 HD21 ' HB2' ' A' ' 32' ' ' LEU . 10.2 tp -74.46 -59.0 2.93 Favored 'General case' 0 C--N 1.31 -1.129 0 O-C-N 121.334 -0.854 . . . . 0.0 109.121 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.001 HD21 ' HB2' ' A' ' 16' ' ' LEU . 1.5 mt -63.24 -40.56 97.79 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.496 -0.752 . . . . 0.0 110.389 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 1.054 HD11 ' HB3' ' A' ' 100' ' ' ALA . 0.4 OUTLIER -53.37 -70.5 0.09 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.135 -0.978 . . . . 0.0 110.344 -179.616 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.725 HD23 ' O ' ' A' ' 61' ' ' GLU . 3.2 pp -51.35 -24.41 4.68 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.443 -0.786 . . . . 0.0 109.827 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.518 ' CG ' HD11 ' A' ' 32' ' ' LEU . 1.8 m80 -84.98 -27.2 26.62 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.752 -0.593 . . . . 0.0 110.147 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 63' ' ' LEU . . . 128.94 43.54 0.22 Allowed Glycine 0 N--CA 1.479 1.521 0 C-N-CA 120.136 -1.031 . . . . 0.0 110.906 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.601 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -72.9 -153.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.73 -1.453 . . . . 0.0 109.22 179.057 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.536 ' HB2' ' HB3' ' A' ' 47' ' ' ARG . 0.3 OUTLIER -124.09 67.25 43.46 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.258 -0.901 . . . . 0.0 110.358 179.59 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -72.75 -25.93 16.55 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.91 1.479 . . . . 0.0 110.209 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -104.82 -36.44 7.39 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.334 -0.854 . . . . 0.0 110.006 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.3 m -60.76 164.27 4.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.425 -0.797 . . . . 0.0 110.792 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -165.04 -157.73 0.36 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.483 -0.761 . . . . 0.0 109.724 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.496 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.8 OUTLIER -105.02 138.35 19.48 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.157 -0.964 . . . . 0.0 109.981 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -74.67 -22.17 15.87 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.517 1.272 . . . . 0.0 110.644 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.98 -76.53 0.05 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.288 -0.883 . . . . 0.0 109.853 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 108' ' ' ASP . 0.3 OUTLIER -109.52 31.5 5.73 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.517 -0.739 . . . . 0.0 110.518 -179.744 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.512 HD13 HG23 ' A' ' 106' ' ' VAL . 4.6 mt 40.66 31.27 0.11 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.56 -0.712 . . . . 0.0 110.906 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.463 ' HA ' ' OD1' ' A' ' 108' ' ' ASP . 93.9 m -57.84 87.68 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.379 -0.826 . . . . 0.0 109.538 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.655 ' CG ' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -71.23 161.43 78.33 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.357 -0.839 . . . . 0.0 110.558 -179.086 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.15 -24.46 23.47 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 124.007 1.53 . . . . 0.0 110.251 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.797 HG11 ' HG ' ' A' ' 104' ' ' LEU . 25.1 t -58.86 -27.62 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.429 -0.794 . . . . 0.0 109.856 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 47.8 m80 -65.67 -42.74 90.97 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.885 0.85 . . . . 0.0 109.35 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.658 ' HB3' ' HE2' ' A' ' 54' ' ' MET . 0.9 OUTLIER -54.1 -57.41 11.21 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.732 -179.604 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.727 ' HB1' ' CD1' ' A' ' 94' ' ' LEU . . . -48.18 -63.62 1.02 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.449 -0.782 . . . . 0.0 109.867 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.813 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -56.41 -50.32 71.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.337 -0.852 . . . . 0.0 110.571 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.567 ' HD3' HD12 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -48.71 -34.01 11.22 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.402 -0.811 . . . . 0.0 110.992 -179.349 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.451 ' HB2' ' HB3' ' A' ' 54' ' ' MET . 12.8 tp10 -93.51 -7.83 43.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.201 -0.937 . . . . 0.0 110.618 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.524 ' HA2' ' CG ' ' A' ' 123' ' ' HIS . . . 80.17 16.89 75.52 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.514 ' O ' ' CD1' ' A' ' 94' ' ' LEU . 0.3 OUTLIER -87.22 156.25 19.74 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.046 -1.267 . . . . 0.0 110.351 -179.875 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.588 HD22 HG22 ' A' ' 126' ' ' VAL . 0.0 OUTLIER -122.9 -53.62 1.85 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.66 -0.65 . . . . 0.0 109.644 179.639 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.853 ' O ' HG23 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -44.14 -41.36 5.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.623 -0.673 . . . . 0.0 109.689 179.835 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.406 ' O ' ' HB ' ' A' ' 96' ' ' VAL . 18.5 m -58.41 -49.68 76.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.635 -0.666 . . . . 0.0 109.792 178.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.727 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 0.6 OUTLIER -55.17 -54.12 47.36 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.165 -0.959 . . . . 0.0 109.585 179.727 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.2 t -50.24 -47.69 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.629 -0.669 . . . . 0.0 109.256 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.876 ' CG1' HD22 ' A' ' 64' ' ' LEU . 58.4 t -52.81 -50.82 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.429 HD23 ' HB1' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -54.03 -68.92 0.14 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.502 -0.749 . . . . 0.0 110.293 179.399 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -52.65 -32.17 40.71 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.16 -0.962 . . . . 0.0 109.636 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 25.3 ttm-85 -68.38 -12.66 61.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.521 -0.737 . . . . 0.0 110.048 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 1.054 ' HB3' HD11 ' A' ' 64' ' ' LEU . . . -137.19 60.94 1.63 Allowed 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.234 -0.916 . . . . 0.0 110.738 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 53.94 102.66 0.01 OUTLIER Glycine 0 N--CA 1.494 2.522 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.429 ' HB1' HD23 ' A' ' 97' ' ' LEU . . . -160.25 114.17 2.18 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.133 -1.216 . . . . 0.0 110.544 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 12.8 tpp180 -68.35 159.39 31.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.632 -0.667 . . . . 0.0 110.088 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.918 HD23 ' HB2' ' A' ' 134' ' ' ALA . 0.0 OUTLIER -145.52 10.47 1.25 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.36 -0.837 . . . . 0.0 110.976 -179.577 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -111.57 46.46 1.11 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.048 -1.033 . . . . 0.0 110.268 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.655 HG11 ' CG ' ' A' ' 80' ' ' ARG . 2.5 p -105.7 167.25 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.488 -0.758 . . . . 0.0 109.307 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.546 ' HG3' HD12 ' A' ' 113' ' ' LEU . 6.6 ttt85 -136.37 51.7 2.0 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.389 -0.82 . . . . 0.0 110.29 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ASP . . . . . 0.475 ' HA ' ' O ' ' A' ' 77' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.497 1.905 0 O-C-N 121.631 -0.668 . . . . 0.0 110.39 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.546 HD12 ' HG3' ' A' ' 107' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.81 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' PRO . . . . . 0.527 ' HD2' HD23 ' A' ' 113' ' ' LEU . 37.9 Cg_endo -63.81 -57.14 0.38 Allowed 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.373 1.196 . . . . 0.0 110.941 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.586 ' HA ' HD21 ' A' ' 130' ' ' LEU . 2.4 p -51.72 -31.12 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 120.905 -1.122 . . . . 0.0 110.33 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -66.2 -28.31 68.66 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.295 -0.878 . . . . 0.0 110.35 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.567 HD12 ' HD3' ' A' ' 87' ' ' ARG . 2.2 mm? -67.92 -38.57 83.06 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.126 -0.984 . . . . 0.0 110.116 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.689 ' CB ' ' HB2' ' A' ' 127' ' ' ALA . . . -68.48 -50.88 49.09 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.411 -0.806 . . . . 0.0 110.111 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -61.0 -45.54 94.43 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.269 -0.895 . . . . 0.0 110.319 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -54.27 -52.78 60.34 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.314 -0.866 . . . . 0.0 109.719 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.67 -86.43 0.06 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.362 -0.836 . . . . 0.0 110.216 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 174.06 31.34 0.03 OUTLIER Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.524 ' CG ' ' HA2' ' A' ' 89' ' ' GLY . 45.8 m-70 -95.05 46.73 1.13 Allowed 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.417 -1.049 . . . . 0.0 108.685 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.4 ' O ' ' HB2' ' A' ' 128' ' ' ARG . 0.4 OUTLIER -47.14 -33.33 5.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.784 -0.573 . . . . 0.0 109.832 -179.456 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.55 -40.99 98.59 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.813 HG11 ' HA ' ' A' ' 86' ' ' ALA . 3.4 t -75.82 -46.2 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.447 -0.783 . . . . 0.0 109.308 178.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.689 ' HB2' ' CB ' ' A' ' 118' ' ' ALA . . . -53.2 -53.42 50.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.302 -0.874 . . . . 0.0 109.408 179.079 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 124' ' ' ARG . 0.6 OUTLIER -49.8 -53.2 26.74 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.167 -0.958 . . . . 0.0 110.493 179.335 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -71.57 -56.37 6.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.372 -0.83 . . . . 0.0 110.746 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.626 HD22 ' HB2' ' A' ' 86' ' ' ALA . 0.3 OUTLIER -60.25 -30.58 69.52 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.366 -0.834 . . . . 0.0 111.025 -179.033 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.558 ' CB ' ' O ' ' A' ' 127' ' ' ALA . 4.3 ttp-105 -73.07 -27.54 61.79 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.028 -1.045 . . . . 0.0 110.432 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.95 -42.0 77.26 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.212 -0.93 . . . . 0.0 109.23 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.621 ' HB3' HD22 ' A' ' 104' ' ' LEU . . . -87.94 -10.17 51.35 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.638 -0.664 . . . . 0.0 110.336 179.4 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.918 ' HB2' HD23 ' A' ' 104' ' ' LEU . . . . . . . . 0 N--CA 1.494 1.729 0 O-C-N 121.232 -0.918 . . . . 0.0 110.59 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.621 ' O ' ' N ' ' A' ' 17' ' ' ALA . 2.8 m-20 . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 120.981 0.419 . . . . 2.92 110.021 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.505 ' HB3' HD13 ' A' ' 31' ' ' LEU . 4.4 m0 -41.61 -36.87 1.02 Allowed 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.854 -0.738 . . . . 4.18 109.036 178.436 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 1.074 HD13 HD21 ' A' ' 63' ' ' LEU . 3.4 pp -74.99 -33.16 61.82 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.376 -0.972 . . . . 2.77 108.376 177.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.621 ' N ' ' O ' ' A' ' 14' ' ' ASP . . . -80.45 -54.24 5.86 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.942 -0.762 . . . . 1.94 108.942 177.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.547 ' N ' ' O ' ' A' ' 14' ' ' ASP . 0.5 OUTLIER -54.3 -48.87 70.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.267 -0.896 . . . . 2.64 108.753 178.457 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.472 ' CB ' ' O ' ' A' ' 15' ' ' TRP . . . -63.87 -35.01 79.23 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.574 -0.899 . . . . 2.45 108.574 178.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.678 ' HB1' HG11 ' A' ' 59' ' ' VAL . . . -66.87 -43.61 83.08 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.664 -0.865 . . . . 1.89 108.664 178.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.436 ' N ' ' HA ' ' A' ' 52' ' ' MET . . . -61.58 -26.8 68.2 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.558 -0.713 . . . . 2.07 109.348 179.159 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -95.91 20.32 10.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.647 -0.658 . . . . 4.97 110.087 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 55.81 34.18 60.88 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.38 -1.088 . . . . 2.84 110.38 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.619 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -99.53 74.44 1.89 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.283 -1.127 . . . . 4.37 109.984 179.646 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.756 HG22 ' CG2' ' A' ' 59' ' ' VAL . 62.0 t -57.85 -46.14 87.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.374 -0.829 . . . . 2.98 110.353 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -54.93 -51.45 66.05 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.387 -0.82 . . . . 4.64 110.4 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.16 -46.04 68.73 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.23 -0.919 . . . . 3.3 109.963 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.886 HG12 HD12 ' A' ' 32' ' ' LEU . 5.7 t -69.66 -42.19 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.398 -0.814 . . . . 3.02 109.622 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.994 ' HA ' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -48.5 -48.11 38.3 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.55 -0.719 . . . . 4.19 110.093 179.676 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.5 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -78.73 -35.23 45.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.505 -0.747 . . . . 4.02 110.057 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.505 HD13 ' HB3' ' A' ' 15' ' ' TRP . 25.8 mt -64.26 -65.69 0.64 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.369 -0.832 . . . . 3.44 110.03 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.911 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 3.8 mt -48.33 -42.51 31.44 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.43 -0.794 . . . . 3.6 110.544 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -75.23 -17.27 60.37 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.255 -0.903 . . . . 4.87 110.24 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' A' ' 30' ' ' ALA . . . -86.36 -7.45 58.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -0.924 . . . . 4.13 110.896 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.29 26.91 1.92 Allowed Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.888 -1.148 . . . . 3.84 110.466 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 1.029 ' HB1' HD23 ' A' ' 16' ' ' LEU . . . -79.14 126.79 31.19 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.176 -1.191 . . . . 3.33 110.341 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.468 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 0.4 OUTLIER -53.44 123.83 37.95 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.375 -0.828 . . . . 3.61 110.337 179.938 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.427 ' HD2' HD13 ' A' ' 37' ' ' LEU . 43.2 Cg_endo -72.56 -23.87 19.44 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.539 1.284 . . . . 3.28 108.966 178.453 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -112.7 51.77 0.81 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.63 -0.669 . . . . 3.8 109.246 178.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.468 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -92.88 116.4 66.44 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.413 -0.804 . . . . 2.68 110.46 -179.38 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.32 121.12 6.27 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.696 1.366 . . . . 3.15 110.487 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -78.75 175.41 10.48 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.296 -0.877 . . . . 3.3 110.351 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.7 m -83.48 -6.53 59.48 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.317 -0.865 . . . . 3.78 110.502 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -84.46 12.05 7.56 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.153 -0.967 . . . . 3.84 110.375 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.22 16.22 62.07 Favored Glycine 0 N--CA 1.484 1.889 0 N-CA-C 109.064 -1.615 . . . . 2.97 109.064 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 61.3 mtt180 -113.52 -167.51 1.21 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.47 -1.018 . . . . 3.32 110.179 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.709 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 0.8 OUTLIER -108.96 -174.37 0.3 Allowed Pre-proline 0 N--CA 1.492 1.631 0 N-CA-C 108.848 -0.797 . . . . 3.66 108.848 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.709 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 43.3 Cg_endo -74.25 -19.59 19.66 Favored 'Trans proline' 0 C--N 1.314 -1.249 0 O-C-N 123.001 1.0 . . . . 2.19 111.4 -178.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.412 ' O ' ' HG2' ' A' ' 52' ' ' MET . 14.1 mt -108.73 -36.56 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 120.99 -1.069 . . . . 1.71 108.909 178.61 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.417 ' HG3' ' CA ' ' A' ' 81' ' ' PRO . 0.4 OUTLIER -56.55 -17.6 8.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.479 -0.763 . . . . 2.69 110.062 179.246 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.8 p -107.81 -5.16 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.31 -0.869 . . . . 1.77 111.277 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' MET . . . . . 0.828 ' HE1' ' HB2' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -62.33 164.86 6.6 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.73 -1.231 . . . . 2.02 109.728 -179.902 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 5.0 tmm? -57.13 -10.32 1.17 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.256 -0.902 . . . . 2.68 111.478 -178.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.693 ' HE2' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 57.67 16.97 3.74 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.08 -1.012 . . . . 1.71 109.95 -179.432 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.462 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -121.26 10.63 9.96 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 108.944 -1.662 . . . . 2.31 108.944 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.39 86.97 1.49 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.453 -1.028 . . . . 2.49 109.197 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.95 -24.72 6.84 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.466 -0.771 . . . . 2.01 110.6 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.42 ' HB3' HG11 ' A' ' 25' ' ' VAL . 0.8 OUTLIER -53.62 -38.59 64.18 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.233 -0.917 . . . . 4.52 109.347 179.56 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.756 ' CG2' HG22 ' A' ' 25' ' ' VAL . 27.1 t -64.78 -49.01 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.043 -1.095 . . . . 2.06 108.043 178.176 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.828 ' HB2' ' HE1' ' A' ' 52' ' ' MET . . . -55.77 -43.04 76.38 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.888 -0.782 . . . . 2.1 108.888 178.425 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -58.65 -64.04 1.07 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.323 -0.86 . . . . 3.67 108.785 178.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.994 HD11 ' HA ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -41.9 -59.36 1.73 Allowed 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.769 0.795 . . . . 3.13 109.811 177.936 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.074 HD21 HD13 ' A' ' 16' ' ' LEU . 10.4 mt -59.75 -56.01 27.19 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.271 0.558 . . . . 2.64 110.84 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.831 HD21 ' CB ' ' A' ' 100' ' ' ALA . 1.2 tt -56.53 -56.63 18.86 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.426 -0.796 . . . . 3.02 110.918 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.653 ' O ' HD12 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -55.99 -29.89 60.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.141 -0.974 . . . . 3.74 109.935 -179.377 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' HIS . . . . . 0.615 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -82.39 -25.14 34.02 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.423 -0.798 . . . . 4.0 109.395 179.606 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 124.08 42.18 0.37 Allowed Glycine 0 N--CA 1.479 1.518 0 N-CA-C 110.507 -1.037 . . . . 3.14 110.507 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.681 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -66.41 -161.79 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.855 -1.38 . . . . 2.73 109.474 179.261 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.591 ' HB2' ' HB3' ' A' ' 47' ' ' ARG . 1.7 mp0 -115.88 62.13 2.02 Favored Pre-proline 0 C--N 1.302 -1.487 0 O-C-N 121.362 -0.836 . . . . 3.37 110.324 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.606 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 43.1 Cg_endo -68.89 -11.71 32.55 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.608 1.32 . . . . 2.64 109.455 178.791 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.51 ' OD1' ' HB2' ' A' ' 103' ' ' ARG . 1.4 t-20 -106.05 -42.05 5.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.532 -0.73 . . . . 4.06 110.223 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.419 ' HB3' ' HD2' ' A' ' 47' ' ' ARG . 0.3 OUTLIER -69.73 143.84 52.95 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.153 -0.967 . . . . 3.77 110.734 -179.275 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.573 ' HB2' ' HG2' ' A' ' 80' ' ' ARG . . . -132.98 -146.43 0.27 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.426 -0.796 . . . . 3.45 110.103 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 78' ' ' LEU . 1.0 OUTLIER -109.3 138.27 20.45 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.117 -0.989 . . . . 3.88 110.109 -179.939 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -77.35 -6.04 16.1 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.467 1.246 . . . . 4.82 110.551 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -99.12 -35.7 9.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.163 -0.961 . . . . 4.58 110.116 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.2 p -132.21 7.51 4.27 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.323 -0.861 . . . . 4.37 110.696 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.46 ' HA ' HD23 ' A' ' 78' ' ' LEU . 6.0 mt 45.59 31.66 0.99 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.319 -0.863 . . . . 4.3 110.63 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.9 m -69.12 76.9 0.35 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.413 -0.804 . . . . 3.38 110.472 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ARG . . . . . 0.587 ' HB2' HG11 ' A' ' 106' ' ' VAL . 3.8 mtt85 -57.61 161.27 6.32 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.091 -1.005 . . . . 3.91 109.273 179.326 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.606 ' HG3' ' HA ' ' A' ' 70' ' ' PRO . 39.4 Cg_endo -67.81 -6.84 17.88 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.555 1.292 . . . . 2.39 110.954 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.557 HG21 ' HA ' ' A' ' 104' ' ' LEU . 19.4 t -71.03 -35.51 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.216 -0.927 . . . . 2.38 109.674 179.397 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 31.8 m80 -67.48 -44.89 77.46 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.381 -0.825 . . . . 3.04 109.195 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.693 ' HB3' ' HE2' ' A' ' 54' ' ' MET . 0.3 OUTLIER -49.53 -51.76 34.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.886 -0.509 . . . . 2.28 110.902 -179.792 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.523 ' HB3' ' CD1' ' A' ' 94' ' ' LEU . . . -58.1 -58.36 8.78 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.102 -0.999 . . . . 1.5 109.682 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.84 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -59.79 -40.44 88.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.417 -0.802 . . . . 1.91 110.348 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.9 -34.73 21.21 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.31 -0.869 . . . . 3.67 110.332 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.41 1.85 38.81 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.39 -0.819 . . . . 2.79 110.642 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.499 ' HA2' ' HB3' ' A' ' 123' ' ' HIS . . . 73.62 38.14 51.47 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.521 -1.431 . . . . 2.01 109.521 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.462 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 0.3 OUTLIER -110.8 105.17 13.92 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.311 -1.111 . . . . 2.43 111.101 -179.265 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.624 HD21 ' CB ' ' A' ' 129' ' ' TYR . 0.5 OUTLIER -78.64 -36.85 43.38 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.25 -0.906 . . . . 2.6 109.356 178.872 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.715 ' O ' HG23 ' A' ' 96' ' ' VAL . 19.4 m-20 -48.17 -43.38 31.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.592 -0.692 . . . . 2.72 109.747 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 54.6 m -65.82 -43.92 87.17 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.722 -0.844 . . . . 1.77 108.722 178.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.867 HD21 ' CD2' ' A' ' 130' ' ' LEU . 1.1 tp -57.48 -49.09 77.43 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.435 -0.791 . . . . 2.24 109.006 178.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.507 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 85.7 t -54.94 -54.56 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 108.87 -0.789 . . . . 2.83 108.87 178.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 92' ' ' ASP . 89.1 t -49.37 -50.79 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.739 -0.601 . . . . 2.71 109.861 178.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.487 ' HA ' ' CD1' ' A' ' 64' ' ' LEU . 0.4 OUTLIER -52.45 -64.39 0.83 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.42 -0.8 . . . . 2.9 109.833 179.373 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -57.67 -22.99 49.15 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.34 -0.85 . . . . 3.77 110.683 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.507 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 4.3 ttt180 -73.47 -17.05 61.28 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.222 -0.924 . . . . 4.95 110.893 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.831 ' CB ' HD21 ' A' ' 64' ' ' LEU . . . -141.11 67.99 1.34 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.052 -1.03 . . . . 3.94 111.245 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 48.55 94.98 0.01 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.899 -0.88 . . . . 3.62 110.899 179.03 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.463 ' O ' HD12 ' A' ' 104' ' ' LEU . . . -150.25 101.54 3.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.396 -1.061 . . . . 3.21 109.021 179.07 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.51 ' HB2' ' OD1' ' A' ' 71' ' ' ASN . 3.0 tpt180 -54.23 120.95 7.21 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.314 -0.866 . . . . 4.85 111.002 -178.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.617 HD23 ' HB2' ' A' ' 134' ' ' ALA . 0.2 OUTLIER -107.5 -7.12 16.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.721 -0.612 . . . . 3.3 109.911 179.45 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -98.32 48.19 0.99 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.101 -1.0 . . . . 4.05 112.525 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.591 HG22 ' H ' ' A' ' 107' ' ' ARG . 1.4 p -113.02 -175.18 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.684 -1.26 . . . . 3.77 109.869 178.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.591 ' H ' HG22 ' A' ' 106' ' ' VAL . 4.2 ptt180 -138.98 158.52 44.05 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.512 -0.742 . . . . 5.47 109.211 178.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.496 1.841 0 O-C-N 121.065 -1.022 . . . . 4.46 111.459 -178.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.574 ' HB3' HG12 ' A' ' 115' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 120.637 0.256 . . . . 4.08 110.884 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -68.0 -26.4 37.38 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.853 1.449 . . . . 3.1 108.643 177.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.574 HG12 ' HB3' ' A' ' 113' ' ' LEU . 7.2 p -76.29 -35.43 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 108.634 -0.876 . . . . 3.3 108.634 178.462 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.37 -26.41 66.45 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.701 -0.799 . . . . 4.01 109.767 179.094 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.54 -33.79 54.08 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.43 -0.794 . . . . 3.43 110.358 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.699 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -74.08 -37.99 64.04 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.301 -0.875 . . . . 2.83 110.566 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.442 ' HG3' ' HB1' ' A' ' 127' ' ' ALA . 3.6 mt-10 -70.2 -32.3 70.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.331 -0.856 . . . . 3.91 110.561 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -70.91 -57.23 4.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.114 -0.991 . . . . 4.27 109.777 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.93 -81.07 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.304 -0.872 . . . . 3.4 109.993 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.26 40.59 0.03 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.929 -1.669 . . . . 3.23 108.929 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' HIS . . . . . 0.565 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 48.0 m-70 -107.94 53.12 0.7 Allowed 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.482 -1.011 . . . . 2.7 109.511 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.434 ' O ' ' HB2' ' A' ' 128' ' ' ARG . 20.9 mtt180 -47.5 -52.41 17.41 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.766 -0.584 . . . . 4.13 109.957 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.426 ' O ' HD11 ' A' ' 91' ' ' LEU . 1.0 OUTLIER -48.68 -40.51 28.37 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.486 -0.759 . . . . 2.92 109.915 179.435 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.84 HG11 ' HA ' ' A' ' 86' ' ' ALA . 2.2 t -81.37 -47.24 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.36 -0.837 . . . . 2.25 109.501 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.508 ' HB2' ' CB ' ' A' ' 118' ' ' ALA . . . -56.12 -41.84 75.92 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.211 -0.931 . . . . 2.77 109.89 179.222 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -59.96 -56.65 19.09 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.275 -0.89 . . . . 4.43 109.353 179.327 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.631 ' HD2' HD23 ' A' ' 94' ' ' LEU . 60.0 t80 -60.59 -33.0 72.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.374 -0.829 . . . . 3.06 109.012 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.867 ' CD2' HD21 ' A' ' 94' ' ' LEU . 28.2 mt -65.63 -52.38 52.32 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.959 -0.696 . . . . 3.09 109.315 179.204 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 3.1 ttt-85 -57.88 -19.16 27.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.93 -1.106 . . . . 4.86 109.341 178.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.67 -51.33 6.53 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.59 -0.893 . . . . 3.81 108.59 178.085 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.431 ' HB3' HD22 ' A' ' 104' ' ' LEU . . . -92.5 -52.11 4.81 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.099 -1.001 . . . . 3.53 109.963 178.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.631 ' N ' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.494 1.747 0 O-C-N 121.677 -0.639 . . . . 3.93 112.282 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 121.203 0.525 . . . . 0.0 110.359 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.422 ' HA ' ' HD2' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -99.29 110.21 57.37 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.324 -0.86 . . . . 0.0 110.214 179.841 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 2' ' ' GLU . 44.1 Cg_endo -69.15 154.75 69.66 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.632 1.333 . . . . 0.0 110.495 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -167.65 142.05 3.65 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.54 -0.725 . . . . 0.0 110.203 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -145.26 -44.64 0.22 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.382 -0.824 . . . . 0.0 110.289 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 150.64 -86.85 0.14 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.4 p -49.85 112.5 0.67 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.378 -1.072 . . . . 0.0 109.843 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 t -92.45 160.05 15.25 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.209 -0.932 . . . . 0.0 110.617 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.21 97.74 5.66 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.72 -0.612 . . . . 0.0 109.983 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -146.81 90.17 5.53 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.313 -0.867 . . . . 0.0 109.965 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -76.89 76.45 4.11 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.905 1.476 . . . . 0.0 111.037 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 m -62.01 179.51 0.28 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.144 -0.972 . . . . 0.0 109.753 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.444 ' HB3' ' HG ' ' A' ' 37' ' ' LEU . . . -54.26 128.79 32.76 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.197 -0.94 . . . . 0.0 110.273 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.494 ' O ' ' OG1' ' A' ' 18' ' ' THR . 25.8 t0 -157.65 20.14 0.27 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.468 -0.77 . . . . 0.0 110.62 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.477 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 40.9 m0 -76.66 -56.51 4.54 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.307 -0.87 . . . . 0.0 110.612 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.7 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 0.8 OUTLIER -41.62 -40.76 2.01 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.698 -0.626 . . . . 0.0 111.042 -179.821 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.2 -56.27 5.32 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.174 -0.954 . . . . 0.0 110.07 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.494 ' OG1' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -43.73 -53.93 5.49 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.587 -0.696 . . . . 0.0 110.719 -179.939 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.665 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -52.97 -55.91 19.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.411 -0.806 . . . . 0.0 110.445 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.457 ' CB ' HG11 ' A' ' 59' ' ' VAL . . . -47.08 -62.58 1.35 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.567 -0.708 . . . . 0.0 111.077 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.622 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -46.15 -28.5 1.25 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.612 -0.68 . . . . 0.0 110.855 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -90.79 30.35 1.2 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.299 -0.876 . . . . 0.0 110.291 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.553 ' CA ' ' HE2' ' A' ' 53' ' ' MET . . . 44.94 27.5 1.48 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.406 -1.077 . . . . 0.0 110.406 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.541 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -105.17 98.47 8.17 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.258 -1.142 . . . . 0.0 110.323 -179.771 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.817 HG22 ' CG2' ' A' ' 59' ' ' VAL . 69.9 t -78.73 -37.26 20.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.633 -0.667 . . . . 0.0 110.172 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -54.65 -52.38 62.49 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.544 -0.722 . . . . 0.0 110.899 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.456 ' O ' HD12 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -58.04 -35.1 70.82 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.225 -0.922 . . . . 0.0 110.821 -179.233 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.852 HG12 HD13 ' A' ' 62' ' ' LEU . 6.2 t -76.41 -47.85 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.274 -0.891 . . . . 0.0 110.171 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.809 ' N ' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -52.73 -46.34 67.37 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.022 -1.049 . . . . 0.0 109.688 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -70.66 -31.0 67.76 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.418 -0.801 . . . . 0.0 109.559 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' ' 27' ' ' GLU . 10.2 mt -79.4 -53.26 7.08 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.402 -0.811 . . . . 0.0 110.815 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.924 HD12 ' CD2' ' A' ' 66' ' ' HIS . 0.0 OUTLIER -47.88 -38.76 17.03 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.164 -0.96 . . . . 0.0 110.161 -179.695 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -83.09 -25.06 32.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.332 -0.855 . . . . 0.0 109.855 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.426 ' HB2' ' O ' ' A' ' 30' ' ' ALA . . . -74.25 -3.81 32.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.42 -0.8 . . . . 0.0 110.03 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.82 24.44 5.23 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.761 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -61.04 133.74 56.37 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.071 -1.252 . . . . 0.0 109.809 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.968 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 3.1 mm? -57.09 112.89 5.17 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.399 -0.813 . . . . 0.0 109.778 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.47 -30.42 36.03 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 123.543 1.286 . . . . 0.0 109.88 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.52 ' HA ' ' OE2' ' A' ' 69' ' ' GLU . 33.0 m120 -121.01 56.67 1.01 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.425 -0.797 . . . . 0.0 110.125 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.968 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -100.9 110.89 62.23 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.856 -0.527 . . . . 0.0 109.604 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.92 124.6 9.76 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.494 1.26 . . . . 0.0 109.638 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.498 ' ND2' ' HB2' ' A' ' 44' ' ' TYR . 36.9 t30 -88.2 161.97 16.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.408 -0.808 . . . . 0.0 110.035 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.405 ' N ' ' OD1' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -74.76 -0.99 20.01 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.428 -0.795 . . . . 0.0 110.967 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.498 ' HB2' ' ND2' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -84.64 1.37 46.52 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.004 -1.06 . . . . 0.0 110.093 179.529 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.82 23.24 44.2 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.521 ' O ' ' CB ' ' A' ' 50' ' ' GLN . 46.1 mtt180 -121.66 37.63 4.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.316 -1.108 . . . . 0.0 110.968 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.487 ' HG3' ' HD3' ' A' ' 48' ' ' PRO . 0.0 OUTLIER 43.52 -172.65 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.089 0 O-C-N 121.517 -0.739 . . . . 0.0 111.064 178.926 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.694 ' HB2' HD22 ' A' ' 63' ' ' LEU . 53.0 Cg_endo -85.5 -23.89 2.1 Favored 'Trans proline' 0 C--N 1.317 -1.089 0 O-C-N 123.476 1.251 . . . . 0.0 110.377 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.582 HG13 ' HB1' ' A' ' 68' ' ' ALA . 2.7 mt -102.63 -43.85 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.229 -0.919 . . . . 0.0 108.95 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.58 ' HG2' ' HA ' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -49.68 -21.17 0.97 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.381 -0.824 . . . . 0.0 109.822 178.808 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.622 HG22 ' HB2' ' A' ' 21' ' ' ALA . 9.3 p -112.99 33.23 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.089 -1.007 . . . . 0.0 110.579 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.563 ' HE1' ' HB2' ' A' ' 60' ' ' ALA . 0.1 OUTLIER -96.96 35.08 1.61 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.061 -1.024 . . . . 0.0 109.483 179.111 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.553 ' HE2' ' CA ' ' A' ' 23' ' ' GLY . 6.2 tmm? 64.55 -6.26 0.31 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.667 -0.645 . . . . 0.0 111.109 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.588 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 44.53 26.79 0.2 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.253 -0.904 . . . . 0.0 110.57 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.537 ' HA2' ' CD2' ' A' ' 90' ' ' PHE . . . -128.79 8.73 6.44 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.648 ' HB3' HG23 ' A' ' 59' ' ' VAL . 0.6 OUTLIER -145.66 70.29 1.24 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.318 -1.107 . . . . 0.0 109.972 179.663 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.505 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . . . -42.79 -36.56 1.5 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.507 -0.746 . . . . 0.0 110.7 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -46.31 -35.29 5.2 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.653 -0.654 . . . . 0.0 109.463 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.817 ' CG2' HG22 ' A' ' 25' ' ' VAL . 46.6 t -67.16 -51.55 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.563 ' HB2' ' HE1' ' A' ' 52' ' ' MET . . . -43.85 -58.13 2.91 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.649 -0.657 . . . . 0.0 110.03 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.93 -49.35 30.41 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.852 HD13 HG12 ' A' ' 28' ' ' VAL . 0.4 OUTLIER -46.11 -62.67 1.23 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.704 -0.622 . . . . 0.0 110.115 178.935 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.883 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 0.9 OUTLIER -69.98 -55.18 10.27 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.385 -0.822 . . . . 0.0 110.615 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.904 HD22 ' CG1' ' A' ' 96' ' ' VAL . 0.4 OUTLIER -48.39 -63.69 1.01 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.302 -0.874 . . . . 0.0 110.701 -179.528 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.723 HD12 ' C ' ' A' ' 65' ' ' LEU . 0.8 OUTLIER -50.68 -28.12 8.35 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.406 -0.809 . . . . 0.0 109.36 -179.702 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.924 ' CD2' HD12 ' A' ' 32' ' ' LEU . 2.4 m80 -84.47 -31.98 24.26 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.778 -0.576 . . . . 0.0 109.748 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 63' ' ' LEU . . . 125.81 55.37 0.16 Allowed Glycine 0 N--CA 1.482 1.707 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.883 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -80.02 -150.97 0.07 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.971 -1.311 . . . . 0.0 109.049 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.52 ' OE2' ' HA ' ' A' ' 39' ' ' ASN . 2.0 mt-10 -124.38 68.0 48.45 Favored Pre-proline 0 C--N 1.3 -1.582 0 O-C-N 121.412 -0.805 . . . . 0.0 109.49 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.518 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 49.0 Cg_endo -71.24 -3.89 13.84 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 O-C-N 123.716 1.377 . . . . 0.0 110.293 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.454 ' O ' ' NE ' ' A' ' 80' ' ' ARG . 37.0 m-20 -112.55 -67.67 0.98 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.303 -0.873 . . . . 0.0 109.587 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.8 t -43.69 155.52 0.07 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.57 -0.706 . . . . 0.0 110.128 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.556 ' HB2' ' HA ' ' A' ' 80' ' ' ARG . . . -152.07 -142.26 0.12 Allowed 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.569 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.413 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 0.4 OUTLIER -100.01 139.59 20.88 Favored Pre-proline 0 N--CA 1.484 1.254 0 O-C-N 121.219 -0.926 . . . . 0.0 110.563 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 74' ' ' ASP . 55.2 Cg_endo -84.31 2.77 7.96 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.988 1.52 . . . . 0.0 110.428 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -101.79 -33.87 9.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.16 -0.963 . . . . 0.0 110.027 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.787 HG23 ' CH2' ' A' ' 110' ' ' TRP . 0.3 OUTLIER -140.24 10.18 2.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.473 -0.767 . . . . 0.0 110.518 -179.836 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 78' ' ' LEU . 21.7 mt 53.86 38.49 28.77 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.303 -0.873 . . . . 0.0 110.731 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.475 ' HA ' ' OD1' ' A' ' 108' ' ' ASP . 36.5 m -72.91 88.38 1.35 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.423 -0.911 . . . . 0.0 110.313 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.781 ' CD ' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -72.78 168.43 24.36 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.471 -0.768 . . . . 0.0 109.675 179.752 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.58 ' HA ' ' HG2' ' A' ' 50' ' ' GLN . 47.9 Cg_endo -73.26 -2.26 11.82 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.697 1.367 . . . . 0.0 109.998 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 23.9 t -76.59 -36.11 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.585 -0.697 . . . . 0.0 109.612 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.522 ' O ' ' CB ' ' A' ' 87' ' ' ARG . 23.1 m80 -69.39 -40.46 77.35 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.588 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 0.3 OUTLIER -52.1 -52.27 52.48 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.304 -0.873 . . . . 0.0 110.676 179.374 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.674 ' HB1' ' CD1' ' A' ' 94' ' ' LEU . . . -55.46 -64.74 0.75 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.224 -0.922 . . . . 0.0 110.154 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.825 ' HB1' ' HB2' ' A' ' 118' ' ' ALA . . . -58.94 -56.09 26.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.195 -0.941 . . . . 0.0 110.423 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.522 ' CB ' ' O ' ' A' ' 83' ' ' HIS . 0.1 OUTLIER -43.39 -25.85 0.16 Allowed 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.342 -0.849 . . . . 0.0 111.291 -179.821 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.53 ' CB ' ' HB3' ' A' ' 54' ' ' MET . 0.0 OUTLIER -104.34 -13.56 16.08 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.076 -1.015 . . . . 0.0 110.657 179.446 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.04 25.65 39.96 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.537 ' CD2' ' HA2' ' A' ' 55' ' ' GLY . 0.5 OUTLIER -106.12 93.69 4.76 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.283 -1.128 . . . . 0.0 110.722 -179.693 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.434 HD21 ' CG ' ' A' ' 129' ' ' TYR . 0.2 OUTLIER -66.75 -44.22 82.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.509 -0.745 . . . . 0.0 109.908 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.511 ' O ' HG23 ' A' ' 96' ' ' VAL . 36.2 t0 -40.75 -38.69 0.95 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.576 -0.703 . . . . 0.0 110.121 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.404 ' CG2' ' HB2' ' A' ' 85' ' ' ALA . 22.4 m -63.04 -58.87 5.83 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.496 -0.753 . . . . 0.0 109.593 179.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.806 ' CD2' HD21 ' A' ' 130' ' ' LEU . 1.2 mp -48.94 -46.29 43.07 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.398 -0.814 . . . . 0.0 110.023 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 71.6 t -49.84 -54.86 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.904 ' CG1' HD22 ' A' ' 64' ' ' LEU . 85.0 t -53.09 -57.15 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 121.26 0.552 . . . . 0.0 109.716 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.774 ' C ' ' HB2' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -45.62 -56.3 5.34 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.33 0.586 . . . . 0.0 110.034 179.785 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -63.7 -21.0 66.17 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.19 -0.944 . . . . 0.0 109.836 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.36 -15.59 61.37 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.247 -0.908 . . . . 0.0 110.727 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.783 ' HB3' HD11 ' A' ' 64' ' ' LEU . . . -134.47 62.2 1.65 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.237 -0.914 . . . . 0.0 110.249 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 47.54 80.31 0.06 OUTLIER Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.774 ' HB2' ' C ' ' A' ' 97' ' ' LEU . . . -101.51 144.94 29.67 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.378 -1.072 . . . . 0.0 109.991 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -87.04 59.29 5.54 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.19 -0.944 . . . . 0.0 110.317 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.609 ' O ' ' HA ' ' A' ' 134' ' ' ALA . 0.6 OUTLIER -68.95 61.81 0.11 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.542 -0.723 . . . . 0.0 110.592 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -167.44 29.15 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.782 -1.199 . . . . 0.0 110.574 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.781 HG11 ' CD ' ' A' ' 80' ' ' ARG . 1.0 OUTLIER -100.65 -169.86 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 121.27 -0.894 . . . . 0.0 109.283 179.234 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.608 ' H ' HG22 ' A' ' 106' ' ' VAL . 3.7 ptm180 -141.85 131.31 23.78 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 120.118 -0.633 . . . . 0.0 109.877 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 110' ' ' TRP . 0.4 OUTLIER -70.99 57.93 0.21 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.474 -0.766 . . . . 0.0 109.715 179.79 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 52.96 -83.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.556 -0.715 . . . . 0.0 110.542 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.787 ' CH2' HG23 ' A' ' 77' ' ' THR . 0.1 OUTLIER -101.81 -8.05 21.99 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.007 -1.058 . . . . 0.0 109.874 179.556 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.449 ' O ' ' CB ' ' A' ' 112' ' ' ARG . . . -74.19 0.14 54.62 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.586 ' O ' HD12 ' A' ' 113' ' ' LEU . 0.9 OUTLIER 68.41 -68.82 0.16 Allowed 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.325 -1.103 . . . . 0.0 110.258 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.586 HD12 ' O ' ' A' ' 112' ' ' ARG . 0.1 OUTLIER -166.41 163.78 11.23 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.353 -0.842 . . . . 0.0 109.938 -179.739 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.476 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 44.0 Cg_endo -73.65 -32.2 7.87 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 O-C-N 123.686 1.361 . . . . 0.0 109.999 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.577 HG23 ' CB ' ' A' ' 130' ' ' LEU . 6.8 p -65.9 -36.39 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.415 -0.803 . . . . 0.0 109.409 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -74.97 -42.69 57.12 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.475 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.405 ' HG ' HD12 ' A' ' 121' ' ' LEU . 6.2 tt -61.56 -31.84 71.89 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.33 -0.856 . . . . 0.0 109.162 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.825 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -68.28 -43.37 77.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.466 -0.772 . . . . 0.0 109.944 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -68.22 -46.53 70.31 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.456 -0.778 . . . . 0.0 111.16 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -61.06 -54.37 45.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.298 -0.876 . . . . 0.0 110.276 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.405 HD12 ' HG ' ' A' ' 117' ' ' LEU . 0.2 OUTLIER -56.67 -81.03 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.277 -0.889 . . . . 0.0 110.174 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 173.89 38.76 0.04 OUTLIER Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.555 ' CG ' ' O ' ' A' ' 86' ' ' ALA . 51.3 m-70 -118.16 47.73 1.54 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.495 -1.003 . . . . 0.0 109.663 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -45.83 -53.46 9.63 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.713 -0.617 . . . . 0.0 110.315 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.424 ' O ' HD11 ' A' ' 91' ' ' LEU . 17.2 m-20 -48.0 -34.2 8.99 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.587 -0.696 . . . . 0.0 109.563 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.746 HG11 ' HA ' ' A' ' 86' ' ' ALA . 2.8 t -88.81 -44.9 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.631 -0.668 . . . . 0.0 109.331 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.439 ' O ' HG23 ' A' ' 115' ' ' VAL . . . -52.99 -49.09 66.87 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.397 -0.814 . . . . 0.0 110.176 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.74 -61.58 2.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.134 -0.979 . . . . 0.0 110.105 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.434 ' CG ' HD21 ' A' ' 91' ' ' LEU . 12.2 t80 -53.53 -30.72 43.03 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.421 -0.799 . . . . 0.0 109.379 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.806 HD21 ' CD2' ' A' ' 94' ' ' LEU . 5.9 mt -64.04 -52.16 60.7 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.026 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -54.82 -29.81 55.75 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.303 -0.873 . . . . 0.0 110.272 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -80.94 -33.06 34.31 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.488 -0.758 . . . . 0.0 110.153 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.435 ' HB1' HD13 ' A' ' 104' ' ' LEU . . . -90.12 -21.64 22.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.358 -0.839 . . . . 0.0 110.524 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.609 ' HA ' ' O ' ' A' ' 104' ' ' LEU . . . -101.27 -14.12 17.79 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.081 -1.012 . . . . 0.0 110.238 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 56.13 173.22 0.16 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.51 ' C ' HG22 ' A' ' 137' ' ' THR . . . -166.68 -168.72 29.29 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.51 HG22 ' C ' ' A' ' 136' ' ' GLY . 8.9 t 35.56 34.52 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.769 -0.842 . . . . 0.0 111.707 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.407 ' N ' ' O ' ' A' ' 136' ' ' GLY . 0.0 OUTLIER -96.3 122.43 39.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.244 -0.91 . . . . 0.0 110.024 179.776 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 93.18 26.63 15.5 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.61 24.33 0.06 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.477 -1.014 . . . . 0.0 110.567 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -70.37 67.6 0.33 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.308 -0.87 . . . . 0.0 110.18 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -123.22 -66.9 0.98 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.129 -0.982 . . . . 0.0 110.44 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -101.08 -36.11 9.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.176 -0.953 . . . . 0.0 110.242 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.44 64.52 1.81 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.195 -0.94 . . . . 0.0 110.098 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.406 ' O ' ' CG1' ' A' ' 145' ' ' ILE . 3.1 tt -176.26 67.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.331 -0.856 . . . . 0.0 109.779 -179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.5 t0 50.39 -175.68 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.321 -0.862 . . . . 0.0 109.956 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.04 97.49 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.253 -0.904 . . . . 0.0 109.551 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.3 -179.37 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.331 -0.856 . . . . 0.0 110.681 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.14 125.63 32.96 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.332 -0.855 . . . . 0.0 110.377 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 120.1 148.59 8.17 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -79.1 112.36 3.05 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 123.883 1.465 . . . . 0.0 110.413 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 1.5 m -75.92 149.83 37.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.3 -0.875 . . . . 0.0 110.095 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.43 142.69 27.44 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.288 -0.882 . . . . 0.0 110.175 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 1.8 pt -136.51 78.5 43.88 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.357 -0.839 . . . . 0.0 110.961 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -78.28 114.21 3.5 Favored 'Trans proline' 0 C--N 1.309 -1.553 0 O-C-N 123.534 1.281 . . . . 0.0 110.811 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.496 1.851 0 CA-C-O 117.955 -1.021 . . . . 0.0 110.011 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 ttt . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 121.225 0.536 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.484 ' N ' ' HD2' ' A' ' 3' ' ' PRO . 0.5 OUTLIER -57.48 -55.54 43.51 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.232 -0.917 . . . . 0.0 110.134 179.82 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 2' ' ' GLU . 47.8 Cg_endo -73.79 107.35 2.39 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 123.548 1.289 . . . . 0.0 110.229 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -81.92 144.14 31.16 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.273 -0.892 . . . . 0.0 109.849 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -103.57 11.9 35.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.289 -0.882 . . . . 0.0 110.801 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.1 50.25 0.15 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.5 m 57.16 -170.06 0.1 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.377 -1.073 . . . . 0.0 110.749 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.77 41.73 1.07 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.41 -0.807 . . . . 0.0 110.658 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.7 -39.63 23.99 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.3 -0.875 . . . . 0.0 109.735 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.23 63.78 69.57 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.507 -0.746 . . . . 0.0 109.539 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -78.82 175.99 10.36 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 123.851 1.448 . . . . 0.0 110.874 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.535 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 14.5 t -85.56 -76.59 0.32 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.396 -0.815 . . . . 0.0 110.206 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 12' ' ' SER . . . 61.81 91.63 0.06 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.311 -0.868 . . . . 0.0 110.169 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.402 ' O ' ' OG1' ' A' ' 18' ' ' THR . 6.9 m-20 -124.76 18.13 8.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.466 -0.771 . . . . 0.0 110.356 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.552 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 33.6 m0 -80.35 -6.94 58.8 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.345 -0.847 . . . . 0.0 110.721 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.672 HD11 ' HB1' ' A' ' 36' ' ' ALA . 14.6 mt -86.61 -49.29 7.63 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.201 -0.937 . . . . 0.0 109.387 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.84 -31.16 71.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.562 -0.711 . . . . 0.0 109.37 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.552 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.2 OUTLIER -66.01 -61.17 2.19 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.656 -0.653 . . . . 0.0 109.961 179.68 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.742 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -54.26 -34.78 61.55 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.28 -0.887 . . . . 0.0 110.102 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.77 ' HB1' ' CB ' ' A' ' 52' ' ' MET . . . -65.65 -55.89 15.07 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.248 -0.907 . . . . 0.0 109.23 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.42 -29.96 69.32 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.458 -0.776 . . . . 0.0 109.741 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -98.51 17.26 19.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.402 -0.811 . . . . 0.0 110.243 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.408 ' CA ' ' HE2' ' A' ' 53' ' ' MET . . . 50.06 82.13 0.04 OUTLIER Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.736 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 1.1 ttt180 -143.19 63.91 1.36 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.29 -1.123 . . . . 0.0 109.819 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.529 HG12 ' HD3' ' A' ' 29' ' ' ARG . 94.1 t -48.73 -64.94 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.484 -0.76 . . . . 0.0 111.267 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -49.64 -38.32 31.71 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.355 -0.84 . . . . 0.0 110.959 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.42 -37.64 86.61 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.393 -0.817 . . . . 0.0 110.263 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.826 HG12 HD12 ' A' ' 32' ' ' LEU . 2.8 t -82.95 -45.11 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.4 -0.812 . . . . 0.0 109.924 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.529 ' HD3' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -42.96 -43.9 4.38 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.518 -0.739 . . . . 0.0 110.335 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.94 -41.47 36.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.452 -0.78 . . . . 0.0 109.94 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.431 ' HB2' ' HA ' ' A' ' 28' ' ' VAL . 27.0 mt -53.8 -65.56 0.55 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.281 -0.887 . . . . 0.0 109.729 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.949 HD22 ' CB ' ' A' ' 66' ' ' HIS . 2.8 mt -48.82 -43.92 38.87 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.648 -0.657 . . . . 0.0 110.637 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -70.84 -21.1 62.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.204 -0.935 . . . . 0.0 109.956 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.45 -6.47 59.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.337 -0.852 . . . . 0.0 110.615 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.16 27.28 3.21 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.891 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -66.77 169.01 8.58 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.157 -1.202 . . . . 0.0 109.894 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.572 HD13 ' HD2' ' A' ' 38' ' ' PRO . 1.9 mm? -87.66 125.99 63.24 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.422 -0.799 . . . . 0.0 110.046 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.572 ' HD2' HD13 ' A' ' 37' ' ' LEU . 42.7 Cg_endo -69.22 -36.96 11.2 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.354 1.186 . . . . 0.0 109.716 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.423 ' O ' ' HD3' ' A' ' 41' ' ' PRO . 74.7 m-20 -121.41 70.91 0.94 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.502 -0.749 . . . . 0.0 109.45 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.497 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -93.42 104.76 13.31 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.469 -0.769 . . . . 0.0 110.129 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' ' 39' ' ' ASN . 48.6 Cg_endo -70.73 106.8 1.91 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 123.672 1.354 . . . . 0.0 110.533 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.6 p30 -82.9 178.14 8.31 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.189 -0.945 . . . . 0.0 110.015 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.4 m -90.53 40.24 1.01 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.293 -0.88 . . . . 0.0 109.649 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -119.28 12.58 12.59 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.495 -0.753 . . . . 0.0 110.42 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 52.86 25.12 22.19 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.796 -1.722 . . . . 0.0 108.796 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -143.8 117.72 9.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.623 -0.927 . . . . 0.0 110.136 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.499 ' CB ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -60.07 -179.33 0.17 Allowed Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.409 -0.807 . . . . 0.0 109.672 179.578 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.533 ' O ' ' N ' ' A' ' 50' ' ' GLN . 39.2 Cg_endo -65.16 169.55 11.97 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.399 1.21 . . . . 0.0 110.313 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.553 HG13 ' HB1' ' A' ' 68' ' ' ALA . 3.1 mt 63.4 -61.35 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 O-C-N 121.621 -0.674 . . . . 0.0 109.984 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.533 ' N ' ' O ' ' A' ' 48' ' ' PRO . 1.7 tt0 -50.02 -23.88 2.31 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.033 -1.042 . . . . 0.0 110.011 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.3 p -108.46 8.42 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.214 -0.929 . . . . 0.0 110.572 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.77 ' CB ' ' HB1' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -78.29 159.12 28.63 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.959 -1.088 . . . . 0.0 109.534 179.369 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.408 ' HE2' ' CA ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -48.83 -17.62 0.2 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.389 -0.819 . . . . 0.0 111.989 -178.84 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.728 ' HE2' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 61.52 15.41 6.71 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.837 -1.164 . . . . 0.0 109.715 -178.842 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.413 ' C ' ' CE2' ' A' ' 90' ' ' PHE . . . -112.91 17.97 22.18 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -161.2 102.41 1.25 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.37 -1.077 . . . . 0.0 110.25 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.438 ' CB ' ' HB3' ' A' ' 92' ' ' ASP . . . -63.03 -17.87 62.71 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.283 -0.886 . . . . 0.0 109.216 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.24 -42.27 73.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.478 -0.764 . . . . 0.0 109.885 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.588 HG12 HD12 ' A' ' 63' ' ' LEU . 7.4 t -61.5 -53.63 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.347 -0.846 . . . . 0.0 109.516 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.421 ' O ' ' CB ' ' A' ' 64' ' ' LEU . . . -53.7 -51.67 62.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.442 -0.786 . . . . 0.0 110.363 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.462 ' O ' ' HB3' ' A' ' 65' ' ' LEU . 5.6 tt0 -50.34 -44.72 54.57 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.129 -0.982 . . . . 0.0 110.539 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.645 ' CD1' HD13 ' A' ' 32' ' ' LEU . 1.4 tp -70.53 -57.28 4.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.571 -0.706 . . . . 0.0 109.68 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.635 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 6.1 mt -57.77 -45.02 86.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.255 -0.903 . . . . 0.0 109.225 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.854 HD22 HG12 ' A' ' 96' ' ' VAL . 1.0 OUTLIER -64.75 -52.9 54.55 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.58 -0.7 . . . . 0.0 110.407 179.595 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.462 ' HB3' ' O ' ' A' ' 61' ' ' GLU . 12.1 tp -50.95 -39.87 56.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.421 -0.8 . . . . 0.0 109.285 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.949 ' CB ' HD22 ' A' ' 32' ' ' LEU . 4.4 m80 -78.45 -37.73 42.92 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.147 0.499 . . . . 0.0 110.003 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 38' ' ' PRO . . . 139.78 54.04 0.05 OUTLIER Glycine 0 N--CA 1.481 1.643 0 C-N-CA 120.062 -1.065 . . . . 0.0 110.823 179.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.635 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -68.43 -151.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.765 -1.432 . . . . 0.0 109.768 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.486 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 3.6 mm-40 -131.87 61.06 55.91 Favored Pre-proline 0 C--N 1.303 -1.42 0 O-C-N 121.494 -0.754 . . . . 0.0 109.973 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.558 ' HA ' ' CG ' ' A' ' 81' ' ' PRO . 47.3 Cg_endo -72.14 1.62 5.79 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 123.951 1.5 . . . . 0.0 110.677 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.495 ' N ' ' OD1' ' A' ' 71' ' ' ASN . 1.5 m-20 -115.96 -54.35 2.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.048 -1.032 . . . . 0.0 110.018 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -48.41 154.85 0.58 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.521 -0.737 . . . . 0.0 110.691 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.43 ' HB2' ' HE ' ' A' ' 80' ' ' ARG . . . -151.52 -157.52 0.82 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.444 -0.785 . . . . 0.0 109.923 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' A' ' 78' ' ' LEU . 0.5 OUTLIER -105.16 140.23 20.9 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.263 -0.898 . . . . 0.0 109.566 179.507 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.28 -11.01 24.69 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.589 1.31 . . . . 0.0 110.767 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.98 -43.65 24.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.13 -0.981 . . . . 0.0 110.16 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.81 HG23 ' CH2' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -139.6 25.62 2.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.459 -0.776 . . . . 0.0 110.171 -179.521 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.438 HD22 HH11 ' A' ' 80' ' ' ARG . 5.7 mt 40.6 36.57 0.39 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.525 -0.734 . . . . 0.0 110.631 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.82 92.13 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.448 -0.783 . . . . 0.0 110.55 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.896 ' CD ' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -73.92 163.31 69.28 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.274 -0.891 . . . . 0.0 109.241 179.146 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.558 ' CG ' ' HA ' ' A' ' 70' ' ' PRO . 46.3 Cg_endo -73.08 -3.34 13.48 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.699 1.368 . . . . 0.0 110.738 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 40.5 t -74.09 -26.37 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.234 -0.916 . . . . 0.0 109.747 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.495 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 9.2 m80 -74.07 -33.85 63.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.479 -0.763 . . . . 0.0 109.38 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.728 ' HB3' ' HE2' ' A' ' 54' ' ' MET . 0.3 OUTLIER -58.73 -50.74 72.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.677 -0.639 . . . . 0.0 110.141 179.583 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.581 ' CB ' HD13 ' A' ' 94' ' ' LEU . . . -53.57 -56.74 14.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.373 -0.83 . . . . 0.0 109.261 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.905 ' HB2' HD11 ' A' ' 130' ' ' LEU . . . -59.99 -52.2 66.4 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.718 -0.614 . . . . 0.0 110.287 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -43.91 -37.8 3.06 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.527 -0.733 . . . . 0.0 111.229 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.9 16.28 26.43 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.22 -0.925 . . . . 0.0 110.373 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' A' ' 123' ' ' HIS . . . 51.58 55.01 22.05 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.413 ' CE2' ' C ' ' A' ' 55' ' ' GLY . 0.4 OUTLIER -123.98 85.33 2.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.387 -1.066 . . . . 0.0 110.623 -179.626 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.25 -34.47 78.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 0.0 110.175 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.549 ' O ' HG23 ' A' ' 96' ' ' VAL . 94.7 m-20 -48.53 -38.38 20.22 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.35 -0.844 . . . . 0.0 109.829 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.6 m -68.64 -54.26 17.47 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.816 HD22 HG13 ' A' ' 126' ' ' VAL . 1.1 tp -47.42 -48.74 26.24 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.528 -0.733 . . . . 0.0 109.572 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 47.5 t -48.4 -51.61 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 CA-C-O 121.372 0.605 . . . . 0.0 109.737 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.854 HG12 HD22 ' A' ' 64' ' ' LEU . 52.2 t -55.64 -52.88 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-O 121.32 0.581 . . . . 0.0 110.325 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.461 HD12 ' N ' ' A' ' 97' ' ' LEU . 10.9 mp -52.67 -42.61 64.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.489 -0.757 . . . . 0.0 109.756 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -78.66 -24.44 45.18 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.252 -0.905 . . . . 0.0 109.49 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.449 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 5.8 mtt180 -74.4 -10.99 60.12 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.33 -0.856 . . . . 0.0 110.878 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.809 ' CB ' HD21 ' A' ' 64' ' ' LEU . . . -124.2 -106.31 0.35 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.281 -0.887 . . . . 0.0 110.616 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -142.93 50.21 0.71 Allowed Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.692 -1.242 . . . . 0.0 110.143 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.519 ' CB ' ' HB2' ' A' ' 70' ' ' PRO . . . -102.59 114.93 29.57 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.342 -1.093 . . . . 0.0 110.261 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 32.0 ttt180 -58.76 111.28 1.22 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.32 -0.863 . . . . 0.0 109.709 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.45 54.64 0.88 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.41 -0.806 . . . . 0.0 110.545 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -165.38 54.02 0.11 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.018 -1.051 . . . . 0.0 110.827 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.896 HG11 ' CD ' ' A' ' 80' ' ' ARG . 4.1 p -109.61 -173.93 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.2 -0.938 . . . . 0.0 109.977 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.701 ' H ' HG22 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -137.95 137.31 37.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.535 -0.728 . . . . 0.0 109.642 179.575 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.519 ' HA ' ' O ' ' A' ' 77' ' ' THR . 0.3 OUTLIER -73.61 61.55 0.73 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.278 -0.889 . . . . 0.0 109.766 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 55.57 -83.37 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.51 -0.744 . . . . 0.0 110.2 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.81 ' CH2' HG23 ' A' ' 77' ' ' THR . 0.2 OUTLIER -133.59 25.82 4.06 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.065 -1.022 . . . . 0.0 110.187 179.397 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -96.29 -83.8 1.68 Allowed Glycine 0 N--CA 1.479 1.535 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.73 149.84 0.48 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.424 -1.045 . . . . 0.0 110.77 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.541 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 89.4 mt -57.61 169.66 0.77 Allowed Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.48 -0.762 . . . . 0.0 109.275 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.66 ' HG2' HD22 ' A' ' 130' ' ' LEU . 42.9 Cg_endo -69.68 -25.25 29.16 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.431 1.227 . . . . 0.0 109.46 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.55 ' HB ' ' HB3' ' A' ' 130' ' ' LEU . 9.9 p -70.69 -36.05 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.419 -0.801 . . . . 0.0 109.804 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.414 ' N ' HG13 ' A' ' 115' ' ' VAL . 1.9 m-20 -54.44 -34.74 62.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.44 -0.788 . . . . 0.0 110.153 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.596 HD12 HD13 ' A' ' 121' ' ' LEU . 0.3 OUTLIER -65.0 -57.94 7.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.51 -0.744 . . . . 0.0 110.408 -179.776 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.649 ' HB1' ' HB2' ' A' ' 127' ' ' ALA . . . -47.53 -31.44 4.34 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.644 -0.66 . . . . 0.0 110.874 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.03 -30.96 58.63 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.444 -0.785 . . . . 0.0 109.753 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.6 -53.75 8.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.431 -0.793 . . . . 0.0 110.772 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.596 HD13 HD12 ' A' ' 117' ' ' LEU . 3.1 mp -81.27 -94.22 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.31 -0.869 . . . . 0.0 110.662 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -171.66 31.61 0.13 Allowed Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.594 -1.289 . . . . 0.0 110.128 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.555 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 27.1 m-70 -88.08 49.9 1.88 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.057 -1.261 . . . . 0.0 108.837 179.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.4 ttm-85 -45.84 -38.13 6.93 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.673 -0.642 . . . . 0.0 110.554 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -66.07 -42.29 89.6 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.361 -0.837 . . . . 0.0 109.835 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.816 HG13 HD22 ' A' ' 94' ' ' LEU . 8.3 t -77.97 -29.6 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.134 -0.979 . . . . 0.0 110.321 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.649 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . . . -60.15 -41.8 93.53 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.165 -0.96 . . . . 0.0 109.722 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.18 -62.63 1.69 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.519 -0.738 . . . . 0.0 110.549 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.424 ' HB3' HD23 ' A' ' 94' ' ' LEU . 0.6 OUTLIER -54.33 -37.82 65.3 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.282 -0.886 . . . . 0.0 110.096 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.905 HD11 ' HB2' ' A' ' 86' ' ' ALA . 44.3 mt -69.6 -18.45 63.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.541 -0.724 . . . . 0.0 110.417 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -89.44 -28.86 19.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.139 -0.975 . . . . 0.0 109.927 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -84.01 -43.48 15.11 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.327 -0.858 . . . . 0.0 110.409 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -90.42 -34.52 15.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.167 -0.958 . . . . 0.0 110.598 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.874 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . -103.6 45.22 0.97 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.289 -0.882 . . . . 0.0 110.194 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -168.61 -121.11 0.56 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -84.16 83.22 1.63 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 8.9 t -54.47 161.54 1.39 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.273 -1.133 . . . . 0.0 110.83 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -173.3 -157.95 0.09 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.566 -0.709 . . . . 0.0 109.73 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 89.78 19.58 47.25 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 78.1 p -173.65 -138.69 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.342 -1.093 . . . . 0.0 109.413 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -88.84 -163.79 1.04 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.914 -1.116 . . . . 0.0 109.512 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -111.12 49.69 0.86 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.15 -0.969 . . . . 0.0 109.92 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -128.24 98.71 5.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.59 -0.694 . . . . 0.0 109.824 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.11 136.34 42.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.437 -0.789 . . . . 0.0 110.049 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 6.6 tp -71.11 143.54 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.412 -0.805 . . . . 0.0 110.492 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.24 143.2 34.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.35 -0.843 . . . . 0.0 110.413 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.496 ' O ' ' HB3' ' A' ' 148' ' ' ALA . . . -66.48 164.95 15.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.285 -0.884 . . . . 0.0 109.494 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.496 ' HB3' ' O ' ' A' ' 147' ' ' ALA . . . 59.13 168.8 0.06 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.152 -0.967 . . . . 0.0 109.764 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -144.54 63.19 1.32 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.145 -0.972 . . . . 0.0 110.501 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 144.3 176.39 18.28 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.443 ' O ' HD11 ' A' ' 154' ' ' ILE . 45.4 Cg_endo -71.48 161.89 44.03 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.87 1.458 . . . . 0.0 110.418 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 7.6 t -74.18 140.45 45.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.344 -0.848 . . . . 0.0 110.39 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 54.28 106.06 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.484 -0.76 . . . . 0.0 110.847 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.443 HD11 ' O ' ' A' ' 151' ' ' PRO . 4.1 mp -116.03 77.69 7.11 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.179 -0.95 . . . . 0.0 109.608 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -81.46 118.66 3.25 Favored 'Trans proline' 0 C--N 1.313 -1.311 0 O-C-N 123.759 1.399 . . . . 0.0 110.561 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.074 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.8 ttt . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.3 0.572 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -138.23 132.11 16.71 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.291 -0.88 . . . . 0.0 109.992 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -74.22 151.61 43.9 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.626 1.33 . . . . 0.0 110.655 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.405 ' O ' ' HB3' ' A' ' 5' ' ' ALA . . . -98.42 82.65 2.91 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.454 -0.779 . . . . 0.0 110.069 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 4' ' ' ALA . . . 55.35 63.01 2.23 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.248 -0.908 . . . . 0.0 110.31 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -110.94 48.54 0.93 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 48.0 t 51.56 -168.23 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.337 -1.096 . . . . 0.0 110.423 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -124.9 76.45 1.52 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.395 -0.816 . . . . 0.0 110.1 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 54.17 96.19 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.345 -0.847 . . . . 0.0 110.325 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -109.14 77.81 0.93 Allowed Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.332 -0.855 . . . . 0.0 110.557 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.57 135.07 25.51 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.653 1.344 . . . . 0.0 110.591 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.7 p -66.42 133.98 51.57 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.427 -0.796 . . . . 0.0 110.027 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.55 ' HB1' HD12 ' A' ' 37' ' ' LEU . . . -127.89 -42.56 1.57 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.319 -0.863 . . . . 0.0 110.306 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -64.69 -9.4 19.62 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.342 -0.848 . . . . 0.0 110.905 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.484 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 7.3 m0 -54.81 -25.88 31.17 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.119 -0.988 . . . . 0.0 111.171 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.904 HD13 HD21 ' A' ' 63' ' ' LEU . 4.0 pp -65.93 -38.84 89.72 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.03 -1.044 . . . . 0.0 110.51 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.663 ' N ' HD12 ' A' ' 16' ' ' LEU . . . -81.46 -42.61 20.06 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.13 -0.981 . . . . 0.0 110.321 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.484 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.0 OUTLIER -58.88 -56.28 24.32 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.357 -0.839 . . . . 0.0 110.286 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.75 -41.73 74.39 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.255 -0.903 . . . . 0.0 109.834 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.543 ' HB1' HG11 ' A' ' 59' ' ' VAL . . . -55.73 -35.31 65.99 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.416 -0.803 . . . . 0.0 110.063 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.97 -23.87 59.54 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.442 -0.786 . . . . 0.0 110.512 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 -93.65 23.58 4.61 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.272 -0.892 . . . . 0.0 110.457 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 55.34 46.71 78.99 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -118.53 90.91 3.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.274 -1.133 . . . . 0.0 109.805 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.683 HG22 HG23 ' A' ' 59' ' ' VAL . 46.0 t -73.73 -38.96 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.357 -0.84 . . . . 0.0 110.307 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -60.88 -44.83 96.54 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.291 -0.881 . . . . 0.0 110.794 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.757 ' O ' HD12 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -68.5 -38.65 81.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.252 -0.905 . . . . 0.0 110.199 -179.696 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 54.5 t -73.89 -45.24 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.375 -0.828 . . . . 0.0 110.401 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.548 ' HA ' ' CD1' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -62.48 -47.89 81.99 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.077 -1.014 . . . . 0.0 109.441 179.81 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.94 -20.99 64.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.277 -0.889 . . . . 0.0 109.922 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.757 HD12 ' O ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -68.5 -58.83 3.72 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.323 -0.861 . . . . 0.0 110.04 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.841 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 5.0 mt -51.32 -41.68 60.7 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.351 -0.843 . . . . 0.0 110.192 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -70.5 -18.18 62.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.32 -0.862 . . . . 0.0 109.596 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.47 -8.65 47.09 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.32 -0.862 . . . . 0.0 110.706 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.12 29.05 1.71 Allowed Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.876 -1.154 . . . . 0.0 110.676 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.841 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -71.28 161.13 31.58 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.022 -1.281 . . . . 0.0 110.177 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.816 ' HB2' ' HB2' ' A' ' 40' ' ' ALA . 75.5 mt -92.01 142.3 26.23 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.346 -0.846 . . . . 0.0 110.236 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.17 -42.99 1.24 Allowed 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.497 1.262 . . . . 0.0 110.121 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -121.03 58.7 0.95 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.462 -0.774 . . . . 0.0 110.092 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.816 ' HB2' ' HB2' ' A' ' 37' ' ' LEU . . . -79.7 116.39 60.59 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.311 -0.868 . . . . 0.0 109.776 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.52 120.53 7.0 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.68 1.358 . . . . 0.0 110.596 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.425 HD22 ' HB3' ' A' ' 17' ' ' ALA . 1.6 t-20 -99.66 -150.07 0.37 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.447 -0.783 . . . . 0.0 109.996 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.424 ' O ' ' OG ' ' A' ' 43' ' ' SER . 0.1 OUTLIER -109.1 20.82 17.94 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.172 -0.955 . . . . 0.0 110.246 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -118.31 -1.8 11.24 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.053 -1.029 . . . . 0.0 110.849 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.54 25.77 50.85 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.929 -1.269 . . . . 0.0 109.929 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.429 ' HB3' ' HB3' ' A' ' 50' ' ' GLN . 36.5 mtt180 -123.42 16.23 9.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -1.123 . . . . 0.0 110.92 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.637 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER 45.98 -166.68 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.083 0 O-C-N 121.706 -0.621 . . . . 0.0 109.744 179.314 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.637 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 46.8 Cg_endo -78.87 172.77 14.5 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 122.758 0.873 . . . . 0.0 110.939 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.542 ' O ' ' HG2' ' A' ' 52' ' ' MET . 9.0 mt 61.74 -63.89 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 O-C-N 121.771 -0.58 . . . . 0.0 110.69 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.515 ' N ' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -49.87 -20.26 0.85 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.824 -1.172 . . . . 0.0 110.401 179.707 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 51' ' ' VAL . 12.8 p -107.82 -5.38 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.192 -0.942 . . . . 0.0 110.76 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.542 ' HG2' ' O ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -63.06 165.65 6.79 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.893 -1.129 . . . . 0.0 109.955 -179.777 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 33.8 ttp -61.23 -8.43 3.67 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.341 -0.849 . . . . 0.0 111.079 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.623 ' HE1' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 57.09 18.2 3.93 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.133 -0.979 . . . . 0.0 110.016 -179.398 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.432 ' C ' ' CE2' ' A' ' 90' ' ' PHE . . . -112.43 3.12 26.47 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.41 95.71 2.71 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.433 -1.039 . . . . 0.0 109.727 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.77 -23.11 16.47 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.279 -0.888 . . . . 0.0 109.663 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.442 ' HA ' ' HB2' ' A' ' 61' ' ' GLU . 13.1 mtt180 -55.5 -40.24 71.48 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.338 -0.851 . . . . 0.0 109.572 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.683 HG23 HG22 ' A' ' 25' ' ' VAL . 95.5 t -53.6 -59.07 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.544 -0.722 . . . . 0.0 109.225 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -61.63 -26.97 68.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.518 -0.739 . . . . 0.0 109.882 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.442 ' HB2' ' HA ' ' A' ' 58' ' ' ARG . 3.6 tp10 -50.71 -71.56 0.06 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.194 -0.941 . . . . 0.0 110.579 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.548 ' CD1' ' HA ' ' A' ' 29' ' ' ARG . 0.4 OUTLIER -65.55 -50.05 66.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.041 -1.037 . . . . 0.0 110.448 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.904 HD21 HD13 ' A' ' 16' ' ' LEU . 0.9 OUTLIER -49.09 -57.63 6.29 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.252 -0.905 . . . . 0.0 109.933 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.655 HD13 HG12 ' A' ' 96' ' ' VAL . 1.2 tt -63.33 -43.8 96.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.304 -0.872 . . . . 0.0 109.233 179.023 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.448 ' HB3' ' HA ' ' A' ' 62' ' ' LEU . 12.8 tp -56.09 -31.12 62.96 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.539 -0.726 . . . . 0.0 109.585 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.718 ' CB ' HD22 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -87.21 -45.61 10.48 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.548 -0.72 . . . . 0.0 109.981 -179.569 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 156.18 44.94 0.02 OUTLIER Glycine 0 N--CA 1.483 1.771 0 C-N-CA 119.811 -1.185 . . . . 0.0 110.754 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.465 ' HA ' ' HG2' ' A' ' 48' ' ' PRO . . . -70.66 -152.64 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.889 -1.36 . . . . 0.0 109.882 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -114.75 66.94 1.85 Allowed Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.336 -0.852 . . . . 0.0 110.211 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.502 ' HG3' HD21 ' A' ' 64' ' ' LEU . 50.9 Cg_endo -73.42 -32.55 7.9 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.757 1.398 . . . . 0.0 110.359 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.421 ' O ' ' NE ' ' A' ' 80' ' ' ARG . 6.8 t30 -100.75 -54.74 2.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.509 -0.744 . . . . 0.0 110.891 -179.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.1 m -48.02 151.48 0.95 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.253 -0.904 . . . . 0.0 111.147 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.602 ' HB2' ' HG2' ' A' ' 80' ' ' ARG . . . -135.5 -159.73 0.99 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.411 -0.806 . . . . 0.0 109.958 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.44 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -105.77 136.54 19.26 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.292 -0.88 . . . . 0.0 109.873 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.38 -23.54 20.4 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 123.41 1.216 . . . . 0.0 110.595 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.38 -60.81 2.85 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.117 -0.99 . . . . 0.0 109.745 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.668 HG22 ' CZ2' ' A' ' 110' ' ' TRP . 62.9 p -136.76 34.14 2.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.43 -0.794 . . . . 0.0 109.801 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.505 ' HA ' HD23 ' A' ' 78' ' ' LEU . 8.0 mt 49.1 33.92 5.31 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.547 -0.721 . . . . 0.0 111.331 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 94.1 m -65.88 102.85 0.82 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.142 -0.974 . . . . 0.0 109.649 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.602 ' HG2' ' HB2' ' A' ' 73' ' ' ALA . 0.1 OUTLIER -82.31 167.37 30.87 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.271 -0.893 . . . . 0.0 110.193 -179.751 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -70.37 -14.76 34.48 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.771 1.406 . . . . 0.0 109.932 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 65.1 t -67.81 -29.26 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.598 -0.689 . . . . 0.0 109.94 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.436 ' CE1' ' HB3' ' A' ' 114' ' ' PRO . 23.4 m80 -75.59 -35.55 60.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.29 -0.881 . . . . 0.0 109.497 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.623 ' HB3' ' HE1' ' A' ' 54' ' ' MET . 0.3 OUTLIER -58.21 -50.31 73.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.658 -0.651 . . . . 0.0 109.736 179.444 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.409 ' HB3' ' CD1' ' A' ' 94' ' ' LEU . . . -56.96 -64.63 0.81 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.265 -0.897 . . . . 0.0 110.066 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.778 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -58.84 -30.08 67.42 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.317 -0.864 . . . . 0.0 111.271 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.4 ' HB3' ' O ' ' A' ' 84' ' ' ASP . 6.2 tpt180 -52.5 -54.43 32.59 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.048 -1.032 . . . . 0.0 110.237 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.26 -2.99 58.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.191 -0.943 . . . . 0.0 110.047 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.473 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 81.26 44.88 7.78 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.432 ' CE2' ' C ' ' A' ' 55' ' ' GLY . 0.5 OUTLIER -110.59 104.68 13.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.2 -1.176 . . . . 0.0 110.328 179.636 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.536 HD11 ' O ' ' A' ' 125' ' ' ASP . 0.3 OUTLIER -80.38 -38.42 30.38 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.456 -0.778 . . . . 0.0 110.109 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.648 ' O ' HG23 ' A' ' 96' ' ' VAL . 0.8 OUTLIER -47.36 -37.26 10.8 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.511 -0.743 . . . . 0.0 110.312 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.8 m -70.99 -45.71 63.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.47 -0.769 . . . . 0.0 109.273 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.602 HD21 ' HG ' ' A' ' 130' ' ' LEU . 1.2 tp -49.67 -49.73 46.29 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.461 -0.774 . . . . 0.0 110.204 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.413 ' O ' ' CB ' ' A' ' 99' ' ' ARG . 58.0 t -55.08 -47.0 77.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.403 -0.81 . . . . 0.0 109.644 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.655 HG12 HD13 ' A' ' 64' ' ' LEU . 36.6 t -54.45 -51.21 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.526 -0.734 . . . . 0.0 109.834 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.536 ' HA ' HD11 ' A' ' 64' ' ' LEU . 9.1 mp -52.11 -67.02 0.29 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.51 -0.744 . . . . 0.0 110.805 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -57.24 -38.76 74.3 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.172 -0.955 . . . . 0.0 110.15 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.42 ' O ' ' HG2' ' A' ' 99' ' ' ARG . 0.1 OUTLIER -66.3 -14.66 62.36 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.392 -0.817 . . . . 0.0 110.474 179.754 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -132.96 54.03 1.98 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.135 -0.978 . . . . 0.0 110.494 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 58.19 105.15 0.01 OUTLIER Glycine 0 N--CA 1.488 2.126 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -164.9 94.69 0.68 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.322 -1.105 . . . . 0.0 110.231 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.423 ' HB3' ' NH2' ' A' ' 80' ' ' ARG . 20.3 ttt180 -52.69 104.96 0.1 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.314 -0.866 . . . . 0.0 109.717 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.505 ' CD2' HD23 ' A' ' 130' ' ' LEU . 0.0 OUTLIER -98.58 67.18 1.74 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.424 -0.798 . . . . 0.0 110.484 -179.515 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -168.46 42.87 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.2 -0.937 . . . . 0.0 110.378 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.66 HG22 ' H ' ' A' ' 107' ' ' ARG . 4.3 p -101.32 -178.0 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.271 -0.893 . . . . 0.0 110.021 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.66 ' H ' HG22 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -128.57 142.01 51.19 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.521 -0.737 . . . . 0.0 109.291 179.157 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.608 ' O ' ' N ' ' A' ' 110' ' ' TRP . 17.3 p-10 -73.36 54.55 0.43 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.216 -0.928 . . . . 0.0 110.438 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.532 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 59.0 -63.53 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.58 -0.7 . . . . 0.0 110.89 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.668 ' CZ2' HG22 ' A' ' 77' ' ' THR . 0.1 OUTLIER -50.87 -54.59 22.62 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.256 -0.903 . . . . 0.0 109.993 -179.691 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 155.65 -32.86 0.63 Allowed Glycine 0 N--CA 1.484 1.885 0 N-CA-C 110.151 -1.179 . . . . 0.0 110.151 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -53.27 168.24 0.16 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.39 -1.065 . . . . 0.0 110.927 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.489 HD23 ' O ' ' A' ' 106' ' ' VAL . 50.1 mt -124.34 167.9 14.4 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.485 -0.759 . . . . 0.0 110.235 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 41.3 Cg_endo -67.47 -27.53 39.59 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 O-C-N 123.676 1.356 . . . . 0.0 110.044 178.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 127' ' ' ALA . 7.8 p -80.74 -35.55 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.412 -0.805 . . . . 0.0 109.761 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.403 ' N ' HG13 ' A' ' 115' ' ' VAL . 37.7 t70 -70.4 -29.85 66.58 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.467 -0.77 . . . . 0.0 110.009 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.3 tt -70.4 -44.48 67.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.422 -0.799 . . . . 0.0 110.303 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.654 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -68.27 -48.61 64.58 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.29 -0.881 . . . . 0.0 110.413 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.54 ' HG2' ' HB1' ' A' ' 127' ' ' ALA . 2.4 mm-40 -55.67 -29.47 59.39 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.293 -0.879 . . . . 0.0 110.068 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -78.31 -39.72 38.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.464 -0.773 . . . . 0.0 110.235 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.33 -88.03 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.346 -0.846 . . . . 0.0 110.281 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -177.86 25.99 0.06 OUTLIER Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.451 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 36.0 m-70 -108.11 50.59 0.77 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.024 -1.28 . . . . 0.0 108.994 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.481 ' HA ' ' HB3' ' A' ' 127' ' ' ALA . 5.4 ttt180 -46.09 -37.37 6.73 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.71 -0.619 . . . . 0.0 110.124 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.536 ' O ' HD11 ' A' ' 91' ' ' LEU . 7.2 p-10 -59.92 -42.25 93.53 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.406 -0.809 . . . . 0.0 109.201 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.778 HG11 ' HA ' ' A' ' 86' ' ' ALA . 2.6 t -81.35 -32.56 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.437 -0.789 . . . . 0.0 109.037 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.54 ' HB1' ' HG2' ' A' ' 119' ' ' GLU . . . -69.2 -39.05 78.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.512 -0.743 . . . . 0.0 109.45 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.51 -61.21 2.79 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.277 -0.889 . . . . 0.0 109.676 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.432 ' HD2' HD23 ' A' ' 94' ' ' LEU . 71.0 t80 -54.48 -37.18 64.97 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.348 -0.845 . . . . 0.0 109.467 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.776 HD11 ' HB2' ' A' ' 86' ' ' ALA . 14.8 mt -63.77 -30.08 71.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.519 -0.738 . . . . 0.0 109.525 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.412 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 1.3 tmm_? -68.79 -30.62 69.24 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.536 -0.728 . . . . 0.0 110.121 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -87.01 -36.59 18.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.286 -0.884 . . . . 0.0 110.408 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -89.22 -15.85 32.67 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.291 -0.88 . . . . 0.0 110.678 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.691 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . -125.19 -39.24 2.23 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.23 -0.919 . . . . 0.0 110.432 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 131' ' ' ARG . . . 84.28 140.52 4.65 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -124.41 62.96 0.57 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.6 p -53.47 137.63 35.59 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.36 -1.082 . . . . 0.0 110.344 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 5.1 ttt85 -113.33 92.16 3.9 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.414 -0.804 . . . . 0.0 110.342 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -130.31 117.24 2.23 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 70.1 m -54.47 -34.74 62.09 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.384 -1.068 . . . . 0.0 110.444 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -137.87 -61.01 0.63 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.379 -0.825 . . . . 0.0 109.862 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -108.83 99.95 9.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.439 -0.788 . . . . 0.0 110.079 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -56.82 -179.37 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.444 -0.785 . . . . 0.0 110.327 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -53.98 175.52 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.289 -0.882 . . . . 0.0 110.365 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 43.5 mm 51.81 81.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.314 -0.866 . . . . 0.0 110.097 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -49.83 110.63 0.41 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.402 -0.811 . . . . 0.0 110.253 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.522 ' O ' ' HB3' ' A' ' 148' ' ' ALA . . . -49.94 126.11 13.49 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.414 -0.804 . . . . 0.0 110.362 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 147' ' ' ALA . . . 61.04 114.39 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.42 -0.8 . . . . 0.0 109.879 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.89 111.89 3.51 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.315 -0.866 . . . . 0.0 110.169 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 79.28 152.86 7.19 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -74.27 135.91 21.25 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.855 1.45 . . . . 0.0 110.273 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.35 126.83 32.07 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.363 -0.836 . . . . 0.0 110.336 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -79.32 133.51 36.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.417 -0.802 . . . . 0.0 110.36 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.444 ' O ' HG23 ' A' ' 154' ' ' ILE . 5.4 tt -166.94 97.78 0.67 Allowed Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.397 -0.814 . . . . 0.0 109.764 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -73.16 90.69 0.86 Allowed 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 123.581 1.306 . . . . 0.0 110.767 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.2 t0 . . . . . 0 N--CA 1.498 1.932 0 CA-C-O 118.07 -0.967 . . . . 0.0 111.066 179.687 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mtt . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.308 0.575 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 50.75 75.0 0.71 Allowed Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.437 -0.79 . . . . 0.0 110.484 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -77.92 77.01 4.08 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.69 1.363 . . . . 0.0 110.022 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -50.65 121.75 6.27 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.548 -0.72 . . . . 0.0 110.412 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -100.71 8.12 43.49 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.492 -0.755 . . . . 0.0 110.872 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 65.14 100.39 0.01 OUTLIER Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 54.46 175.58 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.256 -1.143 . . . . 0.0 110.52 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.8 p -114.28 167.4 10.73 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.383 -0.823 . . . . 0.0 110.094 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.5 mmt -68.84 -80.11 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.354 -0.841 . . . . 0.0 110.156 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -169.37 148.53 3.51 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.212 -0.93 . . . . 0.0 110.166 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.09 90.65 0.85 Allowed 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.776 1.408 . . . . 0.0 110.744 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.1 p 178.83 -47.14 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.439 -0.788 . . . . 0.0 110.149 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 51.57 25.17 2.62 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.343 -0.848 . . . . 0.0 110.226 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.441 ' OD1' HG23 ' A' ' 18' ' ' THR . 10.7 t0 -82.4 -10.31 59.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.469 -0.769 . . . . 0.0 110.404 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.666 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 1.3 t90 -65.66 -10.25 34.54 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.139 -0.976 . . . . 0.0 110.442 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.693 HD23 ' HB3' ' A' ' 40' ' ' ALA . 1.8 tp -73.0 -54.37 8.76 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.245 -0.91 . . . . 0.0 109.72 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.649 ' HB2' ' HA ' ' A' ' 48' ' ' PRO . . . -75.77 -42.82 49.25 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.368 -0.833 . . . . 0.0 110.488 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.666 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 3.1 p -49.37 -46.29 47.0 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.468 -0.77 . . . . 0.0 110.76 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.62 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -66.3 -47.18 74.42 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.283 -0.886 . . . . 0.0 110.299 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.48 ' HB1' HG11 ' A' ' 59' ' ' VAL . . . -52.54 -36.11 54.89 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.409 -0.807 . . . . 0.0 110.475 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.402 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -78.92 -26.01 43.68 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.343 -0.848 . . . . 0.0 110.323 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -93.25 19.22 8.38 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.203 -0.936 . . . . 0.0 110.735 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 52.98 53.0 35.95 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.86 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -122.06 61.4 0.96 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.405 -1.056 . . . . 0.0 109.93 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.991 HG22 HG23 ' A' ' 59' ' ' VAL . 37.5 t -50.22 -46.31 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.475 -0.766 . . . . 0.0 110.672 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -59.1 -36.43 75.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.316 -0.865 . . . . 0.0 110.349 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -73.73 -31.43 63.36 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.234 -0.916 . . . . 0.0 109.616 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.86 HG23 ' O ' ' A' ' 24' ' ' ARG . 3.4 t -76.48 -50.19 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.554 -0.716 . . . . 0.0 109.57 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.936 ' HA ' HD22 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -49.09 -45.26 43.02 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.481 -0.762 . . . . 0.0 110.132 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -77.36 -41.83 38.86 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.454 -0.779 . . . . 0.0 109.877 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.459 HD11 ' CD1' ' A' ' 15' ' ' TRP . 12.6 mt -57.14 -67.8 0.29 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.361 -0.837 . . . . 0.0 110.439 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.905 ' HB3' HD11 ' A' ' 62' ' ' LEU . 0.3 OUTLIER -48.54 -46.0 38.18 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.585 -0.697 . . . . 0.0 111.016 -179.382 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.13 -14.08 61.31 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.26 -0.9 . . . . 0.0 110.324 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 30' ' ' ALA . . . -92.07 -8.52 45.64 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.223 -0.923 . . . . 0.0 111.024 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 146.72 -28.98 1.59 Allowed Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.741 -1.219 . . . . 0.0 110.265 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.745 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -53.76 106.33 0.18 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.107 -1.231 . . . . 0.0 110.579 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.69 ' HG ' ' HB2' ' A' ' 40' ' ' ALA . 0.6 OUTLIER -66.96 152.22 96.17 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.361 -0.837 . . . . 0.0 109.734 179.701 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -74.57 -28.49 9.94 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.715 1.376 . . . . 0.0 111.083 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 55.6 m-20 -90.26 32.62 0.92 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.209 -0.932 . . . . 0.0 110.246 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.693 ' HB3' HD23 ' A' ' 16' ' ' LEU . . . -84.73 112.65 44.17 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.385 -0.822 . . . . 0.0 110.097 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.45 123.11 8.86 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.652 1.343 . . . . 0.0 110.148 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.546 HD22 HG11 ' A' ' 51' ' ' VAL . 48.4 p-10 -80.6 5.93 14.06 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.381 -0.824 . . . . 0.0 110.702 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 58.54 17.53 5.02 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.092 -1.005 . . . . 0.0 110.024 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -107.3 15.19 25.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.422 -0.799 . . . . 0.0 109.412 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.0 24.64 43.47 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.5 ' O ' ' CB ' ' A' ' 50' ' ' GLN . 35.3 mtt180 -135.79 32.0 3.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.308 -1.113 . . . . 0.0 111.1 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.583 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 0.6 OUTLIER 42.56 -166.72 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.119 0 O-C-N 121.501 -0.749 . . . . 0.0 110.937 178.589 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.649 ' HA ' ' HB2' ' A' ' 17' ' ' ALA . 48.9 Cg_endo -85.6 -24.57 1.85 Allowed 'Trans proline' 0 C--N 1.318 -1.036 0 O-C-N 122.998 0.999 . . . . 0.0 110.81 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.65 HG12 HD22 ' A' ' 63' ' ' LEU . 5.8 mt -107.04 -40.16 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.129 -0.982 . . . . 0.0 110.047 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.5 ' CB ' ' O ' ' A' ' 46' ' ' ARG . 0.9 OUTLIER -47.1 -27.11 1.27 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.488 -0.757 . . . . 0.0 110.555 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.546 HG11 HD22 ' A' ' 42' ' ' ASN . 9.0 p -97.06 -2.47 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.218 -0.926 . . . . 0.0 110.19 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.466 ' CE ' ' CE ' ' A' ' 54' ' ' MET . 56.8 ttp -52.15 154.33 2.36 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.515 -0.741 . . . . 0.0 109.789 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 1.4 tmm? -69.77 -2.91 13.31 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.377 -0.827 . . . . 0.0 111.07 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.468 ' SD ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 52.62 22.77 2.33 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.989 -1.07 . . . . 0.0 110.115 -179.687 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.416 ' C ' ' CZ ' ' A' ' 90' ' ' PHE . . . -123.95 9.25 8.53 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 178.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.522 ' HB3' HG23 ' A' ' 59' ' ' VAL . 0.6 OUTLIER -144.82 80.73 1.63 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.436 -1.038 . . . . 0.0 109.931 179.887 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -52.23 -25.08 8.39 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.215 -0.928 . . . . 0.0 109.757 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.6 mtt180 -61.21 -36.73 80.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.472 -0.768 . . . . 0.0 109.503 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.991 HG23 HG22 ' A' ' 25' ' ' VAL . 37.3 t -55.4 -69.95 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.263 -0.898 . . . . 0.0 109.256 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -47.44 -34.42 7.22 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.296 -0.878 . . . . 0.0 109.498 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.436 ' O ' ' CB ' ' A' ' 65' ' ' LEU . 11.1 tt0 -54.27 -32.17 55.53 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.269 -0.894 . . . . 0.0 109.845 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.936 HD22 ' HA ' ' A' ' 29' ' ' ARG . 1.0 OUTLIER -87.06 -45.66 10.52 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.607 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.699 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 4.5 mp -62.65 -53.46 54.15 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.718 -0.614 . . . . 0.0 109.98 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.602 ' CD2' ' HB3' ' A' ' 100' ' ' ALA . 0.2 OUTLIER -63.42 -42.9 98.75 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.226 -0.921 . . . . 0.0 109.565 179.553 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.436 ' CB ' ' O ' ' A' ' 61' ' ' GLU . 10.0 tp -54.06 -37.49 64.23 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.363 -0.836 . . . . 0.0 108.804 178.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.737 ' CG ' HD22 ' A' ' 32' ' ' LEU . 7.8 m80 -85.76 -21.54 28.17 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.357 0.598 . . . . 0.0 109.69 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.24 56.83 0.73 Allowed Glycine 0 N--CA 1.479 1.533 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 179.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.699 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -64.82 -148.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.033 -1.275 . . . . 0.0 109.089 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.576 ' HB2' ' HB3' ' A' ' 47' ' ' ARG . 53.9 mt-10 -117.27 55.98 1.76 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.189 -0.944 . . . . 0.0 110.079 179.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.566 ' HB2' ' HB2' ' A' ' 102' ' ' ALA . 44.3 Cg_endo -69.4 -11.19 30.74 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 O-C-N 123.631 1.332 . . . . 0.0 110.392 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.433 ' HA ' ' CZ ' ' A' ' 80' ' ' ARG . 2.8 m120 -95.91 -56.48 2.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.257 -0.902 . . . . 0.0 110.415 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -50.12 148.62 3.29 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.315 -0.865 . . . . 0.0 110.919 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.69 -158.2 0.84 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.478 -0.764 . . . . 0.0 109.721 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.496 ' O ' ' N ' ' A' ' 78' ' ' LEU . 19.1 m-20 -106.43 126.21 30.99 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.321 -0.862 . . . . 0.0 109.53 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.12 -20.58 28.4 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.389 1.205 . . . . 0.0 110.434 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.79 -42.05 88.14 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.236 -0.915 . . . . 0.0 110.141 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.959 HG23 ' CH2' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -148.26 21.83 1.07 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.478 -0.764 . . . . 0.0 109.842 -179.832 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 74' ' ' ASP . 1.4 mt 50.72 41.39 26.08 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.561 -0.712 . . . . 0.0 111.164 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 18.4 m -73.95 100.62 3.59 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.105 -0.997 . . . . 0.0 109.618 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.9 ' HG3' HG11 ' A' ' 106' ' ' VAL . 0.3 OUTLIER -76.84 164.02 61.93 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.381 -0.825 . . . . 0.0 109.98 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.55 -14.17 27.55 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.68 1.358 . . . . 0.0 110.649 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 42.0 t -63.63 -28.2 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.233 -0.917 . . . . 0.0 109.927 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.431 ' O ' ' CB ' ' A' ' 87' ' ' ARG . 29.1 m80 -65.52 -44.39 87.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.441 -0.787 . . . . 0.0 109.351 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.497 ' OD2' ' HG2' ' A' ' 50' ' ' GLN . 67.8 m-20 -49.95 -55.86 12.86 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.664 -0.647 . . . . 0.0 111.244 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.599 ' CB ' HD13 ' A' ' 94' ' ' LEU . . . -54.22 -68.0 0.22 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.173 -0.954 . . . . 0.0 109.971 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.846 ' HB1' ' HB2' ' A' ' 118' ' ' ALA . . . -54.92 -40.86 70.32 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.318 -0.864 . . . . 0.0 111.098 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 83' ' ' HIS . 6.2 tmm_? -51.47 -31.67 24.25 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.91 -1.119 . . . . 0.0 110.228 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -107.87 16.62 23.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.519 -0.738 . . . . 0.0 110.308 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.502 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 55.43 48.52 69.42 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.417 ' CE2' ' N ' ' A' ' 56' ' ' SER . 0.1 OUTLIER -116.57 91.31 3.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.455 -1.026 . . . . 0.0 110.694 -179.1 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.563 HD23 ' HB3' ' A' ' 94' ' ' LEU . 0.4 OUTLIER -75.58 -39.01 58.71 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.313 -0.867 . . . . 0.0 110.679 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.598 ' O ' HG23 ' A' ' 96' ' ' VAL . 27.3 m-20 -47.32 -44.95 24.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.429 -0.795 . . . . 0.0 109.902 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.455 HG21 ' HE3' ' A' ' 54' ' ' MET . 23.1 m -68.86 -40.0 79.54 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.615 HD21 HD21 ' A' ' 130' ' ' LEU . 5.0 tp -59.36 -47.49 85.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.638 -0.664 . . . . 0.0 109.924 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 53.2 t -53.84 -45.92 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.411 -0.806 . . . . 0.0 109.496 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 92' ' ' ASP . 24.8 t -62.47 -43.15 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.555 -0.715 . . . . 0.0 109.545 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.739 HD23 ' CB ' ' A' ' 102' ' ' ALA . 0.2 OUTLIER -53.59 -46.14 70.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.629 -0.669 . . . . 0.0 110.443 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -83.86 -28.28 28.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.354 -0.841 . . . . 0.0 110.426 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.7 mtp85 -66.25 -11.72 51.94 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.378 -0.826 . . . . 0.0 111.044 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.602 ' HB3' ' CD2' ' A' ' 64' ' ' LEU . . . -124.42 -79.48 0.61 Allowed 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.157 -0.964 . . . . 0.0 110.891 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -159.26 88.07 0.11 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.016 -1.233 . . . . 0.0 110.016 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.739 ' CB ' HD23 ' A' ' 97' ' ' LEU . . . -160.78 110.73 1.73 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.286 -1.126 . . . . 0.0 110.314 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 8.1 ttt180 -50.58 167.16 0.07 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.373 -0.83 . . . . 0.0 110.662 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.568 ' CD2' HD23 ' A' ' 130' ' ' LEU . 0.1 OUTLIER -149.14 43.47 0.96 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.417 -0.802 . . . . 0.0 110.067 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -161.01 48.47 0.22 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.195 -0.941 . . . . 0.0 110.778 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.9 HG11 ' HG3' ' A' ' 80' ' ' ARG . 4.2 p -109.21 -174.47 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.188 -0.945 . . . . 0.0 109.563 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.67 ' H ' HG22 ' A' ' 106' ' ' VAL . 7.7 ptt180 -141.67 147.85 38.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.428 -0.795 . . . . 0.0 109.521 178.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.475 ' O ' ' N ' ' A' ' 110' ' ' TRP . 3.4 t0 -69.88 63.2 0.2 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.336 -0.852 . . . . 0.0 110.058 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 52.38 -86.66 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.383 -0.823 . . . . 0.0 110.667 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.959 ' CH2' HG23 ' A' ' 77' ' ' THR . 38.3 p90 -121.59 6.02 10.05 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.189 -0.945 . . . . 0.0 110.467 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -82.12 -77.91 1.03 Allowed Glycine 0 N--CA 1.481 1.671 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -175.76 -158.91 0.07 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.421 -1.047 . . . . 0.0 110.47 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.494 ' HG ' ' HD2' ' A' ' 114' ' ' PRO . 0.6 OUTLIER -106.41 167.19 9.92 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.404 -0.81 . . . . 0.0 110.669 -179.446 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.494 ' HD2' ' HG ' ' A' ' 113' ' ' LEU . 44.7 Cg_endo -72.35 -35.96 5.93 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 O-C-N 123.868 1.457 . . . . 0.0 110.053 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.494 HG12 ' HB3' ' A' ' 113' ' ' LEU . 12.0 p -67.75 -26.79 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.273 -0.892 . . . . 0.0 109.831 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -65.28 -42.45 93.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.472 -0.767 . . . . 0.0 109.775 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.564 ' O ' HD12 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -63.47 -49.64 72.82 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.529 -0.732 . . . . 0.0 110.267 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.846 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -48.68 -64.8 0.7 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.346 -0.846 . . . . 0.0 110.804 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -55.1 -23.7 22.0 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.278 -0.889 . . . . 0.0 110.151 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.82 -33.8 72.82 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.412 -0.805 . . . . 0.0 110.027 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.564 HD12 ' O ' ' A' ' 117' ' ' LEU . 0.7 OUTLIER -96.25 -8.56 32.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.326 -0.858 . . . . 0.0 110.384 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.33 32.71 6.24 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.497 ' ND1' ' O ' ' A' ' 86' ' ' ALA . 36.0 m170 -95.11 55.33 1.78 Allowed 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.072 -1.252 . . . . 0.0 109.478 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.407 ' O ' ' CB ' ' A' ' 128' ' ' ARG . 12.2 ttm180 -45.9 -30.13 1.63 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.594 -0.691 . . . . 0.0 110.286 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.434 ' HB3' HD12 ' A' ' 91' ' ' LEU . 0.6 OUTLIER -69.96 -41.1 74.94 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.571 -0.706 . . . . 0.0 109.488 179.32 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.783 HG11 ' HA ' ' A' ' 86' ' ' ALA . 2.1 t -89.5 -39.64 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.427 -0.795 . . . . 0.0 110.343 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.59 -34.29 77.92 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.296 -0.877 . . . . 0.0 109.957 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.407 ' CB ' ' O ' ' A' ' 124' ' ' ARG . 34.5 ttt85 -74.01 -56.83 4.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.354 -0.841 . . . . 0.0 109.742 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -56.02 -26.36 48.49 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.302 -0.874 . . . . 0.0 109.605 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.777 HD11 ' HB2' ' A' ' 86' ' ' ALA . 14.2 mt -78.5 -50.76 11.04 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.454 -0.779 . . . . 0.0 109.994 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.6 tpt85 -52.56 -25.97 11.96 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.436 -0.79 . . . . 0.0 110.597 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -79.46 -53.12 7.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.204 -0.935 . . . . 0.0 109.957 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -81.35 -7.15 59.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.435 -0.791 . . . . 0.0 110.511 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . -116.0 -31.59 5.68 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.18 -0.95 . . . . 0.0 110.279 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -111.56 -13.15 13.35 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -45.89 122.11 5.65 Favored Glycine 0 N--CA 1.498 2.769 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.482 ' O ' ' N ' ' A' ' 139' ' ' GLY . 2.1 t -135.63 49.49 2.16 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.399 -1.059 . . . . 0.0 110.726 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.71 -71.79 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.418 -0.801 . . . . 0.0 110.449 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 137' ' ' THR . . . -140.17 173.3 23.06 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.7 t -82.98 -46.83 12.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.325 -1.103 . . . . 0.0 110.15 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 21.4 m120 52.74 -162.19 0.1 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.247 -0.908 . . . . 0.0 110.159 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 29.1 p80 -152.6 31.49 0.51 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.356 -0.84 . . . . 0.0 110.362 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -156.0 27.34 0.37 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.279 -0.888 . . . . 0.0 110.223 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.494 ' C ' HG22 ' A' ' 145' ' ' ILE . 28.5 ttp180 -86.54 135.88 33.28 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.306 -0.871 . . . . 0.0 110.34 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.494 HG22 ' C ' ' A' ' 144' ' ' ARG . 1.3 tt 33.21 71.59 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.773 -0.579 . . . . 0.0 111.426 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -47.72 92.58 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.489 -0.757 . . . . 0.0 110.94 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 145' ' ' ILE . . . -81.45 118.53 22.78 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.477 -0.764 . . . . 0.0 110.049 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -82.9 128.73 34.71 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.354 -0.841 . . . . 0.0 110.408 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -103.29 -17.08 15.46 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.422 -0.799 . . . . 0.0 109.886 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 75.08 150.24 2.34 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -71.25 123.4 9.56 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.74 1.389 . . . . 0.0 110.297 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.08 168.0 1.12 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.211 -0.931 . . . . 0.0 110.02 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -52.38 150.35 4.86 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.243 -0.911 . . . . 0.0 110.277 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 76.6 mt -122.84 93.96 47.88 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.423 -0.798 . . . . 0.0 110.201 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.52 136.22 28.0 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.717 1.377 . . . . 0.0 110.43 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 . . . . . 0 N--CA 1.494 1.754 0 CA-C-O 118.081 -0.961 . . . . 0.0 110.174 179.901 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.138 0.494 . . . . 0.0 110.221 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 46.64 57.14 17.14 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.542 -0.724 . . . . 0.0 110.527 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.97 -171.37 0.77 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.732 1.385 . . . . 0.0 110.301 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -113.47 131.34 56.07 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.25 -0.906 . . . . 0.0 110.466 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -152.56 -60.12 0.15 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.419 -0.8 . . . . 0.0 110.217 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.14 108.51 0.26 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.6 t -126.27 -141.16 0.28 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.378 -1.072 . . . . 0.0 109.398 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 39.9 t -61.43 -179.94 0.19 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.854 -1.154 . . . . 0.0 110.002 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -64.35 -54.83 26.81 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.164 -0.96 . . . . 0.0 109.852 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.532 ' CB ' ' CD ' ' A' ' 11' ' ' PRO . 0.3 OUTLIER -136.48 -65.56 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.447 -0.783 . . . . 0.0 110.029 179.416 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.532 ' CD ' ' CB ' ' A' ' 10' ' ' GLU . 48.7 Cg_endo -73.77 123.11 8.26 Favored 'Trans proline' 0 C--N 1.316 -1.132 0 O-C-N 123.185 1.097 . . . . 0.0 110.42 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.9 p -75.15 130.03 38.52 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.253 -0.904 . . . . 0.0 110.079 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.462 ' O ' ' CB ' ' A' ' 40' ' ' ALA . . . -62.09 99.37 0.13 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.346 -0.846 . . . . 0.0 110.327 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.408 ' O ' ' OG1' ' A' ' 18' ' ' THR . 11.4 p30 -131.94 3.63 4.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.125 -0.985 . . . . 0.0 110.946 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.452 ' CD1' ' OE1' ' A' ' 27' ' ' GLU . 0.3 OUTLIER -60.15 -11.56 6.43 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.343 -0.848 . . . . 0.0 111.299 -179.644 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.525 HD21 ' HB1' ' A' ' 36' ' ' ALA . 23.8 mt -78.36 -57.05 3.98 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.936 -1.102 . . . . 0.0 109.534 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.496 ' HB3' ' OD1' ' A' ' 42' ' ' ASN . . . -58.47 -48.38 80.95 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.508 -0.745 . . . . 0.0 109.471 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.424 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.2 OUTLIER -54.52 -59.95 4.0 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.39 -0.819 . . . . 0.0 110.128 179.341 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.522 ' HB1' ' HB3' ' A' ' 27' ' ' GLU . . . -54.3 -56.78 15.08 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.49 -0.757 . . . . 0.0 110.181 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.628 ' CB ' HG11 ' A' ' 59' ' ' VAL . . . -52.87 -47.87 67.53 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.45 -0.781 . . . . 0.0 109.847 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.555 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -61.07 -19.2 61.14 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.468 -0.77 . . . . 0.0 109.863 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.71 18.03 15.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.501 -0.749 . . . . 0.0 110.703 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 54.17 47.85 65.89 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.65 98.84 4.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.304 -1.115 . . . . 0.0 109.716 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.661 HG12 ' CG ' ' A' ' 29' ' ' ARG . 3.1 t -74.31 -43.73 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.463 -0.773 . . . . 0.0 109.821 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -45.4 -54.26 7.55 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.455 -0.778 . . . . 0.0 110.781 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.522 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -48.91 -49.46 39.88 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.371 -0.831 . . . . 0.0 110.041 179.801 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.01 HG12 HD12 ' A' ' 32' ' ' LEU . 6.2 t -74.13 -45.63 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.587 -0.696 . . . . 0.0 110.307 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.936 ' HA ' HD11 ' A' ' 62' ' ' LEU . 9.3 mmm180 -45.34 -41.65 9.13 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.501 -0.749 . . . . 0.0 109.93 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.46 -39.59 31.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.544 -0.723 . . . . 0.0 109.646 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.48 ' HB2' ' HA ' ' A' ' 28' ' ' VAL . 32.8 mt -61.06 -67.12 0.43 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.419 -0.8 . . . . 0.0 110.137 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.01 HD12 HG12 ' A' ' 28' ' ' VAL . 13.7 mt -51.85 -36.88 49.88 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.476 -0.765 . . . . 0.0 110.461 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.422 ' HB2' ' O ' ' A' ' 29' ' ' ARG . 46.9 mt-10 -72.37 -18.08 61.77 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.308 -0.87 . . . . 0.0 110.022 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.97 -7.5 48.81 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.359 -0.838 . . . . 0.0 110.435 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.61 23.73 6.14 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.525 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -61.22 164.45 5.31 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.296 -1.12 . . . . 0.0 110.073 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.457 ' O ' HD12 ' A' ' 16' ' ' LEU . 40.8 tp -97.18 99.15 5.62 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.536 -0.727 . . . . 0.0 109.927 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.54 ' HB3' HD21 ' A' ' 32' ' ' LEU . 44.1 Cg_endo -68.56 -23.11 37.37 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 O-C-N 123.656 1.345 . . . . 0.0 110.437 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.41 34.25 1.06 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.252 -0.905 . . . . 0.0 110.018 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.462 ' CB ' ' O ' ' A' ' 13' ' ' ALA . . . -86.82 122.52 71.42 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.333 -0.855 . . . . 0.0 110.274 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -73.42 111.81 3.38 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.609 1.321 . . . . 0.0 110.38 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.496 ' OD1' ' HB3' ' A' ' 17' ' ' ALA . 2.2 m-80 -90.13 166.65 13.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.404 -0.81 . . . . 0.0 109.916 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.457 ' C ' ' CG ' ' A' ' 44' ' ' TYR . 70.8 m -62.58 -157.04 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.433 -0.792 . . . . 0.0 109.732 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.573 ' CD1' ' N ' ' A' ' 44' ' ' TYR . 0.1 OUTLIER 58.86 13.72 2.9 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.166 -0.959 . . . . 0.0 109.791 -179.607 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.2 24.24 20.91 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.87 171.95 7.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.44 -1.036 . . . . 0.0 110.956 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.571 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -113.92 -165.21 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.688 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.562 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.571 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 49.1 Cg_endo -76.19 166.48 27.67 Favored 'Trans proline' 0 C--N 1.315 -1.228 0 O-C-N 122.85 0.921 . . . . 0.0 109.787 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.541 ' O ' ' HG2' ' A' ' 52' ' ' MET . 4.7 mt 63.96 -59.6 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 121.668 -0.645 . . . . 0.0 110.224 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.513 ' N ' ' O ' ' A' ' 48' ' ' PRO . 7.3 mt-30 -43.7 -27.19 0.29 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.811 -1.181 . . . . 0.0 110.54 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.708 HG22 ' O ' ' A' ' 51' ' ' VAL . 6.8 p -118.8 26.06 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.426 -0.796 . . . . 0.0 110.53 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.727 ' HE1' ' HB2' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -83.73 41.04 0.77 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.77 -1.206 . . . . 0.0 109.421 178.872 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.434 ' HB3' ' HE2' ' A' ' 53' ' ' MET . 2.9 tmm? 64.97 -6.82 0.31 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.285 -0.884 . . . . 0.0 110.552 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.451 ' H ' ' C ' ' A' ' 52' ' ' MET . 0.0 OUTLIER 43.12 29.89 0.23 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.307 -0.871 . . . . 0.0 110.516 -179.781 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.451 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -134.54 12.64 4.58 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -146.1 71.5 1.26 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.425 -1.044 . . . . 0.0 109.544 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.562 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . . . -47.97 -27.75 2.37 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.649 -0.657 . . . . 0.0 109.89 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.508 ' HG2' HG11 ' A' ' 25' ' ' VAL . 3.1 tpt180 -52.07 -38.23 56.49 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.654 -0.654 . . . . 0.0 109.359 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.628 HG11 ' CB ' ' A' ' 20' ' ' ALA . 67.0 t -69.48 -49.05 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.359 -0.838 . . . . 0.0 109.028 178.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.727 ' HB2' ' HE1' ' A' ' 52' ' ' MET . . . -46.44 -45.82 18.36 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.52 -0.738 . . . . 0.0 109.664 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.485 ' O ' HD23 ' A' ' 65' ' ' LEU . 0.7 OUTLIER -58.05 -48.39 80.24 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.545 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.936 HD11 ' HA ' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -49.92 -66.73 0.34 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.586 -0.696 . . . . 0.0 109.688 178.348 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.967 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 85.1 mt -58.44 -54.68 44.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.57 -0.706 . . . . 0.0 110.178 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.826 HD13 HG12 ' A' ' 96' ' ' VAL . 1.9 tt -43.67 -68.3 0.21 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.501 -0.749 . . . . 0.0 111.212 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.485 HD23 ' O ' ' A' ' 61' ' ' GLU . 1.1 pp -56.31 -23.2 35.41 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.104 -0.997 . . . . 0.0 110.159 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.76 ' CG ' HD22 ' A' ' 32' ' ' LEU . 2.2 m80 -82.86 -48.79 10.36 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 121.293 -0.88 . . . . 0.0 110.153 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 149.34 43.41 0.03 OUTLIER Glycine 0 N--CA 1.483 1.79 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.967 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -72.25 -157.32 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.849 -1.383 . . . . 0.0 109.92 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.449 ' CG ' ' HD2' ' A' ' 48' ' ' PRO . 4.6 mm-40 -121.21 62.73 11.81 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.43 ' HG2' ' ND2' ' A' ' 71' ' ' ASN . 40.4 Cg_endo -69.05 -5.5 15.93 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.875 1.461 . . . . 0.0 111.083 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.43 ' ND2' ' HG2' ' A' ' 70' ' ' PRO . 12.2 m-80 -113.88 -67.12 1.02 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.022 -1.048 . . . . 0.0 110.065 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.8 t -44.88 163.28 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.465 -0.772 . . . . 0.0 110.83 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.885 ' HB2' ' HG2' ' A' ' 80' ' ' ARG . . . -138.59 -155.44 0.6 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.186 -0.946 . . . . 0.0 110.925 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' A' ' 78' ' ' LEU . 50.8 m-20 -107.77 126.23 30.35 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.533 -0.729 . . . . 0.0 109.766 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -74.96 -2.06 12.03 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 123.332 1.175 . . . . 0.0 110.668 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -93.32 -36.3 12.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 0.0 109.84 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.599 ' C ' ' HB2' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -132.76 6.99 4.04 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.376 -0.827 . . . . 0.0 110.142 179.374 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.688 HD13 ' O ' ' A' ' 107' ' ' ARG . 1.0 OUTLIER 48.48 23.22 0.57 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.381 -0.824 . . . . 0.0 111.477 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 35.8 m -78.83 102.74 8.34 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.956 -1.09 . . . . 0.0 109.517 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.885 ' HG2' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -71.11 171.97 7.51 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.361 -0.837 . . . . 0.0 110.285 -179.676 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.66 -14.5 36.51 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.816 1.429 . . . . 0.0 109.375 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.599 HG12 ' CB ' ' A' ' 114' ' ' PRO . 48.7 t -72.08 -30.26 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.778 -0.576 . . . . 0.0 109.896 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.562 ' HB3' HD13 ' A' ' 117' ' ' LEU . 5.3 m80 -77.8 -34.68 52.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.391 -0.818 . . . . 0.0 109.25 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.02 -41.99 84.31 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 120.322 -0.551 . . . . 0.0 109.884 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.549 ' HB3' ' CD1' ' A' ' 94' ' ' LEU . . . -66.64 -61.51 1.94 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.232 -0.918 . . . . 0.0 109.653 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 1.033 ' HB1' ' HB2' ' A' ' 118' ' ' ALA . . . -56.88 -44.84 82.69 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.262 -0.899 . . . . 0.0 110.929 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.617 ' O ' HD22 ' A' ' 121' ' ' LEU . 2.9 ttp180 -48.64 -43.44 36.47 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.329 -0.857 . . . . 0.0 110.291 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.439 ' HG3' ' HB3' ' A' ' 54' ' ' MET . 0.0 OUTLIER -93.82 4.68 53.57 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.454 -0.779 . . . . 0.0 110.655 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.604 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 60.72 51.79 56.45 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.562 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.8 OUTLIER -120.45 74.87 1.08 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.385 -1.068 . . . . 0.0 110.187 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.415 HD11 ' O ' ' A' ' 125' ' ' ASP . 0.3 OUTLIER -52.17 -37.89 56.02 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.428 -0.795 . . . . 0.0 110.663 -179.844 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.782 ' O ' HG23 ' A' ' 96' ' ' VAL . 48.1 t0 -47.9 -39.24 18.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.3 -0.875 . . . . 0.0 109.559 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 87.6 m -69.8 -45.06 68.79 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.761 HD21 ' CD2' ' A' ' 130' ' ' LEU . 1.6 tp -55.37 -43.24 74.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.563 -0.711 . . . . 0.0 109.809 179.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 69.2 t -59.91 -47.85 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.222 -0.923 . . . . 0.0 109.429 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.826 HG12 HD13 ' A' ' 64' ' ' LEU . 6.5 t -58.88 -50.52 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.304 -0.872 . . . . 0.0 109.004 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.76 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 0.0 OUTLIER -44.56 -55.4 5.17 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.77 -0.582 . . . . 0.0 109.93 179.267 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -65.73 -30.92 71.65 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.512 -0.743 . . . . 0.0 109.89 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -14.81 36.43 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.399 -0.813 . . . . 0.0 110.665 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.562 ' CB ' HD21 ' A' ' 64' ' ' LEU . . . -151.31 70.13 0.96 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.98 -1.075 . . . . 0.0 111.075 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 58.22 105.82 0.01 OUTLIER Glycine 0 N--CA 1.488 2.1 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.76 ' HB2' ' O ' ' A' ' 97' ' ' LEU . . . -147.51 103.86 3.58 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.589 -0.948 . . . . 0.0 109.702 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.415 ' O ' HG21 ' A' ' 82' ' ' VAL . 2.8 tpp180 -65.31 101.59 0.58 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.353 -0.842 . . . . 0.0 110.377 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 134' ' ' ALA . 1.7 mt -102.37 59.86 0.82 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.427 -0.796 . . . . 0.0 110.226 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -170.92 44.72 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.988 -1.07 . . . . 0.0 110.907 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.668 HG22 ' H ' ' A' ' 107' ' ' ARG . 3.1 p -105.88 -171.24 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.243 -0.911 . . . . 0.0 109.539 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.688 ' O ' HD13 ' A' ' 78' ' ' LEU . 0.5 OUTLIER -131.26 115.1 15.87 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.178 -0.951 . . . . 0.0 110.064 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.52 160.51 1.23 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.475 -0.765 . . . . 0.0 109.558 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.599 ' HB2' ' C ' ' A' ' 77' ' ' THR . . . -63.74 -14.03 48.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.201 -0.937 . . . . 0.0 110.254 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.473 ' CH2' ' CG2' ' A' ' 77' ' ' THR . 6.0 m-90 -89.89 17.73 6.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.307 -0.871 . . . . 0.0 110.311 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 60.21 57.94 16.59 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 16.2 mtt180 -145.96 -160.69 1.18 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.379 -1.071 . . . . 0.0 110.317 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.486 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER -140.57 171.19 8.07 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.308 -0.87 . . . . 0.0 109.963 -179.897 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.599 ' CB ' HG12 ' A' ' 82' ' ' VAL . 45.4 Cg_endo -74.65 -48.54 0.19 Allowed 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.661 1.348 . . . . 0.0 110.025 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 127' ' ' ALA . 7.2 p -55.56 -32.68 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.353 -0.842 . . . . 0.0 109.729 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.01 -38.54 79.31 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.481 -0.762 . . . . 0.0 109.688 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.631 ' O ' HD12 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -57.11 -69.36 0.16 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.508 -0.745 . . . . 0.0 110.143 179.674 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 1.033 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -44.46 -52.86 7.48 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.461 -0.774 . . . . 0.0 110.998 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -53.97 -45.04 71.27 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.347 -0.845 . . . . 0.0 110.156 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -64.89 -32.02 73.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.391 -0.818 . . . . 0.0 110.06 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.631 HD12 ' O ' ' A' ' 117' ' ' LEU . 1.0 OUTLIER -90.07 2.05 55.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.375 -0.828 . . . . 0.0 110.767 -179.668 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 89.96 11.42 63.39 Favored Glycine 0 N--CA 1.489 2.209 0 C-N-CA 119.931 -1.128 . . . . 0.0 111.075 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.698 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . 47.9 m-70 -93.07 50.31 1.52 Allowed 'General case' 0 N--CA 1.484 1.232 0 O-C-N 120.841 -1.387 . . . . 0.0 109.085 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.0 mtt-85 -47.75 -31.47 4.85 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.626 -0.671 . . . . 0.0 109.407 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 125' ' ' ASP . 8.5 m-20 -62.3 -47.85 82.46 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.82 HG11 ' HA ' ' A' ' 86' ' ' ALA . 6.0 t -75.3 -40.52 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.426 -0.796 . . . . 0.0 109.758 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.698 ' O ' HG23 ' A' ' 115' ' ' VAL . . . -57.21 -36.37 70.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.303 -0.873 . . . . 0.0 109.607 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.13 -61.19 2.73 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.418 -0.801 . . . . 0.0 110.1 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.417 ' HD2' HD23 ' A' ' 94' ' ' LEU . 19.2 t80 -53.26 -40.42 64.64 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.293 -0.879 . . . . 0.0 109.824 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.93 HD11 ' HB2' ' A' ' 86' ' ' ALA . 78.3 mt -67.59 -39.43 84.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.424 -0.797 . . . . 0.0 109.463 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.486 ' HG3' HG21 ' A' ' 115' ' ' VAL . 3.2 ttt180 -59.34 -19.43 46.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.19 -0.943 . . . . 0.0 110.201 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.1 -57.63 3.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.352 -0.843 . . . . 0.0 110.432 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -81.72 -15.49 54.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.346 -0.846 . . . . 0.0 110.959 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.717 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . -108.04 -20.48 13.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.199 -0.938 . . . . 0.0 110.103 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -68.75 120.36 10.95 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.04 -135.33 0.04 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.529 HG22 ' NH2' ' A' ' 144' ' ' ARG . 21.4 p 48.14 92.79 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.588 -0.948 . . . . 0.0 110.428 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.22 61.37 0.72 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.237 -0.914 . . . . 0.0 110.698 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 156.56 -24.22 0.5 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.0 t -127.73 171.55 11.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.173 -1.192 . . . . 0.0 110.617 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -142.06 62.63 1.43 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.456 -0.778 . . . . 0.0 109.899 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -115.43 136.94 52.57 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.419 -0.801 . . . . 0.0 110.159 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.04 147.12 54.05 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.39 -0.819 . . . . 0.0 110.421 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.529 ' NH2' HG22 ' A' ' 137' ' ' THR . 0.1 OUTLIER -163.5 44.21 0.11 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.349 -0.844 . . . . 0.0 110.109 179.634 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.424 HG22 ' H ' ' A' ' 145' ' ' ILE . 2.1 tt -77.76 132.03 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.704 -0.623 . . . . 0.0 110.731 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.4 t70 42.2 60.1 2.41 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.548 -0.72 . . . . 0.0 110.932 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -82.92 126.12 32.13 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.362 -0.836 . . . . 0.0 110.449 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 52.96 -168.78 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.261 -0.9 . . . . 0.0 110.334 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 60.08 13.06 3.55 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.436 -0.79 . . . . 0.0 110.406 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 165.92 167.55 26.73 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.286 -1.525 . . . . 0.0 109.286 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -76.04 149.43 32.56 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 O-C-N 123.564 1.297 . . . . 0.0 110.52 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 28.6 m -63.1 173.07 1.54 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.297 -0.877 . . . . 0.0 110.25 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -51.57 162.42 0.38 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.331 -0.855 . . . . 0.0 110.835 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.666 ' O ' HG23 ' A' ' 154' ' ' ILE . 0.8 OUTLIER -153.07 81.82 5.05 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.428 -0.795 . . . . 0.0 110.04 179.748 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.91 135.7 23.82 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 O-C-N 123.737 1.388 . . . . 0.0 110.646 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.6 t0 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.853 -1.07 . . . . 0.0 110.392 -179.601 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.813 0 CA-C-O 121.01 0.433 . . . . 0.0 110.357 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 50.43 71.16 1.64 Allowed Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 121.278 -0.889 . . . . 0.0 109.762 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -72.17 -176.5 2.19 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.779 1.41 . . . . 0.0 109.792 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 49.82 55.59 9.18 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.345 -0.847 . . . . 0.0 110.029 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -113.44 -61.48 1.73 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.43 -0.794 . . . . 0.0 110.679 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.3 61.54 3.63 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.78 -72.63 0.15 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.481 -1.011 . . . . 0.0 109.954 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 m -149.36 177.74 9.41 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.466 -0.771 . . . . 0.0 110.14 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.31 -173.89 2.62 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.318 -0.864 . . . . 0.0 109.606 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.29 123.88 51.4 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.07 -1.019 . . . . 0.0 109.604 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.89 -172.82 1.2 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.582 1.307 . . . . 0.0 110.604 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.73 -21.21 15.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.417 -0.802 . . . . 0.0 110.334 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 52.06 24.8 2.85 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.391 -0.818 . . . . 0.0 109.573 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -86.03 9.19 17.86 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.511 -0.743 . . . . 0.0 110.868 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.411 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 40.2 m0 -46.44 -34.73 4.94 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.334 -0.854 . . . . 0.0 109.976 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.858 ' HB2' HD21 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -63.1 -37.84 88.8 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.6 -0.687 . . . . 0.0 109.997 178.62 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.66 -53.86 6.43 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.27 -0.893 . . . . 0.0 110.309 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.411 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.0 OUTLIER -44.96 -54.09 6.93 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.565 -0.709 . . . . 0.0 110.836 -179.591 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.777 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -61.3 -52.8 63.2 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.356 -0.84 . . . . 0.0 110.447 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.801 ' HB1' HG11 ' A' ' 59' ' ' VAL . . . -46.78 -46.9 20.88 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.502 -0.749 . . . . 0.0 110.355 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.442 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -54.44 -40.01 67.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.55 -0.719 . . . . 0.0 110.425 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.409 ' HB3' ' HD2' ' A' ' 24' ' ' ARG . 5.6 mpt_? -86.53 26.58 1.06 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.484 -0.76 . . . . 0.0 110.414 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 49.05 24.22 4.39 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.727 ' O ' HG23 ' A' ' 28' ' ' VAL . 10.2 mtt180 -93.65 65.39 3.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.365 -1.079 . . . . 0.0 109.738 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 1.059 HG22 HG22 ' A' ' 59' ' ' VAL . 60.2 t -55.67 -42.66 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.657 -0.652 . . . . 0.0 110.881 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -43.36 -56.03 3.77 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.471 -0.768 . . . . 0.0 110.604 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.432 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 1.8 tp10 -63.99 -34.89 79.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.481 -0.762 . . . . 0.0 110.141 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.826 HG12 HD13 ' A' ' 62' ' ' LEU . 4.7 t -70.29 -44.97 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.231 -0.918 . . . . 0.0 109.871 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.822 ' CA ' HD11 ' A' ' 62' ' ' LEU . 1.8 mmm180 -53.37 -45.87 69.38 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.201 -0.937 . . . . 0.0 109.254 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -70.59 -42.38 71.11 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 120.078 -0.649 . . . . 0.0 109.739 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 27' ' ' GLU . 44.6 mt -59.18 -63.05 1.44 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.289 -0.882 . . . . 0.0 110.969 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.889 HD12 ' CD2' ' A' ' 66' ' ' HIS . 0.0 OUTLIER -44.44 -44.52 8.52 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.424 -0.798 . . . . 0.0 110.594 -179.484 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -81.25 -18.5 45.75 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.74 -0.6 . . . . 0.0 110.443 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.465 ' HB2' ' O ' ' A' ' 30' ' ' ALA . . . -84.42 -5.63 59.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.111 -0.993 . . . . 0.0 110.748 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.09 22.61 2.35 Favored Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.802 -1.189 . . . . 0.0 110.99 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.882 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -66.6 162.24 21.43 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.916 -1.343 . . . . 0.0 109.892 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.734 HD13 ' HD2' ' A' ' 38' ' ' PRO . 1.8 mm? -87.19 133.49 38.68 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.365 -0.835 . . . . 0.0 110.124 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.734 ' HD2' HD13 ' A' ' 37' ' ' LEU . 44.3 Cg_endo -70.68 -47.07 0.7 Allowed 'Trans proline' 0 C--N 1.315 -1.229 0 O-C-N 123.547 1.288 . . . . 0.0 109.906 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -102.83 51.56 0.8 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.585 -0.697 . . . . 0.0 109.59 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.627 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -85.35 112.34 43.25 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.524 -0.735 . . . . 0.0 110.228 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.17 140.78 34.78 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 O-C-N 123.679 1.357 . . . . 0.0 110.607 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.508 ' ND2' HG21 ' A' ' 51' ' ' VAL . 14.9 t30 -85.92 -164.74 1.08 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.302 -0.874 . . . . 0.0 109.956 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.3 -8.0 14.77 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.199 -0.938 . . . . 0.0 110.564 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -96.62 24.29 6.12 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.179 -0.951 . . . . 0.0 109.917 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.41 23.05 66.25 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.92 -152.44 0.47 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.205 -1.174 . . . . 0.0 110.159 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.525 ' CB ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -130.22 -176.8 0.58 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.32 -0.862 . . . . 0.0 109.989 -179.466 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.645 ' HB2' HD22 ' A' ' 63' ' ' LEU . 43.2 Cg_endo -68.69 -25.84 33.65 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 O-C-N 123.36 1.19 . . . . 0.0 110.456 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.503 ' O ' ' HG2' ' A' ' 52' ' ' MET . 4.8 mt -108.93 -33.1 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.236 -0.915 . . . . 0.0 109.919 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.497 ' HG3' ' HB3' ' A' ' 81' ' ' PRO . 13.0 mt-30 -56.89 -17.62 10.18 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.31 -0.869 . . . . 0.0 110.188 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.508 HG21 ' ND2' ' A' ' 42' ' ' ASN . 8.5 p -113.52 35.09 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.329 -0.857 . . . . 0.0 110.922 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.675 ' HE1' ' HB2' ' A' ' 60' ' ' ALA . 0.1 OUTLIER -100.33 37.57 1.65 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.017 -1.052 . . . . 0.0 110.567 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.413 ' CB ' ' O ' ' A' ' 52' ' ' MET . 20.4 ttp 65.3 -4.27 0.55 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.421 -0.799 . . . . 0.0 110.66 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.565 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 41.41 30.82 0.14 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.384 -0.823 . . . . 0.0 110.555 -179.681 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.438 ' C ' ' CE2' ' A' ' 90' ' ' PHE . . . -133.17 11.01 5.07 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.571 ' HB3' HG23 ' A' ' 59' ' ' VAL . 0.5 OUTLIER -147.81 87.86 1.65 Allowed 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.443 -1.034 . . . . 0.0 109.687 179.801 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.54 -20.14 7.25 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.52 -0.737 . . . . 0.0 109.733 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -58.09 -29.71 65.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.464 -0.773 . . . . 0.0 109.671 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 1.059 HG22 HG22 ' A' ' 25' ' ' VAL . 2.8 t -76.64 -50.42 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.445 -0.785 . . . . 0.0 109.426 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.675 ' HB2' ' HE1' ' A' ' 52' ' ' MET . . . -49.1 -59.82 3.32 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.206 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.593 ' O ' HD23 ' A' ' 65' ' ' LEU . 3.4 tt0 -46.7 -52.19 14.42 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.488 -0.758 . . . . 0.0 109.544 178.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.826 HD13 HG12 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -45.74 -71.79 0.07 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.735 -0.603 . . . . 0.0 110.416 178.745 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.858 HD21 ' HB2' ' A' ' 16' ' ' LEU . 1.9 mt -65.31 -45.84 82.73 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.499 -0.751 . . . . 0.0 111.069 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.88 HD22 ' CG1' ' A' ' 96' ' ' VAL . 0.5 OUTLIER -52.26 -70.24 0.09 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.184 -0.948 . . . . 0.0 110.641 -179.501 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.593 HD23 ' O ' ' A' ' 61' ' ' GLU . 2.1 pp -50.69 -25.81 4.75 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.402 -0.812 . . . . 0.0 109.88 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.889 ' CD2' HD12 ' A' ' 32' ' ' LEU . 1.4 m80 -80.74 -48.8 12.0 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.604 -0.685 . . . . 0.0 109.929 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 159.46 32.34 0.02 OUTLIER Glycine 0 CA--C 1.54 1.604 0 C-N-CA 120.05 -1.072 . . . . 0.0 111.305 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.586 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -70.37 178.4 2.91 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.436 -1.626 . . . . 0.0 109.602 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.445 ' HB2' ' HG2' ' A' ' 47' ' ' ARG . 0.6 OUTLIER -107.78 78.9 0.78 Allowed Pre-proline 0 C--N 1.302 -1.459 0 O-C-N 121.32 -0.863 . . . . 0.0 110.23 179.516 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 68' ' ' ALA . 50.3 Cg_endo -74.71 -0.85 10.35 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 O-C-N 123.682 1.359 . . . . 0.0 110.171 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.548 ' O ' ' NE ' ' A' ' 80' ' ' ARG . 1.7 m-20 -113.71 -70.58 0.8 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.194 -0.941 . . . . 0.0 110.014 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.422 ' C ' ' O ' ' A' ' 71' ' ' ASN . 49.3 t -40.04 147.85 0.09 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.375 -0.828 . . . . 0.0 110.893 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.572 ' HB2' ' HG2' ' A' ' 80' ' ' ARG . . . -133.25 -150.33 0.4 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.525 -0.735 . . . . 0.0 109.875 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 78' ' ' LEU . 1.0 OUTLIER -114.98 130.33 24.3 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.887 . . . . 0.0 109.893 -179.904 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.74 -13.08 38.49 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.344 1.181 . . . . 0.0 110.254 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.71 -55.81 30.07 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.322 -0.861 . . . . 0.0 109.171 178.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.663 HG22 ' CH2' ' A' ' 110' ' ' TRP . 43.7 p -141.71 25.36 1.99 Allowed 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.567 0.699 . . . . 0.0 109.374 179.203 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.501 ' HA ' HD23 ' A' ' 78' ' ' LEU . 2.9 mt 52.86 30.06 8.59 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.53 -0.731 . . . . 0.0 111.107 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.84 97.57 0.23 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.989 -1.069 . . . . 0.0 109.883 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.888 ' CG ' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -72.23 168.52 22.54 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.211 -0.931 . . . . 0.0 109.382 179.701 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.497 ' HB3' ' HG3' ' A' ' 50' ' ' GLN . 50.8 Cg_endo -73.7 -21.77 18.67 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.74 1.39 . . . . 0.0 109.867 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.431 ' CG1' ' HG ' ' A' ' 104' ' ' LEU . 56.3 t -59.57 -35.0 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.523 -0.736 . . . . 0.0 110.37 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.467 ' O ' ' CB ' ' A' ' 87' ' ' ARG . 42.3 m80 -64.99 -31.59 72.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.441 -0.787 . . . . 0.0 110.009 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.565 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 0.7 OUTLIER -61.24 -52.08 66.27 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.528 -0.732 . . . . 0.0 110.652 -179.732 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.548 ' HB3' ' CD1' ' A' ' 94' ' ' LEU . . . -57.8 -61.3 2.62 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.807 -1.183 . . . . 0.0 109.745 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.88 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -57.14 -55.93 28.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.525 -0.734 . . . . 0.0 111.594 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.467 ' CB ' ' O ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -44.67 -28.72 0.64 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.216 -0.927 . . . . 0.0 111.529 -178.863 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.37 -8.13 23.65 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.019 -1.051 . . . . 0.0 110.807 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.558 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 77.08 36.01 36.81 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.548 ' HD1' ' HG1' ' A' ' 93' ' ' THR . 0.9 OUTLIER -108.2 90.86 3.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.389 -1.066 . . . . 0.0 110.525 179.903 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.515 ' CD2' ' HA ' ' A' ' 126' ' ' VAL . 0.1 OUTLIER -64.69 -36.6 84.79 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.446 -0.784 . . . . 0.0 110.384 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.502 ' O ' HG23 ' A' ' 96' ' ' VAL . 40.0 t0 -53.6 -26.31 21.31 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.165 -0.959 . . . . 0.0 109.371 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.548 ' HG1' ' HD1' ' A' ' 90' ' ' PHE . 26.6 m -78.25 -46.72 19.59 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.623 -0.673 . . . . 0.0 109.873 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.829 HD21 ' HG ' ' A' ' 130' ' ' LEU . 1.1 tp -54.36 -36.98 64.42 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.216 -0.928 . . . . 0.0 109.695 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 91' ' ' LEU . 27.0 t -65.54 -47.55 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.474 -0.766 . . . . 0.0 109.425 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.88 ' CG1' HD22 ' A' ' 64' ' ' LEU . 84.3 t -56.12 -53.17 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.217 -0.927 . . . . 0.0 110.094 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.0 mp -52.8 -51.83 59.23 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.182 -0.949 . . . . 0.0 109.719 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -54.6 -38.22 66.51 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.618 -0.676 . . . . 0.0 109.421 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 96' ' ' VAL . 66.9 mtp180 -66.78 -13.65 61.71 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.707 -0.621 . . . . 0.0 110.141 179.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.742 ' HB3' HD11 ' A' ' 64' ' ' LEU . . . -117.32 38.72 3.48 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.387 -0.82 . . . . 0.0 110.534 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 45.8 47.33 13.76 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.455 ' O ' HD12 ' A' ' 104' ' ' LEU . . . -89.13 110.68 21.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.346 -1.091 . . . . 0.0 110.197 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.518 ' N ' ' OD1' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -49.68 138.73 13.82 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.586 -0.697 . . . . 0.0 110.491 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.854 HD23 HD23 ' A' ' 130' ' ' LEU . 0.2 OUTLIER -128.3 22.87 6.03 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.427 -0.796 . . . . 0.0 110.055 179.623 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -125.52 47.3 2.22 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.021 -1.049 . . . . 0.0 110.911 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.888 HG11 ' CG ' ' A' ' 80' ' ' ARG . 3.4 p -108.7 -172.4 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.318 -0.864 . . . . 0.0 110.347 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.725 ' H ' HG22 ' A' ' 106' ' ' VAL . 2.6 mtm180 -132.42 158.92 40.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.454 -0.779 . . . . 0.0 109.941 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.606 ' O ' ' N ' ' A' ' 110' ' ' TRP . 52.1 p30 -93.73 50.51 1.46 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.382 -0.824 . . . . 0.0 110.242 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.588 ' HB2' ' C ' ' A' ' 77' ' ' THR . . . 59.06 -66.63 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.806 -0.559 . . . . 0.0 110.353 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.663 ' CH2' HG22 ' A' ' 77' ' ' THR . 0.0 OUTLIER -45.79 -62.37 1.33 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.488 -0.758 . . . . 0.0 110.263 179.815 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 164.77 -45.14 0.3 Allowed Glycine 0 N--CA 1.483 1.782 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 57.1 mtt180 -50.59 156.25 0.95 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.424 -1.045 . . . . 0.0 111.144 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.598 HD21 ' HG3' ' A' ' 107' ' ' ARG . 56.7 mt -110.1 170.42 5.34 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.544 -0.722 . . . . 0.0 109.717 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.538 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 40.9 Cg_endo -66.84 -21.01 51.29 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.707 1.372 . . . . 0.0 109.896 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.564 ' HA ' HD13 ' A' ' 130' ' ' LEU . 4.8 p -85.35 -40.7 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.287 -0.883 . . . . 0.0 110.421 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.442 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 1.0 OUTLIER -59.98 -32.28 70.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.044 -1.035 . . . . 0.0 109.871 179.94 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.4 mt -70.54 -45.4 65.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.498 -0.751 . . . . 0.0 110.049 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.533 ' CB ' ' HB2' ' A' ' 127' ' ' ALA . . . -55.33 -51.28 67.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.367 -0.833 . . . . 0.0 110.066 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.564 ' N ' ' HB2' ' A' ' 127' ' ' ALA . 10.7 pt-20 -68.71 -25.0 64.55 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.614 -0.678 . . . . 0.0 110.484 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.45 -62.9 1.47 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.439 -0.788 . . . . 0.0 110.643 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.12 -87.34 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.028 -1.045 . . . . 0.0 110.703 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -169.52 35.86 0.19 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.511 ' HB2' ' HA ' ' A' ' 118' ' ' ALA . 7.5 m-70 -113.65 43.56 1.77 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.561 -0.964 . . . . 0.0 109.272 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -43.52 -55.99 3.91 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.782 -0.574 . . . . 0.0 110.073 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 125' ' ' ASP . 13.4 p-10 -49.25 -34.33 14.9 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.436 0.636 . . . . 0.0 109.636 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.88 HG11 ' HA ' ' A' ' 86' ' ' ALA . 1.3 t -84.43 -31.08 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.564 ' HB2' ' N ' ' A' ' 119' ' ' GLU . . . -68.28 -35.74 78.33 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.436 -0.79 . . . . 0.0 109.364 179.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 26.7 ttt180 -72.42 -63.55 1.13 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.275 -0.891 . . . . 0.0 109.556 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.692 ' HD2' HD23 ' A' ' 94' ' ' LEU . 66.6 t80 -50.71 -28.86 9.9 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.372 -0.83 . . . . 0.0 109.812 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.854 HD23 HD23 ' A' ' 104' ' ' LEU . 6.7 mt -65.36 -62.08 1.74 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.406 -0.809 . . . . 0.0 109.465 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -51.96 -16.84 0.81 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.54 -0.725 . . . . 0.0 111.002 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -78.94 -53.2 7.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.969 -1.082 . . . . 0.0 109.693 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -87.33 -20.29 26.99 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.413 -0.804 . . . . 0.0 109.631 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.413 ' CB ' ' O ' ' A' ' 104' ' ' LEU . . . -86.41 15.18 5.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.31 -0.869 . . . . 0.0 110.653 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 173.41 -52.44 0.16 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 89.39 -50.23 3.55 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.8 p -44.93 138.38 3.62 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.554 -0.968 . . . . 0.0 111.091 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -159.18 -64.51 0.08 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.445 -0.785 . . . . 0.0 110.33 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -159.46 -154.41 7.25 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.0 p 55.64 170.43 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.492 -1.005 . . . . 0.0 110.307 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -64.79 -65.05 0.72 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.264 -0.897 . . . . 0.0 109.718 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.451 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 0.1 OUTLIER 51.35 23.63 1.81 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.448 -0.782 . . . . 0.0 110.725 179.607 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 142' ' ' HIS . . . 57.99 34.09 23.89 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.279 -0.888 . . . . 0.0 110.513 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.413 ' HG3' ' N ' ' A' ' 145' ' ' ILE . 0.0 OUTLIER -54.77 152.32 7.31 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.257 -0.902 . . . . 0.0 110.374 179.753 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.413 ' N ' ' HG3' ' A' ' 144' ' ' ARG . 36.8 mm -81.09 153.87 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.204 -0.935 . . . . 0.0 109.93 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 177.96 62.13 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.486 -0.759 . . . . 0.0 110.103 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.68 148.76 50.9 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.289 -0.882 . . . . 0.0 109.706 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.457 ' O ' ' N ' ' A' ' 150' ' ' GLY . . . -59.11 119.52 7.47 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.192 -0.942 . . . . 0.0 110.652 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 45.96 -92.63 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.523 -0.736 . . . . 0.0 110.561 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 148' ' ' ALA . . . 178.42 -133.65 2.19 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.6 160.96 45.32 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.663 1.349 . . . . 0.0 110.524 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 39.3 m -122.66 -43.01 2.29 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.47 -0.769 . . . . 0.0 109.991 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 8.5 t0 53.77 102.72 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.461 -0.775 . . . . 0.0 110.554 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.415 ' O ' HG23 ' A' ' 154' ' ' ILE . 5.1 tt -146.95 86.78 6.45 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.239 -0.913 . . . . 0.0 111.073 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -75.95 115.28 4.12 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 O-C-N 123.622 1.327 . . . . 0.0 109.763 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.233 -179.711 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.135 0.493 . . . . 0.0 109.894 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.449 ' CG ' ' O ' ' A' ' 2' ' ' GLU . 21.5 pt-20 -77.38 118.13 69.98 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.306 -0.871 . . . . 0.0 110.652 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -76.89 110.03 2.96 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.389 1.205 . . . . 0.0 109.894 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.507 ' O ' ' HB3' ' A' ' 5' ' ' ALA . . . -101.38 122.57 43.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.305 -0.872 . . . . 0.0 110.183 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 4' ' ' ALA . . . 60.36 -159.79 0.3 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.393 -0.817 . . . . 0.0 110.104 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -125.19 26.85 5.46 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 74.8 m 48.89 84.24 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.301 -1.117 . . . . 0.0 110.101 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -48.94 119.74 3.41 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.553 -0.717 . . . . 0.0 110.655 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -154.76 138.46 16.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.403 -0.811 . . . . 0.0 109.992 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 57.4 91.05 0.08 OUTLIER Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.421 -0.8 . . . . 0.0 110.228 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -76.78 136.73 17.19 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.803 1.423 . . . . 0.0 110.582 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.8 p -71.37 -143.29 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.461 -0.774 . . . . 0.0 109.841 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -44.88 122.85 3.44 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.059 -1.026 . . . . 0.0 110.844 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -166.03 -48.57 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.16 -0.963 . . . . 0.0 110.544 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.551 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 42.0 m0 -67.54 -5.19 14.13 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.398 -0.814 . . . . 0.0 110.972 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.732 HD11 HD21 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -77.99 -55.55 5.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.922 -1.111 . . . . 0.0 109.867 179.901 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.5 ' O ' ' HB3' ' A' ' 20' ' ' ALA . . . -70.55 -43.3 69.8 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.274 -0.891 . . . . 0.0 110.31 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.551 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.8 OUTLIER -52.25 -55.53 20.68 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.422 -0.799 . . . . 0.0 110.709 -179.888 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.808 ' HB1' ' HB3' ' A' ' 24' ' ' ARG . . . -55.02 -41.0 70.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.323 -0.861 . . . . 0.0 109.895 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.572 ' HA ' HG11 ' A' ' 59' ' ' VAL . . . -52.63 -49.68 64.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.482 -0.761 . . . . 0.0 109.793 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.593 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -69.24 -34.1 74.29 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.429 -0.794 . . . . 0.0 110.198 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.38 27.67 1.89 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.393 -0.817 . . . . 0.0 110.927 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 44.71 57.06 5.43 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.808 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -115.56 56.05 0.77 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.345 -1.091 . . . . 0.0 109.894 179.891 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.669 HG22 HG23 ' A' ' 59' ' ' VAL . 25.5 t -45.37 -55.01 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.583 -0.698 . . . . 0.0 110.844 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -54.23 -40.62 67.85 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.401 -0.812 . . . . 0.0 110.315 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.747 ' O ' HD12 ' A' ' 31' ' ' LEU . 0.5 OUTLIER -63.95 -35.43 80.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.431 -0.793 . . . . 0.0 109.753 179.851 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.877 HG12 HD12 ' A' ' 32' ' ' LEU . 11.7 t -77.27 -47.69 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.345 -0.847 . . . . 0.0 111.077 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.979 ' CA ' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -49.27 -45.26 44.68 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.124 -0.985 . . . . 0.0 110.255 -179.493 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.05 -42.29 48.11 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.431 -0.793 . . . . 0.0 109.542 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.747 HD12 ' O ' ' A' ' 27' ' ' GLU . 6.4 mt -60.55 -58.67 7.5 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.475 -0.766 . . . . 0.0 110.178 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.932 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 7.6 mt -51.15 -42.53 60.85 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.363 -0.835 . . . . 0.0 109.561 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -76.14 -9.43 58.62 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.625 -0.672 . . . . 0.0 110.571 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -93.9 -13.58 26.99 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.144 -0.972 . . . . 0.0 111.081 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 137.74 -0.79 2.79 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.581 -1.295 . . . . 0.0 110.909 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.932 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -46.41 151.31 0.55 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.017 -1.284 . . . . 0.0 110.174 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.77 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 12.6 tp -90.48 139.25 26.62 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.163 -0.961 . . . . 0.0 110.302 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.445 ' HB2' ' O ' ' A' ' 67' ' ' GLY . 43.6 Cg_endo -72.61 -39.14 2.79 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 O-C-N 123.647 1.341 . . . . 0.0 110.753 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -115.62 60.4 0.71 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.039 -1.038 . . . . 0.0 110.167 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.77 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -93.11 105.5 15.55 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.454 -0.779 . . . . 0.0 109.722 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.64 102.65 0.75 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.565 1.297 . . . . 0.0 110.188 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -89.4 172.71 8.81 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.499 -0.75 . . . . 0.0 109.973 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.441 ' O ' ' HB2' ' A' ' 44' ' ' TYR . 0.1 OUTLIER -63.2 -157.78 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.32 -0.863 . . . . 0.0 110.407 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.441 ' HB2' ' O ' ' A' ' 43' ' ' SER . 14.0 m-85 64.71 11.01 6.46 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.589 -0.694 . . . . 0.0 111.037 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 59.54 47.02 92.95 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -160.72 -171.3 3.06 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.482 -1.011 . . . . 0.0 110.743 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.638 ' CB ' ' HD2' ' A' ' 48' ' ' PRO . 2.1 mmt180 -124.4 -155.04 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.647 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.638 ' HD2' ' CB ' ' A' ' 47' ' ' ARG . 47.9 Cg_endo -75.72 166.64 27.93 Favored 'Trans proline' 0 N--CA 1.484 0.965 0 O-C-N 122.501 0.738 . . . . 0.0 110.727 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.502 ' HA ' ' HB2' ' A' ' 52' ' ' MET . 5.0 mt 65.97 -53.83 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.756 -0.59 . . . . 0.0 110.862 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.52 ' CG ' ' HB3' ' A' ' 81' ' ' PRO . 73.9 mt-30 -50.38 -29.17 9.45 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.772 -1.205 . . . . 0.0 110.187 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.593 HG22 ' HB2' ' A' ' 21' ' ' ALA . 10.6 p -99.09 7.31 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.537 -0.727 . . . . 0.0 109.71 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.522 ' CE ' ' HE3' ' A' ' 54' ' ' MET . 44.4 ttp -66.56 161.62 22.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.557 -0.714 . . . . 0.0 110.127 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 48.7 ttp -70.28 -4.34 21.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.259 -0.9 . . . . 0.0 110.213 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.522 ' HE3' ' CE ' ' A' ' 52' ' ' MET . 0.0 OUTLIER 53.96 23.79 4.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.003 -1.061 . . . . 0.0 110.069 -179.797 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.539 ' HA2' ' CE1' ' A' ' 90' ' ' PHE . . . -123.95 -5.63 7.41 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.48 90.4 2.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.334 -1.098 . . . . 0.0 110.129 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.659 ' HB2' ' HE2' ' A' ' 90' ' ' PHE . . . -53.48 -24.83 14.09 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.087 -1.008 . . . . 0.0 109.872 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.9 -48.37 64.17 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.549 -0.72 . . . . 0.0 110.442 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.669 HG23 HG22 ' A' ' 25' ' ' VAL . 32.1 t -59.36 -57.74 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.189 -0.944 . . . . 0.0 109.694 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -46.46 -59.71 2.8 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.429 -0.794 . . . . 0.0 110.091 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.553 ' HA ' HG11 ' A' ' 96' ' ' VAL . 17.1 tt0 -46.68 -43.47 17.8 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.382 -0.824 . . . . 0.0 109.208 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.979 HD11 ' CA ' ' A' ' 29' ' ' ARG . 0.3 OUTLIER -57.65 -64.74 0.79 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.284 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.841 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 2.6 mt -56.46 -48.94 76.01 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.637 HD13 HG12 ' A' ' 96' ' ' VAL . 0.3 OUTLIER -56.39 -56.67 18.2 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.469 -0.77 . . . . 0.0 109.659 179.323 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.469 ' HB3' ' O ' ' A' ' 61' ' ' GLU . 9.5 tp -53.06 -30.35 35.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.311 -0.868 . . . . 0.0 109.185 179.068 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.824 ' CG ' HD22 ' A' ' 32' ' ' LEU . 1.5 m-70 -86.2 -21.3 27.54 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.716 -0.615 . . . . 0.0 109.652 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.445 ' O ' ' HB2' ' A' ' 38' ' ' PRO . . . 110.49 48.81 0.73 Allowed Glycine 0 N--CA 1.482 1.72 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 178.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.841 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -64.5 -150.85 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.885 -1.362 . . . . 0.0 109.402 179.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.49 ' HG3' ' HD2' ' A' ' 48' ' ' PRO . 1.7 mm-40 -119.61 53.37 2.41 Favored Pre-proline 0 C--N 1.301 -1.508 0 O-C-N 121.357 -0.84 . . . . 0.0 109.58 178.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.456 ' HG3' ' HG ' ' A' ' 64' ' ' LEU . 47.3 Cg_endo -70.4 -16.33 34.85 Favored 'Trans proline' 0 C--N 1.317 -1.082 0 O-C-N 123.755 1.397 . . . . 0.0 109.99 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -95.41 -57.27 2.45 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.516 -0.74 . . . . 0.0 110.002 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.51 178.15 0.16 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.442 -0.786 . . . . 0.0 110.215 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -150.7 -152.61 0.44 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.512 -0.742 . . . . 0.0 109.914 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.439 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 39.1 m-20 -116.78 130.44 24.56 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.341 -0.849 . . . . 0.0 109.263 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.674 ' O ' ' HB3' ' A' ' 76' ' ' ALA . 42.0 Cg_endo -69.74 -177.2 1.76 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.426 1.224 . . . . 0.0 110.322 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.674 ' HB3' ' O ' ' A' ' 75' ' ' PRO . . . 71.42 -58.59 0.57 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.475 -0.766 . . . . 0.0 109.802 -178.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.539 ' C ' ' HB2' ' A' ' 109' ' ' ALA . 0.2 OUTLIER -115.57 0.45 13.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.16 -0.962 . . . . 0.0 110.621 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.508 ' HB3' ' O ' ' A' ' 107' ' ' ARG . 1.2 mt 48.62 53.37 12.31 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.222 -0.924 . . . . 0.0 111.41 179.429 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 60.2 m -88.42 98.51 11.66 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.086 -1.009 . . . . 0.0 110.474 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.693 ' CD ' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -74.18 165.77 50.53 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.326 -0.859 . . . . 0.0 109.392 179.368 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.581 ' HD2' ' CG ' ' A' ' 80' ' ' ARG . 45.4 Cg_endo -79.14 -0.71 10.98 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 O-C-N 123.308 1.162 . . . . 0.0 110.339 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.699 HG21 ' O ' ' A' ' 103' ' ' ARG . 22.1 t -76.93 -31.55 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.558 -0.714 . . . . 0.0 109.391 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.476 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 5.7 m80 -70.65 -36.69 73.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.519 -0.738 . . . . 0.0 109.44 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.519 ' O ' ' HB3' ' A' ' 87' ' ' ARG . 67.8 m-20 -54.0 -50.24 67.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.68 -0.637 . . . . 0.0 109.688 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.755 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -55.81 -67.91 0.25 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.142 -0.974 . . . . 0.0 109.356 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.763 ' HB2' HD11 ' A' ' 130' ' ' LEU . . . -52.92 -38.64 62.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.287 -0.883 . . . . 0.0 110.892 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.519 ' HB3' ' O ' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -44.9 -47.16 11.2 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.51 -0.744 . . . . 0.0 110.894 -179.307 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -97.12 8.38 44.63 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.209 -0.932 . . . . 0.0 110.156 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.446 ' HA3' ' ND1' ' A' ' 123' ' ' HIS . . . 70.87 40.85 63.44 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.154 -1.579 . . . . 0.0 109.154 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.659 ' HE2' ' HB2' ' A' ' 57' ' ' ALA . 1.9 t80 -106.88 116.41 31.88 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.315 -1.109 . . . . 0.0 110.673 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.457 HD21 ' CG ' ' A' ' 129' ' ' TYR . 0.4 OUTLIER -94.77 -42.67 8.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.633 -0.667 . . . . 0.0 110.844 -179.487 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.604 ' O ' HG23 ' A' ' 96' ' ' VAL . 92.1 m-20 -43.64 -44.46 6.36 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.383 -0.823 . . . . 0.0 109.734 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.4 m -66.41 -49.06 68.07 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.798 HD22 HG13 ' A' ' 126' ' ' VAL . 4.2 tp -53.38 -39.93 64.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.583 -0.698 . . . . 0.0 109.529 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.418 ' O ' ' N ' ' A' ' 99' ' ' ARG . 84.4 t -62.59 -53.16 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.375 -0.828 . . . . 0.0 108.964 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.637 HG12 HD13 ' A' ' 64' ' ' LEU . 63.7 t -50.23 -47.97 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.512 -0.742 . . . . 0.0 109.653 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.53 ' HA ' HD11 ' A' ' 64' ' ' LEU . 1.2 mp -56.9 -45.27 82.73 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.619 -0.676 . . . . 0.0 109.679 179.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -75.79 -29.36 58.71 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.368 -0.833 . . . . 0.0 109.874 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 95' ' ' VAL . 0.4 OUTLIER -67.72 -13.14 61.86 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.374 -0.829 . . . . 0.0 110.735 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.586 ' HB3' HD21 ' A' ' 64' ' ' LEU . . . -118.98 -93.24 0.52 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.315 -0.866 . . . . 0.0 110.792 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -156.71 45.21 0.51 Allowed Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.512 -1.328 . . . . 0.0 110.298 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -78.03 -171.4 2.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.09 -1.241 . . . . 0.0 109.692 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.699 ' O ' HG21 ' A' ' 82' ' ' VAL . 15.8 tpt180 -123.44 137.98 54.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.181 -0.949 . . . . 0.0 109.947 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.521 ' O ' ' HA ' ' A' ' 134' ' ' ALA . 14.0 mt -135.63 64.91 1.56 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.283 -0.885 . . . . 0.0 110.204 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -174.68 38.77 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.874 -1.142 . . . . 0.0 110.159 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.693 HG11 ' CD ' ' A' ' 80' ' ' ARG . 12.6 p -110.19 173.92 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.348 -0.845 . . . . 0.0 110.433 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.584 ' N ' HG22 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -127.91 138.66 52.74 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.145 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 110' ' ' TRP . 28.0 p-10 -68.73 61.88 0.1 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.353 -0.842 . . . . 0.0 111.121 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.539 ' HB2' ' C ' ' A' ' 77' ' ' THR . . . 59.88 -74.36 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.557 -0.714 . . . . 0.0 110.877 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.534 ' CZ3' ' CG2' ' A' ' 77' ' ' THR . 4.7 m-90 -47.88 -85.09 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.415 -0.803 . . . . 0.0 111.072 -179.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -178.74 57.28 0.09 OUTLIER Glycine 0 N--CA 1.482 1.717 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.54 ' O ' HD12 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -131.2 -164.8 1.48 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.218 -1.166 . . . . 0.0 110.143 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.54 HD12 ' O ' ' A' ' 112' ' ' ARG . 0.1 OUTLIER -155.39 165.46 18.29 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.509 -0.744 . . . . 0.0 109.825 -179.812 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.435 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 41.8 Cg_endo -69.02 -30.12 26.27 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.452 1.238 . . . . 0.0 109.982 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.447 ' HB ' ' HB3' ' A' ' 130' ' ' LEU . 10.9 p -82.63 -37.63 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.343 -0.848 . . . . 0.0 109.769 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.443 ' N ' HG13 ' A' ' 115' ' ' VAL . 24.5 t0 -54.19 -38.44 65.61 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.431 -0.793 . . . . 0.0 109.985 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.22 -54.07 16.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.505 -0.747 . . . . 0.0 110.038 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.537 ' CB ' ' HB2' ' A' ' 127' ' ' ALA . . . -46.02 -56.03 6.08 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.454 -0.779 . . . . 0.0 110.785 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -58.88 -28.46 66.17 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.296 -0.878 . . . . 0.0 109.927 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -75.32 -49.73 18.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.432 -0.792 . . . . 0.0 109.84 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.7 mt -73.77 -91.36 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.329 -0.857 . . . . 0.0 109.95 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -173.91 31.02 0.1 OUTLIER Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.684 -1.246 . . . . 0.0 110.106 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.564 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 50.4 m-70 -102.59 44.2 1.03 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.267 -1.137 . . . . 0.0 109.349 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.577 ' HA ' ' HB3' ' A' ' 127' ' ' ALA . 1.7 mtm180 -46.07 -40.26 10.53 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.737 -0.602 . . . . 0.0 109.967 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -55.82 -45.65 78.27 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.798 HG13 HD22 ' A' ' 94' ' ' LEU . 16.8 t -78.05 -40.45 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 119.666 -0.814 . . . . 0.0 109.087 178.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.577 ' HB3' ' HA ' ' A' ' 124' ' ' ARG . . . -57.57 -58.31 8.86 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.593 -0.692 . . . . 0.0 109.677 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.409 ' NH1' ' HG3' ' A' ' 128' ' ' ARG . 38.1 ttm-85 -45.2 -59.79 2.45 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.69 -0.631 . . . . 0.0 109.92 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.457 ' CG ' HD21 ' A' ' 91' ' ' LEU . 5.7 t80 -57.53 -45.76 84.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.582 -0.699 . . . . 0.0 109.214 178.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.763 HD11 ' HB2' ' A' ' 86' ' ' ALA . 7.2 mt -54.86 -41.47 70.83 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.561 -0.712 . . . . 0.0 110.952 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 39.7 ttp85 -62.52 -40.2 96.0 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.253 -0.905 . . . . 0.0 110.202 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -81.04 -30.12 34.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.264 -0.898 . . . . 0.0 110.304 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -89.58 -18.02 27.39 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.214 -0.929 . . . . 0.0 110.164 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.582 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . -124.78 -45.0 1.92 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.18 -0.95 . . . . 0.0 110.586 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.85 -144.53 31.36 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 120.08 34.54 0.95 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 14.8 p -80.01 127.55 32.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.278 -1.131 . . . . 0.0 110.075 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.475 ' HB2' ' CB ' ' A' ' 143' ' ' ALA . 4.2 mpt_? -71.72 93.98 1.33 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.351 -0.843 . . . . 0.0 110.118 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -80.42 3.78 71.4 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.4 p -148.1 60.33 1.11 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.981 -1.305 . . . . 0.0 110.708 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -174.38 55.15 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.144 -0.972 . . . . 0.0 111.039 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 41.32 55.85 3.27 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.412 -0.805 . . . . 0.0 110.755 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.475 ' CB ' ' HB2' ' A' ' 138' ' ' ARG . . . -123.93 -63.58 1.2 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.309 -0.87 . . . . 0.0 110.208 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.69 153.22 19.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.462 -0.774 . . . . 0.0 109.713 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.468 HG23 ' O ' ' A' ' 145' ' ' ILE . 2.6 tt -50.09 129.48 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.29 -0.881 . . . . 0.0 110.135 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -46.51 98.96 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.477 -0.764 . . . . 0.0 110.633 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -53.57 133.52 41.23 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.276 -0.89 . . . . 0.0 110.352 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -75.72 146.11 40.38 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.48 -0.762 . . . . 0.0 110.108 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -123.57 -73.69 0.64 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.323 -0.86 . . . . 0.0 110.166 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 127.26 175.63 14.17 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -76.35 121.74 6.22 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.593 1.312 . . . . 0.0 110.708 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 4.9 t -85.7 122.22 29.48 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.323 -0.861 . . . . 0.0 109.474 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.33 138.27 10.14 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.45 -0.781 . . . . 0.0 110.728 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.587 ' O ' HG23 ' A' ' 154' ' ' ILE . 3.6 tp -128.31 95.16 34.07 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.518 -0.739 . . . . 0.0 110.363 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.34 138.82 33.71 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 123.688 1.362 . . . . 0.0 110.317 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.496 1.841 0 CA-C-O 117.932 -1.032 . . . . 0.0 110.161 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 mtm . . . . . 0 N--CA 1.497 1.914 0 CA-C-O 121.269 0.557 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -161.6 102.16 1.2 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.551 -0.718 . . . . 0.0 109.99 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -79.85 -163.68 0.24 Allowed 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.649 1.341 . . . . 0.0 110.264 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -128.24 93.95 3.78 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.557 -0.714 . . . . 0.0 110.404 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -174.19 50.08 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.239 -0.913 . . . . 0.0 109.741 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 84.51 139.81 4.52 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.0 t 174.07 125.71 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.437 -1.037 . . . . 0.0 110.231 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.3 p -53.64 169.94 0.13 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.266 -0.896 . . . . 0.0 110.537 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.408 ' O ' ' HD3' ' A' ' 11' ' ' PRO . 2.6 mtp 174.45 48.5 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.442 -0.786 . . . . 0.0 110.022 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -101.69 99.64 12.26 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.231 -0.918 . . . . 0.0 110.161 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 9' ' ' MET . 42.1 Cg_endo -70.75 110.09 2.67 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.63 1.332 . . . . 0.0 109.82 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.6 p -62.02 119.23 8.49 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.324 -0.86 . . . . 0.0 110.038 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -117.06 -118.53 0.32 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.426 -0.796 . . . . 0.0 110.262 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.9 t70 62.77 5.26 1.69 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.86 -1.15 . . . . 0.0 111.044 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.524 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 49.1 m0 -68.19 -12.66 61.33 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.176 -0.952 . . . . 0.0 110.68 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.041 ' HB3' HD21 ' A' ' 63' ' ' LEU . 35.6 mt -76.13 -60.78 2.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.166 -0.959 . . . . 0.0 109.477 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.571 ' HB2' ' HA ' ' A' ' 48' ' ' PRO . . . -57.55 -48.2 79.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.519 -0.738 . . . . 0.0 109.861 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.524 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.6 OUTLIER -44.44 -55.27 5.17 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.444 -0.785 . . . . 0.0 110.536 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.808 ' HB1' ' HB3' ' A' ' 24' ' ' ARG . . . -71.8 -32.4 67.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.145 -0.972 . . . . 0.0 109.942 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.455 ' HB1' HG11 ' A' ' 59' ' ' VAL . . . -67.73 -45.88 73.76 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.208 -0.933 . . . . 0.0 109.962 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.14 -25.67 68.46 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.48 -0.762 . . . . 0.0 109.616 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -104.83 25.93 9.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.453 -0.78 . . . . 0.0 110.306 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.571 ' HA3' ' HE2' ' A' ' 53' ' ' MET . . . 48.4 66.79 1.9 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.808 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -133.3 54.61 1.94 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.44 -1.035 . . . . 0.0 109.409 -179.898 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 1.03 HG22 HG23 ' A' ' 59' ' ' VAL . 45.1 t -46.1 -56.93 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.535 -0.728 . . . . 0.0 110.869 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -40.78 -50.91 3.15 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.724 -0.61 . . . . 0.0 110.954 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.709 ' O ' HD12 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -58.77 -41.28 86.24 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.194 -0.942 . . . . 0.0 109.622 179.592 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.749 HG12 HD13 ' A' ' 62' ' ' LEU . 13.6 t -69.81 -49.78 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.503 -0.748 . . . . 0.0 110.289 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.786 ' HA ' HD11 ' A' ' 62' ' ' LEU . 4.4 mmt180 -41.65 -52.3 3.85 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.514 -0.741 . . . . 0.0 110.122 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.41 -53.35 9.75 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.809 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.709 HD12 ' O ' ' A' ' 27' ' ' GLU . 4.7 mt -47.73 -62.74 1.31 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.431 -0.793 . . . . 0.0 110.998 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.779 ' HG ' HD22 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -44.1 -57.5 3.36 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.571 -0.706 . . . . 0.0 110.379 179.89 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -66.27 -10.88 46.65 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.667 -0.646 . . . . 0.0 110.526 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.51 ' HB3' ' O ' ' A' ' 31' ' ' LEU . . . -86.8 -11.86 49.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.067 -1.02 . . . . 0.0 110.239 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 130.19 -6.45 6.02 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.907 -1.139 . . . . 0.0 110.999 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.898 ' CB ' HD21 ' A' ' 16' ' ' LEU . . . -42.78 155.9 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.19 -1.183 . . . . 0.0 110.636 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.985 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 3.2 tp -80.91 131.03 61.21 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.228 -0.92 . . . . 0.0 110.858 -178.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.445 ' O ' ' HA ' ' A' ' 68' ' ' ALA . 49.0 Cg_endo -74.4 -15.64 22.24 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.841 1.443 . . . . 0.0 110.8 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -128.38 25.72 5.76 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.101 -0.999 . . . . 0.0 110.475 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.985 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -66.46 123.92 86.85 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.254 -0.904 . . . . 0.0 109.873 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -76.75 149.19 29.54 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.673 1.354 . . . . 0.0 110.319 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -81.16 -163.27 0.58 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.544 -0.723 . . . . 0.0 109.922 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.407 ' C ' ' CD1' ' A' ' 44' ' ' TYR . 0.1 OUTLIER -99.12 6.17 46.59 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.883 -1.136 . . . . 0.0 110.571 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.407 ' CD1' ' C ' ' A' ' 43' ' ' SER . 2.4 m-85 -119.01 36.37 4.48 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.28 -0.887 . . . . 0.0 109.434 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.41 28.33 35.66 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.74 -157.46 0.61 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.55 -0.97 . . . . 0.0 110.822 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.609 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 0.3 OUTLIER -121.2 -173.14 0.25 Allowed Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.33 -0.856 . . . . 0.0 110.638 -178.604 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.794 ' HB2' HD22 ' A' ' 63' ' ' LEU . 42.2 Cg_endo -77.99 -26.52 6.52 Favored 'Trans proline' 0 C--N 1.32 -0.958 0 O-C-N 123.467 1.246 . . . . 0.0 111.438 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.425 ' CD1' ' HA ' ' A' ' 60' ' ' ALA . 12.0 mt -109.71 -37.65 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 120.768 -1.207 . . . . 0.0 109.389 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.479 ' HB2' ' HB3' ' A' ' 81' ' ' PRO . 2.5 tt0 -53.8 -16.67 1.85 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.691 -0.63 . . . . 0.0 110.686 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 51' ' ' VAL . 7.4 p -114.35 6.78 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.023 -1.048 . . . . 0.0 111.225 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.475 ' CE ' ' HE1' ' A' ' 54' ' ' MET . 0.0 OUTLIER -67.92 168.54 11.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.774 -1.204 . . . . 0.0 109.495 179.825 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.571 ' HE2' ' HA3' ' A' ' 23' ' ' GLY . 3.1 tmm? -67.8 -1.92 6.28 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.21 -0.931 . . . . 0.0 111.301 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.475 ' HE1' ' CE ' ' A' ' 52' ' ' MET . 12.9 mmt 48.56 23.04 0.56 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.259 -0.901 . . . . 0.0 110.361 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.433 ' HA3' ' SD ' ' A' ' 53' ' ' MET . . . -120.46 3.19 12.39 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.279 -1.928 . . . . 0.0 108.279 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.41 74.07 1.45 Allowed 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.75 -0.853 . . . . 0.0 108.88 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.757 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . . . -43.71 -27.57 0.33 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.421 -0.8 . . . . 0.0 110.151 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.474 ' HB3' HG11 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -49.37 -49.33 44.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.541 -0.724 . . . . 0.0 109.639 178.744 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 1.03 HG23 HG22 ' A' ' 25' ' ' VAL . 63.5 t -48.72 -59.87 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.659 -0.65 . . . . 0.0 109.945 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.486 ' O ' ' HB3' ' A' ' 64' ' ' LEU . . . -45.45 -46.23 13.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.676 -0.64 . . . . 0.0 109.794 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.57 ' O ' ' HB3' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -51.19 -59.66 3.95 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.657 -0.652 . . . . 0.0 109.516 178.982 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.786 HD11 ' HA ' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -46.52 -72.27 0.06 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.609 -0.682 . . . . 0.0 110.373 179.114 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.041 HD21 ' HB3' ' A' ' 16' ' ' LEU . 4.0 mt -51.22 -50.08 59.83 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.393 -0.817 . . . . 0.0 110.616 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.945 HD13 HG12 ' A' ' 96' ' ' VAL . 0.9 OUTLIER -59.11 -59.14 5.94 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.489 -0.757 . . . . 0.0 110.744 -179.628 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.679 ' O ' HD12 ' A' ' 65' ' ' LEU . 0.8 OUTLIER -48.76 -34.58 12.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.318 -0.864 . . . . 0.0 108.736 179.755 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.444 ' ND1' ' CD1' ' A' ' 32' ' ' LEU . 0.3 OUTLIER -82.11 -30.59 31.12 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.282 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 63' ' ' LEU . . . 124.0 52.76 0.19 Allowed Glycine 0 N--CA 1.479 1.561 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.655 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -62.19 -154.24 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.08 -1.247 . . . . 0.0 109.529 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.504 ' HB2' ' HB3' ' A' ' 47' ' ' ARG . 4.8 mt-10 -121.31 55.9 5.49 Favored Pre-proline 0 C--N 1.302 -1.499 0 O-C-N 121.33 -0.857 . . . . 0.0 109.448 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 69' ' ' GLU . 40.6 Cg_endo -66.28 -10.46 27.55 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.847 1.446 . . . . 0.0 110.351 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.532 ' HA ' ' NH2' ' A' ' 80' ' ' ARG . 72.2 m-20 -99.06 -72.87 0.64 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.193 -0.942 . . . . 0.0 110.146 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -42.89 161.8 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.663 -0.648 . . . . 0.0 110.953 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.468 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -148.2 -149.27 0.29 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.383 -0.823 . . . . 0.0 110.184 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.522 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -105.06 135.21 19.33 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 120.956 -1.09 . . . . 0.0 110.269 -179.724 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.28 -22.04 22.5 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 N-CA-C 109.239 -1.1 . . . . 0.0 109.239 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.73 -67.77 0.26 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.588 -0.695 . . . . 0.0 109.677 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.535 ' HA ' ' CB ' ' A' ' 109' ' ' ALA . 14.6 p -124.82 27.47 6.79 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.391 -0.818 . . . . 0.0 109.342 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.522 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 1.3 mt 43.94 38.21 2.08 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.464 -0.772 . . . . 0.0 110.659 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.463 ' HA ' ' OD2' ' A' ' 108' ' ' ASP . 22.2 m -73.04 100.87 3.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.443 -0.786 . . . . 0.0 109.637 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.888 ' HG3' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -71.12 162.47 72.29 Favored Pre-proline 0 C--N 1.302 -1.471 0 O-C-N 121.401 -0.812 . . . . 0.0 110.806 -179.48 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.505 ' HA ' ' OD2' ' A' ' 84' ' ' ASP . 42.3 Cg_endo -69.95 -14.93 36.11 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 O-C-N 124.444 1.76 . . . . 0.0 110.219 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.897 HG21 ' HA ' ' A' ' 104' ' ' LEU . 20.1 t -68.38 -29.44 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.522 -0.737 . . . . 0.0 110.102 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.475 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 6.2 m80 -70.77 -28.53 64.74 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.393 -0.817 . . . . 0.0 109.136 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.505 ' OD2' ' HA ' ' A' ' 81' ' ' PRO . 72.2 m-20 -62.23 -57.13 12.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.35 -0.844 . . . . 0.0 110.042 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.615 ' HB2' ' CG2' ' A' ' 93' ' ' THR . . . -49.46 -57.48 6.93 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.452 -0.78 . . . . 0.0 109.757 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.876 ' CB ' HG11 ' A' ' 126' ' ' VAL . . . -57.19 -50.17 73.67 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.282 -0.886 . . . . 0.0 109.936 179.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.427 ' HD3' ' CD1' ' A' ' 121' ' ' LEU . 1.7 mmt85 -47.52 -21.51 0.35 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.588 -0.695 . . . . 0.0 111.483 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.458 ' HG2' ' HB2' ' A' ' 54' ' ' MET . 3.8 mp0 -110.69 -7.65 14.64 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.201 -0.937 . . . . 0.0 110.479 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.464 ' HA2' ' HB3' ' A' ' 123' ' ' HIS . . . 78.15 22.53 68.06 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.757 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -95.22 111.79 23.59 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.533 -0.981 . . . . 0.0 110.427 -179.628 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.715 HD22 HG22 ' A' ' 126' ' ' VAL . 0.5 OUTLIER -82.43 -45.14 15.18 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.551 -0.718 . . . . 0.0 110.252 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.493 ' O ' HG23 ' A' ' 96' ' ' VAL . 20.9 m-20 -41.47 -43.56 2.66 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.548 0.69 . . . . 0.0 109.535 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.615 ' CG2' ' HB2' ' A' ' 85' ' ' ALA . 11.5 m -61.24 -59.58 5.09 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.753 -0.592 . . . . 0.0 109.596 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.743 HD12 ' O ' ' A' ' 90' ' ' PHE . 0.6 OUTLIER -46.75 -38.88 10.7 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.379 -0.826 . . . . 0.0 109.395 179.49 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.474 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 58.0 t -66.41 -43.88 90.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.945 HG12 HD13 ' A' ' 64' ' ' LEU . 45.8 t -58.58 -55.73 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.453 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 6.5 mp -47.21 -61.47 1.88 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.423 -0.798 . . . . 0.0 110.133 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -61.16 -36.01 78.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.162 -0.961 . . . . 0.0 109.838 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 1.1 mtp-105 -58.4 -13.18 4.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.394 -0.816 . . . . 0.0 110.536 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.802 ' HB3' HD11 ' A' ' 64' ' ' LEU . . . -146.58 61.8 1.21 Allowed 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.228 -0.92 . . . . 0.0 110.625 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 60.08 107.9 0.01 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.356 -1.097 . . . . 0.0 110.356 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.519 ' HA ' ' OD1' ' A' ' 71' ' ' ASN . . . -165.64 89.36 0.44 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.423 -1.045 . . . . 0.0 110.39 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.5 96.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.968 -1.082 . . . . 0.0 109.776 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.897 ' HA ' HG21 ' A' ' 82' ' ' VAL . 1.8 mp -87.45 41.87 1.01 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.214 -0.929 . . . . 0.0 110.457 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.63 ' HB2' ' HA ' ' A' ' 134' ' ' ALA . 30.9 t0 -146.9 41.78 1.11 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.905 -1.122 . . . . 0.0 110.829 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.888 HG11 ' HG3' ' A' ' 80' ' ' ARG . 7.1 p -99.01 177.13 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.378 -0.826 . . . . 0.0 109.754 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.557 ' H ' HG22 ' A' ' 106' ' ' VAL . 8.8 mtm180 -111.62 136.79 50.36 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.372 -0.83 . . . . 0.0 109.933 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' A' ' 110' ' ' TRP . 5.5 t70 -74.94 53.08 0.58 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.409 -0.807 . . . . 0.0 109.447 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.535 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 56.98 -78.9 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.657 -0.652 . . . . 0.0 110.382 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.522 ' N ' ' O ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -37.18 -60.67 0.63 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.6 -0.687 . . . . 0.0 110.906 -179.893 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 160.74 -34.58 0.41 Allowed Glycine 0 N--CA 1.482 1.7 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.08 134.66 17.23 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.737 -0.861 . . . . 0.0 110.933 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.618 ' O ' HD12 ' A' ' 117' ' ' LEU . 16.2 mt -96.66 169.79 8.33 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.283 -0.886 . . . . 0.0 109.923 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 38.2 Cg_endo -64.97 -36.24 39.4 Favored 'Trans proline' 0 N--CA 1.49 1.295 0 O-C-N 123.674 1.355 . . . . 0.0 110.155 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 127' ' ' ALA . 10.7 p -78.9 -33.23 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.439 -0.788 . . . . 0.0 109.264 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.512 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 3.1 t0 -60.85 -23.98 65.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.507 -0.745 . . . . 0.0 109.898 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.618 HD12 ' O ' ' A' ' 113' ' ' LEU . 0.3 OUTLIER -76.25 -65.12 0.96 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.427 -0.796 . . . . 0.0 110.102 179.848 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.537 ' HB1' ' HB2' ' A' ' 123' ' ' HIS . . . -44.48 -53.61 6.8 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.568 -0.707 . . . . 0.0 111.077 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.19 -45.61 75.82 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.291 -0.881 . . . . 0.0 110.444 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.512 ' HB2' ' O ' ' A' ' 116' ' ' ASP . 0.0 OUTLIER -71.51 -45.13 63.27 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.467 -0.77 . . . . 0.0 109.967 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.427 ' CD1' ' HD3' ' A' ' 87' ' ' ARG . 4.8 mt -69.15 -94.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.615 -0.678 . . . . 0.0 109.92 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -177.26 47.83 0.1 Allowed Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.537 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . 71.4 m-70 -124.91 52.55 1.56 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.463 -1.022 . . . . 0.0 109.528 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 124' ' ' ARG . 26.8 mtm105 -43.59 -49.17 7.64 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.811 -0.556 . . . . 0.0 110.633 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.4 ' C ' HD21 ' A' ' 91' ' ' LEU . 36.8 t0 -46.16 -46.88 17.57 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.876 HG11 ' CB ' ' A' ' 86' ' ' ALA . 22.4 t -76.08 -49.91 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.933 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.447 ' O ' HG23 ' A' ' 115' ' ' VAL . . . -43.6 -48.72 7.67 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.321 -0.862 . . . . 0.0 110.19 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 36.7 mtt-85 -64.28 -64.88 0.77 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.502 -0.749 . . . . 0.0 109.754 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -50.27 -41.7 51.0 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.371 -0.831 . . . . 0.0 110.818 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.71 ' O ' ' HB3' ' A' ' 134' ' ' ALA . 12.2 mt -58.15 -56.99 14.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.103 -0.998 . . . . 0.0 109.767 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -47.32 -23.44 0.57 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.366 -0.834 . . . . 0.0 110.858 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.452 ' O ' ' N ' ' A' ' 136' ' ' GLY . . . -83.95 -73.46 0.42 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.197 -0.94 . . . . 0.0 109.921 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.14 -11.72 22.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.167 -0.958 . . . . 0.0 110.377 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.71 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . -107.39 61.19 0.62 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.353 -0.842 . . . . 0.0 109.661 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 95.27 38.43 4.8 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 132' ' ' ALA . . . -56.2 -77.57 0.15 Allowed Glycine 0 N--CA 1.492 2.427 0 N-CA-C 108.924 -1.671 . . . . 0.0 108.924 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.468 ' O ' HG23 ' A' ' 137' ' ' THR . 15.4 t -90.84 131.87 36.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.441 -1.035 . . . . 0.0 109.942 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -141.02 118.47 11.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.137 -0.977 . . . . 0.0 110.282 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 169.19 -48.67 0.22 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 52.49 19.18 1.11 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.337 -1.096 . . . . 0.0 110.426 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -129.95 71.02 1.43 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.343 -0.848 . . . . 0.0 109.487 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 63.51 44.89 5.03 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.462 -0.774 . . . . 0.0 109.943 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -122.56 -170.35 2.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.384 -0.822 . . . . 0.0 110.012 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.421 ' O ' ' HB ' ' A' ' 145' ' ' ILE . 14.0 ttp85 49.53 74.4 0.2 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.423 -0.798 . . . . 0.0 110.219 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.421 ' HB ' ' O ' ' A' ' 144' ' ' ARG . 7.7 mt 61.02 165.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.444 -0.785 . . . . 0.0 109.678 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -43.6 158.26 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.336 -0.853 . . . . 0.0 110.539 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -47.6 169.41 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.47 -0.769 . . . . 0.0 110.567 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.1 170.26 1.3 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.352 -0.843 . . . . 0.0 109.785 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -155.66 -42.47 0.08 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.542 -0.724 . . . . 0.0 109.249 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -115.5 137.33 13.75 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.404 ' O ' ' HB3' ' A' ' 152' ' ' SER . 45.9 Cg_endo -69.6 128.01 15.55 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 O-C-N 123.699 1.368 . . . . 0.0 110.401 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 151' ' ' PRO . 75.7 p -177.04 152.43 0.9 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.411 -0.805 . . . . 0.0 109.799 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 58.6 86.68 0.08 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.257 -0.902 . . . . 0.0 110.191 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 9.2 mt -132.86 85.13 47.47 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.252 -0.905 . . . . 0.0 110.517 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -79.86 122.47 4.88 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 O-C-N 123.89 1.468 . . . . 0.0 110.161 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 21.1 p30 . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 118.041 -0.981 . . . . 0.0 110.395 -179.696 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.874 0 CA-C-O 121.099 0.476 . . . . 0.0 110.165 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -129.2 130.44 23.38 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.284 -0.885 . . . . 0.0 110.661 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -72.16 161.89 43.28 Favored 'Trans proline' 0 C--N 1.315 -1.231 0 O-C-N 123.561 1.295 . . . . 0.0 110.245 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -106.99 114.9 29.26 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.414 -0.804 . . . . 0.0 110.458 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -166.45 130.5 2.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.349 -0.844 . . . . 0.0 110.268 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -128.72 99.76 0.5 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.5 m -60.62 174.77 0.54 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.245 -1.15 . . . . 0.0 110.451 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.7 p -155.75 -179.82 8.49 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.323 -0.861 . . . . 0.0 110.323 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 21.9 mtt -97.79 -87.01 0.33 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.231 -0.918 . . . . 0.0 110.936 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -138.5 101.52 8.14 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.16 -0.962 . . . . 0.0 110.723 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -75.81 85.23 1.65 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 123.856 1.451 . . . . 0.0 110.607 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.0 m -58.88 150.07 25.18 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.135 -0.978 . . . . 0.0 110.376 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.19 107.54 0.43 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.28 -0.888 . . . . 0.0 110.502 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.49 28.73 8.47 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.367 -0.833 . . . . 0.0 109.916 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.54 ' O ' HD13 ' A' ' 31' ' ' LEU . 31.1 m0 -85.93 -24.88 26.39 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.365 -0.835 . . . . 0.0 110.349 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.134 HD11 HD21 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -71.29 -37.24 71.86 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.268 -0.895 . . . . 0.0 109.379 179.511 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.677 ' HB2' ' ND2' ' A' ' 42' ' ' ASN . . . -81.21 -47.92 12.77 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.443 -0.786 . . . . 0.0 110.914 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.518 HG23 ' N ' ' A' ' 19' ' ' ALA . 14.6 t -48.78 -43.06 37.61 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.357 -0.84 . . . . 0.0 111.09 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.6 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -75.89 -36.52 59.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.192 -0.943 . . . . 0.0 109.999 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.4 ' CB ' HG11 ' A' ' 59' ' ' VAL . . . -69.1 -28.4 66.46 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.126 -0.984 . . . . 0.0 110.088 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.435 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -80.53 -36.02 33.72 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.369 -0.832 . . . . 0.0 110.64 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -84.42 21.95 1.36 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.226 -0.921 . . . . 0.0 110.861 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.53 ' HA3' ' HE1' ' A' ' 53' ' ' MET . . . 44.85 65.01 1.93 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.496 ' HB3' ' HB3' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -133.38 62.82 1.65 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.341 -1.094 . . . . 0.0 109.35 179.374 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 24' ' ' ARG . 77.3 t -34.78 -53.82 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.872 -0.518 . . . . 0.0 111.421 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -53.0 -45.06 67.71 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.355 -0.841 . . . . 0.0 110.683 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.496 ' HB3' ' HB3' ' A' ' 24' ' ' ARG . 2.1 tp10 -64.64 -28.42 69.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.235 -0.916 . . . . 0.0 110.149 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.069 HG12 HD23 ' A' ' 62' ' ' LEU . 47.5 t -85.3 -51.24 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.181 -0.949 . . . . 0.0 110.428 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 1.013 ' HA ' HD22 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -43.44 -48.62 7.2 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.516 -0.74 . . . . 0.0 111.014 -179.916 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.46 -50.02 15.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.48 -0.762 . . . . 0.0 110.391 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.54 HD13 ' O ' ' A' ' 15' ' ' TRP . 10.7 mt -44.48 -61.03 1.68 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.495 -0.753 . . . . 0.0 110.497 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.859 ' HB3' HD11 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -57.21 -44.56 83.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.537 -0.727 . . . . 0.0 109.704 179.429 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -68.43 -7.41 31.49 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.36 -0.838 . . . . 0.0 110.562 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -105.32 -18.07 14.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.165 -0.959 . . . . 0.0 111.014 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' A' ' 37' ' ' LEU . . . 161.09 -36.51 0.41 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.724 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -45.63 96.31 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.404 -1.057 . . . . 0.0 110.093 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.636 ' HG ' ' HB2' ' A' ' 40' ' ' ALA . 0.8 OUTLIER -66.33 152.03 95.02 Favored Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 121.299 -0.876 . . . . 0.0 110.099 -179.071 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.465 ' HB2' ' HA ' ' A' ' 68' ' ' ALA . 44.3 Cg_endo -70.65 -34.35 11.75 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 124.025 1.539 . . . . 0.0 111.922 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -88.3 42.73 1.08 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.924 -1.11 . . . . 0.0 110.355 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.636 ' HB2' ' HG ' ' A' ' 37' ' ' LEU . . . -97.7 107.13 37.98 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.289 -0.882 . . . . 0.0 110.097 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -69.94 133.47 25.32 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.644 1.339 . . . . 0.0 109.528 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.677 ' ND2' ' HB2' ' A' ' 17' ' ' ALA . 5.7 m120 -77.05 -176.98 4.23 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.431 -0.793 . . . . 0.0 110.059 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 69.2 m -102.39 23.86 11.18 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.31 -0.869 . . . . 0.0 109.44 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.46 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 7.4 m-85 -122.59 19.24 10.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.73 -0.606 . . . . 0.0 109.479 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.431 ' C ' ' HG2' ' A' ' 46' ' ' ARG . . . 60.94 26.9 66.12 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.46 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 0.0 OUTLIER -129.1 130.5 46.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.219 -1.165 . . . . 0.0 109.889 -179.772 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.581 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 3.4 mmp_? -48.02 168.95 0.14 Allowed Pre-proline 0 N--CA 1.499 2.016 0 O-C-N 121.574 -0.704 . . . . 0.0 110.475 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.581 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 39.2 Cg_endo -67.01 -17.91 51.53 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.562 1.296 . . . . 0.0 110.329 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.765 ' CG1' HD22 ' A' ' 63' ' ' LEU . 4.9 mt -107.38 -34.16 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 177.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.436 ' HG2' ' HB3' ' A' ' 46' ' ' ARG . 44.6 tt0 -50.45 -24.85 3.37 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.627 -0.671 . . . . 0.0 109.362 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.505 HG11 ' HB1' ' A' ' 17' ' ' ALA . 11.9 p -99.53 7.93 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.471 -0.768 . . . . 0.0 110.246 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.503 ' HB2' ' O ' ' A' ' 49' ' ' ILE . 2.2 tmm? -61.66 158.07 16.22 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.232 -0.917 . . . . 0.0 109.318 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.53 ' HE1' ' HA3' ' A' ' 23' ' ' GLY . 54.7 ttp -70.64 -5.29 28.36 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.223 -0.923 . . . . 0.0 110.135 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.566 ' HB3' ' CB ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER 53.53 22.37 2.93 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.053 -1.03 . . . . 0.0 109.519 -179.116 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.563 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -121.38 -7.41 8.31 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.731 -1.747 . . . . 0.0 108.731 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.1 m -134.73 87.13 2.32 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.426 -1.044 . . . . 0.0 109.638 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.556 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . . . -53.48 -25.7 17.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.325 -0.859 . . . . 0.0 109.643 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.408 ' O ' ' CB ' ' A' ' 61' ' ' GLU . 5.9 mtt85 -54.8 -38.24 67.06 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.595 -0.691 . . . . 0.0 110.093 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.4 HG11 ' CB ' ' A' ' 20' ' ' ALA . 59.6 t -55.86 -66.71 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.022 -1.048 . . . . 0.0 109.364 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -45.82 -27.78 0.93 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.406 -0.809 . . . . 0.0 109.838 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -59.56 -53.69 55.13 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.428 -0.795 . . . . 0.0 110.152 179.54 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.069 HD23 HG12 ' A' ' 28' ' ' VAL . 0.5 OUTLIER -65.46 -42.54 92.21 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.239 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.134 HD21 HD11 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -60.54 -53.54 56.3 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.148 179.729 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.847 HD13 HG12 ' A' ' 96' ' ' VAL . 0.3 OUTLIER -61.75 -29.81 70.37 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.302 -0.959 . . . . 0.0 108.996 178.648 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.507 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 0.4 OUTLIER -54.92 -49.97 69.97 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.963 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.676 ' CG ' HD22 ' A' ' 32' ' ' LEU 0.261 80.3 m80 -87.25 -9.19 55.7 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.794 179.639 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 38' ' ' PRO . . . 82.29 71.32 1.31 Allowed Glycine 0 N--CA 1.482 1.741 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.549 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -65.38 -143.9 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.367 -1.078 . . . . 0.0 109.489 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.505 ' HB3' ' HD3' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -116.36 50.51 0.82 Allowed Pre-proline 0 C--N 1.3 -1.584 0 O-C-N 121.174 -0.954 . . . . 0.0 110.236 179.195 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.602 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 50.1 Cg_endo -72.86 52.39 2.15 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 O-C-N 123.24 1.126 . . . . 0.0 110.266 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.481 ' N ' ' HG3' ' A' ' 81' ' ' PRO . 26.0 m-20 -162.19 -74.64 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.309 -0.87 . . . . 0.0 110.065 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.412 ' HB3' ' NH1' ' A' ' 47' ' ' ARG . 6.2 m -52.22 118.99 3.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.091 -1.005 . . . . 0.0 109.235 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.614 ' HB2' ' HA ' ' A' ' 80' ' ' ARG . . . -107.0 -145.5 0.39 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.433 -0.792 . . . . 0.0 110.477 -178.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER -114.29 134.89 22.18 Favored Pre-proline 0 N--CA 1.487 1.41 0 O-C-N 121.241 -0.912 . . . . 0.0 110.042 -179.879 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -71.58 -9.32 24.87 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.555 1.292 . . . . 0.0 109.96 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.04 -51.15 8.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.274 -0.891 . . . . 0.0 110.107 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.574 ' HB ' ' CH2' ' A' ' 110' ' ' TRP . 11.5 p -123.29 8.86 9.12 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.527 -0.733 . . . . 0.0 110.504 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.488 ' HA ' HD23 ' A' ' 78' ' ' LEU . 0.4 OUTLIER 43.65 37.65 1.64 Allowed 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.543 0.687 . . . . 0.0 110.061 -179.577 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.66 92.16 4.72 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.341 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.826 ' CG ' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -68.89 171.2 6.73 Favored Pre-proline 0 C--N 1.303 -1.446 0 C-N-CA 119.319 -0.952 . . . . 0.0 108.702 179.799 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.602 ' HG3' ' HA ' ' A' ' 70' ' ' PRO . 40.6 Cg_endo -73.34 1.51 6.67 Favored 'Trans proline' 0 C--N 1.299 -2.073 0 O-C-N 123.88 1.463 . . . . 0.0 110.662 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.589 HG11 ' HG ' ' A' ' 104' ' ' LEU . 4.3 t -90.18 -36.18 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.298 -0.876 . . . . 0.0 109.412 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.545 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 19.7 m80 -61.69 -28.68 69.58 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.431 0.634 . . . . 0.0 109.506 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.564 ' HB3' ' SD ' ' A' ' 54' ' ' MET . 43.4 m-20 -64.01 -58.78 5.67 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.38 -0.825 . . . . 0.0 110.162 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.45 ' CB ' ' CD1' ' A' ' 94' ' ' LEU . . . -49.86 -67.88 0.22 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.383 -0.823 . . . . 0.0 110.394 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.803 ' HB2' HD11 ' A' ' 130' ' ' LEU . . . -51.83 -51.4 56.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.351 -0.843 . . . . 0.0 110.94 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.545 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -43.75 -26.58 0.26 Allowed 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.012 -1.055 . . . . 0.0 111.062 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.566 ' CB ' ' HB3' ' A' ' 54' ' ' MET . 5.7 tm-20 -105.78 -15.58 14.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.159 -0.963 . . . . 0.0 110.12 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.561 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 91.52 29.19 12.52 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.126 -1.189 . . . . 0.0 110.126 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.563 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 0.3 OUTLIER -101.52 93.07 5.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.177 -1.19 . . . . 0.0 110.881 179.945 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.586 HD11 ' O ' ' A' ' 125' ' ' ASP . 0.3 OUTLIER -66.76 -42.56 85.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.454 -0.778 . . . . 0.0 110.276 179.652 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.692 ' O ' HG23 ' A' ' 96' ' ' VAL . 67.4 t0 -45.52 -51.47 11.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.345 -0.847 . . . . 0.0 110.239 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 98.1 m -47.41 -52.42 16.93 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.533 -0.729 . . . . 0.0 109.626 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.678 ' HA ' HD12 ' A' ' 97' ' ' LEU . 3.7 mp -51.21 -58.57 5.8 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.422 -0.799 . . . . 0.0 109.785 178.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.479 ' O ' ' CB ' ' A' ' 99' ' ' ARG . 46.8 t -44.07 -51.92 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-O 121.139 0.495 . . . . 0.0 109.834 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.847 HG12 HD13 ' A' ' 64' ' ' LEU . 5.7 t -54.89 -50.78 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.37 -0.831 . . . . 0.0 110.08 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.678 ' HA ' HD21 ' A' ' 64' ' ' LEU . 56.5 mt -52.35 -60.84 2.75 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.453 -0.779 . . . . 0.0 110.378 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -68.76 -26.55 65.29 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.435 -0.791 . . . . 0.0 110.446 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.479 ' CB ' ' O ' ' A' ' 95' ' ' VAL . 45.8 ttt85 -70.03 -9.36 55.04 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.187 -0.945 . . . . 0.0 110.637 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.449 ' HB3' HD22 ' A' ' 64' ' ' LEU . . . -136.0 -53.4 0.75 Allowed 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.005 -1.059 . . . . 0.0 110.928 -179.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 102' ' ' ALA . . . 178.43 110.81 0.28 Allowed Glycine 0 N--CA 1.486 1.982 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.489 ' CB ' ' HB3' ' A' ' 97' ' ' LEU . . . -177.03 141.17 0.33 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.253 -1.145 . . . . 0.0 110.381 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.729 ' O ' HD12 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -86.63 156.39 20.04 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.621 -0.674 . . . . 0.0 109.549 179.306 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.729 HD12 ' O ' ' A' ' 103' ' ' ARG . 0.3 OUTLIER -144.22 46.11 1.42 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.247 -0.908 . . . . 0.0 110.433 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.418 ' OD2' ' O ' ' A' ' 134' ' ' ALA . 1.1 t70 -152.32 40.2 0.6 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.192 -0.942 . . . . 0.0 110.112 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.826 HG11 ' CG ' ' A' ' 80' ' ' ARG . 4.0 p -104.55 170.21 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.652 -0.655 . . . . 0.0 109.846 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.533 ' N ' HG22 ' A' ' 106' ' ' VAL . 11.3 mtp180 -97.84 176.89 5.64 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.541 -0.724 . . . . 0.0 109.812 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.524 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 22.4 p-10 -117.63 30.92 7.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.908 . . . . 0.0 109.707 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.531 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 64.6 -57.04 0.26 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.751 -0.593 . . . . 0.0 110.264 -179.1 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.574 ' CH2' ' HB ' ' A' ' 77' ' ' THR . 7.6 m-90 -56.6 -60.66 3.22 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.159 -0.963 . . . . 0.0 109.541 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 155.87 -26.53 0.57 Allowed Glycine 0 N--CA 1.484 1.883 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.483 ' HG3' ' HB3' ' A' ' 116' ' ' ASP . 0.4 OUTLIER -80.35 107.58 13.26 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.315 -1.109 . . . . 0.0 110.783 -179.442 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.579 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER -55.74 177.36 0.15 Allowed Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 121.429 -0.794 . . . . 0.0 110.235 179.759 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.579 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 40.6 Cg_endo -69.3 -33.64 17.87 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 O-C-N 123.586 1.308 . . . . 0.0 109.347 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.472 HG12 ' HB3' ' A' ' 113' ' ' LEU . 12.8 p -78.4 -33.36 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-O 121.535 0.683 . . . . 0.0 109.437 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.483 ' HB3' ' HG3' ' A' ' 112' ' ' ARG . 0.6 OUTLIER -71.89 -34.26 69.01 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.539 -0.725 . . . . 0.0 109.44 179.438 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.651 HD22 HD11 ' A' ' 121' ' ' LEU . 0.6 OUTLIER -61.19 -39.36 89.88 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.387 -0.821 . . . . 0.0 110.243 179.805 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.578 ' HB1' ' HB2' ' A' ' 123' ' ' HIS . . . -67.45 -51.96 45.27 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.208 -0.933 . . . . 0.0 110.736 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -46.89 -35.4 6.38 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.348 -0.845 . . . . 0.0 110.545 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.54 -58.83 2.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.35 -0.844 . . . . 0.0 109.575 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.651 HD11 HD22 ' A' ' 117' ' ' LEU . 50.2 mt -53.38 -93.29 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.465 -0.772 . . . . 0.0 110.463 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 178.31 36.9 0.06 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.578 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . 35.6 m-70 -108.51 41.33 1.6 Allowed 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.314 -1.109 . . . . 0.0 109.273 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -43.5 -33.57 1.14 Allowed 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.437 0.637 . . . . 0.0 110.16 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.586 ' O ' HD11 ' A' ' 91' ' ' LEU . 2.5 t0 -63.72 -41.3 98.1 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.367 -0.833 . . . . 0.0 108.863 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.707 HG11 ' HA ' ' A' ' 86' ' ' ALA . 3.2 t -80.81 -43.9 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.716 -0.615 . . . . 0.0 110.94 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.464 ' HB2' ' HB3' ' A' ' 118' ' ' ALA . . . -51.31 -35.89 39.98 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.279 -0.888 . . . . 0.0 110.034 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.91 -65.98 0.61 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.418 -0.801 . . . . 0.0 109.887 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.476 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 11.6 t80 -54.07 -42.72 69.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.472 -0.768 . . . . 0.0 109.225 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.803 HD11 ' HB2' ' A' ' 86' ' ' ALA . 14.0 mt -55.96 -58.12 9.24 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.823 -0.548 . . . . 0.0 110.281 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.409 ' HG3' HG21 ' A' ' 115' ' ' VAL . 9.4 ttm180 -56.14 -15.68 4.06 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.176 -0.952 . . . . 0.0 110.854 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 129' ' ' TYR . . . -82.66 -57.18 3.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.055 -1.028 . . . . 0.0 109.809 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -85.47 -12.32 52.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.562 -0.711 . . . . 0.0 110.501 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.613 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . -108.57 -48.52 3.31 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.219 -0.926 . . . . 0.0 110.768 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.03 150.65 13.02 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 108.834 -1.707 . . . . 0.0 108.834 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -108.74 -26.29 5.37 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 10.8 p -71.67 132.82 45.12 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.24 -1.153 . . . . 0.0 110.725 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.421 ' C ' ' CD ' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -101.48 -18.98 15.72 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.295 -0.878 . . . . 0.0 109.882 179.164 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -178.48 -89.55 0.08 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -131.27 126.54 35.7 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.309 -1.112 . . . . 0.0 110.215 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -130.45 21.35 5.17 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.28 -0.888 . . . . 0.0 110.483 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 48.61 24.77 0.82 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.195 -0.94 . . . . 0.0 110.228 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -117.04 -61.05 1.77 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.51 -0.744 . . . . 0.0 110.146 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.81 146.75 49.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.528 -0.733 . . . . 0.0 110.08 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 5.3 mt 55.91 88.73 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.452 -0.78 . . . . 0.0 110.376 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -43.69 107.04 0.08 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.563 -0.711 . . . . 0.0 110.071 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -75.31 123.52 25.49 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.522 -0.736 . . . . 0.0 110.606 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -76.73 164.47 25.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.606 -0.684 . . . . 0.0 110.304 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -55.77 -169.88 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.631 -0.668 . . . . 0.0 110.609 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -74.8 144.21 32.23 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.85 163.85 37.56 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 O-C-N 123.641 1.337 . . . . 0.0 110.938 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.69 10.08 24.86 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.39 -0.819 . . . . 0.0 110.644 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.54 ' O ' HD13 ' A' ' 154' ' ' ILE . 35.3 t70 -67.9 146.36 53.7 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.963 -1.085 . . . . 0.0 109.901 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.54 HD13 ' O ' ' A' ' 153' ' ' ASP . 16.9 mm -137.46 83.71 25.11 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.211 -0.93 . . . . 0.0 110.12 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 156' ' ' ASP . 48.5 Cg_endo -78.16 123.96 6.39 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.817 1.43 . . . . 0.0 109.795 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.431 ' O ' ' O ' ' A' ' 155' ' ' PRO . 4.0 t70 . . . . . 0 N--CA 1.495 1.8 0 CA-C-O 118.088 -0.958 . . . . 0.0 110.68 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.404 ' HG3' ' HD3' ' A' ' 3' ' ' PRO . 5.4 ptp . . . . . 0 N--CA 1.497 1.921 0 CA-C-O 121.232 0.539 . . . . 0.0 110.374 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -139.81 83.28 16.66 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.381 -0.825 . . . . 0.0 110.118 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.404 ' HD3' ' HG3' ' A' ' 1' ' ' MET . 50.5 Cg_endo -74.82 105.97 2.17 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.662 1.349 . . . . 0.0 110.379 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -123.17 83.08 2.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.358 -0.839 . . . . 0.0 110.288 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.52 156.22 31.11 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.285 -0.885 . . . . 0.0 110.236 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.7 -155.47 52.1 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.3 t 52.86 91.26 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.311 -1.111 . . . . 0.0 110.681 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 83.9 p -91.38 59.71 3.95 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.373 -0.829 . . . . 0.0 109.686 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 5.9 tpt -91.52 38.6 0.98 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.327 -0.858 . . . . 0.0 110.547 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.44 147.27 24.93 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.421 -0.8 . . . . 0.0 109.842 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -74.13 124.56 9.15 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.6 1.316 . . . . 0.0 109.817 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -50.17 100.78 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.391 -0.818 . . . . 0.0 110.292 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.909 ' HB1' ' HB2' ' A' ' 37' ' ' LEU . . . -61.76 -13.73 26.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.463 -0.773 . . . . 0.0 110.544 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -81.29 4.46 20.43 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.072 -1.018 . . . . 0.0 110.698 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.676 ' HB3' HD13 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -71.6 -5.21 31.77 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.151 -0.968 . . . . 0.0 110.4 179.773 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.851 HD21 ' CB ' ' A' ' 36' ' ' ALA . 22.7 mt -78.56 -61.48 1.99 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.096 -1.002 . . . . 0.0 109.629 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.521 ' HB1' HG11 ' A' ' 51' ' ' VAL . . . -57.0 -43.77 82.08 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.481 -0.762 . . . . 0.0 109.641 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.571 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.8 OUTLIER -54.18 -54.99 32.26 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.642 -0.662 . . . . 0.0 110.292 179.576 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.621 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -68.54 -40.07 80.87 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.337 -0.852 . . . . 0.0 109.778 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.534 ' HB1' HG11 ' A' ' 59' ' ' VAL . . . -57.62 -50.68 72.33 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.323 -0.861 . . . . 0.0 109.687 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.644 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -58.79 -27.16 64.77 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.612 -0.68 . . . . 0.0 110.587 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.37 23.06 4.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.317 -0.864 . . . . 0.0 110.618 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.43 48.81 40.77 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.2 mtm180 -121.55 58.68 0.99 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.388 -1.066 . . . . 0.0 110.164 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.772 HG22 HG22 ' A' ' 59' ' ' VAL . 51.1 t -44.74 -51.43 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.591 -0.693 . . . . 0.0 110.886 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -51.09 -44.04 61.16 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.335 -0.853 . . . . 0.0 110.622 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.468 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 1.0 OUTLIER -61.25 -39.03 88.84 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.387 -0.821 . . . . 0.0 109.969 179.731 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.837 HG12 HD13 ' A' ' 62' ' ' LEU . 23.6 t -76.81 -48.41 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.471 -0.768 . . . . 0.0 110.465 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.931 ' HA ' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -46.85 -34.94 5.8 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.348 -0.845 . . . . 0.0 109.7 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.56 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -79.88 -51.96 8.48 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.353 -0.842 . . . . 0.0 108.901 178.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.676 HD13 ' HB3' ' A' ' 15' ' ' TRP . 18.6 mt -58.84 -65.13 0.71 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.935 0.874 . . . . 0.0 109.728 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.811 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 1.1 tp -47.21 -49.19 23.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.743 -0.598 . . . . 0.0 110.929 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.521 ' HB2' ' O ' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -75.34 -14.56 60.49 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.152 -0.967 . . . . 0.0 110.47 179.617 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.56 ' HB2' ' O ' ' A' ' 30' ' ' ALA . . . -82.64 -9.54 59.34 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.07 -1.019 . . . . 0.0 110.532 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 125.95 17.5 2.51 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.787 -1.197 . . . . 0.0 110.825 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.851 ' CB ' HD21 ' A' ' 16' ' ' LEU . . . -64.44 176.04 1.2 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.053 -1.263 . . . . 0.0 110.092 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.909 ' HB2' ' HB1' ' A' ' 13' ' ' ALA . 1.6 mm? -91.46 133.45 31.27 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.264 -0.897 . . . . 0.0 110.281 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.643 ' HD2' HD13 ' A' ' 37' ' ' LEU . 44.8 Cg_endo -70.89 -49.29 0.41 Allowed 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 123.603 1.317 . . . . 0.0 110.37 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -95.62 18.48 12.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.31 -0.869 . . . . 0.0 110.484 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.573 ' HB2' ' CB ' ' A' ' 37' ' ' LEU . . . -42.38 109.09 0.68 Allowed Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 121.63 -0.669 . . . . 0.0 110.908 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.5 91.89 0.86 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.709 1.373 . . . . 0.0 110.412 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -65.33 -177.83 0.44 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.484 -0.76 . . . . 0.0 109.898 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.33 22.53 2.47 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.209 -0.932 . . . . 0.0 110.422 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.538 ' HB3' ' CD ' ' A' ' 46' ' ' ARG . 2.8 m-85 -103.09 3.86 36.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -0.904 . . . . 0.0 110.681 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 57.06 35.12 67.83 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.538 ' CD ' ' HB3' ' A' ' 44' ' ' TYR . 7.6 ptm180 -160.4 26.11 0.16 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.261 -1.141 . . . . 0.0 110.697 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.5 ' CB ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER 49.04 -174.63 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.038 0 O-C-N 121.552 -0.718 . . . . 0.0 110.154 179.689 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.734 ' HB2' HD13 ' A' ' 63' ' ' LEU . 46.2 Cg_endo -72.43 -167.33 0.32 Allowed 'Trans proline' 0 C--N 1.315 -1.207 0 O-C-N 123.141 1.074 . . . . 0.0 110.538 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.506 ' O ' ' HG2' ' A' ' 52' ' ' MET . 3.5 mt 60.2 -65.59 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.748 -0.595 . . . . 0.0 109.625 -178.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.592 ' N ' ' O ' ' A' ' 48' ' ' PRO . 5.6 mt-30 -45.8 -25.43 0.51 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.959 -1.088 . . . . 0.0 109.803 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.644 HG22 ' HB2' ' A' ' 21' ' ' ALA . 8.9 p -119.02 40.58 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.485 -0.76 . . . . 0.0 109.789 178.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.562 ' HE1' ' HB2' ' A' ' 60' ' ' ALA . 0.1 OUTLIER -102.52 37.62 1.87 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.028 -1.045 . . . . 0.0 110.21 179.863 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.431 ' CB ' ' O ' ' A' ' 52' ' ' MET . 3.6 tmm? 66.34 -11.73 0.22 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.374 -0.829 . . . . 0.0 111.158 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.498 ' HE1' ' CG ' ' A' ' 52' ' ' MET . 0.0 OUTLIER 48.03 27.55 1.24 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.205 -0.935 . . . . 0.0 110.358 -179.703 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.445 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -125.52 9.5 7.73 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.56 ' HB3' HG23 ' A' ' 59' ' ' VAL . 1.0 OUTLIER -148.99 81.06 1.43 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.41 -1.053 . . . . 0.0 109.629 -179.955 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -49.81 -27.87 5.6 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.464 -0.772 . . . . 0.0 109.775 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.5 mtt85 -52.23 -29.16 21.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.537 -0.727 . . . . 0.0 109.356 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.772 HG22 HG22 ' A' ' 25' ' ' VAL . 29.2 t -71.15 -51.63 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.364 -0.835 . . . . 0.0 108.946 178.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.562 ' HB2' ' HE1' ' A' ' 52' ' ' MET . . . -49.13 -42.31 38.97 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.65 -0.656 . . . . 0.0 109.676 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.5 ' O ' ' HB3' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -61.27 -55.59 30.19 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.486 -0.759 . . . . 0.0 109.317 179.012 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.931 HD11 ' HA ' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -44.25 -58.94 2.61 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.468 -0.77 . . . . 0.0 110.152 178.999 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.81 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 13.9 mt -69.43 -41.9 75.71 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.663 -0.648 . . . . 0.0 110.486 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.891 HD22 HG12 ' A' ' 96' ' ' VAL . 0.5 OUTLIER -61.68 -55.49 29.89 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.039 -1.038 . . . . 0.0 109.739 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.545 ' O ' HD12 ' A' ' 65' ' ' LEU . 0.6 OUTLIER -53.97 -26.81 27.69 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.379 -0.825 . . . . 0.0 109.458 179.366 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.419 ' ND1' ' CD1' ' A' ' 32' ' ' LEU . 1.0 OUTLIER -88.6 -49.04 7.13 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.518 -0.739 . . . . 0.0 109.8 -179.847 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 151.39 50.64 0.02 OUTLIER Glycine 0 N--CA 1.481 1.676 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.81 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -74.05 -157.58 0.05 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.798 -1.413 . . . . 0.0 109.805 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -122.21 63.99 18.69 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.35 -0.844 . . . . 0.0 110.055 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.608 ' HG3' HD12 ' A' ' 64' ' ' LEU . 47.3 Cg_endo -72.3 -8.66 23.11 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.858 1.451 . . . . 0.0 110.574 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -108.05 -78.77 0.58 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.291 -0.881 . . . . 0.0 109.549 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.73 -175.82 0.1 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.55 -0.719 . . . . 0.0 110.527 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.751 ' HB1' ' O ' ' A' ' 79' ' ' THR . . . -167.39 -83.19 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.425 -0.797 . . . . 0.0 110.298 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -146.71 123.36 5.73 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.291 -0.881 . . . . 0.0 109.674 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.37 -2.43 11.7 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.511 1.269 . . . . 0.0 110.645 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -96.52 -27.79 14.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.215 -0.928 . . . . 0.0 110.19 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.529 ' HA ' ' HB3' ' A' ' 109' ' ' ALA . 71.9 p -137.11 4.56 2.72 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.259 -0.901 . . . . 0.0 111.103 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.52 ' HA ' HD23 ' A' ' 78' ' ' LEU . 5.2 mt 47.01 27.93 0.81 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.246 -0.909 . . . . 0.0 111.244 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.751 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 66.4 m -69.66 88.62 0.52 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.963 -1.086 . . . . 0.0 109.783 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.773 ' HD3' HG21 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -67.98 165.11 35.14 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.309 -0.869 . . . . 0.0 109.946 -179.605 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.56 ' HD2' ' HG3' ' A' ' 80' ' ' ARG . 46.5 Cg_endo -76.0 -7.98 18.6 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.622 1.328 . . . . 0.0 109.767 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.407 ' H ' HG23 ' A' ' 82' ' ' VAL . 6.0 t -71.54 -23.92 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.552 -0.717 . . . . 0.0 109.593 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.527 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 4.0 m80 -75.46 -23.39 56.86 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.475 ' HB3' ' SD ' ' A' ' 54' ' ' MET . 51.7 m-20 -75.39 -57.39 3.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.829 -0.544 . . . . 0.0 110.92 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.755 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -53.38 -50.77 64.41 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.194 -0.941 . . . . 0.0 109.507 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.844 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -65.51 -32.05 73.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.455 -0.778 . . . . 0.0 110.105 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.56 ' HA ' HD13 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -56.18 -51.02 69.54 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.297 -0.877 . . . . 0.0 110.374 -179.851 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.465 ' HB2' ' HB3' ' A' ' 54' ' ' MET . 0.9 OUTLIER -93.28 16.58 12.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.301 -0.874 . . . . 0.0 110.422 -179.793 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.686 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 53.28 55.03 26.49 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.445 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 0.2 OUTLIER -115.5 94.93 4.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.418 -1.048 . . . . 0.0 110.744 -179.349 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.828 HD11 ' CG ' ' A' ' 129' ' ' TYR . 0.3 OUTLIER -66.69 -45.5 78.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.348 -0.845 . . . . 0.0 109.967 179.645 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.882 ' O ' HG23 ' A' ' 96' ' ' VAL . 69.6 m-20 -47.91 -40.05 20.75 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.52 -0.737 . . . . 0.0 109.723 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.432 HG23 ' HE1' ' A' ' 52' ' ' MET . 7.1 m -66.17 -55.81 14.5 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.613 -0.68 . . . . 0.0 109.252 179.001 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.815 HD21 ' HB2' ' A' ' 130' ' ' LEU . 4.8 tp -52.03 -47.82 64.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.741 -0.6 . . . . 0.0 109.741 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 91' ' ' LEU . 58.4 t -51.45 -43.76 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.498 -0.751 . . . . 0.0 109.697 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.891 HG12 HD22 ' A' ' 64' ' ' LEU . 23.0 t -57.55 -52.5 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.52 -0.738 . . . . 0.0 109.47 179.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.505 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 4.7 mp -50.51 -57.51 7.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.563 -0.711 . . . . 0.0 109.995 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -62.39 -30.13 70.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.415 -0.803 . . . . 0.0 109.69 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.9 mtt180 -68.01 -11.93 59.85 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.503 -0.748 . . . . 0.0 110.489 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.585 ' CB ' HD21 ' A' ' 64' ' ' LEU . . . -144.43 63.41 1.32 Allowed 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.162 -0.961 . . . . 0.0 110.859 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 53.51 101.53 0.01 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 97' ' ' LEU . . . -151.97 101.25 2.72 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.256 -1.143 . . . . 0.0 110.122 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -55.82 93.62 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.493 -0.755 . . . . 0.0 109.92 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.563 HD22 ' HB3' ' A' ' 133' ' ' ALA . 0.0 OUTLIER -84.67 8.38 17.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.35 -0.844 . . . . 0.0 110.548 -179.699 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.46 ' HB3' ' HA ' ' A' ' 134' ' ' ALA . 6.0 p30 -123.85 60.54 1.11 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.097 -1.002 . . . . 0.0 110.827 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.773 HG21 ' HD3' ' A' ' 80' ' ' ARG . 1.7 p -112.21 -170.48 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.134 -0.979 . . . . 0.0 109.766 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.647 ' H ' HG22 ' A' ' 106' ' ' VAL . 0.2 OUTLIER -138.54 126.11 22.01 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.298 -0.877 . . . . 0.0 109.788 179.417 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -66.05 133.94 51.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 0.0 109.657 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.529 ' HB3' ' HA ' ' A' ' 77' ' ' THR . . . -46.44 -31.56 2.75 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.553 -0.717 . . . . 0.0 110.909 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.518 ' CH2' HG22 ' A' ' 77' ' ' THR . 7.3 m95 -59.56 -65.03 0.74 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.447 -0.783 . . . . 0.0 109.955 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 163.46 -28.33 0.23 Allowed Glycine 0 N--CA 1.48 1.618 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -85.8 137.5 32.74 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.287 -1.126 . . . . 0.0 110.422 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.501 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER -84.17 176.65 3.55 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.499 -0.751 . . . . 0.0 109.465 179.399 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.501 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 41.3 Cg_endo -68.51 -30.22 29.45 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.385 1.202 . . . . 0.0 109.559 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.847 ' HB ' HD11 ' A' ' 130' ' ' LEU . 4.8 p -82.99 -26.21 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.338 -0.852 . . . . 0.0 109.421 179.029 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -56.37 -40.65 74.9 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.502 -0.749 . . . . 0.0 110.664 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.56 HD13 ' HA ' ' A' ' 87' ' ' ARG . 3.5 pp -77.16 -27.78 53.89 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.217 -0.927 . . . . 0.0 109.94 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.588 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -69.21 -26.73 64.96 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.36 -0.838 . . . . 0.0 110.164 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -88.74 -34.35 17.18 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.365 -0.835 . . . . 0.0 109.646 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -74.37 -63.84 1.15 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.405 -0.809 . . . . 0.0 110.535 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.407 ' HB3' ' NE2' ' A' ' 123' ' ' HIS . 0.2 OUTLIER -54.38 -86.77 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.246 -0.909 . . . . 0.0 110.602 -179.486 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 174.31 52.91 0.05 OUTLIER Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.429 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 44.7 m-70 -120.95 44.22 2.57 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.474 -1.015 . . . . 0.0 109.266 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.677 ' HA ' ' HB3' ' A' ' 127' ' ' ALA . 9.5 ptm180 -43.55 -38.19 2.83 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.759 -0.588 . . . . 0.0 110.538 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.506 ' O ' HD21 ' A' ' 91' ' ' LEU . 80.9 m-20 -56.79 -43.47 80.92 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.844 HG11 ' HA ' ' A' ' 86' ' ' ALA . 2.1 t -82.03 -40.03 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.677 ' HB3' ' HA ' ' A' ' 124' ' ' ARG . . . -55.86 -45.4 78.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.394 -0.816 . . . . 0.0 109.657 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -74.9 -52.26 11.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.383 -0.823 . . . . 0.0 109.526 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.828 ' CG ' HD11 ' A' ' 91' ' ' LEU . 80.6 t80 -61.5 -65.16 0.73 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.453 -0.779 . . . . 0.0 110.851 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.847 HD11 ' HB ' ' A' ' 115' ' ' VAL . 0.3 OUTLIER -52.34 -26.16 11.57 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.285 -0.884 . . . . 0.0 110.499 -179.147 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.498 ' HB2' HG21 ' A' ' 115' ' ' VAL . 17.2 ttt-85 -73.12 -42.63 62.68 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.122 -0.986 . . . . 0.0 109.543 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.28 -33.21 72.01 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.563 ' HB3' HD22 ' A' ' 104' ' ' LEU . . . -89.28 -22.58 22.62 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.46 ' HA ' ' HB3' ' A' ' 105' ' ' ASP . . . -92.18 5.23 51.16 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.554 -0.716 . . . . 0.0 110.272 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -57.83 169.78 4.28 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 163.17 -28.14 0.24 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 16.4 p -117.98 -157.27 0.67 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.291 -1.123 . . . . 0.0 110.227 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.25 -153.49 0.47 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.487 -0.758 . . . . 0.0 109.952 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -149.71 -107.84 0.43 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.408 ' O ' ' O ' ' A' ' 141' ' ' ASN . 0.7 OUTLIER -58.47 177.19 0.14 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.278 -1.131 . . . . 0.0 109.574 179.517 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.408 ' O ' ' O ' ' A' ' 140' ' ' SER . 6.6 t30 57.29 108.85 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.302 -0.874 . . . . 0.0 110.257 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -46.54 154.73 0.28 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.261 -0.899 . . . . 0.0 110.795 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -165.45 -58.81 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.44 -0.788 . . . . 0.0 110.657 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 4.6 ttt-85 -72.17 112.87 8.62 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.365 -0.835 . . . . 0.0 110.818 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.4 tt -74.59 152.1 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.399 -0.813 . . . . 0.0 109.631 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.426 ' N ' ' OD1' ' A' ' 146' ' ' ASP . 27.3 p-10 -49.18 173.06 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.305 -0.872 . . . . 0.0 110.832 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' A' ' 148' ' ' ALA . . . -49.1 126.87 13.44 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.229 -0.92 . . . . 0.0 109.935 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 147' ' ' ALA . . . 58.71 167.88 0.05 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.202 -0.936 . . . . 0.0 109.588 -178.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -84.78 129.61 34.8 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.128 -0.982 . . . . 0.0 110.431 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 73.11 -144.69 35.15 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.47 147.52 46.55 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.623 1.328 . . . . 0.0 110.404 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 40.8 m -57.27 -176.76 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.474 -0.766 . . . . 0.0 110.21 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -170.33 -169.58 0.85 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.277 -0.889 . . . . 0.0 110.686 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 154' ' ' ILE . 21.0 mm -131.7 88.44 42.56 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.47 -0.769 . . . . 0.0 109.584 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.29 142.16 33.25 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.795 1.418 . . . . 0.0 110.43 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 118.014 -0.994 . . . . 0.0 110.233 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.774 0 CA-C-O 121.121 0.486 . . . . 0.0 110.122 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -170.7 79.7 0.56 Allowed Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.416 -0.802 . . . . 0.0 110.359 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -74.03 93.23 0.88 Allowed 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.72 1.379 . . . . 0.0 110.194 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -100.31 54.89 0.9 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.383 -0.823 . . . . 0.0 110.384 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.32 -64.07 1.01 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.319 -0.863 . . . . 0.0 109.769 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.78 -145.93 24.01 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.6 m -59.69 162.39 5.25 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.45 -1.03 . . . . 0.0 110.523 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.6 t 179.81 165.31 1.15 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.594 -0.691 . . . . 0.0 109.599 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 52.83 31.81 11.26 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.291 -0.881 . . . . 0.0 110.332 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.1 123.33 64.3 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.35 -0.844 . . . . 0.0 110.438 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -73.03 75.22 2.8 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.672 1.354 . . . . 0.0 110.391 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.0 m -152.05 -42.91 0.11 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.366 -0.834 . . . . 0.0 110.166 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.509 ' HB1' ' HB2' ' A' ' 37' ' ' LEU . . . -64.66 -14.27 57.55 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.369 -0.832 . . . . 0.0 110.483 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -71.56 -5.76 35.71 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.286 -0.884 . . . . 0.0 110.909 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.599 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 27.8 m0 -75.34 -10.87 59.84 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.015 -1.053 . . . . 0.0 110.699 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.788 HD21 HD21 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -78.11 -54.62 6.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.183 -0.948 . . . . 0.0 109.924 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.469 ' N ' ' HG ' ' A' ' 16' ' ' LEU . . . -69.28 -40.03 77.99 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.097 -1.002 . . . . 0.0 109.813 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.599 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 2.8 p -51.43 -56.77 11.42 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.579 -0.7 . . . . 0.0 110.687 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.741 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -56.49 -38.54 71.89 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.269 -0.895 . . . . 0.0 110.227 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.61 -23.99 66.95 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.292 -0.88 . . . . 0.0 110.14 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.506 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -82.54 -27.65 31.52 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.281 -0.887 . . . . 0.0 110.606 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 -94.31 22.75 5.69 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.293 -0.88 . . . . 0.0 110.454 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 55.57 66.57 2.74 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.75 75.62 1.48 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.382 -1.069 . . . . 0.0 109.588 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.875 HG22 ' CG2' ' A' ' 59' ' ' VAL . 11.6 t -56.19 -53.26 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.357 -0.84 . . . . 0.0 110.246 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -45.92 -42.23 12.52 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.457 -0.777 . . . . 0.0 111.067 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.654 ' O ' HD12 ' A' ' 31' ' ' LEU . 1.3 mp0 -64.78 -46.64 81.22 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.319 -0.863 . . . . 0.0 109.776 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.944 HG12 HD12 ' A' ' 32' ' ' LEU . 13.7 t -73.49 -45.41 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.412 -0.805 . . . . 0.0 109.548 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.873 ' CG ' HG12 ' A' ' 25' ' ' VAL . 27.6 mmm-85 -48.53 -43.52 35.42 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.536 -0.727 . . . . 0.0 109.902 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.26 -45.32 33.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.542 -0.724 . . . . 0.0 109.896 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.654 HD12 ' O ' ' A' ' 27' ' ' GLU . 4.1 mt -54.42 -56.96 13.37 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.281 -0.887 . . . . 0.0 109.876 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.944 HD12 HG12 ' A' ' 28' ' ' VAL . 3.0 mt -57.42 -44.82 84.95 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.394 -0.816 . . . . 0.0 110.077 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -63.18 -17.42 62.37 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.507 -0.746 . . . . 0.0 110.188 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.43 -14.12 31.11 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.325 -0.86 . . . . 0.0 110.167 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.63 28.13 1.64 Allowed Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.951 -1.119 . . . . 0.0 110.403 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.655 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -58.7 152.3 19.11 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.208 -1.172 . . . . 0.0 110.078 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.897 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 2.1 mm? -66.71 122.08 80.5 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.409 -0.807 . . . . 0.0 109.989 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.481 ' HD2' HD13 ' A' ' 37' ' ' LEU . 42.4 Cg_endo -68.8 -42.68 4.31 Favored 'Trans proline' 0 C--N 1.312 -1.342 0 O-C-N 123.601 1.316 . . . . 0.0 110.361 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -108.9 56.71 0.62 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.429 -0.794 . . . . 0.0 109.592 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.897 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -94.38 117.2 67.05 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.396 -0.815 . . . . 0.0 110.193 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.53 109.56 2.49 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.626 1.329 . . . . 0.0 110.072 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.586 ' ND2' HG11 ' A' ' 51' ' ' VAL . 18.3 t-20 -50.86 175.59 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.448 -0.782 . . . . 0.0 110.882 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.4 t -87.01 4.83 40.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.542 -0.724 . . . . 0.0 110.78 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -117.01 31.33 6.81 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.119 -0.988 . . . . 0.0 109.94 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 55.38 23.47 34.39 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.57 141.31 48.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.405 -1.056 . . . . 0.0 110.049 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.509 ' CG ' ' HB2' ' A' ' 69' ' ' GLU . 0.2 OUTLIER -57.12 176.96 0.21 Allowed Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.543 -0.723 . . . . 0.0 110.417 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.446 ' HD2' ' CB ' ' A' ' 47' ' ' ARG . 41.1 Cg_endo -67.29 -24.41 43.69 Favored 'Trans proline' 0 C--N 1.315 -1.208 0 O-C-N 123.576 1.303 . . . . 0.0 111.116 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.491 HG13 HD13 ' A' ' 63' ' ' LEU . 7.2 mt -109.01 -31.13 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.9 -1.125 . . . . 0.0 109.064 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.471 ' HA ' ' OD2' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -51.5 -25.9 7.38 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.563 -0.711 . . . . 0.0 109.992 179.365 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.586 HG11 ' ND2' ' A' ' 42' ' ' ASN . 10.9 p -97.21 3.34 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.21 -0.931 . . . . 0.0 109.881 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.564 ' CE ' ' HB2' ' A' ' 60' ' ' ALA . 51.6 ttp -56.13 164.54 1.23 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.491 -0.756 . . . . 0.0 110.256 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 3.5 tmm? -75.49 -6.81 52.05 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.252 -0.905 . . . . 0.0 111.0 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.495 ' SD ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 52.55 23.42 2.57 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.181 -0.949 . . . . 0.0 110.192 -179.694 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -122.06 8.45 9.82 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -160.11 106.13 1.56 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.445 -1.033 . . . . 0.0 109.903 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.638 ' HB2' ' HB3' ' A' ' 92' ' ' ASP . . . -63.79 -26.42 68.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.325 -0.86 . . . . 0.0 109.977 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.422 ' HB3' HG11 ' A' ' 25' ' ' VAL . 53.8 mtt180 -50.68 -29.17 10.5 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.348 -0.845 . . . . 0.0 109.858 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.875 ' CG2' HG22 ' A' ' 25' ' ' VAL . 49.0 t -74.75 -56.31 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.564 ' HB2' ' CE ' ' A' ' 52' ' ' MET . . . -54.09 -45.13 71.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.303 -0.873 . . . . 0.0 109.508 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.455 ' O ' HD23 ' A' ' 65' ' ' LEU . 12.4 tt0 -61.96 -35.05 77.31 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.273 -0.892 . . . . 0.0 109.197 179.292 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.682 ' CD1' HD13 ' A' ' 32' ' ' LEU . 1.1 tp -71.86 -48.42 46.03 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.294 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.788 HD21 HD21 ' A' ' 16' ' ' LEU . 1.0 OUTLIER -72.7 -37.8 67.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.55 -0.719 . . . . 0.0 109.998 179.7 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.783 HD21 ' CB ' ' A' ' 100' ' ' ALA . 0.6 OUTLIER -65.26 -63.2 1.16 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.431 -0.793 . . . . 0.0 110.411 -179.853 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.566 ' O ' HD12 ' A' ' 65' ' ' LEU . 0.4 OUTLIER -52.75 -25.31 10.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.877 . . . . 0.0 109.54 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.899 ' CG ' HD22 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -80.54 -52.13 7.96 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.559 -0.713 . . . . 0.0 109.431 179.412 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.444 ' HA3' ' HB2' ' A' ' 38' ' ' PRO . . . 159.57 32.56 0.02 OUTLIER Glycine 0 N--CA 1.481 1.643 0 C-N-CA 119.672 -1.251 . . . . 0.0 111.456 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.526 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -70.39 172.21 8.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.52 -1.576 . . . . 0.0 109.363 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.509 ' HB2' ' CG ' ' A' ' 47' ' ' ARG . 6.5 mm-40 -108.76 78.61 0.94 Allowed Pre-proline 0 C--N 1.301 -1.51 0 O-C-N 121.341 -0.849 . . . . 0.0 109.54 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.494 ' HG3' HD12 ' A' ' 64' ' ' LEU . 43.1 Cg_endo -68.42 -10.75 29.94 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.9 1.474 . . . . 0.0 110.521 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -104.3 -61.21 1.48 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.102 -0.999 . . . . 0.0 110.036 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 3.9 t -46.51 149.59 0.77 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.462 -0.774 . . . . 0.0 111.108 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -140.43 -148.14 0.24 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.503 -0.748 . . . . 0.0 109.79 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.455 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.4 OUTLIER -104.63 140.41 21.05 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.124 -0.985 . . . . 0.0 109.79 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -76.19 -12.64 19.21 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.345 1.182 . . . . 0.0 110.679 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.53 -43.9 25.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.248 -0.907 . . . . 0.0 110.27 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.65 ' C ' ' HB2' ' A' ' 109' ' ' ALA . 0.2 OUTLIER -133.22 9.8 4.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.264 -0.897 . . . . 0.0 110.614 179.793 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.507 ' HA ' HD23 ' A' ' 78' ' ' LEU . 0.8 OUTLIER 46.38 40.51 7.97 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.338 -0.851 . . . . 0.0 111.18 179.708 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.3 m -78.45 100.15 6.73 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.917 . . . . 0.0 110.17 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.747 ' HB2' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -69.4 161.78 71.21 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.361 -0.837 . . . . 0.0 109.393 179.769 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.506 ' HD2' ' CG ' ' A' ' 80' ' ' ARG . 44.0 Cg_endo -70.6 -16.68 34.06 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.451 1.238 . . . . 0.0 109.936 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 74.4 t -59.68 -27.79 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.417 -0.802 . . . . 0.0 109.662 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.512 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 4.8 m80 -75.7 -33.93 60.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.496 -0.753 . . . . 0.0 109.056 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.495 ' HB3' ' SD ' ' A' ' 54' ' ' MET . 3.3 m-20 -57.28 -49.03 77.36 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.806 -0.559 . . . . 0.0 109.852 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.701 ' HB1' HD12 ' A' ' 94' ' ' LEU . . . -58.68 -62.27 1.99 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.331 -0.856 . . . . 0.0 109.179 178.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.785 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -55.62 -49.57 72.47 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.299 -0.876 . . . . 0.0 110.839 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.618 ' HD3' HD12 ' A' ' 117' ' ' LEU . 5.4 tpp85 -40.7 -38.99 0.99 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.38 -0.825 . . . . 0.0 111.401 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.37 -2.62 35.82 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.044 -1.035 . . . . 0.0 111.032 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.45 19.1 59.16 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.553 ' HE2' ' HB2' ' A' ' 57' ' ' ALA . 1.0 OUTLIER -91.08 132.19 36.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.186 -1.185 . . . . 0.0 109.915 179.736 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.666 HD11 ' O ' ' A' ' 125' ' ' ASP . 0.4 OUTLIER -108.76 -43.6 4.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.393 -0.817 . . . . 0.0 110.354 179.859 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.638 ' HB3' ' HB2' ' A' ' 57' ' ' ALA . 34.6 t0 -45.82 -29.25 1.28 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.476 -0.765 . . . . 0.0 110.052 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.437 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 11.8 m -73.4 -43.94 59.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.644 -0.66 . . . . 0.0 109.448 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.719 HD13 HG13 ' A' ' 126' ' ' VAL . 0.8 OUTLIER -56.0 -50.29 71.27 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.259 -0.901 . . . . 0.0 110.023 179.716 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.434 ' O ' ' CB ' ' A' ' 99' ' ' ARG . 43.5 t -53.78 -49.43 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.5 -0.75 . . . . 0.0 109.366 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.742 ' CG1' HD22 ' A' ' 64' ' ' LEU . 70.3 t -52.92 -47.71 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.515 -0.74 . . . . 0.0 109.632 179.049 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.466 ' CD2' ' HB3' ' A' ' 70' ' ' PRO . 96.6 mt -56.66 -72.63 0.07 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.513 -0.742 . . . . 0.0 109.986 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 17.3 t-160 -51.42 -33.35 30.19 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.477 -0.765 . . . . 0.0 110.465 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.434 ' CB ' ' O ' ' A' ' 95' ' ' VAL . 3.5 ttm180 -66.09 -15.49 63.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.41 -0.806 . . . . 0.0 110.517 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.783 ' CB ' HD21 ' A' ' 64' ' ' LEU . . . -142.52 75.5 1.49 Allowed 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.106 -0.996 . . . . 0.0 110.955 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 51.47 97.76 0.01 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -164.33 101.62 0.84 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.358 -1.083 . . . . 0.0 110.08 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 11.1 ttt180 -61.0 120.21 9.8 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.462 -0.774 . . . . 0.0 110.198 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.18 10.06 41.25 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.5 -0.75 . . . . 0.0 110.508 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -124.51 55.55 1.32 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.309 -0.869 . . . . 0.0 110.318 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.747 HG11 ' HB2' ' A' ' 80' ' ' ARG . 2.3 p -106.37 -169.28 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.394 -0.817 . . . . 0.0 109.613 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.648 ' H ' HG22 ' A' ' 106' ' ' VAL . 6.8 mtt180 -140.31 151.64 45.22 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.333 -0.854 . . . . 0.0 110.019 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -77.95 59.96 2.24 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.314 -0.867 . . . . 0.0 109.69 179.662 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.65 ' HB2' ' C ' ' A' ' 77' ' ' THR . . . 61.38 -65.97 0.07 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.742 -0.599 . . . . 0.0 110.672 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.606 ' CZ3' ' CG2' ' A' ' 77' ' ' THR . 5.4 m-90 -66.18 -58.51 5.25 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.2 -0.937 . . . . 0.0 110.321 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 176.0 -24.85 0.06 OUTLIER Glycine 0 N--CA 1.483 1.828 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.13 157.78 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.321 -1.106 . . . . 0.0 111.132 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.477 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER -126.71 169.95 10.88 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.323 -0.861 . . . . 0.0 110.402 -179.655 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.477 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 43.3 Cg_endo -70.33 -45.21 1.35 Allowed 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.633 1.333 . . . . 0.0 109.656 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.458 ' HA ' HD13 ' A' ' 130' ' ' LEU . 10.2 p -62.78 -28.05 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.401 -0.812 . . . . 0.0 109.243 179.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.3 -40.37 81.8 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.434 -0.791 . . . . 0.0 109.976 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.618 HD12 ' HD3' ' A' ' 87' ' ' ARG . 1.0 OUTLIER -68.14 -22.59 64.86 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.397 -0.814 . . . . 0.0 110.128 179.732 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.448 ' HB1' ' HB2' ' A' ' 127' ' ' ALA . . . -80.39 -53.97 6.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.375 -0.828 . . . . 0.0 110.429 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -57.63 -27.53 62.88 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.287 -0.883 . . . . 0.0 110.431 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -72.11 -51.39 21.67 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.399 -0.813 . . . . 0.0 110.219 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.515 ' HB2' ' CD2' ' A' ' 123' ' ' HIS . 37.5 mt -85.41 1.17 49.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.312 -0.868 . . . . 0.0 110.599 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 75.72 40.95 30.2 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.515 ' CD2' ' HB2' ' A' ' 121' ' ' LEU . 25.3 m-70 -89.8 55.43 3.17 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.02 -1.282 . . . . 0.0 109.465 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 28.7 mtt-85 -44.48 -38.19 3.96 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.773 -0.579 . . . . 0.0 110.278 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.666 ' O ' HD11 ' A' ' 91' ' ' LEU . 0.5 OUTLIER -58.4 -48.36 80.9 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.39 -0.819 . . . . 0.0 109.071 178.919 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.785 HG11 ' HA ' ' A' ' 86' ' ' ALA . 3.5 t -81.33 -43.65 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.473 -0.767 . . . . 0.0 110.244 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.448 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . . . -54.71 -49.51 70.57 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.292 -0.88 . . . . 0.0 110.541 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.1 mtp-105 -56.02 -55.13 36.6 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.208 -0.933 . . . . 0.0 110.18 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -65.03 -33.65 76.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.393 -0.817 . . . . 0.0 110.05 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.72 HD11 ' HB2' ' A' ' 86' ' ' ALA . 10.9 mt -66.29 -67.96 0.41 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.345 -0.847 . . . . 0.0 110.468 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -48.18 -24.62 1.2 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.353 -0.842 . . . . 0.0 110.857 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -82.81 -53.8 5.6 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.306 -0.871 . . . . 0.0 110.017 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -87.44 5.98 36.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.399 -0.813 . . . . 0.0 111.034 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 130' ' ' LEU . . . -115.88 51.94 0.92 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.096 -1.003 . . . . 0.0 110.514 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 57.11 -137.79 48.72 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 113.81 13.88 9.89 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 50.7 p 42.76 73.98 0.12 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.572 -0.957 . . . . 0.0 110.957 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.14 101.79 0.44 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.339 -0.85 . . . . 0.0 109.937 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 148.37 -26.5 1.38 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.5 t -156.81 -168.52 2.69 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.316 -1.108 . . . . 0.0 110.016 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -134.35 51.05 2.14 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.261 -0.899 . . . . 0.0 110.206 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 4.4 m80 -135.98 -80.59 0.41 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.308 -0.87 . . . . 0.0 110.352 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -165.79 48.93 0.09 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.244 -0.91 . . . . 0.0 109.944 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.51 173.01 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.389 -0.819 . . . . 0.0 110.413 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.4 tp -52.91 149.18 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.482 -0.761 . . . . 0.0 110.222 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 56.6 104.29 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.336 -0.853 . . . . 0.0 110.196 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -49.37 143.16 6.74 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.393 -0.817 . . . . 0.0 110.652 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.24 157.28 1.43 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.466 -0.771 . . . . 0.0 110.353 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -87.53 136.93 32.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.334 -0.854 . . . . 0.0 110.388 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 165.73 132.98 1.44 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -74.05 108.24 2.61 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.669 1.352 . . . . 0.0 110.347 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' SER . . . . . 0.567 ' O ' HG23 ' A' ' 154' ' ' ILE . 51.5 p -79.86 155.75 27.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.413 -0.804 . . . . 0.0 110.242 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -61.03 127.34 31.08 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.43 -0.794 . . . . 0.0 109.873 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.567 HG23 ' O ' ' A' ' 152' ' ' SER . 1.2 pp -129.34 88.49 50.48 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.256 -0.903 . . . . 0.0 110.606 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.81 95.12 0.8 Allowed 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.613 1.322 . . . . 0.0 110.151 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.268 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.09 0.471 . . . . 0.0 110.228 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.52 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -48.94 -61.29 3.46 Favored Pre-proline 0 N--CA 1.499 2.009 0 O-C-N 121.453 -0.779 . . . . 0.0 110.595 -179.757 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.52 ' CD ' ' CB ' ' A' ' 2' ' ' GLU . 45.5 Cg_endo -72.75 86.51 1.05 Allowed 'Trans proline' 0 C--N 1.316 -1.161 0 O-C-N 123.561 1.295 . . . . 0.0 110.633 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.517 ' HB2' ' O ' ' A' ' 3' ' ' PRO . . . 176.54 -168.87 0.06 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.419 -0.801 . . . . 0.0 109.764 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -141.36 45.01 1.75 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.333 -0.854 . . . . 0.0 110.432 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 116.11 129.32 4.41 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.8 m -53.09 -96.48 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.356 -1.085 . . . . 0.0 110.948 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 m -109.63 -170.59 1.68 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.809 -1.182 . . . . 0.0 110.403 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.0 132.65 50.97 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.498 -0.751 . . . . 0.0 110.326 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.48 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 5.1 mt-10 -69.87 -54.68 9.76 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.359 -0.838 . . . . 0.0 110.373 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 10' ' ' GLU . 48.1 Cg_endo -73.98 69.88 4.58 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 O-C-N 123.547 1.288 . . . . 0.0 110.71 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 31.9 p -159.08 110.66 2.11 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.359 -0.838 . . . . 0.0 110.546 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 49.85 24.41 1.28 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.366 -0.834 . . . . 0.0 110.888 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.13 -44.5 12.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.221 -0.924 . . . . 0.0 109.8 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.533 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 37.0 m0 -69.76 -4.79 21.43 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.583 -0.698 . . . . 0.0 110.348 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.981 HD11 HD21 ' A' ' 63' ' ' LEU . 0.8 OUTLIER -78.0 -55.66 5.11 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.268 -0.895 . . . . 0.0 109.641 179.594 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.412 ' N ' ' HG ' ' A' ' 16' ' ' LEU . . . -73.15 -37.3 66.64 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.261 -0.899 . . . . 0.0 110.752 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.533 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.7 OUTLIER -59.91 -50.67 72.85 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.291 -0.881 . . . . 0.0 110.94 -179.559 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.725 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -61.82 -36.19 80.43 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.276 -0.89 . . . . 0.0 110.526 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.654 ' HA ' HG11 ' A' ' 59' ' ' VAL . . . -60.01 -33.38 71.92 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.339 -0.851 . . . . 0.0 110.008 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.603 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -81.34 -28.55 34.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.442 -0.787 . . . . 0.0 110.441 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.4 ttt180 -92.7 32.62 1.21 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.379 -0.826 . . . . 0.0 110.778 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 47.22 47.74 21.02 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.558 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -117.07 95.56 5.05 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.195 -1.179 . . . . 0.0 110.129 179.857 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.6 HG12 ' HD3' ' A' ' 29' ' ' ARG . 57.3 t -73.13 -57.59 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.567 -0.708 . . . . 0.0 110.019 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -47.63 -51.42 21.43 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.596 -0.69 . . . . 0.0 111.071 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.436 ' HB3' ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -48.58 -53.75 17.15 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.486 -0.759 . . . . 0.0 110.022 179.827 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.92 HG12 HD12 ' A' ' 32' ' ' LEU . 4.8 t -72.98 -50.68 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.365 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.6 ' HD3' HG12 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -45.46 -49.62 13.31 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.317 -0.864 . . . . 0.0 109.898 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.12 -35.88 66.63 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.583 -0.698 . . . . 0.0 109.829 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.499 ' HB2' ' HA ' ' A' ' 28' ' ' VAL . 14.8 mt -64.19 -58.55 6.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.363 -0.836 . . . . 0.0 110.437 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.971 HD22 ' CG ' ' A' ' 66' ' ' HIS . 0.5 OUTLIER -50.05 -37.83 35.18 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.184 -0.948 . . . . 0.0 110.292 -179.568 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -79.33 -16.17 56.75 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.394 -0.816 . . . . 0.0 110.164 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -93.48 -4.98 50.19 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.231 -0.918 . . . . 0.0 111.435 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 134.06 -19.7 4.1 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.434 -1.365 . . . . 0.0 110.937 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.65 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -46.12 121.14 3.1 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.07 -1.253 . . . . 0.0 110.594 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.542 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 0.7 OUTLIER -75.48 128.67 83.69 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.396 -0.815 . . . . 0.0 110.421 -179.434 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.506 ' HB2' ' C ' ' A' ' 67' ' ' GLY . 46.3 Cg_endo -68.97 -37.77 10.61 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 O-C-N 123.493 1.259 . . . . 0.0 111.185 -179.261 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.53 48.95 1.16 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.148 -0.97 . . . . 0.0 110.069 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.542 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -100.87 95.88 5.02 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.189 -0.944 . . . . 0.0 110.192 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.43 128.76 18.84 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.432 1.227 . . . . 0.0 110.245 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -122.18 178.16 5.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.363 -0.836 . . . . 0.0 110.499 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.448 ' O ' ' CB ' ' A' ' 44' ' ' TYR . 1.1 p -60.8 -157.11 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.427 -0.796 . . . . 0.0 110.042 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.448 ' CB ' ' O ' ' A' ' 43' ' ' SER . 3.5 t80 68.17 5.87 4.92 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.423 -0.798 . . . . 0.0 110.644 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 52.04 25.65 17.77 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.471 ' HB3' ' HB ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -116.8 -167.45 1.3 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.317 -1.108 . . . . 0.0 110.87 -179.585 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.579 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -124.3 -161.45 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.805 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -179.884 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.664 ' HB2' HD22 ' A' ' 63' ' ' LEU . 51.2 Cg_endo -78.69 -32.19 2.18 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 O-C-N 122.698 0.841 . . . . 0.0 110.921 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.524 HG13 ' HB1' ' A' ' 68' ' ' ALA . 5.7 mt -109.02 -36.77 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 120.869 -1.145 . . . . 0.0 109.91 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.469 ' OE1' ' HA ' ' A' ' 46' ' ' ARG . 17.0 tt0 -48.62 -26.56 2.31 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.248 -0.908 . . . . 0.0 109.518 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.603 HG22 ' HB2' ' A' ' 21' ' ' ALA . 8.3 p -97.12 21.39 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.491 -0.756 . . . . 0.0 110.382 179.273 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.704 ' CE ' ' HB2' ' A' ' 60' ' ' ALA . 0.4 OUTLIER -77.18 159.1 29.96 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.139 -0.975 . . . . 0.0 109.761 179.579 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 37.6 ttp -70.09 -5.4 26.6 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.261 -0.899 . . . . 0.0 110.165 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.618 ' HE2' ' HB3' ' A' ' 52' ' ' MET . 16.0 mmt 49.68 28.26 2.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.348 -0.845 . . . . 0.0 109.835 -179.151 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.439 ' C ' ' CE2' ' A' ' 90' ' ' PHE . . . -124.33 5.7 8.74 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 178.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -156.1 85.72 1.02 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.654 -0.909 . . . . 0.0 109.221 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.423 ' HB2' ' HB3' ' A' ' 92' ' ' ASP . . . -46.98 -26.94 1.12 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.589 -0.694 . . . . 0.0 110.102 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -46.55 -42.71 16.29 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.662 -0.649 . . . . 0.0 109.798 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.654 HG11 ' HA ' ' A' ' 20' ' ' ALA . 10.9 t -65.74 -60.63 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.63 -0.669 . . . . 0.0 109.282 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.704 ' HB2' ' CE ' ' A' ' 52' ' ' MET . . . -48.43 -47.63 37.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.456 -0.778 . . . . 0.0 109.311 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.482 ' O ' HD23 ' A' ' 65' ' ' LEU . 0.5 OUTLIER -60.19 -40.76 91.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.589 -0.694 . . . . 0.0 109.263 178.685 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.688 HD21 HG12 ' A' ' 28' ' ' VAL . 2.8 tp -66.27 -51.99 51.99 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.461 -0.774 . . . . 0.0 109.474 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.981 HD21 HD11 ' A' ' 16' ' ' LEU . 2.8 mt -67.86 -41.54 82.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.313 -0.867 . . . . 0.0 110.16 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.508 ' CD1' HG12 ' A' ' 96' ' ' VAL . 0.5 OUTLIER -68.78 -57.98 4.84 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.192 -0.943 . . . . 0.0 110.372 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.743 HD12 ' C ' ' A' ' 65' ' ' LEU . 1.3 pp -49.94 -25.63 3.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.118 -0.989 . . . . 0.0 109.096 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.971 ' CG ' HD22 ' A' ' 32' ' ' LEU . 0.5 OUTLIER -82.11 -51.32 8.11 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.789 -0.569 . . . . 0.0 109.481 179.227 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.506 ' C ' ' HB2' ' A' ' 38' ' ' PRO . . . 152.74 38.78 0.03 OUTLIER Glycine 0 N--CA 1.485 1.914 0 C-N-CA 120.03 -1.081 . . . . 0.0 110.794 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.524 ' HB1' HG13 ' A' ' 49' ' ' ILE . . . -69.67 -170.19 0.29 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.867 -1.372 . . . . 0.0 110.06 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -109.17 79.37 1.17 Allowed Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.39 -0.818 . . . . 0.0 109.611 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.448 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 49.5 Cg_endo -70.83 -12.55 31.01 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.8 1.421 . . . . 0.0 110.546 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.527 ' O ' ' NE ' ' A' ' 80' ' ' ARG . 26.3 t-20 -113.43 -58.46 2.15 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.285 -0.884 . . . . 0.0 110.669 -179.266 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.417 ' C ' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -41.1 137.46 1.31 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.26 -0.9 . . . . 0.0 110.918 -179.515 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.459 ' HB2' ' CD ' ' A' ' 80' ' ' ARG . . . -131.43 -155.22 0.68 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.623 -0.673 . . . . 0.0 110.286 -179.172 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -106.15 145.52 31.11 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.197 -0.939 . . . . 0.0 110.487 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -75.57 -25.4 11.04 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.712 1.375 . . . . 0.0 110.048 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.11 -59.32 5.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.314 -0.866 . . . . 0.0 110.175 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.544 ' OG1' ' HB3' ' A' ' 109' ' ' ALA . 2.2 t -137.0 29.31 2.82 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.337 -0.852 . . . . 0.0 110.908 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.459 ' HA ' HD23 ' A' ' 78' ' ' LEU . 20.2 mt 51.53 52.91 13.72 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.203 -0.936 . . . . 0.0 111.372 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 16.7 m -83.41 106.48 15.2 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.032 -1.042 . . . . 0.0 109.736 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.654 ' HB2' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -95.35 170.66 7.5 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.372 -0.83 . . . . 0.0 109.721 179.745 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.553 ' HD2' ' CG ' ' A' ' 80' ' ' ARG . 48.1 Cg_endo -71.74 -0.09 7.83 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.564 1.297 . . . . 0.0 110.425 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.874 HG21 ' HA ' ' A' ' 104' ' ' LEU . 43.3 t -79.87 -45.04 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -0.932 . . . . 0.0 110.279 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.429 ' O ' ' CB ' ' A' ' 87' ' ' ARG . 37.4 m80 -59.01 -37.73 77.58 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.389 -0.819 . . . . 0.0 109.221 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.459 ' CB ' ' HE3' ' A' ' 54' ' ' MET . 62.3 m-20 -54.43 -57.55 10.88 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.714 -0.616 . . . . 0.0 110.566 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.476 ' CB ' HD13 ' A' ' 94' ' ' LEU . . . -51.01 -63.83 1.0 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.102 -0.998 . . . . 0.0 109.884 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.941 ' HB2' HD11 ' A' ' 130' ' ' LEU . . . -56.65 -50.73 71.2 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.337 -0.852 . . . . 0.0 110.687 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.429 ' CB ' ' O ' ' A' ' 83' ' ' HIS . 11.0 tpp85 -43.44 -28.82 0.39 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.294 -0.879 . . . . 0.0 110.852 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -103.59 -11.12 17.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.397 -0.814 . . . . 0.0 110.459 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.598 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 86.35 34.55 12.0 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.439 ' CE2' ' C ' ' A' ' 55' ' ' GLY . 0.4 OUTLIER -108.28 121.15 44.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.112 -1.228 . . . . 0.0 110.732 -179.818 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.565 HD11 ' O ' ' A' ' 125' ' ' ASP . 0.4 OUTLIER -94.75 -41.65 9.14 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.497 -0.752 . . . . 0.0 110.222 179.737 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.878 ' O ' HG23 ' A' ' 96' ' ' VAL . 0.4 OUTLIER -52.05 -30.15 24.46 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.348 -0.845 . . . . 0.0 109.088 179.53 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.521 ' O ' HD12 ' A' ' 97' ' ' LEU . 72.4 m -72.85 -38.57 67.03 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.912 HD21 ' CD2' ' A' ' 130' ' ' LEU . 1.6 tp -64.42 -47.72 78.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.571 -0.705 . . . . 0.0 109.416 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.45 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 41.4 t -57.2 -48.31 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.47 -0.769 . . . . 0.0 108.951 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.878 HG23 ' O ' ' A' ' 92' ' ' ASP . 98.7 t -52.56 -53.78 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.781 -0.574 . . . . 0.0 110.072 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.521 HD12 ' O ' ' A' ' 93' ' ' THR . 0.3 OUTLIER -52.56 -65.29 0.58 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.391 -0.818 . . . . 0.0 109.965 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -58.48 -28.47 65.38 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.272 -0.893 . . . . 0.0 110.339 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.45 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 17.7 ttp180 -67.16 -15.83 63.94 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.256 -0.903 . . . . 0.0 110.424 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.95 72.35 1.33 Allowed 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.347 -0.845 . . . . 0.0 110.863 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 54.64 102.79 0.01 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.419 ' CB ' ' C ' ' A' ' 97' ' ' LEU . . . -163.57 102.47 0.93 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.333 -1.098 . . . . 0.0 110.167 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -71.63 98.26 1.87 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.428 -0.795 . . . . 0.0 110.015 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.874 ' HA ' HG21 ' A' ' 82' ' ' VAL . 1.1 mp -89.9 10.53 23.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.451 -0.78 . . . . 0.0 109.706 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -103.13 36.88 2.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.311 -0.868 . . . . 0.0 110.719 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.654 HG11 ' HB2' ' A' ' 80' ' ' ARG . 0.7 OUTLIER -98.25 -171.82 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.024 -1.047 . . . . 0.0 109.77 179.555 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.567 ' H ' HG22 ' A' ' 106' ' ' VAL . 4.4 ptt-85 -140.44 135.48 32.05 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.625 -0.672 . . . . 0.0 109.666 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.509 ' O ' ' N ' ' A' ' 110' ' ' TRP . 41.9 p-10 -79.47 44.04 0.59 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.125 -0.984 . . . . 0.0 110.615 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.544 ' HB3' ' OG1' ' A' ' 77' ' ' THR . . . 38.71 -86.52 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.135 0 CA-C-O 121.006 0.431 . . . . 0.0 112.122 178.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.509 ' N ' ' O ' ' A' ' 108' ' ' ASP . 7.7 m0 -76.75 51.08 0.74 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.257 -0.902 . . . . 0.0 110.856 -179.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.492 ' O ' ' CG ' ' A' ' 112' ' ' ARG . . . -155.31 -89.34 0.07 OUTLIER Glycine 0 N--CA 1.479 1.521 0 N-CA-C 108.338 -1.905 . . . . 0.0 108.338 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.616 ' O ' HD12 ' A' ' 113' ' ' LEU . 0.0 OUTLIER 164.85 -57.48 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 O-C-N 122.084 -0.656 . . . . 0.0 109.773 179.079 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.616 HD12 ' O ' ' A' ' 112' ' ' ARG . 0.0 OUTLIER -173.43 159.62 3.27 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.237 -0.914 . . . . 0.0 110.666 -179.603 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.462 ' HD2' HD23 ' A' ' 113' ' ' LEU . 42.1 Cg_endo -68.27 -29.26 32.56 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.674 1.355 . . . . 0.0 110.743 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.8 p -78.71 -32.69 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.999 -1.063 . . . . 0.0 109.834 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -64.39 -26.89 68.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.345 -0.847 . . . . 0.0 109.367 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.498 HD23 ' CD1' ' A' ' 121' ' ' LEU . 0.2 OUTLIER -70.47 -37.03 74.22 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.506 -0.746 . . . . 0.0 109.636 179.258 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.5 ' CB ' ' HB2' ' A' ' 123' ' ' HIS . . . -70.18 -35.89 74.28 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.447 -0.783 . . . . 0.0 109.915 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -63.33 -39.1 93.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.42 -0.8 . . . . 0.0 110.307 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.05 -69.62 0.51 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.371 -0.831 . . . . 0.0 110.396 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.498 ' CD1' HD23 ' A' ' 117' ' ' LEU . 0.2 OUTLIER -47.3 -89.14 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.499 -0.751 . . . . 0.0 111.142 -179.54 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 173.53 36.56 0.04 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.584 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 51.6 m-70 -101.19 43.99 1.03 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.364 -1.08 . . . . 0.0 109.11 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.77 -53.87 4.37 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-O 121.211 0.529 . . . . 0.0 110.698 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.565 ' O ' HD11 ' A' ' 91' ' ' LEU . 0.5 OUTLIER -51.45 -40.29 59.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.422 -0.799 . . . . 0.0 109.426 179.292 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.803 HG11 ' HA ' ' A' ' 86' ' ' ALA . 2.0 t -78.73 -35.5 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.383 -0.823 . . . . 0.0 109.611 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.473 ' HB2' ' CB ' ' A' ' 118' ' ' ALA . . . -59.06 -48.05 83.0 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.215 -0.928 . . . . 0.0 109.805 179.276 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.5 ttm180 -50.0 -63.94 0.96 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.486 -0.759 . . . . 0.0 109.854 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.427 ' CD2' HD21 ' A' ' 91' ' ' LEU . 3.5 t80 -52.93 -55.21 25.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.556 -0.715 . . . . 0.0 110.393 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.941 HD11 ' HB2' ' A' ' 86' ' ' ALA . 25.2 mt -48.07 -48.78 33.16 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.558 -0.713 . . . . 0.0 109.945 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.81 -28.95 17.24 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.367 -0.833 . . . . 0.0 109.929 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -89.0 -54.02 4.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.485 -0.759 . . . . 0.0 110.361 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.725 ' HB1' HD13 ' A' ' 104' ' ' LEU . . . -75.71 -7.49 54.49 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.32 -0.862 . . . . 0.0 110.902 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.638 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . -112.73 -60.31 1.89 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.094 -1.003 . . . . 0.0 110.067 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 114.35 91.32 1.83 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -90.91 129.89 10.01 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 37.6 p -68.36 134.02 49.62 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.425 -1.044 . . . . 0.0 110.253 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.6 155.46 44.97 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.338 -0.851 . . . . 0.0 110.488 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -79.78 -5.63 89.36 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.07 -88.49 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.311 -1.111 . . . . 0.0 110.293 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -107.85 78.48 1.19 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.057 -1.027 . . . . 0.0 110.022 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -78.32 78.92 4.78 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.221 -0.924 . . . . 0.0 109.95 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -98.31 8.2 45.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.311 -0.868 . . . . 0.0 110.34 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 10.0 ttt180 -83.33 126.72 32.99 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.216 -0.928 . . . . 0.0 109.957 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -85.87 155.34 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.302 -0.874 . . . . 0.0 109.536 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -51.48 172.82 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.179 -0.951 . . . . 0.0 110.268 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.92 132.94 49.83 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.145 -0.972 . . . . 0.0 110.147 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.33 145.41 38.1 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.239 -0.913 . . . . 0.0 109.755 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -45.39 111.8 0.38 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.31 -0.869 . . . . 0.0 110.101 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -160.83 118.92 0.85 Allowed Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.516 -1.326 . . . . 0.0 110.47 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -74.3 -165.72 0.28 Allowed 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.76 1.4 . . . . 0.0 110.826 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.93 112.91 0.86 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.402 -0.811 . . . . 0.0 110.661 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -69.67 155.75 40.03 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.409 -0.807 . . . . 0.0 110.21 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 11.6 pt -103.0 161.98 21.49 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.248 -0.908 . . . . 0.0 110.418 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.5 127.6 11.93 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.856 1.451 . . . . 0.0 110.139 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.1 t70 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 118.083 -0.961 . . . . 0.0 109.998 -179.749 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.138 0.494 . . . . 0.0 110.279 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.97 128.34 5.58 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.221 -0.924 . . . . 0.0 110.575 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -76.03 59.38 5.85 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.575 1.303 . . . . 0.0 110.561 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.479 ' O ' ' HB3' ' A' ' 5' ' ' ALA . . . 48.59 82.12 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.414 -0.804 . . . . 0.0 110.701 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 4' ' ' ALA . . . 59.68 87.96 0.08 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.52 -0.738 . . . . 0.0 110.275 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -121.37 20.8 8.3 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.7 p -89.58 28.86 1.22 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.297 -1.12 . . . . 0.0 110.383 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.3 t -102.1 108.22 19.56 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.374 -0.829 . . . . 0.0 110.055 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 16.4 mtp -88.9 -60.06 2.06 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.265 -0.897 . . . . 0.0 110.468 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -116.08 77.31 6.96 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.345 -0.847 . . . . 0.0 110.279 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -70.89 109.74 2.61 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 O-C-N 123.568 1.299 . . . . 0.0 109.78 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -47.41 161.13 0.09 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.484 -0.76 . . . . 0.0 110.986 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -173.53 -39.83 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.568 -0.708 . . . . 0.0 110.006 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -92.73 -16.64 25.21 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.376 -0.827 . . . . 0.0 111.03 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.592 ' CE3' HD21 ' A' ' 31' ' ' LEU . 3.2 t90 -72.49 -2.4 19.5 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.089 -1.007 . . . . 0.0 110.932 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.602 HD11 ' HB1' ' A' ' 36' ' ' ALA . 31.7 mt -81.58 -53.86 5.9 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.072 -1.017 . . . . 0.0 109.545 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.45 -38.33 87.13 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.605 -0.685 . . . . 0.0 110.245 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.503 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.1 OUTLIER -60.66 -48.58 81.16 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.321 -0.862 . . . . 0.0 109.838 179.572 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.654 ' HB1' ' HB3' ' A' ' 24' ' ' ARG . . . -67.96 -49.2 63.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.386 -0.821 . . . . 0.0 109.651 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.542 ' HB1' ' CB ' ' A' ' 52' ' ' MET . . . -54.09 -45.42 71.78 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.38 -0.825 . . . . 0.0 109.681 179.48 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.34 -26.71 65.74 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.474 -0.766 . . . . 0.0 109.986 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.5 mtp85 -95.91 27.42 3.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.428 -0.795 . . . . 0.0 110.148 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.09 42.89 40.68 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.654 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -113.24 69.29 0.69 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.401 -1.058 . . . . 0.0 110.667 -179.576 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 1.03 HG22 HG22 ' A' ' 59' ' ' VAL . 85.9 t -58.71 -54.32 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.255 -0.903 . . . . 0.0 110.288 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -54.18 -41.58 68.7 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.428 -0.795 . . . . 0.0 110.854 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.407 ' OE1' ' HG2' ' A' ' 24' ' ' ARG . 1.6 tp10 -56.73 -45.23 82.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.192 -0.943 . . . . 0.0 110.035 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.959 HG12 HD12 ' A' ' 32' ' ' LEU . 20.1 t -68.72 -36.68 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.248 -0.907 . . . . 0.0 110.176 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.949 ' HA ' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -49.98 -41.86 47.76 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.422 -0.799 . . . . 0.0 109.927 -179.665 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.587 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -75.71 -31.32 59.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.443 -0.786 . . . . 0.0 110.239 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.818 HD12 ' HA ' ' A' ' 28' ' ' VAL . 21.8 mt -74.23 -67.51 0.61 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.452 -0.78 . . . . 0.0 110.52 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.959 HD12 HG12 ' A' ' 28' ' ' VAL . 6.4 mt -45.58 -45.27 13.53 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.625 -0.672 . . . . 0.0 110.282 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -71.98 -23.88 61.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.527 -0.733 . . . . 0.0 110.405 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 30' ' ' ALA . . . -79.76 -4.66 52.93 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.139 -0.976 . . . . 0.0 110.509 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.23 26.89 4.42 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.776 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -71.41 165.28 24.11 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.432 -1.04 . . . . 0.0 110.414 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.501 ' O ' HD12 ' A' ' 16' ' ' LEU . 1.7 tp -98.02 110.7 56.93 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.555 -0.715 . . . . 0.0 110.074 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.496 ' O ' ' HG3' ' A' ' 48' ' ' PRO . 44.3 Cg_endo -70.37 -11.97 30.95 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.445 1.234 . . . . 0.0 110.844 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.436 ' O ' ' HD3' ' A' ' 41' ' ' PRO . 4.3 m-20 -103.01 16.05 27.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -0.928 . . . . 0.0 110.029 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.406 ' N ' HD23 ' A' ' 37' ' ' LEU . . . -76.67 111.29 15.07 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.418 -0.801 . . . . 0.0 110.118 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 39' ' ' ASN . 48.1 Cg_endo -72.8 146.61 42.98 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 123.603 1.318 . . . . 0.0 110.358 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -75.64 -156.94 0.06 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.418 -0.801 . . . . 0.0 109.864 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.15 2.14 24.63 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.335 -0.853 . . . . 0.0 110.035 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -102.0 20.49 16.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.269 -0.894 . . . . 0.0 109.907 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.85 40.24 98.57 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.68 -163.18 1.24 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.671 -0.899 . . . . 0.0 110.517 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.483 ' O ' HG12 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -114.32 176.24 1.57 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.482 -0.761 . . . . 0.0 110.591 -179.243 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.496 ' HG3' ' O ' ' A' ' 38' ' ' PRO . 43.1 Cg_endo -70.97 -20.3 29.3 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.825 1.434 . . . . 0.0 110.791 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.487 ' O ' ' CG ' ' A' ' 52' ' ' MET . 6.3 mt -107.09 -40.28 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.284 -0.885 . . . . 0.0 109.39 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.47 ' HB2' ' HB2' ' A' ' 47' ' ' ARG . 1.1 tt0 -48.46 -28.73 3.49 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.282 -0.886 . . . . 0.0 110.477 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 47' ' ' ARG . 9.1 p -109.88 16.94 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.513 -0.742 . . . . 0.0 110.554 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.556 ' CE ' ' HB2' ' A' ' 60' ' ' ALA . 0.5 OUTLIER -84.58 166.72 16.93 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.09 -1.006 . . . . 0.0 110.261 179.533 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -62.26 91.41 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.334 -0.854 . . . . 0.0 109.092 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.591 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -56.07 -14.28 2.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.21 -0.931 . . . . 0.0 110.31 -179.429 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.401 ' C ' ' CE2' ' A' ' 90' ' ' PHE . . . -84.11 15.37 39.11 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 178.412 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.624 ' O ' HG23 ' A' ' 59' ' ' VAL . 0.4 OUTLIER -151.06 92.83 1.85 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.208 -1.172 . . . . 0.0 109.987 179.703 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.643 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . . . -58.49 -21.06 50.55 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.254 -0.903 . . . . 0.0 109.509 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.84 -28.74 66.35 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.553 -0.717 . . . . 0.0 110.083 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 1.03 HG22 HG22 ' A' ' 25' ' ' VAL . 2.1 t -70.89 -55.21 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.268 -0.895 . . . . 0.0 109.231 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.556 ' HB2' ' CE ' ' A' ' 52' ' ' MET . . . -51.42 -38.12 51.97 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.382 -0.824 . . . . 0.0 109.585 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.493 ' O ' ' HB3' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -53.35 -61.1 2.52 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.626 -0.671 . . . . 0.0 110.35 179.818 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.949 HD11 ' HA ' ' A' ' 29' ' ' ARG . 0.1 OUTLIER -45.81 -63.62 0.93 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.324 -0.86 . . . . 0.0 110.345 179.74 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.839 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 7.0 mt -57.9 -57.19 13.88 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.456 -0.778 . . . . 0.0 110.118 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.815 HD22 ' CG1' ' A' ' 96' ' ' VAL . 0.6 OUTLIER -53.21 -54.02 42.22 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.266 -0.896 . . . . 0.0 110.109 179.878 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.493 ' HB3' ' O ' ' A' ' 61' ' ' GLU . 13.2 tp -50.27 -36.76 32.74 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.87 ' CG ' HD22 ' A' ' 32' ' ' LEU . 2.1 m80 -79.55 -28.24 41.24 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.504 0.669 . . . . 0.0 109.64 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 117.75 50.86 0.35 Allowed Glycine 0 N--CA 1.476 1.344 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.839 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -60.6 -159.94 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.21 -1.17 . . . . 0.0 109.477 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.45 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 0.6 OUTLIER -120.61 59.67 7.41 Favored Pre-proline 0 C--N 1.299 -1.616 0 O-C-N 121.231 -0.918 . . . . 0.0 109.465 178.941 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.431 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 47.7 Cg_endo -70.29 57.51 1.72 Allowed 'Trans proline' 0 C--N 1.313 -1.293 0 O-C-N 123.7 1.369 . . . . 0.0 110.415 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -167.3 -62.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.46 -0.775 . . . . 0.0 109.942 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 22.3 m -50.03 138.79 15.06 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.4 -0.812 . . . . 0.0 110.624 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.425 ' HB2' ' HA ' ' A' ' 80' ' ' ARG . . . -136.94 -144.07 0.19 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.397 -0.814 . . . . 0.0 110.109 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.3 144.04 28.38 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.006 -1.059 . . . . 0.0 109.906 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -72.59 -53.73 0.14 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.549 1.289 . . . . 0.0 110.55 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.86 -9.14 49.79 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.241 -0.912 . . . . 0.0 109.714 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.465 ' CG2' ' CH2' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -153.48 105.03 2.8 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.642 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.608 HD22 ' NH1' ' A' ' 80' ' ' ARG . 27.8 mt -67.77 53.29 0.06 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.507 -0.746 . . . . 0.0 111.08 -178.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.514 ' HA ' ' OD1' ' A' ' 108' ' ' ASP . 3.6 m -79.8 85.02 5.51 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.104 -0.997 . . . . 0.0 109.528 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.78 ' CD ' HG11 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -71.96 169.95 14.3 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.488 -0.757 . . . . 0.0 109.568 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.486 ' HD2' ' CG ' ' A' ' 80' ' ' ARG . 46.9 Cg_endo -74.42 -2.32 12.23 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.578 1.304 . . . . 0.0 110.391 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.902 HG13 HD23 ' A' ' 104' ' ' LEU . 10.5 t -77.7 -31.32 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.465 -0.772 . . . . 0.0 109.766 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.411 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 27.2 m80 -69.78 -27.26 64.76 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.43 -0.794 . . . . 0.0 109.915 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.591 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 1.1 m-20 -67.64 -53.88 24.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.863 -0.523 . . . . 0.0 110.263 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.51 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -50.02 -58.05 6.29 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.538 -0.727 . . . . 0.0 109.581 179.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.809 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -63.41 -38.06 89.67 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.47 -0.769 . . . . 0.0 110.52 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 1.5 mmm-85 -40.7 -59.87 1.28 Allowed 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.116 -0.99 . . . . 0.0 111.125 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -85.18 3.73 37.82 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.232 -0.917 . . . . 0.0 110.156 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.645 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 74.75 48.22 12.99 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.643 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.3 OUTLIER -111.56 97.49 6.77 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.398 -1.06 . . . . 0.0 111.049 -179.536 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.49 HD12 ' HB3' ' A' ' 125' ' ' ASP . 0.3 OUTLIER -67.06 -42.48 84.69 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.592 -0.692 . . . . 0.0 110.498 179.603 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.431 ' O ' HG23 ' A' ' 96' ' ' VAL . 50.0 m-20 -45.65 -63.61 0.92 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.464 -0.772 . . . . 0.0 110.37 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.472 ' O ' HD12 ' A' ' 97' ' ' LEU . 70.9 m -47.39 -38.49 13.35 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.702 -0.624 . . . . 0.0 109.549 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.718 HD21 ' HG ' ' A' ' 130' ' ' LEU . 4.1 tp -61.84 -48.85 78.71 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.405 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.426 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 98.2 t -60.96 -50.87 78.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.815 ' CG1' HD22 ' A' ' 64' ' ' LEU . 95.0 t -48.85 -57.31 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.727 -0.608 . . . . 0.0 110.209 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.632 HD23 ' HB1' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -43.07 -66.26 0.39 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.782 -0.574 . . . . 0.0 110.218 179.885 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -55.37 -32.6 62.72 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.261 -0.899 . . . . 0.0 109.816 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 0.1 OUTLIER -61.71 -13.87 26.79 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.412 -0.805 . . . . 0.0 110.274 179.439 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.674 ' HB3' HD11 ' A' ' 64' ' ' LEU . . . -140.71 56.68 1.58 Allowed 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.374 -0.829 . . . . 0.0 110.575 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 57.7 98.17 0.01 OUTLIER Glycine 0 N--CA 1.489 2.185 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.632 ' HB1' HD23 ' A' ' 97' ' ' LEU . . . -157.84 95.89 1.44 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.333 -1.098 . . . . 0.0 110.018 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -62.15 106.97 0.8 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.293 -0.88 . . . . 0.0 110.028 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.902 HD23 HG13 ' A' ' 82' ' ' VAL . 1.8 mp -96.62 26.75 4.26 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.321 -0.862 . . . . 0.0 109.898 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -123.36 47.52 1.99 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.346 -0.846 . . . . 0.0 110.792 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.78 HG11 ' CD ' ' A' ' 80' ' ' ARG . 5.1 p -105.18 -175.33 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.189 -0.944 . . . . 0.0 109.454 179.172 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.694 ' H ' HG22 ' A' ' 106' ' ' VAL . 1.0 OUTLIER -142.56 122.02 13.21 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.187 -0.946 . . . . 0.0 110.83 -179.589 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.514 ' OD1' ' HA ' ' A' ' 79' ' ' THR . 1.6 m-20 -52.2 165.87 0.2 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.558 -0.714 . . . . 0.0 109.715 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.426 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . -70.97 -15.55 62.59 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 109.772 179.398 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.465 ' CH2' ' CG2' ' A' ' 77' ' ' THR . 6.8 m-90 -86.92 15.61 5.74 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.252 -0.905 . . . . 0.0 109.877 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.59 12.32 55.98 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.471 ' O ' ' HB2' ' A' ' 108' ' ' ASP . 2.6 ttm180 -94.52 129.0 41.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.417 -1.049 . . . . 0.0 109.73 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.425 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.0 OUTLIER -91.62 163.5 27.94 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.135 -0.978 . . . . 0.0 109.725 179.843 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.425 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 43.5 Cg_endo -70.37 -31.13 18.33 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.703 1.37 . . . . 0.0 110.768 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.447 HG13 ' N ' ' A' ' 116' ' ' ASP . 9.6 p -80.09 -38.93 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.16 -0.963 . . . . 0.0 110.489 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.447 ' N ' HG13 ' A' ' 115' ' ' VAL . 81.7 m-20 -65.86 -34.39 78.02 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.266 -0.897 . . . . 0.0 110.023 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.01 -34.49 78.12 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.261 -0.9 . . . . 0.0 109.925 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.869 ' HB1' ' HB2' ' A' ' 123' ' ' HIS . . . -70.96 -55.23 8.79 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.314 -0.866 . . . . 0.0 110.7 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.51 ' HG3' ' HB1' ' A' ' 127' ' ' ALA . 12.8 mt-10 -46.84 -39.51 12.11 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.403 -0.811 . . . . 0.0 110.622 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -67.51 -51.34 52.23 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.482 -0.761 . . . . 0.0 109.904 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.436 ' HB3' ' NE2' ' A' ' 123' ' ' HIS . 0.2 OUTLIER -67.19 -87.39 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.354 -0.841 . . . . 0.0 110.225 179.807 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 179.36 32.29 0.06 OUTLIER Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.752 -1.213 . . . . 0.0 110.07 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.869 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . 0.9 OUTLIER -98.29 45.96 1.01 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.171 -1.193 . . . . 0.0 108.882 179.415 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -44.58 -37.17 3.41 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.502 0.668 . . . . 0.0 109.836 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.49 ' HB3' HD12 ' A' ' 91' ' ' LEU . 0.4 OUTLIER -66.58 -44.66 81.63 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.67 -0.644 . . . . 0.0 109.556 179.058 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.809 HG11 ' HA ' ' A' ' 86' ' ' ALA . 2.4 t -75.52 -44.36 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.229 -0.919 . . . . 0.0 110.031 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.51 ' HB1' ' HG3' ' A' ' 119' ' ' GLU . . . -57.27 -24.18 53.19 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.191 -0.943 . . . . 0.0 109.965 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.74 -63.0 1.18 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.297 -0.877 . . . . 0.0 109.818 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -59.05 -41.26 87.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.483 -0.761 . . . . 0.0 109.36 179.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.718 ' HG ' HD21 ' A' ' 94' ' ' LEU . 13.2 mt -51.3 -64.24 0.87 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.495 -0.753 . . . . 0.0 109.539 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.7 ttt-85 -51.6 -21.69 2.76 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.298 -0.876 . . . . 0.0 110.317 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -88.51 -51.69 5.57 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.383 -0.823 . . . . 0.0 110.515 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -86.78 -16.46 36.22 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.247 -0.908 . . . . 0.0 111.206 -179.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . -84.88 49.71 1.78 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.034 -1.041 . . . . 0.0 110.33 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 79.35 137.1 1.4 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -160.06 45.16 0.42 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 10.9 t -63.83 153.43 36.7 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.316 -1.108 . . . . 0.0 110.514 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.5 tpt85 -98.9 108.8 21.57 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.349 -0.844 . . . . 0.0 109.972 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -176.4 111.32 0.34 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.9 t 59.27 163.62 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.297 -1.119 . . . . 0.0 110.07 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -73.47 -51.41 17.26 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.196 -0.94 . . . . 0.0 109.856 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 -148.4 78.01 1.41 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.467 -0.771 . . . . 0.0 109.652 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -154.38 -53.18 0.1 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.301 -0.874 . . . . 0.0 110.224 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.07 114.75 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.5 -0.75 . . . . 0.0 110.527 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.428 ' O ' ' N ' ' A' ' 147' ' ' ALA . 10.5 mt -69.03 132.82 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.32 -0.862 . . . . 0.0 109.524 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -55.3 90.45 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.281 -0.887 . . . . 0.0 110.173 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 145' ' ' ILE . . . -60.86 159.4 11.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.24 -0.912 . . . . 0.0 110.43 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -47.98 146.98 2.25 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.646 -0.659 . . . . 0.0 110.537 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -174.45 -50.0 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.185 -0.947 . . . . 0.0 110.236 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -73.3 168.87 53.59 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.42 119.74 6.58 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 O-C-N 123.95 1.5 . . . . 0.0 110.401 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.8 14.8 14.37 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.251 -0.906 . . . . 0.0 110.645 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.58 134.05 56.66 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.139 -0.975 . . . . 0.0 110.01 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.438 HG22 ' O ' ' A' ' 154' ' ' ILE . 5.1 mt -115.11 81.97 8.39 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.327 -0.858 . . . . 0.0 110.071 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -75.52 160.46 38.43 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 123.816 1.43 . . . . 0.0 110.369 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.725 0 CA-C-O 118.073 -0.965 . . . . 0.0 110.27 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 ptt? . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 121.163 0.506 . . . . 0.0 110.419 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -151.84 71.77 8.0 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.4 -0.813 . . . . 0.0 110.19 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.496 ' O ' ' N ' ' A' ' 5' ' ' ALA . 47.3 Cg_endo -73.69 161.42 41.94 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 123.605 1.318 . . . . 0.0 110.006 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.97 78.19 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.411 -0.806 . . . . 0.0 110.144 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.496 ' N ' ' O ' ' A' ' 3' ' ' PRO . . . -128.36 87.8 2.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.599 -0.688 . . . . 0.0 110.309 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 96.16 -178.99 34.86 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 71.4 m -129.43 140.03 51.45 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.298 -1.119 . . . . 0.0 110.675 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.6 m -120.53 19.04 12.03 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.502 -0.749 . . . . 0.0 110.202 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 3.7 tpp -73.29 -38.16 65.98 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.26 -0.9 . . . . 0.0 109.791 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -179.52 95.32 0.2 Allowed Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.364 -0.835 . . . . 0.0 109.743 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.32 99.98 1.26 Allowed 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.834 1.439 . . . . 0.0 110.901 -179.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 86.0 p -140.86 -64.16 0.46 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.575 -0.703 . . . . 0.0 109.429 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 45.29 25.0 0.17 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.587 -0.696 . . . . 0.0 110.723 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -108.55 11.19 26.91 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.392 -0.817 . . . . 0.0 110.411 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.45 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 16.0 m0 -75.4 -20.22 59.06 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.148 -0.97 . . . . 0.0 109.981 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.719 HD13 HD11 ' A' ' 63' ' ' LEU . 1.2 pp -67.86 -35.22 78.16 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.396 -0.815 . . . . 0.0 110.043 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.14 -42.11 24.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.39 -0.819 . . . . 0.0 110.394 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.45 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.0 OUTLIER -59.85 -58.4 8.74 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.363 -0.836 . . . . 0.0 110.51 -179.655 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.19 -45.38 65.14 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.165 -0.959 . . . . 0.0 109.784 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.553 ' HB1' ' CB ' ' A' ' 52' ' ' MET . . . -50.83 -53.79 29.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.604 -0.685 . . . . 0.0 110.037 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.799 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -56.01 -31.8 63.41 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.164 -0.96 . . . . 0.0 110.078 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.58 21.8 5.99 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.38 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 49.43 76.02 0.18 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -140.76 63.84 1.45 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.57 -0.959 . . . . 0.0 109.405 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.501 ' CG1' ' NE ' ' A' ' 29' ' ' ARG . 13.6 t -49.21 -51.44 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.493 -0.755 . . . . 0.0 110.101 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.69 -51.14 52.37 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.74 -0.6 . . . . 0.0 110.669 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.506 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 5.4 tt0 -56.09 -44.96 79.52 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.329 -0.857 . . . . 0.0 109.874 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.81 HG12 ' CD1' ' A' ' 62' ' ' LEU . 38.4 t -71.28 -47.06 62.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.472 -0.767 . . . . 0.0 109.796 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.511 ' HA ' ' CD1' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -39.17 -52.68 1.91 Allowed 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.55 -0.719 . . . . 0.0 110.285 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.9 -49.53 14.02 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.679 -0.638 . . . . 0.0 110.733 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 27' ' ' GLU . 41.2 mt -44.73 -66.76 0.35 Allowed 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.32 -0.863 . . . . 0.0 110.635 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.98 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 0.6 OUTLIER -50.2 -53.93 24.49 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.46 -0.775 . . . . 0.0 110.296 179.681 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 29' ' ' ARG . 0.5 OUTLIER -63.84 -6.86 6.52 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.442 -0.786 . . . . 0.0 110.962 179.325 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -100.81 -13.43 18.41 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.853 -1.154 . . . . 0.0 111.56 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 146.38 -10.62 1.52 Allowed Glycine 0 N--CA 1.49 2.27 0 C-N-CA 119.323 -1.418 . . . . 0.0 110.45 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.98 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -56.18 140.56 43.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.929 -1.336 . . . . 0.0 109.87 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.951 ' HB2' ' HB2' ' A' ' 40' ' ' ALA . 18.3 mt -79.21 143.07 59.95 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.382 -0.824 . . . . 0.0 110.213 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.491 ' HB3' ' HB3' ' A' ' 66' ' ' HIS . 43.5 Cg_endo -72.54 -37.35 4.22 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.358 1.188 . . . . 0.0 110.125 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -100.59 5.64 43.99 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.403 -0.811 . . . . 0.0 110.534 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.951 ' HB2' ' HB2' ' A' ' 37' ' ' LEU . . . -39.75 101.36 0.23 Allowed Pre-proline 0 N--CA 1.501 2.098 0 O-C-N 121.471 -0.768 . . . . 0.0 111.358 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 40' ' ' ALA . 54.1 Cg_endo -72.58 159.26 49.29 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.828 1.436 . . . . 0.0 109.651 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.51 ' N ' ' OD1' ' A' ' 42' ' ' ASN . 10.8 p-10 -131.5 170.87 14.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.473 -0.767 . . . . 0.0 109.913 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.5 m -87.13 12.37 11.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.387 -0.821 . . . . 0.0 110.434 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.465 ' HB3' ' ND2' ' A' ' 42' ' ' ASN . 4.2 t80 -93.16 19.77 7.64 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.241 -0.912 . . . . 0.0 109.644 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 48.38 23.2 2.89 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 -179.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -138.57 106.17 5.59 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.63 -0.924 . . . . 0.0 110.845 -179.242 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.532 ' CB ' ' HD2' ' A' ' 48' ' ' PRO . 1.1 mpt_? -54.86 -175.39 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.55 -0.719 . . . . 0.0 109.619 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.532 ' HD2' ' CB ' ' A' ' 47' ' ' ARG . 43.0 Cg_endo -69.09 170.55 15.53 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.145 1.076 . . . . 0.0 109.732 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.531 ' O ' ' CG ' ' A' ' 52' ' ' MET . 3.2 mt 63.27 -58.78 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.794 -0.566 . . . . 0.0 110.578 -179.09 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.488 ' N ' ' O ' ' A' ' 48' ' ' PRO . 0.4 OUTLIER -48.68 -25.57 1.85 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.569 -1.332 . . . . 0.0 109.797 179.342 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.799 HG22 ' HB2' ' A' ' 21' ' ' ALA . 12.0 p -110.39 18.6 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 121.606 -0.684 . . . . 0.0 109.378 178.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.553 ' CB ' ' HB1' ' A' ' 20' ' ' ALA . 0.5 OUTLIER -92.72 167.67 11.73 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.242 -0.911 . . . . 0.0 110.057 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 5.5 ttp -69.26 107.52 3.29 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.159 -1.016 . . . . 0.0 109.32 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.527 ' HE2' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -66.41 -3.91 7.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.087 -1.008 . . . . 0.0 109.861 179.501 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -89.97 16.91 55.85 Favored Glycine 0 N--CA 1.484 1.889 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 178.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.93 117.29 2.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -1.177 . . . . 0.0 109.704 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.513 ' HB2' ' HE2' ' A' ' 90' ' ' PHE . . . -79.52 -27.06 41.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.308 -0.87 . . . . 0.0 110.368 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.51 ' O ' ' NH1' ' A' ' 29' ' ' ARG . 5.8 mmt180 -48.84 -38.25 21.77 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.181 -0.95 . . . . 0.0 110.267 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.438 HG22 ' CG2' ' A' ' 25' ' ' VAL . 24.3 t -62.64 -63.56 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 120.987 -1.071 . . . . 0.0 109.116 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.528 ' HB2' ' CE ' ' A' ' 52' ' ' MET . . . -52.13 -29.87 23.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.46 -0.775 . . . . 0.0 109.375 178.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -54.53 -66.4 0.41 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.029 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.81 ' CD1' HG12 ' A' ' 28' ' ' VAL . 0.1 OUTLIER -44.09 -61.63 1.41 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.402 -0.811 . . . . 0.0 109.564 178.746 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.816 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 4.3 mm? -47.92 -66.87 0.33 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.309 0.576 . . . . 0.0 109.927 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 1.032 HD23 HG12 ' A' ' 96' ' ' VAL . 20.0 tp -52.85 -53.01 54.87 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.438 -0.788 . . . . 0.0 110.633 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.451 ' HB3' ' O ' ' A' ' 61' ' ' GLU . 13.5 tp -49.53 -39.04 32.94 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.844 0.831 . . . . 0.0 108.956 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.927 ' CG ' HD22 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -81.34 -31.15 33.56 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.458 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 63' ' ' LEU . . . 124.21 56.19 0.18 Allowed Glycine 0 N--CA 1.481 1.661 0 C-N-CA 120.367 -0.92 . . . . 0.0 111.116 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.816 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -73.91 -154.4 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.841 -1.388 . . . . 0.0 110.103 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -122.49 77.58 45.83 Favored Pre-proline 0 N--CA 1.489 1.478 0 C-N-CA 119.824 -0.75 . . . . 0.0 109.985 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.508 ' HG3' ' CD1' ' A' ' 64' ' ' LEU . 53.7 Cg_endo -76.85 -11.61 18.17 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 O-C-N 124.067 1.562 . . . . 0.0 110.0 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.418 ' OD1' ' CB ' ' A' ' 103' ' ' ARG . 7.1 t30 -108.5 -64.36 1.23 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.493 -0.754 . . . . 0.0 109.741 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -46.07 139.95 4.15 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.421 0.629 . . . . 0.0 110.761 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.535 ' HB2' ' HA ' ' A' ' 80' ' ' ARG . . . -132.82 -150.39 0.41 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.658 -0.651 . . . . 0.0 110.187 -179.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.515 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -101.33 143.47 26.67 Favored Pre-proline 0 C--N 1.305 -1.343 0 O-C-N 121.216 -0.928 . . . . 0.0 109.746 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -71.87 -29.87 14.8 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.517 1.272 . . . . 0.0 110.728 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -47.86 -80.83 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.412 -0.805 . . . . 0.0 110.702 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.71 HG22 ' CZ2' ' A' ' 110' ' ' TRP . 4.1 p -115.31 30.71 7.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.423 -0.798 . . . . 0.0 109.878 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.515 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 2.8 mt 44.54 46.22 8.09 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.607 -0.683 . . . . 0.0 111.541 179.303 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.484 ' O ' ' NE2' ' A' ' 50' ' ' GLN . 0.2 OUTLIER -72.77 95.62 1.93 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.21 -0.931 . . . . 0.0 109.881 179.62 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.754 ' HD3' HG21 ' A' ' 106' ' ' VAL . 0.5 OUTLIER -71.92 154.4 92.65 Favored Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.397 -0.814 . . . . 0.0 109.952 179.805 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.597 ' HD2' ' HG3' ' A' ' 80' ' ' ARG . 48.3 Cg_endo -72.01 -13.71 28.96 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 O-C-N 123.577 1.303 . . . . 0.0 109.973 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.418 ' CG1' HD21 ' A' ' 130' ' ' LEU . 21.2 t -61.96 -27.4 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 CA-C-O 121.534 0.683 . . . . 0.0 109.661 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.512 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 4.2 m80 -72.72 -42.86 63.69 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.527 ' HB3' ' HE2' ' A' ' 54' ' ' MET . 0.6 OUTLIER -45.23 -51.78 10.32 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.548 -0.72 . . . . 0.0 110.091 179.249 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.528 ' HB1' HD13 ' A' ' 94' ' ' LEU . . . -56.78 -64.94 0.71 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.582 -0.699 . . . . 0.0 109.794 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.824 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -61.22 -54.0 49.72 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.58 -0.7 . . . . 0.0 111.594 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.724 ' O ' HD22 ' A' ' 121' ' ' LEU . 0.4 OUTLIER -40.18 -31.48 0.13 Allowed 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.3 -0.875 . . . . 0.0 110.976 -179.741 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -100.88 -17.85 16.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.154 -0.966 . . . . 0.0 109.602 179.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.537 ' HA3' ' CE1' ' A' ' 123' ' ' HIS . . . 89.27 41.31 5.85 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.513 ' HE2' ' HB2' ' A' ' 57' ' ' ALA . 2.1 t80 -110.64 123.48 50.08 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.656 -0.908 . . . . 0.0 110.368 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.545 ' CD2' ' HA ' ' A' ' 126' ' ' VAL . 0.0 OUTLIER -94.38 -44.31 7.97 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.5 -0.75 . . . . 0.0 110.24 -179.748 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.812 ' O ' HG23 ' A' ' 96' ' ' VAL . 0.9 OUTLIER -44.58 -31.35 1.11 Allowed 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 121.368 0.604 . . . . 0.0 109.858 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.456 HG22 HD13 ' A' ' 97' ' ' LEU . 8.7 m -76.1 -49.19 18.09 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.326 -0.859 . . . . 0.0 108.767 178.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.005 HD21 ' HG ' ' A' ' 130' ' ' LEU . 1.1 mp -50.74 -49.05 58.77 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.01 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.503 HG23 HD12 ' A' ' 91' ' ' LEU . 84.5 t -56.52 -60.96 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.695 -0.628 . . . . 0.0 109.536 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 1.032 HG12 HD23 ' A' ' 64' ' ' LEU . 49.1 t -47.36 -52.25 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.456 HD13 HG22 ' A' ' 93' ' ' THR . 0.1 OUTLIER -46.02 -64.15 0.81 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.797 -0.564 . . . . 0.0 111.038 179.228 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -63.08 -31.26 72.36 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.156 -0.965 . . . . 0.0 110.084 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.488 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 1.2 ttt85 -63.07 -12.97 30.4 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.263 -0.898 . . . . 0.0 110.825 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.665 ' HB3' HD21 ' A' ' 64' ' ' LEU . . . -139.94 58.54 1.59 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.216 -0.928 . . . . 0.0 110.647 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 55.93 106.03 0.01 OUTLIER Glycine 0 N--CA 1.488 2.15 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.307 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -164.36 124.76 2.08 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.426 -1.044 . . . . 0.0 109.787 179.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.418 ' CB ' ' OD1' ' A' ' 71' ' ' ASN . 10.9 ttp180 -82.58 135.52 35.06 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.237 -0.914 . . . . 0.0 110.287 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.77 HD13 ' HB1' ' A' ' 133' ' ' ALA . 1.7 mp -121.36 21.2 11.14 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.263 -0.898 . . . . 0.0 110.504 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -123.63 54.0 1.32 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.325 -0.859 . . . . 0.0 111.126 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.754 HG21 ' HD3' ' A' ' 80' ' ' ARG . 3.9 p -112.93 -174.11 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.824 -1.172 . . . . 0.0 110.405 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.712 ' H ' HG22 ' A' ' 106' ' ' VAL . 18.7 mtm180 -133.91 138.83 45.77 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.623 -0.673 . . . . 0.0 109.306 179.045 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.617 ' O ' ' N ' ' A' ' 110' ' ' TRP . 0.3 OUTLIER -71.63 53.1 0.22 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.437 -0.789 . . . . 0.0 109.941 179.651 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.622 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 55.53 -73.19 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.481 -0.762 . . . . 0.0 110.24 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.71 ' CZ2' HG22 ' A' ' 77' ' ' THR . 0.5 OUTLIER -46.04 -64.43 0.75 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.483 -0.761 . . . . 0.0 109.546 179.485 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 167.01 -39.23 0.24 Allowed Glycine 0 C--N 1.302 -1.32 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 179.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -44.12 122.03 2.74 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.756 -0.849 . . . . 0.0 110.392 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.484 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER -92.32 172.67 5.99 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.689 -0.632 . . . . 0.0 110.259 -179.579 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.49 ' HB3' ' CE1' ' A' ' 83' ' ' HIS . 41.4 Cg_endo -74.05 -47.81 0.24 Allowed 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.975 1.513 . . . . 0.0 109.524 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.419 HG13 ' N ' ' A' ' 116' ' ' ASP . 8.8 p -60.58 -35.46 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.528 -0.733 . . . . 0.0 110.382 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.419 ' N ' HG13 ' A' ' 115' ' ' VAL . 0.7 OUTLIER -61.63 -51.88 66.67 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.407 -0.808 . . . . 0.0 109.739 179.873 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.57 HD23 HD13 ' A' ' 121' ' ' LEU . 0.3 OUTLIER -57.58 -37.32 73.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.764 -0.585 . . . . 0.0 111.078 -179.382 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.764 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -57.5 -54.67 44.25 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.286 -0.884 . . . . 0.0 110.498 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -65.51 -17.8 64.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.286 -0.884 . . . . 0.0 110.444 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -76.12 -44.68 37.37 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.306 -0.871 . . . . 0.0 110.557 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.724 HD22 ' O ' ' A' ' 87' ' ' ARG . 6.7 mp -88.26 13.83 10.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -0.904 . . . . 0.0 110.411 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 76.8 48.04 9.12 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.537 ' CE1' ' HA3' ' A' ' 89' ' ' GLY . 30.1 m-70 -120.55 45.13 2.29 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.019 -1.283 . . . . 0.0 109.343 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -43.82 -46.04 7.62 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.524 -0.735 . . . . 0.0 110.077 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.497 ' O ' HD21 ' A' ' 91' ' ' LEU . 6.0 t70 -54.56 -44.0 72.54 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.528 0.68 . . . . 0.0 109.63 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.824 HG11 ' HA ' ' A' ' 86' ' ' ALA . 1.8 t -76.74 -28.45 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.13 -57.25 6.37 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.761 -0.587 . . . . 0.0 109.801 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -50.4 -57.93 6.86 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.413 -0.804 . . . . 0.0 110.472 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.479 ' HB3' HD23 ' A' ' 94' ' ' LEU . 33.5 t80 -53.41 -35.99 61.01 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.37 -0.832 . . . . 0.0 109.146 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 1.005 ' HG ' HD21 ' A' ' 94' ' ' LEU . 10.1 mt -71.9 -59.53 2.7 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.593 -0.692 . . . . 0.0 109.24 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -49.0 -27.8 3.44 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.691 -0.631 . . . . 0.0 110.821 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -76.6 -52.04 10.45 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.111 -0.993 . . . . 0.0 109.944 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.77 ' HB1' HD13 ' A' ' 104' ' ' LEU . . . -84.54 -10.4 57.46 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.429 -0.794 . . . . 0.0 110.489 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.568 ' CB ' ' O ' ' A' ' 104' ' ' LEU . . . -95.95 -15.46 22.34 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.29 -0.881 . . . . 0.0 109.878 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.408 ' O ' ' O ' ' A' ' 134' ' ' ALA . . . -60.92 -117.26 0.01 OUTLIER Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 162.99 -32.19 0.29 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.9 p -79.94 135.65 36.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.627 -0.926 . . . . 0.0 110.659 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.84 -24.73 23.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.146 -0.971 . . . . 0.0 109.551 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -104.28 175.17 22.67 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.5 p -92.61 -34.36 14.04 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.179 -1.189 . . . . 0.0 111.262 -179.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -101.76 115.35 30.35 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.21 -0.931 . . . . 0.0 109.824 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 177.19 178.48 0.27 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.233 -0.917 . . . . 0.0 110.71 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -161.1 55.49 0.29 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.281 -0.887 . . . . 0.0 110.283 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.46 157.14 0.23 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.514 -0.741 . . . . 0.0 111.031 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.417 ' O ' ' CB ' ' A' ' 146' ' ' ASP . 3.3 tp -53.58 129.17 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.459 -0.776 . . . . 0.0 110.233 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.417 ' CB ' ' O ' ' A' ' 145' ' ' ILE . 0.3 OUTLIER 172.15 76.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.464 -0.773 . . . . 0.0 109.783 179.439 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -78.79 117.2 19.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -0.929 . . . . 0.0 109.61 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.97 145.21 53.81 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.348 -0.845 . . . . 0.0 109.53 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -49.9 144.64 6.33 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.3 -0.875 . . . . 0.0 110.165 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 47.14 -162.69 0.22 Allowed Glycine 0 N--CA 1.497 2.731 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -76.11 149.46 32.34 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.713 1.375 . . . . 0.0 110.001 179.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.82 60.77 1.79 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.152 -0.968 . . . . 0.0 109.231 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -54.03 97.63 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.508 -0.745 . . . . 0.0 111.181 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 71.8 mt -132.16 103.75 13.96 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.448 -0.783 . . . . 0.0 109.867 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -73.53 105.47 2.0 Allowed 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.88 1.463 . . . . 0.0 110.257 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 117.863 -1.065 . . . . 0.0 110.455 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.757 0 CA-C-O 121.376 0.608 . . . . 0.0 110.095 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 56.02 69.51 1.84 Allowed Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.458 -0.776 . . . . 0.0 110.661 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -74.59 69.91 5.09 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.795 1.418 . . . . 0.0 110.18 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -175.12 116.61 0.16 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.38 -0.825 . . . . 0.0 110.218 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -122.38 -56.58 1.8 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.108 -0.995 . . . . 0.0 110.752 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -76.38 -75.69 0.86 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.4 t 52.15 48.32 22.95 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.43 -1.041 . . . . 0.0 110.366 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 65.2 p -51.16 119.1 3.69 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.388 -0.82 . . . . 0.0 110.203 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.417 ' O ' ' HB2' ' A' ' 10' ' ' GLU . 13.0 ttm -175.73 126.25 0.23 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.502 -0.749 . . . . 0.0 109.999 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 9' ' ' MET . 0.0 OUTLIER 62.42 137.63 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.69 -0.631 . . . . 0.0 110.286 179.449 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.433 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 47.1 Cg_endo -71.93 119.27 6.08 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 O-C-N 123.632 1.332 . . . . 0.0 110.403 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 t -98.32 -16.58 19.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.653 -0.655 . . . . 0.0 110.166 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.751 ' HB1' ' HB2' ' A' ' 37' ' ' LEU . . . -154.57 54.16 0.67 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.293 -0.879 . . . . 0.0 109.921 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.433 ' HB2' ' HB2' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -114.71 2.94 14.59 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.727 -0.608 . . . . 0.0 110.035 179.735 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.539 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 1.1 t90 -74.96 -6.77 51.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.394 -0.816 . . . . 0.0 110.734 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.752 HD11 ' HB1' ' A' ' 36' ' ' ALA . 19.1 mt -78.69 -49.52 12.98 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.17 -0.956 . . . . 0.0 109.463 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.498 ' HB2' ' ND2' ' A' ' 42' ' ' ASN . . . -69.35 -44.99 70.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.567 -0.708 . . . . 0.0 109.988 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.539 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.0 OUTLIER -50.31 -59.89 3.52 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.473 -0.767 . . . . 0.0 110.435 179.799 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.729 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -63.52 -33.83 76.44 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.505 -0.747 . . . . 0.0 110.206 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.527 ' HB1' ' CB ' ' A' ' 52' ' ' MET . . . -68.55 -43.88 75.69 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.093 -1.004 . . . . 0.0 109.699 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.98 -20.14 63.54 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.383 -0.823 . . . . 0.0 109.786 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -99.58 22.28 11.06 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.422 -0.799 . . . . 0.0 110.451 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.493 ' HA3' ' HE2' ' A' ' 53' ' ' MET . . . 47.68 55.15 9.87 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.473 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . 0.8 OUTLIER -126.37 89.93 3.09 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.513 -0.992 . . . . 0.0 109.483 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.543 HG22 ' CG2' ' A' ' 59' ' ' VAL . 55.7 t -64.31 -63.61 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.435 -0.79 . . . . 0.0 111.199 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -43.71 -33.48 1.25 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.551 -0.718 . . . . 0.0 111.043 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.673 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -60.8 -65.92 0.61 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.292 -0.88 . . . . 0.0 109.661 179.288 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.859 HG12 HD12 ' A' ' 32' ' ' LEU . 5.1 t -63.66 -41.04 91.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.821 -0.55 . . . . 0.0 110.289 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.455 ' CA ' HD22 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -44.7 -39.09 4.84 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.629 -0.669 . . . . 0.0 110.438 -179.548 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.64 -43.99 24.89 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.458 -0.776 . . . . 0.0 110.008 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.61 HD12 ' HA ' ' A' ' 28' ' ' VAL . 50.3 mt -55.46 -64.59 0.8 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.087 -1.008 . . . . 0.0 109.663 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.923 HD22 ' CG ' ' A' ' 66' ' ' HIS . 2.3 mt -49.37 -39.3 31.59 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.471 -0.768 . . . . 0.0 110.384 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -67.32 -25.58 66.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.527 -0.733 . . . . 0.0 110.177 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.17 -8.1 58.76 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.319 -0.863 . . . . 0.0 109.91 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.46 31.84 2.09 Favored Glycine 0 N--CA 1.489 2.179 0 C-N-CA 120.19 -1.005 . . . . 0.0 110.844 178.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.752 ' HB1' HD11 ' A' ' 16' ' ' LEU . . . -63.3 178.59 0.51 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.956 -1.32 . . . . 0.0 110.52 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.751 ' HB2' ' HB1' ' A' ' 13' ' ' ALA . 0.4 OUTLIER -92.18 124.19 60.45 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.398 -0.814 . . . . 0.0 109.947 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.513 ' HB2' ' O ' ' A' ' 67' ' ' GLY . 43.2 Cg_endo -68.22 -39.77 9.7 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.629 1.331 . . . . 0.0 110.742 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.469 ' HA ' ' OE1' ' A' ' 69' ' ' GLU . 3.2 m-20 -112.24 61.63 0.63 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.236 -0.915 . . . . 0.0 109.758 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.719 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -92.57 109.27 37.44 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.302 -0.874 . . . . 0.0 110.296 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -71.81 113.69 3.73 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 O-C-N 123.634 1.334 . . . . 0.0 109.595 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.498 ' ND2' ' HB2' ' A' ' 17' ' ' ALA . 16.3 m120 -73.68 174.23 8.66 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.559 -0.713 . . . . 0.0 109.596 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.95 21.91 1.83 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.358 -0.839 . . . . 0.0 110.354 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -109.58 20.76 17.8 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.163 -0.961 . . . . 0.0 110.533 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 57.88 24.22 53.28 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 55.0 mtt180 -131.75 -163.85 1.38 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.346 -1.09 . . . . 0.0 109.701 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.609 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 1.6 mmt180 -109.11 -171.1 0.21 Allowed Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.189 -0.944 . . . . 0.0 110.231 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.609 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 42.6 Cg_endo -80.13 -18.16 10.14 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 O-C-N 123.303 1.159 . . . . 0.0 111.08 -178.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.546 ' O ' ' HG2' ' A' ' 52' ' ' MET . 6.6 mt -107.1 -43.44 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.991 -1.068 . . . . 0.0 108.867 178.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 49' ' ' ILE . 0.8 OUTLIER -43.88 -31.47 0.87 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.095 -1.003 . . . . 0.0 109.909 179.556 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 51' ' ' VAL . 7.9 p -111.53 34.16 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.442 -0.786 . . . . 0.0 110.138 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.591 ' CE ' ' HB2' ' A' ' 60' ' ' ALA . 0.1 OUTLIER -91.11 30.1 1.29 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.027 -1.045 . . . . 0.0 109.643 179.19 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.506 ' CB ' ' O ' ' A' ' 52' ' ' MET . 4.8 tmm? 75.61 -13.54 0.86 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.859 -0.526 . . . . 0.0 111.866 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.552 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 47.11 28.18 0.9 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.956 -1.09 . . . . 0.0 110.234 -179.873 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.456 ' C ' ' CE2' ' A' ' 90' ' ' PHE . . . -125.85 4.56 7.96 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.452 ' HB3' HG23 ' A' ' 59' ' ' VAL . 0.5 OUTLIER -149.25 79.14 1.4 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.348 -1.089 . . . . 0.0 110.301 179.294 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -46.56 -34.04 4.6 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.397 -0.814 . . . . 0.0 109.592 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 56.3 mtt180 -44.44 -44.27 8.35 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.369 0.604 . . . . 0.0 109.668 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.543 ' CG2' HG22 ' A' ' 25' ' ' VAL . 60.8 t -62.05 -56.94 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.036 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.591 ' HB2' ' CE ' ' A' ' 52' ' ' MET . . . -47.61 -38.13 13.95 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.52 -0.737 . . . . 0.0 109.401 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -66.34 -35.29 79.98 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.638 -0.664 . . . . 0.0 109.843 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.61 ' CD1' HD13 ' A' ' 32' ' ' LEU . 1.5 tp -71.57 -44.13 65.08 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.42 -0.8 . . . . 0.0 109.477 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.625 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 2.6 mt -77.71 -35.14 52.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 0.0 109.427 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.836 HD11 ' HB3' ' A' ' 100' ' ' ALA . 0.7 OUTLIER -64.84 -61.01 2.44 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.422 -0.799 . . . . 0.0 110.159 -179.709 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.7 HD12 ' C ' ' A' ' 65' ' ' LEU . 0.3 OUTLIER -52.37 -33.97 45.59 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.836 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.923 ' CG ' HD22 ' A' ' 32' ' ' LEU . 1.7 m80 -73.64 -39.84 64.19 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.299 0.571 . . . . 0.0 109.658 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.513 ' O ' ' HB2' ' A' ' 38' ' ' PRO . . . 134.54 45.82 0.1 Allowed Glycine 0 N--CA 1.481 1.643 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.625 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -64.76 -162.22 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.94 -1.329 . . . . 0.0 110.208 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.531 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -116.86 61.64 2.61 Favored Pre-proline 0 C--N 1.301 -1.514 0 O-C-N 121.628 -0.67 . . . . 0.0 109.347 179.504 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.483 ' O ' ' HG3' ' A' ' 81' ' ' PRO . 52.1 Cg_endo -71.29 -2.15 10.75 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 O-C-N 123.792 1.417 . . . . 0.0 111.107 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.479 ' HA ' ' NH1' ' A' ' 80' ' ' ARG . 4.2 m-80 -108.77 -61.08 1.66 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.278 -0.889 . . . . 0.0 110.115 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 29.8 t -45.25 166.62 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.66 -0.65 . . . . 0.0 110.562 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.422 ' HB2' ' HG2' ' A' ' 80' ' ' ARG . . . -160.4 -148.62 0.17 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.104 -0.997 . . . . 0.0 110.303 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.54 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.6 OUTLIER -110.06 140.22 22.13 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.189 -0.944 . . . . 0.0 109.845 179.871 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -78.21 -23.58 8.8 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.641 1.337 . . . . 0.0 110.533 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.02 -81.3 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.888 . . . . 0.0 110.249 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.987 HG23 ' CH2' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -104.56 40.73 1.43 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.429 -0.794 . . . . 0.0 109.844 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.54 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 9.4 mt 31.95 40.56 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.0 m -67.45 104.63 1.59 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.983 -1.073 . . . . 0.0 110.181 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.841 ' HG3' HG11 ' A' ' 106' ' ' VAL . 0.7 OUTLIER -87.55 170.45 11.81 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.165 -0.959 . . . . 0.0 109.915 179.588 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.483 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 38.0 Cg_endo -68.71 -2.68 9.81 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.743 1.391 . . . . 0.0 109.72 178.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.738 HG13 HD23 ' A' ' 104' ' ' LEU . 10.5 t -82.06 -27.66 9.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 O-C-N 121.596 -0.69 . . . . 0.0 109.458 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.506 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 10.4 m80 -77.72 -40.08 42.43 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.298 -0.876 . . . . 0.0 108.794 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.558 ' O ' ' HB3' ' A' ' 87' ' ' ARG . 0.3 OUTLIER -54.64 -46.78 74.01 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.492 -0.755 . . . . 0.0 109.186 178.656 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.805 ' HB1' ' CD1' ' A' ' 94' ' ' LEU . . . -59.01 -69.01 0.21 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.244 -0.91 . . . . 0.0 109.214 178.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.807 ' HB1' ' HB2' ' A' ' 118' ' ' ALA . . . -60.38 -15.84 29.84 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.221 -0.925 . . . . 0.0 111.104 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.619 ' HA ' HD21 ' A' ' 117' ' ' LEU . 9.5 tpt180 -60.74 -45.82 92.83 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.854 -1.154 . . . . 0.0 109.455 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -101.66 -4.3 26.77 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.833 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.882 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 83.09 48.25 5.48 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.456 ' CE2' ' C ' ' A' ' 55' ' ' GLY . 0.4 OUTLIER -112.12 82.34 1.61 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.359 -1.083 . . . . 0.0 110.883 -179.245 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.622 HD11 ' O ' ' A' ' 125' ' ' ASP . 0.1 OUTLIER -57.08 -46.41 82.55 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.447 -0.783 . . . . 0.0 110.782 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.837 ' O ' HG23 ' A' ' 96' ' ' VAL . 35.7 t0 -45.84 -35.46 4.5 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.496 -0.753 . . . . 0.0 109.778 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 25.5 m -66.51 -59.33 3.74 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.841 HD13 HG13 ' A' ' 126' ' ' VAL . 1.2 mp -46.01 -52.65 11.45 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.684 -0.635 . . . . 0.0 109.462 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.461 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 26.4 t -44.84 -55.13 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.837 HG23 ' O ' ' A' ' 92' ' ' ASP . 13.4 t -55.49 -45.58 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.505 ' C ' ' HB2' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -56.31 -70.01 0.13 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.889 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' HIS . . . . . 0.469 ' HA ' ' HB3' ' A' ' 102' ' ' ALA . 3.4 t-160 -51.39 -40.84 60.08 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.493 -0.754 . . . . 0.0 109.44 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 7.5 ttt180 -59.81 -14.18 13.74 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.533 -0.729 . . . . 0.0 110.036 179.01 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.836 ' HB3' HD11 ' A' ' 64' ' ' LEU . . . -143.93 89.94 2.09 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 121.26 -0.9 . . . . 0.0 110.856 -179.26 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 100' ' ' ALA . . . 35.18 90.92 0.01 OUTLIER Glycine 0 N--CA 1.503 3.122 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 179.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.505 ' HB2' ' C ' ' A' ' 97' ' ' LEU . . . -143.91 89.81 2.08 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.107 -1.231 . . . . 0.0 110.739 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.9 ttt180 -64.72 133.73 52.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.151 -0.968 . . . . 0.0 110.078 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.738 HD23 HG13 ' A' ' 82' ' ' VAL . 0.8 OUTLIER -122.91 20.29 10.04 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.48 0.657 . . . . 0.0 109.286 179.631 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.22 39.87 1.43 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.504 -0.747 . . . . 0.0 110.037 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.841 HG11 ' HG3' ' A' ' 80' ' ' ARG . 2.5 p -109.65 -179.22 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.176 -0.952 . . . . 0.0 110.582 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.578 ' H ' HG22 ' A' ' 106' ' ' VAL . 59.4 mtt180 -141.31 140.7 33.86 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.49 -0.756 . . . . 0.0 109.771 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.49 ' HA ' ' O ' ' A' ' 77' ' ' THR . 3.6 p-10 -71.27 56.81 0.23 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.984 -1.072 . . . . 0.0 110.357 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.475 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 59.69 -89.57 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.207 -0.933 . . . . 0.0 110.613 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.987 ' CH2' HG23 ' A' ' 77' ' ' THR . 46.2 p90 -112.2 72.23 0.77 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.854 -1.153 . . . . 0.0 111.103 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.467 ' O ' ' CG ' ' A' ' 112' ' ' ARG . . . -161.62 -83.62 0.05 OUTLIER Glycine 0 N--CA 1.478 1.478 0 N-CA-C 109.631 -1.387 . . . . 0.0 109.631 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.467 ' CG ' ' O ' ' A' ' 111' ' ' GLY . 0.0 OUTLIER 171.81 -154.87 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.515 -0.991 . . . . 0.0 109.963 -179.776 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.819 ' HB2' HG12 ' A' ' 115' ' ' VAL . 15.2 mt -92.02 164.16 24.56 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.402 -0.811 . . . . 0.0 109.606 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.592 ' HG3' ' CG1' ' A' ' 82' ' ' VAL . 37.8 Cg_endo -64.26 -11.07 26.14 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.844 1.444 . . . . 0.0 111.006 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.819 HG12 ' HB2' ' A' ' 113' ' ' LEU . 3.5 p -72.81 -32.47 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.149 -0.969 . . . . 0.0 109.725 179.215 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.64 -52.96 11.61 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.15 -0.969 . . . . 0.0 110.02 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.619 HD21 ' HA ' ' A' ' 87' ' ' ARG . 0.6 OUTLIER -57.2 -26.35 60.52 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.414 -0.804 . . . . 0.0 109.722 179.466 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.807 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -65.72 -58.25 6.12 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.374 -0.829 . . . . 0.0 108.895 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.07 -31.02 70.69 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.673 -0.642 . . . . 0.0 109.636 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.403 ' HB2' ' HA ' ' A' ' 117' ' ' LEU . 2.0 mt-10 -65.72 -49.73 67.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.611 -0.68 . . . . 0.0 110.343 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.551 ' HB3' ' NE2' ' A' ' 123' ' ' HIS . 22.7 mt -77.42 5.51 8.68 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.363 -0.836 . . . . 0.0 111.087 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 89.75 29.6 15.49 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 120.085 -1.055 . . . . 0.0 111.219 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.551 ' NE2' ' HB3' ' A' ' 121' ' ' LEU . 61.4 m-70 -109.37 54.48 0.66 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.002 -1.293 . . . . 0.0 109.836 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.486 ' HG3' ' N ' ' A' ' 125' ' ' ASP . 37.5 ptt180 -49.29 -39.92 32.69 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.487 0.661 . . . . 0.0 109.911 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.622 ' O ' HD11 ' A' ' 91' ' ' LEU . 4.6 m-20 -61.45 -45.18 95.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.618 -0.677 . . . . 0.0 109.611 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.882 HG21 ' HA2' ' A' ' 89' ' ' GLY . 3.2 t -75.65 -36.26 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.465 -0.772 . . . . 0.0 109.637 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.55 -58.16 7.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.626 -0.671 . . . . 0.0 109.417 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.3 ttt-85 -44.92 -55.83 5.11 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.611 -0.681 . . . . 0.0 110.505 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -60.52 -49.57 77.01 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.447 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.693 HD11 ' HB2' ' A' ' 86' ' ' ALA . 10.2 mt -53.54 -52.97 57.96 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.694 -0.629 . . . . 0.0 110.081 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.448 ' CA ' HG21 ' A' ' 115' ' ' VAL . 25.1 ttp180 -46.04 -37.3 6.52 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.57 -0.706 . . . . 0.0 110.282 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.79 -53.78 4.92 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.51 -0.743 . . . . 0.0 110.492 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -66.02 -7.96 20.27 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.307 -0.87 . . . . 0.0 110.385 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . -117.2 -18.91 9.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.354 -0.841 . . . . 0.0 109.967 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.1 169.24 43.44 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.435 ' O ' ' OG1' ' A' ' 137' ' ' THR . . . -80.93 -127.08 0.76 Allowed Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 136' ' ' GLY . 61.0 p 44.1 27.38 0.2 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.703 -0.881 . . . . 0.0 111.063 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.62 149.17 52.4 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.286 -0.884 . . . . 0.0 109.665 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 179.95 -102.65 0.17 Allowed Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.735 -1.221 . . . . 0.0 110.124 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 68.0 m -103.11 -16.08 15.86 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.404 -1.056 . . . . 0.0 110.309 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -116.66 158.67 23.41 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.341 -0.849 . . . . 0.0 109.638 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -83.12 -13.05 56.4 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.392 -0.818 . . . . 0.0 109.721 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -141.2 84.88 1.94 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.453 -0.78 . . . . 0.0 109.928 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.525 ' NH1' ' HA ' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -79.36 87.74 5.01 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.259 -0.901 . . . . 0.0 109.588 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.417 ' O ' ' CB ' ' A' ' 146' ' ' ASP . 2.4 mt -89.06 165.55 2.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.44 -0.787 . . . . 0.0 109.455 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.417 ' CB ' ' O ' ' A' ' 145' ' ' ILE . 0.7 OUTLIER 65.05 115.0 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.398 -0.814 . . . . 0.0 109.523 -179.38 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.525 ' HA ' ' NH1' ' A' ' 144' ' ' ARG . . . -85.98 117.53 24.88 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.418 -0.801 . . . . 0.0 110.006 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -48.61 122.13 5.24 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.594 -0.691 . . . . 0.0 110.292 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 -88.93 -2.64 58.69 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.46 -0.775 . . . . 0.0 110.415 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 102.06 150.44 23.17 Favored Glycine 0 N--CA 1.488 2.16 0 C-N-CA 119.982 -1.104 . . . . 0.0 110.509 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.405 ' O ' ' O ' ' A' ' 152' ' ' SER . 44.8 Cg_endo -73.17 -173.72 1.36 Allowed 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 124.123 1.591 . . . . 0.0 110.36 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' SER . . . . . 0.405 ' O ' ' O ' ' A' ' 151' ' ' PRO . 0.4 OUTLIER 57.85 113.15 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.443 -0.786 . . . . 0.0 110.432 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.6 t0 56.87 -178.24 0.05 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.21 -0.931 . . . . 0.0 110.238 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.573 ' O ' HG23 ' A' ' 154' ' ' ILE . 0.5 OUTLIER -138.32 81.13 26.16 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 120.998 -1.063 . . . . 0.0 111.174 -179.465 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -76.21 133.82 15.22 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.789 1.415 . . . . 0.0 110.222 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.7 p30 . . . . . 0 N--CA 1.498 1.931 0 CA-C-O 117.974 -1.013 . . . . 0.0 110.561 -179.428 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.825 0 CA-C-O 121.017 0.436 . . . . 0.0 110.123 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -140.1 99.59 7.32 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.242 -0.911 . . . . 0.0 110.409 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -75.91 65.99 6.82 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.691 1.364 . . . . 0.0 110.594 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.46 116.16 27.15 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.142 -0.974 . . . . 0.0 110.589 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.08 55.98 3.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.446 -0.784 . . . . 0.0 110.067 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.73 -52.91 3.95 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.9 m 58.21 164.77 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.444 -1.033 . . . . 0.0 110.505 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.34 71.69 0.14 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.582 -0.699 . . . . 0.0 109.915 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 45.0 ttm -124.13 -68.78 0.84 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.322 -0.861 . . . . 0.0 110.687 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.499 ' CB ' ' CD ' ' A' ' 11' ' ' PRO . 1.9 mp0 -44.8 -59.84 3.69 Favored Pre-proline 0 N--CA 1.502 2.135 0 O-C-N 121.596 -0.69 . . . . 0.0 111.179 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.499 ' CD ' ' CB ' ' A' ' 10' ' ' GLU . 46.1 Cg_endo -72.43 177.61 7.17 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.429 1.226 . . . . 0.0 110.436 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 64.34 11.01 6.1 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.479 -0.763 . . . . 0.0 110.761 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.43 ' HB1' ' HB2' ' A' ' 37' ' ' LEU . . . -74.52 -14.34 60.8 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.178 -0.951 . . . . 0.0 110.213 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -79.35 -2.18 40.39 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.396 -0.815 . . . . 0.0 110.23 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.568 ' HA ' ' CG2' ' A' ' 18' ' ' THR . 25.3 m0 -89.37 -15.58 32.99 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.176 -0.953 . . . . 0.0 111.03 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.743 HD23 ' O ' ' A' ' 37' ' ' LEU . 1.0 OUTLIER -79.17 -44.88 21.04 Favored 'General case' 0 N--CA 1.483 1.217 0 O-C-N 120.864 -1.148 . . . . 0.0 109.039 179.54 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.475 ' CB ' ' OD1' ' A' ' 42' ' ' ASN . . . -74.8 -41.18 60.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.437 -0.789 . . . . 0.0 110.109 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.568 ' CG2' ' HA ' ' A' ' 15' ' ' TRP . 4.3 t -58.43 -43.09 88.61 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.324 -0.86 . . . . 0.0 109.739 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.646 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -63.7 -44.12 94.6 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.345 -0.847 . . . . 0.0 110.054 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.584 ' HB1' ' CB ' ' A' ' 52' ' ' MET . . . -59.85 -45.27 92.97 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.411 -0.806 . . . . 0.0 110.3 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.571 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -68.13 -27.49 66.49 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.358 -0.839 . . . . 0.0 111.032 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' A' ' 18' ' ' THR . 11.0 mtp180 -94.4 20.49 8.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.248 -0.908 . . . . 0.0 110.77 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.83 37.29 83.74 Favored Glycine 0 N--CA 1.486 1.974 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.542 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -107.15 64.11 0.63 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.291 -1.123 . . . . 0.0 110.186 179.58 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.957 HG22 HG22 ' A' ' 59' ' ' VAL . 30.5 t -55.15 -44.78 76.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.42 -0.8 . . . . 0.0 109.179 179.296 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.86 -48.7 66.9 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.57 -0.706 . . . . 0.0 110.704 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.473 ' O ' ' HB2' ' A' ' 31' ' ' LEU . 0.8 OUTLIER -62.57 -34.34 76.77 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.253 -0.904 . . . . 0.0 110.35 -179.776 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 1.014 HG12 HD12 ' A' ' 32' ' ' LEU . 21.3 t -76.73 -50.19 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.385 -0.822 . . . . 0.0 110.181 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.959 ' CA ' HD11 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -43.4 -44.01 5.48 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.285 -0.884 . . . . 0.0 109.19 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.501 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -79.64 -54.79 5.54 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 120.124 -0.63 . . . . 0.0 109.486 178.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 27' ' ' GLU . 8.2 mt -50.56 -61.52 2.14 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.364 -0.835 . . . . 0.0 110.307 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.014 HD12 HG12 ' A' ' 28' ' ' VAL . 3.6 mt -45.76 -62.55 1.25 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.399 -0.813 . . . . 0.0 109.962 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -64.91 -16.12 62.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.455 -0.778 . . . . 0.0 110.832 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.501 ' HB2' ' O ' ' A' ' 30' ' ' ALA . . . -85.76 -6.79 59.06 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.239 -0.913 . . . . 0.0 111.308 -179.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.27 26.35 1.67 Allowed Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.719 -1.229 . . . . 0.0 110.466 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.935 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -74.61 170.64 15.36 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.145 -1.209 . . . . 0.0 110.308 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.898 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 1.3 mm? -103.22 96.64 8.53 Favored Pre-proline 0 C--N 1.302 -1.482 0 O-C-N 121.604 -0.685 . . . . 0.0 110.367 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.54 ' HB3' ' HB3' ' A' ' 66' ' ' HIS . 41.6 Cg_endo -68.16 -14.85 41.76 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.741 1.39 . . . . 0.0 110.791 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.472 ' O ' ' HD3' ' A' ' 41' ' ' PRO . 2.1 m-20 -111.31 16.16 21.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.025 -1.047 . . . . 0.0 110.342 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.898 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -75.23 110.52 10.47 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.282 -0.886 . . . . 0.0 110.595 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 39' ' ' ASN . 45.9 Cg_endo -74.46 108.18 2.62 Favored 'Trans proline' 0 C--N 1.318 -1.03 0 O-C-N 123.552 1.29 . . . . 0.0 109.788 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.475 ' OD1' ' CB ' ' A' ' 17' ' ' ALA . 27.8 m-80 -57.43 167.62 0.96 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.64 -0.663 . . . . 0.0 110.813 -179.116 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.13 2.66 17.3 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.516 -0.74 . . . . 0.0 110.329 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.552 ' CD1' ' N ' ' A' ' 44' ' ' TYR . 1.2 m-85 -91.49 21.64 4.47 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.272 -0.892 . . . . 0.0 109.478 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.445 ' O ' ' NH2' ' A' ' 47' ' ' ARG . . . 53.75 22.1 17.39 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 -178.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 16.8 mtt180 -119.95 -176.65 3.23 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.661 -0.905 . . . . 0.0 110.188 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.638 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 5.2 mmt180 -106.25 -173.48 0.28 Allowed Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.641 -0.662 . . . . 0.0 110.393 -178.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.638 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 52.2 Cg_endo -79.32 0.65 9.84 Favored 'Trans proline' 0 C--N 1.318 -1.038 0 O-C-N 123.438 1.23 . . . . 0.0 110.594 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.518 HG12 HD13 ' A' ' 63' ' ' LEU . 7.8 mt -121.53 -43.63 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.362 -0.836 . . . . 0.0 108.94 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.486 ' HG2' ' HB3' ' A' ' 81' ' ' PRO . 5.7 mt-30 -50.07 -23.11 1.91 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.323 -0.861 . . . . 0.0 109.59 178.327 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.571 HG22 ' HB2' ' A' ' 21' ' ' ALA . 8.8 p -106.75 -7.44 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.73 -0.606 . . . . 0.0 110.867 -179.379 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.617 ' HE1' ' HB2' ' A' ' 60' ' ' ALA . 0.3 OUTLIER -68.06 158.68 32.43 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.97 -1.081 . . . . 0.0 109.817 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.59 96.4 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.094 -1.004 . . . . 0.0 109.267 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.543 ' HE1' ' CE ' ' A' ' 52' ' ' MET . 0.0 OUTLIER -56.72 -14.8 3.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.176 -0.952 . . . . 0.0 110.414 -179.514 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.443 ' HA2' ' CD2' ' A' ' 90' ' ' PHE . . . -88.13 35.23 3.59 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 178.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -171.54 99.56 0.19 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.421 -1.047 . . . . 0.0 109.668 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.501 ' HB2' ' HE1' ' A' ' 90' ' ' PHE . . . -68.31 -25.0 64.91 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.213 -0.93 . . . . 0.0 110.017 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.89 -33.14 3.04 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.572 -0.705 . . . . 0.0 110.531 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.994 HG12 HD11 ' A' ' 63' ' ' LEU . 3.0 t -72.66 -58.78 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.454 -0.779 . . . . 0.0 109.341 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.617 ' HB2' ' HE1' ' A' ' 52' ' ' MET . . . -41.17 -46.7 3.12 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.656 -0.653 . . . . 0.0 110.311 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.625 ' OE2' HG13 ' A' ' 96' ' ' VAL . 0.8 OUTLIER -55.57 -55.3 33.59 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.204 -0.935 . . . . 0.0 109.643 179.235 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.997 HD13 HG12 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -47.79 -61.5 1.92 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.68 -0.637 . . . . 0.0 109.833 178.993 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.994 HD11 HG12 ' A' ' 59' ' ' VAL . 0.9 OUTLIER -59.66 -55.07 38.99 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.256 0.551 . . . . 0.0 109.604 179.411 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.828 HD13 HG12 ' A' ' 96' ' ' VAL . 0.6 OUTLIER -49.8 -55.62 13.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.62 -0.675 . . . . 0.0 109.439 179.48 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 22.1 tp -53.94 -37.56 64.01 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.843 0.83 . . . . 0.0 108.819 178.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.971 ' CG ' HD22 ' A' ' 32' ' ' LEU . 1.9 m80 -80.55 -5.59 56.99 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.271 0.557 . . . . 0.0 110.302 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 89.4 63.74 1.29 Allowed Glycine 0 N--CA 1.479 1.537 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.557 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -79.3 -155.02 0.09 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.031 -1.276 . . . . 0.0 109.504 179.255 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.79 57.14 5.64 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.139 -0.976 . . . . 0.0 110.208 179.389 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.509 ' HB2' ' HG ' ' A' ' 97' ' ' LEU . 48.7 Cg_endo -73.99 -1.17 10.49 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.673 1.354 . . . . 0.0 110.648 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -108.66 -45.29 3.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 110.0 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.3 m -52.11 177.55 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.336 -0.852 . . . . 0.0 110.521 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -162.66 -143.35 0.08 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.361 -0.837 . . . . 0.0 110.136 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.442 ' O ' ' N ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -122.49 132.55 24.25 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.046 -1.034 . . . . 0.0 110.18 -179.566 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -74.25 1.89 6.79 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 O-C-N 123.348 1.183 . . . . 0.0 110.777 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -103.57 -48.55 3.93 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.185 -0.947 . . . . 0.0 109.365 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.898 HG23 ' CH2' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -128.72 18.02 6.26 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.834 -0.541 . . . . 0.0 109.841 179.875 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.51 ' HA ' HD23 ' A' ' 78' ' ' LEU . 9.0 mt 44.75 34.5 1.19 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.506 -0.747 . . . . 0.0 110.689 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 83.6 m -59.03 89.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.565 -0.71 . . . . 0.0 110.552 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.88 ' HG3' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -71.04 161.61 77.19 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.168 -0.958 . . . . 0.0 109.52 179.431 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.531 ' HD2' ' HD3' ' A' ' 80' ' ' ARG . 48.4 Cg_endo -73.96 -13.09 23.98 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.696 1.366 . . . . 0.0 110.549 179.422 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.425 HG13 HD23 ' A' ' 94' ' ' LEU . 90.7 t -67.28 -25.35 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.45 -0.781 . . . . 0.0 110.125 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.531 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 5.2 m80 -71.64 -40.81 69.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.277 -0.89 . . . . 0.0 109.236 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.52 ' HB3' ' SD ' ' A' ' 54' ' ' MET . 9.9 m-20 -52.27 -46.72 65.95 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.547 -0.721 . . . . 0.0 110.483 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.47 ' CB ' ' HG ' ' A' ' 94' ' ' LEU . . . -57.29 -68.46 0.23 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.05 -1.031 . . . . 0.0 108.993 178.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.799 ' CA ' HG11 ' A' ' 126' ' ' VAL . . . -52.35 -34.77 49.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.482 -0.761 . . . . 0.0 109.861 179.127 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.531 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 0.1 OUTLIER -40.37 -61.29 0.93 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.917 -0.489 . . . . 0.0 111.136 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -89.19 9.68 24.81 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.224 -0.923 . . . . 0.0 110.491 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.423 ' HA2' ' HB3' ' A' ' 123' ' ' HIS . . . 77.87 33.4 41.78 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.52 ' HD1' ' HG1' ' A' ' 93' ' ' THR . 0.6 OUTLIER -96.82 131.74 43.25 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.148 -1.207 . . . . 0.0 110.065 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.591 HD11 ' O ' ' A' ' 125' ' ' ASP . 0.5 OUTLIER -105.47 -47.6 3.89 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.272 -0.893 . . . . 0.0 110.45 179.87 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.776 ' O ' HG23 ' A' ' 96' ' ' VAL . 47.5 m-20 -47.32 -28.3 1.95 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.419 -0.801 . . . . 0.0 109.769 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.52 ' HG1' ' HD1' ' A' ' 90' ' ' PHE . 61.6 m -65.19 -56.82 10.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.588 -0.695 . . . . 0.0 109.604 178.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.697 ' CD2' HD21 ' A' ' 130' ' ' LEU . 1.5 mp -53.91 -49.16 69.22 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.217 -0.927 . . . . 0.0 109.661 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.455 ' O ' ' N ' ' A' ' 99' ' ' ARG . 74.7 t -44.3 -45.47 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.828 HG12 HD13 ' A' ' 64' ' ' LEU . 22.0 t -59.97 -54.09 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.556 -0.715 . . . . 0.0 109.436 179.033 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.509 ' HG ' ' HB2' ' A' ' 70' ' ' PRO . 7.3 mp -48.52 -50.05 33.55 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.543 0.687 . . . . 0.0 110.265 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -77.82 -21.65 51.2 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.583 -0.698 . . . . 0.0 109.881 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.539 ' HB3' ' HA ' ' A' ' 96' ' ' VAL . 1.4 ttm180 -72.94 -9.96 59.28 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.413 -0.804 . . . . 0.0 110.949 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.812 ' CB ' HD21 ' A' ' 64' ' ' LEU . . . -136.39 -66.73 0.53 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.064 -1.022 . . . . 0.0 110.923 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -167.51 105.51 0.24 Allowed Glycine 0 N--CA 1.486 1.979 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.458 ' HB3' ' C ' ' A' ' 97' ' ' LEU . . . -177.29 119.37 0.11 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.317 -1.107 . . . . 0.0 110.31 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 -68.11 134.84 51.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -0.892 . . . . 0.0 109.437 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 1.036 HD21 HD23 ' A' ' 130' ' ' LEU . 1.4 tt -112.27 13.28 20.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.376 -0.828 . . . . 0.0 110.665 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.499 ' HB3' ' HA ' ' A' ' 134' ' ' ALA . 1.1 p30 -127.65 47.54 2.37 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.425 -0.797 . . . . 0.0 110.325 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.88 HG11 ' HG3' ' A' ' 80' ' ' ARG . 0.8 OUTLIER -99.73 -175.09 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.143 -0.973 . . . . 0.0 110.659 -179.848 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.584 ' H ' HG22 ' A' ' 106' ' ' VAL . 6.6 ttp180 -141.01 148.89 41.0 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.521 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 3.6 m-20 -89.55 45.08 1.25 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.356 -0.84 . . . . 0.0 110.45 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 108' ' ' ASP . . . 62.11 -77.92 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.357 -0.839 . . . . 0.0 110.38 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.898 ' CH2' HG23 ' A' ' 77' ' ' THR . 1.1 p-90 -136.74 16.3 3.1 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.206 -0.934 . . . . 0.0 110.498 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -86.77 -79.71 1.21 Allowed Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 178.14 133.82 0.07 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.476 -1.014 . . . . 0.0 110.13 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.525 ' HG ' ' HD2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER -51.02 166.39 0.32 Allowed Pre-proline 0 N--CA 1.498 1.962 0 O-C-N 121.387 -0.821 . . . . 0.0 110.548 179.791 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.525 ' HD2' ' HG ' ' A' ' 113' ' ' LEU . 40.7 Cg_endo -69.72 -23.28 31.15 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.79 1.416 . . . . 0.0 110.226 179.008 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.614 HG21 ' CG ' ' A' ' 131' ' ' ARG . 4.7 p -86.72 -33.91 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.884 . . . . 0.0 109.776 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.31 -44.04 97.87 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.661 -0.649 . . . . 0.0 110.351 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.56 -31.09 67.66 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.283 -0.885 . . . . 0.0 109.73 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.782 ' HB1' ' HB2' ' A' ' 123' ' ' HIS . . . -81.61 -20.66 39.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.448 -0.782 . . . . 0.0 110.708 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -74.72 -40.92 61.03 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.4 -0.813 . . . . 0.0 110.691 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.47 -40.6 35.05 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.255 -0.903 . . . . 0.0 110.622 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.511 ' HB3' ' NE2' ' A' ' 123' ' ' HIS . 0.2 OUTLIER -72.57 -81.47 0.06 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.432 -0.793 . . . . 0.0 110.552 -179.339 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 162.14 47.26 0.02 OUTLIER Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.701 -1.237 . . . . 0.0 110.162 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.782 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . 3.6 m170 -108.49 52.94 0.7 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.127 -1.22 . . . . 0.0 109.643 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 28.4 mtt180 -48.22 -44.07 32.71 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.285 -0.884 . . . . 0.0 110.029 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.591 ' O ' HD11 ' A' ' 91' ' ' LEU . 5.5 t0 -54.27 -43.3 70.89 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.501 -0.75 . . . . 0.0 109.415 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.799 HG11 ' CA ' ' A' ' 86' ' ' ALA . 15.9 t -85.31 -45.55 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.277 -0.89 . . . . 0.0 110.12 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -47.31 -58.12 4.48 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.348 -0.845 . . . . 0.0 110.454 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 11.2 mtp180 -50.77 -65.85 0.49 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.473 -0.767 . . . . 0.0 110.052 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -50.36 -31.84 15.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.527 -0.733 . . . . 0.0 109.887 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 1.036 HD23 HD21 ' A' ' 104' ' ' LEU . 11.3 mt -72.89 -57.11 4.3 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.594 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.614 ' CG ' HG21 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -51.94 -21.78 3.32 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.355 -0.841 . . . . 0.0 110.689 -179.767 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -83.85 -61.18 1.89 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.311 -0.868 . . . . 0.0 109.729 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 1.016 ' HB3' HD22 ' A' ' 104' ' ' LEU . . . -75.1 -6.78 51.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.603 -0.686 . . . . 0.0 110.609 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.499 ' HA ' ' HB3' ' A' ' 105' ' ' ASP . . . -99.55 -20.78 16.21 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.093 -1.004 . . . . 0.0 109.284 179.004 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -53.42 146.63 19.96 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -138.14 17.38 3.38 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.559 ' O ' HG23 ' A' ' 137' ' ' THR . 2.9 t -79.7 104.47 10.32 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.493 -1.004 . . . . 0.0 110.821 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 178.07 57.59 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.472 -0.767 . . . . 0.0 110.129 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -162.5 -119.11 0.48 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 68.4 p -98.81 40.36 1.2 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.429 -1.042 . . . . 0.0 110.647 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -112.59 -178.29 3.36 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.084 -1.01 . . . . 0.0 109.813 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -55.28 -171.28 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.263 -0.898 . . . . 0.0 110.057 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -138.72 149.08 44.68 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.948 -1.095 . . . . 0.0 110.676 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -70.38 154.31 42.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.409 -0.807 . . . . 0.0 110.362 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.527 HG23 ' O ' ' A' ' 145' ' ' ILE . 1.2 tt -75.59 61.69 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.281 -0.887 . . . . 0.0 110.0 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.411 ' CB ' ' O ' ' A' ' 145' ' ' ILE . 1.1 t0 65.09 172.94 0.21 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.498 -0.751 . . . . 0.0 110.457 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.424 ' O ' ' C ' ' A' ' 148' ' ' ALA . . . -53.1 158.51 1.48 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.405 -0.809 . . . . 0.0 109.801 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 147' ' ' ALA . . . -39.58 120.45 1.09 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.506 -0.746 . . . . 0.0 111.009 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -52.43 130.57 31.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.351 -0.843 . . . . 0.0 109.523 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -145.88 -151.45 5.42 Favored Glycine 0 N--CA 1.489 2.178 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.225 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -75.41 127.46 10.42 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 124.11 1.584 . . . . 0.0 110.079 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 6.5 p -162.32 118.53 1.97 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.235 -0.915 . . . . 0.0 110.568 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 55.02 96.55 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.466 -0.771 . . . . 0.0 109.978 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 2.1 mt -114.91 87.97 16.04 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.302 -0.874 . . . . 0.0 109.455 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -78.48 110.56 2.86 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.82 1.431 . . . . 0.0 110.52 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 12.9 t0 . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.032 179.892 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.0 ptt? . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.297 0.57 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.444 ' N ' ' HD2' ' A' ' 3' ' ' PRO . 0.8 OUTLIER -54.67 -55.26 40.01 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.188 -0.945 . . . . 0.0 110.237 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 2' ' ' GLU . 50.5 Cg_endo -76.41 178.85 7.01 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.528 1.278 . . . . 0.0 110.414 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 49.52 64.18 1.86 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.488 -0.758 . . . . 0.0 110.764 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.85 -25.64 63.44 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.29 -0.881 . . . . 0.0 110.328 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -149.41 155.75 26.46 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -123.15 173.9 7.59 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.411 -1.053 . . . . 0.0 110.335 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 58.6 -177.37 0.08 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.427 -0.796 . . . . 0.0 110.294 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 35.3 mtm -64.27 -157.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.321 -0.862 . . . . 0.0 109.972 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 52.24 61.58 11.81 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.244 -0.91 . . . . 0.0 110.502 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -75.2 157.16 42.09 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.746 1.393 . . . . 0.0 110.653 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.8 149.04 36.27 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.429 -0.794 . . . . 0.0 110.264 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -169.64 -153.88 0.11 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.26 -0.9 . . . . 0.0 110.316 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.9 t0 62.2 14.88 7.03 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.262 -0.899 . . . . 0.0 110.865 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.455 ' HE3' HD22 ' A' ' 31' ' ' LEU . 22.6 m0 -95.01 -37.22 11.23 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.035 -1.041 . . . . 0.0 109.923 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.652 ' CD2' ' HB1' ' A' ' 36' ' ' ALA . 0.9 OUTLIER -71.49 -28.37 63.87 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.358 -0.839 . . . . 0.0 110.006 179.478 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.77 -44.91 12.89 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.326 -0.859 . . . . 0.0 110.185 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.429 ' CG2' ' N ' ' A' ' 19' ' ' ALA . 1.6 t -61.94 -39.08 90.85 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.408 -0.808 . . . . 0.0 110.345 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.607 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -68.8 -48.87 62.54 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.453 -0.779 . . . . 0.0 109.975 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.703 ' CB ' HG11 ' A' ' 59' ' ' VAL . . . -56.9 -53.5 57.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.528 -0.733 . . . . 0.0 109.811 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.567 ' HB2' ' O ' ' A' ' 51' ' ' VAL . . . -53.51 -28.47 31.22 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.48 -0.762 . . . . 0.0 110.182 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.57 14.41 15.08 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.468 -0.77 . . . . 0.0 110.474 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.444 ' HA3' ' CE ' ' A' ' 53' ' ' MET . . . 55.0 49.89 60.92 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -121.25 63.18 0.89 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.401 -1.058 . . . . 0.0 110.138 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.589 HG22 HG23 ' A' ' 59' ' ' VAL . 41.1 t -47.49 -51.17 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.549 -0.719 . . . . 0.0 110.163 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -47.12 -42.26 18.89 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.603 -0.686 . . . . 0.0 110.686 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.07 -37.24 72.48 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.249 -0.907 . . . . 0.0 110.086 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.984 HG12 HD13 ' A' ' 62' ' ' LEU . 21.6 t -73.45 -41.23 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.328 -0.857 . . . . 0.0 110.351 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.903 ' CA ' HD11 ' A' ' 62' ' ' LEU . 9.6 mmm180 -53.9 -44.81 70.82 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.126 -0.984 . . . . 0.0 109.639 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.63 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -78.85 -41.25 30.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.659 -0.65 . . . . 0.0 109.917 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.455 HD22 ' HE3' ' A' ' 15' ' ' TRP . 35.0 mt -65.53 -59.15 4.28 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.547 -0.721 . . . . 0.0 110.236 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.967 HD23 HD22 ' A' ' 62' ' ' LEU . 33.1 tp -50.83 -45.86 59.8 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.369 -0.832 . . . . 0.0 110.526 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -76.19 -15.6 60.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.294 -0.879 . . . . 0.0 110.031 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.63 ' HB2' ' O ' ' A' ' 30' ' ' ALA . . . -82.79 -8.75 59.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.301 -0.874 . . . . 0.0 110.652 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.54 23.19 1.93 Allowed Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.782 -1.199 . . . . 0.0 110.711 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.939 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -69.95 152.56 44.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.99 -1.3 . . . . 0.0 109.664 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.851 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -79.08 116.59 61.33 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.274 -0.891 . . . . 0.0 110.09 -179.728 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.73 -33.03 22.18 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.372 1.196 . . . . 0.0 110.317 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -115.57 58.05 0.73 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.311 -0.868 . . . . 0.0 109.744 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.851 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -88.69 116.97 67.79 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.324 -0.86 . . . . 0.0 110.11 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -72.35 82.94 1.31 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.647 1.341 . . . . 0.0 110.08 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -60.92 -174.95 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.391 -0.818 . . . . 0.0 110.026 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.5 p -93.63 26.57 3.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.397 -0.815 . . . . 0.0 110.171 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -114.78 17.88 16.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.248 -0.908 . . . . 0.0 110.248 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 59.74 44.26 97.12 Favored Glycine 0 N--CA 1.484 1.88 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -174.55 161.35 3.25 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.307 -1.114 . . . . 0.0 110.79 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.633 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 2.2 mtt180 -87.7 -154.47 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.635 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.633 ' CD ' ' HB3' ' A' ' 47' ' ' ARG . 45.3 Cg_endo -77.36 -170.53 0.95 Allowed 'Trans proline' 0 N--CA 1.483 0.855 0 O-C-N 122.53 0.753 . . . . 0.0 111.008 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.555 ' O ' ' HG2' ' A' ' 52' ' ' MET . 4.0 mt 62.62 -62.86 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.729 -0.607 . . . . 0.0 110.057 -178.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.522 ' N ' ' O ' ' A' ' 48' ' ' PRO . 8.4 mt-30 -48.15 -23.55 0.89 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.596 -1.315 . . . . 0.0 109.757 179.014 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.567 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 9.1 p -118.54 31.37 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.337 -0.852 . . . . 0.0 109.873 178.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.7 ' HE1' ' HB2' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -93.03 36.66 1.03 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.139 -0.976 . . . . 0.0 109.963 179.627 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.444 ' CE ' ' HA3' ' A' ' 23' ' ' GLY . 7.7 ttp 63.44 -6.95 0.19 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.468 -0.77 . . . . 0.0 110.965 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.561 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 45.94 28.81 0.65 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.212 -0.93 . . . . 0.0 110.579 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.407 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -126.26 4.15 7.76 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.08 84.94 1.85 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.378 -1.072 . . . . 0.0 109.596 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.442 ' CB ' ' HB3' ' A' ' 92' ' ' ASP . . . -51.27 -22.97 3.08 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.417 -0.802 . . . . 0.0 110.514 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.548 ' HB2' HG21 ' A' ' 25' ' ' VAL . 1.8 mmt180 -54.07 -45.94 71.85 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.284 -0.885 . . . . 0.0 110.047 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.703 HG11 ' CB ' ' A' ' 20' ' ' ALA . 46.7 t -58.05 -45.22 88.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.418 -0.802 . . . . 0.0 109.723 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.7 ' HB2' ' HE1' ' A' ' 52' ' ' MET . . . -49.48 -53.19 24.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.515 -0.741 . . . . 0.0 109.719 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.473 ' O ' HD23 ' A' ' 65' ' ' LEU . 1.6 tt0 -52.21 -51.34 58.8 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.437 -0.789 . . . . 0.0 109.313 178.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.984 HD13 HG12 ' A' ' 28' ' ' VAL . 0.9 OUTLIER -49.55 -70.99 0.07 Allowed 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.638 0.732 . . . . 0.0 110.049 178.675 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.837 HD22 HD22 ' A' ' 32' ' ' LEU . 4.5 mm? -56.5 -46.81 80.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.867 -0.521 . . . . 0.0 110.931 -179.144 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.915 HD13 HG12 ' A' ' 96' ' ' VAL . 1.2 tt -61.56 -59.09 5.74 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.342 -0.849 . . . . 0.0 111.171 -179.157 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.473 HD23 ' O ' ' A' ' 61' ' ' GLU . 0.6 OUTLIER -53.35 -23.55 9.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.067 -1.021 . . . . 0.0 109.935 -179.328 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.519 ' ND1' ' HG ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -88.9 -50.81 5.97 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.611 -0.681 . . . . 0.0 109.433 179.505 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.98 52.23 0.01 OUTLIER Glycine 0 N--CA 1.483 1.774 0 C-N-CA 119.937 -1.125 . . . . 0.0 111.061 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.799 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -79.29 -151.74 0.06 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.827 -1.396 . . . . 0.0 109.99 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.428 ' HB2' ' CB ' ' A' ' 47' ' ' ARG . 1.2 tt0 -123.28 54.89 7.3 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.365 -0.835 . . . . 0.0 110.088 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.5 ' HG3' HD12 ' A' ' 64' ' ' LEU . 43.0 Cg_endo -70.21 -13.91 34.06 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.641 1.337 . . . . 0.0 110.274 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.5 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 2.1 t-20 -108.36 -73.0 0.7 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.368 -0.832 . . . . 0.0 110.02 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 4.1 t -50.27 169.0 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.189 -0.944 . . . . 0.0 110.979 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.465 ' HB1' ' O ' ' A' ' 79' ' ' THR . . . -153.86 -155.45 0.59 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.334 -0.854 . . . . 0.0 110.149 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -101.71 135.34 19.78 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.406 -0.809 . . . . 0.0 109.746 179.876 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -74.3 -22.86 16.0 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.685 1.36 . . . . 0.0 110.661 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.03 -39.37 66.09 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.204 -0.935 . . . . 0.0 110.085 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' THR . . . . . 1.045 HG23 ' CH2' ' A' ' 110' ' ' TRP . 0.3 OUTLIER -147.43 16.07 1.15 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.601 -0.687 . . . . 0.0 110.13 179.929 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.476 ' HB3' ' O ' ' A' ' 107' ' ' ARG . 0.4 OUTLIER 48.22 35.11 5.04 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.481 -0.762 . . . . 0.0 111.513 179.664 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.465 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 2.5 m -71.31 104.82 3.27 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.219 -0.926 . . . . 0.0 109.886 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.833 ' CG ' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -80.06 160.13 69.19 Favored Pre-proline 0 N--CA 1.498 1.928 0 O-C-N 121.351 -0.843 . . . . 0.0 110.747 -179.571 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.417 ' O ' ' HB2' ' A' ' 84' ' ' ASP . 45.7 Cg_endo -72.1 -17.46 28.12 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.822 1.433 . . . . 0.0 110.604 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 98.6 t -62.7 -24.06 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.209 -0.932 . . . . 0.0 110.205 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.495 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 13.4 m80 -76.68 -32.83 58.16 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.413 -0.804 . . . . 0.0 109.108 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.561 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 3.3 m-20 -57.98 -50.86 71.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.616 -0.678 . . . . 0.0 110.297 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.491 ' HB3' ' CD1' ' A' ' 94' ' ' LEU . . . -58.95 -58.33 9.11 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.343 -0.848 . . . . 0.0 109.856 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.884 ' HB2' HD11 ' A' ' 130' ' ' LEU . . . -59.36 -45.0 92.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.42 -0.8 . . . . 0.0 110.847 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 0.3 OUTLIER -47.71 -44.65 27.9 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.327 -0.858 . . . . 0.0 110.902 -179.589 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -95.96 13.32 27.31 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.284 -0.885 . . . . 0.0 110.495 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.575 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 59.84 60.1 9.29 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.407 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 0.3 OUTLIER -129.04 94.32 3.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.266 -1.138 . . . . 0.0 110.707 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.651 HD11 ' O ' ' A' ' 125' ' ' ASP . 0.3 OUTLIER -69.31 -37.38 77.73 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.336 -0.853 . . . . 0.0 109.958 179.68 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.442 ' HB3' ' CB ' ' A' ' 57' ' ' ALA . 31.5 m-20 -50.08 -40.98 47.19 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.503 -0.748 . . . . 0.0 110.055 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 60.5 m -66.16 -42.45 88.96 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.725 HD21 ' HG ' ' A' ' 130' ' ' LEU . 1.2 tp -58.83 -38.27 78.28 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.596 -0.69 . . . . 0.0 109.312 178.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 91' ' ' LEU . 47.3 t -61.41 -50.6 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.582 -0.699 . . . . 0.0 109.607 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.915 HG12 HD13 ' A' ' 64' ' ' LEU . 92.9 t -54.17 -54.51 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.543 -0.723 . . . . 0.0 109.433 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.681 HD23 ' HB1' ' A' ' 102' ' ' ALA . 1.1 mp -47.51 -53.56 14.02 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.735 -0.603 . . . . 0.0 110.825 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -72.98 -29.61 63.18 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.307 -0.871 . . . . 0.0 110.084 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -65.86 -9.4 28.78 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.367 -0.833 . . . . 0.0 110.604 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.88 ' HB2' HD21 ' A' ' 64' ' ' LEU . . . -136.9 -74.6 0.42 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.117 -0.99 . . . . 0.0 111.051 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -160.14 102.21 0.21 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.681 ' HB1' HD23 ' A' ' 97' ' ' LEU . . . -162.43 111.18 1.39 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.405 -1.056 . . . . 0.0 109.878 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -77.86 145.47 36.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.38 -0.825 . . . . 0.0 110.38 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.745 HD22 ' HB3' ' A' ' 133' ' ' ALA . 2.4 mp -116.36 4.23 13.39 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.46 -0.775 . . . . 0.0 110.286 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -98.68 39.29 1.27 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.187 -0.946 . . . . 0.0 109.764 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.833 HG11 ' CG ' ' A' ' 80' ' ' ARG . 3.0 p -108.4 -170.18 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.369 -0.832 . . . . 0.0 109.791 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.695 ' H ' HG22 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -157.43 155.09 29.86 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.344 -0.848 . . . . 0.0 109.556 179.677 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 110' ' ' TRP . 85.4 m-20 -74.49 58.09 0.75 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.117 -0.99 . . . . 0.0 110.2 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.509 ' HB2' ' C ' ' A' ' 77' ' ' THR . . . 54.8 -88.36 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.465 -0.772 . . . . 0.0 110.74 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 1.045 ' CH2' HG23 ' A' ' 77' ' ' THR . 42.9 p90 -117.5 34.98 4.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.918 -1.114 . . . . 0.0 110.279 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -113.39 -84.94 1.36 Allowed Glycine 0 N--CA 1.481 1.674 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -169.75 -160.13 0.23 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.263 -1.139 . . . . 0.0 110.502 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.481 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.3 OUTLIER -103.82 175.9 2.02 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.455 -0.778 . . . . 0.0 109.883 179.742 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.481 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 46.4 Cg_endo -74.01 -50.39 0.17 Allowed 'Trans proline' 0 C--N 1.312 -1.349 0 O-C-N 123.604 1.318 . . . . 0.0 110.386 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.4 HG13 ' N ' ' A' ' 116' ' ' ASP . 12.2 p -58.62 -34.52 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.321 -0.862 . . . . 0.0 109.72 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.4 ' N ' HG13 ' A' ' 115' ' ' VAL . 6.5 m-20 -70.86 -25.5 62.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.53 -0.731 . . . . 0.0 109.698 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.2 tt -79.68 -28.18 40.74 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.428 -0.795 . . . . 0.0 110.073 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -73.56 -45.29 54.36 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.402 -0.811 . . . . 0.0 109.891 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -62.8 -37.11 85.44 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.465 -0.772 . . . . 0.0 109.806 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.21 -45.29 85.35 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.534 -0.729 . . . . 0.0 110.037 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.1 -81.8 0.1 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.383 -0.823 . . . . 0.0 110.378 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 167.8 53.25 0.03 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.498 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 53.4 m-70 -127.88 52.87 1.82 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -1.149 . . . . 0.0 109.483 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.4 mtp180 -47.43 -43.0 23.52 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.544 -0.723 . . . . 0.0 110.258 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.651 ' O ' HD11 ' A' ' 91' ' ' LEU . 76.7 m-20 -55.6 -42.94 75.53 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.391 -0.818 . . . . 0.0 109.295 179.194 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.865 HG11 ' HA ' ' A' ' 86' ' ' ALA . 3.0 t -78.94 -34.0 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.495 -0.753 . . . . 0.0 109.127 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.77 -31.99 72.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.501 -0.749 . . . . 0.0 109.517 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.9 mtp180 -60.65 -66.7 0.49 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.543 -0.723 . . . . 0.0 110.099 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.464 ' HB3' HD23 ' A' ' 94' ' ' LEU . 10.1 t80 -55.03 -28.87 55.51 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.346 -0.847 . . . . 0.0 109.627 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.884 HD11 ' HB2' ' A' ' 86' ' ' ALA . 68.1 mt -72.74 -43.52 62.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.574 -0.704 . . . . 0.0 109.569 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.79 -19.53 62.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.203 -0.936 . . . . 0.0 110.391 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.31 -50.71 7.12 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.277 -0.89 . . . . 0.0 110.399 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.745 ' HB3' HD22 ' A' ' 104' ' ' LEU . . . -88.26 -19.74 26.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.295 -0.878 . . . . 0.0 110.174 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.698 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . -112.87 34.98 4.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.498 -0.751 . . . . 0.0 109.687 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -51.63 121.25 12.08 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -125.96 73.86 0.43 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.527 ' O ' HG23 ' A' ' 137' ' ' THR . 7.8 t -54.21 123.6 13.27 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.373 -1.075 . . . . 0.0 110.33 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.21 179.18 8.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.139 -0.976 . . . . 0.0 110.637 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 155.31 -103.79 0.24 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 89.6 p -132.75 177.98 7.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.453 -1.028 . . . . 0.0 110.216 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 60.64 -162.47 0.27 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.271 -0.893 . . . . 0.0 110.583 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -86.87 -24.0 25.05 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.367 -0.833 . . . . 0.0 110.715 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . 53.19 -146.31 0.54 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.103 -0.998 . . . . 0.0 110.359 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.34 165.9 1.88 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.161 -0.962 . . . . 0.0 110.294 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 3.3 tp -85.43 137.45 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.444 -0.785 . . . . 0.0 110.1 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -177.23 73.17 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.196 -0.94 . . . . 0.0 110.513 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.73 141.9 58.6 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.304 -0.872 . . . . 0.0 110.177 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.49 164.78 21.75 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.368 -0.832 . . . . 0.0 110.545 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.437 ' CG ' ' O ' ' A' ' 149' ' ' GLU . 6.4 pt-20 -83.44 109.79 17.64 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.313 -0.867 . . . . 0.0 110.029 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 93.43 -148.8 19.18 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.57 156.52 61.06 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.731 1.385 . . . . 0.0 110.415 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.22 -51.15 2.63 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.284 -0.885 . . . . 0.0 110.535 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -52.06 141.65 17.82 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.253 -0.904 . . . . 0.0 110.495 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 3.5 mt -126.58 78.11 72.83 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.364 -0.835 . . . . 0.0 110.375 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -77.47 166.47 25.86 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.805 1.424 . . . . 0.0 109.761 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 . . . . . 0 N--CA 1.496 1.875 0 CA-C-O 117.938 -1.03 . . . . 0.0 110.538 -179.847 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.097 0.475 . . . . 0.0 110.063 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.416 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 64.1 mt-10 47.68 54.67 15.96 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.445 -0.784 . . . . 0.0 110.178 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.416 ' CD ' ' N ' ' A' ' 2' ' ' GLU . 44.5 Cg_endo -71.5 69.59 2.69 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.822 1.433 . . . . 0.0 110.532 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.8 152.64 35.38 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.461 -0.775 . . . . 0.0 110.094 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.46 -169.79 0.58 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.299 -0.875 . . . . 0.0 110.005 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 66.09 -121.78 19.64 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 50.94 77.45 0.13 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.419 -1.047 . . . . 0.0 110.328 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.11 -140.74 0.16 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.377 -0.827 . . . . 0.0 110.107 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.09 -0.05 21.38 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.012 -1.055 . . . . 0.0 110.946 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -57.91 135.05 83.54 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.088 -1.008 . . . . 0.0 110.111 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.61 -176.36 1.42 Allowed 'Trans proline' 0 C--N 1.312 -1.375 0 O-C-N 123.611 1.321 . . . . 0.0 110.714 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 m -129.24 -30.27 2.18 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.359 -0.838 . . . . 0.0 110.845 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' A' ' 37' ' ' LEU . . . -52.99 -28.32 23.33 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.128 -0.983 . . . . 0.0 110.165 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.11 -12.77 52.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.434 -0.791 . . . . 0.0 110.006 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.571 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 2.2 t90 -70.37 -7.59 44.08 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.287 -0.883 . . . . 0.0 110.423 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.951 HD21 HD21 ' A' ' 63' ' ' LEU . 0.9 OUTLIER -80.4 -57.96 3.35 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.038 -1.039 . . . . 0.0 109.674 179.77 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.468 ' N ' ' HG ' ' A' ' 16' ' ' LEU . . . -63.26 -38.89 92.95 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.222 -0.924 . . . . 0.0 109.761 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.571 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 1.5 p -52.8 -54.22 37.22 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.527 -0.733 . . . . 0.0 110.385 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.713 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -59.77 -39.01 83.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.338 -0.851 . . . . 0.0 110.071 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.469 ' HB1' HG11 ' A' ' 59' ' ' VAL . . . -54.12 -61.91 2.0 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.116 -0.99 . . . . 0.0 109.561 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.937 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -54.64 -22.21 12.89 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.515 -0.74 . . . . 0.0 110.206 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -90.64 16.6 8.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.354 -0.841 . . . . 0.0 110.69 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 49.76 34.95 22.77 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 179.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.434 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . 6.2 mmt180 -109.49 67.54 0.65 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.338 -1.095 . . . . 0.0 110.052 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.476 HG22 HG22 ' A' ' 59' ' ' VAL . 93.2 t -49.17 -54.28 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.638 -0.663 . . . . 0.0 110.973 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -46.89 -43.02 18.46 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.5 -0.75 . . . . 0.0 110.818 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.55 ' O ' ' HB2' ' A' ' 31' ' ' LEU . 20.3 mt-10 -62.17 -44.86 95.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.233 -0.917 . . . . 0.0 110.166 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.757 HG12 HD13 ' A' ' 62' ' ' LEU . 3.5 t -72.92 -43.06 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.419 -0.801 . . . . 0.0 110.471 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.83 ' CA ' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -45.8 -47.81 15.67 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.409 -0.807 . . . . 0.0 109.853 -179.516 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.41 -49.06 11.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.418 -0.802 . . . . 0.0 110.379 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.55 ' HB2' ' O ' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -57.13 -56.99 14.67 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.165 -0.959 . . . . 0.0 110.255 179.849 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 1.016 HD23 HD22 ' A' ' 62' ' ' LEU . 15.2 tp -50.35 -49.65 53.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.5 -0.75 . . . . 0.0 110.665 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -74.73 -8.9 57.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.269 -0.894 . . . . 0.0 110.537 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.56 -11.69 39.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -0.912 . . . . 0.0 111.127 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 139.12 -9.38 3.29 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 119.619 -1.277 . . . . 0.0 110.763 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.961 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -44.68 154.72 0.12 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.179 -1.189 . . . . 0.0 110.611 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.884 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 2.3 mm? -93.73 111.31 52.11 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.378 -0.826 . . . . 0.0 110.658 -179.14 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.484 ' O ' ' HG3' ' A' ' 48' ' ' PRO . 43.2 Cg_endo -70.57 -19.02 32.78 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 123.622 1.327 . . . . 0.0 110.485 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -109.43 17.49 21.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.33 -0.856 . . . . 0.0 110.209 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.884 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -77.75 129.65 75.89 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.257 -0.902 . . . . 0.0 110.405 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -73.89 146.31 37.42 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 123.656 1.345 . . . . 0.0 109.983 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -88.96 -157.97 0.47 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.237 -0.914 . . . . 0.0 109.941 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.8 m -111.43 14.49 21.48 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.051 -1.03 . . . . 0.0 111.205 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -123.76 33.52 5.3 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.096 -1.002 . . . . 0.0 109.964 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.25 23.7 26.62 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.216 -1.553 . . . . 0.0 109.216 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.8 mtm-85 -108.05 -159.79 0.7 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.502 -0.999 . . . . 0.0 110.126 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.626 ' O ' HG12 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -127.89 179.69 1.19 Allowed Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.482 -0.761 . . . . 0.0 110.067 -179.651 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.692 ' HB2' HD22 ' A' ' 63' ' ' LEU . 42.1 Cg_endo -68.9 -24.52 33.65 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.611 1.322 . . . . 0.0 111.287 -179.424 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.579 ' O ' ' HG2' ' A' ' 52' ' ' MET . 4.3 mt -106.24 -36.83 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.044 -1.035 . . . . 0.0 108.64 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.403 ' HB2' ' HB2' ' A' ' 47' ' ' ARG . 24.6 mt-30 -54.73 -18.91 5.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.25 -0.906 . . . . 0.0 109.375 178.43 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.937 HG22 ' HB2' ' A' ' 21' ' ' ALA . 9.3 p -116.07 39.23 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.478 -0.764 . . . . 0.0 110.601 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.579 ' HG2' ' O ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -103.55 39.21 1.64 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.946 -1.096 . . . . 0.0 109.443 179.267 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' MET . . . . . 0.412 ' CB ' ' O ' ' A' ' 52' ' ' MET . 0.0 OUTLIER 68.79 -5.61 0.98 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.729 -0.607 . . . . 0.0 110.918 -179.536 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.534 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.1 OUTLIER 39.94 89.32 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.364 -0.835 . . . . 0.0 110.937 179.82 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.533 ' HA2' ' CG ' ' A' ' 90' ' ' PHE . . . 159.13 -28.95 0.4 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.232 -1.947 . . . . 0.0 108.232 -179.287 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.67 79.91 1.72 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.733 -0.863 . . . . 0.0 110.16 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -48.8 -25.18 1.72 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.255 -0.903 . . . . 0.0 110.196 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.62 -39.24 57.68 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.463 -0.773 . . . . 0.0 109.789 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.476 HG22 HG22 ' A' ' 25' ' ' VAL . 23.8 t -69.22 -51.29 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.395 -0.816 . . . . 0.0 109.257 179.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.557 ' HB2' ' HE1' ' A' ' 52' ' ' MET . . . -48.91 -43.66 39.51 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.253 -0.904 . . . . 0.0 109.908 179.008 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.436 ' O ' HD23 ' A' ' 65' ' ' LEU . 5.4 tt0 -53.58 -51.72 62.08 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.501 -0.749 . . . . 0.0 109.677 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.016 HD22 HD23 ' A' ' 32' ' ' LEU . 1.2 mt -50.32 -66.51 0.38 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.593 -0.692 . . . . 0.0 109.912 178.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.951 HD21 HD21 ' A' ' 16' ' ' LEU . 11.0 mt -60.27 -39.27 86.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.676 -0.64 . . . . 0.0 110.798 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.891 HD22 HG13 ' A' ' 96' ' ' VAL . 0.5 OUTLIER -63.09 -60.15 3.83 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.174 -0.954 . . . . 0.0 110.458 -179.78 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.436 HD23 ' O ' ' A' ' 61' ' ' GLU . 0.7 OUTLIER -53.34 -22.67 7.7 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.427 -0.796 . . . . 0.0 110.019 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.582 ' CD2' ' HG ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -90.87 -25.15 19.99 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.611 -0.681 . . . . 0.0 109.679 179.849 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.94 56.58 0.5 Allowed Glycine 0 N--CA 1.481 1.643 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.854 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -70.1 -149.78 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.171 -1.193 . . . . 0.0 109.767 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.428 ' HG2' ' HB3' ' A' ' 72' ' ' CYS . 0.3 OUTLIER -120.46 59.31 6.85 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.498 -0.751 . . . . 0.0 109.628 179.251 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.415 ' HD3' ' C ' ' A' ' 68' ' ' ALA . 43.5 Cg_endo -71.13 -1.53 9.71 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 O-C-N 123.808 1.425 . . . . 0.0 110.712 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -113.35 -66.4 1.09 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.128 -0.982 . . . . 0.0 110.014 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.428 ' HB3' ' HG2' ' A' ' 69' ' ' GLU . 3.1 t -50.57 166.59 0.08 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.453 -0.78 . . . . 0.0 110.534 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.575 ' HB2' ' HA ' ' A' ' 80' ' ' ARG . . . -159.22 -140.18 0.07 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.395 -0.815 . . . . 0.0 110.04 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 78' ' ' LEU . 11.0 t70 -105.05 127.35 28.88 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.062 -1.024 . . . . 0.0 109.765 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.83 -2.6 12.17 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.432 1.228 . . . . 0.0 111.208 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.41 ' HB3' ' OD2' ' A' ' 74' ' ' ASP . . . -97.15 -44.0 7.14 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.096 -1.003 . . . . 0.0 109.72 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.616 ' C ' ' HB2' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -121.79 7.77 9.94 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.454 -0.779 . . . . 0.0 110.265 179.529 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.501 ' HB3' ' O ' ' A' ' 107' ' ' ARG . 1.3 mt 45.61 27.68 0.44 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.335 -0.853 . . . . 0.0 111.102 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.7 m -65.32 88.72 0.08 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.113 -0.992 . . . . 0.0 109.642 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.892 ' CG ' HG11 ' A' ' 106' ' ' VAL . 1.1 mtt180 -69.12 165.91 33.93 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.426 -0.796 . . . . 0.0 110.35 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.407 ' HG3' ' C ' ' A' ' 70' ' ' PRO . 42.8 Cg_endo -69.61 -12.97 34.32 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.728 1.383 . . . . 0.0 111.164 -179.08 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.9 t -66.13 -42.1 90.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.007 -1.058 . . . . 0.0 109.597 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.473 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 69.3 m80 -55.14 -45.49 75.65 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.609 0.719 . . . . 0.0 109.676 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.534 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 1.2 m-20 -49.32 -51.31 35.07 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.093 0.473 . . . . 0.0 110.957 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.666 ' HA ' ' CZ ' ' A' ' 90' ' ' PHE . . . -57.46 -60.69 3.27 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.172 -0.955 . . . . 0.0 109.639 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.824 ' HB1' ' HB2' ' A' ' 118' ' ' ALA . . . -63.14 -9.75 12.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.399 -0.813 . . . . 0.0 109.996 178.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.473 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -70.67 -54.38 12.1 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.039 -1.038 . . . . 0.0 110.665 -179.812 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.479 ' HB3' ' CD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -90.07 -19.11 24.74 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.141 -0.975 . . . . 0.0 109.862 -179.918 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.822 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 87.32 59.91 1.7 Allowed Glycine 0 N--CA 1.487 2.077 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.33 178.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.666 ' CZ ' ' HA ' ' A' ' 85' ' ' ALA . 1.3 p90 -135.17 89.02 2.47 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.012 -1.287 . . . . 0.0 109.912 178.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.714 HD11 ' O ' ' A' ' 125' ' ' ASP . 0.2 OUTLIER -51.58 -35.12 40.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.868 -0.52 . . . . 0.0 110.883 -179.31 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 91' ' ' LEU . 1.7 m-20 -41.86 -33.7 0.56 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.319 -0.863 . . . . 0.0 109.128 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.577 ' O ' HD12 ' A' ' 97' ' ' LEU . 1.1 m -79.52 -49.73 11.8 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.18 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.832 HD21 ' HG ' ' A' ' 130' ' ' LEU . 2.5 tp -54.2 -41.33 68.5 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.65 -0.656 . . . . 0.0 109.587 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 89.8 t -59.99 -53.04 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.327 -0.858 . . . . 0.0 109.182 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.891 HG13 HD22 ' A' ' 64' ' ' LEU . 40.6 t -51.86 -46.46 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.638 -0.664 . . . . 0.0 109.435 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.873 HD23 ' HB1' ' A' ' 102' ' ' ALA . 0.6 OUTLIER -52.32 -55.41 21.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.623 -0.673 . . . . 0.0 109.877 179.588 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -70.63 -28.12 64.59 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.363 -0.835 . . . . 0.0 110.168 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.434 ' HB2' ' HA ' ' A' ' 96' ' ' VAL . 3.1 mtt180 -68.49 -9.57 49.84 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.287 -0.883 . . . . 0.0 110.995 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.832 ' HB2' HD21 ' A' ' 64' ' ' LEU . . . -127.99 -87.12 0.57 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.168 -0.958 . . . . 0.0 110.617 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -163.68 54.39 0.29 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.873 ' HB1' HD23 ' A' ' 97' ' ' LEU . . . -102.26 133.1 47.7 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.252 -1.146 . . . . 0.0 110.305 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.38 152.58 33.69 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.263 -0.898 . . . . 0.0 109.639 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.464 HD13 ' HB1' ' A' ' 133' ' ' ALA . 6.6 mt -143.08 46.46 1.54 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.166 -0.958 . . . . 0.0 110.908 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -169.44 52.7 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.182 -0.949 . . . . 0.0 110.815 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.892 HG11 ' CG ' ' A' ' 80' ' ' ARG . 9.6 p -113.63 -178.14 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 0.0 109.97 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.664 ' H ' HG22 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -129.32 138.04 51.35 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.386 -0.821 . . . . 0.0 109.882 179.129 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.631 ' O ' ' N ' ' A' ' 110' ' ' TRP . 15.5 t0 -72.09 58.92 0.37 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.421 -0.8 . . . . 0.0 110.404 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.616 ' HB2' ' C ' ' A' ' 77' ' ' THR . . . 56.75 -66.34 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.552 -0.718 . . . . 0.0 110.76 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.631 ' N ' ' O ' ' A' ' 108' ' ' ASP . 6.6 m-90 -45.76 -65.11 0.59 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.377 -0.827 . . . . 0.0 110.596 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 159.97 -28.7 0.36 Allowed Glycine 0 N--CA 1.483 1.82 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -62.49 135.38 57.39 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.486 -1.009 . . . . 0.0 110.703 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.428 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 66.0 mt -87.65 165.39 30.43 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.42 -0.8 . . . . 0.0 110.226 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 40.9 Cg_endo -67.78 -28.51 36.6 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.779 1.41 . . . . 0.0 110.081 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.509 HG21 ' CA ' ' A' ' 131' ' ' ARG . 11.1 p -75.53 -35.89 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.399 -0.813 . . . . 0.0 109.939 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.422 ' N ' HG13 ' A' ' 115' ' ' VAL . 1.0 OUTLIER -68.94 -29.87 68.21 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.425 -0.797 . . . . 0.0 109.952 179.744 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.826 HD23 ' N ' ' A' ' 118' ' ' ALA . 4.3 tt -66.08 -58.53 5.26 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.459 -0.776 . . . . 0.0 109.934 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.826 ' N ' HD23 ' A' ' 117' ' ' LEU . . . -50.12 -48.01 53.73 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.383 -0.823 . . . . 0.0 110.969 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -50.77 -41.31 56.73 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.33 -0.856 . . . . 0.0 110.086 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -74.45 -55.1 6.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.57 -0.706 . . . . 0.0 109.94 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.487 HD12 HD21 ' A' ' 117' ' ' LEU . 1.6 mt -53.07 -82.02 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.253 -0.905 . . . . 0.0 110.549 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.82 39.62 0.03 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.543 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . 27.2 m-70 -124.08 52.83 1.44 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.276 -1.132 . . . . 0.0 109.188 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.476 ' HA ' ' HB3' ' A' ' 127' ' ' ALA . 1.1 ttt-85 -46.21 -45.44 16.91 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.73 -0.606 . . . . 0.0 110.341 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.714 ' O ' HD11 ' A' ' 91' ' ' LEU . 1.9 m-20 -52.53 -46.83 66.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.371 -0.831 . . . . 0.0 109.18 179.131 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.822 HG21 ' HA2' ' A' ' 89' ' ' GLY . 2.5 t -75.72 -27.51 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.5 -0.75 . . . . 0.0 109.556 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.476 ' HB3' ' HA ' ' A' ' 124' ' ' ARG . . . -75.19 -48.87 21.48 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.37 -0.831 . . . . 0.0 109.929 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.27 -54.93 41.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.28 -0.887 . . . . 0.0 110.157 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.631 ' HD2' HD23 ' A' ' 94' ' ' LEU . 36.8 t80 -59.33 -36.84 76.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.276 -0.89 . . . . 0.0 109.782 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.832 ' HG ' HD21 ' A' ' 94' ' ' LEU . 8.4 mt -64.03 -49.56 71.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.224 -0.923 . . . . 0.0 109.457 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.509 ' CA ' HG21 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -52.94 -29.77 30.65 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.301 -0.875 . . . . 0.0 110.288 179.856 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -86.34 -42.78 13.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.35 -0.844 . . . . 0.0 109.836 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.464 ' HB1' HD13 ' A' ' 104' ' ' LEU . . . -79.81 -5.66 55.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.435 -0.791 . . . . 0.0 110.513 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -129.6 -65.72 0.83 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.172 -0.955 . . . . 0.0 110.622 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -63.44 144.36 49.11 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 94.83 -76.26 0.92 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 41.0 p -70.4 133.61 47.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.41 -1.053 . . . . 0.0 110.103 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 6.0 mtt85 -98.21 -70.81 0.71 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.278 -0.889 . . . . 0.0 110.767 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -115.21 -145.82 8.75 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.5 p -129.22 39.86 3.7 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.478 -1.013 . . . . 0.0 110.619 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -66.08 133.81 51.53 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.312 -0.867 . . . . 0.0 110.391 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 54.58 32.81 17.77 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.347 -0.845 . . . . 0.0 110.412 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . 50.59 29.35 4.03 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.489 -0.757 . . . . 0.0 110.51 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.47 88.09 0.11 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.495 -0.753 . . . . 0.0 111.302 179.495 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 3.0 mt 40.43 79.56 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.677 -0.639 . . . . 0.0 111.7 179.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 177.05 121.82 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.109 -0.995 . . . . 0.0 110.596 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.417 ' O ' ' HB3' ' A' ' 148' ' ' ALA . . . -72.05 139.01 48.26 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.302 -0.873 . . . . 0.0 109.888 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 147' ' ' ALA . . . 56.24 177.85 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.234 -0.916 . . . . 0.0 110.199 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -150.99 95.97 2.27 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.231 -0.918 . . . . 0.0 110.21 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 173.73 -125.88 1.17 Allowed Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.738 -1.22 . . . . 0.0 110.348 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -80.78 -87.46 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.304 0 O-C-N 123.745 1.392 . . . . 0.0 111.64 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 64.48 16.7 10.41 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.037 -1.039 . . . . 0.0 110.665 -179.438 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.9 t70 57.12 -174.79 0.07 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.145 -0.972 . . . . 0.0 110.662 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 86.3 mt -125.63 74.44 69.69 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.396 -0.815 . . . . 0.0 110.162 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -78.39 146.66 22.18 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.819 1.431 . . . . 0.0 110.764 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.495 1.812 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.078 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 121.254 0.55 . . . . 0.0 109.981 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -50.04 139.81 17.29 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.375 -0.828 . . . . 0.0 110.588 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.58 -178.45 4.05 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.548 1.289 . . . . 0.0 110.031 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 47.8 70.0 0.47 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.524 -0.735 . . . . 0.0 110.197 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -110.87 56.42 0.63 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.343 -0.848 . . . . 0.0 110.444 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -143.39 -81.17 0.05 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.5 m -99.4 156.08 17.2 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.216 -1.167 . . . . 0.0 111.028 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.0 t -100.85 140.89 34.5 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.396 -0.815 . . . . 0.0 109.865 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 63.15 137.37 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.408 -0.808 . . . . 0.0 110.481 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -122.81 106.14 34.65 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.372 -0.83 . . . . 0.0 109.724 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.04 107.61 2.41 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.559 1.294 . . . . 0.0 110.794 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.23 -170.81 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.384 -0.823 . . . . 0.0 110.261 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.22 51.1 2.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.391 -0.818 . . . . 0.0 110.098 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.415 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 5.7 m-20 -83.39 -2.68 56.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.408 -0.808 . . . . 0.0 110.357 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.527 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 0.1 OUTLIER -46.44 -62.78 1.21 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.366 -0.834 . . . . 0.0 110.345 -179.584 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.001 ' HB2' HD21 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -45.81 -35.26 4.27 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.392 0.615 . . . . 0.0 110.115 179.16 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 14' ' ' ASP . . . -77.66 -48.57 16.46 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.463 -0.773 . . . . 0.0 109.639 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.527 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.0 OUTLIER -52.97 -60.26 3.5 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.515 -0.74 . . . . 0.0 110.517 179.72 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.815 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -53.3 -43.44 67.56 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.332 -0.855 . . . . 0.0 109.905 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.484 ' C ' ' HA ' ' A' ' 52' ' ' MET . . . -55.39 -40.17 71.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.572 -0.705 . . . . 0.0 109.527 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.35 -34.43 70.49 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.434 -0.791 . . . . 0.0 110.363 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.9 mtm180 -94.65 22.61 6.1 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.245 -0.909 . . . . 0.0 110.885 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 52.41 72.31 0.54 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.926 ' O ' HG23 ' A' ' 28' ' ' VAL . 4.3 mtt85 -129.87 56.57 1.72 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.428 -1.042 . . . . 0.0 109.769 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.85 HG22 HG23 ' A' ' 59' ' ' VAL . 89.5 t -47.4 -55.14 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.558 -0.714 . . . . 0.0 110.649 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -61.67 -31.46 71.58 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.404 -0.81 . . . . 0.0 110.936 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.456 ' CB ' ' HB3' ' A' ' 24' ' ' ARG . 0.3 OUTLIER -76.43 -33.31 58.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.151 -0.968 . . . . 0.0 109.557 179.876 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.926 HG23 ' O ' ' A' ' 24' ' ' ARG . 5.0 t -78.77 -46.67 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.453 -0.78 . . . . 0.0 109.653 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.533 ' HA ' HD22 ' A' ' 62' ' ' LEU . 15.2 mmm180 -49.22 -48.08 45.75 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.431 -0.793 . . . . 0.0 109.74 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.622 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -72.04 -37.93 69.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.646 -0.659 . . . . 0.0 109.673 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.419 ' HB2' ' O ' ' A' ' 27' ' ' GLU . 6.3 mt -66.58 -56.47 10.59 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.469 -0.77 . . . . 0.0 110.565 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.947 ' HB2' HD21 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -44.45 -56.41 4.29 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.634 -0.666 . . . . 0.0 110.551 -179.809 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.48 -14.64 61.27 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.354 -0.841 . . . . 0.0 110.382 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.622 ' HB2' ' O ' ' A' ' 30' ' ' ALA . . . -79.15 -7.63 58.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.088 -1.007 . . . . 0.0 110.6 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 134.96 -12.19 4.47 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.771 -1.205 . . . . 0.0 110.578 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.941 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -48.73 149.32 1.79 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.172 -1.193 . . . . 0.0 110.509 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.935 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 0.2 OUTLIER -86.33 140.1 34.19 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.373 -0.829 . . . . 0.0 110.253 -179.713 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -74.79 -56.66 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.812 1.427 . . . . 0.0 110.51 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.422 ' ND2' ' O ' ' A' ' 67' ' ' GLY . 0.2 OUTLIER -95.4 55.92 1.78 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.264 -0.897 . . . . 0.0 109.825 179.565 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.935 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -101.76 108.25 55.22 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.169 -0.957 . . . . 0.0 110.774 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.8 132.26 19.82 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.617 1.325 . . . . 0.0 109.554 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.41 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 19.1 p-10 -124.19 71.06 1.11 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.054 -1.029 . . . . 0.0 111.112 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.8 m 44.46 -157.29 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.358 -0.839 . . . . 0.0 110.362 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 60.64 7.56 1.44 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.124 -0.985 . . . . 0.0 110.734 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 50.44 26.66 10.2 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.537 ' HG2' ' HB3' ' A' ' 50' ' ' GLN . 6.0 mtm-85 -125.78 -170.47 2.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.534 -0.98 . . . . 0.0 110.775 -179.28 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.563 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 3.5 mmp_? -119.78 -163.48 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.332 -0.855 . . . . 0.0 109.331 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.945 ' HB2' HD22 ' A' ' 63' ' ' LEU . 43.9 Cg_endo -80.04 -22.43 7.32 Favored 'Trans proline' 0 C--N 1.321 -0.895 0 O-C-N 122.987 0.993 . . . . 0.0 110.911 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.508 ' O ' ' HG2' ' A' ' 52' ' ' MET . 10.1 mt -107.05 -42.47 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.241 -0.912 . . . . 0.0 109.242 178.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.537 ' HB3' ' HG2' ' A' ' 46' ' ' ARG . 1.1 mt-30 -53.1 -22.55 6.32 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.158 -0.963 . . . . 0.0 109.994 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 47' ' ' ARG . 9.2 p -101.61 1.76 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 0.0 110.532 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.508 ' HG2' ' O ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -70.42 157.82 37.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.874 -1.141 . . . . 0.0 109.426 179.936 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -52.09 -13.74 0.34 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.194 -0.941 . . . . 0.0 111.225 -179.318 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.658 ' HE2' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 62.93 10.96 4.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.325 -0.859 . . . . 0.0 109.543 -178.908 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.505 ' O ' ' CE1' ' A' ' 90' ' ' PHE . . . -113.82 -2.95 23.73 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.463 -1.855 . . . . 0.0 108.463 178.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.505 ' HB3' HG23 ' A' ' 59' ' ' VAL . 0.9 OUTLIER -130.25 79.37 1.9 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.395 -1.062 . . . . 0.0 109.99 179.866 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.54 ' CB ' ' HB3' ' A' ' 92' ' ' ASP . . . -50.32 -26.27 4.66 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.425 -0.797 . . . . 0.0 109.62 179.415 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.49 -44.28 65.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.476 -0.765 . . . . 0.0 109.507 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.85 HG23 HG22 ' A' ' 25' ' ' VAL . 43.2 t -59.5 -56.83 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.289 -0.882 . . . . 0.0 109.436 179.235 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.491 ' HB2' ' CE ' ' A' ' 52' ' ' MET . . . -53.72 -42.45 68.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.408 -0.808 . . . . 0.0 109.611 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.725 ' O ' HD23 ' A' ' 65' ' ' LEU . 4.0 tt0 -59.18 -31.88 69.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 110.091 179.627 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.947 HD21 ' HB2' ' A' ' 32' ' ' LEU . 10.2 tp -74.46 -59.0 2.93 Favored 'General case' 0 C--N 1.31 -1.129 0 O-C-N 121.334 -0.854 . . . . 0.0 109.121 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.001 HD21 ' HB2' ' A' ' 16' ' ' LEU . 1.5 mt -63.24 -40.56 97.79 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.496 -0.752 . . . . 0.0 110.389 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 1.054 HD11 ' HB3' ' A' ' 100' ' ' ALA . 0.4 OUTLIER -53.37 -70.5 0.09 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.135 -0.978 . . . . 0.0 110.344 -179.616 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.725 HD23 ' O ' ' A' ' 61' ' ' GLU . 3.2 pp -51.35 -24.41 4.68 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.443 -0.786 . . . . 0.0 109.827 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.518 ' CG ' HD11 ' A' ' 32' ' ' LEU . 1.8 m80 -84.98 -27.2 26.62 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.752 -0.593 . . . . 0.0 110.147 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 63' ' ' LEU . . . 128.94 43.54 0.22 Allowed Glycine 0 N--CA 1.479 1.521 0 C-N-CA 120.136 -1.031 . . . . 0.0 110.906 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.601 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -72.9 -153.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.73 -1.453 . . . . 0.0 109.22 179.057 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.536 ' HB2' ' HB3' ' A' ' 47' ' ' ARG . 0.3 OUTLIER -124.09 67.25 43.46 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.258 -0.901 . . . . 0.0 110.358 179.59 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -72.75 -25.93 16.55 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.91 1.479 . . . . 0.0 110.209 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -104.82 -36.44 7.39 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.334 -0.854 . . . . 0.0 110.006 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.3 m -60.76 164.27 4.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.425 -0.797 . . . . 0.0 110.792 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -165.04 -157.73 0.36 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.483 -0.761 . . . . 0.0 109.724 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.496 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.8 OUTLIER -105.02 138.35 19.48 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.157 -0.964 . . . . 0.0 109.981 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -74.67 -22.17 15.87 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.517 1.272 . . . . 0.0 110.644 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.98 -76.53 0.05 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.288 -0.883 . . . . 0.0 109.853 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.915 HG23 ' CZ3' ' A' ' 110' ' ' TRP . 0.3 OUTLIER -109.52 31.5 5.73 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.517 -0.739 . . . . 0.0 110.518 -179.744 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.602 ' HB2' ' HB2' ' A' ' 109' ' ' ALA . 4.6 mt 40.66 31.27 0.11 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.56 -0.712 . . . . 0.0 110.906 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.463 ' HA ' ' OD1' ' A' ' 108' ' ' ASP . 93.9 m -57.84 87.68 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.379 -0.826 . . . . 0.0 109.538 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.655 ' CG ' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -71.23 161.43 78.33 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.357 -0.839 . . . . 0.0 110.558 -179.086 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.15 -24.46 23.47 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 124.007 1.53 . . . . 0.0 110.251 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.797 HG11 ' HG ' ' A' ' 104' ' ' LEU . 25.1 t -58.86 -27.62 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.429 -0.794 . . . . 0.0 109.856 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 47.8 m80 -65.67 -42.74 90.97 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.885 0.85 . . . . 0.0 109.35 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.658 ' HB3' ' HE2' ' A' ' 54' ' ' MET . 0.9 OUTLIER -54.1 -57.41 11.21 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.732 -179.604 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.727 ' HB1' ' CD1' ' A' ' 94' ' ' LEU . . . -48.18 -63.62 1.02 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.449 -0.782 . . . . 0.0 109.867 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.813 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -56.41 -50.32 71.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.337 -0.852 . . . . 0.0 110.571 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.567 ' HD3' HD12 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -48.71 -34.01 11.22 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.402 -0.811 . . . . 0.0 110.992 -179.349 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.451 ' HB2' ' HB3' ' A' ' 54' ' ' MET . 12.8 tp10 -93.51 -7.83 43.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.201 -0.937 . . . . 0.0 110.618 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.524 ' HA2' ' CG ' ' A' ' 123' ' ' HIS . . . 80.17 16.89 75.52 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.514 ' O ' ' CD1' ' A' ' 94' ' ' LEU . 0.3 OUTLIER -87.22 156.25 19.74 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.046 -1.267 . . . . 0.0 110.351 -179.875 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.588 HD22 HG22 ' A' ' 126' ' ' VAL . 0.0 OUTLIER -122.9 -53.62 1.85 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.66 -0.65 . . . . 0.0 109.644 179.639 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.853 ' O ' HG23 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -44.14 -41.36 5.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.623 -0.673 . . . . 0.0 109.689 179.835 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.406 ' O ' ' HB ' ' A' ' 96' ' ' VAL . 18.5 m -58.41 -49.68 76.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.635 -0.666 . . . . 0.0 109.792 178.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.727 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 0.6 OUTLIER -55.17 -54.12 47.36 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.165 -0.959 . . . . 0.0 109.585 179.727 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.2 t -50.24 -47.69 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.629 -0.669 . . . . 0.0 109.256 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.876 ' CG1' HD22 ' A' ' 64' ' ' LEU . 58.4 t -52.81 -50.82 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.429 HD23 ' HB1' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -54.03 -68.92 0.14 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.502 -0.749 . . . . 0.0 110.293 179.399 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -52.65 -32.17 40.71 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.16 -0.962 . . . . 0.0 109.636 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 25.3 ttm-85 -68.38 -12.66 61.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.521 -0.737 . . . . 0.0 110.048 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 1.054 ' HB3' HD11 ' A' ' 64' ' ' LEU . . . -137.19 60.94 1.63 Allowed 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.234 -0.916 . . . . 0.0 110.738 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 53.94 102.66 0.01 OUTLIER Glycine 0 N--CA 1.494 2.522 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.429 ' HB1' HD23 ' A' ' 97' ' ' LEU . . . -160.25 114.17 2.18 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.133 -1.216 . . . . 0.0 110.544 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 12.8 tpp180 -68.35 159.39 31.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.632 -0.667 . . . . 0.0 110.088 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.918 HD23 ' HB2' ' A' ' 134' ' ' ALA . 0.0 OUTLIER -145.52 10.47 1.25 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.36 -0.837 . . . . 0.0 110.976 -179.577 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -111.57 46.46 1.11 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.048 -1.033 . . . . 0.0 110.268 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.655 HG11 ' CG ' ' A' ' 80' ' ' ARG . 2.5 p -105.7 167.25 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.488 -0.758 . . . . 0.0 109.307 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.546 ' HG3' HD12 ' A' ' 113' ' ' LEU . 6.6 ttt85 -136.37 51.7 2.0 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.389 -0.82 . . . . 0.0 110.29 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.521 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.2 OUTLIER 41.34 35.93 0.47 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.631 -0.668 . . . . 0.0 110.39 179.837 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.602 ' HB2' ' HB2' ' A' ' 78' ' ' LEU . . . 64.2 -66.07 0.12 Allowed 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.59 -0.694 . . . . 0.0 109.82 -179.104 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 0.915 ' CZ3' HG23 ' A' ' 77' ' ' THR . 0.8 OUTLIER -154.85 40.75 0.44 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.398 -0.814 . . . . 0.0 109.874 179.295 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -119.96 -64.06 0.27 Allowed Glycine 0 N--CA 1.481 1.688 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.78 -156.52 0.36 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.32 -1.106 . . . . 0.0 110.397 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.546 HD12 ' HG3' ' A' ' 107' ' ' ARG . 0.1 OUTLIER -133.3 159.69 71.58 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.347 -0.845 . . . . 0.0 109.883 -179.965 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.527 ' HD2' HD23 ' A' ' 113' ' ' LEU . 37.9 Cg_endo -63.81 -57.14 0.38 Allowed 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.373 1.196 . . . . 0.0 110.941 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.586 ' HA ' HD21 ' A' ' 130' ' ' LEU . 2.4 p -51.72 -31.12 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 120.905 -1.122 . . . . 0.0 110.33 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -66.2 -28.31 68.66 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.295 -0.878 . . . . 0.0 110.35 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.567 HD12 ' HD3' ' A' ' 87' ' ' ARG . 2.2 mm? -67.92 -38.57 83.06 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.126 -0.984 . . . . 0.0 110.116 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.689 ' CB ' ' HB2' ' A' ' 127' ' ' ALA . . . -68.48 -50.88 49.09 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.411 -0.806 . . . . 0.0 110.111 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -61.0 -45.54 94.43 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.269 -0.895 . . . . 0.0 110.319 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -54.27 -52.78 60.34 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.314 -0.866 . . . . 0.0 109.719 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.67 -86.43 0.06 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.362 -0.836 . . . . 0.0 110.216 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 174.06 31.34 0.03 OUTLIER Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.524 ' CG ' ' HA2' ' A' ' 89' ' ' GLY . 45.8 m-70 -95.05 46.73 1.13 Allowed 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.417 -1.049 . . . . 0.0 108.685 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.4 ' O ' ' HB2' ' A' ' 128' ' ' ARG . 0.4 OUTLIER -47.14 -33.33 5.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.784 -0.573 . . . . 0.0 109.832 -179.456 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.55 -40.99 98.59 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.813 HG11 ' HA ' ' A' ' 86' ' ' ALA . 3.4 t -75.82 -46.2 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.447 -0.783 . . . . 0.0 109.308 178.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.689 ' HB2' ' CB ' ' A' ' 118' ' ' ALA . . . -53.2 -53.42 50.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.302 -0.874 . . . . 0.0 109.408 179.079 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 124' ' ' ARG . 0.6 OUTLIER -49.8 -53.2 26.74 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.167 -0.958 . . . . 0.0 110.493 179.335 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -71.57 -56.37 6.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.372 -0.83 . . . . 0.0 110.746 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.626 HD22 ' HB2' ' A' ' 86' ' ' ALA . 0.3 OUTLIER -60.25 -30.58 69.52 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.366 -0.834 . . . . 0.0 111.025 -179.033 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.558 ' CB ' ' O ' ' A' ' 127' ' ' ALA . 4.3 ttp-105 -73.07 -27.54 61.79 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.028 -1.045 . . . . 0.0 110.432 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.95 -42.0 77.26 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.212 -0.93 . . . . 0.0 109.23 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.621 ' HB3' HD22 ' A' ' 104' ' ' LEU . . . -87.94 -10.17 51.35 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.638 -0.664 . . . . 0.0 110.336 179.4 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.918 ' HB2' HD23 ' A' ' 104' ' ' LEU . . . -104.12 -10.05 18.27 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.232 -0.918 . . . . 0.0 110.59 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -49.25 155.5 1.87 Allowed Glycine 0 N--CA 1.494 2.547 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -139.08 22.22 2.94 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.77 173.56 0.99 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.294 -1.121 . . . . 0.0 110.006 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.78 61.36 1.25 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.32 -0.863 . . . . 0.0 110.475 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.4 ' O ' ' C ' ' A' ' 140' ' ' SER . . . -153.71 36.92 0.73 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 139' ' ' GLY . 0.1 OUTLIER 43.07 -150.13 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.553 -0.969 . . . . 0.0 110.11 -179.974 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -101.77 39.22 1.49 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.12 -0.988 . . . . 0.0 109.73 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -115.56 21.42 13.99 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.291 -0.88 . . . . 0.0 110.613 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -172.93 -143.07 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.398 -0.814 . . . . 0.0 109.876 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 53.51 81.35 0.09 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.952 -1.093 . . . . 0.0 110.65 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 25.8 mt 56.19 97.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.422 -0.798 . . . . 0.0 110.615 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 177.73 65.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.309 -0.869 . . . . 0.0 109.958 179.524 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.76 156.44 17.01 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.162 -0.961 . . . . 0.0 110.267 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.78 150.39 5.34 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.349 -0.844 . . . . 0.0 110.379 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -91.19 110.85 22.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.491 -0.756 . . . . 0.0 110.157 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -137.66 -94.88 0.36 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.189 -1.565 . . . . 0.0 109.189 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.47 -162.69 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.897 1.472 . . . . 0.0 110.31 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 1.1 p 60.82 -170.44 0.15 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.291 -0.881 . . . . 0.0 110.119 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -58.19 150.17 22.17 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.435 -0.791 . . . . 0.0 110.048 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.529 ' O ' HG23 ' A' ' 154' ' ' ILE . 13.6 tt -148.09 74.16 11.0 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.345 -0.847 . . . . 0.0 110.503 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -77.65 156.77 31.87 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.83 1.437 . . . . 0.0 110.716 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.1 t0 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.125 -0.94 . . . . 0.0 110.05 179.618 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.471 ' CG ' ' H ' ' A' ' 2' ' ' GLU . 8.2 ttt . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 120.95 0.405 . . . . 17.06 110.719 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.495 ' HG3' ' O ' ' A' ' 5' ' ' ALA . 8.3 tp10 -108.55 71.25 0.4 Allowed Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 120.97 -1.081 . . . . 13.73 112.453 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.413 ' HD3' ' C ' ' A' ' 1' ' ' MET . 42.3 Cg_endo -75.05 178.83 6.76 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 N-CA-C 107.622 -1.722 . . . . 12.37 107.622 176.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 50.01 27.27 2.38 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.765 -1.21 . . . . 11.36 109.359 -179.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.542 ' HB1' ' HB3' ' A' ' 8' ' ' SER . . . 53.39 -93.56 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 115.161 1.541 . . . . 10.61 115.161 177.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.38 -36.72 2.59 Favored Glycine 0 N--CA 1.506 3.344 0 N-CA-C 105.331 -3.108 . . . . 9.42 105.331 -174.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.531 ' H ' ' C ' ' A' ' 5' ' ' ALA . 0.1 OUTLIER -97.27 23.41 7.5 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 106.292 -1.744 . . . . 8.35 106.292 175.229 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.542 ' HB3' ' HB1' ' A' ' 5' ' ' ALA . 3.3 p -84.12 20.9 1.46 Allowed 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.245 0.545 . . . . 7.39 110.186 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.586 ' N ' ' SD ' ' A' ' 9' ' ' MET . 0.0 OUTLIER -67.24 7.97 0.36 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.063 -1.023 . . . . 9.32 110.193 178.521 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.672 ' C ' ' H ' ' A' ' 12' ' ' SER . 1.4 mm-40 27.22 98.75 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.667 0 C-N-CA 122.549 0.34 . . . . 6.56 111.815 -178.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.576 ' O ' ' O ' ' A' ' 12' ' ' SER . 51.9 Cg_endo -77.64 14.92 1.34 Allowed 'Trans proline' 0 C--N 1.304 -1.787 0 N-CA-C 105.432 -2.565 . . . . 5.1 105.432 175.504 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.672 ' H ' ' C ' ' A' ' 10' ' ' GLU . 13.6 p 18.1 120.87 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 114.175 -1.375 . . . . 4.21 113.502 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 1.061 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -45.3 -23.51 0.2 Allowed 'General case' 0 C--O 1.204 -1.342 0 N-CA-C 107.407 -1.331 . . . . 2.96 107.407 176.515 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.621 ' O ' ' N ' ' A' ' 17' ' ' ALA . 2.8 m-20 -26.61 -43.32 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 115.699 -0.682 . . . . 2.92 110.021 177.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.507 ' N ' ' O ' ' A' ' 13' ' ' ALA . 4.4 m0 -41.61 -36.87 1.02 Allowed 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.854 -0.738 . . . . 4.18 109.036 178.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 1.074 HD13 HD21 ' A' ' 63' ' ' LEU . 3.4 pp -74.99 -33.16 61.82 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.376 -0.972 . . . . 2.77 108.376 177.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.621 ' N ' ' O ' ' A' ' 14' ' ' ASP . . . -80.45 -54.24 5.86 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.942 -0.762 . . . . 1.94 108.942 177.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.547 ' N ' ' O ' ' A' ' 14' ' ' ASP . 0.5 OUTLIER -54.3 -48.87 70.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.267 -0.896 . . . . 2.64 108.753 178.457 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.472 ' CB ' ' O ' ' A' ' 15' ' ' TRP . . . -63.87 -35.01 79.23 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.574 -0.899 . . . . 2.45 108.574 178.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.678 ' HB1' HG11 ' A' ' 59' ' ' VAL . . . -66.87 -43.61 83.08 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.664 -0.865 . . . . 1.89 108.664 178.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.436 ' N ' ' HA ' ' A' ' 52' ' ' MET . . . -61.58 -26.8 68.2 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.558 -0.713 . . . . 2.07 109.348 179.159 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -95.91 20.32 10.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.647 -0.658 . . . . 4.97 110.087 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 55.81 34.18 60.88 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.38 -1.088 . . . . 2.84 110.38 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.619 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -99.53 74.44 1.89 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.283 -1.127 . . . . 4.37 109.984 179.646 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.756 HG22 ' CG2' ' A' ' 59' ' ' VAL . 62.0 t -57.85 -46.14 87.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.374 -0.829 . . . . 2.98 110.353 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -54.93 -51.45 66.05 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.387 -0.82 . . . . 4.64 110.4 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.16 -46.04 68.73 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.23 -0.919 . . . . 3.3 109.963 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.886 HG12 HD12 ' A' ' 32' ' ' LEU . 5.7 t -69.66 -42.19 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.398 -0.814 . . . . 3.02 109.622 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.994 ' HA ' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -48.5 -48.11 38.3 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.55 -0.719 . . . . 4.19 110.093 179.676 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.5 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -78.73 -35.23 45.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.505 -0.747 . . . . 4.02 110.057 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.505 HD13 ' HB3' ' A' ' 15' ' ' TRP . 25.8 mt -64.26 -65.69 0.64 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.369 -0.832 . . . . 3.44 110.03 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.911 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 3.8 mt -48.33 -42.51 31.44 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.43 -0.794 . . . . 3.6 110.544 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -75.23 -17.27 60.37 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.255 -0.903 . . . . 4.87 110.24 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' A' ' 30' ' ' ALA . . . -86.36 -7.45 58.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -0.924 . . . . 4.13 110.896 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.29 26.91 1.92 Allowed Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.888 -1.148 . . . . 3.84 110.466 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 1.029 ' HB1' HD23 ' A' ' 16' ' ' LEU . . . -79.14 126.79 31.19 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.176 -1.191 . . . . 3.33 110.341 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.583 ' HB2' ' HB2' ' A' ' 13' ' ' ALA . 0.4 OUTLIER -53.44 123.83 37.95 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.375 -0.828 . . . . 3.61 110.337 179.938 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.427 ' HD2' HD13 ' A' ' 37' ' ' LEU . 43.2 Cg_endo -72.56 -23.87 19.44 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.539 1.284 . . . . 3.28 108.966 178.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -112.7 51.77 0.81 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.63 -0.669 . . . . 3.8 109.246 178.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.734 ' CB ' ' HB3' ' A' ' 13' ' ' ALA . . . -92.88 116.4 66.44 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.413 -0.804 . . . . 2.68 110.46 -179.38 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.32 121.12 6.27 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.696 1.366 . . . . 3.15 110.487 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -78.75 175.41 10.48 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.296 -0.877 . . . . 3.3 110.351 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.7 m -83.48 -6.53 59.48 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.317 -0.865 . . . . 3.78 110.502 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -84.46 12.05 7.56 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.153 -0.967 . . . . 3.84 110.375 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.22 16.22 62.07 Favored Glycine 0 N--CA 1.484 1.889 0 N-CA-C 109.064 -1.615 . . . . 2.97 109.064 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 61.3 mtt180 -113.52 -167.51 1.21 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.47 -1.018 . . . . 3.32 110.179 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.709 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 0.8 OUTLIER -108.96 -174.37 0.3 Allowed Pre-proline 0 N--CA 1.492 1.631 0 N-CA-C 108.848 -0.797 . . . . 3.66 108.848 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.709 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 43.3 Cg_endo -74.25 -19.59 19.66 Favored 'Trans proline' 0 C--N 1.314 -1.249 0 O-C-N 123.001 1.0 . . . . 2.19 111.4 -178.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.412 ' O ' ' HG2' ' A' ' 52' ' ' MET . 14.1 mt -108.73 -36.56 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 120.99 -1.069 . . . . 1.71 108.909 178.61 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.417 ' HG3' ' CA ' ' A' ' 81' ' ' PRO . 0.4 OUTLIER -56.55 -17.6 8.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.479 -0.763 . . . . 2.69 110.062 179.246 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.8 p -107.81 -5.16 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.31 -0.869 . . . . 1.77 111.277 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.828 ' HE1' ' HB2' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -62.33 164.86 6.6 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.73 -1.231 . . . . 2.02 109.728 -179.902 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 5.0 tmm? -57.13 -10.32 1.17 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.256 -0.902 . . . . 2.68 111.478 -178.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.693 ' HE2' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 57.67 16.97 3.74 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.08 -1.012 . . . . 1.71 109.95 -179.432 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.462 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -121.26 10.63 9.96 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 108.944 -1.662 . . . . 2.31 108.944 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.39 86.97 1.49 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.453 -1.028 . . . . 2.49 109.197 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.95 -24.72 6.84 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.466 -0.771 . . . . 2.01 110.6 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.42 ' HB3' HG11 ' A' ' 25' ' ' VAL . 0.8 OUTLIER -53.62 -38.59 64.18 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.233 -0.917 . . . . 4.52 109.347 179.56 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.756 ' CG2' HG22 ' A' ' 25' ' ' VAL . 27.1 t -64.78 -49.01 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.043 -1.095 . . . . 2.06 108.043 178.176 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.828 ' HB2' ' HE1' ' A' ' 52' ' ' MET . . . -55.77 -43.04 76.38 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.888 -0.782 . . . . 2.1 108.888 178.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -58.65 -64.04 1.07 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.323 -0.86 . . . . 3.67 108.785 178.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.994 HD11 ' HA ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -41.9 -59.36 1.73 Allowed 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.769 0.795 . . . . 3.13 109.811 177.936 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.074 HD21 HD13 ' A' ' 16' ' ' LEU . 10.4 mt -59.75 -56.01 27.19 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.271 0.558 . . . . 2.64 110.84 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.831 HD21 ' CB ' ' A' ' 100' ' ' ALA . 1.2 tt -56.53 -56.63 18.86 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.426 -0.796 . . . . 3.02 110.918 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.653 ' O ' HD12 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -55.99 -29.89 60.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.141 -0.974 . . . . 3.74 109.935 -179.377 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' HIS . . . . . 0.615 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -82.39 -25.14 34.02 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.423 -0.798 . . . . 4.0 109.395 179.606 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 124.08 42.18 0.37 Allowed Glycine 0 N--CA 1.479 1.518 0 N-CA-C 110.507 -1.037 . . . . 3.14 110.507 179.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.681 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -66.41 -161.79 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.855 -1.38 . . . . 2.73 109.474 179.261 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.591 ' HB2' ' HB3' ' A' ' 47' ' ' ARG . 1.7 mp0 -115.88 62.13 2.02 Favored Pre-proline 0 C--N 1.302 -1.487 0 O-C-N 121.362 -0.836 . . . . 3.37 110.324 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.606 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 43.1 Cg_endo -68.89 -11.71 32.55 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.608 1.32 . . . . 2.64 109.455 178.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.51 ' OD1' ' HB2' ' A' ' 103' ' ' ARG . 1.4 t-20 -106.05 -42.05 5.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.532 -0.73 . . . . 4.06 110.223 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.419 ' HB3' ' HD2' ' A' ' 47' ' ' ARG . 0.3 OUTLIER -69.73 143.84 52.95 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.153 -0.967 . . . . 3.77 110.734 -179.275 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.573 ' HB2' ' HG2' ' A' ' 80' ' ' ARG . . . -132.98 -146.43 0.27 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.426 -0.796 . . . . 3.45 110.103 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 78' ' ' LEU . 1.0 OUTLIER -109.3 138.27 20.45 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.117 -0.989 . . . . 3.88 110.109 -179.939 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -77.35 -6.04 16.1 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.467 1.246 . . . . 4.82 110.551 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -99.12 -35.7 9.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.163 -0.961 . . . . 4.58 110.116 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' THR . . . . . 1.0 HG22 ' CZ3' ' A' ' 110' ' ' TRP . 1.2 p -132.21 7.51 4.27 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.323 -0.861 . . . . 4.37 110.696 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.46 ' HA ' HD23 ' A' ' 78' ' ' LEU . 6.0 mt 45.59 31.66 0.99 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.319 -0.863 . . . . 4.3 110.63 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.9 m -69.12 76.9 0.35 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.413 -0.804 . . . . 3.38 110.472 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ARG . . . . . 0.587 ' HB2' HG11 ' A' ' 106' ' ' VAL . 3.8 mtt85 -57.61 161.27 6.32 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.091 -1.005 . . . . 3.91 109.273 179.326 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.606 ' HG3' ' HA ' ' A' ' 70' ' ' PRO . 39.4 Cg_endo -67.81 -6.84 17.88 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.555 1.292 . . . . 2.39 110.954 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.557 HG21 ' HA ' ' A' ' 104' ' ' LEU . 19.4 t -71.03 -35.51 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.216 -0.927 . . . . 2.38 109.674 179.397 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 31.8 m80 -67.48 -44.89 77.46 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.381 -0.825 . . . . 3.04 109.195 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.693 ' HB3' ' HE2' ' A' ' 54' ' ' MET . 0.3 OUTLIER -49.53 -51.76 34.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.886 -0.509 . . . . 2.28 110.902 -179.792 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.523 ' HB3' ' CD1' ' A' ' 94' ' ' LEU . . . -58.1 -58.36 8.78 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.102 -0.999 . . . . 1.5 109.682 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.84 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -59.79 -40.44 88.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.417 -0.802 . . . . 1.91 110.348 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.9 -34.73 21.21 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.31 -0.869 . . . . 3.67 110.332 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.41 1.85 38.81 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.39 -0.819 . . . . 2.79 110.642 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.499 ' HA2' ' HB3' ' A' ' 123' ' ' HIS . . . 73.62 38.14 51.47 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.521 -1.431 . . . . 2.01 109.521 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.462 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 0.3 OUTLIER -110.8 105.17 13.92 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.311 -1.111 . . . . 2.43 111.101 -179.265 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.624 HD21 ' CB ' ' A' ' 129' ' ' TYR . 0.5 OUTLIER -78.64 -36.85 43.38 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.25 -0.906 . . . . 2.6 109.356 178.872 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.715 ' O ' HG23 ' A' ' 96' ' ' VAL . 19.4 m-20 -48.17 -43.38 31.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.592 -0.692 . . . . 2.72 109.747 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 54.6 m -65.82 -43.92 87.17 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.722 -0.844 . . . . 1.77 108.722 178.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.867 HD21 ' CD2' ' A' ' 130' ' ' LEU . 1.1 tp -57.48 -49.09 77.43 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.435 -0.791 . . . . 2.24 109.006 178.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.507 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 85.7 t -54.94 -54.56 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 108.87 -0.789 . . . . 2.83 108.87 178.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 92' ' ' ASP . 89.1 t -49.37 -50.79 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.739 -0.601 . . . . 2.71 109.861 178.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.487 ' HA ' ' CD1' ' A' ' 64' ' ' LEU . 0.4 OUTLIER -52.45 -64.39 0.83 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.42 -0.8 . . . . 2.9 109.833 179.373 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -57.67 -22.99 49.15 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.34 -0.85 . . . . 3.77 110.683 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.507 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 4.3 ttt180 -73.47 -17.05 61.28 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.222 -0.924 . . . . 4.95 110.893 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.831 ' CB ' HD21 ' A' ' 64' ' ' LEU . . . -141.11 67.99 1.34 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.052 -1.03 . . . . 3.94 111.245 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 48.55 94.98 0.01 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.899 -0.88 . . . . 3.62 110.899 179.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.463 ' O ' HD12 ' A' ' 104' ' ' LEU . . . -150.25 101.54 3.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.396 -1.061 . . . . 3.21 109.021 179.07 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.51 ' HB2' ' OD1' ' A' ' 71' ' ' ASN . 3.0 tpt180 -54.23 120.95 7.21 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.314 -0.866 . . . . 4.85 111.002 -178.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.617 HD23 ' HB2' ' A' ' 134' ' ' ALA . 0.2 OUTLIER -107.5 -7.12 16.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.721 -0.612 . . . . 3.3 109.911 179.45 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -98.32 48.19 0.99 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.101 -1.0 . . . . 4.05 112.525 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.591 HG22 ' H ' ' A' ' 107' ' ' ARG . 1.4 p -113.02 -175.18 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.684 -1.26 . . . . 3.77 109.869 178.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.591 ' H ' HG22 ' A' ' 106' ' ' VAL . 4.2 ptt180 -138.98 158.52 44.05 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.512 -0.742 . . . . 5.47 109.211 178.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASP . . . . . 0.565 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.4 OUTLIER -79.31 48.15 0.86 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.065 -1.022 . . . . 4.46 111.459 -178.74 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' A' ' 108' ' ' ASP . . . 63.49 -63.2 0.13 Allowed 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.462 -0.774 . . . . 4.92 112.205 178.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' TRP . . . . . 1.0 ' CZ3' HG22 ' A' ' 77' ' ' THR . 2.5 m-90 -54.14 -65.88 0.49 Allowed 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 120.094 -0.643 . . . . 5.58 111.652 -176.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.1 38.65 0.02 OUTLIER Glycine 0 N--CA 1.483 1.776 0 C-N-CA 119.358 -1.401 . . . . 4.93 110.917 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -140.55 138.97 34.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.997 -1.296 . . . . 5.54 110.612 179.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.574 ' HB3' HG12 ' A' ' 115' ' ' VAL . 0.2 OUTLIER -90.33 170.53 10.02 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.465 -0.772 . . . . 4.08 110.884 -179.515 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -68.0 -26.4 37.38 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.853 1.449 . . . . 3.1 108.643 177.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.574 HG12 ' HB3' ' A' ' 113' ' ' LEU . 7.2 p -76.29 -35.43 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 108.634 -0.876 . . . . 3.3 108.634 178.462 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.37 -26.41 66.45 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.701 -0.799 . . . . 4.01 109.767 179.094 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.54 -33.79 54.08 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.43 -0.794 . . . . 3.43 110.358 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.699 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -74.08 -37.99 64.04 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.301 -0.875 . . . . 2.83 110.566 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.442 ' HG3' ' HB1' ' A' ' 127' ' ' ALA . 3.6 mt-10 -70.2 -32.3 70.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.331 -0.856 . . . . 3.91 110.561 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -70.91 -57.23 4.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.114 -0.991 . . . . 4.27 109.777 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.93 -81.07 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.304 -0.872 . . . . 3.4 109.993 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.26 40.59 0.03 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.929 -1.669 . . . . 3.23 108.929 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.565 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 48.0 m-70 -107.94 53.12 0.7 Allowed 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.482 -1.011 . . . . 2.7 109.511 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.434 ' O ' ' HB2' ' A' ' 128' ' ' ARG . 20.9 mtt180 -47.5 -52.41 17.41 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.766 -0.584 . . . . 4.13 109.957 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.426 ' O ' HD11 ' A' ' 91' ' ' LEU . 1.0 OUTLIER -48.68 -40.51 28.37 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.486 -0.759 . . . . 2.92 109.915 179.435 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.84 HG11 ' HA ' ' A' ' 86' ' ' ALA . 2.2 t -81.37 -47.24 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.36 -0.837 . . . . 2.25 109.501 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.508 ' HB2' ' CB ' ' A' ' 118' ' ' ALA . . . -56.12 -41.84 75.92 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.211 -0.931 . . . . 2.77 109.89 179.222 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -59.96 -56.65 19.09 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.275 -0.89 . . . . 4.43 109.353 179.327 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.631 ' HD2' HD23 ' A' ' 94' ' ' LEU . 60.0 t80 -60.59 -33.0 72.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.374 -0.829 . . . . 3.06 109.012 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.867 ' CD2' HD21 ' A' ' 94' ' ' LEU . 28.2 mt -65.63 -52.38 52.32 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.959 -0.696 . . . . 3.09 109.315 179.204 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 3.1 ttt-85 -57.88 -19.16 27.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.93 -1.106 . . . . 4.86 109.341 178.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.568 ' O ' ' NH2' ' A' ' 138' ' ' ARG . . . -85.67 -51.33 6.53 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.59 -0.893 . . . . 3.81 108.59 178.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.431 ' HB3' HD22 ' A' ' 104' ' ' LEU . . . -92.5 -52.11 4.81 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.099 -1.001 . . . . 3.53 109.963 178.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.631 ' N ' ' O ' ' A' ' 130' ' ' LEU . . . -88.34 8.03 29.55 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.677 -0.639 . . . . 3.93 112.282 -179.053 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 130' ' ' LEU . . . -64.62 127.08 33.62 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.094 -2.002 . . . . 4.52 108.094 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.684 ' O ' HG23 ' A' ' 137' ' ' THR . . . -83.34 43.92 3.21 Favored Glycine 0 N--CA 1.495 2.589 0 O-C-N 121.011 -1.288 . . . . 6.23 111.173 -178.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' THR . . . . . 0.684 HG23 ' O ' ' A' ' 136' ' ' GLY . 0.2 OUTLIER -164.0 -61.5 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.955 -1.321 . . . . 5.97 110.743 179.089 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.649 ' O ' ' O ' ' A' ' 139' ' ' GLY . 0.0 OUTLIER 73.86 -58.2 0.6 Allowed 'General case' 0 N--CA 1.508 2.442 0 O-C-N 120.869 -1.144 . . . . 12.31 112.105 178.669 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.774 ' O ' ' HB3' ' A' ' 140' ' ' SER . . . -47.43 -117.03 0.0 OUTLIER Glycine 1 N--CA 1.522 4.391 0 O-C-N 120.402 -1.436 . . . . 8.65 110.59 179.489 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 140' ' ' SER . . . . . 0.774 ' HB3' ' O ' ' A' ' 139' ' ' GLY . 54.0 p 125.96 46.48 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.376 0 N-CA-C 114.033 1.123 . . . . 9.9 114.033 177.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -113.35 -89.87 0.52 Allowed 'General case' 0 N--CA 1.507 2.395 0 N-CA-C 106.852 -1.536 . . . . 9.88 106.852 176.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' HIS . . . . . 0.482 ' O ' ' HB2' ' A' ' 143' ' ' ALA 0.277 4.7 t-160 -88.98 -7.35 56.17 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 103.652 -2.722 . . . . 9.73 103.652 173.511 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.482 ' HB2' ' O ' ' A' ' 142' ' ' HIS . . . 157.09 -151.5 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 102.185 -3.265 . . . . 6.4 102.185 -178.569 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ARG . . . . . 0.638 ' HD2' ' O ' ' A' ' 137' ' ' THR . 14.0 ttt85 -79.77 59.45 3.1 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 103.943 -2.614 . . . . 6.18 103.943 174.335 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.526 HG22 ' O ' ' A' ' 144' ' ' ARG . 1.4 tp 46.07 47.15 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 N-CA-C 105.758 -1.941 . . . . 7.91 105.758 -172.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.574 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 9.9 m-20 53.43 45.12 28.96 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.473 -1.24 . . . . 8.23 107.72 -177.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.574 ' HB3' ' O ' ' A' ' 146' ' ' ASP . . . 65.93 165.49 0.19 Allowed 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 106.838 -1.541 . . . . 8.52 106.838 -177.136 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.26 78.79 0.15 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.465 -1.397 . . . . 9.9 108.728 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.524 ' HB3' ' CB ' ' A' ' 153' ' ' ASP . 95.7 mt-10 -138.06 -31.59 0.76 Allowed 'General case' 0 C--N 1.291 -1.962 0 O-C-N 121.479 -0.763 . . . . 12.51 110.735 -177.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 106.98 -111.79 3.6 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 107.063 -2.415 . . . . 13.41 107.063 -177.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.869 ' O ' ' OG ' ' A' ' 152' ' ' SER . 37.9 Cg_endo -67.95 -26.61 37.47 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.101 1.053 . . . . 15.4 110.397 178.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' SER . . . . . 0.869 ' OG ' ' O ' ' A' ' 151' ' ' PRO . 0.0 OUTLIER 151.9 1.93 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.185 0 O-C-N 121.808 -0.557 . . . . 16.09 111.04 179.177 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.524 ' CB ' ' HB3' ' A' ' 149' ' ' GLU . 0.7 OUTLIER 49.86 36.17 10.82 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.583 -1.265 . . . . 17.47 107.583 -176.331 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ILE . . . . . 0.744 HG23 ' HB2' ' A' ' 152' ' ' SER . 0.2 OUTLIER -65.19 159.98 61.23 Favored Pre-proline 0 N--CA 1.498 1.949 0 N-CA-C 109.473 -0.566 . . . . 20.05 109.473 -179.556 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -75.71 115.51 4.21 Favored 'Trans proline' 0 C--N 1.316 -1.139 0 O-C-N 123.682 1.359 . . . . 21.09 110.323 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.6 p30 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.947 -1.025 . . . . 23.42 110.019 -179.946 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.494 ' O ' ' OG1' ' A' ' 18' ' ' THR . 25.8 t0 . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 120.862 0.363 . . . . 0.0 110.62 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.477 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 40.9 m0 -76.66 -56.51 4.54 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.307 -0.87 . . . . 0.0 110.612 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.7 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 0.8 OUTLIER -41.62 -40.76 2.01 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.698 -0.626 . . . . 0.0 111.042 -179.821 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.2 -56.27 5.32 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.174 -0.954 . . . . 0.0 110.07 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.494 ' OG1' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -43.73 -53.93 5.49 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.587 -0.696 . . . . 0.0 110.719 -179.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.665 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -52.97 -55.91 19.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.411 -0.806 . . . . 0.0 110.445 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.457 ' CB ' HG11 ' A' ' 59' ' ' VAL . . . -47.08 -62.58 1.35 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.567 -0.708 . . . . 0.0 111.077 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.622 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -46.15 -28.5 1.25 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.612 -0.68 . . . . 0.0 110.855 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -90.79 30.35 1.2 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.299 -0.876 . . . . 0.0 110.291 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.553 ' CA ' ' HE2' ' A' ' 53' ' ' MET . . . 44.94 27.5 1.48 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.406 -1.077 . . . . 0.0 110.406 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.541 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -105.17 98.47 8.17 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.258 -1.142 . . . . 0.0 110.323 -179.771 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.817 HG22 ' CG2' ' A' ' 59' ' ' VAL . 69.9 t -78.73 -37.26 20.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.633 -0.667 . . . . 0.0 110.172 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -54.65 -52.38 62.49 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.544 -0.722 . . . . 0.0 110.899 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.456 ' O ' HD12 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -58.04 -35.1 70.82 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.225 -0.922 . . . . 0.0 110.821 -179.233 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.852 HG12 HD13 ' A' ' 62' ' ' LEU . 6.2 t -76.41 -47.85 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.274 -0.891 . . . . 0.0 110.171 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.809 ' N ' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -52.73 -46.34 67.37 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.022 -1.049 . . . . 0.0 109.688 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -70.66 -31.0 67.76 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.418 -0.801 . . . . 0.0 109.559 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' ' 27' ' ' GLU . 10.2 mt -79.4 -53.26 7.08 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.402 -0.811 . . . . 0.0 110.815 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.761 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -47.88 -38.76 17.03 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.164 -0.96 . . . . 0.0 110.161 -179.695 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -83.09 -25.06 32.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.332 -0.855 . . . . 0.0 109.855 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.426 ' HB2' ' O ' ' A' ' 30' ' ' ALA . . . -74.25 -3.81 32.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.42 -0.8 . . . . 0.0 110.03 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.82 24.44 5.23 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.761 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -61.04 133.74 56.37 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.071 -1.252 . . . . 0.0 109.809 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.968 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 3.1 mm? -57.09 112.89 5.17 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.399 -0.813 . . . . 0.0 109.778 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.47 -30.42 36.03 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 123.543 1.286 . . . . 0.0 109.88 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.52 ' HA ' ' OE2' ' A' ' 69' ' ' GLU . 33.0 m120 -121.01 56.67 1.01 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.425 -0.797 . . . . 0.0 110.125 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.968 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -100.9 110.89 62.23 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.856 -0.527 . . . . 0.0 109.604 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.92 124.6 9.76 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.494 1.26 . . . . 0.0 109.638 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.498 ' ND2' ' HB2' ' A' ' 44' ' ' TYR . 36.9 t30 -88.2 161.97 16.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.408 -0.808 . . . . 0.0 110.035 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.405 ' N ' ' OD1' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -74.76 -0.99 20.01 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.428 -0.795 . . . . 0.0 110.967 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.498 ' HB2' ' ND2' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -84.64 1.37 46.52 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.004 -1.06 . . . . 0.0 110.093 179.529 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.82 23.24 44.2 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.521 ' O ' ' CB ' ' A' ' 50' ' ' GLN . 46.1 mtt180 -121.66 37.63 4.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.316 -1.108 . . . . 0.0 110.968 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.487 ' HG3' ' HD3' ' A' ' 48' ' ' PRO . 0.0 OUTLIER 43.52 -172.65 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.089 0 O-C-N 121.517 -0.739 . . . . 0.0 111.064 178.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.694 ' HB2' HD22 ' A' ' 63' ' ' LEU . 53.0 Cg_endo -85.5 -23.89 2.1 Favored 'Trans proline' 0 C--N 1.317 -1.089 0 O-C-N 123.476 1.251 . . . . 0.0 110.377 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.582 HG13 ' HB1' ' A' ' 68' ' ' ALA . 2.7 mt -102.63 -43.85 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.229 -0.919 . . . . 0.0 108.95 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.58 ' HG2' ' HA ' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -49.68 -21.17 0.97 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.381 -0.824 . . . . 0.0 109.822 178.808 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.622 HG22 ' HB2' ' A' ' 21' ' ' ALA . 9.3 p -112.99 33.23 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.089 -1.007 . . . . 0.0 110.579 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.563 ' HE1' ' HB2' ' A' ' 60' ' ' ALA . 0.1 OUTLIER -96.96 35.08 1.61 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.061 -1.024 . . . . 0.0 109.483 179.111 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.553 ' HE2' ' CA ' ' A' ' 23' ' ' GLY . 6.2 tmm? 64.55 -6.26 0.31 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.667 -0.645 . . . . 0.0 111.109 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.588 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 44.53 26.79 0.2 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.253 -0.904 . . . . 0.0 110.57 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.537 ' HA2' ' CD2' ' A' ' 90' ' ' PHE . . . -128.79 8.73 6.44 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.648 ' HB3' HG23 ' A' ' 59' ' ' VAL . 0.6 OUTLIER -145.66 70.29 1.24 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.318 -1.107 . . . . 0.0 109.972 179.663 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.505 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . . . -42.79 -36.56 1.5 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.507 -0.746 . . . . 0.0 110.7 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -46.31 -35.29 5.2 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.653 -0.654 . . . . 0.0 109.463 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.817 ' CG2' HG22 ' A' ' 25' ' ' VAL . 46.6 t -67.16 -51.55 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.563 ' HB2' ' HE1' ' A' ' 52' ' ' MET . . . -43.85 -58.13 2.91 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.649 -0.657 . . . . 0.0 110.03 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.93 -49.35 30.41 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.852 HD13 HG12 ' A' ' 28' ' ' VAL . 0.4 OUTLIER -46.11 -62.67 1.23 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.704 -0.622 . . . . 0.0 110.115 178.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.883 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 0.9 OUTLIER -69.98 -55.18 10.27 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.385 -0.822 . . . . 0.0 110.615 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.904 HD22 ' CG1' ' A' ' 96' ' ' VAL . 0.4 OUTLIER -48.39 -63.69 1.01 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.302 -0.874 . . . . 0.0 110.701 -179.528 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.723 HD12 ' C ' ' A' ' 65' ' ' LEU . 0.8 OUTLIER -50.68 -28.12 8.35 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.406 -0.809 . . . . 0.0 109.36 -179.702 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.724 ' ND1' HD12 ' A' ' 32' ' ' LEU . 2.4 m-70 -84.47 -31.98 24.26 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.778 -0.576 . . . . 0.0 109.748 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 63' ' ' LEU . . . 125.81 55.37 0.16 Allowed Glycine 0 N--CA 1.482 1.707 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.883 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -80.02 -150.97 0.07 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.971 -1.311 . . . . 0.0 109.049 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.52 ' OE2' ' HA ' ' A' ' 39' ' ' ASN . 2.0 mt-10 -124.38 68.0 48.45 Favored Pre-proline 0 C--N 1.3 -1.582 0 O-C-N 121.412 -0.805 . . . . 0.0 109.49 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.518 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 49.0 Cg_endo -71.24 -3.89 13.84 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 O-C-N 123.716 1.377 . . . . 0.0 110.293 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.454 ' O ' ' NE ' ' A' ' 80' ' ' ARG . 37.0 m-20 -112.55 -67.67 0.98 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.303 -0.873 . . . . 0.0 109.587 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.8 t -43.69 155.52 0.07 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.57 -0.706 . . . . 0.0 110.128 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.556 ' HB2' ' HA ' ' A' ' 80' ' ' ARG . . . -152.07 -142.26 0.12 Allowed 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.569 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.413 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 0.4 OUTLIER -100.01 139.59 20.88 Favored Pre-proline 0 N--CA 1.484 1.254 0 O-C-N 121.219 -0.926 . . . . 0.0 110.563 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 74' ' ' ASP . 55.2 Cg_endo -84.31 2.77 7.96 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.988 1.52 . . . . 0.0 110.428 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -101.79 -33.87 9.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.16 -0.963 . . . . 0.0 110.027 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -140.24 10.18 2.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.473 -0.767 . . . . 0.0 110.518 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 78' ' ' LEU . 21.7 mt 53.86 38.49 28.77 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.303 -0.873 . . . . 0.0 110.731 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.475 ' HA ' ' OD1' ' A' ' 108' ' ' ASP . 36.5 m -72.91 88.38 1.35 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.423 -0.911 . . . . 0.0 110.313 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.781 ' CD ' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -72.78 168.43 24.36 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.471 -0.768 . . . . 0.0 109.675 179.752 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.58 ' HA ' ' HG2' ' A' ' 50' ' ' GLN . 47.9 Cg_endo -73.26 -2.26 11.82 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.697 1.367 . . . . 0.0 109.998 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 23.9 t -76.59 -36.11 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.585 -0.697 . . . . 0.0 109.612 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.522 ' O ' ' CB ' ' A' ' 87' ' ' ARG . 23.1 m80 -69.39 -40.46 77.35 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.588 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 0.3 OUTLIER -52.1 -52.27 52.48 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.304 -0.873 . . . . 0.0 110.676 179.374 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.674 ' HB1' ' CD1' ' A' ' 94' ' ' LEU . . . -55.46 -64.74 0.75 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.224 -0.922 . . . . 0.0 110.154 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.825 ' HB1' ' HB2' ' A' ' 118' ' ' ALA . . . -58.94 -56.09 26.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.195 -0.941 . . . . 0.0 110.423 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.522 ' CB ' ' O ' ' A' ' 83' ' ' HIS . 0.1 OUTLIER -43.39 -25.85 0.16 Allowed 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.342 -0.849 . . . . 0.0 111.291 -179.821 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.53 ' CB ' ' HB3' ' A' ' 54' ' ' MET . 0.0 OUTLIER -104.34 -13.56 16.08 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.076 -1.015 . . . . 0.0 110.657 179.446 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.04 25.65 39.96 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.537 ' CD2' ' HA2' ' A' ' 55' ' ' GLY . 0.5 OUTLIER -106.12 93.69 4.76 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.283 -1.128 . . . . 0.0 110.722 -179.693 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.434 HD21 ' CG ' ' A' ' 129' ' ' TYR . 0.2 OUTLIER -66.75 -44.22 82.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.509 -0.745 . . . . 0.0 109.908 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.511 ' O ' HG23 ' A' ' 96' ' ' VAL . 36.2 t0 -40.75 -38.69 0.95 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.576 -0.703 . . . . 0.0 110.121 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.404 ' CG2' ' HB2' ' A' ' 85' ' ' ALA . 22.4 m -63.04 -58.87 5.83 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.496 -0.753 . . . . 0.0 109.593 179.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.806 ' CD2' HD21 ' A' ' 130' ' ' LEU . 1.2 mp -48.94 -46.29 43.07 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.398 -0.814 . . . . 0.0 110.023 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 71.6 t -49.84 -54.86 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.904 ' CG1' HD22 ' A' ' 64' ' ' LEU . 85.0 t -53.09 -57.15 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 121.26 0.552 . . . . 0.0 109.716 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.774 ' C ' ' HB2' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -45.62 -56.3 5.34 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.33 0.586 . . . . 0.0 110.034 179.785 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -63.7 -21.0 66.17 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.19 -0.944 . . . . 0.0 109.836 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.36 -15.59 61.37 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.247 -0.908 . . . . 0.0 110.727 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.783 ' HB3' HD11 ' A' ' 64' ' ' LEU . . . -134.47 62.2 1.65 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.237 -0.914 . . . . 0.0 110.249 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 47.54 80.31 0.06 OUTLIER Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.774 ' HB2' ' C ' ' A' ' 97' ' ' LEU . . . -101.51 144.94 29.67 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.378 -1.072 . . . . 0.0 109.991 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -87.04 59.29 5.54 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.19 -0.944 . . . . 0.0 110.317 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.609 ' O ' ' HA ' ' A' ' 134' ' ' ALA . 0.6 OUTLIER -68.95 61.81 0.11 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.542 -0.723 . . . . 0.0 110.592 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -167.44 29.15 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.782 -1.199 . . . . 0.0 110.574 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.781 HG11 ' CD ' ' A' ' 80' ' ' ARG . 1.0 OUTLIER -100.65 -169.86 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 121.27 -0.894 . . . . 0.0 109.283 179.234 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.608 ' H ' HG22 ' A' ' 106' ' ' VAL . 3.7 ptm180 -141.85 131.31 23.78 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 120.118 -0.633 . . . . 0.0 109.877 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.475 ' OD1' ' HA ' ' A' ' 79' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 O-C-N 121.474 -0.766 . . . . 0.0 109.715 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.478 ' HB3' HG12 ' A' ' 115' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.938 -0.394 . . . . 0.0 109.938 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.476 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 44.0 Cg_endo -73.65 -32.2 7.87 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 O-C-N 123.686 1.361 . . . . 0.0 109.999 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.577 HG23 ' CB ' ' A' ' 130' ' ' LEU . 6.8 p -65.9 -36.39 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.415 -0.803 . . . . 0.0 109.409 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -74.97 -42.69 57.12 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.475 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.405 ' HG ' HD12 ' A' ' 121' ' ' LEU . 6.2 tt -61.56 -31.84 71.89 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.33 -0.856 . . . . 0.0 109.162 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.825 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -68.28 -43.37 77.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.466 -0.772 . . . . 0.0 109.944 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -68.22 -46.53 70.31 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.456 -0.778 . . . . 0.0 111.16 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -61.06 -54.37 45.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.298 -0.876 . . . . 0.0 110.276 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.405 HD12 ' HG ' ' A' ' 117' ' ' LEU . 0.2 OUTLIER -56.67 -81.03 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.277 -0.889 . . . . 0.0 110.174 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 173.89 38.76 0.04 OUTLIER Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.555 ' CG ' ' O ' ' A' ' 86' ' ' ALA . 51.3 m-70 -118.16 47.73 1.54 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.495 -1.003 . . . . 0.0 109.663 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -45.83 -53.46 9.63 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.713 -0.617 . . . . 0.0 110.315 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.424 ' O ' HD11 ' A' ' 91' ' ' LEU . 17.2 m-20 -48.0 -34.2 8.99 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.587 -0.696 . . . . 0.0 109.563 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.746 HG11 ' HA ' ' A' ' 86' ' ' ALA . 2.8 t -88.81 -44.9 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.631 -0.668 . . . . 0.0 109.331 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.439 ' O ' HG23 ' A' ' 115' ' ' VAL . . . -52.99 -49.09 66.87 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.397 -0.814 . . . . 0.0 110.176 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.74 -61.58 2.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.134 -0.979 . . . . 0.0 110.105 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.434 ' CG ' HD21 ' A' ' 91' ' ' LEU . 12.2 t80 -53.53 -30.72 43.03 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.421 -0.799 . . . . 0.0 109.379 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.806 HD21 ' CD2' ' A' ' 94' ' ' LEU . 5.9 mt -64.04 -52.16 60.7 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.026 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -54.82 -29.81 55.75 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.303 -0.873 . . . . 0.0 110.272 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -80.94 -33.06 34.31 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.488 -0.758 . . . . 0.0 110.153 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.435 ' HB1' HD13 ' A' ' 104' ' ' LEU . . . -90.12 -21.64 22.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.358 -0.839 . . . . 0.0 110.524 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.609 ' HA ' ' O ' ' A' ' 104' ' ' LEU . . . . . . . . 0 N--CA 1.494 1.774 0 O-C-N 121.081 -1.012 . . . . 0.0 110.238 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.402 ' O ' ' OG1' ' A' ' 18' ' ' THR . 6.9 m-20 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 120.95 0.405 . . . . 0.0 110.356 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.552 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 33.6 m0 -80.35 -6.94 58.8 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.345 -0.847 . . . . 0.0 110.721 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.672 HD11 ' HB1' ' A' ' 36' ' ' ALA . 14.6 mt -86.61 -49.29 7.63 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.201 -0.937 . . . . 0.0 109.387 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.84 -31.16 71.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.562 -0.711 . . . . 0.0 109.37 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.552 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.2 OUTLIER -66.01 -61.17 2.19 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.656 -0.653 . . . . 0.0 109.961 179.68 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.742 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -54.26 -34.78 61.55 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.28 -0.887 . . . . 0.0 110.102 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.77 ' HB1' ' CB ' ' A' ' 52' ' ' MET . . . -65.65 -55.89 15.07 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.248 -0.907 . . . . 0.0 109.23 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.42 -29.96 69.32 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.458 -0.776 . . . . 0.0 109.741 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -98.51 17.26 19.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.402 -0.811 . . . . 0.0 110.243 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.408 ' CA ' ' HE2' ' A' ' 53' ' ' MET . . . 50.06 82.13 0.04 OUTLIER Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.736 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 1.1 ttt180 -143.19 63.91 1.36 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.29 -1.123 . . . . 0.0 109.819 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.529 HG12 ' HD3' ' A' ' 29' ' ' ARG . 94.1 t -48.73 -64.94 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.484 -0.76 . . . . 0.0 111.267 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -49.64 -38.32 31.71 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.355 -0.84 . . . . 0.0 110.959 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.42 -37.64 86.61 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.393 -0.817 . . . . 0.0 110.263 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.826 HG12 HD12 ' A' ' 32' ' ' LEU . 2.8 t -82.95 -45.11 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.4 -0.812 . . . . 0.0 109.924 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.529 ' HD3' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -42.96 -43.9 4.38 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.518 -0.739 . . . . 0.0 110.335 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.94 -41.47 36.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.452 -0.78 . . . . 0.0 109.94 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.431 ' HB2' ' HA ' ' A' ' 28' ' ' VAL . 27.0 mt -53.8 -65.56 0.55 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.281 -0.887 . . . . 0.0 109.729 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.949 HD22 ' CB ' ' A' ' 66' ' ' HIS . 2.8 mt -48.82 -43.92 38.87 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.648 -0.657 . . . . 0.0 110.637 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -70.84 -21.1 62.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.204 -0.935 . . . . 0.0 109.956 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.45 -6.47 59.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.337 -0.852 . . . . 0.0 110.615 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.16 27.28 3.21 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.891 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -66.77 169.01 8.58 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.157 -1.202 . . . . 0.0 109.894 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.572 HD13 ' HD2' ' A' ' 38' ' ' PRO . 1.9 mm? -87.66 125.99 63.24 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.422 -0.799 . . . . 0.0 110.046 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.572 ' HD2' HD13 ' A' ' 37' ' ' LEU . 42.7 Cg_endo -69.22 -36.96 11.2 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.354 1.186 . . . . 0.0 109.716 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.432 ' ND2' ' O ' ' A' ' 67' ' ' GLY . 14.1 m120 -121.41 70.91 0.94 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.502 -0.749 . . . . 0.0 109.45 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.497 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -93.42 104.76 13.31 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.469 -0.769 . . . . 0.0 110.129 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' ' 39' ' ' ASN . 48.6 Cg_endo -70.73 106.8 1.91 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 123.672 1.354 . . . . 0.0 110.533 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.6 p30 -82.9 178.14 8.31 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.189 -0.945 . . . . 0.0 110.015 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.4 m -90.53 40.24 1.01 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.293 -0.88 . . . . 0.0 109.649 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -119.28 12.58 12.59 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.495 -0.753 . . . . 0.0 110.42 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 52.86 25.12 22.19 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.796 -1.722 . . . . 0.0 108.796 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -143.8 117.72 9.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.623 -0.927 . . . . 0.0 110.136 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.499 ' CB ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -60.07 -179.33 0.17 Allowed Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.409 -0.807 . . . . 0.0 109.672 179.578 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.533 ' O ' ' N ' ' A' ' 50' ' ' GLN . 39.2 Cg_endo -65.16 169.55 11.97 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.399 1.21 . . . . 0.0 110.313 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.553 HG13 ' HB1' ' A' ' 68' ' ' ALA . 3.1 mt 63.4 -61.35 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 O-C-N 121.621 -0.674 . . . . 0.0 109.984 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.533 ' N ' ' O ' ' A' ' 48' ' ' PRO . 1.7 tt0 -50.02 -23.88 2.31 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.033 -1.042 . . . . 0.0 110.011 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.3 p -108.46 8.42 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.214 -0.929 . . . . 0.0 110.572 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.77 ' CB ' ' HB1' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -78.29 159.12 28.63 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.959 -1.088 . . . . 0.0 109.534 179.369 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.408 ' HE2' ' CA ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -48.83 -17.62 0.2 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.389 -0.819 . . . . 0.0 111.989 -178.84 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.728 ' HE2' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 61.52 15.41 6.71 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.837 -1.164 . . . . 0.0 109.715 -178.842 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.413 ' C ' ' CE2' ' A' ' 90' ' ' PHE . . . -112.91 17.97 22.18 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -161.2 102.41 1.25 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.37 -1.077 . . . . 0.0 110.25 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.438 ' CB ' ' HB3' ' A' ' 92' ' ' ASP . . . -63.03 -17.87 62.71 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.283 -0.886 . . . . 0.0 109.216 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.24 -42.27 73.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.478 -0.764 . . . . 0.0 109.885 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.588 HG12 HD12 ' A' ' 63' ' ' LEU . 7.4 t -61.5 -53.63 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.347 -0.846 . . . . 0.0 109.516 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.421 ' O ' ' CB ' ' A' ' 64' ' ' LEU . . . -53.7 -51.67 62.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.442 -0.786 . . . . 0.0 110.363 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.462 ' O ' ' HB3' ' A' ' 65' ' ' LEU . 5.6 tt0 -50.34 -44.72 54.57 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.129 -0.982 . . . . 0.0 110.539 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.645 ' CD1' HD13 ' A' ' 32' ' ' LEU . 1.4 tp -70.53 -57.28 4.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.571 -0.706 . . . . 0.0 109.68 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.635 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 6.1 mt -57.77 -45.02 86.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.255 -0.903 . . . . 0.0 109.225 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.854 HD22 HG12 ' A' ' 96' ' ' VAL . 1.0 OUTLIER -64.75 -52.9 54.55 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.58 -0.7 . . . . 0.0 110.407 179.595 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.462 ' HB3' ' O ' ' A' ' 61' ' ' GLU . 12.1 tp -50.95 -39.87 56.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.421 -0.8 . . . . 0.0 109.285 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.949 ' CB ' HD22 ' A' ' 32' ' ' LEU . 2.1 m-70 -78.45 -37.73 42.92 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.147 0.499 . . . . 0.0 110.003 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 38' ' ' PRO . . . 139.78 54.04 0.05 OUTLIER Glycine 0 N--CA 1.481 1.643 0 C-N-CA 120.062 -1.065 . . . . 0.0 110.823 179.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.635 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -68.43 -151.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.765 -1.432 . . . . 0.0 109.768 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.486 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 3.6 mm-40 -131.87 61.06 55.91 Favored Pre-proline 0 C--N 1.303 -1.42 0 O-C-N 121.494 -0.754 . . . . 0.0 109.973 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.558 ' HA ' ' CG ' ' A' ' 81' ' ' PRO . 47.3 Cg_endo -72.14 1.62 5.79 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 123.951 1.5 . . . . 0.0 110.677 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.495 ' N ' ' OD1' ' A' ' 71' ' ' ASN . 1.5 m-20 -115.96 -54.35 2.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.048 -1.032 . . . . 0.0 110.018 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -48.41 154.85 0.58 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.521 -0.737 . . . . 0.0 110.691 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.43 ' HB2' ' HE ' ' A' ' 80' ' ' ARG . . . -151.52 -157.52 0.82 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.444 -0.785 . . . . 0.0 109.923 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' A' ' 78' ' ' LEU . 0.5 OUTLIER -105.16 140.23 20.9 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.263 -0.898 . . . . 0.0 109.566 179.507 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.28 -11.01 24.69 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.589 1.31 . . . . 0.0 110.767 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.98 -43.65 24.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.13 -0.981 . . . . 0.0 110.16 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.519 ' O ' ' HA ' ' A' ' 108' ' ' ASP . 0.2 OUTLIER -139.6 25.62 2.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.459 -0.776 . . . . 0.0 110.171 -179.521 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.438 HD22 HH11 ' A' ' 80' ' ' ARG . 5.7 mt 40.6 36.57 0.39 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.525 -0.734 . . . . 0.0 110.631 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.82 92.13 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.448 -0.783 . . . . 0.0 110.55 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.896 ' CD ' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -73.92 163.31 69.28 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.274 -0.891 . . . . 0.0 109.241 179.146 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.558 ' CG ' ' HA ' ' A' ' 70' ' ' PRO . 46.3 Cg_endo -73.08 -3.34 13.48 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.699 1.368 . . . . 0.0 110.738 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 40.5 t -74.09 -26.37 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.234 -0.916 . . . . 0.0 109.747 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.495 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 9.2 m80 -74.07 -33.85 63.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.479 -0.763 . . . . 0.0 109.38 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.728 ' HB3' ' HE2' ' A' ' 54' ' ' MET . 0.3 OUTLIER -58.73 -50.74 72.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.677 -0.639 . . . . 0.0 110.141 179.583 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.581 ' CB ' HD13 ' A' ' 94' ' ' LEU . . . -53.57 -56.74 14.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.373 -0.83 . . . . 0.0 109.261 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.905 ' HB2' HD11 ' A' ' 130' ' ' LEU . . . -59.99 -52.2 66.4 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.718 -0.614 . . . . 0.0 110.287 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -43.91 -37.8 3.06 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.527 -0.733 . . . . 0.0 111.229 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.9 16.28 26.43 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.22 -0.925 . . . . 0.0 110.373 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' A' ' 123' ' ' HIS . . . 51.58 55.01 22.05 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.413 ' CE2' ' C ' ' A' ' 55' ' ' GLY . 0.4 OUTLIER -123.98 85.33 2.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.387 -1.066 . . . . 0.0 110.623 -179.626 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.25 -34.47 78.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 0.0 110.175 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.549 ' O ' HG23 ' A' ' 96' ' ' VAL . 94.7 m-20 -48.53 -38.38 20.22 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.35 -0.844 . . . . 0.0 109.829 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.6 m -68.64 -54.26 17.47 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.816 HD22 HG13 ' A' ' 126' ' ' VAL . 1.1 tp -47.42 -48.74 26.24 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.528 -0.733 . . . . 0.0 109.572 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 47.5 t -48.4 -51.61 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 CA-C-O 121.372 0.605 . . . . 0.0 109.737 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.854 HG12 HD22 ' A' ' 64' ' ' LEU . 52.2 t -55.64 -52.88 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-O 121.32 0.581 . . . . 0.0 110.325 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.461 HD12 ' N ' ' A' ' 97' ' ' LEU . 10.9 mp -52.67 -42.61 64.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.489 -0.757 . . . . 0.0 109.756 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -78.66 -24.44 45.18 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.252 -0.905 . . . . 0.0 109.49 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.449 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 5.8 mtt180 -74.4 -10.99 60.12 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.33 -0.856 . . . . 0.0 110.878 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.809 ' CB ' HD21 ' A' ' 64' ' ' LEU . . . -124.2 -106.31 0.35 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.281 -0.887 . . . . 0.0 110.616 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -142.93 50.21 0.71 Allowed Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.692 -1.242 . . . . 0.0 110.143 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.519 ' CB ' ' HB2' ' A' ' 70' ' ' PRO . . . -102.59 114.93 29.57 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.342 -1.093 . . . . 0.0 110.261 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 32.0 ttt180 -58.76 111.28 1.22 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.32 -0.863 . . . . 0.0 109.709 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.45 54.64 0.88 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.41 -0.806 . . . . 0.0 110.545 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -165.38 54.02 0.11 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.018 -1.051 . . . . 0.0 110.827 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.896 HG11 ' CD ' ' A' ' 80' ' ' ARG . 4.1 p -109.61 -173.93 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.2 -0.938 . . . . 0.0 109.977 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.701 ' H ' HG22 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -137.95 137.31 37.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.535 -0.728 . . . . 0.0 109.642 179.575 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.519 ' HA ' ' O ' ' A' ' 77' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.278 -0.889 . . . . 0.0 109.766 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.541 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 89.4 mt . . . . . 0 N--CA 1.495 1.816 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.66 ' HG2' HD22 ' A' ' 130' ' ' LEU . 42.9 Cg_endo -69.68 -25.25 29.16 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.431 1.227 . . . . 0.0 109.46 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.55 ' HB ' ' HB3' ' A' ' 130' ' ' LEU . 9.9 p -70.69 -36.05 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.419 -0.801 . . . . 0.0 109.804 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.414 ' N ' HG13 ' A' ' 115' ' ' VAL . 1.9 m-20 -54.44 -34.74 62.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.44 -0.788 . . . . 0.0 110.153 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.596 HD12 HD13 ' A' ' 121' ' ' LEU . 0.3 OUTLIER -65.0 -57.94 7.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.51 -0.744 . . . . 0.0 110.408 -179.776 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.649 ' HB1' ' HB2' ' A' ' 127' ' ' ALA . . . -47.53 -31.44 4.34 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.644 -0.66 . . . . 0.0 110.874 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.03 -30.96 58.63 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.444 -0.785 . . . . 0.0 109.753 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.6 -53.75 8.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.431 -0.793 . . . . 0.0 110.772 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.596 HD13 HD12 ' A' ' 117' ' ' LEU . 3.1 mp -81.27 -94.22 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.31 -0.869 . . . . 0.0 110.662 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -171.66 31.61 0.13 Allowed Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.594 -1.289 . . . . 0.0 110.128 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.555 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 27.1 m-70 -88.08 49.9 1.88 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.057 -1.261 . . . . 0.0 108.837 179.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.4 ttm-85 -45.84 -38.13 6.93 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.673 -0.642 . . . . 0.0 110.554 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -66.07 -42.29 89.6 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.361 -0.837 . . . . 0.0 109.835 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.816 HG13 HD22 ' A' ' 94' ' ' LEU . 8.3 t -77.97 -29.6 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.134 -0.979 . . . . 0.0 110.321 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.649 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . . . -60.15 -41.8 93.53 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.165 -0.96 . . . . 0.0 109.722 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.18 -62.63 1.69 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.519 -0.738 . . . . 0.0 110.549 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.424 ' HB3' HD23 ' A' ' 94' ' ' LEU . 0.6 OUTLIER -54.33 -37.82 65.3 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.282 -0.886 . . . . 0.0 110.096 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.905 HD11 ' HB2' ' A' ' 86' ' ' ALA . 44.3 mt -69.6 -18.45 63.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.541 -0.724 . . . . 0.0 110.417 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -89.44 -28.86 19.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.139 -0.975 . . . . 0.0 109.927 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -84.01 -43.48 15.11 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.327 -0.858 . . . . 0.0 110.409 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -90.42 -34.52 15.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.167 -0.958 . . . . 0.0 110.598 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.874 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.667 0 O-C-N 121.289 -0.882 . . . . 0.0 110.194 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 . . . . . 0 N--CA 1.495 1.792 0 CA-C-O 120.95 0.405 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.484 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 7.3 m0 -54.81 -25.88 31.17 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.119 -0.988 . . . . 0.0 111.171 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.904 HD13 HD21 ' A' ' 63' ' ' LEU . 4.0 pp -65.93 -38.84 89.72 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.03 -1.044 . . . . 0.0 110.51 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.663 ' N ' HD12 ' A' ' 16' ' ' LEU . . . -81.46 -42.61 20.06 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.13 -0.981 . . . . 0.0 110.321 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.484 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.0 OUTLIER -58.88 -56.28 24.32 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.357 -0.839 . . . . 0.0 110.286 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.75 -41.73 74.39 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.255 -0.903 . . . . 0.0 109.834 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.543 ' HB1' HG11 ' A' ' 59' ' ' VAL . . . -55.73 -35.31 65.99 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.416 -0.803 . . . . 0.0 110.063 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.97 -23.87 59.54 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.442 -0.786 . . . . 0.0 110.512 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 -93.65 23.58 4.61 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.272 -0.892 . . . . 0.0 110.457 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 55.34 46.71 78.99 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -118.53 90.91 3.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.274 -1.133 . . . . 0.0 109.805 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.683 HG22 HG23 ' A' ' 59' ' ' VAL . 46.0 t -73.73 -38.96 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.357 -0.84 . . . . 0.0 110.307 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -60.88 -44.83 96.54 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.291 -0.881 . . . . 0.0 110.794 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.757 ' O ' HD12 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -68.5 -38.65 81.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.252 -0.905 . . . . 0.0 110.199 -179.696 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 54.5 t -73.89 -45.24 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.375 -0.828 . . . . 0.0 110.401 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.548 ' HA ' ' CD1' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -62.48 -47.89 81.99 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.077 -1.014 . . . . 0.0 109.441 179.81 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.94 -20.99 64.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.277 -0.889 . . . . 0.0 109.922 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.757 HD12 ' O ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -68.5 -58.83 3.72 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.323 -0.861 . . . . 0.0 110.04 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.841 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 5.0 mt -51.32 -41.68 60.7 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.351 -0.843 . . . . 0.0 110.192 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -70.5 -18.18 62.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.32 -0.862 . . . . 0.0 109.596 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.47 -8.65 47.09 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.32 -0.862 . . . . 0.0 110.706 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.12 29.05 1.71 Allowed Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.876 -1.154 . . . . 0.0 110.676 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.841 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -71.28 161.13 31.58 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.022 -1.281 . . . . 0.0 110.177 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.816 ' HB2' ' HB2' ' A' ' 40' ' ' ALA . 75.5 mt -92.01 142.3 26.23 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.346 -0.846 . . . . 0.0 110.236 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.17 -42.99 1.24 Allowed 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.497 1.262 . . . . 0.0 110.121 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -121.03 58.7 0.95 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.462 -0.774 . . . . 0.0 110.092 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.816 ' HB2' ' HB2' ' A' ' 37' ' ' LEU . . . -79.7 116.39 60.59 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.311 -0.868 . . . . 0.0 109.776 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.52 120.53 7.0 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.68 1.358 . . . . 0.0 110.596 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.425 HD22 ' HB3' ' A' ' 17' ' ' ALA . 1.6 t-20 -99.66 -150.07 0.37 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.447 -0.783 . . . . 0.0 109.996 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.424 ' O ' ' OG ' ' A' ' 43' ' ' SER . 0.1 OUTLIER -109.1 20.82 17.94 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.172 -0.955 . . . . 0.0 110.246 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -118.31 -1.8 11.24 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.053 -1.029 . . . . 0.0 110.849 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.54 25.77 50.85 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.929 -1.269 . . . . 0.0 109.929 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.429 ' HB3' ' HB3' ' A' ' 50' ' ' GLN . 36.5 mtt180 -123.42 16.23 9.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -1.123 . . . . 0.0 110.92 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.637 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER 45.98 -166.68 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.083 0 O-C-N 121.706 -0.621 . . . . 0.0 109.744 179.314 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.637 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 46.8 Cg_endo -78.87 172.77 14.5 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 122.758 0.873 . . . . 0.0 110.939 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.542 ' O ' ' HG2' ' A' ' 52' ' ' MET . 9.0 mt 61.74 -63.89 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 O-C-N 121.771 -0.58 . . . . 0.0 110.69 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.515 ' N ' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -49.87 -20.26 0.85 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.824 -1.172 . . . . 0.0 110.401 179.707 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 51' ' ' VAL . 12.8 p -107.82 -5.38 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.192 -0.942 . . . . 0.0 110.76 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.542 ' HG2' ' O ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -63.06 165.65 6.79 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.893 -1.129 . . . . 0.0 109.955 -179.777 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 33.8 ttp -61.23 -8.43 3.67 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.341 -0.849 . . . . 0.0 111.079 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.623 ' HE1' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 57.09 18.2 3.93 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.133 -0.979 . . . . 0.0 110.016 -179.398 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.432 ' C ' ' CE2' ' A' ' 90' ' ' PHE . . . -112.43 3.12 26.47 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.41 95.71 2.71 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.433 -1.039 . . . . 0.0 109.727 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.77 -23.11 16.47 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.279 -0.888 . . . . 0.0 109.663 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.442 ' HA ' ' HB2' ' A' ' 61' ' ' GLU . 13.1 mtt180 -55.5 -40.24 71.48 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.338 -0.851 . . . . 0.0 109.572 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.683 HG23 HG22 ' A' ' 25' ' ' VAL . 95.5 t -53.6 -59.07 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.544 -0.722 . . . . 0.0 109.225 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -61.63 -26.97 68.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.518 -0.739 . . . . 0.0 109.882 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.442 ' HB2' ' HA ' ' A' ' 58' ' ' ARG . 3.6 tp10 -50.71 -71.56 0.06 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.194 -0.941 . . . . 0.0 110.579 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.548 ' CD1' ' HA ' ' A' ' 29' ' ' ARG . 0.4 OUTLIER -65.55 -50.05 66.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.041 -1.037 . . . . 0.0 110.448 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.904 HD21 HD13 ' A' ' 16' ' ' LEU . 0.9 OUTLIER -49.09 -57.63 6.29 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.252 -0.905 . . . . 0.0 109.933 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.655 HD13 HG12 ' A' ' 96' ' ' VAL . 1.2 tt -63.33 -43.8 96.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.304 -0.872 . . . . 0.0 109.233 179.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.448 ' HB3' ' HA ' ' A' ' 62' ' ' LEU . 12.8 tp -56.09 -31.12 62.96 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.539 -0.726 . . . . 0.0 109.585 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.718 ' CB ' HD22 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -87.21 -45.61 10.48 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.548 -0.72 . . . . 0.0 109.981 -179.569 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 156.18 44.94 0.02 OUTLIER Glycine 0 N--CA 1.483 1.771 0 C-N-CA 119.811 -1.185 . . . . 0.0 110.754 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.465 ' HA ' ' HG2' ' A' ' 48' ' ' PRO . . . -70.66 -152.64 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.889 -1.36 . . . . 0.0 109.882 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -114.75 66.94 1.85 Allowed Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.336 -0.852 . . . . 0.0 110.211 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.502 ' HG3' HD21 ' A' ' 64' ' ' LEU . 50.9 Cg_endo -73.42 -32.55 7.9 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.757 1.398 . . . . 0.0 110.359 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.421 ' O ' ' NE ' ' A' ' 80' ' ' ARG . 6.8 t30 -100.75 -54.74 2.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.509 -0.744 . . . . 0.0 110.891 -179.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.1 m -48.02 151.48 0.95 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.253 -0.904 . . . . 0.0 111.147 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.602 ' HB2' ' HG2' ' A' ' 80' ' ' ARG . . . -135.5 -159.73 0.99 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.411 -0.806 . . . . 0.0 109.958 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.44 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -105.77 136.54 19.26 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.292 -0.88 . . . . 0.0 109.873 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.38 -23.54 20.4 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 123.41 1.216 . . . . 0.0 110.595 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.38 -60.81 2.85 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.117 -0.99 . . . . 0.0 109.745 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 62.9 p -136.76 34.14 2.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.43 -0.794 . . . . 0.0 109.801 179.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.505 ' HA ' HD23 ' A' ' 78' ' ' LEU . 8.0 mt 49.1 33.92 5.31 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.547 -0.721 . . . . 0.0 111.331 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 94.1 m -65.88 102.85 0.82 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.142 -0.974 . . . . 0.0 109.649 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.602 ' HG2' ' HB2' ' A' ' 73' ' ' ALA . 0.1 OUTLIER -82.31 167.37 30.87 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.271 -0.893 . . . . 0.0 110.193 -179.751 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -70.37 -14.76 34.48 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.771 1.406 . . . . 0.0 109.932 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 65.1 t -67.81 -29.26 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.598 -0.689 . . . . 0.0 109.94 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.436 ' CE1' ' HB3' ' A' ' 114' ' ' PRO . 23.4 m80 -75.59 -35.55 60.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.29 -0.881 . . . . 0.0 109.497 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.623 ' HB3' ' HE1' ' A' ' 54' ' ' MET . 0.3 OUTLIER -58.21 -50.31 73.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.658 -0.651 . . . . 0.0 109.736 179.444 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.409 ' HB3' ' CD1' ' A' ' 94' ' ' LEU . . . -56.96 -64.63 0.81 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.265 -0.897 . . . . 0.0 110.066 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.778 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -58.84 -30.08 67.42 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.317 -0.864 . . . . 0.0 111.271 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.4 ' HB3' ' O ' ' A' ' 84' ' ' ASP . 6.2 tpt180 -52.5 -54.43 32.59 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.048 -1.032 . . . . 0.0 110.237 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.26 -2.99 58.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.191 -0.943 . . . . 0.0 110.047 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.473 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 81.26 44.88 7.78 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.432 ' CE2' ' C ' ' A' ' 55' ' ' GLY . 0.5 OUTLIER -110.59 104.68 13.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.2 -1.176 . . . . 0.0 110.328 179.636 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.536 HD11 ' O ' ' A' ' 125' ' ' ASP . 0.3 OUTLIER -80.38 -38.42 30.38 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.456 -0.778 . . . . 0.0 110.109 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.648 ' O ' HG23 ' A' ' 96' ' ' VAL . 0.8 OUTLIER -47.36 -37.26 10.8 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.511 -0.743 . . . . 0.0 110.312 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.8 m -70.99 -45.71 63.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.47 -0.769 . . . . 0.0 109.273 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.602 HD21 ' HG ' ' A' ' 130' ' ' LEU . 1.2 tp -49.67 -49.73 46.29 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.461 -0.774 . . . . 0.0 110.204 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.413 ' O ' ' CB ' ' A' ' 99' ' ' ARG . 58.0 t -55.08 -47.0 77.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.403 -0.81 . . . . 0.0 109.644 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.655 HG12 HD13 ' A' ' 64' ' ' LEU . 36.6 t -54.45 -51.21 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.526 -0.734 . . . . 0.0 109.834 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.536 ' HA ' HD11 ' A' ' 64' ' ' LEU . 9.1 mp -52.11 -67.02 0.29 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.51 -0.744 . . . . 0.0 110.805 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -57.24 -38.76 74.3 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.172 -0.955 . . . . 0.0 110.15 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.42 ' O ' ' HG2' ' A' ' 99' ' ' ARG . 0.1 OUTLIER -66.3 -14.66 62.36 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.392 -0.817 . . . . 0.0 110.474 179.754 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -132.96 54.03 1.98 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.135 -0.978 . . . . 0.0 110.494 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 58.19 105.15 0.01 OUTLIER Glycine 0 N--CA 1.488 2.126 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -164.9 94.69 0.68 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.322 -1.105 . . . . 0.0 110.231 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.423 ' HB3' ' NH2' ' A' ' 80' ' ' ARG . 20.3 ttt180 -52.69 104.96 0.1 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.314 -0.866 . . . . 0.0 109.717 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.505 ' CD2' HD23 ' A' ' 130' ' ' LEU . 0.0 OUTLIER -98.58 67.18 1.74 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.424 -0.798 . . . . 0.0 110.484 -179.515 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -168.46 42.87 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.2 -0.937 . . . . 0.0 110.378 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.66 HG22 ' H ' ' A' ' 107' ' ' ARG . 4.3 p -101.32 -178.0 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.271 -0.893 . . . . 0.0 110.021 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.66 ' H ' HG22 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -128.57 142.01 51.19 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.521 -0.737 . . . . 0.0 109.291 179.157 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 . . . . . 0 N--CA 1.493 1.723 0 O-C-N 121.216 -0.928 . . . . 0.0 110.438 -179.589 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.489 HD23 ' O ' ' A' ' 106' ' ' VAL . 50.1 mt . . . . . 0 N--CA 1.494 1.761 0 N-CA-C 110.235 -0.284 . . . . 0.0 110.235 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 41.3 Cg_endo -67.47 -27.53 39.59 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 O-C-N 123.676 1.356 . . . . 0.0 110.044 178.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 127' ' ' ALA . 7.8 p -80.74 -35.55 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.412 -0.805 . . . . 0.0 109.761 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.403 ' N ' HG13 ' A' ' 115' ' ' VAL . 37.7 t70 -70.4 -29.85 66.58 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.467 -0.77 . . . . 0.0 110.009 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.3 tt -70.4 -44.48 67.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.422 -0.799 . . . . 0.0 110.303 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.654 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -68.27 -48.61 64.58 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.29 -0.881 . . . . 0.0 110.413 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.54 ' HG2' ' HB1' ' A' ' 127' ' ' ALA . 2.4 mm-40 -55.67 -29.47 59.39 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.293 -0.879 . . . . 0.0 110.068 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -78.31 -39.72 38.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.464 -0.773 . . . . 0.0 110.235 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.33 -88.03 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.346 -0.846 . . . . 0.0 110.281 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -177.86 25.99 0.06 OUTLIER Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.451 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 36.0 m-70 -108.11 50.59 0.77 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.024 -1.28 . . . . 0.0 108.994 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.481 ' HA ' ' HB3' ' A' ' 127' ' ' ALA . 5.4 ttt180 -46.09 -37.37 6.73 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.71 -0.619 . . . . 0.0 110.124 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.536 ' O ' HD11 ' A' ' 91' ' ' LEU . 7.2 p-10 -59.92 -42.25 93.53 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.406 -0.809 . . . . 0.0 109.201 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.778 HG11 ' HA ' ' A' ' 86' ' ' ALA . 2.6 t -81.35 -32.56 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.437 -0.789 . . . . 0.0 109.037 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.54 ' HB1' ' HG2' ' A' ' 119' ' ' GLU . . . -69.2 -39.05 78.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.512 -0.743 . . . . 0.0 109.45 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.51 -61.21 2.79 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.277 -0.889 . . . . 0.0 109.676 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.432 ' HD2' HD23 ' A' ' 94' ' ' LEU . 71.0 t80 -54.48 -37.18 64.97 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.348 -0.845 . . . . 0.0 109.467 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.776 HD11 ' HB2' ' A' ' 86' ' ' ALA . 14.8 mt -63.77 -30.08 71.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.519 -0.738 . . . . 0.0 109.525 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -68.79 -30.62 69.24 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.536 -0.728 . . . . 0.0 110.121 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -87.01 -36.59 18.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.286 -0.884 . . . . 0.0 110.408 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -89.22 -15.85 32.67 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.291 -0.88 . . . . 0.0 110.678 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.691 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.23 -0.919 . . . . 0.0 110.432 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.441 ' OD1' HG23 ' A' ' 18' ' ' THR . 10.7 t0 . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 121.002 0.43 . . . . 0.0 110.404 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.666 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 1.3 t90 -65.66 -10.25 34.54 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.139 -0.976 . . . . 0.0 110.442 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.693 HD23 ' HB3' ' A' ' 40' ' ' ALA . 1.8 tp -73.0 -54.37 8.76 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.245 -0.91 . . . . 0.0 109.72 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.649 ' HB2' ' HA ' ' A' ' 48' ' ' PRO . . . -75.77 -42.82 49.25 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.368 -0.833 . . . . 0.0 110.488 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.666 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 3.1 p -49.37 -46.29 47.0 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.468 -0.77 . . . . 0.0 110.76 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.62 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -66.3 -47.18 74.42 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.283 -0.886 . . . . 0.0 110.299 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.48 ' HB1' HG11 ' A' ' 59' ' ' VAL . . . -52.54 -36.11 54.89 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.409 -0.807 . . . . 0.0 110.475 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.402 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -78.92 -26.01 43.68 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.343 -0.848 . . . . 0.0 110.323 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -93.25 19.22 8.38 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.203 -0.936 . . . . 0.0 110.735 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 52.98 53.0 35.95 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.86 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -122.06 61.4 0.96 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.405 -1.056 . . . . 0.0 109.93 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.991 HG22 HG23 ' A' ' 59' ' ' VAL . 37.5 t -50.22 -46.31 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.475 -0.766 . . . . 0.0 110.672 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -59.1 -36.43 75.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.316 -0.865 . . . . 0.0 110.349 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -73.73 -31.43 63.36 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.234 -0.916 . . . . 0.0 109.616 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.86 HG23 ' O ' ' A' ' 24' ' ' ARG . 3.4 t -76.48 -50.19 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.554 -0.716 . . . . 0.0 109.57 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.936 ' HA ' HD22 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -49.09 -45.26 43.02 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.481 -0.762 . . . . 0.0 110.132 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -77.36 -41.83 38.86 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.454 -0.779 . . . . 0.0 109.877 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.459 HD11 ' CD1' ' A' ' 15' ' ' TRP . 12.6 mt -57.14 -67.8 0.29 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.361 -0.837 . . . . 0.0 110.439 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.905 ' HB3' HD11 ' A' ' 62' ' ' LEU . 0.3 OUTLIER -48.54 -46.0 38.18 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.585 -0.697 . . . . 0.0 111.016 -179.382 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.13 -14.08 61.31 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.26 -0.9 . . . . 0.0 110.324 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 30' ' ' ALA . . . -92.07 -8.52 45.64 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.223 -0.923 . . . . 0.0 111.024 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 146.72 -28.98 1.59 Allowed Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.741 -1.219 . . . . 0.0 110.265 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.745 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -53.76 106.33 0.18 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.107 -1.231 . . . . 0.0 110.579 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.69 ' HG ' ' HB2' ' A' ' 40' ' ' ALA . 0.6 OUTLIER -66.96 152.22 96.17 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.361 -0.837 . . . . 0.0 109.734 179.701 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -74.57 -28.49 9.94 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.715 1.376 . . . . 0.0 111.083 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -90.26 32.62 0.92 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.209 -0.932 . . . . 0.0 110.246 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.693 ' HB3' HD23 ' A' ' 16' ' ' LEU . . . -84.73 112.65 44.17 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.385 -0.822 . . . . 0.0 110.097 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.45 123.11 8.86 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.652 1.343 . . . . 0.0 110.148 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.546 HD22 HG11 ' A' ' 51' ' ' VAL . 48.4 p-10 -80.6 5.93 14.06 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.381 -0.824 . . . . 0.0 110.702 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 58.54 17.53 5.02 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.092 -1.005 . . . . 0.0 110.024 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -107.3 15.19 25.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.422 -0.799 . . . . 0.0 109.412 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.0 24.64 43.47 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.5 ' O ' ' CB ' ' A' ' 50' ' ' GLN . 35.3 mtt180 -135.79 32.0 3.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.308 -1.113 . . . . 0.0 111.1 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.583 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 0.6 OUTLIER 42.56 -166.72 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.119 0 O-C-N 121.501 -0.749 . . . . 0.0 110.937 178.589 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.649 ' HA ' ' HB2' ' A' ' 17' ' ' ALA . 48.9 Cg_endo -85.6 -24.57 1.85 Allowed 'Trans proline' 0 C--N 1.318 -1.036 0 O-C-N 122.998 0.999 . . . . 0.0 110.81 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.65 HG12 HD22 ' A' ' 63' ' ' LEU . 5.8 mt -107.04 -40.16 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.129 -0.982 . . . . 0.0 110.047 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.5 ' CB ' ' O ' ' A' ' 46' ' ' ARG . 0.9 OUTLIER -47.1 -27.11 1.27 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.488 -0.757 . . . . 0.0 110.555 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.546 HG11 HD22 ' A' ' 42' ' ' ASN . 9.0 p -97.06 -2.47 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.218 -0.926 . . . . 0.0 110.19 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.466 ' CE ' ' CE ' ' A' ' 54' ' ' MET . 56.8 ttp -52.15 154.33 2.36 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.515 -0.741 . . . . 0.0 109.789 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 1.4 tmm? -69.77 -2.91 13.31 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.377 -0.827 . . . . 0.0 111.07 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.468 ' SD ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 52.62 22.77 2.33 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.989 -1.07 . . . . 0.0 110.115 -179.687 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.416 ' C ' ' CZ ' ' A' ' 90' ' ' PHE . . . -123.95 9.25 8.53 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 178.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.522 ' HB3' HG23 ' A' ' 59' ' ' VAL . 0.6 OUTLIER -144.82 80.73 1.63 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.436 -1.038 . . . . 0.0 109.931 179.887 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -52.23 -25.08 8.39 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.215 -0.928 . . . . 0.0 109.757 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.6 mtt180 -61.21 -36.73 80.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.472 -0.768 . . . . 0.0 109.503 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.991 HG23 HG22 ' A' ' 25' ' ' VAL . 37.3 t -55.4 -69.95 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.263 -0.898 . . . . 0.0 109.256 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -47.44 -34.42 7.22 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.296 -0.878 . . . . 0.0 109.498 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.436 ' O ' ' CB ' ' A' ' 65' ' ' LEU . 11.1 tt0 -54.27 -32.17 55.53 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.269 -0.894 . . . . 0.0 109.845 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.936 HD22 ' HA ' ' A' ' 29' ' ' ARG . 1.0 OUTLIER -87.06 -45.66 10.52 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.607 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.699 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 4.5 mp -62.65 -53.46 54.15 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.718 -0.614 . . . . 0.0 109.98 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.602 ' CD2' ' HB3' ' A' ' 100' ' ' ALA . 0.2 OUTLIER -63.42 -42.9 98.75 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.226 -0.921 . . . . 0.0 109.565 179.553 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.436 ' CB ' ' O ' ' A' ' 61' ' ' GLU . 10.0 tp -54.06 -37.49 64.23 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.363 -0.836 . . . . 0.0 108.804 178.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.737 ' CG ' HD22 ' A' ' 32' ' ' LEU . 7.8 m80 -85.76 -21.54 28.17 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.357 0.598 . . . . 0.0 109.69 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.24 56.83 0.73 Allowed Glycine 0 N--CA 1.479 1.533 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 179.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.699 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -64.82 -148.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.033 -1.275 . . . . 0.0 109.089 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.576 ' HB2' ' HB3' ' A' ' 47' ' ' ARG . 53.9 mt-10 -117.27 55.98 1.76 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.189 -0.944 . . . . 0.0 110.079 179.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.566 ' HB2' ' HB2' ' A' ' 102' ' ' ALA . 44.3 Cg_endo -69.4 -11.19 30.74 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 O-C-N 123.631 1.332 . . . . 0.0 110.392 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.433 ' HA ' ' CZ ' ' A' ' 80' ' ' ARG . 2.8 m120 -95.91 -56.48 2.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.257 -0.902 . . . . 0.0 110.415 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -50.12 148.62 3.29 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.315 -0.865 . . . . 0.0 110.919 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.69 -158.2 0.84 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.478 -0.764 . . . . 0.0 109.721 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.496 ' O ' ' N ' ' A' ' 78' ' ' LEU . 19.1 m-20 -106.43 126.21 30.99 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.321 -0.862 . . . . 0.0 109.53 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.12 -20.58 28.4 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.389 1.205 . . . . 0.0 110.434 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.79 -42.05 88.14 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.236 -0.915 . . . . 0.0 110.141 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.26 21.83 1.07 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.478 -0.764 . . . . 0.0 109.842 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 74' ' ' ASP . 1.4 mt 50.72 41.39 26.08 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.561 -0.712 . . . . 0.0 111.164 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 18.4 m -73.95 100.62 3.59 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.105 -0.997 . . . . 0.0 109.618 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.9 ' HG3' HG11 ' A' ' 106' ' ' VAL . 0.3 OUTLIER -76.84 164.02 61.93 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.381 -0.825 . . . . 0.0 109.98 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.55 -14.17 27.55 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.68 1.358 . . . . 0.0 110.649 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 42.0 t -63.63 -28.2 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.233 -0.917 . . . . 0.0 109.927 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.431 ' O ' ' CB ' ' A' ' 87' ' ' ARG . 29.1 m80 -65.52 -44.39 87.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.441 -0.787 . . . . 0.0 109.351 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.497 ' OD2' ' HG2' ' A' ' 50' ' ' GLN . 67.8 m-20 -49.95 -55.86 12.86 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.664 -0.647 . . . . 0.0 111.244 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.599 ' CB ' HD13 ' A' ' 94' ' ' LEU . . . -54.22 -68.0 0.22 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.173 -0.954 . . . . 0.0 109.971 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.846 ' HB1' ' HB2' ' A' ' 118' ' ' ALA . . . -54.92 -40.86 70.32 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.318 -0.864 . . . . 0.0 111.098 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 83' ' ' HIS . 6.2 tmm_? -51.47 -31.67 24.25 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.91 -1.119 . . . . 0.0 110.228 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -107.87 16.62 23.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.519 -0.738 . . . . 0.0 110.308 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.502 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 55.43 48.52 69.42 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.417 ' CE2' ' N ' ' A' ' 56' ' ' SER . 0.1 OUTLIER -116.57 91.31 3.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.455 -1.026 . . . . 0.0 110.694 -179.1 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.563 HD23 ' HB3' ' A' ' 94' ' ' LEU . 0.4 OUTLIER -75.58 -39.01 58.71 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.313 -0.867 . . . . 0.0 110.679 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.598 ' O ' HG23 ' A' ' 96' ' ' VAL . 27.3 m-20 -47.32 -44.95 24.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.429 -0.795 . . . . 0.0 109.902 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.455 HG21 ' HE3' ' A' ' 54' ' ' MET . 23.1 m -68.86 -40.0 79.54 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.615 HD21 HD21 ' A' ' 130' ' ' LEU . 5.0 tp -59.36 -47.49 85.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.638 -0.664 . . . . 0.0 109.924 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 53.2 t -53.84 -45.92 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.411 -0.806 . . . . 0.0 109.496 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 92' ' ' ASP . 24.8 t -62.47 -43.15 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.555 -0.715 . . . . 0.0 109.545 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.739 HD23 ' CB ' ' A' ' 102' ' ' ALA . 0.2 OUTLIER -53.59 -46.14 70.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.629 -0.669 . . . . 0.0 110.443 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -83.86 -28.28 28.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.354 -0.841 . . . . 0.0 110.426 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.7 mtp85 -66.25 -11.72 51.94 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.378 -0.826 . . . . 0.0 111.044 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.602 ' HB3' ' CD2' ' A' ' 64' ' ' LEU . . . -124.42 -79.48 0.61 Allowed 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.157 -0.964 . . . . 0.0 110.891 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -159.26 88.07 0.11 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.016 -1.233 . . . . 0.0 110.016 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.739 ' CB ' HD23 ' A' ' 97' ' ' LEU . . . -160.78 110.73 1.73 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.286 -1.126 . . . . 0.0 110.314 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 8.1 ttt180 -50.58 167.16 0.07 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.373 -0.83 . . . . 0.0 110.662 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.568 ' CD2' HD23 ' A' ' 130' ' ' LEU . 0.1 OUTLIER -149.14 43.47 0.96 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.417 -0.802 . . . . 0.0 110.067 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -161.01 48.47 0.22 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.195 -0.941 . . . . 0.0 110.778 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.9 HG11 ' HG3' ' A' ' 80' ' ' ARG . 4.2 p -109.21 -174.47 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.188 -0.945 . . . . 0.0 109.563 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.67 ' H ' HG22 ' A' ' 106' ' ' VAL . 7.7 ptt180 -141.67 147.85 38.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.428 -0.795 . . . . 0.0 109.521 178.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.4 t0 . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.336 -0.852 . . . . 0.0 110.058 -179.771 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.494 ' HG ' ' HD2' ' A' ' 114' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.746 0 CA-C-O 120.563 0.221 . . . . 0.0 110.669 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.494 ' HD2' ' HG ' ' A' ' 113' ' ' LEU . 44.7 Cg_endo -72.35 -35.96 5.93 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 O-C-N 123.868 1.457 . . . . 0.0 110.053 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.494 HG12 ' HB3' ' A' ' 113' ' ' LEU . 12.0 p -67.75 -26.79 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.273 -0.892 . . . . 0.0 109.831 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -65.28 -42.45 93.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.472 -0.767 . . . . 0.0 109.775 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.564 ' O ' HD12 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -63.47 -49.64 72.82 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.529 -0.732 . . . . 0.0 110.267 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.846 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -48.68 -64.8 0.7 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.346 -0.846 . . . . 0.0 110.804 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -55.1 -23.7 22.0 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.278 -0.889 . . . . 0.0 110.151 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.82 -33.8 72.82 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.412 -0.805 . . . . 0.0 110.027 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.564 HD12 ' O ' ' A' ' 117' ' ' LEU . 0.7 OUTLIER -96.25 -8.56 32.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.326 -0.858 . . . . 0.0 110.384 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.33 32.71 6.24 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.497 ' ND1' ' O ' ' A' ' 86' ' ' ALA . 36.0 m170 -95.11 55.33 1.78 Allowed 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.072 -1.252 . . . . 0.0 109.478 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.407 ' O ' ' CB ' ' A' ' 128' ' ' ARG . 12.2 ttm180 -45.9 -30.13 1.63 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.594 -0.691 . . . . 0.0 110.286 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.434 ' HB3' HD12 ' A' ' 91' ' ' LEU . 0.6 OUTLIER -69.96 -41.1 74.94 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.571 -0.706 . . . . 0.0 109.488 179.32 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.783 HG11 ' HA ' ' A' ' 86' ' ' ALA . 2.1 t -89.5 -39.64 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.427 -0.795 . . . . 0.0 110.343 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.59 -34.29 77.92 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.296 -0.877 . . . . 0.0 109.957 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.407 ' CB ' ' O ' ' A' ' 124' ' ' ARG . 34.5 ttt85 -74.01 -56.83 4.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.354 -0.841 . . . . 0.0 109.742 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -56.02 -26.36 48.49 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.302 -0.874 . . . . 0.0 109.605 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.777 HD11 ' HB2' ' A' ' 86' ' ' ALA . 14.2 mt -78.5 -50.76 11.04 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.454 -0.779 . . . . 0.0 109.994 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.6 tpt85 -52.56 -25.97 11.96 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.436 -0.79 . . . . 0.0 110.597 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -79.46 -53.12 7.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.204 -0.935 . . . . 0.0 109.957 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -81.35 -7.15 59.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.435 -0.791 . . . . 0.0 110.511 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.674 0 O-C-N 121.18 -0.95 . . . . 0.0 110.279 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.408 ' O ' ' OG1' ' A' ' 18' ' ' THR . 11.4 p30 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 120.83 0.348 . . . . 0.0 110.946 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.452 ' CD1' ' OE1' ' A' ' 27' ' ' GLU . 0.3 OUTLIER -60.15 -11.56 6.43 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.343 -0.848 . . . . 0.0 111.299 -179.644 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.525 HD21 ' HB1' ' A' ' 36' ' ' ALA . 23.8 mt -78.36 -57.05 3.98 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.936 -1.102 . . . . 0.0 109.534 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.643 ' HB3' ' ND2' ' A' ' 42' ' ' ASN . . . -58.47 -48.38 80.95 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.508 -0.745 . . . . 0.0 109.471 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.424 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.2 OUTLIER -54.52 -59.95 4.0 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.39 -0.819 . . . . 0.0 110.128 179.341 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.522 ' HB1' ' HB3' ' A' ' 27' ' ' GLU . . . -54.3 -56.78 15.08 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.49 -0.757 . . . . 0.0 110.181 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.628 ' CB ' HG11 ' A' ' 59' ' ' VAL . . . -52.87 -47.87 67.53 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.45 -0.781 . . . . 0.0 109.847 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.555 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -61.07 -19.2 61.14 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.468 -0.77 . . . . 0.0 109.863 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.71 18.03 15.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.501 -0.749 . . . . 0.0 110.703 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 54.17 47.85 65.89 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.65 98.84 4.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.304 -1.115 . . . . 0.0 109.716 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.661 HG12 ' CG ' ' A' ' 29' ' ' ARG . 3.1 t -74.31 -43.73 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.463 -0.773 . . . . 0.0 109.821 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -45.4 -54.26 7.55 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.455 -0.778 . . . . 0.0 110.781 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.522 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -48.91 -49.46 39.88 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.371 -0.831 . . . . 0.0 110.041 179.801 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 1.01 HG12 HD12 ' A' ' 32' ' ' LEU . 6.2 t -74.13 -45.63 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.587 -0.696 . . . . 0.0 110.307 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.936 ' HA ' HD11 ' A' ' 62' ' ' LEU . 9.3 mmm180 -45.34 -41.65 9.13 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.501 -0.749 . . . . 0.0 109.93 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.46 -39.59 31.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.544 -0.723 . . . . 0.0 109.646 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.48 ' HB2' ' HA ' ' A' ' 28' ' ' VAL . 32.8 mt -61.06 -67.12 0.43 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.419 -0.8 . . . . 0.0 110.137 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.01 HD12 HG12 ' A' ' 28' ' ' VAL . 13.7 mt -51.85 -36.88 49.88 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.476 -0.765 . . . . 0.0 110.461 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.422 ' HB2' ' O ' ' A' ' 29' ' ' ARG . 46.9 mt-10 -72.37 -18.08 61.77 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.308 -0.87 . . . . 0.0 110.022 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.97 -7.5 48.81 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.359 -0.838 . . . . 0.0 110.435 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.61 23.73 6.14 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.525 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -61.22 164.45 5.31 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.296 -1.12 . . . . 0.0 110.073 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.457 ' O ' HD12 ' A' ' 16' ' ' LEU . 40.8 tp -97.18 99.15 5.62 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.536 -0.727 . . . . 0.0 109.927 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.54 ' HB3' HD21 ' A' ' 32' ' ' LEU . 44.1 Cg_endo -68.56 -23.11 37.37 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 O-C-N 123.656 1.345 . . . . 0.0 110.437 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.41 34.25 1.06 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.252 -0.905 . . . . 0.0 110.018 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.82 122.52 71.42 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.333 -0.855 . . . . 0.0 110.274 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -73.42 111.81 3.38 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.609 1.321 . . . . 0.0 110.38 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.643 ' ND2' ' HB3' ' A' ' 17' ' ' ALA . 2.9 m120 -90.13 166.65 13.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.404 -0.81 . . . . 0.0 109.916 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.457 ' C ' ' CG ' ' A' ' 44' ' ' TYR . 70.8 m -62.58 -157.04 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.433 -0.792 . . . . 0.0 109.732 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.573 ' CD1' ' N ' ' A' ' 44' ' ' TYR . 0.1 OUTLIER 58.86 13.72 2.9 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.166 -0.959 . . . . 0.0 109.791 -179.607 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.2 24.24 20.91 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.87 171.95 7.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.44 -1.036 . . . . 0.0 110.956 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.571 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -113.92 -165.21 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.688 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.562 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.571 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 49.1 Cg_endo -76.19 166.48 27.67 Favored 'Trans proline' 0 C--N 1.315 -1.228 0 O-C-N 122.85 0.921 . . . . 0.0 109.787 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.541 ' O ' ' HG2' ' A' ' 52' ' ' MET . 4.7 mt 63.96 -59.6 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 121.668 -0.645 . . . . 0.0 110.224 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.513 ' N ' ' O ' ' A' ' 48' ' ' PRO . 7.3 mt-30 -43.7 -27.19 0.29 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.811 -1.181 . . . . 0.0 110.54 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.708 HG22 ' O ' ' A' ' 51' ' ' VAL . 6.8 p -118.8 26.06 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.426 -0.796 . . . . 0.0 110.53 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.727 ' HE1' ' HB2' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -83.73 41.04 0.77 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.77 -1.206 . . . . 0.0 109.421 178.872 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.434 ' HB3' ' HE2' ' A' ' 53' ' ' MET . 2.9 tmm? 64.97 -6.82 0.31 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.285 -0.884 . . . . 0.0 110.552 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.451 ' H ' ' C ' ' A' ' 52' ' ' MET . 0.0 OUTLIER 43.12 29.89 0.23 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.307 -0.871 . . . . 0.0 110.516 -179.781 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.451 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -134.54 12.64 4.58 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -146.1 71.5 1.26 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.425 -1.044 . . . . 0.0 109.544 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.562 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . . . -47.97 -27.75 2.37 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.649 -0.657 . . . . 0.0 109.89 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.508 ' HG2' HG11 ' A' ' 25' ' ' VAL . 3.1 tpt180 -52.07 -38.23 56.49 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.654 -0.654 . . . . 0.0 109.359 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.628 HG11 ' CB ' ' A' ' 20' ' ' ALA . 67.0 t -69.48 -49.05 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.359 -0.838 . . . . 0.0 109.028 178.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.727 ' HB2' ' HE1' ' A' ' 52' ' ' MET . . . -46.44 -45.82 18.36 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.52 -0.738 . . . . 0.0 109.664 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.485 ' O ' HD23 ' A' ' 65' ' ' LEU . 0.7 OUTLIER -58.05 -48.39 80.24 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.545 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.936 HD11 ' HA ' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -49.92 -66.73 0.34 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.586 -0.696 . . . . 0.0 109.688 178.348 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.967 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 85.1 mt -58.44 -54.68 44.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.57 -0.706 . . . . 0.0 110.178 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.826 HD13 HG12 ' A' ' 96' ' ' VAL . 1.9 tt -43.67 -68.3 0.21 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.501 -0.749 . . . . 0.0 111.212 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.485 HD23 ' O ' ' A' ' 61' ' ' GLU . 1.1 pp -56.31 -23.2 35.41 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.104 -0.997 . . . . 0.0 110.159 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.76 ' CG ' HD22 ' A' ' 32' ' ' LEU . 2.2 m80 -82.86 -48.79 10.36 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 121.293 -0.88 . . . . 0.0 110.153 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 149.34 43.41 0.03 OUTLIER Glycine 0 N--CA 1.483 1.79 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.967 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -72.25 -157.32 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.849 -1.383 . . . . 0.0 109.92 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.449 ' CG ' ' HD2' ' A' ' 48' ' ' PRO . 4.6 mm-40 -121.21 62.73 11.81 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.43 ' HG2' ' ND2' ' A' ' 71' ' ' ASN . 40.4 Cg_endo -69.05 -5.5 15.93 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.875 1.461 . . . . 0.0 111.083 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.43 ' ND2' ' HG2' ' A' ' 70' ' ' PRO . 12.2 m-80 -113.88 -67.12 1.02 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.022 -1.048 . . . . 0.0 110.065 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.8 t -44.88 163.28 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.465 -0.772 . . . . 0.0 110.83 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.885 ' HB2' ' HG2' ' A' ' 80' ' ' ARG . . . -138.59 -155.44 0.6 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.186 -0.946 . . . . 0.0 110.925 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' A' ' 78' ' ' LEU . 50.8 m-20 -107.77 126.23 30.35 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.533 -0.729 . . . . 0.0 109.766 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -74.96 -2.06 12.03 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 123.332 1.175 . . . . 0.0 110.668 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -93.32 -36.3 12.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 0.0 109.84 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.76 6.99 4.04 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.376 -0.827 . . . . 0.0 110.142 179.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.688 HD13 ' O ' ' A' ' 107' ' ' ARG . 1.0 OUTLIER 48.48 23.22 0.57 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.381 -0.824 . . . . 0.0 111.477 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 35.8 m -78.83 102.74 8.34 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.956 -1.09 . . . . 0.0 109.517 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.885 ' HG2' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -71.11 171.97 7.51 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.361 -0.837 . . . . 0.0 110.285 -179.676 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.66 -14.5 36.51 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.816 1.429 . . . . 0.0 109.375 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.599 HG12 ' CB ' ' A' ' 114' ' ' PRO . 48.7 t -72.08 -30.26 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.778 -0.576 . . . . 0.0 109.896 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.562 ' HB3' HD13 ' A' ' 117' ' ' LEU . 5.3 m80 -77.8 -34.68 52.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.391 -0.818 . . . . 0.0 109.25 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.02 -41.99 84.31 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 120.322 -0.551 . . . . 0.0 109.884 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.549 ' HB3' ' CD1' ' A' ' 94' ' ' LEU . . . -66.64 -61.51 1.94 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.232 -0.918 . . . . 0.0 109.653 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 1.033 ' HB1' ' HB2' ' A' ' 118' ' ' ALA . . . -56.88 -44.84 82.69 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.262 -0.899 . . . . 0.0 110.929 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.617 ' O ' HD22 ' A' ' 121' ' ' LEU . 2.9 ttp180 -48.64 -43.44 36.47 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.329 -0.857 . . . . 0.0 110.291 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.439 ' HG3' ' HB3' ' A' ' 54' ' ' MET . 0.0 OUTLIER -93.82 4.68 53.57 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.454 -0.779 . . . . 0.0 110.655 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.604 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 60.72 51.79 56.45 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.562 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.8 OUTLIER -120.45 74.87 1.08 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.385 -1.068 . . . . 0.0 110.187 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.415 HD11 ' O ' ' A' ' 125' ' ' ASP . 0.3 OUTLIER -52.17 -37.89 56.02 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.428 -0.795 . . . . 0.0 110.663 -179.844 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.782 ' O ' HG23 ' A' ' 96' ' ' VAL . 48.1 t0 -47.9 -39.24 18.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.3 -0.875 . . . . 0.0 109.559 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 87.6 m -69.8 -45.06 68.79 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.761 HD21 ' CD2' ' A' ' 130' ' ' LEU . 1.6 tp -55.37 -43.24 74.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.563 -0.711 . . . . 0.0 109.809 179.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 69.2 t -59.91 -47.85 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.222 -0.923 . . . . 0.0 109.429 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.826 HG12 HD13 ' A' ' 64' ' ' LEU . 6.5 t -58.88 -50.52 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.304 -0.872 . . . . 0.0 109.004 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.76 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 0.0 OUTLIER -44.56 -55.4 5.17 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.77 -0.582 . . . . 0.0 109.93 179.267 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -65.73 -30.92 71.65 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.512 -0.743 . . . . 0.0 109.89 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -14.81 36.43 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.399 -0.813 . . . . 0.0 110.665 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.562 ' CB ' HD21 ' A' ' 64' ' ' LEU . . . -151.31 70.13 0.96 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.98 -1.075 . . . . 0.0 111.075 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 58.22 105.82 0.01 OUTLIER Glycine 0 N--CA 1.488 2.1 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.76 ' HB2' ' O ' ' A' ' 97' ' ' LEU . . . -147.51 103.86 3.58 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.589 -0.948 . . . . 0.0 109.702 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.415 ' O ' HG21 ' A' ' 82' ' ' VAL . 2.8 tpp180 -65.31 101.59 0.58 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.353 -0.842 . . . . 0.0 110.377 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 134' ' ' ALA . 1.7 mt -102.37 59.86 0.82 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.427 -0.796 . . . . 0.0 110.226 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -170.92 44.72 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.988 -1.07 . . . . 0.0 110.907 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.668 HG22 ' H ' ' A' ' 107' ' ' ARG . 3.1 p -105.88 -171.24 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.243 -0.911 . . . . 0.0 109.539 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.688 ' O ' HD13 ' A' ' 78' ' ' LEU . 0.5 OUTLIER -131.26 115.1 15.87 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.178 -0.951 . . . . 0.0 110.064 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.704 0 O-C-N 121.475 -0.765 . . . . 0.0 109.558 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.486 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.599 ' CB ' HG12 ' A' ' 82' ' ' VAL . 45.4 Cg_endo -74.65 -48.54 0.19 Allowed 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.661 1.348 . . . . 0.0 110.025 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 127' ' ' ALA . 7.2 p -55.56 -32.68 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.353 -0.842 . . . . 0.0 109.729 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.01 -38.54 79.31 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.481 -0.762 . . . . 0.0 109.688 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.631 ' O ' HD12 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -57.11 -69.36 0.16 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.508 -0.745 . . . . 0.0 110.143 179.674 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 1.033 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -44.46 -52.86 7.48 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.461 -0.774 . . . . 0.0 110.998 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -53.97 -45.04 71.27 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.347 -0.845 . . . . 0.0 110.156 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -64.89 -32.02 73.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.391 -0.818 . . . . 0.0 110.06 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.631 HD12 ' O ' ' A' ' 117' ' ' LEU . 1.0 OUTLIER -90.07 2.05 55.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.375 -0.828 . . . . 0.0 110.767 -179.668 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 89.96 11.42 63.39 Favored Glycine 0 N--CA 1.489 2.209 0 C-N-CA 119.931 -1.128 . . . . 0.0 111.075 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.698 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . 47.9 m-70 -93.07 50.31 1.52 Allowed 'General case' 0 N--CA 1.484 1.232 0 O-C-N 120.841 -1.387 . . . . 0.0 109.085 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.0 mtt-85 -47.75 -31.47 4.85 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.626 -0.671 . . . . 0.0 109.407 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 125' ' ' ASP . 8.5 m-20 -62.3 -47.85 82.46 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.82 HG11 ' HA ' ' A' ' 86' ' ' ALA . 6.0 t -75.3 -40.52 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.426 -0.796 . . . . 0.0 109.758 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.698 ' O ' HG23 ' A' ' 115' ' ' VAL . . . -57.21 -36.37 70.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.303 -0.873 . . . . 0.0 109.607 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.13 -61.19 2.73 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.418 -0.801 . . . . 0.0 110.1 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.417 ' HD2' HD23 ' A' ' 94' ' ' LEU . 19.2 t80 -53.26 -40.42 64.64 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.293 -0.879 . . . . 0.0 109.824 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.93 HD11 ' HB2' ' A' ' 86' ' ' ALA . 78.3 mt -67.59 -39.43 84.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.424 -0.797 . . . . 0.0 109.463 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.486 ' HG3' HG21 ' A' ' 115' ' ' VAL . 3.2 ttt180 -59.34 -19.43 46.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.19 -0.943 . . . . 0.0 110.201 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.1 -57.63 3.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.352 -0.843 . . . . 0.0 110.432 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -81.72 -15.49 54.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.346 -0.846 . . . . 0.0 110.959 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.717 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.199 -0.938 . . . . 0.0 110.103 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 120.7 0.285 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.411 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 40.2 m0 -46.44 -34.73 4.94 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.334 -0.854 . . . . 0.0 109.976 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.858 ' HB2' HD21 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -63.1 -37.84 88.8 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.6 -0.687 . . . . 0.0 109.997 178.62 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.66 -53.86 6.43 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.27 -0.893 . . . . 0.0 110.309 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.411 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.0 OUTLIER -44.96 -54.09 6.93 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.565 -0.709 . . . . 0.0 110.836 -179.591 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.777 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -61.3 -52.8 63.2 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.356 -0.84 . . . . 0.0 110.447 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.801 ' HB1' HG11 ' A' ' 59' ' ' VAL . . . -46.78 -46.9 20.88 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.502 -0.749 . . . . 0.0 110.355 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.442 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -54.44 -40.01 67.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.55 -0.719 . . . . 0.0 110.425 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.409 ' HB3' ' HD2' ' A' ' 24' ' ' ARG . 5.6 mpt_? -86.53 26.58 1.06 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.484 -0.76 . . . . 0.0 110.414 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 49.05 24.22 4.39 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.727 ' O ' HG23 ' A' ' 28' ' ' VAL . 10.2 mtt180 -93.65 65.39 3.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.365 -1.079 . . . . 0.0 109.738 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 1.059 HG22 HG22 ' A' ' 59' ' ' VAL . 60.2 t -55.67 -42.66 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.657 -0.652 . . . . 0.0 110.881 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -43.36 -56.03 3.77 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.471 -0.768 . . . . 0.0 110.604 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.432 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 1.8 tp10 -63.99 -34.89 79.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.481 -0.762 . . . . 0.0 110.141 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.826 HG12 HD13 ' A' ' 62' ' ' LEU . 4.7 t -70.29 -44.97 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.231 -0.918 . . . . 0.0 109.871 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.822 ' CA ' HD11 ' A' ' 62' ' ' LEU . 1.8 mmm180 -53.37 -45.87 69.38 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.201 -0.937 . . . . 0.0 109.254 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -70.59 -42.38 71.11 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 120.078 -0.649 . . . . 0.0 109.739 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 27' ' ' GLU . 44.6 mt -59.18 -63.05 1.44 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.289 -0.882 . . . . 0.0 110.969 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.882 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -44.44 -44.52 8.52 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.424 -0.798 . . . . 0.0 110.594 -179.484 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -81.25 -18.5 45.75 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.74 -0.6 . . . . 0.0 110.443 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.465 ' HB2' ' O ' ' A' ' 30' ' ' ALA . . . -84.42 -5.63 59.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.111 -0.993 . . . . 0.0 110.748 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.09 22.61 2.35 Favored Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.802 -1.189 . . . . 0.0 110.99 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.882 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -66.6 162.24 21.43 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.916 -1.343 . . . . 0.0 109.892 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.734 HD13 ' HD2' ' A' ' 38' ' ' PRO . 1.8 mm? -87.19 133.49 38.68 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.365 -0.835 . . . . 0.0 110.124 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.734 ' HD2' HD13 ' A' ' 37' ' ' LEU . 44.3 Cg_endo -70.68 -47.07 0.7 Allowed 'Trans proline' 0 C--N 1.315 -1.229 0 O-C-N 123.547 1.288 . . . . 0.0 109.906 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -102.83 51.56 0.8 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.585 -0.697 . . . . 0.0 109.59 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.627 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -85.35 112.34 43.25 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.524 -0.735 . . . . 0.0 110.228 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.17 140.78 34.78 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 O-C-N 123.679 1.357 . . . . 0.0 110.607 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.508 ' ND2' HG21 ' A' ' 51' ' ' VAL . 14.9 t30 -85.92 -164.74 1.08 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.302 -0.874 . . . . 0.0 109.956 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.3 -8.0 14.77 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.199 -0.938 . . . . 0.0 110.564 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -96.62 24.29 6.12 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.179 -0.951 . . . . 0.0 109.917 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.41 23.05 66.25 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.92 -152.44 0.47 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.205 -1.174 . . . . 0.0 110.159 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.545 ' HD2' ' NE2' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -130.22 -176.8 0.58 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.32 -0.862 . . . . 0.0 109.989 -179.466 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.645 ' HB2' HD22 ' A' ' 63' ' ' LEU . 43.2 Cg_endo -68.69 -25.84 33.65 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 O-C-N 123.36 1.19 . . . . 0.0 110.456 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.503 ' O ' ' HG2' ' A' ' 52' ' ' MET . 4.8 mt -108.93 -33.1 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.236 -0.915 . . . . 0.0 109.919 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.545 ' NE2' ' HD2' ' A' ' 47' ' ' ARG . 14.7 mt-30 -56.89 -17.62 10.18 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.31 -0.869 . . . . 0.0 110.188 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.508 HG21 ' ND2' ' A' ' 42' ' ' ASN . 8.5 p -113.52 35.09 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.329 -0.857 . . . . 0.0 110.922 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.675 ' HE1' ' HB2' ' A' ' 60' ' ' ALA . 0.1 OUTLIER -100.33 37.57 1.65 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.017 -1.052 . . . . 0.0 110.567 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.413 ' CB ' ' O ' ' A' ' 52' ' ' MET . 20.4 ttp 65.3 -4.27 0.55 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.421 -0.799 . . . . 0.0 110.66 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.565 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 41.41 30.82 0.14 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.384 -0.823 . . . . 0.0 110.555 -179.681 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.438 ' C ' ' CE2' ' A' ' 90' ' ' PHE . . . -133.17 11.01 5.07 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.571 ' HB3' HG23 ' A' ' 59' ' ' VAL . 0.5 OUTLIER -147.81 87.86 1.65 Allowed 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.443 -1.034 . . . . 0.0 109.687 179.801 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.54 -20.14 7.25 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.52 -0.737 . . . . 0.0 109.733 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -58.09 -29.71 65.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.464 -0.773 . . . . 0.0 109.671 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 1.059 HG22 HG22 ' A' ' 25' ' ' VAL . 2.8 t -76.64 -50.42 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.445 -0.785 . . . . 0.0 109.426 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.675 ' HB2' ' HE1' ' A' ' 52' ' ' MET . . . -49.1 -59.82 3.32 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.206 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.593 ' O ' HD23 ' A' ' 65' ' ' LEU . 3.4 tt0 -46.7 -52.19 14.42 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.488 -0.758 . . . . 0.0 109.544 178.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.826 HD13 HG12 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -45.74 -71.79 0.07 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.735 -0.603 . . . . 0.0 110.416 178.745 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.858 HD21 ' HB2' ' A' ' 16' ' ' LEU . 1.9 mt -65.31 -45.84 82.73 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.499 -0.751 . . . . 0.0 111.069 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.88 HD22 ' CG1' ' A' ' 96' ' ' VAL . 0.5 OUTLIER -52.26 -70.24 0.09 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.184 -0.948 . . . . 0.0 110.641 -179.501 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.593 HD23 ' O ' ' A' ' 61' ' ' GLU . 2.1 pp -50.69 -25.81 4.75 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.402 -0.812 . . . . 0.0 109.88 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.686 ' ND1' HD12 ' A' ' 32' ' ' LEU . 3.3 m-70 -80.74 -48.8 12.0 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.604 -0.685 . . . . 0.0 109.929 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 159.46 32.34 0.02 OUTLIER Glycine 0 CA--C 1.54 1.604 0 C-N-CA 120.05 -1.072 . . . . 0.0 111.305 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.586 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -70.37 178.4 2.91 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.436 -1.626 . . . . 0.0 109.602 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.445 ' HB2' ' HG2' ' A' ' 47' ' ' ARG . 0.6 OUTLIER -107.78 78.9 0.78 Allowed Pre-proline 0 C--N 1.302 -1.459 0 O-C-N 121.32 -0.863 . . . . 0.0 110.23 179.516 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 68' ' ' ALA . 50.3 Cg_endo -74.71 -0.85 10.35 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 O-C-N 123.682 1.359 . . . . 0.0 110.171 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.548 ' O ' ' NE ' ' A' ' 80' ' ' ARG . 1.7 m-20 -113.71 -70.58 0.8 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.194 -0.941 . . . . 0.0 110.014 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.422 ' C ' ' O ' ' A' ' 71' ' ' ASN . 49.3 t -40.04 147.85 0.09 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.375 -0.828 . . . . 0.0 110.893 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.572 ' HB2' ' HG2' ' A' ' 80' ' ' ARG . . . -133.25 -150.33 0.4 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.525 -0.735 . . . . 0.0 109.875 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 78' ' ' LEU . 1.0 OUTLIER -114.98 130.33 24.3 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.887 . . . . 0.0 109.893 -179.904 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.74 -13.08 38.49 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.344 1.181 . . . . 0.0 110.254 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.71 -55.81 30.07 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.322 -0.861 . . . . 0.0 109.171 178.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 43.7 p -141.71 25.36 1.99 Allowed 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.567 0.699 . . . . 0.0 109.374 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.501 ' HA ' HD23 ' A' ' 78' ' ' LEU . 2.9 mt 52.86 30.06 8.59 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.53 -0.731 . . . . 0.0 111.107 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.84 97.57 0.23 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.989 -1.069 . . . . 0.0 109.883 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.888 ' CG ' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -72.23 168.52 22.54 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.211 -0.931 . . . . 0.0 109.382 179.701 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.497 ' HB3' ' HG3' ' A' ' 50' ' ' GLN . 50.8 Cg_endo -73.7 -21.77 18.67 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.74 1.39 . . . . 0.0 109.867 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.431 ' CG1' ' HG ' ' A' ' 104' ' ' LEU . 56.3 t -59.57 -35.0 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.523 -0.736 . . . . 0.0 110.37 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.467 ' O ' ' CB ' ' A' ' 87' ' ' ARG . 42.3 m80 -64.99 -31.59 72.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.441 -0.787 . . . . 0.0 110.009 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.565 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 0.7 OUTLIER -61.24 -52.08 66.27 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.528 -0.732 . . . . 0.0 110.652 -179.732 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.548 ' HB3' ' CD1' ' A' ' 94' ' ' LEU . . . -57.8 -61.3 2.62 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.807 -1.183 . . . . 0.0 109.745 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.88 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -57.14 -55.93 28.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.525 -0.734 . . . . 0.0 111.594 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.467 ' CB ' ' O ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -44.67 -28.72 0.64 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.216 -0.927 . . . . 0.0 111.529 -178.863 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.37 -8.13 23.65 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.019 -1.051 . . . . 0.0 110.807 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.558 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 77.08 36.01 36.81 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.548 ' HD1' ' HG1' ' A' ' 93' ' ' THR . 0.9 OUTLIER -108.2 90.86 3.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.389 -1.066 . . . . 0.0 110.525 179.903 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.515 ' CD2' ' HA ' ' A' ' 126' ' ' VAL . 0.1 OUTLIER -64.69 -36.6 84.79 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.446 -0.784 . . . . 0.0 110.384 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.502 ' O ' HG23 ' A' ' 96' ' ' VAL . 40.0 t0 -53.6 -26.31 21.31 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.165 -0.959 . . . . 0.0 109.371 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.548 ' HG1' ' HD1' ' A' ' 90' ' ' PHE . 26.6 m -78.25 -46.72 19.59 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.623 -0.673 . . . . 0.0 109.873 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.829 HD21 ' HG ' ' A' ' 130' ' ' LEU . 1.1 tp -54.36 -36.98 64.42 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.216 -0.928 . . . . 0.0 109.695 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 91' ' ' LEU . 27.0 t -65.54 -47.55 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.474 -0.766 . . . . 0.0 109.425 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.88 ' CG1' HD22 ' A' ' 64' ' ' LEU . 84.3 t -56.12 -53.17 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.217 -0.927 . . . . 0.0 110.094 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.0 mp -52.8 -51.83 59.23 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.182 -0.949 . . . . 0.0 109.719 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -54.6 -38.22 66.51 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.618 -0.676 . . . . 0.0 109.421 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 96' ' ' VAL . 66.9 mtp180 -66.78 -13.65 61.71 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.707 -0.621 . . . . 0.0 110.141 179.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.742 ' HB3' HD11 ' A' ' 64' ' ' LEU . . . -117.32 38.72 3.48 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.387 -0.82 . . . . 0.0 110.534 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 45.8 47.33 13.76 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.455 ' O ' HD12 ' A' ' 104' ' ' LEU . . . -89.13 110.68 21.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.346 -1.091 . . . . 0.0 110.197 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.518 ' N ' ' OD1' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -49.68 138.73 13.82 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.586 -0.697 . . . . 0.0 110.491 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.854 HD23 HD23 ' A' ' 130' ' ' LEU . 0.2 OUTLIER -128.3 22.87 6.03 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.427 -0.796 . . . . 0.0 110.055 179.623 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -125.52 47.3 2.22 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.021 -1.049 . . . . 0.0 110.911 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.888 HG11 ' CG ' ' A' ' 80' ' ' ARG . 3.4 p -108.7 -172.4 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.318 -0.864 . . . . 0.0 110.347 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.725 ' H ' HG22 ' A' ' 106' ' ' VAL . 2.6 mtm180 -132.42 158.92 40.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.454 -0.779 . . . . 0.0 109.941 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 52.1 p30 . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.382 -0.824 . . . . 0.0 110.242 -179.872 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.598 HD21 ' HG3' ' A' ' 107' ' ' ARG . 56.7 mt . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.538 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 40.9 Cg_endo -66.84 -21.01 51.29 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.707 1.372 . . . . 0.0 109.896 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.564 ' HA ' HD13 ' A' ' 130' ' ' LEU . 4.8 p -85.35 -40.7 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.287 -0.883 . . . . 0.0 110.421 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.442 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 1.0 OUTLIER -59.98 -32.28 70.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.044 -1.035 . . . . 0.0 109.871 179.94 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.4 mt -70.54 -45.4 65.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.498 -0.751 . . . . 0.0 110.049 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.533 ' CB ' ' HB2' ' A' ' 127' ' ' ALA . . . -55.33 -51.28 67.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.367 -0.833 . . . . 0.0 110.066 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.564 ' N ' ' HB2' ' A' ' 127' ' ' ALA . 10.7 pt-20 -68.71 -25.0 64.55 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.614 -0.678 . . . . 0.0 110.484 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.45 -62.9 1.47 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.439 -0.788 . . . . 0.0 110.643 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.12 -87.34 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.028 -1.045 . . . . 0.0 110.703 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -169.52 35.86 0.19 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.511 ' HB2' ' HA ' ' A' ' 118' ' ' ALA . 7.5 m-70 -113.65 43.56 1.77 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.561 -0.964 . . . . 0.0 109.272 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -43.52 -55.99 3.91 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.782 -0.574 . . . . 0.0 110.073 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 125' ' ' ASP . 13.4 p-10 -49.25 -34.33 14.9 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.436 0.636 . . . . 0.0 109.636 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.88 HG11 ' HA ' ' A' ' 86' ' ' ALA . 1.3 t -84.43 -31.08 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.564 ' HB2' ' N ' ' A' ' 119' ' ' GLU . . . -68.28 -35.74 78.33 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.436 -0.79 . . . . 0.0 109.364 179.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 26.7 ttt180 -72.42 -63.55 1.13 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.275 -0.891 . . . . 0.0 109.556 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.692 ' HD2' HD23 ' A' ' 94' ' ' LEU . 66.6 t80 -50.71 -28.86 9.9 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.372 -0.83 . . . . 0.0 109.812 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.854 HD23 HD23 ' A' ' 104' ' ' LEU . 6.7 mt -65.36 -62.08 1.74 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.406 -0.809 . . . . 0.0 109.465 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -51.96 -16.84 0.81 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.54 -0.725 . . . . 0.0 111.002 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -78.94 -53.2 7.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.969 -1.082 . . . . 0.0 109.693 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -87.33 -20.29 26.99 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.413 -0.804 . . . . 0.0 109.631 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.413 ' CB ' ' O ' ' A' ' 104' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.31 -0.869 . . . . 0.0 110.653 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.3 t0 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 120.969 0.414 . . . . 0.0 110.544 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.551 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 42.0 m0 -67.54 -5.19 14.13 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.398 -0.814 . . . . 0.0 110.972 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.732 HD11 HD21 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -77.99 -55.55 5.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.922 -1.111 . . . . 0.0 109.867 179.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.5 ' O ' ' HB3' ' A' ' 20' ' ' ALA . . . -70.55 -43.3 69.8 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.274 -0.891 . . . . 0.0 110.31 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.551 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.8 OUTLIER -52.25 -55.53 20.68 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.422 -0.799 . . . . 0.0 110.709 -179.888 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.808 ' HB1' ' HB3' ' A' ' 24' ' ' ARG . . . -55.02 -41.0 70.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.323 -0.861 . . . . 0.0 109.895 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.572 ' HA ' HG11 ' A' ' 59' ' ' VAL . . . -52.63 -49.68 64.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.482 -0.761 . . . . 0.0 109.793 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.593 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -69.24 -34.1 74.29 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.429 -0.794 . . . . 0.0 110.198 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.38 27.67 1.89 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.393 -0.817 . . . . 0.0 110.927 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 44.71 57.06 5.43 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.808 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -115.56 56.05 0.77 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.345 -1.091 . . . . 0.0 109.894 179.891 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.669 HG22 HG23 ' A' ' 59' ' ' VAL . 25.5 t -45.37 -55.01 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.583 -0.698 . . . . 0.0 110.844 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -54.23 -40.62 67.85 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.401 -0.812 . . . . 0.0 110.315 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.747 ' O ' HD12 ' A' ' 31' ' ' LEU . 0.5 OUTLIER -63.95 -35.43 80.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.431 -0.793 . . . . 0.0 109.753 179.851 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.877 HG12 HD12 ' A' ' 32' ' ' LEU . 11.7 t -77.27 -47.69 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.345 -0.847 . . . . 0.0 111.077 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.979 ' CA ' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -49.27 -45.26 44.68 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.124 -0.985 . . . . 0.0 110.255 -179.493 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.05 -42.29 48.11 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.431 -0.793 . . . . 0.0 109.542 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.747 HD12 ' O ' ' A' ' 27' ' ' GLU . 6.4 mt -60.55 -58.67 7.5 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.475 -0.766 . . . . 0.0 110.178 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.932 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 7.6 mt -51.15 -42.53 60.85 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.363 -0.835 . . . . 0.0 109.561 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -76.14 -9.43 58.62 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.625 -0.672 . . . . 0.0 110.571 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -93.9 -13.58 26.99 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.144 -0.972 . . . . 0.0 111.081 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 137.74 -0.79 2.79 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.581 -1.295 . . . . 0.0 110.909 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.932 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -46.41 151.31 0.55 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.017 -1.284 . . . . 0.0 110.174 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.77 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 12.6 tp -90.48 139.25 26.62 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.163 -0.961 . . . . 0.0 110.302 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.445 ' HB2' ' O ' ' A' ' 67' ' ' GLY . 43.6 Cg_endo -72.61 -39.14 2.79 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 O-C-N 123.647 1.341 . . . . 0.0 110.753 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -115.62 60.4 0.71 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.039 -1.038 . . . . 0.0 110.167 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.77 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -93.11 105.5 15.55 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.454 -0.779 . . . . 0.0 109.722 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.64 102.65 0.75 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.565 1.297 . . . . 0.0 110.188 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -89.4 172.71 8.81 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.499 -0.75 . . . . 0.0 109.973 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.441 ' O ' ' HB2' ' A' ' 44' ' ' TYR . 0.1 OUTLIER -63.2 -157.78 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.32 -0.863 . . . . 0.0 110.407 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.441 ' HB2' ' O ' ' A' ' 43' ' ' SER . 14.0 m-85 64.71 11.01 6.46 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.589 -0.694 . . . . 0.0 111.037 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 59.54 47.02 92.95 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -160.72 -171.3 3.06 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.482 -1.011 . . . . 0.0 110.743 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.638 ' CB ' ' HD2' ' A' ' 48' ' ' PRO . 2.1 mmt180 -124.4 -155.04 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.647 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.638 ' HD2' ' CB ' ' A' ' 47' ' ' ARG . 47.9 Cg_endo -75.72 166.64 27.93 Favored 'Trans proline' 0 N--CA 1.484 0.965 0 O-C-N 122.501 0.738 . . . . 0.0 110.727 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.502 ' HA ' ' HB2' ' A' ' 52' ' ' MET . 5.0 mt 65.97 -53.83 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.756 -0.59 . . . . 0.0 110.862 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.52 ' CG ' ' HB3' ' A' ' 81' ' ' PRO . 73.9 mt-30 -50.38 -29.17 9.45 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.772 -1.205 . . . . 0.0 110.187 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.593 HG22 ' HB2' ' A' ' 21' ' ' ALA . 10.6 p -99.09 7.31 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.537 -0.727 . . . . 0.0 109.71 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.522 ' CE ' ' HE3' ' A' ' 54' ' ' MET . 44.4 ttp -66.56 161.62 22.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.557 -0.714 . . . . 0.0 110.127 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 48.7 ttp -70.28 -4.34 21.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.259 -0.9 . . . . 0.0 110.213 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.522 ' HE3' ' CE ' ' A' ' 52' ' ' MET . 0.0 OUTLIER 53.96 23.79 4.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.003 -1.061 . . . . 0.0 110.069 -179.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.539 ' HA2' ' CE1' ' A' ' 90' ' ' PHE . . . -123.95 -5.63 7.41 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.48 90.4 2.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.334 -1.098 . . . . 0.0 110.129 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.659 ' HB2' ' HE2' ' A' ' 90' ' ' PHE . . . -53.48 -24.83 14.09 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.087 -1.008 . . . . 0.0 109.872 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.9 -48.37 64.17 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.549 -0.72 . . . . 0.0 110.442 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.669 HG23 HG22 ' A' ' 25' ' ' VAL . 32.1 t -59.36 -57.74 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.189 -0.944 . . . . 0.0 109.694 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -46.46 -59.71 2.8 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.429 -0.794 . . . . 0.0 110.091 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.553 ' HA ' HG11 ' A' ' 96' ' ' VAL . 17.1 tt0 -46.68 -43.47 17.8 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.382 -0.824 . . . . 0.0 109.208 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.979 HD11 ' CA ' ' A' ' 29' ' ' ARG . 0.3 OUTLIER -57.65 -64.74 0.79 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.284 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.841 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 2.6 mt -56.46 -48.94 76.01 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.637 HD13 HG12 ' A' ' 96' ' ' VAL . 0.3 OUTLIER -56.39 -56.67 18.2 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.469 -0.77 . . . . 0.0 109.659 179.323 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.469 ' HB3' ' O ' ' A' ' 61' ' ' GLU . 9.5 tp -53.06 -30.35 35.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.311 -0.868 . . . . 0.0 109.185 179.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.824 ' CG ' HD22 ' A' ' 32' ' ' LEU . 1.5 m-70 -86.2 -21.3 27.54 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.716 -0.615 . . . . 0.0 109.652 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.445 ' O ' ' HB2' ' A' ' 38' ' ' PRO . . . 110.49 48.81 0.73 Allowed Glycine 0 N--CA 1.482 1.72 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 178.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.841 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -64.5 -150.85 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.885 -1.362 . . . . 0.0 109.402 179.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.49 ' HG3' ' HD2' ' A' ' 48' ' ' PRO . 1.7 mm-40 -119.61 53.37 2.41 Favored Pre-proline 0 C--N 1.301 -1.508 0 O-C-N 121.357 -0.84 . . . . 0.0 109.58 178.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.456 ' HG3' ' HG ' ' A' ' 64' ' ' LEU . 47.3 Cg_endo -70.4 -16.33 34.85 Favored 'Trans proline' 0 C--N 1.317 -1.082 0 O-C-N 123.755 1.397 . . . . 0.0 109.99 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -95.41 -57.27 2.45 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.516 -0.74 . . . . 0.0 110.002 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.51 178.15 0.16 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.442 -0.786 . . . . 0.0 110.215 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -150.7 -152.61 0.44 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.512 -0.742 . . . . 0.0 109.914 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.439 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 39.1 m-20 -116.78 130.44 24.56 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.341 -0.849 . . . . 0.0 109.263 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.674 ' O ' ' HB3' ' A' ' 76' ' ' ALA . 42.0 Cg_endo -69.74 -177.2 1.76 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.426 1.224 . . . . 0.0 110.322 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.674 ' HB3' ' O ' ' A' ' 75' ' ' PRO . . . 71.42 -58.59 0.57 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.475 -0.766 . . . . 0.0 109.802 -178.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.57 0.45 13.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.16 -0.962 . . . . 0.0 110.621 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.508 ' HB3' ' O ' ' A' ' 107' ' ' ARG . 1.2 mt 48.62 53.37 12.31 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.222 -0.924 . . . . 0.0 111.41 179.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 60.2 m -88.42 98.51 11.66 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.086 -1.009 . . . . 0.0 110.474 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.693 ' CD ' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -74.18 165.77 50.53 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.326 -0.859 . . . . 0.0 109.392 179.368 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.581 ' HD2' ' CG ' ' A' ' 80' ' ' ARG . 45.4 Cg_endo -79.14 -0.71 10.98 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 O-C-N 123.308 1.162 . . . . 0.0 110.339 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.699 HG21 ' O ' ' A' ' 103' ' ' ARG . 22.1 t -76.93 -31.55 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.558 -0.714 . . . . 0.0 109.391 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.476 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 5.7 m80 -70.65 -36.69 73.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.519 -0.738 . . . . 0.0 109.44 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.519 ' O ' ' HB3' ' A' ' 87' ' ' ARG . 67.8 m-20 -54.0 -50.24 67.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.68 -0.637 . . . . 0.0 109.688 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.755 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -55.81 -67.91 0.25 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.142 -0.974 . . . . 0.0 109.356 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.763 ' HB2' HD11 ' A' ' 130' ' ' LEU . . . -52.92 -38.64 62.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.287 -0.883 . . . . 0.0 110.892 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.519 ' HB3' ' O ' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -44.9 -47.16 11.2 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.51 -0.744 . . . . 0.0 110.894 -179.307 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -97.12 8.38 44.63 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.209 -0.932 . . . . 0.0 110.156 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.446 ' HA3' ' ND1' ' A' ' 123' ' ' HIS . . . 70.87 40.85 63.44 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.154 -1.579 . . . . 0.0 109.154 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.659 ' HE2' ' HB2' ' A' ' 57' ' ' ALA . 1.9 t80 -106.88 116.41 31.88 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.315 -1.109 . . . . 0.0 110.673 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.457 HD21 ' CG ' ' A' ' 129' ' ' TYR . 0.4 OUTLIER -94.77 -42.67 8.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.633 -0.667 . . . . 0.0 110.844 -179.487 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.604 ' O ' HG23 ' A' ' 96' ' ' VAL . 92.1 m-20 -43.64 -44.46 6.36 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.383 -0.823 . . . . 0.0 109.734 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.4 m -66.41 -49.06 68.07 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.798 HD22 HG13 ' A' ' 126' ' ' VAL . 4.2 tp -53.38 -39.93 64.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.583 -0.698 . . . . 0.0 109.529 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.418 ' O ' ' N ' ' A' ' 99' ' ' ARG . 84.4 t -62.59 -53.16 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.375 -0.828 . . . . 0.0 108.964 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.637 HG12 HD13 ' A' ' 64' ' ' LEU . 63.7 t -50.23 -47.97 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.512 -0.742 . . . . 0.0 109.653 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.53 ' HA ' HD11 ' A' ' 64' ' ' LEU . 1.2 mp -56.9 -45.27 82.73 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.619 -0.676 . . . . 0.0 109.679 179.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -75.79 -29.36 58.71 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.368 -0.833 . . . . 0.0 109.874 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 95' ' ' VAL . 0.4 OUTLIER -67.72 -13.14 61.86 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.374 -0.829 . . . . 0.0 110.735 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.586 ' HB3' HD21 ' A' ' 64' ' ' LEU . . . -118.98 -93.24 0.52 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.315 -0.866 . . . . 0.0 110.792 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -156.71 45.21 0.51 Allowed Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.512 -1.328 . . . . 0.0 110.298 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -78.03 -171.4 2.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.09 -1.241 . . . . 0.0 109.692 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.699 ' O ' HG21 ' A' ' 82' ' ' VAL . 15.8 tpt180 -123.44 137.98 54.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.181 -0.949 . . . . 0.0 109.947 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.521 ' O ' ' HA ' ' A' ' 134' ' ' ALA . 14.0 mt -135.63 64.91 1.56 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.283 -0.885 . . . . 0.0 110.204 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -174.68 38.77 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.874 -1.142 . . . . 0.0 110.159 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.693 HG11 ' CD ' ' A' ' 80' ' ' ARG . 12.6 p -110.19 173.92 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.348 -0.845 . . . . 0.0 110.433 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.584 ' N ' HG22 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -127.91 138.66 52.74 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.145 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 28.0 p-10 . . . . . 0 N--CA 1.497 1.912 0 O-C-N 121.353 -0.842 . . . . 0.0 111.121 -179.14 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.435 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.435 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 41.8 Cg_endo -69.02 -30.12 26.27 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.452 1.238 . . . . 0.0 109.982 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.447 ' HB ' ' HB3' ' A' ' 130' ' ' LEU . 10.9 p -82.63 -37.63 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.343 -0.848 . . . . 0.0 109.769 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.443 ' N ' HG13 ' A' ' 115' ' ' VAL . 24.5 t0 -54.19 -38.44 65.61 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.431 -0.793 . . . . 0.0 109.985 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.22 -54.07 16.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.505 -0.747 . . . . 0.0 110.038 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.537 ' CB ' ' HB2' ' A' ' 127' ' ' ALA . . . -46.02 -56.03 6.08 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.454 -0.779 . . . . 0.0 110.785 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -58.88 -28.46 66.17 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.296 -0.878 . . . . 0.0 109.927 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -75.32 -49.73 18.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.432 -0.792 . . . . 0.0 109.84 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.7 mt -73.77 -91.36 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.329 -0.857 . . . . 0.0 109.95 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -173.91 31.02 0.1 OUTLIER Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.684 -1.246 . . . . 0.0 110.106 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.564 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 50.4 m-70 -102.59 44.2 1.03 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.267 -1.137 . . . . 0.0 109.349 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.577 ' HA ' ' HB3' ' A' ' 127' ' ' ALA . 1.7 mtm180 -46.07 -40.26 10.53 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.737 -0.602 . . . . 0.0 109.967 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -55.82 -45.65 78.27 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.798 HG13 HD22 ' A' ' 94' ' ' LEU . 16.8 t -78.05 -40.45 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 119.666 -0.814 . . . . 0.0 109.087 178.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.577 ' HB3' ' HA ' ' A' ' 124' ' ' ARG . . . -57.57 -58.31 8.86 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.593 -0.692 . . . . 0.0 109.677 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.409 ' NH1' ' HG3' ' A' ' 128' ' ' ARG . 38.1 ttm-85 -45.2 -59.79 2.45 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.69 -0.631 . . . . 0.0 109.92 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.457 ' CG ' HD21 ' A' ' 91' ' ' LEU . 5.7 t80 -57.53 -45.76 84.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.582 -0.699 . . . . 0.0 109.214 178.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.763 HD11 ' HB2' ' A' ' 86' ' ' ALA . 7.2 mt -54.86 -41.47 70.83 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.561 -0.712 . . . . 0.0 110.952 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 39.7 ttp85 -62.52 -40.2 96.0 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.253 -0.905 . . . . 0.0 110.202 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -81.04 -30.12 34.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.264 -0.898 . . . . 0.0 110.304 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -89.58 -18.02 27.39 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.214 -0.929 . . . . 0.0 110.164 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.582 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.18 -0.95 . . . . 0.0 110.586 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.9 t70 . . . . . 0 N--CA 1.498 1.933 0 CA-C-O 120.69 0.281 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.524 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 49.1 m0 -68.19 -12.66 61.33 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.176 -0.952 . . . . 0.0 110.68 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.041 ' HB3' HD21 ' A' ' 63' ' ' LEU . 35.6 mt -76.13 -60.78 2.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.166 -0.959 . . . . 0.0 109.477 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.571 ' HB2' ' HA ' ' A' ' 48' ' ' PRO . . . -57.55 -48.2 79.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.519 -0.738 . . . . 0.0 109.861 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.524 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.6 OUTLIER -44.44 -55.27 5.17 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.444 -0.785 . . . . 0.0 110.536 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.808 ' HB1' ' HB3' ' A' ' 24' ' ' ARG . . . -71.8 -32.4 67.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.145 -0.972 . . . . 0.0 109.942 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.455 ' HB1' HG11 ' A' ' 59' ' ' VAL . . . -67.73 -45.88 73.76 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.208 -0.933 . . . . 0.0 109.962 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.14 -25.67 68.46 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.48 -0.762 . . . . 0.0 109.616 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -104.83 25.93 9.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.453 -0.78 . . . . 0.0 110.306 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.571 ' HA3' ' HE2' ' A' ' 53' ' ' MET . . . 48.4 66.79 1.9 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.808 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -133.3 54.61 1.94 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.44 -1.035 . . . . 0.0 109.409 -179.898 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 1.03 HG22 HG23 ' A' ' 59' ' ' VAL . 45.1 t -46.1 -56.93 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.535 -0.728 . . . . 0.0 110.869 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -40.78 -50.91 3.15 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.724 -0.61 . . . . 0.0 110.954 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.709 ' O ' HD12 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -58.77 -41.28 86.24 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.194 -0.942 . . . . 0.0 109.622 179.592 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.749 HG12 HD13 ' A' ' 62' ' ' LEU . 13.6 t -69.81 -49.78 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.503 -0.748 . . . . 0.0 110.289 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.786 ' HA ' HD11 ' A' ' 62' ' ' LEU . 4.4 mmt180 -41.65 -52.3 3.85 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.514 -0.741 . . . . 0.0 110.122 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.41 -53.35 9.75 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.809 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.709 HD12 ' O ' ' A' ' 27' ' ' GLU . 4.7 mt -47.73 -62.74 1.31 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.431 -0.793 . . . . 0.0 110.998 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.779 ' HG ' HD22 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -44.1 -57.5 3.36 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.571 -0.706 . . . . 0.0 110.379 179.89 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -66.27 -10.88 46.65 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.667 -0.646 . . . . 0.0 110.526 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.51 ' HB3' ' O ' ' A' ' 31' ' ' LEU . . . -86.8 -11.86 49.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.067 -1.02 . . . . 0.0 110.239 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 130.19 -6.45 6.02 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.907 -1.139 . . . . 0.0 110.999 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.898 ' CB ' HD21 ' A' ' 16' ' ' LEU . . . -42.78 155.9 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.19 -1.183 . . . . 0.0 110.636 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.985 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 3.2 tp -80.91 131.03 61.21 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.228 -0.92 . . . . 0.0 110.858 -178.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.445 ' O ' ' HA ' ' A' ' 68' ' ' ALA . 49.0 Cg_endo -74.4 -15.64 22.24 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.841 1.443 . . . . 0.0 110.8 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.434 ' ND2' ' HG2' ' A' ' 69' ' ' GLU . 0.5 OUTLIER -128.38 25.72 5.76 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.101 -0.999 . . . . 0.0 110.475 -179.636 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.985 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -66.46 123.92 86.85 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.254 -0.904 . . . . 0.0 109.873 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -76.75 149.19 29.54 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.673 1.354 . . . . 0.0 110.319 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -81.16 -163.27 0.58 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.544 -0.723 . . . . 0.0 109.922 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.407 ' C ' ' CD1' ' A' ' 44' ' ' TYR . 0.1 OUTLIER -99.12 6.17 46.59 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.883 -1.136 . . . . 0.0 110.571 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.407 ' CD1' ' C ' ' A' ' 43' ' ' SER . 2.4 m-85 -119.01 36.37 4.48 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.28 -0.887 . . . . 0.0 109.434 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.41 28.33 35.66 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.74 -157.46 0.61 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.55 -0.97 . . . . 0.0 110.822 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.609 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 0.3 OUTLIER -121.2 -173.14 0.25 Allowed Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.33 -0.856 . . . . 0.0 110.638 -178.604 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.794 ' HB2' HD22 ' A' ' 63' ' ' LEU . 42.2 Cg_endo -77.99 -26.52 6.52 Favored 'Trans proline' 0 C--N 1.32 -0.958 0 O-C-N 123.467 1.246 . . . . 0.0 111.438 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.425 ' CD1' ' HA ' ' A' ' 60' ' ' ALA . 12.0 mt -109.71 -37.65 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 120.768 -1.207 . . . . 0.0 109.389 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.479 ' HB2' ' HB3' ' A' ' 81' ' ' PRO . 2.5 tt0 -53.8 -16.67 1.85 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.691 -0.63 . . . . 0.0 110.686 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 51' ' ' VAL . 7.4 p -114.35 6.78 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.023 -1.048 . . . . 0.0 111.225 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.475 ' CE ' ' HE1' ' A' ' 54' ' ' MET . 0.0 OUTLIER -67.92 168.54 11.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.774 -1.204 . . . . 0.0 109.495 179.825 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.571 ' HE2' ' HA3' ' A' ' 23' ' ' GLY . 3.1 tmm? -67.8 -1.92 6.28 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.21 -0.931 . . . . 0.0 111.301 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.475 ' HE1' ' CE ' ' A' ' 52' ' ' MET . 12.9 mmt 48.56 23.04 0.56 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.259 -0.901 . . . . 0.0 110.361 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.433 ' HA3' ' SD ' ' A' ' 53' ' ' MET . . . -120.46 3.19 12.39 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.279 -1.928 . . . . 0.0 108.279 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.41 74.07 1.45 Allowed 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.75 -0.853 . . . . 0.0 108.88 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.757 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . . . -43.71 -27.57 0.33 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.421 -0.8 . . . . 0.0 110.151 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.474 ' HB3' HG11 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -49.37 -49.33 44.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.541 -0.724 . . . . 0.0 109.639 178.744 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 1.03 HG23 HG22 ' A' ' 25' ' ' VAL . 63.5 t -48.72 -59.87 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.659 -0.65 . . . . 0.0 109.945 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.486 ' O ' ' HB3' ' A' ' 64' ' ' LEU . . . -45.45 -46.23 13.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.676 -0.64 . . . . 0.0 109.794 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.57 ' O ' ' HB3' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -51.19 -59.66 3.95 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.657 -0.652 . . . . 0.0 109.516 178.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.786 HD11 ' HA ' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -46.52 -72.27 0.06 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.609 -0.682 . . . . 0.0 110.373 179.114 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.041 HD21 ' HB3' ' A' ' 16' ' ' LEU . 4.0 mt -51.22 -50.08 59.83 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.393 -0.817 . . . . 0.0 110.616 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.945 HD13 HG12 ' A' ' 96' ' ' VAL . 0.9 OUTLIER -59.11 -59.14 5.94 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.489 -0.757 . . . . 0.0 110.744 -179.628 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.679 ' O ' HD12 ' A' ' 65' ' ' LEU . 0.8 OUTLIER -48.76 -34.58 12.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.318 -0.864 . . . . 0.0 108.736 179.755 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.444 ' ND1' ' CD1' ' A' ' 32' ' ' LEU . 0.3 OUTLIER -82.11 -30.59 31.12 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.282 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 63' ' ' LEU . . . 124.0 52.76 0.19 Allowed Glycine 0 N--CA 1.479 1.561 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.655 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -62.19 -154.24 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.08 -1.247 . . . . 0.0 109.529 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.504 ' HB2' ' HB3' ' A' ' 47' ' ' ARG . 4.8 mt-10 -121.31 55.9 5.49 Favored Pre-proline 0 C--N 1.302 -1.499 0 O-C-N 121.33 -0.857 . . . . 0.0 109.448 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 69' ' ' GLU . 40.6 Cg_endo -66.28 -10.46 27.55 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.847 1.446 . . . . 0.0 110.351 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.532 ' HA ' ' NH2' ' A' ' 80' ' ' ARG . 72.2 m-20 -99.06 -72.87 0.64 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.193 -0.942 . . . . 0.0 110.146 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -42.89 161.8 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.663 -0.648 . . . . 0.0 110.953 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.468 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -148.2 -149.27 0.29 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.383 -0.823 . . . . 0.0 110.184 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.522 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -105.06 135.21 19.33 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 120.956 -1.09 . . . . 0.0 110.269 -179.724 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.28 -22.04 22.5 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 N-CA-C 109.239 -1.1 . . . . 0.0 109.239 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.73 -67.77 0.26 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.588 -0.695 . . . . 0.0 109.677 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.44 ' OG1' ' OG1' ' A' ' 79' ' ' THR . 14.6 p -124.82 27.47 6.79 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.391 -0.818 . . . . 0.0 109.342 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.522 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 1.3 mt 43.94 38.21 2.08 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.464 -0.772 . . . . 0.0 110.659 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.463 ' HA ' ' OD2' ' A' ' 108' ' ' ASP . 22.2 m -73.04 100.87 3.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.443 -0.786 . . . . 0.0 109.637 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.888 ' HG3' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -71.12 162.47 72.29 Favored Pre-proline 0 C--N 1.302 -1.471 0 O-C-N 121.401 -0.812 . . . . 0.0 110.806 -179.48 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.505 ' HA ' ' OD2' ' A' ' 84' ' ' ASP . 42.3 Cg_endo -69.95 -14.93 36.11 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 O-C-N 124.444 1.76 . . . . 0.0 110.219 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.897 HG21 ' HA ' ' A' ' 104' ' ' LEU . 20.1 t -68.38 -29.44 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.522 -0.737 . . . . 0.0 110.102 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.475 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 6.2 m80 -70.77 -28.53 64.74 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.393 -0.817 . . . . 0.0 109.136 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.505 ' OD2' ' HA ' ' A' ' 81' ' ' PRO . 72.2 m-20 -62.23 -57.13 12.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.35 -0.844 . . . . 0.0 110.042 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.615 ' HB2' ' CG2' ' A' ' 93' ' ' THR . . . -49.46 -57.48 6.93 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.452 -0.78 . . . . 0.0 109.757 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.876 ' CB ' HG11 ' A' ' 126' ' ' VAL . . . -57.19 -50.17 73.67 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.282 -0.886 . . . . 0.0 109.936 179.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.427 ' HD3' ' CD1' ' A' ' 121' ' ' LEU . 1.7 mmt85 -47.52 -21.51 0.35 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.588 -0.695 . . . . 0.0 111.483 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.458 ' HG2' ' HB2' ' A' ' 54' ' ' MET . 3.8 mp0 -110.69 -7.65 14.64 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.201 -0.937 . . . . 0.0 110.479 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.464 ' HA2' ' HB3' ' A' ' 123' ' ' HIS . . . 78.15 22.53 68.06 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.757 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -95.22 111.79 23.59 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.533 -0.981 . . . . 0.0 110.427 -179.628 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.715 HD22 HG22 ' A' ' 126' ' ' VAL . 0.5 OUTLIER -82.43 -45.14 15.18 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.551 -0.718 . . . . 0.0 110.252 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.493 ' O ' HG23 ' A' ' 96' ' ' VAL . 20.9 m-20 -41.47 -43.56 2.66 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.548 0.69 . . . . 0.0 109.535 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.615 ' CG2' ' HB2' ' A' ' 85' ' ' ALA . 11.5 m -61.24 -59.58 5.09 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.753 -0.592 . . . . 0.0 109.596 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.743 HD12 ' O ' ' A' ' 90' ' ' PHE . 0.6 OUTLIER -46.75 -38.88 10.7 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.379 -0.826 . . . . 0.0 109.395 179.49 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.474 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 58.0 t -66.41 -43.88 90.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.945 HG12 HD13 ' A' ' 64' ' ' LEU . 45.8 t -58.58 -55.73 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.453 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 6.5 mp -47.21 -61.47 1.88 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.423 -0.798 . . . . 0.0 110.133 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -61.16 -36.01 78.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.162 -0.961 . . . . 0.0 109.838 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 1.1 mtp-105 -58.4 -13.18 4.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.394 -0.816 . . . . 0.0 110.536 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.802 ' HB3' HD11 ' A' ' 64' ' ' LEU . . . -146.58 61.8 1.21 Allowed 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.228 -0.92 . . . . 0.0 110.625 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 60.08 107.9 0.01 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.356 -1.097 . . . . 0.0 110.356 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.519 ' HA ' ' OD1' ' A' ' 71' ' ' ASN . . . -165.64 89.36 0.44 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.423 -1.045 . . . . 0.0 110.39 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.5 96.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.968 -1.082 . . . . 0.0 109.776 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.897 ' HA ' HG21 ' A' ' 82' ' ' VAL . 1.8 mp -87.45 41.87 1.01 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.214 -0.929 . . . . 0.0 110.457 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.63 ' HB2' ' HA ' ' A' ' 134' ' ' ALA . 30.9 t0 -146.9 41.78 1.11 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.905 -1.122 . . . . 0.0 110.829 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.888 HG11 ' HG3' ' A' ' 80' ' ' ARG . 7.1 p -99.01 177.13 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.378 -0.826 . . . . 0.0 109.754 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.557 ' H ' HG22 ' A' ' 106' ' ' VAL . 8.8 mtm180 -111.62 136.79 50.36 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.372 -0.83 . . . . 0.0 109.933 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.463 ' OD2' ' HA ' ' A' ' 79' ' ' THR . 5.5 t70 . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.409 -0.807 . . . . 0.0 109.447 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.618 ' O ' HD12 ' A' ' 117' ' ' LEU . 16.2 mt . . . . . 0 N--CA 1.494 1.774 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 38.2 Cg_endo -64.97 -36.24 39.4 Favored 'Trans proline' 0 N--CA 1.49 1.295 0 O-C-N 123.674 1.355 . . . . 0.0 110.155 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 127' ' ' ALA . 10.7 p -78.9 -33.23 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.439 -0.788 . . . . 0.0 109.264 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.512 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 3.1 t0 -60.85 -23.98 65.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.507 -0.745 . . . . 0.0 109.898 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.618 HD12 ' O ' ' A' ' 113' ' ' LEU . 0.3 OUTLIER -76.25 -65.12 0.96 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.427 -0.796 . . . . 0.0 110.102 179.848 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.537 ' HB1' ' HB2' ' A' ' 123' ' ' HIS . . . -44.48 -53.61 6.8 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.568 -0.707 . . . . 0.0 111.077 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.19 -45.61 75.82 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.291 -0.881 . . . . 0.0 110.444 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.512 ' HB2' ' O ' ' A' ' 116' ' ' ASP . 0.0 OUTLIER -71.51 -45.13 63.27 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.467 -0.77 . . . . 0.0 109.967 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.427 ' CD1' ' HD3' ' A' ' 87' ' ' ARG . 4.8 mt -69.15 -94.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.615 -0.678 . . . . 0.0 109.92 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -177.26 47.83 0.1 Allowed Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.537 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . 71.4 m-70 -124.91 52.55 1.56 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.463 -1.022 . . . . 0.0 109.528 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 124' ' ' ARG . 26.8 mtm105 -43.59 -49.17 7.64 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.811 -0.556 . . . . 0.0 110.633 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.4 ' C ' HD21 ' A' ' 91' ' ' LEU . 36.8 t0 -46.16 -46.88 17.57 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.876 HG11 ' CB ' ' A' ' 86' ' ' ALA . 22.4 t -76.08 -49.91 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.933 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.447 ' O ' HG23 ' A' ' 115' ' ' VAL . . . -43.6 -48.72 7.67 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.321 -0.862 . . . . 0.0 110.19 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 36.7 mtt-85 -64.28 -64.88 0.77 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.502 -0.749 . . . . 0.0 109.754 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -50.27 -41.7 51.0 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.371 -0.831 . . . . 0.0 110.818 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.71 ' O ' ' HB3' ' A' ' 134' ' ' ALA . 12.2 mt -58.15 -56.99 14.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.103 -0.998 . . . . 0.0 109.767 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -47.32 -23.44 0.57 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.366 -0.834 . . . . 0.0 110.858 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -83.95 -73.46 0.42 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.197 -0.94 . . . . 0.0 109.921 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.14 -11.72 22.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.167 -0.958 . . . . 0.0 110.377 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.71 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.353 -0.842 . . . . 0.0 109.661 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 121.076 0.465 . . . . 0.0 109.916 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.54 ' O ' HD13 ' A' ' 31' ' ' LEU . 31.1 m0 -85.93 -24.88 26.39 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.365 -0.835 . . . . 0.0 110.349 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.134 HD11 HD21 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -71.29 -37.24 71.86 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.268 -0.895 . . . . 0.0 109.379 179.511 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.677 ' HB2' ' ND2' ' A' ' 42' ' ' ASN . . . -81.21 -47.92 12.77 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.443 -0.786 . . . . 0.0 110.914 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.518 HG23 ' N ' ' A' ' 19' ' ' ALA . 14.6 t -48.78 -43.06 37.61 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.357 -0.84 . . . . 0.0 111.09 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.6 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -75.89 -36.52 59.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.192 -0.943 . . . . 0.0 109.999 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.4 ' CB ' HG11 ' A' ' 59' ' ' VAL . . . -69.1 -28.4 66.46 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.126 -0.984 . . . . 0.0 110.088 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.435 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -80.53 -36.02 33.72 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.369 -0.832 . . . . 0.0 110.64 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -84.42 21.95 1.36 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.226 -0.921 . . . . 0.0 110.861 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.53 ' HA3' ' HE1' ' A' ' 53' ' ' MET . . . 44.85 65.01 1.93 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.496 ' HB3' ' HB3' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -133.38 62.82 1.65 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.341 -1.094 . . . . 0.0 109.35 179.374 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 24' ' ' ARG . 77.3 t -34.78 -53.82 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.872 -0.518 . . . . 0.0 111.421 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -53.0 -45.06 67.71 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.355 -0.841 . . . . 0.0 110.683 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.496 ' HB3' ' HB3' ' A' ' 24' ' ' ARG . 2.1 tp10 -64.64 -28.42 69.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.235 -0.916 . . . . 0.0 110.149 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 1.069 HG12 HD23 ' A' ' 62' ' ' LEU . 47.5 t -85.3 -51.24 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.181 -0.949 . . . . 0.0 110.428 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 1.013 ' HA ' HD22 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -43.44 -48.62 7.2 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.516 -0.74 . . . . 0.0 111.014 -179.916 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.46 -50.02 15.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.48 -0.762 . . . . 0.0 110.391 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.54 HD13 ' O ' ' A' ' 15' ' ' TRP . 10.7 mt -44.48 -61.03 1.68 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.495 -0.753 . . . . 0.0 110.497 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.859 ' HB3' HD11 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -57.21 -44.56 83.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.537 -0.727 . . . . 0.0 109.704 179.429 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -68.43 -7.41 31.49 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.36 -0.838 . . . . 0.0 110.562 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -105.32 -18.07 14.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.165 -0.959 . . . . 0.0 111.014 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' A' ' 37' ' ' LEU . . . 161.09 -36.51 0.41 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.724 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -45.63 96.31 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.404 -1.057 . . . . 0.0 110.093 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.636 ' HG ' ' HB2' ' A' ' 40' ' ' ALA . 0.8 OUTLIER -66.33 152.03 95.02 Favored Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 121.299 -0.876 . . . . 0.0 110.099 -179.071 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.465 ' HB2' ' HA ' ' A' ' 68' ' ' ALA . 44.3 Cg_endo -70.65 -34.35 11.75 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 124.025 1.539 . . . . 0.0 111.922 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -88.3 42.73 1.08 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.924 -1.11 . . . . 0.0 110.355 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.636 ' HB2' ' HG ' ' A' ' 37' ' ' LEU . . . -97.7 107.13 37.98 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.289 -0.882 . . . . 0.0 110.097 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -69.94 133.47 25.32 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.644 1.339 . . . . 0.0 109.528 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.677 ' ND2' ' HB2' ' A' ' 17' ' ' ALA . 5.7 m120 -77.05 -176.98 4.23 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.431 -0.793 . . . . 0.0 110.059 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 69.2 m -102.39 23.86 11.18 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.31 -0.869 . . . . 0.0 109.44 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.46 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 7.4 m-85 -122.59 19.24 10.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.73 -0.606 . . . . 0.0 109.479 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.431 ' C ' ' HG2' ' A' ' 46' ' ' ARG . . . 60.94 26.9 66.12 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.46 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 0.0 OUTLIER -129.1 130.5 46.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.219 -1.165 . . . . 0.0 109.889 -179.772 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.581 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 3.4 mmp_? -48.02 168.95 0.14 Allowed Pre-proline 0 N--CA 1.499 2.016 0 O-C-N 121.574 -0.704 . . . . 0.0 110.475 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.581 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 39.2 Cg_endo -67.01 -17.91 51.53 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.562 1.296 . . . . 0.0 110.329 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.765 ' CG1' HD22 ' A' ' 63' ' ' LEU . 4.9 mt -107.38 -34.16 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 177.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.436 ' HG2' ' HB3' ' A' ' 46' ' ' ARG . 44.6 tt0 -50.45 -24.85 3.37 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.627 -0.671 . . . . 0.0 109.362 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.505 HG11 ' HB1' ' A' ' 17' ' ' ALA . 11.9 p -99.53 7.93 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.471 -0.768 . . . . 0.0 110.246 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.503 ' HB2' ' O ' ' A' ' 49' ' ' ILE . 2.2 tmm? -61.66 158.07 16.22 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.232 -0.917 . . . . 0.0 109.318 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.53 ' HE1' ' HA3' ' A' ' 23' ' ' GLY . 54.7 ttp -70.64 -5.29 28.36 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.223 -0.923 . . . . 0.0 110.135 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.566 ' HB3' ' CB ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER 53.53 22.37 2.93 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.053 -1.03 . . . . 0.0 109.519 -179.116 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.563 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -121.38 -7.41 8.31 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.731 -1.747 . . . . 0.0 108.731 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.1 m -134.73 87.13 2.32 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.426 -1.044 . . . . 0.0 109.638 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.556 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . . . -53.48 -25.7 17.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.325 -0.859 . . . . 0.0 109.643 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.408 ' O ' ' CB ' ' A' ' 61' ' ' GLU . 5.9 mtt85 -54.8 -38.24 67.06 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.595 -0.691 . . . . 0.0 110.093 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.4 HG11 ' CB ' ' A' ' 20' ' ' ALA . 59.6 t -55.86 -66.71 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.022 -1.048 . . . . 0.0 109.364 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -45.82 -27.78 0.93 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.406 -0.809 . . . . 0.0 109.838 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -59.56 -53.69 55.13 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.428 -0.795 . . . . 0.0 110.152 179.54 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 1.069 HD23 HG12 ' A' ' 28' ' ' VAL . 0.5 OUTLIER -65.46 -42.54 92.21 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.239 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.134 HD21 HD11 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -60.54 -53.54 56.3 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.148 179.729 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.847 HD13 HG12 ' A' ' 96' ' ' VAL . 0.3 OUTLIER -61.75 -29.81 70.37 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.302 -0.959 . . . . 0.0 108.996 178.648 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.507 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 0.4 OUTLIER -54.92 -49.97 69.97 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.676 ' CG ' HD22 ' A' ' 32' ' ' LEU 0.261 80.3 m80 -87.25 -9.19 55.7 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.794 179.639 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 38' ' ' PRO . . . 82.29 71.32 1.31 Allowed Glycine 0 N--CA 1.482 1.741 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.549 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -65.38 -143.9 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.367 -1.078 . . . . 0.0 109.489 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.505 ' HB3' ' HD3' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -116.36 50.51 0.82 Allowed Pre-proline 0 C--N 1.3 -1.584 0 O-C-N 121.174 -0.954 . . . . 0.0 110.236 179.195 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.602 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 50.1 Cg_endo -72.86 52.39 2.15 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 O-C-N 123.24 1.126 . . . . 0.0 110.266 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.481 ' N ' ' HG3' ' A' ' 81' ' ' PRO . 26.0 m-20 -162.19 -74.64 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.309 -0.87 . . . . 0.0 110.065 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.412 ' HB3' ' NH1' ' A' ' 47' ' ' ARG . 6.2 m -52.22 118.99 3.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.091 -1.005 . . . . 0.0 109.235 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.614 ' HB2' ' HA ' ' A' ' 80' ' ' ARG . . . -107.0 -145.5 0.39 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.433 -0.792 . . . . 0.0 110.477 -178.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER -114.29 134.89 22.18 Favored Pre-proline 0 N--CA 1.487 1.41 0 O-C-N 121.241 -0.912 . . . . 0.0 110.042 -179.879 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -71.58 -9.32 24.87 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.555 1.292 . . . . 0.0 109.96 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.04 -51.15 8.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.274 -0.891 . . . . 0.0 110.107 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 11.5 p -123.29 8.86 9.12 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.527 -0.733 . . . . 0.0 110.504 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.488 ' HA ' HD23 ' A' ' 78' ' ' LEU . 0.4 OUTLIER 43.65 37.65 1.64 Allowed 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.543 0.687 . . . . 0.0 110.061 -179.577 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.66 92.16 4.72 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.341 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.826 ' CG ' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -68.89 171.2 6.73 Favored Pre-proline 0 C--N 1.303 -1.446 0 C-N-CA 119.319 -0.952 . . . . 0.0 108.702 179.799 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.602 ' HG3' ' HA ' ' A' ' 70' ' ' PRO . 40.6 Cg_endo -73.34 1.51 6.67 Favored 'Trans proline' 0 C--N 1.299 -2.073 0 O-C-N 123.88 1.463 . . . . 0.0 110.662 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.589 HG11 ' HG ' ' A' ' 104' ' ' LEU . 4.3 t -90.18 -36.18 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.298 -0.876 . . . . 0.0 109.412 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.545 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 19.7 m80 -61.69 -28.68 69.58 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.431 0.634 . . . . 0.0 109.506 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.564 ' HB3' ' SD ' ' A' ' 54' ' ' MET . 43.4 m-20 -64.01 -58.78 5.67 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.38 -0.825 . . . . 0.0 110.162 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.45 ' CB ' ' CD1' ' A' ' 94' ' ' LEU . . . -49.86 -67.88 0.22 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.383 -0.823 . . . . 0.0 110.394 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.803 ' HB2' HD11 ' A' ' 130' ' ' LEU . . . -51.83 -51.4 56.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.351 -0.843 . . . . 0.0 110.94 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.545 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -43.75 -26.58 0.26 Allowed 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.012 -1.055 . . . . 0.0 111.062 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.566 ' CB ' ' HB3' ' A' ' 54' ' ' MET . 5.7 tm-20 -105.78 -15.58 14.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.159 -0.963 . . . . 0.0 110.12 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.561 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 91.52 29.19 12.52 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.126 -1.189 . . . . 0.0 110.126 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.563 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 0.3 OUTLIER -101.52 93.07 5.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.177 -1.19 . . . . 0.0 110.881 179.945 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.586 HD11 ' O ' ' A' ' 125' ' ' ASP . 0.3 OUTLIER -66.76 -42.56 85.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.454 -0.778 . . . . 0.0 110.276 179.652 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.692 ' O ' HG23 ' A' ' 96' ' ' VAL . 67.4 t0 -45.52 -51.47 11.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.345 -0.847 . . . . 0.0 110.239 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 98.1 m -47.41 -52.42 16.93 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.533 -0.729 . . . . 0.0 109.626 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.678 ' HA ' HD12 ' A' ' 97' ' ' LEU . 3.7 mp -51.21 -58.57 5.8 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.422 -0.799 . . . . 0.0 109.785 178.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.479 ' O ' ' CB ' ' A' ' 99' ' ' ARG . 46.8 t -44.07 -51.92 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-O 121.139 0.495 . . . . 0.0 109.834 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.847 HG12 HD13 ' A' ' 64' ' ' LEU . 5.7 t -54.89 -50.78 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.37 -0.831 . . . . 0.0 110.08 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.678 ' HA ' HD21 ' A' ' 64' ' ' LEU . 56.5 mt -52.35 -60.84 2.75 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.453 -0.779 . . . . 0.0 110.378 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -68.76 -26.55 65.29 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.435 -0.791 . . . . 0.0 110.446 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.479 ' CB ' ' O ' ' A' ' 95' ' ' VAL . 45.8 ttt85 -70.03 -9.36 55.04 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.187 -0.945 . . . . 0.0 110.637 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.449 ' HB3' HD22 ' A' ' 64' ' ' LEU . . . -136.0 -53.4 0.75 Allowed 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.005 -1.059 . . . . 0.0 110.928 -179.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 102' ' ' ALA . . . 178.43 110.81 0.28 Allowed Glycine 0 N--CA 1.486 1.982 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.489 ' CB ' ' HB3' ' A' ' 97' ' ' LEU . . . -177.03 141.17 0.33 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.253 -1.145 . . . . 0.0 110.381 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.729 ' O ' HD12 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -86.63 156.39 20.04 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.621 -0.674 . . . . 0.0 109.549 179.306 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.729 HD12 ' O ' ' A' ' 103' ' ' ARG . 0.3 OUTLIER -144.22 46.11 1.42 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.247 -0.908 . . . . 0.0 110.433 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.418 ' OD2' ' O ' ' A' ' 134' ' ' ALA . 1.1 t70 -152.32 40.2 0.6 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.192 -0.942 . . . . 0.0 110.112 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.826 HG11 ' CG ' ' A' ' 80' ' ' ARG . 4.0 p -104.55 170.21 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.652 -0.655 . . . . 0.0 109.846 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.533 ' N ' HG22 ' A' ' 106' ' ' VAL . 11.3 mtp180 -97.84 176.89 5.64 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.541 -0.724 . . . . 0.0 109.812 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 22.4 p-10 . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.908 . . . . 0.0 109.707 179.575 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.579 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.502 2.141 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.579 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 40.6 Cg_endo -69.3 -33.64 17.87 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 O-C-N 123.586 1.308 . . . . 0.0 109.347 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.472 HG12 ' HB3' ' A' ' 113' ' ' LEU . 12.8 p -78.4 -33.36 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-O 121.535 0.683 . . . . 0.0 109.437 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -71.89 -34.26 69.01 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.539 -0.725 . . . . 0.0 109.44 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.651 HD22 HD11 ' A' ' 121' ' ' LEU . 0.6 OUTLIER -61.19 -39.36 89.88 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.387 -0.821 . . . . 0.0 110.243 179.805 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.578 ' HB1' ' HB2' ' A' ' 123' ' ' HIS . . . -67.45 -51.96 45.27 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.208 -0.933 . . . . 0.0 110.736 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -46.89 -35.4 6.38 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.348 -0.845 . . . . 0.0 110.545 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.54 -58.83 2.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.35 -0.844 . . . . 0.0 109.575 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.651 HD11 HD22 ' A' ' 117' ' ' LEU . 50.2 mt -53.38 -93.29 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.465 -0.772 . . . . 0.0 110.463 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 178.31 36.9 0.06 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.578 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . 35.6 m-70 -108.51 41.33 1.6 Allowed 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.314 -1.109 . . . . 0.0 109.273 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -43.5 -33.57 1.14 Allowed 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.437 0.637 . . . . 0.0 110.16 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.586 ' O ' HD11 ' A' ' 91' ' ' LEU . 2.5 t0 -63.72 -41.3 98.1 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.367 -0.833 . . . . 0.0 108.863 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.707 HG11 ' HA ' ' A' ' 86' ' ' ALA . 3.2 t -80.81 -43.9 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.716 -0.615 . . . . 0.0 110.94 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.464 ' HB2' ' HB3' ' A' ' 118' ' ' ALA . . . -51.31 -35.89 39.98 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.279 -0.888 . . . . 0.0 110.034 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.91 -65.98 0.61 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.418 -0.801 . . . . 0.0 109.887 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.476 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 11.6 t80 -54.07 -42.72 69.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.472 -0.768 . . . . 0.0 109.225 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.803 HD11 ' HB2' ' A' ' 86' ' ' ALA . 14.0 mt -55.96 -58.12 9.24 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.823 -0.548 . . . . 0.0 110.281 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.409 ' HG3' HG21 ' A' ' 115' ' ' VAL . 9.4 ttm180 -56.14 -15.68 4.06 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.176 -0.952 . . . . 0.0 110.854 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 129' ' ' TYR . . . -82.66 -57.18 3.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.055 -1.028 . . . . 0.0 109.809 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -85.47 -12.32 52.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.562 -0.711 . . . . 0.0 110.501 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.613 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.494 1.74 0 O-C-N 121.219 -0.926 . . . . 0.0 110.768 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.6 p30 . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 121.004 0.43 . . . . 0.0 110.698 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.676 ' HB3' HD13 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -71.6 -5.21 31.77 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.151 -0.968 . . . . 0.0 110.4 179.773 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.851 HD21 ' CB ' ' A' ' 36' ' ' ALA . 22.7 mt -78.56 -61.48 1.99 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.096 -1.002 . . . . 0.0 109.629 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.521 ' HB1' HG11 ' A' ' 51' ' ' VAL . . . -57.0 -43.77 82.08 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.481 -0.762 . . . . 0.0 109.641 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.571 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.8 OUTLIER -54.18 -54.99 32.26 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.642 -0.662 . . . . 0.0 110.292 179.576 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.621 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -68.54 -40.07 80.87 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.337 -0.852 . . . . 0.0 109.778 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.534 ' HB1' HG11 ' A' ' 59' ' ' VAL . . . -57.62 -50.68 72.33 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.323 -0.861 . . . . 0.0 109.687 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.644 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -58.79 -27.16 64.77 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.612 -0.68 . . . . 0.0 110.587 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.37 23.06 4.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.317 -0.864 . . . . 0.0 110.618 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.43 48.81 40.77 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.2 mtm180 -121.55 58.68 0.99 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.388 -1.066 . . . . 0.0 110.164 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.772 HG22 HG22 ' A' ' 59' ' ' VAL . 51.1 t -44.74 -51.43 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.591 -0.693 . . . . 0.0 110.886 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -51.09 -44.04 61.16 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.335 -0.853 . . . . 0.0 110.622 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.468 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 1.0 OUTLIER -61.25 -39.03 88.84 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.387 -0.821 . . . . 0.0 109.969 179.731 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.837 HG12 HD13 ' A' ' 62' ' ' LEU . 23.6 t -76.81 -48.41 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.471 -0.768 . . . . 0.0 110.465 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.931 ' HA ' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -46.85 -34.94 5.8 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.348 -0.845 . . . . 0.0 109.7 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.56 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -79.88 -51.96 8.48 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.353 -0.842 . . . . 0.0 108.901 178.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.676 HD13 ' HB3' ' A' ' 15' ' ' TRP . 18.6 mt -58.84 -65.13 0.71 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.935 0.874 . . . . 0.0 109.728 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.811 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 1.1 tp -47.21 -49.19 23.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.743 -0.598 . . . . 0.0 110.929 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.521 ' HB2' ' O ' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -75.34 -14.56 60.49 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.152 -0.967 . . . . 0.0 110.47 179.617 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.56 ' HB2' ' O ' ' A' ' 30' ' ' ALA . . . -82.64 -9.54 59.34 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.07 -1.019 . . . . 0.0 110.532 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 125.95 17.5 2.51 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.787 -1.197 . . . . 0.0 110.825 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.851 ' CB ' HD21 ' A' ' 16' ' ' LEU . . . -64.44 176.04 1.2 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.053 -1.263 . . . . 0.0 110.092 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.643 HD13 ' HD2' ' A' ' 38' ' ' PRO . 1.6 mm? -91.46 133.45 31.27 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.264 -0.897 . . . . 0.0 110.281 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.643 ' HD2' HD13 ' A' ' 37' ' ' LEU . 44.8 Cg_endo -70.89 -49.29 0.41 Allowed 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 123.603 1.317 . . . . 0.0 110.37 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -95.62 18.48 12.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.31 -0.869 . . . . 0.0 110.484 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.573 ' HB2' ' CB ' ' A' ' 37' ' ' LEU . . . -42.38 109.09 0.68 Allowed Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 121.63 -0.669 . . . . 0.0 110.908 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.5 91.89 0.86 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.709 1.373 . . . . 0.0 110.412 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -65.33 -177.83 0.44 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.484 -0.76 . . . . 0.0 109.898 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.33 22.53 2.47 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.209 -0.932 . . . . 0.0 110.422 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.538 ' HB3' ' CD ' ' A' ' 46' ' ' ARG . 2.8 m-85 -103.09 3.86 36.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -0.904 . . . . 0.0 110.681 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 57.06 35.12 67.83 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.538 ' CD ' ' HB3' ' A' ' 44' ' ' TYR . 7.6 ptm180 -160.4 26.11 0.16 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.261 -1.141 . . . . 0.0 110.697 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.5 ' CB ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER 49.04 -174.63 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.038 0 O-C-N 121.552 -0.718 . . . . 0.0 110.154 179.689 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.734 ' HB2' HD13 ' A' ' 63' ' ' LEU . 46.2 Cg_endo -72.43 -167.33 0.32 Allowed 'Trans proline' 0 C--N 1.315 -1.207 0 O-C-N 123.141 1.074 . . . . 0.0 110.538 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.506 ' O ' ' HG2' ' A' ' 52' ' ' MET . 3.5 mt 60.2 -65.59 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.748 -0.595 . . . . 0.0 109.625 -178.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.592 ' N ' ' O ' ' A' ' 48' ' ' PRO . 19.6 mt-30 -45.8 -25.43 0.51 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.959 -1.088 . . . . 0.0 109.803 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.644 HG22 ' HB2' ' A' ' 21' ' ' ALA . 8.9 p -119.02 40.58 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.485 -0.76 . . . . 0.0 109.789 178.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.562 ' HE1' ' HB2' ' A' ' 60' ' ' ALA . 0.1 OUTLIER -102.52 37.62 1.87 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.028 -1.045 . . . . 0.0 110.21 179.863 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.431 ' CB ' ' O ' ' A' ' 52' ' ' MET . 3.6 tmm? 66.34 -11.73 0.22 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.374 -0.829 . . . . 0.0 111.158 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.498 ' HE1' ' CG ' ' A' ' 52' ' ' MET . 0.0 OUTLIER 48.03 27.55 1.24 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.205 -0.935 . . . . 0.0 110.358 -179.703 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.445 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -125.52 9.5 7.73 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.56 ' HB3' HG23 ' A' ' 59' ' ' VAL . 1.0 OUTLIER -148.99 81.06 1.43 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.41 -1.053 . . . . 0.0 109.629 -179.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -49.81 -27.87 5.6 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.464 -0.772 . . . . 0.0 109.775 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.5 mtt85 -52.23 -29.16 21.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.537 -0.727 . . . . 0.0 109.356 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.772 HG22 HG22 ' A' ' 25' ' ' VAL . 29.2 t -71.15 -51.63 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.364 -0.835 . . . . 0.0 108.946 178.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.562 ' HB2' ' HE1' ' A' ' 52' ' ' MET . . . -49.13 -42.31 38.97 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.65 -0.656 . . . . 0.0 109.676 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.5 ' O ' ' HB3' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -61.27 -55.59 30.19 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.486 -0.759 . . . . 0.0 109.317 179.012 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.931 HD11 ' HA ' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -44.25 -58.94 2.61 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.468 -0.77 . . . . 0.0 110.152 178.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.81 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 13.9 mt -69.43 -41.9 75.71 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.663 -0.648 . . . . 0.0 110.486 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.891 HD22 HG12 ' A' ' 96' ' ' VAL . 0.5 OUTLIER -61.68 -55.49 29.89 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.039 -1.038 . . . . 0.0 109.739 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.545 ' O ' HD12 ' A' ' 65' ' ' LEU . 0.6 OUTLIER -53.97 -26.81 27.69 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.379 -0.825 . . . . 0.0 109.458 179.366 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.419 ' ND1' ' CD1' ' A' ' 32' ' ' LEU . 1.0 OUTLIER -88.6 -49.04 7.13 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.518 -0.739 . . . . 0.0 109.8 -179.847 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 151.39 50.64 0.02 OUTLIER Glycine 0 N--CA 1.481 1.676 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.81 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -74.05 -157.58 0.05 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.798 -1.413 . . . . 0.0 109.805 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -122.21 63.99 18.69 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.35 -0.844 . . . . 0.0 110.055 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.608 ' HG3' HD12 ' A' ' 64' ' ' LEU . 47.3 Cg_endo -72.3 -8.66 23.11 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.858 1.451 . . . . 0.0 110.574 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -108.05 -78.77 0.58 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.291 -0.881 . . . . 0.0 109.549 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.73 -175.82 0.1 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.55 -0.719 . . . . 0.0 110.527 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.751 ' HB1' ' O ' ' A' ' 79' ' ' THR . . . -167.39 -83.19 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.425 -0.797 . . . . 0.0 110.298 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -146.71 123.36 5.73 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.291 -0.881 . . . . 0.0 109.674 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.37 -2.43 11.7 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.511 1.269 . . . . 0.0 110.645 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -96.52 -27.79 14.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.215 -0.928 . . . . 0.0 110.19 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 71.9 p -137.11 4.56 2.72 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.259 -0.901 . . . . 0.0 111.103 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.52 ' HA ' HD23 ' A' ' 78' ' ' LEU . 5.2 mt 47.01 27.93 0.81 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.246 -0.909 . . . . 0.0 111.244 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.751 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 66.4 m -69.66 88.62 0.52 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.963 -1.086 . . . . 0.0 109.783 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.773 ' HD3' HG21 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -67.98 165.11 35.14 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.309 -0.869 . . . . 0.0 109.946 -179.605 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.56 ' HD2' ' HG3' ' A' ' 80' ' ' ARG . 46.5 Cg_endo -76.0 -7.98 18.6 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.622 1.328 . . . . 0.0 109.767 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.407 ' H ' HG23 ' A' ' 82' ' ' VAL . 6.0 t -71.54 -23.92 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.552 -0.717 . . . . 0.0 109.593 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.527 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 4.0 m80 -75.46 -23.39 56.86 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.475 ' HB3' ' SD ' ' A' ' 54' ' ' MET . 51.7 m-20 -75.39 -57.39 3.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.829 -0.544 . . . . 0.0 110.92 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.755 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -53.38 -50.77 64.41 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.194 -0.941 . . . . 0.0 109.507 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.844 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -65.51 -32.05 73.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.455 -0.778 . . . . 0.0 110.105 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.56 ' HA ' HD13 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -56.18 -51.02 69.54 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.297 -0.877 . . . . 0.0 110.374 -179.851 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.465 ' HB2' ' HB3' ' A' ' 54' ' ' MET . 0.9 OUTLIER -93.28 16.58 12.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.301 -0.874 . . . . 0.0 110.422 -179.793 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.686 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 53.28 55.03 26.49 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.445 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 0.2 OUTLIER -115.5 94.93 4.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.418 -1.048 . . . . 0.0 110.744 -179.349 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.828 HD11 ' CG ' ' A' ' 129' ' ' TYR . 0.3 OUTLIER -66.69 -45.5 78.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.348 -0.845 . . . . 0.0 109.967 179.645 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.882 ' O ' HG23 ' A' ' 96' ' ' VAL . 69.6 m-20 -47.91 -40.05 20.75 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.52 -0.737 . . . . 0.0 109.723 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.432 HG23 ' HE1' ' A' ' 52' ' ' MET . 7.1 m -66.17 -55.81 14.5 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.613 -0.68 . . . . 0.0 109.252 179.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.815 HD21 ' HB2' ' A' ' 130' ' ' LEU . 4.8 tp -52.03 -47.82 64.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.741 -0.6 . . . . 0.0 109.741 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 91' ' ' LEU . 58.4 t -51.45 -43.76 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.498 -0.751 . . . . 0.0 109.697 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.891 HG12 HD22 ' A' ' 64' ' ' LEU . 23.0 t -57.55 -52.5 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.52 -0.738 . . . . 0.0 109.47 179.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.505 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 4.7 mp -50.51 -57.51 7.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.563 -0.711 . . . . 0.0 109.995 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -62.39 -30.13 70.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.415 -0.803 . . . . 0.0 109.69 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.9 mtt180 -68.01 -11.93 59.85 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.503 -0.748 . . . . 0.0 110.489 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.585 ' CB ' HD21 ' A' ' 64' ' ' LEU . . . -144.43 63.41 1.32 Allowed 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.162 -0.961 . . . . 0.0 110.859 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 53.51 101.53 0.01 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 97' ' ' LEU . . . -151.97 101.25 2.72 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.256 -1.143 . . . . 0.0 110.122 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -55.82 93.62 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.493 -0.755 . . . . 0.0 109.92 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.563 HD22 ' HB3' ' A' ' 133' ' ' ALA . 0.0 OUTLIER -84.67 8.38 17.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.35 -0.844 . . . . 0.0 110.548 -179.699 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.46 ' HB3' ' HA ' ' A' ' 134' ' ' ALA . 6.0 p30 -123.85 60.54 1.11 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.097 -1.002 . . . . 0.0 110.827 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.773 HG21 ' HD3' ' A' ' 80' ' ' ARG . 1.7 p -112.21 -170.48 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.134 -0.979 . . . . 0.0 109.766 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.647 ' H ' HG22 ' A' ' 106' ' ' VAL . 0.2 OUTLIER -138.54 126.11 22.01 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.298 -0.877 . . . . 0.0 109.788 179.417 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.1 t0 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 0.0 109.657 179.918 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.501 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.744 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.501 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 41.3 Cg_endo -68.51 -30.22 29.45 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.385 1.202 . . . . 0.0 109.559 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.847 ' HB ' HD11 ' A' ' 130' ' ' LEU . 4.8 p -82.99 -26.21 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.338 -0.852 . . . . 0.0 109.421 179.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -56.37 -40.65 74.9 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.502 -0.749 . . . . 0.0 110.664 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.56 HD13 ' HA ' ' A' ' 87' ' ' ARG . 3.5 pp -77.16 -27.78 53.89 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.217 -0.927 . . . . 0.0 109.94 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.588 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -69.21 -26.73 64.96 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.36 -0.838 . . . . 0.0 110.164 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -88.74 -34.35 17.18 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.365 -0.835 . . . . 0.0 109.646 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -74.37 -63.84 1.15 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.405 -0.809 . . . . 0.0 110.535 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.407 ' HB3' ' NE2' ' A' ' 123' ' ' HIS . 0.2 OUTLIER -54.38 -86.77 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.246 -0.909 . . . . 0.0 110.602 -179.486 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 174.31 52.91 0.05 OUTLIER Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.429 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 44.7 m-70 -120.95 44.22 2.57 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.474 -1.015 . . . . 0.0 109.266 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.677 ' HA ' ' HB3' ' A' ' 127' ' ' ALA . 9.5 ptm180 -43.55 -38.19 2.83 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.759 -0.588 . . . . 0.0 110.538 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.506 ' O ' HD21 ' A' ' 91' ' ' LEU . 80.9 m-20 -56.79 -43.47 80.92 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.844 HG11 ' HA ' ' A' ' 86' ' ' ALA . 2.1 t -82.03 -40.03 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.677 ' HB3' ' HA ' ' A' ' 124' ' ' ARG . . . -55.86 -45.4 78.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.394 -0.816 . . . . 0.0 109.657 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -74.9 -52.26 11.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.383 -0.823 . . . . 0.0 109.526 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.828 ' CG ' HD11 ' A' ' 91' ' ' LEU . 80.6 t80 -61.5 -65.16 0.73 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.453 -0.779 . . . . 0.0 110.851 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.847 HD11 ' HB ' ' A' ' 115' ' ' VAL . 0.3 OUTLIER -52.34 -26.16 11.57 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.285 -0.884 . . . . 0.0 110.499 -179.147 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.498 ' HB2' HG21 ' A' ' 115' ' ' VAL . 17.2 ttt-85 -73.12 -42.63 62.68 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.122 -0.986 . . . . 0.0 109.543 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.28 -33.21 72.01 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.563 ' HB3' HD22 ' A' ' 104' ' ' LEU . . . -89.28 -22.58 22.62 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.46 ' HA ' ' HB3' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.554 -0.716 . . . . 0.0 110.272 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.6 t70 . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 120.841 0.353 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.599 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 27.8 m0 -75.34 -10.87 59.84 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.015 -1.053 . . . . 0.0 110.699 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.788 HD21 HD21 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -78.11 -54.62 6.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.183 -0.948 . . . . 0.0 109.924 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.469 ' N ' ' HG ' ' A' ' 16' ' ' LEU . . . -69.28 -40.03 77.99 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.097 -1.002 . . . . 0.0 109.813 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.599 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 2.8 p -51.43 -56.77 11.42 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.579 -0.7 . . . . 0.0 110.687 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.741 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -56.49 -38.54 71.89 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.269 -0.895 . . . . 0.0 110.227 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.61 -23.99 66.95 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.292 -0.88 . . . . 0.0 110.14 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.506 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -82.54 -27.65 31.52 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.281 -0.887 . . . . 0.0 110.606 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 -94.31 22.75 5.69 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.293 -0.88 . . . . 0.0 110.454 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 55.57 66.57 2.74 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.75 75.62 1.48 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.382 -1.069 . . . . 0.0 109.588 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.875 HG22 ' CG2' ' A' ' 59' ' ' VAL . 11.6 t -56.19 -53.26 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.357 -0.84 . . . . 0.0 110.246 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -45.92 -42.23 12.52 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.457 -0.777 . . . . 0.0 111.067 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.654 ' O ' HD12 ' A' ' 31' ' ' LEU . 1.3 mp0 -64.78 -46.64 81.22 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.319 -0.863 . . . . 0.0 109.776 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.944 HG12 HD12 ' A' ' 32' ' ' LEU . 13.7 t -73.49 -45.41 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.412 -0.805 . . . . 0.0 109.548 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.873 ' CG ' HG12 ' A' ' 25' ' ' VAL . 27.6 mmm-85 -48.53 -43.52 35.42 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.536 -0.727 . . . . 0.0 109.902 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.26 -45.32 33.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.542 -0.724 . . . . 0.0 109.896 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.654 HD12 ' O ' ' A' ' 27' ' ' GLU . 4.1 mt -54.42 -56.96 13.37 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.281 -0.887 . . . . 0.0 109.876 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.944 HD12 HG12 ' A' ' 28' ' ' VAL . 3.0 mt -57.42 -44.82 84.95 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.394 -0.816 . . . . 0.0 110.077 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -63.18 -17.42 62.37 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.507 -0.746 . . . . 0.0 110.188 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.43 -14.12 31.11 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.325 -0.86 . . . . 0.0 110.167 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.63 28.13 1.64 Allowed Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.951 -1.119 . . . . 0.0 110.403 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.655 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -58.7 152.3 19.11 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.208 -1.172 . . . . 0.0 110.078 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.897 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 2.1 mm? -66.71 122.08 80.5 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.409 -0.807 . . . . 0.0 109.989 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.481 ' HD2' HD13 ' A' ' 37' ' ' LEU . 42.4 Cg_endo -68.8 -42.68 4.31 Favored 'Trans proline' 0 C--N 1.312 -1.342 0 O-C-N 123.601 1.316 . . . . 0.0 110.361 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -108.9 56.71 0.62 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.429 -0.794 . . . . 0.0 109.592 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.897 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -94.38 117.2 67.05 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.396 -0.815 . . . . 0.0 110.193 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.53 109.56 2.49 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.626 1.329 . . . . 0.0 110.072 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.586 ' ND2' HG11 ' A' ' 51' ' ' VAL . 18.3 t-20 -50.86 175.59 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.448 -0.782 . . . . 0.0 110.882 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.4 t -87.01 4.83 40.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.542 -0.724 . . . . 0.0 110.78 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -117.01 31.33 6.81 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.119 -0.988 . . . . 0.0 109.94 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 55.38 23.47 34.39 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.57 141.31 48.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.405 -1.056 . . . . 0.0 110.049 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.509 ' CG ' ' HB2' ' A' ' 69' ' ' GLU . 0.2 OUTLIER -57.12 176.96 0.21 Allowed Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.543 -0.723 . . . . 0.0 110.417 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.446 ' HD2' ' CB ' ' A' ' 47' ' ' ARG . 41.1 Cg_endo -67.29 -24.41 43.69 Favored 'Trans proline' 0 C--N 1.315 -1.208 0 O-C-N 123.576 1.303 . . . . 0.0 111.116 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.491 HG13 HD13 ' A' ' 63' ' ' LEU . 7.2 mt -109.01 -31.13 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.9 -1.125 . . . . 0.0 109.064 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.471 ' HA ' ' OD2' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -51.5 -25.9 7.38 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.563 -0.711 . . . . 0.0 109.992 179.365 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.586 HG11 ' ND2' ' A' ' 42' ' ' ASN . 10.9 p -97.21 3.34 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.21 -0.931 . . . . 0.0 109.881 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.564 ' CE ' ' HB2' ' A' ' 60' ' ' ALA . 51.6 ttp -56.13 164.54 1.23 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.491 -0.756 . . . . 0.0 110.256 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 3.5 tmm? -75.49 -6.81 52.05 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.252 -0.905 . . . . 0.0 111.0 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.495 ' SD ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 52.55 23.42 2.57 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.181 -0.949 . . . . 0.0 110.192 -179.694 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -122.06 8.45 9.82 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -160.11 106.13 1.56 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.445 -1.033 . . . . 0.0 109.903 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.638 ' HB2' ' HB3' ' A' ' 92' ' ' ASP . . . -63.79 -26.42 68.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.325 -0.86 . . . . 0.0 109.977 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.422 ' HB3' HG11 ' A' ' 25' ' ' VAL . 53.8 mtt180 -50.68 -29.17 10.5 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.348 -0.845 . . . . 0.0 109.858 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.875 ' CG2' HG22 ' A' ' 25' ' ' VAL . 49.0 t -74.75 -56.31 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.564 ' HB2' ' CE ' ' A' ' 52' ' ' MET . . . -54.09 -45.13 71.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.303 -0.873 . . . . 0.0 109.508 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.455 ' O ' HD23 ' A' ' 65' ' ' LEU . 12.4 tt0 -61.96 -35.05 77.31 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.273 -0.892 . . . . 0.0 109.197 179.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.682 ' CD1' HD13 ' A' ' 32' ' ' LEU . 1.1 tp -71.86 -48.42 46.03 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.788 HD21 HD21 ' A' ' 16' ' ' LEU . 1.0 OUTLIER -72.7 -37.8 67.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.55 -0.719 . . . . 0.0 109.998 179.7 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.783 HD21 ' CB ' ' A' ' 100' ' ' ALA . 0.6 OUTLIER -65.26 -63.2 1.16 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.431 -0.793 . . . . 0.0 110.411 -179.853 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.566 ' O ' HD12 ' A' ' 65' ' ' LEU . 0.4 OUTLIER -52.75 -25.31 10.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.877 . . . . 0.0 109.54 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.899 ' CG ' HD22 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -80.54 -52.13 7.96 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.559 -0.713 . . . . 0.0 109.431 179.412 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.444 ' HA3' ' HB2' ' A' ' 38' ' ' PRO . . . 159.57 32.56 0.02 OUTLIER Glycine 0 N--CA 1.481 1.643 0 C-N-CA 119.672 -1.251 . . . . 0.0 111.456 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.526 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -70.39 172.21 8.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.52 -1.576 . . . . 0.0 109.363 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.509 ' HB2' ' CG ' ' A' ' 47' ' ' ARG . 6.5 mm-40 -108.76 78.61 0.94 Allowed Pre-proline 0 C--N 1.301 -1.51 0 O-C-N 121.341 -0.849 . . . . 0.0 109.54 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.494 ' HG3' HD12 ' A' ' 64' ' ' LEU . 43.1 Cg_endo -68.42 -10.75 29.94 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.9 1.474 . . . . 0.0 110.521 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.3 -61.21 1.48 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.102 -0.999 . . . . 0.0 110.036 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 3.9 t -46.51 149.59 0.77 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.462 -0.774 . . . . 0.0 111.108 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -140.43 -148.14 0.24 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.503 -0.748 . . . . 0.0 109.79 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.455 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.4 OUTLIER -104.63 140.41 21.05 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.124 -0.985 . . . . 0.0 109.79 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -76.19 -12.64 19.21 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.345 1.182 . . . . 0.0 110.679 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.53 -43.9 25.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.248 -0.907 . . . . 0.0 110.27 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.22 9.8 4.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.264 -0.897 . . . . 0.0 110.614 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.507 ' HA ' HD23 ' A' ' 78' ' ' LEU . 0.8 OUTLIER 46.38 40.51 7.97 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.338 -0.851 . . . . 0.0 111.18 179.708 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.3 m -78.45 100.15 6.73 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.917 . . . . 0.0 110.17 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.747 ' HB2' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -69.4 161.78 71.21 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.361 -0.837 . . . . 0.0 109.393 179.769 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.506 ' HD2' ' CG ' ' A' ' 80' ' ' ARG . 44.0 Cg_endo -70.6 -16.68 34.06 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.451 1.238 . . . . 0.0 109.936 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 74.4 t -59.68 -27.79 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.417 -0.802 . . . . 0.0 109.662 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.512 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 4.8 m80 -75.7 -33.93 60.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.496 -0.753 . . . . 0.0 109.056 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.495 ' HB3' ' SD ' ' A' ' 54' ' ' MET . 3.3 m-20 -57.28 -49.03 77.36 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.806 -0.559 . . . . 0.0 109.852 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.701 ' HB1' HD12 ' A' ' 94' ' ' LEU . . . -58.68 -62.27 1.99 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.331 -0.856 . . . . 0.0 109.179 178.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.785 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -55.62 -49.57 72.47 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.299 -0.876 . . . . 0.0 110.839 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.618 ' HD3' HD12 ' A' ' 117' ' ' LEU . 5.4 tpp85 -40.7 -38.99 0.99 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.38 -0.825 . . . . 0.0 111.401 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.37 -2.62 35.82 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.044 -1.035 . . . . 0.0 111.032 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.45 19.1 59.16 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.553 ' HE2' ' HB2' ' A' ' 57' ' ' ALA . 1.0 OUTLIER -91.08 132.19 36.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.186 -1.185 . . . . 0.0 109.915 179.736 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.666 HD11 ' O ' ' A' ' 125' ' ' ASP . 0.4 OUTLIER -108.76 -43.6 4.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.393 -0.817 . . . . 0.0 110.354 179.859 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.638 ' HB3' ' HB2' ' A' ' 57' ' ' ALA . 34.6 t0 -45.82 -29.25 1.28 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.476 -0.765 . . . . 0.0 110.052 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.437 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 11.8 m -73.4 -43.94 59.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.644 -0.66 . . . . 0.0 109.448 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.719 HD13 HG13 ' A' ' 126' ' ' VAL . 0.8 OUTLIER -56.0 -50.29 71.27 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.259 -0.901 . . . . 0.0 110.023 179.716 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.434 ' O ' ' CB ' ' A' ' 99' ' ' ARG . 43.5 t -53.78 -49.43 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.5 -0.75 . . . . 0.0 109.366 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.742 ' CG1' HD22 ' A' ' 64' ' ' LEU . 70.3 t -52.92 -47.71 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.515 -0.74 . . . . 0.0 109.632 179.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.466 ' CD2' ' HB3' ' A' ' 70' ' ' PRO . 96.6 mt -56.66 -72.63 0.07 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.513 -0.742 . . . . 0.0 109.986 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 17.3 t-160 -51.42 -33.35 30.19 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.477 -0.765 . . . . 0.0 110.465 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.434 ' CB ' ' O ' ' A' ' 95' ' ' VAL . 3.5 ttm180 -66.09 -15.49 63.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.41 -0.806 . . . . 0.0 110.517 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.783 ' CB ' HD21 ' A' ' 64' ' ' LEU . . . -142.52 75.5 1.49 Allowed 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.106 -0.996 . . . . 0.0 110.955 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 51.47 97.76 0.01 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -164.33 101.62 0.84 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.358 -1.083 . . . . 0.0 110.08 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 11.1 ttt180 -61.0 120.21 9.8 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.462 -0.774 . . . . 0.0 110.198 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.18 10.06 41.25 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.5 -0.75 . . . . 0.0 110.508 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -124.51 55.55 1.32 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.309 -0.869 . . . . 0.0 110.318 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.747 HG11 ' HB2' ' A' ' 80' ' ' ARG . 2.3 p -106.37 -169.28 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.394 -0.817 . . . . 0.0 109.613 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.648 ' H ' HG22 ' A' ' 106' ' ' VAL . 6.8 mtt180 -140.31 151.64 45.22 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.333 -0.854 . . . . 0.0 110.019 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.7 0 O-C-N 121.314 -0.867 . . . . 0.0 109.69 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.477 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.477 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 43.3 Cg_endo -70.33 -45.21 1.35 Allowed 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.633 1.333 . . . . 0.0 109.656 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.458 ' HA ' HD13 ' A' ' 130' ' ' LEU . 10.2 p -62.78 -28.05 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.401 -0.812 . . . . 0.0 109.243 179.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.3 -40.37 81.8 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.434 -0.791 . . . . 0.0 109.976 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.618 HD12 ' HD3' ' A' ' 87' ' ' ARG . 1.0 OUTLIER -68.14 -22.59 64.86 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.397 -0.814 . . . . 0.0 110.128 179.732 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.448 ' HB1' ' HB2' ' A' ' 127' ' ' ALA . . . -80.39 -53.97 6.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.375 -0.828 . . . . 0.0 110.429 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -57.63 -27.53 62.88 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.287 -0.883 . . . . 0.0 110.431 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -72.11 -51.39 21.67 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.399 -0.813 . . . . 0.0 110.219 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.515 ' HB2' ' CD2' ' A' ' 123' ' ' HIS . 37.5 mt -85.41 1.17 49.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.312 -0.868 . . . . 0.0 110.599 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 75.72 40.95 30.2 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.515 ' CD2' ' HB2' ' A' ' 121' ' ' LEU . 25.3 m-70 -89.8 55.43 3.17 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.02 -1.282 . . . . 0.0 109.465 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 28.7 mtt-85 -44.48 -38.19 3.96 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.773 -0.579 . . . . 0.0 110.278 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.666 ' O ' HD11 ' A' ' 91' ' ' LEU . 0.5 OUTLIER -58.4 -48.36 80.9 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.39 -0.819 . . . . 0.0 109.071 178.919 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.785 HG11 ' HA ' ' A' ' 86' ' ' ALA . 3.5 t -81.33 -43.65 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.473 -0.767 . . . . 0.0 110.244 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.448 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . . . -54.71 -49.51 70.57 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.292 -0.88 . . . . 0.0 110.541 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.1 mtp-105 -56.02 -55.13 36.6 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.208 -0.933 . . . . 0.0 110.18 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -65.03 -33.65 76.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.393 -0.817 . . . . 0.0 110.05 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.72 HD11 ' HB2' ' A' ' 86' ' ' ALA . 10.9 mt -66.29 -67.96 0.41 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.345 -0.847 . . . . 0.0 110.468 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -48.18 -24.62 1.2 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.353 -0.842 . . . . 0.0 110.857 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -82.81 -53.8 5.6 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.306 -0.871 . . . . 0.0 110.017 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -87.44 5.98 36.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.399 -0.813 . . . . 0.0 111.034 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.495 1.813 0 O-C-N 121.096 -1.003 . . . . 0.0 110.514 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.126 0.488 . . . . 0.0 109.8 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.533 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 37.0 m0 -69.76 -4.79 21.43 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.583 -0.698 . . . . 0.0 110.348 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.981 HD11 HD21 ' A' ' 63' ' ' LEU . 0.8 OUTLIER -78.0 -55.66 5.11 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.268 -0.895 . . . . 0.0 109.641 179.594 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.412 ' N ' ' HG ' ' A' ' 16' ' ' LEU . . . -73.15 -37.3 66.64 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.261 -0.899 . . . . 0.0 110.752 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.533 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.7 OUTLIER -59.91 -50.67 72.85 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.291 -0.881 . . . . 0.0 110.94 -179.559 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.725 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -61.82 -36.19 80.43 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.276 -0.89 . . . . 0.0 110.526 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.654 ' HA ' HG11 ' A' ' 59' ' ' VAL . . . -60.01 -33.38 71.92 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.339 -0.851 . . . . 0.0 110.008 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.603 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -81.34 -28.55 34.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.442 -0.787 . . . . 0.0 110.441 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.4 ttt180 -92.7 32.62 1.21 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.379 -0.826 . . . . 0.0 110.778 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 47.22 47.74 21.02 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.558 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -117.07 95.56 5.05 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.195 -1.179 . . . . 0.0 110.129 179.857 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.6 HG12 ' HD3' ' A' ' 29' ' ' ARG . 57.3 t -73.13 -57.59 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.567 -0.708 . . . . 0.0 110.019 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -47.63 -51.42 21.43 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.596 -0.69 . . . . 0.0 111.071 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.436 ' HB3' ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -48.58 -53.75 17.15 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.486 -0.759 . . . . 0.0 110.022 179.827 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.92 HG12 HD12 ' A' ' 32' ' ' LEU . 4.8 t -72.98 -50.68 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.365 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.6 ' HD3' HG12 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -45.46 -49.62 13.31 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.317 -0.864 . . . . 0.0 109.898 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.12 -35.88 66.63 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.583 -0.698 . . . . 0.0 109.829 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.499 ' HB2' ' HA ' ' A' ' 28' ' ' VAL . 14.8 mt -64.19 -58.55 6.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.363 -0.836 . . . . 0.0 110.437 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.971 HD22 ' CG ' ' A' ' 66' ' ' HIS . 0.5 OUTLIER -50.05 -37.83 35.18 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.184 -0.948 . . . . 0.0 110.292 -179.568 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -79.33 -16.17 56.75 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.394 -0.816 . . . . 0.0 110.164 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -93.48 -4.98 50.19 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.231 -0.918 . . . . 0.0 111.435 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 134.06 -19.7 4.1 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.434 -1.365 . . . . 0.0 110.937 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.65 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -46.12 121.14 3.1 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.07 -1.253 . . . . 0.0 110.594 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.542 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 0.7 OUTLIER -75.48 128.67 83.69 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.396 -0.815 . . . . 0.0 110.421 -179.434 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.506 ' HB2' ' C ' ' A' ' 67' ' ' GLY . 46.3 Cg_endo -68.97 -37.77 10.61 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 O-C-N 123.493 1.259 . . . . 0.0 111.185 -179.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.53 48.95 1.16 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.148 -0.97 . . . . 0.0 110.069 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.542 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -100.87 95.88 5.02 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.189 -0.944 . . . . 0.0 110.192 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.43 128.76 18.84 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.432 1.227 . . . . 0.0 110.245 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -122.18 178.16 5.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.363 -0.836 . . . . 0.0 110.499 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.448 ' O ' ' CB ' ' A' ' 44' ' ' TYR . 1.1 p -60.8 -157.11 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.427 -0.796 . . . . 0.0 110.042 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.448 ' CB ' ' O ' ' A' ' 43' ' ' SER . 3.5 t80 68.17 5.87 4.92 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.423 -0.798 . . . . 0.0 110.644 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 52.04 25.65 17.77 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.471 ' HB3' ' HB ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -116.8 -167.45 1.3 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.317 -1.108 . . . . 0.0 110.87 -179.585 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.579 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -124.3 -161.45 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.805 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -179.884 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.664 ' HB2' HD22 ' A' ' 63' ' ' LEU . 51.2 Cg_endo -78.69 -32.19 2.18 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 O-C-N 122.698 0.841 . . . . 0.0 110.921 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.524 HG13 ' HB1' ' A' ' 68' ' ' ALA . 5.7 mt -109.02 -36.77 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 120.869 -1.145 . . . . 0.0 109.91 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.469 ' OE1' ' HA ' ' A' ' 46' ' ' ARG . 17.0 tt0 -48.62 -26.56 2.31 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.248 -0.908 . . . . 0.0 109.518 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.603 HG22 ' HB2' ' A' ' 21' ' ' ALA . 8.3 p -97.12 21.39 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.491 -0.756 . . . . 0.0 110.382 179.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.704 ' CE ' ' HB2' ' A' ' 60' ' ' ALA . 0.4 OUTLIER -77.18 159.1 29.96 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.139 -0.975 . . . . 0.0 109.761 179.579 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 37.6 ttp -70.09 -5.4 26.6 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.261 -0.899 . . . . 0.0 110.165 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.618 ' HE2' ' HB3' ' A' ' 52' ' ' MET . 16.0 mmt 49.68 28.26 2.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.348 -0.845 . . . . 0.0 109.835 -179.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.439 ' C ' ' CE2' ' A' ' 90' ' ' PHE . . . -124.33 5.7 8.74 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 178.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -156.1 85.72 1.02 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.654 -0.909 . . . . 0.0 109.221 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.423 ' HB2' ' HB3' ' A' ' 92' ' ' ASP . . . -46.98 -26.94 1.12 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.589 -0.694 . . . . 0.0 110.102 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -46.55 -42.71 16.29 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.662 -0.649 . . . . 0.0 109.798 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.654 HG11 ' HA ' ' A' ' 20' ' ' ALA . 10.9 t -65.74 -60.63 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.63 -0.669 . . . . 0.0 109.282 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.704 ' HB2' ' CE ' ' A' ' 52' ' ' MET . . . -48.43 -47.63 37.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.456 -0.778 . . . . 0.0 109.311 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.482 ' O ' HD23 ' A' ' 65' ' ' LEU . 0.5 OUTLIER -60.19 -40.76 91.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.589 -0.694 . . . . 0.0 109.263 178.685 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.688 HD21 HG12 ' A' ' 28' ' ' VAL . 2.8 tp -66.27 -51.99 51.99 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.461 -0.774 . . . . 0.0 109.474 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.981 HD21 HD11 ' A' ' 16' ' ' LEU . 2.8 mt -67.86 -41.54 82.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.313 -0.867 . . . . 0.0 110.16 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.508 ' CD1' HG12 ' A' ' 96' ' ' VAL . 0.5 OUTLIER -68.78 -57.98 4.84 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.192 -0.943 . . . . 0.0 110.372 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.743 HD12 ' C ' ' A' ' 65' ' ' LEU . 1.3 pp -49.94 -25.63 3.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.118 -0.989 . . . . 0.0 109.096 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.971 ' CG ' HD22 ' A' ' 32' ' ' LEU . 1.4 m-70 -82.11 -51.32 8.11 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.789 -0.569 . . . . 0.0 109.481 179.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.506 ' C ' ' HB2' ' A' ' 38' ' ' PRO . . . 152.74 38.78 0.03 OUTLIER Glycine 0 N--CA 1.485 1.914 0 C-N-CA 120.03 -1.081 . . . . 0.0 110.794 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.524 ' HB1' HG13 ' A' ' 49' ' ' ILE . . . -69.67 -170.19 0.29 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.867 -1.372 . . . . 0.0 110.06 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -109.17 79.37 1.17 Allowed Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.39 -0.818 . . . . 0.0 109.611 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.448 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 49.5 Cg_endo -70.83 -12.55 31.01 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.8 1.421 . . . . 0.0 110.546 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.527 ' O ' ' NE ' ' A' ' 80' ' ' ARG . 26.3 t-20 -113.43 -58.46 2.15 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.285 -0.884 . . . . 0.0 110.669 -179.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.417 ' C ' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -41.1 137.46 1.31 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.26 -0.9 . . . . 0.0 110.918 -179.515 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.459 ' HB2' ' CD ' ' A' ' 80' ' ' ARG . . . -131.43 -155.22 0.68 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.623 -0.673 . . . . 0.0 110.286 -179.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -106.15 145.52 31.11 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.197 -0.939 . . . . 0.0 110.487 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -75.57 -25.4 11.04 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.712 1.375 . . . . 0.0 110.048 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.11 -59.32 5.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.314 -0.866 . . . . 0.0 110.175 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 77' ' ' THR . 2.2 t -137.0 29.31 2.82 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.337 -0.852 . . . . 0.0 110.908 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.459 ' HA ' HD23 ' A' ' 78' ' ' LEU . 20.2 mt 51.53 52.91 13.72 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.203 -0.936 . . . . 0.0 111.372 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 16.7 m -83.41 106.48 15.2 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.032 -1.042 . . . . 0.0 109.736 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.654 ' HB2' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -95.35 170.66 7.5 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.372 -0.83 . . . . 0.0 109.721 179.745 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.553 ' HD2' ' CG ' ' A' ' 80' ' ' ARG . 48.1 Cg_endo -71.74 -0.09 7.83 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.564 1.297 . . . . 0.0 110.425 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.874 HG21 ' HA ' ' A' ' 104' ' ' LEU . 43.3 t -79.87 -45.04 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -0.932 . . . . 0.0 110.279 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.429 ' O ' ' CB ' ' A' ' 87' ' ' ARG . 37.4 m80 -59.01 -37.73 77.58 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.389 -0.819 . . . . 0.0 109.221 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.459 ' CB ' ' HE3' ' A' ' 54' ' ' MET . 62.3 m-20 -54.43 -57.55 10.88 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.714 -0.616 . . . . 0.0 110.566 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.476 ' CB ' HD13 ' A' ' 94' ' ' LEU . . . -51.01 -63.83 1.0 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.102 -0.998 . . . . 0.0 109.884 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.941 ' HB2' HD11 ' A' ' 130' ' ' LEU . . . -56.65 -50.73 71.2 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.337 -0.852 . . . . 0.0 110.687 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.429 ' CB ' ' O ' ' A' ' 83' ' ' HIS . 11.0 tpp85 -43.44 -28.82 0.39 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.294 -0.879 . . . . 0.0 110.852 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -103.59 -11.12 17.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.397 -0.814 . . . . 0.0 110.459 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.598 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 86.35 34.55 12.0 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.439 ' CE2' ' C ' ' A' ' 55' ' ' GLY . 0.4 OUTLIER -108.28 121.15 44.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.112 -1.228 . . . . 0.0 110.732 -179.818 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.565 HD11 ' O ' ' A' ' 125' ' ' ASP . 0.4 OUTLIER -94.75 -41.65 9.14 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.497 -0.752 . . . . 0.0 110.222 179.737 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.878 ' O ' HG23 ' A' ' 96' ' ' VAL . 0.4 OUTLIER -52.05 -30.15 24.46 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.348 -0.845 . . . . 0.0 109.088 179.53 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.521 ' O ' HD12 ' A' ' 97' ' ' LEU . 72.4 m -72.85 -38.57 67.03 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.912 HD21 ' CD2' ' A' ' 130' ' ' LEU . 1.6 tp -64.42 -47.72 78.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.571 -0.705 . . . . 0.0 109.416 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.45 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 41.4 t -57.2 -48.31 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.47 -0.769 . . . . 0.0 108.951 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.878 HG23 ' O ' ' A' ' 92' ' ' ASP . 98.7 t -52.56 -53.78 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.781 -0.574 . . . . 0.0 110.072 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.521 HD12 ' O ' ' A' ' 93' ' ' THR . 0.3 OUTLIER -52.56 -65.29 0.58 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.391 -0.818 . . . . 0.0 109.965 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -58.48 -28.47 65.38 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.272 -0.893 . . . . 0.0 110.339 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.45 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 17.7 ttp180 -67.16 -15.83 63.94 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.256 -0.903 . . . . 0.0 110.424 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.95 72.35 1.33 Allowed 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.347 -0.845 . . . . 0.0 110.863 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 54.64 102.79 0.01 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.419 ' CB ' ' C ' ' A' ' 97' ' ' LEU . . . -163.57 102.47 0.93 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.333 -1.098 . . . . 0.0 110.167 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -71.63 98.26 1.87 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.428 -0.795 . . . . 0.0 110.015 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.874 ' HA ' HG21 ' A' ' 82' ' ' VAL . 1.1 mp -89.9 10.53 23.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.451 -0.78 . . . . 0.0 109.706 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -103.13 36.88 2.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.311 -0.868 . . . . 0.0 110.719 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.654 HG11 ' HB2' ' A' ' 80' ' ' ARG . 0.7 OUTLIER -98.25 -171.82 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.024 -1.047 . . . . 0.0 109.77 179.555 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.567 ' H ' HG22 ' A' ' 106' ' ' VAL . 4.4 ptt-85 -140.44 135.48 32.05 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.625 -0.672 . . . . 0.0 109.666 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.508 ' HA ' ' O ' ' A' ' 77' ' ' THR . 41.9 p-10 . . . . . 0 N--CA 1.494 1.764 0 O-C-N 121.125 -0.984 . . . . 0.0 110.615 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.462 HD23 ' HD2' ' A' ' 114' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.764 0 CA-C-O 120.534 0.207 . . . . 0.0 110.666 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.462 ' HD2' HD23 ' A' ' 113' ' ' LEU . 42.1 Cg_endo -68.27 -29.26 32.56 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.674 1.355 . . . . 0.0 110.743 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.8 p -78.71 -32.69 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.999 -1.063 . . . . 0.0 109.834 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -64.39 -26.89 68.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.345 -0.847 . . . . 0.0 109.367 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.498 HD23 ' CD1' ' A' ' 121' ' ' LEU . 0.2 OUTLIER -70.47 -37.03 74.22 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.506 -0.746 . . . . 0.0 109.636 179.258 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.5 ' CB ' ' HB2' ' A' ' 123' ' ' HIS . . . -70.18 -35.89 74.28 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.447 -0.783 . . . . 0.0 109.915 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -63.33 -39.1 93.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.42 -0.8 . . . . 0.0 110.307 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.05 -69.62 0.51 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.371 -0.831 . . . . 0.0 110.396 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.498 ' CD1' HD23 ' A' ' 117' ' ' LEU . 0.2 OUTLIER -47.3 -89.14 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.499 -0.751 . . . . 0.0 111.142 -179.54 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 173.53 36.56 0.04 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.584 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 51.6 m-70 -101.19 43.99 1.03 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.364 -1.08 . . . . 0.0 109.11 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.77 -53.87 4.37 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-O 121.211 0.529 . . . . 0.0 110.698 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.565 ' O ' HD11 ' A' ' 91' ' ' LEU . 0.5 OUTLIER -51.45 -40.29 59.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.422 -0.799 . . . . 0.0 109.426 179.292 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.803 HG11 ' HA ' ' A' ' 86' ' ' ALA . 2.0 t -78.73 -35.5 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.383 -0.823 . . . . 0.0 109.611 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.473 ' HB2' ' CB ' ' A' ' 118' ' ' ALA . . . -59.06 -48.05 83.0 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.215 -0.928 . . . . 0.0 109.805 179.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.5 ttm180 -50.0 -63.94 0.96 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.486 -0.759 . . . . 0.0 109.854 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.427 ' CD2' HD21 ' A' ' 91' ' ' LEU . 3.5 t80 -52.93 -55.21 25.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.556 -0.715 . . . . 0.0 110.393 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.941 HD11 ' HB2' ' A' ' 86' ' ' ALA . 25.2 mt -48.07 -48.78 33.16 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.558 -0.713 . . . . 0.0 109.945 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.81 -28.95 17.24 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.367 -0.833 . . . . 0.0 109.929 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -89.0 -54.02 4.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.485 -0.759 . . . . 0.0 110.361 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.725 ' HB1' HD13 ' A' ' 104' ' ' LEU . . . -75.71 -7.49 54.49 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.32 -0.862 . . . . 0.0 110.902 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.638 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.493 1.71 0 O-C-N 121.094 -1.003 . . . . 0.0 110.067 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 120.755 0.312 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.592 ' CE3' HD21 ' A' ' 31' ' ' LEU . 3.2 t90 -72.49 -2.4 19.5 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.089 -1.007 . . . . 0.0 110.932 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.602 HD11 ' HB1' ' A' ' 36' ' ' ALA . 31.7 mt -81.58 -53.86 5.9 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.072 -1.017 . . . . 0.0 109.545 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.45 -38.33 87.13 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.605 -0.685 . . . . 0.0 110.245 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.503 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.1 OUTLIER -60.66 -48.58 81.16 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.321 -0.862 . . . . 0.0 109.838 179.572 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.654 ' HB1' ' HB3' ' A' ' 24' ' ' ARG . . . -67.96 -49.2 63.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.386 -0.821 . . . . 0.0 109.651 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.542 ' HB1' ' CB ' ' A' ' 52' ' ' MET . . . -54.09 -45.42 71.78 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.38 -0.825 . . . . 0.0 109.681 179.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.34 -26.71 65.74 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.474 -0.766 . . . . 0.0 109.986 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.5 mtp85 -95.91 27.42 3.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.428 -0.795 . . . . 0.0 110.148 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.09 42.89 40.68 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.654 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -113.24 69.29 0.69 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.401 -1.058 . . . . 0.0 110.667 -179.576 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 1.03 HG22 HG22 ' A' ' 59' ' ' VAL . 85.9 t -58.71 -54.32 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.255 -0.903 . . . . 0.0 110.288 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -54.18 -41.58 68.7 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.428 -0.795 . . . . 0.0 110.854 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.407 ' OE1' ' HG2' ' A' ' 24' ' ' ARG . 1.6 tp10 -56.73 -45.23 82.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.192 -0.943 . . . . 0.0 110.035 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.959 HG12 HD12 ' A' ' 32' ' ' LEU . 20.1 t -68.72 -36.68 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.248 -0.907 . . . . 0.0 110.176 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.949 ' HA ' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -49.98 -41.86 47.76 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.422 -0.799 . . . . 0.0 109.927 -179.665 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.587 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -75.71 -31.32 59.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.443 -0.786 . . . . 0.0 110.239 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.818 HD12 ' HA ' ' A' ' 28' ' ' VAL . 21.8 mt -74.23 -67.51 0.61 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.452 -0.78 . . . . 0.0 110.52 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.959 HD12 HG12 ' A' ' 28' ' ' VAL . 6.4 mt -45.58 -45.27 13.53 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.625 -0.672 . . . . 0.0 110.282 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -71.98 -23.88 61.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.527 -0.733 . . . . 0.0 110.405 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 30' ' ' ALA . . . -79.76 -4.66 52.93 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.139 -0.976 . . . . 0.0 110.509 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.23 26.89 4.42 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.776 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -71.41 165.28 24.11 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.432 -1.04 . . . . 0.0 110.414 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.501 ' O ' HD12 ' A' ' 16' ' ' LEU . 1.7 tp -98.02 110.7 56.93 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.555 -0.715 . . . . 0.0 110.074 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.496 ' O ' ' HG3' ' A' ' 48' ' ' PRO . 44.3 Cg_endo -70.37 -11.97 30.95 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.445 1.234 . . . . 0.0 110.844 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.436 ' O ' ' HD3' ' A' ' 41' ' ' PRO . 0.7 OUTLIER -103.01 16.05 27.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -0.928 . . . . 0.0 110.029 179.78 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.406 ' N ' HD23 ' A' ' 37' ' ' LEU . . . -76.67 111.29 15.07 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.418 -0.801 . . . . 0.0 110.118 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 39' ' ' ASN . 48.1 Cg_endo -72.8 146.61 42.98 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 123.603 1.318 . . . . 0.0 110.358 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -75.64 -156.94 0.06 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.418 -0.801 . . . . 0.0 109.864 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.15 2.14 24.63 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.335 -0.853 . . . . 0.0 110.035 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -102.0 20.49 16.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.269 -0.894 . . . . 0.0 109.907 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.85 40.24 98.57 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.68 -163.18 1.24 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.671 -0.899 . . . . 0.0 110.517 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.483 ' O ' HG12 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -114.32 176.24 1.57 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.482 -0.761 . . . . 0.0 110.591 -179.243 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.496 ' HG3' ' O ' ' A' ' 38' ' ' PRO . 43.1 Cg_endo -70.97 -20.3 29.3 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.825 1.434 . . . . 0.0 110.791 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.487 ' O ' ' CG ' ' A' ' 52' ' ' MET . 6.3 mt -107.09 -40.28 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.284 -0.885 . . . . 0.0 109.39 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.47 ' HB2' ' HB2' ' A' ' 47' ' ' ARG . 1.1 tt0 -48.46 -28.73 3.49 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.282 -0.886 . . . . 0.0 110.477 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 47' ' ' ARG . 9.1 p -109.88 16.94 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.513 -0.742 . . . . 0.0 110.554 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.556 ' CE ' ' HB2' ' A' ' 60' ' ' ALA . 0.5 OUTLIER -84.58 166.72 16.93 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.09 -1.006 . . . . 0.0 110.261 179.533 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -62.26 91.41 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.334 -0.854 . . . . 0.0 109.092 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.591 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -56.07 -14.28 2.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.21 -0.931 . . . . 0.0 110.31 -179.429 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.401 ' C ' ' CE2' ' A' ' 90' ' ' PHE . . . -84.11 15.37 39.11 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 178.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.624 ' O ' HG23 ' A' ' 59' ' ' VAL . 0.4 OUTLIER -151.06 92.83 1.85 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.208 -1.172 . . . . 0.0 109.987 179.703 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.643 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . . . -58.49 -21.06 50.55 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.254 -0.903 . . . . 0.0 109.509 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.84 -28.74 66.35 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.553 -0.717 . . . . 0.0 110.083 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 1.03 HG22 HG22 ' A' ' 25' ' ' VAL . 2.1 t -70.89 -55.21 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.268 -0.895 . . . . 0.0 109.231 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.556 ' HB2' ' CE ' ' A' ' 52' ' ' MET . . . -51.42 -38.12 51.97 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.382 -0.824 . . . . 0.0 109.585 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.493 ' O ' ' HB3' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -53.35 -61.1 2.52 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.626 -0.671 . . . . 0.0 110.35 179.818 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.949 HD11 ' HA ' ' A' ' 29' ' ' ARG . 0.1 OUTLIER -45.81 -63.62 0.93 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.324 -0.86 . . . . 0.0 110.345 179.74 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.839 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 7.0 mt -57.9 -57.19 13.88 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.456 -0.778 . . . . 0.0 110.118 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.815 HD22 ' CG1' ' A' ' 96' ' ' VAL . 0.6 OUTLIER -53.21 -54.02 42.22 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.266 -0.896 . . . . 0.0 110.109 179.878 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.493 ' HB3' ' O ' ' A' ' 61' ' ' GLU . 13.2 tp -50.27 -36.76 32.74 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.87 ' CG ' HD22 ' A' ' 32' ' ' LEU . 1.9 m-70 -79.55 -28.24 41.24 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.504 0.669 . . . . 0.0 109.64 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 117.75 50.86 0.35 Allowed Glycine 0 N--CA 1.476 1.344 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.839 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -60.6 -159.94 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.21 -1.17 . . . . 0.0 109.477 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.45 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 0.6 OUTLIER -120.61 59.67 7.41 Favored Pre-proline 0 C--N 1.299 -1.616 0 O-C-N 121.231 -0.918 . . . . 0.0 109.465 178.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.431 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 47.7 Cg_endo -70.29 57.51 1.72 Allowed 'Trans proline' 0 C--N 1.313 -1.293 0 O-C-N 123.7 1.369 . . . . 0.0 110.415 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -167.3 -62.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.46 -0.775 . . . . 0.0 109.942 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 22.3 m -50.03 138.79 15.06 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.4 -0.812 . . . . 0.0 110.624 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.425 ' HB2' ' HA ' ' A' ' 80' ' ' ARG . . . -136.94 -144.07 0.19 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.397 -0.814 . . . . 0.0 110.109 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.3 144.04 28.38 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.006 -1.059 . . . . 0.0 109.906 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -72.59 -53.73 0.14 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.549 1.289 . . . . 0.0 110.55 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.86 -9.14 49.79 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.241 -0.912 . . . . 0.0 109.714 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 79' ' ' THR . 0.2 OUTLIER -153.48 105.03 2.8 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.642 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.608 HD22 ' NH1' ' A' ' 80' ' ' ARG . 27.8 mt -67.77 53.29 0.06 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.507 -0.746 . . . . 0.0 111.08 -178.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.514 ' HA ' ' OD1' ' A' ' 108' ' ' ASP . 3.6 m -79.8 85.02 5.51 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.104 -0.997 . . . . 0.0 109.528 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.78 ' CD ' HG11 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -71.96 169.95 14.3 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.488 -0.757 . . . . 0.0 109.568 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.486 ' HD2' ' CG ' ' A' ' 80' ' ' ARG . 46.9 Cg_endo -74.42 -2.32 12.23 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.578 1.304 . . . . 0.0 110.391 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.902 HG13 HD23 ' A' ' 104' ' ' LEU . 10.5 t -77.7 -31.32 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.465 -0.772 . . . . 0.0 109.766 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.411 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 27.2 m80 -69.78 -27.26 64.76 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.43 -0.794 . . . . 0.0 109.915 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.591 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 1.1 m-20 -67.64 -53.88 24.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.863 -0.523 . . . . 0.0 110.263 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.51 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -50.02 -58.05 6.29 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.538 -0.727 . . . . 0.0 109.581 179.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.809 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -63.41 -38.06 89.67 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.47 -0.769 . . . . 0.0 110.52 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 1.5 mmm-85 -40.7 -59.87 1.28 Allowed 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.116 -0.99 . . . . 0.0 111.125 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -85.18 3.73 37.82 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.232 -0.917 . . . . 0.0 110.156 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.645 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 74.75 48.22 12.99 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.643 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.3 OUTLIER -111.56 97.49 6.77 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.398 -1.06 . . . . 0.0 111.049 -179.536 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.49 HD12 ' HB3' ' A' ' 125' ' ' ASP . 0.3 OUTLIER -67.06 -42.48 84.69 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.592 -0.692 . . . . 0.0 110.498 179.603 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.431 ' O ' HG23 ' A' ' 96' ' ' VAL . 50.0 m-20 -45.65 -63.61 0.92 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.464 -0.772 . . . . 0.0 110.37 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.472 ' O ' HD12 ' A' ' 97' ' ' LEU . 70.9 m -47.39 -38.49 13.35 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.702 -0.624 . . . . 0.0 109.549 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.718 HD21 ' HG ' ' A' ' 130' ' ' LEU . 4.1 tp -61.84 -48.85 78.71 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.426 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 98.2 t -60.96 -50.87 78.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.815 ' CG1' HD22 ' A' ' 64' ' ' LEU . 95.0 t -48.85 -57.31 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.727 -0.608 . . . . 0.0 110.209 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.632 HD23 ' HB1' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -43.07 -66.26 0.39 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.782 -0.574 . . . . 0.0 110.218 179.885 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -55.37 -32.6 62.72 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.261 -0.899 . . . . 0.0 109.816 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 0.1 OUTLIER -61.71 -13.87 26.79 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.412 -0.805 . . . . 0.0 110.274 179.439 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.674 ' HB3' HD11 ' A' ' 64' ' ' LEU . . . -140.71 56.68 1.58 Allowed 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.374 -0.829 . . . . 0.0 110.575 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 57.7 98.17 0.01 OUTLIER Glycine 0 N--CA 1.489 2.185 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.632 ' HB1' HD23 ' A' ' 97' ' ' LEU . . . -157.84 95.89 1.44 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.333 -1.098 . . . . 0.0 110.018 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -62.15 106.97 0.8 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.293 -0.88 . . . . 0.0 110.028 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.902 HD23 HG13 ' A' ' 82' ' ' VAL . 1.8 mp -96.62 26.75 4.26 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.321 -0.862 . . . . 0.0 109.898 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -123.36 47.52 1.99 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.346 -0.846 . . . . 0.0 110.792 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.78 HG11 ' CD ' ' A' ' 80' ' ' ARG . 5.1 p -105.18 -175.33 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.189 -0.944 . . . . 0.0 109.454 179.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.694 ' H ' HG22 ' A' ' 106' ' ' VAL . 1.0 OUTLIER -142.56 122.02 13.21 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.187 -0.946 . . . . 0.0 110.83 -179.589 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.514 ' OD1' ' HA ' ' A' ' 79' ' ' THR . 1.6 m-20 . . . . . 0 N--CA 1.495 1.789 0 O-C-N 121.558 -0.714 . . . . 0.0 109.715 179.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.425 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.712 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.425 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 43.5 Cg_endo -70.37 -31.13 18.33 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.703 1.37 . . . . 0.0 110.768 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.447 HG13 ' N ' ' A' ' 116' ' ' ASP . 9.6 p -80.09 -38.93 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.16 -0.963 . . . . 0.0 110.489 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.447 ' N ' HG13 ' A' ' 115' ' ' VAL . 81.7 m-20 -65.86 -34.39 78.02 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.266 -0.897 . . . . 0.0 110.023 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.01 -34.49 78.12 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.261 -0.9 . . . . 0.0 109.925 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.869 ' HB1' ' HB2' ' A' ' 123' ' ' HIS . . . -70.96 -55.23 8.79 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.314 -0.866 . . . . 0.0 110.7 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.51 ' HG3' ' HB1' ' A' ' 127' ' ' ALA . 12.8 mt-10 -46.84 -39.51 12.11 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.403 -0.811 . . . . 0.0 110.622 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -67.51 -51.34 52.23 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.482 -0.761 . . . . 0.0 109.904 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.436 ' HB3' ' NE2' ' A' ' 123' ' ' HIS . 0.2 OUTLIER -67.19 -87.39 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.354 -0.841 . . . . 0.0 110.225 179.807 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 179.36 32.29 0.06 OUTLIER Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.752 -1.213 . . . . 0.0 110.07 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.869 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . 0.9 OUTLIER -98.29 45.96 1.01 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.171 -1.193 . . . . 0.0 108.882 179.415 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -44.58 -37.17 3.41 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.502 0.668 . . . . 0.0 109.836 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.49 ' HB3' HD12 ' A' ' 91' ' ' LEU . 0.4 OUTLIER -66.58 -44.66 81.63 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.67 -0.644 . . . . 0.0 109.556 179.058 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.809 HG11 ' HA ' ' A' ' 86' ' ' ALA . 2.4 t -75.52 -44.36 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.229 -0.919 . . . . 0.0 110.031 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.51 ' HB1' ' HG3' ' A' ' 119' ' ' GLU . . . -57.27 -24.18 53.19 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.191 -0.943 . . . . 0.0 109.965 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.74 -63.0 1.18 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.297 -0.877 . . . . 0.0 109.818 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -59.05 -41.26 87.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.483 -0.761 . . . . 0.0 109.36 179.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.718 ' HG ' HD21 ' A' ' 94' ' ' LEU . 13.2 mt -51.3 -64.24 0.87 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.495 -0.753 . . . . 0.0 109.539 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.7 ttt-85 -51.6 -21.69 2.76 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.298 -0.876 . . . . 0.0 110.317 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -88.51 -51.69 5.57 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.383 -0.823 . . . . 0.0 110.515 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -86.78 -16.46 36.22 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.247 -0.908 . . . . 0.0 111.206 -179.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.494 1.742 0 O-C-N 121.034 -1.041 . . . . 0.0 110.33 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 121.105 0.479 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.45 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 16.0 m0 -75.4 -20.22 59.06 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.148 -0.97 . . . . 0.0 109.981 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.719 HD13 HD11 ' A' ' 63' ' ' LEU . 1.2 pp -67.86 -35.22 78.16 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.396 -0.815 . . . . 0.0 110.043 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.14 -42.11 24.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.39 -0.819 . . . . 0.0 110.394 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.45 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.0 OUTLIER -59.85 -58.4 8.74 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.363 -0.836 . . . . 0.0 110.51 -179.655 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.19 -45.38 65.14 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.165 -0.959 . . . . 0.0 109.784 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.553 ' HB1' ' CB ' ' A' ' 52' ' ' MET . . . -50.83 -53.79 29.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.604 -0.685 . . . . 0.0 110.037 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.799 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -56.01 -31.8 63.41 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.164 -0.96 . . . . 0.0 110.078 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.58 21.8 5.99 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.38 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 49.43 76.02 0.18 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -140.76 63.84 1.45 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.57 -0.959 . . . . 0.0 109.405 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.501 ' CG1' ' NE ' ' A' ' 29' ' ' ARG . 13.6 t -49.21 -51.44 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.493 -0.755 . . . . 0.0 110.101 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.69 -51.14 52.37 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.74 -0.6 . . . . 0.0 110.669 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.506 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 5.4 tt0 -56.09 -44.96 79.52 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.329 -0.857 . . . . 0.0 109.874 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.81 HG12 ' CD1' ' A' ' 62' ' ' LEU . 38.4 t -71.28 -47.06 62.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.472 -0.767 . . . . 0.0 109.796 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.511 ' HA ' ' CD1' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -39.17 -52.68 1.91 Allowed 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.55 -0.719 . . . . 0.0 110.285 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.9 -49.53 14.02 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.679 -0.638 . . . . 0.0 110.733 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 27' ' ' GLU . 41.2 mt -44.73 -66.76 0.35 Allowed 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.32 -0.863 . . . . 0.0 110.635 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.98 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 0.6 OUTLIER -50.2 -53.93 24.49 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.46 -0.775 . . . . 0.0 110.296 179.681 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 29' ' ' ARG . 0.5 OUTLIER -63.84 -6.86 6.52 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.442 -0.786 . . . . 0.0 110.962 179.325 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -100.81 -13.43 18.41 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.853 -1.154 . . . . 0.0 111.56 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 146.38 -10.62 1.52 Allowed Glycine 0 N--CA 1.49 2.27 0 C-N-CA 119.323 -1.418 . . . . 0.0 110.45 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.98 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -56.18 140.56 43.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.929 -1.336 . . . . 0.0 109.87 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.951 ' HB2' ' HB2' ' A' ' 40' ' ' ALA . 18.3 mt -79.21 143.07 59.95 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.382 -0.824 . . . . 0.0 110.213 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.491 ' HB3' ' HB3' ' A' ' 66' ' ' HIS . 43.5 Cg_endo -72.54 -37.35 4.22 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.358 1.188 . . . . 0.0 110.125 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -100.59 5.64 43.99 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.403 -0.811 . . . . 0.0 110.534 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.951 ' HB2' ' HB2' ' A' ' 37' ' ' LEU . . . -39.75 101.36 0.23 Allowed Pre-proline 0 N--CA 1.501 2.098 0 O-C-N 121.471 -0.768 . . . . 0.0 111.358 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 40' ' ' ALA . 54.1 Cg_endo -72.58 159.26 49.29 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.828 1.436 . . . . 0.0 109.651 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.51 ' N ' ' OD1' ' A' ' 42' ' ' ASN . 10.8 p-10 -131.5 170.87 14.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.473 -0.767 . . . . 0.0 109.913 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.5 m -87.13 12.37 11.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.387 -0.821 . . . . 0.0 110.434 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.465 ' HB3' ' ND2' ' A' ' 42' ' ' ASN . 4.2 t80 -93.16 19.77 7.64 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.241 -0.912 . . . . 0.0 109.644 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 48.38 23.2 2.89 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 -179.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -138.57 106.17 5.59 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.63 -0.924 . . . . 0.0 110.845 -179.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.532 ' CB ' ' HD2' ' A' ' 48' ' ' PRO . 1.1 mpt_? -54.86 -175.39 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.55 -0.719 . . . . 0.0 109.619 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.532 ' HD2' ' CB ' ' A' ' 47' ' ' ARG . 43.0 Cg_endo -69.09 170.55 15.53 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.145 1.076 . . . . 0.0 109.732 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.531 ' O ' ' CG ' ' A' ' 52' ' ' MET . 3.2 mt 63.27 -58.78 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.794 -0.566 . . . . 0.0 110.578 -179.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.488 ' N ' ' O ' ' A' ' 48' ' ' PRO . 0.4 OUTLIER -48.68 -25.57 1.85 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.569 -1.332 . . . . 0.0 109.797 179.342 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.799 HG22 ' HB2' ' A' ' 21' ' ' ALA . 12.0 p -110.39 18.6 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 121.606 -0.684 . . . . 0.0 109.378 178.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.553 ' CB ' ' HB1' ' A' ' 20' ' ' ALA . 0.5 OUTLIER -92.72 167.67 11.73 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.242 -0.911 . . . . 0.0 110.057 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 5.5 ttp -69.26 107.52 3.29 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.159 -1.016 . . . . 0.0 109.32 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.527 ' HE2' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -66.41 -3.91 7.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.087 -1.008 . . . . 0.0 109.861 179.501 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -89.97 16.91 55.85 Favored Glycine 0 N--CA 1.484 1.889 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 178.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.93 117.29 2.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -1.177 . . . . 0.0 109.704 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.513 ' HB2' ' HE2' ' A' ' 90' ' ' PHE . . . -79.52 -27.06 41.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.308 -0.87 . . . . 0.0 110.368 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.51 ' O ' ' NH1' ' A' ' 29' ' ' ARG . 5.8 mmt180 -48.84 -38.25 21.77 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.181 -0.95 . . . . 0.0 110.267 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.438 HG22 ' CG2' ' A' ' 25' ' ' VAL . 24.3 t -62.64 -63.56 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 120.987 -1.071 . . . . 0.0 109.116 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.528 ' HB2' ' CE ' ' A' ' 52' ' ' MET . . . -52.13 -29.87 23.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.46 -0.775 . . . . 0.0 109.375 178.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -54.53 -66.4 0.41 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.029 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.81 ' CD1' HG12 ' A' ' 28' ' ' VAL . 0.1 OUTLIER -44.09 -61.63 1.41 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.402 -0.811 . . . . 0.0 109.564 178.746 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.816 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 4.3 mm? -47.92 -66.87 0.33 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.309 0.576 . . . . 0.0 109.927 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 1.032 HD23 HG12 ' A' ' 96' ' ' VAL . 20.0 tp -52.85 -53.01 54.87 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.438 -0.788 . . . . 0.0 110.633 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.451 ' HB3' ' O ' ' A' ' 61' ' ' GLU . 13.5 tp -49.53 -39.04 32.94 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.844 0.831 . . . . 0.0 108.956 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.927 ' CG ' HD22 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -81.34 -31.15 33.56 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.458 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 63' ' ' LEU . . . 124.21 56.19 0.18 Allowed Glycine 0 N--CA 1.481 1.661 0 C-N-CA 120.367 -0.92 . . . . 0.0 111.116 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.816 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -73.91 -154.4 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.841 -1.388 . . . . 0.0 110.103 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -122.49 77.58 45.83 Favored Pre-proline 0 N--CA 1.489 1.478 0 C-N-CA 119.824 -0.75 . . . . 0.0 109.985 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.508 ' HG3' ' CD1' ' A' ' 64' ' ' LEU . 53.7 Cg_endo -76.85 -11.61 18.17 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 O-C-N 124.067 1.562 . . . . 0.0 110.0 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.418 ' OD1' ' CB ' ' A' ' 103' ' ' ARG . 7.1 t30 -108.5 -64.36 1.23 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.493 -0.754 . . . . 0.0 109.741 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -46.07 139.95 4.15 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.421 0.629 . . . . 0.0 110.761 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.535 ' HB2' ' HA ' ' A' ' 80' ' ' ARG . . . -132.82 -150.39 0.41 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.658 -0.651 . . . . 0.0 110.187 -179.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.515 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -101.33 143.47 26.67 Favored Pre-proline 0 C--N 1.305 -1.343 0 O-C-N 121.216 -0.928 . . . . 0.0 109.746 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -71.87 -29.87 14.8 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.517 1.272 . . . . 0.0 110.728 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -47.86 -80.83 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.412 -0.805 . . . . 0.0 110.702 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.1 p -115.31 30.71 7.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.423 -0.798 . . . . 0.0 109.878 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.515 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 2.8 mt 44.54 46.22 8.09 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.607 -0.683 . . . . 0.0 111.541 179.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.484 ' O ' ' NE2' ' A' ' 50' ' ' GLN . 0.2 OUTLIER -72.77 95.62 1.93 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.21 -0.931 . . . . 0.0 109.881 179.62 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.754 ' HD3' HG21 ' A' ' 106' ' ' VAL . 0.5 OUTLIER -71.92 154.4 92.65 Favored Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.397 -0.814 . . . . 0.0 109.952 179.805 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.597 ' HD2' ' HG3' ' A' ' 80' ' ' ARG . 48.3 Cg_endo -72.01 -13.71 28.96 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 O-C-N 123.577 1.303 . . . . 0.0 109.973 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.418 ' CG1' HD21 ' A' ' 130' ' ' LEU . 21.2 t -61.96 -27.4 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 CA-C-O 121.534 0.683 . . . . 0.0 109.661 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.512 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 4.2 m80 -72.72 -42.86 63.69 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.527 ' HB3' ' HE2' ' A' ' 54' ' ' MET . 0.6 OUTLIER -45.23 -51.78 10.32 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.548 -0.72 . . . . 0.0 110.091 179.249 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.528 ' HB1' HD13 ' A' ' 94' ' ' LEU . . . -56.78 -64.94 0.71 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.582 -0.699 . . . . 0.0 109.794 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.824 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -61.22 -54.0 49.72 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.58 -0.7 . . . . 0.0 111.594 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.724 ' O ' HD22 ' A' ' 121' ' ' LEU . 0.4 OUTLIER -40.18 -31.48 0.13 Allowed 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.3 -0.875 . . . . 0.0 110.976 -179.741 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -100.88 -17.85 16.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.154 -0.966 . . . . 0.0 109.602 179.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.537 ' HA3' ' CE1' ' A' ' 123' ' ' HIS . . . 89.27 41.31 5.85 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.513 ' HE2' ' HB2' ' A' ' 57' ' ' ALA . 2.1 t80 -110.64 123.48 50.08 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.656 -0.908 . . . . 0.0 110.368 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.545 ' CD2' ' HA ' ' A' ' 126' ' ' VAL . 0.0 OUTLIER -94.38 -44.31 7.97 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.5 -0.75 . . . . 0.0 110.24 -179.748 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.812 ' O ' HG23 ' A' ' 96' ' ' VAL . 0.9 OUTLIER -44.58 -31.35 1.11 Allowed 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 121.368 0.604 . . . . 0.0 109.858 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.456 HG22 HD13 ' A' ' 97' ' ' LEU . 8.7 m -76.1 -49.19 18.09 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.326 -0.859 . . . . 0.0 108.767 178.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 1.005 HD21 ' HG ' ' A' ' 130' ' ' LEU . 1.1 mp -50.74 -49.05 58.77 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.503 HG23 HD12 ' A' ' 91' ' ' LEU . 84.5 t -56.52 -60.96 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.695 -0.628 . . . . 0.0 109.536 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 1.032 HG12 HD23 ' A' ' 64' ' ' LEU . 49.1 t -47.36 -52.25 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.456 HD13 HG22 ' A' ' 93' ' ' THR . 0.1 OUTLIER -46.02 -64.15 0.81 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.797 -0.564 . . . . 0.0 111.038 179.228 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -63.08 -31.26 72.36 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.156 -0.965 . . . . 0.0 110.084 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.488 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 1.2 ttt85 -63.07 -12.97 30.4 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.263 -0.898 . . . . 0.0 110.825 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.665 ' HB3' HD21 ' A' ' 64' ' ' LEU . . . -139.94 58.54 1.59 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.216 -0.928 . . . . 0.0 110.647 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 55.93 106.03 0.01 OUTLIER Glycine 0 N--CA 1.488 2.15 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.307 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -164.36 124.76 2.08 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.426 -1.044 . . . . 0.0 109.787 179.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.418 ' CB ' ' OD1' ' A' ' 71' ' ' ASN . 10.9 ttp180 -82.58 135.52 35.06 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.237 -0.914 . . . . 0.0 110.287 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.77 HD13 ' HB1' ' A' ' 133' ' ' ALA . 1.7 mp -121.36 21.2 11.14 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.263 -0.898 . . . . 0.0 110.504 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -123.63 54.0 1.32 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.325 -0.859 . . . . 0.0 111.126 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.754 HG21 ' HD3' ' A' ' 80' ' ' ARG . 3.9 p -112.93 -174.11 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.824 -1.172 . . . . 0.0 110.405 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.712 ' H ' HG22 ' A' ' 106' ' ' VAL . 18.7 mtm180 -133.91 138.83 45.77 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.623 -0.673 . . . . 0.0 109.306 179.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.437 -0.789 . . . . 0.0 109.941 179.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.484 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 110.259 -0.274 . . . . 0.0 110.259 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.49 ' HB3' ' CE1' ' A' ' 83' ' ' HIS . 41.4 Cg_endo -74.05 -47.81 0.24 Allowed 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.975 1.513 . . . . 0.0 109.524 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.419 HG13 ' N ' ' A' ' 116' ' ' ASP . 8.8 p -60.58 -35.46 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.528 -0.733 . . . . 0.0 110.382 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.419 ' N ' HG13 ' A' ' 115' ' ' VAL . 0.7 OUTLIER -61.63 -51.88 66.67 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.407 -0.808 . . . . 0.0 109.739 179.873 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.57 HD23 HD13 ' A' ' 121' ' ' LEU . 0.3 OUTLIER -57.58 -37.32 73.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.764 -0.585 . . . . 0.0 111.078 -179.382 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.764 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -57.5 -54.67 44.25 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.286 -0.884 . . . . 0.0 110.498 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -65.51 -17.8 64.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.286 -0.884 . . . . 0.0 110.444 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -76.12 -44.68 37.37 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.306 -0.871 . . . . 0.0 110.557 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.724 HD22 ' O ' ' A' ' 87' ' ' ARG . 6.7 mp -88.26 13.83 10.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -0.904 . . . . 0.0 110.411 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 76.8 48.04 9.12 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.537 ' CE1' ' HA3' ' A' ' 89' ' ' GLY . 30.1 m-70 -120.55 45.13 2.29 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.019 -1.283 . . . . 0.0 109.343 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -43.82 -46.04 7.62 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.524 -0.735 . . . . 0.0 110.077 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.497 ' O ' HD21 ' A' ' 91' ' ' LEU . 6.0 t70 -54.56 -44.0 72.54 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.528 0.68 . . . . 0.0 109.63 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.824 HG11 ' HA ' ' A' ' 86' ' ' ALA . 1.8 t -76.74 -28.45 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.13 -57.25 6.37 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.761 -0.587 . . . . 0.0 109.801 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -50.4 -57.93 6.86 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.413 -0.804 . . . . 0.0 110.472 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.479 ' HB3' HD23 ' A' ' 94' ' ' LEU . 33.5 t80 -53.41 -35.99 61.01 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.37 -0.832 . . . . 0.0 109.146 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 1.005 ' HG ' HD21 ' A' ' 94' ' ' LEU . 10.1 mt -71.9 -59.53 2.7 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.593 -0.692 . . . . 0.0 109.24 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -49.0 -27.8 3.44 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.691 -0.631 . . . . 0.0 110.821 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -76.6 -52.04 10.45 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.111 -0.993 . . . . 0.0 109.944 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.77 ' HB1' HD13 ' A' ' 104' ' ' LEU . . . -84.54 -10.4 57.46 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.429 -0.794 . . . . 0.0 110.489 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.568 ' CB ' ' O ' ' A' ' 104' ' ' LEU . . . . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.29 -0.881 . . . . 0.0 109.878 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.404 ' O ' ' OG1' ' A' ' 18' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.372 0 CA-C-O 120.931 0.396 . . . . 0.0 110.035 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.539 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 1.1 t90 -74.96 -6.77 51.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.394 -0.816 . . . . 0.0 110.734 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.752 HD11 ' HB1' ' A' ' 36' ' ' ALA . 19.1 mt -78.69 -49.52 12.98 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.17 -0.956 . . . . 0.0 109.463 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.498 ' HB2' ' ND2' ' A' ' 42' ' ' ASN . . . -69.35 -44.99 70.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.567 -0.708 . . . . 0.0 109.988 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.539 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.0 OUTLIER -50.31 -59.89 3.52 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.473 -0.767 . . . . 0.0 110.435 179.799 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.729 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -63.52 -33.83 76.44 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.505 -0.747 . . . . 0.0 110.206 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.527 ' HB1' ' CB ' ' A' ' 52' ' ' MET . . . -68.55 -43.88 75.69 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.093 -1.004 . . . . 0.0 109.699 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.98 -20.14 63.54 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.383 -0.823 . . . . 0.0 109.786 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -99.58 22.28 11.06 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.422 -0.799 . . . . 0.0 110.451 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.493 ' HA3' ' HE2' ' A' ' 53' ' ' MET . . . 47.68 55.15 9.87 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.473 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . 0.8 OUTLIER -126.37 89.93 3.09 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.513 -0.992 . . . . 0.0 109.483 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.543 HG22 ' CG2' ' A' ' 59' ' ' VAL . 55.7 t -64.31 -63.61 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.435 -0.79 . . . . 0.0 111.199 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -43.71 -33.48 1.25 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.551 -0.718 . . . . 0.0 111.043 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.673 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -60.8 -65.92 0.61 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.292 -0.88 . . . . 0.0 109.661 179.288 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.859 HG12 HD12 ' A' ' 32' ' ' LEU . 5.1 t -63.66 -41.04 91.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.821 -0.55 . . . . 0.0 110.289 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.455 ' CA ' HD22 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -44.7 -39.09 4.84 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.629 -0.669 . . . . 0.0 110.438 -179.548 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.64 -43.99 24.89 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.458 -0.776 . . . . 0.0 110.008 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.61 HD12 ' HA ' ' A' ' 28' ' ' VAL . 50.3 mt -55.46 -64.59 0.8 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.087 -1.008 . . . . 0.0 109.663 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.923 HD22 ' CG ' ' A' ' 66' ' ' HIS . 2.3 mt -49.37 -39.3 31.59 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.471 -0.768 . . . . 0.0 110.384 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -67.32 -25.58 66.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.527 -0.733 . . . . 0.0 110.177 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.17 -8.1 58.76 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.319 -0.863 . . . . 0.0 109.91 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.46 31.84 2.09 Favored Glycine 0 N--CA 1.489 2.179 0 C-N-CA 120.19 -1.005 . . . . 0.0 110.844 178.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.752 ' HB1' HD11 ' A' ' 16' ' ' LEU . . . -63.3 178.59 0.51 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.956 -1.32 . . . . 0.0 110.52 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.719 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 0.4 OUTLIER -92.18 124.19 60.45 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.398 -0.814 . . . . 0.0 109.947 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.513 ' HB2' ' O ' ' A' ' 67' ' ' GLY . 43.2 Cg_endo -68.22 -39.77 9.7 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.629 1.331 . . . . 0.0 110.742 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.469 ' HA ' ' OE1' ' A' ' 69' ' ' GLU . 0.4 OUTLIER -112.24 61.63 0.63 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.236 -0.915 . . . . 0.0 109.758 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.719 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -92.57 109.27 37.44 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.302 -0.874 . . . . 0.0 110.296 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -71.81 113.69 3.73 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 O-C-N 123.634 1.334 . . . . 0.0 109.595 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.498 ' ND2' ' HB2' ' A' ' 17' ' ' ALA . 16.3 m120 -73.68 174.23 8.66 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.559 -0.713 . . . . 0.0 109.596 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.95 21.91 1.83 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.358 -0.839 . . . . 0.0 110.354 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -109.58 20.76 17.8 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.163 -0.961 . . . . 0.0 110.533 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 57.88 24.22 53.28 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 55.0 mtt180 -131.75 -163.85 1.38 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.346 -1.09 . . . . 0.0 109.701 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.609 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 1.6 mmt180 -109.11 -171.1 0.21 Allowed Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.189 -0.944 . . . . 0.0 110.231 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.609 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 42.6 Cg_endo -80.13 -18.16 10.14 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 O-C-N 123.303 1.159 . . . . 0.0 111.08 -178.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.546 ' O ' ' HG2' ' A' ' 52' ' ' MET . 6.6 mt -107.1 -43.44 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.991 -1.068 . . . . 0.0 108.867 178.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 49' ' ' ILE . 0.8 OUTLIER -43.88 -31.47 0.87 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.095 -1.003 . . . . 0.0 109.909 179.556 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 51' ' ' VAL . 7.9 p -111.53 34.16 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.442 -0.786 . . . . 0.0 110.138 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.591 ' CE ' ' HB2' ' A' ' 60' ' ' ALA . 0.1 OUTLIER -91.11 30.1 1.29 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.027 -1.045 . . . . 0.0 109.643 179.19 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.506 ' CB ' ' O ' ' A' ' 52' ' ' MET . 4.8 tmm? 75.61 -13.54 0.86 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.859 -0.526 . . . . 0.0 111.866 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.552 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 47.11 28.18 0.9 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.956 -1.09 . . . . 0.0 110.234 -179.873 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.456 ' C ' ' CE2' ' A' ' 90' ' ' PHE . . . -125.85 4.56 7.96 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.452 ' HB3' HG23 ' A' ' 59' ' ' VAL . 0.5 OUTLIER -149.25 79.14 1.4 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.348 -1.089 . . . . 0.0 110.301 179.294 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -46.56 -34.04 4.6 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.397 -0.814 . . . . 0.0 109.592 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 56.3 mtt180 -44.44 -44.27 8.35 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.369 0.604 . . . . 0.0 109.668 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.543 ' CG2' HG22 ' A' ' 25' ' ' VAL . 60.8 t -62.05 -56.94 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.591 ' HB2' ' CE ' ' A' ' 52' ' ' MET . . . -47.61 -38.13 13.95 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.52 -0.737 . . . . 0.0 109.401 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -66.34 -35.29 79.98 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.638 -0.664 . . . . 0.0 109.843 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.61 ' CD1' HD13 ' A' ' 32' ' ' LEU . 1.5 tp -71.57 -44.13 65.08 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.42 -0.8 . . . . 0.0 109.477 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.625 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 2.6 mt -77.71 -35.14 52.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 0.0 109.427 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.836 HD11 ' HB3' ' A' ' 100' ' ' ALA . 0.7 OUTLIER -64.84 -61.01 2.44 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.422 -0.799 . . . . 0.0 110.159 -179.709 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.7 HD12 ' C ' ' A' ' 65' ' ' LEU . 0.3 OUTLIER -52.37 -33.97 45.59 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.836 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.923 ' CG ' HD22 ' A' ' 32' ' ' LEU . 1.7 m80 -73.64 -39.84 64.19 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.299 0.571 . . . . 0.0 109.658 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.513 ' O ' ' HB2' ' A' ' 38' ' ' PRO . . . 134.54 45.82 0.1 Allowed Glycine 0 N--CA 1.481 1.643 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.625 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -64.76 -162.22 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.94 -1.329 . . . . 0.0 110.208 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.531 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -116.86 61.64 2.61 Favored Pre-proline 0 C--N 1.301 -1.514 0 O-C-N 121.628 -0.67 . . . . 0.0 109.347 179.504 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.483 ' O ' ' HG3' ' A' ' 81' ' ' PRO . 52.1 Cg_endo -71.29 -2.15 10.75 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 O-C-N 123.792 1.417 . . . . 0.0 111.107 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.479 ' HA ' ' NH1' ' A' ' 80' ' ' ARG . 4.2 m-80 -108.77 -61.08 1.66 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.278 -0.889 . . . . 0.0 110.115 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 29.8 t -45.25 166.62 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.66 -0.65 . . . . 0.0 110.562 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.422 ' HB2' ' HG2' ' A' ' 80' ' ' ARG . . . -160.4 -148.62 0.17 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.104 -0.997 . . . . 0.0 110.303 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.54 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.6 OUTLIER -110.06 140.22 22.13 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.189 -0.944 . . . . 0.0 109.845 179.871 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -78.21 -23.58 8.8 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.641 1.337 . . . . 0.0 110.533 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.02 -81.3 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.888 . . . . 0.0 110.249 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.49 ' O ' ' HA ' ' A' ' 108' ' ' ASP . 0.2 OUTLIER -104.56 40.73 1.43 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.429 -0.794 . . . . 0.0 109.844 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.54 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 9.4 mt 31.95 40.56 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.0 m -67.45 104.63 1.59 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.983 -1.073 . . . . 0.0 110.181 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.841 ' HG3' HG11 ' A' ' 106' ' ' VAL . 0.7 OUTLIER -87.55 170.45 11.81 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.165 -0.959 . . . . 0.0 109.915 179.588 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.483 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 38.0 Cg_endo -68.71 -2.68 9.81 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.743 1.391 . . . . 0.0 109.72 178.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.738 HG13 HD23 ' A' ' 104' ' ' LEU . 10.5 t -82.06 -27.66 9.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 O-C-N 121.596 -0.69 . . . . 0.0 109.458 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.506 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 10.4 m80 -77.72 -40.08 42.43 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.298 -0.876 . . . . 0.0 108.794 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.558 ' O ' ' HB3' ' A' ' 87' ' ' ARG . 0.3 OUTLIER -54.64 -46.78 74.01 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.492 -0.755 . . . . 0.0 109.186 178.656 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.805 ' HB1' ' CD1' ' A' ' 94' ' ' LEU . . . -59.01 -69.01 0.21 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.244 -0.91 . . . . 0.0 109.214 178.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.807 ' HB1' ' HB2' ' A' ' 118' ' ' ALA . . . -60.38 -15.84 29.84 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.221 -0.925 . . . . 0.0 111.104 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.619 ' HA ' HD21 ' A' ' 117' ' ' LEU . 9.5 tpt180 -60.74 -45.82 92.83 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.854 -1.154 . . . . 0.0 109.455 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -101.66 -4.3 26.77 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.833 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.882 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 83.09 48.25 5.48 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.456 ' CE2' ' C ' ' A' ' 55' ' ' GLY . 0.4 OUTLIER -112.12 82.34 1.61 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.359 -1.083 . . . . 0.0 110.883 -179.245 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.622 HD11 ' O ' ' A' ' 125' ' ' ASP . 0.1 OUTLIER -57.08 -46.41 82.55 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.447 -0.783 . . . . 0.0 110.782 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.837 ' O ' HG23 ' A' ' 96' ' ' VAL . 35.7 t0 -45.84 -35.46 4.5 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.496 -0.753 . . . . 0.0 109.778 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 25.5 m -66.51 -59.33 3.74 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.841 HD13 HG13 ' A' ' 126' ' ' VAL . 1.2 mp -46.01 -52.65 11.45 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.684 -0.635 . . . . 0.0 109.462 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.461 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 26.4 t -44.84 -55.13 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.837 HG23 ' O ' ' A' ' 92' ' ' ASP . 13.4 t -55.49 -45.58 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.505 ' C ' ' HB2' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -56.31 -70.01 0.13 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.889 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . 0.469 ' HA ' ' HB3' ' A' ' 102' ' ' ALA . 3.4 t-160 -51.39 -40.84 60.08 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.493 -0.754 . . . . 0.0 109.44 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 7.5 ttt180 -59.81 -14.18 13.74 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.533 -0.729 . . . . 0.0 110.036 179.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.836 ' HB3' HD11 ' A' ' 64' ' ' LEU . . . -143.93 89.94 2.09 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 121.26 -0.9 . . . . 0.0 110.856 -179.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 100' ' ' ALA . . . 35.18 90.92 0.01 OUTLIER Glycine 0 N--CA 1.503 3.122 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 179.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.505 ' HB2' ' C ' ' A' ' 97' ' ' LEU . . . -143.91 89.81 2.08 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.107 -1.231 . . . . 0.0 110.739 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.9 ttt180 -64.72 133.73 52.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.151 -0.968 . . . . 0.0 110.078 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.738 HD23 HG13 ' A' ' 82' ' ' VAL . 0.8 OUTLIER -122.91 20.29 10.04 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.48 0.657 . . . . 0.0 109.286 179.631 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.22 39.87 1.43 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.504 -0.747 . . . . 0.0 110.037 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.841 HG11 ' HG3' ' A' ' 80' ' ' ARG . 2.5 p -109.65 -179.22 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.176 -0.952 . . . . 0.0 110.582 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.578 ' H ' HG22 ' A' ' 106' ' ' VAL . 59.4 mtt180 -141.31 140.7 33.86 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.49 -0.756 . . . . 0.0 109.771 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.49 ' HA ' ' O ' ' A' ' 77' ' ' THR . 3.6 p-10 . . . . . 0 N--CA 1.495 1.813 0 O-C-N 120.984 -1.072 . . . . 0.0 110.357 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.819 ' HB2' HG12 ' A' ' 115' ' ' VAL . 15.2 mt . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.592 ' HG3' ' CG1' ' A' ' 82' ' ' VAL . 37.8 Cg_endo -64.26 -11.07 26.14 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.844 1.444 . . . . 0.0 111.006 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.819 HG12 ' HB2' ' A' ' 113' ' ' LEU . 3.5 p -72.81 -32.47 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.149 -0.969 . . . . 0.0 109.725 179.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.64 -52.96 11.61 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.15 -0.969 . . . . 0.0 110.02 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.619 HD21 ' HA ' ' A' ' 87' ' ' ARG . 0.6 OUTLIER -57.2 -26.35 60.52 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.414 -0.804 . . . . 0.0 109.722 179.466 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.807 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -65.72 -58.25 6.12 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.374 -0.829 . . . . 0.0 108.895 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.07 -31.02 70.69 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.673 -0.642 . . . . 0.0 109.636 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.403 ' HB2' ' HA ' ' A' ' 117' ' ' LEU . 2.0 mt-10 -65.72 -49.73 67.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.611 -0.68 . . . . 0.0 110.343 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.551 ' HB3' ' NE2' ' A' ' 123' ' ' HIS . 22.7 mt -77.42 5.51 8.68 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.363 -0.836 . . . . 0.0 111.087 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 89.75 29.6 15.49 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 120.085 -1.055 . . . . 0.0 111.219 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.551 ' NE2' ' HB3' ' A' ' 121' ' ' LEU . 61.4 m-70 -109.37 54.48 0.66 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.002 -1.293 . . . . 0.0 109.836 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.486 ' HG3' ' N ' ' A' ' 125' ' ' ASP . 37.5 ptt180 -49.29 -39.92 32.69 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.487 0.661 . . . . 0.0 109.911 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.622 ' O ' HD11 ' A' ' 91' ' ' LEU . 4.6 m-20 -61.45 -45.18 95.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.618 -0.677 . . . . 0.0 109.611 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.882 HG21 ' HA2' ' A' ' 89' ' ' GLY . 3.2 t -75.65 -36.26 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.465 -0.772 . . . . 0.0 109.637 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.55 -58.16 7.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.626 -0.671 . . . . 0.0 109.417 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.3 ttt-85 -44.92 -55.83 5.11 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.611 -0.681 . . . . 0.0 110.505 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -60.52 -49.57 77.01 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.447 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.693 HD11 ' HB2' ' A' ' 86' ' ' ALA . 10.2 mt -53.54 -52.97 57.96 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.694 -0.629 . . . . 0.0 110.081 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.448 ' CA ' HG21 ' A' ' 115' ' ' VAL . 25.1 ttp180 -46.04 -37.3 6.52 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.57 -0.706 . . . . 0.0 110.282 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.79 -53.78 4.92 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.51 -0.743 . . . . 0.0 110.492 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -66.02 -7.96 20.27 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.307 -0.87 . . . . 0.0 110.385 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.354 -0.841 . . . . 0.0 109.967 179.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 121.014 0.435 . . . . 0.0 110.23 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.568 ' HA ' ' CG2' ' A' ' 18' ' ' THR . 25.3 m0 -89.37 -15.58 32.99 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.176 -0.953 . . . . 0.0 111.03 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.743 HD23 ' O ' ' A' ' 37' ' ' LEU . 1.0 OUTLIER -79.17 -44.88 21.04 Favored 'General case' 0 N--CA 1.483 1.217 0 O-C-N 120.864 -1.148 . . . . 0.0 109.039 179.54 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.475 ' CB ' ' OD1' ' A' ' 42' ' ' ASN . . . -74.8 -41.18 60.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.437 -0.789 . . . . 0.0 110.109 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.568 ' CG2' ' HA ' ' A' ' 15' ' ' TRP . 4.3 t -58.43 -43.09 88.61 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.324 -0.86 . . . . 0.0 109.739 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.646 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -63.7 -44.12 94.6 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.345 -0.847 . . . . 0.0 110.054 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.584 ' HB1' ' CB ' ' A' ' 52' ' ' MET . . . -59.85 -45.27 92.97 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.411 -0.806 . . . . 0.0 110.3 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.571 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -68.13 -27.49 66.49 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.358 -0.839 . . . . 0.0 111.032 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' A' ' 18' ' ' THR . 11.0 mtp180 -94.4 20.49 8.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.248 -0.908 . . . . 0.0 110.77 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.83 37.29 83.74 Favored Glycine 0 N--CA 1.486 1.974 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.542 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -107.15 64.11 0.63 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.291 -1.123 . . . . 0.0 110.186 179.58 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.957 HG22 HG22 ' A' ' 59' ' ' VAL . 30.5 t -55.15 -44.78 76.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.42 -0.8 . . . . 0.0 109.179 179.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.86 -48.7 66.9 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.57 -0.706 . . . . 0.0 110.704 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.473 ' O ' ' HB2' ' A' ' 31' ' ' LEU . 0.8 OUTLIER -62.57 -34.34 76.77 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.253 -0.904 . . . . 0.0 110.35 -179.776 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 1.014 HG12 HD12 ' A' ' 32' ' ' LEU . 21.3 t -76.73 -50.19 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.385 -0.822 . . . . 0.0 110.181 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.959 ' CA ' HD11 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -43.4 -44.01 5.48 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.285 -0.884 . . . . 0.0 109.19 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.501 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -79.64 -54.79 5.54 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 120.124 -0.63 . . . . 0.0 109.486 178.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 27' ' ' GLU . 8.2 mt -50.56 -61.52 2.14 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.364 -0.835 . . . . 0.0 110.307 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.014 HD12 HG12 ' A' ' 28' ' ' VAL . 3.6 mt -45.76 -62.55 1.25 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.399 -0.813 . . . . 0.0 109.962 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -64.91 -16.12 62.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.455 -0.778 . . . . 0.0 110.832 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.501 ' HB2' ' O ' ' A' ' 30' ' ' ALA . . . -85.76 -6.79 59.06 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.239 -0.913 . . . . 0.0 111.308 -179.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.27 26.35 1.67 Allowed Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.719 -1.229 . . . . 0.0 110.466 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.935 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -74.61 170.64 15.36 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.145 -1.209 . . . . 0.0 110.308 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.898 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 1.3 mm? -103.22 96.64 8.53 Favored Pre-proline 0 C--N 1.302 -1.482 0 O-C-N 121.604 -0.685 . . . . 0.0 110.367 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.54 ' HB3' ' HB3' ' A' ' 66' ' ' HIS . 41.6 Cg_endo -68.16 -14.85 41.76 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.741 1.39 . . . . 0.0 110.791 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.472 ' O ' ' HD3' ' A' ' 41' ' ' PRO . 0.4 OUTLIER -111.31 16.16 21.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.025 -1.047 . . . . 0.0 110.342 179.84 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.898 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -75.23 110.52 10.47 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.282 -0.886 . . . . 0.0 110.595 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 39' ' ' ASN . 45.9 Cg_endo -74.46 108.18 2.62 Favored 'Trans proline' 0 C--N 1.318 -1.03 0 O-C-N 123.552 1.29 . . . . 0.0 109.788 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.475 ' OD1' ' CB ' ' A' ' 17' ' ' ALA . 27.8 m-80 -57.43 167.62 0.96 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.64 -0.663 . . . . 0.0 110.813 -179.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.13 2.66 17.3 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.516 -0.74 . . . . 0.0 110.329 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.552 ' CD1' ' N ' ' A' ' 44' ' ' TYR . 1.2 m-85 -91.49 21.64 4.47 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.272 -0.892 . . . . 0.0 109.478 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.445 ' O ' ' NH2' ' A' ' 47' ' ' ARG . . . 53.75 22.1 17.39 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 -178.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 16.8 mtt180 -119.95 -176.65 3.23 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.661 -0.905 . . . . 0.0 110.188 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.638 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 5.2 mmt180 -106.25 -173.48 0.28 Allowed Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.641 -0.662 . . . . 0.0 110.393 -178.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.638 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 52.2 Cg_endo -79.32 0.65 9.84 Favored 'Trans proline' 0 C--N 1.318 -1.038 0 O-C-N 123.438 1.23 . . . . 0.0 110.594 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.518 HG12 HD13 ' A' ' 63' ' ' LEU . 7.8 mt -121.53 -43.63 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.362 -0.836 . . . . 0.0 108.94 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.486 ' HG2' ' HB3' ' A' ' 81' ' ' PRO . 5.7 mt-30 -50.07 -23.11 1.91 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.323 -0.861 . . . . 0.0 109.59 178.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.571 HG22 ' HB2' ' A' ' 21' ' ' ALA . 8.8 p -106.75 -7.44 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.73 -0.606 . . . . 0.0 110.867 -179.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.617 ' HE1' ' HB2' ' A' ' 60' ' ' ALA . 0.3 OUTLIER -68.06 158.68 32.43 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.97 -1.081 . . . . 0.0 109.817 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.59 96.4 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.094 -1.004 . . . . 0.0 109.267 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.543 ' HE1' ' CE ' ' A' ' 52' ' ' MET . 0.0 OUTLIER -56.72 -14.8 3.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.176 -0.952 . . . . 0.0 110.414 -179.514 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.443 ' HA2' ' CD2' ' A' ' 90' ' ' PHE . . . -88.13 35.23 3.59 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 178.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -171.54 99.56 0.19 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.421 -1.047 . . . . 0.0 109.668 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.501 ' HB2' ' HE1' ' A' ' 90' ' ' PHE . . . -68.31 -25.0 64.91 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.213 -0.93 . . . . 0.0 110.017 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.89 -33.14 3.04 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.572 -0.705 . . . . 0.0 110.531 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.994 HG12 HD11 ' A' ' 63' ' ' LEU . 3.0 t -72.66 -58.78 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.454 -0.779 . . . . 0.0 109.341 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.617 ' HB2' ' HE1' ' A' ' 52' ' ' MET . . . -41.17 -46.7 3.12 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.656 -0.653 . . . . 0.0 110.311 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.625 ' OE2' HG13 ' A' ' 96' ' ' VAL . 0.8 OUTLIER -55.57 -55.3 33.59 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.204 -0.935 . . . . 0.0 109.643 179.235 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.997 HD13 HG12 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -47.79 -61.5 1.92 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.68 -0.637 . . . . 0.0 109.833 178.993 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.994 HD11 HG12 ' A' ' 59' ' ' VAL . 0.9 OUTLIER -59.66 -55.07 38.99 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.256 0.551 . . . . 0.0 109.604 179.411 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.828 HD13 HG12 ' A' ' 96' ' ' VAL . 0.6 OUTLIER -49.8 -55.62 13.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.62 -0.675 . . . . 0.0 109.439 179.48 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 22.1 tp -53.94 -37.56 64.01 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.843 0.83 . . . . 0.0 108.819 178.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.971 ' CG ' HD22 ' A' ' 32' ' ' LEU . 2.0 m-70 -80.55 -5.59 56.99 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.271 0.557 . . . . 0.0 110.302 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.436 ' O ' ' ND2' ' A' ' 39' ' ' ASN . . . 89.4 63.74 1.29 Allowed Glycine 0 N--CA 1.479 1.537 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.557 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -79.3 -155.02 0.09 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.031 -1.276 . . . . 0.0 109.504 179.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.422 ' OE1' ' ND2' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -120.79 57.14 5.64 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.139 -0.976 . . . . 0.0 110.208 179.389 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.509 ' HB2' ' HG ' ' A' ' 97' ' ' LEU . 48.7 Cg_endo -73.99 -1.17 10.49 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.673 1.354 . . . . 0.0 110.648 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -108.66 -45.29 3.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 110.0 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.3 m -52.11 177.55 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.336 -0.852 . . . . 0.0 110.521 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -162.66 -143.35 0.08 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.361 -0.837 . . . . 0.0 110.136 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.442 ' O ' ' N ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -122.49 132.55 24.25 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.046 -1.034 . . . . 0.0 110.18 -179.566 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -74.25 1.89 6.79 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 O-C-N 123.348 1.183 . . . . 0.0 110.777 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -103.57 -48.55 3.93 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.185 -0.947 . . . . 0.0 109.365 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 108' ' ' ASP . 0.2 OUTLIER -128.72 18.02 6.26 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.834 -0.541 . . . . 0.0 109.841 179.875 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.51 ' HA ' HD23 ' A' ' 78' ' ' LEU . 9.0 mt 44.75 34.5 1.19 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.506 -0.747 . . . . 0.0 110.689 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 83.6 m -59.03 89.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.565 -0.71 . . . . 0.0 110.552 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.88 ' HG3' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -71.04 161.61 77.19 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.168 -0.958 . . . . 0.0 109.52 179.431 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.531 ' HD2' ' HD3' ' A' ' 80' ' ' ARG . 48.4 Cg_endo -73.96 -13.09 23.98 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.696 1.366 . . . . 0.0 110.549 179.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.425 HG13 HD23 ' A' ' 94' ' ' LEU . 90.7 t -67.28 -25.35 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.45 -0.781 . . . . 0.0 110.125 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.531 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 5.2 m80 -71.64 -40.81 69.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.277 -0.89 . . . . 0.0 109.236 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.52 ' HB3' ' SD ' ' A' ' 54' ' ' MET . 9.9 m-20 -52.27 -46.72 65.95 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.547 -0.721 . . . . 0.0 110.483 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.47 ' CB ' ' HG ' ' A' ' 94' ' ' LEU . . . -57.29 -68.46 0.23 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.05 -1.031 . . . . 0.0 108.993 178.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.799 ' CA ' HG11 ' A' ' 126' ' ' VAL . . . -52.35 -34.77 49.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.482 -0.761 . . . . 0.0 109.861 179.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.531 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 0.1 OUTLIER -40.37 -61.29 0.93 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.917 -0.489 . . . . 0.0 111.136 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -89.19 9.68 24.81 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.224 -0.923 . . . . 0.0 110.491 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.423 ' HA2' ' HB3' ' A' ' 123' ' ' HIS . . . 77.87 33.4 41.78 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.52 ' HD1' ' HG1' ' A' ' 93' ' ' THR . 0.6 OUTLIER -96.82 131.74 43.25 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.148 -1.207 . . . . 0.0 110.065 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.591 HD11 ' O ' ' A' ' 125' ' ' ASP . 0.5 OUTLIER -105.47 -47.6 3.89 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.272 -0.893 . . . . 0.0 110.45 179.87 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.776 ' O ' HG23 ' A' ' 96' ' ' VAL . 47.5 m-20 -47.32 -28.3 1.95 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.419 -0.801 . . . . 0.0 109.769 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.52 ' HG1' ' HD1' ' A' ' 90' ' ' PHE . 61.6 m -65.19 -56.82 10.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.588 -0.695 . . . . 0.0 109.604 178.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.697 ' CD2' HD21 ' A' ' 130' ' ' LEU . 1.5 mp -53.91 -49.16 69.22 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.217 -0.927 . . . . 0.0 109.661 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.455 ' O ' ' N ' ' A' ' 99' ' ' ARG . 74.7 t -44.3 -45.47 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.828 HG12 HD13 ' A' ' 64' ' ' LEU . 22.0 t -59.97 -54.09 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.556 -0.715 . . . . 0.0 109.436 179.033 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.509 ' HG ' ' HB2' ' A' ' 70' ' ' PRO . 7.3 mp -48.52 -50.05 33.55 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.543 0.687 . . . . 0.0 110.265 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -77.82 -21.65 51.2 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.583 -0.698 . . . . 0.0 109.881 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.539 ' HB3' ' HA ' ' A' ' 96' ' ' VAL . 1.4 ttm180 -72.94 -9.96 59.28 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.413 -0.804 . . . . 0.0 110.949 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.812 ' CB ' HD21 ' A' ' 64' ' ' LEU . . . -136.39 -66.73 0.53 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.064 -1.022 . . . . 0.0 110.923 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -167.51 105.51 0.24 Allowed Glycine 0 N--CA 1.486 1.979 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.458 ' HB3' ' C ' ' A' ' 97' ' ' LEU . . . -177.29 119.37 0.11 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.317 -1.107 . . . . 0.0 110.31 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 -68.11 134.84 51.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -0.892 . . . . 0.0 109.437 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 1.036 HD21 HD23 ' A' ' 130' ' ' LEU . 1.4 tt -112.27 13.28 20.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.376 -0.828 . . . . 0.0 110.665 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.499 ' HB3' ' HA ' ' A' ' 134' ' ' ALA . 1.1 p30 -127.65 47.54 2.37 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.425 -0.797 . . . . 0.0 110.325 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.88 HG11 ' HG3' ' A' ' 80' ' ' ARG . 0.8 OUTLIER -99.73 -175.09 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.143 -0.973 . . . . 0.0 110.659 -179.848 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.584 ' H ' HG22 ' A' ' 106' ' ' VAL . 6.6 ttp180 -141.01 148.89 41.0 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.487 ' HA ' ' O ' ' A' ' 77' ' ' THR . 3.6 m-20 . . . . . 0 C--N 1.302 -1.483 0 O-C-N 121.356 -0.84 . . . . 0.0 110.45 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.525 ' HG ' ' HD2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.498 1.962 0 N-CA-C 110.548 -0.168 . . . . 0.0 110.548 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.525 ' HD2' ' HG ' ' A' ' 113' ' ' LEU . 40.7 Cg_endo -69.72 -23.28 31.15 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.79 1.416 . . . . 0.0 110.226 179.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.614 HG21 ' CG ' ' A' ' 131' ' ' ARG . 4.7 p -86.72 -33.91 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.884 . . . . 0.0 109.776 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.31 -44.04 97.87 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.661 -0.649 . . . . 0.0 110.351 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.56 -31.09 67.66 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.283 -0.885 . . . . 0.0 109.73 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.782 ' HB1' ' HB2' ' A' ' 123' ' ' HIS . . . -81.61 -20.66 39.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.448 -0.782 . . . . 0.0 110.708 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -74.72 -40.92 61.03 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.4 -0.813 . . . . 0.0 110.691 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.47 -40.6 35.05 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.255 -0.903 . . . . 0.0 110.622 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.511 ' HB3' ' NE2' ' A' ' 123' ' ' HIS . 0.2 OUTLIER -72.57 -81.47 0.06 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.432 -0.793 . . . . 0.0 110.552 -179.339 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 162.14 47.26 0.02 OUTLIER Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.701 -1.237 . . . . 0.0 110.162 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.782 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . 3.6 m170 -108.49 52.94 0.7 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.127 -1.22 . . . . 0.0 109.643 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 28.4 mtt180 -48.22 -44.07 32.71 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.285 -0.884 . . . . 0.0 110.029 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.591 ' O ' HD11 ' A' ' 91' ' ' LEU . 5.5 t0 -54.27 -43.3 70.89 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.501 -0.75 . . . . 0.0 109.415 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.799 HG11 ' CA ' ' A' ' 86' ' ' ALA . 15.9 t -85.31 -45.55 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.277 -0.89 . . . . 0.0 110.12 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -47.31 -58.12 4.48 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.348 -0.845 . . . . 0.0 110.454 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 11.2 mtp180 -50.77 -65.85 0.49 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.473 -0.767 . . . . 0.0 110.052 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -50.36 -31.84 15.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.527 -0.733 . . . . 0.0 109.887 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 1.036 HD23 HD21 ' A' ' 104' ' ' LEU . 11.3 mt -72.89 -57.11 4.3 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.594 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.614 ' CG ' HG21 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -51.94 -21.78 3.32 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.355 -0.841 . . . . 0.0 110.689 -179.767 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -83.85 -61.18 1.89 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.311 -0.868 . . . . 0.0 109.729 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 1.016 ' HB3' HD22 ' A' ' 104' ' ' LEU . . . -75.1 -6.78 51.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.603 -0.686 . . . . 0.0 110.609 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.499 ' HA ' ' HB3' ' A' ' 105' ' ' ASP . . . . . . . . 0 N--CA 1.497 1.898 0 O-C-N 121.093 -1.004 . . . . 0.0 109.284 179.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.9 t0 . . . . . 0 N--CA 1.497 1.892 0 CA-C-O 121.057 0.456 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.455 ' HE3' HD22 ' A' ' 31' ' ' LEU . 22.6 m0 -95.01 -37.22 11.23 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.035 -1.041 . . . . 0.0 109.923 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.652 ' CD2' ' HB1' ' A' ' 36' ' ' ALA . 0.9 OUTLIER -71.49 -28.37 63.87 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.358 -0.839 . . . . 0.0 110.006 179.478 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.77 -44.91 12.89 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.326 -0.859 . . . . 0.0 110.185 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.429 ' CG2' ' N ' ' A' ' 19' ' ' ALA . 1.6 t -61.94 -39.08 90.85 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.408 -0.808 . . . . 0.0 110.345 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.607 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -68.8 -48.87 62.54 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.453 -0.779 . . . . 0.0 109.975 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.703 ' CB ' HG11 ' A' ' 59' ' ' VAL . . . -56.9 -53.5 57.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.528 -0.733 . . . . 0.0 109.811 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.567 ' HB2' ' O ' ' A' ' 51' ' ' VAL . . . -53.51 -28.47 31.22 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.48 -0.762 . . . . 0.0 110.182 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.57 14.41 15.08 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.468 -0.77 . . . . 0.0 110.474 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.444 ' HA3' ' CE ' ' A' ' 53' ' ' MET . . . 55.0 49.89 60.92 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -121.25 63.18 0.89 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.401 -1.058 . . . . 0.0 110.138 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.589 HG22 HG23 ' A' ' 59' ' ' VAL . 41.1 t -47.49 -51.17 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.549 -0.719 . . . . 0.0 110.163 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -47.12 -42.26 18.89 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.603 -0.686 . . . . 0.0 110.686 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.07 -37.24 72.48 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.249 -0.907 . . . . 0.0 110.086 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.984 HG12 HD13 ' A' ' 62' ' ' LEU . 21.6 t -73.45 -41.23 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.328 -0.857 . . . . 0.0 110.351 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.903 ' CA ' HD11 ' A' ' 62' ' ' LEU . 9.6 mmm180 -53.9 -44.81 70.82 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.126 -0.984 . . . . 0.0 109.639 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.63 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -78.85 -41.25 30.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.659 -0.65 . . . . 0.0 109.917 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.455 HD22 ' HE3' ' A' ' 15' ' ' TRP . 35.0 mt -65.53 -59.15 4.28 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.547 -0.721 . . . . 0.0 110.236 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.967 HD23 HD22 ' A' ' 62' ' ' LEU . 33.1 tp -50.83 -45.86 59.8 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.369 -0.832 . . . . 0.0 110.526 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -76.19 -15.6 60.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.294 -0.879 . . . . 0.0 110.031 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.63 ' HB2' ' O ' ' A' ' 30' ' ' ALA . . . -82.79 -8.75 59.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.301 -0.874 . . . . 0.0 110.652 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.54 23.19 1.93 Allowed Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.782 -1.199 . . . . 0.0 110.711 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.939 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -69.95 152.56 44.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.99 -1.3 . . . . 0.0 109.664 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.851 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -79.08 116.59 61.33 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.274 -0.891 . . . . 0.0 110.09 -179.728 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.73 -33.03 22.18 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.372 1.196 . . . . 0.0 110.317 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -115.57 58.05 0.73 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.311 -0.868 . . . . 0.0 109.744 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.851 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -88.69 116.97 67.79 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.324 -0.86 . . . . 0.0 110.11 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -72.35 82.94 1.31 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.647 1.341 . . . . 0.0 110.08 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -60.92 -174.95 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.391 -0.818 . . . . 0.0 110.026 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.5 p -93.63 26.57 3.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.397 -0.815 . . . . 0.0 110.171 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -114.78 17.88 16.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.248 -0.908 . . . . 0.0 110.248 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 59.74 44.26 97.12 Favored Glycine 0 N--CA 1.484 1.88 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -174.55 161.35 3.25 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.307 -1.114 . . . . 0.0 110.79 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.633 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 2.2 mtt180 -87.7 -154.47 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.635 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.633 ' CD ' ' HB3' ' A' ' 47' ' ' ARG . 45.3 Cg_endo -77.36 -170.53 0.95 Allowed 'Trans proline' 0 N--CA 1.483 0.855 0 O-C-N 122.53 0.753 . . . . 0.0 111.008 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.555 ' O ' ' HG2' ' A' ' 52' ' ' MET . 4.0 mt 62.62 -62.86 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.729 -0.607 . . . . 0.0 110.057 -178.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.522 ' N ' ' O ' ' A' ' 48' ' ' PRO . 8.4 mt-30 -48.15 -23.55 0.89 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.596 -1.315 . . . . 0.0 109.757 179.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.567 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 9.1 p -118.54 31.37 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.337 -0.852 . . . . 0.0 109.873 178.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.7 ' HE1' ' HB2' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -93.03 36.66 1.03 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.139 -0.976 . . . . 0.0 109.963 179.627 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.444 ' CE ' ' HA3' ' A' ' 23' ' ' GLY . 7.7 ttp 63.44 -6.95 0.19 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.468 -0.77 . . . . 0.0 110.965 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.561 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 45.94 28.81 0.65 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.212 -0.93 . . . . 0.0 110.579 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.407 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -126.26 4.15 7.76 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.08 84.94 1.85 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.378 -1.072 . . . . 0.0 109.596 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.442 ' CB ' ' HB3' ' A' ' 92' ' ' ASP . . . -51.27 -22.97 3.08 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.417 -0.802 . . . . 0.0 110.514 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.548 ' HB2' HG21 ' A' ' 25' ' ' VAL . 1.8 mmt180 -54.07 -45.94 71.85 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.284 -0.885 . . . . 0.0 110.047 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.703 HG11 ' CB ' ' A' ' 20' ' ' ALA . 46.7 t -58.05 -45.22 88.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.418 -0.802 . . . . 0.0 109.723 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.7 ' HB2' ' HE1' ' A' ' 52' ' ' MET . . . -49.48 -53.19 24.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.515 -0.741 . . . . 0.0 109.719 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.473 ' O ' HD23 ' A' ' 65' ' ' LEU . 1.6 tt0 -52.21 -51.34 58.8 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.437 -0.789 . . . . 0.0 109.313 178.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.984 HD13 HG12 ' A' ' 28' ' ' VAL . 0.9 OUTLIER -49.55 -70.99 0.07 Allowed 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.638 0.732 . . . . 0.0 110.049 178.675 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.837 HD22 HD22 ' A' ' 32' ' ' LEU . 4.5 mm? -56.5 -46.81 80.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.867 -0.521 . . . . 0.0 110.931 -179.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.915 HD13 HG12 ' A' ' 96' ' ' VAL . 1.2 tt -61.56 -59.09 5.74 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.342 -0.849 . . . . 0.0 111.171 -179.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.473 HD23 ' O ' ' A' ' 61' ' ' GLU . 0.6 OUTLIER -53.35 -23.55 9.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.067 -1.021 . . . . 0.0 109.935 -179.328 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.519 ' ND1' ' HG ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -88.9 -50.81 5.97 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.611 -0.681 . . . . 0.0 109.433 179.505 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.98 52.23 0.01 OUTLIER Glycine 0 N--CA 1.483 1.774 0 C-N-CA 119.937 -1.125 . . . . 0.0 111.061 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.799 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -79.29 -151.74 0.06 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.827 -1.396 . . . . 0.0 109.99 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.428 ' HB2' ' CB ' ' A' ' 47' ' ' ARG . 1.2 tt0 -123.28 54.89 7.3 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.365 -0.835 . . . . 0.0 110.088 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.5 ' HG3' HD12 ' A' ' 64' ' ' LEU . 43.0 Cg_endo -70.21 -13.91 34.06 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.641 1.337 . . . . 0.0 110.274 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.5 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 2.1 t-20 -108.36 -73.0 0.7 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.368 -0.832 . . . . 0.0 110.02 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 4.1 t -50.27 169.0 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.189 -0.944 . . . . 0.0 110.979 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.465 ' HB1' ' O ' ' A' ' 79' ' ' THR . . . -153.86 -155.45 0.59 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.334 -0.854 . . . . 0.0 110.149 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -101.71 135.34 19.78 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.406 -0.809 . . . . 0.0 109.746 179.876 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -74.3 -22.86 16.0 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.685 1.36 . . . . 0.0 110.661 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.03 -39.37 66.09 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.204 -0.935 . . . . 0.0 110.085 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -147.43 16.07 1.15 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.601 -0.687 . . . . 0.0 110.13 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.476 ' HB3' ' O ' ' A' ' 107' ' ' ARG . 0.4 OUTLIER 48.22 35.11 5.04 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.481 -0.762 . . . . 0.0 111.513 179.664 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.465 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 2.5 m -71.31 104.82 3.27 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.219 -0.926 . . . . 0.0 109.886 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.833 ' CG ' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -80.06 160.13 69.19 Favored Pre-proline 0 N--CA 1.498 1.928 0 O-C-N 121.351 -0.843 . . . . 0.0 110.747 -179.571 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.417 ' O ' ' HB2' ' A' ' 84' ' ' ASP . 45.7 Cg_endo -72.1 -17.46 28.12 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.822 1.433 . . . . 0.0 110.604 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 98.6 t -62.7 -24.06 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.209 -0.932 . . . . 0.0 110.205 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.495 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 13.4 m80 -76.68 -32.83 58.16 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.413 -0.804 . . . . 0.0 109.108 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.561 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 3.3 m-20 -57.98 -50.86 71.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.616 -0.678 . . . . 0.0 110.297 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.491 ' HB3' ' CD1' ' A' ' 94' ' ' LEU . . . -58.95 -58.33 9.11 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.343 -0.848 . . . . 0.0 109.856 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.884 ' HB2' HD11 ' A' ' 130' ' ' LEU . . . -59.36 -45.0 92.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.42 -0.8 . . . . 0.0 110.847 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 0.3 OUTLIER -47.71 -44.65 27.9 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.327 -0.858 . . . . 0.0 110.902 -179.589 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -95.96 13.32 27.31 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.284 -0.885 . . . . 0.0 110.495 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.575 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 59.84 60.1 9.29 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.407 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 0.3 OUTLIER -129.04 94.32 3.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.266 -1.138 . . . . 0.0 110.707 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.651 HD11 ' O ' ' A' ' 125' ' ' ASP . 0.3 OUTLIER -69.31 -37.38 77.73 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.336 -0.853 . . . . 0.0 109.958 179.68 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.442 ' HB3' ' CB ' ' A' ' 57' ' ' ALA . 31.5 m-20 -50.08 -40.98 47.19 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.503 -0.748 . . . . 0.0 110.055 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 60.5 m -66.16 -42.45 88.96 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.725 HD21 ' HG ' ' A' ' 130' ' ' LEU . 1.2 tp -58.83 -38.27 78.28 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.596 -0.69 . . . . 0.0 109.312 178.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 91' ' ' LEU . 47.3 t -61.41 -50.6 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.582 -0.699 . . . . 0.0 109.607 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.915 HG12 HD13 ' A' ' 64' ' ' LEU . 92.9 t -54.17 -54.51 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.543 -0.723 . . . . 0.0 109.433 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.681 HD23 ' HB1' ' A' ' 102' ' ' ALA . 1.1 mp -47.51 -53.56 14.02 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.735 -0.603 . . . . 0.0 110.825 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -72.98 -29.61 63.18 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.307 -0.871 . . . . 0.0 110.084 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -65.86 -9.4 28.78 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.367 -0.833 . . . . 0.0 110.604 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.88 ' HB2' HD21 ' A' ' 64' ' ' LEU . . . -136.9 -74.6 0.42 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.117 -0.99 . . . . 0.0 111.051 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -160.14 102.21 0.21 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.681 ' HB1' HD23 ' A' ' 97' ' ' LEU . . . -162.43 111.18 1.39 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.405 -1.056 . . . . 0.0 109.878 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -77.86 145.47 36.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.38 -0.825 . . . . 0.0 110.38 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.745 HD22 ' HB3' ' A' ' 133' ' ' ALA . 2.4 mp -116.36 4.23 13.39 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.46 -0.775 . . . . 0.0 110.286 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -98.68 39.29 1.27 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.187 -0.946 . . . . 0.0 109.764 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.833 HG11 ' CG ' ' A' ' 80' ' ' ARG . 3.0 p -108.4 -170.18 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.369 -0.832 . . . . 0.0 109.791 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.695 ' H ' HG22 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -157.43 155.09 29.86 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.344 -0.848 . . . . 0.0 109.556 179.677 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 . . . . . 0 N--CA 1.494 1.761 0 O-C-N 121.117 -0.99 . . . . 0.0 110.2 -179.91 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.481 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.846 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.481 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 46.4 Cg_endo -74.01 -50.39 0.17 Allowed 'Trans proline' 0 C--N 1.312 -1.349 0 O-C-N 123.604 1.318 . . . . 0.0 110.386 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.4 HG13 ' N ' ' A' ' 116' ' ' ASP . 12.2 p -58.62 -34.52 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.321 -0.862 . . . . 0.0 109.72 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.4 ' N ' HG13 ' A' ' 115' ' ' VAL . 6.5 m-20 -70.86 -25.5 62.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.53 -0.731 . . . . 0.0 109.698 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.2 tt -79.68 -28.18 40.74 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.428 -0.795 . . . . 0.0 110.073 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -73.56 -45.29 54.36 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.402 -0.811 . . . . 0.0 109.891 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -62.8 -37.11 85.44 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.465 -0.772 . . . . 0.0 109.806 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.21 -45.29 85.35 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.534 -0.729 . . . . 0.0 110.037 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.1 -81.8 0.1 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.383 -0.823 . . . . 0.0 110.378 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 167.8 53.25 0.03 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.498 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 53.4 m-70 -127.88 52.87 1.82 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -1.149 . . . . 0.0 109.483 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.4 mtp180 -47.43 -43.0 23.52 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.544 -0.723 . . . . 0.0 110.258 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.651 ' O ' HD11 ' A' ' 91' ' ' LEU . 76.7 m-20 -55.6 -42.94 75.53 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.391 -0.818 . . . . 0.0 109.295 179.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.865 HG11 ' HA ' ' A' ' 86' ' ' ALA . 3.0 t -78.94 -34.0 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.495 -0.753 . . . . 0.0 109.127 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.77 -31.99 72.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.501 -0.749 . . . . 0.0 109.517 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.9 mtp180 -60.65 -66.7 0.49 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.543 -0.723 . . . . 0.0 110.099 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.464 ' HB3' HD23 ' A' ' 94' ' ' LEU . 10.1 t80 -55.03 -28.87 55.51 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.346 -0.847 . . . . 0.0 109.627 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.884 HD11 ' HB2' ' A' ' 86' ' ' ALA . 68.1 mt -72.74 -43.52 62.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.574 -0.704 . . . . 0.0 109.569 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.79 -19.53 62.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.203 -0.936 . . . . 0.0 110.391 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.31 -50.71 7.12 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.277 -0.89 . . . . 0.0 110.399 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.745 ' HB3' HD22 ' A' ' 104' ' ' LEU . . . -88.26 -19.74 26.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.295 -0.878 . . . . 0.0 110.174 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.698 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.498 -0.751 . . . . 0.0 109.687 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.278 0.561 . . . . 0.0 110.006 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.571 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 2.2 t90 -70.37 -7.59 44.08 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.287 -0.883 . . . . 0.0 110.423 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.951 HD21 HD21 ' A' ' 63' ' ' LEU . 0.9 OUTLIER -80.4 -57.96 3.35 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.038 -1.039 . . . . 0.0 109.674 179.77 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.468 ' N ' ' HG ' ' A' ' 16' ' ' LEU . . . -63.26 -38.89 92.95 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.222 -0.924 . . . . 0.0 109.761 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.571 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 1.5 p -52.8 -54.22 37.22 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.527 -0.733 . . . . 0.0 110.385 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.713 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -59.77 -39.01 83.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.338 -0.851 . . . . 0.0 110.071 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.469 ' HB1' HG11 ' A' ' 59' ' ' VAL . . . -54.12 -61.91 2.0 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.116 -0.99 . . . . 0.0 109.561 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.937 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -54.64 -22.21 12.89 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.515 -0.74 . . . . 0.0 110.206 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -90.64 16.6 8.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.354 -0.841 . . . . 0.0 110.69 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 49.76 34.95 22.77 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 179.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.434 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . 6.2 mmt180 -109.49 67.54 0.65 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.338 -1.095 . . . . 0.0 110.052 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.476 HG22 HG22 ' A' ' 59' ' ' VAL . 93.2 t -49.17 -54.28 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.638 -0.663 . . . . 0.0 110.973 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -46.89 -43.02 18.46 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.5 -0.75 . . . . 0.0 110.818 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.55 ' O ' ' HB2' ' A' ' 31' ' ' LEU . 20.3 mt-10 -62.17 -44.86 95.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.233 -0.917 . . . . 0.0 110.166 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.757 HG12 HD13 ' A' ' 62' ' ' LEU . 3.5 t -72.92 -43.06 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.419 -0.801 . . . . 0.0 110.471 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.83 ' CA ' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -45.8 -47.81 15.67 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.409 -0.807 . . . . 0.0 109.853 -179.516 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.41 -49.06 11.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.418 -0.802 . . . . 0.0 110.379 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.55 ' HB2' ' O ' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -57.13 -56.99 14.67 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.165 -0.959 . . . . 0.0 110.255 179.849 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 1.016 HD23 HD22 ' A' ' 62' ' ' LEU . 15.2 tp -50.35 -49.65 53.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.5 -0.75 . . . . 0.0 110.665 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -74.73 -8.9 57.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.269 -0.894 . . . . 0.0 110.537 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.56 -11.69 39.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -0.912 . . . . 0.0 111.127 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 139.12 -9.38 3.29 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 119.619 -1.277 . . . . 0.0 110.763 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.961 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -44.68 154.72 0.12 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.179 -1.189 . . . . 0.0 110.611 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.884 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 2.3 mm? -93.73 111.31 52.11 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.378 -0.826 . . . . 0.0 110.658 -179.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.484 ' O ' ' HG3' ' A' ' 48' ' ' PRO . 43.2 Cg_endo -70.57 -19.02 32.78 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 123.622 1.327 . . . . 0.0 110.485 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -109.43 17.49 21.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.33 -0.856 . . . . 0.0 110.209 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.884 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -77.75 129.65 75.89 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.257 -0.902 . . . . 0.0 110.405 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -73.89 146.31 37.42 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 123.656 1.345 . . . . 0.0 109.983 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -88.96 -157.97 0.47 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.237 -0.914 . . . . 0.0 109.941 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.8 m -111.43 14.49 21.48 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.051 -1.03 . . . . 0.0 111.205 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -123.76 33.52 5.3 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.096 -1.002 . . . . 0.0 109.964 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.25 23.7 26.62 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.216 -1.553 . . . . 0.0 109.216 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.8 mtm-85 -108.05 -159.79 0.7 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.502 -0.999 . . . . 0.0 110.126 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.626 ' O ' HG12 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -127.89 179.69 1.19 Allowed Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.482 -0.761 . . . . 0.0 110.067 -179.651 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.692 ' HB2' HD22 ' A' ' 63' ' ' LEU . 42.1 Cg_endo -68.9 -24.52 33.65 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.611 1.322 . . . . 0.0 111.287 -179.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.579 ' O ' ' HG2' ' A' ' 52' ' ' MET . 4.3 mt -106.24 -36.83 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.044 -1.035 . . . . 0.0 108.64 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.403 ' HB2' ' HB2' ' A' ' 47' ' ' ARG . 24.6 mt-30 -54.73 -18.91 5.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.25 -0.906 . . . . 0.0 109.375 178.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.937 HG22 ' HB2' ' A' ' 21' ' ' ALA . 9.3 p -116.07 39.23 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.478 -0.764 . . . . 0.0 110.601 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.579 ' HG2' ' O ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -103.55 39.21 1.64 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.946 -1.096 . . . . 0.0 109.443 179.267 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . 0.412 ' CB ' ' O ' ' A' ' 52' ' ' MET . 0.0 OUTLIER 68.79 -5.61 0.98 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.729 -0.607 . . . . 0.0 110.918 -179.536 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.534 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.1 OUTLIER 39.94 89.32 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.364 -0.835 . . . . 0.0 110.937 179.82 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.533 ' HA2' ' CG ' ' A' ' 90' ' ' PHE . . . 159.13 -28.95 0.4 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.232 -1.947 . . . . 0.0 108.232 -179.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.67 79.91 1.72 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.733 -0.863 . . . . 0.0 110.16 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -48.8 -25.18 1.72 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.255 -0.903 . . . . 0.0 110.196 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.62 -39.24 57.68 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.463 -0.773 . . . . 0.0 109.789 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.476 HG22 HG22 ' A' ' 25' ' ' VAL . 23.8 t -69.22 -51.29 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.395 -0.816 . . . . 0.0 109.257 179.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.557 ' HB2' ' HE1' ' A' ' 52' ' ' MET . . . -48.91 -43.66 39.51 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.253 -0.904 . . . . 0.0 109.908 179.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.436 ' O ' HD23 ' A' ' 65' ' ' LEU . 5.4 tt0 -53.58 -51.72 62.08 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.501 -0.749 . . . . 0.0 109.677 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 1.016 HD22 HD23 ' A' ' 32' ' ' LEU . 1.2 mt -50.32 -66.51 0.38 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.593 -0.692 . . . . 0.0 109.912 178.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.951 HD21 HD21 ' A' ' 16' ' ' LEU . 11.0 mt -60.27 -39.27 86.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.676 -0.64 . . . . 0.0 110.798 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.891 HD22 HG13 ' A' ' 96' ' ' VAL . 0.5 OUTLIER -63.09 -60.15 3.83 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.174 -0.954 . . . . 0.0 110.458 -179.78 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.436 HD23 ' O ' ' A' ' 61' ' ' GLU . 0.7 OUTLIER -53.34 -22.67 7.7 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.427 -0.796 . . . . 0.0 110.019 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.582 ' CD2' ' HG ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -90.87 -25.15 19.99 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.611 -0.681 . . . . 0.0 109.679 179.849 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.94 56.58 0.5 Allowed Glycine 0 N--CA 1.481 1.643 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.854 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -70.1 -149.78 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.171 -1.193 . . . . 0.0 109.767 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.428 ' HG2' ' HB3' ' A' ' 72' ' ' CYS . 0.3 OUTLIER -120.46 59.31 6.85 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.498 -0.751 . . . . 0.0 109.628 179.251 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.415 ' HD3' ' C ' ' A' ' 68' ' ' ALA . 43.5 Cg_endo -71.13 -1.53 9.71 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 O-C-N 123.808 1.425 . . . . 0.0 110.712 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -113.35 -66.4 1.09 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.128 -0.982 . . . . 0.0 110.014 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.428 ' HB3' ' HG2' ' A' ' 69' ' ' GLU . 3.1 t -50.57 166.59 0.08 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.453 -0.78 . . . . 0.0 110.534 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.575 ' HB2' ' HA ' ' A' ' 80' ' ' ARG . . . -159.22 -140.18 0.07 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.395 -0.815 . . . . 0.0 110.04 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 78' ' ' LEU . 11.0 t70 -105.05 127.35 28.88 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.062 -1.024 . . . . 0.0 109.765 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.83 -2.6 12.17 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.432 1.228 . . . . 0.0 111.208 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.41 ' HB3' ' OD2' ' A' ' 74' ' ' ASP . . . -97.15 -44.0 7.14 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.096 -1.003 . . . . 0.0 109.72 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -121.79 7.77 9.94 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.454 -0.779 . . . . 0.0 110.265 179.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.501 ' HB3' ' O ' ' A' ' 107' ' ' ARG . 1.3 mt 45.61 27.68 0.44 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.335 -0.853 . . . . 0.0 111.102 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.7 m -65.32 88.72 0.08 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.113 -0.992 . . . . 0.0 109.642 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.892 ' CG ' HG11 ' A' ' 106' ' ' VAL . 1.1 mtt180 -69.12 165.91 33.93 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.426 -0.796 . . . . 0.0 110.35 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.407 ' HG3' ' C ' ' A' ' 70' ' ' PRO . 42.8 Cg_endo -69.61 -12.97 34.32 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.728 1.383 . . . . 0.0 111.164 -179.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.9 t -66.13 -42.1 90.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.007 -1.058 . . . . 0.0 109.597 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.473 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 69.3 m80 -55.14 -45.49 75.65 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.609 0.719 . . . . 0.0 109.676 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.534 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 1.2 m-20 -49.32 -51.31 35.07 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.093 0.473 . . . . 0.0 110.957 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.666 ' HA ' ' CZ ' ' A' ' 90' ' ' PHE . . . -57.46 -60.69 3.27 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.172 -0.955 . . . . 0.0 109.639 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.824 ' HB1' ' HB2' ' A' ' 118' ' ' ALA . . . -63.14 -9.75 12.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.399 -0.813 . . . . 0.0 109.996 178.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.473 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -70.67 -54.38 12.1 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.039 -1.038 . . . . 0.0 110.665 -179.812 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.479 ' HB3' ' CD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -90.07 -19.11 24.74 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.141 -0.975 . . . . 0.0 109.862 -179.918 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.822 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 87.32 59.91 1.7 Allowed Glycine 0 N--CA 1.487 2.077 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.33 178.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.666 ' CZ ' ' HA ' ' A' ' 85' ' ' ALA . 1.3 p90 -135.17 89.02 2.47 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.012 -1.287 . . . . 0.0 109.912 178.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.714 HD11 ' O ' ' A' ' 125' ' ' ASP . 0.2 OUTLIER -51.58 -35.12 40.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.868 -0.52 . . . . 0.0 110.883 -179.31 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 91' ' ' LEU . 1.7 m-20 -41.86 -33.7 0.56 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.319 -0.863 . . . . 0.0 109.128 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.577 ' O ' HD12 ' A' ' 97' ' ' LEU . 1.1 m -79.52 -49.73 11.8 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.832 HD21 ' HG ' ' A' ' 130' ' ' LEU . 2.5 tp -54.2 -41.33 68.5 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.65 -0.656 . . . . 0.0 109.587 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 89.8 t -59.99 -53.04 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.327 -0.858 . . . . 0.0 109.182 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.891 HG13 HD22 ' A' ' 64' ' ' LEU . 40.6 t -51.86 -46.46 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.638 -0.664 . . . . 0.0 109.435 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.873 HD23 ' HB1' ' A' ' 102' ' ' ALA . 0.6 OUTLIER -52.32 -55.41 21.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.623 -0.673 . . . . 0.0 109.877 179.588 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -70.63 -28.12 64.59 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.363 -0.835 . . . . 0.0 110.168 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.434 ' HB2' ' HA ' ' A' ' 96' ' ' VAL . 3.1 mtt180 -68.49 -9.57 49.84 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.287 -0.883 . . . . 0.0 110.995 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.832 ' HB2' HD21 ' A' ' 64' ' ' LEU . . . -127.99 -87.12 0.57 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.168 -0.958 . . . . 0.0 110.617 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -163.68 54.39 0.29 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.873 ' HB1' HD23 ' A' ' 97' ' ' LEU . . . -102.26 133.1 47.7 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.252 -1.146 . . . . 0.0 110.305 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.38 152.58 33.69 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.263 -0.898 . . . . 0.0 109.639 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.464 HD13 ' HB1' ' A' ' 133' ' ' ALA . 6.6 mt -143.08 46.46 1.54 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.166 -0.958 . . . . 0.0 110.908 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -169.44 52.7 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.182 -0.949 . . . . 0.0 110.815 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.892 HG11 ' CG ' ' A' ' 80' ' ' ARG . 9.6 p -113.63 -178.14 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 0.0 109.97 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.664 ' H ' HG22 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -129.32 138.04 51.35 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.386 -0.821 . . . . 0.0 109.882 179.129 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.5 t0 . . . . . 0 N--CA 1.494 1.749 0 O-C-N 121.421 -0.8 . . . . 0.0 110.404 -179.833 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.428 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 66.0 mt . . . . . 0 N--CA 1.493 1.713 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 40.9 Cg_endo -67.78 -28.51 36.6 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.779 1.41 . . . . 0.0 110.081 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.509 HG21 ' CA ' ' A' ' 131' ' ' ARG . 11.1 p -75.53 -35.89 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.399 -0.813 . . . . 0.0 109.939 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.422 ' N ' HG13 ' A' ' 115' ' ' VAL . 1.0 OUTLIER -68.94 -29.87 68.21 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.425 -0.797 . . . . 0.0 109.952 179.744 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.826 HD23 ' N ' ' A' ' 118' ' ' ALA . 4.3 tt -66.08 -58.53 5.26 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.459 -0.776 . . . . 0.0 109.934 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.826 ' N ' HD23 ' A' ' 117' ' ' LEU . . . -50.12 -48.01 53.73 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.383 -0.823 . . . . 0.0 110.969 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -50.77 -41.31 56.73 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.33 -0.856 . . . . 0.0 110.086 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -74.45 -55.1 6.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.57 -0.706 . . . . 0.0 109.94 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.487 HD12 HD21 ' A' ' 117' ' ' LEU . 1.6 mt -53.07 -82.02 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.253 -0.905 . . . . 0.0 110.549 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.82 39.62 0.03 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.543 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . 27.2 m-70 -124.08 52.83 1.44 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.276 -1.132 . . . . 0.0 109.188 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.476 ' HA ' ' HB3' ' A' ' 127' ' ' ALA . 1.1 ttt-85 -46.21 -45.44 16.91 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.73 -0.606 . . . . 0.0 110.341 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.714 ' O ' HD11 ' A' ' 91' ' ' LEU . 1.9 m-20 -52.53 -46.83 66.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.371 -0.831 . . . . 0.0 109.18 179.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.822 HG21 ' HA2' ' A' ' 89' ' ' GLY . 2.5 t -75.72 -27.51 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.5 -0.75 . . . . 0.0 109.556 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.476 ' HB3' ' HA ' ' A' ' 124' ' ' ARG . . . -75.19 -48.87 21.48 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.37 -0.831 . . . . 0.0 109.929 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.27 -54.93 41.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.28 -0.887 . . . . 0.0 110.157 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.631 ' HD2' HD23 ' A' ' 94' ' ' LEU . 36.8 t80 -59.33 -36.84 76.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.276 -0.89 . . . . 0.0 109.782 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.832 ' HG ' HD21 ' A' ' 94' ' ' LEU . 8.4 mt -64.03 -49.56 71.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.224 -0.923 . . . . 0.0 109.457 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.509 ' CA ' HG21 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -52.94 -29.77 30.65 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.301 -0.875 . . . . 0.0 110.288 179.856 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -86.34 -42.78 13.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.35 -0.844 . . . . 0.0 109.836 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.464 ' HB1' HD13 ' A' ' 104' ' ' LEU . . . -79.81 -5.66 55.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.435 -0.791 . . . . 0.0 110.513 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.733 0 O-C-N 121.172 -0.955 . . . . 0.0 110.622 -179.568 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.415 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 5.7 m-20 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 120.741 0.305 . . . . 0.0 110.357 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.527 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 0.1 OUTLIER -46.44 -62.78 1.21 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.366 -0.834 . . . . 0.0 110.345 -179.584 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.001 ' HB2' HD21 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -45.81 -35.26 4.27 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.392 0.615 . . . . 0.0 110.115 179.16 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 14' ' ' ASP . . . -77.66 -48.57 16.46 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.463 -0.773 . . . . 0.0 109.639 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.527 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.0 OUTLIER -52.97 -60.26 3.5 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.515 -0.74 . . . . 0.0 110.517 179.72 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.815 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -53.3 -43.44 67.56 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.332 -0.855 . . . . 0.0 109.905 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.484 ' C ' ' HA ' ' A' ' 52' ' ' MET . . . -55.39 -40.17 71.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.572 -0.705 . . . . 0.0 109.527 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.35 -34.43 70.49 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.434 -0.791 . . . . 0.0 110.363 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.9 mtm180 -94.65 22.61 6.1 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.245 -0.909 . . . . 0.0 110.885 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 52.41 72.31 0.54 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.926 ' O ' HG23 ' A' ' 28' ' ' VAL . 4.3 mtt85 -129.87 56.57 1.72 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.428 -1.042 . . . . 0.0 109.769 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.85 HG22 HG23 ' A' ' 59' ' ' VAL . 89.5 t -47.4 -55.14 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.558 -0.714 . . . . 0.0 110.649 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -61.67 -31.46 71.58 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.404 -0.81 . . . . 0.0 110.936 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.456 ' CB ' ' HB3' ' A' ' 24' ' ' ARG . 0.3 OUTLIER -76.43 -33.31 58.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.151 -0.968 . . . . 0.0 109.557 179.876 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.926 HG23 ' O ' ' A' ' 24' ' ' ARG . 5.0 t -78.77 -46.67 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.453 -0.78 . . . . 0.0 109.653 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.533 ' HA ' HD22 ' A' ' 62' ' ' LEU . 15.2 mmm180 -49.22 -48.08 45.75 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.431 -0.793 . . . . 0.0 109.74 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.622 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -72.04 -37.93 69.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.646 -0.659 . . . . 0.0 109.673 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.419 ' HB2' ' O ' ' A' ' 27' ' ' GLU . 6.3 mt -66.58 -56.47 10.59 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.469 -0.77 . . . . 0.0 110.565 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.947 ' HB2' HD21 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -44.45 -56.41 4.29 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.634 -0.666 . . . . 0.0 110.551 -179.809 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.48 -14.64 61.27 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.354 -0.841 . . . . 0.0 110.382 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.622 ' HB2' ' O ' ' A' ' 30' ' ' ALA . . . -79.15 -7.63 58.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.088 -1.007 . . . . 0.0 110.6 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 134.96 -12.19 4.47 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.771 -1.205 . . . . 0.0 110.578 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.941 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -48.73 149.32 1.79 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.172 -1.193 . . . . 0.0 110.509 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.935 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 0.2 OUTLIER -86.33 140.1 34.19 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.373 -0.829 . . . . 0.0 110.253 -179.713 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -74.79 -56.66 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.812 1.427 . . . . 0.0 110.51 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.422 ' ND2' ' O ' ' A' ' 67' ' ' GLY . 0.2 OUTLIER -95.4 55.92 1.78 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.264 -0.897 . . . . 0.0 109.825 179.565 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.935 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -101.76 108.25 55.22 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.169 -0.957 . . . . 0.0 110.774 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.8 132.26 19.82 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.617 1.325 . . . . 0.0 109.554 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.41 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 19.1 p-10 -124.19 71.06 1.11 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.054 -1.029 . . . . 0.0 111.112 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.8 m 44.46 -157.29 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.358 -0.839 . . . . 0.0 110.362 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 60.64 7.56 1.44 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.124 -0.985 . . . . 0.0 110.734 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 50.44 26.66 10.2 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.537 ' HG2' ' HB3' ' A' ' 50' ' ' GLN . 6.0 mtm-85 -125.78 -170.47 2.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.534 -0.98 . . . . 0.0 110.775 -179.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.563 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 3.5 mmp_? -119.78 -163.48 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.332 -0.855 . . . . 0.0 109.331 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.945 ' HB2' HD22 ' A' ' 63' ' ' LEU . 43.9 Cg_endo -80.04 -22.43 7.32 Favored 'Trans proline' 0 C--N 1.321 -0.895 0 O-C-N 122.987 0.993 . . . . 0.0 110.911 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.508 ' O ' ' HG2' ' A' ' 52' ' ' MET . 10.1 mt -107.05 -42.47 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.241 -0.912 . . . . 0.0 109.242 178.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.537 ' HB3' ' HG2' ' A' ' 46' ' ' ARG . 1.1 mt-30 -53.1 -22.55 6.32 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.158 -0.963 . . . . 0.0 109.994 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 47' ' ' ARG . 9.2 p -101.61 1.76 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 0.0 110.532 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.508 ' HG2' ' O ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -70.42 157.82 37.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.874 -1.141 . . . . 0.0 109.426 179.936 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -52.09 -13.74 0.34 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.194 -0.941 . . . . 0.0 111.225 -179.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.658 ' HE2' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 62.93 10.96 4.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.325 -0.859 . . . . 0.0 109.543 -178.908 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.505 ' O ' ' CE1' ' A' ' 90' ' ' PHE . . . -113.82 -2.95 23.73 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.463 -1.855 . . . . 0.0 108.463 178.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.505 ' HB3' HG23 ' A' ' 59' ' ' VAL . 0.9 OUTLIER -130.25 79.37 1.9 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.395 -1.062 . . . . 0.0 109.99 179.866 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.54 ' CB ' ' HB3' ' A' ' 92' ' ' ASP . . . -50.32 -26.27 4.66 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.425 -0.797 . . . . 0.0 109.62 179.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.49 -44.28 65.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.476 -0.765 . . . . 0.0 109.507 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.85 HG23 HG22 ' A' ' 25' ' ' VAL . 43.2 t -59.5 -56.83 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.289 -0.882 . . . . 0.0 109.436 179.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.491 ' HB2' ' CE ' ' A' ' 52' ' ' MET . . . -53.72 -42.45 68.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.408 -0.808 . . . . 0.0 109.611 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.725 ' O ' HD23 ' A' ' 65' ' ' LEU . 4.0 tt0 -59.18 -31.88 69.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 110.091 179.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.947 HD21 ' HB2' ' A' ' 32' ' ' LEU . 10.2 tp -74.46 -59.0 2.93 Favored 'General case' 0 C--N 1.31 -1.129 0 O-C-N 121.334 -0.854 . . . . 0.0 109.121 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.001 HD21 ' HB2' ' A' ' 16' ' ' LEU . 1.5 mt -63.24 -40.56 97.79 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.496 -0.752 . . . . 0.0 110.389 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 1.054 HD11 ' HB3' ' A' ' 100' ' ' ALA . 0.4 OUTLIER -53.37 -70.5 0.09 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.135 -0.978 . . . . 0.0 110.344 -179.616 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.725 HD23 ' O ' ' A' ' 61' ' ' GLU . 3.2 pp -51.35 -24.41 4.68 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.443 -0.786 . . . . 0.0 109.827 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.518 ' CG ' HD11 ' A' ' 32' ' ' LEU . 1.8 m80 -84.98 -27.2 26.62 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.752 -0.593 . . . . 0.0 110.147 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 63' ' ' LEU . . . 128.94 43.54 0.22 Allowed Glycine 0 N--CA 1.479 1.521 0 C-N-CA 120.136 -1.031 . . . . 0.0 110.906 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.601 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -72.9 -153.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.73 -1.453 . . . . 0.0 109.22 179.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.536 ' HB2' ' HB3' ' A' ' 47' ' ' ARG . 0.3 OUTLIER -124.09 67.25 43.46 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.258 -0.901 . . . . 0.0 110.358 179.59 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -72.75 -25.93 16.55 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.91 1.479 . . . . 0.0 110.209 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -104.82 -36.44 7.39 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.334 -0.854 . . . . 0.0 110.006 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.3 m -60.76 164.27 4.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.425 -0.797 . . . . 0.0 110.792 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -165.04 -157.73 0.36 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.483 -0.761 . . . . 0.0 109.724 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.496 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.8 OUTLIER -105.02 138.35 19.48 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.157 -0.964 . . . . 0.0 109.981 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -74.67 -22.17 15.87 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.517 1.272 . . . . 0.0 110.644 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.98 -76.53 0.05 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.288 -0.883 . . . . 0.0 109.853 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 108' ' ' ASP . 0.3 OUTLIER -109.52 31.5 5.73 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.517 -0.739 . . . . 0.0 110.518 -179.744 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.512 HD13 HG23 ' A' ' 106' ' ' VAL . 4.6 mt 40.66 31.27 0.11 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.56 -0.712 . . . . 0.0 110.906 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.463 ' HA ' ' OD1' ' A' ' 108' ' ' ASP . 93.9 m -57.84 87.68 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.379 -0.826 . . . . 0.0 109.538 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.655 ' CG ' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -71.23 161.43 78.33 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.357 -0.839 . . . . 0.0 110.558 -179.086 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.15 -24.46 23.47 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 124.007 1.53 . . . . 0.0 110.251 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.797 HG11 ' HG ' ' A' ' 104' ' ' LEU . 25.1 t -58.86 -27.62 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.429 -0.794 . . . . 0.0 109.856 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 47.8 m80 -65.67 -42.74 90.97 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.885 0.85 . . . . 0.0 109.35 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.658 ' HB3' ' HE2' ' A' ' 54' ' ' MET . 0.9 OUTLIER -54.1 -57.41 11.21 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.732 -179.604 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.727 ' HB1' ' CD1' ' A' ' 94' ' ' LEU . . . -48.18 -63.62 1.02 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.449 -0.782 . . . . 0.0 109.867 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.813 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -56.41 -50.32 71.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.337 -0.852 . . . . 0.0 110.571 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.567 ' HD3' HD12 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -48.71 -34.01 11.22 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.402 -0.811 . . . . 0.0 110.992 -179.349 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.451 ' HB2' ' HB3' ' A' ' 54' ' ' MET . 12.8 tp10 -93.51 -7.83 43.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.201 -0.937 . . . . 0.0 110.618 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.524 ' HA2' ' CG ' ' A' ' 123' ' ' HIS . . . 80.17 16.89 75.52 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.514 ' O ' ' CD1' ' A' ' 94' ' ' LEU . 0.3 OUTLIER -87.22 156.25 19.74 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.046 -1.267 . . . . 0.0 110.351 -179.875 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.588 HD22 HG22 ' A' ' 126' ' ' VAL . 0.0 OUTLIER -122.9 -53.62 1.85 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.66 -0.65 . . . . 0.0 109.644 179.639 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.853 ' O ' HG23 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -44.14 -41.36 5.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.623 -0.673 . . . . 0.0 109.689 179.835 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.406 ' O ' ' HB ' ' A' ' 96' ' ' VAL . 18.5 m -58.41 -49.68 76.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.635 -0.666 . . . . 0.0 109.792 178.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.727 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 0.6 OUTLIER -55.17 -54.12 47.36 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.165 -0.959 . . . . 0.0 109.585 179.727 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.2 t -50.24 -47.69 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.629 -0.669 . . . . 0.0 109.256 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.876 ' CG1' HD22 ' A' ' 64' ' ' LEU . 58.4 t -52.81 -50.82 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.429 HD23 ' HB1' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -54.03 -68.92 0.14 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.502 -0.749 . . . . 0.0 110.293 179.399 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -52.65 -32.17 40.71 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.16 -0.962 . . . . 0.0 109.636 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 25.3 ttm-85 -68.38 -12.66 61.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.521 -0.737 . . . . 0.0 110.048 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 1.054 ' HB3' HD11 ' A' ' 64' ' ' LEU . . . -137.19 60.94 1.63 Allowed 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.234 -0.916 . . . . 0.0 110.738 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 53.94 102.66 0.01 OUTLIER Glycine 0 N--CA 1.494 2.522 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.429 ' HB1' HD23 ' A' ' 97' ' ' LEU . . . -160.25 114.17 2.18 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.133 -1.216 . . . . 0.0 110.544 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 12.8 tpp180 -68.35 159.39 31.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.632 -0.667 . . . . 0.0 110.088 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.918 HD23 ' HB2' ' A' ' 134' ' ' ALA . 0.0 OUTLIER -145.52 10.47 1.25 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.36 -0.837 . . . . 0.0 110.976 -179.577 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -111.57 46.46 1.11 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.048 -1.033 . . . . 0.0 110.268 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.655 HG11 ' CG ' ' A' ' 80' ' ' ARG . 2.5 p -105.7 167.25 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.488 -0.758 . . . . 0.0 109.307 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.546 ' HG3' HD12 ' A' ' 113' ' ' LEU . 6.6 ttt85 -136.37 51.7 2.0 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.389 -0.82 . . . . 0.0 110.29 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . 0.475 ' HA ' ' O ' ' A' ' 77' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.497 1.905 0 O-C-N 121.631 -0.668 . . . . 0.0 110.39 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.546 HD12 ' HG3' ' A' ' 107' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.81 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . 0.527 ' HD2' HD23 ' A' ' 113' ' ' LEU . 37.9 Cg_endo -63.81 -57.14 0.38 Allowed 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.373 1.196 . . . . 0.0 110.941 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.586 ' HA ' HD21 ' A' ' 130' ' ' LEU . 2.4 p -51.72 -31.12 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 120.905 -1.122 . . . . 0.0 110.33 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -66.2 -28.31 68.66 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.295 -0.878 . . . . 0.0 110.35 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.567 HD12 ' HD3' ' A' ' 87' ' ' ARG . 2.2 mm? -67.92 -38.57 83.06 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.126 -0.984 . . . . 0.0 110.116 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.689 ' CB ' ' HB2' ' A' ' 127' ' ' ALA . . . -68.48 -50.88 49.09 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.411 -0.806 . . . . 0.0 110.111 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -61.0 -45.54 94.43 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.269 -0.895 . . . . 0.0 110.319 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -54.27 -52.78 60.34 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.314 -0.866 . . . . 0.0 109.719 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.67 -86.43 0.06 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.362 -0.836 . . . . 0.0 110.216 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 174.06 31.34 0.03 OUTLIER Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.524 ' CG ' ' HA2' ' A' ' 89' ' ' GLY . 45.8 m-70 -95.05 46.73 1.13 Allowed 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.417 -1.049 . . . . 0.0 108.685 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.4 ' O ' ' HB2' ' A' ' 128' ' ' ARG . 0.4 OUTLIER -47.14 -33.33 5.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.784 -0.573 . . . . 0.0 109.832 -179.456 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.55 -40.99 98.59 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.813 HG11 ' HA ' ' A' ' 86' ' ' ALA . 3.4 t -75.82 -46.2 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.447 -0.783 . . . . 0.0 109.308 178.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.689 ' HB2' ' CB ' ' A' ' 118' ' ' ALA . . . -53.2 -53.42 50.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.302 -0.874 . . . . 0.0 109.408 179.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 124' ' ' ARG . 0.6 OUTLIER -49.8 -53.2 26.74 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.167 -0.958 . . . . 0.0 110.493 179.335 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -71.57 -56.37 6.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.372 -0.83 . . . . 0.0 110.746 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.626 HD22 ' HB2' ' A' ' 86' ' ' ALA . 0.3 OUTLIER -60.25 -30.58 69.52 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.366 -0.834 . . . . 0.0 111.025 -179.033 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.558 ' CB ' ' O ' ' A' ' 127' ' ' ALA . 4.3 ttp-105 -73.07 -27.54 61.79 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.028 -1.045 . . . . 0.0 110.432 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.95 -42.0 77.26 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.212 -0.93 . . . . 0.0 109.23 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.621 ' HB3' HD22 ' A' ' 104' ' ' LEU . . . -87.94 -10.17 51.35 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.638 -0.664 . . . . 0.0 110.336 179.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.918 ' HB2' HD23 ' A' ' 104' ' ' LEU . . . . . . . . 0 N--CA 1.494 1.729 0 O-C-N 121.232 -0.918 . . . . 0.0 110.59 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.621 ' O ' ' N ' ' A' ' 17' ' ' ALA . 2.8 m-20 . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 120.981 0.419 . . . . 2.92 110.021 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.505 ' HB3' HD13 ' A' ' 31' ' ' LEU . 4.4 m0 -41.61 -36.87 1.02 Allowed 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.854 -0.738 . . . . 4.18 109.036 178.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 1.074 HD13 HD21 ' A' ' 63' ' ' LEU . 3.4 pp -74.99 -33.16 61.82 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.376 -0.972 . . . . 2.77 108.376 177.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.621 ' N ' ' O ' ' A' ' 14' ' ' ASP . . . -80.45 -54.24 5.86 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.942 -0.762 . . . . 1.94 108.942 177.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.547 ' N ' ' O ' ' A' ' 14' ' ' ASP . 0.5 OUTLIER -54.3 -48.87 70.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.267 -0.896 . . . . 2.64 108.753 178.457 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.472 ' CB ' ' O ' ' A' ' 15' ' ' TRP . . . -63.87 -35.01 79.23 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.574 -0.899 . . . . 2.45 108.574 178.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.678 ' HB1' HG11 ' A' ' 59' ' ' VAL . . . -66.87 -43.61 83.08 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.664 -0.865 . . . . 1.89 108.664 178.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.436 ' N ' ' HA ' ' A' ' 52' ' ' MET . . . -61.58 -26.8 68.2 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.558 -0.713 . . . . 2.07 109.348 179.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -95.91 20.32 10.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.647 -0.658 . . . . 4.97 110.087 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 55.81 34.18 60.88 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.38 -1.088 . . . . 2.84 110.38 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.619 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -99.53 74.44 1.89 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.283 -1.127 . . . . 4.37 109.984 179.646 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.756 HG22 ' CG2' ' A' ' 59' ' ' VAL . 62.0 t -57.85 -46.14 87.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.374 -0.829 . . . . 2.98 110.353 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -54.93 -51.45 66.05 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.387 -0.82 . . . . 4.64 110.4 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.16 -46.04 68.73 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.23 -0.919 . . . . 3.3 109.963 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.886 HG12 HD12 ' A' ' 32' ' ' LEU . 5.7 t -69.66 -42.19 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.398 -0.814 . . . . 3.02 109.622 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.994 ' HA ' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -48.5 -48.11 38.3 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.55 -0.719 . . . . 4.19 110.093 179.676 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.5 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -78.73 -35.23 45.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.505 -0.747 . . . . 4.02 110.057 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.505 HD13 ' HB3' ' A' ' 15' ' ' TRP . 25.8 mt -64.26 -65.69 0.64 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.369 -0.832 . . . . 3.44 110.03 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.911 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 3.8 mt -48.33 -42.51 31.44 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.43 -0.794 . . . . 3.6 110.544 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -75.23 -17.27 60.37 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.255 -0.903 . . . . 4.87 110.24 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' A' ' 30' ' ' ALA . . . -86.36 -7.45 58.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -0.924 . . . . 4.13 110.896 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.29 26.91 1.92 Allowed Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.888 -1.148 . . . . 3.84 110.466 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 1.029 ' HB1' HD23 ' A' ' 16' ' ' LEU . . . -79.14 126.79 31.19 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.176 -1.191 . . . . 3.33 110.341 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.468 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 0.4 OUTLIER -53.44 123.83 37.95 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.375 -0.828 . . . . 3.61 110.337 179.938 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.427 ' HD2' HD13 ' A' ' 37' ' ' LEU . 43.2 Cg_endo -72.56 -23.87 19.44 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.539 1.284 . . . . 3.28 108.966 178.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.403 ' ND2' ' O ' ' A' ' 67' ' ' GLY . 0.6 OUTLIER -112.7 51.77 0.81 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.63 -0.669 . . . . 3.8 109.246 178.829 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.468 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -92.88 116.4 66.44 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.413 -0.804 . . . . 2.68 110.46 -179.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.32 121.12 6.27 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.696 1.366 . . . . 3.15 110.487 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -78.75 175.41 10.48 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.296 -0.877 . . . . 3.3 110.351 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.7 m -83.48 -6.53 59.48 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.317 -0.865 . . . . 3.78 110.502 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -84.46 12.05 7.56 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.153 -0.967 . . . . 3.84 110.375 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.22 16.22 62.07 Favored Glycine 0 N--CA 1.484 1.889 0 N-CA-C 109.064 -1.615 . . . . 2.97 109.064 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 61.3 mtt180 -113.52 -167.51 1.21 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.47 -1.018 . . . . 3.32 110.179 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.709 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 0.8 OUTLIER -108.96 -174.37 0.3 Allowed Pre-proline 0 N--CA 1.492 1.631 0 N-CA-C 108.848 -0.797 . . . . 3.66 108.848 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.709 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 43.3 Cg_endo -74.25 -19.59 19.66 Favored 'Trans proline' 0 C--N 1.314 -1.249 0 O-C-N 123.001 1.0 . . . . 2.19 111.4 -178.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.412 ' O ' ' HG2' ' A' ' 52' ' ' MET . 14.1 mt -108.73 -36.56 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 120.99 -1.069 . . . . 1.71 108.909 178.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.417 ' HG3' ' CA ' ' A' ' 81' ' ' PRO . 0.4 OUTLIER -56.55 -17.6 8.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.479 -0.763 . . . . 2.69 110.062 179.246 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.8 p -107.81 -5.16 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.31 -0.869 . . . . 1.77 111.277 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' MET . . . . . 0.828 ' HE1' ' HB2' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -62.33 164.86 6.6 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.73 -1.231 . . . . 2.02 109.728 -179.902 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 5.0 tmm? -57.13 -10.32 1.17 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.256 -0.902 . . . . 2.68 111.478 -178.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.693 ' HE2' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 57.67 16.97 3.74 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.08 -1.012 . . . . 1.71 109.95 -179.432 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.462 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -121.26 10.63 9.96 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 108.944 -1.662 . . . . 2.31 108.944 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.39 86.97 1.49 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.453 -1.028 . . . . 2.49 109.197 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.95 -24.72 6.84 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.466 -0.771 . . . . 2.01 110.6 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.42 ' HB3' HG11 ' A' ' 25' ' ' VAL . 0.8 OUTLIER -53.62 -38.59 64.18 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.233 -0.917 . . . . 4.52 109.347 179.56 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.756 ' CG2' HG22 ' A' ' 25' ' ' VAL . 27.1 t -64.78 -49.01 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.043 -1.095 . . . . 2.06 108.043 178.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.828 ' HB2' ' HE1' ' A' ' 52' ' ' MET . . . -55.77 -43.04 76.38 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.888 -0.782 . . . . 2.1 108.888 178.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -58.65 -64.04 1.07 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.323 -0.86 . . . . 3.67 108.785 178.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.994 HD11 ' HA ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -41.9 -59.36 1.73 Allowed 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.769 0.795 . . . . 3.13 109.811 177.936 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.074 HD21 HD13 ' A' ' 16' ' ' LEU . 10.4 mt -59.75 -56.01 27.19 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.271 0.558 . . . . 2.64 110.84 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.831 HD21 ' CB ' ' A' ' 100' ' ' ALA . 1.2 tt -56.53 -56.63 18.86 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.426 -0.796 . . . . 3.02 110.918 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.653 ' O ' HD12 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -55.99 -29.89 60.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.141 -0.974 . . . . 3.74 109.935 -179.377 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' HIS . . . . . 0.615 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -82.39 -25.14 34.02 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.423 -0.798 . . . . 4.0 109.395 179.606 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.403 ' O ' ' ND2' ' A' ' 39' ' ' ASN . . . 124.08 42.18 0.37 Allowed Glycine 0 N--CA 1.479 1.518 0 N-CA-C 110.507 -1.037 . . . . 3.14 110.507 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.681 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -66.41 -161.79 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.855 -1.38 . . . . 2.73 109.474 179.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.591 ' HB2' ' HB3' ' A' ' 47' ' ' ARG . 1.7 mp0 -115.88 62.13 2.02 Favored Pre-proline 0 C--N 1.302 -1.487 0 O-C-N 121.362 -0.836 . . . . 3.37 110.324 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.606 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 43.1 Cg_endo -68.89 -11.71 32.55 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.608 1.32 . . . . 2.64 109.455 178.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.51 ' OD1' ' HB2' ' A' ' 103' ' ' ARG . 1.4 t-20 -106.05 -42.05 5.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.532 -0.73 . . . . 4.06 110.223 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.419 ' HB3' ' HD2' ' A' ' 47' ' ' ARG . 0.3 OUTLIER -69.73 143.84 52.95 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.153 -0.967 . . . . 3.77 110.734 -179.275 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.573 ' HB2' ' HG2' ' A' ' 80' ' ' ARG . . . -132.98 -146.43 0.27 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.426 -0.796 . . . . 3.45 110.103 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 78' ' ' LEU . 1.0 OUTLIER -109.3 138.27 20.45 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.117 -0.989 . . . . 3.88 110.109 -179.939 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -77.35 -6.04 16.1 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.467 1.246 . . . . 4.82 110.551 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -99.12 -35.7 9.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.163 -0.961 . . . . 4.58 110.116 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.2 p -132.21 7.51 4.27 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.323 -0.861 . . . . 4.37 110.696 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.46 ' HA ' HD23 ' A' ' 78' ' ' LEU . 6.0 mt 45.59 31.66 0.99 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.319 -0.863 . . . . 4.3 110.63 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.9 m -69.12 76.9 0.35 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.413 -0.804 . . . . 3.38 110.472 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . 0.587 ' HB2' HG11 ' A' ' 106' ' ' VAL . 3.8 mtt85 -57.61 161.27 6.32 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.091 -1.005 . . . . 3.91 109.273 179.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.606 ' HG3' ' HA ' ' A' ' 70' ' ' PRO . 39.4 Cg_endo -67.81 -6.84 17.88 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.555 1.292 . . . . 2.39 110.954 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.557 HG21 ' HA ' ' A' ' 104' ' ' LEU . 19.4 t -71.03 -35.51 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.216 -0.927 . . . . 2.38 109.674 179.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 31.8 m80 -67.48 -44.89 77.46 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.381 -0.825 . . . . 3.04 109.195 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.693 ' HB3' ' HE2' ' A' ' 54' ' ' MET . 0.3 OUTLIER -49.53 -51.76 34.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.886 -0.509 . . . . 2.28 110.902 -179.792 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.523 ' HB3' ' CD1' ' A' ' 94' ' ' LEU . . . -58.1 -58.36 8.78 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.102 -0.999 . . . . 1.5 109.682 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.84 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -59.79 -40.44 88.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.417 -0.802 . . . . 1.91 110.348 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.9 -34.73 21.21 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.31 -0.869 . . . . 3.67 110.332 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.41 1.85 38.81 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.39 -0.819 . . . . 2.79 110.642 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.499 ' HA2' ' HB3' ' A' ' 123' ' ' HIS . . . 73.62 38.14 51.47 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.521 -1.431 . . . . 2.01 109.521 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.462 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 0.3 OUTLIER -110.8 105.17 13.92 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.311 -1.111 . . . . 2.43 111.101 -179.265 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.624 HD21 ' CB ' ' A' ' 129' ' ' TYR . 0.5 OUTLIER -78.64 -36.85 43.38 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.25 -0.906 . . . . 2.6 109.356 178.872 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.715 ' O ' HG23 ' A' ' 96' ' ' VAL . 19.4 m-20 -48.17 -43.38 31.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.592 -0.692 . . . . 2.72 109.747 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 54.6 m -65.82 -43.92 87.17 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.722 -0.844 . . . . 1.77 108.722 178.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.867 HD21 ' CD2' ' A' ' 130' ' ' LEU . 1.1 tp -57.48 -49.09 77.43 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.435 -0.791 . . . . 2.24 109.006 178.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.507 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 85.7 t -54.94 -54.56 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 108.87 -0.789 . . . . 2.83 108.87 178.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 92' ' ' ASP . 89.1 t -49.37 -50.79 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.739 -0.601 . . . . 2.71 109.861 178.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.487 ' HA ' ' CD1' ' A' ' 64' ' ' LEU . 0.4 OUTLIER -52.45 -64.39 0.83 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.42 -0.8 . . . . 2.9 109.833 179.373 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -57.67 -22.99 49.15 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.34 -0.85 . . . . 3.77 110.683 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.507 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 4.3 ttt180 -73.47 -17.05 61.28 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.222 -0.924 . . . . 4.95 110.893 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.831 ' CB ' HD21 ' A' ' 64' ' ' LEU . . . -141.11 67.99 1.34 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.052 -1.03 . . . . 3.94 111.245 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 48.55 94.98 0.01 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.899 -0.88 . . . . 3.62 110.899 179.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.463 ' O ' HD12 ' A' ' 104' ' ' LEU . . . -150.25 101.54 3.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.396 -1.061 . . . . 3.21 109.021 179.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.51 ' HB2' ' OD1' ' A' ' 71' ' ' ASN . 3.0 tpt180 -54.23 120.95 7.21 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.314 -0.866 . . . . 4.85 111.002 -178.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.617 HD23 ' HB2' ' A' ' 134' ' ' ALA . 0.2 OUTLIER -107.5 -7.12 16.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.721 -0.612 . . . . 3.3 109.911 179.45 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -98.32 48.19 0.99 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.101 -1.0 . . . . 4.05 112.525 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.591 HG22 ' H ' ' A' ' 107' ' ' ARG . 1.4 p -113.02 -175.18 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.684 -1.26 . . . . 3.77 109.869 178.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.591 ' H ' HG22 ' A' ' 106' ' ' VAL . 4.2 ptt180 -138.98 158.52 44.05 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.512 -0.742 . . . . 5.47 109.211 178.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.496 1.841 0 O-C-N 121.065 -1.022 . . . . 4.46 111.459 -178.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.574 ' HB3' HG12 ' A' ' 115' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 120.637 0.256 . . . . 4.08 110.884 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -68.0 -26.4 37.38 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.853 1.449 . . . . 3.1 108.643 177.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.574 HG12 ' HB3' ' A' ' 113' ' ' LEU . 7.2 p -76.29 -35.43 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 108.634 -0.876 . . . . 3.3 108.634 178.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.37 -26.41 66.45 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.701 -0.799 . . . . 4.01 109.767 179.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.54 -33.79 54.08 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.43 -0.794 . . . . 3.43 110.358 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.699 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -74.08 -37.99 64.04 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.301 -0.875 . . . . 2.83 110.566 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.442 ' HG3' ' HB1' ' A' ' 127' ' ' ALA . 3.6 mt-10 -70.2 -32.3 70.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.331 -0.856 . . . . 3.91 110.561 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -70.91 -57.23 4.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.114 -0.991 . . . . 4.27 109.777 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.93 -81.07 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.304 -0.872 . . . . 3.4 109.993 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.26 40.59 0.03 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.929 -1.669 . . . . 3.23 108.929 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . 0.565 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 48.0 m-70 -107.94 53.12 0.7 Allowed 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.482 -1.011 . . . . 2.7 109.511 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.434 ' O ' ' HB2' ' A' ' 128' ' ' ARG . 20.9 mtt180 -47.5 -52.41 17.41 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.766 -0.584 . . . . 4.13 109.957 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.426 ' O ' HD11 ' A' ' 91' ' ' LEU . 1.0 OUTLIER -48.68 -40.51 28.37 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.486 -0.759 . . . . 2.92 109.915 179.435 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.84 HG11 ' HA ' ' A' ' 86' ' ' ALA . 2.2 t -81.37 -47.24 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.36 -0.837 . . . . 2.25 109.501 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.508 ' HB2' ' CB ' ' A' ' 118' ' ' ALA . . . -56.12 -41.84 75.92 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.211 -0.931 . . . . 2.77 109.89 179.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -59.96 -56.65 19.09 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.275 -0.89 . . . . 4.43 109.353 179.327 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.631 ' HD2' HD23 ' A' ' 94' ' ' LEU . 60.0 t80 -60.59 -33.0 72.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.374 -0.829 . . . . 3.06 109.012 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.867 ' CD2' HD21 ' A' ' 94' ' ' LEU . 28.2 mt -65.63 -52.38 52.32 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.959 -0.696 . . . . 3.09 109.315 179.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 3.1 ttt-85 -57.88 -19.16 27.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.93 -1.106 . . . . 4.86 109.341 178.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.67 -51.33 6.53 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.59 -0.893 . . . . 3.81 108.59 178.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.431 ' HB3' HD22 ' A' ' 104' ' ' LEU . . . -92.5 -52.11 4.81 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.099 -1.001 . . . . 3.53 109.963 178.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.631 ' N ' ' O ' ' A' ' 130' ' ' LEU . . . . . . . . 0 N--CA 1.494 1.747 0 O-C-N 121.677 -0.639 . . . . 3.93 112.282 -179.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 121.203 0.525 . . . . 0.0 110.359 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.422 ' HA ' ' HD2' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -99.29 110.21 57.37 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.324 -0.86 . . . . 0.0 110.214 179.841 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 2' ' ' GLU . 44.1 Cg_endo -69.15 154.75 69.66 Favored 'Trans proline' 0 C--N 1.312 -1.345 0 O-C-N 123.632 1.333 . . . . 0.0 110.495 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -167.65 142.05 3.65 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.54 -0.725 . . . . 0.0 110.203 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -145.26 -44.64 0.22 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.382 -0.824 . . . . 0.0 110.289 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 150.64 -86.85 0.14 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 108.991 -1.644 . . . . 0.0 108.991 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.4 p -49.85 112.5 0.67 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.378 -1.072 . . . . 0.0 109.843 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 t -92.45 160.05 15.25 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.209 -0.932 . . . . 0.0 110.617 -179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -121.21 97.74 5.66 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.72 -0.612 . . . . 0.0 109.983 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -146.81 90.17 5.53 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.313 -0.867 . . . . 0.0 109.965 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -76.89 76.45 4.11 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.905 1.476 . . . . 0.0 111.037 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 m -62.01 179.51 0.28 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.144 -0.972 . . . . 0.0 109.753 179.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.444 ' HB3' ' HG ' ' A' ' 37' ' ' LEU . . . -54.26 128.79 32.76 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.197 -0.94 . . . . 0.0 110.273 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.494 ' O ' ' OG1' ' A' ' 18' ' ' THR . 25.8 t0 -157.65 20.14 0.27 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.468 -0.77 . . . . 0.0 110.62 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.477 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 40.9 m0 -76.66 -56.51 4.54 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.307 -0.87 . . . . 0.0 110.612 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.7 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 0.8 OUTLIER -41.62 -40.76 2.01 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.698 -0.626 . . . . 0.0 111.042 -179.821 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.2 -56.27 5.32 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.174 -0.954 . . . . 0.0 110.07 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.494 ' OG1' ' O ' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -43.73 -53.93 5.49 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.587 -0.696 . . . . 0.0 110.719 -179.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.665 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -52.97 -55.91 19.97 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.411 -0.806 . . . . 0.0 110.445 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.457 ' CB ' HG11 ' A' ' 59' ' ' VAL . . . -47.08 -62.58 1.35 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.567 -0.708 . . . . 0.0 111.077 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.622 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -46.15 -28.5 1.25 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.612 -0.68 . . . . 0.0 110.855 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -90.79 30.35 1.2 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.299 -0.876 . . . . 0.0 110.291 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.553 ' CA ' ' HE2' ' A' ' 53' ' ' MET . . . 44.94 27.5 1.48 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.406 -1.077 . . . . 0.0 110.406 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.541 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -105.17 98.47 8.17 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.258 -1.142 . . . . 0.0 110.323 -179.771 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.817 HG22 ' CG2' ' A' ' 59' ' ' VAL . 69.9 t -78.73 -37.26 20.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.633 -0.667 . . . . 0.0 110.172 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -54.65 -52.38 62.49 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.544 -0.722 . . . . 0.0 110.899 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.456 ' O ' HD12 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -58.04 -35.1 70.82 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.225 -0.922 . . . . 0.0 110.821 -179.233 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.852 HG12 HD13 ' A' ' 62' ' ' LEU . 6.2 t -76.41 -47.85 28.96 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.274 -0.891 . . . . 0.0 110.171 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.809 ' N ' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -52.73 -46.34 67.37 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.022 -1.049 . . . . 0.0 109.688 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -70.66 -31.0 67.76 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.418 -0.801 . . . . 0.0 109.559 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.456 HD12 ' O ' ' A' ' 27' ' ' GLU . 10.2 mt -79.4 -53.26 7.08 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.402 -0.811 . . . . 0.0 110.815 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.761 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -47.88 -38.76 17.03 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.164 -0.96 . . . . 0.0 110.161 -179.695 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 84.9 mt-10 -83.09 -25.06 32.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.332 -0.855 . . . . 0.0 109.855 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.426 ' HB2' ' O ' ' A' ' 30' ' ' ALA . . . -74.25 -3.81 32.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.42 -0.8 . . . . 0.0 110.03 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.82 24.44 5.23 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.761 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -61.04 133.74 56.37 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.071 -1.252 . . . . 0.0 109.809 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.968 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 3.1 mm? -57.09 112.89 5.17 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.399 -0.813 . . . . 0.0 109.778 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.47 -30.42 36.03 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 123.543 1.286 . . . . 0.0 109.88 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.52 ' HA ' ' OE2' ' A' ' 69' ' ' GLU . 33.0 m120 -121.01 56.67 1.01 Allowed 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.425 -0.797 . . . . 0.0 110.125 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.968 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -100.9 110.89 62.23 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.856 -0.527 . . . . 0.0 109.604 179.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.92 124.6 9.76 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.494 1.26 . . . . 0.0 109.638 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.498 ' ND2' ' HB2' ' A' ' 44' ' ' TYR . 36.9 t30 -88.2 161.97 16.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.408 -0.808 . . . . 0.0 110.035 -179.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.405 ' N ' ' OD1' ' A' ' 42' ' ' ASN . 0.4 OUTLIER -74.76 -0.99 20.01 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.428 -0.795 . . . . 0.0 110.967 -179.802 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.498 ' HB2' ' ND2' ' A' ' 42' ' ' ASN . 0.1 OUTLIER -84.64 1.37 46.52 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.004 -1.06 . . . . 0.0 110.093 179.529 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.82 23.24 44.2 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.521 ' O ' ' CB ' ' A' ' 50' ' ' GLN . 46.1 mtt180 -121.66 37.63 4.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.316 -1.108 . . . . 0.0 110.968 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.487 ' HG3' ' HD3' ' A' ' 48' ' ' PRO . 0.0 OUTLIER 43.52 -172.65 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.089 0 O-C-N 121.517 -0.739 . . . . 0.0 111.064 178.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.694 ' HB2' HD22 ' A' ' 63' ' ' LEU . 53.0 Cg_endo -85.5 -23.89 2.1 Favored 'Trans proline' 0 C--N 1.317 -1.089 0 O-C-N 123.476 1.251 . . . . 0.0 110.377 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.582 HG13 ' HB1' ' A' ' 68' ' ' ALA . 2.7 mt -102.63 -43.85 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.229 -0.919 . . . . 0.0 108.95 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.58 ' HG2' ' HA ' ' A' ' 81' ' ' PRO . 0.0 OUTLIER -49.68 -21.17 0.97 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.381 -0.824 . . . . 0.0 109.822 178.808 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.622 HG22 ' HB2' ' A' ' 21' ' ' ALA . 9.3 p -112.99 33.23 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.089 -1.007 . . . . 0.0 110.579 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.563 ' HE1' ' HB2' ' A' ' 60' ' ' ALA . 0.1 OUTLIER -96.96 35.08 1.61 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.061 -1.024 . . . . 0.0 109.483 179.111 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.553 ' HE2' ' CA ' ' A' ' 23' ' ' GLY . 6.2 tmm? 64.55 -6.26 0.31 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.667 -0.645 . . . . 0.0 111.109 -179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.588 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 44.53 26.79 0.2 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.253 -0.904 . . . . 0.0 110.57 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.537 ' HA2' ' CD2' ' A' ' 90' ' ' PHE . . . -128.79 8.73 6.44 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.648 ' HB3' HG23 ' A' ' 59' ' ' VAL . 0.6 OUTLIER -145.66 70.29 1.24 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.318 -1.107 . . . . 0.0 109.972 179.663 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.505 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . . . -42.79 -36.56 1.5 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.507 -0.746 . . . . 0.0 110.7 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -46.31 -35.29 5.2 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.653 -0.654 . . . . 0.0 109.463 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.817 ' CG2' HG22 ' A' ' 25' ' ' VAL . 46.6 t -67.16 -51.55 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.563 ' HB2' ' HE1' ' A' ' 52' ' ' MET . . . -43.85 -58.13 2.91 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.649 -0.657 . . . . 0.0 110.03 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.93 -49.35 30.41 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.852 HD13 HG12 ' A' ' 28' ' ' VAL . 0.4 OUTLIER -46.11 -62.67 1.23 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.704 -0.622 . . . . 0.0 110.115 178.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.883 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 0.9 OUTLIER -69.98 -55.18 10.27 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.385 -0.822 . . . . 0.0 110.615 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.904 HD22 ' CG1' ' A' ' 96' ' ' VAL . 0.4 OUTLIER -48.39 -63.69 1.01 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.302 -0.874 . . . . 0.0 110.701 -179.528 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.723 HD12 ' C ' ' A' ' 65' ' ' LEU . 0.8 OUTLIER -50.68 -28.12 8.35 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.406 -0.809 . . . . 0.0 109.36 -179.702 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.724 ' ND1' HD12 ' A' ' 32' ' ' LEU . 2.4 m-70 -84.47 -31.98 24.26 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.778 -0.576 . . . . 0.0 109.748 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 63' ' ' LEU . . . 125.81 55.37 0.16 Allowed Glycine 0 N--CA 1.482 1.707 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.883 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -80.02 -150.97 0.07 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.971 -1.311 . . . . 0.0 109.049 178.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.52 ' OE2' ' HA ' ' A' ' 39' ' ' ASN . 2.0 mt-10 -124.38 68.0 48.45 Favored Pre-proline 0 C--N 1.3 -1.582 0 O-C-N 121.412 -0.805 . . . . 0.0 109.49 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.518 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 49.0 Cg_endo -71.24 -3.89 13.84 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 O-C-N 123.716 1.377 . . . . 0.0 110.293 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.454 ' O ' ' NE ' ' A' ' 80' ' ' ARG . 37.0 m-20 -112.55 -67.67 0.98 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.303 -0.873 . . . . 0.0 109.587 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.8 t -43.69 155.52 0.07 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.57 -0.706 . . . . 0.0 110.128 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.556 ' HB2' ' HA ' ' A' ' 80' ' ' ARG . . . -152.07 -142.26 0.12 Allowed 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.569 -179.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.413 ' HA ' ' HD3' ' A' ' 75' ' ' PRO . 0.4 OUTLIER -100.01 139.59 20.88 Favored Pre-proline 0 N--CA 1.484 1.254 0 O-C-N 121.219 -0.926 . . . . 0.0 110.563 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 74' ' ' ASP . 55.2 Cg_endo -84.31 2.77 7.96 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.988 1.52 . . . . 0.0 110.428 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -101.79 -33.87 9.65 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.16 -0.963 . . . . 0.0 110.027 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.787 HG23 ' CH2' ' A' ' 110' ' ' TRP . 0.3 OUTLIER -140.24 10.18 2.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.473 -0.767 . . . . 0.0 110.518 -179.836 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 78' ' ' LEU . 21.7 mt 53.86 38.49 28.77 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.303 -0.873 . . . . 0.0 110.731 -179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.475 ' HA ' ' OD1' ' A' ' 108' ' ' ASP . 36.5 m -72.91 88.38 1.35 Allowed 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.423 -0.911 . . . . 0.0 110.313 179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.781 ' CD ' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -72.78 168.43 24.36 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.471 -0.768 . . . . 0.0 109.675 179.752 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.58 ' HA ' ' HG2' ' A' ' 50' ' ' GLN . 47.9 Cg_endo -73.26 -2.26 11.82 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 O-C-N 123.697 1.367 . . . . 0.0 109.998 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 23.9 t -76.59 -36.11 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.585 -0.697 . . . . 0.0 109.612 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.522 ' O ' ' CB ' ' A' ' 87' ' ' ARG . 23.1 m80 -69.39 -40.46 77.35 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.588 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 0.3 OUTLIER -52.1 -52.27 52.48 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.304 -0.873 . . . . 0.0 110.676 179.374 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.674 ' HB1' ' CD1' ' A' ' 94' ' ' LEU . . . -55.46 -64.74 0.75 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.224 -0.922 . . . . 0.0 110.154 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.825 ' HB1' ' HB2' ' A' ' 118' ' ' ALA . . . -58.94 -56.09 26.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.195 -0.941 . . . . 0.0 110.423 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.522 ' CB ' ' O ' ' A' ' 83' ' ' HIS . 0.1 OUTLIER -43.39 -25.85 0.16 Allowed 'General case' 0 N--CA 1.501 2.075 0 O-C-N 121.342 -0.849 . . . . 0.0 111.291 -179.821 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.53 ' CB ' ' HB3' ' A' ' 54' ' ' MET . 0.0 OUTLIER -104.34 -13.56 16.08 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.076 -1.015 . . . . 0.0 110.657 179.446 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.04 25.65 39.96 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.537 ' CD2' ' HA2' ' A' ' 55' ' ' GLY . 0.5 OUTLIER -106.12 93.69 4.76 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.283 -1.128 . . . . 0.0 110.722 -179.693 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.434 HD21 ' CG ' ' A' ' 129' ' ' TYR . 0.2 OUTLIER -66.75 -44.22 82.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.509 -0.745 . . . . 0.0 109.908 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.511 ' O ' HG23 ' A' ' 96' ' ' VAL . 36.2 t0 -40.75 -38.69 0.95 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.576 -0.703 . . . . 0.0 110.121 179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.404 ' CG2' ' HB2' ' A' ' 85' ' ' ALA . 22.4 m -63.04 -58.87 5.83 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.496 -0.753 . . . . 0.0 109.593 179.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.806 ' CD2' HD21 ' A' ' 130' ' ' LEU . 1.2 mp -48.94 -46.29 43.07 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.398 -0.814 . . . . 0.0 110.023 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 71.6 t -49.84 -54.86 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.904 ' CG1' HD22 ' A' ' 64' ' ' LEU . 85.0 t -53.09 -57.15 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 CA-C-O 121.26 0.552 . . . . 0.0 109.716 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.774 ' C ' ' HB2' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -45.62 -56.3 5.34 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.33 0.586 . . . . 0.0 110.034 179.785 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -63.7 -21.0 66.17 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.19 -0.944 . . . . 0.0 109.836 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.36 -15.59 61.37 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.247 -0.908 . . . . 0.0 110.727 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.783 ' HB3' HD11 ' A' ' 64' ' ' LEU . . . -134.47 62.2 1.65 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.237 -0.914 . . . . 0.0 110.249 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 47.54 80.31 0.06 OUTLIER Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.774 ' HB2' ' C ' ' A' ' 97' ' ' LEU . . . -101.51 144.94 29.67 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.378 -1.072 . . . . 0.0 109.991 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -87.04 59.29 5.54 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.19 -0.944 . . . . 0.0 110.317 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.609 ' O ' ' HA ' ' A' ' 134' ' ' ALA . 0.6 OUTLIER -68.95 61.81 0.11 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.542 -0.723 . . . . 0.0 110.592 179.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -167.44 29.15 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.782 -1.199 . . . . 0.0 110.574 179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.781 HG11 ' CD ' ' A' ' 80' ' ' ARG . 1.0 OUTLIER -100.65 -169.86 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 O-C-N 121.27 -0.894 . . . . 0.0 109.283 179.234 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.608 ' H ' HG22 ' A' ' 106' ' ' VAL . 3.7 ptm180 -141.85 131.31 23.78 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 120.118 -0.633 . . . . 0.0 109.877 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 110' ' ' TRP . 0.4 OUTLIER -70.99 57.93 0.21 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.474 -0.766 . . . . 0.0 109.715 179.79 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 52.96 -83.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.556 -0.715 . . . . 0.0 110.542 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.787 ' CH2' HG23 ' A' ' 77' ' ' THR . 0.1 OUTLIER -101.81 -8.05 21.99 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.007 -1.058 . . . . 0.0 109.874 179.556 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.449 ' O ' ' CB ' ' A' ' 112' ' ' ARG . . . -74.19 0.14 54.62 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.586 ' O ' HD12 ' A' ' 113' ' ' LEU . 0.9 OUTLIER 68.41 -68.82 0.16 Allowed 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.325 -1.103 . . . . 0.0 110.258 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.586 HD12 ' O ' ' A' ' 112' ' ' ARG . 0.1 OUTLIER -166.41 163.78 11.23 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.353 -0.842 . . . . 0.0 109.938 -179.739 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.476 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 44.0 Cg_endo -73.65 -32.2 7.87 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 O-C-N 123.686 1.361 . . . . 0.0 109.999 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.577 HG23 ' CB ' ' A' ' 130' ' ' LEU . 6.8 p -65.9 -36.39 77.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.415 -0.803 . . . . 0.0 109.409 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -74.97 -42.69 57.12 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.475 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.405 ' HG ' HD12 ' A' ' 121' ' ' LEU . 6.2 tt -61.56 -31.84 71.89 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.33 -0.856 . . . . 0.0 109.162 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.825 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -68.28 -43.37 77.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.466 -0.772 . . . . 0.0 109.944 179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -68.22 -46.53 70.31 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.456 -0.778 . . . . 0.0 111.16 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -61.06 -54.37 45.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.298 -0.876 . . . . 0.0 110.276 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.405 HD12 ' HG ' ' A' ' 117' ' ' LEU . 0.2 OUTLIER -56.67 -81.03 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.277 -0.889 . . . . 0.0 110.174 -179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 173.89 38.76 0.04 OUTLIER Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.555 ' CG ' ' O ' ' A' ' 86' ' ' ALA . 51.3 m-70 -118.16 47.73 1.54 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.495 -1.003 . . . . 0.0 109.663 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.4 mtt-85 -45.83 -53.46 9.63 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.713 -0.617 . . . . 0.0 110.315 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.424 ' O ' HD11 ' A' ' 91' ' ' LEU . 17.2 m-20 -48.0 -34.2 8.99 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.587 -0.696 . . . . 0.0 109.563 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.746 HG11 ' HA ' ' A' ' 86' ' ' ALA . 2.8 t -88.81 -44.9 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.631 -0.668 . . . . 0.0 109.331 179.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.439 ' O ' HG23 ' A' ' 115' ' ' VAL . . . -52.99 -49.09 66.87 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.397 -0.814 . . . . 0.0 110.176 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.74 -61.58 2.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.134 -0.979 . . . . 0.0 110.105 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.434 ' CG ' HD21 ' A' ' 91' ' ' LEU . 12.2 t80 -53.53 -30.72 43.03 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.421 -0.799 . . . . 0.0 109.379 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.806 HD21 ' CD2' ' A' ' 94' ' ' LEU . 5.9 mt -64.04 -52.16 60.7 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.026 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -54.82 -29.81 55.75 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.303 -0.873 . . . . 0.0 110.272 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -80.94 -33.06 34.31 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.488 -0.758 . . . . 0.0 110.153 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.435 ' HB1' HD13 ' A' ' 104' ' ' LEU . . . -90.12 -21.64 22.16 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.358 -0.839 . . . . 0.0 110.524 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.609 ' HA ' ' O ' ' A' ' 104' ' ' LEU . . . -101.27 -14.12 17.79 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.081 -1.012 . . . . 0.0 110.238 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 56.13 173.22 0.16 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.51 ' C ' HG22 ' A' ' 137' ' ' THR . . . -166.68 -168.72 29.29 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.51 HG22 ' C ' ' A' ' 136' ' ' GLY . 8.9 t 35.56 34.52 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.769 -0.842 . . . . 0.0 111.707 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.407 ' N ' ' O ' ' A' ' 136' ' ' GLY . 0.0 OUTLIER -96.3 122.43 39.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.244 -0.91 . . . . 0.0 110.024 179.776 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 93.18 26.63 15.5 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -164.61 24.33 0.06 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.477 -1.014 . . . . 0.0 110.567 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -70.37 67.6 0.33 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.308 -0.87 . . . . 0.0 110.18 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -123.22 -66.9 0.98 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.129 -0.982 . . . . 0.0 110.44 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -101.08 -36.11 9.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.176 -0.953 . . . . 0.0 110.242 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.44 64.52 1.81 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.195 -0.94 . . . . 0.0 110.098 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.406 ' O ' ' CG1' ' A' ' 145' ' ' ILE . 3.1 tt -176.26 67.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.331 -0.856 . . . . 0.0 109.779 -179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.5 t0 50.39 -175.68 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.321 -0.862 . . . . 0.0 109.956 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.04 97.49 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.253 -0.904 . . . . 0.0 109.551 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -51.3 -179.37 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.331 -0.856 . . . . 0.0 110.681 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.14 125.63 32.96 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.332 -0.855 . . . . 0.0 110.377 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 120.1 148.59 8.17 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -79.1 112.36 3.05 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 123.883 1.465 . . . . 0.0 110.413 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 1.5 m -75.92 149.83 37.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.3 -0.875 . . . . 0.0 110.095 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -89.43 142.69 27.44 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.288 -0.882 . . . . 0.0 110.175 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 1.8 pt -136.51 78.5 43.88 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 121.357 -0.839 . . . . 0.0 110.961 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -78.28 114.21 3.5 Favored 'Trans proline' 0 C--N 1.309 -1.553 0 O-C-N 123.534 1.281 . . . . 0.0 110.811 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.496 1.851 0 CA-C-O 117.955 -1.021 . . . . 0.0 110.011 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 ttt . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 121.225 0.536 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.484 ' N ' ' HD2' ' A' ' 3' ' ' PRO . 0.5 OUTLIER -57.48 -55.54 43.51 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.232 -0.917 . . . . 0.0 110.134 179.82 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 2' ' ' GLU . 47.8 Cg_endo -73.79 107.35 2.39 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 123.548 1.289 . . . . 0.0 110.229 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -81.92 144.14 31.16 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.273 -0.892 . . . . 0.0 109.849 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -103.57 11.9 35.64 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.289 -0.882 . . . . 0.0 110.801 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.1 50.25 0.15 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.5 m 57.16 -170.06 0.1 Allowed 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.377 -1.073 . . . . 0.0 110.749 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.77 41.73 1.07 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.41 -0.807 . . . . 0.0 110.658 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.7 -39.63 23.99 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.3 -0.875 . . . . 0.0 109.735 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.23 63.78 69.57 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.507 -0.746 . . . . 0.0 109.539 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -78.82 175.99 10.36 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 123.851 1.448 . . . . 0.0 110.874 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.535 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 14.5 t -85.56 -76.59 0.32 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.396 -0.815 . . . . 0.0 110.206 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 12' ' ' SER . . . 61.81 91.63 0.06 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.311 -0.868 . . . . 0.0 110.169 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.402 ' O ' ' OG1' ' A' ' 18' ' ' THR . 6.9 m-20 -124.76 18.13 8.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.466 -0.771 . . . . 0.0 110.356 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.552 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 33.6 m0 -80.35 -6.94 58.8 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.345 -0.847 . . . . 0.0 110.721 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.672 HD11 ' HB1' ' A' ' 36' ' ' ALA . 14.6 mt -86.61 -49.29 7.63 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.201 -0.937 . . . . 0.0 109.387 179.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.84 -31.16 71.97 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.562 -0.711 . . . . 0.0 109.37 179.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.552 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.2 OUTLIER -66.01 -61.17 2.19 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.656 -0.653 . . . . 0.0 109.961 179.68 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.742 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -54.26 -34.78 61.55 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.28 -0.887 . . . . 0.0 110.102 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.77 ' HB1' ' CB ' ' A' ' 52' ' ' MET . . . -65.65 -55.89 15.07 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.248 -0.907 . . . . 0.0 109.23 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.42 -29.96 69.32 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.458 -0.776 . . . . 0.0 109.741 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -98.51 17.26 19.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.402 -0.811 . . . . 0.0 110.243 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.408 ' CA ' ' HE2' ' A' ' 53' ' ' MET . . . 50.06 82.13 0.04 OUTLIER Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.13 -1.188 . . . . 0.0 110.13 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.736 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 1.1 ttt180 -143.19 63.91 1.36 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.29 -1.123 . . . . 0.0 109.819 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.529 HG12 ' HD3' ' A' ' 29' ' ' ARG . 94.1 t -48.73 -64.94 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.484 -0.76 . . . . 0.0 111.267 -179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -49.64 -38.32 31.71 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.355 -0.84 . . . . 0.0 110.959 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -62.42 -37.64 86.61 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.393 -0.817 . . . . 0.0 110.263 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.826 HG12 HD12 ' A' ' 32' ' ' LEU . 2.8 t -82.95 -45.11 19.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.4 -0.812 . . . . 0.0 109.924 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.529 ' HD3' HG12 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -42.96 -43.9 4.38 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.518 -0.739 . . . . 0.0 110.335 -179.844 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.94 -41.47 36.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.452 -0.78 . . . . 0.0 109.94 179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.431 ' HB2' ' HA ' ' A' ' 28' ' ' VAL . 27.0 mt -53.8 -65.56 0.55 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.281 -0.887 . . . . 0.0 109.729 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.949 HD22 ' CB ' ' A' ' 66' ' ' HIS . 2.8 mt -48.82 -43.92 38.87 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.648 -0.657 . . . . 0.0 110.637 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -70.84 -21.1 62.47 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.204 -0.935 . . . . 0.0 109.956 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.45 -6.47 59.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.337 -0.852 . . . . 0.0 110.615 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.16 27.28 3.21 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.975 -1.25 . . . . 0.0 109.975 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.891 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -66.77 169.01 8.58 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.157 -1.202 . . . . 0.0 109.894 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.572 HD13 ' HD2' ' A' ' 38' ' ' PRO . 1.9 mm? -87.66 125.99 63.24 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.422 -0.799 . . . . 0.0 110.046 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.572 ' HD2' HD13 ' A' ' 37' ' ' LEU . 42.7 Cg_endo -69.22 -36.96 11.2 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.354 1.186 . . . . 0.0 109.716 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.432 ' ND2' ' O ' ' A' ' 67' ' ' GLY . 14.1 m120 -121.41 70.91 0.94 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.502 -0.749 . . . . 0.0 109.45 179.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.497 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -93.42 104.76 13.31 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.469 -0.769 . . . . 0.0 110.129 -179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' ' 39' ' ' ASN . 48.6 Cg_endo -70.73 106.8 1.91 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 123.672 1.354 . . . . 0.0 110.533 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 51.6 p30 -82.9 178.14 8.31 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.189 -0.945 . . . . 0.0 110.015 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.4 m -90.53 40.24 1.01 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.293 -0.88 . . . . 0.0 109.649 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -119.28 12.58 12.59 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.495 -0.753 . . . . 0.0 110.42 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 52.86 25.12 22.19 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.796 -1.722 . . . . 0.0 108.796 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -143.8 117.72 9.38 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.623 -0.927 . . . . 0.0 110.136 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.499 ' CB ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -60.07 -179.33 0.17 Allowed Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.409 -0.807 . . . . 0.0 109.672 179.578 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.533 ' O ' ' N ' ' A' ' 50' ' ' GLN . 39.2 Cg_endo -65.16 169.55 11.97 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.399 1.21 . . . . 0.0 110.313 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.553 HG13 ' HB1' ' A' ' 68' ' ' ALA . 3.1 mt 63.4 -61.35 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.227 0 O-C-N 121.621 -0.674 . . . . 0.0 109.984 -178.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.533 ' N ' ' O ' ' A' ' 48' ' ' PRO . 1.7 tt0 -50.02 -23.88 2.31 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.033 -1.042 . . . . 0.0 110.011 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.3 p -108.46 8.42 9.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.214 -0.929 . . . . 0.0 110.572 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.77 ' CB ' ' HB1' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -78.29 159.12 28.63 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.959 -1.088 . . . . 0.0 109.534 179.369 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.408 ' HE2' ' CA ' ' A' ' 23' ' ' GLY . 0.0 OUTLIER -48.83 -17.62 0.2 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.389 -0.819 . . . . 0.0 111.989 -178.84 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.728 ' HE2' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 61.52 15.41 6.71 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.837 -1.164 . . . . 0.0 109.715 -178.842 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.413 ' C ' ' CE2' ' A' ' 90' ' ' PHE . . . -112.91 17.97 22.18 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -161.2 102.41 1.25 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.37 -1.077 . . . . 0.0 110.25 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.438 ' CB ' ' HB3' ' A' ' 92' ' ' ASP . . . -63.03 -17.87 62.71 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.283 -0.886 . . . . 0.0 109.216 179.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -55.24 -42.27 73.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.478 -0.764 . . . . 0.0 109.885 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.588 HG12 HD12 ' A' ' 63' ' ' LEU . 7.4 t -61.5 -53.63 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.347 -0.846 . . . . 0.0 109.516 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.421 ' O ' ' CB ' ' A' ' 64' ' ' LEU . . . -53.7 -51.67 62.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.442 -0.786 . . . . 0.0 110.363 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.462 ' O ' ' HB3' ' A' ' 65' ' ' LEU . 5.6 tt0 -50.34 -44.72 54.57 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.129 -0.982 . . . . 0.0 110.539 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.645 ' CD1' HD13 ' A' ' 32' ' ' LEU . 1.4 tp -70.53 -57.28 4.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.571 -0.706 . . . . 0.0 109.68 179.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.635 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 6.1 mt -57.77 -45.02 86.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.255 -0.903 . . . . 0.0 109.225 179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.854 HD22 HG12 ' A' ' 96' ' ' VAL . 1.0 OUTLIER -64.75 -52.9 54.55 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.58 -0.7 . . . . 0.0 110.407 179.595 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.462 ' HB3' ' O ' ' A' ' 61' ' ' GLU . 12.1 tp -50.95 -39.87 56.11 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.421 -0.8 . . . . 0.0 109.285 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.949 ' CB ' HD22 ' A' ' 32' ' ' LEU . 2.1 m-70 -78.45 -37.73 42.92 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 121.147 0.499 . . . . 0.0 110.003 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 38' ' ' PRO . . . 139.78 54.04 0.05 OUTLIER Glycine 0 N--CA 1.481 1.643 0 C-N-CA 120.062 -1.065 . . . . 0.0 110.823 179.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.635 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -68.43 -151.88 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.765 -1.432 . . . . 0.0 109.768 179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.486 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 3.6 mm-40 -131.87 61.06 55.91 Favored Pre-proline 0 C--N 1.303 -1.42 0 O-C-N 121.494 -0.754 . . . . 0.0 109.973 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.558 ' HA ' ' CG ' ' A' ' 81' ' ' PRO . 47.3 Cg_endo -72.14 1.62 5.79 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 123.951 1.5 . . . . 0.0 110.677 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.495 ' N ' ' OD1' ' A' ' 71' ' ' ASN . 1.5 m-20 -115.96 -54.35 2.5 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.048 -1.032 . . . . 0.0 110.018 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -48.41 154.85 0.58 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.521 -0.737 . . . . 0.0 110.691 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.43 ' HB2' ' HE ' ' A' ' 80' ' ' ARG . . . -151.52 -157.52 0.82 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.444 -0.785 . . . . 0.0 109.923 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' A' ' 78' ' ' LEU . 0.5 OUTLIER -105.16 140.23 20.9 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.263 -0.898 . . . . 0.0 109.566 179.507 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.28 -11.01 24.69 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.589 1.31 . . . . 0.0 110.767 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.98 -43.65 24.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.13 -0.981 . . . . 0.0 110.16 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.81 HG23 ' CH2' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -139.6 25.62 2.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.459 -0.776 . . . . 0.0 110.171 -179.521 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.438 HD22 HH11 ' A' ' 80' ' ' ARG . 5.7 mt 40.6 36.57 0.39 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.525 -0.734 . . . . 0.0 110.631 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.82 92.13 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.448 -0.783 . . . . 0.0 110.55 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.896 ' CD ' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -73.92 163.31 69.28 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.274 -0.891 . . . . 0.0 109.241 179.146 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.558 ' CG ' ' HA ' ' A' ' 70' ' ' PRO . 46.3 Cg_endo -73.08 -3.34 13.48 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.699 1.368 . . . . 0.0 110.738 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 40.5 t -74.09 -26.37 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.234 -0.916 . . . . 0.0 109.747 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.495 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 9.2 m80 -74.07 -33.85 63.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.479 -0.763 . . . . 0.0 109.38 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.728 ' HB3' ' HE2' ' A' ' 54' ' ' MET . 0.3 OUTLIER -58.73 -50.74 72.78 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.677 -0.639 . . . . 0.0 110.141 179.583 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.581 ' CB ' HD13 ' A' ' 94' ' ' LEU . . . -53.57 -56.74 14.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.373 -0.83 . . . . 0.0 109.261 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.905 ' HB2' HD11 ' A' ' 130' ' ' LEU . . . -59.99 -52.2 66.4 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.718 -0.614 . . . . 0.0 110.287 179.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 2.3 tpt180 -43.91 -37.8 3.06 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.527 -0.733 . . . . 0.0 111.229 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.9 16.28 26.43 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.22 -0.925 . . . . 0.0 110.373 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' A' ' 123' ' ' HIS . . . 51.58 55.01 22.05 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.413 ' CE2' ' C ' ' A' ' 55' ' ' GLY . 0.4 OUTLIER -123.98 85.33 2.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.387 -1.066 . . . . 0.0 110.623 -179.626 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.25 -34.47 78.19 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.327 -0.858 . . . . 0.0 110.175 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.549 ' O ' HG23 ' A' ' 96' ' ' VAL . 94.7 m-20 -48.53 -38.38 20.22 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.35 -0.844 . . . . 0.0 109.829 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.6 m -68.64 -54.26 17.47 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.816 HD22 HG13 ' A' ' 126' ' ' VAL . 1.1 tp -47.42 -48.74 26.24 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.528 -0.733 . . . . 0.0 109.572 179.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 47.5 t -48.4 -51.61 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 CA-C-O 121.372 0.605 . . . . 0.0 109.737 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.854 HG12 HD22 ' A' ' 64' ' ' LEU . 52.2 t -55.64 -52.88 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-O 121.32 0.581 . . . . 0.0 110.325 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.461 HD12 ' N ' ' A' ' 97' ' ' LEU . 10.9 mp -52.67 -42.61 64.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.489 -0.757 . . . . 0.0 109.756 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -78.66 -24.44 45.18 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.252 -0.905 . . . . 0.0 109.49 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.449 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 5.8 mtt180 -74.4 -10.99 60.12 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.33 -0.856 . . . . 0.0 110.878 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.809 ' CB ' HD21 ' A' ' 64' ' ' LEU . . . -124.2 -106.31 0.35 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.281 -0.887 . . . . 0.0 110.616 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -142.93 50.21 0.71 Allowed Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.692 -1.242 . . . . 0.0 110.143 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.519 ' CB ' ' HB2' ' A' ' 70' ' ' PRO . . . -102.59 114.93 29.57 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.342 -1.093 . . . . 0.0 110.261 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 32.0 ttt180 -58.76 111.28 1.22 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.32 -0.863 . . . . 0.0 109.709 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.45 54.64 0.88 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.41 -0.806 . . . . 0.0 110.545 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -165.38 54.02 0.11 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.018 -1.051 . . . . 0.0 110.827 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.896 HG11 ' CD ' ' A' ' 80' ' ' ARG . 4.1 p -109.61 -173.93 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.2 -0.938 . . . . 0.0 109.977 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.701 ' H ' HG22 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -137.95 137.31 37.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.535 -0.728 . . . . 0.0 109.642 179.575 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.519 ' HA ' ' O ' ' A' ' 77' ' ' THR . 0.3 OUTLIER -73.61 61.55 0.73 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.278 -0.889 . . . . 0.0 109.766 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 55.57 -83.37 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.51 -0.744 . . . . 0.0 110.2 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.81 ' CH2' HG23 ' A' ' 77' ' ' THR . 0.2 OUTLIER -133.59 25.82 4.06 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.065 -1.022 . . . . 0.0 110.187 179.397 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -96.29 -83.8 1.68 Allowed Glycine 0 N--CA 1.479 1.535 0 N-CA-C 110.063 -1.215 . . . . 0.0 110.063 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -178.73 149.84 0.48 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.424 -1.045 . . . . 0.0 110.77 -179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.541 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 89.4 mt -57.61 169.66 0.77 Allowed Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.48 -0.762 . . . . 0.0 109.275 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.66 ' HG2' HD22 ' A' ' 130' ' ' LEU . 42.9 Cg_endo -69.68 -25.25 29.16 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.431 1.227 . . . . 0.0 109.46 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.55 ' HB ' ' HB3' ' A' ' 130' ' ' LEU . 9.9 p -70.69 -36.05 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.419 -0.801 . . . . 0.0 109.804 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.414 ' N ' HG13 ' A' ' 115' ' ' VAL . 1.9 m-20 -54.44 -34.74 62.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.44 -0.788 . . . . 0.0 110.153 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.596 HD12 HD13 ' A' ' 121' ' ' LEU . 0.3 OUTLIER -65.0 -57.94 7.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.51 -0.744 . . . . 0.0 110.408 -179.776 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.649 ' HB1' ' HB2' ' A' ' 127' ' ' ALA . . . -47.53 -31.44 4.34 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.644 -0.66 . . . . 0.0 110.874 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -76.03 -30.96 58.63 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.444 -0.785 . . . . 0.0 109.753 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.6 -53.75 8.77 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.431 -0.793 . . . . 0.0 110.772 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.596 HD13 HD12 ' A' ' 117' ' ' LEU . 3.1 mp -81.27 -94.22 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.31 -0.869 . . . . 0.0 110.662 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -171.66 31.61 0.13 Allowed Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.594 -1.289 . . . . 0.0 110.128 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.555 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 27.1 m-70 -88.08 49.9 1.88 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.057 -1.261 . . . . 0.0 108.837 179.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.4 ttm-85 -45.84 -38.13 6.93 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.673 -0.642 . . . . 0.0 110.554 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -66.07 -42.29 89.6 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.361 -0.837 . . . . 0.0 109.835 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.816 HG13 HD22 ' A' ' 94' ' ' LEU . 8.3 t -77.97 -29.6 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.134 -0.979 . . . . 0.0 110.321 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.649 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . . . -60.15 -41.8 93.53 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.165 -0.96 . . . . 0.0 109.722 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.18 -62.63 1.69 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.519 -0.738 . . . . 0.0 110.549 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.424 ' HB3' HD23 ' A' ' 94' ' ' LEU . 0.6 OUTLIER -54.33 -37.82 65.3 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.282 -0.886 . . . . 0.0 110.096 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.905 HD11 ' HB2' ' A' ' 86' ' ' ALA . 44.3 mt -69.6 -18.45 63.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.541 -0.724 . . . . 0.0 110.417 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.5 tpp180 -89.44 -28.86 19.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.139 -0.975 . . . . 0.0 109.927 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -84.01 -43.48 15.11 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.327 -0.858 . . . . 0.0 110.409 -179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -90.42 -34.52 15.6 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.167 -0.958 . . . . 0.0 110.598 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.874 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . -103.6 45.22 0.97 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.289 -0.882 . . . . 0.0 110.194 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -168.61 -121.11 0.56 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -84.16 83.22 1.63 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.221 -1.552 . . . . 0.0 109.221 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 8.9 t -54.47 161.54 1.39 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.273 -1.133 . . . . 0.0 110.83 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -173.3 -157.95 0.09 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.566 -0.709 . . . . 0.0 109.73 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 89.78 19.58 47.25 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 78.1 p -173.65 -138.69 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.342 -1.093 . . . . 0.0 109.413 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -88.84 -163.79 1.04 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.914 -1.116 . . . . 0.0 109.512 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -111.12 49.69 0.86 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.15 -0.969 . . . . 0.0 109.92 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -128.24 98.71 5.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.59 -0.694 . . . . 0.0 109.824 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.11 136.34 42.95 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.437 -0.789 . . . . 0.0 110.049 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 6.6 tp -71.11 143.54 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.412 -0.805 . . . . 0.0 110.492 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.24 143.2 34.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.35 -0.843 . . . . 0.0 110.413 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.496 ' O ' ' HB3' ' A' ' 148' ' ' ALA . . . -66.48 164.95 15.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.285 -0.884 . . . . 0.0 109.494 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.496 ' HB3' ' O ' ' A' ' 147' ' ' ALA . . . 59.13 168.8 0.06 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.152 -0.967 . . . . 0.0 109.764 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -144.54 63.19 1.32 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.145 -0.972 . . . . 0.0 110.501 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 144.3 176.39 18.28 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.443 ' O ' HD11 ' A' ' 154' ' ' ILE . 45.4 Cg_endo -71.48 161.89 44.03 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.87 1.458 . . . . 0.0 110.418 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 7.6 t -74.18 140.45 45.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.344 -0.848 . . . . 0.0 110.39 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 54.28 106.06 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.484 -0.76 . . . . 0.0 110.847 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.443 HD11 ' O ' ' A' ' 151' ' ' PRO . 4.1 mp -116.03 77.69 7.11 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.179 -0.95 . . . . 0.0 109.608 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -81.46 118.66 3.25 Favored 'Trans proline' 0 C--N 1.313 -1.311 0 O-C-N 123.759 1.399 . . . . 0.0 110.561 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.973 -1.013 . . . . 0.0 110.074 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.8 ttt . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.3 0.572 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -138.23 132.11 16.71 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.291 -0.88 . . . . 0.0 109.992 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -74.22 151.61 43.9 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.626 1.33 . . . . 0.0 110.655 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.405 ' O ' ' HB3' ' A' ' 5' ' ' ALA . . . -98.42 82.65 2.91 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.454 -0.779 . . . . 0.0 110.069 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.405 ' HB3' ' O ' ' A' ' 4' ' ' ALA . . . 55.35 63.01 2.23 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.248 -0.908 . . . . 0.0 110.31 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -110.94 48.54 0.93 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 48.0 t 51.56 -168.23 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.337 -1.096 . . . . 0.0 110.423 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -124.9 76.45 1.52 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.395 -0.816 . . . . 0.0 110.1 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 54.17 96.19 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.345 -0.847 . . . . 0.0 110.325 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -109.14 77.81 0.93 Allowed Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.332 -0.855 . . . . 0.0 110.557 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.57 135.07 25.51 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.653 1.344 . . . . 0.0 110.591 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.7 p -66.42 133.98 51.57 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.427 -0.796 . . . . 0.0 110.027 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.55 ' HB1' HD12 ' A' ' 37' ' ' LEU . . . -127.89 -42.56 1.57 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.319 -0.863 . . . . 0.0 110.306 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -64.69 -9.4 19.62 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.342 -0.848 . . . . 0.0 110.905 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.484 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 7.3 m0 -54.81 -25.88 31.17 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.119 -0.988 . . . . 0.0 111.171 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.904 HD13 HD21 ' A' ' 63' ' ' LEU . 4.0 pp -65.93 -38.84 89.72 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.03 -1.044 . . . . 0.0 110.51 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.663 ' N ' HD12 ' A' ' 16' ' ' LEU . . . -81.46 -42.61 20.06 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.13 -0.981 . . . . 0.0 110.321 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.484 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.0 OUTLIER -58.88 -56.28 24.32 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.357 -0.839 . . . . 0.0 110.286 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.75 -41.73 74.39 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.255 -0.903 . . . . 0.0 109.834 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.543 ' HB1' HG11 ' A' ' 59' ' ' VAL . . . -55.73 -35.31 65.99 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.416 -0.803 . . . . 0.0 110.063 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.97 -23.87 59.54 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.442 -0.786 . . . . 0.0 110.512 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 -93.65 23.58 4.61 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.272 -0.892 . . . . 0.0 110.457 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 55.34 46.71 78.99 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -118.53 90.91 3.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.274 -1.133 . . . . 0.0 109.805 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.683 HG22 HG23 ' A' ' 59' ' ' VAL . 46.0 t -73.73 -38.96 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.357 -0.84 . . . . 0.0 110.307 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -60.88 -44.83 96.54 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.291 -0.881 . . . . 0.0 110.794 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.757 ' O ' HD12 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -68.5 -38.65 81.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.252 -0.905 . . . . 0.0 110.199 -179.696 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 54.5 t -73.89 -45.24 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.375 -0.828 . . . . 0.0 110.401 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.548 ' HA ' ' CD1' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -62.48 -47.89 81.99 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.077 -1.014 . . . . 0.0 109.441 179.81 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.94 -20.99 64.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.277 -0.889 . . . . 0.0 109.922 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.757 HD12 ' O ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -68.5 -58.83 3.72 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.323 -0.861 . . . . 0.0 110.04 179.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.841 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 5.0 mt -51.32 -41.68 60.7 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.351 -0.843 . . . . 0.0 110.192 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -70.5 -18.18 62.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.32 -0.862 . . . . 0.0 109.596 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.47 -8.65 47.09 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.32 -0.862 . . . . 0.0 110.706 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.12 29.05 1.71 Allowed Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.876 -1.154 . . . . 0.0 110.676 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.841 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -71.28 161.13 31.58 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.022 -1.281 . . . . 0.0 110.177 179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.816 ' HB2' ' HB2' ' A' ' 40' ' ' ALA . 75.5 mt -92.01 142.3 26.23 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.346 -0.846 . . . . 0.0 110.236 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.17 -42.99 1.24 Allowed 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.497 1.262 . . . . 0.0 110.121 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -121.03 58.7 0.95 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.462 -0.774 . . . . 0.0 110.092 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.816 ' HB2' ' HB2' ' A' ' 37' ' ' LEU . . . -79.7 116.39 60.59 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.311 -0.868 . . . . 0.0 109.776 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.52 120.53 7.0 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.68 1.358 . . . . 0.0 110.596 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.425 HD22 ' HB3' ' A' ' 17' ' ' ALA . 1.6 t-20 -99.66 -150.07 0.37 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.447 -0.783 . . . . 0.0 109.996 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.424 ' O ' ' OG ' ' A' ' 43' ' ' SER . 0.1 OUTLIER -109.1 20.82 17.94 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.172 -0.955 . . . . 0.0 110.246 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -118.31 -1.8 11.24 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.053 -1.029 . . . . 0.0 110.849 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.54 25.77 50.85 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.929 -1.269 . . . . 0.0 109.929 179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.429 ' HB3' ' HB3' ' A' ' 50' ' ' GLN . 36.5 mtt180 -123.42 16.23 9.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -1.123 . . . . 0.0 110.92 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.637 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER 45.98 -166.68 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.083 0 O-C-N 121.706 -0.621 . . . . 0.0 109.744 179.314 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.637 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 46.8 Cg_endo -78.87 172.77 14.5 Favored 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 122.758 0.873 . . . . 0.0 110.939 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.542 ' O ' ' HG2' ' A' ' 52' ' ' MET . 9.0 mt 61.74 -63.89 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 O-C-N 121.771 -0.58 . . . . 0.0 110.69 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.515 ' N ' ' O ' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -49.87 -20.26 0.85 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.824 -1.172 . . . . 0.0 110.401 179.707 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 51' ' ' VAL . 12.8 p -107.82 -5.38 10.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.192 -0.942 . . . . 0.0 110.76 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.542 ' HG2' ' O ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -63.06 165.65 6.79 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.893 -1.129 . . . . 0.0 109.955 -179.777 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 33.8 ttp -61.23 -8.43 3.67 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.341 -0.849 . . . . 0.0 111.079 -179.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.623 ' HE1' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 57.09 18.2 3.93 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.133 -0.979 . . . . 0.0 110.016 -179.398 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.432 ' C ' ' CE2' ' A' ' 90' ' ' PHE . . . -112.43 3.12 26.47 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -145.41 95.71 2.71 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.433 -1.039 . . . . 0.0 109.727 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.77 -23.11 16.47 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.279 -0.888 . . . . 0.0 109.663 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.442 ' HA ' ' HB2' ' A' ' 61' ' ' GLU . 13.1 mtt180 -55.5 -40.24 71.48 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.338 -0.851 . . . . 0.0 109.572 179.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.683 HG23 HG22 ' A' ' 25' ' ' VAL . 95.5 t -53.6 -59.07 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.544 -0.722 . . . . 0.0 109.225 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -61.63 -26.97 68.33 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.518 -0.739 . . . . 0.0 109.882 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.442 ' HB2' ' HA ' ' A' ' 58' ' ' ARG . 3.6 tp10 -50.71 -71.56 0.06 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.194 -0.941 . . . . 0.0 110.579 -179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.548 ' CD1' ' HA ' ' A' ' 29' ' ' ARG . 0.4 OUTLIER -65.55 -50.05 66.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.041 -1.037 . . . . 0.0 110.448 179.956 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.904 HD21 HD13 ' A' ' 16' ' ' LEU . 0.9 OUTLIER -49.09 -57.63 6.29 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.252 -0.905 . . . . 0.0 109.933 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.655 HD13 HG12 ' A' ' 96' ' ' VAL . 1.2 tt -63.33 -43.8 96.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.304 -0.872 . . . . 0.0 109.233 179.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.448 ' HB3' ' HA ' ' A' ' 62' ' ' LEU . 12.8 tp -56.09 -31.12 62.96 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.539 -0.726 . . . . 0.0 109.585 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.718 ' CB ' HD22 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -87.21 -45.61 10.48 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.548 -0.72 . . . . 0.0 109.981 -179.569 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 156.18 44.94 0.02 OUTLIER Glycine 0 N--CA 1.483 1.771 0 C-N-CA 119.811 -1.185 . . . . 0.0 110.754 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.465 ' HA ' ' HG2' ' A' ' 48' ' ' PRO . . . -70.66 -152.64 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.889 -1.36 . . . . 0.0 109.882 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -114.75 66.94 1.85 Allowed Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.336 -0.852 . . . . 0.0 110.211 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.502 ' HG3' HD21 ' A' ' 64' ' ' LEU . 50.9 Cg_endo -73.42 -32.55 7.9 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.757 1.398 . . . . 0.0 110.359 179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.421 ' O ' ' NE ' ' A' ' 80' ' ' ARG . 6.8 t30 -100.75 -54.74 2.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.509 -0.744 . . . . 0.0 110.891 -179.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.1 m -48.02 151.48 0.95 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.253 -0.904 . . . . 0.0 111.147 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.602 ' HB2' ' HG2' ' A' ' 80' ' ' ARG . . . -135.5 -159.73 0.99 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.411 -0.806 . . . . 0.0 109.958 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.44 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.7 OUTLIER -105.77 136.54 19.26 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.292 -0.88 . . . . 0.0 109.873 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.38 -23.54 20.4 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 O-C-N 123.41 1.216 . . . . 0.0 110.595 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.38 -60.81 2.85 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.117 -0.99 . . . . 0.0 109.745 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.668 HG22 ' CZ2' ' A' ' 110' ' ' TRP . 62.9 p -136.76 34.14 2.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.43 -0.794 . . . . 0.0 109.801 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.505 ' HA ' HD23 ' A' ' 78' ' ' LEU . 8.0 mt 49.1 33.92 5.31 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.547 -0.721 . . . . 0.0 111.331 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 94.1 m -65.88 102.85 0.82 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.142 -0.974 . . . . 0.0 109.649 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.602 ' HG2' ' HB2' ' A' ' 73' ' ' ALA . 0.1 OUTLIER -82.31 167.37 30.87 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.271 -0.893 . . . . 0.0 110.193 -179.751 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -70.37 -14.76 34.48 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.771 1.406 . . . . 0.0 109.932 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 65.1 t -67.81 -29.26 44.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.598 -0.689 . . . . 0.0 109.94 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.436 ' CE1' ' HB3' ' A' ' 114' ' ' PRO . 23.4 m80 -75.59 -35.55 60.54 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.29 -0.881 . . . . 0.0 109.497 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.623 ' HB3' ' HE1' ' A' ' 54' ' ' MET . 0.3 OUTLIER -58.21 -50.31 73.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.658 -0.651 . . . . 0.0 109.736 179.444 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.409 ' HB3' ' CD1' ' A' ' 94' ' ' LEU . . . -56.96 -64.63 0.81 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.265 -0.897 . . . . 0.0 110.066 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.778 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -58.84 -30.08 67.42 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.317 -0.864 . . . . 0.0 111.271 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.4 ' HB3' ' O ' ' A' ' 84' ' ' ASP . 6.2 tpt180 -52.5 -54.43 32.59 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.048 -1.032 . . . . 0.0 110.237 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -85.26 -2.99 58.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.191 -0.943 . . . . 0.0 110.047 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.473 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 81.26 44.88 7.78 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.432 ' CE2' ' C ' ' A' ' 55' ' ' GLY . 0.5 OUTLIER -110.59 104.68 13.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.2 -1.176 . . . . 0.0 110.328 179.636 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.536 HD11 ' O ' ' A' ' 125' ' ' ASP . 0.3 OUTLIER -80.38 -38.42 30.38 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.456 -0.778 . . . . 0.0 110.109 179.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.648 ' O ' HG23 ' A' ' 96' ' ' VAL . 0.8 OUTLIER -47.36 -37.26 10.8 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.511 -0.743 . . . . 0.0 110.312 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 23.8 m -70.99 -45.71 63.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.47 -0.769 . . . . 0.0 109.273 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.602 HD21 ' HG ' ' A' ' 130' ' ' LEU . 1.2 tp -49.67 -49.73 46.29 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.461 -0.774 . . . . 0.0 110.204 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.413 ' O ' ' CB ' ' A' ' 99' ' ' ARG . 58.0 t -55.08 -47.0 77.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.403 -0.81 . . . . 0.0 109.644 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.655 HG12 HD13 ' A' ' 64' ' ' LEU . 36.6 t -54.45 -51.21 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.526 -0.734 . . . . 0.0 109.834 179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.536 ' HA ' HD11 ' A' ' 64' ' ' LEU . 9.1 mp -52.11 -67.02 0.29 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.51 -0.744 . . . . 0.0 110.805 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -57.24 -38.76 74.3 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.172 -0.955 . . . . 0.0 110.15 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.42 ' O ' ' HG2' ' A' ' 99' ' ' ARG . 0.1 OUTLIER -66.3 -14.66 62.36 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.392 -0.817 . . . . 0.0 110.474 179.754 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -132.96 54.03 1.98 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.135 -0.978 . . . . 0.0 110.494 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 58.19 105.15 0.01 OUTLIER Glycine 0 N--CA 1.488 2.126 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -164.9 94.69 0.68 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.322 -1.105 . . . . 0.0 110.231 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.423 ' HB3' ' NH2' ' A' ' 80' ' ' ARG . 20.3 ttt180 -52.69 104.96 0.1 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.314 -0.866 . . . . 0.0 109.717 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.505 ' CD2' HD23 ' A' ' 130' ' ' LEU . 0.0 OUTLIER -98.58 67.18 1.74 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.424 -0.798 . . . . 0.0 110.484 -179.515 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -168.46 42.87 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.2 -0.937 . . . . 0.0 110.378 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.66 HG22 ' H ' ' A' ' 107' ' ' ARG . 4.3 p -101.32 -178.0 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.271 -0.893 . . . . 0.0 110.021 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.66 ' H ' HG22 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -128.57 142.01 51.19 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.521 -0.737 . . . . 0.0 109.291 179.157 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.608 ' O ' ' N ' ' A' ' 110' ' ' TRP . 17.3 p-10 -73.36 54.55 0.43 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.216 -0.928 . . . . 0.0 110.438 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.532 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 59.0 -63.53 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.58 -0.7 . . . . 0.0 110.89 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.668 ' CZ2' HG22 ' A' ' 77' ' ' THR . 0.1 OUTLIER -50.87 -54.59 22.62 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.256 -0.903 . . . . 0.0 109.993 -179.691 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 155.65 -32.86 0.63 Allowed Glycine 0 N--CA 1.484 1.885 0 N-CA-C 110.151 -1.179 . . . . 0.0 110.151 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -53.27 168.24 0.16 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.39 -1.065 . . . . 0.0 110.927 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.489 HD23 ' O ' ' A' ' 106' ' ' VAL . 50.1 mt -124.34 167.9 14.4 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.485 -0.759 . . . . 0.0 110.235 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.441 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 41.3 Cg_endo -67.47 -27.53 39.59 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 O-C-N 123.676 1.356 . . . . 0.0 110.044 178.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 127' ' ' ALA . 7.8 p -80.74 -35.55 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.412 -0.805 . . . . 0.0 109.761 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.403 ' N ' HG13 ' A' ' 115' ' ' VAL . 37.7 t70 -70.4 -29.85 66.58 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.467 -0.77 . . . . 0.0 110.009 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.3 tt -70.4 -44.48 67.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.422 -0.799 . . . . 0.0 110.303 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.654 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -68.27 -48.61 64.58 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.29 -0.881 . . . . 0.0 110.413 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.54 ' HG2' ' HB1' ' A' ' 127' ' ' ALA . 2.4 mm-40 -55.67 -29.47 59.39 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.293 -0.879 . . . . 0.0 110.068 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -78.31 -39.72 38.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.464 -0.773 . . . . 0.0 110.235 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.33 -88.03 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.346 -0.846 . . . . 0.0 110.281 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -177.86 25.99 0.06 OUTLIER Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.209 -1.156 . . . . 0.0 110.209 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.451 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 36.0 m-70 -108.11 50.59 0.77 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.024 -1.28 . . . . 0.0 108.994 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.481 ' HA ' ' HB3' ' A' ' 127' ' ' ALA . 5.4 ttt180 -46.09 -37.37 6.73 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.71 -0.619 . . . . 0.0 110.124 -179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.536 ' O ' HD11 ' A' ' 91' ' ' LEU . 7.2 p-10 -59.92 -42.25 93.53 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.406 -0.809 . . . . 0.0 109.201 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.778 HG11 ' HA ' ' A' ' 86' ' ' ALA . 2.6 t -81.35 -32.56 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.437 -0.789 . . . . 0.0 109.037 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.54 ' HB1' ' HG2' ' A' ' 119' ' ' GLU . . . -69.2 -39.05 78.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.512 -0.743 . . . . 0.0 109.45 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.51 -61.21 2.79 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.277 -0.889 . . . . 0.0 109.676 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.432 ' HD2' HD23 ' A' ' 94' ' ' LEU . 71.0 t80 -54.48 -37.18 64.97 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.348 -0.845 . . . . 0.0 109.467 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.776 HD11 ' HB2' ' A' ' 86' ' ' ALA . 14.8 mt -63.77 -30.08 71.22 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.519 -0.738 . . . . 0.0 109.525 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.412 ' O ' ' HA2' ' A' ' 135' ' ' GLY . 1.3 tmm_? -68.79 -30.62 69.24 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.536 -0.728 . . . . 0.0 110.121 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -87.01 -36.59 18.14 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.286 -0.884 . . . . 0.0 110.408 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -89.22 -15.85 32.67 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.291 -0.88 . . . . 0.0 110.678 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.691 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . -125.19 -39.24 2.23 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.23 -0.919 . . . . 0.0 110.432 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 131' ' ' ARG . . . 84.28 140.52 4.65 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -124.41 62.96 0.57 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 2.6 p -53.47 137.63 35.59 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.36 -1.082 . . . . 0.0 110.344 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 5.1 ttt85 -113.33 92.16 3.9 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.414 -0.804 . . . . 0.0 110.342 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -130.31 117.24 2.23 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 70.1 m -54.47 -34.74 62.09 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.384 -1.068 . . . . 0.0 110.444 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -137.87 -61.01 0.63 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.379 -0.825 . . . . 0.0 109.862 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -108.83 99.95 9.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.439 -0.788 . . . . 0.0 110.079 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -56.82 -179.37 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.444 -0.785 . . . . 0.0 110.327 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 9.0 ptp180 -53.98 175.52 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.289 -0.882 . . . . 0.0 110.365 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 43.5 mm 51.81 81.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.314 -0.866 . . . . 0.0 110.097 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -49.83 110.63 0.41 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.402 -0.811 . . . . 0.0 110.253 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.522 ' O ' ' HB3' ' A' ' 148' ' ' ALA . . . -49.94 126.11 13.49 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.414 -0.804 . . . . 0.0 110.362 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.522 ' HB3' ' O ' ' A' ' 147' ' ' ALA . . . 61.04 114.39 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.42 -0.8 . . . . 0.0 109.879 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.89 111.89 3.51 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.315 -0.866 . . . . 0.0 110.169 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 79.28 152.86 7.19 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -74.27 135.91 21.25 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 O-C-N 123.855 1.45 . . . . 0.0 110.273 179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.35 126.83 32.07 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.363 -0.836 . . . . 0.0 110.336 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -79.32 133.51 36.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.417 -0.802 . . . . 0.0 110.36 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.444 ' O ' HG23 ' A' ' 154' ' ' ILE . 5.4 tt -166.94 97.78 0.67 Allowed Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.397 -0.814 . . . . 0.0 109.764 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -73.16 90.69 0.86 Allowed 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 123.581 1.306 . . . . 0.0 110.767 -179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.2 t0 . . . . . 0 N--CA 1.498 1.932 0 CA-C-O 118.07 -0.967 . . . . 0.0 111.066 179.687 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mtt . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.308 0.575 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 50.75 75.0 0.71 Allowed Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.437 -0.79 . . . . 0.0 110.484 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -77.92 77.01 4.08 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.69 1.363 . . . . 0.0 110.022 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -50.65 121.75 6.27 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.548 -0.72 . . . . 0.0 110.412 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -100.71 8.12 43.49 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.492 -0.755 . . . . 0.0 110.872 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 65.14 100.39 0.01 OUTLIER Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 54.46 175.58 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.256 -1.143 . . . . 0.0 110.52 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.8 p -114.28 167.4 10.73 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.383 -0.823 . . . . 0.0 110.094 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.5 mmt -68.84 -80.11 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.354 -0.841 . . . . 0.0 110.156 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -169.37 148.53 3.51 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.212 -0.93 . . . . 0.0 110.166 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.09 90.65 0.85 Allowed 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.776 1.408 . . . . 0.0 110.744 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.1 p 178.83 -47.14 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.439 -0.788 . . . . 0.0 110.149 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 51.57 25.17 2.62 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.343 -0.848 . . . . 0.0 110.226 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.441 ' OD1' HG23 ' A' ' 18' ' ' THR . 10.7 t0 -82.4 -10.31 59.1 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.469 -0.769 . . . . 0.0 110.404 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.666 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 1.3 t90 -65.66 -10.25 34.54 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.139 -0.976 . . . . 0.0 110.442 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.693 HD23 ' HB3' ' A' ' 40' ' ' ALA . 1.8 tp -73.0 -54.37 8.76 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.245 -0.91 . . . . 0.0 109.72 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.649 ' HB2' ' HA ' ' A' ' 48' ' ' PRO . . . -75.77 -42.82 49.25 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.368 -0.833 . . . . 0.0 110.488 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.666 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 3.1 p -49.37 -46.29 47.0 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.468 -0.77 . . . . 0.0 110.76 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.62 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -66.3 -47.18 74.42 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.283 -0.886 . . . . 0.0 110.299 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.48 ' HB1' HG11 ' A' ' 59' ' ' VAL . . . -52.54 -36.11 54.89 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.409 -0.807 . . . . 0.0 110.475 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.402 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -78.92 -26.01 43.68 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.343 -0.848 . . . . 0.0 110.323 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.7 mmt180 -93.25 19.22 8.38 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.203 -0.936 . . . . 0.0 110.735 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 52.98 53.0 35.95 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.86 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -122.06 61.4 0.96 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.405 -1.056 . . . . 0.0 109.93 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.991 HG22 HG23 ' A' ' 59' ' ' VAL . 37.5 t -50.22 -46.31 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 121.475 -0.766 . . . . 0.0 110.672 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -59.1 -36.43 75.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.316 -0.865 . . . . 0.0 110.349 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -73.73 -31.43 63.36 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.234 -0.916 . . . . 0.0 109.616 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.86 HG23 ' O ' ' A' ' 24' ' ' ARG . 3.4 t -76.48 -50.19 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.554 -0.716 . . . . 0.0 109.57 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.936 ' HA ' HD22 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -49.09 -45.26 43.02 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.481 -0.762 . . . . 0.0 110.132 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -77.36 -41.83 38.86 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.454 -0.779 . . . . 0.0 109.877 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.459 HD11 ' CD1' ' A' ' 15' ' ' TRP . 12.6 mt -57.14 -67.8 0.29 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.361 -0.837 . . . . 0.0 110.439 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.905 ' HB3' HD11 ' A' ' 62' ' ' LEU . 0.3 OUTLIER -48.54 -46.0 38.18 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.585 -0.697 . . . . 0.0 111.016 -179.382 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.13 -14.08 61.31 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.26 -0.9 . . . . 0.0 110.324 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 30' ' ' ALA . . . -92.07 -8.52 45.64 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.223 -0.923 . . . . 0.0 111.024 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 146.72 -28.98 1.59 Allowed Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.741 -1.219 . . . . 0.0 110.265 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.745 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -53.76 106.33 0.18 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.107 -1.231 . . . . 0.0 110.579 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.69 ' HG ' ' HB2' ' A' ' 40' ' ' ALA . 0.6 OUTLIER -66.96 152.22 96.17 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.361 -0.837 . . . . 0.0 109.734 179.701 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -74.57 -28.49 9.94 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 O-C-N 123.715 1.376 . . . . 0.0 111.083 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -90.26 32.62 0.92 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.209 -0.932 . . . . 0.0 110.246 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.693 ' HB3' HD23 ' A' ' 16' ' ' LEU . . . -84.73 112.65 44.17 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.385 -0.822 . . . . 0.0 110.097 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.45 123.11 8.86 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.652 1.343 . . . . 0.0 110.148 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.546 HD22 HG11 ' A' ' 51' ' ' VAL . 48.4 p-10 -80.6 5.93 14.06 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.381 -0.824 . . . . 0.0 110.702 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 58.54 17.53 5.02 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.092 -1.005 . . . . 0.0 110.024 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -107.3 15.19 25.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.422 -0.799 . . . . 0.0 109.412 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 56.0 24.64 43.47 Favored Glycine 0 N--CA 1.486 2.005 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.5 ' O ' ' CB ' ' A' ' 50' ' ' GLN . 35.3 mtt180 -135.79 32.0 3.01 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.308 -1.113 . . . . 0.0 111.1 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.583 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 0.6 OUTLIER 42.56 -166.72 0.0 OUTLIER Pre-proline 0 N--CA 1.501 2.119 0 O-C-N 121.501 -0.749 . . . . 0.0 110.937 178.589 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.649 ' HA ' ' HB2' ' A' ' 17' ' ' ALA . 48.9 Cg_endo -85.6 -24.57 1.85 Allowed 'Trans proline' 0 C--N 1.318 -1.036 0 O-C-N 122.998 0.999 . . . . 0.0 110.81 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.65 HG12 HD22 ' A' ' 63' ' ' LEU . 5.8 mt -107.04 -40.16 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.129 -0.982 . . . . 0.0 110.047 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.5 ' CB ' ' O ' ' A' ' 46' ' ' ARG . 0.9 OUTLIER -47.1 -27.11 1.27 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.488 -0.757 . . . . 0.0 110.555 -179.907 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.546 HG11 HD22 ' A' ' 42' ' ' ASN . 9.0 p -97.06 -2.47 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.218 -0.926 . . . . 0.0 110.19 179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.466 ' CE ' ' CE ' ' A' ' 54' ' ' MET . 56.8 ttp -52.15 154.33 2.36 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.515 -0.741 . . . . 0.0 109.789 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 1.4 tmm? -69.77 -2.91 13.31 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.377 -0.827 . . . . 0.0 111.07 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.468 ' SD ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 52.62 22.77 2.33 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.989 -1.07 . . . . 0.0 110.115 -179.687 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.416 ' C ' ' CZ ' ' A' ' 90' ' ' PHE . . . -123.95 9.25 8.53 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 178.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.522 ' HB3' HG23 ' A' ' 59' ' ' VAL . 0.6 OUTLIER -144.82 80.73 1.63 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.436 -1.038 . . . . 0.0 109.931 179.887 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -52.23 -25.08 8.39 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.215 -0.928 . . . . 0.0 109.757 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.6 mtt180 -61.21 -36.73 80.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.472 -0.768 . . . . 0.0 109.503 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.991 HG23 HG22 ' A' ' 25' ' ' VAL . 37.3 t -55.4 -69.95 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.263 -0.898 . . . . 0.0 109.256 179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -47.44 -34.42 7.22 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.296 -0.878 . . . . 0.0 109.498 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.436 ' O ' ' CB ' ' A' ' 65' ' ' LEU . 11.1 tt0 -54.27 -32.17 55.53 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.269 -0.894 . . . . 0.0 109.845 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.936 HD22 ' HA ' ' A' ' 29' ' ' ARG . 1.0 OUTLIER -87.06 -45.66 10.52 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.607 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.699 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 4.5 mp -62.65 -53.46 54.15 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.718 -0.614 . . . . 0.0 109.98 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.602 ' CD2' ' HB3' ' A' ' 100' ' ' ALA . 0.2 OUTLIER -63.42 -42.9 98.75 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.226 -0.921 . . . . 0.0 109.565 179.553 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.436 ' CB ' ' O ' ' A' ' 61' ' ' GLU . 10.0 tp -54.06 -37.49 64.23 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.363 -0.836 . . . . 0.0 108.804 178.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.737 ' CG ' HD22 ' A' ' 32' ' ' LEU . 7.8 m80 -85.76 -21.54 28.17 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.357 0.598 . . . . 0.0 109.69 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 104.24 56.83 0.73 Allowed Glycine 0 N--CA 1.479 1.533 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 179.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.699 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -64.82 -148.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.033 -1.275 . . . . 0.0 109.089 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.576 ' HB2' ' HB3' ' A' ' 47' ' ' ARG . 53.9 mt-10 -117.27 55.98 1.76 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.189 -0.944 . . . . 0.0 110.079 179.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.566 ' HB2' ' HB2' ' A' ' 102' ' ' ALA . 44.3 Cg_endo -69.4 -11.19 30.74 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 O-C-N 123.631 1.332 . . . . 0.0 110.392 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.433 ' HA ' ' CZ ' ' A' ' 80' ' ' ARG . 2.8 m120 -95.91 -56.48 2.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.257 -0.902 . . . . 0.0 110.415 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -50.12 148.62 3.29 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.315 -0.865 . . . . 0.0 110.919 -179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.69 -158.2 0.84 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.478 -0.764 . . . . 0.0 109.721 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.496 ' O ' ' N ' ' A' ' 78' ' ' LEU . 19.1 m-20 -106.43 126.21 30.99 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.321 -0.862 . . . . 0.0 109.53 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.12 -20.58 28.4 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.389 1.205 . . . . 0.0 110.434 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.79 -42.05 88.14 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.236 -0.915 . . . . 0.0 110.141 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.959 HG23 ' CH2' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -148.26 21.83 1.07 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.478 -0.764 . . . . 0.0 109.842 -179.832 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 74' ' ' ASP . 1.4 mt 50.72 41.39 26.08 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.561 -0.712 . . . . 0.0 111.164 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 18.4 m -73.95 100.62 3.59 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.105 -0.997 . . . . 0.0 109.618 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.9 ' HG3' HG11 ' A' ' 106' ' ' VAL . 0.3 OUTLIER -76.84 164.02 61.93 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.381 -0.825 . . . . 0.0 109.98 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.55 -14.17 27.55 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.68 1.358 . . . . 0.0 110.649 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 42.0 t -63.63 -28.2 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.233 -0.917 . . . . 0.0 109.927 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.431 ' O ' ' CB ' ' A' ' 87' ' ' ARG . 29.1 m80 -65.52 -44.39 87.07 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.441 -0.787 . . . . 0.0 109.351 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.497 ' OD2' ' HG2' ' A' ' 50' ' ' GLN . 67.8 m-20 -49.95 -55.86 12.86 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.664 -0.647 . . . . 0.0 111.244 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.599 ' CB ' HD13 ' A' ' 94' ' ' LEU . . . -54.22 -68.0 0.22 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.173 -0.954 . . . . 0.0 109.971 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.846 ' HB1' ' HB2' ' A' ' 118' ' ' ALA . . . -54.92 -40.86 70.32 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.318 -0.864 . . . . 0.0 111.098 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.431 ' CB ' ' O ' ' A' ' 83' ' ' HIS . 6.2 tmm_? -51.47 -31.67 24.25 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 120.91 -1.119 . . . . 0.0 110.228 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -107.87 16.62 23.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.519 -0.738 . . . . 0.0 110.308 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.502 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 55.43 48.52 69.42 Favored Glycine 0 N--CA 1.495 2.579 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.417 ' CE2' ' N ' ' A' ' 56' ' ' SER . 0.1 OUTLIER -116.57 91.31 3.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.455 -1.026 . . . . 0.0 110.694 -179.1 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.563 HD23 ' HB3' ' A' ' 94' ' ' LEU . 0.4 OUTLIER -75.58 -39.01 58.71 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.313 -0.867 . . . . 0.0 110.679 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.598 ' O ' HG23 ' A' ' 96' ' ' VAL . 27.3 m-20 -47.32 -44.95 24.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.429 -0.795 . . . . 0.0 109.902 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.455 HG21 ' HE3' ' A' ' 54' ' ' MET . 23.1 m -68.86 -40.0 79.54 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 178.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.615 HD21 HD21 ' A' ' 130' ' ' LEU . 5.0 tp -59.36 -47.49 85.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.638 -0.664 . . . . 0.0 109.924 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 53.2 t -53.84 -45.92 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.411 -0.806 . . . . 0.0 109.496 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 92' ' ' ASP . 24.8 t -62.47 -43.15 98.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.555 -0.715 . . . . 0.0 109.545 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.739 HD23 ' CB ' ' A' ' 102' ' ' ALA . 0.2 OUTLIER -53.59 -46.14 70.25 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.629 -0.669 . . . . 0.0 110.443 179.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -83.86 -28.28 28.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.354 -0.841 . . . . 0.0 110.426 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.7 mtp85 -66.25 -11.72 51.94 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.378 -0.826 . . . . 0.0 111.044 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.602 ' HB3' ' CD2' ' A' ' 64' ' ' LEU . . . -124.42 -79.48 0.61 Allowed 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.157 -0.964 . . . . 0.0 110.891 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -159.26 88.07 0.11 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.016 -1.233 . . . . 0.0 110.016 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.739 ' CB ' HD23 ' A' ' 97' ' ' LEU . . . -160.78 110.73 1.73 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.286 -1.126 . . . . 0.0 110.314 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 8.1 ttt180 -50.58 167.16 0.07 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.373 -0.83 . . . . 0.0 110.662 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.568 ' CD2' HD23 ' A' ' 130' ' ' LEU . 0.1 OUTLIER -149.14 43.47 0.96 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.417 -0.802 . . . . 0.0 110.067 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -161.01 48.47 0.22 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.195 -0.941 . . . . 0.0 110.778 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.9 HG11 ' HG3' ' A' ' 80' ' ' ARG . 4.2 p -109.21 -174.47 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.188 -0.945 . . . . 0.0 109.563 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.67 ' H ' HG22 ' A' ' 106' ' ' VAL . 7.7 ptt180 -141.67 147.85 38.18 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.428 -0.795 . . . . 0.0 109.521 178.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.475 ' O ' ' N ' ' A' ' 110' ' ' TRP . 3.4 t0 -69.88 63.2 0.2 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.336 -0.852 . . . . 0.0 110.058 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . 52.38 -86.66 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.383 -0.823 . . . . 0.0 110.667 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.959 ' CH2' HG23 ' A' ' 77' ' ' THR . 38.3 p90 -121.59 6.02 10.05 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.189 -0.945 . . . . 0.0 110.467 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -82.12 -77.91 1.03 Allowed Glycine 0 N--CA 1.481 1.671 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -175.76 -158.91 0.07 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.421 -1.047 . . . . 0.0 110.47 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.494 ' HG ' ' HD2' ' A' ' 114' ' ' PRO . 0.6 OUTLIER -106.41 167.19 9.92 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 121.404 -0.81 . . . . 0.0 110.669 -179.446 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.494 ' HD2' ' HG ' ' A' ' 113' ' ' LEU . 44.7 Cg_endo -72.35 -35.96 5.93 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 O-C-N 123.868 1.457 . . . . 0.0 110.053 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.494 HG12 ' HB3' ' A' ' 113' ' ' LEU . 12.0 p -67.75 -26.79 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.273 -0.892 . . . . 0.0 109.831 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -65.28 -42.45 93.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.472 -0.767 . . . . 0.0 109.775 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.564 ' O ' HD12 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -63.47 -49.64 72.82 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.529 -0.732 . . . . 0.0 110.267 179.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.846 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -48.68 -64.8 0.7 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.346 -0.846 . . . . 0.0 110.804 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -55.1 -23.7 22.0 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.278 -0.889 . . . . 0.0 110.151 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.82 -33.8 72.82 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.412 -0.805 . . . . 0.0 110.027 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.564 HD12 ' O ' ' A' ' 117' ' ' LEU . 0.7 OUTLIER -96.25 -8.56 32.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.326 -0.858 . . . . 0.0 110.384 179.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 97.33 32.71 6.24 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 110.375 -1.09 . . . . 0.0 110.375 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.497 ' ND1' ' O ' ' A' ' 86' ' ' ALA . 36.0 m170 -95.11 55.33 1.78 Allowed 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.072 -1.252 . . . . 0.0 109.478 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.407 ' O ' ' CB ' ' A' ' 128' ' ' ARG . 12.2 ttm180 -45.9 -30.13 1.63 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.594 -0.691 . . . . 0.0 110.286 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.434 ' HB3' HD12 ' A' ' 91' ' ' LEU . 0.6 OUTLIER -69.96 -41.1 74.94 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.571 -0.706 . . . . 0.0 109.488 179.32 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.783 HG11 ' HA ' ' A' ' 86' ' ' ALA . 2.1 t -89.5 -39.64 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.427 -0.795 . . . . 0.0 110.343 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -64.59 -34.29 77.92 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.296 -0.877 . . . . 0.0 109.957 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.407 ' CB ' ' O ' ' A' ' 124' ' ' ARG . 34.5 ttt85 -74.01 -56.83 4.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.354 -0.841 . . . . 0.0 109.742 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -56.02 -26.36 48.49 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.302 -0.874 . . . . 0.0 109.605 179.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.777 HD11 ' HB2' ' A' ' 86' ' ' ALA . 14.2 mt -78.5 -50.76 11.04 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.454 -0.779 . . . . 0.0 109.994 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.6 tpt85 -52.56 -25.97 11.96 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.436 -0.79 . . . . 0.0 110.597 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -79.46 -53.12 7.2 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.204 -0.935 . . . . 0.0 109.957 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -81.35 -7.15 59.53 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.435 -0.791 . . . . 0.0 110.511 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . -116.0 -31.59 5.68 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.18 -0.95 . . . . 0.0 110.279 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -111.56 -13.15 13.35 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -45.89 122.11 5.65 Favored Glycine 0 N--CA 1.498 2.769 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.482 ' O ' ' N ' ' A' ' 139' ' ' GLY . 2.1 t -135.63 49.49 2.16 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.399 -1.059 . . . . 0.0 110.726 -179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.71 -71.79 0.05 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.418 -0.801 . . . . 0.0 110.449 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.482 ' N ' ' O ' ' A' ' 137' ' ' THR . . . -140.17 173.3 23.06 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.7 t -82.98 -46.83 12.42 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.325 -1.103 . . . . 0.0 110.15 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 21.4 m120 52.74 -162.19 0.1 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.247 -0.908 . . . . 0.0 110.159 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 29.1 p80 -152.6 31.49 0.51 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.356 -0.84 . . . . 0.0 110.362 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -156.0 27.34 0.37 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.279 -0.888 . . . . 0.0 110.223 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.494 ' C ' HG22 ' A' ' 145' ' ' ILE . 28.5 ttp180 -86.54 135.88 33.28 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.306 -0.871 . . . . 0.0 110.34 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.494 HG22 ' C ' ' A' ' 144' ' ' ARG . 1.3 tt 33.21 71.59 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 O-C-N 121.773 -0.579 . . . . 0.0 111.426 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -47.72 92.58 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.489 -0.757 . . . . 0.0 110.94 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.448 ' N ' ' O ' ' A' ' 145' ' ' ILE . . . -81.45 118.53 22.78 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.477 -0.764 . . . . 0.0 110.049 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -82.9 128.73 34.71 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.354 -0.841 . . . . 0.0 110.408 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -103.29 -17.08 15.46 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.422 -0.799 . . . . 0.0 109.886 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 75.08 150.24 2.34 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -71.25 123.4 9.56 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 O-C-N 123.74 1.389 . . . . 0.0 110.297 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.08 168.0 1.12 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.211 -0.931 . . . . 0.0 110.02 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -52.38 150.35 4.86 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.243 -0.911 . . . . 0.0 110.277 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 76.6 mt -122.84 93.96 47.88 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.423 -0.798 . . . . 0.0 110.201 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.52 136.22 28.0 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 O-C-N 123.717 1.377 . . . . 0.0 110.43 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 . . . . . 0 N--CA 1.494 1.754 0 CA-C-O 118.081 -0.961 . . . . 0.0 110.174 179.901 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.138 0.494 . . . . 0.0 110.221 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 46.64 57.14 17.14 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.542 -0.724 . . . . 0.0 110.527 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.97 -171.37 0.77 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.732 1.385 . . . . 0.0 110.301 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -113.47 131.34 56.07 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.25 -0.906 . . . . 0.0 110.466 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -152.56 -60.12 0.15 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.419 -0.8 . . . . 0.0 110.217 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 158.14 108.51 0.26 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.6 t -126.27 -141.16 0.28 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.378 -1.072 . . . . 0.0 109.398 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 39.9 t -61.43 -179.94 0.19 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.854 -1.154 . . . . 0.0 110.002 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -64.35 -54.83 26.81 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.164 -0.96 . . . . 0.0 109.852 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.532 ' CB ' ' CD ' ' A' ' 11' ' ' PRO . 0.3 OUTLIER -136.48 -65.56 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.447 -0.783 . . . . 0.0 110.029 179.416 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.532 ' CD ' ' CB ' ' A' ' 10' ' ' GLU . 48.7 Cg_endo -73.77 123.11 8.26 Favored 'Trans proline' 0 C--N 1.316 -1.132 0 O-C-N 123.185 1.097 . . . . 0.0 110.42 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.9 p -75.15 130.03 38.52 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.253 -0.904 . . . . 0.0 110.079 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.462 ' O ' ' CB ' ' A' ' 40' ' ' ALA . . . -62.09 99.37 0.13 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.346 -0.846 . . . . 0.0 110.327 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.408 ' O ' ' OG1' ' A' ' 18' ' ' THR . 11.4 p30 -131.94 3.63 4.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.125 -0.985 . . . . 0.0 110.946 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.452 ' CD1' ' OE1' ' A' ' 27' ' ' GLU . 0.3 OUTLIER -60.15 -11.56 6.43 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.343 -0.848 . . . . 0.0 111.299 -179.644 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.525 HD21 ' HB1' ' A' ' 36' ' ' ALA . 23.8 mt -78.36 -57.05 3.98 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.936 -1.102 . . . . 0.0 109.534 179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.643 ' HB3' ' ND2' ' A' ' 42' ' ' ASN . . . -58.47 -48.38 80.95 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.508 -0.745 . . . . 0.0 109.471 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.424 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.2 OUTLIER -54.52 -59.95 4.0 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.39 -0.819 . . . . 0.0 110.128 179.341 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.522 ' HB1' ' HB3' ' A' ' 27' ' ' GLU . . . -54.3 -56.78 15.08 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.49 -0.757 . . . . 0.0 110.181 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.628 ' CB ' HG11 ' A' ' 59' ' ' VAL . . . -52.87 -47.87 67.53 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.45 -0.781 . . . . 0.0 109.847 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.555 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -61.07 -19.2 61.14 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.468 -0.77 . . . . 0.0 109.863 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.71 18.03 15.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.501 -0.749 . . . . 0.0 110.703 -179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 54.17 47.85 65.89 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.65 98.84 4.16 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.304 -1.115 . . . . 0.0 109.716 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.661 HG12 ' CG ' ' A' ' 29' ' ' ARG . 3.1 t -74.31 -43.73 49.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.463 -0.773 . . . . 0.0 109.821 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -45.4 -54.26 7.55 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.455 -0.778 . . . . 0.0 110.781 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.522 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -48.91 -49.46 39.88 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.371 -0.831 . . . . 0.0 110.041 179.801 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.01 HG12 HD12 ' A' ' 32' ' ' LEU . 6.2 t -74.13 -45.63 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.587 -0.696 . . . . 0.0 110.307 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.936 ' HA ' HD11 ' A' ' 62' ' ' LEU . 9.3 mmm180 -45.34 -41.65 9.13 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.501 -0.749 . . . . 0.0 109.93 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.46 -39.59 31.86 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.544 -0.723 . . . . 0.0 109.646 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.48 ' HB2' ' HA ' ' A' ' 28' ' ' VAL . 32.8 mt -61.06 -67.12 0.43 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.419 -0.8 . . . . 0.0 110.137 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.01 HD12 HG12 ' A' ' 28' ' ' VAL . 13.7 mt -51.85 -36.88 49.88 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.476 -0.765 . . . . 0.0 110.461 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.422 ' HB2' ' O ' ' A' ' 29' ' ' ARG . 46.9 mt-10 -72.37 -18.08 61.77 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.308 -0.87 . . . . 0.0 110.022 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.97 -7.5 48.81 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.359 -0.838 . . . . 0.0 110.435 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 109.61 23.73 6.14 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.525 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -61.22 164.45 5.31 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.296 -1.12 . . . . 0.0 110.073 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.457 ' O ' HD12 ' A' ' 16' ' ' LEU . 40.8 tp -97.18 99.15 5.62 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.536 -0.727 . . . . 0.0 109.927 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.54 ' HB3' HD21 ' A' ' 32' ' ' LEU . 44.1 Cg_endo -68.56 -23.11 37.37 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 O-C-N 123.656 1.345 . . . . 0.0 110.437 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -92.41 34.25 1.06 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.252 -0.905 . . . . 0.0 110.018 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.462 ' CB ' ' O ' ' A' ' 13' ' ' ALA . . . -86.82 122.52 71.42 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.333 -0.855 . . . . 0.0 110.274 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -73.42 111.81 3.38 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.609 1.321 . . . . 0.0 110.38 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.643 ' ND2' ' HB3' ' A' ' 17' ' ' ALA . 2.9 m120 -90.13 166.65 13.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.404 -0.81 . . . . 0.0 109.916 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.457 ' C ' ' CG ' ' A' ' 44' ' ' TYR . 70.8 m -62.58 -157.04 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.433 -0.792 . . . . 0.0 109.732 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.573 ' CD1' ' N ' ' A' ' 44' ' ' TYR . 0.1 OUTLIER 58.86 13.72 2.9 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.166 -0.959 . . . . 0.0 109.791 -179.607 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.2 24.24 20.91 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.87 171.95 7.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.44 -1.036 . . . . 0.0 110.956 -179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.571 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -113.92 -165.21 0.06 OUTLIER Pre-proline 0 N--CA 1.493 1.688 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.562 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.571 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 49.1 Cg_endo -76.19 166.48 27.67 Favored 'Trans proline' 0 C--N 1.315 -1.228 0 O-C-N 122.85 0.921 . . . . 0.0 109.787 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.541 ' O ' ' HG2' ' A' ' 52' ' ' MET . 4.7 mt 63.96 -59.6 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 O-C-N 121.668 -0.645 . . . . 0.0 110.224 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.513 ' N ' ' O ' ' A' ' 48' ' ' PRO . 7.3 mt-30 -43.7 -27.19 0.29 Allowed 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.811 -1.181 . . . . 0.0 110.54 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.708 HG22 ' O ' ' A' ' 51' ' ' VAL . 6.8 p -118.8 26.06 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.426 -0.796 . . . . 0.0 110.53 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.727 ' HE1' ' HB2' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -83.73 41.04 0.77 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.77 -1.206 . . . . 0.0 109.421 178.872 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.434 ' HB3' ' HE2' ' A' ' 53' ' ' MET . 2.9 tmm? 64.97 -6.82 0.31 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.285 -0.884 . . . . 0.0 110.552 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.451 ' H ' ' C ' ' A' ' 52' ' ' MET . 0.0 OUTLIER 43.12 29.89 0.23 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.307 -0.871 . . . . 0.0 110.516 -179.781 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.451 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -134.54 12.64 4.58 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -146.1 71.5 1.26 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.425 -1.044 . . . . 0.0 109.544 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.562 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . . . -47.97 -27.75 2.37 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.649 -0.657 . . . . 0.0 109.89 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.508 ' HG2' HG11 ' A' ' 25' ' ' VAL . 3.1 tpt180 -52.07 -38.23 56.49 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.654 -0.654 . . . . 0.0 109.359 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.628 HG11 ' CB ' ' A' ' 20' ' ' ALA . 67.0 t -69.48 -49.05 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.359 -0.838 . . . . 0.0 109.028 178.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.727 ' HB2' ' HE1' ' A' ' 52' ' ' MET . . . -46.44 -45.82 18.36 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.52 -0.738 . . . . 0.0 109.664 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.485 ' O ' HD23 ' A' ' 65' ' ' LEU . 0.7 OUTLIER -58.05 -48.39 80.24 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.545 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.936 HD11 ' HA ' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -49.92 -66.73 0.34 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.586 -0.696 . . . . 0.0 109.688 178.348 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.967 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 85.1 mt -58.44 -54.68 44.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.57 -0.706 . . . . 0.0 110.178 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.826 HD13 HG12 ' A' ' 96' ' ' VAL . 1.9 tt -43.67 -68.3 0.21 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.501 -0.749 . . . . 0.0 111.212 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.485 HD23 ' O ' ' A' ' 61' ' ' GLU . 1.1 pp -56.31 -23.2 35.41 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.104 -0.997 . . . . 0.0 110.159 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.76 ' CG ' HD22 ' A' ' 32' ' ' LEU . 2.2 m80 -82.86 -48.79 10.36 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 121.293 -0.88 . . . . 0.0 110.153 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 149.34 43.41 0.03 OUTLIER Glycine 0 N--CA 1.483 1.79 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.967 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -72.25 -157.32 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.849 -1.383 . . . . 0.0 109.92 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.449 ' CG ' ' HD2' ' A' ' 48' ' ' PRO . 4.6 mm-40 -121.21 62.73 11.81 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.43 ' HG2' ' ND2' ' A' ' 71' ' ' ASN . 40.4 Cg_endo -69.05 -5.5 15.93 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.875 1.461 . . . . 0.0 111.083 -179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.43 ' ND2' ' HG2' ' A' ' 70' ' ' PRO . 12.2 m-80 -113.88 -67.12 1.02 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.022 -1.048 . . . . 0.0 110.065 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.8 t -44.88 163.28 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.465 -0.772 . . . . 0.0 110.83 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.885 ' HB2' ' HG2' ' A' ' 80' ' ' ARG . . . -138.59 -155.44 0.6 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.186 -0.946 . . . . 0.0 110.925 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' A' ' 78' ' ' LEU . 50.8 m-20 -107.77 126.23 30.35 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.533 -0.729 . . . . 0.0 109.766 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -74.96 -2.06 12.03 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 123.332 1.175 . . . . 0.0 110.668 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -93.32 -36.3 12.61 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 0.0 109.84 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.599 ' C ' ' HB2' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -132.76 6.99 4.04 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.376 -0.827 . . . . 0.0 110.142 179.374 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.688 HD13 ' O ' ' A' ' 107' ' ' ARG . 1.0 OUTLIER 48.48 23.22 0.57 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.381 -0.824 . . . . 0.0 111.477 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 35.8 m -78.83 102.74 8.34 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.956 -1.09 . . . . 0.0 109.517 179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.885 ' HG2' ' HB2' ' A' ' 73' ' ' ALA . 0.0 OUTLIER -71.11 171.97 7.51 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.361 -0.837 . . . . 0.0 110.285 -179.676 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.66 -14.5 36.51 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.816 1.429 . . . . 0.0 109.375 179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.599 HG12 ' CB ' ' A' ' 114' ' ' PRO . 48.7 t -72.08 -30.26 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.778 -0.576 . . . . 0.0 109.896 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.562 ' HB3' HD13 ' A' ' 117' ' ' LEU . 5.3 m80 -77.8 -34.68 52.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.391 -0.818 . . . . 0.0 109.25 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.02 -41.99 84.31 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 120.322 -0.551 . . . . 0.0 109.884 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.549 ' HB3' ' CD1' ' A' ' 94' ' ' LEU . . . -66.64 -61.51 1.94 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.232 -0.918 . . . . 0.0 109.653 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 1.033 ' HB1' ' HB2' ' A' ' 118' ' ' ALA . . . -56.88 -44.84 82.69 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.262 -0.899 . . . . 0.0 110.929 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.617 ' O ' HD22 ' A' ' 121' ' ' LEU . 2.9 ttp180 -48.64 -43.44 36.47 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.329 -0.857 . . . . 0.0 110.291 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.439 ' HG3' ' HB3' ' A' ' 54' ' ' MET . 0.0 OUTLIER -93.82 4.68 53.57 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.454 -0.779 . . . . 0.0 110.655 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.604 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 60.72 51.79 56.45 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.562 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.8 OUTLIER -120.45 74.87 1.08 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.385 -1.068 . . . . 0.0 110.187 179.83 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.415 HD11 ' O ' ' A' ' 125' ' ' ASP . 0.3 OUTLIER -52.17 -37.89 56.02 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.428 -0.795 . . . . 0.0 110.663 -179.844 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.782 ' O ' HG23 ' A' ' 96' ' ' VAL . 48.1 t0 -47.9 -39.24 18.39 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.3 -0.875 . . . . 0.0 109.559 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 87.6 m -69.8 -45.06 68.79 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.761 HD21 ' CD2' ' A' ' 130' ' ' LEU . 1.6 tp -55.37 -43.24 74.92 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.563 -0.711 . . . . 0.0 109.809 179.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 69.2 t -59.91 -47.85 90.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.222 -0.923 . . . . 0.0 109.429 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.826 HG12 HD13 ' A' ' 64' ' ' LEU . 6.5 t -58.88 -50.52 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.304 -0.872 . . . . 0.0 109.004 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.76 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 0.0 OUTLIER -44.56 -55.4 5.17 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.77 -0.582 . . . . 0.0 109.93 179.267 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -65.73 -30.92 71.65 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.512 -0.743 . . . . 0.0 109.89 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.81 -14.81 36.43 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.399 -0.813 . . . . 0.0 110.665 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.562 ' CB ' HD21 ' A' ' 64' ' ' LEU . . . -151.31 70.13 0.96 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.98 -1.075 . . . . 0.0 111.075 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 58.22 105.82 0.01 OUTLIER Glycine 0 N--CA 1.488 2.1 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.76 ' HB2' ' O ' ' A' ' 97' ' ' LEU . . . -147.51 103.86 3.58 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.589 -0.948 . . . . 0.0 109.702 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.415 ' O ' HG21 ' A' ' 82' ' ' VAL . 2.8 tpp180 -65.31 101.59 0.58 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.353 -0.842 . . . . 0.0 110.377 -179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 134' ' ' ALA . 1.7 mt -102.37 59.86 0.82 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.427 -0.796 . . . . 0.0 110.226 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -170.92 44.72 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.988 -1.07 . . . . 0.0 110.907 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.668 HG22 ' H ' ' A' ' 107' ' ' ARG . 3.1 p -105.88 -171.24 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.243 -0.911 . . . . 0.0 109.539 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.688 ' O ' HD13 ' A' ' 78' ' ' LEU . 0.5 OUTLIER -131.26 115.1 15.87 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.178 -0.951 . . . . 0.0 110.064 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.52 160.51 1.23 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.475 -0.765 . . . . 0.0 109.558 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.599 ' HB2' ' C ' ' A' ' 77' ' ' THR . . . -63.74 -14.03 48.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.201 -0.937 . . . . 0.0 110.254 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.473 ' CH2' ' CG2' ' A' ' 77' ' ' THR . 6.0 m-90 -89.89 17.73 6.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.307 -0.871 . . . . 0.0 110.311 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 60.21 57.94 16.59 Favored Glycine 0 N--CA 1.486 1.992 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 16.2 mtt180 -145.96 -160.69 1.18 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.379 -1.071 . . . . 0.0 110.317 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.486 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER -140.57 171.19 8.07 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.308 -0.87 . . . . 0.0 109.963 -179.897 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.599 ' CB ' HG12 ' A' ' 82' ' ' VAL . 45.4 Cg_endo -74.65 -48.54 0.19 Allowed 'Trans proline' 0 C--N 1.309 -1.509 0 O-C-N 123.661 1.348 . . . . 0.0 110.025 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.698 HG23 ' O ' ' A' ' 127' ' ' ALA . 7.2 p -55.56 -32.68 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.353 -0.842 . . . . 0.0 109.729 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.01 -38.54 79.31 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.481 -0.762 . . . . 0.0 109.688 179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.631 ' O ' HD12 ' A' ' 121' ' ' LEU . 0.2 OUTLIER -57.11 -69.36 0.16 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.508 -0.745 . . . . 0.0 110.143 179.674 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 1.033 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -44.46 -52.86 7.48 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.461 -0.774 . . . . 0.0 110.998 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -53.97 -45.04 71.27 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.347 -0.845 . . . . 0.0 110.156 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -64.89 -32.02 73.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.391 -0.818 . . . . 0.0 110.06 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.631 HD12 ' O ' ' A' ' 117' ' ' LEU . 1.0 OUTLIER -90.07 2.05 55.67 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.375 -0.828 . . . . 0.0 110.767 -179.668 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 89.96 11.42 63.39 Favored Glycine 0 N--CA 1.489 2.209 0 C-N-CA 119.931 -1.128 . . . . 0.0 111.075 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.698 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . 47.9 m-70 -93.07 50.31 1.52 Allowed 'General case' 0 N--CA 1.484 1.232 0 O-C-N 120.841 -1.387 . . . . 0.0 109.085 179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 6.0 mtt-85 -47.75 -31.47 4.85 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.626 -0.671 . . . . 0.0 109.407 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.42 ' OD1' ' N ' ' A' ' 125' ' ' ASP . 8.5 m-20 -62.3 -47.85 82.46 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.82 HG11 ' HA ' ' A' ' 86' ' ' ALA . 6.0 t -75.3 -40.52 43.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.426 -0.796 . . . . 0.0 109.758 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.698 ' O ' HG23 ' A' ' 115' ' ' VAL . . . -57.21 -36.37 70.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.303 -0.873 . . . . 0.0 109.607 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.13 -61.19 2.73 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.418 -0.801 . . . . 0.0 110.1 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.417 ' HD2' HD23 ' A' ' 94' ' ' LEU . 19.2 t80 -53.26 -40.42 64.64 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.293 -0.879 . . . . 0.0 109.824 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.93 HD11 ' HB2' ' A' ' 86' ' ' ALA . 78.3 mt -67.59 -39.43 84.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.424 -0.797 . . . . 0.0 109.463 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.486 ' HG3' HG21 ' A' ' 115' ' ' VAL . 3.2 ttt180 -59.34 -19.43 46.48 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.19 -0.943 . . . . 0.0 110.201 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.1 -57.63 3.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.352 -0.843 . . . . 0.0 110.432 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -81.72 -15.49 54.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.346 -0.846 . . . . 0.0 110.959 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.717 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . -108.04 -20.48 13.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.199 -0.938 . . . . 0.0 110.103 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -68.75 120.36 10.95 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -67.04 -135.33 0.04 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.529 HG22 ' NH2' ' A' ' 144' ' ' ARG . 21.4 p 48.14 92.79 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.588 -0.948 . . . . 0.0 110.428 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.22 61.37 0.72 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.237 -0.914 . . . . 0.0 110.698 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 156.56 -24.22 0.5 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.146 -1.182 . . . . 0.0 110.146 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.0 t -127.73 171.55 11.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.173 -1.192 . . . . 0.0 110.617 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -142.06 62.63 1.43 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.456 -0.778 . . . . 0.0 109.899 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -115.43 136.94 52.57 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.419 -0.801 . . . . 0.0 110.159 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.04 147.12 54.05 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.39 -0.819 . . . . 0.0 110.421 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.529 ' NH2' HG22 ' A' ' 137' ' ' THR . 0.1 OUTLIER -163.5 44.21 0.11 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.349 -0.844 . . . . 0.0 110.109 179.634 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.424 HG22 ' H ' ' A' ' 145' ' ' ILE . 2.1 tt -77.76 132.03 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.704 -0.623 . . . . 0.0 110.731 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 34.4 t70 42.2 60.1 2.41 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.548 -0.72 . . . . 0.0 110.932 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -82.92 126.12 32.13 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.362 -0.836 . . . . 0.0 110.449 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . 52.96 -168.78 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.261 -0.9 . . . . 0.0 110.334 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 60.08 13.06 3.55 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.436 -0.79 . . . . 0.0 110.406 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 165.92 167.55 26.73 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.286 -1.525 . . . . 0.0 109.286 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -76.04 149.43 32.56 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 O-C-N 123.564 1.297 . . . . 0.0 110.52 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 28.6 m -63.1 173.07 1.54 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.297 -0.877 . . . . 0.0 110.25 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -51.57 162.42 0.38 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.331 -0.855 . . . . 0.0 110.835 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.666 ' O ' HG23 ' A' ' 154' ' ' ILE . 0.8 OUTLIER -153.07 81.82 5.05 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.428 -0.795 . . . . 0.0 110.04 179.748 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.91 135.7 23.82 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 O-C-N 123.737 1.388 . . . . 0.0 110.646 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.6 t0 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.853 -1.07 . . . . 0.0 110.392 -179.601 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.813 0 CA-C-O 121.01 0.433 . . . . 0.0 110.357 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 50.43 71.16 1.64 Allowed Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 121.278 -0.889 . . . . 0.0 109.762 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -72.17 -176.5 2.19 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.779 1.41 . . . . 0.0 109.792 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 49.82 55.59 9.18 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.345 -0.847 . . . . 0.0 110.029 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -113.44 -61.48 1.73 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.43 -0.794 . . . . 0.0 110.679 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 72.3 61.54 3.63 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -151.78 -72.63 0.15 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.481 -1.011 . . . . 0.0 109.954 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 m -149.36 177.74 9.41 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.466 -0.771 . . . . 0.0 110.14 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.31 -173.89 2.62 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.318 -0.864 . . . . 0.0 109.606 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.29 123.88 51.4 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.07 -1.019 . . . . 0.0 109.604 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -73.89 -172.82 1.2 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.582 1.307 . . . . 0.0 110.604 -179.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -99.73 -21.21 15.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.417 -0.802 . . . . 0.0 110.334 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 52.06 24.8 2.85 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.391 -0.818 . . . . 0.0 109.573 -179.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 -86.03 9.19 17.86 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.511 -0.743 . . . . 0.0 110.868 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.411 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 40.2 m0 -46.44 -34.73 4.94 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.334 -0.854 . . . . 0.0 109.976 179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.858 ' HB2' HD21 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -63.1 -37.84 88.8 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.6 -0.687 . . . . 0.0 109.997 178.62 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.66 -53.86 6.43 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.27 -0.893 . . . . 0.0 110.309 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.411 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.0 OUTLIER -44.96 -54.09 6.93 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.565 -0.709 . . . . 0.0 110.836 -179.591 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.777 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -61.3 -52.8 63.2 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.356 -0.84 . . . . 0.0 110.447 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.801 ' HB1' HG11 ' A' ' 59' ' ' VAL . . . -46.78 -46.9 20.88 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.502 -0.749 . . . . 0.0 110.355 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.442 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -54.44 -40.01 67.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.55 -0.719 . . . . 0.0 110.425 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.409 ' HB3' ' HD2' ' A' ' 24' ' ' ARG . 5.6 mpt_? -86.53 26.58 1.06 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.484 -0.76 . . . . 0.0 110.414 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 49.05 24.22 4.39 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.727 ' O ' HG23 ' A' ' 28' ' ' VAL . 10.2 mtt180 -93.65 65.39 3.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.365 -1.079 . . . . 0.0 109.738 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 1.059 HG22 HG22 ' A' ' 59' ' ' VAL . 60.2 t -55.67 -42.66 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.657 -0.652 . . . . 0.0 110.881 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -43.36 -56.03 3.77 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.471 -0.768 . . . . 0.0 110.604 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.432 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 1.8 tp10 -63.99 -34.89 79.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.481 -0.762 . . . . 0.0 110.141 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.826 HG12 HD13 ' A' ' 62' ' ' LEU . 4.7 t -70.29 -44.97 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.231 -0.918 . . . . 0.0 109.871 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.822 ' CA ' HD11 ' A' ' 62' ' ' LEU . 1.8 mmm180 -53.37 -45.87 69.38 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.201 -0.937 . . . . 0.0 109.254 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -70.59 -42.38 71.11 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 120.078 -0.649 . . . . 0.0 109.739 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 27' ' ' GLU . 44.6 mt -59.18 -63.05 1.44 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.289 -0.882 . . . . 0.0 110.969 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.882 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 0.0 OUTLIER -44.44 -44.52 8.52 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.424 -0.798 . . . . 0.0 110.594 -179.484 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -81.25 -18.5 45.75 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.74 -0.6 . . . . 0.0 110.443 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.465 ' HB2' ' O ' ' A' ' 30' ' ' ALA . . . -84.42 -5.63 59.3 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.111 -0.993 . . . . 0.0 110.748 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.09 22.61 2.35 Favored Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.802 -1.189 . . . . 0.0 110.99 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.882 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -66.6 162.24 21.43 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.916 -1.343 . . . . 0.0 109.892 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.734 HD13 ' HD2' ' A' ' 38' ' ' PRO . 1.8 mm? -87.19 133.49 38.68 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.365 -0.835 . . . . 0.0 110.124 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.734 ' HD2' HD13 ' A' ' 37' ' ' LEU . 44.3 Cg_endo -70.68 -47.07 0.7 Allowed 'Trans proline' 0 C--N 1.315 -1.229 0 O-C-N 123.547 1.288 . . . . 0.0 109.906 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -102.83 51.56 0.8 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.585 -0.697 . . . . 0.0 109.59 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.627 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -85.35 112.34 43.25 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.524 -0.735 . . . . 0.0 110.228 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.17 140.78 34.78 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 O-C-N 123.679 1.357 . . . . 0.0 110.607 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.508 ' ND2' HG21 ' A' ' 51' ' ' VAL . 14.9 t30 -85.92 -164.74 1.08 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.302 -0.874 . . . . 0.0 109.956 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -110.3 -8.0 14.77 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.199 -0.938 . . . . 0.0 110.564 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -96.62 24.29 6.12 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.179 -0.951 . . . . 0.0 109.917 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 63.41 23.05 66.25 Favored Glycine 0 N--CA 1.486 2.018 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.92 -152.44 0.47 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.205 -1.174 . . . . 0.0 110.159 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.545 ' HD2' ' NE2' ' A' ' 50' ' ' GLN . 0.0 OUTLIER -130.22 -176.8 0.58 Allowed Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.32 -0.862 . . . . 0.0 109.989 -179.466 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.645 ' HB2' HD22 ' A' ' 63' ' ' LEU . 43.2 Cg_endo -68.69 -25.84 33.65 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 O-C-N 123.36 1.19 . . . . 0.0 110.456 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.503 ' O ' ' HG2' ' A' ' 52' ' ' MET . 4.8 mt -108.93 -33.1 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.236 -0.915 . . . . 0.0 109.919 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.545 ' NE2' ' HD2' ' A' ' 47' ' ' ARG . 14.7 mt-30 -56.89 -17.62 10.18 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.31 -0.869 . . . . 0.0 110.188 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.508 HG21 ' ND2' ' A' ' 42' ' ' ASN . 8.5 p -113.52 35.09 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.329 -0.857 . . . . 0.0 110.922 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.675 ' HE1' ' HB2' ' A' ' 60' ' ' ALA . 0.1 OUTLIER -100.33 37.57 1.65 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.017 -1.052 . . . . 0.0 110.567 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.413 ' CB ' ' O ' ' A' ' 52' ' ' MET . 20.4 ttp 65.3 -4.27 0.55 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.421 -0.799 . . . . 0.0 110.66 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.565 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 41.41 30.82 0.14 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.384 -0.823 . . . . 0.0 110.555 -179.681 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.438 ' C ' ' CE2' ' A' ' 90' ' ' PHE . . . -133.17 11.01 5.07 Favored Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.571 ' HB3' HG23 ' A' ' 59' ' ' VAL . 0.5 OUTLIER -147.81 87.86 1.65 Allowed 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.443 -1.034 . . . . 0.0 109.687 179.801 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.54 -20.14 7.25 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.52 -0.737 . . . . 0.0 109.733 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -58.09 -29.71 65.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.464 -0.773 . . . . 0.0 109.671 179.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 1.059 HG22 HG22 ' A' ' 25' ' ' VAL . 2.8 t -76.64 -50.42 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.445 -0.785 . . . . 0.0 109.426 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.675 ' HB2' ' HE1' ' A' ' 52' ' ' MET . . . -49.1 -59.82 3.32 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.206 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.593 ' O ' HD23 ' A' ' 65' ' ' LEU . 3.4 tt0 -46.7 -52.19 14.42 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.488 -0.758 . . . . 0.0 109.544 178.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.826 HD13 HG12 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -45.74 -71.79 0.07 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.735 -0.603 . . . . 0.0 110.416 178.745 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.858 HD21 ' HB2' ' A' ' 16' ' ' LEU . 1.9 mt -65.31 -45.84 82.73 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.499 -0.751 . . . . 0.0 111.069 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.88 HD22 ' CG1' ' A' ' 96' ' ' VAL . 0.5 OUTLIER -52.26 -70.24 0.09 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.184 -0.948 . . . . 0.0 110.641 -179.501 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.593 HD23 ' O ' ' A' ' 61' ' ' GLU . 2.1 pp -50.69 -25.81 4.75 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.402 -0.812 . . . . 0.0 109.88 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.686 ' ND1' HD12 ' A' ' 32' ' ' LEU . 3.3 m-70 -80.74 -48.8 12.0 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.604 -0.685 . . . . 0.0 109.929 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 159.46 32.34 0.02 OUTLIER Glycine 0 CA--C 1.54 1.604 0 C-N-CA 120.05 -1.072 . . . . 0.0 111.305 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.586 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -70.37 178.4 2.91 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.436 -1.626 . . . . 0.0 109.602 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.445 ' HB2' ' HG2' ' A' ' 47' ' ' ARG . 0.6 OUTLIER -107.78 78.9 0.78 Allowed Pre-proline 0 C--N 1.302 -1.459 0 O-C-N 121.32 -0.863 . . . . 0.0 110.23 179.516 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 68' ' ' ALA . 50.3 Cg_endo -74.71 -0.85 10.35 Favored 'Trans proline' 0 C--N 1.314 -1.246 0 O-C-N 123.682 1.359 . . . . 0.0 110.171 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.548 ' O ' ' NE ' ' A' ' 80' ' ' ARG . 1.7 m-20 -113.71 -70.58 0.8 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.194 -0.941 . . . . 0.0 110.014 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.422 ' C ' ' O ' ' A' ' 71' ' ' ASN . 49.3 t -40.04 147.85 0.09 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.375 -0.828 . . . . 0.0 110.893 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.572 ' HB2' ' HG2' ' A' ' 80' ' ' ARG . . . -133.25 -150.33 0.4 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.525 -0.735 . . . . 0.0 109.875 -179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' A' ' 78' ' ' LEU . 1.0 OUTLIER -114.98 130.33 24.3 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.887 . . . . 0.0 109.893 -179.904 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -66.74 -13.08 38.49 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.344 1.181 . . . . 0.0 110.254 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.71 -55.81 30.07 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.322 -0.861 . . . . 0.0 109.171 178.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.663 HG22 ' CH2' ' A' ' 110' ' ' TRP . 43.7 p -141.71 25.36 1.99 Allowed 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 121.567 0.699 . . . . 0.0 109.374 179.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.501 ' HA ' HD23 ' A' ' 78' ' ' LEU . 2.9 mt 52.86 30.06 8.59 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.53 -0.731 . . . . 0.0 111.107 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.84 97.57 0.23 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.989 -1.069 . . . . 0.0 109.883 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.888 ' CG ' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -72.23 168.52 22.54 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.211 -0.931 . . . . 0.0 109.382 179.701 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.497 ' HB3' ' HG3' ' A' ' 50' ' ' GLN . 50.8 Cg_endo -73.7 -21.77 18.67 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.74 1.39 . . . . 0.0 109.867 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.431 ' CG1' ' HG ' ' A' ' 104' ' ' LEU . 56.3 t -59.57 -35.0 56.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.523 -0.736 . . . . 0.0 110.37 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.467 ' O ' ' CB ' ' A' ' 87' ' ' ARG . 42.3 m80 -64.99 -31.59 72.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.441 -0.787 . . . . 0.0 110.009 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.565 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 0.7 OUTLIER -61.24 -52.08 66.27 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.528 -0.732 . . . . 0.0 110.652 -179.732 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.548 ' HB3' ' CD1' ' A' ' 94' ' ' LEU . . . -57.8 -61.3 2.62 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.807 -1.183 . . . . 0.0 109.745 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.88 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -57.14 -55.93 28.3 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.525 -0.734 . . . . 0.0 111.594 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.467 ' CB ' ' O ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -44.67 -28.72 0.64 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.216 -0.927 . . . . 0.0 111.529 -178.863 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.37 -8.13 23.65 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.019 -1.051 . . . . 0.0 110.807 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.558 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 77.08 36.01 36.81 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.548 ' HD1' ' HG1' ' A' ' 93' ' ' THR . 0.9 OUTLIER -108.2 90.86 3.42 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.389 -1.066 . . . . 0.0 110.525 179.903 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.515 ' CD2' ' HA ' ' A' ' 126' ' ' VAL . 0.1 OUTLIER -64.69 -36.6 84.79 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.446 -0.784 . . . . 0.0 110.384 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.502 ' O ' HG23 ' A' ' 96' ' ' VAL . 40.0 t0 -53.6 -26.31 21.31 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.165 -0.959 . . . . 0.0 109.371 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.548 ' HG1' ' HD1' ' A' ' 90' ' ' PHE . 26.6 m -78.25 -46.72 19.59 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.623 -0.673 . . . . 0.0 109.873 179.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.829 HD21 ' HG ' ' A' ' 130' ' ' LEU . 1.1 tp -54.36 -36.98 64.42 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.216 -0.928 . . . . 0.0 109.695 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 91' ' ' LEU . 27.0 t -65.54 -47.55 86.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.474 -0.766 . . . . 0.0 109.425 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.88 ' CG1' HD22 ' A' ' 64' ' ' LEU . 84.3 t -56.12 -53.17 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.217 -0.927 . . . . 0.0 110.094 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.0 mp -52.8 -51.83 59.23 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.182 -0.949 . . . . 0.0 109.719 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 8.2 t-160 -54.6 -38.22 66.51 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.618 -0.676 . . . . 0.0 109.421 179.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 96' ' ' VAL . 66.9 mtp180 -66.78 -13.65 61.71 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.707 -0.621 . . . . 0.0 110.141 179.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.742 ' HB3' HD11 ' A' ' 64' ' ' LEU . . . -117.32 38.72 3.48 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.387 -0.82 . . . . 0.0 110.534 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 45.8 47.33 13.76 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.354 -1.098 . . . . 0.0 110.354 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.455 ' O ' HD12 ' A' ' 104' ' ' LEU . . . -89.13 110.68 21.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.346 -1.091 . . . . 0.0 110.197 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.518 ' N ' ' OD1' ' A' ' 71' ' ' ASN . 0.0 OUTLIER -49.68 138.73 13.82 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.586 -0.697 . . . . 0.0 110.491 179.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.854 HD23 HD23 ' A' ' 130' ' ' LEU . 0.2 OUTLIER -128.3 22.87 6.03 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.427 -0.796 . . . . 0.0 110.055 179.623 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -125.52 47.3 2.22 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.021 -1.049 . . . . 0.0 110.911 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.888 HG11 ' CG ' ' A' ' 80' ' ' ARG . 3.4 p -108.7 -172.4 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.318 -0.864 . . . . 0.0 110.347 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.725 ' H ' HG22 ' A' ' 106' ' ' VAL . 2.6 mtm180 -132.42 158.92 40.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.454 -0.779 . . . . 0.0 109.941 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.606 ' O ' ' N ' ' A' ' 110' ' ' TRP . 52.1 p30 -93.73 50.51 1.46 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.382 -0.824 . . . . 0.0 110.242 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.588 ' HB2' ' C ' ' A' ' 77' ' ' THR . . . 59.06 -66.63 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.806 -0.559 . . . . 0.0 110.353 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.663 ' CH2' HG22 ' A' ' 77' ' ' THR . 0.0 OUTLIER -45.79 -62.37 1.33 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.488 -0.758 . . . . 0.0 110.263 179.815 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 164.77 -45.14 0.3 Allowed Glycine 0 N--CA 1.483 1.782 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 57.1 mtt180 -50.59 156.25 0.95 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.424 -1.045 . . . . 0.0 111.144 -179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.598 HD21 ' HG3' ' A' ' 107' ' ' ARG . 56.7 mt -110.1 170.42 5.34 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.544 -0.722 . . . . 0.0 109.717 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.538 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 40.9 Cg_endo -66.84 -21.01 51.29 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.707 1.372 . . . . 0.0 109.896 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.564 ' HA ' HD13 ' A' ' 130' ' ' LEU . 4.8 p -85.35 -40.7 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.287 -0.883 . . . . 0.0 110.421 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.442 ' N ' ' CG1' ' A' ' 115' ' ' VAL . 1.0 OUTLIER -59.98 -32.28 70.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.044 -1.035 . . . . 0.0 109.871 179.94 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.4 mt -70.54 -45.4 65.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.498 -0.751 . . . . 0.0 110.049 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.533 ' CB ' ' HB2' ' A' ' 127' ' ' ALA . . . -55.33 -51.28 67.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.367 -0.833 . . . . 0.0 110.066 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.564 ' N ' ' HB2' ' A' ' 127' ' ' ALA . 10.7 pt-20 -68.71 -25.0 64.55 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.614 -0.678 . . . . 0.0 110.484 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.45 -62.9 1.47 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.439 -0.788 . . . . 0.0 110.643 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.12 -87.34 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.028 -1.045 . . . . 0.0 110.703 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -169.52 35.86 0.19 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.511 ' HB2' ' HA ' ' A' ' 118' ' ' ALA . 7.5 m-70 -113.65 43.56 1.77 Allowed 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.561 -0.964 . . . . 0.0 109.272 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -43.52 -55.99 3.91 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.782 -0.574 . . . . 0.0 110.073 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 125' ' ' ASP . 13.4 p-10 -49.25 -34.33 14.9 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.436 0.636 . . . . 0.0 109.636 179.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.88 HG11 ' HA ' ' A' ' 86' ' ' ALA . 1.3 t -84.43 -31.08 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.564 ' HB2' ' N ' ' A' ' 119' ' ' GLU . . . -68.28 -35.74 78.33 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.436 -0.79 . . . . 0.0 109.364 179.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 26.7 ttt180 -72.42 -63.55 1.13 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.275 -0.891 . . . . 0.0 109.556 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.692 ' HD2' HD23 ' A' ' 94' ' ' LEU . 66.6 t80 -50.71 -28.86 9.9 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.372 -0.83 . . . . 0.0 109.812 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.854 HD23 HD23 ' A' ' 104' ' ' LEU . 6.7 mt -65.36 -62.08 1.74 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.406 -0.809 . . . . 0.0 109.465 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -51.96 -16.84 0.81 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.54 -0.725 . . . . 0.0 111.002 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -78.94 -53.2 7.29 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.969 -1.082 . . . . 0.0 109.693 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -87.33 -20.29 26.99 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.413 -0.804 . . . . 0.0 109.631 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.413 ' CB ' ' O ' ' A' ' 104' ' ' LEU . . . -86.41 15.18 5.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.31 -0.869 . . . . 0.0 110.653 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 173.41 -52.44 0.16 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 89.39 -50.23 3.55 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.8 p -44.93 138.38 3.62 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.554 -0.968 . . . . 0.0 111.091 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -159.18 -64.51 0.08 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.445 -0.785 . . . . 0.0 110.33 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -159.46 -154.41 7.25 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.0 p 55.64 170.43 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.492 -1.005 . . . . 0.0 110.307 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 -64.79 -65.05 0.72 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.264 -0.897 . . . . 0.0 109.718 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.451 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 0.1 OUTLIER 51.35 23.63 1.81 Allowed 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.448 -0.782 . . . . 0.0 110.725 179.607 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 142' ' ' HIS . . . 57.99 34.09 23.89 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.279 -0.888 . . . . 0.0 110.513 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.413 ' HG3' ' N ' ' A' ' 145' ' ' ILE . 0.0 OUTLIER -54.77 152.32 7.31 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.257 -0.902 . . . . 0.0 110.374 179.753 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.413 ' N ' ' HG3' ' A' ' 144' ' ' ARG . 36.8 mm -81.09 153.87 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.204 -0.935 . . . . 0.0 109.93 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 177.96 62.13 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.486 -0.759 . . . . 0.0 110.103 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -67.68 148.76 50.9 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.289 -0.882 . . . . 0.0 109.706 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.457 ' O ' ' N ' ' A' ' 150' ' ' GLY . . . -59.11 119.52 7.47 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.192 -0.942 . . . . 0.0 110.652 -179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 45.96 -92.63 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.523 -0.736 . . . . 0.0 110.561 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 148' ' ' ALA . . . 178.42 -133.65 2.19 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.6 160.96 45.32 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.663 1.349 . . . . 0.0 110.524 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 39.3 m -122.66 -43.01 2.29 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.47 -0.769 . . . . 0.0 109.991 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 8.5 t0 53.77 102.72 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.461 -0.775 . . . . 0.0 110.554 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.415 ' O ' HG23 ' A' ' 154' ' ' ILE . 5.1 tt -146.95 86.78 6.45 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.239 -0.913 . . . . 0.0 111.073 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -75.95 115.28 4.12 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 O-C-N 123.622 1.327 . . . . 0.0 109.763 178.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.233 -179.711 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.135 0.493 . . . . 0.0 109.894 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.449 ' CG ' ' O ' ' A' ' 2' ' ' GLU . 21.5 pt-20 -77.38 118.13 69.98 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.306 -0.871 . . . . 0.0 110.652 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -76.89 110.03 2.96 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.389 1.205 . . . . 0.0 109.894 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.507 ' O ' ' HB3' ' A' ' 5' ' ' ALA . . . -101.38 122.57 43.98 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.305 -0.872 . . . . 0.0 110.183 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 4' ' ' ALA . . . 60.36 -159.79 0.3 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.393 -0.817 . . . . 0.0 110.104 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -125.19 26.85 5.46 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 74.8 m 48.89 84.24 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.301 -1.117 . . . . 0.0 110.101 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -48.94 119.74 3.41 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.553 -0.717 . . . . 0.0 110.655 -179.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -154.76 138.46 16.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.403 -0.811 . . . . 0.0 109.992 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 57.4 91.05 0.08 OUTLIER Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.421 -0.8 . . . . 0.0 110.228 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -76.78 136.73 17.19 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.803 1.423 . . . . 0.0 110.582 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 79.8 p -71.37 -143.29 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.461 -0.774 . . . . 0.0 109.841 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -44.88 122.85 3.44 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.059 -1.026 . . . . 0.0 110.844 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -166.03 -48.57 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.16 -0.963 . . . . 0.0 110.544 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.551 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 42.0 m0 -67.54 -5.19 14.13 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.398 -0.814 . . . . 0.0 110.972 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.732 HD11 HD21 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -77.99 -55.55 5.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.922 -1.111 . . . . 0.0 109.867 179.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.5 ' O ' ' HB3' ' A' ' 20' ' ' ALA . . . -70.55 -43.3 69.8 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.274 -0.891 . . . . 0.0 110.31 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.551 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.8 OUTLIER -52.25 -55.53 20.68 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.422 -0.799 . . . . 0.0 110.709 -179.888 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.808 ' HB1' ' HB3' ' A' ' 24' ' ' ARG . . . -55.02 -41.0 70.78 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.323 -0.861 . . . . 0.0 109.895 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.572 ' HA ' HG11 ' A' ' 59' ' ' VAL . . . -52.63 -49.68 64.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.482 -0.761 . . . . 0.0 109.793 179.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.593 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -69.24 -34.1 74.29 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.429 -0.794 . . . . 0.0 110.198 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.38 27.67 1.89 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.393 -0.817 . . . . 0.0 110.927 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 44.71 57.06 5.43 Favored Glycine 0 N--CA 1.496 2.668 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.808 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -115.56 56.05 0.77 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.345 -1.091 . . . . 0.0 109.894 179.891 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.669 HG22 HG23 ' A' ' 59' ' ' VAL . 25.5 t -45.37 -55.01 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.583 -0.698 . . . . 0.0 110.844 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -54.23 -40.62 67.85 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.401 -0.812 . . . . 0.0 110.315 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.747 ' O ' HD12 ' A' ' 31' ' ' LEU . 0.5 OUTLIER -63.95 -35.43 80.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.431 -0.793 . . . . 0.0 109.753 179.851 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.877 HG12 HD12 ' A' ' 32' ' ' LEU . 11.7 t -77.27 -47.69 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.345 -0.847 . . . . 0.0 111.077 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.979 ' CA ' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -49.27 -45.26 44.68 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.124 -0.985 . . . . 0.0 110.255 -179.493 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.05 -42.29 48.11 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.431 -0.793 . . . . 0.0 109.542 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.747 HD12 ' O ' ' A' ' 27' ' ' GLU . 6.4 mt -60.55 -58.67 7.5 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.475 -0.766 . . . . 0.0 110.178 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.932 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 7.6 mt -51.15 -42.53 60.85 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.363 -0.835 . . . . 0.0 109.561 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -76.14 -9.43 58.62 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.625 -0.672 . . . . 0.0 110.571 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -93.9 -13.58 26.99 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.144 -0.972 . . . . 0.0 111.081 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 137.74 -0.79 2.79 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.581 -1.295 . . . . 0.0 110.909 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.932 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -46.41 151.31 0.55 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.017 -1.284 . . . . 0.0 110.174 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.77 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 12.6 tp -90.48 139.25 26.62 Favored Pre-proline 0 N--CA 1.496 1.828 0 O-C-N 121.163 -0.961 . . . . 0.0 110.302 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.445 ' HB2' ' O ' ' A' ' 67' ' ' GLY . 43.6 Cg_endo -72.61 -39.14 2.79 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 O-C-N 123.647 1.341 . . . . 0.0 110.753 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -115.62 60.4 0.71 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.039 -1.038 . . . . 0.0 110.167 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.77 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -93.11 105.5 15.55 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.454 -0.779 . . . . 0.0 109.722 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.64 102.65 0.75 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.565 1.297 . . . . 0.0 110.188 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -89.4 172.71 8.81 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.499 -0.75 . . . . 0.0 109.973 -179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.441 ' O ' ' HB2' ' A' ' 44' ' ' TYR . 0.1 OUTLIER -63.2 -157.78 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.32 -0.863 . . . . 0.0 110.407 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.441 ' HB2' ' O ' ' A' ' 43' ' ' SER . 14.0 m-85 64.71 11.01 6.46 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.589 -0.694 . . . . 0.0 111.037 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 59.54 47.02 92.95 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 179.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -160.72 -171.3 3.06 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.482 -1.011 . . . . 0.0 110.743 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.638 ' CB ' ' HD2' ' A' ' 48' ' ' PRO . 2.1 mmt180 -124.4 -155.04 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.647 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.638 ' HD2' ' CB ' ' A' ' 47' ' ' ARG . 47.9 Cg_endo -75.72 166.64 27.93 Favored 'Trans proline' 0 N--CA 1.484 0.965 0 O-C-N 122.501 0.738 . . . . 0.0 110.727 -179.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.502 ' HA ' ' HB2' ' A' ' 52' ' ' MET . 5.0 mt 65.97 -53.83 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.756 -0.59 . . . . 0.0 110.862 -179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.52 ' CG ' ' HB3' ' A' ' 81' ' ' PRO . 73.9 mt-30 -50.38 -29.17 9.45 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.772 -1.205 . . . . 0.0 110.187 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.593 HG22 ' HB2' ' A' ' 21' ' ' ALA . 10.6 p -99.09 7.31 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.537 -0.727 . . . . 0.0 109.71 179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.522 ' CE ' ' HE3' ' A' ' 54' ' ' MET . 44.4 ttp -66.56 161.62 22.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.557 -0.714 . . . . 0.0 110.127 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 48.7 ttp -70.28 -4.34 21.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.259 -0.9 . . . . 0.0 110.213 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.522 ' HE3' ' CE ' ' A' ' 52' ' ' MET . 0.0 OUTLIER 53.96 23.79 4.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.003 -1.061 . . . . 0.0 110.069 -179.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.539 ' HA2' ' CE1' ' A' ' 90' ' ' PHE . . . -123.95 -5.63 7.41 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.48 90.4 2.72 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.334 -1.098 . . . . 0.0 110.129 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.659 ' HB2' ' HE2' ' A' ' 90' ' ' PHE . . . -53.48 -24.83 14.09 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.087 -1.008 . . . . 0.0 109.872 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -51.9 -48.37 64.17 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.549 -0.72 . . . . 0.0 110.442 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.669 HG23 HG22 ' A' ' 25' ' ' VAL . 32.1 t -59.36 -57.74 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.189 -0.944 . . . . 0.0 109.694 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -46.46 -59.71 2.8 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.429 -0.794 . . . . 0.0 110.091 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.553 ' HA ' HG11 ' A' ' 96' ' ' VAL . 17.1 tt0 -46.68 -43.47 17.8 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.382 -0.824 . . . . 0.0 109.208 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.979 HD11 ' CA ' ' A' ' 29' ' ' ARG . 0.3 OUTLIER -57.65 -64.74 0.79 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.284 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.841 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 2.6 mt -56.46 -48.94 76.01 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.637 HD13 HG12 ' A' ' 96' ' ' VAL . 0.3 OUTLIER -56.39 -56.67 18.2 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.469 -0.77 . . . . 0.0 109.659 179.323 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.469 ' HB3' ' O ' ' A' ' 61' ' ' GLU . 9.5 tp -53.06 -30.35 35.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.311 -0.868 . . . . 0.0 109.185 179.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.824 ' CG ' HD22 ' A' ' 32' ' ' LEU . 1.5 m-70 -86.2 -21.3 27.54 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.716 -0.615 . . . . 0.0 109.652 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.445 ' O ' ' HB2' ' A' ' 38' ' ' PRO . . . 110.49 48.81 0.73 Allowed Glycine 0 N--CA 1.482 1.72 0 N-CA-C 110.829 -0.908 . . . . 0.0 110.829 178.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.841 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -64.5 -150.85 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.885 -1.362 . . . . 0.0 109.402 179.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.49 ' HG3' ' HD2' ' A' ' 48' ' ' PRO . 1.7 mm-40 -119.61 53.37 2.41 Favored Pre-proline 0 C--N 1.301 -1.508 0 O-C-N 121.357 -0.84 . . . . 0.0 109.58 178.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.456 ' HG3' ' HG ' ' A' ' 64' ' ' LEU . 47.3 Cg_endo -70.4 -16.33 34.85 Favored 'Trans proline' 0 C--N 1.317 -1.082 0 O-C-N 123.755 1.397 . . . . 0.0 109.99 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -95.41 -57.27 2.45 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.516 -0.74 . . . . 0.0 110.002 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -59.51 178.15 0.16 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.442 -0.786 . . . . 0.0 110.215 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -150.7 -152.61 0.44 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.512 -0.742 . . . . 0.0 109.914 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.439 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 39.1 m-20 -116.78 130.44 24.56 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.341 -0.849 . . . . 0.0 109.263 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.674 ' O ' ' HB3' ' A' ' 76' ' ' ALA . 42.0 Cg_endo -69.74 -177.2 1.76 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 O-C-N 123.426 1.224 . . . . 0.0 110.322 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.674 ' HB3' ' O ' ' A' ' 75' ' ' PRO . . . 71.42 -58.59 0.57 Allowed 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.475 -0.766 . . . . 0.0 109.802 -178.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.539 ' C ' ' HB2' ' A' ' 109' ' ' ALA . 0.2 OUTLIER -115.57 0.45 13.31 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.16 -0.962 . . . . 0.0 110.621 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.508 ' HB3' ' O ' ' A' ' 107' ' ' ARG . 1.2 mt 48.62 53.37 12.31 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.222 -0.924 . . . . 0.0 111.41 179.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 60.2 m -88.42 98.51 11.66 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.086 -1.009 . . . . 0.0 110.474 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.693 ' CD ' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -74.18 165.77 50.53 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.326 -0.859 . . . . 0.0 109.392 179.368 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.581 ' HD2' ' CG ' ' A' ' 80' ' ' ARG . 45.4 Cg_endo -79.14 -0.71 10.98 Favored 'Trans proline' 0 C--N 1.314 -1.261 0 O-C-N 123.308 1.162 . . . . 0.0 110.339 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.699 HG21 ' O ' ' A' ' 103' ' ' ARG . 22.1 t -76.93 -31.55 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.558 -0.714 . . . . 0.0 109.391 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.476 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 5.7 m80 -70.65 -36.69 73.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.519 -0.738 . . . . 0.0 109.44 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.519 ' O ' ' HB3' ' A' ' 87' ' ' ARG . 67.8 m-20 -54.0 -50.24 67.05 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.68 -0.637 . . . . 0.0 109.688 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.755 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -55.81 -67.91 0.25 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.142 -0.974 . . . . 0.0 109.356 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.763 ' HB2' HD11 ' A' ' 130' ' ' LEU . . . -52.92 -38.64 62.07 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.287 -0.883 . . . . 0.0 110.892 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.519 ' HB3' ' O ' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -44.9 -47.16 11.2 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.51 -0.744 . . . . 0.0 110.894 -179.307 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -97.12 8.38 44.63 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.209 -0.932 . . . . 0.0 110.156 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.446 ' HA3' ' ND1' ' A' ' 123' ' ' HIS . . . 70.87 40.85 63.44 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.154 -1.579 . . . . 0.0 109.154 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.659 ' HE2' ' HB2' ' A' ' 57' ' ' ALA . 1.9 t80 -106.88 116.41 31.88 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.315 -1.109 . . . . 0.0 110.673 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.457 HD21 ' CG ' ' A' ' 129' ' ' TYR . 0.4 OUTLIER -94.77 -42.67 8.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.633 -0.667 . . . . 0.0 110.844 -179.487 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.604 ' O ' HG23 ' A' ' 96' ' ' VAL . 92.1 m-20 -43.64 -44.46 6.36 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.383 -0.823 . . . . 0.0 109.734 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.4 m -66.41 -49.06 68.07 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.798 HD22 HG13 ' A' ' 126' ' ' VAL . 4.2 tp -53.38 -39.93 64.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.583 -0.698 . . . . 0.0 109.529 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.418 ' O ' ' N ' ' A' ' 99' ' ' ARG . 84.4 t -62.59 -53.16 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.375 -0.828 . . . . 0.0 108.964 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.637 HG12 HD13 ' A' ' 64' ' ' LEU . 63.7 t -50.23 -47.97 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.512 -0.742 . . . . 0.0 109.653 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.53 ' HA ' HD11 ' A' ' 64' ' ' LEU . 1.2 mp -56.9 -45.27 82.73 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.619 -0.676 . . . . 0.0 109.679 179.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -75.79 -29.36 58.71 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.368 -0.833 . . . . 0.0 109.874 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 95' ' ' VAL . 0.4 OUTLIER -67.72 -13.14 61.86 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.374 -0.829 . . . . 0.0 110.735 179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.586 ' HB3' HD21 ' A' ' 64' ' ' LEU . . . -118.98 -93.24 0.52 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.315 -0.866 . . . . 0.0 110.792 -179.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -156.71 45.21 0.51 Allowed Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.512 -1.328 . . . . 0.0 110.298 -179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -78.03 -171.4 2.3 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.09 -1.241 . . . . 0.0 109.692 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.699 ' O ' HG21 ' A' ' 82' ' ' VAL . 15.8 tpt180 -123.44 137.98 54.68 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.181 -0.949 . . . . 0.0 109.947 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.521 ' O ' ' HA ' ' A' ' 134' ' ' ALA . 14.0 mt -135.63 64.91 1.56 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.283 -0.885 . . . . 0.0 110.204 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -174.68 38.77 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.874 -1.142 . . . . 0.0 110.159 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.693 HG11 ' CD ' ' A' ' 80' ' ' ARG . 12.6 p -110.19 173.92 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.348 -0.845 . . . . 0.0 110.433 -179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.584 ' N ' HG22 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -127.91 138.66 52.74 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 179.145 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 110' ' ' TRP . 28.0 p-10 -68.73 61.88 0.1 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.353 -0.842 . . . . 0.0 111.121 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.539 ' HB2' ' C ' ' A' ' 77' ' ' THR . . . 59.88 -74.36 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.557 -0.714 . . . . 0.0 110.877 179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.534 ' CZ3' ' CG2' ' A' ' 77' ' ' THR . 4.7 m-90 -47.88 -85.09 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.415 -0.803 . . . . 0.0 111.072 -179.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -178.74 57.28 0.09 OUTLIER Glycine 0 N--CA 1.482 1.717 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.54 ' O ' HD12 ' A' ' 113' ' ' LEU . 0.0 OUTLIER -131.2 -164.8 1.48 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.218 -1.166 . . . . 0.0 110.143 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.54 HD12 ' O ' ' A' ' 112' ' ' ARG . 0.1 OUTLIER -155.39 165.46 18.29 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.509 -0.744 . . . . 0.0 109.825 -179.812 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.435 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 41.8 Cg_endo -69.02 -30.12 26.27 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.452 1.238 . . . . 0.0 109.982 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.447 ' HB ' ' HB3' ' A' ' 130' ' ' LEU . 10.9 p -82.63 -37.63 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.343 -0.848 . . . . 0.0 109.769 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.443 ' N ' HG13 ' A' ' 115' ' ' VAL . 24.5 t0 -54.19 -38.44 65.61 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.431 -0.793 . . . . 0.0 109.985 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -69.22 -54.07 16.64 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.505 -0.747 . . . . 0.0 110.038 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.537 ' CB ' ' HB2' ' A' ' 127' ' ' ALA . . . -46.02 -56.03 6.08 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.454 -0.779 . . . . 0.0 110.785 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -58.88 -28.46 66.17 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.296 -0.878 . . . . 0.0 109.927 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -75.32 -49.73 18.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.432 -0.792 . . . . 0.0 109.84 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.7 mt -73.77 -91.36 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.329 -0.857 . . . . 0.0 109.95 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -173.91 31.02 0.1 OUTLIER Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.684 -1.246 . . . . 0.0 110.106 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.564 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 50.4 m-70 -102.59 44.2 1.03 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.267 -1.137 . . . . 0.0 109.349 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.577 ' HA ' ' HB3' ' A' ' 127' ' ' ALA . 1.7 mtm180 -46.07 -40.26 10.53 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.737 -0.602 . . . . 0.0 109.967 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -55.82 -45.65 78.27 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.798 HG13 HD22 ' A' ' 94' ' ' LEU . 16.8 t -78.05 -40.45 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 C-N-CA 119.666 -0.814 . . . . 0.0 109.087 178.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.577 ' HB3' ' HA ' ' A' ' 124' ' ' ARG . . . -57.57 -58.31 8.86 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.593 -0.692 . . . . 0.0 109.677 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.409 ' NH1' ' HG3' ' A' ' 128' ' ' ARG . 38.1 ttm-85 -45.2 -59.79 2.45 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.69 -0.631 . . . . 0.0 109.92 179.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.457 ' CG ' HD21 ' A' ' 91' ' ' LEU . 5.7 t80 -57.53 -45.76 84.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.582 -0.699 . . . . 0.0 109.214 178.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.763 HD11 ' HB2' ' A' ' 86' ' ' ALA . 7.2 mt -54.86 -41.47 70.83 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.561 -0.712 . . . . 0.0 110.952 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 39.7 ttp85 -62.52 -40.2 96.0 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.253 -0.905 . . . . 0.0 110.202 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -81.04 -30.12 34.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.264 -0.898 . . . . 0.0 110.304 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -89.58 -18.02 27.39 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.214 -0.929 . . . . 0.0 110.164 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.582 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . -124.78 -45.0 1.92 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.18 -0.95 . . . . 0.0 110.586 -179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.85 -144.53 31.36 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 120.08 34.54 0.95 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 14.8 p -80.01 127.55 32.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.278 -1.131 . . . . 0.0 110.075 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.475 ' HB2' ' CB ' ' A' ' 143' ' ' ALA . 4.2 mpt_? -71.72 93.98 1.33 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.351 -0.843 . . . . 0.0 110.118 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -80.42 3.78 71.4 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.4 p -148.1 60.33 1.11 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.981 -1.305 . . . . 0.0 110.708 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -174.38 55.15 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.144 -0.972 . . . . 0.0 111.039 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 41.32 55.85 3.27 Favored 'General case' 0 N--CA 1.504 2.23 0 O-C-N 121.412 -0.805 . . . . 0.0 110.755 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.475 ' CB ' ' HB2' ' A' ' 138' ' ' ARG . . . -123.93 -63.58 1.2 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.309 -0.87 . . . . 0.0 110.208 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.69 153.22 19.08 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.462 -0.774 . . . . 0.0 109.713 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.468 HG23 ' O ' ' A' ' 145' ' ' ILE . 2.6 tt -50.09 129.48 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.29 -0.881 . . . . 0.0 110.135 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -46.51 98.96 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.477 -0.764 . . . . 0.0 110.633 -179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -53.57 133.52 41.23 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.276 -0.89 . . . . 0.0 110.352 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -75.72 146.11 40.38 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.48 -0.762 . . . . 0.0 110.108 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -123.57 -73.69 0.64 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.323 -0.86 . . . . 0.0 110.166 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 127.26 175.63 14.17 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.181 -1.568 . . . . 0.0 109.181 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -76.35 121.74 6.22 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.593 1.312 . . . . 0.0 110.708 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 4.9 t -85.7 122.22 29.48 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.323 -0.861 . . . . 0.0 109.474 179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.33 138.27 10.14 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.45 -0.781 . . . . 0.0 110.728 -179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.587 ' O ' HG23 ' A' ' 154' ' ' ILE . 3.6 tp -128.31 95.16 34.07 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.518 -0.739 . . . . 0.0 110.363 -179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.34 138.82 33.71 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 O-C-N 123.688 1.362 . . . . 0.0 110.317 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.496 1.841 0 CA-C-O 117.932 -1.032 . . . . 0.0 110.161 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 mtm . . . . . 0 N--CA 1.497 1.914 0 CA-C-O 121.269 0.557 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -161.6 102.16 1.2 Allowed Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.551 -0.718 . . . . 0.0 109.99 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -79.85 -163.68 0.24 Allowed 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.649 1.341 . . . . 0.0 110.264 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -128.24 93.95 3.78 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.557 -0.714 . . . . 0.0 110.404 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -174.19 50.08 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.239 -0.913 . . . . 0.0 109.741 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 84.51 139.81 4.52 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.0 t 174.07 125.71 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.437 -1.037 . . . . 0.0 110.231 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.3 p -53.64 169.94 0.13 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.266 -0.896 . . . . 0.0 110.537 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.408 ' O ' ' HD3' ' A' ' 11' ' ' PRO . 2.6 mtp 174.45 48.5 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.442 -0.786 . . . . 0.0 110.022 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -101.69 99.64 12.26 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.231 -0.918 . . . . 0.0 110.161 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 9' ' ' MET . 42.1 Cg_endo -70.75 110.09 2.67 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.63 1.332 . . . . 0.0 109.82 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.6 p -62.02 119.23 8.49 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.324 -0.86 . . . . 0.0 110.038 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -117.06 -118.53 0.32 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.426 -0.796 . . . . 0.0 110.262 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.9 t70 62.77 5.26 1.69 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.86 -1.15 . . . . 0.0 111.044 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.524 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 49.1 m0 -68.19 -12.66 61.33 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.176 -0.952 . . . . 0.0 110.68 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.041 ' HB3' HD21 ' A' ' 63' ' ' LEU . 35.6 mt -76.13 -60.78 2.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.166 -0.959 . . . . 0.0 109.477 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.571 ' HB2' ' HA ' ' A' ' 48' ' ' PRO . . . -57.55 -48.2 79.97 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.519 -0.738 . . . . 0.0 109.861 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.524 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.6 OUTLIER -44.44 -55.27 5.17 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.444 -0.785 . . . . 0.0 110.536 179.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.808 ' HB1' ' HB3' ' A' ' 24' ' ' ARG . . . -71.8 -32.4 67.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.145 -0.972 . . . . 0.0 109.942 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.455 ' HB1' HG11 ' A' ' 59' ' ' VAL . . . -67.73 -45.88 73.76 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.208 -0.933 . . . . 0.0 109.962 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.14 -25.67 68.46 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.48 -0.762 . . . . 0.0 109.616 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -104.83 25.93 9.8 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.453 -0.78 . . . . 0.0 110.306 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.571 ' HA3' ' HE2' ' A' ' 53' ' ' MET . . . 48.4 66.79 1.9 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.808 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -133.3 54.61 1.94 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.44 -1.035 . . . . 0.0 109.409 -179.898 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 1.03 HG22 HG23 ' A' ' 59' ' ' VAL . 45.1 t -46.1 -56.93 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.535 -0.728 . . . . 0.0 110.869 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -40.78 -50.91 3.15 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.724 -0.61 . . . . 0.0 110.954 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.709 ' O ' HD12 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -58.77 -41.28 86.24 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.194 -0.942 . . . . 0.0 109.622 179.592 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.749 HG12 HD13 ' A' ' 62' ' ' LEU . 13.6 t -69.81 -49.78 54.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.503 -0.748 . . . . 0.0 110.289 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.786 ' HA ' HD11 ' A' ' 62' ' ' LEU . 4.4 mmt180 -41.65 -52.3 3.85 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.514 -0.741 . . . . 0.0 110.122 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.41 -53.35 9.75 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.809 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.709 HD12 ' O ' ' A' ' 27' ' ' GLU . 4.7 mt -47.73 -62.74 1.31 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.431 -0.793 . . . . 0.0 110.998 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.779 ' HG ' HD22 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -44.1 -57.5 3.36 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.571 -0.706 . . . . 0.0 110.379 179.89 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -66.27 -10.88 46.65 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.667 -0.646 . . . . 0.0 110.526 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.51 ' HB3' ' O ' ' A' ' 31' ' ' LEU . . . -86.8 -11.86 49.71 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.067 -1.02 . . . . 0.0 110.239 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 130.19 -6.45 6.02 Favored Glycine 0 N--CA 1.491 2.304 0 C-N-CA 119.907 -1.139 . . . . 0.0 110.999 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.898 ' CB ' HD21 ' A' ' 16' ' ' LEU . . . -42.78 155.9 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.19 -1.183 . . . . 0.0 110.636 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.985 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 3.2 tp -80.91 131.03 61.21 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.228 -0.92 . . . . 0.0 110.858 -178.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.445 ' O ' ' HA ' ' A' ' 68' ' ' ALA . 49.0 Cg_endo -74.4 -15.64 22.24 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.841 1.443 . . . . 0.0 110.8 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.434 ' ND2' ' HG2' ' A' ' 69' ' ' GLU . 0.5 OUTLIER -128.38 25.72 5.76 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.101 -0.999 . . . . 0.0 110.475 -179.636 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.985 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -66.46 123.92 86.85 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.254 -0.904 . . . . 0.0 109.873 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -76.75 149.19 29.54 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.673 1.354 . . . . 0.0 110.319 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -81.16 -163.27 0.58 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.544 -0.723 . . . . 0.0 109.922 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.407 ' C ' ' CD1' ' A' ' 44' ' ' TYR . 0.1 OUTLIER -99.12 6.17 46.59 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.883 -1.136 . . . . 0.0 110.571 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.407 ' CD1' ' C ' ' A' ' 43' ' ' SER . 2.4 m-85 -119.01 36.37 4.48 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.28 -0.887 . . . . 0.0 109.434 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 53.41 28.33 35.66 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.74 -157.46 0.61 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.55 -0.97 . . . . 0.0 110.822 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.609 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 0.3 OUTLIER -121.2 -173.14 0.25 Allowed Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.33 -0.856 . . . . 0.0 110.638 -178.604 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.794 ' HB2' HD22 ' A' ' 63' ' ' LEU . 42.2 Cg_endo -77.99 -26.52 6.52 Favored 'Trans proline' 0 C--N 1.32 -0.958 0 O-C-N 123.467 1.246 . . . . 0.0 111.438 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.425 ' CD1' ' HA ' ' A' ' 60' ' ' ALA . 12.0 mt -109.71 -37.65 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 120.768 -1.207 . . . . 0.0 109.389 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.479 ' HB2' ' HB3' ' A' ' 81' ' ' PRO . 2.5 tt0 -53.8 -16.67 1.85 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.691 -0.63 . . . . 0.0 110.686 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 51' ' ' VAL . 7.4 p -114.35 6.78 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.023 -1.048 . . . . 0.0 111.225 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.475 ' CE ' ' HE1' ' A' ' 54' ' ' MET . 0.0 OUTLIER -67.92 168.54 11.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.774 -1.204 . . . . 0.0 109.495 179.825 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.571 ' HE2' ' HA3' ' A' ' 23' ' ' GLY . 3.1 tmm? -67.8 -1.92 6.28 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.21 -0.931 . . . . 0.0 111.301 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.475 ' HE1' ' CE ' ' A' ' 52' ' ' MET . 12.9 mmt 48.56 23.04 0.56 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.259 -0.901 . . . . 0.0 110.361 -179.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.433 ' HA3' ' SD ' ' A' ' 53' ' ' MET . . . -120.46 3.19 12.39 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 108.279 -1.928 . . . . 0.0 108.279 178.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.41 74.07 1.45 Allowed 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.75 -0.853 . . . . 0.0 108.88 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.757 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . . . -43.71 -27.57 0.33 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.421 -0.8 . . . . 0.0 110.151 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.474 ' HB3' HG11 ' A' ' 25' ' ' VAL . 0.0 OUTLIER -49.37 -49.33 44.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.541 -0.724 . . . . 0.0 109.639 178.744 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 1.03 HG23 HG22 ' A' ' 25' ' ' VAL . 63.5 t -48.72 -59.87 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.659 -0.65 . . . . 0.0 109.945 179.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.486 ' O ' ' HB3' ' A' ' 64' ' ' LEU . . . -45.45 -46.23 13.44 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.676 -0.64 . . . . 0.0 109.794 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.57 ' O ' ' HB3' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -51.19 -59.66 3.95 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.657 -0.652 . . . . 0.0 109.516 178.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.786 HD11 ' HA ' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -46.52 -72.27 0.06 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.609 -0.682 . . . . 0.0 110.373 179.114 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.041 HD21 ' HB3' ' A' ' 16' ' ' LEU . 4.0 mt -51.22 -50.08 59.83 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.393 -0.817 . . . . 0.0 110.616 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.945 HD13 HG12 ' A' ' 96' ' ' VAL . 0.9 OUTLIER -59.11 -59.14 5.94 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.489 -0.757 . . . . 0.0 110.744 -179.628 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.679 ' O ' HD12 ' A' ' 65' ' ' LEU . 0.8 OUTLIER -48.76 -34.58 12.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.318 -0.864 . . . . 0.0 108.736 179.755 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.444 ' ND1' ' CD1' ' A' ' 32' ' ' LEU . 0.3 OUTLIER -82.11 -30.59 31.12 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.282 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 63' ' ' LEU . . . 124.0 52.76 0.19 Allowed Glycine 0 N--CA 1.479 1.561 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 179.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.655 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -62.19 -154.24 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.08 -1.247 . . . . 0.0 109.529 179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.504 ' HB2' ' HB3' ' A' ' 47' ' ' ARG . 4.8 mt-10 -121.31 55.9 5.49 Favored Pre-proline 0 C--N 1.302 -1.499 0 O-C-N 121.33 -0.857 . . . . 0.0 109.448 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.424 ' CD ' ' N ' ' A' ' 69' ' ' GLU . 40.6 Cg_endo -66.28 -10.46 27.55 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.847 1.446 . . . . 0.0 110.351 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.532 ' HA ' ' NH2' ' A' ' 80' ' ' ARG . 72.2 m-20 -99.06 -72.87 0.64 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.193 -0.942 . . . . 0.0 110.146 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -42.89 161.8 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.663 -0.648 . . . . 0.0 110.953 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.468 ' O ' ' NH1' ' A' ' 47' ' ' ARG . . . -148.2 -149.27 0.29 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.383 -0.823 . . . . 0.0 110.184 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.522 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -105.06 135.21 19.33 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 120.956 -1.09 . . . . 0.0 110.269 -179.724 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.28 -22.04 22.5 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 N-CA-C 109.239 -1.1 . . . . 0.0 109.239 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.73 -67.77 0.26 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.588 -0.695 . . . . 0.0 109.677 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.535 ' HA ' ' CB ' ' A' ' 109' ' ' ALA . 14.6 p -124.82 27.47 6.79 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.391 -0.818 . . . . 0.0 109.342 179.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.522 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 1.3 mt 43.94 38.21 2.08 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.464 -0.772 . . . . 0.0 110.659 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.463 ' HA ' ' OD2' ' A' ' 108' ' ' ASP . 22.2 m -73.04 100.87 3.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.443 -0.786 . . . . 0.0 109.637 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.888 ' HG3' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -71.12 162.47 72.29 Favored Pre-proline 0 C--N 1.302 -1.471 0 O-C-N 121.401 -0.812 . . . . 0.0 110.806 -179.48 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.505 ' HA ' ' OD2' ' A' ' 84' ' ' ASP . 42.3 Cg_endo -69.95 -14.93 36.11 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 O-C-N 124.444 1.76 . . . . 0.0 110.219 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.897 HG21 ' HA ' ' A' ' 104' ' ' LEU . 20.1 t -68.38 -29.44 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.522 -0.737 . . . . 0.0 110.102 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.475 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 6.2 m80 -70.77 -28.53 64.74 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.393 -0.817 . . . . 0.0 109.136 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.505 ' OD2' ' HA ' ' A' ' 81' ' ' PRO . 72.2 m-20 -62.23 -57.13 12.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.35 -0.844 . . . . 0.0 110.042 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.615 ' HB2' ' CG2' ' A' ' 93' ' ' THR . . . -49.46 -57.48 6.93 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.452 -0.78 . . . . 0.0 109.757 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.876 ' CB ' HG11 ' A' ' 126' ' ' VAL . . . -57.19 -50.17 73.67 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.282 -0.886 . . . . 0.0 109.936 179.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.427 ' HD3' ' CD1' ' A' ' 121' ' ' LEU . 1.7 mmt85 -47.52 -21.51 0.35 Allowed 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.588 -0.695 . . . . 0.0 111.483 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.458 ' HG2' ' HB2' ' A' ' 54' ' ' MET . 3.8 mp0 -110.69 -7.65 14.64 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.201 -0.937 . . . . 0.0 110.479 179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.464 ' HA2' ' HB3' ' A' ' 123' ' ' HIS . . . 78.15 22.53 68.06 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.757 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.4 OUTLIER -95.22 111.79 23.59 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.533 -0.981 . . . . 0.0 110.427 -179.628 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.715 HD22 HG22 ' A' ' 126' ' ' VAL . 0.5 OUTLIER -82.43 -45.14 15.18 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.551 -0.718 . . . . 0.0 110.252 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.493 ' O ' HG23 ' A' ' 96' ' ' VAL . 20.9 m-20 -41.47 -43.56 2.66 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 121.548 0.69 . . . . 0.0 109.535 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.615 ' CG2' ' HB2' ' A' ' 85' ' ' ALA . 11.5 m -61.24 -59.58 5.09 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.753 -0.592 . . . . 0.0 109.596 179.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.743 HD12 ' O ' ' A' ' 90' ' ' PHE . 0.6 OUTLIER -46.75 -38.88 10.7 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.379 -0.826 . . . . 0.0 109.395 179.49 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.474 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 58.0 t -66.41 -43.88 90.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.945 HG12 HD13 ' A' ' 64' ' ' LEU . 45.8 t -58.58 -55.73 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 178.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.453 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 6.5 mp -47.21 -61.47 1.88 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.423 -0.798 . . . . 0.0 110.133 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -61.16 -36.01 78.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.162 -0.961 . . . . 0.0 109.838 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 1.1 mtp-105 -58.4 -13.18 4.81 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.394 -0.816 . . . . 0.0 110.536 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.802 ' HB3' HD11 ' A' ' 64' ' ' LEU . . . -146.58 61.8 1.21 Allowed 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.228 -0.92 . . . . 0.0 110.625 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 60.08 107.9 0.01 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 110.356 -1.097 . . . . 0.0 110.356 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.519 ' HA ' ' OD1' ' A' ' 71' ' ' ASN . . . -165.64 89.36 0.44 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.423 -1.045 . . . . 0.0 110.39 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.5 96.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.968 -1.082 . . . . 0.0 109.776 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.897 ' HA ' HG21 ' A' ' 82' ' ' VAL . 1.8 mp -87.45 41.87 1.01 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.214 -0.929 . . . . 0.0 110.457 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.63 ' HB2' ' HA ' ' A' ' 134' ' ' ALA . 30.9 t0 -146.9 41.78 1.11 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.905 -1.122 . . . . 0.0 110.829 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.888 HG11 ' HG3' ' A' ' 80' ' ' ARG . 7.1 p -99.01 177.13 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.378 -0.826 . . . . 0.0 109.754 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.557 ' H ' HG22 ' A' ' 106' ' ' VAL . 8.8 mtm180 -111.62 136.79 50.36 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.372 -0.83 . . . . 0.0 109.933 179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' A' ' 110' ' ' TRP . 5.5 t70 -74.94 53.08 0.58 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.409 -0.807 . . . . 0.0 109.447 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.535 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 56.98 -78.9 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.657 -0.652 . . . . 0.0 110.382 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.522 ' N ' ' O ' ' A' ' 108' ' ' ASP . 0.0 OUTLIER -37.18 -60.67 0.63 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.6 -0.687 . . . . 0.0 110.906 -179.893 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 160.74 -34.58 0.41 Allowed Glycine 0 N--CA 1.482 1.7 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.08 134.66 17.23 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.737 -0.861 . . . . 0.0 110.933 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.618 ' O ' HD12 ' A' ' 117' ' ' LEU . 16.2 mt -96.66 169.79 8.33 Favored Pre-proline 0 N--CA 1.494 1.774 0 O-C-N 121.283 -0.886 . . . . 0.0 109.923 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 38.2 Cg_endo -64.97 -36.24 39.4 Favored 'Trans proline' 0 N--CA 1.49 1.295 0 O-C-N 123.674 1.355 . . . . 0.0 110.155 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 127' ' ' ALA . 10.7 p -78.9 -33.23 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.439 -0.788 . . . . 0.0 109.264 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.512 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 3.1 t0 -60.85 -23.98 65.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.507 -0.745 . . . . 0.0 109.898 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.618 HD12 ' O ' ' A' ' 113' ' ' LEU . 0.3 OUTLIER -76.25 -65.12 0.96 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.427 -0.796 . . . . 0.0 110.102 179.848 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.537 ' HB1' ' HB2' ' A' ' 123' ' ' HIS . . . -44.48 -53.61 6.8 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.568 -0.707 . . . . 0.0 111.077 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.19 -45.61 75.82 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.291 -0.881 . . . . 0.0 110.444 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.512 ' HB2' ' O ' ' A' ' 116' ' ' ASP . 0.0 OUTLIER -71.51 -45.13 63.27 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.467 -0.77 . . . . 0.0 109.967 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.427 ' CD1' ' HD3' ' A' ' 87' ' ' ARG . 4.8 mt -69.15 -94.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.615 -0.678 . . . . 0.0 109.92 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -177.26 47.83 0.1 Allowed Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.786 -1.726 . . . . 0.0 108.786 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.537 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . 71.4 m-70 -124.91 52.55 1.56 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.463 -1.022 . . . . 0.0 109.528 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 124' ' ' ARG . 26.8 mtm105 -43.59 -49.17 7.64 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.811 -0.556 . . . . 0.0 110.633 -179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.4 ' C ' HD21 ' A' ' 91' ' ' LEU . 36.8 t0 -46.16 -46.88 17.57 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.876 HG11 ' CB ' ' A' ' 86' ' ' ALA . 22.4 t -76.08 -49.91 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 119.683 -0.807 . . . . 0.0 109.933 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.447 ' O ' HG23 ' A' ' 115' ' ' VAL . . . -43.6 -48.72 7.67 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.321 -0.862 . . . . 0.0 110.19 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 36.7 mtt-85 -64.28 -64.88 0.77 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.502 -0.749 . . . . 0.0 109.754 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -50.27 -41.7 51.0 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.371 -0.831 . . . . 0.0 110.818 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.71 ' O ' ' HB3' ' A' ' 134' ' ' ALA . 12.2 mt -58.15 -56.99 14.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.103 -0.998 . . . . 0.0 109.767 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -47.32 -23.44 0.57 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.366 -0.834 . . . . 0.0 110.858 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.452 ' O ' ' N ' ' A' ' 136' ' ' GLY . . . -83.95 -73.46 0.42 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.197 -0.94 . . . . 0.0 109.921 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.14 -11.72 22.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.167 -0.958 . . . . 0.0 110.377 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.71 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . -107.39 61.19 0.62 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.353 -0.842 . . . . 0.0 109.661 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 95.27 38.43 4.8 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 132' ' ' ALA . . . -56.2 -77.57 0.15 Allowed Glycine 0 N--CA 1.492 2.427 0 N-CA-C 108.924 -1.671 . . . . 0.0 108.924 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.468 ' O ' HG23 ' A' ' 137' ' ' THR . 15.4 t -90.84 131.87 36.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.441 -1.035 . . . . 0.0 109.942 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -141.02 118.47 11.49 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.137 -0.977 . . . . 0.0 110.282 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 169.19 -48.67 0.22 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.682 -1.367 . . . . 0.0 109.682 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 52.49 19.18 1.11 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.337 -1.096 . . . . 0.0 110.426 -179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -129.95 71.02 1.43 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.343 -0.848 . . . . 0.0 109.487 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 63.51 44.89 5.03 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.462 -0.774 . . . . 0.0 109.943 -179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -122.56 -170.35 2.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.384 -0.822 . . . . 0.0 110.012 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.421 ' O ' ' HB ' ' A' ' 145' ' ' ILE . 14.0 ttp85 49.53 74.4 0.2 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.423 -0.798 . . . . 0.0 110.219 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.421 ' HB ' ' O ' ' A' ' 144' ' ' ARG . 7.7 mt 61.02 165.11 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.444 -0.785 . . . . 0.0 109.678 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -43.6 158.26 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.336 -0.853 . . . . 0.0 110.539 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -47.6 169.41 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.47 -0.769 . . . . 0.0 110.567 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -60.1 170.26 1.3 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.352 -0.843 . . . . 0.0 109.785 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -155.66 -42.47 0.08 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.542 -0.724 . . . . 0.0 109.249 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -115.5 137.33 13.75 Favored Glycine 0 N--CA 1.487 2.066 0 N-CA-C 108.811 -1.716 . . . . 0.0 108.811 178.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.404 ' O ' ' HB3' ' A' ' 152' ' ' SER . 45.9 Cg_endo -69.6 128.01 15.55 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 O-C-N 123.699 1.368 . . . . 0.0 110.401 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 151' ' ' PRO . 75.7 p -177.04 152.43 0.9 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.411 -0.805 . . . . 0.0 109.799 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 58.6 86.68 0.08 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.257 -0.902 . . . . 0.0 110.191 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 9.2 mt -132.86 85.13 47.47 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.252 -0.905 . . . . 0.0 110.517 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -79.86 122.47 4.88 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 O-C-N 123.89 1.468 . . . . 0.0 110.161 179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 21.1 p30 . . . . . 0 N--CA 1.493 1.713 0 CA-C-O 118.041 -0.981 . . . . 0.0 110.395 -179.696 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.874 0 CA-C-O 121.099 0.476 . . . . 0.0 110.165 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -129.2 130.44 23.38 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.284 -0.885 . . . . 0.0 110.661 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -72.16 161.89 43.28 Favored 'Trans proline' 0 C--N 1.315 -1.231 0 O-C-N 123.561 1.295 . . . . 0.0 110.245 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -106.99 114.9 29.26 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.414 -0.804 . . . . 0.0 110.458 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -166.45 130.5 2.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.349 -0.844 . . . . 0.0 110.268 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -128.72 99.76 0.5 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.5 m -60.62 174.77 0.54 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.245 -1.15 . . . . 0.0 110.451 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 6.7 p -155.75 -179.82 8.49 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.323 -0.861 . . . . 0.0 110.323 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 21.9 mtt -97.79 -87.01 0.33 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.231 -0.918 . . . . 0.0 110.936 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -138.5 101.52 8.14 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.16 -0.962 . . . . 0.0 110.723 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -75.81 85.23 1.65 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 123.856 1.451 . . . . 0.0 110.607 179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.0 m -58.88 150.07 25.18 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.135 -0.978 . . . . 0.0 110.376 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.19 107.54 0.43 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.28 -0.888 . . . . 0.0 110.502 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -111.49 28.73 8.47 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.367 -0.833 . . . . 0.0 109.916 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.54 ' O ' HD13 ' A' ' 31' ' ' LEU . 31.1 m0 -85.93 -24.88 26.39 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.365 -0.835 . . . . 0.0 110.349 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.134 HD11 HD21 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -71.29 -37.24 71.86 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.268 -0.895 . . . . 0.0 109.379 179.511 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.677 ' HB2' ' ND2' ' A' ' 42' ' ' ASN . . . -81.21 -47.92 12.77 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.443 -0.786 . . . . 0.0 110.914 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.518 HG23 ' N ' ' A' ' 19' ' ' ALA . 14.6 t -48.78 -43.06 37.61 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.357 -0.84 . . . . 0.0 111.09 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.6 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -75.89 -36.52 59.46 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.192 -0.943 . . . . 0.0 109.999 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.4 ' CB ' HG11 ' A' ' 59' ' ' VAL . . . -69.1 -28.4 66.46 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.126 -0.984 . . . . 0.0 110.088 179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.435 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -80.53 -36.02 33.72 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.369 -0.832 . . . . 0.0 110.64 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -84.42 21.95 1.36 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.226 -0.921 . . . . 0.0 110.861 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.53 ' HA3' ' HE1' ' A' ' 53' ' ' MET . . . 44.85 65.01 1.93 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.496 ' HB3' ' HB3' ' A' ' 27' ' ' GLU . 0.0 OUTLIER -133.38 62.82 1.65 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.341 -1.094 . . . . 0.0 109.35 179.374 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.438 ' C ' ' O ' ' A' ' 24' ' ' ARG . 77.3 t -34.78 -53.82 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.872 -0.518 . . . . 0.0 111.421 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -53.0 -45.06 67.71 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.355 -0.841 . . . . 0.0 110.683 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.496 ' HB3' ' HB3' ' A' ' 24' ' ' ARG . 2.1 tp10 -64.64 -28.42 69.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.235 -0.916 . . . . 0.0 110.149 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.069 HG12 HD23 ' A' ' 62' ' ' LEU . 47.5 t -85.3 -51.24 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.181 -0.949 . . . . 0.0 110.428 -179.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 1.013 ' HA ' HD22 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -43.44 -48.62 7.2 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.516 -0.74 . . . . 0.0 111.014 -179.916 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.46 -50.02 15.15 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.48 -0.762 . . . . 0.0 110.391 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.54 HD13 ' O ' ' A' ' 15' ' ' TRP . 10.7 mt -44.48 -61.03 1.68 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.495 -0.753 . . . . 0.0 110.497 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.859 ' HB3' HD11 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -57.21 -44.56 83.82 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.537 -0.727 . . . . 0.0 109.704 179.429 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -68.43 -7.41 31.49 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.36 -0.838 . . . . 0.0 110.562 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -105.32 -18.07 14.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.165 -0.959 . . . . 0.0 111.014 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' A' ' 37' ' ' LEU . . . 161.09 -36.51 0.41 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.724 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -45.63 96.31 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.404 -1.057 . . . . 0.0 110.093 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.636 ' HG ' ' HB2' ' A' ' 40' ' ' ALA . 0.8 OUTLIER -66.33 152.03 95.02 Favored Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 121.299 -0.876 . . . . 0.0 110.099 -179.071 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.465 ' HB2' ' HA ' ' A' ' 68' ' ' ALA . 44.3 Cg_endo -70.65 -34.35 11.75 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 O-C-N 124.025 1.539 . . . . 0.0 111.922 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -88.3 42.73 1.08 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.924 -1.11 . . . . 0.0 110.355 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.636 ' HB2' ' HG ' ' A' ' 37' ' ' LEU . . . -97.7 107.13 37.98 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.289 -0.882 . . . . 0.0 110.097 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -69.94 133.47 25.32 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.644 1.339 . . . . 0.0 109.528 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.677 ' ND2' ' HB2' ' A' ' 17' ' ' ALA . 5.7 m120 -77.05 -176.98 4.23 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.431 -0.793 . . . . 0.0 110.059 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 69.2 m -102.39 23.86 11.18 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.31 -0.869 . . . . 0.0 109.44 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.46 ' O ' ' HG2' ' A' ' 46' ' ' ARG . 7.4 m-85 -122.59 19.24 10.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.73 -0.606 . . . . 0.0 109.479 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.431 ' C ' ' HG2' ' A' ' 46' ' ' ARG . . . 60.94 26.9 66.12 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.46 ' HG2' ' O ' ' A' ' 44' ' ' TYR . 0.0 OUTLIER -129.1 130.5 46.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.219 -1.165 . . . . 0.0 109.889 -179.772 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.581 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 3.4 mmp_? -48.02 168.95 0.14 Allowed Pre-proline 0 N--CA 1.499 2.016 0 O-C-N 121.574 -0.704 . . . . 0.0 110.475 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.581 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 39.2 Cg_endo -67.01 -17.91 51.53 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.562 1.296 . . . . 0.0 110.329 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.765 ' CG1' HD22 ' A' ' 63' ' ' LEU . 4.9 mt -107.38 -34.16 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 177.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.436 ' HG2' ' HB3' ' A' ' 46' ' ' ARG . 44.6 tt0 -50.45 -24.85 3.37 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.627 -0.671 . . . . 0.0 109.362 178.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.505 HG11 ' HB1' ' A' ' 17' ' ' ALA . 11.9 p -99.53 7.93 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.471 -0.768 . . . . 0.0 110.246 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.503 ' HB2' ' O ' ' A' ' 49' ' ' ILE . 2.2 tmm? -61.66 158.07 16.22 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.232 -0.917 . . . . 0.0 109.318 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.53 ' HE1' ' HA3' ' A' ' 23' ' ' GLY . 54.7 ttp -70.64 -5.29 28.36 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.223 -0.923 . . . . 0.0 110.135 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.566 ' HB3' ' CB ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER 53.53 22.37 2.93 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.053 -1.03 . . . . 0.0 109.519 -179.116 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.563 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -121.38 -7.41 8.31 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.731 -1.747 . . . . 0.0 108.731 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.1 m -134.73 87.13 2.32 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.426 -1.044 . . . . 0.0 109.638 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.556 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . . . -53.48 -25.7 17.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.325 -0.859 . . . . 0.0 109.643 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.408 ' O ' ' CB ' ' A' ' 61' ' ' GLU . 5.9 mtt85 -54.8 -38.24 67.06 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.595 -0.691 . . . . 0.0 110.093 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.4 HG11 ' CB ' ' A' ' 20' ' ' ALA . 59.6 t -55.86 -66.71 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.022 -1.048 . . . . 0.0 109.364 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 64' ' ' LEU . . . -45.82 -27.78 0.93 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.406 -0.809 . . . . 0.0 109.838 178.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -59.56 -53.69 55.13 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.428 -0.795 . . . . 0.0 110.152 179.54 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.069 HD23 HG12 ' A' ' 28' ' ' VAL . 0.5 OUTLIER -65.46 -42.54 92.21 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.239 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.134 HD21 HD11 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -60.54 -53.54 56.3 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 119.78 -0.768 . . . . 0.0 109.148 179.729 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.847 HD13 HG12 ' A' ' 96' ' ' VAL . 0.3 OUTLIER -61.75 -29.81 70.37 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.302 -0.959 . . . . 0.0 108.996 178.648 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.507 ' HB3' ' O ' ' A' ' 62' ' ' LEU . 0.4 OUTLIER -54.92 -49.97 69.97 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 177.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.676 ' CG ' HD22 ' A' ' 32' ' ' LEU 0.261 80.3 m80 -87.25 -9.19 55.7 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.794 179.639 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 38' ' ' PRO . . . 82.29 71.32 1.31 Allowed Glycine 0 N--CA 1.482 1.741 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.549 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -65.38 -143.9 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.367 -1.078 . . . . 0.0 109.489 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.505 ' HB3' ' HD3' ' A' ' 47' ' ' ARG . 0.1 OUTLIER -116.36 50.51 0.82 Allowed Pre-proline 0 C--N 1.3 -1.584 0 O-C-N 121.174 -0.954 . . . . 0.0 110.236 179.195 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.602 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 50.1 Cg_endo -72.86 52.39 2.15 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 O-C-N 123.24 1.126 . . . . 0.0 110.266 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.481 ' N ' ' HG3' ' A' ' 81' ' ' PRO . 26.0 m-20 -162.19 -74.64 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.309 -0.87 . . . . 0.0 110.065 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.412 ' HB3' ' NH1' ' A' ' 47' ' ' ARG . 6.2 m -52.22 118.99 3.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.091 -1.005 . . . . 0.0 109.235 179.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.614 ' HB2' ' HA ' ' A' ' 80' ' ' ARG . . . -107.0 -145.5 0.39 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.433 -0.792 . . . . 0.0 110.477 -178.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.464 ' O ' ' N ' ' A' ' 78' ' ' LEU . 0.3 OUTLIER -114.29 134.89 22.18 Favored Pre-proline 0 N--CA 1.487 1.41 0 O-C-N 121.241 -0.912 . . . . 0.0 110.042 -179.879 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -71.58 -9.32 24.87 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.555 1.292 . . . . 0.0 109.96 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.04 -51.15 8.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.274 -0.891 . . . . 0.0 110.107 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.574 ' HB ' ' CH2' ' A' ' 110' ' ' TRP . 11.5 p -123.29 8.86 9.12 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.527 -0.733 . . . . 0.0 110.504 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.488 ' HA ' HD23 ' A' ' 78' ' ' LEU . 0.4 OUTLIER 43.65 37.65 1.64 Allowed 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.543 0.687 . . . . 0.0 110.061 -179.577 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -78.66 92.16 4.72 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 119.76 -0.776 . . . . 0.0 109.341 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.826 ' CG ' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -68.89 171.2 6.73 Favored Pre-proline 0 C--N 1.303 -1.446 0 C-N-CA 119.319 -0.952 . . . . 0.0 108.702 179.799 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.602 ' HG3' ' HA ' ' A' ' 70' ' ' PRO . 40.6 Cg_endo -73.34 1.51 6.67 Favored 'Trans proline' 0 C--N 1.299 -2.073 0 O-C-N 123.88 1.463 . . . . 0.0 110.662 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.589 HG11 ' HG ' ' A' ' 104' ' ' LEU . 4.3 t -90.18 -36.18 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.298 -0.876 . . . . 0.0 109.412 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.545 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 19.7 m80 -61.69 -28.68 69.58 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.431 0.634 . . . . 0.0 109.506 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.564 ' HB3' ' SD ' ' A' ' 54' ' ' MET . 43.4 m-20 -64.01 -58.78 5.67 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.38 -0.825 . . . . 0.0 110.162 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.45 ' CB ' ' CD1' ' A' ' 94' ' ' LEU . . . -49.86 -67.88 0.22 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.383 -0.823 . . . . 0.0 110.394 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.803 ' HB2' HD11 ' A' ' 130' ' ' LEU . . . -51.83 -51.4 56.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.351 -0.843 . . . . 0.0 110.94 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.545 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -43.75 -26.58 0.26 Allowed 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.012 -1.055 . . . . 0.0 111.062 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.566 ' CB ' ' HB3' ' A' ' 54' ' ' MET . 5.7 tm-20 -105.78 -15.58 14.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.159 -0.963 . . . . 0.0 110.12 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.561 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 91.52 29.19 12.52 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.126 -1.189 . . . . 0.0 110.126 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.563 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 0.3 OUTLIER -101.52 93.07 5.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.177 -1.19 . . . . 0.0 110.881 179.945 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.586 HD11 ' O ' ' A' ' 125' ' ' ASP . 0.3 OUTLIER -66.76 -42.56 85.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.454 -0.778 . . . . 0.0 110.276 179.652 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.692 ' O ' HG23 ' A' ' 96' ' ' VAL . 67.4 t0 -45.52 -51.47 11.71 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.345 -0.847 . . . . 0.0 110.239 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 98.1 m -47.41 -52.42 16.93 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.533 -0.729 . . . . 0.0 109.626 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.678 ' HA ' HD12 ' A' ' 97' ' ' LEU . 3.7 mp -51.21 -58.57 5.8 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.422 -0.799 . . . . 0.0 109.785 178.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.479 ' O ' ' CB ' ' A' ' 99' ' ' ARG . 46.8 t -44.07 -51.92 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-O 121.139 0.495 . . . . 0.0 109.834 179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.847 HG12 HD13 ' A' ' 64' ' ' LEU . 5.7 t -54.89 -50.78 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.37 -0.831 . . . . 0.0 110.08 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.678 ' HA ' HD21 ' A' ' 64' ' ' LEU . 56.5 mt -52.35 -60.84 2.75 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.453 -0.779 . . . . 0.0 110.378 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -68.76 -26.55 65.29 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.435 -0.791 . . . . 0.0 110.446 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.479 ' CB ' ' O ' ' A' ' 95' ' ' VAL . 45.8 ttt85 -70.03 -9.36 55.04 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.187 -0.945 . . . . 0.0 110.637 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.449 ' HB3' HD22 ' A' ' 64' ' ' LEU . . . -136.0 -53.4 0.75 Allowed 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.005 -1.059 . . . . 0.0 110.928 -179.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 102' ' ' ALA . . . 178.43 110.81 0.28 Allowed Glycine 0 N--CA 1.486 1.982 0 N-CA-C 110.091 -1.204 . . . . 0.0 110.091 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.489 ' CB ' ' HB3' ' A' ' 97' ' ' LEU . . . -177.03 141.17 0.33 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.253 -1.145 . . . . 0.0 110.381 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.729 ' O ' HD12 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -86.63 156.39 20.04 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.621 -0.674 . . . . 0.0 109.549 179.306 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.729 HD12 ' O ' ' A' ' 103' ' ' ARG . 0.3 OUTLIER -144.22 46.11 1.42 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.247 -0.908 . . . . 0.0 110.433 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.418 ' OD2' ' O ' ' A' ' 134' ' ' ALA . 1.1 t70 -152.32 40.2 0.6 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.192 -0.942 . . . . 0.0 110.112 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.826 HG11 ' CG ' ' A' ' 80' ' ' ARG . 4.0 p -104.55 170.21 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.652 -0.655 . . . . 0.0 109.846 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.533 ' N ' HG22 ' A' ' 106' ' ' VAL . 11.3 mtp180 -97.84 176.89 5.64 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.541 -0.724 . . . . 0.0 109.812 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.524 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 22.4 p-10 -117.63 30.92 7.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.908 . . . . 0.0 109.707 179.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.531 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 64.6 -57.04 0.26 Allowed 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.751 -0.593 . . . . 0.0 110.264 -179.1 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.574 ' CH2' ' HB ' ' A' ' 77' ' ' THR . 7.6 m-90 -56.6 -60.66 3.22 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.159 -0.963 . . . . 0.0 109.541 179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 155.87 -26.53 0.57 Allowed Glycine 0 N--CA 1.484 1.883 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.483 ' HG3' ' HB3' ' A' ' 116' ' ' ASP . 0.4 OUTLIER -80.35 107.58 13.26 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.315 -1.109 . . . . 0.0 110.783 -179.442 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.579 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER -55.74 177.36 0.15 Allowed Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 121.429 -0.794 . . . . 0.0 110.235 179.759 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.579 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 40.6 Cg_endo -69.3 -33.64 17.87 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 O-C-N 123.586 1.308 . . . . 0.0 109.347 179.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.472 HG12 ' HB3' ' A' ' 113' ' ' LEU . 12.8 p -78.4 -33.36 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 CA-C-O 121.535 0.683 . . . . 0.0 109.437 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.483 ' HB3' ' HG3' ' A' ' 112' ' ' ARG . 0.6 OUTLIER -71.89 -34.26 69.01 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.539 -0.725 . . . . 0.0 109.44 179.438 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.651 HD22 HD11 ' A' ' 121' ' ' LEU . 0.6 OUTLIER -61.19 -39.36 89.88 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.387 -0.821 . . . . 0.0 110.243 179.805 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.578 ' HB1' ' HB2' ' A' ' 123' ' ' HIS . . . -67.45 -51.96 45.27 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.208 -0.933 . . . . 0.0 110.736 -179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 61.0 mm-40 -46.89 -35.4 6.38 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.348 -0.845 . . . . 0.0 110.545 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.54 -58.83 2.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.35 -0.844 . . . . 0.0 109.575 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.651 HD11 HD22 ' A' ' 117' ' ' LEU . 50.2 mt -53.38 -93.29 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.465 -0.772 . . . . 0.0 110.463 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 178.31 36.9 0.06 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.578 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . 35.6 m-70 -108.51 41.33 1.6 Allowed 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.314 -1.109 . . . . 0.0 109.273 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -43.5 -33.57 1.14 Allowed 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.437 0.637 . . . . 0.0 110.16 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.586 ' O ' HD11 ' A' ' 91' ' ' LEU . 2.5 t0 -63.72 -41.3 98.1 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.367 -0.833 . . . . 0.0 108.863 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.707 HG11 ' HA ' ' A' ' 86' ' ' ALA . 3.2 t -80.81 -43.9 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.716 -0.615 . . . . 0.0 110.94 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.464 ' HB2' ' HB3' ' A' ' 118' ' ' ALA . . . -51.31 -35.89 39.98 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.279 -0.888 . . . . 0.0 110.034 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.91 -65.98 0.61 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.418 -0.801 . . . . 0.0 109.887 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.476 ' O ' ' HB3' ' A' ' 132' ' ' ALA . 11.6 t80 -54.07 -42.72 69.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.472 -0.768 . . . . 0.0 109.225 179.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.803 HD11 ' HB2' ' A' ' 86' ' ' ALA . 14.0 mt -55.96 -58.12 9.24 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.823 -0.548 . . . . 0.0 110.281 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.409 ' HG3' HG21 ' A' ' 115' ' ' VAL . 9.4 ttm180 -56.14 -15.68 4.06 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.176 -0.952 . . . . 0.0 110.854 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' A' ' 129' ' ' TYR . . . -82.66 -57.18 3.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.055 -1.028 . . . . 0.0 109.809 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -85.47 -12.32 52.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.562 -0.711 . . . . 0.0 110.501 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.613 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . -108.57 -48.52 3.31 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.219 -0.926 . . . . 0.0 110.768 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 110.03 150.65 13.02 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 108.834 -1.707 . . . . 0.0 108.834 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -108.74 -26.29 5.37 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 10.8 p -71.67 132.82 45.12 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.24 -1.153 . . . . 0.0 110.725 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.421 ' C ' ' CD ' ' A' ' 138' ' ' ARG . 0.0 OUTLIER -101.48 -18.98 15.72 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.295 -0.878 . . . . 0.0 109.882 179.164 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -178.48 -89.55 0.08 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -131.27 126.54 35.7 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.309 -1.112 . . . . 0.0 110.215 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -130.45 21.35 5.17 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.28 -0.888 . . . . 0.0 110.483 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 48.61 24.77 0.82 Allowed 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.195 -0.94 . . . . 0.0 110.228 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -117.04 -61.05 1.77 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.51 -0.744 . . . . 0.0 110.146 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.81 146.75 49.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.528 -0.733 . . . . 0.0 110.08 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 5.3 mt 55.91 88.73 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.452 -0.78 . . . . 0.0 110.376 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -43.69 107.04 0.08 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.563 -0.711 . . . . 0.0 110.071 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -75.31 123.52 25.49 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.522 -0.736 . . . . 0.0 110.606 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -76.73 164.47 25.84 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.606 -0.684 . . . . 0.0 110.304 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -55.77 -169.88 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.631 -0.668 . . . . 0.0 110.609 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -74.8 144.21 32.23 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.85 163.85 37.56 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 O-C-N 123.641 1.337 . . . . 0.0 110.938 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -109.69 10.08 24.86 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.39 -0.819 . . . . 0.0 110.644 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.54 ' O ' HD13 ' A' ' 154' ' ' ILE . 35.3 t70 -67.9 146.36 53.7 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.963 -1.085 . . . . 0.0 109.901 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.54 HD13 ' O ' ' A' ' 153' ' ' ASP . 16.9 mm -137.46 83.71 25.11 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.211 -0.93 . . . . 0.0 110.12 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.431 ' O ' ' O ' ' A' ' 156' ' ' ASP . 48.5 Cg_endo -78.16 123.96 6.39 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.817 1.43 . . . . 0.0 109.795 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.431 ' O ' ' O ' ' A' ' 155' ' ' PRO . 4.0 t70 . . . . . 0 N--CA 1.495 1.8 0 CA-C-O 118.088 -0.958 . . . . 0.0 110.68 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.404 ' HG3' ' HD3' ' A' ' 3' ' ' PRO . 5.4 ptp . . . . . 0 N--CA 1.497 1.921 0 CA-C-O 121.232 0.539 . . . . 0.0 110.374 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -139.81 83.28 16.66 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.381 -0.825 . . . . 0.0 110.118 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.404 ' HD3' ' HG3' ' A' ' 1' ' ' MET . 50.5 Cg_endo -74.82 105.97 2.17 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.662 1.349 . . . . 0.0 110.379 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -123.17 83.08 2.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.358 -0.839 . . . . 0.0 110.288 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -77.52 156.22 31.11 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.285 -0.885 . . . . 0.0 110.236 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 71.7 -155.47 52.1 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 13.3 t 52.86 91.26 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.311 -1.111 . . . . 0.0 110.681 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 83.9 p -91.38 59.71 3.95 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.373 -0.829 . . . . 0.0 109.686 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 5.9 tpt -91.52 38.6 0.98 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.327 -0.858 . . . . 0.0 110.547 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.44 147.27 24.93 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.421 -0.8 . . . . 0.0 109.842 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -74.13 124.56 9.15 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.6 1.316 . . . . 0.0 109.817 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -50.17 100.78 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.391 -0.818 . . . . 0.0 110.292 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.909 ' HB1' ' HB2' ' A' ' 37' ' ' LEU . . . -61.76 -13.73 26.12 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.463 -0.773 . . . . 0.0 110.544 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -81.29 4.46 20.43 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.072 -1.018 . . . . 0.0 110.698 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.676 ' HB3' HD13 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -71.6 -5.21 31.77 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.151 -0.968 . . . . 0.0 110.4 179.773 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.851 HD21 ' CB ' ' A' ' 36' ' ' ALA . 22.7 mt -78.56 -61.48 1.99 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.096 -1.002 . . . . 0.0 109.629 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.521 ' HB1' HG11 ' A' ' 51' ' ' VAL . . . -57.0 -43.77 82.08 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.481 -0.762 . . . . 0.0 109.641 179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.571 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.8 OUTLIER -54.18 -54.99 32.26 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.642 -0.662 . . . . 0.0 110.292 179.576 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.621 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -68.54 -40.07 80.87 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.337 -0.852 . . . . 0.0 109.778 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.534 ' HB1' HG11 ' A' ' 59' ' ' VAL . . . -57.62 -50.68 72.33 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.323 -0.861 . . . . 0.0 109.687 179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.644 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -58.79 -27.16 64.77 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.612 -0.68 . . . . 0.0 110.587 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.37 23.06 4.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.317 -0.864 . . . . 0.0 110.618 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.43 48.81 40.77 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 179.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 15.2 mtm180 -121.55 58.68 0.99 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.388 -1.066 . . . . 0.0 110.164 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.772 HG22 HG22 ' A' ' 59' ' ' VAL . 51.1 t -44.74 -51.43 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.591 -0.693 . . . . 0.0 110.886 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 53.2 mm-40 -51.09 -44.04 61.16 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.335 -0.853 . . . . 0.0 110.622 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.468 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 1.0 OUTLIER -61.25 -39.03 88.84 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.387 -0.821 . . . . 0.0 109.969 179.731 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.837 HG12 HD13 ' A' ' 62' ' ' LEU . 23.6 t -76.81 -48.41 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.471 -0.768 . . . . 0.0 110.465 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.931 ' HA ' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -46.85 -34.94 5.8 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.348 -0.845 . . . . 0.0 109.7 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.56 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -79.88 -51.96 8.48 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.353 -0.842 . . . . 0.0 108.901 178.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.676 HD13 ' HB3' ' A' ' 15' ' ' TRP . 18.6 mt -58.84 -65.13 0.71 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.935 0.874 . . . . 0.0 109.728 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.811 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 1.1 tp -47.21 -49.19 23.47 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.743 -0.598 . . . . 0.0 110.929 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.521 ' HB2' ' O ' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -75.34 -14.56 60.49 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.152 -0.967 . . . . 0.0 110.47 179.617 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.56 ' HB2' ' O ' ' A' ' 30' ' ' ALA . . . -82.64 -9.54 59.34 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.07 -1.019 . . . . 0.0 110.532 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 125.95 17.5 2.51 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.787 -1.197 . . . . 0.0 110.825 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.851 ' CB ' HD21 ' A' ' 16' ' ' LEU . . . -64.44 176.04 1.2 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.053 -1.263 . . . . 0.0 110.092 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.909 ' HB2' ' HB1' ' A' ' 13' ' ' ALA . 1.6 mm? -91.46 133.45 31.27 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.264 -0.897 . . . . 0.0 110.281 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.643 ' HD2' HD13 ' A' ' 37' ' ' LEU . 44.8 Cg_endo -70.89 -49.29 0.41 Allowed 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 123.603 1.317 . . . . 0.0 110.37 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -95.62 18.48 12.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.31 -0.869 . . . . 0.0 110.484 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.573 ' HB2' ' CB ' ' A' ' 37' ' ' LEU . . . -42.38 109.09 0.68 Allowed Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 121.63 -0.669 . . . . 0.0 110.908 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.5 91.89 0.86 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.709 1.373 . . . . 0.0 110.412 -179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -65.33 -177.83 0.44 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.484 -0.76 . . . . 0.0 109.898 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.33 22.53 2.47 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.209 -0.932 . . . . 0.0 110.422 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.538 ' HB3' ' CD ' ' A' ' 46' ' ' ARG . 2.8 m-85 -103.09 3.86 36.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -0.904 . . . . 0.0 110.681 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 57.06 35.12 67.83 Favored Glycine 0 N--CA 1.487 2.09 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.538 ' CD ' ' HB3' ' A' ' 44' ' ' TYR . 7.6 ptm180 -160.4 26.11 0.16 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.261 -1.141 . . . . 0.0 110.697 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.5 ' CB ' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER 49.04 -174.63 0.0 OUTLIER Pre-proline 0 N--CA 1.5 2.038 0 O-C-N 121.552 -0.718 . . . . 0.0 110.154 179.689 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.734 ' HB2' HD13 ' A' ' 63' ' ' LEU . 46.2 Cg_endo -72.43 -167.33 0.32 Allowed 'Trans proline' 0 C--N 1.315 -1.207 0 O-C-N 123.141 1.074 . . . . 0.0 110.538 -179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.506 ' O ' ' HG2' ' A' ' 52' ' ' MET . 3.5 mt 60.2 -65.59 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 O-C-N 121.748 -0.595 . . . . 0.0 109.625 -178.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.592 ' N ' ' O ' ' A' ' 48' ' ' PRO . 19.6 mt-30 -45.8 -25.43 0.51 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.959 -1.088 . . . . 0.0 109.803 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.644 HG22 ' HB2' ' A' ' 21' ' ' ALA . 8.9 p -119.02 40.58 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.485 -0.76 . . . . 0.0 109.789 178.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.562 ' HE1' ' HB2' ' A' ' 60' ' ' ALA . 0.1 OUTLIER -102.52 37.62 1.87 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.028 -1.045 . . . . 0.0 110.21 179.863 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.431 ' CB ' ' O ' ' A' ' 52' ' ' MET . 3.6 tmm? 66.34 -11.73 0.22 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.374 -0.829 . . . . 0.0 111.158 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.498 ' HE1' ' CG ' ' A' ' 52' ' ' MET . 0.0 OUTLIER 48.03 27.55 1.24 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.205 -0.935 . . . . 0.0 110.358 -179.703 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.445 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -125.52 9.5 7.73 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.56 ' HB3' HG23 ' A' ' 59' ' ' VAL . 1.0 OUTLIER -148.99 81.06 1.43 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.41 -1.053 . . . . 0.0 109.629 -179.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -49.81 -27.87 5.6 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.464 -0.772 . . . . 0.0 109.775 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.5 mtt85 -52.23 -29.16 21.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.537 -0.727 . . . . 0.0 109.356 179.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.772 HG22 HG22 ' A' ' 25' ' ' VAL . 29.2 t -71.15 -51.63 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.364 -0.835 . . . . 0.0 108.946 178.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.562 ' HB2' ' HE1' ' A' ' 52' ' ' MET . . . -49.13 -42.31 38.97 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.65 -0.656 . . . . 0.0 109.676 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.5 ' O ' ' HB3' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -61.27 -55.59 30.19 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.486 -0.759 . . . . 0.0 109.317 179.012 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.931 HD11 ' HA ' ' A' ' 29' ' ' ARG . 0.2 OUTLIER -44.25 -58.94 2.61 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.468 -0.77 . . . . 0.0 110.152 178.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.81 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 13.9 mt -69.43 -41.9 75.71 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.663 -0.648 . . . . 0.0 110.486 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.891 HD22 HG12 ' A' ' 96' ' ' VAL . 0.5 OUTLIER -61.68 -55.49 29.89 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.039 -1.038 . . . . 0.0 109.739 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.545 ' O ' HD12 ' A' ' 65' ' ' LEU . 0.6 OUTLIER -53.97 -26.81 27.69 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.379 -0.825 . . . . 0.0 109.458 179.366 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.419 ' ND1' ' CD1' ' A' ' 32' ' ' LEU . 1.0 OUTLIER -88.6 -49.04 7.13 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.518 -0.739 . . . . 0.0 109.8 -179.847 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 151.39 50.64 0.02 OUTLIER Glycine 0 N--CA 1.481 1.676 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.81 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -74.05 -157.58 0.05 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.798 -1.413 . . . . 0.0 109.805 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -122.21 63.99 18.69 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.35 -0.844 . . . . 0.0 110.055 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.608 ' HG3' HD12 ' A' ' 64' ' ' LEU . 47.3 Cg_endo -72.3 -8.66 23.11 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 O-C-N 123.858 1.451 . . . . 0.0 110.574 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -108.05 -78.77 0.58 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.291 -0.881 . . . . 0.0 109.549 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.73 -175.82 0.1 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.55 -0.719 . . . . 0.0 110.527 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.751 ' HB1' ' O ' ' A' ' 79' ' ' THR . . . -167.39 -83.19 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.425 -0.797 . . . . 0.0 110.298 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -146.71 123.36 5.73 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.291 -0.881 . . . . 0.0 109.674 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.37 -2.43 11.7 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.511 1.269 . . . . 0.0 110.645 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -96.52 -27.79 14.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.215 -0.928 . . . . 0.0 110.19 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.529 ' HA ' ' HB3' ' A' ' 109' ' ' ALA . 71.9 p -137.11 4.56 2.72 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.259 -0.901 . . . . 0.0 111.103 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.52 ' HA ' HD23 ' A' ' 78' ' ' LEU . 5.2 mt 47.01 27.93 0.81 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.246 -0.909 . . . . 0.0 111.244 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.751 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 66.4 m -69.66 88.62 0.52 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.963 -1.086 . . . . 0.0 109.783 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.773 ' HD3' HG21 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -67.98 165.11 35.14 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.309 -0.869 . . . . 0.0 109.946 -179.605 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.56 ' HD2' ' HG3' ' A' ' 80' ' ' ARG . 46.5 Cg_endo -76.0 -7.98 18.6 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 123.622 1.328 . . . . 0.0 109.767 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.407 ' H ' HG23 ' A' ' 82' ' ' VAL . 6.0 t -71.54 -23.92 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.552 -0.717 . . . . 0.0 109.593 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.527 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 4.0 m80 -75.46 -23.39 56.86 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.475 ' HB3' ' SD ' ' A' ' 54' ' ' MET . 51.7 m-20 -75.39 -57.39 3.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.829 -0.544 . . . . 0.0 110.92 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.755 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -53.38 -50.77 64.41 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.194 -0.941 . . . . 0.0 109.507 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.844 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -65.51 -32.05 73.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.455 -0.778 . . . . 0.0 110.105 179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.56 ' HA ' HD13 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -56.18 -51.02 69.54 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.297 -0.877 . . . . 0.0 110.374 -179.851 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.465 ' HB2' ' HB3' ' A' ' 54' ' ' MET . 0.9 OUTLIER -93.28 16.58 12.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.301 -0.874 . . . . 0.0 110.422 -179.793 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.686 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 53.28 55.03 26.49 Favored Glycine 0 N--CA 1.495 2.568 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.445 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 0.2 OUTLIER -115.5 94.93 4.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.418 -1.048 . . . . 0.0 110.744 -179.349 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.828 HD11 ' CG ' ' A' ' 129' ' ' TYR . 0.3 OUTLIER -66.69 -45.5 78.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.348 -0.845 . . . . 0.0 109.967 179.645 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.882 ' O ' HG23 ' A' ' 96' ' ' VAL . 69.6 m-20 -47.91 -40.05 20.75 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.52 -0.737 . . . . 0.0 109.723 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.432 HG23 ' HE1' ' A' ' 52' ' ' MET . 7.1 m -66.17 -55.81 14.5 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.613 -0.68 . . . . 0.0 109.252 179.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.815 HD21 ' HB2' ' A' ' 130' ' ' LEU . 4.8 tp -52.03 -47.82 64.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.741 -0.6 . . . . 0.0 109.741 179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.655 HG23 ' O ' ' A' ' 91' ' ' LEU . 58.4 t -51.45 -43.76 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.498 -0.751 . . . . 0.0 109.697 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.891 HG12 HD22 ' A' ' 64' ' ' LEU . 23.0 t -57.55 -52.5 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.52 -0.738 . . . . 0.0 109.47 179.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.505 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 4.7 mp -50.51 -57.51 7.93 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.563 -0.711 . . . . 0.0 109.995 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -62.39 -30.13 70.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.415 -0.803 . . . . 0.0 109.69 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.9 mtt180 -68.01 -11.93 59.85 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.503 -0.748 . . . . 0.0 110.489 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.585 ' CB ' HD21 ' A' ' 64' ' ' LEU . . . -144.43 63.41 1.32 Allowed 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.162 -0.961 . . . . 0.0 110.859 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 53.51 101.53 0.01 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 97' ' ' LEU . . . -151.97 101.25 2.72 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.256 -1.143 . . . . 0.0 110.122 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -55.82 93.62 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.493 -0.755 . . . . 0.0 109.92 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.563 HD22 ' HB3' ' A' ' 133' ' ' ALA . 0.0 OUTLIER -84.67 8.38 17.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.35 -0.844 . . . . 0.0 110.548 -179.699 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.46 ' HB3' ' HA ' ' A' ' 134' ' ' ALA . 6.0 p30 -123.85 60.54 1.11 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.097 -1.002 . . . . 0.0 110.827 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.773 HG21 ' HD3' ' A' ' 80' ' ' ARG . 1.7 p -112.21 -170.48 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.134 -0.979 . . . . 0.0 109.766 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.647 ' H ' HG22 ' A' ' 106' ' ' VAL . 0.2 OUTLIER -138.54 126.11 22.01 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.298 -0.877 . . . . 0.0 109.788 179.417 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -66.05 133.94 51.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 0.0 109.657 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.529 ' HB3' ' HA ' ' A' ' 77' ' ' THR . . . -46.44 -31.56 2.75 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.553 -0.717 . . . . 0.0 110.909 -179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.518 ' CH2' HG22 ' A' ' 77' ' ' THR . 7.3 m95 -59.56 -65.03 0.74 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.447 -0.783 . . . . 0.0 109.955 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 163.46 -28.33 0.23 Allowed Glycine 0 N--CA 1.48 1.618 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -85.8 137.5 32.74 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.287 -1.126 . . . . 0.0 110.422 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.501 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER -84.17 176.65 3.55 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.499 -0.751 . . . . 0.0 109.465 179.399 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.501 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 41.3 Cg_endo -68.51 -30.22 29.45 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.385 1.202 . . . . 0.0 109.559 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.847 ' HB ' HD11 ' A' ' 130' ' ' LEU . 4.8 p -82.99 -26.21 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.338 -0.852 . . . . 0.0 109.421 179.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 38.4 t0 -56.37 -40.65 74.9 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.502 -0.749 . . . . 0.0 110.664 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.56 HD13 ' HA ' ' A' ' 87' ' ' ARG . 3.5 pp -77.16 -27.78 53.89 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.217 -0.927 . . . . 0.0 109.94 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.588 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -69.21 -26.73 64.96 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.36 -0.838 . . . . 0.0 110.164 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -88.74 -34.35 17.18 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.365 -0.835 . . . . 0.0 109.646 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -74.37 -63.84 1.15 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.405 -0.809 . . . . 0.0 110.535 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.407 ' HB3' ' NE2' ' A' ' 123' ' ' HIS . 0.2 OUTLIER -54.38 -86.77 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.246 -0.909 . . . . 0.0 110.602 -179.486 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 174.31 52.91 0.05 OUTLIER Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.429 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 44.7 m-70 -120.95 44.22 2.57 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.474 -1.015 . . . . 0.0 109.266 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.677 ' HA ' ' HB3' ' A' ' 127' ' ' ALA . 9.5 ptm180 -43.55 -38.19 2.83 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.759 -0.588 . . . . 0.0 110.538 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.506 ' O ' HD21 ' A' ' 91' ' ' LEU . 80.9 m-20 -56.79 -43.47 80.92 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.844 HG11 ' HA ' ' A' ' 86' ' ' ALA . 2.1 t -82.03 -40.03 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.677 ' HB3' ' HA ' ' A' ' 124' ' ' ARG . . . -55.86 -45.4 78.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.394 -0.816 . . . . 0.0 109.657 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -74.9 -52.26 11.74 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.383 -0.823 . . . . 0.0 109.526 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.828 ' CG ' HD11 ' A' ' 91' ' ' LEU . 80.6 t80 -61.5 -65.16 0.73 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.453 -0.779 . . . . 0.0 110.851 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.847 HD11 ' HB ' ' A' ' 115' ' ' VAL . 0.3 OUTLIER -52.34 -26.16 11.57 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.285 -0.884 . . . . 0.0 110.499 -179.147 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.498 ' HB2' HG21 ' A' ' 115' ' ' VAL . 17.2 ttt-85 -73.12 -42.63 62.68 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.122 -0.986 . . . . 0.0 109.543 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -60.28 -33.21 72.01 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.563 ' HB3' HD22 ' A' ' 104' ' ' LEU . . . -89.28 -22.58 22.62 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 178.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.46 ' HA ' ' HB3' ' A' ' 105' ' ' ASP . . . -92.18 5.23 51.16 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.554 -0.716 . . . . 0.0 110.272 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -57.83 169.78 4.28 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.905 -1.278 . . . . 0.0 109.905 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 163.17 -28.14 0.24 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 16.4 p -117.98 -157.27 0.67 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.291 -1.123 . . . . 0.0 110.227 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -103.25 -153.49 0.47 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.487 -0.758 . . . . 0.0 109.952 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -149.71 -107.84 0.43 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.408 ' O ' ' O ' ' A' ' 141' ' ' ASN . 0.7 OUTLIER -58.47 177.19 0.14 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.278 -1.131 . . . . 0.0 109.574 179.517 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.408 ' O ' ' O ' ' A' ' 140' ' ' SER . 6.6 t30 57.29 108.85 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.302 -0.874 . . . . 0.0 110.257 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -46.54 154.73 0.28 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.261 -0.899 . . . . 0.0 110.795 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -165.45 -58.81 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.44 -0.788 . . . . 0.0 110.657 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 4.6 ttt-85 -72.17 112.87 8.62 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.365 -0.835 . . . . 0.0 110.818 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.4 tt -74.59 152.1 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.399 -0.813 . . . . 0.0 109.631 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.426 ' N ' ' OD1' ' A' ' 146' ' ' ASP . 27.3 p-10 -49.18 173.06 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.305 -0.872 . . . . 0.0 110.832 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' A' ' 148' ' ' ALA . . . -49.1 126.87 13.44 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.229 -0.92 . . . . 0.0 109.935 179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 147' ' ' ALA . . . 58.71 167.88 0.05 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.202 -0.936 . . . . 0.0 109.588 -178.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -84.78 129.61 34.8 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.128 -0.982 . . . . 0.0 110.431 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 73.11 -144.69 35.15 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.47 147.52 46.55 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.623 1.328 . . . . 0.0 110.404 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 40.8 m -57.27 -176.76 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.474 -0.766 . . . . 0.0 110.21 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -170.33 -169.58 0.85 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.277 -0.889 . . . . 0.0 110.686 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.45 HG22 ' O ' ' A' ' 154' ' ' ILE . 21.0 mm -131.7 88.44 42.56 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.47 -0.769 . . . . 0.0 109.584 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.29 142.16 33.25 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.795 1.418 . . . . 0.0 110.43 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 118.014 -0.994 . . . . 0.0 110.233 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.774 0 CA-C-O 121.121 0.486 . . . . 0.0 110.122 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -170.7 79.7 0.56 Allowed Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.416 -0.802 . . . . 0.0 110.359 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -74.03 93.23 0.88 Allowed 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.72 1.379 . . . . 0.0 110.194 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -100.31 54.89 0.9 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.383 -0.823 . . . . 0.0 110.384 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.32 -64.07 1.01 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.319 -0.863 . . . . 0.0 109.769 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.78 -145.93 24.01 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.6 m -59.69 162.39 5.25 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.45 -1.03 . . . . 0.0 110.523 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.6 t 179.81 165.31 1.15 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.594 -0.691 . . . . 0.0 109.599 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 52.83 31.81 11.26 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.291 -0.881 . . . . 0.0 110.332 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.1 123.33 64.3 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.35 -0.844 . . . . 0.0 110.438 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -73.03 75.22 2.8 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 O-C-N 123.672 1.354 . . . . 0.0 110.391 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.0 m -152.05 -42.91 0.11 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.366 -0.834 . . . . 0.0 110.166 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.509 ' HB1' ' HB2' ' A' ' 37' ' ' LEU . . . -64.66 -14.27 57.55 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.369 -0.832 . . . . 0.0 110.483 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -71.56 -5.76 35.71 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.286 -0.884 . . . . 0.0 110.909 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.599 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 27.8 m0 -75.34 -10.87 59.84 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.015 -1.053 . . . . 0.0 110.699 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.788 HD21 HD21 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -78.11 -54.62 6.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.183 -0.948 . . . . 0.0 109.924 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.469 ' N ' ' HG ' ' A' ' 16' ' ' LEU . . . -69.28 -40.03 77.99 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.097 -1.002 . . . . 0.0 109.813 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.599 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 2.8 p -51.43 -56.77 11.42 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.579 -0.7 . . . . 0.0 110.687 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.741 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -56.49 -38.54 71.89 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.269 -0.895 . . . . 0.0 110.227 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.61 -23.99 66.95 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.292 -0.88 . . . . 0.0 110.14 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.506 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -82.54 -27.65 31.52 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.281 -0.887 . . . . 0.0 110.606 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 2.3 mmt180 -94.31 22.75 5.69 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.293 -0.88 . . . . 0.0 110.454 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 55.57 66.57 2.74 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.75 75.62 1.48 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.382 -1.069 . . . . 0.0 109.588 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.875 HG22 ' CG2' ' A' ' 59' ' ' VAL . 11.6 t -56.19 -53.26 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.357 -0.84 . . . . 0.0 110.246 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -45.92 -42.23 12.52 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.457 -0.777 . . . . 0.0 111.067 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.654 ' O ' HD12 ' A' ' 31' ' ' LEU . 1.3 mp0 -64.78 -46.64 81.22 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.319 -0.863 . . . . 0.0 109.776 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.944 HG12 HD12 ' A' ' 32' ' ' LEU . 13.7 t -73.49 -45.41 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.412 -0.805 . . . . 0.0 109.548 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.873 ' CG ' HG12 ' A' ' 25' ' ' VAL . 27.6 mmm-85 -48.53 -43.52 35.42 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.536 -0.727 . . . . 0.0 109.902 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -76.26 -45.32 33.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.542 -0.724 . . . . 0.0 109.896 179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.654 HD12 ' O ' ' A' ' 27' ' ' GLU . 4.1 mt -54.42 -56.96 13.37 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.281 -0.887 . . . . 0.0 109.876 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.944 HD12 HG12 ' A' ' 28' ' ' VAL . 3.0 mt -57.42 -44.82 84.95 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.394 -0.816 . . . . 0.0 110.077 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -63.18 -17.42 62.37 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.507 -0.746 . . . . 0.0 110.188 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.43 -14.12 31.11 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.325 -0.86 . . . . 0.0 110.167 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.63 28.13 1.64 Allowed Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.951 -1.119 . . . . 0.0 110.403 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.655 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -58.7 152.3 19.11 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.208 -1.172 . . . . 0.0 110.078 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.897 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 2.1 mm? -66.71 122.08 80.5 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.409 -0.807 . . . . 0.0 109.989 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.481 ' HD2' HD13 ' A' ' 37' ' ' LEU . 42.4 Cg_endo -68.8 -42.68 4.31 Favored 'Trans proline' 0 C--N 1.312 -1.342 0 O-C-N 123.601 1.316 . . . . 0.0 110.361 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 20.7 m120 -108.9 56.71 0.62 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.429 -0.794 . . . . 0.0 109.592 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.897 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -94.38 117.2 67.05 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.396 -0.815 . . . . 0.0 110.193 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.53 109.56 2.49 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.626 1.329 . . . . 0.0 110.072 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.586 ' ND2' HG11 ' A' ' 51' ' ' VAL . 18.3 t-20 -50.86 175.59 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.448 -0.782 . . . . 0.0 110.882 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.4 t -87.01 4.83 40.29 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.542 -0.724 . . . . 0.0 110.78 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -117.01 31.33 6.81 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.119 -0.988 . . . . 0.0 109.94 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 55.38 23.47 34.39 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.57 141.31 48.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.405 -1.056 . . . . 0.0 110.049 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.509 ' CG ' ' HB2' ' A' ' 69' ' ' GLU . 0.2 OUTLIER -57.12 176.96 0.21 Allowed Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.543 -0.723 . . . . 0.0 110.417 -179.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.446 ' HD2' ' CB ' ' A' ' 47' ' ' ARG . 41.1 Cg_endo -67.29 -24.41 43.69 Favored 'Trans proline' 0 C--N 1.315 -1.208 0 O-C-N 123.576 1.303 . . . . 0.0 111.116 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.491 HG13 HD13 ' A' ' 63' ' ' LEU . 7.2 mt -109.01 -31.13 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.9 -1.125 . . . . 0.0 109.064 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.471 ' HA ' ' OD2' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -51.5 -25.9 7.38 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.563 -0.711 . . . . 0.0 109.992 179.365 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.586 HG11 ' ND2' ' A' ' 42' ' ' ASN . 10.9 p -97.21 3.34 10.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.21 -0.931 . . . . 0.0 109.881 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.564 ' CE ' ' HB2' ' A' ' 60' ' ' ALA . 51.6 ttp -56.13 164.54 1.23 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.491 -0.756 . . . . 0.0 110.256 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 3.5 tmm? -75.49 -6.81 52.05 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.252 -0.905 . . . . 0.0 111.0 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.495 ' SD ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 52.55 23.42 2.57 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.181 -0.949 . . . . 0.0 110.192 -179.694 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -122.06 8.45 9.82 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.768 -1.733 . . . . 0.0 108.768 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -160.11 106.13 1.56 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.445 -1.033 . . . . 0.0 109.903 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.638 ' HB2' ' HB3' ' A' ' 92' ' ' ASP . . . -63.79 -26.42 68.63 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.325 -0.86 . . . . 0.0 109.977 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.422 ' HB3' HG11 ' A' ' 25' ' ' VAL . 53.8 mtt180 -50.68 -29.17 10.5 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.348 -0.845 . . . . 0.0 109.858 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.875 ' CG2' HG22 ' A' ' 25' ' ' VAL . 49.0 t -74.75 -56.31 9.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.564 ' HB2' ' CE ' ' A' ' 52' ' ' MET . . . -54.09 -45.13 71.71 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.303 -0.873 . . . . 0.0 109.508 178.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.455 ' O ' HD23 ' A' ' 65' ' ' LEU . 12.4 tt0 -61.96 -35.05 77.31 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.273 -0.892 . . . . 0.0 109.197 179.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.682 ' CD1' HD13 ' A' ' 32' ' ' LEU . 1.1 tp -71.86 -48.42 46.03 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.788 HD21 HD21 ' A' ' 16' ' ' LEU . 1.0 OUTLIER -72.7 -37.8 67.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.55 -0.719 . . . . 0.0 109.998 179.7 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.783 HD21 ' CB ' ' A' ' 100' ' ' ALA . 0.6 OUTLIER -65.26 -63.2 1.16 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.431 -0.793 . . . . 0.0 110.411 -179.853 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.566 ' O ' HD12 ' A' ' 65' ' ' LEU . 0.4 OUTLIER -52.75 -25.31 10.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.877 . . . . 0.0 109.54 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.899 ' CG ' HD22 ' A' ' 32' ' ' LEU . 0.8 OUTLIER -80.54 -52.13 7.96 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.559 -0.713 . . . . 0.0 109.431 179.412 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.444 ' HA3' ' HB2' ' A' ' 38' ' ' PRO . . . 159.57 32.56 0.02 OUTLIER Glycine 0 N--CA 1.481 1.643 0 C-N-CA 119.672 -1.251 . . . . 0.0 111.456 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.526 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -70.39 172.21 8.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.52 -1.576 . . . . 0.0 109.363 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.509 ' HB2' ' CG ' ' A' ' 47' ' ' ARG . 6.5 mm-40 -108.76 78.61 0.94 Allowed Pre-proline 0 C--N 1.301 -1.51 0 O-C-N 121.341 -0.849 . . . . 0.0 109.54 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.494 ' HG3' HD12 ' A' ' 64' ' ' LEU . 43.1 Cg_endo -68.42 -10.75 29.94 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.9 1.474 . . . . 0.0 110.521 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -104.3 -61.21 1.48 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.102 -0.999 . . . . 0.0 110.036 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 3.9 t -46.51 149.59 0.77 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.462 -0.774 . . . . 0.0 111.108 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -140.43 -148.14 0.24 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.503 -0.748 . . . . 0.0 109.79 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.455 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.4 OUTLIER -104.63 140.41 21.05 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 121.124 -0.985 . . . . 0.0 109.79 179.941 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -76.19 -12.64 19.21 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.345 1.182 . . . . 0.0 110.679 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.53 -43.9 25.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.248 -0.907 . . . . 0.0 110.27 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.65 ' C ' ' HB2' ' A' ' 109' ' ' ALA . 0.2 OUTLIER -133.22 9.8 4.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.264 -0.897 . . . . 0.0 110.614 179.793 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.507 ' HA ' HD23 ' A' ' 78' ' ' LEU . 0.8 OUTLIER 46.38 40.51 7.97 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.338 -0.851 . . . . 0.0 111.18 179.708 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 3.3 m -78.45 100.15 6.73 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.234 -0.917 . . . . 0.0 110.17 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.747 ' HB2' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -69.4 161.78 71.21 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.361 -0.837 . . . . 0.0 109.393 179.769 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.506 ' HD2' ' CG ' ' A' ' 80' ' ' ARG . 44.0 Cg_endo -70.6 -16.68 34.06 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.451 1.238 . . . . 0.0 109.936 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 74.4 t -59.68 -27.79 38.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.417 -0.802 . . . . 0.0 109.662 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.512 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 4.8 m80 -75.7 -33.93 60.37 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.496 -0.753 . . . . 0.0 109.056 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.495 ' HB3' ' SD ' ' A' ' 54' ' ' MET . 3.3 m-20 -57.28 -49.03 77.36 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.806 -0.559 . . . . 0.0 109.852 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.701 ' HB1' HD12 ' A' ' 94' ' ' LEU . . . -58.68 -62.27 1.99 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.331 -0.856 . . . . 0.0 109.179 178.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.785 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -55.62 -49.57 72.47 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.299 -0.876 . . . . 0.0 110.839 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.618 ' HD3' HD12 ' A' ' 117' ' ' LEU . 5.4 tpp85 -40.7 -38.99 0.99 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.38 -0.825 . . . . 0.0 111.401 -179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.37 -2.62 35.82 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.044 -1.035 . . . . 0.0 111.032 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.45 19.1 59.16 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.553 ' HE2' ' HB2' ' A' ' 57' ' ' ALA . 1.0 OUTLIER -91.08 132.19 36.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.186 -1.185 . . . . 0.0 109.915 179.736 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.666 HD11 ' O ' ' A' ' 125' ' ' ASP . 0.4 OUTLIER -108.76 -43.6 4.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.393 -0.817 . . . . 0.0 110.354 179.859 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.638 ' HB3' ' HB2' ' A' ' 57' ' ' ALA . 34.6 t0 -45.82 -29.25 1.28 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.476 -0.765 . . . . 0.0 110.052 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.437 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 11.8 m -73.4 -43.94 59.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.644 -0.66 . . . . 0.0 109.448 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.719 HD13 HG13 ' A' ' 126' ' ' VAL . 0.8 OUTLIER -56.0 -50.29 71.27 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.259 -0.901 . . . . 0.0 110.023 179.716 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.434 ' O ' ' CB ' ' A' ' 99' ' ' ARG . 43.5 t -53.78 -49.43 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.5 -0.75 . . . . 0.0 109.366 179.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.742 ' CG1' HD22 ' A' ' 64' ' ' LEU . 70.3 t -52.92 -47.71 52.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.515 -0.74 . . . . 0.0 109.632 179.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.466 ' CD2' ' HB3' ' A' ' 70' ' ' PRO . 96.6 mt -56.66 -72.63 0.07 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.513 -0.742 . . . . 0.0 109.986 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 17.3 t-160 -51.42 -33.35 30.19 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.477 -0.765 . . . . 0.0 110.465 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.434 ' CB ' ' O ' ' A' ' 95' ' ' VAL . 3.5 ttm180 -66.09 -15.49 63.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.41 -0.806 . . . . 0.0 110.517 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.783 ' CB ' HD21 ' A' ' 64' ' ' LEU . . . -142.52 75.5 1.49 Allowed 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.106 -0.996 . . . . 0.0 110.955 -179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 51.47 97.76 0.01 OUTLIER Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 179.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -164.33 101.62 0.84 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.358 -1.083 . . . . 0.0 110.08 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 11.1 ttt180 -61.0 120.21 9.8 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.462 -0.774 . . . . 0.0 110.198 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -101.18 10.06 41.25 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.5 -0.75 . . . . 0.0 110.508 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -124.51 55.55 1.32 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.309 -0.869 . . . . 0.0 110.318 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.747 HG11 ' HB2' ' A' ' 80' ' ' ARG . 2.3 p -106.37 -169.28 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.394 -0.817 . . . . 0.0 109.613 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.648 ' H ' HG22 ' A' ' 106' ' ' VAL . 6.8 mtt180 -140.31 151.64 45.22 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.333 -0.854 . . . . 0.0 110.019 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' A' ' 110' ' ' TRP . 0.1 OUTLIER -77.95 59.96 2.24 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.314 -0.867 . . . . 0.0 109.69 179.662 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.65 ' HB2' ' C ' ' A' ' 77' ' ' THR . . . 61.38 -65.97 0.07 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.742 -0.599 . . . . 0.0 110.672 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.606 ' CZ3' ' CG2' ' A' ' 77' ' ' THR . 5.4 m-90 -66.18 -58.51 5.25 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.2 -0.937 . . . . 0.0 110.321 -179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 176.0 -24.85 0.06 OUTLIER Glycine 0 N--CA 1.483 1.828 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.13 157.78 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 O-C-N 121.321 -1.106 . . . . 0.0 111.132 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.477 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.1 OUTLIER -126.71 169.95 10.88 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.323 -0.861 . . . . 0.0 110.402 -179.655 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.477 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 43.3 Cg_endo -70.33 -45.21 1.35 Allowed 'Trans proline' 0 C--N 1.311 -1.427 0 O-C-N 123.633 1.333 . . . . 0.0 109.656 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.458 ' HA ' HD13 ' A' ' 130' ' ' LEU . 10.2 p -62.78 -28.05 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.401 -0.812 . . . . 0.0 109.243 179.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.3 -40.37 81.8 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.434 -0.791 . . . . 0.0 109.976 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.618 HD12 ' HD3' ' A' ' 87' ' ' ARG . 1.0 OUTLIER -68.14 -22.59 64.86 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.397 -0.814 . . . . 0.0 110.128 179.732 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.448 ' HB1' ' HB2' ' A' ' 127' ' ' ALA . . . -80.39 -53.97 6.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.375 -0.828 . . . . 0.0 110.429 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 57.3 mm-40 -57.63 -27.53 62.88 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.287 -0.883 . . . . 0.0 110.431 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -72.11 -51.39 21.67 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.399 -0.813 . . . . 0.0 110.219 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.515 ' HB2' ' CD2' ' A' ' 123' ' ' HIS . 37.5 mt -85.41 1.17 49.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.312 -0.868 . . . . 0.0 110.599 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 75.72 40.95 30.2 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.515 ' CD2' ' HB2' ' A' ' 121' ' ' LEU . 25.3 m-70 -89.8 55.43 3.17 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.02 -1.282 . . . . 0.0 109.465 179.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 28.7 mtt-85 -44.48 -38.19 3.96 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.773 -0.579 . . . . 0.0 110.278 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.666 ' O ' HD11 ' A' ' 91' ' ' LEU . 0.5 OUTLIER -58.4 -48.36 80.9 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.39 -0.819 . . . . 0.0 109.071 178.919 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.785 HG11 ' HA ' ' A' ' 86' ' ' ALA . 3.5 t -81.33 -43.65 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.473 -0.767 . . . . 0.0 110.244 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.448 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . . . -54.71 -49.51 70.57 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.292 -0.88 . . . . 0.0 110.541 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.1 mtp-105 -56.02 -55.13 36.6 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.208 -0.933 . . . . 0.0 110.18 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -65.03 -33.65 76.55 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.393 -0.817 . . . . 0.0 110.05 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.72 HD11 ' HB2' ' A' ' 86' ' ' ALA . 10.9 mt -66.29 -67.96 0.41 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.345 -0.847 . . . . 0.0 110.468 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -48.18 -24.62 1.2 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.353 -0.842 . . . . 0.0 110.857 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -82.81 -53.8 5.6 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.306 -0.871 . . . . 0.0 110.017 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -87.44 5.98 36.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.399 -0.813 . . . . 0.0 111.034 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.433 ' N ' ' O ' ' A' ' 130' ' ' LEU . . . -115.88 51.94 0.92 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.096 -1.003 . . . . 0.0 110.514 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 57.11 -137.79 48.72 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 113.81 13.88 9.89 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 50.7 p 42.76 73.98 0.12 Allowed 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.572 -0.957 . . . . 0.0 110.957 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.14 101.79 0.44 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.339 -0.85 . . . . 0.0 109.937 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 148.37 -26.5 1.38 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.5 t -156.81 -168.52 2.69 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.316 -1.108 . . . . 0.0 110.016 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -134.35 51.05 2.14 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.261 -0.899 . . . . 0.0 110.206 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 4.4 m80 -135.98 -80.59 0.41 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.308 -0.87 . . . . 0.0 110.352 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -165.79 48.93 0.09 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.244 -0.91 . . . . 0.0 109.944 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.51 173.01 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.389 -0.819 . . . . 0.0 110.413 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.4 tp -52.91 149.18 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.482 -0.761 . . . . 0.0 110.222 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 56.6 104.29 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.336 -0.853 . . . . 0.0 110.196 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -49.37 143.16 6.74 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.393 -0.817 . . . . 0.0 110.652 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.24 157.28 1.43 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.466 -0.771 . . . . 0.0 110.353 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -87.53 136.93 32.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.334 -0.854 . . . . 0.0 110.388 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 165.73 132.98 1.44 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -74.05 108.24 2.61 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.669 1.352 . . . . 0.0 110.347 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . 0.567 ' O ' HG23 ' A' ' 154' ' ' ILE . 51.5 p -79.86 155.75 27.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.413 -0.804 . . . . 0.0 110.242 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -61.03 127.34 31.08 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.43 -0.794 . . . . 0.0 109.873 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.567 HG23 ' O ' ' A' ' 152' ' ' SER . 1.2 pp -129.34 88.49 50.48 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.256 -0.903 . . . . 0.0 110.606 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.81 95.12 0.8 Allowed 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.613 1.322 . . . . 0.0 110.151 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 117.949 -1.024 . . . . 0.0 110.268 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 121.09 0.471 . . . . 0.0 110.228 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.52 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -48.94 -61.29 3.46 Favored Pre-proline 0 N--CA 1.499 2.009 0 O-C-N 121.453 -0.779 . . . . 0.0 110.595 -179.757 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.52 ' CD ' ' CB ' ' A' ' 2' ' ' GLU . 45.5 Cg_endo -72.75 86.51 1.05 Allowed 'Trans proline' 0 C--N 1.316 -1.161 0 O-C-N 123.561 1.295 . . . . 0.0 110.633 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.517 ' HB2' ' O ' ' A' ' 3' ' ' PRO . . . 176.54 -168.87 0.06 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.419 -0.801 . . . . 0.0 109.764 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -141.36 45.01 1.75 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.333 -0.854 . . . . 0.0 110.432 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 116.11 129.32 4.41 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.8 m -53.09 -96.48 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.356 -1.085 . . . . 0.0 110.948 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.5 m -109.63 -170.59 1.68 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.809 -1.182 . . . . 0.0 110.403 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.0 132.65 50.97 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.498 -0.751 . . . . 0.0 110.326 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.48 ' N ' ' HD2' ' A' ' 11' ' ' PRO . 5.1 mt-10 -69.87 -54.68 9.76 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.359 -0.838 . . . . 0.0 110.373 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' A' ' 10' ' ' GLU . 48.1 Cg_endo -73.98 69.88 4.58 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 O-C-N 123.547 1.288 . . . . 0.0 110.71 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 31.9 p -159.08 110.66 2.11 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.359 -0.838 . . . . 0.0 110.546 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 49.85 24.41 1.28 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.366 -0.834 . . . . 0.0 110.888 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.13 -44.5 12.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.221 -0.924 . . . . 0.0 109.8 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.533 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 37.0 m0 -69.76 -4.79 21.43 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.583 -0.698 . . . . 0.0 110.348 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.981 HD11 HD21 ' A' ' 63' ' ' LEU . 0.8 OUTLIER -78.0 -55.66 5.11 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.268 -0.895 . . . . 0.0 109.641 179.594 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.412 ' N ' ' HG ' ' A' ' 16' ' ' LEU . . . -73.15 -37.3 66.64 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.261 -0.899 . . . . 0.0 110.752 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.533 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.7 OUTLIER -59.91 -50.67 72.85 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.291 -0.881 . . . . 0.0 110.94 -179.559 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.725 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -61.82 -36.19 80.43 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.276 -0.89 . . . . 0.0 110.526 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.654 ' HA ' HG11 ' A' ' 59' ' ' VAL . . . -60.01 -33.38 71.92 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.339 -0.851 . . . . 0.0 110.008 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.603 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -81.34 -28.55 34.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.442 -0.787 . . . . 0.0 110.441 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 8.4 ttt180 -92.7 32.62 1.21 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.379 -0.826 . . . . 0.0 110.778 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 47.22 47.74 21.02 Favored Glycine 0 N--CA 1.495 2.569 0 N-CA-C 110.494 -1.042 . . . . 0.0 110.494 179.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.558 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -117.07 95.56 5.05 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.195 -1.179 . . . . 0.0 110.129 179.857 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.6 HG12 ' HD3' ' A' ' 29' ' ' ARG . 57.3 t -73.13 -57.59 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.567 -0.708 . . . . 0.0 110.019 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -47.63 -51.42 21.43 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.596 -0.69 . . . . 0.0 111.071 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.436 ' HB3' ' CB ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -48.58 -53.75 17.15 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.486 -0.759 . . . . 0.0 110.022 179.827 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.92 HG12 HD12 ' A' ' 32' ' ' LEU . 4.8 t -72.98 -50.68 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 C-N-CA 120.06 -0.656 . . . . 0.0 110.365 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.6 ' HD3' HG12 ' A' ' 25' ' ' VAL . 0.1 OUTLIER -45.46 -49.62 13.31 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.317 -0.864 . . . . 0.0 109.898 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.12 -35.88 66.63 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.583 -0.698 . . . . 0.0 109.829 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.499 ' HB2' ' HA ' ' A' ' 28' ' ' VAL . 14.8 mt -64.19 -58.55 6.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.363 -0.836 . . . . 0.0 110.437 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.971 HD22 ' CG ' ' A' ' 66' ' ' HIS . 0.5 OUTLIER -50.05 -37.83 35.18 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.184 -0.948 . . . . 0.0 110.292 -179.568 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -79.33 -16.17 56.75 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.394 -0.816 . . . . 0.0 110.164 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -93.48 -4.98 50.19 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.231 -0.918 . . . . 0.0 111.435 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 134.06 -19.7 4.1 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.434 -1.365 . . . . 0.0 110.937 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.65 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -46.12 121.14 3.1 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.07 -1.253 . . . . 0.0 110.594 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.542 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 0.7 OUTLIER -75.48 128.67 83.69 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.396 -0.815 . . . . 0.0 110.421 -179.434 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.506 ' HB2' ' C ' ' A' ' 67' ' ' GLY . 46.3 Cg_endo -68.97 -37.77 10.61 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 O-C-N 123.493 1.259 . . . . 0.0 111.185 -179.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.53 48.95 1.16 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.148 -0.97 . . . . 0.0 110.069 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.542 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -100.87 95.88 5.02 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.189 -0.944 . . . . 0.0 110.192 179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.43 128.76 18.84 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.432 1.227 . . . . 0.0 110.245 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -122.18 178.16 5.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.363 -0.836 . . . . 0.0 110.499 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.448 ' O ' ' CB ' ' A' ' 44' ' ' TYR . 1.1 p -60.8 -157.11 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.427 -0.796 . . . . 0.0 110.042 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.448 ' CB ' ' O ' ' A' ' 43' ' ' SER . 3.5 t80 68.17 5.87 4.92 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.423 -0.798 . . . . 0.0 110.644 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 52.04 25.65 17.77 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.471 ' HB3' ' HB ' ' A' ' 51' ' ' VAL . 0.1 OUTLIER -116.8 -167.45 1.3 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.317 -1.108 . . . . 0.0 110.87 -179.585 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.579 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 0.5 OUTLIER -124.3 -161.45 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.805 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -179.884 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.664 ' HB2' HD22 ' A' ' 63' ' ' LEU . 51.2 Cg_endo -78.69 -32.19 2.18 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 O-C-N 122.698 0.841 . . . . 0.0 110.921 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.524 HG13 ' HB1' ' A' ' 68' ' ' ALA . 5.7 mt -109.02 -36.77 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 O-C-N 120.869 -1.145 . . . . 0.0 109.91 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.469 ' OE1' ' HA ' ' A' ' 46' ' ' ARG . 17.0 tt0 -48.62 -26.56 2.31 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.248 -0.908 . . . . 0.0 109.518 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.603 HG22 ' HB2' ' A' ' 21' ' ' ALA . 8.3 p -97.12 21.39 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.491 -0.756 . . . . 0.0 110.382 179.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.704 ' CE ' ' HB2' ' A' ' 60' ' ' ALA . 0.4 OUTLIER -77.18 159.1 29.96 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.139 -0.975 . . . . 0.0 109.761 179.579 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 37.6 ttp -70.09 -5.4 26.6 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.261 -0.899 . . . . 0.0 110.165 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.618 ' HE2' ' HB3' ' A' ' 52' ' ' MET . 16.0 mmt 49.68 28.26 2.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.348 -0.845 . . . . 0.0 109.835 -179.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.439 ' C ' ' CE2' ' A' ' 90' ' ' PHE . . . -124.33 5.7 8.74 Favored Glycine 0 N--CA 1.488 2.109 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 178.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -156.1 85.72 1.02 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.654 -0.909 . . . . 0.0 109.221 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.423 ' HB2' ' HB3' ' A' ' 92' ' ' ASP . . . -46.98 -26.94 1.12 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.589 -0.694 . . . . 0.0 110.102 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -46.55 -42.71 16.29 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.662 -0.649 . . . . 0.0 109.798 179.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.654 HG11 ' HA ' ' A' ' 20' ' ' ALA . 10.9 t -65.74 -60.63 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.63 -0.669 . . . . 0.0 109.282 179.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.704 ' HB2' ' CE ' ' A' ' 52' ' ' MET . . . -48.43 -47.63 37.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.456 -0.778 . . . . 0.0 109.311 179.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.482 ' O ' HD23 ' A' ' 65' ' ' LEU . 0.5 OUTLIER -60.19 -40.76 91.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.589 -0.694 . . . . 0.0 109.263 178.685 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.688 HD21 HG12 ' A' ' 28' ' ' VAL . 2.8 tp -66.27 -51.99 51.99 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.461 -0.774 . . . . 0.0 109.474 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.981 HD21 HD11 ' A' ' 16' ' ' LEU . 2.8 mt -67.86 -41.54 82.73 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.313 -0.867 . . . . 0.0 110.16 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.508 ' CD1' HG12 ' A' ' 96' ' ' VAL . 0.5 OUTLIER -68.78 -57.98 4.84 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.192 -0.943 . . . . 0.0 110.372 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.743 HD12 ' C ' ' A' ' 65' ' ' LEU . 1.3 pp -49.94 -25.63 3.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.118 -0.989 . . . . 0.0 109.096 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.971 ' CG ' HD22 ' A' ' 32' ' ' LEU . 1.4 m-70 -82.11 -51.32 8.11 Favored 'General case' 0 C--N 1.307 -1.265 0 O-C-N 121.789 -0.569 . . . . 0.0 109.481 179.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.506 ' C ' ' HB2' ' A' ' 38' ' ' PRO . . . 152.74 38.78 0.03 OUTLIER Glycine 0 N--CA 1.485 1.914 0 C-N-CA 120.03 -1.081 . . . . 0.0 110.794 179.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.524 ' HB1' HG13 ' A' ' 49' ' ' ILE . . . -69.67 -170.19 0.29 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.867 -1.372 . . . . 0.0 110.06 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -109.17 79.37 1.17 Allowed Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.39 -0.818 . . . . 0.0 109.611 179.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.448 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 49.5 Cg_endo -70.83 -12.55 31.01 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 O-C-N 123.8 1.421 . . . . 0.0 110.546 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.527 ' O ' ' NE ' ' A' ' 80' ' ' ARG . 26.3 t-20 -113.43 -58.46 2.15 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.285 -0.884 . . . . 0.0 110.669 -179.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.417 ' C ' ' O ' ' A' ' 71' ' ' ASN . 0.1 OUTLIER -41.1 137.46 1.31 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.26 -0.9 . . . . 0.0 110.918 -179.515 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.459 ' HB2' ' CD ' ' A' ' 80' ' ' ARG . . . -131.43 -155.22 0.68 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.623 -0.673 . . . . 0.0 110.286 -179.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -106.15 145.52 31.11 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.197 -0.939 . . . . 0.0 110.487 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -75.57 -25.4 11.04 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.712 1.375 . . . . 0.0 110.048 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.11 -59.32 5.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.314 -0.866 . . . . 0.0 110.175 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.544 ' OG1' ' HB3' ' A' ' 109' ' ' ALA . 2.2 t -137.0 29.31 2.82 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.337 -0.852 . . . . 0.0 110.908 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.459 ' HA ' HD23 ' A' ' 78' ' ' LEU . 20.2 mt 51.53 52.91 13.72 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.203 -0.936 . . . . 0.0 111.372 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 16.7 m -83.41 106.48 15.2 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.032 -1.042 . . . . 0.0 109.736 179.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.654 ' HB2' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -95.35 170.66 7.5 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.372 -0.83 . . . . 0.0 109.721 179.745 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.553 ' HD2' ' CG ' ' A' ' 80' ' ' ARG . 48.1 Cg_endo -71.74 -0.09 7.83 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.564 1.297 . . . . 0.0 110.425 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.874 HG21 ' HA ' ' A' ' 104' ' ' LEU . 43.3 t -79.87 -45.04 23.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -0.932 . . . . 0.0 110.279 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.429 ' O ' ' CB ' ' A' ' 87' ' ' ARG . 37.4 m80 -59.01 -37.73 77.58 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.389 -0.819 . . . . 0.0 109.221 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.459 ' CB ' ' HE3' ' A' ' 54' ' ' MET . 62.3 m-20 -54.43 -57.55 10.88 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.714 -0.616 . . . . 0.0 110.566 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.476 ' CB ' HD13 ' A' ' 94' ' ' LEU . . . -51.01 -63.83 1.0 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.102 -0.998 . . . . 0.0 109.884 -179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.941 ' HB2' HD11 ' A' ' 130' ' ' LEU . . . -56.65 -50.73 71.2 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.337 -0.852 . . . . 0.0 110.687 179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.429 ' CB ' ' O ' ' A' ' 83' ' ' HIS . 11.0 tpp85 -43.44 -28.82 0.39 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.294 -0.879 . . . . 0.0 110.852 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -103.59 -11.12 17.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.397 -0.814 . . . . 0.0 110.459 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.598 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 86.35 34.55 12.0 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.439 ' CE2' ' C ' ' A' ' 55' ' ' GLY . 0.4 OUTLIER -108.28 121.15 44.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.112 -1.228 . . . . 0.0 110.732 -179.818 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.565 HD11 ' O ' ' A' ' 125' ' ' ASP . 0.4 OUTLIER -94.75 -41.65 9.14 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.497 -0.752 . . . . 0.0 110.222 179.737 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.878 ' O ' HG23 ' A' ' 96' ' ' VAL . 0.4 OUTLIER -52.05 -30.15 24.46 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.348 -0.845 . . . . 0.0 109.088 179.53 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.521 ' O ' HD12 ' A' ' 97' ' ' LEU . 72.4 m -72.85 -38.57 67.03 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.912 HD21 ' CD2' ' A' ' 130' ' ' LEU . 1.6 tp -64.42 -47.72 78.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.571 -0.705 . . . . 0.0 109.416 179.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.45 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 41.4 t -57.2 -48.31 82.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.47 -0.769 . . . . 0.0 108.951 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.878 HG23 ' O ' ' A' ' 92' ' ' ASP . 98.7 t -52.56 -53.78 18.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.781 -0.574 . . . . 0.0 110.072 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.521 HD12 ' O ' ' A' ' 93' ' ' THR . 0.3 OUTLIER -52.56 -65.29 0.58 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.391 -0.818 . . . . 0.0 109.965 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -58.48 -28.47 65.38 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.272 -0.893 . . . . 0.0 110.339 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.45 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 17.7 ttp180 -67.16 -15.83 63.94 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.256 -0.903 . . . . 0.0 110.424 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.95 72.35 1.33 Allowed 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.347 -0.845 . . . . 0.0 110.863 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 54.64 102.79 0.01 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.419 ' CB ' ' C ' ' A' ' 97' ' ' LEU . . . -163.57 102.47 0.93 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.333 -1.098 . . . . 0.0 110.167 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -71.63 98.26 1.87 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.428 -0.795 . . . . 0.0 110.015 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.874 ' HA ' HG21 ' A' ' 82' ' ' VAL . 1.1 mp -89.9 10.53 23.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.451 -0.78 . . . . 0.0 109.706 179.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -103.13 36.88 2.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.311 -0.868 . . . . 0.0 110.719 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.654 HG11 ' HB2' ' A' ' 80' ' ' ARG . 0.7 OUTLIER -98.25 -171.82 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.024 -1.047 . . . . 0.0 109.77 179.555 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.567 ' H ' HG22 ' A' ' 106' ' ' VAL . 4.4 ptt-85 -140.44 135.48 32.05 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.625 -0.672 . . . . 0.0 109.666 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.509 ' O ' ' N ' ' A' ' 110' ' ' TRP . 41.9 p-10 -79.47 44.04 0.59 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.125 -0.984 . . . . 0.0 110.615 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.544 ' HB3' ' OG1' ' A' ' 77' ' ' THR . . . 38.71 -86.52 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.135 0 CA-C-O 121.006 0.431 . . . . 0.0 112.122 178.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.509 ' N ' ' O ' ' A' ' 108' ' ' ASP . 7.7 m0 -76.75 51.08 0.74 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.257 -0.902 . . . . 0.0 110.856 -179.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.492 ' O ' ' CG ' ' A' ' 112' ' ' ARG . . . -155.31 -89.34 0.07 OUTLIER Glycine 0 N--CA 1.479 1.521 0 N-CA-C 108.338 -1.905 . . . . 0.0 108.338 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.616 ' O ' HD12 ' A' ' 113' ' ' LEU . 0.0 OUTLIER 164.85 -57.48 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.021 0 O-C-N 122.084 -0.656 . . . . 0.0 109.773 179.079 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.616 HD12 ' O ' ' A' ' 112' ' ' ARG . 0.0 OUTLIER -173.43 159.62 3.27 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.237 -0.914 . . . . 0.0 110.666 -179.603 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.462 ' HD2' HD23 ' A' ' 113' ' ' LEU . 42.1 Cg_endo -68.27 -29.26 32.56 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.674 1.355 . . . . 0.0 110.743 179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 9.8 p -78.71 -32.69 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.999 -1.063 . . . . 0.0 109.834 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -64.39 -26.89 68.66 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.345 -0.847 . . . . 0.0 109.367 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.498 HD23 ' CD1' ' A' ' 121' ' ' LEU . 0.2 OUTLIER -70.47 -37.03 74.22 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.506 -0.746 . . . . 0.0 109.636 179.258 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.5 ' CB ' ' HB2' ' A' ' 123' ' ' HIS . . . -70.18 -35.89 74.28 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.447 -0.783 . . . . 0.0 109.915 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -63.33 -39.1 93.62 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.42 -0.8 . . . . 0.0 110.307 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.05 -69.62 0.51 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.371 -0.831 . . . . 0.0 110.396 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.498 ' CD1' HD23 ' A' ' 117' ' ' LEU . 0.2 OUTLIER -47.3 -89.14 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.499 -0.751 . . . . 0.0 111.142 -179.54 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 173.53 36.56 0.04 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.584 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 51.6 m-70 -101.19 43.99 1.03 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.364 -1.08 . . . . 0.0 109.11 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.77 -53.87 4.37 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-O 121.211 0.529 . . . . 0.0 110.698 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.565 ' O ' HD11 ' A' ' 91' ' ' LEU . 0.5 OUTLIER -51.45 -40.29 59.12 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.422 -0.799 . . . . 0.0 109.426 179.292 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.803 HG11 ' HA ' ' A' ' 86' ' ' ALA . 2.0 t -78.73 -35.5 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.383 -0.823 . . . . 0.0 109.611 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.473 ' HB2' ' CB ' ' A' ' 118' ' ' ALA . . . -59.06 -48.05 83.0 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.215 -0.928 . . . . 0.0 109.805 179.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 2.5 ttm180 -50.0 -63.94 0.96 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.486 -0.759 . . . . 0.0 109.854 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.427 ' CD2' HD21 ' A' ' 91' ' ' LEU . 3.5 t80 -52.93 -55.21 25.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.556 -0.715 . . . . 0.0 110.393 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.941 HD11 ' HB2' ' A' ' 86' ' ' ALA . 25.2 mt -48.07 -48.78 33.16 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.558 -0.713 . . . . 0.0 109.945 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.81 -28.95 17.24 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.367 -0.833 . . . . 0.0 109.929 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -89.0 -54.02 4.32 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.485 -0.759 . . . . 0.0 110.361 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.725 ' HB1' HD13 ' A' ' 104' ' ' LEU . . . -75.71 -7.49 54.49 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.32 -0.862 . . . . 0.0 110.902 -179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.638 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . -112.73 -60.31 1.89 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.094 -1.003 . . . . 0.0 110.067 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 114.35 91.32 1.83 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -90.91 129.89 10.01 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 37.6 p -68.36 134.02 49.62 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.425 -1.044 . . . . 0.0 110.253 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.6 155.46 44.97 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.338 -0.851 . . . . 0.0 110.488 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -79.78 -5.63 89.36 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -64.07 -88.49 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.311 -1.111 . . . . 0.0 110.293 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -107.85 78.48 1.19 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.057 -1.027 . . . . 0.0 110.022 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -78.32 78.92 4.78 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.221 -0.924 . . . . 0.0 109.95 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -98.31 8.2 45.17 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.311 -0.868 . . . . 0.0 110.34 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 10.0 ttt180 -83.33 126.72 32.99 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.216 -0.928 . . . . 0.0 109.957 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -85.87 155.34 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.302 -0.874 . . . . 0.0 109.536 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -51.48 172.82 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.179 -0.951 . . . . 0.0 110.268 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -65.92 132.94 49.83 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.145 -0.972 . . . . 0.0 110.147 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -58.33 145.41 38.1 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.239 -0.913 . . . . 0.0 109.755 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -45.39 111.8 0.38 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.31 -0.869 . . . . 0.0 110.101 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -160.83 118.92 0.85 Allowed Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.516 -1.326 . . . . 0.0 110.47 -179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -74.3 -165.72 0.28 Allowed 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.76 1.4 . . . . 0.0 110.826 179.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -51.93 112.91 0.86 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.402 -0.811 . . . . 0.0 110.661 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -69.67 155.75 40.03 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.409 -0.807 . . . . 0.0 110.21 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 11.6 pt -103.0 161.98 21.49 Favored Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.248 -0.908 . . . . 0.0 110.418 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.5 127.6 11.93 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.856 1.451 . . . . 0.0 110.139 179.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.1 t70 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 118.083 -0.961 . . . . 0.0 109.998 -179.749 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.138 0.494 . . . . 0.0 110.279 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -150.97 128.34 5.58 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.221 -0.924 . . . . 0.0 110.575 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -76.03 59.38 5.85 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.575 1.303 . . . . 0.0 110.561 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.479 ' O ' ' HB3' ' A' ' 5' ' ' ALA . . . 48.59 82.12 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.414 -0.804 . . . . 0.0 110.701 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 4' ' ' ALA . . . 59.68 87.96 0.08 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.52 -0.738 . . . . 0.0 110.275 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -121.37 20.8 8.3 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.7 p -89.58 28.86 1.22 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.297 -1.12 . . . . 0.0 110.383 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 5.3 t -102.1 108.22 19.56 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.374 -0.829 . . . . 0.0 110.055 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 16.4 mtp -88.9 -60.06 2.06 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.265 -0.897 . . . . 0.0 110.468 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -116.08 77.31 6.96 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.345 -0.847 . . . . 0.0 110.279 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -70.89 109.74 2.61 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 O-C-N 123.568 1.299 . . . . 0.0 109.78 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -47.41 161.13 0.09 Allowed 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.484 -0.76 . . . . 0.0 110.986 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -173.53 -39.83 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.568 -0.708 . . . . 0.0 110.006 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -92.73 -16.64 25.21 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.376 -0.827 . . . . 0.0 111.03 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.592 ' CE3' HD21 ' A' ' 31' ' ' LEU . 3.2 t90 -72.49 -2.4 19.5 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.089 -1.007 . . . . 0.0 110.932 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.602 HD11 ' HB1' ' A' ' 36' ' ' ALA . 31.7 mt -81.58 -53.86 5.9 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.072 -1.017 . . . . 0.0 109.545 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.45 -38.33 87.13 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.605 -0.685 . . . . 0.0 110.245 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.503 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.1 OUTLIER -60.66 -48.58 81.16 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.321 -0.862 . . . . 0.0 109.838 179.572 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.654 ' HB1' ' HB3' ' A' ' 24' ' ' ARG . . . -67.96 -49.2 63.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.386 -0.821 . . . . 0.0 109.651 179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.542 ' HB1' ' CB ' ' A' ' 52' ' ' MET . . . -54.09 -45.42 71.78 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.38 -0.825 . . . . 0.0 109.681 179.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.34 -26.71 65.74 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.474 -0.766 . . . . 0.0 109.986 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.5 mtp85 -95.91 27.42 3.57 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.428 -0.795 . . . . 0.0 110.148 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 50.09 42.89 40.68 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.654 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -113.24 69.29 0.69 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.401 -1.058 . . . . 0.0 110.667 -179.576 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 1.03 HG22 HG22 ' A' ' 59' ' ' VAL . 85.9 t -58.71 -54.32 35.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.255 -0.903 . . . . 0.0 110.288 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -54.18 -41.58 68.7 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.428 -0.795 . . . . 0.0 110.854 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.407 ' OE1' ' HG2' ' A' ' 24' ' ' ARG . 1.6 tp10 -56.73 -45.23 82.07 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.192 -0.943 . . . . 0.0 110.035 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.959 HG12 HD12 ' A' ' 32' ' ' LEU . 20.1 t -68.72 -36.68 75.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.248 -0.907 . . . . 0.0 110.176 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.949 ' HA ' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -49.98 -41.86 47.76 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.422 -0.799 . . . . 0.0 109.927 -179.665 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.587 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -75.71 -31.32 59.61 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.443 -0.786 . . . . 0.0 110.239 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.818 HD12 ' HA ' ' A' ' 28' ' ' VAL . 21.8 mt -74.23 -67.51 0.61 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.452 -0.78 . . . . 0.0 110.52 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.959 HD12 HG12 ' A' ' 28' ' ' VAL . 6.4 mt -45.58 -45.27 13.53 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.625 -0.672 . . . . 0.0 110.282 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -71.98 -23.88 61.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.527 -0.733 . . . . 0.0 110.405 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 30' ' ' ALA . . . -79.76 -4.66 52.93 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.139 -0.976 . . . . 0.0 110.509 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.23 26.89 4.42 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.776 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -71.41 165.28 24.11 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.432 -1.04 . . . . 0.0 110.414 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.501 ' O ' HD12 ' A' ' 16' ' ' LEU . 1.7 tp -98.02 110.7 56.93 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.555 -0.715 . . . . 0.0 110.074 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.496 ' O ' ' HG3' ' A' ' 48' ' ' PRO . 44.3 Cg_endo -70.37 -11.97 30.95 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.445 1.234 . . . . 0.0 110.844 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.436 ' O ' ' HD3' ' A' ' 41' ' ' PRO . 0.7 OUTLIER -103.01 16.05 27.72 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -0.928 . . . . 0.0 110.029 179.78 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.406 ' N ' HD23 ' A' ' 37' ' ' LEU . . . -76.67 111.29 15.07 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.418 -0.801 . . . . 0.0 110.118 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 39' ' ' ASN . 48.1 Cg_endo -72.8 146.61 42.98 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 123.603 1.318 . . . . 0.0 110.358 -179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -75.64 -156.94 0.06 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.418 -0.801 . . . . 0.0 109.864 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.15 2.14 24.63 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.335 -0.853 . . . . 0.0 110.035 179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -102.0 20.49 16.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.269 -0.894 . . . . 0.0 109.907 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 61.85 40.24 98.57 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.8 -1.72 . . . . 0.0 108.8 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.68 -163.18 1.24 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.671 -0.899 . . . . 0.0 110.517 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.483 ' O ' HG12 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -114.32 176.24 1.57 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.482 -0.761 . . . . 0.0 110.591 -179.243 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.496 ' HG3' ' O ' ' A' ' 38' ' ' PRO . 43.1 Cg_endo -70.97 -20.3 29.3 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.825 1.434 . . . . 0.0 110.791 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.487 ' O ' ' CG ' ' A' ' 52' ' ' MET . 6.3 mt -107.09 -40.28 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.284 -0.885 . . . . 0.0 109.39 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.47 ' HB2' ' HB2' ' A' ' 47' ' ' ARG . 1.1 tt0 -48.46 -28.73 3.49 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.282 -0.886 . . . . 0.0 110.477 179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 47' ' ' ARG . 9.1 p -109.88 16.94 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.513 -0.742 . . . . 0.0 110.554 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.556 ' CE ' ' HB2' ' A' ' 60' ' ' ALA . 0.5 OUTLIER -84.58 166.72 16.93 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.09 -1.006 . . . . 0.0 110.261 179.533 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -62.26 91.41 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.334 -0.854 . . . . 0.0 109.092 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.591 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -56.07 -14.28 2.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.21 -0.931 . . . . 0.0 110.31 -179.429 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.401 ' C ' ' CE2' ' A' ' 90' ' ' PHE . . . -84.11 15.37 39.11 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.296 -1.522 . . . . 0.0 109.296 178.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.624 ' O ' HG23 ' A' ' 59' ' ' VAL . 0.4 OUTLIER -151.06 92.83 1.85 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.208 -1.172 . . . . 0.0 109.987 179.703 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.643 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . . . -58.49 -21.06 50.55 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.254 -0.903 . . . . 0.0 109.509 179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.84 -28.74 66.35 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.553 -0.717 . . . . 0.0 110.083 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 1.03 HG22 HG22 ' A' ' 25' ' ' VAL . 2.1 t -70.89 -55.21 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.268 -0.895 . . . . 0.0 109.231 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.556 ' HB2' ' CE ' ' A' ' 52' ' ' MET . . . -51.42 -38.12 51.97 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.382 -0.824 . . . . 0.0 109.585 179.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.493 ' O ' ' HB3' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -53.35 -61.1 2.52 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.626 -0.671 . . . . 0.0 110.35 179.818 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.949 HD11 ' HA ' ' A' ' 29' ' ' ARG . 0.1 OUTLIER -45.81 -63.62 0.93 Allowed 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.324 -0.86 . . . . 0.0 110.345 179.74 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.839 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 7.0 mt -57.9 -57.19 13.88 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.456 -0.778 . . . . 0.0 110.118 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.815 HD22 ' CG1' ' A' ' 96' ' ' VAL . 0.6 OUTLIER -53.21 -54.02 42.22 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.266 -0.896 . . . . 0.0 110.109 179.878 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.493 ' HB3' ' O ' ' A' ' 61' ' ' GLU . 13.2 tp -50.27 -36.76 32.74 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.87 ' CG ' HD22 ' A' ' 32' ' ' LEU . 1.9 m-70 -79.55 -28.24 41.24 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-O 121.504 0.669 . . . . 0.0 109.64 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 117.75 50.86 0.35 Allowed Glycine 0 N--CA 1.476 1.344 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.839 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -60.6 -159.94 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.21 -1.17 . . . . 0.0 109.477 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.45 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 0.6 OUTLIER -120.61 59.67 7.41 Favored Pre-proline 0 C--N 1.299 -1.616 0 O-C-N 121.231 -0.918 . . . . 0.0 109.465 178.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.431 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 47.7 Cg_endo -70.29 57.51 1.72 Allowed 'Trans proline' 0 C--N 1.313 -1.293 0 O-C-N 123.7 1.369 . . . . 0.0 110.415 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -167.3 -62.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.46 -0.775 . . . . 0.0 109.942 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 22.3 m -50.03 138.79 15.06 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.4 -0.812 . . . . 0.0 110.624 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.425 ' HB2' ' HA ' ' A' ' 80' ' ' ARG . . . -136.94 -144.07 0.19 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.397 -0.814 . . . . 0.0 110.109 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.3 144.04 28.38 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.006 -1.059 . . . . 0.0 109.906 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -72.59 -53.73 0.14 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 O-C-N 123.549 1.289 . . . . 0.0 110.55 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.86 -9.14 49.79 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.241 -0.912 . . . . 0.0 109.714 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.465 ' CG2' ' CH2' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -153.48 105.03 2.8 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.642 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.608 HD22 ' NH1' ' A' ' 80' ' ' ARG . 27.8 mt -67.77 53.29 0.06 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.507 -0.746 . . . . 0.0 111.08 -178.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.514 ' HA ' ' OD1' ' A' ' 108' ' ' ASP . 3.6 m -79.8 85.02 5.51 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.104 -0.997 . . . . 0.0 109.528 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.78 ' CD ' HG11 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -71.96 169.95 14.3 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.488 -0.757 . . . . 0.0 109.568 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.486 ' HD2' ' CG ' ' A' ' 80' ' ' ARG . 46.9 Cg_endo -74.42 -2.32 12.23 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.578 1.304 . . . . 0.0 110.391 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.902 HG13 HD23 ' A' ' 104' ' ' LEU . 10.5 t -77.7 -31.32 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.465 -0.772 . . . . 0.0 109.766 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.411 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 27.2 m80 -69.78 -27.26 64.76 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.43 -0.794 . . . . 0.0 109.915 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.591 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 1.1 m-20 -67.64 -53.88 24.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.863 -0.523 . . . . 0.0 110.263 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.51 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -50.02 -58.05 6.29 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.538 -0.727 . . . . 0.0 109.581 179.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.809 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -63.41 -38.06 89.67 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.47 -0.769 . . . . 0.0 110.52 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 1.5 mmm-85 -40.7 -59.87 1.28 Allowed 'General case' 0 N--CA 1.506 2.341 0 O-C-N 121.116 -0.99 . . . . 0.0 111.125 179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -85.18 3.73 37.82 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.232 -0.917 . . . . 0.0 110.156 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.645 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 74.75 48.22 12.99 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.143 -1.583 . . . . 0.0 109.143 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.643 ' CE1' ' HB2' ' A' ' 57' ' ' ALA . 0.3 OUTLIER -111.56 97.49 6.77 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.398 -1.06 . . . . 0.0 111.049 -179.536 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.49 HD12 ' HB3' ' A' ' 125' ' ' ASP . 0.3 OUTLIER -67.06 -42.48 84.69 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.592 -0.692 . . . . 0.0 110.498 179.603 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.431 ' O ' HG23 ' A' ' 96' ' ' VAL . 50.0 m-20 -45.65 -63.61 0.92 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.464 -0.772 . . . . 0.0 110.37 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.472 ' O ' HD12 ' A' ' 97' ' ' LEU . 70.9 m -47.39 -38.49 13.35 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.702 -0.624 . . . . 0.0 109.549 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.718 HD21 ' HG ' ' A' ' 130' ' ' LEU . 4.1 tp -61.84 -48.85 78.71 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 178.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.426 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 98.2 t -60.96 -50.87 78.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.815 ' CG1' HD22 ' A' ' 64' ' ' LEU . 95.0 t -48.85 -57.31 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.727 -0.608 . . . . 0.0 110.209 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.632 HD23 ' HB1' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -43.07 -66.26 0.39 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.782 -0.574 . . . . 0.0 110.218 179.885 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -55.37 -32.6 62.72 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.261 -0.899 . . . . 0.0 109.816 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 0.1 OUTLIER -61.71 -13.87 26.79 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.412 -0.805 . . . . 0.0 110.274 179.439 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.674 ' HB3' HD11 ' A' ' 64' ' ' LEU . . . -140.71 56.68 1.58 Allowed 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.374 -0.829 . . . . 0.0 110.575 -179.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 57.7 98.17 0.01 OUTLIER Glycine 0 N--CA 1.489 2.185 0 N-CA-C 110.149 -1.18 . . . . 0.0 110.149 179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.632 ' HB1' HD23 ' A' ' 97' ' ' LEU . . . -157.84 95.89 1.44 Allowed 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.333 -1.098 . . . . 0.0 110.018 179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -62.15 106.97 0.8 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.293 -0.88 . . . . 0.0 110.028 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.902 HD23 HG13 ' A' ' 82' ' ' VAL . 1.8 mp -96.62 26.75 4.26 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.321 -0.862 . . . . 0.0 109.898 179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -123.36 47.52 1.99 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.346 -0.846 . . . . 0.0 110.792 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.78 HG11 ' CD ' ' A' ' 80' ' ' ARG . 5.1 p -105.18 -175.33 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.189 -0.944 . . . . 0.0 109.454 179.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.694 ' H ' HG22 ' A' ' 106' ' ' VAL . 1.0 OUTLIER -142.56 122.02 13.21 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.187 -0.946 . . . . 0.0 110.83 -179.589 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.514 ' OD1' ' HA ' ' A' ' 79' ' ' THR . 1.6 m-20 -52.2 165.87 0.2 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.558 -0.714 . . . . 0.0 109.715 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.426 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . -70.97 -15.55 62.59 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.278 -0.889 . . . . 0.0 109.772 179.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.465 ' CH2' ' CG2' ' A' ' 77' ' ' THR . 6.8 m-90 -86.92 15.61 5.74 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.252 -0.905 . . . . 0.0 109.877 179.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 65.59 12.32 55.98 Favored Glycine 0 N--CA 1.484 1.872 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.471 ' O ' ' HB2' ' A' ' 108' ' ' ASP . 2.6 ttm180 -94.52 129.0 41.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.417 -1.049 . . . . 0.0 109.73 179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.425 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.0 OUTLIER -91.62 163.5 27.94 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.135 -0.978 . . . . 0.0 109.725 179.843 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.425 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 43.5 Cg_endo -70.37 -31.13 18.33 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.703 1.37 . . . . 0.0 110.768 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.447 HG13 ' N ' ' A' ' 116' ' ' ASP . 9.6 p -80.09 -38.93 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.16 -0.963 . . . . 0.0 110.489 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.447 ' N ' HG13 ' A' ' 115' ' ' VAL . 81.7 m-20 -65.86 -34.39 78.02 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.266 -0.897 . . . . 0.0 110.023 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.01 -34.49 78.12 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.261 -0.9 . . . . 0.0 109.925 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.869 ' HB1' ' HB2' ' A' ' 123' ' ' HIS . . . -70.96 -55.23 8.79 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.314 -0.866 . . . . 0.0 110.7 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.51 ' HG3' ' HB1' ' A' ' 127' ' ' ALA . 12.8 mt-10 -46.84 -39.51 12.11 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.403 -0.811 . . . . 0.0 110.622 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -67.51 -51.34 52.23 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.482 -0.761 . . . . 0.0 109.904 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.436 ' HB3' ' NE2' ' A' ' 123' ' ' HIS . 0.2 OUTLIER -67.19 -87.39 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.354 -0.841 . . . . 0.0 110.225 179.807 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 179.36 32.29 0.06 OUTLIER Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.752 -1.213 . . . . 0.0 110.07 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.869 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . 0.9 OUTLIER -98.29 45.96 1.01 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.171 -1.193 . . . . 0.0 108.882 179.415 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -44.58 -37.17 3.41 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.502 0.668 . . . . 0.0 109.836 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.49 ' HB3' HD12 ' A' ' 91' ' ' LEU . 0.4 OUTLIER -66.58 -44.66 81.63 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.67 -0.644 . . . . 0.0 109.556 179.058 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.809 HG11 ' HA ' ' A' ' 86' ' ' ALA . 2.4 t -75.52 -44.36 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.229 -0.919 . . . . 0.0 110.031 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.51 ' HB1' ' HG3' ' A' ' 119' ' ' GLU . . . -57.27 -24.18 53.19 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.191 -0.943 . . . . 0.0 109.965 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -70.74 -63.0 1.18 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.297 -0.877 . . . . 0.0 109.818 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -59.05 -41.26 87.44 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.483 -0.761 . . . . 0.0 109.36 179.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.718 ' HG ' HD21 ' A' ' 94' ' ' LEU . 13.2 mt -51.3 -64.24 0.87 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.495 -0.753 . . . . 0.0 109.539 179.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 1.7 ttt-85 -51.6 -21.69 2.76 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.298 -0.876 . . . . 0.0 110.317 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -88.51 -51.69 5.57 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.383 -0.823 . . . . 0.0 110.515 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -86.78 -16.46 36.22 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.247 -0.908 . . . . 0.0 111.206 -179.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . -84.88 49.71 1.78 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.034 -1.041 . . . . 0.0 110.33 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 79.35 137.1 1.4 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -160.06 45.16 0.42 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 10.9 t -63.83 153.43 36.7 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.316 -1.108 . . . . 0.0 110.514 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.5 tpt85 -98.9 108.8 21.57 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.349 -0.844 . . . . 0.0 109.972 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -176.4 111.32 0.34 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.9 t 59.27 163.62 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.297 -1.119 . . . . 0.0 110.07 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -73.47 -51.41 17.26 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.196 -0.94 . . . . 0.0 109.856 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.433 ' O ' ' CD2' ' A' ' 142' ' ' HIS . 68.6 t60 -148.4 78.01 1.41 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.467 -0.771 . . . . 0.0 109.652 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -154.38 -53.18 0.1 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.301 -0.874 . . . . 0.0 110.224 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.07 114.75 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.5 -0.75 . . . . 0.0 110.527 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.428 ' O ' ' N ' ' A' ' 147' ' ' ALA . 10.5 mt -69.03 132.82 32.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.32 -0.862 . . . . 0.0 109.524 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -55.3 90.45 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.281 -0.887 . . . . 0.0 110.173 179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 145' ' ' ILE . . . -60.86 159.4 11.28 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.24 -0.912 . . . . 0.0 110.43 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -47.98 146.98 2.25 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.646 -0.659 . . . . 0.0 110.537 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -174.45 -50.0 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.185 -0.947 . . . . 0.0 110.236 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -73.3 168.87 53.59 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.42 119.74 6.58 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 O-C-N 123.95 1.5 . . . . 0.0 110.401 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.8 14.8 14.37 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.251 -0.906 . . . . 0.0 110.645 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.58 134.05 56.66 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.139 -0.975 . . . . 0.0 110.01 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.438 HG22 ' O ' ' A' ' 154' ' ' ILE . 5.1 mt -115.11 81.97 8.39 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.327 -0.858 . . . . 0.0 110.071 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -75.52 160.46 38.43 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 123.816 1.43 . . . . 0.0 110.369 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.725 0 CA-C-O 118.073 -0.965 . . . . 0.0 110.27 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 ptt? . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 121.163 0.506 . . . . 0.0 110.419 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -151.84 71.77 8.0 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.4 -0.813 . . . . 0.0 110.19 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.496 ' O ' ' N ' ' A' ' 5' ' ' ALA . 47.3 Cg_endo -73.69 161.42 41.94 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 123.605 1.318 . . . . 0.0 110.006 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -60.97 78.19 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.411 -0.806 . . . . 0.0 110.144 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.496 ' N ' ' O ' ' A' ' 3' ' ' PRO . . . -128.36 87.8 2.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.599 -0.688 . . . . 0.0 110.309 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 96.16 -178.99 34.86 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 71.4 m -129.43 140.03 51.45 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.298 -1.119 . . . . 0.0 110.675 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.6 m -120.53 19.04 12.03 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.502 -0.749 . . . . 0.0 110.202 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 3.7 tpp -73.29 -38.16 65.98 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.26 -0.9 . . . . 0.0 109.791 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -179.52 95.32 0.2 Allowed Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.364 -0.835 . . . . 0.0 109.743 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.32 99.98 1.26 Allowed 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.834 1.439 . . . . 0.0 110.901 -179.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 86.0 p -140.86 -64.16 0.46 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.575 -0.703 . . . . 0.0 109.429 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 45.29 25.0 0.17 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.587 -0.696 . . . . 0.0 110.723 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -108.55 11.19 26.91 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.392 -0.817 . . . . 0.0 110.411 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.45 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 16.0 m0 -75.4 -20.22 59.06 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.148 -0.97 . . . . 0.0 109.981 179.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.719 HD13 HD11 ' A' ' 63' ' ' LEU . 1.2 pp -67.86 -35.22 78.16 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.396 -0.815 . . . . 0.0 110.043 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.14 -42.11 24.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.39 -0.819 . . . . 0.0 110.394 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.45 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.0 OUTLIER -59.85 -58.4 8.74 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.363 -0.836 . . . . 0.0 110.51 -179.655 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.19 -45.38 65.14 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.165 -0.959 . . . . 0.0 109.784 179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.553 ' HB1' ' CB ' ' A' ' 52' ' ' MET . . . -50.83 -53.79 29.25 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.604 -0.685 . . . . 0.0 110.037 179.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.799 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -56.01 -31.8 63.41 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.164 -0.96 . . . . 0.0 110.078 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.58 21.8 5.99 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.799 -0.76 . . . . 0.0 110.38 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 49.43 76.02 0.18 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -140.76 63.84 1.45 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.57 -0.959 . . . . 0.0 109.405 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.501 ' CG1' ' NE ' ' A' ' 29' ' ' ARG . 13.6 t -49.21 -51.44 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.493 -0.755 . . . . 0.0 110.101 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -50.69 -51.14 52.37 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.74 -0.6 . . . . 0.0 110.669 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.506 ' O ' ' HG ' ' A' ' 31' ' ' LEU . 5.4 tt0 -56.09 -44.96 79.52 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.329 -0.857 . . . . 0.0 109.874 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.81 HG12 ' CD1' ' A' ' 62' ' ' LEU . 38.4 t -71.28 -47.06 62.17 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 O-C-N 121.472 -0.767 . . . . 0.0 109.796 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.511 ' HA ' ' CD1' ' A' ' 62' ' ' LEU . 0.1 OUTLIER -39.17 -52.68 1.91 Allowed 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.55 -0.719 . . . . 0.0 110.285 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.9 -49.53 14.02 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.679 -0.638 . . . . 0.0 110.733 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 27' ' ' GLU . 41.2 mt -44.73 -66.76 0.35 Allowed 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.32 -0.863 . . . . 0.0 110.635 -179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.98 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 0.6 OUTLIER -50.2 -53.93 24.49 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.46 -0.775 . . . . 0.0 110.296 179.681 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 29' ' ' ARG . 0.5 OUTLIER -63.84 -6.86 6.52 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.442 -0.786 . . . . 0.0 110.962 179.325 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -100.81 -13.43 18.41 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.853 -1.154 . . . . 0.0 111.56 -178.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 146.38 -10.62 1.52 Allowed Glycine 0 N--CA 1.49 2.27 0 C-N-CA 119.323 -1.418 . . . . 0.0 110.45 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.98 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -56.18 140.56 43.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.929 -1.336 . . . . 0.0 109.87 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.951 ' HB2' ' HB2' ' A' ' 40' ' ' ALA . 18.3 mt -79.21 143.07 59.95 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.382 -0.824 . . . . 0.0 110.213 -179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.491 ' HB3' ' HB3' ' A' ' 66' ' ' HIS . 43.5 Cg_endo -72.54 -37.35 4.22 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.358 1.188 . . . . 0.0 110.125 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -100.59 5.64 43.99 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.403 -0.811 . . . . 0.0 110.534 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.951 ' HB2' ' HB2' ' A' ' 37' ' ' LEU . . . -39.75 101.36 0.23 Allowed Pre-proline 0 N--CA 1.501 2.098 0 O-C-N 121.471 -0.768 . . . . 0.0 111.358 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 40' ' ' ALA . 54.1 Cg_endo -72.58 159.26 49.29 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 O-C-N 123.828 1.436 . . . . 0.0 109.651 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.51 ' N ' ' OD1' ' A' ' 42' ' ' ASN . 10.8 p-10 -131.5 170.87 14.1 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.473 -0.767 . . . . 0.0 109.913 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.5 m -87.13 12.37 11.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.387 -0.821 . . . . 0.0 110.434 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.465 ' HB3' ' ND2' ' A' ' 42' ' ' ASN . 4.2 t80 -93.16 19.77 7.64 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.241 -0.912 . . . . 0.0 109.644 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 48.38 23.2 2.89 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 -179.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -138.57 106.17 5.59 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.63 -0.924 . . . . 0.0 110.845 -179.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.532 ' CB ' ' HD2' ' A' ' 48' ' ' PRO . 1.1 mpt_? -54.86 -175.39 0.04 OUTLIER Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.55 -0.719 . . . . 0.0 109.619 179.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.532 ' HD2' ' CB ' ' A' ' 47' ' ' ARG . 43.0 Cg_endo -69.09 170.55 15.53 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.145 1.076 . . . . 0.0 109.732 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.531 ' O ' ' CG ' ' A' ' 52' ' ' MET . 3.2 mt 63.27 -58.78 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.794 -0.566 . . . . 0.0 110.578 -179.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.488 ' N ' ' O ' ' A' ' 48' ' ' PRO . 0.4 OUTLIER -48.68 -25.57 1.85 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.569 -1.332 . . . . 0.0 109.797 179.342 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.799 HG22 ' HB2' ' A' ' 21' ' ' ALA . 12.0 p -110.39 18.6 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 O-C-N 121.606 -0.684 . . . . 0.0 109.378 178.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.553 ' CB ' ' HB1' ' A' ' 20' ' ' ALA . 0.5 OUTLIER -92.72 167.67 11.73 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.242 -0.911 . . . . 0.0 110.057 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 5.5 ttp -69.26 107.52 3.29 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.159 -1.016 . . . . 0.0 109.32 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.527 ' HE2' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -66.41 -3.91 7.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.087 -1.008 . . . . 0.0 109.861 179.501 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -89.97 16.91 55.85 Favored Glycine 0 N--CA 1.484 1.889 0 N-CA-C 108.79 -1.724 . . . . 0.0 108.79 178.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.93 117.29 2.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.199 -1.177 . . . . 0.0 109.704 -179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.513 ' HB2' ' HE2' ' A' ' 90' ' ' PHE . . . -79.52 -27.06 41.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.308 -0.87 . . . . 0.0 110.368 -179.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.51 ' O ' ' NH1' ' A' ' 29' ' ' ARG . 5.8 mmt180 -48.84 -38.25 21.77 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.181 -0.95 . . . . 0.0 110.267 -179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.438 HG22 ' CG2' ' A' ' 25' ' ' VAL . 24.3 t -62.64 -63.56 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 120.987 -1.071 . . . . 0.0 109.116 179.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.528 ' HB2' ' CE ' ' A' ' 52' ' ' MET . . . -52.13 -29.87 23.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.46 -0.775 . . . . 0.0 109.375 178.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -54.53 -66.4 0.41 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.029 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.81 ' CD1' HG12 ' A' ' 28' ' ' VAL . 0.1 OUTLIER -44.09 -61.63 1.41 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.402 -0.811 . . . . 0.0 109.564 178.746 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.816 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 4.3 mm? -47.92 -66.87 0.33 Allowed 'General case' 0 N--CA 1.492 1.641 0 CA-C-O 121.309 0.576 . . . . 0.0 109.927 179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 1.032 HD23 HG12 ' A' ' 96' ' ' VAL . 20.0 tp -52.85 -53.01 54.87 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.438 -0.788 . . . . 0.0 110.633 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.451 ' HB3' ' O ' ' A' ' 61' ' ' GLU . 13.5 tp -49.53 -39.04 32.94 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.844 0.831 . . . . 0.0 108.956 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.927 ' CG ' HD22 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -81.34 -31.15 33.56 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.458 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 63' ' ' LEU . . . 124.21 56.19 0.18 Allowed Glycine 0 N--CA 1.481 1.661 0 C-N-CA 120.367 -0.92 . . . . 0.0 111.116 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.816 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -73.91 -154.4 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.841 -1.388 . . . . 0.0 110.103 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -122.49 77.58 45.83 Favored Pre-proline 0 N--CA 1.489 1.478 0 C-N-CA 119.824 -0.75 . . . . 0.0 109.985 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.508 ' HG3' ' CD1' ' A' ' 64' ' ' LEU . 53.7 Cg_endo -76.85 -11.61 18.17 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 O-C-N 124.067 1.562 . . . . 0.0 110.0 -179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.418 ' OD1' ' CB ' ' A' ' 103' ' ' ARG . 7.1 t30 -108.5 -64.36 1.23 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.493 -0.754 . . . . 0.0 109.741 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -46.07 139.95 4.15 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.421 0.629 . . . . 0.0 110.761 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.535 ' HB2' ' HA ' ' A' ' 80' ' ' ARG . . . -132.82 -150.39 0.41 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.658 -0.651 . . . . 0.0 110.187 -179.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.515 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -101.33 143.47 26.67 Favored Pre-proline 0 C--N 1.305 -1.343 0 O-C-N 121.216 -0.928 . . . . 0.0 109.746 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -71.87 -29.87 14.8 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.517 1.272 . . . . 0.0 110.728 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -47.86 -80.83 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.412 -0.805 . . . . 0.0 110.702 179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.71 HG22 ' CZ2' ' A' ' 110' ' ' TRP . 4.1 p -115.31 30.71 7.17 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.423 -0.798 . . . . 0.0 109.878 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.515 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 2.8 mt 44.54 46.22 8.09 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.607 -0.683 . . . . 0.0 111.541 179.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.484 ' O ' ' NE2' ' A' ' 50' ' ' GLN . 0.2 OUTLIER -72.77 95.62 1.93 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.21 -0.931 . . . . 0.0 109.881 179.62 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.754 ' HD3' HG21 ' A' ' 106' ' ' VAL . 0.5 OUTLIER -71.92 154.4 92.65 Favored Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.397 -0.814 . . . . 0.0 109.952 179.805 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.597 ' HD2' ' HG3' ' A' ' 80' ' ' ARG . 48.3 Cg_endo -72.01 -13.71 28.96 Favored 'Trans proline' 0 N--CA 1.489 1.23 0 O-C-N 123.577 1.303 . . . . 0.0 109.973 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.418 ' CG1' HD21 ' A' ' 130' ' ' LEU . 21.2 t -61.96 -27.4 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 CA-C-O 121.534 0.683 . . . . 0.0 109.661 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.512 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 4.2 m80 -72.72 -42.86 63.69 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.527 ' HB3' ' HE2' ' A' ' 54' ' ' MET . 0.6 OUTLIER -45.23 -51.78 10.32 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.548 -0.72 . . . . 0.0 110.091 179.249 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.528 ' HB1' HD13 ' A' ' 94' ' ' LEU . . . -56.78 -64.94 0.71 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.582 -0.699 . . . . 0.0 109.794 179.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.824 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -61.22 -54.0 49.72 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.58 -0.7 . . . . 0.0 111.594 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.724 ' O ' HD22 ' A' ' 121' ' ' LEU . 0.4 OUTLIER -40.18 -31.48 0.13 Allowed 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.3 -0.875 . . . . 0.0 110.976 -179.741 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -100.88 -17.85 16.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.154 -0.966 . . . . 0.0 109.602 179.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.537 ' HA3' ' CE1' ' A' ' 123' ' ' HIS . . . 89.27 41.31 5.85 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.513 ' HE2' ' HB2' ' A' ' 57' ' ' ALA . 2.1 t80 -110.64 123.48 50.08 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.656 -0.908 . . . . 0.0 110.368 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.545 ' CD2' ' HA ' ' A' ' 126' ' ' VAL . 0.0 OUTLIER -94.38 -44.31 7.97 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.5 -0.75 . . . . 0.0 110.24 -179.748 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.812 ' O ' HG23 ' A' ' 96' ' ' VAL . 0.9 OUTLIER -44.58 -31.35 1.11 Allowed 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 121.368 0.604 . . . . 0.0 109.858 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.456 HG22 HD13 ' A' ' 97' ' ' LEU . 8.7 m -76.1 -49.19 18.09 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.326 -0.859 . . . . 0.0 108.767 178.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.005 HD21 ' HG ' ' A' ' 130' ' ' LEU . 1.1 mp -50.74 -49.05 58.77 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.503 HG23 HD12 ' A' ' 91' ' ' LEU . 84.5 t -56.52 -60.96 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.695 -0.628 . . . . 0.0 109.536 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 1.032 HG12 HD23 ' A' ' 64' ' ' LEU . 49.1 t -47.36 -52.25 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.456 HD13 HG22 ' A' ' 93' ' ' THR . 0.1 OUTLIER -46.02 -64.15 0.81 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.797 -0.564 . . . . 0.0 111.038 179.228 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -63.08 -31.26 72.36 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.156 -0.965 . . . . 0.0 110.084 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.488 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 1.2 ttt85 -63.07 -12.97 30.4 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.263 -0.898 . . . . 0.0 110.825 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.665 ' HB3' HD21 ' A' ' 64' ' ' LEU . . . -139.94 58.54 1.59 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.216 -0.928 . . . . 0.0 110.647 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 55.93 106.03 0.01 OUTLIER Glycine 0 N--CA 1.488 2.15 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.307 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -164.36 124.76 2.08 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.426 -1.044 . . . . 0.0 109.787 179.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.418 ' CB ' ' OD1' ' A' ' 71' ' ' ASN . 10.9 ttp180 -82.58 135.52 35.06 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.237 -0.914 . . . . 0.0 110.287 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.77 HD13 ' HB1' ' A' ' 133' ' ' ALA . 1.7 mp -121.36 21.2 11.14 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.263 -0.898 . . . . 0.0 110.504 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -123.63 54.0 1.32 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.325 -0.859 . . . . 0.0 111.126 -179.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.754 HG21 ' HD3' ' A' ' 80' ' ' ARG . 3.9 p -112.93 -174.11 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.824 -1.172 . . . . 0.0 110.405 -179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.712 ' H ' HG22 ' A' ' 106' ' ' VAL . 18.7 mtm180 -133.91 138.83 45.77 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.623 -0.673 . . . . 0.0 109.306 179.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.617 ' O ' ' N ' ' A' ' 110' ' ' TRP . 0.3 OUTLIER -71.63 53.1 0.22 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.437 -0.789 . . . . 0.0 109.941 179.651 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.622 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 55.53 -73.19 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.481 -0.762 . . . . 0.0 110.24 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.71 ' CZ2' HG22 ' A' ' 77' ' ' THR . 0.5 OUTLIER -46.04 -64.43 0.75 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.483 -0.761 . . . . 0.0 109.546 179.485 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 167.01 -39.23 0.24 Allowed Glycine 0 C--N 1.302 -1.32 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 179.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -44.12 122.03 2.74 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.756 -0.849 . . . . 0.0 110.392 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.484 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER -92.32 172.67 5.99 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.689 -0.632 . . . . 0.0 110.259 -179.579 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.49 ' HB3' ' CE1' ' A' ' 83' ' ' HIS . 41.4 Cg_endo -74.05 -47.81 0.24 Allowed 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.975 1.513 . . . . 0.0 109.524 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.419 HG13 ' N ' ' A' ' 116' ' ' ASP . 8.8 p -60.58 -35.46 63.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.528 -0.733 . . . . 0.0 110.382 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.419 ' N ' HG13 ' A' ' 115' ' ' VAL . 0.7 OUTLIER -61.63 -51.88 66.67 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.407 -0.808 . . . . 0.0 109.739 179.873 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.57 HD23 HD13 ' A' ' 121' ' ' LEU . 0.3 OUTLIER -57.58 -37.32 73.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.764 -0.585 . . . . 0.0 111.078 -179.382 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.764 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -57.5 -54.67 44.25 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.286 -0.884 . . . . 0.0 110.498 -179.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -65.51 -17.8 64.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.286 -0.884 . . . . 0.0 110.444 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -76.12 -44.68 37.37 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.306 -0.871 . . . . 0.0 110.557 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.724 HD22 ' O ' ' A' ' 87' ' ' ARG . 6.7 mp -88.26 13.83 10.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -0.904 . . . . 0.0 110.411 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 76.8 48.04 9.12 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.537 ' CE1' ' HA3' ' A' ' 89' ' ' GLY . 30.1 m-70 -120.55 45.13 2.29 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.019 -1.283 . . . . 0.0 109.343 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -43.82 -46.04 7.62 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.524 -0.735 . . . . 0.0 110.077 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.497 ' O ' HD21 ' A' ' 91' ' ' LEU . 6.0 t70 -54.56 -44.0 72.54 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.528 0.68 . . . . 0.0 109.63 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.824 HG11 ' HA ' ' A' ' 86' ' ' ALA . 1.8 t -76.74 -28.45 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.13 -57.25 6.37 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.761 -0.587 . . . . 0.0 109.801 178.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -50.4 -57.93 6.86 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.413 -0.804 . . . . 0.0 110.472 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.479 ' HB3' HD23 ' A' ' 94' ' ' LEU . 33.5 t80 -53.41 -35.99 61.01 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.37 -0.832 . . . . 0.0 109.146 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 1.005 ' HG ' HD21 ' A' ' 94' ' ' LEU . 10.1 mt -71.9 -59.53 2.7 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.593 -0.692 . . . . 0.0 109.24 178.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -49.0 -27.8 3.44 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.691 -0.631 . . . . 0.0 110.821 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -76.6 -52.04 10.45 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.111 -0.993 . . . . 0.0 109.944 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.77 ' HB1' HD13 ' A' ' 104' ' ' LEU . . . -84.54 -10.4 57.46 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.429 -0.794 . . . . 0.0 110.489 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.568 ' CB ' ' O ' ' A' ' 104' ' ' LEU . . . -95.95 -15.46 22.34 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.29 -0.881 . . . . 0.0 109.878 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.408 ' O ' ' O ' ' A' ' 134' ' ' ALA . . . -60.92 -117.26 0.01 OUTLIER Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 162.99 -32.19 0.29 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.759 -1.336 . . . . 0.0 109.759 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 18.9 p -79.94 135.65 36.46 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.627 -0.926 . . . . 0.0 110.659 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.84 -24.73 23.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.146 -0.971 . . . . 0.0 109.551 179.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -104.28 175.17 22.67 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.117 -1.593 . . . . 0.0 109.117 179.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.5 p -92.61 -34.36 14.04 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.179 -1.189 . . . . 0.0 111.262 -179.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -101.76 115.35 30.35 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.21 -0.931 . . . . 0.0 109.824 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 177.19 178.48 0.27 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.233 -0.917 . . . . 0.0 110.71 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -161.1 55.49 0.29 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.281 -0.887 . . . . 0.0 110.283 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.46 157.14 0.23 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.514 -0.741 . . . . 0.0 111.031 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.417 ' O ' ' CB ' ' A' ' 146' ' ' ASP . 3.3 tp -53.58 129.17 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.459 -0.776 . . . . 0.0 110.233 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.417 ' CB ' ' O ' ' A' ' 145' ' ' ILE . 0.3 OUTLIER 172.15 76.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.464 -0.773 . . . . 0.0 109.783 179.439 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -78.79 117.2 19.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -0.929 . . . . 0.0 109.61 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -68.97 145.21 53.81 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.348 -0.845 . . . . 0.0 109.53 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -49.9 144.64 6.33 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.3 -0.875 . . . . 0.0 110.165 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 47.14 -162.69 0.22 Allowed Glycine 0 N--CA 1.497 2.731 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -76.11 149.46 32.34 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.713 1.375 . . . . 0.0 110.001 179.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.82 60.77 1.79 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.152 -0.968 . . . . 0.0 109.231 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -54.03 97.63 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.508 -0.745 . . . . 0.0 111.181 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 71.8 mt -132.16 103.75 13.96 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.448 -0.783 . . . . 0.0 109.867 179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -73.53 105.47 2.0 Allowed 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.88 1.463 . . . . 0.0 110.257 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.494 1.756 0 CA-C-O 117.863 -1.065 . . . . 0.0 110.455 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.757 0 CA-C-O 121.376 0.608 . . . . 0.0 110.095 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 56.02 69.51 1.84 Allowed Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.458 -0.776 . . . . 0.0 110.661 179.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -74.59 69.91 5.09 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 O-C-N 123.795 1.418 . . . . 0.0 110.18 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -175.12 116.61 0.16 Allowed 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.38 -0.825 . . . . 0.0 110.218 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -122.38 -56.58 1.8 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.108 -0.995 . . . . 0.0 110.752 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -76.38 -75.69 0.86 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.4 t 52.15 48.32 22.95 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.43 -1.041 . . . . 0.0 110.366 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 65.2 p -51.16 119.1 3.69 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.388 -0.82 . . . . 0.0 110.203 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.417 ' O ' ' HB2' ' A' ' 10' ' ' GLU . 13.0 ttm -175.73 126.25 0.23 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.502 -0.749 . . . . 0.0 109.999 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 9' ' ' MET . 0.0 OUTLIER 62.42 137.63 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.69 -0.631 . . . . 0.0 110.286 179.449 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.433 ' HB2' ' HB2' ' A' ' 14' ' ' ASP . 47.1 Cg_endo -71.93 119.27 6.08 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 O-C-N 123.632 1.332 . . . . 0.0 110.403 -179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 t -98.32 -16.58 19.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.653 -0.655 . . . . 0.0 110.166 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.751 ' HB1' ' HB2' ' A' ' 37' ' ' LEU . . . -154.57 54.16 0.67 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.293 -0.879 . . . . 0.0 109.921 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.433 ' HB2' ' HB2' ' A' ' 11' ' ' PRO . 0.2 OUTLIER -114.71 2.94 14.59 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.727 -0.608 . . . . 0.0 110.035 179.735 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.539 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 1.1 t90 -74.96 -6.77 51.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.394 -0.816 . . . . 0.0 110.734 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.752 HD11 ' HB1' ' A' ' 36' ' ' ALA . 19.1 mt -78.69 -49.52 12.98 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.17 -0.956 . . . . 0.0 109.463 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.498 ' HB2' ' ND2' ' A' ' 42' ' ' ASN . . . -69.35 -44.99 70.5 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.567 -0.708 . . . . 0.0 109.988 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.539 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.0 OUTLIER -50.31 -59.89 3.52 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.473 -0.767 . . . . 0.0 110.435 179.799 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.729 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -63.52 -33.83 76.44 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.505 -0.747 . . . . 0.0 110.206 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.527 ' HB1' ' CB ' ' A' ' 52' ' ' MET . . . -68.55 -43.88 75.69 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.093 -1.004 . . . . 0.0 109.699 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.98 -20.14 63.54 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.383 -0.823 . . . . 0.0 109.786 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -99.58 22.28 11.06 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.422 -0.799 . . . . 0.0 110.451 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.493 ' HA3' ' HE2' ' A' ' 53' ' ' MET . . . 47.68 55.15 9.87 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.473 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . 0.8 OUTLIER -126.37 89.93 3.09 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.513 -0.992 . . . . 0.0 109.483 179.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.543 HG22 ' CG2' ' A' ' 59' ' ' VAL . 55.7 t -64.31 -63.61 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.435 -0.79 . . . . 0.0 111.199 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -43.71 -33.48 1.25 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.551 -0.718 . . . . 0.0 111.043 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.673 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 0.7 OUTLIER -60.8 -65.92 0.61 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.292 -0.88 . . . . 0.0 109.661 179.288 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.859 HG12 HD12 ' A' ' 32' ' ' LEU . 5.1 t -63.66 -41.04 91.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.821 -0.55 . . . . 0.0 110.289 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.455 ' CA ' HD22 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -44.7 -39.09 4.84 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.629 -0.669 . . . . 0.0 110.438 -179.548 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.64 -43.99 24.89 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.458 -0.776 . . . . 0.0 110.008 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.61 HD12 ' HA ' ' A' ' 28' ' ' VAL . 50.3 mt -55.46 -64.59 0.8 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.087 -1.008 . . . . 0.0 109.663 179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.923 HD22 ' CG ' ' A' ' 66' ' ' HIS . 2.3 mt -49.37 -39.3 31.59 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.471 -0.768 . . . . 0.0 110.384 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -67.32 -25.58 66.09 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.527 -0.733 . . . . 0.0 110.177 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.17 -8.1 58.76 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.319 -0.863 . . . . 0.0 109.91 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 114.46 31.84 2.09 Favored Glycine 0 N--CA 1.489 2.179 0 C-N-CA 120.19 -1.005 . . . . 0.0 110.844 178.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.752 ' HB1' HD11 ' A' ' 16' ' ' LEU . . . -63.3 178.59 0.51 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.956 -1.32 . . . . 0.0 110.52 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.751 ' HB2' ' HB1' ' A' ' 13' ' ' ALA . 0.4 OUTLIER -92.18 124.19 60.45 Favored Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.398 -0.814 . . . . 0.0 109.947 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.513 ' HB2' ' O ' ' A' ' 67' ' ' GLY . 43.2 Cg_endo -68.22 -39.77 9.7 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 O-C-N 123.629 1.331 . . . . 0.0 110.742 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.469 ' HA ' ' OE1' ' A' ' 69' ' ' GLU . 0.4 OUTLIER -112.24 61.63 0.63 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.236 -0.915 . . . . 0.0 109.758 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.719 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -92.57 109.27 37.44 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.302 -0.874 . . . . 0.0 110.296 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -71.81 113.69 3.73 Favored 'Trans proline' 0 C--N 1.313 -1.306 0 O-C-N 123.634 1.334 . . . . 0.0 109.595 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.498 ' ND2' ' HB2' ' A' ' 17' ' ' ALA . 16.3 m120 -73.68 174.23 8.66 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.559 -0.713 . . . . 0.0 109.596 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.95 21.91 1.83 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.358 -0.839 . . . . 0.0 110.354 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -109.58 20.76 17.8 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.163 -0.961 . . . . 0.0 110.533 -179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 57.88 24.22 53.28 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 55.0 mtt180 -131.75 -163.85 1.38 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.346 -1.09 . . . . 0.0 109.701 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.609 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 1.6 mmt180 -109.11 -171.1 0.21 Allowed Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.189 -0.944 . . . . 0.0 110.231 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.609 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 42.6 Cg_endo -80.13 -18.16 10.14 Favored 'Trans proline' 0 C--N 1.315 -1.188 0 O-C-N 123.303 1.159 . . . . 0.0 111.08 -178.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.546 ' O ' ' HG2' ' A' ' 52' ' ' MET . 6.6 mt -107.1 -43.44 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.991 -1.068 . . . . 0.0 108.867 178.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.417 ' C ' ' O ' ' A' ' 49' ' ' ILE . 0.8 OUTLIER -43.88 -31.47 0.87 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.095 -1.003 . . . . 0.0 109.909 179.556 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 51' ' ' VAL . 7.9 p -111.53 34.16 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.442 -0.786 . . . . 0.0 110.138 179.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.591 ' CE ' ' HB2' ' A' ' 60' ' ' ALA . 0.1 OUTLIER -91.11 30.1 1.29 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.027 -1.045 . . . . 0.0 109.643 179.19 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.506 ' CB ' ' O ' ' A' ' 52' ' ' MET . 4.8 tmm? 75.61 -13.54 0.86 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.859 -0.526 . . . . 0.0 111.866 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.552 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 47.11 28.18 0.9 Allowed 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.956 -1.09 . . . . 0.0 110.234 -179.873 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.456 ' C ' ' CE2' ' A' ' 90' ' ' PHE . . . -125.85 4.56 7.96 Favored Glycine 0 N--CA 1.484 1.847 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.452 ' HB3' HG23 ' A' ' 59' ' ' VAL . 0.5 OUTLIER -149.25 79.14 1.4 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.348 -1.089 . . . . 0.0 110.301 179.294 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -46.56 -34.04 4.6 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.397 -0.814 . . . . 0.0 109.592 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 56.3 mtt180 -44.44 -44.27 8.35 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 121.369 0.604 . . . . 0.0 109.668 179.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.543 ' CG2' HG22 ' A' ' 25' ' ' VAL . 60.8 t -62.05 -56.94 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 179.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.591 ' HB2' ' CE ' ' A' ' 52' ' ' MET . . . -47.61 -38.13 13.95 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.52 -0.737 . . . . 0.0 109.401 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -66.34 -35.29 79.98 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.638 -0.664 . . . . 0.0 109.843 179.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.61 ' CD1' HD13 ' A' ' 32' ' ' LEU . 1.5 tp -71.57 -44.13 65.08 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.42 -0.8 . . . . 0.0 109.477 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.625 ' HB3' ' HB2' ' A' ' 68' ' ' ALA . 2.6 mt -77.71 -35.14 52.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 0.0 109.427 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.836 HD11 ' HB3' ' A' ' 100' ' ' ALA . 0.7 OUTLIER -64.84 -61.01 2.44 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.422 -0.799 . . . . 0.0 110.159 -179.709 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.7 HD12 ' C ' ' A' ' 65' ' ' LEU . 0.3 OUTLIER -52.37 -33.97 45.59 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.836 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.923 ' CG ' HD22 ' A' ' 32' ' ' LEU . 1.7 m80 -73.64 -39.84 64.19 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.299 0.571 . . . . 0.0 109.658 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.513 ' O ' ' HB2' ' A' ' 38' ' ' PRO . . . 134.54 45.82 0.1 Allowed Glycine 0 N--CA 1.481 1.643 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.625 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -64.76 -162.22 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.94 -1.329 . . . . 0.0 110.208 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.531 ' HB2' ' HD2' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -116.86 61.64 2.61 Favored Pre-proline 0 C--N 1.301 -1.514 0 O-C-N 121.628 -0.67 . . . . 0.0 109.347 179.504 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.483 ' O ' ' HG3' ' A' ' 81' ' ' PRO . 52.1 Cg_endo -71.29 -2.15 10.75 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 O-C-N 123.792 1.417 . . . . 0.0 111.107 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.479 ' HA ' ' NH1' ' A' ' 80' ' ' ARG . 4.2 m-80 -108.77 -61.08 1.66 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.278 -0.889 . . . . 0.0 110.115 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 29.8 t -45.25 166.62 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.66 -0.65 . . . . 0.0 110.562 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.422 ' HB2' ' HG2' ' A' ' 80' ' ' ARG . . . -160.4 -148.62 0.17 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.104 -0.997 . . . . 0.0 110.303 -179.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.54 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.6 OUTLIER -110.06 140.22 22.13 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.189 -0.944 . . . . 0.0 109.845 179.871 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -78.21 -23.58 8.8 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 O-C-N 123.641 1.337 . . . . 0.0 110.533 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.02 -81.3 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.28 -0.888 . . . . 0.0 110.249 -179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.987 HG23 ' CH2' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -104.56 40.73 1.43 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.429 -0.794 . . . . 0.0 109.844 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.54 ' HA ' ' O ' ' A' ' 74' ' ' ASP . 9.4 mt 31.95 40.56 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 2.0 m -67.45 104.63 1.59 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.983 -1.073 . . . . 0.0 110.181 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.841 ' HG3' HG11 ' A' ' 106' ' ' VAL . 0.7 OUTLIER -87.55 170.45 11.81 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.165 -0.959 . . . . 0.0 109.915 179.588 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.483 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 38.0 Cg_endo -68.71 -2.68 9.81 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 O-C-N 123.743 1.391 . . . . 0.0 109.72 178.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.738 HG13 HD23 ' A' ' 104' ' ' LEU . 10.5 t -82.06 -27.66 9.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.28 0 O-C-N 121.596 -0.69 . . . . 0.0 109.458 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.506 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 10.4 m80 -77.72 -40.08 42.43 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.298 -0.876 . . . . 0.0 108.794 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.558 ' O ' ' HB3' ' A' ' 87' ' ' ARG . 0.3 OUTLIER -54.64 -46.78 74.01 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.492 -0.755 . . . . 0.0 109.186 178.656 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.805 ' HB1' ' CD1' ' A' ' 94' ' ' LEU . . . -59.01 -69.01 0.21 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.244 -0.91 . . . . 0.0 109.214 178.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.807 ' HB1' ' HB2' ' A' ' 118' ' ' ALA . . . -60.38 -15.84 29.84 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.221 -0.925 . . . . 0.0 111.104 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.619 ' HA ' HD21 ' A' ' 117' ' ' LEU . 9.5 tpt180 -60.74 -45.82 92.83 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.854 -1.154 . . . . 0.0 109.455 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -101.66 -4.3 26.77 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.833 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.882 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 83.09 48.25 5.48 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.456 ' CE2' ' C ' ' A' ' 55' ' ' GLY . 0.4 OUTLIER -112.12 82.34 1.61 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.359 -1.083 . . . . 0.0 110.883 -179.245 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.622 HD11 ' O ' ' A' ' 125' ' ' ASP . 0.1 OUTLIER -57.08 -46.41 82.55 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.447 -0.783 . . . . 0.0 110.782 179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.837 ' O ' HG23 ' A' ' 96' ' ' VAL . 35.7 t0 -45.84 -35.46 4.5 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.496 -0.753 . . . . 0.0 109.778 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 25.5 m -66.51 -59.33 3.74 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.841 HD13 HG13 ' A' ' 126' ' ' VAL . 1.2 mp -46.01 -52.65 11.45 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.684 -0.635 . . . . 0.0 109.462 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.461 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 26.4 t -44.84 -55.13 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 178.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.837 HG23 ' O ' ' A' ' 92' ' ' ASP . 13.4 t -55.49 -45.58 78.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.505 ' C ' ' HB2' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -56.31 -70.01 0.13 Allowed 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.889 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . 0.469 ' HA ' ' HB3' ' A' ' 102' ' ' ALA . 3.4 t-160 -51.39 -40.84 60.08 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.493 -0.754 . . . . 0.0 109.44 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 7.5 ttt180 -59.81 -14.18 13.74 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.533 -0.729 . . . . 0.0 110.036 179.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.836 ' HB3' HD11 ' A' ' 64' ' ' LEU . . . -143.93 89.94 2.09 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 121.26 -0.9 . . . . 0.0 110.856 -179.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.433 ' C ' ' O ' ' A' ' 100' ' ' ALA . . . 35.18 90.92 0.01 OUTLIER Glycine 0 N--CA 1.503 3.122 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 179.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.505 ' HB2' ' C ' ' A' ' 97' ' ' LEU . . . -143.91 89.81 2.08 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.107 -1.231 . . . . 0.0 110.739 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 7.9 ttt180 -64.72 133.73 52.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.151 -0.968 . . . . 0.0 110.078 179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.738 HD23 HG13 ' A' ' 82' ' ' VAL . 0.8 OUTLIER -122.91 20.29 10.04 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.48 0.657 . . . . 0.0 109.286 179.631 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -102.22 39.87 1.43 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.504 -0.747 . . . . 0.0 110.037 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.841 HG11 ' HG3' ' A' ' 80' ' ' ARG . 2.5 p -109.65 -179.22 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.176 -0.952 . . . . 0.0 110.582 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.578 ' H ' HG22 ' A' ' 106' ' ' VAL . 59.4 mtt180 -141.31 140.7 33.86 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.49 -0.756 . . . . 0.0 109.771 179.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.49 ' HA ' ' O ' ' A' ' 77' ' ' THR . 3.6 p-10 -71.27 56.81 0.23 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.984 -1.072 . . . . 0.0 110.357 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.475 ' CB ' ' HA ' ' A' ' 77' ' ' THR . . . 59.69 -89.57 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.207 -0.933 . . . . 0.0 110.613 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.987 ' CH2' HG23 ' A' ' 77' ' ' THR . 46.2 p90 -112.2 72.23 0.77 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.854 -1.153 . . . . 0.0 111.103 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.467 ' O ' ' CG ' ' A' ' 112' ' ' ARG . . . -161.62 -83.62 0.05 OUTLIER Glycine 0 N--CA 1.478 1.478 0 N-CA-C 109.631 -1.387 . . . . 0.0 109.631 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.467 ' CG ' ' O ' ' A' ' 111' ' ' GLY . 0.0 OUTLIER 171.81 -154.87 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.515 -0.991 . . . . 0.0 109.963 -179.776 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.819 ' HB2' HG12 ' A' ' 115' ' ' VAL . 15.2 mt -92.02 164.16 24.56 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.402 -0.811 . . . . 0.0 109.606 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.592 ' HG3' ' CG1' ' A' ' 82' ' ' VAL . 37.8 Cg_endo -64.26 -11.07 26.14 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 O-C-N 123.844 1.444 . . . . 0.0 111.006 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.819 HG12 ' HB2' ' A' ' 113' ' ' LEU . 3.5 p -72.81 -32.47 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.149 -0.969 . . . . 0.0 109.725 179.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.64 -52.96 11.61 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.15 -0.969 . . . . 0.0 110.02 179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.619 HD21 ' HA ' ' A' ' 87' ' ' ARG . 0.6 OUTLIER -57.2 -26.35 60.52 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.414 -0.804 . . . . 0.0 109.722 179.466 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.807 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -65.72 -58.25 6.12 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.374 -0.829 . . . . 0.0 108.895 179.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.07 -31.02 70.69 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.673 -0.642 . . . . 0.0 109.636 179.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.403 ' HB2' ' HA ' ' A' ' 117' ' ' LEU . 2.0 mt-10 -65.72 -49.73 67.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.611 -0.68 . . . . 0.0 110.343 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.551 ' HB3' ' NE2' ' A' ' 123' ' ' HIS . 22.7 mt -77.42 5.51 8.68 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.363 -0.836 . . . . 0.0 111.087 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 89.75 29.6 15.49 Favored Glycine 0 N--CA 1.492 2.406 0 C-N-CA 120.085 -1.055 . . . . 0.0 111.219 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.551 ' NE2' ' HB3' ' A' ' 121' ' ' LEU . 61.4 m-70 -109.37 54.48 0.66 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.002 -1.293 . . . . 0.0 109.836 179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.486 ' HG3' ' N ' ' A' ' 125' ' ' ASP . 37.5 ptt180 -49.29 -39.92 32.69 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.487 0.661 . . . . 0.0 109.911 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.622 ' O ' HD11 ' A' ' 91' ' ' LEU . 4.6 m-20 -61.45 -45.18 95.36 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.618 -0.677 . . . . 0.0 109.611 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.882 HG21 ' HA2' ' A' ' 89' ' ' GLY . 3.2 t -75.65 -36.26 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.465 -0.772 . . . . 0.0 109.637 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -63.55 -58.16 7.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.626 -0.671 . . . . 0.0 109.417 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 6.3 ttt-85 -44.92 -55.83 5.11 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.611 -0.681 . . . . 0.0 110.505 179.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -60.52 -49.57 77.01 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.577 -0.849 . . . . 0.0 109.447 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.693 HD11 ' HB2' ' A' ' 86' ' ' ALA . 10.2 mt -53.54 -52.97 57.96 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.694 -0.629 . . . . 0.0 110.081 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.448 ' CA ' HG21 ' A' ' 115' ' ' VAL . 25.1 ttp180 -46.04 -37.3 6.52 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.57 -0.706 . . . . 0.0 110.282 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.79 -53.78 4.92 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.51 -0.743 . . . . 0.0 110.492 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -66.02 -7.96 20.27 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.307 -0.87 . . . . 0.0 110.385 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . -117.2 -18.91 9.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.354 -0.841 . . . . 0.0 109.967 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -69.1 169.24 43.44 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.435 ' O ' ' OG1' ' A' ' 137' ' ' THR . . . -80.93 -127.08 0.76 Allowed Glycine 0 N--CA 1.488 2.118 0 N-CA-C 109.272 -1.531 . . . . 0.0 109.272 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 136' ' ' GLY . 61.0 p 44.1 27.38 0.2 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.703 -0.881 . . . . 0.0 111.063 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.62 149.17 52.4 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.286 -0.884 . . . . 0.0 109.665 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 179.95 -102.65 0.17 Allowed Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.735 -1.221 . . . . 0.0 110.124 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 68.0 m -103.11 -16.08 15.86 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.404 -1.056 . . . . 0.0 110.309 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -116.66 158.67 23.41 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.341 -0.849 . . . . 0.0 109.638 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 33.6 m-70 -83.12 -13.05 56.4 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.392 -0.818 . . . . 0.0 109.721 179.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -141.2 84.88 1.94 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.453 -0.78 . . . . 0.0 109.928 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.525 ' NH1' ' HA ' ' A' ' 147' ' ' ALA . 0.0 OUTLIER -79.36 87.74 5.01 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.259 -0.901 . . . . 0.0 109.588 179.905 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.417 ' O ' ' CB ' ' A' ' 146' ' ' ASP . 2.4 mt -89.06 165.55 2.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.44 -0.787 . . . . 0.0 109.455 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.417 ' CB ' ' O ' ' A' ' 145' ' ' ILE . 0.7 OUTLIER 65.05 115.0 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.398 -0.814 . . . . 0.0 109.523 -179.38 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.525 ' HA ' ' NH1' ' A' ' 144' ' ' ARG . . . -85.98 117.53 24.88 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.418 -0.801 . . . . 0.0 110.006 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -48.61 122.13 5.24 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.594 -0.691 . . . . 0.0 110.292 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 -88.93 -2.64 58.69 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.46 -0.775 . . . . 0.0 110.415 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 102.06 150.44 23.17 Favored Glycine 0 N--CA 1.488 2.16 0 C-N-CA 119.982 -1.104 . . . . 0.0 110.509 179.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.405 ' O ' ' O ' ' A' ' 152' ' ' SER . 44.8 Cg_endo -73.17 -173.72 1.36 Allowed 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 124.123 1.591 . . . . 0.0 110.36 179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . 0.405 ' O ' ' O ' ' A' ' 151' ' ' PRO . 0.4 OUTLIER 57.85 113.15 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.443 -0.786 . . . . 0.0 110.432 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.6 t0 56.87 -178.24 0.05 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.21 -0.931 . . . . 0.0 110.238 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.573 ' O ' HG23 ' A' ' 154' ' ' ILE . 0.5 OUTLIER -138.32 81.13 26.16 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 120.998 -1.063 . . . . 0.0 111.174 -179.465 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -76.21 133.82 15.22 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.789 1.415 . . . . 0.0 110.222 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.7 p30 . . . . . 0 N--CA 1.498 1.931 0 CA-C-O 117.974 -1.013 . . . . 0.0 110.561 -179.428 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.825 0 CA-C-O 121.017 0.436 . . . . 0.0 110.123 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -140.1 99.59 7.32 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.242 -0.911 . . . . 0.0 110.409 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -75.91 65.99 6.82 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 O-C-N 123.691 1.364 . . . . 0.0 110.594 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -116.46 116.16 27.15 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.142 -0.974 . . . . 0.0 110.589 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.08 55.98 3.04 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.446 -0.784 . . . . 0.0 110.067 179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.73 -52.91 3.95 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.9 m 58.21 164.77 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.444 -1.033 . . . . 0.0 110.505 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -166.34 71.69 0.14 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.582 -0.699 . . . . 0.0 109.915 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 45.0 ttm -124.13 -68.78 0.84 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.322 -0.861 . . . . 0.0 110.687 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.499 ' CB ' ' CD ' ' A' ' 11' ' ' PRO . 1.9 mp0 -44.8 -59.84 3.69 Favored Pre-proline 0 N--CA 1.502 2.135 0 O-C-N 121.596 -0.69 . . . . 0.0 111.179 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.499 ' CD ' ' CB ' ' A' ' 10' ' ' GLU . 46.1 Cg_endo -72.43 177.61 7.17 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.429 1.226 . . . . 0.0 110.436 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 64.34 11.01 6.1 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.479 -0.763 . . . . 0.0 110.761 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.43 ' HB1' ' HB2' ' A' ' 37' ' ' LEU . . . -74.52 -14.34 60.8 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.178 -0.951 . . . . 0.0 110.213 179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -79.35 -2.18 40.39 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.396 -0.815 . . . . 0.0 110.23 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.568 ' HA ' ' CG2' ' A' ' 18' ' ' THR . 25.3 m0 -89.37 -15.58 32.99 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.176 -0.953 . . . . 0.0 111.03 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.743 HD23 ' O ' ' A' ' 37' ' ' LEU . 1.0 OUTLIER -79.17 -44.88 21.04 Favored 'General case' 0 N--CA 1.483 1.217 0 O-C-N 120.864 -1.148 . . . . 0.0 109.039 179.54 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.475 ' CB ' ' OD1' ' A' ' 42' ' ' ASN . . . -74.8 -41.18 60.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.437 -0.789 . . . . 0.0 110.109 179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.568 ' CG2' ' HA ' ' A' ' 15' ' ' TRP . 4.3 t -58.43 -43.09 88.61 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.324 -0.86 . . . . 0.0 109.739 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.646 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -63.7 -44.12 94.6 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.345 -0.847 . . . . 0.0 110.054 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.584 ' HB1' ' CB ' ' A' ' 52' ' ' MET . . . -59.85 -45.27 92.97 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.411 -0.806 . . . . 0.0 110.3 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.571 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -68.13 -27.49 66.49 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.358 -0.839 . . . . 0.0 111.032 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' A' ' 18' ' ' THR . 11.0 mtp180 -94.4 20.49 8.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.248 -0.908 . . . . 0.0 110.77 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 57.83 37.29 83.74 Favored Glycine 0 N--CA 1.486 1.974 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.542 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -107.15 64.11 0.63 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.291 -1.123 . . . . 0.0 110.186 179.58 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.957 HG22 HG22 ' A' ' 59' ' ' VAL . 30.5 t -55.15 -44.78 76.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.42 -0.8 . . . . 0.0 109.179 179.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.86 -48.7 66.9 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.57 -0.706 . . . . 0.0 110.704 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.473 ' O ' ' HB2' ' A' ' 31' ' ' LEU . 0.8 OUTLIER -62.57 -34.34 76.77 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.253 -0.904 . . . . 0.0 110.35 -179.776 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 1.014 HG12 HD12 ' A' ' 32' ' ' LEU . 21.3 t -76.73 -50.19 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.385 -0.822 . . . . 0.0 110.181 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.959 ' CA ' HD11 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -43.4 -44.01 5.48 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.285 -0.884 . . . . 0.0 109.19 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.501 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -79.64 -54.79 5.54 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 120.124 -0.63 . . . . 0.0 109.486 178.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 27' ' ' GLU . 8.2 mt -50.56 -61.52 2.14 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.364 -0.835 . . . . 0.0 110.307 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.014 HD12 HG12 ' A' ' 28' ' ' VAL . 3.6 mt -45.76 -62.55 1.25 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.399 -0.813 . . . . 0.0 109.962 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -64.91 -16.12 62.87 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.455 -0.778 . . . . 0.0 110.832 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.501 ' HB2' ' O ' ' A' ' 30' ' ' ALA . . . -85.76 -6.79 59.06 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.239 -0.913 . . . . 0.0 111.308 -179.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.27 26.35 1.67 Allowed Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.719 -1.229 . . . . 0.0 110.466 179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.935 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -74.61 170.64 15.36 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.145 -1.209 . . . . 0.0 110.308 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.898 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 1.3 mm? -103.22 96.64 8.53 Favored Pre-proline 0 C--N 1.302 -1.482 0 O-C-N 121.604 -0.685 . . . . 0.0 110.367 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.54 ' HB3' ' HB3' ' A' ' 66' ' ' HIS . 41.6 Cg_endo -68.16 -14.85 41.76 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 O-C-N 123.741 1.39 . . . . 0.0 110.791 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.472 ' O ' ' HD3' ' A' ' 41' ' ' PRO . 0.4 OUTLIER -111.31 16.16 21.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.025 -1.047 . . . . 0.0 110.342 179.84 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.898 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -75.23 110.52 10.47 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.282 -0.886 . . . . 0.0 110.595 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 39' ' ' ASN . 45.9 Cg_endo -74.46 108.18 2.62 Favored 'Trans proline' 0 C--N 1.318 -1.03 0 O-C-N 123.552 1.29 . . . . 0.0 109.788 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.475 ' OD1' ' CB ' ' A' ' 17' ' ' ALA . 27.8 m-80 -57.43 167.62 0.96 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.64 -0.663 . . . . 0.0 110.813 -179.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.13 2.66 17.3 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.516 -0.74 . . . . 0.0 110.329 179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.552 ' CD1' ' N ' ' A' ' 44' ' ' TYR . 1.2 m-85 -91.49 21.64 4.47 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.272 -0.892 . . . . 0.0 109.478 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.445 ' O ' ' NH2' ' A' ' 47' ' ' ARG . . . 53.75 22.1 17.39 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 108.83 -1.708 . . . . 0.0 108.83 -178.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 16.8 mtt180 -119.95 -176.65 3.23 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.661 -0.905 . . . . 0.0 110.188 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.638 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 5.2 mmt180 -106.25 -173.48 0.28 Allowed Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.641 -0.662 . . . . 0.0 110.393 -178.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.638 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 52.2 Cg_endo -79.32 0.65 9.84 Favored 'Trans proline' 0 C--N 1.318 -1.038 0 O-C-N 123.438 1.23 . . . . 0.0 110.594 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.518 HG12 HD13 ' A' ' 63' ' ' LEU . 7.8 mt -121.53 -43.63 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.362 -0.836 . . . . 0.0 108.94 179.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.486 ' HG2' ' HB3' ' A' ' 81' ' ' PRO . 5.7 mt-30 -50.07 -23.11 1.91 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.323 -0.861 . . . . 0.0 109.59 178.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.571 HG22 ' HB2' ' A' ' 21' ' ' ALA . 8.8 p -106.75 -7.44 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.73 -0.606 . . . . 0.0 110.867 -179.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.617 ' HE1' ' HB2' ' A' ' 60' ' ' ALA . 0.3 OUTLIER -68.06 158.68 32.43 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.97 -1.081 . . . . 0.0 109.817 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.59 96.4 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.094 -1.004 . . . . 0.0 109.267 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.543 ' HE1' ' CE ' ' A' ' 52' ' ' MET . 0.0 OUTLIER -56.72 -14.8 3.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.176 -0.952 . . . . 0.0 110.414 -179.514 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.443 ' HA2' ' CD2' ' A' ' 90' ' ' PHE . . . -88.13 35.23 3.59 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.011 -1.636 . . . . 0.0 109.011 178.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -171.54 99.56 0.19 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.421 -1.047 . . . . 0.0 109.668 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.501 ' HB2' ' HE1' ' A' ' 90' ' ' PHE . . . -68.31 -25.0 64.91 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.213 -0.93 . . . . 0.0 110.017 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.89 -33.14 3.04 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.572 -0.705 . . . . 0.0 110.531 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.994 HG12 HD11 ' A' ' 63' ' ' LEU . 3.0 t -72.66 -58.78 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.454 -0.779 . . . . 0.0 109.341 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.617 ' HB2' ' HE1' ' A' ' 52' ' ' MET . . . -41.17 -46.7 3.12 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.656 -0.653 . . . . 0.0 110.311 179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.625 ' OE2' HG13 ' A' ' 96' ' ' VAL . 0.8 OUTLIER -55.57 -55.3 33.59 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.204 -0.935 . . . . 0.0 109.643 179.235 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.997 HD13 HG12 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -47.79 -61.5 1.92 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.68 -0.637 . . . . 0.0 109.833 178.993 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.994 HD11 HG12 ' A' ' 59' ' ' VAL . 0.9 OUTLIER -59.66 -55.07 38.99 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-O 121.256 0.551 . . . . 0.0 109.604 179.411 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.828 HD13 HG12 ' A' ' 96' ' ' VAL . 0.6 OUTLIER -49.8 -55.62 13.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.62 -0.675 . . . . 0.0 109.439 179.48 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 22.1 tp -53.94 -37.56 64.01 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 121.843 0.83 . . . . 0.0 108.819 178.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.971 ' CG ' HD22 ' A' ' 32' ' ' LEU . 2.0 m-70 -80.55 -5.59 56.99 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.271 0.557 . . . . 0.0 110.302 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.436 ' O ' ' ND2' ' A' ' 39' ' ' ASN . . . 89.4 63.74 1.29 Allowed Glycine 0 N--CA 1.479 1.537 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.557 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -79.3 -155.02 0.09 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.031 -1.276 . . . . 0.0 109.504 179.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.422 ' OE1' ' ND2' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -120.79 57.14 5.64 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.139 -0.976 . . . . 0.0 110.208 179.389 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.509 ' HB2' ' HG ' ' A' ' 97' ' ' LEU . 48.7 Cg_endo -73.99 -1.17 10.49 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 O-C-N 123.673 1.354 . . . . 0.0 110.648 179.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -108.66 -45.29 3.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 110.0 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.3 m -52.11 177.55 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.336 -0.852 . . . . 0.0 110.521 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -162.66 -143.35 0.08 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.361 -0.837 . . . . 0.0 110.136 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.442 ' O ' ' N ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -122.49 132.55 24.25 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.046 -1.034 . . . . 0.0 110.18 -179.566 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -74.25 1.89 6.79 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 O-C-N 123.348 1.183 . . . . 0.0 110.777 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -103.57 -48.55 3.93 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.185 -0.947 . . . . 0.0 109.365 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.898 HG23 ' CH2' ' A' ' 110' ' ' TRP . 0.2 OUTLIER -128.72 18.02 6.26 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.834 -0.541 . . . . 0.0 109.841 179.875 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.51 ' HA ' HD23 ' A' ' 78' ' ' LEU . 9.0 mt 44.75 34.5 1.19 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.506 -0.747 . . . . 0.0 110.689 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 83.6 m -59.03 89.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.565 -0.71 . . . . 0.0 110.552 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.88 ' HG3' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -71.04 161.61 77.19 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.168 -0.958 . . . . 0.0 109.52 179.431 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.531 ' HD2' ' HD3' ' A' ' 80' ' ' ARG . 48.4 Cg_endo -73.96 -13.09 23.98 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.696 1.366 . . . . 0.0 110.549 179.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.425 HG13 HD23 ' A' ' 94' ' ' LEU . 90.7 t -67.28 -25.35 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.45 -0.781 . . . . 0.0 110.125 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.531 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 5.2 m80 -71.64 -40.81 69.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.277 -0.89 . . . . 0.0 109.236 179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.52 ' HB3' ' SD ' ' A' ' 54' ' ' MET . 9.9 m-20 -52.27 -46.72 65.95 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.547 -0.721 . . . . 0.0 110.483 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.47 ' CB ' ' HG ' ' A' ' 94' ' ' LEU . . . -57.29 -68.46 0.23 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.05 -1.031 . . . . 0.0 108.993 178.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.799 ' CA ' HG11 ' A' ' 126' ' ' VAL . . . -52.35 -34.77 49.04 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.482 -0.761 . . . . 0.0 109.861 179.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.531 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 0.1 OUTLIER -40.37 -61.29 0.93 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.917 -0.489 . . . . 0.0 111.136 -179.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -89.19 9.68 24.81 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.224 -0.923 . . . . 0.0 110.491 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.423 ' HA2' ' HB3' ' A' ' 123' ' ' HIS . . . 77.87 33.4 41.78 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.52 ' HD1' ' HG1' ' A' ' 93' ' ' THR . 0.6 OUTLIER -96.82 131.74 43.25 Favored 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.148 -1.207 . . . . 0.0 110.065 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.591 HD11 ' O ' ' A' ' 125' ' ' ASP . 0.5 OUTLIER -105.47 -47.6 3.89 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.272 -0.893 . . . . 0.0 110.45 179.87 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.776 ' O ' HG23 ' A' ' 96' ' ' VAL . 47.5 m-20 -47.32 -28.3 1.95 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.419 -0.801 . . . . 0.0 109.769 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.52 ' HG1' ' HD1' ' A' ' 90' ' ' PHE . 61.6 m -65.19 -56.82 10.66 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.588 -0.695 . . . . 0.0 109.604 178.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.697 ' CD2' HD21 ' A' ' 130' ' ' LEU . 1.5 mp -53.91 -49.16 69.22 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.217 -0.927 . . . . 0.0 109.661 179.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.455 ' O ' ' N ' ' A' ' 99' ' ' ARG . 74.7 t -44.3 -45.47 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.828 HG12 HD13 ' A' ' 64' ' ' LEU . 22.0 t -59.97 -54.09 39.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.556 -0.715 . . . . 0.0 109.436 179.033 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.509 ' HG ' ' HB2' ' A' ' 70' ' ' PRO . 7.3 mp -48.52 -50.05 33.55 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.543 0.687 . . . . 0.0 110.265 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -77.82 -21.65 51.2 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.583 -0.698 . . . . 0.0 109.881 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.539 ' HB3' ' HA ' ' A' ' 96' ' ' VAL . 1.4 ttm180 -72.94 -9.96 59.28 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.413 -0.804 . . . . 0.0 110.949 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.812 ' CB ' HD21 ' A' ' 64' ' ' LEU . . . -136.39 -66.73 0.53 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.064 -1.022 . . . . 0.0 110.923 -179.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -167.51 105.51 0.24 Allowed Glycine 0 N--CA 1.486 1.979 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.458 ' HB3' ' C ' ' A' ' 97' ' ' LEU . . . -177.29 119.37 0.11 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.317 -1.107 . . . . 0.0 110.31 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 -68.11 134.84 51.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -0.892 . . . . 0.0 109.437 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 1.036 HD21 HD23 ' A' ' 130' ' ' LEU . 1.4 tt -112.27 13.28 20.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.376 -0.828 . . . . 0.0 110.665 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.499 ' HB3' ' HA ' ' A' ' 134' ' ' ALA . 1.1 p30 -127.65 47.54 2.37 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.425 -0.797 . . . . 0.0 110.325 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.88 HG11 ' HG3' ' A' ' 80' ' ' ARG . 0.8 OUTLIER -99.73 -175.09 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.143 -0.973 . . . . 0.0 110.659 -179.848 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.584 ' H ' HG22 ' A' ' 106' ' ' VAL . 6.6 ttp180 -141.01 148.89 41.0 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.521 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 3.6 m-20 -89.55 45.08 1.25 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.356 -0.84 . . . . 0.0 110.45 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 108' ' ' ASP . . . 62.11 -77.92 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.357 -0.839 . . . . 0.0 110.38 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.898 ' CH2' HG23 ' A' ' 77' ' ' THR . 1.1 p-90 -136.74 16.3 3.1 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.206 -0.934 . . . . 0.0 110.498 179.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -86.77 -79.71 1.21 Allowed Glycine 0 N--CA 1.485 1.912 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 178.14 133.82 0.07 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.476 -1.014 . . . . 0.0 110.13 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.525 ' HG ' ' HD2' ' A' ' 114' ' ' PRO . 0.2 OUTLIER -51.02 166.39 0.32 Allowed Pre-proline 0 N--CA 1.498 1.962 0 O-C-N 121.387 -0.821 . . . . 0.0 110.548 179.791 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.525 ' HD2' ' HG ' ' A' ' 113' ' ' LEU . 40.7 Cg_endo -69.72 -23.28 31.15 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.79 1.416 . . . . 0.0 110.226 179.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.614 HG21 ' CG ' ' A' ' 131' ' ' ARG . 4.7 p -86.72 -33.91 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.884 . . . . 0.0 109.776 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.31 -44.04 97.87 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.661 -0.649 . . . . 0.0 110.351 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.56 -31.09 67.66 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.283 -0.885 . . . . 0.0 109.73 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.782 ' HB1' ' HB2' ' A' ' 123' ' ' HIS . . . -81.61 -20.66 39.3 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.448 -0.782 . . . . 0.0 110.708 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -74.72 -40.92 61.03 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.4 -0.813 . . . . 0.0 110.691 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.47 -40.6 35.05 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.255 -0.903 . . . . 0.0 110.622 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.511 ' HB3' ' NE2' ' A' ' 123' ' ' HIS . 0.2 OUTLIER -72.57 -81.47 0.06 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.432 -0.793 . . . . 0.0 110.552 -179.339 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 162.14 47.26 0.02 OUTLIER Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.701 -1.237 . . . . 0.0 110.162 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.782 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . 3.6 m170 -108.49 52.94 0.7 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.127 -1.22 . . . . 0.0 109.643 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 28.4 mtt180 -48.22 -44.07 32.71 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.285 -0.884 . . . . 0.0 110.029 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.591 ' O ' HD11 ' A' ' 91' ' ' LEU . 5.5 t0 -54.27 -43.3 70.89 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.501 -0.75 . . . . 0.0 109.415 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.799 HG11 ' CA ' ' A' ' 86' ' ' ALA . 15.9 t -85.31 -45.55 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.277 -0.89 . . . . 0.0 110.12 179.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -47.31 -58.12 4.48 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.348 -0.845 . . . . 0.0 110.454 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 11.2 mtp180 -50.77 -65.85 0.49 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.473 -0.767 . . . . 0.0 110.052 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -50.36 -31.84 15.79 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.527 -0.733 . . . . 0.0 109.887 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 1.036 HD23 HD21 ' A' ' 104' ' ' LEU . 11.3 mt -72.89 -57.11 4.3 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.594 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.614 ' CG ' HG21 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -51.94 -21.78 3.32 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.355 -0.841 . . . . 0.0 110.689 -179.767 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -83.85 -61.18 1.89 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.311 -0.868 . . . . 0.0 109.729 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 1.016 ' HB3' HD22 ' A' ' 104' ' ' LEU . . . -75.1 -6.78 51.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.603 -0.686 . . . . 0.0 110.609 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.499 ' HA ' ' HB3' ' A' ' 105' ' ' ASP . . . -99.55 -20.78 16.21 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.093 -1.004 . . . . 0.0 109.284 179.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -53.42 146.63 19.96 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -138.14 17.38 3.38 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.559 ' O ' HG23 ' A' ' 137' ' ' THR . 2.9 t -79.7 104.47 10.32 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.493 -1.004 . . . . 0.0 110.821 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 178.07 57.59 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.472 -0.767 . . . . 0.0 110.129 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -162.5 -119.11 0.48 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 68.4 p -98.81 40.36 1.2 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.429 -1.042 . . . . 0.0 110.647 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -112.59 -178.29 3.36 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.084 -1.01 . . . . 0.0 109.813 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -55.28 -171.28 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.263 -0.898 . . . . 0.0 110.057 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -138.72 149.08 44.68 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.948 -1.095 . . . . 0.0 110.676 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -70.38 154.31 42.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.409 -0.807 . . . . 0.0 110.362 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.527 HG23 ' O ' ' A' ' 145' ' ' ILE . 1.2 tt -75.59 61.69 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.281 -0.887 . . . . 0.0 110.0 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.411 ' CB ' ' O ' ' A' ' 145' ' ' ILE . 1.1 t0 65.09 172.94 0.21 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.498 -0.751 . . . . 0.0 110.457 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.424 ' O ' ' C ' ' A' ' 148' ' ' ALA . . . -53.1 158.51 1.48 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.405 -0.809 . . . . 0.0 109.801 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 147' ' ' ALA . . . -39.58 120.45 1.09 Allowed 'General case' 0 N--CA 1.5 2.064 0 O-C-N 121.506 -0.746 . . . . 0.0 111.009 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -52.43 130.57 31.81 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.351 -0.843 . . . . 0.0 109.523 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -145.88 -151.45 5.42 Favored Glycine 0 N--CA 1.489 2.178 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.225 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -75.41 127.46 10.42 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 124.11 1.584 . . . . 0.0 110.079 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 6.5 p -162.32 118.53 1.97 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.235 -0.915 . . . . 0.0 110.568 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 55.02 96.55 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.466 -0.771 . . . . 0.0 109.978 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 2.1 mt -114.91 87.97 16.04 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.302 -0.874 . . . . 0.0 109.455 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -78.48 110.56 2.86 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.82 1.431 . . . . 0.0 110.52 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 12.9 t0 . . . . . 0 N--CA 1.493 1.71 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.032 179.892 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.0 ptt? . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.297 0.57 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.444 ' N ' ' HD2' ' A' ' 3' ' ' PRO . 0.8 OUTLIER -54.67 -55.26 40.01 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.188 -0.945 . . . . 0.0 110.237 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 2' ' ' GLU . 50.5 Cg_endo -76.41 178.85 7.01 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.528 1.278 . . . . 0.0 110.414 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 49.52 64.18 1.86 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.488 -0.758 . . . . 0.0 110.764 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.85 -25.64 63.44 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.29 -0.881 . . . . 0.0 110.328 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -149.41 155.75 26.46 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -123.15 173.9 7.59 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.411 -1.053 . . . . 0.0 110.335 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 58.6 -177.37 0.08 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.427 -0.796 . . . . 0.0 110.294 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 35.3 mtm -64.27 -157.07 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.321 -0.862 . . . . 0.0 109.972 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 52.24 61.58 11.81 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.244 -0.91 . . . . 0.0 110.502 179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -75.2 157.16 42.09 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.746 1.393 . . . . 0.0 110.653 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.8 149.04 36.27 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.429 -0.794 . . . . 0.0 110.264 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -169.64 -153.88 0.11 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.26 -0.9 . . . . 0.0 110.316 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.9 t0 62.2 14.88 7.03 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.262 -0.899 . . . . 0.0 110.865 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.455 ' HE3' HD22 ' A' ' 31' ' ' LEU . 22.6 m0 -95.01 -37.22 11.23 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.035 -1.041 . . . . 0.0 109.923 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.652 ' CD2' ' HB1' ' A' ' 36' ' ' ALA . 0.9 OUTLIER -71.49 -28.37 63.87 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.358 -0.839 . . . . 0.0 110.006 179.478 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -84.77 -44.91 12.89 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.326 -0.859 . . . . 0.0 110.185 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.429 ' CG2' ' N ' ' A' ' 19' ' ' ALA . 1.6 t -61.94 -39.08 90.85 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.408 -0.808 . . . . 0.0 110.345 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.607 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -68.8 -48.87 62.54 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.453 -0.779 . . . . 0.0 109.975 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.703 ' CB ' HG11 ' A' ' 59' ' ' VAL . . . -56.9 -53.5 57.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.528 -0.733 . . . . 0.0 109.811 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.567 ' HB2' ' O ' ' A' ' 51' ' ' VAL . . . -53.51 -28.47 31.22 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.48 -0.762 . . . . 0.0 110.182 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.57 14.41 15.08 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.468 -0.77 . . . . 0.0 110.474 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.444 ' HA3' ' CE ' ' A' ' 53' ' ' MET . . . 55.0 49.89 60.92 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.1 mmp_? -121.25 63.18 0.89 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.401 -1.058 . . . . 0.0 110.138 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.589 HG22 HG23 ' A' ' 59' ' ' VAL . 41.1 t -47.49 -51.17 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.549 -0.719 . . . . 0.0 110.163 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -47.12 -42.26 18.89 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.603 -0.686 . . . . 0.0 110.686 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.07 -37.24 72.48 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.249 -0.907 . . . . 0.0 110.086 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.984 HG12 HD13 ' A' ' 62' ' ' LEU . 21.6 t -73.45 -41.23 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.328 -0.857 . . . . 0.0 110.351 -179.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.903 ' CA ' HD11 ' A' ' 62' ' ' LEU . 9.6 mmm180 -53.9 -44.81 70.82 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.126 -0.984 . . . . 0.0 109.639 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.63 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -78.85 -41.25 30.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.659 -0.65 . . . . 0.0 109.917 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.455 HD22 ' HE3' ' A' ' 15' ' ' TRP . 35.0 mt -65.53 -59.15 4.28 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.547 -0.721 . . . . 0.0 110.236 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.967 HD23 HD22 ' A' ' 62' ' ' LEU . 33.1 tp -50.83 -45.86 59.8 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.369 -0.832 . . . . 0.0 110.526 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -76.19 -15.6 60.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.294 -0.879 . . . . 0.0 110.031 179.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.63 ' HB2' ' O ' ' A' ' 30' ' ' ALA . . . -82.79 -8.75 59.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.301 -0.874 . . . . 0.0 110.652 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.54 23.19 1.93 Allowed Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.782 -1.199 . . . . 0.0 110.711 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.939 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -69.95 152.56 44.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.99 -1.3 . . . . 0.0 109.664 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.851 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -79.08 116.59 61.33 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.274 -0.891 . . . . 0.0 110.09 -179.728 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -68.73 -33.03 22.18 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.372 1.196 . . . . 0.0 110.317 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 24.7 m120 -115.57 58.05 0.73 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.311 -0.868 . . . . 0.0 109.744 179.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.851 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -88.69 116.97 67.79 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.324 -0.86 . . . . 0.0 110.11 -179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -72.35 82.94 1.31 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 O-C-N 123.647 1.341 . . . . 0.0 110.08 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -60.92 -174.95 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.391 -0.818 . . . . 0.0 110.026 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.5 p -93.63 26.57 3.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.397 -0.815 . . . . 0.0 110.171 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -114.78 17.88 16.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.248 -0.908 . . . . 0.0 110.248 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 59.74 44.26 97.12 Favored Glycine 0 N--CA 1.484 1.88 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -174.55 161.35 3.25 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.307 -1.114 . . . . 0.0 110.79 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.633 ' HB3' ' CD ' ' A' ' 48' ' ' PRO . 2.2 mtt180 -87.7 -154.47 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.635 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.633 ' CD ' ' HB3' ' A' ' 47' ' ' ARG . 45.3 Cg_endo -77.36 -170.53 0.95 Allowed 'Trans proline' 0 N--CA 1.483 0.855 0 O-C-N 122.53 0.753 . . . . 0.0 111.008 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.555 ' O ' ' HG2' ' A' ' 52' ' ' MET . 4.0 mt 62.62 -62.86 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.729 -0.607 . . . . 0.0 110.057 -178.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.522 ' N ' ' O ' ' A' ' 48' ' ' PRO . 8.4 mt-30 -48.15 -23.55 0.89 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.596 -1.315 . . . . 0.0 109.757 179.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.567 ' O ' ' HB2' ' A' ' 21' ' ' ALA . 9.1 p -118.54 31.37 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 O-C-N 121.337 -0.852 . . . . 0.0 109.873 178.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.7 ' HE1' ' HB2' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -93.03 36.66 1.03 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.139 -0.976 . . . . 0.0 109.963 179.627 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.444 ' CE ' ' HA3' ' A' ' 23' ' ' GLY . 7.7 ttp 63.44 -6.95 0.19 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.468 -0.77 . . . . 0.0 110.965 -179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.561 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 45.94 28.81 0.65 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.212 -0.93 . . . . 0.0 110.579 -179.902 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.407 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -126.26 4.15 7.76 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.08 84.94 1.85 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.378 -1.072 . . . . 0.0 109.596 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.442 ' CB ' ' HB3' ' A' ' 92' ' ' ASP . . . -51.27 -22.97 3.08 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.417 -0.802 . . . . 0.0 110.514 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.548 ' HB2' HG21 ' A' ' 25' ' ' VAL . 1.8 mmt180 -54.07 -45.94 71.85 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.284 -0.885 . . . . 0.0 110.047 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.703 HG11 ' CB ' ' A' ' 20' ' ' ALA . 46.7 t -58.05 -45.22 88.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.418 -0.802 . . . . 0.0 109.723 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.7 ' HB2' ' HE1' ' A' ' 52' ' ' MET . . . -49.48 -53.19 24.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.515 -0.741 . . . . 0.0 109.719 179.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.473 ' O ' HD23 ' A' ' 65' ' ' LEU . 1.6 tt0 -52.21 -51.34 58.8 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.437 -0.789 . . . . 0.0 109.313 178.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.984 HD13 HG12 ' A' ' 28' ' ' VAL . 0.9 OUTLIER -49.55 -70.99 0.07 Allowed 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.638 0.732 . . . . 0.0 110.049 178.675 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.837 HD22 HD22 ' A' ' 32' ' ' LEU . 4.5 mm? -56.5 -46.81 80.33 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.867 -0.521 . . . . 0.0 110.931 -179.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.915 HD13 HG12 ' A' ' 96' ' ' VAL . 1.2 tt -61.56 -59.09 5.74 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.342 -0.849 . . . . 0.0 111.171 -179.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.473 HD23 ' O ' ' A' ' 61' ' ' GLU . 0.6 OUTLIER -53.35 -23.55 9.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.067 -1.021 . . . . 0.0 109.935 -179.328 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.519 ' ND1' ' HG ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -88.9 -50.81 5.97 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.611 -0.681 . . . . 0.0 109.433 179.505 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 152.98 52.23 0.01 OUTLIER Glycine 0 N--CA 1.483 1.774 0 C-N-CA 119.937 -1.125 . . . . 0.0 111.061 179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.799 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -79.29 -151.74 0.06 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.827 -1.396 . . . . 0.0 109.99 179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.428 ' HB2' ' CB ' ' A' ' 47' ' ' ARG . 1.2 tt0 -123.28 54.89 7.3 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.365 -0.835 . . . . 0.0 110.088 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.5 ' HG3' HD12 ' A' ' 64' ' ' LEU . 43.0 Cg_endo -70.21 -13.91 34.06 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.641 1.337 . . . . 0.0 110.274 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.5 ' O ' ' NH1' ' A' ' 80' ' ' ARG . 2.1 t-20 -108.36 -73.0 0.7 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.368 -0.832 . . . . 0.0 110.02 179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 4.1 t -50.27 169.0 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.189 -0.944 . . . . 0.0 110.979 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.465 ' HB1' ' O ' ' A' ' 79' ' ' THR . . . -153.86 -155.45 0.59 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.334 -0.854 . . . . 0.0 110.149 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 78' ' ' LEU . 0.2 OUTLIER -101.71 135.34 19.78 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.406 -0.809 . . . . 0.0 109.746 179.876 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -74.3 -22.86 16.0 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.685 1.36 . . . . 0.0 110.661 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.03 -39.37 66.09 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.204 -0.935 . . . . 0.0 110.085 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 1.045 HG23 ' CH2' ' A' ' 110' ' ' TRP . 0.3 OUTLIER -147.43 16.07 1.15 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.601 -0.687 . . . . 0.0 110.13 179.929 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.476 ' HB3' ' O ' ' A' ' 107' ' ' ARG . 0.4 OUTLIER 48.22 35.11 5.04 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.481 -0.762 . . . . 0.0 111.513 179.664 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.465 ' O ' ' HB1' ' A' ' 73' ' ' ALA . 2.5 m -71.31 104.82 3.27 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.219 -0.926 . . . . 0.0 109.886 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.833 ' CG ' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -80.06 160.13 69.19 Favored Pre-proline 0 N--CA 1.498 1.928 0 O-C-N 121.351 -0.843 . . . . 0.0 110.747 -179.571 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.417 ' O ' ' HB2' ' A' ' 84' ' ' ASP . 45.7 Cg_endo -72.1 -17.46 28.12 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.822 1.433 . . . . 0.0 110.604 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 98.6 t -62.7 -24.06 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.209 -0.932 . . . . 0.0 110.205 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.495 ' N ' ' ND1' ' A' ' 83' ' ' HIS . 13.4 m80 -76.68 -32.83 58.16 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.413 -0.804 . . . . 0.0 109.108 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.561 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 3.3 m-20 -57.98 -50.86 71.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.616 -0.678 . . . . 0.0 110.297 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.491 ' HB3' ' CD1' ' A' ' 94' ' ' LEU . . . -58.95 -58.33 9.11 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.343 -0.848 . . . . 0.0 109.856 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.884 ' HB2' HD11 ' A' ' 130' ' ' LEU . . . -59.36 -45.0 92.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.42 -0.8 . . . . 0.0 110.847 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 0.3 OUTLIER -47.71 -44.65 27.9 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.327 -0.858 . . . . 0.0 110.902 -179.589 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -95.96 13.32 27.31 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.284 -0.885 . . . . 0.0 110.495 179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.575 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 59.84 60.1 9.29 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.407 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 0.3 OUTLIER -129.04 94.32 3.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.266 -1.138 . . . . 0.0 110.707 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.651 HD11 ' O ' ' A' ' 125' ' ' ASP . 0.3 OUTLIER -69.31 -37.38 77.73 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.336 -0.853 . . . . 0.0 109.958 179.68 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.442 ' HB3' ' CB ' ' A' ' 57' ' ' ALA . 31.5 m-20 -50.08 -40.98 47.19 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.503 -0.748 . . . . 0.0 110.055 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 60.5 m -66.16 -42.45 88.96 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.725 HD21 ' HG ' ' A' ' 130' ' ' LEU . 1.2 tp -58.83 -38.27 78.28 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.596 -0.69 . . . . 0.0 109.312 178.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 91' ' ' LEU . 47.3 t -61.41 -50.6 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.582 -0.699 . . . . 0.0 109.607 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.915 HG12 HD13 ' A' ' 64' ' ' LEU . 92.9 t -54.17 -54.51 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.543 -0.723 . . . . 0.0 109.433 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.681 HD23 ' HB1' ' A' ' 102' ' ' ALA . 1.1 mp -47.51 -53.56 14.02 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.735 -0.603 . . . . 0.0 110.825 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -72.98 -29.61 63.18 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.307 -0.871 . . . . 0.0 110.084 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -65.86 -9.4 28.78 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.367 -0.833 . . . . 0.0 110.604 179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.88 ' HB2' HD21 ' A' ' 64' ' ' LEU . . . -136.9 -74.6 0.42 Allowed 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.117 -0.99 . . . . 0.0 111.051 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -160.14 102.21 0.21 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 -179.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.681 ' HB1' HD23 ' A' ' 97' ' ' LEU . . . -162.43 111.18 1.39 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.405 -1.056 . . . . 0.0 109.878 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -77.86 145.47 36.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.38 -0.825 . . . . 0.0 110.38 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.745 HD22 ' HB3' ' A' ' 133' ' ' ALA . 2.4 mp -116.36 4.23 13.39 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.46 -0.775 . . . . 0.0 110.286 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 20.1 t0 -98.68 39.29 1.27 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.187 -0.946 . . . . 0.0 109.764 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.833 HG11 ' CG ' ' A' ' 80' ' ' ARG . 3.0 p -108.4 -170.18 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.369 -0.832 . . . . 0.0 109.791 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.695 ' H ' HG22 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -157.43 155.09 29.86 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.344 -0.848 . . . . 0.0 109.556 179.677 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.402 ' O ' ' N ' ' A' ' 110' ' ' TRP . 85.4 m-20 -74.49 58.09 0.75 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.117 -0.99 . . . . 0.0 110.2 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.509 ' HB2' ' C ' ' A' ' 77' ' ' THR . . . 54.8 -88.36 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.465 -0.772 . . . . 0.0 110.74 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 1.045 ' CH2' HG23 ' A' ' 77' ' ' THR . 42.9 p90 -117.5 34.98 4.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.918 -1.114 . . . . 0.0 110.279 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -113.39 -84.94 1.36 Allowed Glycine 0 N--CA 1.481 1.674 0 N-CA-C 109.948 -1.261 . . . . 0.0 109.948 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -169.75 -160.13 0.23 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.263 -1.139 . . . . 0.0 110.502 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.481 ' CG ' ' HD2' ' A' ' 114' ' ' PRO . 0.3 OUTLIER -103.82 175.9 2.02 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.455 -0.778 . . . . 0.0 109.883 179.742 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.481 ' HD2' ' CG ' ' A' ' 113' ' ' LEU . 46.4 Cg_endo -74.01 -50.39 0.17 Allowed 'Trans proline' 0 C--N 1.312 -1.349 0 O-C-N 123.604 1.318 . . . . 0.0 110.386 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.4 HG13 ' N ' ' A' ' 116' ' ' ASP . 12.2 p -58.62 -34.52 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.321 -0.862 . . . . 0.0 109.72 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.4 ' N ' HG13 ' A' ' 115' ' ' VAL . 6.5 m-20 -70.86 -25.5 62.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.53 -0.731 . . . . 0.0 109.698 179.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.2 tt -79.68 -28.18 40.74 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.428 -0.795 . . . . 0.0 110.073 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -73.56 -45.29 54.36 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.402 -0.811 . . . . 0.0 109.891 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -62.8 -37.11 85.44 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.465 -0.772 . . . . 0.0 109.806 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.21 -45.29 85.35 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.534 -0.729 . . . . 0.0 110.037 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.1 -81.8 0.1 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.383 -0.823 . . . . 0.0 110.378 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 167.8 53.25 0.03 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.498 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 53.4 m-70 -127.88 52.87 1.82 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -1.149 . . . . 0.0 109.483 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 5.4 mtp180 -47.43 -43.0 23.52 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.544 -0.723 . . . . 0.0 110.258 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.651 ' O ' HD11 ' A' ' 91' ' ' LEU . 76.7 m-20 -55.6 -42.94 75.53 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.391 -0.818 . . . . 0.0 109.295 179.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.865 HG11 ' HA ' ' A' ' 86' ' ' ALA . 3.0 t -78.94 -34.0 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.495 -0.753 . . . . 0.0 109.127 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -61.77 -31.99 72.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.501 -0.749 . . . . 0.0 109.517 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.9 mtp180 -60.65 -66.7 0.49 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.543 -0.723 . . . . 0.0 110.099 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.464 ' HB3' HD23 ' A' ' 94' ' ' LEU . 10.1 t80 -55.03 -28.87 55.51 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.346 -0.847 . . . . 0.0 109.627 179.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.884 HD11 ' HB2' ' A' ' 86' ' ' ALA . 68.1 mt -72.74 -43.52 62.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.574 -0.704 . . . . 0.0 109.569 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.79 -19.53 62.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.203 -0.936 . . . . 0.0 110.391 -179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -85.31 -50.71 7.12 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.277 -0.89 . . . . 0.0 110.399 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.745 ' HB3' HD22 ' A' ' 104' ' ' LEU . . . -88.26 -19.74 26.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.295 -0.878 . . . . 0.0 110.174 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.698 ' HB3' ' O ' ' A' ' 130' ' ' LEU . . . -112.87 34.98 4.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.498 -0.751 . . . . 0.0 109.687 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -51.63 121.25 12.08 Favored Glycine 0 N--CA 1.496 2.682 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -125.96 73.86 0.43 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.527 ' O ' HG23 ' A' ' 137' ' ' THR . 7.8 t -54.21 123.6 13.27 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.373 -1.075 . . . . 0.0 110.33 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -162.21 179.18 8.1 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.139 -0.976 . . . . 0.0 110.637 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 155.31 -103.79 0.24 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 89.6 p -132.75 177.98 7.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.453 -1.028 . . . . 0.0 110.216 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 60.64 -162.47 0.27 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.271 -0.893 . . . . 0.0 110.583 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -86.87 -24.0 25.05 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.367 -0.833 . . . . 0.0 110.715 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . 53.19 -146.31 0.54 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.103 -0.998 . . . . 0.0 110.359 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.34 165.9 1.88 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.161 -0.962 . . . . 0.0 110.294 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 3.3 tp -85.43 137.45 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.444 -0.785 . . . . 0.0 110.1 179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -177.23 73.17 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.196 -0.94 . . . . 0.0 110.513 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -63.73 141.9 58.6 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.304 -0.872 . . . . 0.0 110.177 179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -81.49 164.78 21.75 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.368 -0.832 . . . . 0.0 110.545 -179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.437 ' CG ' ' O ' ' A' ' 149' ' ' GLU . 6.4 pt-20 -83.44 109.79 17.64 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.313 -0.867 . . . . 0.0 110.029 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 93.43 -148.8 19.18 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.57 156.52 61.06 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.731 1.385 . . . . 0.0 110.415 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -116.22 -51.15 2.63 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.284 -0.885 . . . . 0.0 110.535 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -52.06 141.65 17.82 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.253 -0.904 . . . . 0.0 110.495 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 3.5 mt -126.58 78.11 72.83 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.364 -0.835 . . . . 0.0 110.375 -179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -77.47 166.47 25.86 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.805 1.424 . . . . 0.0 109.761 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 . . . . . 0 N--CA 1.496 1.875 0 CA-C-O 117.938 -1.03 . . . . 0.0 110.538 -179.847 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.097 0.475 . . . . 0.0 110.063 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.416 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 64.1 mt-10 47.68 54.67 15.96 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.445 -0.784 . . . . 0.0 110.178 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.416 ' CD ' ' N ' ' A' ' 2' ' ' GLU . 44.5 Cg_endo -71.5 69.59 2.69 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 O-C-N 123.822 1.433 . . . . 0.0 110.532 -179.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.8 152.64 35.38 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.461 -0.775 . . . . 0.0 110.094 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.46 -169.79 0.58 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.299 -0.875 . . . . 0.0 110.005 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 66.09 -121.78 19.64 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 50.94 77.45 0.13 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.419 -1.047 . . . . 0.0 110.328 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.11 -140.74 0.16 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.377 -0.827 . . . . 0.0 110.107 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.09 -0.05 21.38 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.012 -1.055 . . . . 0.0 110.946 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -57.91 135.05 83.54 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.088 -1.008 . . . . 0.0 110.111 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -69.61 -176.36 1.42 Allowed 'Trans proline' 0 C--N 1.312 -1.375 0 O-C-N 123.611 1.321 . . . . 0.0 110.714 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.8 m -129.24 -30.27 2.18 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.359 -0.838 . . . . 0.0 110.845 -179.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.49 ' HB1' ' HB2' ' A' ' 37' ' ' LEU . . . -52.99 -28.32 23.33 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.128 -0.983 . . . . 0.0 110.165 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.11 -12.77 52.13 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.434 -0.791 . . . . 0.0 110.006 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.571 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 2.2 t90 -70.37 -7.59 44.08 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.287 -0.883 . . . . 0.0 110.423 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.951 HD21 HD21 ' A' ' 63' ' ' LEU . 0.9 OUTLIER -80.4 -57.96 3.35 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.038 -1.039 . . . . 0.0 109.674 179.77 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.468 ' N ' ' HG ' ' A' ' 16' ' ' LEU . . . -63.26 -38.89 92.95 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.222 -0.924 . . . . 0.0 109.761 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.571 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 1.5 p -52.8 -54.22 37.22 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.527 -0.733 . . . . 0.0 110.385 179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.713 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -59.77 -39.01 83.41 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.338 -0.851 . . . . 0.0 110.071 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.469 ' HB1' HG11 ' A' ' 59' ' ' VAL . . . -54.12 -61.91 2.0 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.116 -0.99 . . . . 0.0 109.561 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.937 ' HB2' HG22 ' A' ' 51' ' ' VAL . . . -54.64 -22.21 12.89 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.515 -0.74 . . . . 0.0 110.206 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -90.64 16.6 8.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.354 -0.841 . . . . 0.0 110.69 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 49.76 34.95 22.77 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 179.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.434 ' HB3' ' HB2' ' A' ' 27' ' ' GLU . 6.2 mmt180 -109.49 67.54 0.65 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.338 -1.095 . . . . 0.0 110.052 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.476 HG22 HG22 ' A' ' 59' ' ' VAL . 93.2 t -49.17 -54.28 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.638 -0.663 . . . . 0.0 110.973 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -46.89 -43.02 18.46 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.5 -0.75 . . . . 0.0 110.818 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.55 ' O ' ' HB2' ' A' ' 31' ' ' LEU . 20.3 mt-10 -62.17 -44.86 95.66 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.233 -0.917 . . . . 0.0 110.166 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.757 HG12 HD13 ' A' ' 62' ' ' LEU . 3.5 t -72.92 -43.06 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.419 -0.801 . . . . 0.0 110.471 -179.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.83 ' CA ' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -45.8 -47.81 15.67 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.409 -0.807 . . . . 0.0 109.853 -179.516 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -80.41 -49.06 11.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.418 -0.802 . . . . 0.0 110.379 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.55 ' HB2' ' O ' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -57.13 -56.99 14.67 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.165 -0.959 . . . . 0.0 110.255 179.849 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 1.016 HD23 HD22 ' A' ' 62' ' ' LEU . 15.2 tp -50.35 -49.65 53.43 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.5 -0.75 . . . . 0.0 110.665 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -74.73 -8.9 57.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.269 -0.894 . . . . 0.0 110.537 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.56 -11.69 39.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.242 -0.912 . . . . 0.0 111.127 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 139.12 -9.38 3.29 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 119.619 -1.277 . . . . 0.0 110.763 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.961 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -44.68 154.72 0.12 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.179 -1.189 . . . . 0.0 110.611 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.884 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 2.3 mm? -93.73 111.31 52.11 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.378 -0.826 . . . . 0.0 110.658 -179.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.484 ' O ' ' HG3' ' A' ' 48' ' ' PRO . 43.2 Cg_endo -70.57 -19.02 32.78 Favored 'Trans proline' 0 C--N 1.312 -1.378 0 O-C-N 123.622 1.327 . . . . 0.0 110.485 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -109.43 17.49 21.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.33 -0.856 . . . . 0.0 110.209 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.884 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -77.75 129.65 75.89 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.257 -0.902 . . . . 0.0 110.405 -179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -73.89 146.31 37.42 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 123.656 1.345 . . . . 0.0 109.983 179.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -88.96 -157.97 0.47 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.237 -0.914 . . . . 0.0 109.941 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.8 m -111.43 14.49 21.48 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.051 -1.03 . . . . 0.0 111.205 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -123.76 33.52 5.3 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.096 -1.002 . . . . 0.0 109.964 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 54.25 23.7 26.62 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.216 -1.553 . . . . 0.0 109.216 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 2.8 mtm-85 -108.05 -159.79 0.7 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.502 -0.999 . . . . 0.0 110.126 -179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.626 ' O ' HG12 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -127.89 179.69 1.19 Allowed Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.482 -0.761 . . . . 0.0 110.067 -179.651 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.692 ' HB2' HD22 ' A' ' 63' ' ' LEU . 42.1 Cg_endo -68.9 -24.52 33.65 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.611 1.322 . . . . 0.0 111.287 -179.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.579 ' O ' ' HG2' ' A' ' 52' ' ' MET . 4.3 mt -106.24 -36.83 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.044 -1.035 . . . . 0.0 108.64 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.403 ' HB2' ' HB2' ' A' ' 47' ' ' ARG . 24.6 mt-30 -54.73 -18.91 5.25 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.25 -0.906 . . . . 0.0 109.375 178.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.937 HG22 ' HB2' ' A' ' 21' ' ' ALA . 9.3 p -116.07 39.23 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.478 -0.764 . . . . 0.0 110.601 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.579 ' HG2' ' O ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -103.55 39.21 1.64 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.946 -1.096 . . . . 0.0 109.443 179.267 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . 0.412 ' CB ' ' O ' ' A' ' 52' ' ' MET . 0.0 OUTLIER 68.79 -5.61 0.98 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.729 -0.607 . . . . 0.0 110.918 -179.536 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.534 ' CE ' ' HB3' ' A' ' 84' ' ' ASP . 0.1 OUTLIER 39.94 89.32 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.364 -0.835 . . . . 0.0 110.937 179.82 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.533 ' HA2' ' CG ' ' A' ' 90' ' ' PHE . . . 159.13 -28.95 0.4 Allowed Glycine 0 N--CA 1.489 2.207 0 N-CA-C 108.232 -1.947 . . . . 0.0 108.232 -179.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.67 79.91 1.72 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.733 -0.863 . . . . 0.0 110.16 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -48.8 -25.18 1.72 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.255 -0.903 . . . . 0.0 110.196 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.62 -39.24 57.68 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.463 -0.773 . . . . 0.0 109.789 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.476 HG22 HG22 ' A' ' 25' ' ' VAL . 23.8 t -69.22 -51.29 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.395 -0.816 . . . . 0.0 109.257 179.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.557 ' HB2' ' HE1' ' A' ' 52' ' ' MET . . . -48.91 -43.66 39.51 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.253 -0.904 . . . . 0.0 109.908 179.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.436 ' O ' HD23 ' A' ' 65' ' ' LEU . 5.4 tt0 -53.58 -51.72 62.08 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.501 -0.749 . . . . 0.0 109.677 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.016 HD22 HD23 ' A' ' 32' ' ' LEU . 1.2 mt -50.32 -66.51 0.38 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.593 -0.692 . . . . 0.0 109.912 178.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.951 HD21 HD21 ' A' ' 16' ' ' LEU . 11.0 mt -60.27 -39.27 86.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.676 -0.64 . . . . 0.0 110.798 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.891 HD22 HG13 ' A' ' 96' ' ' VAL . 0.5 OUTLIER -63.09 -60.15 3.83 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.174 -0.954 . . . . 0.0 110.458 -179.78 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.436 HD23 ' O ' ' A' ' 61' ' ' GLU . 0.7 OUTLIER -53.34 -22.67 7.7 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.427 -0.796 . . . . 0.0 110.019 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.582 ' CD2' ' HG ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -90.87 -25.15 19.99 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.611 -0.681 . . . . 0.0 109.679 179.849 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 110.94 56.58 0.5 Allowed Glycine 0 N--CA 1.481 1.643 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.854 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -70.1 -149.78 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.171 -1.193 . . . . 0.0 109.767 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.428 ' HG2' ' HB3' ' A' ' 72' ' ' CYS . 0.3 OUTLIER -120.46 59.31 6.85 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.498 -0.751 . . . . 0.0 109.628 179.251 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.415 ' HD3' ' C ' ' A' ' 68' ' ' ALA . 43.5 Cg_endo -71.13 -1.53 9.71 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 O-C-N 123.808 1.425 . . . . 0.0 110.712 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -113.35 -66.4 1.09 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.128 -0.982 . . . . 0.0 110.014 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.428 ' HB3' ' HG2' ' A' ' 69' ' ' GLU . 3.1 t -50.57 166.59 0.08 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.453 -0.78 . . . . 0.0 110.534 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.575 ' HB2' ' HA ' ' A' ' 80' ' ' ARG . . . -159.22 -140.18 0.07 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.395 -0.815 . . . . 0.0 110.04 -179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 78' ' ' LEU . 11.0 t70 -105.05 127.35 28.88 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.062 -1.024 . . . . 0.0 109.765 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.83 -2.6 12.17 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.432 1.228 . . . . 0.0 111.208 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.41 ' HB3' ' OD2' ' A' ' 74' ' ' ASP . . . -97.15 -44.0 7.14 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.096 -1.003 . . . . 0.0 109.72 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.616 ' C ' ' HB2' ' A' ' 109' ' ' ALA . 0.5 OUTLIER -121.79 7.77 9.94 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.454 -0.779 . . . . 0.0 110.265 179.529 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.501 ' HB3' ' O ' ' A' ' 107' ' ' ARG . 1.3 mt 45.61 27.68 0.44 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.335 -0.853 . . . . 0.0 111.102 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.7 m -65.32 88.72 0.08 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.113 -0.992 . . . . 0.0 109.642 179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.892 ' CG ' HG11 ' A' ' 106' ' ' VAL . 1.1 mtt180 -69.12 165.91 33.93 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.426 -0.796 . . . . 0.0 110.35 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.407 ' HG3' ' C ' ' A' ' 70' ' ' PRO . 42.8 Cg_endo -69.61 -12.97 34.32 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.728 1.383 . . . . 0.0 111.164 -179.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 39.9 t -66.13 -42.1 90.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.007 -1.058 . . . . 0.0 109.597 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.473 ' O ' ' HB2' ' A' ' 87' ' ' ARG . 69.3 m80 -55.14 -45.49 75.65 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.609 0.719 . . . . 0.0 109.676 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.534 ' HB3' ' CE ' ' A' ' 54' ' ' MET . 1.2 m-20 -49.32 -51.31 35.07 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 121.093 0.473 . . . . 0.0 110.957 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.666 ' HA ' ' CZ ' ' A' ' 90' ' ' PHE . . . -57.46 -60.69 3.27 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.172 -0.955 . . . . 0.0 109.639 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.824 ' HB1' ' HB2' ' A' ' 118' ' ' ALA . . . -63.14 -9.75 12.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.399 -0.813 . . . . 0.0 109.996 178.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.473 ' HB2' ' O ' ' A' ' 83' ' ' HIS . 0.0 OUTLIER -70.67 -54.38 12.1 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.039 -1.038 . . . . 0.0 110.665 -179.812 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.479 ' HB3' ' CD1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -90.07 -19.11 24.74 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.141 -0.975 . . . . 0.0 109.862 -179.918 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.822 ' HA2' HG21 ' A' ' 126' ' ' VAL . . . 87.32 59.91 1.7 Allowed Glycine 0 N--CA 1.487 2.077 0 C-N-CA 120.147 -1.025 . . . . 0.0 111.33 178.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.666 ' CZ ' ' HA ' ' A' ' 85' ' ' ALA . 1.3 p90 -135.17 89.02 2.47 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.012 -1.287 . . . . 0.0 109.912 178.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.714 HD11 ' O ' ' A' ' 125' ' ' ASP . 0.2 OUTLIER -51.58 -35.12 40.02 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.868 -0.52 . . . . 0.0 110.883 -179.31 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 91' ' ' LEU . 1.7 m-20 -41.86 -33.7 0.56 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.319 -0.863 . . . . 0.0 109.128 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.577 ' O ' HD12 ' A' ' 97' ' ' LEU . 1.1 m -79.52 -49.73 11.8 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 178.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.832 HD21 ' HG ' ' A' ' 130' ' ' LEU . 2.5 tp -54.2 -41.33 68.5 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.65 -0.656 . . . . 0.0 109.587 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 89.8 t -59.99 -53.04 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.327 -0.858 . . . . 0.0 109.182 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.891 HG13 HD22 ' A' ' 64' ' ' LEU . 40.6 t -51.86 -46.46 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.638 -0.664 . . . . 0.0 109.435 179.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.873 HD23 ' HB1' ' A' ' 102' ' ' ALA . 0.6 OUTLIER -52.32 -55.41 21.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.623 -0.673 . . . . 0.0 109.877 179.588 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -70.63 -28.12 64.59 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.363 -0.835 . . . . 0.0 110.168 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.434 ' HB2' ' HA ' ' A' ' 96' ' ' VAL . 3.1 mtt180 -68.49 -9.57 49.84 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.287 -0.883 . . . . 0.0 110.995 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.832 ' HB2' HD21 ' A' ' 64' ' ' LEU . . . -127.99 -87.12 0.57 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.168 -0.958 . . . . 0.0 110.617 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -163.68 54.39 0.29 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.873 ' HB1' HD23 ' A' ' 97' ' ' LEU . . . -102.26 133.1 47.7 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.252 -1.146 . . . . 0.0 110.305 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.38 152.58 33.69 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.263 -0.898 . . . . 0.0 109.639 179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.464 HD13 ' HB1' ' A' ' 133' ' ' ALA . 6.6 mt -143.08 46.46 1.54 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.166 -0.958 . . . . 0.0 110.908 -179.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -169.44 52.7 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.182 -0.949 . . . . 0.0 110.815 179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.892 HG11 ' CG ' ' A' ' 80' ' ' ARG . 9.6 p -113.63 -178.14 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 0.0 109.97 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.664 ' H ' HG22 ' A' ' 106' ' ' VAL . 0.1 OUTLIER -129.32 138.04 51.35 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.386 -0.821 . . . . 0.0 109.882 179.129 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.631 ' O ' ' N ' ' A' ' 110' ' ' TRP . 15.5 t0 -72.09 58.92 0.37 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.421 -0.8 . . . . 0.0 110.404 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.616 ' HB2' ' C ' ' A' ' 77' ' ' THR . . . 56.75 -66.34 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.552 -0.718 . . . . 0.0 110.76 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.631 ' N ' ' O ' ' A' ' 108' ' ' ASP . 6.6 m-90 -45.76 -65.11 0.59 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.377 -0.827 . . . . 0.0 110.596 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 159.97 -28.7 0.36 Allowed Glycine 0 N--CA 1.483 1.82 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? -62.49 135.38 57.39 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.486 -1.009 . . . . 0.0 110.703 -179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.428 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 66.0 mt -87.65 165.39 30.43 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.42 -0.8 . . . . 0.0 110.226 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 113' ' ' LEU . 40.9 Cg_endo -67.78 -28.51 36.6 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.779 1.41 . . . . 0.0 110.081 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.509 HG21 ' CA ' ' A' ' 131' ' ' ARG . 11.1 p -75.53 -35.89 33.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.399 -0.813 . . . . 0.0 109.939 179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.422 ' N ' HG13 ' A' ' 115' ' ' VAL . 1.0 OUTLIER -68.94 -29.87 68.21 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.425 -0.797 . . . . 0.0 109.952 179.744 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.826 HD23 ' N ' ' A' ' 118' ' ' ALA . 4.3 tt -66.08 -58.53 5.26 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.459 -0.776 . . . . 0.0 109.934 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.826 ' N ' HD23 ' A' ' 117' ' ' LEU . . . -50.12 -48.01 53.73 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.383 -0.823 . . . . 0.0 110.969 -179.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -50.77 -41.31 56.73 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.33 -0.856 . . . . 0.0 110.086 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -74.45 -55.1 6.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.57 -0.706 . . . . 0.0 109.94 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.487 HD12 HD21 ' A' ' 117' ' ' LEU . 1.6 mt -53.07 -82.02 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.253 -0.905 . . . . 0.0 110.549 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.82 39.62 0.03 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.543 ' HB2' ' HB1' ' A' ' 118' ' ' ALA . 27.2 m-70 -124.08 52.83 1.44 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.276 -1.132 . . . . 0.0 109.188 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.476 ' HA ' ' HB3' ' A' ' 127' ' ' ALA . 1.1 ttt-85 -46.21 -45.44 16.91 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.73 -0.606 . . . . 0.0 110.341 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.714 ' O ' HD11 ' A' ' 91' ' ' LEU . 1.9 m-20 -52.53 -46.83 66.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.371 -0.831 . . . . 0.0 109.18 179.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.822 HG21 ' HA2' ' A' ' 89' ' ' GLY . 2.5 t -75.72 -27.51 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.5 -0.75 . . . . 0.0 109.556 179.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.476 ' HB3' ' HA ' ' A' ' 124' ' ' ARG . . . -75.19 -48.87 21.48 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.37 -0.831 . . . . 0.0 109.929 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.27 -54.93 41.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.28 -0.887 . . . . 0.0 110.157 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.631 ' HD2' HD23 ' A' ' 94' ' ' LEU . 36.8 t80 -59.33 -36.84 76.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.276 -0.89 . . . . 0.0 109.782 179.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.832 ' HG ' HD21 ' A' ' 94' ' ' LEU . 8.4 mt -64.03 -49.56 71.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.224 -0.923 . . . . 0.0 109.457 179.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.509 ' CA ' HG21 ' A' ' 115' ' ' VAL . 0.0 OUTLIER -52.94 -29.77 30.65 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.301 -0.875 . . . . 0.0 110.288 179.856 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -86.34 -42.78 13.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.35 -0.844 . . . . 0.0 109.836 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.464 ' HB1' HD13 ' A' ' 104' ' ' LEU . . . -79.81 -5.66 55.83 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.435 -0.791 . . . . 0.0 110.513 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -129.6 -65.72 0.83 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.172 -0.955 . . . . 0.0 110.622 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -63.44 144.36 49.11 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 94.83 -76.26 0.92 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 41.0 p -70.4 133.61 47.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.41 -1.053 . . . . 0.0 110.103 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 6.0 mtt85 -98.21 -70.81 0.71 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.278 -0.889 . . . . 0.0 110.767 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -115.21 -145.82 8.75 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 110.188 -1.165 . . . . 0.0 110.188 -179.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.5 p -129.22 39.86 3.7 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.478 -1.013 . . . . 0.0 110.619 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -66.08 133.81 51.53 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.312 -0.867 . . . . 0.0 110.391 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 54.58 32.81 17.77 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.347 -0.845 . . . . 0.0 110.412 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . 50.59 29.35 4.03 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.489 -0.757 . . . . 0.0 110.51 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 64.47 88.09 0.11 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.495 -0.753 . . . . 0.0 111.302 179.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 3.0 mt 40.43 79.56 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.677 -0.639 . . . . 0.0 111.7 179.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 177.05 121.82 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.109 -0.995 . . . . 0.0 110.596 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.417 ' O ' ' HB3' ' A' ' 148' ' ' ALA . . . -72.05 139.01 48.26 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.302 -0.873 . . . . 0.0 109.888 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 147' ' ' ALA . . . 56.24 177.85 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.234 -0.916 . . . . 0.0 110.199 -179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -150.99 95.97 2.27 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.231 -0.918 . . . . 0.0 110.21 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 173.73 -125.88 1.17 Allowed Glycine 0 N--CA 1.49 2.296 0 C-N-CA 119.738 -1.22 . . . . 0.0 110.348 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -80.78 -87.46 0.0 OUTLIER 'Trans proline' 0 C--N 1.313 -1.304 0 O-C-N 123.745 1.392 . . . . 0.0 111.64 -179.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 64.48 16.7 10.41 Favored 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.037 -1.039 . . . . 0.0 110.665 -179.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.9 t70 57.12 -174.79 0.07 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.145 -0.972 . . . . 0.0 110.662 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . . . . . . . . . 86.3 mt -125.63 74.44 69.69 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.396 -0.815 . . . . 0.0 110.162 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -78.39 146.66 22.18 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.819 1.431 . . . . 0.0 110.764 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.495 1.812 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.078 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 121.254 0.55 . . . . 0.0 109.981 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -50.04 139.81 17.29 Favored Pre-proline 0 N--CA 1.496 1.855 0 O-C-N 121.375 -0.828 . . . . 0.0 110.588 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.58 -178.45 4.05 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.548 1.289 . . . . 0.0 110.031 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 47.8 70.0 0.47 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.524 -0.735 . . . . 0.0 110.197 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -110.87 56.42 0.63 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.343 -0.848 . . . . 0.0 110.444 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -143.39 -81.17 0.05 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.5 m -99.4 156.08 17.2 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.216 -1.167 . . . . 0.0 111.028 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.0 t -100.85 140.89 34.5 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.396 -0.815 . . . . 0.0 109.865 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 63.15 137.37 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.408 -0.808 . . . . 0.0 110.481 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -122.81 106.14 34.65 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.372 -0.83 . . . . 0.0 109.724 179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.04 107.61 2.41 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.559 1.294 . . . . 0.0 110.794 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.23 -170.81 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.384 -0.823 . . . . 0.0 110.261 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.22 51.1 2.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.391 -0.818 . . . . 0.0 110.098 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.415 ' O ' ' HB3' ' A' ' 17' ' ' ALA . 5.7 m-20 -83.39 -2.68 56.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.408 -0.808 . . . . 0.0 110.357 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.527 ' HA ' ' OG1' ' A' ' 18' ' ' THR . 0.1 OUTLIER -46.44 -62.78 1.21 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.366 -0.834 . . . . 0.0 110.345 -179.584 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.001 ' HB2' HD21 ' A' ' 63' ' ' LEU . 0.3 OUTLIER -45.81 -35.26 4.27 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-O 121.392 0.615 . . . . 0.0 110.115 179.16 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 14' ' ' ASP . . . -77.66 -48.57 16.46 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.463 -0.773 . . . . 0.0 109.639 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.527 ' OG1' ' HA ' ' A' ' 15' ' ' TRP . 0.0 OUTLIER -52.97 -60.26 3.5 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.515 -0.74 . . . . 0.0 110.517 179.72 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.815 ' HB3' HG22 ' A' ' 28' ' ' VAL . . . -53.3 -43.44 67.56 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.332 -0.855 . . . . 0.0 109.905 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.484 ' C ' ' HA ' ' A' ' 52' ' ' MET . . . -55.39 -40.17 71.06 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.572 -0.705 . . . . 0.0 109.527 179.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.35 -34.43 70.49 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.434 -0.791 . . . . 0.0 110.363 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.9 mtm180 -94.65 22.61 6.1 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.245 -0.909 . . . . 0.0 110.885 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 52.41 72.31 0.54 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.926 ' O ' HG23 ' A' ' 28' ' ' VAL . 4.3 mtt85 -129.87 56.57 1.72 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.428 -1.042 . . . . 0.0 109.769 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.85 HG22 HG23 ' A' ' 59' ' ' VAL . 89.5 t -47.4 -55.14 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.558 -0.714 . . . . 0.0 110.649 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -61.67 -31.46 71.58 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.404 -0.81 . . . . 0.0 110.936 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.456 ' CB ' ' HB3' ' A' ' 24' ' ' ARG . 0.3 OUTLIER -76.43 -33.31 58.78 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.151 -0.968 . . . . 0.0 109.557 179.876 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.926 HG23 ' O ' ' A' ' 24' ' ' ARG . 5.0 t -78.77 -46.67 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.453 -0.78 . . . . 0.0 109.653 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.533 ' HA ' HD22 ' A' ' 62' ' ' LEU . 15.2 mmm180 -49.22 -48.08 45.75 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.431 -0.793 . . . . 0.0 109.74 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.622 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -72.04 -37.93 69.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.646 -0.659 . . . . 0.0 109.673 179.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.419 ' HB2' ' O ' ' A' ' 27' ' ' GLU . 6.3 mt -66.58 -56.47 10.59 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.469 -0.77 . . . . 0.0 110.565 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.947 ' HB2' HD21 ' A' ' 62' ' ' LEU . 0.1 OUTLIER -44.45 -56.41 4.29 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.634 -0.666 . . . . 0.0 110.551 -179.809 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.48 -14.64 61.27 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.354 -0.841 . . . . 0.0 110.382 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.622 ' HB2' ' O ' ' A' ' 30' ' ' ALA . . . -79.15 -7.63 58.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.088 -1.007 . . . . 0.0 110.6 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 134.96 -12.19 4.47 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.771 -1.205 . . . . 0.0 110.578 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.941 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . . . -48.73 149.32 1.79 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.172 -1.193 . . . . 0.0 110.509 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.935 ' HB3' ' HB2' ' A' ' 40' ' ' ALA . 0.2 OUTLIER -86.33 140.1 34.19 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.373 -0.829 . . . . 0.0 110.253 -179.713 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -74.79 -56.66 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.812 1.427 . . . . 0.0 110.51 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.422 ' ND2' ' O ' ' A' ' 67' ' ' GLY . 0.2 OUTLIER -95.4 55.92 1.78 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.264 -0.897 . . . . 0.0 109.825 179.565 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.935 ' HB2' ' HB3' ' A' ' 37' ' ' LEU . . . -101.76 108.25 55.22 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.169 -0.957 . . . . 0.0 110.774 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.8 132.26 19.82 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.617 1.325 . . . . 0.0 109.554 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.41 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . 19.1 p-10 -124.19 71.06 1.11 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.054 -1.029 . . . . 0.0 111.112 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.8 m 44.46 -157.29 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.358 -0.839 . . . . 0.0 110.362 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 60.64 7.56 1.44 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.124 -0.985 . . . . 0.0 110.734 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 50.44 26.66 10.2 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.537 ' HG2' ' HB3' ' A' ' 50' ' ' GLN . 6.0 mtm-85 -125.78 -170.47 2.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.534 -0.98 . . . . 0.0 110.775 -179.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.563 ' CB ' ' CD ' ' A' ' 48' ' ' PRO . 3.5 mmp_? -119.78 -163.48 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.733 0 O-C-N 121.332 -0.855 . . . . 0.0 109.331 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.945 ' HB2' HD22 ' A' ' 63' ' ' LEU . 43.9 Cg_endo -80.04 -22.43 7.32 Favored 'Trans proline' 0 C--N 1.321 -0.895 0 O-C-N 122.987 0.993 . . . . 0.0 110.911 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.508 ' O ' ' HG2' ' A' ' 52' ' ' MET . 10.1 mt -107.05 -42.47 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.241 -0.912 . . . . 0.0 109.242 178.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.537 ' HB3' ' HG2' ' A' ' 46' ' ' ARG . 1.1 mt-30 -53.1 -22.55 6.32 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.158 -0.963 . . . . 0.0 109.994 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 47' ' ' ARG . 9.2 p -101.61 1.76 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.34 -0.85 . . . . 0.0 110.532 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.508 ' HG2' ' O ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -70.42 157.82 37.11 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.874 -1.141 . . . . 0.0 109.426 179.936 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -52.09 -13.74 0.34 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.194 -0.941 . . . . 0.0 111.225 -179.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.658 ' HE2' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 62.93 10.96 4.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.325 -0.859 . . . . 0.0 109.543 -178.908 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.505 ' O ' ' CE1' ' A' ' 90' ' ' PHE . . . -113.82 -2.95 23.73 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.463 -1.855 . . . . 0.0 108.463 178.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.505 ' HB3' HG23 ' A' ' 59' ' ' VAL . 0.9 OUTLIER -130.25 79.37 1.9 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.395 -1.062 . . . . 0.0 109.99 179.866 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.54 ' CB ' ' HB3' ' A' ' 92' ' ' ASP . . . -50.32 -26.27 4.66 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.425 -0.797 . . . . 0.0 109.62 179.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.49 -44.28 65.54 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.476 -0.765 . . . . 0.0 109.507 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.85 HG23 HG22 ' A' ' 25' ' ' VAL . 43.2 t -59.5 -56.83 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.289 -0.882 . . . . 0.0 109.436 179.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.491 ' HB2' ' CE ' ' A' ' 52' ' ' MET . . . -53.72 -42.45 68.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.408 -0.808 . . . . 0.0 109.611 179.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.725 ' O ' HD23 ' A' ' 65' ' ' LEU . 4.0 tt0 -59.18 -31.88 69.4 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 110.091 179.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.947 HD21 ' HB2' ' A' ' 32' ' ' LEU . 10.2 tp -74.46 -59.0 2.93 Favored 'General case' 0 C--N 1.31 -1.129 0 O-C-N 121.334 -0.854 . . . . 0.0 109.121 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.001 HD21 ' HB2' ' A' ' 16' ' ' LEU . 1.5 mt -63.24 -40.56 97.79 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.496 -0.752 . . . . 0.0 110.389 -179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 1.054 HD11 ' HB3' ' A' ' 100' ' ' ALA . 0.4 OUTLIER -53.37 -70.5 0.09 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.135 -0.978 . . . . 0.0 110.344 -179.616 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.725 HD23 ' O ' ' A' ' 61' ' ' GLU . 3.2 pp -51.35 -24.41 4.68 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.443 -0.786 . . . . 0.0 109.827 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.518 ' CG ' HD11 ' A' ' 32' ' ' LEU . 1.8 m80 -84.98 -27.2 26.62 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.752 -0.593 . . . . 0.0 110.147 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.458 ' N ' ' O ' ' A' ' 63' ' ' LEU . . . 128.94 43.54 0.22 Allowed Glycine 0 N--CA 1.479 1.521 0 C-N-CA 120.136 -1.031 . . . . 0.0 110.906 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.601 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -72.9 -153.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.73 -1.453 . . . . 0.0 109.22 179.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.536 ' HB2' ' HB3' ' A' ' 47' ' ' ARG . 0.3 OUTLIER -124.09 67.25 43.46 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.258 -0.901 . . . . 0.0 110.358 179.59 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -72.75 -25.93 16.55 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.91 1.479 . . . . 0.0 110.209 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -104.82 -36.44 7.39 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.334 -0.854 . . . . 0.0 110.006 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 1.3 m -60.76 164.27 4.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.425 -0.797 . . . . 0.0 110.792 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -165.04 -157.73 0.36 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.483 -0.761 . . . . 0.0 109.724 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.496 ' O ' ' HA ' ' A' ' 78' ' ' LEU . 0.8 OUTLIER -105.02 138.35 19.48 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.157 -0.964 . . . . 0.0 109.981 -179.975 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -74.67 -22.17 15.87 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.517 1.272 . . . . 0.0 110.644 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.98 -76.53 0.05 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.288 -0.883 . . . . 0.0 109.853 179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.915 HG23 ' CZ3' ' A' ' 110' ' ' TRP . 0.3 OUTLIER -109.52 31.5 5.73 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.517 -0.739 . . . . 0.0 110.518 -179.744 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.602 ' HB2' ' HB2' ' A' ' 109' ' ' ALA . 4.6 mt 40.66 31.27 0.11 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.56 -0.712 . . . . 0.0 110.906 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.463 ' HA ' ' OD1' ' A' ' 108' ' ' ASP . 93.9 m -57.84 87.68 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.379 -0.826 . . . . 0.0 109.538 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.655 ' CG ' HG11 ' A' ' 106' ' ' VAL . 0.0 OUTLIER -71.23 161.43 78.33 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.357 -0.839 . . . . 0.0 110.558 -179.086 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.15 -24.46 23.47 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 124.007 1.53 . . . . 0.0 110.251 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.797 HG11 ' HG ' ' A' ' 104' ' ' LEU . 25.1 t -58.86 -27.62 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.429 -0.794 . . . . 0.0 109.856 -179.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 47.8 m80 -65.67 -42.74 90.97 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 121.885 0.85 . . . . 0.0 109.35 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.658 ' HB3' ' HE2' ' A' ' 54' ' ' MET . 0.9 OUTLIER -54.1 -57.41 11.21 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.732 -179.604 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.727 ' HB1' ' CD1' ' A' ' 94' ' ' LEU . . . -48.18 -63.62 1.02 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.449 -0.782 . . . . 0.0 109.867 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.813 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -56.41 -50.32 71.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.337 -0.852 . . . . 0.0 110.571 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.567 ' HD3' HD12 ' A' ' 117' ' ' LEU . 0.1 OUTLIER -48.71 -34.01 11.22 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.402 -0.811 . . . . 0.0 110.992 -179.349 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.451 ' HB2' ' HB3' ' A' ' 54' ' ' MET . 12.8 tp10 -93.51 -7.83 43.16 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.201 -0.937 . . . . 0.0 110.618 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.524 ' HA2' ' CG ' ' A' ' 123' ' ' HIS . . . 80.17 16.89 75.52 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.514 ' O ' ' CD1' ' A' ' 94' ' ' LEU . 0.3 OUTLIER -87.22 156.25 19.74 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.046 -1.267 . . . . 0.0 110.351 -179.875 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.588 HD22 HG22 ' A' ' 126' ' ' VAL . 0.0 OUTLIER -122.9 -53.62 1.85 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.66 -0.65 . . . . 0.0 109.644 179.639 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.853 ' O ' HG23 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -44.14 -41.36 5.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.623 -0.673 . . . . 0.0 109.689 179.835 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.406 ' O ' ' HB ' ' A' ' 96' ' ' VAL . 18.5 m -58.41 -49.68 76.39 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.635 -0.666 . . . . 0.0 109.792 178.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.727 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 0.6 OUTLIER -55.17 -54.12 47.36 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.165 -0.959 . . . . 0.0 109.585 179.727 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 93.2 t -50.24 -47.69 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.629 -0.669 . . . . 0.0 109.256 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.876 ' CG1' HD22 ' A' ' 64' ' ' LEU . 58.4 t -52.81 -50.82 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.429 HD23 ' HB1' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -54.03 -68.92 0.14 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.502 -0.749 . . . . 0.0 110.293 179.399 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -52.65 -32.17 40.71 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.16 -0.962 . . . . 0.0 109.636 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 25.3 ttm-85 -68.38 -12.66 61.46 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.521 -0.737 . . . . 0.0 110.048 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 1.054 ' HB3' HD11 ' A' ' 64' ' ' LEU . . . -137.19 60.94 1.63 Allowed 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.234 -0.916 . . . . 0.0 110.738 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 53.94 102.66 0.01 OUTLIER Glycine 0 N--CA 1.494 2.522 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.429 ' HB1' HD23 ' A' ' 97' ' ' LEU . . . -160.25 114.17 2.18 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.133 -1.216 . . . . 0.0 110.544 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 12.8 tpp180 -68.35 159.39 31.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.632 -0.667 . . . . 0.0 110.088 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.918 HD23 ' HB2' ' A' ' 134' ' ' ALA . 0.0 OUTLIER -145.52 10.47 1.25 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.36 -0.837 . . . . 0.0 110.976 -179.577 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -111.57 46.46 1.11 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.048 -1.033 . . . . 0.0 110.268 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.655 HG11 ' CG ' ' A' ' 80' ' ' ARG . 2.5 p -105.7 167.25 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.488 -0.758 . . . . 0.0 109.307 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.546 ' HG3' HD12 ' A' ' 113' ' ' LEU . 6.6 ttt85 -136.37 51.7 2.0 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.389 -0.82 . . . . 0.0 110.29 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.521 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.2 OUTLIER 41.34 35.93 0.47 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.631 -0.668 . . . . 0.0 110.39 179.837 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.602 ' HB2' ' HB2' ' A' ' 78' ' ' LEU . . . 64.2 -66.07 0.12 Allowed 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.59 -0.694 . . . . 0.0 109.82 -179.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 0.915 ' CZ3' HG23 ' A' ' 77' ' ' THR . 0.8 OUTLIER -154.85 40.75 0.44 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.398 -0.814 . . . . 0.0 109.874 179.295 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -119.96 -64.06 0.27 Allowed Glycine 0 N--CA 1.481 1.688 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.78 -156.52 0.36 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.32 -1.106 . . . . 0.0 110.397 -179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.546 HD12 ' HG3' ' A' ' 107' ' ' ARG . 0.1 OUTLIER -133.3 159.69 71.58 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.347 -0.845 . . . . 0.0 109.883 -179.965 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.527 ' HD2' HD23 ' A' ' 113' ' ' LEU . 37.9 Cg_endo -63.81 -57.14 0.38 Allowed 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.373 1.196 . . . . 0.0 110.941 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.586 ' HA ' HD21 ' A' ' 130' ' ' LEU . 2.4 p -51.72 -31.12 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 120.905 -1.122 . . . . 0.0 110.33 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -66.2 -28.31 68.66 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.295 -0.878 . . . . 0.0 110.35 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.567 HD12 ' HD3' ' A' ' 87' ' ' ARG . 2.2 mm? -67.92 -38.57 83.06 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.126 -0.984 . . . . 0.0 110.116 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.689 ' CB ' ' HB2' ' A' ' 127' ' ' ALA . . . -68.48 -50.88 49.09 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.411 -0.806 . . . . 0.0 110.111 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -61.0 -45.54 94.43 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.269 -0.895 . . . . 0.0 110.319 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -54.27 -52.78 60.34 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.314 -0.866 . . . . 0.0 109.719 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.67 -86.43 0.06 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.362 -0.836 . . . . 0.0 110.216 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 174.06 31.34 0.03 OUTLIER Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.524 ' CG ' ' HA2' ' A' ' 89' ' ' GLY . 45.8 m-70 -95.05 46.73 1.13 Allowed 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.417 -1.049 . . . . 0.0 108.685 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.4 ' O ' ' HB2' ' A' ' 128' ' ' ARG . 0.4 OUTLIER -47.14 -33.33 5.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.784 -0.573 . . . . 0.0 109.832 -179.456 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -62.55 -40.99 98.59 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.813 HG11 ' HA ' ' A' ' 86' ' ' ALA . 3.4 t -75.82 -46.2 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.447 -0.783 . . . . 0.0 109.308 178.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.689 ' HB2' ' CB ' ' A' ' 118' ' ' ALA . . . -53.2 -53.42 50.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.302 -0.874 . . . . 0.0 109.408 179.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 124' ' ' ARG . 0.6 OUTLIER -49.8 -53.2 26.74 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.167 -0.958 . . . . 0.0 110.493 179.335 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -71.57 -56.37 6.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.372 -0.83 . . . . 0.0 110.746 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.626 HD22 ' HB2' ' A' ' 86' ' ' ALA . 0.3 OUTLIER -60.25 -30.58 69.52 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.366 -0.834 . . . . 0.0 111.025 -179.033 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.558 ' CB ' ' O ' ' A' ' 127' ' ' ALA . 4.3 ttp-105 -73.07 -27.54 61.79 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.028 -1.045 . . . . 0.0 110.432 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -68.95 -42.0 77.26 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.212 -0.93 . . . . 0.0 109.23 179.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.621 ' HB3' HD22 ' A' ' 104' ' ' LEU . . . -87.94 -10.17 51.35 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.638 -0.664 . . . . 0.0 110.336 179.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.918 ' HB2' HD23 ' A' ' 104' ' ' LEU . . . -104.12 -10.05 18.27 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.232 -0.918 . . . . 0.0 110.59 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -49.25 155.5 1.87 Allowed Glycine 0 N--CA 1.494 2.547 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -139.08 22.22 2.94 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -61.77 173.56 0.99 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.294 -1.121 . . . . 0.0 110.006 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.78 61.36 1.25 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.32 -0.863 . . . . 0.0 110.475 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.4 ' O ' ' C ' ' A' ' 140' ' ' SER . . . -153.71 36.92 0.73 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.4 ' C ' ' O ' ' A' ' 139' ' ' GLY . 0.1 OUTLIER 43.07 -150.13 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.553 -0.969 . . . . 0.0 110.11 -179.974 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -101.77 39.22 1.49 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.12 -0.988 . . . . 0.0 109.73 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -115.56 21.42 13.99 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.291 -0.88 . . . . 0.0 110.613 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -172.93 -143.07 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.398 -0.814 . . . . 0.0 109.876 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . . . . . . . . . 43.9 ttp180 53.51 81.35 0.09 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.952 -1.093 . . . . 0.0 110.65 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 25.8 mt 56.19 97.31 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.422 -0.798 . . . . 0.0 110.615 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 177.73 65.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.309 -0.869 . . . . 0.0 109.958 179.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -60.76 156.44 17.01 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.162 -0.961 . . . . 0.0 110.267 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -52.78 150.39 5.34 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.349 -0.844 . . . . 0.0 110.379 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -91.19 110.85 22.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.491 -0.756 . . . . 0.0 110.157 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -137.66 -94.88 0.36 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.189 -1.565 . . . . 0.0 109.189 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.47 -162.69 0.13 Allowed 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.897 1.472 . . . . 0.0 110.31 179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 1.1 p 60.82 -170.44 0.15 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.291 -0.881 . . . . 0.0 110.119 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -58.19 150.17 22.17 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.435 -0.791 . . . . 0.0 110.048 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.529 ' O ' HG23 ' A' ' 154' ' ' ILE . 13.6 tt -148.09 74.16 11.0 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.345 -0.847 . . . . 0.0 110.503 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -77.65 156.77 31.87 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.83 1.437 . . . . 0.0 110.716 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 9.1 t0 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.125 -0.94 . . . . 0.0 110.05 179.618 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.471 ' CG ' ' H ' ' A' ' 2' ' ' GLU . 8.2 ttt . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 120.95 0.405 . . . . 17.06 110.719 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.495 ' HG3' ' O ' ' A' ' 5' ' ' ALA . 8.3 tp10 -108.55 71.25 0.4 Allowed Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 120.97 -1.081 . . . . 13.73 112.453 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.413 ' HD3' ' C ' ' A' ' 1' ' ' MET . 42.3 Cg_endo -75.05 178.83 6.76 Favored 'Trans proline' 0 C--N 1.313 -1.323 0 N-CA-C 107.622 -1.722 . . . . 12.37 107.622 176.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 50.01 27.27 2.38 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.765 -1.21 . . . . 11.36 109.359 -179.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.542 ' HB1' ' HB3' ' A' ' 8' ' ' SER . . . 53.39 -93.56 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 115.161 1.541 . . . . 10.61 115.161 177.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 82.38 -36.72 2.59 Favored Glycine 0 N--CA 1.506 3.344 0 N-CA-C 105.331 -3.108 . . . . 9.42 105.331 -174.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.531 ' H ' ' C ' ' A' ' 5' ' ' ALA . 0.1 OUTLIER -97.27 23.41 7.5 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 106.292 -1.744 . . . . 8.35 106.292 175.229 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.542 ' HB3' ' HB1' ' A' ' 5' ' ' ALA . 3.3 p -84.12 20.9 1.46 Allowed 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.245 0.545 . . . . 7.39 110.186 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.586 ' N ' ' SD ' ' A' ' 9' ' ' MET . 0.0 OUTLIER -67.24 7.97 0.36 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.063 -1.023 . . . . 9.32 110.193 178.521 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.672 ' C ' ' H ' ' A' ' 12' ' ' SER . 1.4 mm-40 27.22 98.75 0.03 OUTLIER Pre-proline 0 N--CA 1.492 1.667 0 C-N-CA 122.549 0.34 . . . . 6.56 111.815 -178.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.576 ' O ' ' O ' ' A' ' 12' ' ' SER . 51.9 Cg_endo -77.64 14.92 1.34 Allowed 'Trans proline' 0 C--N 1.304 -1.787 0 N-CA-C 105.432 -2.565 . . . . 5.1 105.432 175.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.672 ' H ' ' C ' ' A' ' 10' ' ' GLU . 13.6 p 18.1 120.87 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 114.175 -1.375 . . . . 4.21 113.502 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 1.061 ' HB1' HD21 ' A' ' 16' ' ' LEU . . . -45.3 -23.51 0.2 Allowed 'General case' 0 C--O 1.204 -1.342 0 N-CA-C 107.407 -1.331 . . . . 2.96 107.407 176.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.621 ' O ' ' N ' ' A' ' 17' ' ' ALA . 2.8 m-20 -26.61 -43.32 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 CA-C-N 115.699 -0.682 . . . . 2.92 110.021 177.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.507 ' N ' ' O ' ' A' ' 13' ' ' ALA . 4.4 m0 -41.61 -36.87 1.02 Allowed 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.854 -0.738 . . . . 4.18 109.036 178.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 1.074 HD13 HD21 ' A' ' 63' ' ' LEU . 3.4 pp -74.99 -33.16 61.82 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.376 -0.972 . . . . 2.77 108.376 177.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.621 ' N ' ' O ' ' A' ' 14' ' ' ASP . . . -80.45 -54.24 5.86 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 108.942 -0.762 . . . . 1.94 108.942 177.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.547 ' N ' ' O ' ' A' ' 14' ' ' ASP . 0.5 OUTLIER -54.3 -48.87 70.81 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.267 -0.896 . . . . 2.64 108.753 178.457 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.472 ' CB ' ' O ' ' A' ' 15' ' ' TRP . . . -63.87 -35.01 79.23 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.574 -0.899 . . . . 2.45 108.574 178.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.678 ' HB1' HG11 ' A' ' 59' ' ' VAL . . . -66.87 -43.61 83.08 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.664 -0.865 . . . . 1.89 108.664 178.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.436 ' N ' ' HA ' ' A' ' 52' ' ' MET . . . -61.58 -26.8 68.2 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.558 -0.713 . . . . 2.07 109.348 179.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -95.91 20.32 10.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.647 -0.658 . . . . 4.97 110.087 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 55.81 34.18 60.88 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.38 -1.088 . . . . 2.84 110.38 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.619 ' O ' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -99.53 74.44 1.89 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.283 -1.127 . . . . 4.37 109.984 179.646 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.756 HG22 ' CG2' ' A' ' 59' ' ' VAL . 62.0 t -57.85 -46.14 87.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.374 -0.829 . . . . 2.98 110.353 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -54.93 -51.45 66.05 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.387 -0.82 . . . . 4.64 110.4 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.16 -46.04 68.73 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.23 -0.919 . . . . 3.3 109.963 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.886 HG12 HD12 ' A' ' 32' ' ' LEU . 5.7 t -69.66 -42.19 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.398 -0.814 . . . . 3.02 109.622 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.994 ' HA ' HD11 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -48.5 -48.11 38.3 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.55 -0.719 . . . . 4.19 110.093 179.676 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.5 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -78.73 -35.23 45.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.505 -0.747 . . . . 4.02 110.057 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.505 HD13 ' HB3' ' A' ' 15' ' ' TRP . 25.8 mt -64.26 -65.69 0.64 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.369 -0.832 . . . . 3.44 110.03 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.911 ' HA ' ' HB3' ' A' ' 36' ' ' ALA . 3.8 mt -48.33 -42.51 31.44 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.43 -0.794 . . . . 3.6 110.544 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -75.23 -17.27 60.37 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.255 -0.903 . . . . 4.87 110.24 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' A' ' 30' ' ' ALA . . . -86.36 -7.45 58.46 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -0.924 . . . . 4.13 110.896 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.29 26.91 1.92 Allowed Glycine 0 N--CA 1.492 2.383 0 C-N-CA 119.888 -1.148 . . . . 3.84 110.466 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 1.029 ' HB1' HD23 ' A' ' 16' ' ' LEU . . . -79.14 126.79 31.19 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.176 -1.191 . . . . 3.33 110.341 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.583 ' HB2' ' HB2' ' A' ' 13' ' ' ALA . 0.4 OUTLIER -53.44 123.83 37.95 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.375 -0.828 . . . . 3.61 110.337 179.938 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.427 ' HD2' HD13 ' A' ' 37' ' ' LEU . 43.2 Cg_endo -72.56 -23.87 19.44 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 O-C-N 123.539 1.284 . . . . 3.28 108.966 178.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.403 ' ND2' ' O ' ' A' ' 67' ' ' GLY . 0.6 OUTLIER -112.7 51.77 0.81 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.63 -0.669 . . . . 3.8 109.246 178.829 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.734 ' CB ' ' HB3' ' A' ' 13' ' ' ALA . . . -92.88 116.4 66.44 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.413 -0.804 . . . . 2.68 110.46 -179.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -75.32 121.12 6.27 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.696 1.366 . . . . 3.15 110.487 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -78.75 175.41 10.48 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.296 -0.877 . . . . 3.3 110.351 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.7 m -83.48 -6.53 59.48 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.317 -0.865 . . . . 3.78 110.502 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -84.46 12.05 7.56 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.153 -0.967 . . . . 3.84 110.375 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 65.22 16.22 62.07 Favored Glycine 0 N--CA 1.484 1.889 0 N-CA-C 109.064 -1.615 . . . . 2.97 109.064 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 61.3 mtt180 -113.52 -167.51 1.21 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.47 -1.018 . . . . 3.32 110.179 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.709 ' HB3' ' HD2' ' A' ' 48' ' ' PRO . 0.8 OUTLIER -108.96 -174.37 0.3 Allowed Pre-proline 0 N--CA 1.492 1.631 0 N-CA-C 108.848 -0.797 . . . . 3.66 108.848 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.709 ' HD2' ' HB3' ' A' ' 47' ' ' ARG . 43.3 Cg_endo -74.25 -19.59 19.66 Favored 'Trans proline' 0 C--N 1.314 -1.249 0 O-C-N 123.001 1.0 . . . . 2.19 111.4 -178.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.412 ' O ' ' HG2' ' A' ' 52' ' ' MET . 14.1 mt -108.73 -36.56 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 120.99 -1.069 . . . . 1.71 108.909 178.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.417 ' HG3' ' CA ' ' A' ' 81' ' ' PRO . 0.4 OUTLIER -56.55 -17.6 8.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.479 -0.763 . . . . 2.69 110.062 179.246 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.8 p -107.81 -5.16 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.31 -0.869 . . . . 1.77 111.277 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.828 ' HE1' ' HB2' ' A' ' 60' ' ' ALA . 0.0 OUTLIER -62.33 164.86 6.6 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.73 -1.231 . . . . 2.02 109.728 -179.902 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' MET . . . . . . . . . . . . . 5.0 tmm? -57.13 -10.32 1.17 Allowed 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.256 -0.902 . . . . 2.68 111.478 -178.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.693 ' HE2' ' HB3' ' A' ' 84' ' ' ASP . 0.0 OUTLIER 57.67 16.97 3.74 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.08 -1.012 . . . . 1.71 109.95 -179.432 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.462 ' HA2' ' CE2' ' A' ' 90' ' ' PHE . . . -121.26 10.63 9.96 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 108.944 -1.662 . . . . 2.31 108.944 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.39 86.97 1.49 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.453 -1.028 . . . . 2.49 109.197 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -51.95 -24.72 6.84 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.466 -0.771 . . . . 2.01 110.6 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.42 ' HB3' HG11 ' A' ' 25' ' ' VAL . 0.8 OUTLIER -53.62 -38.59 64.18 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.233 -0.917 . . . . 4.52 109.347 179.56 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.756 ' CG2' HG22 ' A' ' 25' ' ' VAL . 27.1 t -64.78 -49.01 82.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 108.043 -1.095 . . . . 2.06 108.043 178.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.828 ' HB2' ' HE1' ' A' ' 52' ' ' MET . . . -55.77 -43.04 76.38 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.888 -0.782 . . . . 2.1 108.888 178.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -58.65 -64.04 1.07 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.323 -0.86 . . . . 3.67 108.785 178.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.994 HD11 ' HA ' ' A' ' 29' ' ' ARG . 0.0 OUTLIER -41.9 -59.36 1.73 Allowed 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.769 0.795 . . . . 3.13 109.811 177.936 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.074 HD21 HD13 ' A' ' 16' ' ' LEU . 10.4 mt -59.75 -56.01 27.19 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.271 0.558 . . . . 2.64 110.84 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.831 HD21 ' CB ' ' A' ' 100' ' ' ALA . 1.2 tt -56.53 -56.63 18.86 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.426 -0.796 . . . . 3.02 110.918 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.653 ' O ' HD12 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -55.99 -29.89 60.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.141 -0.974 . . . . 3.74 109.935 -179.377 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . 0.615 ' HB2' ' O ' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -82.39 -25.14 34.02 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.423 -0.798 . . . . 4.0 109.395 179.606 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.403 ' O ' ' ND2' ' A' ' 39' ' ' ASN . . . 124.08 42.18 0.37 Allowed Glycine 0 N--CA 1.479 1.518 0 N-CA-C 110.507 -1.037 . . . . 3.14 110.507 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.681 ' HB2' ' HB3' ' A' ' 63' ' ' LEU . . . -66.41 -161.79 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.855 -1.38 . . . . 2.73 109.474 179.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.591 ' HB2' ' HB3' ' A' ' 47' ' ' ARG . 1.7 mp0 -115.88 62.13 2.02 Favored Pre-proline 0 C--N 1.302 -1.487 0 O-C-N 121.362 -0.836 . . . . 3.37 110.324 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.606 ' HA ' ' HG3' ' A' ' 81' ' ' PRO . 43.1 Cg_endo -68.89 -11.71 32.55 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 O-C-N 123.608 1.32 . . . . 2.64 109.455 178.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.51 ' OD1' ' HB2' ' A' ' 103' ' ' ARG . 1.4 t-20 -106.05 -42.05 5.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.532 -0.73 . . . . 4.06 110.223 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.419 ' HB3' ' HD2' ' A' ' 47' ' ' ARG . 0.3 OUTLIER -69.73 143.84 52.95 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.153 -0.967 . . . . 3.77 110.734 -179.275 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.573 ' HB2' ' HG2' ' A' ' 80' ' ' ARG . . . -132.98 -146.43 0.27 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.426 -0.796 . . . . 3.45 110.103 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 78' ' ' LEU . 1.0 OUTLIER -109.3 138.27 20.45 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.117 -0.989 . . . . 3.88 110.109 -179.939 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -77.35 -6.04 16.1 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.467 1.246 . . . . 4.82 110.551 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -99.12 -35.7 9.93 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.163 -0.961 . . . . 4.58 110.116 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 1.0 HG22 ' CZ3' ' A' ' 110' ' ' TRP . 1.2 p -132.21 7.51 4.27 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.323 -0.861 . . . . 4.37 110.696 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.46 ' HA ' HD23 ' A' ' 78' ' ' LEU . 6.0 mt 45.59 31.66 0.99 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.319 -0.863 . . . . 4.3 110.63 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.9 m -69.12 76.9 0.35 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.413 -0.804 . . . . 3.38 110.472 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . 0.587 ' HB2' HG11 ' A' ' 106' ' ' VAL . 3.8 mtt85 -57.61 161.27 6.32 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.091 -1.005 . . . . 3.91 109.273 179.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.606 ' HG3' ' HA ' ' A' ' 70' ' ' PRO . 39.4 Cg_endo -67.81 -6.84 17.88 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.555 1.292 . . . . 2.39 110.954 -179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.557 HG21 ' HA ' ' A' ' 104' ' ' LEU . 19.4 t -71.03 -35.51 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.216 -0.927 . . . . 2.38 109.674 179.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 31.8 m80 -67.48 -44.89 77.46 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.381 -0.825 . . . . 3.04 109.195 179.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.693 ' HB3' ' HE2' ' A' ' 54' ' ' MET . 0.3 OUTLIER -49.53 -51.76 34.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.886 -0.509 . . . . 2.28 110.902 -179.792 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.523 ' HB3' ' CD1' ' A' ' 94' ' ' LEU . . . -58.1 -58.36 8.78 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.102 -0.999 . . . . 1.5 109.682 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.84 ' HA ' HG11 ' A' ' 126' ' ' VAL . . . -59.79 -40.44 88.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.417 -0.802 . . . . 1.91 110.348 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.9 -34.73 21.21 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.31 -0.869 . . . . 3.67 110.332 179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.41 1.85 38.81 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.39 -0.819 . . . . 2.79 110.642 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.499 ' HA2' ' HB3' ' A' ' 123' ' ' HIS . . . 73.62 38.14 51.47 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.521 -1.431 . . . . 2.01 109.521 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.462 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 0.3 OUTLIER -110.8 105.17 13.92 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.311 -1.111 . . . . 2.43 111.101 -179.265 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.624 HD21 ' CB ' ' A' ' 129' ' ' TYR . 0.5 OUTLIER -78.64 -36.85 43.38 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.25 -0.906 . . . . 2.6 109.356 178.872 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.715 ' O ' HG23 ' A' ' 96' ' ' VAL . 19.4 m-20 -48.17 -43.38 31.56 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.592 -0.692 . . . . 2.72 109.747 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 54.6 m -65.82 -43.92 87.17 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.722 -0.844 . . . . 1.77 108.722 178.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.867 HD21 ' CD2' ' A' ' 130' ' ' LEU . 1.1 tp -57.48 -49.09 77.43 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.435 -0.791 . . . . 2.24 109.006 178.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.507 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 85.7 t -54.94 -54.56 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 108.87 -0.789 . . . . 2.83 108.87 178.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.715 HG23 ' O ' ' A' ' 92' ' ' ASP . 89.1 t -49.37 -50.79 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.739 -0.601 . . . . 2.71 109.861 178.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.487 ' HA ' ' CD1' ' A' ' 64' ' ' LEU . 0.4 OUTLIER -52.45 -64.39 0.83 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.42 -0.8 . . . . 2.9 109.833 179.373 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -57.67 -22.99 49.15 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.34 -0.85 . . . . 3.77 110.683 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.507 ' HB2' ' O ' ' A' ' 95' ' ' VAL . 4.3 ttt180 -73.47 -17.05 61.28 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.222 -0.924 . . . . 4.95 110.893 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.831 ' CB ' HD21 ' A' ' 64' ' ' LEU . . . -141.11 67.99 1.34 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.052 -1.03 . . . . 3.94 111.245 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 48.55 94.98 0.01 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 110.899 -0.88 . . . . 3.62 110.899 179.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.463 ' O ' HD12 ' A' ' 104' ' ' LEU . . . -150.25 101.54 3.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.396 -1.061 . . . . 3.21 109.021 179.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.51 ' HB2' ' OD1' ' A' ' 71' ' ' ASN . 3.0 tpt180 -54.23 120.95 7.21 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.314 -0.866 . . . . 4.85 111.002 -178.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.617 HD23 ' HB2' ' A' ' 134' ' ' ALA . 0.2 OUTLIER -107.5 -7.12 16.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.721 -0.612 . . . . 3.3 109.911 179.45 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -98.32 48.19 0.99 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.101 -1.0 . . . . 4.05 112.525 -178.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.591 HG22 ' H ' ' A' ' 107' ' ' ARG . 1.4 p -113.02 -175.18 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.684 -1.26 . . . . 3.77 109.869 178.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.591 ' H ' HG22 ' A' ' 106' ' ' VAL . 4.2 ptt180 -138.98 158.52 44.05 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.512 -0.742 . . . . 5.47 109.211 178.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . 0.565 ' O ' ' HB3' ' A' ' 109' ' ' ALA . 0.4 OUTLIER -79.31 48.15 0.86 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.065 -1.022 . . . . 4.46 111.459 -178.74 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' A' ' 108' ' ' ASP . . . 63.49 -63.2 0.13 Allowed 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.462 -0.774 . . . . 4.92 112.205 178.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' TRP . . . . . 1.0 ' CZ3' HG22 ' A' ' 77' ' ' THR . 2.5 m-90 -54.14 -65.88 0.49 Allowed 'General case' 0 C--N 1.298 -1.65 0 C-N-CA 120.094 -0.643 . . . . 5.58 111.652 -176.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.1 38.65 0.02 OUTLIER Glycine 0 N--CA 1.483 1.776 0 C-N-CA 119.358 -1.401 . . . . 4.93 110.917 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -140.55 138.97 34.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.997 -1.296 . . . . 5.54 110.612 179.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.574 ' HB3' HG12 ' A' ' 115' ' ' VAL . 0.2 OUTLIER -90.33 170.53 10.02 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.465 -0.772 . . . . 4.08 110.884 -179.515 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -68.0 -26.4 37.38 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.853 1.449 . . . . 3.1 108.643 177.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.574 HG12 ' HB3' ' A' ' 113' ' ' LEU . 7.2 p -76.29 -35.43 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 108.634 -0.876 . . . . 3.3 108.634 178.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.37 -26.41 66.45 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.701 -0.799 . . . . 4.01 109.767 179.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.54 -33.79 54.08 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.43 -0.794 . . . . 3.43 110.358 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.699 ' HB2' ' HB1' ' A' ' 86' ' ' ALA . . . -74.08 -37.99 64.04 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.301 -0.875 . . . . 2.83 110.566 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.442 ' HG3' ' HB1' ' A' ' 127' ' ' ALA . 3.6 mt-10 -70.2 -32.3 70.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.331 -0.856 . . . . 3.91 110.561 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -70.91 -57.23 4.8 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.114 -0.991 . . . . 4.27 109.777 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.93 -81.07 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.304 -0.872 . . . . 3.4 109.993 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 169.26 40.59 0.03 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.929 -1.669 . . . . 3.23 108.929 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.565 ' CD2' ' O ' ' A' ' 86' ' ' ALA . 48.0 m-70 -107.94 53.12 0.7 Allowed 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.482 -1.011 . . . . 2.7 109.511 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.434 ' O ' ' HB2' ' A' ' 128' ' ' ARG . 20.9 mtt180 -47.5 -52.41 17.41 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.766 -0.584 . . . . 4.13 109.957 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.426 ' O ' HD11 ' A' ' 91' ' ' LEU . 1.0 OUTLIER -48.68 -40.51 28.37 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.486 -0.759 . . . . 2.92 109.915 179.435 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.84 HG11 ' HA ' ' A' ' 86' ' ' ALA . 2.2 t -81.37 -47.24 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.36 -0.837 . . . . 2.25 109.501 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.508 ' HB2' ' CB ' ' A' ' 118' ' ' ALA . . . -56.12 -41.84 75.92 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.211 -0.931 . . . . 2.77 109.89 179.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 124' ' ' ARG . 0.0 OUTLIER -59.96 -56.65 19.09 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.275 -0.89 . . . . 4.43 109.353 179.327 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.631 ' HD2' HD23 ' A' ' 94' ' ' LEU . 60.0 t80 -60.59 -33.0 72.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.374 -0.829 . . . . 3.06 109.012 179.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.867 ' CD2' HD21 ' A' ' 94' ' ' LEU . 28.2 mt -65.63 -52.38 52.32 Favored 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.959 -0.696 . . . . 3.09 109.315 179.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 3.1 ttt-85 -57.88 -19.16 27.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.93 -1.106 . . . . 4.86 109.341 178.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.568 ' O ' ' NH2' ' A' ' 138' ' ' ARG . . . -85.67 -51.33 6.53 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.59 -0.893 . . . . 3.81 108.59 178.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.431 ' HB3' HD22 ' A' ' 104' ' ' LEU . . . -92.5 -52.11 4.81 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.099 -1.001 . . . . 3.53 109.963 178.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.631 ' N ' ' O ' ' A' ' 130' ' ' LEU . . . -88.34 8.03 29.55 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.677 -0.639 . . . . 3.93 112.282 -179.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 130' ' ' LEU . . . -64.62 127.08 33.62 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 108.094 -2.002 . . . . 4.52 108.094 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.684 ' O ' HG23 ' A' ' 137' ' ' THR . . . -83.34 43.92 3.21 Favored Glycine 0 N--CA 1.495 2.589 0 O-C-N 121.011 -1.288 . . . . 6.23 111.173 -178.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . 0.684 HG23 ' O ' ' A' ' 136' ' ' GLY . 0.2 OUTLIER -164.0 -61.5 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.955 -1.321 . . . . 5.97 110.743 179.089 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.649 ' O ' ' O ' ' A' ' 139' ' ' GLY . 0.0 OUTLIER 73.86 -58.2 0.6 Allowed 'General case' 0 N--CA 1.508 2.442 0 O-C-N 120.869 -1.144 . . . . 12.31 112.105 178.669 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.774 ' O ' ' HB3' ' A' ' 140' ' ' SER . . . -47.43 -117.03 0.0 OUTLIER Glycine 1 N--CA 1.522 4.391 0 O-C-N 120.402 -1.436 . . . . 8.65 110.59 179.489 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . 0.774 ' HB3' ' O ' ' A' ' 139' ' ' GLY . 54.0 p 125.96 46.48 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.376 0 N-CA-C 114.033 1.123 . . . . 9.9 114.033 177.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -113.35 -89.87 0.52 Allowed 'General case' 0 N--CA 1.507 2.395 0 N-CA-C 106.852 -1.536 . . . . 9.88 106.852 176.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' HIS . . . . . 0.482 ' O ' ' HB2' ' A' ' 143' ' ' ALA 0.277 4.7 t-160 -88.98 -7.35 56.17 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 103.652 -2.722 . . . . 9.73 103.652 173.511 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.482 ' HB2' ' O ' ' A' ' 142' ' ' HIS . . . 157.09 -151.5 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 102.185 -3.265 . . . . 6.4 102.185 -178.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ARG . . . . . 0.638 ' HD2' ' O ' ' A' ' 137' ' ' THR . 14.0 ttt85 -79.77 59.45 3.1 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 103.943 -2.614 . . . . 6.18 103.943 174.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.526 HG22 ' O ' ' A' ' 144' ' ' ARG . 1.4 tp 46.07 47.15 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.162 0 N-CA-C 105.758 -1.941 . . . . 7.91 105.758 -172.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.574 ' O ' ' HB3' ' A' ' 147' ' ' ALA . 9.9 m-20 53.43 45.12 28.96 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.473 -1.24 . . . . 8.23 107.72 -177.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.574 ' HB3' ' O ' ' A' ' 146' ' ' ASP . . . 65.93 165.49 0.19 Allowed 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 106.838 -1.541 . . . . 8.52 106.838 -177.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . . . . . . . . . . . -67.26 78.79 0.15 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.465 -1.397 . . . . 9.9 108.728 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.524 ' HB3' ' CB ' ' A' ' 153' ' ' ASP . 95.7 mt-10 -138.06 -31.59 0.76 Allowed 'General case' 0 C--N 1.291 -1.962 0 O-C-N 121.479 -0.763 . . . . 12.51 110.735 -177.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . 106.98 -111.79 3.6 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 107.063 -2.415 . . . . 13.41 107.063 -177.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.869 ' O ' ' OG ' ' A' ' 152' ' ' SER . 37.9 Cg_endo -67.95 -26.61 37.47 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.101 1.053 . . . . 15.4 110.397 178.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . 0.869 ' OG ' ' O ' ' A' ' 151' ' ' PRO . 0.0 OUTLIER 151.9 1.93 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.185 0 O-C-N 121.808 -0.557 . . . . 16.09 111.04 179.177 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.524 ' CB ' ' HB3' ' A' ' 149' ' ' GLU . 0.7 OUTLIER 49.86 36.17 10.82 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.583 -1.265 . . . . 17.47 107.583 -176.331 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ILE . . . . . 0.744 HG23 ' HB2' ' A' ' 152' ' ' SER . 0.2 OUTLIER -65.19 159.98 61.23 Favored Pre-proline 0 N--CA 1.498 1.949 0 N-CA-C 109.473 -0.566 . . . . 20.05 109.473 -179.556 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -75.71 115.51 4.21 Favored 'Trans proline' 0 C--N 1.316 -1.139 0 O-C-N 123.682 1.359 . . . . 21.09 110.323 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.6 p30 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.947 -1.025 . . . . 23.42 110.019 -179.946 . . . . . . . . 0 0 . 1 stop_ save_